PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	PRONK, JC; GIBSON, RA; SAVOIA, A; WIJKER, M; MORGAN, NV; MELCHIONDA, S; FORD, D; TEMTAMY, S; ORTEGA, JJ; JANSEN, S; HAVENGA, C; COHN, RJ; DERAVEL, TJ; ROBERTS, I; WESTERVELD, A; EASTON, DF; JOENJE, H; MATHEW, CG; ARWERT, F				PRONK, JC; GIBSON, RA; SAVOIA, A; WIJKER, M; MORGAN, NV; MELCHIONDA, S; FORD, D; TEMTAMY, S; ORTEGA, JJ; JANSEN, S; HAVENGA, C; COHN, RJ; DERAVEL, TJ; ROBERTS, I; WESTERVELD, A; EASTON, DF; JOENJE, H; MATHEW, CG; ARWERT, F			LOCALIZATION OF THE FANCONI-ANEMIA COMPLEMENTATION GROUP-A GENE TO CHROMOSOME 16Q24.3	NATURE GENETICS			English	Letter							ANEMIA	Fanconi anaemia (FA) is an autosomal recessive disorder associated with diverse developmental abnormalities, bone-marrow failure and predisposition to cancer(1). FA cells show increased chromosome breakage and hypersensitivity to DNA cross-linking agents such as diepoxybutane and mitomycin C. Somatic-cell hybridisation analysis of FA cell lines has demonstrated the existence of at least five complementation groups (FA-A to FA-E)(2,3), the most common of which is FA-A(4). This genetic heterogeneity has been a major obstacle to the positional cloning of FA genes by classical linkage analysis. The FAC gene was cloned by functional complementation(5), and localised to chromosome 9q22.3 (ref. 2), but this approach has thus far failed to yield the genes for the other complementation groups. We have established a panel of families classified as FA-A by complementation analysis, and used them to search for the FAA gene by linkage analysis. We excluded the previous assignment by linkage(6) of an FA gene to chromosome 20q, and obtained conclusive evidence for linkage of FAA to microsatellite markers on chromosome 16q24.3. Strong evidence of allelic association with the disease was detected with the marker D16S303 in the Afrikaner population of South Africa, indicating the presence of a founder effect.	UNITED MED & DENT SCH,GUYS HOSP,DIV MED & MOLEC GENET,LONDON SE1 9RT,ENGLAND; IRCCS,OSPED CASA SOLLIEVO SOFFERENZA,SERV GENET MED,SAN GIOVANNI ROTO,ITALY; INST CANC RES,EPIDEMIOL SECT,SURREY,ENGLAND; NATL RES CTR,DEPT HUMAN GENET,CAIRO,EGYPT; HOSP INFANTIL VALL HEBRON,HEMATOL & BMT UNIT,BARCELONA,SPAIN; UNIV ORANGE FREE STATE,SCH MED,DEPT HUMAN GENET,BLOEMFONTEIN,SOUTH AFRICA; UNIV ORANGE FREE STATE,SCH MED,DEPT PAEDIAT,BLOEMFONTEIN,SOUTH AFRICA; S AFRICAN INST MED RES,DEPT HUMAN GENET,WITWATERSRAND,SOUTH AFRICA; S AFRICAN INST MED RES,DEPT PAEDIAT,WITWATERSRAND,SOUTH AFRICA; UNIV WITWATERSRAND,WITWATERSRAND 2050,SOUTH AFRICA; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HAEMATOL,LONDON,ENGLAND; UNIV AMSTERDAM,ACAD MED CTR,DEPT HUMAN GENET,1105 AZ AMSTERDAM,NETHERLANDS	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; IRCCS Casa Sollievo Della Sofferenza; University of London; Institute of Cancer Research - UK; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Hospital Universitari Vall d'Hebron; University of the Free State; University of the Free State; University of Witwatersrand; Imperial College London; University of Amsterdam; Academic Medical Center Amsterdam	PRONK, JC (corresponding author), FREE UNIV AMSTERDAM,DEPT HUMAN GENET,AMSTERDAM,NETHERLANDS.		Savoia, Anna/AIC-4560-2022; Morgan, Neil V/A-5475-2009; Savoia, Anna/B-6463-2014; Mathew, Christopher G/G-3434-2015	Savoia, Anna/0000-0002-2407-2696; Morgan, Neil V/0000-0001-6433-5692; Savoia, Anna/0000-0002-2407-2696; Mathew, Christopher G/0000-0003-4178-1838; temtamy, samia/0000-0002-6452-823X; Gibson, Rachel/0000-0002-1338-1290; Cohn, Richard/0000-0002-2400-1353	Telethon [E.0033] Funding Source: Medline	Telethon(Fondazione Telethon)		AUERBACH AD, 1989, BLOOD, V73, P391; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; DOGGETT NA, 1995, CYTOGENET CELL GENET, V68, P166, DOI 10.1159/000133909; DUCKWORTHRYSIEC.G, 1985, SOMAT CELL MOLEC GEN, V11, P35; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JOENJE H, IN PRESS BLOOD; JOENJE H, 1995, ACTA HAEMATOLOGICA, V93, P250; JORDE LB, 1995, AM J HUM GENET, V56, P11; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LITT M, 1989, AM J HUM GENET, V44, P397; LIU JM, 1994, BLOOD, V84, P3995, DOI 10.1182/blood.V84.12.3995.bloodjournal84123995; MANN WR, 1991, GENOMICS, V9, P329, DOI 10.1016/0888-7543(91)90261-C; NIKALI K, 1995, AM J HUM GENET, V56, P1088; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; ROSENDORFF J, 1987, AM J MED GENET, V27, P793, DOI 10.1002/ajmg.1320270408; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V358, P434, DOI 10.1038/358434a0	18	82	85	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					338	340		10.1038/ng1195-338	http://dx.doi.org/10.1038/ng1195-338			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581462				2022-12-25	WOS:A1995TC63900027
J	STOKES, CL				STOKES, CL			THE PROS AND CONS OF DRUG TRAFFICKING	NATURE MEDICINE			English	Editorial Material							MONOCLONAL-ANTIBODIES; SPATIAL-DISTRIBUTION; SOLID TUMORS				STOKES, CL (corresponding author), UNIV HOUSTON,DEPT CHEM ENGN,HOUSTON,TX 77204, USA.							BAXTER LT, 1992, CANCER RES, V52, P5838; FUJIMORI K, 1989, CANCER RES, V49, P5656; GHETIE MA, 1994, CURR OPIN IMMUNOL, V6, P707, DOI 10.1016/0952-7915(94)90073-6; JUWEID M, 1992, CANCER RES, V52, P5144; Lauffenburger D.A., 1993, RECEPTORS MODELS BIN; MYRDAL S, 1994, SCANNING, V16, P155; RIPPLEY RK, 1995, BIOPHYS J, V69, P825, DOI 10.1016/S0006-3495(95)79956-8; SHOCKLEY TR, 1992, CANCER RES, V52, P367; SUNG C, 1993, CANCER RES, V53, P2092; VIJAYKUMAR V, IN PRESS PHARMACEUTI; WOLFF J, 1994, GENE THERAPEUTICS ME; YAZDI PT, 1994, CANCER RES, V54, P6387	12	0	0	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1135	1136		10.1038/nm1195-1135	http://dx.doi.org/10.1038/nm1195-1135			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584980				2022-12-25	WOS:A1995TC53700032
J	STRAUB, RE; MACLEAN, CJ; ONEILL, FA; BURKE, J; MURPHY, B; DUKE, F; SHINKWIN, R; WEBB, BT; ZHANG, J; WALSH, D; KENDLER, KS				STRAUB, RE; MACLEAN, CJ; ONEILL, FA; BURKE, J; MURPHY, B; DUKE, F; SHINKWIN, R; WEBB, BT; ZHANG, J; WALSH, D; KENDLER, KS			A POTENTIAL VULNERABILITY LOCUS FOR SCHIZOPHRENIA ON CHROMOSOME 6P24-22 - EVIDENCE FOR GENETIC-HETEROGENEITY	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; ROSCOMMON FAMILY; COMPLEX DISEASES; NUCLEAR FAMILIES; MENTAL-ILLNESS; LOD SCORE; DISORDERS; RELATIVES; TRAITS; MODEL	In 265 Irish pedigrees, with linkage analysis we find evidence for a vulnerability locus for schizophrenia in region 6p24-22. The greatest lod score, assuming locus heterogeneity, is 3.51 (P = 0.0002) with D6S296. Another test, the C test, also supported linkage, the strongest results being obtained with D6S296 (P = 0.00001), D6S274 (P = 0.004) and D6S285 (P = 0.006). Non-parametric analysis yielded suggestive, but substantially weaker, findings. This locus appears to influence the vulnerability to schizophrenia in roughly 15 to 30% of our pedigrees. Evidence for linkage was maximal using an intermediate phenotypic definition and declined when this definition was narrowed or was broadened to include other psychiatric disorders.	VIRGINIA COMMONWEALTH UNIV, DEPT PSYCHIAT, RICHMOND, VA 23298 USA; VIRGINIA COMMONWEALTH UNIV, HUMAN GENET MED COLL VIRGINIA, RICHMOND, VA 23298 USA; QUEENS UNIV BELFAST, DEPT PSYCHIAT, BELFAST, ANTRIM, NORTH IRELAND; HLTH RES BOARD, DUBLIN, IRELAND	Virginia Commonwealth University; Virginia Commonwealth University; Queens University Belfast; Health Research Board - Ireland			Webb, Bradley T/B-1459-2009; O'Neill, Francis A/C-5582-2008; Kendler, Kenneth/AAF-2876-2019	Webb, Bradley T/0000-0002-0576-5366; O'Neill, Francis A/0000-0002-7531-7657; 	NIMH NIH HHS [MH41953, MH45390] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045390, R01MH041953] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANTONARAKIS SE, 1995, NAT GENET, V11, P235, DOI 10.1038/ng1195-235; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1990, NATURE, V346, P618, DOI 10.1038/346618a0; CHEN WJ, 1992, GENET EPIDEMIOL, V9, P123, DOI 10.1002/gepi.1370090205; CLERGETDARPOUX F, 1990, GENET EPIDEMIOL, V7, P245, DOI 10.1002/gepi.1370070403; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CLONINGER CR, 1994, AM J MED GENET, V54, P83, DOI 10.1002/ajmg.1320540202; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EASTON DF, 1993, AM J HUM GENET, V52, P678; ELSTON RC, 1994, GENETIC APPROACHES M, P3; GOLDIN LR, 1987, PSYCHIAT RES, V20, P69, DOI 10.1016/0165-1781(87)90124-7; Gottesman I.I., 1982, SCHIZOPHRENIA EPIGEN; GURLING H, 1995, NAT GENET, V11, P234, DOI 10.1038/ng1195-234; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HODGE SE, 1992, AM J HUM GENET, V50, P1053; KENDLER KK, IN PRESS AM J MED GE; KENDLER KS, 1995, BRIT J PSYCHIAT, V167, P184, DOI 10.1192/bjp.167.2.184; KENDLER KS, 1994, AM J PSYCHIAT, V151, P27; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P781; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P527; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; KENDLER KS, 1995, AM J PSYCHIAT, V152, P755; KENDLER KS, 1989, SCHIZOPHRENIA BULL, V15, P559, DOI 10.1093/schbul/15.4.559; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P645; KENDLER KS, 1988, HDB SCHIZOPHRENIA, V3, P437; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; MACLEAN CJ, 1992, AM J HUM GENET, V50, P1259; MACLEAN CJ, 1994, AM J HUM GENET, V54, P564; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; MARTINEZ M, 1990, GENET EPIDEMIOL, V7, P219, DOI 10.1002/gepi.1370070306; MARTINEZ MM, 1989, AM J HUM GENET, V44, P552; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; MOWRY BJ, 1995, NAT GENET, V11, P233, DOI 10.1038/ng1195-233; ODONOVAN MC, 1992, ANN MED, V24, P171, DOI 10.3109/07853899209147816; OROURKE DH, 1982, AM J HUM GENET, V34, P630; OTT J, 1990, AM J HUM GENET, V46, P219; PRESCOTT CA, 1993, PSYCHIAT CLIN N AM, V16, P245; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RISCH N, 1990, AM J HUM GENET, V46, P222; RISCH N, 1991, AM J HUM GENET, V48, P1058; Risch N.J., 1994, GENETIC APPROACHES M, P47; SANDKUYL LA, 1989, PROG CLIN BIOL RES, V329, P117; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; TANZI R, 1993, GENETICA, V91, P255, DOI 10.1007/BF01436002; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WRIGHT P, 1993, AM J MED GENET, V48, P40, DOI 10.1002/ajmg.1320480110; 1987, DIAGNOSTIC STATISTIC	58	401	416	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1995	11	3					287	293		10.1038/ng1195-287	http://dx.doi.org/10.1038/ng1195-287			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581452				2022-12-25	WOS:A1995TC63900017
J	ALON, T; HEMO, I; ITIN, A; PEER, J; STONE, J; KESHET, E				ALON, T; HEMO, I; ITIN, A; PEER, J; STONE, J; KESHET, E			VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY	NATURE MEDICINE			English	Article							PERMEABILITY FACTOR; MITOGEN; RAT; ANGIOGENESIS; OXYGEN	Retinopathy of prematurity (ROP) is initiated by hyperoxia-induced obliteration of newly formed blood vessels in the retina of the premature newborn. We propose that vessel regression is a consequence of hyperoxia-induced withdrawal of a critical vascular survival factor. We show that regression of retinal capillaries in neonatal rats exposed to high oxygen, is preceded by a shut-off of vascular endothelial growth factor (VEGF) production by nearby neuroglial cells. Vessel regression occurs via selective apoptosis of endothelial cells. Intraocular injection of VEGF at the onset of experimental hyperoxia prevents apoptotic death of endothelial cells and rescues the retinal vasculature. These findings provide evidence for a specific angiogenic factor acting as a vascular survival factor in vivo. The system also provides a paradigm for vascular remodelling as an adaptive response to an increase in oxygen tension and suggests a novel approach to prevention of ROP.	HEBREW UNIV JERUSALEM, HADASSAH MED SCH, DEPT OPHTHALMOL, IL-91120 JERUSALEM, ISRAEL; UNIV SYDNEY, DEPT ANAT & HISTOL, SYDNEY, NSW 2006, AUSTRALIA	Hebrew University of Jerusalem; University of Sydney	ALON, T (corresponding author), HEBREW UNIV JERUSALEM, HADASSAH MED SCH, DIV MOLEC BIOL, POB 12272, IL-91120 JERUSALEM, ISRAEL.		Keshet, Eli/GQR-0445-2022					ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ASHTON N, 1954, BRIT J OPHTHALMOL, V38, P397, DOI 10.1136/bjo.38.7.397; ASHTON N, 1961, BR J OPHTHALMOL, V35, P4321; DVORAK HF, 1991, J EXP MED, V174, P1275, DOI 10.1084/jem.174.5.1275; FRANGAKIS MV, 1984, NEUROCHEM RES, V9, P1689, DOI 10.1007/BF00968079; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GIBSON DL, 1990, PEDIATRICS, V86, P405; GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Michaelson I.C., 1948, T OPHTHALMOL SOC, V68, P137; MILLER JW, 1994, AM J PATHOL, V145, P574; PEER J, 1995, LAB INVEST, V72, P638; PENN JS, 1993, INVEST OPHTH VIS SCI, V34, P576; PHELPS DL, 1990, INVEST OPHTH VIS SCI, V31, P2194; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; STONE J, IN PRESS VIS SCI; TAILOI CL, 1992, INVEST OPHTH VIS SCI, V33, P2128; VILLASCHI S, 1993, AM J PATHOL, V143, P181	24	1273	1349	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	1995	1	10					1024	1028		10.1038/nm1095-1024	http://dx.doi.org/10.1038/nm1095-1024			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489357				2022-12-25	WOS:A1995RX95100041
J	DESANCTIS, GT; MERCHANT, M; BEIER, DR; DREDGE, RD; GROBHOLZ, JK; MARTIN, TR; LANDER, ES; DRAZEN, JM				DESANCTIS, GT; MERCHANT, M; BEIER, DR; DREDGE, RD; GROBHOLZ, JK; MARTIN, TR; LANDER, ES; DRAZEN, JM			QUANTITATIVE LOCUS ANALYSIS OF AIRWAY HYPERRESPONSIVENESS IN A/J AND C57BL/6J MICE	NATURE GENETICS			English	Article							MAST-CELL TRYPTASE; SOLUBLE INTERLEUKIN-2 RECEPTOR; BRONCHIAL HYPERRESPONSIVENESS; GENETIC-FACTORS; HYPERREACTIVITY; ASTHMA; MOUSE; METHACHOLINE; ACTIVATION; RESPONSIVENESS	Airway hyperresponsiveness is a key characteristic of human asthma and a marker for asthma-like conditions in animals. F-1 mice derived from A/J and C57BL/6J display a phenotype which resembles the asthma-like phenotype of the A/J mice. Since airway responsiveness failed to segregate as a mendelian trait, we show significant linkage at two loci, Bhr1 (lod = 3.0) and Bhr2 (lod = 3.7) on chromosomes 2 and 15. A third locus, Bhr3 (lod = 2.83), maps to chromosome 17. Each of these loci maps near candidate loci implicated in the pathobiology of asthma. Our study represents the first linkages established through a genome-wide survey of airway hyperresponsiveness in any mammal.	HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,COMBINED PROGRAM PULM & CRIT CARE MED,BOSTON,MA 02115; WHITEHEAD INST BIOMED RES,MIT,CTR GENOME RES,CAMBRIDGE CTR,CAMBRIDGE,MA 02142; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DIV GENET,BOSTON,MA 02115; CHILDRENS HOSP,DEPT PEDIAT,BOSTON,MA 02115; MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT)			Drazen, Jeffrey M/E-5841-2012	Merchant, Mark/0000-0003-0690-8581	NHLBI NIH HHS [HL36110] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036110] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUBERT JD, 1994, AM J PHYSIOL, V266, pL655, DOI 10.1152/ajplung.1994.266.6.L655; BARNES PJ, 1994, AM J RESP CRIT CARE, V150, pS42, DOI 10.1164/ajrccm/150.5_Pt_2.S42; BROIDE DH, 1992, J ALLERGY CLIN IMMUN, V89, P958, DOI 10.1016/0091-6749(92)90218-Q; CAUGHEY GH, 1988, J PHARMACOL EXP THER, V244, P133; CORRIGAN CJ, 1988, LANCET, V1, P1129; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; GARSSEN J, 1994, TOXICOL LETT, V72, P151, DOI 10.1016/0378-4274(94)90022-1; GAVETT SH, 1993, AM J PHYSIOL, V265, pL493, DOI 10.1152/ajplung.1993.265.5.L493; GORDON JR, 1990, IMMUNOL TODAY, V11, P458, DOI 10.1016/0167-5699(90)90176-A; HASHIMOTO S, 1993, ANN ALLERGY, V71, P455; HIRSHMAN CA, 1984, J APPL PHYSIOL, V56, P1272, DOI 10.1152/jappl.1984.56.5.1272; KIPS JC, 1992, AM REV RESPIR DIS, V145, P332, DOI 10.1164/ajrccm/145.2_Pt_1.332; Konno S, 1993, Arerugi, V42, P42; KROEKER JP, 1977, BIOL CYBERN, V27, P221, DOI 10.1007/BF00344143; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; LEVITT RC, 1989, J APPL PHYSIOL, V67, P1125, DOI 10.1152/jappl.1989.67.3.1125; LEVITT RC, 1988, FASEB J, V2, P2605, DOI 10.1096/fasebj.2.10.3384240; LILLY CM, 1993, J CLIN INVEST, V91, P235, DOI 10.1172/JCI116176; LONGO G, 1987, AM J DIS CHILD, V141, P331, DOI 10.1001/archpedi.1987.04460030109037; MARTIN TR, 1993, J CLIN INVEST, V91, P1176, DOI 10.1172/JCI116277; MARTIN TR, 1988, J APPL PHYSIOL, V64, P2318, DOI 10.1152/jappl.1988.64.6.2318; MATSUMOTO K, 1994, CHEST, V105, P681, DOI 10.1378/chest.105.3.681; MIKAMI H, 1991, EXP ANIM TOKYO, V40, P453, DOI 10.1538/expanim1978.40.4_453; NIEMINEN MM, 1992, CHEST, V102, P1537, DOI 10.1378/chest.102.5.1537; PARK CS, 1993, J ALLERGY CLIN IMMUN, V91, P623, DOI 10.1016/0091-6749(93)90268-K; PATERSON AH, 1991, GENETICS, V127, P181; PAUWELS R, 1985, EUR J RESPIR DIS, V66, P98; PUI CH, 1989, LEUKEMIA, V3, P323; RENZ H, 1992, J ALLERGY CLIN IMMUN, V89, P1127, DOI 10.1016/0091-6749(92)90296-E; RUOSS SJ, 1991, J CLIN INVEST, V88, P493, DOI 10.1172/JCI115330; Sambrook J, 1989, MOL CLONING LABORATO; SEKIZAWA K, 1989, J CLIN INVEST, V83, P175, DOI 10.1172/JCI113855; SIM TC, 1994, AM J RESP CELL MOL, V11, P473, DOI 10.1165/ajrcmb.11.4.7917315; TOWNLEY RG, 1986, J ALLERGY CLIN IMMUN, V77, P101, DOI 10.1016/0091-6749(86)90330-1; TSUKAGOSHI H, 1994, J ALLERGY CLIN IMMUN, V93, P464, DOI 10.1016/0091-6749(94)90355-7; VANBEVER HP, 1993, ALLERGY, V48, P443, DOI 10.1111/j.1398-9995.1993.tb00742.x; WASSERMAN SI, 1990, J ALLERGY CLIN IMMUN, V86, P590, DOI 10.1016/S0091-6749(05)80221-0; WENZEL SE, 1988, AM REV RESPIR DIS, V137, P1002, DOI 10.1164/ajrccm/137.5.1002; Wright S., 1968, GENETIC BIOMETRIC FD; YARKONY KA, 1993, AM REV RESPIR DIS, V147, pA419; YING S, 1991, Clinical and Experimental Allergy, V21, P745, DOI 10.1111/j.1365-2222.1991.tb03205.x; 1991, J ALLERGY CLIN IMMUN, V88, P425	43	235	239	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					150	154		10.1038/ng1095-150	http://dx.doi.org/10.1038/ng1095-150			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550342				2022-12-25	WOS:A1995RX80600016
J	GRAINGER, DJ; WAKEFIELD, L; BETHELL, HW; FARNDALE, RW; METCALFE, JC				GRAINGER, DJ; WAKEFIELD, L; BETHELL, HW; FARNDALE, RW; METCALFE, JC			RELEASE AND ACTIVATION OF PLATELET LATENT TGF-BETA IN BLOOD-CLOTS DURING DISSOLUTION WITH PLASMIN	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; MOLECULAR-WEIGHT COMPLEX; SMOOTH-MUSCLE CELLS; FACTOR-BETA-1; PROLIFERATION; TGF-BETA-1; SEQUENCES; BINDING; PROTEIN	Transforming growth factor beta 1 (TGF-beta 1) is a platelet-derived cytokine involved in both normal wound healing and scarring. We show that human platelets contain two pools of latent TGF-beta 1, which constitute more than 95% of the total TGF-beta assayed in whole platelets. During clotting, one pool, the large latent TGF-beta complex consisting of latent TGF-beta binding protein (LTBP), the latency-associated peptide (LAP) and the 25-kD mature TGF-beta 1 dimer is released into the serum. A second pool, which contains LAP but not LTBP, is retained in the clot, but can be released by RGD peptide. When the clot is dissolved by plasmin this bound TGF-beta 1 is gradually activated and released. if similar mechanisms operate in vivo, the clot will act as a slow-release capsule of TGF-beta 1 activity during wound healing.	NCI,CHEMOPREVENT LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	GRAINGER, DJ (corresponding author), UNIV CAMBRIDGE,DEPT BIOCHEM,TENNIS COURT RD,CAMBRIDGE CB2 1QW,ENGLAND.							ANSCHER MS, 1993, NEW ENGL J MED, V328, P1592, DOI 10.1056/NEJM199306033282203; ASSOIAN RK, 1986, J CELL BIOL, V102, P1712; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; BORDER WA, 1991, J CLIN INVEST, V90, P1; CALRETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; GRAINGER DJ, 1993, BIOCHEM J, V294, P109, DOI 10.1042/bj2940109; GRAINGER DJ, 1995, NAT MED, V1, P74, DOI 10.1038/nm0195-74; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; GRAINGER DJ, 1995, CLIN CHIM ACTA, V235, P11, DOI 10.1016/0009-8981(94)05995-4; GRAINGER DJ, 1993, SCIENCE, V260, P1655, DOI 10.1126/science.8503012; Harpel John G., 1992, Progress in Growth Factor Research, V4, P321, DOI 10.1016/0955-2235(92)90014-9; IVANOVIC V, 1995, NAT MED, V1, P282, DOI 10.1038/nm0495-282; KANZAKI T, 1990, CELL, V61, P1051, DOI 10.1016/0092-8674(90)90069-Q; KOJIMA S, 1993, J CELL BIOL, V121, P439, DOI 10.1083/jcb.121.2.439; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; NOH JW, 1993, NEPHRON, V63, P73, DOI 10.1159/000187146; OLSEN D, 1993, J CELL BIOCH E, V17, P106; SHAH M, 1994, J CELL SCI, V107, P1137; SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R; SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646	28	186	194	1	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	SEP	1995	1	9					932	937		10.1038/nm0995-932	http://dx.doi.org/10.1038/nm0995-932			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585220				2022-12-25	WOS:A1995RT30300048
J	EIBERG, H; BERENDT, I; MOHR, J				EIBERG, H; BERENDT, I; MOHR, J			ASSIGNMENT OF DOMINANT INHERITED NOCTURNAL ENURESIS (ENUR1) TO CHROMOSOME 13Q	NATURE GENETICS			English	Letter							LINKAGE MAP; DESMOPRESSIN; GENE				EIBERG, H (corresponding author), UNIV COPENHAGEN,INST MED BIOCHEM & GENET,DEPT MED GENET,GENOME GRP,DANISH CTR GENOME RES,COPENHAGEN,DENMARK.							ARAI H, 1993, J BIOL CHEM, V268, P3463; BAKWIN H, 1973, BLADDER CONTROL ENUR, P73; Bartolozzi G, 1991, Pediatr Med Chir, V13, P389; BIRKASOVA M, 1978, PEDIATRICS, V62, P970; BOWCOCK A, 1993, GENOMICS, V15, P376, DOI 10.1006/geno.1993.1071; BOWCOCK A, 1991, CYTOGENET CELL GENET, V58, P580, DOI 10.1159/000133173; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; EIBERG H, 1989, CLIN GENET, V35, P313; ELBERG H, 1994, EUR J HUM GENET, V2, P132; FERGUSSON DM, 1986, PEDIATRICS, V78, P884; HOGG RJ, 1993, J UROLOGY, V150, P444, DOI 10.1016/S0022-5347(17)35506-4; HSIEH CL, 1990, SOMAT CELL MOLEC GEN, V16, P567, DOI 10.1007/BF01233097; JARVELIN MR, 1988, ACTA PAEDIATR SCAND, V77, P148, DOI 10.1111/j.1651-2227.1988.tb10614.x; Kaushansky A, 1972, Harefuah, V83, P245; Kolvin I, 1973, BLADDER CONTROL ENUR, P156; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEONARD BE, 1994, INT CLIN PSYCHOPHARM, V9, P7, DOI 10.1097/00004850-199403001-00003; MILLS JN, 1951, J PHYSIOL-LONDON, V113, P528, DOI 10.1113/jphysiol.1951.sp004593; Norgaard J P, 1991, Scand J Urol Nephrol Suppl, V140, P1; OTT J, 1973, AM J HUM GENET, V28, P528; RETTIG WJ, 1987, SOMAT CELL MOLEC GEN, V11, P189; RITTIG S, 1989, AM J PHYSIOL, V25, P664; SUMMAR ML, 1990, MOL ENDOCRINOL, V4, P947, DOI 10.1210/mend-4-6-947; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WIEMSPERGER NF, 1994, J CARDIOVASC PHARM, V23, P37	25	122	127	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					354	356		10.1038/ng0795-354	http://dx.doi.org/10.1038/ng0795-354			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670476				2022-12-25	WOS:A1995RG38600022
J	YAZAWA, I; NUKINA, N; HASHIDA, H; GOTO, J; YAMADA, M; KANAZAWA, I				YAZAWA, I; NUKINA, N; HASHIDA, H; GOTO, J; YAMADA, M; KANAZAWA, I			ABNORMAL GENE-PRODUCT IDENTIFIED IN HEREDITARY DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY (DRPLA) BRAIN	NATURE GENETICS			English	Article							BULBAR MUSCULAR-ATROPHY; HUNTINGTONS-DISEASE GENE; FRAGILE-X SYNDROME; ANDROGEN RECEPTOR; MYOTONIC-DYSTROPHY; TRIPLET REPEAT; RNA-BINDING; FMR-1 GENE; EXPRESSION; PROTEIN	Dentatorubral-pallidoluysian atrophy (DRPLA) is associated with the expansion of an unstable CAG repeat. Using antibodies against a synthetic peptide corresponding to the sequence of the DRPLA gene product C terminus, we have identified the DRPLA gene product in normal human brains as a approximate to 190 kD protein. We also find a larger approximate to 205 kD protein specifically in DRPLA brains. Immunohistochemically, the DRPLA gene product is observed mainly in the neuronal cytoplasm. Our results demonstrate the existence of the expanded CAG repeat gene product and support the possibility that the expanded CAG-encoded polyglutamine stretch may participate in the pathological process of the similar trinucleotide repeat diseases.	UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROL,BUNKYO KU,TOKYO 113,JAPAN; NATL CHILDRENS MED RES CTR,SETAGAYA KU,TOKYO 154,JAPAN	University of Tokyo; National Center for Child Health & Development - Japan			Nukina, Nobuyuki/GPP-6265-2022					ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOMURE O, 1995, NEUROLOGY, V45, P143, DOI 10.1212/WNL.45.1.143; KONDO I, 1990, J MED GENET, V27, P105, DOI 10.1136/jmg.27.2.105; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MATSUURA T, 1992, NEUROLOGY, V42, P1724, DOI 10.1212/WNL.42.9.1724; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; NALTO H, 1982, NEUROLOGY, V32, P798; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PARRISH JE, 1994, NAT GENET, V8, P229, DOI 10.1038/ng1194-229; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; SANO A, 1994, HUM GENET, V93, P699; SMITH JK, 1958, NEUROLOGY, V8, P205, DOI 10.1212/WNL.8.3.205; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TAKAHASHI H, 1988, NEUROLOGY, V38, P1065, DOI 10.1212/WNL.38.7.1065; VANDERVEN PFM, 1993, HUM MOL GENET, V2, P1889; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJ, 1991, CELL, V65, P5; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213; 1993, CELL, V72, P971	33	142	144	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					99	103		10.1038/ng0595-99	http://dx.doi.org/10.1038/ng0595-99			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647802				2022-12-25	WOS:A1995QX57300023
J	MERAJVER, SD; PHAM, TM; CADUFF, RF; CHEN, M; POY, EL; COONEY, KA; WEBER, BL; COLLINS, FS; JOHNSTON, C; FRANK, TS				MERAJVER, SD; PHAM, TM; CADUFF, RF; CHEN, M; POY, EL; COONEY, KA; WEBER, BL; COLLINS, FS; JOHNSTON, C; FRANK, TS			SOMATIC MUTATIONS IN THE BRCA1 GENE IN SPORADIC OVARIAN-TUMORS	NATURE GENETICS			English	Article							FAMILIAL BREAST; ALLELE LOSSES; CANCER; CHROMOSOME-17; LINKAGE; REGION; TUMORS	The BRCA1 gene on chromosome 17q21 is responsible for an autosomal dominant syndrome of increased susceptibility to breast and ovarian cancer but no somatic mutations in tumours have yet been described. To study the potential role of BRCA1 in sporadic carcinogenesis, we analysed the genomic DNA of tumour and normal fractions of 47 ovarian cancers for mutations in BRCA1 using the single-strand conformation polymorphism technique. We now describe somatic mutations in the DNA of four tumours which also had loss of heterozygosity (LOH) at a BRCA1 intragenic marker. Our data support a tumour suppressor mechanism for BRCA1; somatic mutations and LOH may result in inactivation of BRCA1 in at least a small number of ovarian cancers.	UNIV MICHIGAN, SCH MED, DEPT PATHOL, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, SCH MED, DEPT OBSTET & GYNECOL, ANN ARBOR, MI 48109 USA; UNIV PENN, SCH MED, DEPT GENET, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT INTERNAL MED, PHILADELPHIA, PA 19104 USA; NIH, NATL CTR HUMAN GENOME RES, BETHESDA, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	MERAJVER, SD (corresponding author), UNIV MICHIGAN, SCH MED, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA.			Cooney, Kathleen/0000-0003-3831-6943	NCRR NIH HHS [3M01RR00042-34S1] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000042] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CROPP CS, 1994, CANCER RES, V54, P2548; EASTON DF, 1993, AM J HUM GENET, V52, P678; ECCLES DM, 1990, ONCOGENE, V5, P1599; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRANK TS, 1994, MODERN PATHOL, V7, P3; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; JACOBS IJ, 1993, CANCER RES, V53, P1218; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; LEE JH, 1990, CANCER RES, V50, P2724; MERAJVER SD, IN PRESS CLIN CANCER; MILCI Y, 1994, SCIENCE, V266, P66; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SATO T, 1991, CANCER RES, V51, P5118; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; YOUNG RH, 1992, HEMATOL ONCOL CLIN N, V6, P739	22	373	387	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1995	9	4					439	443		10.1038/ng0495-439	http://dx.doi.org/10.1038/ng0495-439			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795652				2022-12-25	WOS:A1995QQ75300024
J	MEULI, M; MEULISIMMEN, C; HUTCHINS, GM; YINGLING, CD; HOFFMAN, KM; HARRISON, MR; ADZICK, NS				MEULI, M; MEULISIMMEN, C; HUTCHINS, GM; YINGLING, CD; HOFFMAN, KM; HARRISON, MR; ADZICK, NS			IN-UTERO SURGERY RESCUES NEUROLOGICAL FUNCTION AT BIRTH IN SHEEP WITH SPINA-BIFIDA	NATURE MEDICINE			English	Article							NEURAL-TUBE DEFECTS; ANATOMICAL PLASTICITY; AMNIOTIC-FLUID; MENINGOMYELOCELE; MODEL; GASTROSCHISIS; DYSRAPHISM; ETIOLOGY; DAMAGE	We hypothesize that the neurologic deficit associated with open spina bifida is not directly caused by the primary defect but rather is due to chronic mechanical and chemical trauma since the unprotected neural tissue is exposed to the intrauterine environment. We report here that exposure of the normal spinal cord to the amniotic cavity in midgestational sheep fetuses leads to a human-like open spina bifida with paraplegia at birth, indicating that the exposed neural tissue is progressively destroyed during pregnancy. When open spina bifida was repaired in, utero at an intermediate stage, the animals mars had near-normal neurologic function. The spinal cord was deformed but largely preserved. These findings suggest that secondary neural tissue destruction during pregnancy is primarily responsible for the functional loss and that timely in utero repair of open spina bifida might rescue neurologic function.	DAVIES MED CTR,MICROSURG LAB,SAN FRANCISCO,CA 94114; JOHNS HOPKINS MED INST,DEPT PATHOL,BALTIMORE,MD 21287; UNIV CALIF SAN FRANCISCO,DEPT ANESTHESIA,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,ANIM CARE FACIL,SAN FRANCISCO,CA 94143	California Pacific Medical Center; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco	MEULI, M (corresponding author), UNIV CALIF SAN FRANCISCO,CTR FETAL TREATMENT,HSW1601,3RD & PARNASSUS AVE,SAN FRANCISCO,CA 94143, USA.		Harrison, Michael/GYD-8608-2022					ADZICK NS, 1994, LANCET, V343, P897, DOI 10.1016/S0140-6736(94)90012-4; BREGMAN BS, 1991, EXP NEUROL, V112, P49, DOI 10.1016/0014-4886(91)90113-Q; BREGMAN BS, 1982, SCIENCE, V217, P553, DOI 10.1126/science.7089581; CAMERON AH, 1956, LANCET, V2, P171; CAMPBELL LR, 1986, TERATOLOGY, V34, P171, DOI 10.1002/tera.1420340206; COPP AJ, 1990, PROG NEUROBIOL, V35, P363, DOI 10.1016/0301-0082(90)90037-H; COPP AJ, 1993, TRENDS NEUROSCI, V16, P381, DOI 10.1016/0166-2236(93)90001-3; EMERY JL, 1973, J PATHOL, V110, P83, DOI 10.1002/path.1711100110; GILBERT JN, 1986, NEUROSURGERY, V18, P559, DOI 10.1227/00006123-198605000-00008; HARRISON MR, 1980, SURGERY, V88, P174; HEFFEZ DS, 1993, NEUROSURGERY, V32, P1005, DOI 10.1227/00006123-199306000-00021; IWASHITA Y, 1994, NATURE, V367, P167, DOI 10.1038/367167a0; JORDAN M A, 1991, Teratology, V43, P472; Keller-Peck C., 1993, Society for Neuroscience Abstracts, V19, P181; KORENROMP MJ, 1986, LANCET, V1, P917, DOI 10.1016/S0140-6736(86)91022-6; LANGER JC, 1989, J PEDIATR SURG, V24, P992, DOI 10.1016/S0022-3468(89)80200-3; LEMIRE RJ, 1988, JAMA-J AM MED ASSOC, V259, P558, DOI 10.1001/jama.259.4.558; LOTGERING FK, 1986, SEMIN PERINATOL, V10, P94; LUTHY DA, 1991, NEW ENGL J MED, V324, P662, DOI 10.1056/NEJM199103073241004; MATSUOKA M, 1993, BIOCHEM PHARMACOL, V46, P159, DOI 10.1016/0006-2952(93)90360-9; MCLAUGHLIN JF, 1985, NEW ENGL J MED, V312, P1589, DOI 10.1056/NEJM198506203122501; MICHEJDA M, 1984, Z KINDERCHIR, V39, P259; NIKU SD, 1994, J UROLOGY, V152, P1025, DOI 10.1016/S0022-5347(17)32648-4; OSAKA K, 1978, J NEUROSURG, V49, P711, DOI 10.3171/jns.1978.49.5.0711; PATTEN BM, 1953, AM J ANAT, V93, P365, DOI 10.1002/aja.1000930304; SCHMIDT W, 1992, ADV ANATOMY EMBRYOLO, P1; SHAW GM, 1994, TERATOLOGY, V49, P143, DOI 10.1002/tera.1420490210; THEVENET A, 1986, ROUX ARCH DEV BIOL, V195, P345, DOI 10.1007/BF00402868; TIBBOEL D, 1986, TERATOLOGY, V33, P267, DOI 10.1002/tera.1420330303	29	251	256	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1995	1	4					342	347		10.1038/nm0495-342	http://dx.doi.org/10.1038/nm0495-342			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585064				2022-12-25	WOS:A1995RN09800030
J	EAGLE, LR; YIN, XY; BROTHMAN, AR; WILLIAMS, BJ; ATKIN, NB; PROCHOWNIK, EV				EAGLE, LR; YIN, XY; BROTHMAN, AR; WILLIAMS, BJ; ATKIN, NB; PROCHOWNIK, EV			MUTATION OF THE MXI1 GENE IN PROSTATE-CANCER	NATURE GENETICS			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; LOOP-HELIX PROTEINS; C-MYC; DNA-BINDING; TRANSCRIPTIONAL ACTIVATION; HETERO-OLIGOMERIZATION; LEUCINE ZIPPER; MAX PROTEINS; MYOD; SEQUENCE	The Mxi1 protein negatively regulates Myc oncoprotein activity and thus potentially serves a tumour suppressor function. MXI1 maps to chromosome 10q24-q25, a region that is deleted in some cases of prostate cancer. We have detected mutations in the retained MXI1 alleles in four primary prostate tumours with 10q24-q25 deletions. Two tumours contained inactivating mutations, whereas two others contained the identical missense mutation. Fluorescence in situ hybridization also demonstrated loss of one MXI1 allele in an additional tumour lacking chromosome 10 abnormalities. MXI1 thus displays allelic loss and mutation in some cases of prostate cancer that may contribute to the pathogenesis or neoplastic evolution of this common malignancy.	CHILDRENS HOSP,DEPT PEDIAT,DIV HEMATOL ONCOL,PITTSBURGH,PA 15213; UNIV UTAH,HLTH SCI CTR,DEPT PEDIAT,SALT LAKE CITY,UT 84132; UNIV UTAH,HLTH SCI CTR,DEPT MED GENET,SALT LAKE CITY,UT 84132; MT VERNON HOSP,DEPT CANC RES,NORTHWOOD HA6 2RN,MIDDX,ENGLAND; UNIV PITTSBURGH,MED CTR,DEPT MOLEC GENET & BIOCHEM,PITTSBURGH,PA 15213	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033741] Funding Source: NIH RePORTER; NCI NIH HHS [CA46293] Funding Source: Medline; NHLBI NIH HHS [HL33741] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; AMATI B, 1993, CELL, V72, P233, DOI 10.1016/0092-8674(93)90663-B; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; AMIN C, 1993, MOL CELL BIOL, V13, P383, DOI 10.1128/MCB.13.1.383; ARPS S, 1993, CANCER GENET CYTOGEN, V66, P93, DOI 10.1016/0165-4608(93)90234-D; ATKIN NB, 1985, HUM GENET, V70, P359, DOI 10.1007/BF00295378; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; BAKER SJ, 1990, CANCER RES, V50, P7717; BIRD ML, 1989, LEUKEMIA, V3, P182; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; BROTHMAN AR, 1990, CANCER RES, V50, P3795; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; DANG CV, 1991, MOL CELL BIOL, V11, P954, DOI 10.1128/MCB.11.2.954; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; EDELHOFF S, 1994, ONCOGENE, V9, P665; EPSTEIN I, 1989, PROSTATE BIOPSY INTE, P39; FLEISCHMAN EW, 1989, HUM GENET, V82, P343; FRANKEL RH, 1992, CANCER RES, V52, P1427; FULTS D, 1993, GENE CHROMOSOME CANC, V7, P173, DOI 10.1002/gcc.2870070311; GU W, 1993, P NATL ACAD SCI USA, V90, P2935, DOI 10.1073/pnas.90.7.2935; HEISLER CH, 1990, EUR J HAEMATOL, V43, P397; JONES E, 1994, GENE CHROMOSOME CANC, V11, P163, DOI 10.1002/gcc.2870110305; KALLIO P, 1991, J VIROL METHODS, V35, P39, DOI 10.1016/0166-0934(91)90083-C; KATO GJ, 1990, MOL CELL BIOL, V10, P5914, DOI 10.1128/MCB.10.11.5914; KAZAZIAN HH, 1988, BLOOD, V72, P1107; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAHOZ EG, 1994, P NATL ACAD SCI USA, V91, P5503, DOI 10.1073/pnas.91.12.5503; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; LEVINE AJ, 1993, ANNU REV BIOCHEM, V62, P623, DOI 10.1146/annurev.bi.62.070193.003203; LUNDGREN R, 1992, GENE CHROMOSOME CANC, V4, P16, DOI 10.1002/gcc.2870040103; MARSHAL R, 1990, BLOOD, V75, P180; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAKAI H, 1992, CANCER RES, V52, P6588; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; PROCHOWNIK EV, 1993, P NATL ACAD SCI USA, V90, P960, DOI 10.1073/pnas.90.3.960; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHWAB M, 1984, P NATL ACAD SCI-BIOL, V81, P4940, DOI 10.1073/pnas.81.15.4940; SHAPIRO DN, 1994, GENOMICS, V23, P282, DOI 10.1006/geno.1994.1496; SIDRANSKY D, 1992, NATURE, V335, P846; SMITH MJ, 1990, MOL CELL BIOL, V10, P5333, DOI 10.1128/MCB.10.10.5333; SREEKANTAIAH C, 1988, CANCER GENET CYTOGEN, V35, P199, DOI 10.1016/0165-4608(88)90241-5; VANANTWERP ME, 1992, P NATL ACAD SCI USA, V89, P9010, DOI 10.1073/pnas.89.19.9010; WEINBERG RA, 1992, SCIENCE, V254, P1138; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; YOFFE G, 1990, J PEDIATR-US, V116, P114, DOI 10.1016/S0022-3476(05)81658-0; ZERVOS AS, 1993, CELL, V72, P223, DOI 10.1016/0092-8674(93)90662-A; ZERVOS AS, 1994, CELL, V79, P389	54	195	201	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					249	255		10.1038/ng0395-249	http://dx.doi.org/10.1038/ng0395-249			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773287				2022-12-25	WOS:A1995QL23200013
J	SUOMALAINEN, A; KAUKONEN, J; AMATI, P; TIMONEN, R; HALTIA, M; WEISSENBACH, J; ZEVIANI, M; SOMER, H; PELTONEN, L				SUOMALAINEN, A; KAUKONEN, J; AMATI, P; TIMONEN, R; HALTIA, M; WEISSENBACH, J; ZEVIANI, M; SOMER, H; PELTONEN, L			AN AUTOSOMAL LOCUS PREDISPOSING TO DELETIONS OF MITOCHONDRIAL-DNA	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR-I; MULTIPLE DELETIONS; LINKAGE ANALYSIS; DIRECT REPEATS; MYOPATHY; PATIENT; TISSUES; PROTEIN; REGION; GENOME	The molecular mechanisms by which the nuclear genome regulates the biosynthesis of mitochondrial DNA (mtDNA) are only beginning to be unravelled. A naturally occurring in vivo model for a defect in this cross-talk of two physically separate genomes is a human disease, an autosomal dominant progressive external ophthalmoplegia, in which multiple deletions of mtDNA accumulate in the patients' tissues. The assignment of this disease locus to 10q 23.3-24.3 is the first direct evidence for involvement of both nuclear and mitochondrial genomes in a single disorder.	HOP NECKER ENFANTS MALAD,INSERM,U393,F-75743 PARIS 15,FRANCE; NATL NEUROL INST CARLO BESTA,DIV BIOCHEM & GENET,I-20133 MILAN,ITALY; UNIV HELSINKI,DEPT PATHOL,HELSINKI,FINLAND; UNIV HELSINKI,DEPT NEUROL,HELSINKI,FINLAND; GENETHON,F-91000 EVRY,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; IRCCS Istituto Neurologico Besta; University of Helsinki; University of Helsinki	SUOMALAINEN, A (corresponding author), NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,MANNERHEIMINTIE 166,SF-00300 HELSINKI,FINLAND.		Zeviani, Massimo/AAU-2632-2021; Zeviani, Massimo/K-2891-2014	Zeviani, Massimo/0000-0002-9067-5508; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195	Telethon [456] Funding Source: Medline	Telethon(Fondazione Telethon)		AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; CLAYTON DA, 1991, TRENDS BIOCHEM SCI, V16, P107, DOI 10.1016/0968-0004(91)90043-U; CORMIER V, 1991, AM J HUM GENET, V48, P643; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; FISHER RP, 1992, J BIOL CHEM, V267, P3358; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; MEGRAW TL, 1993, J BIOL CHEM, V268, P12758; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MOIR DT, 1994, GENOMICS, V22, P1, DOI 10.1006/geno.1994.1338; OHNO K, 1991, ANN NEUROL, V29, P364, DOI 10.1002/ana.410290406; OLDFORS A, 1993, BRAIN, V116, P325, DOI 10.1093/brain/116.2.325; OTSUKA M, 1990, BIOCHEM BIOPH RES CO, V167, P680, DOI 10.1016/0006-291X(90)92079-F; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT J, 1991, ANAL HUMAN GENETIC L, P203; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053; SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525; SUOMALAINEN A, 1992, LANCET, V340, P1319, DOI 10.1016/0140-6736(92)92496-3; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; SYVANEN AC, 1989, FEBS LETT, V258, P71, DOI 10.1016/0014-5793(89)81618-7; TIRANTI V, IN PRESS GENOMICS; TOMINAGA K, 1992, BIOCHIM BIOPHYS ACTA, V1131, P217, DOI 10.1016/0167-4781(92)90082-B; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; WALACE DC, 1992, ANN REV BIOCH, V61, P1175; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; YUZAKI M, 1989, BIOCHEM BIOPH RES CO, V164, P1352, DOI 10.1016/0006-291X(89)91818-4; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; ZEVIANI M, 1992, J INHERIT METAB DIS, V15, P456, DOI 10.1007/BF01799604; ZHENG CJ, 1994, GENOMICS, V22, P55, DOI 10.1006/geno.1994.1345	34	222	222	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					146	151		10.1038/ng0295-146	http://dx.doi.org/10.1038/ng0295-146			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719341				2022-12-25	WOS:A1995QE67200015
J	LAHN, BT; MA, N; BREG, WR; STRATTON, R; SURTI, U; PAGE, DC				LAHN, BT; MA, N; BREG, WR; STRATTON, R; SURTI, U; PAGE, DC			XQ-YQ INTERCHANGE RESULTING IN SUPERNORMAL X-LINKED GENE-EXPRESSION IN SEVERELY RETARDED MALES WITH 46,XYQ-KARYOTYPE	NATURE GENETICS			English	Article							FACTOR-VIII GENE; DINUCLEOTIDE REPEAT POLYMORPHISM; CHROMOSOMAL SHORT ARMS; HUMAN SEX-CHROMOSOMES; TURNER SYNDROME; TERMINAL PORTIONS; DNA-SEQUENCES; HEMOPHILIA-A; LOCALIZATION; INACTIVATION	The critical importance of dosage compensation is underscored by a novel human syndrome (''XYXq syndrome'') in which we have detected partial X disomy, demonstrated supernormal gene expressing resulting from the absence of X inactivation, and correlated this overexpression with its phenotypic consequences. Studies of three unrelated boys with 46,XYq-karyotypes and anomalous phenotypes (severe mental retardation, generalized hypotonia and microcephaly) show the presence of a small portion of distal Xq on the long arm of the Y derivative. Cells from these boys exhibit twice-normal activity of glucose-6-phosphate dehydrogenase, a representative Xq28 gene product. In all threee cases, the presence of Xq DNA on a truncated Y chromosome resulted from an aberrant Xq-Yq interchange occurring in the father's germline.	WHITEHEAD INST,HOWARD HUGHES RES LABS,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02142; COLLABORAT RES INC,DEPT HUMAN & MOLEC GENET,WALTHAM,MA 02154; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; YALE UNIV,SCH MED,DEPT PEDIAT,NEW HAVEN,CT 06510; S TEXAS GENET CTR,SAN ANTONIO,TX 78229; UNIV PITTSBURGH,MAGEE WOMENS HOSP,DEPT PATHOL,PITTSBURGH,PA 15213; UNIV PITTSBURGH,MAGEE WOMENS HOSP,DEPT GENET,PITTSBURGH,PA 15213	HRL Laboratories; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh								ANDERSSON M, 1986, SCIENCE, V233, P786, DOI 10.1126/science.3738510; ARN P, 1994, HUM GENET, V93, P389; BARDONI B, 1993, HUM GENET, V91, P333; BARDONI B, 1994, NAT GENET, V7, P497, DOI 10.1038/ng0894-497; BERNSTEIN R, 1980, J MED GENET, V17, P291, DOI 10.1136/jmg.17.4.291; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; CAMERON IT, 1984, HUM GENET, V67, P457, DOI 10.1007/BF00291411; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; DELACHAPELLE A, 1984, NATURE, V307, P170, DOI 10.1038/307170a0; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; DISTECHE CM, 1986, P NATL ACAD SCI USA, V83, P7841, DOI 10.1073/pnas.83.20.7841; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; FREIJE D, 1992, AM J HUM GENET, V51, P66; HAMERTON JL, 1975, CLIN GENET, V8, P223; HICKS AA, 1991, NUCLEIC ACIDS RES, V19, P4016, DOI 10.1093/nar/19.14.4016; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KAY GF, 1994, CELL, V77, P609; KELLY TE, 1984, CYTOGENET CELL GENET, V38, P122, DOI 10.1159/000132043; KOO GC, 1977, SCIENCE, V198, P940, DOI 10.1126/science.929180; KVALOY K, 1994, HUM MOL GENET, V3, P771, DOI 10.1093/hmg/3.5.771; LALLOZ MRA, 1991, LANCET, V338, P207, DOI 10.1016/0140-6736(91)90348-S; LEVILLIERS J, 1989, P NATL ACAD SCI USA, V86, P2296, DOI 10.1073/pnas.86.7.2296; MAGENIS RE, 1984, J PEDIATR-US, V105, P916, DOI 10.1016/S0022-3476(84)80077-3; MEISNER LF, 1972, J MED GENET, V9, P373, DOI 10.1136/jmg.9.3.373; MIGEON BR, 1983, CURR TOP BIOL MED RE, V9, P189; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; MOHANDAS T, 1979, AM J HUM GENET, V31, P586; Muscatelli F., 1992, Human Molecular Genetics, V1, P115, DOI 10.1093/hmg/1.2.115; NAKAGOME Y, 1965, J PEDIATR, P1163; NUSSBAUM RL, 1983, HUM GENET, V64, P148, DOI 10.1007/BF00327113; PAGE DC, 1986, COLD SPRING HARB SYM, V51, P229, DOI 10.1101/SQB.1986.051.01.028; PAGE DC, 1987, NATURE, V328, P437, DOI 10.1038/328437a0; PETIT C, 1987, CELL, V49, P595, DOI 10.1016/0092-8674(87)90535-6; PODRUCH PE, 1982, J MED GENET, V19, P377, DOI 10.1136/jmg.19.5.377; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; ROSENFELD RG, 1979, AM J HUM GENET, V31, P458; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; SALO P, IN PRESS HUM GENET; SCHMIDT M, 1992, AM J MED GENET, V42, P161, DOI 10.1002/ajmg.1320420205; SCHWARTZ S, 1986, AM J HUM GENET, V38, P741; SIMMLER MC, 1985, NATURE, V317, P692, DOI 10.1038/317692a0; SPEED RM, 1990, HUM GENET, V84, P547; THODE A, 1988, AM J MED GENET, V30, P239, DOI 10.1002/ajmg.1320300125; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; TRASK BJ, 1991, AM J HUM GENET, V48, P1; VANDYKE DL, 1992, AM J MED GENET, V43, P996, DOI 10.1002/ajmg.1320430617; VOILRATH D, 1992, SCIENCE, V258, P52; WEBER C, 1993, HUM MOL GENET, V2, P612; WEIL D, 1994, NAT GENET, V7, P414, DOI 10.1038/ng0794-414; WILLARD HL, 1993, HUMAN GENE MAPPING, P656; WION KL, 1986, NUCLEIC ACIDS RES, V14, P4535, DOI 10.1093/nar/14.11.4535; WOLFF DJ, 1994, AM J HUM GENET, V55, P87; YUNIS E, 1977, HUM GENET, V39, P117, DOI 10.1007/BF00273161; ZINN AR, 1993, TRENDS GENET, V9, P90, DOI 10.1016/0168-9525(93)90230-F	55	45	45	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					243	250		10.1038/ng1194-243	http://dx.doi.org/10.1038/ng1194-243			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874166				2022-12-25	WOS:A1994PP76500013
J	TORCHARD, D; BLANCHETBARDON, C; SEROVA, O; LANGBEIN, L; NAROD, S; JANIN, N; GOGUEL, AF; BERNHEIM, A; FRANKE, WW; LENOIR, GM; FEUNTEUN, J				TORCHARD, D; BLANCHETBARDON, C; SEROVA, O; LANGBEIN, L; NAROD, S; JANIN, N; GOGUEL, AF; BERNHEIM, A; FRANKE, WW; LENOIR, GM; FEUNTEUN, J			EPIDERMOLYTIC PALMOPLANTAR KERATODERMA COSEGREGATES WITH A KERATIN-9 MUTATION IN A PEDIGREE WITH BREAST AND OVARIAN-CANCER	NATURE GENETICS			English	Article							HIGH-RISK FAMILIES; HYPERKERATOSIS; GENES	Epidermolytic palmoplantar keratosis (EPPK) cosegregates with breast and ovarian cancers in a large French pedigree, raising the possibility that a single genetic mutation might cause these conditions and offering a potential lead to the identification of a hereditary breast/ovarian cancer gene. We have performed linkage analysis and show that the EPPK locus lies on the long arm of chromosome 17 near the type I keratin gene cluster and the proposed breast cancer gene (BRCA1). The type I keratin 9 gene has been partially sequenced in four affected individuals. A single base mutation within the rod domain of the protein cosegregates with EPPK in all affected individuals tested. Although inheritance of this mutation is likely responsible for EPPK, it is unlikely to be the cause of the breast and ovarian cancer.	INST GUSTAVE ROUSSY,ONCOL MOLEC LAB,CNRS,URA 1158,F-94805 VILLEJUIF,FRANCE; INST GUSTAVE ROUSSY,CYTOGENET & GENET ONCOL LAB,F-94805 VILLEJUIF,FRANCE; HOP ST LOUIS,MALAD CUTANEES CLIN,F-75010 PARIS,FRANCE; INT AGCY RES CANC,F-69372 LYON,FRANCE; GERMAN CANC RES CTR,W-6900 HEIDELBERG 1,GERMANY; MCGILL UNIV,CTR HUMAN GENET,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT MED,MONTREAL H3A 2T5,QUEBEC,CANADA; MCGILL UNIV,DEPT ONCOL,MONTREAL H3A 2T5,QUEBEC,CANADA; INST GUSTAVE ROUSSY,DEPT MED,F-94805 VILLEJUIF,FRANCE	Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; World Health Organization; International Agency for Research on Cancer (IARC); Helmholtz Association; German Cancer Research Center (DKFZ); McGill University; McGill University; McGill University; UNICANCER; Gustave Roussy			Narod, Steven A/AAA-6112-2022; Feunteun, Jean/AAZ-1267-2020	Feunteun, Jean/0000-0003-1212-9189; Franke, Werner W./0000-0002-4873-8448				ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; BENNION SD, 1984, J AM ACAD DERMATOL, V10, P587, DOI 10.1016/S0190-9622(84)80262-5; BLANCHETBARDON C, 1987, BRIT J DERMATOL, V117, P363, DOI 10.1111/j.1365-2133.1987.tb04144.x; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; CLAUS EB, 1991, AM J HUM GENET, V48, P232; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; EASTON DF, 1993, AM J HUM GENET, V52, P678; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; GO RCP, 1983, J NATL CANCER I, V71, P455; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HOVNANIAN A, 1993, NAT GENET, V3, P327, DOI 10.1038/ng0493-327; HOWELEVANS W, 1958, Q J MED, V27, P413; KLAUS S, 1970, ARCH DERMATOL, V101, P272, DOI 10.1001/archderm.101.3.272; KNAPP AC, 1986, J CELL BIOL, V103, P657, DOI 10.1083/jcb.103.2.657; LANE EB, 1993, NATURE, V356, P2444; LANGBEIN L, IN PRESS DIFFERENTIA; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; LYNCHHT, 1981, GENETICS BREAST CANC; MOLL I, 1987, DIFFERENTIATION, V33, P254, DOI 10.1111/j.1432-0436.1987.tb01565.x; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; REIS A, 1992, HUM GENET, V90, P113; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; SCHILDKRAUT JM, 1988, AM J EPIDEMIOL, V128, P456, DOI 10.1093/oxfordjournals.aje.a114994; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193	27	109	116	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					106	110		10.1038/ng0194-106	http://dx.doi.org/10.1038/ng0194-106			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	7511021				2022-12-25	WOS:A1994MQ17700022
J	VAN BROECKHOVEN, C; BACKHOVENS, H; CRUTS, M; DEWINTER, G; BRUYLAND, M; CRAS, P; MARTIN, JJ				VAN BROECKHOVEN, C; BACKHOVENS, H; CRUTS, M; DEWINTER, G; BRUYLAND, M; CRAS, P; MARTIN, JJ			MAPPING OF A GENE PREDISPOSING TO EARLY-ONSET ALZHEIMERS-DISEASE TO CHROMOSOME 14Q24.3	NATURE GENETICS			English	Article							PRECURSOR PROTEIN GENE; REPEAT POLYMORPHISM; LINKAGE; ALPHA-1-ANTICHYMOTRYPSIN; ALPHA-1-ANTITRYPSIN; MUTATION; MARKERS; LOCUS	Genetic linkage studies with chromosome 21 DNA markers and mutation analysis of the beta-amyloid protein precursor gene located in 21q21.3 have indicated that early-onset Alzheimer's disease (EOAD) is a heterogeneous disorder for which at least one other chromosomal locus exists. We examined two extended histopathologically confirmed EOAD pedigrees, AD/A and AD/B, with highly informative short tandem repeat (STR) polymorphisms and found complete linkage of the disease to a (CA)n dinucleotide repeat polymorphism at locus D14S43 in 14q24.3 (Z(max) = 13.25 at 0 = 0.0). Using additional chromosome 14 STR polymorphisms we were able to delineate the region containing the EOAD gene to an area of, at most, 8.9 centiMorgans between D14S42 and D14S53, flanking D14S43 on both sides.	INNOGENET INC, B-9052 GENT, BELGIUM; CITY HOSP RONSE, DEPT NEUROL, B-9600 RONSE, BELGIUM; UNIV BRUSSELS, DEPT NEUROL, B-1090 BRUSSELS, BELGIUM; UNIV ANTWERP, DEPT MED, BORN BUNGE FDN, NEUROBIOL LABS, B-2610 ANTWERP, BELGIUM; UNIV ANTWERP, DEPT MED, BORN BUNGE FDN, NEUROPATHOL LABS, B-2610 ANTWERP, BELGIUM	Innogenetics NV; University of Antwerp; University of Antwerp	VAN BROECKHOVEN, C (corresponding author), UNIV ANTWERP, BORN BUNGE FDN, DEPT BIOCHEM, NEUROGENET LAB, UNIV PLEIN 1, B-2610 ANTWERP, BELGIUM.		Cruts, Marc/J-6161-2013; Van Broeckhoven, Christine/G-8362-2017; Van Broeckhoven, Christine/M-7853-2019	Cruts, Marc/0000-0002-1338-992X; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665				ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; COX DW, 1989, CYTOGENET CELL GENET, V51, P980; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; CRUTS M, 1992, NUCLEIC ACIDS RES, V20, P1159; FITCH N, 1988, ANN NEUROL, V23, P14, DOI 10.1002/ana.410230104; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HARDY J, 1992, NATURE, V359, P268, DOI 10.1038/359268a0; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MARTIN JJ, 1990, NEUROLOGY, V241, P62; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NAKAMURA Y, 1989, GENOMICS, V4, P76, DOI 10.1016/0888-7543(89)90317-0; OTT J, 1992, AM J HUM GENET, V51, P283; OTT J, 1985, ANAL HUMAN GENETIC L, P141; RABIN M, 1986, SOMAT CELL MOLEC GEN, V12, P209, DOI 10.1007/BF01560668; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SALBAUM JM, 1988, EMBO J, V7, P2807, DOI 10.1002/j.1460-2075.1988.tb03136.x; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; SEFTON L, 1990, GENOMICS, V7, P382, DOI 10.1016/0888-7543(90)90172-Q; SHARMA V, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67-a; SHARMA V, 1991, NUCLEIC ACIDS RES, V19, P1722, DOI 10.1093/nar/19.7.1722; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STINISSEN P, 1991, NUCLEIC ACIDS RES, V19, P5089, DOI 10.1093/nar/19.18.5089; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1992, AM J HUM GENET, V51, P273; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; VANBROECKHOVEN C, 1988, GENETICS ALZHEIMERS, P124; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WARREN AC, IN PRESS HUM GENET; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEITKAMP LR, 1983, AM J HUM GENET, V35, P443	37	295	303	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1992	2	4					335	339		10.1038/ng1292-335	http://dx.doi.org/10.1038/ng1292-335			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303290				2022-12-25	WOS:A1992KB49500021
J	RUDOLPH, JA; SPIER, SJ; BYRNS, G; ROJAS, CV; BERNOCO, D; HOFFMAN, EP				RUDOLPH, JA; SPIER, SJ; BYRNS, G; ROJAS, CV; BERNOCO, D; HOFFMAN, EP			PERIODIC PARALYSIS IN QUARTER HORSES - A SODIUM-CHANNEL MUTATION DISSEMINATED BY SELECTIVE BREEDING	NATURE GENETICS			English	Article							SKELETAL-MUSCLE; PARAMYOTONIA-CONGENITA; ALPHA-SUBUNIT; GENE; INACTIVATION; EXPRESSION	We recently reported on a linkage study within a Quarter Horse lineage segregating hyperkalaemic periodic paralysis (HYPP), an autosomal dominant condition showing potassium-induced attacks of skeletal muscle paralysis. HYPP co-segregated with the equine adult skeletal muscle sodium channel alpha subunit gene, the same gene that causes human HYPP. We now describe the Phe to Leu mutation in transmembrane domain IVS3 which courses the horse disease. This represents the first application of molecular genetics to an important horse disease, and the data will provide an opportunity for control or eradication of this condition.	UNIV PITTSBURGH,SCH MED,DEPT MOLEC GENET & BIOCHEM,PITTSBURGH,PA 15261; UNIV CALIF DAVIS,SCH VET MED,DEPT MED,DAVIS,CA 95616; UNIV CALIF DAVIS,SCH VET MED,DEPT REPROD,DAVIS,CA 95616; UNIV PITTSBURGH,SCH MED,DEPT HUMAN GENET,PITTSBURGH,PA 15261; UNIV PITTSBURGH,SCH MED,DEPT PEDIAT,PITTSBURGH,PA 15261	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh				Hoffman, Eric/0000-0001-6470-5139				BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; CANNON SC, 1991, NEURON, V6, P619, DOI 10.1016/0896-6273(91)90064-7; CUNNINGHAM P, 1991, SCI AM           MAY, P92; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GREEN P, 1992, CYTOGENET CELL GENET, V59, P122, DOI 10.1159/000133221; HOFFMAN EP, 1991, MOL ASPECTS MED, V12, P175, DOI 10.1016/0098-2997(91)90001-3; HOFFMAN EP, 1991, ORDERING MEMBRANE CY, P113; HOLDEN C, 1991, SCIENCE, V252, P34; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; Kandel E.R., 1991, PRINC NEUROSCI; KOCH MC, 1991, HUM GENET, V88, P71, DOI 10.1007/BF00204932; LEHMANNHORN F, 1987, MUSCLE NERVE, V10, P363, DOI 10.1002/mus.880100414; LEIPOLD HW, 1990, LARGE ANIMAL INTERNA, P1567; MCCLATCHEY AI, 1992, CELL, V68, P769, DOI 10.1016/0092-8674(92)90151-2; NAYLOR JM, 1992, CAN J VET RES, V56, P62; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PICKAR JG, 1991, AM J PHYSIOL, V260, pC926, DOI 10.1152/ajpcell.1991.260.5.C926; PTACEK LJ, 1991, AM J HUM GENET, V49, P851; PTACEK LJ, 1991, CELL, V67, P1021; PTACEK LJ, 1992, NEURON, V8, P891; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; RUDEL R, 1986, MYOLOGY, P1297; RUDOLPH JA, 1992, ANIM GENET, V23, P241, DOI 10.1111/j.1365-2052.1992.tb00136.x; SPIER SJ, 1990, J AM VET MED ASSOC, V197, P1009; SPIER SJ, IN PRESS J AM VET ME; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; WANG JZ, 1992, BIOCHEM BIOPH RES CO, V182, P794, DOI 10.1016/0006-291X(92)91802-W; 1991, YOU AM QUARTER HORSE	29	158	163	0	52	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					144	147		10.1038/ng1092-144	http://dx.doi.org/10.1038/ng1092-144			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1338908				2022-12-25	WOS:A1992JR08400015
J	WIJMENGA, C; HEWITT, JE; SANDKUIJL, LA; CLARK, LN; WRIGHT, TJ; DAUWERSE, HG; GRUTER, AM; HOFKER, MH; MOERER, P; WILLIAMSON, R; VANOMMEN, GJB; PADBERG, GW; FRANTS, RR				WIJMENGA, C; HEWITT, JE; SANDKUIJL, LA; CLARK, LN; WRIGHT, TJ; DAUWERSE, HG; GRUTER, AM; HOFKER, MH; MOERER, P; WILLIAMSON, R; VANOMMEN, GJB; PADBERG, GW; FRANTS, RR			CHROMOSOME-4Q DNA REARRANGEMENTS ASSOCIATED WITH FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY	NATURE GENETICS			English	Article								Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant neuromuscular disorder which maps to chromosome 4qter, distal to the D4S139 locus. The cosmid clone 13E, isolated in a search for homeobox genes, was subsequently mapped to 4q35, also distal to D4S139. A subclone, p13E-11, detects in normal individuals a polymorphic EcoRI fragment usually larger than 28 kilobases (kb). Surprisingly, using the same probe we detected de novo DNA rearrangements, characterized by shorter EcoRI fragments (14-28 kb), in 5 out of 6 new FSHD cases. In 10 Dutch families analysed, a specific shorter fragment between 14-28 kb cosegregates with FSHD. Both observations indicate that FSHD is caused by independent de novo DNA rearrangements in the EcoRI fragment detected by p13E-11.	LEIDEN UNIV,MGC,DEPT HUMAN GENET,2333 AL LEIDEN,NETHERLANDS; IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON W2 1PQ,ENGLAND	Leiden University; Leiden University - Excl LUMC; Imperial College London			Padberg, G.W.A.M./H-8079-2014; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Wijmenga, Cisca/0000-0002-5635-1614	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CALLEN DF, 1990, CLIN GENET, V38, P466; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; HEWITT JE, 1991, GENOMICS, V11, P670, DOI 10.1016/0888-7543(91)90074-O; LANGER PR, 1981, P NATL ACAD SCI-BIOL, V78, P6633, DOI 10.1073/pnas.78.11.6633; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; LUNT PW, 1991, J MED GENET, V28, P655, DOI 10.1136/jmg.28.10.655; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MILLS KA, IN PRESS AM J HUM GE; MUNSAT TL, 1986, MYOLOGY BASIC CLIN, P1251; PADBERG GW, 1982, THESIS LEIDEN U; SARFARAZI M, IN PRESS AM J HUM GE; UPADHYAYA M, 1990, LANCET, V336, P1320, DOI 10.1016/0140-6736(90)93005-A; WEBER JL, 1989, AM J HUM GENET, V44, P388; Wijmenga C, 1990, LANCET, V336, P651, DOI 10.1016/0140-6736(90)92148-B; WIJMENGA C, 1991, GENOMICS, V9, P570, DOI 10.1016/0888-7543(91)90348-I	16	538	556	0	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					26	30		10.1038/ng0992-26	http://dx.doi.org/10.1038/ng0992-26			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1363881				2022-12-25	WOS:A1992JM64600011
J	JAFFE, HA; DANEL, C; LONGENECKER, G; METZGER, M; SETOGUCHI, Y; ROSENFELD, MA; GANT, TW; THORGEIRSSON, SS; STRATFORDPERRICAUDET, LD; PERRICAUDET, M; PAVIRANI, A; LECOCQ, JP; CRYSTAL, RG				JAFFE, HA; DANEL, C; LONGENECKER, G; METZGER, M; SETOGUCHI, Y; ROSENFELD, MA; GANT, TW; THORGEIRSSON, SS; STRATFORDPERRICAUDET, LD; PERRICAUDET, M; PAVIRANI, A; LECOCQ, JP; CRYSTAL, RG			ADENOVIRUS-MEDIATED INVIVO GENE-TRANSFER AND EXPRESSION IN NORMAL RAT-LIVER	NATURE GENETICS			English	Article							ADULT-RAT; HUMAN ALPHA-1-ANTITRYPSIN; INSITU HYBRIDIZATION; DEFICIENT RABBITS; NUCLEAR-PROTEIN; THERAPY; TRANSPLANTATION; HEPATOCYTES; CELLS; DNA	Replication deficient, recombinant adenovirus (Ad) vectors do not require target cell replication for transfer and expression of exogenous genes and thus may be useful for in vivo gene therapy in hepatocytes. In vitro, primary cultures of rat hepatocytes infected with a recombinant Ad containing a human alpha-1-antitrypsin cDNA (Ad-alpha-1AT) synthesized and secreted human alpha-1AT for 4 weeks. In rats, in vivo intraportal administration of a recombinant Ad containing the E coli lacZ gene, was followed by expression of beta-galactosidase in hepatocytes 3 days after infection. Intraportal infusion of Ad-alpha-1AT produced detectable serum levels of human alpha-1AT for 4 weeks. Thus, targeted gene expression has been achieved in the liver, albeit at low levels, suggesting that adenovirus vectors may be a useful means for in vivo gene therapy in liver disorders.	NHLBI,PULM BRANCH,BETHESDA,MD 20892; INST GUSTAVE ROUSSY,CNRS,UA 1301,F-94805 VILLEJUIF,FRANCE; NCI,EXPTL CARCINOGENESIS LAB,BETHESDA,MD 20892; TRANSGENE SA,F-67082 STRASBOURG,FRANCE	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Transgene SA			Setoguchi, Yasuhiro/AAE-1448-2021	Setoguchi, Yasuhiro/0000-0002-0892-6364; Gant, Timothy/0000-0001-9057-4937				ALLAN FD, 1960, ESSENTIALS HUMAN EMB, P93; AM PH, 1990, NEW ENGL J MED, V322, P1652; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; BERNAUDIN JF, 1988, J IMMUNOL, V140, P3822; Brues AM, 1937, J EXP MED, V65, P15, DOI 10.1084/jem.65.1.15; BRUSILOW SW, 1989, METABOLIC BASIS INHE, P399; CASOLARO MA, 1987, J APPL PHYSIOL, V63, P2015, DOI 10.1152/jappl.1987.63.5.2015; CHANOCK RM, 1966, J AMER MED ASSOC, V195, P445, DOI 10.1001/jama.195.6.445; CHOWDHURY JR, 1991, SCIENCE, V254, P1802, DOI 10.1126/science.1722351; CURIEL DT, 1989, J BIOL CHEM, V264, P10477; DANNENBERG AM, 1981, METHODS STUDYING MON, P375; DEMETRIOU AA, 1986, SCIENCE, V233, P1190, DOI 10.1126/science.2426782; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; FRENCH T, 1989, CLIN CHEM LABORATORY, P213; FRIEDMANN T, 1989, SCIENCE, V244, P1275, DOI 10.1126/science.2660259; GARVER RI, 1987, SCIENCE, V237, P762, DOI 10.1126/science.3497452; GILARDI P, 1990, FEBS LETT, V267, P60, DOI 10.1016/0014-5793(90)80287-S; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GRIFFITHS PD, 1990, BRIT MED BULL, V46, P512, DOI 10.1093/oxfordjournals.bmb.a072413; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; HATZOGLOU M, 1990, J BIOL CHEM, V265, P17285; HORWICH AL, 1991, CURR T MICR, V168, P186; HORWITZ MS, 1990, VIROLOGY, P01679; INAGAKI M, 1991, CELL STRUCT FUNCT, V16, P283, DOI 10.1247/csf.16.283; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; JONES SN, 1990, J BIOL CHEM, V265, P14684; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALEKO M, 1991, HUM GENE THER, V2, P27, DOI 10.1089/hum.1991.2.1-27; KANEDA Y, 1989, SCIENCE, V243, P375, DOI 10.1126/science.2911748; KANEDA Y, 1989, J BIOL CHEM, V264, P12126; KATO K, 1991, J BIOL CHEM, V266, P3361; KAY MA, 1992, P NATL ACAD SCI USA, V89, P89, DOI 10.1073/pnas.89.1.89; LEDLEY FD, 1990, J INHERIT METAB DIS, V13, P597, DOI 10.1007/BF01799515; LONBERGHOLM K, 1969, J VIROL, V4, P323, DOI 10.1128/JVI.4.4.323-338.1969; MILLER AD, 1990, BLOOD, V76, P271; PALMER TD, 1991, P NATL ACAD SCI USA, V88, P1330, DOI 10.1073/pnas.88.4.1330; PASTAN I, 1986, CONCEPTS VIRAL PATHO, V2, P141; PEARSON B, 1963, LAB INVEST, V12, P1249; PHILIPSON L, 1968, J VIROL, V2, P1064, DOI 10.1128/JVI.2.10.1064-1075.1968; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SEGLEN PO, 1979, J TOXICOL ENV HEALTH, V5, P551, DOI 10.1080/15287397909529766; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; SHIMADA T, 1991, FEBS LETT, V279, P198, DOI 10.1016/0014-5793(91)80148-V; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P7128, DOI 10.1073/pnas.80.23.7128; STRATFORDPERRICAUDET LD, 1990, HUM GENE THER, V1, P241, DOI 10.1089/hum.1990.1.3-241; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; Strauss SE, 1984, ADENOVIRUSES, P451; VEHAR GA, 1989, METABOLIC BASIS INHE, P2107; WILSON JM, 1990, P NATL ACAD SCI USA, V87, P8437, DOI 10.1073/pnas.87.21.8437; WILSON JM, 1992, J BIOL CHEM, V267, P963; WILSON JM, 1990, MOL BIOL MED, V7, P223; WU CH, 1989, J BIOL CHEM, V264, P16985; WU GY, 1991, J BIOL CHEM, V266, P14338; YAMAMOTO T, 1980, CELL, V22, P787, DOI 10.1016/0092-8674(80)90555-3	59	443	505	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1992	1	5					372	378		10.1038/ng0892-372	http://dx.doi.org/10.1038/ng0892-372			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	1302034				2022-12-25	WOS:A1992JJ12100017
J	BATES, GP; VALDES, J; HUMMERICH, H; BAXENDALE, S; LEPASLIER, DL; MONACO, AP; TAGLE, D; MACDONALD, ME; ALTHERR, M; ROSS, M; BROWNSTEIN, BH; BENTLEY, D; WASMUTH, JJ; GUSELLA, JF; COHEN, D; COLLINS, F; LEHRACH, H				BATES, GP; VALDES, J; HUMMERICH, H; BAXENDALE, S; LEPASLIER, DL; MONACO, AP; TAGLE, D; MACDONALD, ME; ALTHERR, M; ROSS, M; BROWNSTEIN, BH; BENTLEY, D; WASMUTH, JJ; GUSELLA, JF; COHEN, D; COLLINS, F; LEHRACH, H			CHARACTERIZATION OF A YEAST ARTIFICIAL CHROMOSOME CONTIG SPANNING THE HUNTINGTONS-DISEASE GENE CANDIDATE REGION	NATURE GENETICS			English	Article							DNA MARKERS; LIBRARY; CONSTRUCTION; TELOMERE; CLONES; LOCUS; D4S95; G8	The Huntington's disease (HD) gene has been localized by recombination events to a region covering 2.2 megabases (Mb) DNA within chromosome 4p16.3. We have screened three yeast artificial chromosome (YAC) libraries in order to isolate and characterize 44 YAC clones mapping to this region. Approximately 50% of the YACs were chimaeric. Unstable YACs were identified across the whole region, but were particularly prevalent around the D4S183 and D4S43 loci. The YACs have been assembled into a contig extending from D4S126 to D4S98 covering roughly 2 Mb DNA except for a gap of about 250 kilobases (kb). The establishment of a YAC contig which spans the region most likely to contain the HD mutation is an essential step in the isolation of the HD gene.	CTR ETUD POLYMORPHISME HUMAIN,F-75010 PARIS,FRANCE; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED & HUMAN GENET,ANN ARBOR,MI 48109; JOHN RADCLIFFE HOSP,INST MOLEC MED,IMPERIAL CANC RES FUND,HUMAN GENET LAB,OXFORD OX3 9DU,ENGLAND; MASSACHUSETTS GEN HOSP,NEUROGENET LAB,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; UNIV CALIF IRVINE,COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717; WASHINGTON UNIV,SCH MED,DEPT GENET,ST LOUIS,MO 63110; GUYS HOSP,DIV MED & MOLEC GENET,LONDON SE1 9RT,ENGLAND	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Oxford; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Irvine; Washington University (WUSTL); Guy's & St Thomas' NHS Foundation Trust	BATES, GP (corresponding author), IMPERIAL CANC RES FUND,GENOME ANAL LAB,44 LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.		Monaco, Anthony P/A-4495-2010; Bates, Gillian P/E-1146-2012	Monaco, Anthony P/0000-0001-7480-3197; Bates, Gillian P/0000-0002-4041-6305; Le Paslier, Denis/0000-0003-4335-9956; Baxendale, Sarah/0000-0002-6760-9457				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALLITTO BA, 1991, GENOMICS, V9, P104, DOI 10.1016/0888-7543(91)90226-5; ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; BARRON L, 1991, J MED GENET, V28, P520, DOI 10.1136/jmg.28.8.520; BATES GP, 1990, AM J HUM GENET, V46, P762; BATES GP, 1991, AM J HUM GENET, V49, P7; BAXENDALE S, 1991, NUCLEIC ACIDS RES, V19, P6651, DOI 10.1093/nar/19.23.6651; BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; BRONSON SK, 1991, P NATL ACAD SCI USA, V88, P1676, DOI 10.1073/pnas.88.5.1676; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BUCAN M, 1990, GENOMICS, V6, P1; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURMEISTER M, 1989, TRENDS GENET, V5, P41, DOI 10.1016/0168-9525(89)90019-X; CARLE GF, 1986, SCIENCE, V232, P65, DOI 10.1126/science.3952500; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; GILLIAM TC, 1987, SCIENCE, V238, P950, DOI 10.1126/science.2890209; GREEN ED, 1991, GENOMICS, V11, P658, DOI 10.1016/0888-7543(91)90073-N; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; GREEN ED, 1990, SCIENCE, V250, P94, DOI 10.1126/science.2218515; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; GUSELLA JF, 1992, GENOMICS, V13, P75, DOI 10.1016/0888-7543(92)90204-6; IMAI T, 1990, GENOMICS, V8, P297, DOI 10.1016/0888-7543(90)90285-3; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LIN CS, 1991, SOMAT CELL MOLEC GEN, V17, P481, DOI 10.1007/BF01233172; MACDONALD M E, 1987, Genomics, V1, P29, DOI 10.1016/0888-7543(87)90101-7; MACDONALD ME, 1989, J CLIN INVEST, V84, P1013, DOI 10.1172/JCI114222; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MONACO AP, 1991, NUCLEIC ACIDS RES, V19, P3315, DOI 10.1093/nar/19.12.3315; NELSON DL, 1990, GENET ANAL-BIOMOL E, V7, P100, DOI 10.1016/0735-0651(90)90014-7; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; PERLINO E, 1985, NUCLEIC ACIDS RES, V9, P8399; POHL TM, 1988, NUCLEIC ACIDS RES, V16, P9185, DOI 10.1093/nar/16.19.9185; RICHARDS JE, 1988, P NATL ACAD SCI USA, V85, P6437, DOI 10.1073/pnas.85.17.6437; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROBBINS C, 1989, AM J HUM GENET, V44, P422; Ross M. T., 1992, Techniques for the analysis of complex genomes., P137; SMITH B, 1988, AM J HUM GENET, V42, P335; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; SNELL RG, 1992, IN PRESS AM J HUM GE; TAGLE DA, IN PRESS HUM MOL GEN; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WASMUTH JJ, 1986, AM J HUM GENET, V39, P397; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WHALEY WL, 1988, NUCLEIC ACIDS RES, V16, P11769, DOI 10.1093/nar/16.24.11769; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P83, DOI 10.1007/BF01233207	48	76	80	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					180	187		10.1038/ng0692-180	http://dx.doi.org/10.1038/ng0692-180			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303232				2022-12-25	WOS:A1992JC98200009
J	TIMMERMAN, V; NELIS, E; VANHUL, W; NIEUWENHUIJSEN, BW; CHEN, KL; WANG, S; OTHMAN, KB; CULLEN, B; LEACH, RJ; HANEMANN, CO; DE JONGHE, P; RAEYMAEKERS, P; VANOMMEN, GJB; MARTIN, JJ; MULLER, HW; VANCE, JM; FISCHBECK, KH; VAN BROECKHOVEN, C				TIMMERMAN, V; NELIS, E; VANHUL, W; NIEUWENHUIJSEN, BW; CHEN, KL; WANG, S; OTHMAN, KB; CULLEN, B; LEACH, RJ; HANEMANN, CO; DE JONGHE, P; RAEYMAEKERS, P; VANOMMEN, GJB; MARTIN, JJ; MULLER, HW; VANCE, JM; FISCHBECK, KH; VAN BROECKHOVEN, C			THE PERIPHERAL MYELIN PROTEIN GENE PMP-22 IS CONTAINED WITHIN THE CHARCOT-MARIE-TOOTH DISEASE TYPE-1A DUPLICATION	NATURE GENETICS			English	Article							NEUROPATHY TYPE-I; MOUSE; MAP	Charcot-Marie-Tooth disease (CMT1) is the most common form of inherited peripheral neuropathy. Although the disease is genetically heterogeneous, it has been demonstrated that the gene defect in the most frequent type (CMT1A) is the result of a partial duplication of band 17p11.2. Recent studies suggested that the peripheral hypomyelination syndrome in the trembler (Tr) mouse, a possible animal model for CMT1 disease, is associated with a point mutation in the peripheral myelin protein-22 gene (pmp-22). Expression of pmp-22 is particularly high in Schwann cells, and the protein is found in peripheral myelin. We now report that the human PMP-22 gene is contained within the CMT1A duplication. We therefore, suggest that increased dosage of the PMP-22 gene may be the cause of CMT1A neuropathy.	UNIV INSTELLING ANTWERP, DEPT BIOCHEM,BORN BUNGE FDN,NEUROGENET LAB, UNIV PLEIN 1, B-2610 WILRIJK, BELGIUM; UNIV PENN, SCH MED, DEPT NEUROL, PHILADELPHIA, PA 19104 USA; DUKE UNIV, MED CTR, DIV NEUROL, DURHAM, NC 27710 USA; UNIV TEXAS, HLTH SCI CTR, SAN ANTONIO, TX 78284 USA; UNIV DUSSELDORF, DEPT NEUROL, MOLEC NEUROBIOL LAB, W-4000 DUSSELDORF 1, GERMANY; UNIV INSTELLING ANTWERP, DEPT MED, BORN BUNGE FDN, NEUROPATHOL LAB, B-2610 WILRIJK, BELGIUM; ACAD HOSP ANTWERP, DIV NEUROL, B-2610 ANTWERP, BELGIUM; LEIDEN UNIV, DEPT HUMAN GENET, 2300 RA LEIDEN, NETHERLANDS	University of Antwerp; University of Pennsylvania; Duke University; University of Texas System; University of Texas Health San Antonio; Heinrich Heine University Dusseldorf; University of Antwerp; University of Antwerp; Leiden University; Leiden University - Excl LUMC			Hanemann, C Oliver/AAV-6257-2020; Van Broeckhoven, Christine/M-7853-2019; Timmerman, Vincent/O-7283-2019	Hanemann, C Oliver/0000-0002-1951-1025; Van Broeckhoven, Christine/0000-0003-0183-7665; Timmerman, Vincent/0000-0002-2162-0933; Vance, Jeffery/0000-0003-3815-8199; Leach, Robin/0000-0002-3201-5579; Van Hul, Wim/0000-0002-5065-7858				AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; BUCHBERG AM, 1989, GENETICS, V122, P153; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLOMBO MP, 1992, MAMM GENOME, V2, P130, DOI 10.1007/BF00353861; DOCHERTY Z, 1983, J MED GENET, V20, P138, DOI 10.1136/jmg.20.2.138; DRIESEN MS, 1991, GENOMICS, V11, P1079, DOI 10.1016/0888-7543(91)90035-D; Dyck P.J., 1984, PERIPHERAL NEUROPATH, P1600; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HENRY EW, 1988, SCIENCE, V241, P344, DOI 10.1126/science.3388045; HOOGENDIJK JE, 1991, HUM GENET, V88, P215, DOI 10.1007/BF00206075; LEBO RV, 1991, HUM GENET, V88, P1, DOI 10.1007/BF00204921; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MAGENIS RE, 1986, AM J MED GENET, V24, P415, DOI 10.1002/ajmg.1320240304; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; OCONNELL P, 1989, SCIENCE, V244, P1087, DOI 10.1126/science.2543077; PHAMDINH D, 1991, P NATL ACAD SCI USA, V88, P7562, DOI 10.1073/pnas.88.17.7562; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TIMMERMAN V, 1990, AM J HUM GENET, V47, P680; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; VANOMMEN GJB, 1986, ANAL HUMAN GENETIC D, P113; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195	29	403	403	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1992	1	3					171	175		10.1038/ng0692-171	http://dx.doi.org/10.1038/ng0692-171			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303230				2022-12-25	WOS:A1992JC98200007
J	ASHWORTH, LK; BATZER, MA; BRANDRIFF, B; BRANSCOMB, E; DEJONG, P; GARCIA, E; GARNES, JA; GORDON, LA; LAMERDIN, JE; LENNON, G; MOHRENWEISER, H; OLSEN, AS; SLEZAK, T; CARRANO, AV				ASHWORTH, LK; BATZER, MA; BRANDRIFF, B; BRANSCOMB, E; DEJONG, P; GARCIA, E; GARNES, JA; GORDON, LA; LAMERDIN, JE; LENNON, G; MOHRENWEISER, H; OLSEN, AS; SLEZAK, T; CARRANO, AV			AN INTEGRATED METRIC PHYSICAL MAP OF HUMAN-CHROMOSOME-19	NATURE GENETICS			English	Article							HUMAN GENOME; HIGH-RESOLUTION; HUMAN DNA; GENE; ORGANIZATION; CLONING; CLONES; LIBRARIES; FRAGMENTS; MARKERS	A metric physical map of human chromosome 19 has been generated. The foundation of the map is sets of overlapping cosmids (contigs) generated by automated fingerprinting spanning over 95% of the euchromatin, about 50 megabases (Mb). Distances between selected cosmid clones were estimated using fluorescence in situ hybridization in sperm pronuclei, providing both order and distance between contigs. An average inter-marker separation of 230 kb has been obtained across the non-centromeric portion of the chromosome. Various types of larger insert clones were used to span gaps between contigs. Currently, the map consists of 51 'islands' containing multiple clone types, whose size, order and relative distance are known. Over 450 genes, genetic markers, sequence tagged sites (STSs), anonymous cDNAs, and other markers have been localized. In addition, EcoRI restriction maps have been generated for >41 Mb (similar to 83%) of the chromosome.			ASHWORTH, LK (corresponding author), LAWRENCE LIVERMORE NATL LAB,CTR HUMAN GENOME,BIOL & BIOTECHNOL RES PROGRAM,L-452,LIVERMORE,CA 94551, USA.		Lennon, Greg/T-4717-2019					ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ASHWORTH LK, 1995, ANAL BIOCHEM, V224, P564, DOI 10.1006/abio.1995.1088; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BELLEFROID EJ, 1993, EMBO J, V12, P1363, DOI 10.1002/j.1460-2075.1993.tb05781.x; BRANDRIFF B, 1991, GENOMICS, V10, P75, DOI 10.1016/0888-7543(91)90486-X; BRANDRIFF BF, 1994, GENOMICS, V23, P582, DOI 10.1006/geno.1994.1546; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; CARRANO AV, 1989, GENOMICS, V4, P129, DOI 10.1016/0888-7543(89)90291-7; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; COHEN D, 1992, NATURE, V366, P698; COPELAND A, 1994, NATURE, V369, P421, DOI 10.1038/369421a0; COX DR, 1994, SCIENCE, V265, P2031, DOI 10.1126/science.8091223; Dausset J, 1992, Behring Inst Mitt, P13; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; GARCIA E, 1995, GENOMICS, V27, P52, DOI 10.1006/geno.1995.1007; GORDON L, IN PRESS GENOMICS; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; HOFFMAN SMG, IN PRESS J MOL EVOL, V41; HROMAS R, 1991, J BIOL CHEM, V266, P14183; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; JOUTEL A, 1993, NAT GENET, V5, P40, DOI 10.1038/ng0993-40; KNOWLTON RG, IN PRESS GENOMICS; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; LAMERDIN JE, 1993, BIOTECHNIQUES, V15, P294; LAMERDIN JE, 1995, GENOMICS, V25, P547, DOI 10.1016/0888-7543(95)80056-R; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; MARTINGALLARDO A, 1992, NAT GENET, V1, P34, DOI 10.1038/ng0492-34; MAYALL BH, 1984, CYTOMETRY, V5, P376, DOI 10.1002/cyto.990050414; MCCURLEY RS, 1995, GENOMICS, V26, P142, DOI 10.1016/0888-7543(95)80094-3; MOHRENWEISER HW, 1995, P GENOME MAPPING SEQ, P215; NELSON DO, 1994, STAT SCI, V9, P334, DOI 10.1214/ss/1177010380; OLSEN A, 1994, GENOMICS, V23, P659, DOI 10.1006/geno.1994.1555; OLSEN AS, 1993, BIOTECHNIQUES, V14, P116; OLSON MV, 1993, COLD SPRING HARB SYM, V58, P349, DOI 10.1101/SQB.1993.058.01.041; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; SLEZAK T, 1994, 28TH P ANN INT C SYS; STRITTMATTER WJ, 1995, P NATL ACAD SCI USA, V92, P4725, DOI 10.1073/pnas.92.11.4725; TEGLUND S, 1994, GENOMICS, V23, P669, DOI 10.1006/geno.1994.1556; TRASK B, 1993, GENOMICS, V15, P133, DOI 10.1006/geno.1993.1021; TRASK BJ, 1993, 3 HUM GEN PROGR USDO, P189; TYNAN K, 1993, GENOMICS, V17, P316, DOI 10.1006/geno.1993.1327; WEBER CA, 1990, EMBO J, V9, P1437, DOI 10.1002/j.1460-2075.1990.tb08260.x; 1994, SCIENCE, V265, P2049	50	172	173	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					422	427		10.1038/ng1295-422	http://dx.doi.org/10.1038/ng1295-422			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493023				2022-12-25	WOS:A1995TH62900020
J	MAYORDOMO, JI; ZORINA, T; STORKUS, WJ; ZITVOGEL, L; CELLUZZI, C; FALO, LD; MELIEF, CJ; ILDSTAD, ST; KAST, WM; DELEO, AB; LOTZE, MT				MAYORDOMO, JI; ZORINA, T; STORKUS, WJ; ZITVOGEL, L; CELLUZZI, C; FALO, LD; MELIEF, CJ; ILDSTAD, ST; KAST, WM; DELEO, AB; LOTZE, MT			BONE-MARROW-DERIVED DENDRITIC CELLS PULSED WITH SYNTHETIC TUMOR PEPTIDES ELICIT PROTECTIVE AND THERAPEUTIC ANTITUMOR IMMUNITY	NATURE MEDICINE			English	Article							COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; LANGERHANS CELLS; LYMPHOCYTES; GENERATION; MOLECULES; INVIVO	Dendritic cells, the most potent 'professional' antigen-presenting cells, hold promise for improving the immunotherapy of cancer. In three different well-characterized tumour models, naive mice injected with bone marrow-derived dendritic cells prepulsed with tumour-associated peptides previously characterized as being recognized by class 1 major histocompatibility complex-restricted cytotoxic T lymphocytes, developed a specific T-lymphocyte response and were protected against a subsequent lethal tumour challenge. Moreover, in the C3 sarcoma and the 3LL lung carcinoma murine models, treatment of animals bearing established macroscopic tumours (up to 1 cm(2) in size) with tumour peptide-pulsed dendritic cells resulted in sustained tumour regression and tumour-free status in more than 80% of cases. These results support the clinical use of tumour peptide-pulsed dendritic cells as components in developing effective cancer vaccines and therapies.	UNIV PITTSBURGH,DEPT CELL THERAPEUT,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT PATHOL,PITTSBURGH,PA 15261; UNIV PITTSBURGH,DEPT DERMATOL,PITTSBURGH,PA 15261; UNIV PITTSBURGH,INST CANC,PITTSBURGH,PA 15261; LEIDEN UNIV HOSP,DEPT IMMUNOHEMATOL,LEIDEN,NETHERLANDS; LEIDEN UNIV HOSP,BLOOD BANK,2333 AA LEIDEN,NETHERLANDS	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	MAYORDOMO, JI (corresponding author), UNIV PITTSBURGH,DEPT SURG,PITTSBURGH,PA 15261, USA.		Falo, Louis/ABD-1499-2020; Mayordomo, Jose/K-3453-2013	Kast, W Martin/0000-0003-2321-3159; ZITVOGEL, laurence/0000-0003-1596-0998; Celluzzi, Christina/0000-0002-2886-5597; Storkus, Walter/0000-0001-8961-4444	NATIONAL CANCER INSTITUTE [R01CA057840, R01CA067407] Funding Source: NIH RePORTER; NCI NIH HHS [CA 57840, CA67407] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AICHELE P, 1995, J EXP MED, V182, P261, DOI 10.1084/jem.182.1.261; BELLONE M, 1994, EUR J IMMUNOL, V24, P2691, DOI 10.1002/eji.1830241118; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; CAUX C, 1995, IMMUNOL TODAY, V16, P2, DOI 10.1016/0167-5699(95)80061-1; CAUX C, 1991, BLOOD, V78, P635; CAUX C, 1994, J EXP MED, V180, P1841, DOI 10.1084/jem.180.5.1841; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; FLAMAND V, 1994, EUR J IMMUNOL, V24, P605, DOI 10.1002/eji.1830240317; FRASSANITO MA, 1995, CANCER RES, V55, P124; GRABBE S, 1991, J IMMUNOL, V146, P3656; GRABBE S, 1995, IMMUNOL TODAY, V16, P116; GYURE LA, 1987, BRIT J CANCER, V55, P17, DOI 10.1038/bjc.1987.4; HSU FJ, 1994, BLOOD, V84, pA520; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; INABA K, 1992, J EXP MED, V175, P1157, DOI 10.1084/jem.175.5.1157; JENKINS MK, 1994, IMMUNITY, V1, P443, DOI 10.1016/1074-7613(94)90086-8; KAST WM, 1988, J IMMUNOL, V140, P3186; KNIGHT SC, 1985, P NATL ACAD SCI USA, V82, P4495, DOI 10.1073/pnas.82.13.4495; KOCH F, 1990, J EXP MED, V171, P159, DOI 10.1084/jem.171.1.159; LANIER LL, 1995, J IMMUNOL, V154, P97; MANDELBOIM O, 1994, NATURE, V369, P67, DOI 10.1038/369067a0; MIZOGUCHI H, 1992, SCIENCE, V258, P1795, DOI 10.1126/science.1465616; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; PAN ZK, 1995, NAT MED, V1, P471, DOI 10.1038/nm0595-471; PARDOLL DM, 1994, NATURE, V369, P357, DOI 10.1038/369357a0; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P432, DOI 10.1073/pnas.92.2.432; PORGADOR A, 1995, J EXP MED, V182, P255, DOI 10.1084/jem.182.1.255; RAZIWOLF Z, 1994, EUR J IMMUNOL, V24, P805, DOI 10.1002/eji.1830240405; ROCK KL, 1993, J IMMUNOL, V150, P1244; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; STORKUS WJ, 1995, BIOL THERAPY CANC, P64; TAKAHASHI H, 1993, INT IMMUNOL, V5, P849, DOI 10.1093/intimm/5.8.849; TAMAKI K, 1979, J IMMUNOL, V123, P784; ZORINA T, 1994, J IMMUNOTHER, V16, P247	38	1016	1073	1	59	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1297	1302		10.1038/nm1295-1297	http://dx.doi.org/10.1038/nm1295-1297			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489412				2022-12-25	WOS:A1995TH78600043
J	NELSON, JB; HEDICAN, SP; GEORGE, DJ; REDDI, AH; PIANTADOSI, S; EISENBERGER, MA; SIMONS, JW				NELSON, JB; HEDICAN, SP; GEORGE, DJ; REDDI, AH; PIANTADOSI, S; EISENBERGER, MA; SIMONS, JW			IDENTIFICATION OF ENDOTHELIN-1 IN THE PATHOPHYSIOLOGY OF METASTATIC ADENOCARCINOMA OF THE PROSTATE	NATURE MEDICINE			English	Article							BREAST-CANCER CELLS; IMMUNOREACTIVE ENDOTHELIN; GENE-EXPRESSION; STROMAL CELLS; HUMAN-PLASMA; DISEASE; GROWTH; ANTIGEN; FAMILY; TUMOR	Prostate cancer is the second most common cause of death from cancer in U.S. men, and advanced, hormone-refractory disease is characterized by painful osteoblastic bone metastases. Endothelin-1, more commonly known as a potent vasoconstrictor, is a normal ejaculate protein that also stimulates osteoblasts. We show here that plasma immunoreactive endothelin concentrations are significantly elevated in men with metastatic prostate cancer and that every human prostate cancer cell line tested produces endothelin-1 messenger RNA and secretes immunoreactive endothelin. Exogenous endothelin-1 is a prostate cancer mitogen in vitro and increases alkaline phosphatase activity in new bone formation, indicating that ectopic endothelin-1 may be a mediator of the osteoblastic response of bone to metastatic prostate cancer.	JOHNS HOPKINS MED INST,JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21287; JOHNS HOPKINS MED INST,DEPT ORTHOPED SURG,BALTIMORE,MD 21287	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	NELSON, JB (corresponding author), JOHNS HOPKINS UNIV HOSP,JAMES BUCHANAN BRADY UROL INST,MARBURG 1,600 N WOLFE ST,BALTIMORE,MD 21287, USA.				NCI NIH HHS [CA 01495, CA 58236] Funding Source: Medline; NIDDK NIH HHS [DK07552] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K11CA001495, P50CA058236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007552] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAM ASMT, 1992, ENDOCRINOLOGY, V130, P3617, DOI 10.1210/en.130.6.3617; BATTISTINI B, 1993, PEPTIDES, V14, P385, DOI 10.1016/0196-9781(93)90057-N; BATTISTINI B, 1993, LAB INVEST, V68, P600; BROWN KD, 1989, BIOCHEM J, V263, P977, DOI 10.1042/bj2630977; CACOUB P, 1993, NEW ENGL J MED, V329, P1967; CASEY ML, 1992, J CLIN ENDOCR METAB, V74, P223, DOI 10.1210/jc.74.1.223; CERNACEK P, 1989, BIOCHEM BIOPH RES CO, V161, P562, DOI 10.1016/0006-291X(89)92636-3; CHARACHE S, 1967, ANN INTERN MED, V67, P1195, DOI 10.7326/0003-4819-67-6-1195; DAHLOF B, 1990, J HYPERTENS, V8, P811, DOI 10.1097/00004872-199009000-00004; ECONOMOS K, 1992, CANCER RES, V52, P554; EISENBERGER MA, 1993, J NATL CANCER I, V85, P611, DOI 10.1093/jnci/85.8.611; ERDOS EG, 1985, LAB INVEST, V52, P437; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; KELLY WK, 1993, J CLIN ONCOL, V11, P607, DOI 10.1200/JCO.1993.11.4.607; KOBAYASHI S, 1994, MOL PHARMACOL, V45, P306; KOBAYASHI S, 1994, J UROLOGY, V151, P763, DOI 10.1016/S0022-5347(17)35083-8; KOCHVA E, 1993, TOXICON, V31, P541, DOI 10.1016/0041-0101(93)90111-U; KOCHVA E, 1982, TOXICON, V20, P581, DOI 10.1016/0041-0101(82)90052-6; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; KRUSKAL WH, 1953, J AM STAT ASSOC, V48, P907, DOI 10.2307/2281082; KUSUHARA M, 1990, CANCER RES, V50, P3257; LAM HC, 1991, J CARDIOVASC PHARM, V17, pS390, DOI 10.1097/00005344-199100177-00109; LANGENSTROER P, 1993, J UROLOGY, V149, P495; LERMAN A, 1991, NEW ENGL J MED, V325, P997, DOI 10.1056/NEJM199110033251404; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACCUMBER MW, 1989, P NATL ACAD SCI USA, V86, P7285, DOI 10.1073/pnas.86.18.7285; MOLLER S, 1993, J HEPATOL, V19, P285, DOI 10.1016/S0168-8278(05)80584-7; MOORE K, 1992, NEW ENGL J MED, V327, P1774, DOI 10.1056/NEJM199212173272502; MULDOON LL, 1989, J BIOL CHEM, V264, P8529; NAKAMUTA M, 1993, AM J GASTROENTEROL, V88, P248; OESTERLING JE, 1988, J UROLOGY, V139, P766, DOI 10.1016/S0022-5347(17)42630-9; OGAWA S, 1993, J CARDIOVASC PHARM, V22, pS364, DOI 10.1097/00005344-199322008-00095; Papandreou C., 1995, Proceedings of the American Association for Cancer Research Annual Meeting, V36, P268; PITTET JF, 1991, ANN SURG, V213, P261, DOI 10.1097/00000658-199103000-00014; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; POLDERMAN KH, 1993, ANN INTERN MED, V118, P429, DOI 10.7326/0003-4819-118-6-199303150-00006; REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601; REDDI AH, 1980, ENDOCRINOLOGY, V107, P1291, DOI 10.1210/endo-107-5-1291; ROLINSKI B, 1994, RES EXP MED, V194, P9, DOI 10.1007/BF02576362; RUBANYI GM, 1991, FASEB J, V5, P2713, DOI 10.1096/fasebj.5.12.1916094; RUBIN SA, 1994, J CLIN ENDOCR METAB, V78, P6, DOI 10.1210/jc.78.1.6; SCHER HI, 1994, SEMIN ONCOL, V21, P630; SCHICHIRI M, 1991, J CLIN INVEST, V87, P1867; SCHREY MP, 1992, CANCER RES, V52, P1786; SCHVARTZ I, 1992, PEPTIDES, V13, P159, DOI 10.1016/0196-9781(92)90157-X; SHIOIDE M, 1993, J CELL BIOCHEM, V53, P176, DOI 10.1002/jcb.240530211; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; SIMONSON MS, 1990, FASEB J, V4, P2989, DOI 10.1096/fasebj.4.12.2168326; STAMEY TA, 1987, NEW ENGL J MED, V317, P909, DOI 10.1056/NEJM198710083171501; SUZUKI N, 1989, J BIOCHEM-TOKYO, V106, P736, DOI 10.1093/oxfordjournals.jbchem.a122925; TAKASAKI C, 1988, NATURE, V335, P303, DOI 10.1038/335303b0; TAKUWA Y, 1990, BIOCHEM BIOPH RES CO, V170, P998, DOI 10.1016/0006-291X(90)90491-5; TAKUWA Y, 1989, AM J PHYSIOL, V257, pE797, DOI 10.1152/ajpendo.1989.257.6.E797; WAGNER OF, 1992, J BIOL CHEM, V267, P16066; WARNER TD, 1994, BIOCHEM PHARMACOL, V48, P625, DOI 10.1016/0006-2952(94)90038-8; WEI CM, 1994, CIRCULATION, V89, P1580, DOI 10.1161/01.CIR.89.4.1580; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; YAMANE K, 1992, J RHEUMATOL, V19, P1566; YAMASHITA J, 1993, CANCER RES, V53, P464; YAMASHITA J, 1992, CANCER RES, V52, P4046; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; YASUDA M, 1990, AM HEART J, V119, P801, DOI 10.1016/S0002-8703(05)80315-1; YOKOKAWA K, 1991, ANN INTERN MED, V114, P213, DOI 10.7326/0003-4819-114-3-213; YOKOKAWA K, 1991, J CARDIOVASC PHARM, V17, pS398, DOI 10.1097/00005344-199100177-00111	65	501	524	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	SEP	1995	1	9					944	949		10.1038/nm0995-944	http://dx.doi.org/10.1038/nm0995-944			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585222				2022-12-25	WOS:A1995RT30300050
J	MONROE, KR; YU, MC; KOLONEL, LN; COETZEE, GA; WILKENS, LR; ROSS, RK; HENDERSON, BE				MONROE, KR; YU, MC; KOLONEL, LN; COETZEE, GA; WILKENS, LR; ROSS, RK; HENDERSON, BE			EVIDENCE OF AN X-LINKED OR RECESSIVE GENETIC COMPONENT TO PROSTATE-CANCER RISK	NATURE MEDICINE			English	Article								We used data from a population-based cohort study of blacks, Hispanics, Japanese and whites to examine the frequency of prevalent prostate and breast cancer by family history status of first-degree relatives (parents and siblings). Independent of race, the age-adjusted relative risk for prevalent prostate cancer in subjects with affected brothers was approximately two times that in subjects with affected fathers (P<0.00005). No such excess risk for breast cancer was observed among subjects with affected sisters compared to those with affected mothers (age- and race-adjusted relative risk = 1.10, P = 0.34). The magnitude of the relative risk for prostate cancer in sibling- versus parent-affected groups was significantly different from that of the comparable relative risk for breast cancer (P <0.00005). An excess risk of prostate cancer in men with affected brothers compared to those with affected fathers is consistent with the hypothesis of an X-linked, or recessive, model of inheritance.	UNIV SO CALIF,SCH MED,DEPT PREVENT MED,LOS ANGELES,CA 90033; UNIV SO CALIF,SCH MED,DEPT UROL,LOS ANGELES,CA 90033; UNIV HAWAII,CANC RES CTR HAWAII,HONOLULU,HI 96813	University of Southern California; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System			Coetzee, Gerhard/AAG-8439-2019; coetzee, Gerhard/AAT-6203-2020	Coetzee, Gerhard/0000-0001-8820-8364	NATIONAL CANCER INSTITUTE [R01CA054281, R35CA053890] Funding Source: NIH RePORTER; NCI NIH HHS [R35 CA53890, R01 CA54281] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; COETZEE GA, 1994, J NATL CANCER I, V86, P872, DOI 10.1093/jnci/86.11.872; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; HAYES RB, 1995, INT J CANCER, V60, P361, DOI 10.1002/ijc.2910600315; IRVINE RA, 1995, CANCER RES, V55, P1937; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; ROSS RK, 1995, CANCER, V75, P1778, DOI 10.1002/1097-0142(19950401)75:7+<1778::AID-CNCR2820751605>3.0.CO;2-J; WHITTEMORE AS, 1995, AM J EPIDEMIOL, V141, P732, DOI 10.1093/oxfordjournals.aje.a117495; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E; 1991, CANCER LOS ANGELES C	11	174	175	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1995	1	8					827	829		10.1038/nm0895-827	http://dx.doi.org/10.1038/nm0895-827			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585188				2022-12-25	WOS:A1995RM63500042
J	MURAKAMI, Y; NAITOU, M; HAGIWARA, H; SHIBATA, T; OZAWA, M; SASANUMA, S; SASANUMA, M; TSUCHIYA, Y; SOEDA, E; YOKOYAMA, K; YAMAZAKI, M; TASHIRO, H; EKI, T				MURAKAMI, Y; NAITOU, M; HAGIWARA, H; SHIBATA, T; OZAWA, M; SASANUMA, S; SASANUMA, M; TSUCHIYA, Y; SOEDA, E; YOKOYAMA, K; YAMAZAKI, M; TASHIRO, H; EKI, T			ANALYSIS OF THE NUCLEOTIDE-SEQUENCE OF CHROMOSOME-VI FROM SACCHAROMYCES-CEREVISIAE	NATURE GENETICS			English	Article							CONSENSUS SEQUENCE; DNA-SEQUENCE; YEAST; REPLICATION; ORIGIN; ARS	The complete nucleotide sequence of Saccharomyces cerevisiae chromosome VI (270 kb) has revealed that it contains 129 predicted or known genes (300 bp or longer). Thirty-seven (28%) of which have been identified previously. Among the 92 novel genes, 39 are highly homologous to previously identified genes. Local sequence motifs were compared to active ARS regions and inactive loci with perfect ARS core sequences to examine the relationship between these motifs and ARS activity. Additional ARS sequences were predominantly observed in 3' flanking sequences of active ARS loci.	SAITAMA UNIV, GRAD SCH SCI & ENGN, URAWA, SAITAMA 338, JAPAN; RIKEN, INST PHYS & CHEM RES, BIODESIGN RES GRP, WAKO, SAITAMA 35101, JAPAN; FUJIYA CO, BIOSCI RES LAB, KANAGAWA 257, JAPAN; RIKEN, INST PHYS & CHEM RES, TSUKUBA LIFE SCI CTR, GENE BANK, TSUKUBA, IBARAKI 305, JAPAN	Saitama University; RIKEN; RIKEN	MURAKAMI, Y (corresponding author), RIKEN, INST PHYS & CHEM RES, TSUKUBA LIFE SCI CTR, DIV HUMAN GENOME RES, 3-1-1 KOYADAI, TSUKUBA, IBARAKI 305, JAPAN.							AMATI BB, 1988, CELL, V54, P967, DOI 10.1016/0092-8674(88)90111-0; BUSSEY H, 1995, P NATL ACAD SCI USA, V92, P3809, DOI 10.1073/pnas.92.9.3809; Campbell JL, 1991, MOL CELLULAR BIOL YE, P41; DESHPANDE AM, 1992, MOL CELL BIOL, V12, P4305, DOI 10.1128/MCB.12.10.4305; DIFFLEY JFX, 1988, CANCER CELL, V6, P235; DUJON B, 1994, NATURE, V369, P371, DOI 10.1038/369371a0; FELDMANN H, EMBO J, V13, P5795; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HOFFMAN JFX, 1989, CELL, V57, P725; HUNKAPILLER T, 1991, SCIENCE, V254, P59, DOI 10.1126/science.1925562; IWASAKI T, 1992, GENE, V11, P81; JOHNSTON M, 1994, SCIENCE, V265, P2077, DOI 10.1126/science.8091229; KIPLING D, 1990, MOL CELL BIOL, V10, P265, DOI 10.1128/MCB.10.1.265; MORTIMER RK, 1993, GENETIC MAPS LOCUS M, P36; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; Olson M., 1991, MOL CELLULAR BIOL YE, P1; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; RILES L, 1993, GENETICS, V134, P81; SAITO I, 1986, P NATL ACAD SCI USA, V83, P8664, DOI 10.1073/pnas.83.22.8664; Sambrook J, 1989, MOL CLONING LABORATO; SHIRAHIGE K, 1993, MOL CELL BIOL, V13, P5043, DOI 10.1128/MCB.13.8.5043; SHORE D, 1987, EMBO J, V6, P461, DOI 10.1002/j.1460-2075.1987.tb04776.x; SPITZNER JR, 1988, NUCLEIC ACIDS RES, V16, P5533, DOI 10.1093/nar/16.12.5533; VANHOUTEN JV, 1990, MOL CELL BIOL, V10, P3917, DOI 10.1128/MCB.10.8.3917; ZORLO DAR, 1994, NATURE, V372, P270	25	97	245	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1995	10	3					261	268		10.1038/ng0795-261	http://dx.doi.org/10.1038/ng0795-261			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670463				2022-12-25	WOS:A1995RG38600008
J	FIGUERA, LE; PANDOLFO, M; DUNNE, PW; CANTU, JM; PATEL, PI				FIGUERA, LE; PANDOLFO, M; DUNNE, PW; CANTU, JM; PATEL, PI			MAPPING OF THE CONGENITAL GENERALIZED HYPERTRICHOSIS LOCUS TO CHROMOSOME XQ24-Q27.1	NATURE GENETICS			English	Article							LINKAGE; DELINEATION; PATTERNS; SKIN; GENE	Congenital generalized hypertrichosis (CGH) is a rare, fully penetrant X-linked dominant trait previously described in a single, multigenerational Mexican family. CGH is a visually striking phenotype characterized by excessive facial and upper torso hair in males and by less severe asymmetric hairiness in females. We have found significant evidence for linkage with several markers from the long arm of the X chromosome. Recombinant chromosomes place the CGH gene within a 22 cM interval between DXS425 and DXS1227 in Xq24-Xq27.1. The localization of a gene for CGH represents the first step towards the isolation of genes involved in hair growth pattern, particularly those involved in restriction of areas in humans.	BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MOLEC & HUMAN GENET, HOUSTON, TX 77030 USA; BAYLOR COLL MED, CTR HUMAN GENOME, HOUSTON, TX 77030 USA; UNIV GUADALAJARA, CIBO IMSS, DIV GENET, GUADALAJARA 44430, JALISCO, MEXICO; UNIV GUADALAJARA, CUCS, GUADALAJARA 44430, JALISCO, MEXICO; IST NAZL NEUROL BESTA, DIV BIOCHEM & GENET, MILAN, ITALY	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Universidad de Guadalajara; Universidad de Guadalajara; IRCCS Istituto Neurologico Besta			Pandolfo, Massimo/B-2853-2010; Figuera, Luis E/V-8429-2017; Patel, Pragna/H-9129-2017	Figuera, Luis E/0000-0002-6096-4579; Patel, Pragna/0000-0003-3584-1072				ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BARTH JH, 1988, ARCH DIS CHILD, V63, P666, DOI 10.1136/adc.63.6.666; BAUMEISTER FAM, 1993, CLIN GENET, V44, P121; BEIGHTON P, 1970, ARCH DERMATOL, V101, P669, DOI 10.1001/archderm.101.6.669; BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204; CANTU JM, 1982, HUM GENET, V60, P36, DOI 10.1007/BF00281261; CANTU JM, 1985, ANN GENET-PARIS, V28, P141; CELLINI A, 1992, DERMATOLOGY, V185, P56, DOI 10.1159/000247404; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Danforth CH, 1925, ARCH DERMATOL SYPH, V11, P804, DOI 10.1001/archderm.1925.02370060085010; DONNELLY A, 1994, GENOMICS, V20, P363, DOI 10.1006/geno.1994.1189; DUGGINS OH, 1951, GROWTH REPLACEMENT T, P569; FELGENHAUER WR, 1969, J GENET HUM, V17, P1; FREIREMAIA N, 1976, CLIN GENET, V10, P303; FUCHS E, 1994, CURR OPIN GENET DEV, V4, P725, DOI 10.1016/0959-437X(94)90140-X; GARN SM, 1951, GROWTH REPLACEMENT, P498; GORLIN RJ, 1960, J PEDIATR-US, V56, P778, DOI 10.1016/S0022-3476(60)80315-0; GREEN MR, 1984, J INVEST DERMATOL, V83, P118, DOI 10.1111/1523-1747.ep12263298; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAPPLE R, 1993, ARCH DERMATOL, V129, P1460, DOI 10.1001/archderm.129.11.1460; HAQUE MFU, 1993, HUM GENET, V91, P17; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; HASPESLAGH M, 1984, CLIN GENET, V26, P374; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; JACKSON L, 1993, AM J MED GENET, V47, P940, DOI 10.1002/ajmg.1320470703; JANAKI VR, 1980, BRIT J DERMATOL, V103, P693, DOI 10.1111/j.1365-2133.1980.tb01695.x; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LYONS KM, 1990, DEVELOPMENT, V109, P833; MACIASFLORES MA, 1984, HUM GENET, V66, P66, DOI 10.1007/BF00275189; Mckusick V.A., 1994, MENDELIAN INHERITANC; MCKUSICK VA, 1972, HERITABLE DISORDERS, P521; Montagna W., 1958, BIOL HAIR GROWTH, V1st; Olsen EA, 1994, DISORDERS HAIR GROWT, P315; OTT J, 1988, ANAL HUMAN GENETIC L; PATEL PI, 1990, AM J HUM GENET, V47, P926; RAMPEN FHJ, 1988, MED HYPOTHESES, V27, P71, DOI 10.1016/0306-9877(88)90087-4; REYNOLDS EL, 1951, GROWTH REPLACEMENT T, P576; ROOK A, 1991, DISEASES HAIR SCALP, P256; SCHINZEL A, 1978, AM J MED GENET, V1, P361, DOI 10.1002/ajmg.1320010402; UPADHYAYA M, 1986, HUM GENET, V74, P391, DOI 10.1007/BF00280492; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; WINTER GB, 1974, ARCH DIS CHILD, V49, P394, DOI 10.1136/adc.49.5.394	45	47	47	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1995	10	2					202	207		10.1038/ng0695-202	http://dx.doi.org/10.1038/ng0695-202			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663516				2022-12-25	WOS:A1995RA85700018
J	KISILEVSKY, R; LEMIEUX, LJ; FRASER, PE; KONG, XQ; HULTIN, PG; SZAREK, WA				KISILEVSKY, R; LEMIEUX, LJ; FRASER, PE; KONG, XQ; HULTIN, PG; SZAREK, WA			ARRESTING AMYLOIDOSIS IN-VIVO USING SMALL-MOLECULE ANIONIC SULFONATES OR SULFATES - IMPLICATIONS FOR ALZHEIMERS-DISEASE	NATURE MEDICINE			English	Article							BASEMENT-MEMBRANE COMPONENTS; HEPARAN-SULFATE PROTEOGLYCAN; HIGH-AFFINITY BINDING; ENHANCING FACTOR; PRECURSOR PROTEINS; PRP ACCUMULATION; INDUCTION; SAA; AMYLOIDOGENESIS; INFLAMMATION	Amyloid is a term for extracellular protein fibril deposits that have characteristic tinctorial and structural properties. Heparan sulphate, or the heparan sulphate proteoglycan perlecan, has been identified in all amyloids and implicated in the earliest stages of inflammation-associated (AA) amyloid induction. Heparan sulphate interacts with the AA amyloid precursor and the beta-peptide of Alzheimer's amyloid, imparting characteristic secondary and tertiary amyloid structural features. These observations suggest that molecules that interfere with this interaction may prevent or arrest amyloidogenesis. We synthesized low-molecular-weight (135-1,000) anionic sulphonate or sulphate compounds. When administered orally, these compounds substantially reduced murine splenic AA amyloid progression. They also interfered with heparan sulphate-stimulated beta-peptide fibril aggregation in vitro.	QUEENS UNIV,DEPT BIOCHEM,KINGSTON,ON K7L 3N6,CANADA; KINGSTON GEN HOSP,SYL & MOLLY APPS RES CTR,KINGSTON,ON K7L 3N6,CANADA; UNIV TORONTO,CTR RES NEURODEGENERAT DISORDERS,TORONTO,ON M5S 1A8,CANADA; QUEENS UNIV,DEPT CHEM,KINGSTON,ON K7L 3N6,CANADA	Queens University - Canada; Queens University - Canada; University of Toronto; Queens University - Canada	KISILEVSKY, R (corresponding author), QUEENS UNIV,DEPT PATHOL,KINGSTON,ON K7L 3N6,CANADA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030361] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS30361] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AILLES L, 1993, LAB INVEST, V69, P443; ANCSIN JB, 1992, LAB INVEST, V66, pA106; AXELRAD MA, 1982, LAB INVEST, V47, P139; BRISSETTE L, 1989, J BIOL CHEM, V264, P19327; CAUGHEY B, 1993, BRIT MED BULL, V49, P860, DOI 10.1093/oxfordjournals.bmb.a072651; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; DEAL CL, 1982, ANN NY ACAD SCI, V389, P439, DOI 10.1111/j.1749-6632.1982.tb22161.x; DEBEER MC, 1993, J BIOL CHEM, V268, P20606; FRASER PE, 1992, J NEUROCHEM, V59, P1531, DOI 10.1111/j.1471-4159.1992.tb08470.x; GANAPATHI MK, 1991, J IMMUNOL, V1147, P1261; GANOWIAK K, 1994, BIOCHEM BIOPH RES CO, V199, P306, DOI 10.1006/bbrc.1994.1229; HOWARD J, 1990, NEUROSCI LETT, V118, P71, DOI 10.1016/0304-3940(90)90251-4; KAGAN DZ, 1974, PROBL TUBERK, V40, P72; KISILEVSKY R, 1983, LAB INVEST, V48, P53; KISILEVSKY R, 1994, MOL NEUROBIOL, V8, P65, DOI 10.1007/BF02778008; KISILEVSKY R, 1992, CRIT REV CL LAB SCI, V29, P59, DOI 10.3109/10408369209105246; LEVEUGLE B, 1994, NEUROREPORT, V5, P1389, DOI 10.1097/00001756-199406000-00025; LYON AW, 1991, LAB INVEST, V64, P785; MACKIEWICZ A, 1991, J IMMUNOL, V146, P3032; MCADAM KPWJ, 1978, J CLIN INVEST, V61, P390, DOI 10.1172/JCI108949; MCADAM KPWJ, 1976, J EXP MED, V144, P1121, DOI 10.1084/jem.144.4.1121; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; NARINDRASORASAK S, 1992, LAB INVEST, V67, P643; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; NARINDRASORASAK S, IN PRESS LAB INVEST; PERLMUTTER LS, 1990, BRAIN RES BULL, V24, P677, DOI 10.1016/0361-9230(90)90007-M; PERLMUTTER LS, 1991, J NEUROSCI RES, V30, P673, DOI 10.1002/jnr.490300411; PUCHTLER H, 1983, HISTOCHEMISTRY, V77, P431, DOI 10.1007/BF00495799; SIPE JD, 1978, BR J EXP PTH B, P305; SMALL DH, 1992, J NEUROSCI, V12, P4143; SNOW AD, 1989, NEUROBIOL AGING, V10, P481, DOI 10.1016/0197-4580(89)90108-5; SNOW AD, 1991, J HISTOCHEM CYTOCHEM, V39, P1321, DOI 10.1177/39.10.1940305; SNOW AD, 1988, LAB INVEST, V57, P687; TATSUTA E, 1982, ANN NY ACAD SCI, V389, P467, DOI 10.1111/j.1749-6632.1982.tb22176.x; TATSUTA E, 1983, J BIOL CHEM, V258, P5414; WOODROW SI, 1994, AMYLOID AMYLOIDOSIS, P195; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; YOUNG ID, 1989, ACTANEUROPATH, V7, P202	39	319	375	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1995	1	2					143	148		10.1038/nm0295-143	http://dx.doi.org/10.1038/nm0295-143			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX558	7585011				2022-12-25	WOS:A1995QX55800025
J	POLLOCK, JD; WILLIAMS, DA; GIFFORD, MAC; LI, LL; DU, XX; FISHERMAN, J; ORKIN, SH; DOERSCHUK, CM; DINAUER, MC				POLLOCK, JD; WILLIAMS, DA; GIFFORD, MAC; LI, LL; DU, XX; FISHERMAN, J; ORKIN, SH; DOERSCHUK, CM; DINAUER, MC			MOUSE MODEL OF X-LINKED CHRONIC GRANULOMATOUS-DISEASE, AN INHERITED DEFECT IN PHAGOCYTE SUPEROXIDE PRODUCTION	NATURE GENETICS			English	Article							NEUTROPHIL CYTOCHROME-B; NADPH OXIDASE; CHROMOSOMAL LOCATION; GENE; ASPERGILLOSIS; COMPONENT; ABSENCE; MICE; MACROPHAGES; DEFICIENCY	Chronic granulomatous disease (CGD) is a recessive disorder characterized by a defective phagocyte respiratory burst oxidase, life-threatening pyogenic infections and inflammatory granulomas. Gene targeting was used to generate mice with a null allele of the gene involved in X-linked CGD, which encodes the 91 kD subunit of the oxidase cytochrome b. Affected hemizygous male mice lacked phagocyte superoxide production, manifested an increased susceptibility to infection with Staphylococcus aureus and Aspergillus fumigatus and had an altered inflammatory response in thioglycollate peritonitis. This animal model should aid in developing new treatments for CGD and in evaluating the role of phagocyte-derived oxidants in inflammation.	INDIANA UNIV,MED CTR,HERMAN B WELLS CTR PEDIAT RES,DEPT PEDIAT,INDIANAPOLIS,IN 46202; INDIANA UNIV,MED CTR,JAMES WHITCOMB RILEY HOSP CHILDREN,DEPT MED & MOLEC GENET,INDIANAPOLIS,IN 46202; INDIANA UNIV,SCH MED,HOWARD HUGHES MED INST,INDIANAPOLIS,IN 46202; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DEPT PEDIAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,CHILDRENS HOSP,DIV HEMATOL ONCOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Howard Hughes Medical Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute			Pollock, Jonathan D/B-1554-2009					BAEHNER RL, 1968, NEW ENGL J MED, V278, P971, DOI 10.1056/NEJM196805022781801; BROCKDORFF N, 1988, CYTOGENET CELL GENET, V48, P124, DOI 10.1159/000132605; CURNUTTE JT, 1993, HEMATOLOGY INFANCY C, P904; DENG CX, 1992, MOL CELL BIOL, V12, P3365, DOI 10.1128/MCB.12.8.3365; DESCHENES SM, 1994, GENOMICS, V23, P62, DOI 10.1006/geno.1994.1459; DIAMOND RD, 1978, AM J PATHOL, V91, P313; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; DINAUER MC, 1991, P NATL ACAD SCI USA, V88, P11231, DOI 10.1073/pnas.88.24.11231; DINAUER MC, 1993, CRIT REV CL LAB SCI, V30, P329, DOI 10.3109/10408369309082591; DINAUER MC, 1987, NATURE, V327, P717, DOI 10.1038/327717a0; DIXON DM, 1989, INFECT IMMUN, V57, P1452, DOI 10.1128/IAI.57.5.1452-1456.1989; DU XX, 1993, BLOOD, V81, P27; Elsbach P, 1992, INFLAMMATION BASIC P, P603; GALLIN JI, 1983, ANN INTERN MED, V99, P657, DOI 10.7326/0003-4819-99-5-657; GALLIN JI, 1983, INFLAMMATION, V7, P227, DOI 10.1007/BF00917259; GRAYBILL JR, 1984, AM REV RESPIR DIS, V129, P292; HEYWORTH PG, 1991, J CLIN INVEST, V87, P352, DOI 10.1172/JCI114993; JACKSON JH, 1988, HEMATOL ONCOL CLIN N, V2, P317, DOI 10.1016/S0889-8588(18)30624-5; KNOLLER S, 1991, J BIOL CHEM, V266, P2795; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; MAYO LA, 1990, METHOD ENZYMOL, V186, P567; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; OCHS HD, 1973, J PEDIATR-US, V83, P77, DOI 10.1016/S0022-3476(73)80316-6; ODELL EW, 1991, J MED MICROBIOL, V34, P129, DOI 10.1099/00222615-34-3-129; PADGETT E, 1968, ADV VET SCI, V12, P239; PARKOS CA, 1989, BLOOD, V73, P1416; PARKOS CA, 1987, J CLIN INVEST, V80, P732, DOI 10.1172/JCI113128; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Robertson E. J., 1987, TERATOCARCINOMAS EMB; ROOS D, 1992, J LEUKOCYTE BIOL, V51, P164, DOI 10.1002/jlb.51.2.164; ROTROSEN D, 1992, SCIENCE, V256, P1459, DOI 10.1126/science.1318579; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; SCHAFFNER A, 1982, J CLIN INVEST, V69, P617, DOI 10.1172/JCI110489; SCHAFFNER A, 1994, MACROPHAGE PATHOGEN, P545; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; SEGAL AW, 1978, LANCET, V2, P446; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; SHUSTER DE, 1992, P NATL ACAD SCI USA, V89, P9225, DOI 10.1073/pnas.89.19.9225; TEAHAN C, 1987, NATURE, V327, P720, DOI 10.1038/327720a0; XIE QW, 1992, BIOL OXIDANTS GENERA, P213; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	42	741	754	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					202	209		10.1038/ng0295-202	http://dx.doi.org/10.1038/ng0295-202			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719350				2022-12-25	WOS:A1995QE67200024
J	DIETZ, HC; KENDZIOR, RJ				DIETZ, HC; KENDZIOR, RJ			MAINTENANCE OF AN OPEN READING FRAME AS AN ADDITIONAL LEVEL OF SCRUTINY DURING SPLICE-SITE SELECTION	NATURE GENETICS			English	Article							MESSENGER-RNA PRECURSORS; NONSENSE MUTATIONS; MARFAN-SYNDROME; MISSENSE MUTATION; PREMESSENGER RNA; FIBRILLIN GENE; EXON; INTRON; SEQUENCES; CELLS	Although nonsense mutations have been associated with the skipping of specific constitutively spliced exons in selected genes, notably the fibrillin gene, the basis for this association is unclear. Now, using chimaeric constructs in a model in vivo expression system, premature termination codons are identified as determinants of splice site selection. Nonsense codon recognition prior to RNA splicing necessitates the ability to read the frame of precursor mRNA in the nucleus. We propose that maintenance of an open reading frame can serve as an additional level of scrutiny during exon definition. This process may have pathogenic and evolutionary significance.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	DIETZ, HC (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205, USA.							BACH G, 1993, AM J HUM GENET, V53, P330; BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BLACK DL, 1991, GENE DEV, V5, P389, DOI 10.1101/gad.5.3.389; CAROTHERS AM, 1993, MOL CELL BIOL, V13, P5085, DOI 10.1128/MCB.13.8.5085; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; CHENG J, 1993, MOL CELL BIOL, V13, P1892, DOI 10.1128/MCB.13.3.1892; COOPER TA, 1992, J BIOL CHEM, V267, P5330; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; DIETZ HC, 1993, GENOMICS, V17, P468, DOI 10.1006/geno.1993.1349; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; DOMENJOUD L, 1991, MOL CELL BIOL, V11, P4581, DOI 10.1128/MCB.11.9.4581; FISHER CW, 1993, AM J HUM GENET, V52, P414; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; HAMOSH A, 1991, J CLIN INVEST, V88, P1880, DOI 10.1172/JCI115510; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; KESSLER O, 1993, MOL CELL BIOL, V13, P6211, DOI 10.1128/MCB.13.10.6211; KRAWCZAK M, 1992, HUM GENET, V90, P41; LIBRI D, 1990, MOL CELL BIOL, V10, P5036, DOI 10.1128/MCB.10.10.5036; MANIATIS T, 1987, NATURE, V325, P673, DOI 10.1038/325673a0; MITCHELL GA, 1988, J BIOL CHEM, V263, P14288; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAEGER LK, 1992, GENE DEV, V6, P1107, DOI 10.1101/gad.6.6.1107; NAYLOR JA, 1993, HUM MOL GENET, V2, P11, DOI 10.1093/hmg/2.1.11; NIWA M, 1992, NATURE, V360, P277, DOI 10.1038/360277a0; OSHIMA Y, 1987, J MOL BIOL, V195, P247; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PEREIRA L, 1993, HUM MOL GENET, V2, P961, DOI 10.1093/hmg/2.7.961; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHARP PA, 1987, SCIENCE, V235, P766, DOI 10.1126/science.3544217; STEINGRIMSDOTTIR H, 1992, NUCLEIC ACIDS RES, V20, P1201, DOI 10.1093/nar/20.6.1201; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868	39	134	140	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1994	8	2					183	188		10.1038/ng1094-183	http://dx.doi.org/10.1038/ng1094-183			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7842017				2022-12-25	WOS:A1994PL12300021
J	KULKENS, T; BOLHUIS, PA; WOLTERMAN, RA; KEMP, S; TENIJENHUIS, S; VALENTIJN, LJ; HENSELS, GW; JENNEKENS, FGI; DEVISSER, M; HOOGENDIJK, JE; BAAS, F				KULKENS, T; BOLHUIS, PA; WOLTERMAN, RA; KEMP, S; TENIJENHUIS, S; VALENTIJN, LJ; HENSELS, GW; JENNEKENS, FGI; DEVISSER, M; HOOGENDIJK, JE; BAAS, F			DELETION OF THE SERINE-34 CODON FROM THE MAJOR PERIPHERAL MYELIN PROTEIN-P(0) GENE IN CHARCOT-MARIE-TOOTH DISEASE TYPE-1B	NATURE GENETICS			English	Article							NEUROPATHY TYPE-I; DUFFY BLOOD-GROUP; TREMBLER-J MOUSE; CHROMOSOME 17P11.2; STRUCTURAL PROTEIN; HEREDITARY MOTOR; POINT MUTATIONS; NERVE MYELIN; DUPLICATION; LINKAGE	Charcot-Marie-Tooth disease type 1B (CMT1B) is genetically linked to chromosome 1q21-23. The major peripheral myelin protein gene, P0, has been cloned and localized to the same chromosomal region. P0 is a 28 kDa glycoprotein involved in the compaction of the multilamellar myelin sheet and accounts for more than half of the peripheral myelin protein content. We checked whether P0 is altered in CMT1B, and show here that a 3 basepair deletion in exon 2 of the P0 gene is present in all affected individuals of a CMT1B family. The mutation results in the deletion of serine 34 in the extracellular domain of P0, suggesting that alterations of P0 cause CMT1B.	UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL,MEIBERGDREEF 9,1105 AZ AMSTERDAM,NETHERLANDS; UNIV UTRECHT,3584 CX UTRECHT,NETHERLANDS	University of Amsterdam; Utrecht University			Kemp, Stephan/A-3935-2008; Baas, Frank/F-9574-2010	Kemp, Stephan/0000-0003-2023-064X; Baas, Frank/0000-0003-3912-5428				AMZEL LM, 1979, ANNU REV BIOCHEM, V48, P961, DOI 10.1146/annurev.bi.48.070179.004525; BIRD TD, 1982, AM J HUM GENET, V34, P388; DEFESCHE JC, 1990, NEUROLOGY, V40, P1450, DOI 10.1212/WNL.40.9.1450; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; DURSO D, 1990, NEURON, V4, P449, DOI 10.1016/0896-6273(90)90057-M; FILBIN MT, 1990, NATURE, V344, P871, DOI 10.1038/344871a0; FLOYDSMITH G, 1986, IMMUNOGENETICS, V24, P171; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GRIFFITHS LR, 1988, AM J HUM GENET, V42, P756; GRUNDY HO, 1989, IMMUNOGENETICS, V29, P331, DOI 10.1007/BF00352843; HARDING AE, 1980, BRAIN, V103, P259, DOI 10.1093/brain/103.2.259; HAYASAKA K, 1991, BIOCHEM BIOPH RES CO, V180, P515, DOI 10.1016/S0006-291X(05)81094-0; HOOGENDIJK JE, 1991, HUM GENET, V88, P215, DOI 10.1007/BF00206075; HOOGENDIJK JE, 1991, HDB CLIN NEUROLOGY, V60; KUHN R, 1990, J NEUROSCI, V10, P205; LEBO RV, 1991, HUM GENET, V88, P1, DOI 10.1007/BF00204921; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; OAKEY RJ, 1992, HUM MOL GENET, V1, P613, DOI 10.1093/hmg/1.8.613; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; RAEYMAEKERS P, 1988, HUM GENET, V78, P76, DOI 10.1007/BF00291239; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; ROGNE S, 1989, GENOMICS, V4, P169, DOI 10.1016/0888-7543(89)90296-6; Sambrook J, 1989, MOL CLONING LABORATO; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; SUZUKI M, 1990, J NEUROCHEM, V55, P1966, DOI 10.1111/j.1471-4159.1990.tb05783.x; SWALLOW DM, 1987, ANN HUM GENET, V51, P289, DOI 10.1111/j.1469-1809.1987.tb01063.x; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; WARMERDAM PAM, 1990, J EXP MED, V172, P19, DOI 10.1084/jem.172.1.19; WEBER LJ, 1992, NUCLEIC ACIDS RES, V15, P4635; YOU KH, 1991, GENOMICS, V9, P751, DOI 10.1016/0888-7543(91)90370-T	41	202	204	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					35	39		10.1038/ng0993-35	http://dx.doi.org/10.1038/ng0993-35			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	7693130				2022-12-25	WOS:A1993LV56500012
J	WEINSTEIN, BM; STEMPLE, DL; DRIEVER, W; FISHMAN, MC				WEINSTEIN, BM; STEMPLE, DL; DRIEVER, W; FISHMAN, MC			GRIDLOCK, A LOCALIZED HERITABLE VASCULAR PATTERNING DEFECT IN THE ZEBRAFISH	NATURE MEDICINE			English	Article							HEART	We are using the zebrafish, Danio rerio, to identify genes that generate and pattern the vertebrate vasculature. We have isolated a recessive mutation, gridlock(m145) (grl(m145)) in which blood flow to the tail is impeded by a localized vascular defect. Using a novel microangiographic method, we show that the blockade is in the anterior trunk, where the paired lateral dorsal aortae normally merge to form the single midline aorta. Arterial-venous shunts and collateral vessels develop in most mutant embryos, bypassing the lesion and reconstituting caudal blood flow. The grl defect resembles coarctation of the aorta, a human congenital cardiovascular malformation of unknown aetiology, in the location of the lesion and its consequences and in the mutants' dependence on collateral vessels for survival.	HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Harvard University; Harvard Medical School	WEINSTEIN, BM (corresponding author), MASSACHUSETTS GEN HOSP,CARDIOVASC RES CTR,149 13TH ST,BOSTON,MA 02129, USA.			Driever, Wolfgang/0000-0002-9551-9141	NHLBI NIH HHS [T32-HL07208, R01-HL49579] Funding Source: Medline; NICHD NIH HHS [R01-HD29761] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029761] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007208, R01HL049579] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		COFFIN JD, 1991, ANAT REC, V231, P383; DEHAAN RL, 1959, DEV BIOL, V1, P586, DOI 10.1016/0012-1606(59)90019-3; HUTCHINS GM, 1971, AM J PATHOL, V63, P203; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; NETTER FF, 1978, HEART; OLLEY PM, 1992, NEONATAL HEART DISEA; OSMOND MK, 1991, DEVELOPMENT, V113, P1405; Perloff JK, 1994, CLIN RECOGNITION CON; Pierpont M.E.M., 1987, GENETICS CARDIOVASCU; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Walker WF, 1992, VERTEBRATE DISSECTIO; Westerfield M, 1994, ZEBRAFISH BOOK; WIELENGA G, 1968, J PATHOL BACTERIOL, V95, P265, DOI 10.1002/path.1700950131; [No title captured]	15	243	257	0	25	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1143	1147		10.1038/nm1195-1143	http://dx.doi.org/10.1038/nm1195-1143			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584985				2022-12-25	WOS:A1995TC53700037
J	DENTON, D; WEISINGER, R; MUNDY, NI; WICKINGS, EJ; DIXSON, A; MOISSON, P; PINGARD, AM; SHADE, R; CAREY, D; ARDAILLOU, R; PAILLARD, F; CHAPMAN, J; THILLET, J; MICHEL, JB				DENTON, D; WEISINGER, R; MUNDY, NI; WICKINGS, EJ; DIXSON, A; MOISSON, P; PINGARD, AM; SHADE, R; CAREY, D; ARDAILLOU, R; PAILLARD, F; CHAPMAN, J; THILLET, J; MICHEL, JB			THE EFFECT OF INCREASED SALT INTAKE ON BLOOD-PRESSURE OF CHIMPANZEES	NATURE MEDICINE			English	Article							SODIUM-INTAKE; CARDIOVASCULAR DISEASE; ESSENTIAL-HYPERTENSION; PREVENTION; MIGRATION; NUTRITION; INDIANS; CULTURE; DIET	A colony of 26 chimpanzees given a fruit and vegetable diet of very low Na and high K intake were maintained in long-standing, socially stable small groups for three years. Half of them had salt added progressively to their diet during 20 months. This addition of salt within the human dietetic range caused a highly significant rise in systolic, mean and diastolic blood pressure. The change reversed completely by six months after cessation of salt. The effect of salt differed between chimpanzees, some having a large blood pressure rise and others small or no rise. These results in the species phylogenetically closest to humans bear directly on causation of human hypertension, particularly in relation to migration of preliterate people, with low Na diet, to a Western urban lifestyle with increased salt intake. The hedonic liking for salt and avid ingestion was apt during human prehistory involving hunter-gatherer-scavenger existence in the interior of continents with a scarcity of salt, but is maladaptive in urban technological life with salt cheap and freely available.	CTR INT RECH MED FRANCEVILLE, FRANCEVILLE, GABON; SW FDN BIOMED RES, SAN ANTONIO, TX 78284 USA; HOP TENON, INSERM, U64, F-75970 PARIS 20, FRANCE; HOP PITIE, INSERM, U321, F-75651 PARIS 13, FRANCE; INSERM, U367, F-75005 PARIS, FRANCE	Texas Biomedical Research Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	DENTON, D (corresponding author), UNIV MELBOURNE, HOWARD FLOREY INST EXPTL PHYSIOL & MED, PARKVILLE, VIC 3052, AUSTRALIA.			Denton, Derek/0000-0002-1931-1365				ALTSCHUL AM, 1980, NUTR REV, V38, P393, DOI 10.1111/j.1753-4887.1980.tb05954.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN JJ, 1984, LANCET, V2, P456; Buss D. H., 1971, P315; CHANGNON N, 1977, YANAMAMO FIERCE PEOP; Clark J.D., 1970, PREHISTORY AFRICA; COPPENS Y, 1994, SCI AM, V270, P88, DOI 10.1038/scientificamerican0594-88; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; DAHL LK, 1972, AM J CLIN NUTR, V25, P231; Denton D.A., 1982, HUNGER SALT ANTHR PH; DENTON DA, 1976, SYSTEMIC EFFECTS ANT, P577; DOUCET C, 1994, J LIPID RES, V35, P263; EATON SB, 1985, NEW ENGL J MED, V312, P283, DOI 10.1056/NEJM198501313120505; EICHBERG JW, 1987, J MED PRIMATOL, V16, P317; FOLKOW B, 1990, NEWS PHYSIOL SCI, V5, P220; FREIS ED, 1976, CIRCULATION, V53, P589, DOI 10.1161/01.CIR.53.4.589; GLIEBERMAN L, 1973, ECOL FOOD NUTR, V2, P143; GOOBBEE DE, 1994, TXB HYPERTENSION, P539; HANNEMAN RL, 1993, 7TH S SALT, P231; HOFMAN A, 1983, JAMA-J AM MED ASSOC, V250, P370, DOI 10.1001/jama.250.3.370; HUU P, 1974, STEROIDS, V24, P587; ISSAC G, 1971, WORLD ARCHEOL    FEB, P278; KAPLAN NM, 1984, CLIN HYPERTENSION, P70; KAWASAKI T, 1978, AM J MED, V64, P193, DOI 10.1016/0002-9343(78)90045-1; LARAGH JH, 1983, ANN INTERN MED, V98, P735, DOI 10.7326/0003-4819-98-5-735; LECKIE B, 1995, CURR BIOL, V5, P260, DOI 10.1016/S0960-9822(95)00055-8; MACGREGOR GA, 1985, HYPERTENSION, V7, P628, DOI 10.1161/01.HYP.7.4.628; MADDOCKS I, 1967, MED J AUSTRALIA, V20, P1123; MCCARRON DA, 1984, SCIENCE, V224, P1392, DOI 10.1126/science.6729459; MENARD J, 1972, ENDOCRINOLOGY, V90, P422, DOI 10.1210/endo-90-2-422; ODEA K, 1992, J INTERN MED, V232, P103, DOI 10.1111/j.1365-2796.1992.tb00559.x; ODEA K, 1992, DIABETES METAB REV, V8, P373, DOI 10.1002/dmr.5610080405; ODEA K, 1991, PHILOS T ROY SOC B, V334, P233, DOI 10.1098/rstb.1991.0112; OLIVER WJ, 1975, CIRCULATION, V52, P146, DOI 10.1161/01.CIR.52.1.146; OLIVER WJ, 1981, CIRCULATION, V63, P110, DOI 10.1161/01.CIR.63.1.110; PAGE LB, 1974, CIRCULATION, V49, P1132, DOI 10.1161/01.CIR.49.6.1132; Paul A. A., 1978, COMPOSITION FOODS; PICKERING GW, 1980, CARDIOVASC REV REP, V1, P1; POULTER NR, 1990, BMJ-BRIT MED J, V300, P967, DOI 10.1136/bmj.300.6730.967; POULTER NR, 1985, CLIN EXP PHARMACOL P, V12, P211, DOI 10.1111/j.1440-1681.1985.tb02633.x; Rose B. D., 1981, PATHOPHYSIOLOGY RENA; ROSE G, 1989, J HUM HYPERTENS, V3, P283; SASAKI N, 1962, JPN HEART J, V3, P313; Sever P., 1994, TXB HYPERTENSION, P22; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SIMPSON FO, 1979, CLIN SCI, V57, pS463, DOI 10.1042/cs057463s; SINNETT PF, 1973, J CHRON DIS, V26, P265, DOI 10.1016/0021-9681(73)90031-3; STAMLER J, 1991, HYPERTENSION, V18, P95, DOI 10.1161/01.HYP.18.3_Suppl.I95; STAMLER J, 1993, ANN NY ACAD SCI, V676, P122; SWALES JD, 1980, LANCET, V1, P1177; SWALES JD, 1988, BRIT MED J, V297, P307, DOI 10.1136/bmj.297.6644.307; TAKAHASHI E, 1962, TOHOKU J EXP MED, V77, P239, DOI 10.1620/tjem.77.239; TROWELL HC, 1980, E AFR MED J, V57, P167; TRUSWELL AS, 1972, AM HEART J, V84, P5, DOI 10.1016/0002-8703(72)90299-2; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; YAMORI Y, 1993, ANN NY ACAD SCI, V676, P92; 1993, 1ST HUMANS, V1, P46; 1972, NUTRIENT REQURIEMENT, P29	58	312	327	1	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	1995	1	10					1009	1016		10.1038/nm1095-1009	http://dx.doi.org/10.1038/nm1095-1009			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489355				2022-12-25	WOS:A1995RX95100039
J	ACOTT, TS; WELEBER, RG				ACOTT, TS; WELEBER, RG			VITAMIN-A MEGATHERAPY FOR RETINAL ABNORMALITIES	NATURE MEDICINE			English	Editorial Material							SORSBY FUNDUS DYSTROPHY; TISSUE INHIBITOR; METALLOPROTEINASES				ACOTT, TS (corresponding author), OREGON HLTH SCI UNIV,CASEY EYE INST,PORTLAND,OR 97201, USA.							ACOTT TS, 1994, TXB OPHTHALMOLOGY, V7; APTE SS, 1994, GENOMICS, V19, P88; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; CAPON MRC, 1989, OPHTHALMOLOGY, V96, P1769; DENHARDT DT, 1993, PHARMACOL THERAPEUT, V59, P329, DOI 10.1016/0163-7258(93)90074-N; HAMILTON WK, 1989, OPHTHALMOLOGY, V96, P1755; JACOBSON SG, 1995, NAT GENET, V11, P27, DOI 10.1038/ng0995-27; LECO KJ, 1994, J BIOL CHEM, V269, P9352; WEBER BHF, 1994, NAT GENET, V7, P158, DOI 10.1038/ng0694-158; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WILLENBROCK F, 1993, BIOCHEMISTRY-US, V32, P4330, DOI 10.1021/bi00067a023; WILLIAMSON RA, 1993, BIOCHIM BIOPHYS ACTA, V1164, P8, DOI 10.1016/0167-4838(93)90105-Z	13	5	5	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	SEP	1995	1	9					884	885		10.1038/nm0995-884	http://dx.doi.org/10.1038/nm0995-884			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585210				2022-12-25	WOS:A1995RT30300038
J	HAMILTON, BS; PAGLIA, D; KWAN, AYM; DEITEL, M				HAMILTON, BS; PAGLIA, D; KWAN, AYM; DEITEL, M			INCREASED OBESE MESSENGER-RNA EXPRESSION IN OMENTAL FAT-CELLS FROM MASSIVELY OBESE HUMANS	NATURE MEDICINE			English	Article								Obesity presents a significant challenge to the general health of affluent nations in terms of the number of people affected, the serious associated maladies and the lack of effective treatments(1-3). While common wisdom has held that obesity results from 'gluttony and sloth', a number of studies have indicated physiological causes underlying the pathogenesis of obesity(2), with the degree of adiposity having a strong genetic component(4,5). Recently, the obese gene in the ob/ob mouse was cloned, along with its human homologue(6). The specific production of the obese protein by adipose tissue suggested that it may function in a feedback loop from fat tissue to the hypothalamus to control energy intake and/or energy expenditure, and that it may play a role in the pathogenesis of human obesity(6-8). In this study we report that obese mRNA expression is elevated in ex vivo omental adipocytes isolated from massively obese humans in the absence of an identifiable mutation. Therefore, we speculate that this increased expression may suggest that the massively obese are insensitive to the putative regulatory function(s) of the obese gene product.	SUNNYBROOK HLTH SCI CTR, N YORK, ON M4N 3M5, CANADA; UNIV TORONTO, DEPT SURG, TORONTO, ON M6R 1B5, CANADA; UNIV TORONTO, DEPT NUTR SCI, TORONTO, ON M6R 1B5, CANADA; ST JOSEPHS HLTH CTR, TORONTO, ON M6R 1B5, CANADA	University of Toronto; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto; Western University (University of Western Ontario)	HAMILTON, BS (corresponding author), UNIV TORONTO, INST MED SCI, 100 COLL ST, TORONTO, ON M5S 1A8, CANADA.							AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOUCHARD C, 1993, ENDOCR REV, V14, P72, DOI 10.1210/er.14.1.72; CHENG AYM, 1993, OBES SURG, V3, P340, DOI 10.1381/096089293765559016; COLEMAN DL, 1973, DIABETOLOGIA, V9, P294, DOI 10.1007/BF01221857; FAUST IM, 1977, SCIENCE, V197, P393, DOI 10.1126/science.877564; FLIER JS, 1995, CELL, V80, P15, DOI 10.1016/0092-8674(95)90445-X; FRIEDMAN JM, 1992, CELL, V69, P217, DOI 10.1016/0092-8674(92)90402-X; HERVEY GR, 1959, J PHYSIOL-LONDON, V145, P336, DOI 10.1113/jphysiol.1959.sp006145; KOPELMAN PG, 1994, INT J OBESITY, V18, P189; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; LISCOVITCH M, 1994, CELL, V77, P329, DOI 10.1016/0092-8674(94)90148-1; MARTIN RJ, 1991, AM SCI, V79, P528; RINK TJ, 1994, NATURE, V372, P406, DOI 10.1038/372406a0; RONCARI DAK, 1993, ADV EXP MED BIOL, V334, P269; Sambrook J, 1989, MOL CLONING LABORATO; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; TEICHERTKULISZEWSKA K, 1994, BIOCHEM CELL BIOL, V72, P54, DOI 10.1139/o94-009; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	20	490	529	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	1995	1	9					953	956		10.1038/nm0995-953	http://dx.doi.org/10.1038/nm0995-953			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585224				2022-12-25	WOS:A1995RT30300052
J	LUBIN, R; ZALCMAN, G; BOUCHET, L; TREDANIEL, J; LEGROS, Y; CAZALS, D; HIRSCH, A; SOUSSI, T				LUBIN, R; ZALCMAN, G; BOUCHET, L; TREDANIEL, J; LEGROS, Y; CAZALS, D; HIRSCH, A; SOUSSI, T			SERUM P53 ANTIBODIES AS EARLY MARKERS OF LUNG-CANCER	NATURE MEDICINE			English	Article							IMMUNE-RESPONSE; BREAST-CANCER; EPITOPES	The p53 alteration is the most common alteration found in human cancer. It usually involves missense mutations that stabilize the p53 protein, which in turn accumulates, reaching levels detectable by immunohistochemistry. We(1-4) and others(5-8) have demonstrated that this overexpression of mutant p53 protein can induce a specific humoral response in cancer patients. This result was assessed by the presence of p53 antibodies in sera of patients with various types of cancers, whereas normal populations do not exhibit such antibodies. In lung cancer, the prevalence of p53 antibodies is high (30%) and is correlated with a very high rate of p53 mutations in this cancer (60-70%)(2,8). We show that these antibodies are always present at the time of diagnosis, but never appear during tumour development, an observation strengthened by the fact that these antibodies are mostly IgG, corresponding to a secondary immune response. These results suggest that the humoral response is an early event and that p53 antibodies can be used as a precocious marker of p53 alteration before clinical manifestation of the disease.	INST GENET MOLEC,INSERM,U301,F-75010 PARIS,FRANCE; HOP ST LOUIS,SERV PNEUMOL,F-75010 PARIS,FRANCE; HOP ST LOUIS,ANATOMOPATHOL LAB,F-75010 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite			ZALCMAN, Gerard/P-4150-2015; ZALCMAN, Gérard/L-7809-2015; ZALCMAN, Gerard/M-8113-2019	ZALCMAN, Gérard/0000-0002-0343-9575; soussi, thierry/0000-0001-8184-3293				ANGELOPOULOU K, 1994, INT J CANCER, V58, P480, DOI 10.1002/ijc.2910580404; BENNETT WP, 1993, CANCER RES, V53, P4817; CRAWFORD LV, 1982, INT J CANCER, V30, P403, DOI 10.1002/ijc.2910300404; DAVIDOFF AM, 1992, P NATL ACAD SCI USA, V89, P3439, DOI 10.1073/pnas.89.8.3439; IDHE DC, 1991, CURR PROBL CANCER, V15, P65; LUBIN R, 1993, CANCER RES, V53, P5872; MAO L, 1994, CANCER RES, V54, P1634; PEYRAT JP, 1995, LANCET, V345, P621, DOI 10.1016/S0140-6736(95)90523-5; SCHLICHTHOLZ B, 1992, CANCER RES, V52, P6380; SCHLICHTHOLZ B, 1994, BRIT J CANCER, V69, P809, DOI 10.1038/bjc.1994.159; SUNDARESAN V, 1992, ONCOGENE, V7, P1989; TENAUD C, 1994, MODERN PATHOL, V7, P853; WINTER SF, 1992, CANCER RES, V52, P4168	13	282	296	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1995	1	7					701	702		10.1038/nm0795-701	http://dx.doi.org/10.1038/nm0795-701			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585154				2022-12-25	WOS:A1995RQ06600047
J	HENDERSON, D; HURLEY, LH				HENDERSON, D; HURLEY, LH			MOLECULAR STRUGGLE FOR TRANSCRIPTIONAL CONTROL	NATURE MEDICINE			English	Editorial Material							DNA				HENDERSON, D (corresponding author), UNIV TEXAS,COLL PHARM,DRUG DYNAM INST,AUSTIN,TX 78712, USA.							ADAMS EG, 1988, CANCER RES, V48, P109; BASU AK, 1988, CHEM RES TOXICOL, V1, P1, DOI 10.1021/tx00001a001; BROWN SJ, 1993, SCIENCE, V261, P603, DOI 10.1126/science.8342024; CHIANG SY, 1994, BIOCHEMISTRY-US, V33, P7033, DOI 10.1021/bi00189a003; DORN A, 1992, EMBO J, V11, P279, DOI 10.1002/j.1460-2075.1992.tb05050.x; FAN JY, 1995, J MED CHEM, V38, P408, DOI 10.1021/jm00003a003; HO SN, 1994, P NATL ACAD SCI USA, V91, P9203, DOI 10.1073/pnas.91.20.9203; HURLEY LH, 1989, J MED CHEM, V32, P2027, DOI 10.1021/jm00129a001; Li B., 1994, Proceedings of the American Association for Cancer Research Annual Meeting, V35, P111; MACLEOD MC, IN PRESS CARCINOGENE; MITSCHER LA, 1992, NUCLEIC ACID TARGETE, P375; POTMESIL M, 1994, CANCER RES, V54, P1431; SUN D, 1994, BIOCHEMISTRY-US, V33, P9578, DOI 10.1021/bi00198a025; Sun D., 1995, Proceedings of the American Association for Cancer Research Annual Meeting, V36, P534; TREIBER DK, 1994, P NATL ACAD SCI USA, V91, P5672, DOI 10.1073/pnas.91.12.5672; WALKER S, 1993, J AM CHEM SOC, V115, P7954, DOI 10.1021/ja00071a004	16	70	74	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1995	1	6					525	527		10.1038/nm0695-525	http://dx.doi.org/10.1038/nm0695-525			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN101	7585116				2022-12-25	WOS:A1995RN10100033
J	HOLT, JT				HOLT, JT			A SENSELESS IMMUNE-RESPONSE TO DNA	NATURE MEDICINE			English	Editorial Material							PROLIFERATION	Antisense oligonucleotides can have dramatic effects, but a recent paper suggests that the mechanism isn't always based on nucleotide sequence interactions.	VANDERBILT UNIV,SCH MED,DEPT PATHOL,NASHVILLE,TN 37232	Vanderbilt University	HOLT, JT (corresponding author), VANDERBILT UNIV,SCH MED,DEPT CELL BIOL,221 KIRKLAND HALL,NASHVILLE,TN 37232, USA.							GILKESON GS, 1995, J CLIN INVEST, V95, P1398, DOI 10.1172/JCI117793; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; KRIEG AM, 1989, J IMMUNOL, V143, P2448; MESSINA JP, 1991, J IMMUNOL, V147, P1759; PEREZ JR, 1994, P NATL ACAD SCI USA, V91, P5957, DOI 10.1073/pnas.91.13.5957; STEIN CA, 1993, SCIENCE, V261, P1004, DOI 10.1126/science.8351515; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0	8	15	15	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1995	1	5					407	408		10.1038/nm0595-407	http://dx.doi.org/10.1038/nm0595-407			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585081				2022-12-25	WOS:A1995RN10000024
J	VANADELSBERG, JS; FRANK, D				VANADELSBERG, JS; FRANK, D			THE PKD1 GENE PRODUCES A DEVELOPMENTALLY-REGULATED PROTEIN IN MESENCHYME AND VASCULATURE	NATURE MEDICINE			English	Article							POLYCYSTIC KIDNEY-DISEASE; EXTRACELLULAR-MATRIX; GROWTH; MEMBRANES; EPITHELIA; CYSTS	Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common human genetic diseases. In addition to polycystic kidneys, the disease can cause cystic changes in liver and other organs, cardiac valvular insufficiency and cerebral arterial aneurysms. Using antibodies raised against the predicted gene product of PKD1, which is mutated in about 85% of ADPKD cases, we show that PKD1 is a 530-kD protein localized to the extracellular matrix of kidney, liver and cerebral blood vessels. We discovered that the PKD1 protein was highly expressed in the mesenchyme of developing kidney and liver, transiently localized in the developing glomerulus and juxtaglomerular apparatus and restricted to perivascular, extraglomerular areas in adult renal cortex. These data suggest that the PKD1 protein plays a role in renal and hepatic morphogenesis.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032	Columbia University	VANADELSBERG, JS (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020999, R37DK020999] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK20999] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAMSON DR, 1991, SEMIN NEPHROL, V11, P375; [Anonymous], 1994, CELL, V77, P881; BAERT L, 1978, KIDNEY INT, V13, P519, DOI 10.1038/ki.1978.75; BIGELOW NH, 1953, AM J MED SCI, V225, P485, DOI 10.1097/00000441-195305000-00004; CALVET JP, 1993, KIDNEY INT, V43, P101, DOI 10.1038/ki.1993.17; CARONE FA, 1993, LAB INVEST, V68, P413; CARONE FA, 1994, LAB INVEST, V70, P645; CHAPMAN AB, 1990, NEW ENGL J MED, V323, P1091, DOI 10.1056/NEJM199010183231602; DALGAARD OZ, 1957, ACTA MED SCAND, V328, P10; Davies J, 1993, Semin Cell Biol, V4, P213, DOI 10.1006/scel.1993.1025; DOUILLARD JY, 1983, METHOD ENZYMOL, V92, P168; EVAN AP, 1979, KIDNEY INT, V16, P743, DOI 10.1038/ki.1979.191; Gabow P A, 1989, Adv Nephrol Necker Hosp, V18, P19; GABOW PA, 1990, HEPATOLOGY, V11, P1033, DOI 10.1002/hep.1840110619; GABOW PA, NW ENGL J MED; GRANTHAM JJ, 1990, AM J KIDNEY DIS, V15, P110, DOI 10.1016/S0272-6386(12)80507-5; GRANTHAM JJ, 1987, KIDNEY INT, V31, P1145, DOI 10.1038/ki.1987.121; GRANTHAM JJ, 1987, KIDNEY INT, V32, P187, DOI 10.1038/ki.1987.191; GRNTHAM JJ, 1995, J CLIN INVEST, V95, P195; LEIER CV, 1984, ANN INTERN MED, V100, P683, DOI 10.7326/0003-4819-100-5-683; MILUTINOVIC J, 1980, AM J MED, V68, P741, DOI 10.1016/0002-9343(80)90266-1; NADASDY T, 1995, J AM SOC NEPHROL, V5, P1642; SCHEFF RT, 1980, ANN INTERN MED, V92, P202, DOI 10.7326/0003-4819-92-2-202; VANADELSBERG J, 1994, CELL, V76, P1053, DOI 10.1016/0092-8674(94)90382-4; Wilson P D, 1992, Adv Nephrol Necker Hosp, V21, P125; WILSON PD, 1991, AM J KIDNEY DIS, V17, P634, DOI 10.1016/S0272-6386(12)80338-6; WILSON PD, 1991, AM J PHYSIOL, V260, pF420, DOI 10.1152/ajprenal.1991.260.3.F420; WILSON PD, 1992, J CELL PHYSIOL, V150, P360, DOI 10.1002/jcp.1041500220	28	31	31	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1995	1	4					359	364		10.1038/nm0495-359	http://dx.doi.org/10.1038/nm0495-359			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585067				2022-12-25	WOS:A1995RN09800033
J	MASHAL, RD; KOONTZ, J; SKLAR, J				MASHAL, RD; KOONTZ, J; SKLAR, J			DETECTION OF MUTATIONS BY CLEAVAGE OF DNA HETERODUPLEXES WITH BACTERIOPHAGE RESOLVASES	NATURE GENETICS			English	Article							ENDONUCLEASE-VII; GEL-ELECTROPHORESIS; RAPID DETECTION; BASE MUTATIONS; PCR; PRODUCTS; DUPLEXES; GENE	We have explored the application of the bacteriophage resolvases T4 endonuclease VII and T7 endonuclease I for detecting mutations in genomic DNA. Heteroduplex DNA fragments prepared by amplification from DNA containing known mutations were cleaved by one or both enzymes at nucleotide mismatches created by 3 of 3 short deletions and 13 of 14 point mutations in fragments as large as 940 basepairs. Heteroduplexes representing all four classes of possible single nucleotide mismatches were cleaved, and the sizes of the cleavage products generated correlated with the location of the mutation. We conclude that bacteriophage resolvases may be useful reagents for the rapid screening of DNA for mutations.	HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV MED ONCOL,BOSTON,MA 02115	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	MASHAL, RD (corresponding author), HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT PATHOL,75 FRANCIS ST,BOSTON,MA 02115, USA.				NATIONAL CANCER INSTITUTE [K11CA001556, P20CA058203] Funding Source: NIH RePORTER; NCI NIH HHS [P20 CA58203, K11 CA01556] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		COTTON RGH, 1993, MUTAT RES, V285, P125, DOI 10.1016/0027-5107(93)90060-S; DAVIDOW LS, 1992, COMPUT APPL BIOSCI, V8, P193; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; ELLIS LA, 1994, NUCLEIC ACIDS RES, V2, P2710; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GANGULY A, 1990, NUCLEIC ACIDS RES, V18, P3933, DOI 10.1093/nar/18.13.3933; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; GROMPE M, 1993, NAT GENET, V5, P111, DOI 10.1038/ng1093-111; JIRICNY J, 1988, NUCLEIC ACIDS RES, V16, P7843, DOI 10.1093/nar/16.16.7843; KEMPER B, 1981, EUR J BIOCHEM, V115, P123; KOSAK HG, 1990, EUR J BIOCHEM, V194, P779, DOI 10.1111/j.1432-1033.1990.tb19469.x; LISHANSKI A, 1994, P NATL ACAD SCI USA, V91, P2674, DOI 10.1073/pnas.91.7.2674; LU AL, 1992, GENOMICS, V14, P249, DOI 10.1016/S0888-7543(05)80213-7; MYERS RM, 1985, SCIENCE, V230, P1242, DOI 10.1126/science.4071043; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; ORITA M, 1989, GENOMICS, V4, P874; PICKSLEY SM, 1990, J MOL BIOL, V212, P723, DOI 10.1016/0022-2836(90)90233-C; SHENK TE, 1975, COLD SPRING HARB SYM, V1, P61; SMOOKER PM, 1993, MUTAT RES, V288, P65, DOI 10.1016/0027-5107(93)90208-W; SOLARO PC, 1993, J MOL BIOL, V230, P868, DOI 10.1006/jmbi.1993.1207; VERPY E, 1994, P NATL ACAD SCI USA, V91, P1873, DOI 10.1073/pnas.91.5.1873; VILLAREJO MR, 1974, J BACTERIOL, V120, P466, DOI 10.1128/JB.120.1.466-474.1974; WHITE MB, 1992, GENOMICS, V5, P301	23	159	202	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					177	183		10.1038/ng0295-177	http://dx.doi.org/10.1038/ng0295-177			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719346				2022-12-25	WOS:A1995QE67200020
J	KOBAYASHI, T; HIRAYAMA, Y; KOBAYASHI, E; KUBO, Y; HINO, O				KOBAYASHI, T; HIRAYAMA, Y; KOBAYASHI, E; KUBO, Y; HINO, O			A GERMLINE INSERTION IN THE TUBEROUS SCLEROSIS (TSC2) GENE GIVES RISE TO THE EKER RAT MODEL OF DOMINANTLY INHERITED CANCER	NATURE GENETICS			English	Article								The Eker rat hereditary renal carcinoma (RC) is an excellent example of a mendelian dominant predisposition to a specific cancer in an experimental animal. We have previously established a new conserved linkage group on rat chromosome 10q and human chromosome 16p13.3, and shown that the Eker mutation is tightly linked to the tuberous sclerosis (Tsc2) gene. We now describe a germline mutation in the gene encoding Tsc2 caused by the insertion of an approximately 5 kilobase DNA fragment in the Eker rat, resulting in aberrant RNA expression from the mutant allele. The phenotype of tuberous sclerosis in humans differs from that of the Eker rat, except for the occurence of renal tumours. The Eker rat may therefore provide insights into species-specific differences in tumourigenesis and/or phenotype-specific mutations.	JAPANESE FDN CANC RES, INST CANC, DEPT EXPTL PATHOL, TOKYO 170, JAPAN	Japanese Foundation for Cancer Research								EKER R, 1961, NATURE, V189, P858, DOI 10.1038/189858b0; EVERITT JI, 1992, J UROLOGY, V148, P1932, DOI 10.1016/S0022-5347(17)37087-8; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; HINO O, 1993, P NATL ACAD SCI USA, V90, P327, DOI 10.1073/pnas.90.1.327; HINO O, 1993, JPN J CANCER RES, V84, P1106, DOI 10.1111/j.1349-7006.1993.tb02808.x; HINO O, 1994, BIOCHEM BIOPH RES CO, V203, P1302, DOI 10.1006/bbrc.1994.2324; HINO O, 1993, P NATL ACAD SCI USA, V90, P730, DOI 10.1073/pnas.90.2.730; HINO O, 1985, INT J CANCER, V35, P5, DOI 10.1002/ijc.2910350103; HINO O, 1993, CANCER RES, V53, P5856; HINO O, 1994, CANCER LETT, V83, P117, DOI 10.1016/0304-3835(94)90307-7; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; KUBO Y, 1994, CANCER RES, V54, P2633; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; NELLIST M, 1993, CELL, V75, P1305; WARD CJ, 1994, CELL, V77, P881; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; YEUNG RS, 1993, P NATL ACAD SCI USA, V90, P8038, DOI 10.1073/pnas.90.17.8038	19	270	273	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1995	9	1					70	74		10.1038/ng0195-70	http://dx.doi.org/10.1038/ng0195-70			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704028				2022-12-25	WOS:A1995PZ91300017
J	WEBER, B; RIESS, O; WOLFF, G; ANDREW, S; COLLINS, C; GRAHAM, R; THEILMANN, J; HAYDEN, MR				WEBER, B; RIESS, O; WOLFF, G; ANDREW, S; COLLINS, C; GRAHAM, R; THEILMANN, J; HAYDEN, MR			DELINEATION OF A 50 KILOBASE DNA SEGMENT CONTAINING THE RECOMBINATION SITE IN A SPORADIC CASE OF HUNTINGTONS-DISEASE	NATURE GENETICS			English	Article							ALU-ALU RECOMBINATION; LINKAGE DISEQUILIBRIUM; CANDIDATE REGION; POINT MUTATIONS; GENE; SEQUENCE; CHROMOSOME-4; EVENTS; IDENTIFICATION; HETEROGENEITY	No detectable rearrangements involving chromosome 4p16.3 have been observed in patients with Huntington's disease (HD). New mutations for HD could involve structural alterations which might aid the localization of the defective gene. We have reinvestigated a well documented sporadic case of HD. DNA haplotyping with markers between D4S10 and the telomeric locus D4S141 reveals a recombination event in one chromosome of the sporadic HD patient. The site of recombination maps within a 50 kilobase (kb) region, about 700 kb from the 4p telomere. Based on the extremely low HD mutation rate and significantly decreased recombination in the distal region of 4p, we hypothesize a direct link between the site of the recombination and HD in this patient.	UNIV BRITISH COLUMBIA, DEPT MED GENET, 2125 EAST MALL, VANCOUVER V6T 1Z4, BC, CANADA; UNIV FREIBURG, INST HUMANGENET & ANTHROPOL, W-7800 FREIBURG, GERMANY	University of British Columbia; University of Freiburg			Hayden, Michael R/D-8581-2011; Graham, Rona K/R-7358-2018	Hayden, Michael R/0000-0001-5159-1419; Graham, Rona K/0000-0003-3722-6241; Weber, Bernhard H.F./0000-0002-8808-7723				ADAM S, 1991, AM J HUM GENET, V48, P595; ANDREW S, 1992, GENOMICS, V13, P301, DOI 10.1016/0888-7543(92)90246-O; BARRON L, 1991, J MED GENET, V28, P520, DOI 10.1136/jmg.28.8.520; BATES GP, 1991, AM J HUM GENET, V49, P7; BUCAN M, 1990, GENOMICS, V6, P1; BUETOW KH, 1991, AM J HUM GENET, V48, P911; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHANDLEY AC, 1989, J MED GENET, V26, P546, DOI 10.1136/jmg.26.9.546; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLLINS C, 1992, GENOMICS, V13, P698, DOI 10.1016/0888-7543(92)90144-H; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; DEVLIN RH, 1990, AM J HUM GENET, V46, P112; EMERSON CP, 1987, ANNU REV BIOCHEM, V56, P695, DOI 10.1146/annurev.bi.56.070187.003403; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GLADE PR, 1976, PROG MED GENET, V1, P1; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; MACDONALD ME, 1989, J CLIN INVEST, V84, P1013, DOI 10.1172/JCI114222; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MAGENIS RE, 1986, AM J HUM GENET, V39, P383; MAGNI GE, 1963, P NATL ACAD SCI USA, V50, P975, DOI 10.1073/pnas.50.5.975; MAGNI GE, 1962, GENETICS, V47, P1097; MARVO SL, 1983, P NATL ACAD SCI-BIOL, V80, P2452, DOI 10.1073/pnas.80.9.2452; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; POLLARD TD, 1981, J CELL BIOL, V91, pS156, DOI 10.1083/jcb.91.3.156s; RIESS O, 1992, NAT GENET, V1, P104, DOI 10.1038/ng0592-104; ROBBINS C, 1989, AM J HUM GENET, V44, P422; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; RULEY HE, 1983, NATURE, V304, P181, DOI 10.1038/304181a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; SNELL RG, 1989, CYTOGENET CELL GENET, V51, P1083; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEVENS D, 1969, J NEUROL NEUROSUR PS, V32, P140, DOI 10.1136/jnnp.32.2.140; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; TREMBLAY J, 1988, ADV SEC MESS PHOSPH, V22, P319; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WEBER B, 1991, NUCLEIC ACIDS RES, V19, P6263, DOI 10.1093/nar/19.22.6263; WEBER B, 1992, AM J HUM GENET, V50, P382; WEBER B, 1991, GENOMICS, V11, P1113, DOI 10.1016/0888-7543(91)90039-H; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P83, DOI 10.1007/BF01233207; WOLFF G, 1989, J MED GENET, V26, P18, DOI 10.1136/jmg.26.1.18	49	7	7	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1992	2	3					216	222		10.1038/ng1192-216	http://dx.doi.org/10.1038/ng1192-216			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345172				2022-12-25	WOS:A1992JW16500012
J	JOHNSON, LG; OLSEN, JC; SARKADI, B; MOORE, KL; SWANSTROM, R; BOUCHER, RC				JOHNSON, LG; OLSEN, JC; SARKADI, B; MOORE, KL; SWANSTROM, R; BOUCHER, RC			EFFICIENCY OF GENE-TRANSFER FOR RESTORATION OF NORMAL AIRWAY EPITHELIAL FUNCTION IN CYSTIC-FIBROSIS	NATURE GENETICS			English	Article							INTERCELLULAR COMMUNICATION; RESPIRATORY EPITHELIUM; ION PERMEABILITY; CELL-MEMBRANE; TRANSPORT; JUNCTIONS; INVITRO; CULTURE	An important issue for in vivo gene therapy for cystic fibrosis (CF) is the percentage of cells within the CF airway that will require correction. In this study, we mixed populations of a CF airway cell line expressing either the normal cystic fibrosis transmembrane conductance regulator (CFTR) cDNA (corrected cells) or a reporter gene in defined percentages. As few as 6-1 0% corrected cells within an epithelial sheet generated Cl-transport properties similar to sheets comprised of 1 00% corrected cells. Cell-cell coupling may serve as the mechanism for amplification of the functional effects of corrected cells. These data suggest that in vivo correction of all CF airway cells may not be mandatory.	UNIV N CAROLINA,DEPT BIOCHEM,CHAPEL HILL,NC 27599; UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599; NATL INST HAEMATOL & BLOOD TRANSFUS,BUDAPEST,HUNGARY	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	JOHNSON, LG (corresponding author), UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27599, USA.		Sarkadi, Balazs/I-5024-2013					Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; CARSON JL, 1989, AM J RESP CELL MOL, V1, P385, DOI 10.1165/ajrcmb/1.5.385; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COTTON CU, 1987, J CLIN INVEST, V79, P80, DOI 10.1172/JCI112812; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; FLAGGNEWTON J, 1979, SCIENCE, V205, P404, DOI 10.1126/science.377490; INOUE S, 1974, LAB INVEST, V31, P68; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; OLSEN JC, 1992, HUM GENE THER, V3, P253, DOI 10.1089/hum.1992.3.3-253; QUINTON PM, 1983, NEW ENGL J MED, V308, P1185, DOI 10.1056/NEJM198305193082002; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; SANDERSON MJ, 1988, AM J PHYSIOL, V254, pC63, DOI 10.1152/ajpcell.1988.254.1.C63; SARKADI B, 1992, J BIOL CHEM, V267, P2087; SCHNEEBERGER EE, 1978, J CELL SCI, V32, P307; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC1045, DOI 10.1152/ajpcell.1989.256.5.C1045; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC1033, DOI 10.1152/ajpcell.1989.256.5.C1033; Willumsen NJ, 1989, AM J PHYSIOL, V256, pC1054, DOI 10.1152/ajpcell.1989.256.5.C1054; YANKASKAS JR, 1985, LANCET, V1, P954	24	365	373	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					21	25		10.1038/ng0992-21	http://dx.doi.org/10.1038/ng0992-21			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1284642				2022-12-25	WOS:A1992JM64600010
J	KANDT, RS; HAINES, JL; SMITH, M; NORTHRUP, H; GARDNER, RJM; SHORT, MP; DUMARS, K; ROACH, ES; STEINGOLD, S; WALL, S; BLANTON, SH; FLODMAN, P; KWIATKOWSKI, DJ; JEWELL, A; WEBER, JL; ROSES, AD; PERICAKVANCE, MA				KANDT, RS; HAINES, JL; SMITH, M; NORTHRUP, H; GARDNER, RJM; SHORT, MP; DUMARS, K; ROACH, ES; STEINGOLD, S; WALL, S; BLANTON, SH; FLODMAN, P; KWIATKOWSKI, DJ; JEWELL, A; WEBER, JL; ROSES, AD; PERICAKVANCE, MA			LINKAGE OF AN IMPORTANT GENE LOCUS FOR TUBEROUS SCLEROSIS TO A CHROMOSOME 16 MARKER FOR POLYCYSTIC KIDNEY-DISEASE	NATURE GENETICS			English	Article							HYDROXYLASE PAH LOCUS; ABO BLOOD-GROUP; PCR DETECTION; V-ABL; HETEROGENEITY; RECOMBINATION; POLYMORPHISM; RFLP	Tuberous sclerosis complex (TSC) is an autosomal dominant disorder of unknown aetiology that affects numerous body systems including skin, brain and kidneys. Some TSC has been linked to chromosome 9, additional TSC genes on chromosomes 11 and 12 have been proposed, but the majority of TSC families remain unlinked. Using TSC families in which data had excluded linkage to chromosome 9, we failed to detect linkage with loci on chromosomes 11, 12 and others. One marker examined was D16S283, the closest locus on the proximal side of the polycystic kidney disease type 1 (PKD1) gene. Linkage between TSC and D16S283 demonstrated a lod score of 9.50 at THETA = 0.02 with one family independently presenting a lod score of 4.44 at THETA = 0.05. These data reveal an important TSC locus near the region of PKD1 on chromosome 16p13.	MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET LAB,CHARLESTON,MA 02129; UNIV CALIF IRVINE,DEPT PEDIAT,IRVINE,CA 92717; UNIV TEXAS,SCH MED,DEPT PEDIAT,DIV MED GENET,HOUSTON,TX 77030; UNIV OTAGO,DEPT PEDIAT & CHILD HLTH,DUNEDIN,NEW ZEALAND; UNIV TEXAS,HLTH SCI CTR,SW MED SCH,DIV PEDIAT NEUROL,DALLAS,TX 75235; UNIV VIRGINIA,DEPT PEDIAT,CHARLOTTESVILLE,VA 22908; BRIGHAM & WOMENS HOSP,DIV EXPTL MED & HEMATOL ONCOL,BOSTON,MA 02115; MARSHFIELD MED RES FDN,MARSHFIELD,WI 54449	Harvard University; Massachusetts General Hospital; University of California System; University of California Irvine; University of Texas System; University of Otago; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Virginia; Harvard University; Brigham & Women's Hospital	KANDT, RS (corresponding author), UNIV N CAROLINA,MED CTR,DEPT PEDIAT,DIV NEUROL,DURHAM,NC 27710, USA.		Blanton, Susan Halloran/ABF-1323-2021; Haines, Jonathan/C-3374-2012; Roach, Ewell/E-3958-2011	Haines, Jonathan/0000-0002-4351-4728; 				ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BERNSTEIN J, 1974, Birth Defects Original Article Series, V10, P35; BURLEY MW, IN PRESS ANN HUM GEN; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; CONNOR JM, 1987, J MED GENET, V24, P544, DOI 10.1136/jmg.24.9.544; DWORNICZAK B, 1991, NUCLEIC ACIDS RES, V19, P1958; FAHSOLD R, 1991, HUM GENET, V88, P85, DOI 10.1007/BF00204934; FRYER AE, 1987, LANCET, V1, P659; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; GLEBEL LB, 1990, NUCLEIC ACIDS RES, V18, P3103; Gomez MR, 1988, TUBEROUS SCLEROSIS; HAINES JL, 1991, ANN NY ACAD SCI, V615, P256; HAINES JL, 1991, CYTOGENET CELL GENET, V58, P1939; HAINES JL, 1991, AM J HUM GENET, V49, P764; HAINES JL, IN PRESS ANN HUM GEN; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; JANSSEN LAJ, 1990, GENOMICS, V8, P237, DOI 10.1016/0888-7543(90)90277-2; JANSSEN LAJ, 1991, ANN NY ACAD SCI, V615, P306; KANDT RS, 1989, EXP NEUROL, V104, P223, DOI 10.1016/0014-4886(89)90033-2; KANDT RS, 1991, ANN NY ACAD SCI, V615, P284; KANDT RS, IN PRESS ANN HUM GEN; KWIATKOWSKI DJ, 1991, AM J HUM GENET, V48, P121; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LITT M, 1990, NUCLEIC ACIDS RES, V18, P5921, DOI 10.1093/nar/18.19.5921-a; NORTHRUP H, 1987, LANCET, V2, P804; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; POVEY S, 1988, LANCET, V2, P279; POVEY S, 1991, ANN NY ACAD SCI, V615, P298; POVEY S, 1992, IN PRESS ANN HUM GEN; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; SAMPSON JR, 1989, J MED GENET, V26, P511, DOI 10.1136/jmg.26.8.511; SANTOS C C, 1990, Current Opinion in Pediatrics, V2, P1075, DOI 10.1097/00008480-199012000-00006; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; SMITH M, 1990, GENOMICS, V6, P105, DOI 10.1016/0888-7543(90)90454-3; STAPLETON FB, 1980, J PEDIATR-US, V97, P574, DOI 10.1016/S0022-3476(80)80011-4; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEDEMEYER N, 1991, NUCLEIC ACIDS RES, V19, P1959, DOI 10.1093/nar/19.8.1959; WIEDERHOLT WC, 1985, NEUROLOGY, V35, P600, DOI 10.1212/WNL.35.4.600	43	270	279	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					37	41		10.1038/ng0992-37	http://dx.doi.org/10.1038/ng0992-37			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303246	Green Published			2022-12-25	WOS:A1992JM64600013
J	LIFTON, RP; DLUHY, RG; POWERS, M; RICH, GM; GUTKIN, M; FALLO, F; GILL, JR; FELD, L; GANGULY, A; LAIDLAW, JC; MURNAGHAN, DJ; KAUFMAN, C; STOCKIGT, JR; ULICK, S; LALOUEL, JM				LIFTON, RP; DLUHY, RG; POWERS, M; RICH, GM; GUTKIN, M; FALLO, F; GILL, JR; FELD, L; GANGULY, A; LAIDLAW, JC; MURNAGHAN, DJ; KAUFMAN, C; STOCKIGT, JR; ULICK, S; LALOUEL, JM			HEREDITARY HYPERTENSION CAUSED BY CHIMERIC GENE DUPLICATIONS AND ECTOPIC EXPRESSION OF ALDOSTERONE SYNTHASE	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; GLUCOCORTICOID-SUPPRESSIBLE ALDOSTERONISM; HYPER-ALDOSTERONISM; DNA; CLONING; IDENTIFICATION; 18-OXOCORTISOL; POLYMORPHISMS; LOCALIZATION; FRAGMENTS	Patients with glucocorticoid-remediable aldosteronism (GRA) from 12 kindreds possess chimaeric gene duplications arising from unequal crossing-over, fusing regulatory sequences of steroid 11-beta-hydroxylase to coding sequences of aldosterone synthase. These chimaeric genes are specific for GRA and explain the biochemistry, physiology and genetics of this form of hypertension. Sites of crossing over range from intron 2 to intron 4. Most mutations have arisen independently from either sister or non-sister chromatid exchange between these genes, which are only 45 kilobases apart. The possibility of a susceptibility allele for GRA of Irish origin is suggested. These findings indicate the utility of a direct genetic test for this disorder.	UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; BRIGHAM & WOMENS HOSP,DIV ENDOCRINE HYPERTENS,BOSTON,MA 02115; HYPERTENS RENAL GRP,LIVINGSTON,NJ 07039; UNIV PADUA,INST SEMEIOT MED,I-35100 PADUA,ITALY; NHLBI,BETHESDA,MD 20892; CHILDRENS HOSP,DIV NEPHROL,BUFFALO,NY 14222; UNIV S FLORIDA,COLL MED,DEPT MED,TAMPA,FL 33620; CANADIAN CANC SOC,TORONTO M4V 3B1,ONTARIO,CANADA; REG HOSP CORK,DEPT MED,CORK,IRELAND; UNIV OKLAHOMA,HLTH SCI CTR,NEPHROL SECT,OKLAHOMA CITY,OK 73112; ALFRED HOSP,EWEN DOWNIE METAB UNIT,MELBOURNE,VIC 3181,AUSTRALIA; VET AFFAIRS HOSP,BRONX,NY 10468	Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; University of Padua; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University System of Florida; University of South Florida; Canadian Cancer Society (CCS); University of Oklahoma System; University of Oklahoma Health Sciences Center; Florey Institute of Neuroscience & Mental Health	LIFTON, RP (corresponding author), UNIV UTAH,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112, USA.			FALLO, FRANCESCO/0000-0002-7511-0226				BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CHU MD, 1982, J BIOL CHEM, V257, P2218; CHUA SC, 1987, P NATL ACAD SCI USA, V84, P7193, DOI 10.1073/pnas.84.20.7193; FALLO F, CLIN ENDOCRINOL, V22, P777; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDINER K, 1986, SOMAT CELL MOLEC GEN, V12, P185, DOI 10.1007/BF01560665; GIEBINK GS, 1973, J CLIN ENDOCR METAB, V36, P715, DOI 10.1210/jcem-36-4-715; GILLILAND G, 1990, P NATL ACAD SCI USA, V87, P2725, DOI 10.1073/pnas.87.7.2725; GOMEZSANCHEZ CE, 1984, J CLIN ENDOCR METAB, V59, P1022, DOI 10.1210/jcem-59-5-1022; GRIM CE, 1980, PEDIATRICS, V65, P597; HAHN RA, 1990, JAMA-J AM MED ASSOC, V264, P2654, DOI 10.1001/jama.264.20.2654; KAWAMOTO T, 1990, BIOCHEM BIOPH RES CO, V173, P309, DOI 10.1016/S0006-291X(05)81058-7; KAZAZIAN HH, 1990, SEMIN HEMATOL, V27, P209; LIFTON RP, 1990, GENOMICS, V7, P131, DOI 10.1016/0888-7543(90)90530-8; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; MORNET E, 1989, J BIOL CHEM, V264, P20961; NATHANS J, 1987, ANNU REV NEUROSCI, V10, P163; NEW MI, 1967, J CLIN ENDOCR METAB, V27, P300, DOI 10.1210/jcem-27-2-300; OGISHIMA T, 1991, J BIOL CHEM, V266, P10731; OMAHONY S, 1989, J HUM HYPERTENS, V3, P255; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RICH GM, 1992, ANN INTERN MED, V116, P813, DOI 10.7326/0003-4819-116-10-813; SCHOWALTER DB, 1989, ANAL BIOCHEM, V177, P90, DOI 10.1016/0003-2697(89)90019-5; SIMPSON ER, 1988, ANNU REV PHYSIOL, V50, P427, DOI 10.1146/annurev.ph.50.030188.002235; STOCKIGT JR, 1987, J CLIN ENDOCR METAB, V64, P22, DOI 10.1210/jcem-64-1-22; SUTHERLAND DJ, 1966, CAN MED ASSOC J, V95, P1109; ULICK S, 1990, J CLIN ENDOCR METAB, V71, P1151, DOI 10.1210/jcem-71-5-1151; ULICK S, 1983, J BIOL CHEM, V258, P5498; WARD R, 1990, DIAGNOSIS MANAGEMENT, P81; WEIR BS, 1990, GENETIC DATA ANAL, P102; WHITE PC, 1991, J CLIN INVEST, V87, P1664, DOI 10.1172/JCI115182; YABU M, 1991, HISTOCHEMISTRY, V96, P391, DOI 10.1007/BF00315995	32	267	276	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					66	74		10.1038/ng0992-66	http://dx.doi.org/10.1038/ng0992-66			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303253	Green Published			2022-12-25	WOS:A1992JM64600019
J	WHITSETT, JA; DEY, CR; STRIPP, BR; WIKENHEISER, KA; CLARK, JC; WERT, SE; GREGORY, RJ; SMITH, AE; COHN, JA; WILSON, JM; ENGELHARDT, J				WHITSETT, JA; DEY, CR; STRIPP, BR; WIKENHEISER, KA; CLARK, JC; WERT, SE; GREGORY, RJ; SMITH, AE; COHN, JA; WILSON, JM; ENGELHARDT, J			HUMAN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR DIRECTED TO RESPIRATORY EPITHELIAL-CELLS OF TRANSGENIC MICE	NATURE GENETICS			English	Article							CHLORIDE CHANNELS; GENE; EXPRESSION; IDENTIFICATION; CLONING; MOUSE; CFTR	Human cystic fibrosis transmembrane conductance regulator (CFTR) was expressed in transgenic mice under the control of transcriptional elements derived from the human surfactant protein C (SP-C) gene. The hCFTR mRNA was expressed in lungs and testes: in the lung, we found hCFTR mRNA in bronchiolar and alveolar epithelial cells, and CFTR protein in respiratory epithelial cells. While the level of expression of hCFTR mRNA varied, hCFTR mRNA and protein were detected in pulmonary epithelial cells of several lines. Lung weight, morphology, somatic growth and reproductive capacity were not altered by expression hCFTR in lung and testes of the transgenics. Our findings suggest that hCFTR can be safely transferred to lung epithelial cells for CF therapy.	GENZYME CORP,FRAMINGHAM,MA 01701; UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,DEPT BIOL CHEM,ANN ARBOR,MI 48109; DUKE UNIV,DEPT MED,DURHAM,NC 27710; DUKE UNIV,VET ADM MED CTR,DURHAM,NC 27710	Sanofi-Aventis; Genzyme Corporation; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	WHITSETT, JA (corresponding author), CHILDRENS HOSP,DIV PULM BIOL,CINCINNATI,OH 45229, USA.		Wilson, James M/F-9220-2011; Stripp, Barry/AAI-1467-2021	Wilson, James M/0000-0002-9630-3131; Engelhardt, John/0000-0003-2389-9277; Stripp, Barry/0000-0003-4348-2137				ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DITULLIO P, 1992, BIO-TECHNOL, V10, P74, DOI 10.1038/nbt0192-74; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; FIEDLER M, IN PRESS AM J PHYSL; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; GLASSER SW, 1990, J BIOL CHEM, V265, P21986; GLASSER SW, 1991, AM PHYS SOC, pL349; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; KORFHAGEN TR, 1990, P NATL ACAD SCI USA, V87, P6122, DOI 10.1073/pnas.87.16.6122; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; MARINO C R, 1991, Gastroenterology, V100, pA287; MARINO CR, 1991, J CLIN INVEST, V88, P712, DOI 10.1172/JCI115358; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; TATA F, 1991, GENOMICS, V10, P301, DOI 10.1016/0888-7543(91)90312-3; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; TRESIZE AEO, 1991, NATURE, V353, P434; WELSH MJ, 1986, SCIENCE, V232, P1648, DOI 10.1126/science.2424085	23	90	91	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					13	20		10.1038/ng0992-13	http://dx.doi.org/10.1038/ng0992-13			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1284640				2022-12-25	WOS:A1992JM64600009
J	MAIER, E; HOHEISEL, JD; MCCARTHY, L; MOTT, R; GRIGORIEV, AV; MONACO, AP; LARIN, Z; LEHRACH, H				MAIER, E; HOHEISEL, JD; MCCARTHY, L; MOTT, R; GRIGORIEV, AV; MONACO, AP; LARIN, Z; LEHRACH, H			COMPLETE COVERAGE OF THE SCHIZOSACCHAROMYCES-POMBE GENOME IN YEAST ARTIFICIAL CHROMOSOMES	NATURE GENETICS			English	Article							S-POMBE; DNA; INTEGRATION; FRAGMENTS; SEQUENCE; DIVISION; CLONING; TYPE-1; REPEAT; CYCLE	The genome of the fission yeast, Schizosaccharomyces pombe, consists of some 14 million base pairs of DNA contained in three chromosomes. On account of its excellent genetics we used it as a test system for a strategy designed to map mammalian chromosomes and genomes. Data obtained from hybridization fingerprinting established an ordered library of 1,248 yeast artificial chromosome clones with an average size of 535 kilobases. The clones fall into three contigs completely representing the three chromosomes of the organism. This work provides a high resolution physical and clone map of the genome, which has been related to available genetic and physical map information.	JOHN RADCLIFFE HOSP,IMPERIAL CANC RES FUND,INST MOLEC MED,HUMAN GENET LAB,OXFORD OX3 9DU,ENGLAND	University of Oxford	MAIER, E (corresponding author), IMPERIAL CANC RES FUND,GENOME ANAL LAB,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.		Monaco, Anthony P/A-4495-2010; Monaco, Zoia L/C-5762-2011	Monaco, Anthony P/0000-0001-7480-3197; Grigoriev, Andrey/0000-0002-3227-532X; Mott, Richard/0000-0002-1022-9330				ALLSHIRE RC, 1987, CELL, V50, P391, DOI 10.1016/0092-8674(87)90493-4; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOOHER R, 1989, CELL, V57, P1009, DOI 10.1016/0092-8674(89)90339-5; BROUGHTON BC, 1991, MOL GEN GENET, V228, P470, DOI 10.1007/BF00260641; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; FAN JB, 1991, NUCLEIC ACIDS RES, V19, P6289, DOI 10.1093/nar/19.22.6289; FAN JB, 1989, NUCLEIC ACIDS RES, V17, P2801, DOI 10.1093/nar/17.7.2801; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; KAUFER NF, 1985, NATURE, V318, P78, DOI 10.1038/318078a0; KINOSHITA N, 1990, CELL, V63, P405, DOI 10.1016/0092-8674(90)90173-C; KOHLI J, 1977, GENETICS, V87, P471; KOHLI J, 1987, CURR GENET, V11, P575, DOI 10.1007/BF00393919; LARIN Z, 1990, GENET RES, V56, P203, DOI 10.1017/S0016672300035308; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; LEHRACH H., 1990, GENOME ANAL, P39; LEVIN HL, 1990, MOL CELL BIOL, V10, P6791, DOI 10.1128/MCB.10.12.6791; LITTLE RD, 1992, P NATL ACAD SCI USA, V89, P177, DOI 10.1073/pnas.89.1.177; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Munz P, 1989, MOL BIOL FISSION YEA, P1; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PRESS WH, 1988, NUMERICAL RECIPES C, P343; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; RUSSELL P, 1986, CELL, V45, P781, DOI 10.1016/0092-8674(86)90550-7; SCHAAK J, 1982, NUCLEIC ACIDS RES, V10, P2851, DOI 10.1093/nar/10.9.2851; STERNBERG N, 1990, P NATL ACAD SCI USA, V87, P103, DOI 10.1073/pnas.87.1.103; TODA T, 1984, CURR GENET, V8, P93, DOI 10.1007/BF00420224; UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6	31	85	89	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1992	1	4					273	277		10.1038/ng0792-273	http://dx.doi.org/10.1038/ng0792-273			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1302023				2022-12-25	WOS:A1992JC98400011
J	BALLINGER, SW; SHOFFNER, JM; HEDAYA, EV; TROUNCE, I; POLAK, MA; KOONTZ, DA; WALLACE, DC				BALLINGER, SW; SHOFFNER, JM; HEDAYA, EV; TROUNCE, I; POLAK, MA; KOONTZ, DA; WALLACE, DC			MATERNALLY TRANSMITTED DIABETES AND DEAFNESS ASSOCIATED WITH A 10.4 KB MITOCHONDRIAL-DNA DELETION	NATURE GENETICS			English	Article							KEARNS-SAYRE SYNDROME; D-GLUCOSE; DISEASE; REPLICATION; OPHTHALMOPLEGIA; MYOPATHIES; INITIATION; MUTATIONS; DOMINANT; GENOMES	Diabetes mellitus (DM) is one of the most common chronic disorders of children and adults. Several reports have suggested an increased incidence of maternal transmission in some forms of DM. Therefore, we tested a pedigree with maternally transmitted DM and deafness for mitochondrial DNA mutations and discovered a 10.4 kilobase (kb) mtDNA deletion. This deletion is unique because it is maternally inherited, removes the light strand origin (O(L)) of mtDNA replication, inhibits mitochondrial protein synthesis, and is not associated with the hallmarks of mtDNA deletion syndromes. This discovery demonstrates that DM can be caused by mtDNA mutations and suggests that some of the heterogeneity of this disease results from the novel features of mtDNA genetics.	EMORY UNIV,SCH MED,DEPT GENET,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT MOLEC MED,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT NEUROL,ATLANTA,GA 30322; ATLANTA NEUROL CLIN,ATLANTA,GA 30322	Emory University; Emory University; Emory University; Emory University			Trounce, Ian A/F-8338-2010	Trounce, Ian A/0000-0002-1070-8892				ARNAUDO E, 1991, LANCET, V337, P508, DOI 10.1016/0140-6736(91)91294-5; DORNER G, 1988, EXP CLIN ENDOCRINOL, V91, P247; DORNER G, 1976, ENDOKRINOLOGIE, V68, P121; DORNER G, 1975, ENDOKRINOLOGIE, V66, P225; DORNER G, 1987, EXP CLIN ENDOCRINOL, V89, P84; EIZIRIK DL, 1988, ENDOCRINOLOGY, V123, P1001, DOI 10.1210/endo-123-2-1001; EVIATAR L, 1990, NEUROLOGY, V40, P1761, DOI 10.1212/WNL.40.11.1761; FREINKEL N, 1986, HORM METAB RES, V18, P427, DOI 10.1055/s-2007-1012338; GIROIX MH, 1991, DIABETES, V40, P227, DOI 10.2337/diabetes.40.2.227; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HIXSON JE, 1986, J BIOL CHEM, V261, P2384; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; LESTIENNE P, 1988, LANCET, V1, P885; NAKASE H, 1990, AM J HUM GENET, V46, P418; OZAWA T, 1988, BIOCHEM BIOPH RES CO, V154, P1240, DOI 10.1016/0006-291X(88)90272-0; OZAWA T, 1988, BIOCHEM BIOPH RES CO, V83, P154; PICCOLO G, 1989, J NEUROL SCI, V94, P163, DOI 10.1016/0022-510X(89)90226-8; PIMENTEL E, 1979, ACTA DIABETOL LAT, V16, P193, DOI 10.1007/BF02629112; POULTON J, 1991, AM J HUM GENET, V48, P649; POULTON J, 1989, LANCET, V1, P236; SCHURR TG, 1990, AM J HUM GENET, V46, P613; SENER A, 1987, BIOCHEM J, V246, P89, DOI 10.1042/bj2460089; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SHOFFNER JM, 1991, ANN NEUROL, V30, P332, DOI 10.1002/ana.410300304; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SVENSSON C, 1991, DIABETES, V40, P771, DOI 10.2337/diabetes.40.6.771; VADHEIM C, 1990, PRINCIPLES PRACTICE, V2, P1521; WALLACE DC, 1986, AM J HUM GENET, V38, P461; WALLACE DC, 1989, TRENDS GENET, V5, P9, DOI 10.1016/0168-9525(89)90005-X; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WALLACE DC, 1991, GENES BRAIN BEHAVIOR, V69, P101; WELSH N, 1991, DIABETOLOGIA, V34, P626, DOI 10.1007/BF00400991; WONG TW, 1985, CELL, V42, P951, DOI 10.1016/0092-8674(85)90291-0; ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; ZHENG XX, 1990, BIOCHIM BIOPHYS ACTA, V1019, P1, DOI 10.1016/0005-2728(90)90118-N	38	544	564	1	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1992	1	1					11	15		10.1038/ng0492-11	http://dx.doi.org/10.1038/ng0492-11			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1301992				2022-12-25	WOS:A1992JC97800005
J	KHAW, BA; TORCHILIN, VP; VURAL, I; NARULA, J				KHAW, BA; TORCHILIN, VP; VURAL, I; NARULA, J			PLUG AND SEAL - PREVENTION OF HYPOXIC CARDIOCYTE DEATH BY SEALING MEMBRANE LESIONS WITH ANTIMYOSIN-LIPOSOMES	NATURE MEDICINE			English	Article							MYOSIN-SPECIFIC ANTIBODY; MYOCARDIAL-INFARCTION; REPERFUSION; SIZE; LOCALIZATION	The hallmark of cell death is the development of cell membrane lesions. Such lesions in the myocardium are usually associated with acute myocardial infarction. Minimizing myocardial necrosis by thrombolytic reperfusion therapy constitutes the only major treatment to date. We envisioned a method to seal these membrane lesions using immunoliposomes as a novel adjunctive approach. An antigen to intracellular cytoskeletal myosin in hypoxic embryonic cardiocytes is used as an anchoring site, and a specific antibody on immunoliposomes as the anchor to plug and to seal the membrane lesions. H9C2 cells were used because they are cardiocytes and are propagated in tissue culture and their viability may be assessed by various methods. Viability assessed by [H-3]thymidine uptake in hypoxic cardiocyte cultures (n = 6 each) treated with antimyosin-immunoliposomes (3.26 +/- 0.483 x 10(6) c.p.m.) was similar to that of normoxic cells (3.68 +/- 0.328 x 10(6) c.p.m.), but was greater than those of untreated hypoxic cells (0.115 +/- 0.155 x 10(6) c.p.m.) or hypoxic cells treated with plain liposomes (1.140 +/- 0.577 x 10(6) c.p.m.). These results were reconfirmed by trypan blue exclusion and by fluorescent, confocal and transmission electron microscopy. They indicated that cell death in hypoxic cardiocytes can be prevented by targeted cell membrane sealing. This concept of cell salvage should be applicable in the prevention of cell death in different biological systems.	MASSACHUSETTS GEN HOSP,BOSTON,MA 02115	Harvard University; Massachusetts General Hospital	KHAW, BA (corresponding author), NORTHWESTERN UNIV,CTR DRUG TARGETING & ANAL,205 MUGAR BLDG,BOSTON,MA 02115, USA.			Vural, Imran/0000-0002-1627-3834				ALLEN TM, 1994, ADV DRUG DELIVER REV, V13, P285, DOI 10.1016/0169-409X(94)90016-7; BLEIFELD W, 1977, CIRCULATION, V55, P303, DOI 10.1161/01.CIR.55.2.303; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; GELTMAN EM, 1979, CIRCULATION, V60, P805, DOI 10.1161/01.CIR.60.4.805; JENNINGS RB, 1985, CIRC RES, V56, P262, DOI 10.1161/01.RES.56.2.262; JENNINGS RB, 1983, CIRCULATION, V68, P25; JENNINGS RB, 1960, ARCH PATHOL, V70, P68; KATZUNG BJ, 1975, PFLEUGERS ARCH EUR J, V260, P193; KHAW BA, 1976, J CLIN INVEST, V58, P439, DOI 10.1172/JCI108488; KHAW BA, 1979, CIRCULATION, V60, P1527, DOI 10.1161/01.CIR.60.7.1527; KHAW BA, 1986, CIRCULATION, V74, P501, DOI 10.1161/01.CIR.74.3.501; NARULA J, 1995, CIRCULATION, V92, P474, DOI 10.1161/01.CIR.92.3.474; PASTERNAK RC, 1994, HARRISONS PRINCIPLES, P1066; REIMER KA, 1983, AM J CARDIOL, V52, pA72; ROBERTS R, 1994, HURSTS HEART ARTERIE, P1107; ROBERTS R, 1979, ISOZYMES CURRENT TOP, P115; ROGERS WJ, 1977, CIRCULATION, V56, P199, DOI 10.1161/01.CIR.56.2.199; SIMOONS ML, 1986, J AM COLL CARDIOL, V7, P717, DOI 10.1016/S0735-1097(86)80329-1; TANDAN R, 1987, J NEUROL SCI, V79, P189, DOI 10.1016/0022-510X(87)90272-3; TORCHILIN VP, 1992, FASEB J, V6, P2716, DOI 10.1096/fasebj.6.9.1612296; TORCHILIN VP, 1988, LIPOSOMES DRUG CARRI, P63	21	68	70	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1195	1198		10.1038/nm1195-1195	http://dx.doi.org/10.1038/nm1195-1195			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584994				2022-12-25	WOS:A1995TC53700046
J	LONNQVIST, F; ARNER, P; NORDFORS, L; SCHALLING, M				LONNQVIST, F; ARNER, P; NORDFORS, L; SCHALLING, M			OVEREXPRESSION OF THE OBESE (OB) GENE IN ADIPOSE-TISSUE OF HUMAN OBESE SUBJECTS	NATURE MEDICINE			English	Article							ENERGY-INTAKE; BODY-FAT; TWIN	Obesity is accompanied by complications such as hypertension, non-insulin-dependent diabetes mellitus and atherosclerosis, which in turn cause ischaemic heart disease, stroke and premature death(1-3). The underlying mechanisms behind imbalance in energy intake and energy expenditure that lead to obesity are still controversial. In most populations, obesity is more common among women than men and is a multifactorial phenotype, which may result from a complex network of genetic and nongenetic factors. The relative importance of genetic factors for obesity is under debate(4-7). Genome searches using polymorphic markers in inbred mice with phenotypes that result in extreme obesity(8,9) and studies of human candidate genes are being performed in an attempt to identify genes that contribute to obesity. There is evidence that body weight is physiologically regulated(4,10,11) and it has been postulated that the storage of fat may provide signals to the brain that the body is obese, which in turn may make the subject eat less and burn more fuel(12,13). One of the molecules that may be involved in such signalling is the obese (ob) gene product. Mutations in ob result in profound obesity and type II diabetes in mice(14,15). The mouse ob gene and its human homologue have been cloned and sequenced(8). The gene is expressed in adipose tissue and the product has features of a secreted protein, We have investigated human ob expression in subcutaneous and omental adipose tissue obtained from non-obese and massively obese subjects using in situ hybridization histochemistry and report on overexpression in obese people.	HUDDINGE UNIV HOSP,DEPT MED,KAROLINSKA INST,S-14186 STOCKHOLM,SWEDEN; HUDDINGE UNIV HOSP,RES CTR,S-14186 STOCKHOLM,SWEDEN	Karolinska Institutet; Karolinska Institutet	LONNQVIST, F (corresponding author), KAROLINSKA HOSP,DEPT MOLEC MED,NEUROGENET UNIT,KAROLINSKA INST,S-17176 STOCKHOLM,SWEDEN.		Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922; Arner, Peter/0000-0002-6208-6220				ASTRUP A, 1992, EUR J CLIN NUTR, V46, P611; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; BODURTHA JN, 1990, PEDIATR RES, V28, P1, DOI 10.1203/00006450-199007000-00001; BOUCHARD C, 1988, ANNU REV NUTR, V8, P259, DOI 10.1146/annurev.nu.08.070188.001355; BOUCHARD C, 1993, ANNU REV NUTR, V13, P337, DOI 10.1146/annurev.nu.13.070193.002005; BROBECK JR, 1948, YALE J BIOL MED, V20, P545; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; ERBA HP, 1986, NUCLEIC ACIDS RES, V14, P5275, DOI 10.1093/nar/14.13.5275; FLIER S, 1995, CELL, V80, P15; FRAYN KN, 1992, CLIN SCI, V82, P1, DOI 10.1042/cs0820001; FRIEDMAN JM, 1991, GENOMICS, V11, P1054, DOI 10.1016/0888-7543(91)90032-A; FRIEDMAN JM, 1992, CELL, V69, P217, DOI 10.1016/0092-8674(92)90402-X; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; KAPLAN NM, 1989, ARCH INTERN MED, V149, P1514, DOI 10.1001/archinte.149.7.1514; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PERUSSE L, 1988, AM J CLIN NUTR, V47, P629, DOI 10.1093/ajcn/47.4.629; SCHALLING M, 1992, GENE EXPRESSION NEUR, P231; STUNKARD AJ, 1986, JAMA-J AM MED ASSOC, V256, P51, DOI 10.1001/jama.256.1.51; TREMBLAY A, 1991, AM J CLIN NUTR, V53, P1134, DOI 10.1093/ajcn/53.5.1134; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	23	651	697	1	29	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	SEP	1995	1	9					950	953		10.1038/nm0995-950	http://dx.doi.org/10.1038/nm0995-950			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585223				2022-12-25	WOS:A1995RT30300051
J	BERRY, R; STEVENS, TJ; WALTER, NAR; WILCOX, AS; RUBANO, T; HOPKINS, JA; WEBER, J; GOOLD, R; SOARES, MB; SIKELA, JM				BERRY, R; STEVENS, TJ; WALTER, NAR; WILCOX, AS; RUBANO, T; HOPKINS, JA; WEBER, J; GOOLD, R; SOARES, MB; SIKELA, JM			GENE-BASED SEQUENCE-TAGGED-SITES (STSS) AS THE BASIS FOR A HUMAN GENE MAP	NATURE GENETICS			English	Article							BRAIN CDNA LIBRARY; HUMAN GENOME; CAENORHABDITIS-ELEGANS; TAGS; CHROMOSOMES; ASSIGNMENT; EXPRESSION	Using our data set of 3,143 single pass sequences from human brain cDNA libraries, we have developed a strategy in which gene-based sequence-tagged-sites (STSs), derived from 3'untranslated regions of human cDNAs, are rapidly assigned to megabase-insert yeast artificial chromosomes and somatic cell hybrids to generate regional gene mapping data, Employing this approach, we have mapped 318 cDNAs, representing 308 human genes. Ninety-two of these mapped to regions implicated in human genetic diseases, identifying them as candidate genes. Extension of this strategy has the potential to result in virtually every human gene having, at its 3'end, its own associated STS, with each STS in turn specifying both a corresponding genomic clone and a specific regional location in the genome.	UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,PROGRAM MOLEC BIOL,DENVER,CO 80262; VET ADM SCHIZOPHRENIA CTR,DENVER,CO 80262; MARSHFIELD MED RES FDN,MARSHFIELD,WI 54449; STANFORD UNIV,CTR HUMAN GENOME MAPPING,STANFORD,CA 94305; COLUMBIA UNIV COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Stanford University; Columbia University; New York State Psychiatry Institute				Walter, Nicole/0000-0003-0431-8078				ADAMS MD, 1993, NAT GENET, V4, P256, DOI 10.1038/ng0793-256; ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; BELLANNECHANTEL.C, 1992, CELL, V70, P1059; BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; GOOLD RD, 1993, HUM MOL GENET, V2, P1271, DOI 10.1093/hmg/2.8.1271; KHAN AS, 1992, NAT GENET, V2, P180, DOI 10.1038/ng1192-180; Lincoln S.E., 1991, PRIMER COMPUTER PROG; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; OLSEN M, 1989, SCIENCE, V245, P1434; POLYMEROPOULOS MH, 1993, NAT GENET, V4, P381, DOI 10.1038/ng0893-381; POLYMEROPOULOS MH, 1992, GENOMICS, V12, P492, DOI 10.1016/0888-7543(92)90439-Y; REID T, 1992, P NATL ACAD SCI USA, V89, P1388; SIKELA JM, 1993, NAT GENET, V3, P189, DOI 10.1038/ng0393-189; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; WEBER JL, 1993, AM J HUM GENET, V53, P1079; WILCOX AS, 1991, NUCLEIC ACIDS RES, V19, P1837, DOI 10.1093/nar/19.8.1837	24	77	81	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					415	423		10.1038/ng0895-415	http://dx.doi.org/10.1038/ng0895-415			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670491				2022-12-25	WOS:A1995RM37500014
J	BUITING, K; SAITOH, S; GROSS, S; DITTRICH, B; SCHWARTZ, S; NICHOLLS, RD; HORSTHEMKE, B				BUITING, K; SAITOH, S; GROSS, S; DITTRICH, B; SCHWARTZ, S; NICHOLLS, RD; HORSTHEMKE, B			INHERITED MICRODELETIONS IN THE ANGELMAN AND PRADER-WILLI SYNDROMES DEFINE AN IMPRINTING CENTER ON HUMAN-CHROMOSOME-15	NATURE GENETICS			English	Article							GLOBIN GENE-CLUSTER; DNA METHYLATION; PARENT	A subset of patients with Angelman and Prader-Willi syndrome have apparently normal chromosomes of biparental origin, but abnormal DNA methylation at several loci within chromosome 15q11-13, and probably have a defect in imprinting. Using probes from a newly established 160-kb contig including D15S63 (PW71) and SNRPN, we have identified inherited microdeletions in two AS families and three PWS families. The deletions probably affect a single genetic element that we term the 15q11-13 imprinting centre (IC). In our model, the IC regulates the chromatin structure, DNA methylation and gene expression in cis throughout 15q11-13. Mutations of the imprinting centre can be transmitted silently through the germline of one sex, but appear to block the resetting of the imprint in the germline of the opposite sex.	UNIV ESSEN GESAMTHSCH KLINIKUM,INST HUMAN GENET,D-45122 ESSEN,GERMANY; CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV HOSP,CTR HUMAN GENET,CLEVELAND,OH 44106	University of Duisburg Essen; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital				Saitoh, Shinji/0000-0001-6911-3351	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031491] Funding Source: NIH RePORTER; NICHD NIH HHS [HD31491] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARLOW DP, 1993, SCIENCE, V260, P309, DOI 10.1126/science.8469984; BUITING K, 1994, HUM MOL GENET, V3, P2092; BULTING K, 1993, HUM MOL GENET, V2, P1991; BUXTON JL, 1994, HUM MOL GENET, V3, P1409, DOI 10.1093/hmg/3.8.1409; DITTRICH B, 1993, HUM MOL GENET, V2, P1995, DOI 10.1093/hmg/2.12.1995; DITTRICH B, 1992, HUM GENET, V90, P313; DITTRICH B, 1994, HUM GENET, V94, P583; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; GABRIEL J, 1994, HUM MOL GENET, V3, P1912, DOI 10.1093/hmg/3.10.1912; GILLESSENKAESBA.G, IN PRESS J MED GENET; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GLENN CC, 1993, HUM MOL GENET, V2, P1377, DOI 10.1093/hmg/2.9.1377; HORSTHERNKE B, IN PRESS P NOBEL C P; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1994, NAT GENET, V6, P41, DOI 10.1038/ng0194-41; LEFF SE, 1994, NAT GENET, V2, P259; LENGAUER C, 1982, GENOMICS, V13, P626; LUBINSKY M, 1987, AM J MED GENET, V28, P37, DOI 10.1002/ajmg.1320280106; MALCOLM S, 1994, CYTOGENET CELL GENET, V67, P1, DOI 10.1159/000133717; MUTIRANGURA A, 1993, GENOMICS, V18, P546, DOI 10.1016/S0888-7543(11)80011-X; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; NICHOLLS RD, 1993, CURR OPIN GENET DEV, V3, P445, DOI 10.1016/0959-437X(93)90119-A; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; ORSTAVIK KH, 1992, AM J MED GENET, V44, P534; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; REIS A, 1994, AM J HUM GENET, V54, P741; SCHMAUSS C, 1992, J BIOL CHEM, V267, P8521; SILVERMAN GA, 1989, P NATL ACAD SCI USA, V86, P7485, DOI 10.1073/pnas.86.19.7485; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; VANIN EF, 1983, CELL, V35, P701, DOI 10.1016/0092-8674(83)90103-4; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877	34	488	495	0	28	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1995	9	4					395	400		10.1038/ng0495-395	http://dx.doi.org/10.1038/ng0495-395			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795645				2022-12-25	WOS:A1995QQ75300017
J	DODT, G; BRAVERMAN, N; WONG, C; MOSER, A; MOSER, HW; WATKINS, P; VALLE, D; GOULD, SJ				DODT, G; BRAVERMAN, N; WONG, C; MOSER, A; MOSER, HW; WATKINS, P; VALLE, D; GOULD, SJ			MUTATIONS IN THE PTS1 RECEPTOR GENE, PXR1, DEFINE COMPLEMENTATION GROUP-2 OF THE PEROXISOME BIOGENESIS DISORDERS	NATURE GENETICS			English	Article							TETRATRICOPEPTIDE-REPEAT PROTEIN; YEAST HANSENULA-POLYMORPHA; TARGETING SIGNAL; ZELLWEGER SYNDROME; SACCHAROMYCES-CEREVISIAE; PICHIA-PASTORIS; FIREFLY LUCIFERASE; DEFICIENT MUTANTS; 3-KETOACYL-COA THIOLASE; CARBOXY TERMINUS	The peroxisome biogenesis disorders (PBDs) are lethal recessive diseases caused by defects in peroxisome assembly. We have isolated PXR1, a human homologue of the yeast P. pastoris PAS8 (peroxisome assembly) gene. PXR1, like PAS8, encodes a receptor for proteins with the type-1 peroxisomal targeting signal (PTSI). Mutations in PXR1 define complementation group 2 of PBDs and expression of PXR1 rescues the PTS1 import defect of fibroblasts from these patients. Based on the observation that PXR1 exists both in the cytosol and in association with peroxisomes, we propose that PXR1 protein recognizes PTS1-containing proteins in the cytosol and directs them to the peroxisome.	JOHNS HOPKINS UNIV HOSP,SCH MED,KENNEDY KRIEGER RES INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT CELL BIOL & ANAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University				Braverman, Nancy/0000-0003-1621-5164	NICHD NIH HHS [HD10981] Funding Source: Medline; NIDDK NIH HHS [DK45787] Funding Source: Medline; NIGMS NIH HHS [T32GM07471] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD010981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007471] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; AITCHISON JD, 1991, J BIOL CHEM, V266, P23197; BELLION E, 1987, CELL, V48, P165, DOI 10.1016/0092-8674(87)90367-9; BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; CRANE DI, 1994, J BIOL CHEM, V269, P21835; CRANE DI, 1994, CURR GENET, V26, P443, DOI 10.1007/BF00309932; CREGG JM, 1990, YEAST, V6, P87, DOI 10.1002/yea.320060202; DIDION T, 1992, FEBS LETT, V303, P113, DOI 10.1016/0014-5793(92)80500-G; ELGERSMA Y, 1993, GENETICS, V135, P731; ERDMANN R, 1989, P NATL ACAD SCI USA, V86, P5419, DOI 10.1073/pnas.86.14.5419; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GARTNER J, 1992, NAT GENET, V1, P16, DOI 10.1038/ng0492-16; GARTNER J, 1994, J INHERIT METAB DIS, V17, P327, DOI 10.1007/BF00711820; GIETL C, 1994, P NATL ACAD SCI USA, V91, P3151, DOI 10.1073/pnas.91.8.3151; GLOVER JR, 1994, J BIOL CHEM, V269, P7558; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; GOULD SJ, 1992, YEAST, V8, P613, DOI 10.1002/yea.320080805; GOULD SJ, 1987, J CELL BIOL, V105, P2923, DOI 10.1083/jcb.105.6.2923; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GOULD SJ, 1990, EMBO J, V9, P85, DOI 10.1002/j.1460-2075.1990.tb08083.x; HANSEN H, 1992, MOL GEN GENET, V235, P269, DOI 10.1007/BF00279370; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; IMANAKA T, 1987, J CELL BIOL, V105, P2915, DOI 10.1083/jcb.105.6.2915; KELLER GA, 1991, J CELL BIOL, V114, P893, DOI 10.1083/jcb.114.5.893; KOUTZ P, 1989, YEAST, V5, P167, DOI 10.1002/yea.320050306; Lazarow P. B., 1989, METABOLIC BASIS INHE, P1479; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LIU H, 1992, J BACTERIOL, V174, P4943, DOI 10.1128/JB.174.15.4943-4951.1992; MCCOLLUM D, 1993, J CELL BIOL, V121, P761, DOI 10.1083/jcb.121.4.761; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; MIURA S, 1992, J BIOL CHEM, V267, P14405; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; MOCZKO M, 1994, J BIOL CHEM, V269, P9045; MOSER HW, 1980, ANN NEUROL, V7, P542, DOI 10.1002/ana.410070607; MOTLEY A, 1994, J CELL BIOL, V125, P755, DOI 10.1083/jcb.125.4.755; NUTTLEY WM, 1994, J BIOL CHEM, V269, P556; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; PENNINGTON R, 1961, BIOCHEM J, V80, P649, DOI 10.1042/bj0800649; PETERS TJ, 1972, J EXP MED, V136, P1179; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; ROSCHER AA, 1989, PEDIATR RES, V26, P67, DOI 10.1203/00006450-198907000-00019; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTOS MJ, 1988, SCIENCE, V239, P1536, DOI 10.1126/science.3281254; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SIKORSKI RS, 1993, MOL CELL BIOL, V13, P1212, DOI 10.1128/MCB.13.2.1212; SLAWECKI M, IN PRESS J CELL SCI; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; SOTO U, 1993, EXP CELL RES, V205, P66, DOI 10.1006/excr.1993.1059; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; SWINKELS BW, 1992, FEBS LETT, V305, P133, DOI 10.1016/0014-5793(92)80880-P; SWINKELS BW, 1991, EMBO J, V10, P3255, DOI 10.1002/j.1460-2075.1991.tb04889.x; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; WALTER P, 1981, J CELL BIOL, V91, P557, DOI 10.1083/jcb.91.2.557; WALTON PA, 1994, J CELL BIOL, V125, P1037, DOI 10.1083/jcb.125.5.1037; WATKINS PA, 1991, ARCH BIOCHEM BIOPHYS, V289, P329, DOI 10.1016/0003-9861(91)90419-J; WENDLAND M, 1993, J CELL BIOL, V120, P675, DOI 10.1083/jcb.120.3.675; Wolff J, 1986, Pediatr Neurol, V2, P141, DOI 10.1016/0887-8994(86)90004-4	62	374	376	2	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					115	125		10.1038/ng0295-115	http://dx.doi.org/10.1038/ng0295-115			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719337				2022-12-25	WOS:A1995QE67200011
J	HOUWEN, RHJ; BAHARLOO, S; BLANKENSHIP, K; RAEYMAEKERS, P; JUYN, J; SANDKUIJL, LA; FREIMER, NB				HOUWEN, RHJ; BAHARLOO, S; BLANKENSHIP, K; RAEYMAEKERS, P; JUYN, J; SANDKUIJL, LA; FREIMER, NB			GENOME SCREENING BY SEARCHING FOR SHARED SEGMENTS - MAPPING A GENE FOR BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	NATURE GENETICS			English	Article							LINKAGE MAP; DISEQUILIBRIUM; PEDIGREE; TRAITS	It is now feasible to map disease genes by screening the genome for linkage disequilibrium between the disease and marker alleles. This report presents the first application of this approach for a previously unmapped locus. A gene for benign recurrent intrahepatic cholestasis (BRIC) was mapped to chromosome 18 by searching for chromosome segments shared by only three distantly related patients. The screening results were confirmed by identyifying an extended haplotype conserved between the patients. Probability calculations indicate that such segment sharing is unlikely to arise by chance. Searching the genome for segments shared by patients is a powerful empirical method for mapping disease genes. Computer simulations suggest that, in appropriate populations, the approach may be used to localize genes for common diseases.	UNIV CALIF SAN FRANCISCO,NEUROGENET LAB,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,CTR NEUROBIOL & PSYCHIAT,DEPT PSYCHIAT,SAN FRANCISCO,CA 94143; WILHELMINA CHILDRENS HOSP,UTRECHT,NETHERLANDS; CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,B-3000 LOUVAIN,BELGIUM; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS; ERASMUS UNIV ROTTERDAM,INST CLIN GENET,ROTTERDAM,NETHERLANDS	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Wilhelmina Kinderziekenhuis; KU Leuven; Leiden University; Leiden University - Excl LUMC; Erasmus University Rotterdam					NATIONAL INSTITUTE OF MENTAL HEALTH [K21MH000916, R01MH049499] Funding Source: NIH RePORTER; NIMH NIH HHS [MH00916, MH49499, MH47563] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BENHAMIDA C, 1993, NAT GENET, V5, P195; BODMER W, 1994, NAT GENET, V6, P217, DOI 10.1038/ng0394-217; BRENARD R, 1989, J CLIN GASTROENTEROL, V11, P546, DOI 10.1097/00004836-198910000-00011; BUETOW K, 1993, AM J HUM GENET, V53, pA176; COOK JTE, 1993, DIABETES, V42, P1536, DOI 10.2337/diabetes.42.10.1536; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; ELSTON RC, 1984, GENET EPIDEMIOL, V1, P315; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; LEWONTIN RC, 1988, GENETICS, V120, P849; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; Ott J., 1991, ANAL HUMAN GENETIC L; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; POLLAK MR, 1993, NAT GENET, V5, P201, DOI 10.1038/ng1093-201; SANDKUYL L, 1989, HUM GENET, V82, P159, DOI 10.1007/BF00284050; SHAPIRO RH, 1963, NEW ENGL J MED, V268, P708; SUMMERSKILL WHJ, 1959, LANCET, V2, P686; VANSOEST S, 1994, GENOMICS, V22, P499, DOI 10.1006/geno.1994.1422; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	27	271	277	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					380	386		10.1038/ng1294-380	http://dx.doi.org/10.1038/ng1294-380			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894490	Green Published			2022-12-25	WOS:A1994PV68200020
J	KAPLITT, MG; LEONE, P; SAMULSKI, RJ; XIAO, X; PFAFF, DW; OMALLEY, KL; DURING, MJ				KAPLITT, MG; LEONE, P; SAMULSKI, RJ; XIAO, X; PFAFF, DW; OMALLEY, KL; DURING, MJ			LONG-TERM GENE-EXPRESSION AND PHENOTYPIC CORRECTION USING ADENOASSOCIATED VIRUS VECTORS IN THE MAMMALIAN BRAIN	NATURE GENETICS			English	Article							HERPES-SIMPLEX VIRUS; ADENOASSOCIATED VIRUS; INSITU DETECTION; DNA; SYSTEM; INTEGRATION; MODEL; REPLICATION; PHYSIOLOGY; AMPLICON	Adeno-associated viral (AAV) vectors are non-pathogenic, integrating DNA vectors in which all viral genes are removed and helper virus is completely eliminated. To evaluate this system in the post-mitotic cells of the brain, we found that an AAV vector containing the lacZ gene (AAVlac) resulted in expression of P-galactosidase up to three months post-injection in vivo. A second vector expressing human tyrosine hydroxylase (AAVth) was injected into the denervated striatum of unilateral 6-hydroxydopamine-lesioned rats. Tyrosine hydroxylase (TH) immunoreactivity was detectable in striatal neurons and glia for up to four months and we also found significant behavioural recovery in lesioned rats treated with AAVth versus AAVlac controls. Safe and stable TH gene transfer into the denervated striatum may have potential for the genetic therapy of Parkinson's disease.	YALE UNIV,SCH MED,DEPT SURG,MOLEC PHARMACOL & NEUROGENET LAB,NEW HAVEN,CT 06520; ROCKEFELLER UNIV,NEUROBIOL & BEHAV LAB,NEW YORK,NY 10021; UNIV N CAROLINA,CTR GENE THERAPY,CHAPEL HILL,NC 27599; MERLIN PHARMACEUT,NEW YORK,NY 10014; WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110	Yale University; Rockefeller University; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL)			During, Matthew/AAC-1388-2020		NHLBI NIH HHS [HL48347] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048347] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; Berns K I, 1979, Adv Virus Res, V25, P407, DOI 10.1016/S0065-3527(08)60574-6; BREAKEFIELD XO, 1991, NEW BIOL, V3, P203; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; DUBACH M, 1990, NEUROSCI LETT, V75, P205; DURING MJ, 1992, EXP NEUROL, V115, P193, DOI 10.1016/0014-4886(92)90053-S; FLOTTE TR, 1993, P NATL ACAD SCI USA, V90, P10613, DOI 10.1073/pnas.90.22.10613; FREED WJ, 1980, ANN NEUROL, V8, P510, DOI 10.1002/ana.410080508; GELLER AI, 1990, P NATL ACAD SCI USA, V87, P8950, DOI 10.1073/pnas.87.22.8950; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HARGRAVES R, 1987, LIFE SCI, V40, P959, DOI 10.1016/0024-3205(87)90315-8; HAYR MD, 1987, PARKINSONS DISEASE; HEFTI F, 1980, BRAIN RES, V195, P123, DOI 10.1016/0006-8993(80)90871-9; HO DY, 1988, VIROLOGY, V167, P279, DOI 10.1016/0042-6822(88)90079-7; HO DY, 1993, P NATL ACAD SCI USA, V90, P3655, DOI 10.1073/pnas.90.8.3655; HORRELOU P, 1990, NEURON, V5, P393; JIAO S, 1993, NATURE, V262, P450; JOHNSON PA, 1992, J VIROL, V66, P2952, DOI 10.1128/JVI.66.5.2952-2965.1992; JONES N, 1978, CELL, V13, P181, DOI 10.1016/0092-8674(78)90148-4; KAPLITT M G, 1991, Molecular and Cellular Neuroscience, V2, P320, DOI 10.1016/1044-7431(91)90062-S; KAPLITT MG, 1994, P NATL ACAD SCI USA, V19, P8979; KWONG AD, 1985, VIROLOGY, V142, P421, DOI 10.1016/0042-6822(85)90351-4; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; LEBKOWSKI JS, 1988, MOL CELL BIOL, V8, P3988, DOI 10.1128/MCB.8.10.3988; MCLAUGHLIN SK, 1988, J VIROL, V62, P1963, DOI 10.1128/JVI.62.6.1963-1973.1988; MILLER DG, 1990, MOL CELL BIOL, V10, P4329; MUZYCZKA N, 1992, CURR TOP MICROBIOL, V158, P97; NEVE RL, 1993, TRENDS NEUROSCI, V16, P251, DOI 10.1016/0166-2236(93)90174-K; Nuovo G J, 1993, PCR Methods Appl, V2, P305; NUOVO GJ, 1991, AM J PATHOL, V139, P1239; OMALLEY KL, 1987, BIOCHEMISTRY-US, V26, P6910, DOI 10.1021/bi00396a007; Paxinos G., 2004, J CHEM INF MODEL, V5th; PERESE DA, 1989, BRAIN RES, V494, P285, DOI 10.1016/0006-8993(89)90597-0; POOLE S, IN PRESS BLOOD; ROIZMAN B, 1985, SCIENCE, V229, P1208, DOI 10.1126/science.2994215; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; SAMULSKI RJ, 1989, J VIROL, V63, P3822, DOI 10.1128/JVI.63.9.3822-3828.1989; SAMULSKI RJ, 1987, J VIROL, V61, P3096, DOI 10.1128/JVI.61.10.3096-3101.1987; SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626; SPAETE RR, 1982, CELL, V30, P295, DOI 10.1016/0092-8674(82)90035-6; WOLFF JA, 1989, P NATL ACAD SCI USA, V86, P9011, DOI 10.1073/pnas.86.22.9011; YAHR MD, 1969, ARCH NEUROL-CHICAGO, V21, P343, DOI 10.1001/archneur.1969.00480160015001	43	868	1172	1	37	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1994	8	2					148	154		10.1038/ng1094-148	http://dx.doi.org/10.1038/ng1094-148			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7842013				2022-12-25	WOS:A1994PL12300016
J	RATCLIFF, R; EVANS, MJ; CUTHBERT, AW; MACVINISH, LJ; FOSTER, D; ANDERSON, JR; COLLEDGE, WH				RATCLIFF, R; EVANS, MJ; CUTHBERT, AW; MACVINISH, LJ; FOSTER, D; ANDERSON, JR; COLLEDGE, WH			PRODUCTION OF A SEVERE CYSTIC-FIBROSIS MUTATION IN MICE BY GENE TARGETING	NATURE GENETICS			English	Article							RESPIRATORY EPITHELIUM; CHLORIDE CHANNELS; CLONING; IDENTIFICATION; ACTIVATION; MEMBRANE; CALCIUM; CELLS	We have used gene targeting in embryonic stem cells to introduce an HPRT mini-gene into the coding sequence of the murine cystic fibrosis gene (cftr). This insertion introduces a termination codon in frame with the cftr coding sequence to terminate prematurely the CFTR protein within the first nucleotide binding domain. Animals homozygous for the cftr disruption fail to thrive and display a range of symptoms including meconium ileus, distal intestinal obstructions, gastrointestinal mucus accumulation and blockage of pancreatic ducts. The animals also show lacrimal gland pathology. Tracheal and caecal transepithelial current measurements demonstrate the lack of a cAMP activatable Cl- channel. These animals will prove useful for the evaluation of new therapeutic drugs and gene therapy strategies.	UNIV CAMBRIDGE,WELLCOME CRC INST CANC & DEV BIOL,TENNIS COURT RD,CAMBRIDGE CB2 1QR,ENGLAND; UNIV CAMBRIDGE,DEPT GENET,CAMBRIDGE CB2 1QR,ENGLAND; UNIV CAMBRIDGE,DEPT PHARMACOL,CAMBRIDGE CB2 1QJ,ENGLAND; ADDENBROOKES HOSP,DEPT HISTOPATHOL,CAMBRIDGE CB2 2QQ,ENGLAND	University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge			Colledge, William/X-4976-2019	Colledge, William/0000-0002-9603-4429	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; CHANG SH, 1990, CELL, V63, P827; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; COLLEDGE WH, 1992, LANCET, V340, P680, DOI 10.1016/0140-6736(92)92223-3; COTTON CU, 1987, J CLIN INVEST, V79, P80, DOI 10.1172/JCI112812; DONNISON AB, 1966, PEDIATRICS, V37, P833; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; EGAN M, 1992, NATURE, V358, P581, DOI 10.1038/358581a0; EVANS MJ, 1989, MOL BIOL MED, V6, P557; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; HADORN B, 1968, J PEDIATR-US, V73, P39, DOI 10.1016/S0022-3476(68)80037-X; HENDERSON RM, 1992, BRIT J PHARMACOL, V106, P109, DOI 10.1111/j.1476-5381.1992.tb14301.x; Hodson ME, 1983, CYSTIC FIBROSIS; HUNTON DB, 1966, GASTROENTEROLOGY, V50, P99; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; MOENS CB, 1992, GENE DEV, V6, P691, DOI 10.1101/gad.6.5.691; Ratcliff Rosemary, 1992, Transgenic Research, V1, P177, DOI 10.1007/BF02522536; RIORDAN JR, 1989, SCIENCE, V245, P1066; SMITH SN, 1992, CLIN SCI, V82, P667, DOI 10.1042/cs0820667; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; TATA F, 1991, GENOMICS, V10, P301, DOI 10.1016/0888-7543(91)90312-3; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; VANDERLUGT N, 1991, GENE, V105, P263, DOI 10.1016/0378-1119(91)90161-4; WAGNER JA, 1991, NATURE, V349, P793, DOI 10.1038/349793a0; WAGNER JA, 1992, P NATL ACAD SCI USA, V89, P6785, DOI 10.1073/pnas.89.15.6785; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, P226	33	222	229	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					35	41		10.1038/ng0593-35	http://dx.doi.org/10.1038/ng0593-35			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	7685652				2022-12-25	WOS:A1993LA33700009
J	GLUSHAKOVA, S; BAIBAKOV, B; MARGOLIS, LB; ZIMMERBERG, J				GLUSHAKOVA, S; BAIBAKOV, B; MARGOLIS, LB; ZIMMERBERG, J			INFECTION OF HUMAN TONSIL HISTOCULTURES - A MODEL FOR HIV PATHOGENESIS	NATURE MEDICINE			English	Editorial Material							AIDS				GLUSHAKOVA, S (corresponding author), NICHHD,THEORET & PHYS BIOL LAB,BETHESDA,MD 20892, USA.							BALTIMORE D, 1995, CELL, V82, P175, DOI 10.1016/0092-8674(95)90303-8; BONYHADI ML, 1995, AIDS RES HUM RETROV, V11, P1073, DOI 10.1089/aid.1995.11.1073; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; FREEMAN AE, 1986, P NATL ACAD SCI USA, V83, P2694, DOI 10.1073/pnas.83.8.2694; Gougeon M L, 1993, Semin Immunol, V5, P187, DOI 10.1006/smim.1993.1022; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; LEIGHTON J, 1957, CANCER RES, V17, P929; MARGOLIS LB, 1995, AIDS RES HUM RETROV, V11, P697, DOI 10.1089/aid.1995.11.697; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; RACZ P, 1990, LYMPHOLOGY, V23, P85; ROSENZWEIG M, 1994, LEUKEMIA, V8, pS163; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	12	146	148	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1320	1322		10.1038/nm1295-1320	http://dx.doi.org/10.1038/nm1295-1320			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489416				2022-12-25	WOS:A1995TH78600048
J	PUTNAM, EA; ZHANG, H; RAMIREZ, F; MILEWICZ, DM				PUTNAM, EA; ZHANG, H; RAMIREZ, F; MILEWICZ, DM			FIBRILLIN-2 (FBN2) MUTATIONS RESULT IN THE MARFAN-LIKE DISORDER, CONGENITAL CONTRACTURAL ARACHNODACTYLY	NATURE GENETICS			English	Note							GENES; CHROMOSOME-15; LINKAGE; DOMAINS		UNIV TEXAS,SCH MED,DEPT INTERNAL MED,HOUSTON,TX 77030; MT SINAI MED CTR,BROOKDALE CTR MOLEC BIOL,NEW YORK,NY 10029; ST LUKES HOSP,TEXAS HEART INST,DIV CARDIOVASC RES,HOUSTON,TX 77030	University of Texas System; Icahn School of Medicine at Mount Sinai; Texas Heart Institute					NIAMS NIH HHS [AR-42044] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042044] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; BEALS RK, 1971, J BONE JOINT SURG AM, VA 53, P987, DOI 10.2106/00004623-197153050-00013; BIDDINGER AL, 1993, HUM MOL GENET, V2, P1323, DOI 10.1093/hmg/2.8.1323; BROWNAUGSBURGER P, 1994, J BIOL CHEM, V269, P28443; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; DAVIS EC, 1994, J CELL SCI, V107, P727; DEVEREUX RB, 1983, PROG MED GENET, V5, P139; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; ELDADAH ZA, 1995, J CLIN INVEST, V95, P874, DOI 10.1172/JCI117737; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; LUJAN JE, 1984, AM J MED GENET, V17, P311, DOI 10.1002/ajmg.1320170124; MILEWICZ DM, 1992, J CLIN INVEST, V89, P79, DOI 10.1172/JCI115589; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; ORITA M, 1989, GENOMICS, V5, P974; RAGHUNATH M, 1995, J MOL BIOL, V248, P901, DOI 10.1006/jmbi.1995.0270; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; Sambrook J, 1989, MOL CLONING LABORATO; SHPRINTZEN RJ, 1982, J CRAN GENET DEV BIO, V2, P65; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; TYNAN K, 1993, HUM MOL GENET, V2, P1813, DOI 10.1093/hmg/2.11.1813; YEH H, 1994, GENOMICS, V23, P443, DOI 10.1006/geno.1994.1521; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165; ZHANG H, 1994, J CELL BIOL, V124, P855, DOI 10.1083/jcb.124.5.855	26	216	225	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					456	458		10.1038/ng1295-456	http://dx.doi.org/10.1038/ng1295-456			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493032				2022-12-25	WOS:A1995TH62900029
J	BIRCHALL, PS; FISHPOOL, RM; ALBERTSON, DG				BIRCHALL, PS; FISHPOOL, RM; ALBERTSON, DG			EXPRESSION PATTERNS OF PREDICTED GENES FROM THE C-ELEGANS GENOME SEQUENCE VISUALIZED BY FISH IN WHOLE ORGANISMS	NATURE GENETICS			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; EMBRYONIC CELL LINEAGES; BIOTIN-LABELED PROBES; INSITU HYBRIDIZATION; RNA LOCALIZATION; PROTEIN; CHROMOSOMES; TRANSPORT; TRACKS; MUSCLE	More than 10 megabases of contiguous genome sequence have been submitted to the databases by the Caenorhabditis elegans Genome Sequencing Consortium. To characterize the genes predicted from the sequence, we have developed high resolution FISH for visualization of mRNA distributions in whole animals. The high resolution and sensitivity afforded by the use of directly fluorescently labelled probes and confocal imaging permitted mRNA distributions to be recorded at the cellular and subcellular level. Expression patterns were obtained for 8 out of 10 genes in an initial test set of predicted gene sequences, indicating that FISH is an effective means of characterizing predicted genes in C. elegans.	MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND; MRC,MOLEC GENET UNIT,CAMBRIDGE CB2 2QH,ENGLAND	MRC Laboratory Molecular Biology; University of Cambridge								AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Albertson DG, 1995, METHOD CELL BIOL, V48, P339; ALBERTSON DG, 1988, EMBO J, V7, P2801, DOI 10.1002/j.1460-2075.1988.tb03135.x; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; ALBERTSON DG, 1985, EMBO J, V4, P2493, DOI 10.1002/j.1460-2075.1985.tb03961.x; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; DIRKS RW, 1993, J CELL SCI, V104, P1187; EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079; FILES JG, 1981, J MOL BIOL, V149, P223, DOI 10.1016/0022-2836(81)90299-0; FIRE A, 1991, DEVELOPMENT, V113, P503; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; HILL DP, 1993, CURR TOP DEV BIOL, V28, P181, DOI 10.1016/S0070-2153(08)60213-6; HOPE IA, 1991, DEVELOPMENT, V113, P399; KIMBLE J, 1983, DEV BIOL, V96, P189, DOI 10.1016/0012-1606(83)90322-6; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; KLASS M, 1982, DEV BIOL, V93, P152, DOI 10.1016/0012-1606(82)90249-4; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; LYNCH AS, 1995, NAT GENET, V11, P309, DOI 10.1038/ng1195-309; MACPHEE DJ, 1994, DEV BIOL, V162, P259, DOI 10.1006/dbio.1994.1083; MITANI S, 1993, DEVELOPMENT, V119, P773; Okita Thomas W., 1994, Trends in Cell Biology, V4, P91, DOI 10.1016/0962-8924(94)90181-3; ROSBASH M, 1993, CELL, V75, P399, DOI 10.1016/0092-8674(93)90373-X; SCHEDIN P, 1991, DEVELOPMENT, V112, P833; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; STEWARD O, 1992, TRENDS NEUROSCI, V15, P180, DOI 10.1016/0166-2236(92)90170-D; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARD S, 1982, DEV BIOL, V92, P203, DOI 10.1016/0012-1606(82)90164-6; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; Waterston R., 1988, NEMATODE C ELEGANS, P281; White J., 1988, NEMATODE CAENORHABDI, V17, P81; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WILHELM JE, 1993, J CELL BIOL, V123, P269, DOI 10.1083/jcb.123.2.269; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Wood WB, 1988, NEMATODE CAENORHABDI, P1; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	45	20	20	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					314	320		10.1038/ng1195-314	http://dx.doi.org/10.1038/ng1195-314			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581456				2022-12-25	WOS:A1995TC63900021
J	EICHLER, EE; KUNST, CB; LUGENBEEL, KA; RYDER, OA; DAVISON, D; WARREN, ST; NELSON, DL				EICHLER, EE; KUNST, CB; LUGENBEEL, KA; RYDER, OA; DAVISON, D; WARREN, ST; NELSON, DL			EVOLUTION OF THE CRYPTIC FMR1 CGG REPEAT	NATURE GENETICS			English	Article							FRAGILE-X-SYNDROME; DNA-SEQUENCES; AFRICAN APES; REGION; INSTABILITY; SITE; GENE; CHROMOSOMES; PERSISTENCE; POPULATION	We have sequenced the 5' untranslated region of the orthologous FMR1 gene from 44 species of mammals. The CGG repeat is present in each species, suggesting conservation of the repeat over 150 million years of mammalian radiation. Most mammals possess small contiguous repeats (mean number of repeats = 8.0 +/- 0.8), but, in primates, the repeats are larger (mean= 20.0 +/- 2.3) and more highly interrupted. Parsimony analysis predicts that enlargement of the FMR1 CGG repeat beyond 20 triplets has occurred in three different primate lineages. In man and gorilla, AGG interruptions occur with higher-order periodicity, suggesting that historical enlargement has involved incremental and vectorial addition of larger arrays demarcated by an interruption. Our data suggest that replication slippage and unequal crossing over have been operative during the evolution of this repeat.	BAYLOR COLL MED,CTR HUMAN GENOME,DEPT HUMAN & MOLEC GENET,HOUSTON,TX 77030; EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PEDIAT,ATLANTA,GA 30322; ZOOL SOC SAN DIEGO,CTR REPROD ENDANGERED SPECIES,SAN DIEGO,CA 92112; UNIV HOUSTON,DEPT BIOCHEM & BIOPHYS SCI & COMP SCI,HOUSTON,TX 77024	Baylor College of Medicine; Emory University; Howard Hughes Medical Institute; Emory University; Zoological Society of San Diego; University of Houston System; University of Houston					NICHD NIH HHS [HD29256] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029256] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARINAMI T, 1993, HUM GENET, V92, P431, DOI 10.1007/BF00216445; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BAUER K, 1993, EXP CLIN IMMUNOGENET, V10, P56; CHONG SS, 1994, AM J MED GENET, V51, P552; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DEELEN W, 1994, AM J MED GENET, V51, P1; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GACY AM, 1995, CELL, V81, P533; HIRST MC, 1994, HUM MOL GENET, V3, P1553, DOI 10.1093/hmg/3.9.1553; JACOBSON DP, 1993, AM J HUM GENET, V53, P443; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; JONES C, 1995, NATURE, V376, P145, DOI 10.1038/376145a0; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LEVINSON G, 1986, MOL BIOL EVOL, V4, P203; MACPHERSON JN, 1995, J MED GENET, V32, P236, DOI 10.1136/jmg.32.3.236; MIYAMOTO MM, 1987, SCIENCE, V238, P369, DOI 10.1126/science.3116671; NANCARROW JK, 1994, SCIENCE, V264, P1938, DOI 10.1126/science.8009225; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PARRISH JE, 1994, NAT GENET, V8, P229, DOI 10.1038/ng1194-229; PERRINPECONTAL P, 1992, J MOL EVOL, V34, P17, DOI 10.1007/BF00163849; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1993, HUM MOL GENET, V2, P1429, DOI 10.1093/hmg/2.9.1429; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RIGGINS GJ, 1992, NAT GENET, V2, P186, DOI 10.1038/ng1192-186; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; RUBINSZTEIN DC, 1994, HUM MOL GENET, V3, P2031; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; SNOW K, 1993, AM J HUM GENET, V53, P1217; SNOW K, 1994, HUM MOL GENET, V3, P1543, DOI 10.1093/hmg/3.9.1543; STEPHAN W, 1989, MOL BIOL EVOL, V6, P198, DOI 10.1093/oxfordjournals.molbev.a040542; STEPHAN W, 1994, GENETICS, V136, P333, DOI 10.1093/genetics/136.1.333; TACHIDA H, 1992, GENETICS, V131, P471; TUCKER PK, 1992, MAMM GENOME, V3, P254, DOI 10.1007/BF00292153; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WALSH JB, 1987, GENETICS, V115, P553; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WOLFF RK, 1989, GENOMICS, V5, P382, DOI 10.1016/0888-7543(89)90076-1; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	40	37	39	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					301	308		10.1038/ng1195-301	http://dx.doi.org/10.1038/ng1195-301			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581454				2022-12-25	WOS:A1995TC63900019
J	STEIN, CA				STEIN, CA			DOES ANTISENSE EXIST	NATURE MEDICINE			English	Editorial Material							OLIGONUCLEOTIDES; DNA				STEIN, CA (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032, USA.							BURGESS TL, 1995, P NATL ACAD SCI USA, V92, P4051, DOI 10.1073/pnas.92.9.4051; GAO WY, 1992, MOL PHARMACOL, V41, P223; GUVAKOVA MA, 1995, J BIOL CHEM, V270, P2620, DOI 10.1074/jbc.270.6.2620; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; LALLIER T, 1993, SCIENCE, V259, P692, DOI 10.1126/science.8430321; MALTESE JY, 1995, NUCLEIC ACIDS RES, V23, P1146, DOI 10.1093/nar/23.7.1146; SIMONS M, 1992, NATURE, V359, P67, DOI 10.1038/359067a0; Stein C A, 1993, Antisense Res Dev, V3, P19; STEIN CA, 1994, ANTISENSE RES DEV, V4, P67, DOI 10.1089/ard.1994.4.67; TAMAMOTO T, 1994, ANTISENSE RES DEV, V4, P119; YAKUBOV L, 1993, J BIOL CHEM, V268, P18818; YAMAMOTO S, 1992, MICROBIOL IMMUNOL, V36, P983, DOI 10.1111/j.1348-0421.1992.tb02102.x	12	225	229	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1119	1121		10.1038/nm1195-1119	http://dx.doi.org/10.1038/nm1195-1119			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584974				2022-12-25	WOS:A1995TC53700026
J	HATADA, I; MUKAI, T				HATADA, I; MUKAI, T			GENOMIC IMPRINTING OF P57(KIP2), CYCLIN-DEPENDENT KINASE INHIBITOR, IN MOUSE	NATURE GENETICS			English	Letter							GENE; METHYLATION; ALLELES				HATADA, I (corresponding author), NATL CARDIOVASC CTR,RES INST,5-7-1 FUJISHIRO DAI,SUITA,OSAKA 565,JAPAN.							BARLOW DP, 1994, TRENDS GENET, V10, P194, DOI 10.1016/0168-9525(94)90255-0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; HATADA I, 1995, NUCLEIC ACIDS RES, V23, P36, DOI 10.1093/nar/23.1.36; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; LUBINSKY M, 1974, LANCET, V1, P932; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; MCLAUGHLIN KJ, IN PRESS GENES DEV; MONGHONG L, 1995, GENE DEV, V9, P639; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; OHLSSON R, 1994, TRENDS GENET, V10, P415, DOI 10.1016/0168-9525(94)90100-7; PAL N, 1990, ONCOGENE, V5, P1665; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; SCHROEDER WT, 1987, AM J HUM GENET, V40, P413; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; SEIZINGER BR, 1991, CYTOGENET CELL GENET, V58, P1080, DOI 10.1159/000133722; SOLTER D, 1988, ANNU REV GENET, V22, P127; VERES G, 1987, SCIENCE, V237, P415, DOI 10.1126/science.3603027; ZEMEL S, 1992, NAT GENET, V2, P259	28	266	269	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					204	206		10.1038/ng1095-204	http://dx.doi.org/10.1038/ng1095-204			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550351				2022-12-25	WOS:A1995RX80600025
J	OBRIEN, SJ				OBRIEN, SJ			GENOMIC PROSPECTING	NATURE MEDICINE			English	Editorial Material							PREVALENCE	The importance of preserving biodiversity extends beyond the discovery of new drugs to understanding how other species have dealt with medical problems we currently face.			OBRIEN, SJ (corresponding author), NCI,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21702, USA.		OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757				BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0; Benveniste R. E., 1985, MOL EVOLUTIONARY GEN, P359; BLACK FL, 1992, SCIENCE, V258, P1739, DOI 10.1126/science.1465610; BROWN EW, 1995, J VIROL, V68, P5953; DESROSIERS RC, 1990, ANNU REV IMMUNOL, V8, P557, DOI 10.1146/annurev.iy.08.040190.003013; FLAM F, 1994, SCIENCE, V266, P1324, DOI 10.1126/science.7973722; GARDNER MB, 1991, TRENDS GENET, V7, P22, DOI 10.1016/0168-9525(91)90017-K; HEENEY JL, 1990, J VIROL, V64, P1964, DOI 10.1128/JVI.64.5.1964-1972.1990; HIRSCH VM, 1994, VIRUS RES, V32, P183, DOI 10.1016/0168-1702(94)90041-8; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; OBRIEN SJ, 1994, ANNU REV GENET, V28, P467, DOI 10.1146/annurev.ge.28.120194.002343; OBRIEN SJ, 1993, NAT GENET, V3, P103, DOI 10.1038/ng0293-103; OLMSTED RA, 1992, J VIROL, V66, P6008, DOI 10.1128/JVI.66.10.6008-6018.1992; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; ROBERTS L, 1992, SCIENCE, V256, P1142, DOI 10.1126/science.256.5060.1142; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; TROWSDALE J, 1993, TRENDS GENET, V9, P117, DOI 10.1016/0168-9525(93)90205-V; Wilkinson D. A., 1994, RETROVIRIDAE, P465	19	11	11	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1995	1	8					742	744		10.1038/nm0895-742	http://dx.doi.org/10.1038/nm0895-742			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585171	Bronze, Green Published			2022-12-25	WOS:A1995RM63500025
J	BUKAWA, H; SEKIGAWA, KI; HAMAJIMA, K; FUKUSHIMA, J; YAMADA, Y; KIYONO, H; OKUDA, K				BUKAWA, H; SEKIGAWA, KI; HAMAJIMA, K; FUKUSHIMA, J; YAMADA, Y; KIYONO, H; OKUDA, K			NEUTRALIZATION OF HIV-1 BY SECRETORY IGA INDUCED BY ORAL IMMUNIZATION WITH A NEW MACROMOLECULAR MULTICOMPONENT PEPTIDE VACCINE CANDIDATE	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY VIRUS-ANTIGEN; CHOLERA-TOXIN; INFECTED INDIVIDUALS; SYNTHETIC PEPTIDES; T-CELL; B-CELL; RESPONSES; ANTIBODY; ADJUVANT; MUCOSAL	Control of pandemic infection of human immunodeficiency virus type 1 (HIV-1) requires some means of developing mucosal immunity against HIV-1 because sexual transmission of the virus occurs mainly through the mucosal tissues. However, there is no evidence as yet that the secretory immunoglobulin A (IgA) antibody induced by immunization with antigens in experimental animals can neutralize HIV-1. We demonstrate here that oral immunization with a new macromolecular peptide antigen and cholera toxin (CT) induces a high titre (1:2(11)) of gut-associated and secretory IgA antibody to HIV-1. Using three different neutralizing assays, we clearly demonstrate that this secretory IgA antibody is able to neutralize HIV-1(III), HIV-1(F2) and HIV-1(MN). Our new approach may prove to be important in the development of a mucosal vaccine that will provide protection of mucosal surfaces against HIV-1.	YOKOHAMA CITY UNIV,SCH MED,DEPT INTERNAL MED 3,KANAZAWA KU,YOKOHAMA,KANAGAWA 236,JAPAN; YOKOHAMA CITY UNIV,SCH MED,DEPT BACTERIOL,KANAZAWA KU,YOKOHAMA,KANAGAWA 236,JAPAN; OSAKA UNIV,DEPT MUCOSAL IMMUNOL,MICROBIAL DIS RES INST,SUITA,OSAKA 565,JAPAN; UNIV ALABAMA,DEPT ORAL BIOL,BIRMINGHAM,AL 35294	Yokohama City University; Yokohama City University; Osaka University; University of Alabama System; University of Alabama Birmingham	BUKAWA, H (corresponding author), YOKOHAMA CITY UNIV,SCH MED,DEPT ORAL & MAXILLOFACIAL SURG,KANAZAWA KU,3-9 FUKUURA,YOKOHAMA,KANAGAWA 236,JAPAN.		Kiyono, Hiroshi/AAC-6735-2022					ACHOUR A, 1990, P NATL ACAD SCI USA, V87, P7045, DOI 10.1073/pnas.87.18.7045; BOUCHER CAB, 1990, J CLIN LAB ANAL, V4, P43, DOI 10.1002/jcla.1860040109; BOURGUIN I, 1993, INFECT IMMUN, V61, P2082, DOI 10.1128/IAI.61.5.2082-2088.1993; BUKAWA H, IN PRESS MICROBIOL I; BURNETT PR, 1994, J IMMUNOL, V152, P4642; DEFOORT JP, 1992, P NATL ACAD SCI USA, V89, P3879, DOI 10.1073/pnas.89.9.3879; DEVOS T, 1991, J IMMUNOL METHODS, V141, P285, DOI 10.1016/0022-1759(91)90155-9; GOUDSMIT J, 1986, LANCET, V2, P177; INAMI S, 1991, AIDS, V5, P1140, DOI 10.1097/00002030-199109000-00015; JACKSON RJ, 1993, INFECT IMMUN, V61, P4272, DOI 10.1128/IAI.61.10.4272-4279.1993; KAARTINEN M, 1978, SCAND J IMMUNOL, V7, P229, DOI 10.1111/j.1365-3083.1978.tb00448.x; KORN AH, 1972, J MOL BIOL, V65, P525, DOI 10.1016/0022-2836(72)90206-9; LAI PK, 1990, AIDS RES HUM RETROV, V6, P205, DOI 10.1089/aid.1990.6.205; LEHNER T, 1993, P NATL ACAD SCI USA, V90, P8638, DOI 10.1073/pnas.90.18.8638; LEHNER T, 1992, SCIENCE, V258, P1365, DOI 10.1126/science.1360702; LEHNER T, 1994, J VIROL, V68, P1624, DOI 10.1128/JVI.68.3.1624-1632.1994; Lehner T, 1992, VACCINE RES, V3, P319; LYCKE N, 1986, IMMUNOLOGY, V59, P301; MCKEATING JA, 1992, VIROLOGY, V191, P732, DOI 10.1016/0042-6822(92)90249-O; NAKASHIMA H, 1990, B YAMAGUCHI MED SCH, V37, P169; NARA PL, 1987, AIDS RES HUM RETROV, V3, P283, DOI 10.1089/aid.1987.3.283; NARDELLI B, 1992, J IMMUNOL, V148, P914; OKUDA K, 1994, J INFECT DIS, V169, P227, DOI 10.1093/infdis/169.1.227; Okuda K, 1993, J Clin Lab Immunol, V40, P97; OKUDA K, 1981, P NATL ACAD SCI-BIOL, V78, P4557, DOI 10.1073/pnas.78.7.4557; Okuda Kenji, 1993, Journal of Molecular Recognition, V6, P101, DOI 10.1002/jmr.300060302; OLSON CA, 1989, P NATL ACAD SCI USA, V86, P1031, DOI 10.1073/pnas.86.3.1031; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; PUTNEY SD, 1986, SCIENCE, V234, P1392, DOI 10.1126/science.2431482; Reichlin M, 1980, Methods Enzymol, V70, P159; STAATS HF, 1994, CURR OPIN IMMUNOL, V6, P572, DOI 10.1016/0952-7915(94)90144-9; UBOLYAM S, 1994, LANCET, V344, P485, DOI 10.1016/S0140-6736(94)91825-2; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309	33	110	111	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1995	1	7					681	685		10.1038/nm0795-681	http://dx.doi.org/10.1038/nm0795-681			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585151				2022-12-25	WOS:A1995RQ06600044
J	PICCOLO, F; ROBERDS, SL; JEANPIERRE, M; LETURCQ, F; AZIBI, K; BELDJORD, C; CARRIE, A; RECAN, D; CHAOUCH, M; REGHIS, A; ELKERCH, F; SEFIANI, A; VOIT, T; MERLINI, L; COLLIN, H; EYMARD, B; BECKMANN, JS; ROMERO, NB; TOME, FMS; FARDEAU, M; CAMPBELL, KP; KAPLAN, JC				PICCOLO, F; ROBERDS, SL; JEANPIERRE, M; LETURCQ, F; AZIBI, K; BELDJORD, C; CARRIE, A; RECAN, D; CHAOUCH, M; REGHIS, A; ELKERCH, F; SEFIANI, A; VOIT, T; MERLINI, L; COLLIN, H; EYMARD, B; BECKMANN, JS; ROMERO, NB; TOME, FMS; FARDEAU, M; CAMPBELL, KP; KAPLAN, JC			PRIMARY ADHALINOPATHY - A COMMON-CAUSE OF AUTOSOMAL RECESSIVE MUSCULAR-DYSTROPHY OF VARIABLE SEVERITY	NATURE GENETICS			English	Note							GLYCOPROTEIN COMPLEX; DEFICIENCY; MUSCLE; LINKAGE		UNIV PARIS 05, BIOCHIM GENET LAB, F-75014 PARIS, FRANCE; UNIV PARIS 05, CHU COCHIN, INSERM, U129, F-75014 PARIS, FRANCE; UNIV IOWA, COLL MED, HOWARD HUGHES MED INST, IOWA CITY, IA 52242 USA; UNIV IOWA, COLL MED, DEPT PHYSIOL & BIOPHYS, IOWA CITY, IA 52242 USA; HOP BEN AKNOUN, CHU ALGER OUEST, Algiers, ALGERIA; CHU MUSTAPHA, ALGIERS, ALGERIA; NATL INST HYG, RABAT, MOROCCO; UNIV ESSEN GESAMTHSCH, KINDERKLIN, ESSEN, GERMANY; IST ORTOPED RIZZOLI, BOLOGNA, ITALY; INSERM, U153, F-75005 PARIS, FRANCE; CEPH, F-75010 PARIS, FRANCE; GENETHON, F-91000 EVRY, FRANCE; HOP ROBERT DEBRE, F-75020 PARIS, FRANCE	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Duisburg Essen; IRCCS Istituto Ortopedico Rizzoli; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite			Merlini, Luciano/N-6478-2019; Roberds, Steven L/AAP-4985-2020; Beckmann, Jacques S/A-9772-2008	Merlini, Luciano/0000-0002-1108-1198; Roberds, Steven L/0000-0003-0676-272X; Beckmann, Jacques S/0000-0002-9741-1900; Campbell, Kevin/0000-0003-2066-5889				ALLAMAND V, 1994, HUM MOL GENET, V3, P2269, DOI 10.1093/hmg/3.12.2269; AZIBI K, 1993, HUM MOL GENET, V2, P1423; BENHAMIDA M, 1990, EXC MED MUSC DYS RES, V527, P43; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; ELKERCH F, 1994, J MED GENET, V31, P342, DOI 10.1136/jmg.31.4.342; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FARDEAU M, 1993, CR ACAD SCI III-VIE, V316, P799; FEMANDEZ E, 1993, PCR METH APPL, V3, P122; HAMIDA MB, 1983, MUSCLE NERVE, V6, P469, DOI 10.1002/mus.880060702; HIGUCHI I, 1994, J CLIN INVEST, V94, P601, DOI 10.1172/JCI117375; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MIZUNO Y, 1994, BIOCHEM BIOPH RES CO, V203, P979, DOI 10.1006/bbrc.1994.2278; NICHOLSON LVB, 1989, J NEUROL SCI, V94, P125, DOI 10.1016/0022-510X(89)90223-2; PASSOSBUENO MR, 1993, HUM MOL GENET, V2, P1945, DOI 10.1093/hmg/2.11.1945; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; ROMERO NB, 1994, CR ACAD SCI III-VIE, V317, P70; Walton J.N., 1994, DISORDERS VOLUNTARY, V6th; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	20	186	190	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1995	10	2					243	245		10.1038/ng0695-243	http://dx.doi.org/10.1038/ng0695-243			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663524				2022-12-25	WOS:A1995RA85700027
J	PAN, ZK; IKONOMIDIS, G; LAZENBY, A; PARDOLL, D; PATERSON, Y				PAN, ZK; IKONOMIDIS, G; LAZENBY, A; PARDOLL, D; PATERSON, Y			A RECOMBINANT LISTERIA-MONOCYTOGENES VACCINE EXPRESSING A MODEL TUMOR-ANTIGEN PROTECTS MICE AGAINST LETHAL TUMOR-CELL CHALLENGE AND CAUSES REGRESSION OF ESTABLISHED TUMORS	NATURE MEDICINE			English	Article							NECROSIS-FACTOR-ALPHA; T-CELLS; GENE; TRANSFECTION; SUPPRESSION; INDUCTION; CARCINOMA; IMMUNITY; GROWTH; CANCER	Listeria monocytogenes is an intracellular organism that has the unusual ability to live in the cytoplasm of the cell. It is thus a good vector for targeting protein antigens to the cellular arm of the immune response. Here we use a model system, consisting of colon and renal carcinomas that express the influenza virus nucleoprotein and a recombinant L. monocytogenes that secretes this antigen, to test the potential of this organism as a cancer immunotherapeutic agent. We show that this recombinant organism can not only protect mice against lethal challenge with tumour cells that express the antigen, but can also cause regression of established macroscopic tumours in an antigen-specific T-cell-dependent manner.	UNIV PENN,DEPT MICROBIOL,PHILADELPHIA,PA 19104; UNIV PENN,CTR CANC,PHILADELPHIA,PA 19104; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT ONCOL,BALTIMORE,MD 21205	University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University				Paterson, Yvonne/0000-0002-9406-4958				ASHER AL, 1991, J IMMUNOL, V146, P3227; BASKAR S, 1993, P NATL ACAD SCI USA, V90, P5687, DOI 10.1073/pnas.90.12.5687; BERCHE P, 1987, J IMMUNOL, V138, P2266; BLANKENSTEIN T, 1991, J EXP MED, V173, P1047, DOI 10.1084/jem.173.5.1047; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; CAMPBELL MJ, 1988, J IMMUNOL, V141, P3227; CASON J, 1993, VACCINE, V11, P603, DOI 10.1016/0264-410X(93)90302-E; COSSART P, 1989, INFECT IMMUN, V57, P3269; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; COX AL, 1994, SCIENCE, V264, P716, DOI 10.1126/science.7513441; DOYLE A, 1985, J EXP MED, V161, P1135, DOI 10.1084/jem.161.5.1135; FEARON ER, 1988, CANCER RES, V38, P2975; FETTEN JV, 1991, J IMMUNOL, V147, P2697; GAUGLER B, 1994, J EXP MED, V179, P921, DOI 10.1084/jem.179.3.921; GEOFFROY C, 1991, INFECT IMMUN, V59, P2382, DOI 10.1128/IAI.59.7.2382-2388.1991; GUO YJ, 1994, SCIENCE, V263, P518, DOI 10.1126/science.7507262; HAHN H, 1991, REV INFECT DIS, V3, P1221; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; HUI K, 1984, NATURE, V311, P750, DOI 10.1038/311750a0; IKONOMIDIS G, 1994, J EXP MED, V180, P2209, DOI 10.1084/jem.180.6.2209; IKONOMIDIS G, IN PRESS VACCINES 95; KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021; KAUFMANN SHE, 1985, INFECT IMMUN, V48, P263, DOI 10.1128/IAI.48.1.263-266.1985; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; KRUISBEEK AM, 1994, CURRENT PROTOCOLS IM; LASSAM N, 1989, J IMMUNOL, V143, P3792; MURPHY GP, 1973, JNCI-J NATL CANCER I, V50, P1013, DOI 10.1093/jnci/50.4.1013; PARDOLL DM, 1993, TRENDS PHARMACOL SCI, V14, P202, DOI 10.1016/0165-6147(93)90209-3; PORGADOR A, 1992, CANCER RES, V52, P3679; RESTIFO NP, 1993, J EXP MED, V177, P265, DOI 10.1084/jem.177.2.265; SCHAFER R, 1992, J IMMUNOL, V149, P53; SCHREIBER H, 1993, FUNDAMENTAL IMMUNOLO, pCH32; SLINGLUFF CL, 1994, CURR OPIN IMMUNOL, V6, P733, DOI 10.1016/0952-7915(94)90077-9; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; TOPALIAN SL, 1994, P NATL ACAD SCI USA, V91, P9461, DOI 10.1073/pnas.91.20.9461; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; WALLICH R, 1985, NATURE, V315, P301, DOI 10.1038/315301a0; WU TC, 1994, CURR OPIN IMMUNOL, V6, P746, DOI 10.1016/0952-7915(94)90079-5	39	194	238	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1995	1	5					471	477		10.1038/nm0595-471	http://dx.doi.org/10.1038/nm0595-471			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585097				2022-12-25	WOS:A1995RN10000040
J	MENG, X; BENSON, K; CHADA, K; HUFF, EJ; SCHWARTZ, DC				MENG, X; BENSON, K; CHADA, K; HUFF, EJ; SCHWARTZ, DC			OPTICAL MAPPING OF BACTERIOPHAGE-LAMBDA CLONES USING RESTRICTION ENDONUCLEASES	NATURE GENETICS			English	Article							FLUORESCENCE DETECTION; DNA-MOLECULES; PHYSICAL MAP; HUMAN GENOME; LARGE-SCALE; CHROMOSOME; YEAST; CONSTRUCTION	Optical mapping is an emerging single molecule approach for the rapid generation of ordered restriction maps, using fluorescence microscopy. We have improved the size resolution of optical mapping by imaging individual DNA molecules elongated and fixed onto derivatized glass surfaces. Averaged fluorescence intensity and apparent length measurements accurately determined the mass of restriction fragments 800 basepairs long. We have used optical mapping to create ordered restriction maps for lambda clones derived from the mouse pygmy locus.	UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT BIOCHEM,PISCATAWAY,NJ 08854; NYU,DEPT CHEM,WM KECK LAB BIOMOLEC IMAGING,NEW YORK,NY 10003	Rutgers State University New Brunswick; Rutgers State University Medical Center; New York University					NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000225] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00225-02] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BAXENDALE S, 1993, NAT GENET, V4, P181, DOI 10.1038/ng0693-181; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7826; CRAIG AG, 1990, NUCLEIC ACIDS RES, V18, P2653; GLAZER AN, 1990, P NATL ACAD SCI USA, V87, P3851, DOI 10.1073/pnas.87.10.3851; GUO XH, 1993, J BIOMOL STRUCT DYN, V11, P1; GUO XH, 1992, NATURE, V359, P783, DOI 10.1038/359783a0; HUNKAPILLER T, 1991, SCIENCE, V254, P59, DOI 10.1126/science.1925562; KAISER R, 1993, METHOD ENZYMOL, V218, P122; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; LUCKHAM PF, 1984, J CHEM SOC FARAD T 1, V80, P865, DOI 10.1039/f19848000865; MATSUMOTO S, 1981, J MOL BIOL, V152, P501, DOI 10.1016/0022-2836(81)90255-2; MENG X, UNPUB INHIBITION RES; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; OLSON M, 1986, P NATL ACAD SCI USA, V83, P7821; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; SETO D, 1993, GENOMICS, V15, P673, DOI 10.1006/geno.1993.1123; WILLIAMS RC, 1977, P NATL ACAD SCI USA, V74, P2311, DOI 10.1073/pnas.74.6.2311; XIANG X, 1990, SCIENCE, V247, P967, DOI 10.1126/science.2305264; YANAGIDA M, 1986, APPLICATIONS FLUORES, P321; YOSHIDA K, 1993, NUCLEIC ACIDS RES, V21, P3553, DOI 10.1093/nar/21.15.3553	25	97	111	0	22	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1995	9	4					432	438		10.1038/ng0495-432	http://dx.doi.org/10.1038/ng0495-432			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795651				2022-12-25	WOS:A1995QQ75300023
J	MOULLIER, P; BOHL, D; CARDOSO, J; HEARD, JM; DANOS, O				MOULLIER, P; BOHL, D; CARDOSO, J; HEARD, JM; DANOS, O			LONG-TERM DELIVERY OF A LYSOSOMAL-ENZYME BY GENETICALLY-MODIFIED FIBROBLASTS IN DOGS	NATURE MEDICINE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE-VII; BETA-GLUCURONIDASE; SKIN FIBROBLASTS; GENE-TRANSFER; RECOGNITION; STORAGE; LIVER; TRANSPLANTATION; SPLEEN; MOUSE	We have evaluated the feasibility and efficacy of intraperitoneal implants (neo-organs) for protein delivery in large animals. Skin biopsies were taken from four healthy dogs. Primary fibroblast cultures were transduced with a retroviral vector coding for the human beta-glucuronidase. One to six lattices each containing 10(9) skin fibroblasts were implanted into the omentum of the donor animal. Laparotomies performed at regular intervals showed vascularized neo-organs without local inflammation. Human beta-glucuronidase levels equivalent to 0.8 to 3.1% of the endogenous canine activity were detected for up to 340 days on liver biopsy samples. These results indicate that neo-organs can be considered for the long-term delivery of therapeutic proteins or enzymes in humans.	INST PASTEUR,RETROVIRUS & TRANSFERT GENET LAB,CNRS,URA 1157,F-75015 PARIS,FRANCE; UER COCHIN PORT ROYAL BIOCHIM MACROMOL,RECH CHIRURG LAB,F-75014 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris			Bohl, Delphine/L-8709-2016	Bohl, Delphine/0000-0001-8262-5642				ACHORD DT, 1978, CELL, V15, P269, DOI 10.1016/0092-8674(78)90102-2; BELL E, 1983, J INVEST DERMATOL, V81, pS2, DOI 10.1111/1523-1747.ep12539993; CARDOSO JE, 1993, HUM GENE THER, V4, P411, DOI 10.1089/hum.1993.4.4-411; DANOS O, 1991, PRACTICAL MOL VIROLO, P17; DWARKI VJ, 1995, P NATL ACAD SCI USA, V92, P1023, DOI 10.1073/pnas.92.4.1023; HAYASHI M, 1963, J HISTOCHEM CYTOCHEM, V12, P293; HOPWOOD JJ, 1990, MOL BIOL MED, V7, P381; KAPLAN A, 1977, P NATL ACAD SCI USA, V74, P2026, DOI 10.1073/pnas.74.5.2026; KRIVIT W, 1992, BONE MARROW TRANSPL, V10, P87; MARECHAL V, 1993, BLOOD, V82, P1358; MOULLIER P, 1993, NAT GENET, V4, P154, DOI 10.1038/ng0693-154; MOULLIER P, 1993, TRANSPLANTATION, V56, P427, DOI 10.1097/00007890-199308000-00034; NAFFAKH N, IN PRESS P NATN ACAD; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; Pfeffer S R, 1991, Curr Top Microbiol Immunol, V170, P43; SANDO GN, 1977, CELL, V12, P619, DOI 10.1016/0092-8674(77)90262-8; ULLRICH K, 1978, BIOCHEM J, V170, P643, DOI 10.1042/bj1700643; VOGLER C, 1993, PEDIATR RES, V34, P837, DOI 10.1203/00006450-199312000-00028; WOLFE JH, 1992, NATURE, V360, P749, DOI 10.1038/360749a0	19	43	46	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1995	1	4					353	357		10.1038/nm0495-353	http://dx.doi.org/10.1038/nm0495-353			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585066				2022-12-25	WOS:A1995RN09800032
J	BODE, L; ZIMMERMANN, W; FERSZT, R; STEINBACH, F; LUDWIG, H				BODE, L; ZIMMERMANN, W; FERSZT, R; STEINBACH, F; LUDWIG, H			BORNA-DISEASE VIRUS GENOME TRANSCRIBED AND EXPRESSED IN PSYCHIATRIC-PATIENTS	NATURE MEDICINE			English	Article							ANTIBODIES; RATS; INFECTION; DISORDERS; HUMANS; CELLS; BRAIN	Borna disease virus (BDV) is a neurotropic, negative and single-stranded enveloped RNA virus that persistently infects various domestic animal species. Infection causes disturbances in behaviour and cognitive functions, but can also lead to a fatal neurologic disease. Human infections seemed likely, since serum antibodies were detected in neuropsychiatric patients. Further proof came from our discovery that peripheral blood monocytes carry viral antigens. Here, we present the first data on different viral genomic transcripts in such patients' cells as well as sequence data of transcripts. Both viral markers seem to coincide with acute episodes of mood disorders, thus pointing to a new human virus infection possibly threatening mental health.	FREE UNIV BERLIN,INST VIROL,D-13353 BERLIN,GERMANY; FREE UNIV BERLIN,KLINIKUM BENJAMIN FRANKLIN,DEPT PSYCHIAT,D-12203 BERLIN,GERMANY	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	BODE, L (corresponding author), ROBERT KOCH INST,DEPT VIROL,D-13353 BERLIN,GERMANY.		Bode, Liv/ABD-1599-2021; Steinbach, Falko/V-1682-2019	Bode, Liv/0000-0002-8935-6198; Steinbach, Falko/0000-0003-1236-2837				Bechter K., 1992, NEUROL PSYCHIAT BR, V1, P23; BODE L, 1994, LANCET, V343, P297, DOI 10.1016/S0140-6736(94)91147-9; BODE L, 1995, CURR TOP MICROBIOL, V190, P103; BODE L, 1994, VET REC, V135, P283, DOI 10.1136/vr.135.12.283; Bode L, 1993, Arch Virol Suppl, V7, P159; BODE L, 1988, LANCET, V2, P689; BODE L, 1992, J MED VIROL, V36, P309, DOI 10.1002/jmv.1890360414; BRIESE T, 1994, P NATL ACAD SCI USA, V91, P4362, DOI 10.1073/pnas.91.10.4362; BRIESE T, 1992, P NATL ACAD SCI USA, V89, P11486, DOI 10.1073/pnas.89.23.11486; CUBITT B, 1994, J VIROL, V68, P1382, DOI 10.1128/JVI.68.3.1382-1396.1994; CUBITT B, 1994, J VIROL, V68, P1371, DOI 10.1128/JVI.68.3.1371-1381.1994; DELATORRE JC, 1994, J VIROL, V68, P7669, DOI 10.1128/JVI.68.12.7669-7675.1994; DITTRICH W, 1989, BIOL PSYCHIAT, V26, P818, DOI 10.1016/0006-3223(89)90122-4; GOLD PW, 1988, NEW ENGL J MED, V319, P413, DOI 10.1056/NEJM198808183190706; GOLD PW, 1988, NEW ENGL J MED, V319, P347; GOSZTONYI G, 1993, LAB INVEST, V68, P285; LIPKIN WI, 1990, P NATL ACAD SCI USA, V87, P4184, DOI 10.1073/pnas.87.11.4184; Ludwig H, 1993, Arch Virol Suppl, V7, P111; LUDWIG H, 1988, PROG MED VIROL, V35, P107; LUNDGREN AL, 1993, J VET MED B, V40, P298, DOI 10.1111/j.1439-0450.1993.tb00142.x; NARAYAN O, 1983, SCIENCE, V220, P1401, DOI 10.1126/science.6602380; OLDSTONE MBA, 1991, J VIROL, V65, P6381, DOI 10.1128/JVI.65.12.6381-6386.1991; RICHT JA, 1989, J EXP MED, V170, P1045, DOI 10.1084/jem.170.3.1045; ROTT R, 1985, SCIENCE, V228, P755, DOI 10.1126/science.3922055; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER PA, 1994, J VIROL, V68, P63, DOI 10.1128/JVI.68.1.63-68.1994; SIERRAHONIGMANN AM, 1993, J NEUROIMMUNOL, V45, P31, DOI 10.1016/0165-5728(93)90160-Z; STEINBACH F, 1994, J IMMUNOL METHODS, V174, P109, DOI 10.1016/0022-1759(94)90015-9; VANDEWOUDE S, 1990, SCIENCE, V250, P1278, DOI 10.1126/science.2244211; ZIMMERMANN W, 1994, J VIROL, V68, P6755, DOI 10.1128/JVI.68.10.6755-6758.1994; ZIMMERMANN W, 1994, J VIROL METHODS, V46, P133, DOI 10.1016/0166-0934(94)90098-1; 1987, DIAGNOSTIC STATISTIC, P567	32	217	228	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1995	1	3					232	236		10.1038/nm0395-232	http://dx.doi.org/10.1038/nm0395-232			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX559	7585039				2022-12-25	WOS:A1995QX55900029
J	ANDRIKOPOULOS, K; LIU, X; KEENE, DR; JAENISCH, R; RAMIREZ, F				ANDRIKOPOULOS, K; LIU, X; KEENE, DR; JAENISCH, R; RAMIREZ, F			TARGETED MUTATION IN THE COL5A2 GENE REVEALS A REGULATORY ROLE FOR TYPE-V COLLAGEN DURING MATRIX ASSEMBLY	NATURE GENETICS			English	Article								The tissue-specific organization of collagen molecules into tridimensional macroaggregates determines the physiomechanical properties of most connective tissues, but the factors and mechanisms controlling this process are unknown. It has been postulated that quantitatively minor types V and XI collagen regulate the growth of type I and II collagen fibrils, respectively. To test this hypothesis, we created mice that produce a structurally abnormal alpha 2(V) collagen chain. Homozygous mutant mice survive poorly, possibly because of complications from spinal deformities, and exhibit skin and eye abnormalities caused by disorganized type I collagen fibrils. Our results demonstrate that type V collagen is a key determinant in the assembly of tissue-specific matrices, and provide an animal model for human connective tissue disorders.	CUNY MT SINAI SCH MED, BROOKDALE CTR MOLEC BIOL, NEW YORK, NY 10029 USA; MIT, WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02142 USA; SHRINERS HOSP CRIPPLED CHILDRENS, PORTLAND, OR 97201 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)					NHLBI NIH HHS [HL 41484] Funding Source: Medline; NIAMS NIH HHS [AR38648] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL041484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038648, R37AR038648] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDRIKOPOULOS K, 1992, DEV DYNAM, V195, P113, DOI 10.1002/aja.1001950205; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024; BIRK DE, 1990, J CELL SCI, V95, P649; Birk DE., 1991, MATRIX ASSEMBLY, P221; BONADIO J, 1990, P NATL ACAD SCI USA, V87, P7145, DOI 10.1073/pnas.87.18.7145; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BROEK DL, 1985, J BIOL CHEM, V260, P555; BYERS PH, 1990, PRINCIPLES PRACTICE, P1065; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; GLORIEUX FH, 1991, BONE, V12, P377, DOI 10.1016/8756-3282(91)90025-E; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; KRATOCHWIL K, 1986, DEV BIOL, V117, P596, DOI 10.1016/0012-1606(86)90328-3; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI Y, IN PRESS CELL; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MORADIAMELI M, 1994, EUR J BIOCHEM, V221, P987, DOI 10.1111/j.1432-1033.1994.tb18815.x; PROCKOP DJ, 1990, J BIOL CHEM, V265, P15349; Rook A., 1982, DISEASES HAIR SCALP; ROSATI R, 1994, NAT GENET, V8, P129, DOI 10.1038/ng1094-129; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Sambrook J, 1989, MOL CLONING LAB MANU, P1; TSENG SCG, 1982, J BIOL CHEM, V257, P2627; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; WOODBURY D, 1989, J BIOL CHEM, V264, P2735	28	184	187	1	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					31	36		10.1038/ng0195-31	http://dx.doi.org/10.1038/ng0195-31			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704020				2022-12-25	WOS:A1995PZ91300011
J	BEDI, GC; WESTRA, WH; FARZADEGAN, H; PITHA, PM; SIDRANSKY, D				BEDI, GC; WESTRA, WH; FARZADEGAN, H; PITHA, PM; SIDRANSKY, D			MICROSATELLITE INSTABILITY IN PRIMARY NEOPLASMS FROM HIV+ PATIENTS	NATURE MEDICINE			English	Article							POLYMERASE CHAIN-REACTION; KAPOSIS-SARCOMA; MISMATCH REPAIR; COLORECTAL-CANCER; AIDS; INFECTION; MUTATIONS; CARCINOGENESIS; PATHOGENESIS; SEQUENCES	AIDS is associated with a high risk of certain malignancies, notably Kaposi's sarcoma (KS) and B-cell non-Hodgkin's lymphoma (NHL). The pathogenesis of these malignancies is not fully understood. One mechanism of malignant transformation recently described in colon tumorigenesis results from defects in DNA mismatch repair, manifest as widespread microsatellite instability. We demonstrate a high rate of microsatellite instability in KS and aggressive lymphomas obtained from HIV-infected patients, whereas there is no evidence of instability in similar lesions from HIV-negative patients. Further elucidation of the underlying mechanisms responsible for HIV-associated instability in primary tumours may provide insight into the pathogenesis of these AIDS-related neoplasms.	JOHNS HOPKINS UNIV,SCH MED,DEPT OTOLARYNGOL HEAD & NECK SURG,DIV HEAD & NECK CANC RES,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV HOSP,JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21287	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University								AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Astrin S M, 1992, Curr Top Microbiol Immunol, V182, P399; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; BERAL V, 1991, LANCET, V337, P805, DOI 10.1016/0140-6736(91)92513-2; BOVI PD, 1986, CANCER RES, V46, P6333; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; COUTLEE F, 1991, MOL CELL PROBE, V5, P241, DOI 10.1016/0890-8508(91)90046-M; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; FARZADEGAN H, 1993, J INFECT DIS, V168, P327, DOI 10.1093/infdis/168.2.327; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GALLOWAY DA, 1983, NATURE, V302, P21, DOI 10.1038/302021a0; GLEBOV OK, 1994, CANCER RES, V54, P3703; GROOPMAN JE, 1986, BLOOD, V67, P612; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Knowles Daniel M., 1993, Current Opinion in Oncology, V5, P845, DOI 10.1097/00001622-199309000-00012; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Levine A M, 1993, Curr Opin Oncol, V5, P819, DOI 10.1097/00001622-199309000-00008; Lipsey Lewis R., 1993, Current Opinion in Oncology, V5, P861, DOI 10.1097/00001622-199309000-00014; MAO L, 1994, P NATL ACAD SCI USA, V91, P9871, DOI 10.1073/pnas.91.21.9871; MERLO A, 1994, CANCER RES, V54, P2098; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PELLICI PG, 1986, J EXP MED, V164, P2049; PETERS BS, 1991, BRIT MED J, V302, P203, DOI 10.1136/bmj.302.6770.203; RADMAN M, 1993, NATURE, V366, P722, DOI 10.1038/366722a0; REYNOLDS P, 1993, AM J EPIDEMIOL, V1, P19; SHIBATA D, 1993, BLOOD, V8, P2102; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; THOMPSON J, 1994, ONCOGENE, V9, P1167; VANDERRIET P, 1994, CANCER RES, V54, P25; VOGEL J, 1988, NATURE, V335, P606, DOI 10.1038/335606a0; WOOSTER R, 1994, NAT GENET, V6, P1152; 1993, MMWR-MORBID MORTAL W, V41, P10	36	91	92	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1995	1	1					65	68		10.1038/nm0195-65	http://dx.doi.org/10.1038/nm0195-65			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX557	7584955				2022-12-25	WOS:A1995QX55700028
J	VILLAR, AJ; PEDERSEN, RA				VILLAR, AJ; PEDERSEN, RA			PARENTAL IMPRINTING OF THE MAS PROTOONCOGENE IN MOUSE	NATURE GENETICS			English	Article							GROWTH FACTOR-II; PATERNAL GENOMES; TGF-ALPHA; ONCOGENE; GENE; METHYLATION; EMBRYOGENESIS; ACTIVATION; EXPRESSION; RELAXATION	The Mas protooncogene on mouse chromosome 17 encodes a mitogenic G-protein-coupled cell surface receptor. We investigated the allele-specific expression pattern of the Mas gene on the basis of its proximity to the known imprinted gene for the insulin growth factor type II receptor (Igf2r). Phenotyping of mRNA demonstrated exclusive expression from the paternal allele in all embryonic tissues, including visceral yolk sac, between 11 and 12.5 days of gestation. By 13.5 days of gestation the paternal allele-specific expression of Mas was restricted to heart, tongue and visceral yolk sac, whereas all other tissues exhibited relaxation of the parental imprint. Our results demonstrate parental imprinting of Mas and suggest that the maternally inherited allele is transcriptionally repressed in a developmental and tissue-specific manner.	UNIV CALIF SAN FRANCISCO, DEPT ANAT, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT OBSTET GYNECOL & REPROD SCI, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	VILLAR, AJ (corresponding author), UNIV CALIF SAN FRANCISCO, RADIOBIOL & ENVIRONM HLTH LAB, SAN FRANCISCO, CA 94143 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD026732] Funding Source: NIH RePORTER; NICHD NIH HHS [HD26732] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDRAWIS NS, 1992, CELL BIOL INT REP, V16, P547, DOI 10.1016/S0309-1651(05)80053-0; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; BIRCHMEIER C, 1986, COLD SPRING HARB SYM, V51, P993, DOI 10.1101/SQB.1986.051.01.113; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CEBRATHOMAS JA, 1992, GENOMICS, V13, P444, DOI 10.1016/0888-7543(92)90267-V; CEBRATHOMAS JA, 1992, GENOMICS, V14, P208; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GOLD JD, 1994, CURR TOP DEV BIOL, V29, P227; HANLEY MR, 1991, J CARDIOVASC PHARM, V18, pS7, DOI 10.1097/00005344-199100182-00003; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; JANSSEN JWG, 1988, LEUKEMIA, V2, P318; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MARTIN KA, 1992, DEV BRAIN RES, V68, P75, DOI 10.1016/0165-3806(92)90249-V; McClelland M, 1987, Gene Amplif Anal, V5, P257; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MONNOT C, 1991, MOL ENDOCRINOL, V5, P1477, DOI 10.1210/mend-5-10-1477; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; PEDERSEN RA, 1993, SERONO SYMP, P212; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RAPPOLEE DA, 1988, SCIENCE, V241, P1823, DOI 10.1126/science.3175624; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; RE RN, 1987, AM J CARDIOL, V60, P1041; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOLTER D, 1988, ANNU REV GENET, V22, P127; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; VANTVEER LJ, 1988, ONCOGENE RES, V3, P247; VANTVEER LJ, 1993, ONCOGENE, V8, P2673; VARMUZA S, 1994, TRENDS GENET, V10, P118, DOI 10.1016/0168-9525(94)90212-7; VILLAR AJ, 1994, MOL REPROD DEV, V37, P247, DOI 10.1002/mrd.1080370302; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61	42	91	93	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					373	379		10.1038/ng1294-373	http://dx.doi.org/10.1038/ng1294-373			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894489				2022-12-25	WOS:A1994PV68200019
J	KAWAGUCHI, Y; OKAMOTO, T; TANIWAKI, M; AIZAWA, M; INOUE, M; KATAYAMA, S; KAWAKAMI, H; NAKAMURA, S; NISHIMURA, M; AKIGUCHI, I; KIMURA, J; NARUMIYA, S; KAKIZUKA, A				KAWAGUCHI, Y; OKAMOTO, T; TANIWAKI, M; AIZAWA, M; INOUE, M; KATAYAMA, S; KAWAKAMI, H; NAKAMURA, S; NISHIMURA, M; AKIGUCHI, I; KIMURA, J; NARUMIYA, S; KAKIZUKA, A			CAG EXPANSIONS IN A NOVEL GENE FOR MACHADO-JOSEPH DISEASE AT CHROMOSOME 14Q32.1	NATURE GENETICS			English	Article							NON-PORTUGUESE FAMILY; MYOTONIC-DYSTROPHY; HUNTINGTONS-DISEASE; PHENOTYPIC VARIATION; AZOREAN DISEASE; REPEAT LENGTH; CTG REPEAT; REGION; ATAXIA; DNA	We have identified a novel gene containing CAG repeats and mapped it to chromosome 14q32.1, the genetic locus for Machado-Joseph disease (MJD). In normal individuals the gene contains between 13 and 36 CAG repeats, whereas most of the clinically diagnosed patients and all of the affected members of a family with the clinical and pathological diagnosis of MJD show expansion of the repeat-number (from 68-79). Southern blot analyses and genomic cloning demonstrates the existence of related genes. These results raise the possibility that similar abnormalities in related genes may give rise to diseases similar to MJD.	KYOTO UNIV,FAC MED,DEPT PHARMACOL,KYOTO 60601,JAPAN; KYOTO UNIV,FAC MED,DEPT NEUROL,KYOTO 60601,JAPAN; KYOTO PREFECTURAL UNIV MED,DEPT INTERNAL MED 3,KYOTO 602,JAPAN; HIROSHIMA UNIV,SCH MED,DEPT INTERNAL MED 3,HIROSHIMA 734,JAPAN	Kyoto University; Kyoto University; Kyoto Prefectural University of Medicine; Hiroshima University			Kawakami, Hideshi/ABE-4077-2021; Kawakami, Hideshi/A-2086-2009	Kawakami, Hideshi/0000-0002-1405-0901; Kawakami, Hideshi/0000-0002-1405-0901				ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BARBEAU A, 1984, CAN J NEUROL SCI, V11, P510, DOI 10.1017/S0317167100034983; BHARUCHA NE, 1986, ARCH NEUROL-CHICAGO, V43, P142, DOI 10.1001/archneur.1986.00520020036014; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HEALTON EB, 1980, NEUROLOGY, V30, P1084, DOI 10.1212/WNL.30.10.1084; HYSLOP PS, 1994, AM J HUM GENET, V55, P120; INOUE J, 1992, CELL, V68, P1109, DOI 10.1016/0092-8674(92)90082-N; ISSELBACHER KJ, 1994, HARRISONS PRINCIPLES; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KAKIZUKA A, 1992, GENE DEV, V6, P578, DOI 10.1101/gad.6.4.578; KARP SJ, 1993, J BIOL CHEM, V268, P3728; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; Krainer AR, 1988, TRANSCRIPTION SPLICI, P131; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LIMA L, 1980, NEUROLOGY, V30, P319, DOI 10.1212/WNL.30.3.319; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Maniatis T, 1989, DECONTAMINATION DILU; MATSUDA F, 1993, NAT GENET, V3, P88, DOI 10.1038/ng0193-88; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAKANO KK, 1972, NEUROLOGY, V22, P49, DOI 10.1212/WNL.22.1.49; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; ROSENBERG RN, 1992, MOVEMENT DISORD, V3, P193; SAKAI T, 1983, NEUROLOGY, V33, P74, DOI 10.1212/WNL.33.1.74; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; SUITE NDA, 1986, J NEUROGENET, V3, P177, DOI 10.3109/01677068609106847; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TANIWAKI M, 1994, BLOOD, V83, P2962, DOI 10.1182/blood.V83.10.2962.2962; TANIWAKI M, 1993, CANCER GENET CYTOGEN, V70, P99, DOI 10.1016/0165-4608(93)90175-L; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; 1993, CELL, V72, P971	39	1507	1557	0	50	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					221	228		10.1038/ng1194-221	http://dx.doi.org/10.1038/ng1194-221			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874163				2022-12-25	WOS:A1994PP76500010
J	POLLAK, MR; BROWN, EM; ESTEP, HL; MCLAINE, PN; KIFOR, O; PARK, J; HEBERT, SC; SEIDMAN, CE; SEIDMAN, JG				POLLAK, MR; BROWN, EM; ESTEP, HL; MCLAINE, PN; KIFOR, O; PARK, J; HEBERT, SC; SEIDMAN, CE; SEIDMAN, JG			AUTOSOMAL-DOMINANT HYPOCALCEMIA CAUSED BY A CA2+-SENSING RECEPTOR GENE MUTATION	NATURE GENETICS			English	Article							PRIMARY HYPERPARATHYROIDISM; HYPERCALCEMIA; EXPRESSION; CLONING	Defects in the human Ca2+-sensing receptor gene have recently been shown to cause familial hypocalciuric hypercalcaemia and neonatal severe hyperparathyroidism. We now demonstrate that a missense mutation (Glu128Ala) in this gene causes familial hypocalcaemia in affected members of one family. Xenopus oocytes expressing the mutant receptor exhibit a larger increase in inositol 1,4,5-triphosphate in response to Ca2+ than oocytes expressing the wild-type receptor. We conclude that this extracellular domain mutation increases the receptor's activity at low Ca2+ concentrations, causing hypocalcaemia in patients heterozygous for such a mutation.	EASTERN VIRGINIA MED SCH,DEPT INTERNAL MED,NORFOLK,VA 23505; CHILDRENS HOSP EASTERN ONTARIO,DEPT PEDIAT,OTTAWA K1H 8L1,ON,CANADA; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115	Eastern Virginia Medical School; University of Ottawa; Children's Hospital of Eastern Ontario; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	POLLAK, MR (corresponding author), CHILDRENS HOSP,HOWARD HUGHES MED INST,DEPT MED,75 FRANCIS ST,BOSTON,MA 02115, USA.		Centeno, Patricia Pacios/O-8368-2016		NIDDK NIH HHS [DK46422, DK44588, DK02138] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044588, R01DK046422, K11DK002138] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel F. M., 1988, CURRENT PROTOCOLS MO; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; CHOU YHW, 1992, NAT GENET, V1, P295, DOI 10.1038/ng0792-295; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; HUNTER AGW, 1981, J MED GENET, V18, P431, DOI 10.1136/jmg.18.6.431; KHOSLA S, 1993, J CLIN ENDOCR METAB, V76, P715, DOI 10.1210/jc.76.3.715; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEFKOWITZ RJ, 1993, NATURE, V365, P603, DOI 10.1038/365603a0; MARX SJ, 1986, J CLIN ENDOCR METAB, V62, P445, DOI 10.1210/jcem-62-2-445; Ott J., 1991, ANAL HUMAN GENETIC L; PARKER I, 1994, CELL CALCIUM, V15, P276, DOI 10.1016/0143-4160(94)90067-1; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; POLLAK MR, 1994, J CLIN INVEST, V93, P1108, DOI 10.1172/JCI117062; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; SHANE E, 1993, PRIMER METABOLIC BON; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; SHERWOOD LM, 1993, PRIMER METABOLIC BON; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	21	459	474	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					303	307		10.1038/ng1194-303	http://dx.doi.org/10.1038/ng1194-303			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874174				2022-12-25	WOS:A1994PP76500023
J	CATTANACH, BM; BARR, JA; EVANS, EP; BURTENSHAW, M; BEECHEY, CV; LEFF, SE; BRANNAN, CI; COPELAND, NG; JENKINS, NA; JONES, J				CATTANACH, BM; BARR, JA; EVANS, EP; BURTENSHAW, M; BEECHEY, CV; LEFF, SE; BRANNAN, CI; COPELAND, NG; JENKINS, NA; JONES, J			A CANDIDATE MOUSE MODEL FOR PRADER-WILLI SYNDROME WHICH SHOWS AN ABSENCE OF SNRPN EXPRESSION	NATURE GENETICS			English	Article							ANGELMAN SYNDROME; PARENTAL ORIGIN; CHROMOSOME-15 DELETION; 15Q DELETIONS; GENE; REGION; 15Q11-13; RECEPTOR; SUBUNIT; RNA	The best examples of imprinting in humans are provided by the Angelman and Prader-Willi syndromes (AS and PWS) which are associated with maternal and paternal 15q11-13 deletions, respectively, and also with paternal and maternal disomy 15. The region of the deletions has homology with a central part of mouse chromosome 7, incompletely tested for imprinting effects. Here, we report that maternal duplication for this region causes a murine imprinting effect which may correspond to PWS. Paternal duplication was not associated with any detectable effect that might correspond with AS. Gene expression studies established that Snrpn is not expressed in mice with the maternal duplication and suggest that the closely-linked Gabrb-3 locus is not subject to imprinting. Flnally, an additional new imprinting effect is described.	STANFORD UNIV,MED CTR,SCH MED,DEPT PHARMACOL,STANFORD,CA 94305; NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702	Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	CATTANACH, BM (corresponding author), MRC,RADIOBIOL UNIT,DIV GENET,DIDCOT OX11 0RD,OXON,ENGLAND.							BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Bartolomei M.S., 1992, SEMIN DEV BIOL, V3, P107; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BUTLER MG, 1983, LANCET, V1, P1285; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; CASSIDY SB, 1989, NEUROL CLIN, V7, P37, DOI 10.1016/S0733-8619(18)30827-2; Cattanach B. M., 1991, GENOME ANAL, P41; CATTANACH BM, 1961, Z VEREBUNGSL, V92, P165, DOI 10.1007/BF00890283; CHAILLET JR, 1991, GENOMICS, V11, P773, DOI 10.1016/0888-7543(91)90090-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; EVANS EP, 1990, MOUSE GENOME, V90, P210; EVANS EP, 1991, MOUSE GENOME, V89, P551; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; FOREJT J, 1992, CELL, V70, P443, DOI 10.1016/0092-8674(92)90168-C; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; KNOLL JHM, 1991, AM J HUM GENET, V48, P16; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LEFF SE, 1992, NAT GENET, V2, P270; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; Maniatis T., 1982, MOL CLONING; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MINTY AJ, 1982, CELL, V30, P185, DOI 10.1016/0092-8674(82)90024-1; MITCHELL MJ, 1991, NATURE, V354, P483, DOI 10.1038/354483a0; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Nicholls RD, 1991, MOUSE GENOME, V89, P254; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; PEMBREY M, 1989, J MED GENET, V26, P73, DOI 10.1136/jmg.26.2.73; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; SEARLE AG, 1985, ANEUPLOIDY ETIOLOGY, P363; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330; WAGSTAFF J, 1991, GENOMICS, V11, P1071, DOI 10.1016/0888-7543(91)90034-C; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; WILLIAMS CA, 1989, AM J MED GENET, V32, P339, DOI 10.1002/ajmg.1320320313; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61	38	166	166	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					270	274		10.1038/ng1292-270	http://dx.doi.org/10.1038/ng1292-270			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303278				2022-12-25	WOS:A1992KB49500009
J	MCCARREY, JR; DILWORTH, DD				MCCARREY, JR; DILWORTH, DD			EXPRESSION OF XIST IN MOUSE GERM-CELLS CORRELATES WITH X-CHROMOSOME INACTIVATION	NATURE GENETICS			English	Article							SPERMATOGENIC CELLS; MORPHOLOGICAL CHARACTERIZATION; GENE; HPRT; RNA	Mammals compensate for different doses of X-chromosome-linked genes in male (XY) and female (XX) somatic cells by terminally inactivating all but one X chromosome in each cell. A transiently inactive X chromosome is also found in germ cells, specifically in premeiotic oogenic cells and in meiotic and postmeiotic spermatogenic cells. Here we show that the Xist gene, which is a expressed predominantly from the inactive X-chromosome in female somatic cells, is also expressed in germ cells of both sexes, but only at those stages when an inactive X chromosome is present. This suggests support for the putative role of Xist as a regulator of X-chromosome inactivation and suggest a common mechanism for the initiation and/or maintenance of X-chromosome inactivation in all cell types.			MCCARREY, JR (corresponding author), SW FDN BIOMED RES, DEPT GENET, POB 28147, SAN ANTONIO, TX 78228 USA.							Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN SDM, 1991, BIOESSAYS, V13, P607, DOI 10.1002/bies.950131112; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dilworth D D, 1992, PCR Methods Appl, V1, P279; Gartler S M, 1972, Cell Differ, V1, P215, DOI 10.1016/0045-6039(72)90039-5; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; HAHNEL AC, 1990, DEVELOPMENT, V110, P555; HAHNEL AC, 1986, GAMETE RES, V15, P25, DOI 10.1002/mrd.1120150104; HANDEL MA, 1991, ANN NY ACAD SCI, V637, P64, DOI 10.1111/j.1749-6632.1991.tb27301.x; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KRATZER PG, 1981, P NATL ACAD SCI-BIOL, V78, P3093, DOI 10.1073/pnas.78.5.3093; KRATZER PG, 1978, NATURE, V274, P503, DOI 10.1038/274503a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MCCARREY JR, 1987, J EXP ZOOL, V242, P107, DOI 10.1002/jez.1402420116; MCCARREY JR, IN PRESS GEN ANAL TE; MCCARREY JR, IN PRESS DEV BIOL, V153; MCMAHON A, 1981, J EMBRYOL EXP MORPH, V64, P251; MONESI V, 1967, ARCH ANAT MICROSC MO, V56, P61; MURAKAWA GJ, 1988, DNA-J MOLEC CELL BIO, V7, P287, DOI 10.1089/dna.1988.7.287; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P1255, DOI 10.1093/nar/18.5.1255; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P1413, DOI 10.1073/pnas.89.4.1413; TOKUNAGA K, 1986, NUCLEIC ACIDS RES, V14, P2829; VENOLIA L, 1984, CHROMOSOMA, V90, P185, DOI 10.1007/BF00292395	29	129	129	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1992	2	3					200	203		10.1038/ng1192-200	http://dx.doi.org/10.1038/ng1192-200			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345169				2022-12-25	WOS:A1992JW16500009
J	DJABALI, M; SELLERI, L; PARRY, P; BOWER, M; YOUNG, BD; EVANS, GA				DJABALI, M; SELLERI, L; PARRY, P; BOWER, M; YOUNG, BD; EVANS, GA			A TRITHORAX-LIKE GENE IS INTERRUPTED BY CHROMOSOME 11Q23 TRANSLOCATIONS IN ACUTE LEUKEMIAS	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; YEAST ARTIFICIAL-CHROMOSOME; ACUTE MONOCYTIC LEUKEMIA; HOMEOBOX GENE; CELL-LINE; BREAKPOINT; PROTEIN; IDENTIFICATION; HYBRIDIZATION; REARRANGEMENT	Some acute lymphocytic leukaemias, particularly those in young children, are associated with a t(4;11)(q21;q23) reciprocal translocation. We have cloned the translocation breakpoint on chromosome 11q23 and isolated corresponding RNA transcripts from this region. The translocation occurs within a cluster of Alu repetitive elements located within an intron of a gene that gives rise to 11.5 (kb) transcript spanning the translocation breakpoint. The 11.5 kb transcript encodes a protein that is highly homologous to the Drosophila trithorax gene, a developmental regulator. An analysis of a series of leukaemic patients carrying t(4;11) and t(9;11) translocations indicate that the majority of breakpoints in infant leukaemias lie within a 5 kb region.	SALK INST BIOL STUDIES,MOLEC GENET LAB,LA JOLLA,CA 92037; ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND,DEPT MED ONCOL,LONDON EC1A 7BE,ENGLAND	Salk Institute; Cancer Research UK; University of London; Queen Mary University London				Bower, Mark/0000-0002-4077-6351				ABE R, 1983, CANCER GENET CYTOGEN, V9, P139, DOI 10.1016/0165-4608(83)90034-1; ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ARTHUR DC, 1982, BLOOD, V59, P96; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BERGER R, 1982, LEUKEMIA RES, V6, P17, DOI 10.1016/0145-2126(82)90039-X; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; CHEN CS, 1991, BLOOD, V78, P2498; CHUU WM, 1990, AM J HEMATOL, V34, P246, DOI 10.1002/ajh.2830340403; CIMINO G, 1992, CANCER RES, V52, P3811; CIMINO G, 1991, CANCER RES, V51, P6712; DERRE J, 1990, GENE CHROMOSOME CANC, V2, P341, DOI 10.1002/gcc.2870020413; DJABALI M, 1990, NUCLEIC ACIDS RES, V20, P6789; EVANS GA, 1988, IMMUNOGENETICS, V28, P365, DOI 10.1007/BF00364236; EVANS GA, 1989, P NATL ACAD SCI USA, V86, P5030, DOI 10.1073/pnas.86.13.5030; FEDER M, 1985, CANCER GENET CYTOGEN, V15, P143, DOI 10.1016/0165-4608(85)90142-6; GIBBONS B, 1990, BRIT J HAEMATOL, V74, P264, DOI 10.1111/j.1365-2141.1990.tb02581.x; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HAGEMEIJER A, 1987, LEUKEMIA, V1, P24; HAGEMEIJER A, 1982, CANCER GENET CYTOGEN, V5, P95, DOI 10.1016/0165-4608(82)90001-2; HATANO M, 1991, SCIENCE, V78, P2996; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KAMPS MP, 1991, GENE DEV, V5, P353; KEARNEY L, IN PRESS BLOOD; KONSUWAN K, 1988, EMBO J, V7, P2131; LICHTER P, 1990, SCIENCE, V85, P9664; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; MCGUIRE EA, 1989, MOL CELL BIOL, V9, P2124, DOI 10.1128/MCB.9.5.2124; PUI CH, 1987, BLOOD, V69, P1289; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; ROWLEY JD, 1990, P NATL ACAD SCI USA, V87, P9358, DOI 10.1073/pnas.87.23.9358; SAIT SNJ, 1987, CANCER GENET CYTOGEN, V24, P181; SELLERI L, 1991, P NATL ACAD SCI USA, V88, P887, DOI 10.1073/pnas.88.3.887; SHEN WF, 1991, NUCLEIC ACIDS RES, V19, P539, DOI 10.1093/nar/19.3.539; STEPHEN F, 1990, J MOL BIOL, V215, P403, DOI DOI 10.1006/JMBI.1990.9999; STONG RC, 1985, BLOOD, V65, P21, DOI 10.1182/blood.V65.1.21.21; VANDERFELTZ MJM, 1989, NUCLEIC ACIDS RES, V17, P1, DOI 10.1093/nar/17.1.1; ZIEMINVANDERPOEL S, 1991, P NATL ACAD SCI USA, V88, P10735, DOI 10.1073/pnas.88.23.10735	37	459	477	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					113	118		10.1038/ng1092-113	http://dx.doi.org/10.1038/ng1092-113			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303259				2022-12-25	WOS:A1992JR08400009
J	SANKILA, EM; TOLVANEN, R; VANDENHURK, JAJM; CREMERS, FPM; DELACHAPELLE, A				SANKILA, EM; TOLVANEN, R; VANDENHURK, JAJM; CREMERS, FPM; DELACHAPELLE, A			ABERRANT SPLICING OF THE CHM GENE IS A SIGNIFICANT CAUSE OF CHOROIDEREMIA	NATURE GENETICS			English	Article							DELETIONS; LINKAGE	Choroideremia (CHM) is an X-linked progressive degeneration of the choroid and retina. 12% of unrelated male patients carry deletions of the partially cloned CHM gene. in Finland, there are more than 120 living CHM patients belonging to eight apparently unrelated pedigrees. Molecular deletions involving the CHM gene have been detected in three families. We have screened the remaining five families for point mutations. In one large family a single nucleotide (T) insertion into the donor splice site of exon C leads to two aberrantly spliced mRNAs both producing a premature stop codon. The mutation can be assayed easily by amplification and digestion with Msel. Our findings provide additional evidence for the pathogenetic role of CHM mutations and provide a diagnostic tool for one fifth of the world's known CHM patients.	UNIV HOSP NIJMEGEN, DEPT HUMAN GENET, 6500 HB NIJMEGEN, NETHERLANDS	Radboud University Nijmegen	SANKILA, EM (corresponding author), UNIV HELSINKI, DEPT MED GENET, HAARTMANINKATU 3, SF-00290 HELSINKI 29, FINLAND.		Cremers, Frans/A-5625-2014	Cremers, Frans/0000-0002-4954-5592				CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; CREMERS FPM, 1989, GENOMICS, V4, P41, DOI 10.1016/0888-7543(89)90312-1; CREMERS FPM, 1990, AM J HUM GENET, V47, P622; FORSIUS H, 1980, POPULATION STRUCTURE, P605; KARNA J, 1986, ACTA OPHTHALMOL, V64, P1; McCULLOCH C, 1948, Trans Am Acad Ophthalmol Otolaryngol, V52, P160; McKusick VA, 1990, MENDELIAN INHERITANC; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; ROBERTS RG, 1991, J HUM GENET, V49, P298; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANKILA EM, 1987, CLIN GENET, V31, P315; SANKILA EM, 1989, HUM GENET, V84, P66, DOI 10.1007/BF00210674; SANKILA EM, 1991, HUM GENET, V87, P348, DOI 10.1007/BF00200918; SANKILA EM, 1990, HUM GENET, V85, P117, DOI 10.1007/BF00276335; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SORSBY A, 1952, BRIT J OPHTHALMOL, V36, P547, DOI 10.1136/bjo.36.10.547; SORSBY A, 1986, BR J OPHTHALMOL, V176, P1; SRIVASTAVA AK, IN PRESS PCR METHODS; VANDENHURK JAJ, IN PRESS AM J HUM GE	19	70	70	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1992	1	2					109	113		10.1038/ng0592-109	http://dx.doi.org/10.1038/ng0592-109			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC980	1302003				2022-12-25	WOS:A1992JC98000009
J	GAYTHER, SA; WARREN, W; MAZOYER, S; RUSSELL, PA; HARRINGTON, PA; CHIANO, M; SEAL, S; HAMOUDI, R; VANRENSBURG, EJ; DUNNING, AM; LOVE, R; EVANS, G; EASTON, D; CLAYTON, D; STRATTON, MR; PONDER, BAJ				GAYTHER, SA; WARREN, W; MAZOYER, S; RUSSELL, PA; HARRINGTON, PA; CHIANO, M; SEAL, S; HAMOUDI, R; VANRENSBURG, EJ; DUNNING, AM; LOVE, R; EVANS, G; EASTON, D; CLAYTON, D; STRATTON, MR; PONDER, BAJ			GERMLINE MUTATIONS OF THE BRCA1 GENE IN BREAST AND OVARIAN-CANCER FAMILIES PROVIDE EVIDENCE FOR A GENOTYPE-PHENOTYPE CORRELATION	NATURE GENETICS			English	Article								Mutations in the BRCA1 gene, discovered in 1994, are associated with an 80-90% lifetime risk of breast cancer. We have analysed 60 families with a history of breast and/or ovarian cancer for germline mutations in BRCA1. Twenty-two different mutations were detected in 32 families (53%), of which 14 are previously unreported. We observed a significant correlation between the location of the mutation in the gene and the ratio of breast to ovarian cancer incidence within each family. Our data suggest a transition in risk such that mutations in the 3' third of the gene are associated with a lower proportion of ovarian cancer. Haplotype analysis supports previous data which suggest some BRCA1 mutation carriers have common ancestors; however, we have found at least two examples where recurrent mutations appear to have arisen independently.	INST CANC RES,HADDOW LABS,MOLEC CARCINOGENESIS SECT,SUTTON SM2 5NG,SURREY,ENGLAND; INST PUBL HLTH,MRC,BIOSTAT UNIT,CAMBRIDGE CB2 2SR,ENGLAND; UNIV PRETORIA,DEPT HUMAN GENET,PRETORIA 0001,SOUTH AFRICA; CANC PREVENT PROGRAMME,MADISON,WI 53706; ST MARYS HOSP,REG GENET SERV,MANCHESTER M13 0JH,LANCS,ENGLAND; INST PUBL HLTH,DEPT COMMUNITY MED,CAMBRIDGE CB2 2SR,ENGLAND	University of London; Institute of Cancer Research - UK; MRC Biostatistics Unit; University of Cambridge; University of Pretoria; University of Manchester; University of Cambridge	GAYTHER, SA (corresponding author), ADDENBROOKES HOSP,CRC,HUMAN CANC GENET RES GRP,BOX 238,HILLS RD,CAMBRIDGE CB2 2QQ,ENGLAND.		van Rensburg, Elizabeth J./B-9104-2011; Mazoyer, Sylvie/N-7559-2017; Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784; Mazoyer, Sylvie/0000-0002-2135-0160; van Rensburg, Elizabeth/0000-0003-2077-230X; Hamoudi, Rifat/0000-0002-1402-0868; Dunning, Alison Margaret/0000-0001-6651-7166				BEAUDET AL, 1989, HUM MUT, V2, P245; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P718; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1995, AM J HUM GENET, V56, P254; NEUHAUSEN SL, 1995, HUM MOL GENET, V3, P1919; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SHEN JC, 1992, CELL, V71, P1073, DOI 10.1016/S0092-8674(05)80057-1; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; STEICHENGERSDOR.E, 1994, AM J HUM GENET, V55, P870; STREUWING JP, 1995, NAT GENET, V11, P198; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; TONIN P, 1995, AM J HUM GENET, V57, P189; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	21	445	455	1	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					428	433		10.1038/ng1295-428	http://dx.doi.org/10.1038/ng1295-428			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493024				2022-12-25	WOS:A1995TH62900021
J	SMITH, RC; LITWIN, MS; LU, Y; ZETTER, BR				SMITH, RC; LITWIN, MS; LU, Y; ZETTER, BR			IDENTIFICATION OF AN ENDOGENOUS INHIBITOR OF PROSTATIC-CARCINOMA CELL-GROWTH	NATURE MEDICINE			English	Article							ORNITHINE DECARBOXYLASE; MELANOMA XENOGRAFTS; ANTITUMOR-ACTIVITY; POLYAMINES; CANCER; TRANSFORMATION; OVEREXPRESSION; PROLIFERATION; STIMULATION; SPERMINE	The rate of expansion of primary prostatic carcinoma is comparatively slow, with tumours frequently taking years or decades to reach clinically relevant size. We now report the presence of an endogenous inhibitor, derived from aqueous extracts of human prostate tissue, which blocks prostatic carcinoma cell proliferation in vitro and prevents subcutaneous tumour expansion in vivo. Purification and characterization revealed the inhibitor to be spermine, a polyamine known to be locally abundant in the prostate. These results suggest that endogenous polyamine can negatively regulate the growth of prostatic carcinoma cells at their primary site in vivo and may explain the slow rate of primary tumour expansion in the prostate.	HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT SURG,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard Medical School	SMITH, RC (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT CELL BIOL,300 LONGWOOD AVE,BOSTON,MA 02115, USA.				NCI NIH HHS [CA 37393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA037393, R01CA037393] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLEN RD, 1987, AM J REPROD IMMUNOL, V143, P4; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BERNACKI RJ, 1992, CANCER RES, V52, P2424; BORING CC, 1994, CA-CANCER J CLIN, V44, P7, DOI 10.3322/canjclin.44.1.7; BRUNTON VG, 1991, BIOCHEM J, V280, P193, DOI 10.1042/bj2800193; CARMICHAEL J, 1987, CANCER RES, V47, P936; CELANO P, 1989, J BIOL CHEM, V264, P8922; CHACKALROY M, 1989, J CLIN INVEST, V84, P43, DOI 10.1172/JCI114167; COFFINO P, 1991, J CELL BIOCHEM, V45, P54, DOI 10.1002/jcb.240450112; DANZIN C, 1979, LIFE SCI, V24, P519, DOI 10.1016/0024-3205(79)90173-5; DAVIDSON NE, 1993, CANCER RES, V53, P2071; GAHL WA, 1978, CHEM-BIOL INTERACT, V22, P91, DOI 10.1016/0009-2797(78)90152-7; HEBY O, 1978, J CHROMATOGR, V145, P73, DOI 10.1016/S0378-4347(00)81669-2; HESTON WDW, 1991, CANCER SURV, V11, P217; HIBSHOOSH H, 1991, ONCOGENE, V6, P739; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; JANNE J, 1964, ACTA PHYSIOL SCAND, V62, P352, DOI 10.1111/j.1748-1716.1964.tb10433.x; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; KAMEJI T, 1987, J BIOL CHEM, V262, P2427; Mann T., 1964, BIOCH SEMEN MALE REP, DOI 10.5694/j.1326-5377.1965.tb72030.x; MCNEAL JE, 1993, CANCER, V71, P984, DOI 10.1002/1097-0142(19930201)71:3+<984::AID-CNCR2820711415>3.0.CO;2-L; MOSHIER JA, 1993, CANCER RES, V53, P2618; PEGG AE, 1988, CANCER RES, V48, P759; PORTER CW, 1993, CANCER RES, V53, P581; ROSSI MC, 1992, P NATL ACAD SCI USA, V89, P6197, DOI 10.1073/pnas.89.13.6197; SCOTT R, 1969, J UROLOGY, V101, P602, DOI 10.1016/S0022-5347(17)62388-7; STAMEY TA, 1993, CANCER, V71, P933, DOI 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L; WEBBER MM, 1980, CELL BIOL INT REP, V4, P185, DOI 10.1016/0309-1651(80)90073-9; ZANEVELD LJD, 1981, PROSTATIC CELL STR A, P265	29	48	50	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	OCT	1995	1	10					1040	1045		10.1038/nm1095-1040	http://dx.doi.org/10.1038/nm1095-1040			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489360				2022-12-25	WOS:A1995RX95100044
J	BARANYI, L; CAMPBELL, W; OHSHIMA, K; FUJIMOTO, S; BOROS, M; OKADA, H				BARANYI, L; CAMPBELL, W; OHSHIMA, K; FUJIMOTO, S; BOROS, M; OKADA, H			THE ANTISENSE HOMOLOGY BOX - A NEW MOTIF WITHIN PROTEINS THAT ENCODES BIOLOGICALLY-ACTIVE PEPTIDES	NATURE MEDICINE			English	Article							HYDROPATHIC COMPLEMENTARITY APPROACH; ANGIOTENSIN-II RECEPTOR; MESSENGER-RNA; ENDOTHELIN RECEPTOR; ACETYLCHOLINE-RECEPTOR; RECOGNITION PROPERTIES; BINDING PEPTIDE; OPIATE RECEPTOR; SENSE PEPTIDES; GENETIC-CODE	Amphiphilic peptides approximately fifteen amino acids in length and their corresponding antisense peptides exist within protein molecules. These regions (termed antisense homology boxes) are separated by approximately fifty amino acids. Because many sense-antisense peptide pairs have been reported to recognize and bind to each other, antisense homology boxes may be involved in folding, chaperoning and oligomer formation of proteins. The antisense homology box-derived peptide CALSVDRYRAVASW, a fragment of human endothelin A receptor, proved to be a specific inhibitor of endothelin peptide (ET-1) in a smooth muscle relaxation assay. The peptide was able to block endotoxin-induced shock in rats as well. Our finding of endothelin receptor inhibitor among antisense homology box-derived peptides indicates that searching proteins for this new motif may be useful in finding biologically active peptides.	NAGOYA CITY UNIV, SCH MED, DEPT PHARMACOL, NAGOYA, AICHI 467, JAPAN; NOYORI FUKUSHIMURA HOSP, CHOJU MED INST, TOYOHASHI, AICHI 441, JAPAN; ALBERT SZENT GYORGYI MED UNIV, INST EXPTL SURG, H-6723 SZEGED, HUNGARY; NAGOYA CITY UNIV, SCH MED, DEPT MOLEC BIOL, NAGOYA, AICHI 467, JAPAN	Nagoya City University; Szeged University; Nagoya City University			Boros, Mihály/B-5195-2008					ALOBEIDI FA, 1989, PEPTIDES 89, P530; ARAGA S, 1993, P NATL ACAD SCI USA, V90, P8747, DOI 10.1073/pnas.90.18.8747; ARAI H, 1990, NATURE, V348, P730, DOI 10.1038/348730a0; BAJPAI A, 1991, BIOCHEM BIOPH RES CO, V180, P1312, DOI 10.1016/S0006-291X(05)81338-5; BASS BL, 1987, CELL, V48, P607, DOI 10.1016/0092-8674(87)90239-X; BLALOCK JE, 1990, TRENDS BIOTECHNOL, V8, P140, DOI 10.1016/0167-7799(90)90159-U; BLALOCK JE, 1984, BIOCHEM BIOPH RES CO, V121, P203, DOI 10.1016/0006-291X(84)90707-1; BOROVSKY D, 1994, FASEB J, V8, P350, DOI 10.1096/fasebj.8.3.7908271; Bost K L, 1989, J Mol Recognit, V1, P179; BOST KL, 1985, BIOCHEM BIOPH RES CO, V128, P1373, DOI 10.1016/0006-291X(85)91092-7; BOST KL, 1985, P NATL ACAD SCI USA, V82, P1372, DOI 10.1073/pnas.82.5.1372; BRENTANI RR, 1988, P NATL ACAD SCI USA, V85, P364, DOI 10.1073/pnas.85.2.364; BRETDIBAT JL, 1994, J NEUROCHEM, V63, P333; CAMPBELLTHOMPSON M, 1993, AM J MED SCI, V305, P365, DOI 10.1097/00000441-199306000-00003; CARR DJJ, 1987, FEBS LETT, V224, P272, DOI 10.1016/0014-5793(87)80468-4; CARR DJJ, 1989, IMMUNOL LETT, V20, P181, DOI 10.1016/0165-2478(89)90077-1; CARR DJJ, 1986, J NEUROIMMUNOL, V12, P329, DOI 10.1016/0165-5728(86)90039-1; CASTRONOVO V, 1991, CANCER RES, V51, P5672; CHAIKEN IM, 1989, PROTEIN RECOGNITION, P257; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CLARKE BL, 1990, P NATL ACAD SCI USA, V87, P9708, DOI 10.1073/pnas.87.24.9708; CLOZEL M, 1993, NATURE, V365, P759, DOI 10.1038/365759a0; DEGASPARO M, 1989, BIOCHEM J, V261, P310, DOI 10.1042/bj2610310; DILLON J, 1991, P NATL ACAD SCI USA, V88, P9726, DOI 10.1073/pnas.88.21.9726; DRAPER KG, 1989, BIOCHEM BIOPH RES CO, V163, P466, DOI 10.1016/0006-291X(89)92159-1; EBERLE A N, 1989, Peptide Research, V2, P213; EBERLE AN, 1991, J RECEPTOR RES, V11, P13, DOI 10.3109/10799899109066387; ELTON TS, 1988, P NATL ACAD SCI USA, V85, P2518, DOI 10.1073/pnas.85.8.2518; FASSINA G, 1992, INT J PEPT PROT RES, V39, P540; FASSINA G, 1992, BIOCHEM J, V282, P773, DOI 10.1042/bj2820773; FASSINA G, 1989, J BIOL CHEM, V264, P11252; FASSINA G, 1992, PEPTIDES 92; FASSINA G, 1989, METHODS PROTEIN SEQU, P431; FREIRE E, 1991, J MOL BIOL, V222, P687, DOI 10.1016/0022-2836(91)90505-Z; GARTNER TK, 1991, BIOCHEM BIOPH RES CO, V180, P1446; GARTNER TK, 1991, P SOC EXP BIOL MED, V198, P649; GHISO J, 1990, P NATL ACAD SCI USA, V87, P1288, DOI 10.1073/pnas.87.4.1288; GOLDSTEIN A, 1989, P NATL ACAD SCI USA, V86, P42, DOI 10.1073/pnas.86.1.42; GROSVENOR CE, 1989, Patent No. 4833166; GUILLEMETTE G, 1989, BIOCHEM J, V261, P309, DOI 10.1042/bj2610309; HAYNES WG, 1993, TRENDS PHARMACOL SCI, V14, P225, DOI 10.1016/0165-6147(93)90012-9; HEYL DL, 1993, PEPTIDE RES, V6, P238; JOHNSON HM, 1988, J IMMUNOL, V141, P2420; KAISER ET, 1983, P NATL ACAD SCI USA, V80, P1137, DOI 10.1073/pnas.80.4.1137; KANG CY, 1988, SCIENCE, V240, P1034, DOI 10.1126/science.3368787; KELLY JM, 1990, PEPTIDES, V11, P857, DOI 10.1016/0196-9781(90)90204-I; KNUTSON VP, 1988, J BIOL CHEM, V263, P14146; KON V, 1992, RENAL FAILURE, V14, P345, DOI 10.3109/08860229209106641; LU FX, 1991, P NATL ACAD SCI USA, V88, P3642, DOI 10.1073/pnas.88.9.3642; MAEMURA K, 1992, GERONTOLOGY, V38, P29; MARKUS G, 1989, ARCH BIOCHEM BIOPHYS, V272, P433, DOI 10.1016/0003-9861(89)90237-3; MCGUIGAN JE, 1992, GASTROENTEROLOGY, V103, P749, DOI 10.1016/0016-5085(92)90002-G; MOFFAT AS, 1991, SCIENCE, V253, P510, DOI 10.1126/science.1857981; MOORE GJ, 1989, BIOCHEM BIOPH RES CO, V160, P1387, DOI 10.1016/S0006-291X(89)80157-3; MULCHAHEY JJ, 1986, P NATL ACAD SCI USA, V83, P9714, DOI 10.1073/pnas.83.24.9714; NAGY GM, 1991, 73 ANN END SOC M, P209; PANEK RL, 1992, BIOCHEM BIOPH RES CO, V183, P566, DOI 10.1016/0006-291X(92)90519-Q; PASQUALINI R, 1989, J BIOL CHEM, V264, P14566; RADDING W, 1992, J AUTONOM NERV SYST, V40, P161, DOI 10.1016/0165-1838(92)90027-E; Rassmundsen UB, 1987, BIOCHEM BIOPH RES CO, V149, P930; REBAGLIATI MR, 1987, CELL, V48, P599, DOI 10.1016/0092-8674(87)90238-8; SAKAMOTO A, 1993, J BIOL CHEM, V268, P8547; SAKURAI T, 1990, NATURE, V348, P732, DOI 10.1038/348732a0; SCAPOL L, 1992, J CHROMATOGR, V600, P235, DOI 10.1016/0021-9673(92)85553-6; SECKLER R, 1992, FASEB J, V6, P2545, DOI 10.1096/fasebj.6.8.1592207; SEO B, 1994, CIRCULATION, V89, P1203, DOI 10.1161/01.CIR.89.3.1203; SHAHABI NA, 1992, J PHARMACOL EXP THER, V263, P876; SHAI Y, 1989, BIOCHEMISTRY-US, V28, P8804, DOI 10.1021/bi00448a019; SLEGEL S, 1988, NONPARAMETRIC STAT, P40; SOFFER RL, 1987, P NATL ACAD SCI USA, V84, P9219, DOI 10.1073/pnas.84.24.9219; SOKOLOVSKY M, 1994, INT J BIOCHEM, V26, P335, DOI 10.1016/0020-711X(94)90053-1; TROSPHA A, 1992, J MOL RECOGNIT, V5, P43; WEIGENT DA, 1986, BIOCHEM BIOPH RES CO, V139, P367, DOI 10.1016/S0006-291X(86)80123-1; WHITAKER JN, 1989, J NEUROIMMUNOL, V22, P157, DOI 10.1016/0165-5728(89)90047-7; ZAMAI M, 1993, BIOCHIM BIOPHYS ACTA, V1202, P337, DOI 10.1016/0167-4838(93)90025-M; ZHOU SR, 1993, J IMMUNOL, V150, P1629; ZULL JE, 1994, NUCLEIC ACIDS RES, V22, P3373, DOI 10.1093/nar/22.16.3373; ZULL JE, 1990, TRENDS BIOCHEM SCI, V15, P257, DOI 10.1016/0968-0004(90)90048-G	78	93	100	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	1995	1	9					894	901		10.1038/nm0995-894	http://dx.doi.org/10.1038/nm0995-894			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585214				2022-12-25	WOS:A1995RT30300042
J	MACIEJEWSKI, JP; WEICHOLD, FF; YOUNG, NS; CARA, A; ZELLA, D; REITZ, MS; GALLO, RC				MACIEJEWSKI, JP; WEICHOLD, FF; YOUNG, NS; CARA, A; ZELLA, D; REITZ, MS; GALLO, RC			INTRACELLULAR EXPRESSION OF ANTIBODY FRAGMENTS DIRECTED AGAINST HIV REVERSE-TRANSCRIPTASE PREVENTS HIV-INFECTION IN-VITRO	NATURE MEDICINE			English	Article							EPSTEIN-BARR VIRUS; SINGLE-CHAIN FV; ESCHERICHIA-COLI; MAMMALIAN-CELLS; GENE-THERAPY; REPLICATION; PROTEIN; TYPE-1; VECTOR; DNA	We have tested a novel strategy of intracellular immunization to block human immunodeficiency virus (HIV) infection. The expression of a specific antibody within a cell was achieved by transduction of genes that encode for immunoglobulin chains with specificity to viral reverse transcriptase. We demonstrated that inhibition of this enzyme makes cells resistant to HIV infection by blocking an early stage of viral replication. If high efficiency transduction with a stable vector into lymphohaematopoietic stem cells or mature lymphocytes can be achieved, gene transfer-mediated intracellular immunization might be a feasible treatment strategy in AIDS.	NHLBI,HEMATOL BRANCH,BETHESDA,MD 20892; NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			ZELLA, DAVIDE/AAC-7630-2020; Cara, Andrea/M-4865-2015; Cara, Andrea/AAA-4238-2021	ZELLA, DAVIDE/0000-0001-5576-5770; Cara, Andrea/0000-0003-4967-1895; Cara, Andrea/0000-0003-4967-1895				BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0; BIOCCA S, 1984, BIOTECHNOLOGY, V12, P396; BRENNER MK, 1993, LANCET, V341, P85, DOI 10.1016/0140-6736(93)92560-G; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; CARA A, 1995, VIROLOGY, V208, P242, DOI 10.1006/viro.1995.1148; CARLSON JR, 1988, MOL CELL BIOL, V8, P2638, DOI 10.1128/MCB.8.6.2638; CARUSO M, 1992, P NATL ACAD SCI USA, V89, P182, DOI 10.1073/pnas.89.1.182; DUAN L, 1994, P NATL ACAD SCI USA, V91, P5015; DUNBAR CE, 1994, STEM CELLS, V12, P563, DOI 10.1002/stem.5530120604; DUNBAR CE, IN PRESS BLOOD; GERNA G, 1984, ANTIMICROB AGENTS CH, V38, P38; GILBOA E, 1986, BIOTECHNIQUES, V4, P584; GROGER RK, 1989, GENE, V81, P285, DOI 10.1016/0378-1119(89)90189-3; HAMBOR JE, 1988, P NATL ACAD SCI USA, V85, P4010, DOI 10.1073/pnas.85.11.4010; HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; LORI F, 1992, J VIROL, V66, P5067, DOI 10.1128/JVI.66.8.5067-5074.1992; MARASCO WA, 1993, P NATL ACAD SCI USA, V90, P7427; MUILINAX RL, 1990, P NATL ACAD SCI USA, V87, P8095; MUROCACHO CA, 1992, J IMMUNOTHER, V11, P231, DOI 10.1097/00002371-199205000-00001; OU CY, 1988, SCIENCE, V239, P295, DOI 10.1126/science.3336784; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; PENG L, 1994, J GEN VIROL, V75, P1917; PLUCKTHUN A, 1991, BIO-TECHNOL, V9, P545, DOI 10.1038/nbt0691-545; SARVER N, 1990, SCIENCE, V247, P1222, DOI 10.1126/science.2107573; SHIMADA T, 1991, Antiviral Chemistry and Chemotherapy, V2, P133; SULLENGER BA, 1990, CELL, V63, P601, DOI 10.1016/0092-8674(90)90455-N; TAI MS, 1990, BIOCHEMISTRY-US, V29, P8024, DOI 10.1021/bi00487a005; TALBOTT R, 1993, P NATL ACAD SCI USA, V90, P4226, DOI 10.1073/pnas.90.9.4226; TAVIADORAKI P, 1993, NATURE, V366, P469; TRATSCHIN JD, 1985, MOL CELL BIOL, V5, P3251, DOI 10.1128/MCB.5.11.3251; TRAVIS J, 1993, SCIENCE, V261, P1114, DOI 10.1126/science.8356445; TRONO D, 1989, CELL, V59, P113, DOI 10.1016/0092-8674(89)90874-X; VERONESE FD, 1976, SCIENCE, V231, P1289; WITHLOW M, 1991, METHOD ENZYMOL, V2, P97; WOFFENDIN C, 1994, P NATL ACAD SCI USA, V91, P11581, DOI 10.1073/pnas.91.24.11581; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YOUNG JM, 1988, GENE, V62, P171, DOI 10.1016/0378-1119(88)90556-2; YU M, 1993, P NATL ACAD SCI USA, V90, P6340, DOI 10.1073/pnas.90.13.6340; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	41	83	84	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1995	1	7					667	673		10.1038/nm0795-667	http://dx.doi.org/10.1038/nm0795-667			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585149				2022-12-25	WOS:A1995RQ06600042
J	SUNDVALL, M; JIRHOLT, J; YANG, HT; JANSSON, L; ENGSTROM, A; PETTERSSON, U; HOLMDAHL, R				SUNDVALL, M; JIRHOLT, J; YANG, HT; JANSSON, L; ENGSTROM, A; PETTERSSON, U; HOLMDAHL, R			IDENTIFICATION OF MURINE LOCI ASSOCIATED WITH SUSCEPTIBILITY TO CHRONIC EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS	NATURE GENETICS			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; RECEPTOR GENE; MICE; MOUSE; EPITOPE; LINKAGE; CHROMOSOME-15; COMPLEMENT	B10.RIII mice develop chronic and relapsing experimental autoimmune encephalomyelitis (EAE) after immunization with the myelin basic protein (MBP) peptide 89-101. The disease is associated with the major histocompatibility complex (MHC) (eae1). We have now investigated the importance of non-MHC regions for the EAE susceptibility in a cross between RIIIS/J and B10.RIII mice which share the MHC region but differ in disease susceptibility, Linkage analysis using microsatellite markers spanning the genome identified a region (eae2) on chromosome 15 which showed linkage to disease (P=0.0002). Our data also suggest linkage to a second region (eae3) on chromosome 3 (P=0.0024), and provide evidence for locus interactions between eae2 and eae3. These results provide clues to the genetic basis of multiple sclerosis.	LUND UNIV,DEPT MED INFLAMMAT RES,LUND,SWEDEN; UNIV UPPSALA,DEPT MED & PHYSIOL CHEM,UPPSALA,SWEDEN	Lund University; Uppsala University	SUNDVALL, M (corresponding author), UNIV UPPSALA,DEPT MED GENET,BOX 589,S-75123 UPPSALA,SWEDEN.		Holmdahl, Rikard/AAI-7682-2020					BARKER CS, 1992, J VIROL, V66, P6763, DOI 10.1128/JVI.66.11.6763-6768.1992; BEMARD C, 1992, CURR OPIN IMMUNOL, V4, P760; BUCHBERG AM, 1989, GENOMICS, V5, P363, DOI 10.1016/0888-7543(89)90071-2; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; FRITZ RB, 1985, J IMMUNOL, V134, P2328; GASSER DL, 1975, J IMMUNOL, V115, P431; GEARING DP, 1993, GENOMICS, V18, P148, DOI 10.1006/geno.1993.1441; HAQQI TM, 1989, J EXP MED, V169, P1903, DOI 10.1084/jem.169.6.1903; HAYAKAWA JI, 1985, IMMUNOGENETICS, V22, P637, DOI 10.1007/BF00430312; HOLMDAHL R, 1995, IMMUNOL REV, V144, P109, DOI 10.1111/j.1600-065X.1995.tb00067.x; JANSSON L, 1991, EUR J IMMUNOL, V21, P693, DOI 10.1002/eji.1830210323; JANSSON L, 1993, IMMUNOGENETICS, V37, P466, DOI 10.1007/BF00222472; JOUVINMARCHE E, 1989, IMMUNOGENETICS, V30, P99, DOI 10.1007/BF02421537; KLUCK PMC, 1993, HUM GENET, V90, P542; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LEE NE, 1984, J EXP MED, V160, P905, DOI 10.1084/jem.160.3.905; MONTGOMERY IN, 1982, J IMMUNOL, V128, P421; MYERS KJ, 1992, J NEUROIMMUNOL, V41, P1, DOI 10.1016/0165-5728(92)90188-Q; OAKEY RJ, 1992, IMMUNOGENETICS, V35, P279, DOI 10.1007/BF00166834; OFFNER H, 1989, J EXP MED, V170, P355, DOI 10.1084/jem.170.2.355; ORREN A, 1985, IMMUNOGENETICS, V21, P591, DOI 10.1007/BF00395883; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; PRINS JB, 1993, SCIENCE, V260, P695, DOI 10.1126/science.8480181; SAKAI K, 1988, J NEUROIMMUNOL, V19, P21, DOI 10.1016/0165-5728(88)90032-X; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; TIENARI PJ, 1994, GENOMICS, V19, P320, DOI 10.1006/geno.1994.1064; TIENARI PJ, 1992, LANCET, V340, P987, DOI 10.1016/0140-6736(92)93007-A; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; VINCEK V, 1990, IMMUNOGENETICS, V31, P45, DOI 10.1007/BF00702488; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; ZHAO ML, 1993, J NEUROIMMUNOL, V42, P209, DOI 10.1016/0165-5728(93)90012-N	34	159	160	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					313	317		10.1038/ng0795-313	http://dx.doi.org/10.1038/ng0795-313			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7545492				2022-12-25	WOS:A1995RG38600015
J	ALBANI, S; KEYSTONE, E; NELSON, JL; OLLIER, WER; LACAVA, A; MONTEMAYOR, AC; WEBER, DA; MONTECUCCO, C; MARTINI, A; CARSON, DA				ALBANI, S; KEYSTONE, E; NELSON, JL; OLLIER, WER; LACAVA, A; MONTEMAYOR, AC; WEBER, DA; MONTECUCCO, C; MARTINI, A; CARSON, DA			POSITIVE SELECTION IN AUTOIMMUNITY - ABNORMAL IMMUNE-RESPONSES TO A BACTERIAL DNAJ ANTIGENIC DETERMINANT IN PATIENTS WITH EARLY RHEUMATOID-ARTHRITIS	NATURE MEDICINE			English	Article							HEAT-SHOCK PROTEINS; NUCLEOTIDE-SEQUENCE; MOLECULAR MIMICRY; CLASS-II; B-CELL; DISEASE; SUSCEPTIBILITY; GENE	A novel 'multistep molecular mimicry' mechanism for induction of rheumatoid arthritis (RA) by bacterial antigens that activate T lymphocytes previously 'educated' by peptides derived from a class of human histocompatibility antigens is reported here. These antigens have the amino acid sequence QKRAA, which is also present on the Escherichia coli heat-shock protein dnaj. Synovial fluid cells of early RA patients have strong immune responses to the bacterial antigen, but cells from normal subjects or controls with other autoimmune diseases do not. The activated T cells may cross-react with autologous dnaj heat-shock proteins that are expressed at synovial sites of inflammation. Our findings may have direct relevance to new strategies for the immune therapy of RA.	UNIV CALIF SAN DIEGO, SAM & ROSE STEIN INST RES AGING, LA JOLLA, CA 92093 USA; UNIV TORONTO, WELLESLEY HOSP, RHEUMAT DIS UNIT, TORONTO, ON M4Y 1J3, CANADA; FRED HUTCHINSON CANC RES CTR, SEATTLE, WA 98104 USA; UNIV MANCHESTER, ARC, EPIDEMIOL RES UNIT, MANCHESTER M13 9PT, LANCS, ENGLAND; UNIV PAVIA, POLICLIN SAN MATTEO, DEPT PEDIAT, I-27100 PAVIA, ITALY	University of California System; University of California San Diego; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Fred Hutchinson Cancer Center; University of Manchester; IRCCS Fondazione San Matteo; University of Pavia	ALBANI, S (corresponding author), UNIV CALIF SAN DIEGO, DEPT MED, 9500 GILMAN DR, LA JOLLA, CA 92093 USA.		/AAG-9576-2020; MONTECUCCO, CARLOMAURIZIO/K-5236-2018	/0000-0002-8839-0933; MONTECUCCO, CARLOMAURIZIO/0000-0001-8263-3925	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007567, R37AR025443, P01AR041897, R01AR025443] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 25443, AR 41897, AR 07567] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALBANI S, 1994, J PEDIATR-US, V124, P561, DOI 10.1016/S0022-3476(05)83134-8; ALBANI S, 1992, J CLIN INVEST, V89, P327, DOI 10.1172/JCI115580; ALLEN PM, 1994, CELL, V76, P593, DOI 10.1016/0092-8674(94)90497-9; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BARDWELL JCA, 1986, J BIOL CHEM, V261, P1782; CHELLAIAH A, 1993, BIOCHIM BIOPHYS ACTA, V1174, P111, DOI 10.1016/0167-4781(93)90103-K; CHEN YH, 1994, SCIENCE, V265, P1237, DOI 10.1126/science.7520605; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; FATENEJAD S, 1993, P NATL ACAD SCI USA, V90, P12010, DOI 10.1073/pnas.90.24.12010; FROUDE J, 1989, CURR TOP MICROBIOL, V145, P5; HARRIS ED, 1990, NEW ENGL J MED, V322, P1277, DOI 10.1056/nejm199005033221805; HODQUIST KA, 1994, CELL, V76, P17; LIFE PF, 1991, IMMUNOL REV, V121, P113, DOI 10.1111/j.1600-065X.1991.tb00825.x; MULLERFASSBENDER HR, 1993, BRIT J RHEUMATOL, V32, P746; NELSON JL, 1993, NEW ENGL J MED, V329, P466, DOI 10.1056/NEJM199308123290704; NEPOM GT, 1992, RHEUM DIS CLIN N AM, V18, P785; OH S, 1993, BIOCHIM BIOPHYS ACTA, V1174, P114, DOI 10.1016/0167-4781(93)90104-L; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; OLLIER W, 1992, RHEUM DIS CLIN N AM, V18, P741; ROUDIER J, 1991, EUR J IMMUNOL, V21, P2063, DOI 10.1002/eji.1830210914; ROUDIER J, 1989, P NATN ACAD SSI US, V86, P5014; SALVAT S, 1994, J IMMUNOL, V153, P5321; SIEPER J, 1991, ARTHRITIS RHEUM-US, V34, P588, DOI 10.1002/art.1780340511; SILMAN AJ, 1993, BRIT J RHEUMATOL, V32, P903; SPECTOR TD, 1990, RHEUM DIS CLIN N AM, V16, P513; THOMSON W, 1992, EUR J IMMUNOGENET, V19, P169, DOI 10.1111/j.1744-313X.1992.tb00056.x; VANASSELDONK M, 1993, J BACTERIOL, V175, P1637, DOI 10.1128/JB.175.6.1637-1644.1993; VANEDEN W, 1991, IMMUNOL REV, V121, P5; WEYAND CM, 1992, ANN INTERN MED, V117, P801, DOI 10.7326/0003-4819-117-10-801; WINCHESTER R, 1992, RHEUM DIS CLIN N AM, V18, P761; WINFIELD JB, 1992, B RHEUM DIS, V41, P4	32	143	156	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	1995	1	5					448	452		10.1038/nm0595-448	http://dx.doi.org/10.1038/nm0595-448			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585093				2022-12-25	WOS:A1995RN10000036
J	KOENIG, S; CONLEY, AJ; BREWAH, YA; JONES, GM; LEATH, S; BOOTS, LJ; DAVEY, V; PANTALEO, G; DEMAREST, JF; CARTER, C; WANNEBO, C; YANNELLI, JR; ROSENBERG, SA; LANE, HC				KOENIG, S; CONLEY, AJ; BREWAH, YA; JONES, GM; LEATH, S; BOOTS, LJ; DAVEY, V; PANTALEO, G; DEMAREST, JF; CARTER, C; WANNEBO, C; YANNELLI, JR; ROSENBERG, SA; LANE, HC			TRANSFER OF HIV-1-SPECIFIC CYTOTOXIC T-LYMPHOCYTES TO AN AIDS PATIENT LEADS TO SELECTION FOR MUTANT HIV VARIANTS AND SUBSEQUENT DISEASE PROGRESSION	NATURE MEDICINE			English	Article							INFECTED RHESUS-MONKEYS; CYTO-TOXIC RESPONSES; ADOPTIVE TRANSFER; NEF PROTEIN; VIRUS; CD8+; CELLS; PROTECTION; VACCINE; INVIVO	An HIV-1-seropositive volunteer was infused with an expanded autologous cytotoxic T lymphocyte (CTL) clone directed against the HIV-1 nef protein. This clone was adoptively transferred to determine whether supplementing CTL activity could reduce viral load or improve clinical course. Unexpectedly, infusion was followed by a decline in circulating CD4(-) T cells and a rise in viral load. Some of the HIV isolates obtained from the plasma or CD4(-) cells of the patient were lacking the nef epitope. These results suggest that active CTL selection of viral variants could contribute to the pathogenesis of AIDS and that clinical progression can occur despite high levels of circulating HIV-1-specific CTLs.	MERCK RES LABS, West Point, PA 19486 USA; NIAID, IMMUNOREGULAT LAB, BETHESDA, MD 20892 USA; NCI, CTR CLIN, TRANSFUS MED BRANCH, BETHESDA, MD 20892 USA; NCI, SURG BRANCH, BETHESDA, MD 20892 USA	Merck & Company; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	KOENIG, S (corresponding author), MEDIMMUNE INC, 35 W WATKINS MILL RD, GAITHERSBURG, MD 20878 USA.		Pantaleo, Giuseppe/K-6163-2016					BINDER D, 1991, J IMMUNOL, V146, P4301; CARMICHAEL A, 1993, J EXP MED, V177, P249, DOI 10.1084/jem.177.2.249; CHEN ZW, 1993, J IMMUNOL, V151, P2177; COUILLIN I, 1994, J EXP MED, V180, P1129, DOI 10.1084/jem.180.3.1129; CULMANN B, 1991, J IMMUNOL, V146, P1560; DAI L C, 1992, Journal of Virology, V66, P3151; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DELVAL M, 1991, J VIROL, V65, P3641, DOI 10.1128/JVI.65.7.3641-3646.1991; DILLON SB, 1992, VACCINE, V10, P309, DOI 10.1016/0264-410X(92)90369-U; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; GOTCH FM, 1990, INT IMMUNOL, V2, P707, DOI 10.1093/intimm/2.8.707; GREEN WR, 1994, J VIROL, V68, P4679, DOI 10.1128/JVI.68.7.4679-4684.1994; HO M, 1993, BLOOD, V81, P2093; HOFFENBACH A, 1989, J IMMUNOL, V142, P452; JACOBSON S, 1990, NATURE, V348, P245, DOI 10.1038/348245a0; JOHNSON RP, 1992, J EXP MED, V175, P961, DOI 10.1084/jem.175.4.961; KAST WM, 1991, P NATL ACAD SCI USA, V88, P2283, DOI 10.1073/pnas.88.6.2283; KOENIG S, 1990, J IMMUNOL, V145, P127; KOENIG S, 1988, P NATL ACAD SCI USA, V85, P8638, DOI 10.1073/pnas.85.22.8638; KOUP RA, 1989, BLOOD, V73, P1909; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; KYBURZ D, 1993, J IMMUNOL, V150, P5051; LAMHAMEDICHERRADI S, 1992, AIDS, V6, P1249, DOI 10.1097/00002030-199211000-00002; MYERS G, 1988, HIV SEQUENCE DATABAS; OEHEN S, 1992, J EXP MED, V176, P1273, DOI 10.1084/jem.176.5.1273; OLDSTONE MBA, 1993, J VIROL, V67, P4372, DOI 10.1128/JVI.67.7.4372-4378.1993; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; PLATA F, 1987, NATURE, V328, P348, DOI 10.1038/328348a0; RIDDELL SR, 1992, SCIENCE, V257, P238; RIVIERE Y, 1989, J VIROL, V63, P2270, DOI 10.1128/JVI.63.5.2270-2277.1989; RUPRECHT RM, 1990, P NATL ACAD SCI USA, V87, P5558, DOI 10.1073/pnas.87.14.5558; Sambrook J, 1989, MOL CLONING LABORATO; SLOBOD KS, 1993, CLIN EXP IMMUNOL, V93, P363, DOI 10.1111/j.1365-2249.1993.tb08186.x; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; WALKER BD, 1988, SCIENCE, V240, P64, DOI 10.1126/science.2451288; WHITTON JL, 1993, J VIROL, V67, P348, DOI 10.1128/JVI.67.1.348-352.1993; WONG RA, 1991, J IMMUNOTHER, V10, P120, DOI 10.1097/00002371-199104000-00006; YASUTOMI Y, 1993, J VIROL, V67, P1707, DOI 10.1128/JVI.67.3.1707-1711.1993	40	318	323	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	1995	1	4					330	336		10.1038/nm0495-330	http://dx.doi.org/10.1038/nm0495-330			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585062				2022-12-25	WOS:A1995RN09800028
J	LASALLE, JM; LALANDE, M				LASALLE, JM; LALANDE, M			DOMAIN ORGANIZATION OF ALLELE-SPECIFIC REPLICATION WITHIN THE GABRB3 GENE-CLUSTER REQUIRES A BIPARENTAL 15Q11-13 CONTRIBUTION	NATURE GENETICS			English	Article							PRADER-WILLI SYNDROME; GROWTH FACTOR-II; CHROMOSOME-15 DELETION; PARENTAL ORIGIN; TME LOCUS; MOUSE; ANGELMAN; SNRPN; EMBRYOGENESIS; TRANSVECTION	Imprinting marks the parental origin of chromosomes, resulting in allele-specific changes in chromatin organization, transcription and replication. We report a 50-60 kb domain of allele-specific replication between the gamma-aminobutyric acid receptor subunit beta 3 (GABRB3) and alpha 5 (GABRA5) genes. Replication of this domain occurs in early S phase on the maternal chromosome 15 but is delayed until the end of S phase on the paternal homologue. In contrast, the genomic regions flanking this domain exhibit paternal earlier replication in mid to late S phase. Uniparental disomy or hemizygous deletion of chromosome 15 results in altered allele-specific replication kinetics compared with normals, suggesting that allele-specific replication within the GABRB3/A5 region may be regulated by reciprocal imprints on the maternal and paternal chromosomes.	HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School			LaSalle, Janine M./A-4643-2008	LaSalle, Janine M./0000-0002-3480-2031	NINDS NIH HHS [R01-NS30628-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030628] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARNDTJOVIN DJ, 1977, J HISTOCHEM CYTOCHEM, V25, P585, DOI 10.1177/25.7.70450; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARLOW DP, 1994, TRENDS GENET, V10, P194, DOI 10.1016/0168-9525(94)90255-0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BOGGS BA, 1994, P NATL ACAD SCI USA, V91, P6083, DOI 10.1073/pnas.91.13.6083; BOTTANI A, 1994, AM J MED GENET, V51, P35, DOI 10.1002/ajmg.1320510109; BUTLER MG, 1983, LANCET, V1, P1285; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; CRISSMAN HA, 1994, EXP CELL RES, V174, P388; CROUSE HV, 1960, GENETICS, V45, P1429; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; HASSAN AB, 1994, J CELL SCI, V107, P1381; JUDD BH, 1988, CELL, V53, P841, DOI 10.1016/S0092-8674(88)90209-7; KAY GF, 1994, CELL, V77, P629; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; KNOLL JHM, 1994, NAT GENET, V6, P41, DOI 10.1038/ng0194-41; LASALLE JM, 1994, J EXP MED, V176, P177; LATHAM KE, 1994, GENE DEV, V8, P290, DOI 10.1101/gad.8.3.290; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MUTTER GL, 1993, AM J HUM GENET, V53, P1096; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; PIRROTTA V, 1990, BIOESSAYS, V12, P409, DOI 10.1002/bies.950120903; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REED ML, 1994, NAT GENET, V6, P163, DOI 10.1038/ng0294-163; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; SINNETT D, 1993, AM J HUM GENET, V52, P1216; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; TORCHIA BS, 1994, AM J HUM GENET, V55, P96; TSAI JY, 1991, GENETICS, V129, P1159; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	40	53	54	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1995	9	4					386	394		10.1038/ng0495-386	http://dx.doi.org/10.1038/ng0495-386			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795644				2022-12-25	WOS:A1995QQ75300016
J	PREZANT, TR; AGAPIAN, JV; BOHLMAN, MC; BU, XD; OZTAS, S; QIU, WQ; ARNOS, KS; CORTOPASSI, GA; JABER, L; ROTTER, JI; SHOHAT, M; FISCHELGHODSIAN, N				PREZANT, TR; AGAPIAN, JV; BOHLMAN, MC; BU, XD; OZTAS, S; QIU, WQ; ARNOS, KS; CORTOPASSI, GA; JABER, L; ROTTER, JI; SHOHAT, M; FISCHELGHODSIAN, N			MITOCHONDRIAL RIBOSOMAL-RNA MUTATION ASSOCIATED WITH BOTH ANTIBIOTIC-INDUCED AND NON-SYNDROMIC DEAFNESS	NATURE GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; COMPLETE NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; OLIGONUCLEOTIDE PROBES; STREPTOMYCIN RESISTANT; POINT MUTATIONS; DNA; GENE; GENOME; IDENTIFICATION	Maternally transmitted non-syndromic deafness was described recently both in pedigrees with susceptibility to aminoglycoside ototoxicity and in a large Arab-Israeli pedigree. Because of the known action of aminoglycosides on bacterial ribosomes, we analysed the sequence of the mitochondrial rRNA genes of three unrelated patients with familial aminoglycoside-induced deafness. We also sequenced the complete mitochondrial genome of the Arab-Israeli pedigree. All four families shared a nucleotide 1555 A to G substitution in the 12S rRNA gene, a site implicated in aminoglycoside activity. Our study offers the first description of a mitochondrial rRNA mutation leading to disease, the first cases of non-syndromic deafness caused by a mitochondrial DNA mutation and the first molecular genetic study of antibiotic-induced ototoxicity.	CEDARS SINAI MED CTR, CTR MED GENET BIRTH DEFECTS, STEVEN SPIELBERG PEDIAT RES CTR, LOS ANGELES, CA 90048 USA; UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA 90048 USA; TIEDAO MED COLL, DEPT MED GENET, SHANGHAI, PEOPLES R CHINA; GALLAUDET UNIV, GALLAUDET RES INST, CTR GENET SERV, WASHINGTON, DC 20002 USA; TEL AVIV UNIV, SCH MED, BASIL & GERALD FELSENSTEIN MED RES CTR, DEPT PEDIAT & MED GENET, IL-49100 PETAH TIQWA, ISRAEL; UNIV SO CALIF, INST TOXICOL, LOS ANGELES, CA 90033 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tel Aviv University; University of Southern California					NIDCD NIH HHS [NIDCD DC01402] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001402] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BRIMACOMBE R, 1988, BIOCHEMISTRY-US, V27, P4207, DOI 10.1021/bi00412a001; BROWN MD, 1992, AM J HUM GENET, V51, P378; BROWN MD, 1992, GENETICS, V130, P163; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BU X, IN PRESS GENET EPIDE; BU XD, 1991, P NATL ACAD SCI USA, V88, P8198, DOI 10.1073/pnas.88.18.8198; BU XD, 1992, GENET EPIDEMIOL, V9, P27, DOI 10.1002/gepi.1370090105; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; DILELLA AG, 1987, METHOD ENZYMOL, V152, P447; ETZOLD T, 1987, FEBS LETT, V219, P343, DOI 10.1016/0014-5793(87)80249-1; GADALETA G, 1989, J MOL EVOL, V28, P497, DOI 10.1007/BF02602930; GAUTHIER A, 1988, MOL GEN GENET, V214, P192, DOI 10.1007/BF00337710; GRAVEL M, 1987, BIOCHEMISTRY-US, V26, P6227, DOI 10.1021/bi00393a041; GUTELL RR, 1988, NUCLEIC ACIDS RES, V16, pR175, DOI 10.1093/nar/16.suppl.r175; GUTELL RR, 1985, PROG NUCLEIC ACID RE, V32, P155, DOI 10.1016/S0079-6603(08)60348-7; HIGASHI K, 1989, CLIN GENET, V35, P433; HORNIG H, 1987, BIOCHIMIE, V69, P803, DOI 10.1016/0300-9084(87)90207-0; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; HOWELL N, 1992, AM J HUM GENET, V50, P1333; HU DN, 1991, J MED GENET, V28, P79, DOI 10.1136/jmg.28.2.79; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; JABER L, 1992, J MED GENET, V29, P86, DOI 10.1136/jmg.29.2.86; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; LI M, 1982, J BIOL CHEM, V257, P5921; MARZUKI S, 1991, HUM GENET, V88, P139; MELANCON P, 1988, NUCLEIC ACIDS RES, V16, P9631, DOI 10.1093/nar/16.20.9631; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; MONTANDON PE, 1986, EMBO J, V5, P3705, DOI 10.1002/j.1460-2075.1986.tb04703.x; NEEFS JM, 1991, NUCLEIC ACIDS RES, V19, P1987, DOI 10.1093/nar/19.suppl.1987; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Prezant Toni R., 1992, Human Mutation, V1, P159, DOI 10.1002/humu.1380010212; PREZANT TR, 1992, AM J MED GENET, V44, P465, DOI 10.1002/ajmg.1320440416; REARDON W, 1992, LANCET, V340, P1376, DOI 10.1016/0140-6736(92)92560-3; ROE BA, 1985, J BIOL CHEM, V260, P9759; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANDE M A, 1990, P1098; SHOFFNER JM, 1990, ADV HUM GENET, V19, P267; SPANGLER EA, 1985, J BIOL CHEM, V260, P6334; VANDENOUWELAND JMW, 1992, NAT GENET, V1, P368, DOI 10.1038/ng0892-368; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5	48	905	1021	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1993	4	3					289	294		10.1038/ng0793-289	http://dx.doi.org/10.1038/ng0793-289			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ842	7689389				2022-12-25	WOS:A1993LJ84200018
J	SMITH, SA; EASTON, DF; EVANS, DGR; PONDER, BAJ				SMITH, SA; EASTON, DF; EVANS, DGR; PONDER, BAJ			ALLELE LOSSES IN THE REGION 17Q12-21 IN FAMILIAL BREAST AND OVARIAN-CANCER INVOLVE THE WILD-TYPE CHROMOSOME	NATURE GENETICS			English	Article							GENE; LOCUS	A predisposing gene for breast and ovarian cancer has recently been mapped to chromosome 17q12-21. If this gene is a tumour suppressor gene, allele losses would be expected in the tumours of affected family members and the losses should affect the wild-type chromosome, reflecting the need for inactivation of the wild-type allele at the predisposing locus. In four multiple case breast-ovarian cancer families, we have found that in each of nine tumours which showed allele losses, the losses were from the wild-type chromosome. This suggests that the putative 'breast-ovarian' cancer gene is indeed a tumour suppressor gene.	INST CANC RES,EPIDEMIOL SECT,SUTTON SM2 5NG,SURREY,ENGLAND; ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,ENGLAND	University of London; Institute of Cancer Research - UK; University of Manchester	SMITH, SA (corresponding author), UNIV CAMBRIDGE,DEPT PATHOL,CANC RES CAMPAIGN,HUMAN CANC GENET RES GRP,COURT RD,CAMBRIDGE CB2 1QP,ENGLAND.		Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784				ECCLES DM, 1990, ONCOGENE, V5, P1599; FUTREAL PA, 1992, CANCER RES, V52, P2624; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HALL JM, IN PRESS AM J HUM GE; NAROD SA, 1991, LANCET, V338, P82; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; RUSSELL SEH, 1990, ONCOGENE, V5, P1581; SATO T, 1992, CANCER RES, V52, P1643; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a	12	392	402	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					128	131		10.1038/ng1092-128	http://dx.doi.org/10.1038/ng1092-128			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303261				2022-12-25	WOS:A1992JR08400011
J	JANSEN, G; MAHADEVAN, M; AMEMIYA, C; WORMSKAMP, N; SEGERS, B; HENDRIKS, W; OHOY, K; BAIRD, S; SABOURIN, L; LENNON, G; JAP, PL; ILES, D; COERWINKEL, M; HOFKER, M; CARRANO, AV; DEJONG, PJ; KORNELUK, RG; WIERINGA, B				JANSEN, G; MAHADEVAN, M; AMEMIYA, C; WORMSKAMP, N; SEGERS, B; HENDRIKS, W; OHOY, K; BAIRD, S; SABOURIN, L; LENNON, G; JAP, PL; ILES, D; COERWINKEL, M; HOFKER, M; CARRANO, AV; DEJONG, PJ; KORNELUK, RG; WIERINGA, B			CHARACTERIZATION OF THE MYOTONIC-DYSTROPHY REGION PREDICTS MULTIPLE PROTEIN ISOFORM-ENCODING MESSENGER-RNAS	NATURE GENETICS			English	Article							DOMAINS; MUSCLE; GENE	The mutation underlying myotonic dystrophy (DM) has been identified as an expansion of a polymorphic CTG-repeat in a gene encoding protein kinase activity. Brain and heart transcripts of the DM-kinase (DMR-B15) gene are subject to alternative RNA splicing in both human and mouse. The unstable [CTG]5-30 Motif is found uniquely in humans, although the flanking nucleotides are also present in mouse. Characterization of the DM region of both species reveals another active gene (DMP-N9) in close proximity to the kinase gene. DMP-N9 transcripts, mainly expressed in brain and testis, possess a single, large open reading frame, but the function of its protein product is unknown. Clinical manifestation of DM may be caused by the expanded CTG-repeat compromising the (alternative) expression of DM-kinase or DMR-N9 proteins.	CATHOLIC UNIV NIJMEGEN,FAC MED SCI,DEPT CELL BIOL & HISTOL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS; CHILDRENS HOSP EASTERN ONTARIO,DIV GENET,OTTAWA K1H 8L1,ONTARIO,CANADA; UNIV OTTAWA,DEPT MICROBIOL & IMMUNOL,OTTAWA K1N 6N5,ONTARIO,CANADA; LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,CTR HUMAN GENOME,LIVERMORE,CA 94550; LEIDEN UNIV,DEPT HUMAN GENET,2300 RA LEIDEN,NETHERLANDS	Radboud University Nijmegen; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Leiden University; Leiden University - Excl LUMC			Lennon, Greg/T-4717-2019; Wieringa, Berend/A-5346-2011; Hendriks, Wiljan J.A.J./A-5214-2013; Jansen, Gert/HCI-8852-2022; Hendriks, Wiljan/Q-4325-2019	Wieringa, Berend/0000-0001-9192-8020; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; Hendriks, Wiljan/0000-0001-9481-8281; Jansen, Gert/0000-0002-7524-171X				ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BRINKMEIER H, 1987, BIOCHEM BIOPH RES CO, V148, P1383, DOI 10.1016/S0006-291X(87)80285-1; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CATTERALL WA, 1991, CELL, V64, P871, DOI 10.1016/0092-8674(91)90309-M; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; GEORGE EL, 1989, MOL CELL BIOL, V9, P2957, DOI 10.1128/MCB.9.7.2957; HALL JG, 1990, AM J HUM GENET, V46, P857; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; JANSEN G, IN PRESS GENOMICS, V13; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Maniatis T, 1989, DECONTAMINATION DILU; MOXLEY RT, 1984, ANN NEUROL, V15, P157, DOI 10.1002/ana.410150208; OBERLE I, 1991, SCIENCE, V252, P97; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PENROSE LS, 1948, ANN EUGENIC, V14, P125; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Ravin A, 1939, AM J MED SCI, V197, P593, DOI 10.1097/00000441-193905000-00001; ROHRKASTEN A, 1988, J BIOL CHEM, V263, P15325; ROSES AD, 1974, NATURE, V250, P254; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SAUNDERS AM, 1990, GENOMICS, V6, P324, DOI 10.1016/0888-7543(90)90573-D; SHUTLER G, IN PRESS GENOMICS, V13; SODERLING TR, 1990, J BIOL CHEM, V265, P1823; SUTHERLAND GR, 1991, LANCET, V338, P289, DOI 10.1016/0140-6736(91)90426-P; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	33	160	165	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1992	1	4					261	266		10.1038/ng0792-261	http://dx.doi.org/10.1038/ng0792-261			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1302022				2022-12-25	WOS:A1992JC98400009
J	RIESS, O; NOERREMOELLE, A; COLLINS, C; MAH, D; WEBER, B; HAYDEN, MR				RIESS, O; NOERREMOELLE, A; COLLINS, C; MAH, D; WEBER, B; HAYDEN, MR			EXCLUSION OF DNA CHANGES IN THE BETA-SUBUNIT OF THE C-GMP PHOSPHODIESTERASE GENE AS THE CAUSE FOR HUNTINGTONS-DISEASE	NATURE GENETICS			English	Article							CGMP PHOSPHODIESTERASE; GEL-ELECTROPHORESIS; POINT MUTATIONS; POLYMORPHISMS; POLYMERASE	To identify expressed sequences within candidate regions for the Huntington's disease (HD) gene in 4p16.3, we isolated the gene encoding the beta-subunit of the human cGMP phosphodiesterase (PDEB). We formally assessed this as a candidate gene for HD based on it's expression in brain, the demonstration of linkage disequilibrium between intragenic DNA markers and HD, and the demonstration that mice with a mutation in this gene have a reduction of neurons in particular brain regions. We investigated all 22 exons of PDEB and 5'-flanking region for point mutations in 16 HD patients of different ethnic origins using single strand conformational polymorphism analysis. The underlying DNA changes found initially exclusively in HD patients were excluded as the cause for HD.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1Z4,BC,CANADA; UNIV COPENHAGEN,INST MED GENET,DK-2200 COPENHAGEN,DENMARK	University of British Columbia; University of Copenhagen			Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419; Norremolle, Anne/0000-0003-2561-7683; Weber, Bernhard H.F./0000-0002-8808-7723				ALTHERR MR, IN PRESS GENOMICS; ANDREW S, IN PRESS GENOMICS; BAEHR W, 1979, J BIOL CHEM, V254, P1669; BAEHR W, 1991, FEBS LETT, V278, P107, DOI 10.1016/0014-5793(91)80095-K; BATES GP, 1991, AM J HUM GENET, V49, P7; BOTTEMA CDK, 1991, AM J HUM GENET, V49, P820; BUCAN M, 1990, GENOMICS, V6, P1; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHIU E, 1976, J MED GENET, V13, P75, DOI 10.1136/jmg.13.1.75; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLLINS C, IN PRESS GENOMICS; CRYSTAL RG, 1989, TRENDS GENET, V5, P411, DOI 10.1016/0168-9525(89)90200-X; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; FARBER DB, 1976, J CYCLIC NUCL PROT, V2, P139; GUSELLA JF, 1985, NATURE, V318, P75, DOI 10.1038/318075a0; HAUGERUD S, 1968, SCHWEIZ MED WSCHR, V98, P2016; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KOEBERL DD, 1990, AM J HUM GENET, V47, P202; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1991, SOMAT CELL MOLEC GEN, V17, P421, DOI 10.1007/BF01233067; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; MCKUSICK VA, 1988, MENDELIAN INHERITANC, P387; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHABB JB, 1991, J BIOL CHEM, V266, P24320; SHABB JB, 1990, J BIOL CHEM, V265, P16031; SKRAASTAD MI, 1989, AM J HUM GENET, V44, P560; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPINARDI L, 1991, NUCLEIC ACIDS RES, V19, P4009, DOI 10.1093/nar/19.14.4009; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; TRIFIRO M, 1991, AM J HUM GENET, V49, P53; TRIGGSRAINE BL, 1991, AM J HUM GENET, V49, P1041; WALLACE D C, 1972, Medical Journal of Australia, V59-1, P299; WANG HS, 1986, AM J HUM GENET, V39, P392; WEBER B, 1991, NUCLEIC ACIDS RES, V19, P6263, DOI 10.1093/nar/19.22.6263; WEBER B, 1991, GENOMICS, V11, P1113, DOI 10.1016/0888-7543(91)90039-H; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P83, DOI 10.1007/BF01233207; WIMER RE, 1991, BRAIN RES, V547, P275, DOI 10.1016/0006-8993(91)90971-W; WOLFF G, 1989, J MED GENET, V26, P18, DOI 10.1136/jmg.26.1.18; YOSHIMURA K, 1991, NUCLEIC ACIDS RES, V19, P5417, DOI 10.1093/nar/19.19.5417; YOSHIMURA K, 1991, J BIOL CHEM, V266, P9140	50	15	17	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1992	1	2					104	108		10.1038/ng0592-104	http://dx.doi.org/10.1038/ng0592-104			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC980	1338767				2022-12-25	WOS:A1992JC98000008
J	CRANE, GM; ISHAUG, SL; MIKOS, AG				CRANE, GM; ISHAUG, SL; MIKOS, AG			BONE TISSUE ENGINEERING	NATURE MEDICINE			English	Editorial Material							MARROW				CRANE, GM (corresponding author), RICE UNIV,INST BIOSCI & BIOENGN,COX LAB BIOMED ENGN,POB 1892,HOUSTON,TX 77251, USA.		Crane, Genevieve M/AAK-9224-2020; Cartmell, Sarah/J-8506-2012	Crane, Genevieve M/0000-0001-9274-0214; Cartmell, Sarah/0000-0001-6864-0846				CRANE GM, 1995, ANN BIOMED ENG, V23, pS45; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; HOLLINGER J, 1989, J ORAL MAXIL SURG, V47, P1182, DOI 10.1016/0278-2391(89)90009-8; ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210; LEE SC, 1994, J BIOMED MATER RES, V28, P1149, DOI 10.1002/jbm.820281005; OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202; SCHOETERS G, 1992, CELL PROLIFERAT, V25, P587, DOI 10.1111/j.1365-2184.1992.tb01462.x; THMOPSON RC, 1995, ADV POLYM SCI, V122, P245; VACANTI CA, 1993, TRANSPLANT P, V25, P10196; YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005; Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41	11	206	251	2	60	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1322	1324		10.1038/nm1295-1322	http://dx.doi.org/10.1038/nm1295-1322			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489417				2022-12-25	WOS:A1995TH78600049
J	WATKINS, H; CONNER, D; THIERFELDER, L; JARCHO, JA; MACRAE, C; MCKENNA, WJ; MARON, BJ; SEIDMAN, JG; SEIDMAN, CE				WATKINS, H; CONNER, D; THIERFELDER, L; JARCHO, JA; MACRAE, C; MCKENNA, WJ; MARON, BJ; SEIDMAN, JG; SEIDMAN, CE			MUTATIONS IN THE CARDIAC MYOSIN BINDING PROTEIN-C GENE ON CHROMOSOME-11 CAUSE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY	NATURE GENETICS			English	Note							MYBP-C; CLINICAL MANIFESTATIONS; PATHO-PHYSIOLOGY; MUSCLE; IMMUNOGLOBULIN-C2; INTERRELATIONS; EXPRESSION; SEQUENCE; THERAPY; DOMAIN		BRIGHAM & WOMENS HOSP,DIV CARDIOVASC,BOSTON,MA 02115; ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON SW17 0RE,ENGLAND; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115; FRANZ VOLHARD KLIN,BERLIN,GERMANY; MAX DELBRUCK CTR MOLEC MED,BERLIN,GERMANY; MINNEAPOLIS HEART INST FDN,MINNEAPOLIS,MN 55407	Harvard University; Brigham & Women's Hospital; St Georges University London; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Franz-Volhard Clinical Research Center; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Minneapolis Heart Institute Foundation	WATKINS, H (corresponding author), BRIGHAM & WOMENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115, USA.		McKenna, William J/C-3243-2008	McKenna, William J/0000-0001-7994-2460; Watkins, Hugh/0000-0002-5287-9016	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; FURST DO, 1992, J CELL SCI, V102, P769; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; GEISTERFERLOWRA.AA, 1990, CELL, V62, P999; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MACRAE CA, IN PRESS J CLIN INVE; MARON BJ, 1987, NEW ENGL J MED, V316, P844, DOI 10.1056/NEJM198704023161405; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MCKENNA WJ, 1995, METABOLIC MOL BASES, P4253; MOOS C, 1980, BIOCHIM BIOPHYS ACTA, V632, P141, DOI 10.1016/0304-4165(80)90071-9; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; SCHLENDER KK, 1991, J BIOL CHEM, V266, P2811; SCHULTHEISS T, 1990, J CELL BIOL, V110, P1159, DOI 10.1083/jcb.110.4.1159; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; VAUGHAN KT, 1992, SYM SOC EXP BIOL, V46, P167; VAUGHAN KT, 1993, J BIOL CHEM, V268, P3670; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1994, CURRENT PROTOCOLS HU; WEBER FE, 1993, EUR J BIOCHEM, V216, P661, DOI 10.1111/j.1432-1033.1993.tb18186.x; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121	24	457	466	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					434	437		10.1038/ng1295-434	http://dx.doi.org/10.1038/ng1295-434			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493025				2022-12-25	WOS:A1995TH62900022
J	HARRY, JL; KOOPMAN, P; BRENNAN, FE; GRAVES, JAM; RENFREE, MB				HARRY, JL; KOOPMAN, P; BRENNAN, FE; GRAVES, JAM; RENFREE, MB			WIDESPREAD EXPRESSION OF THE TESTIS-DETERMINING GENE SRY IN A MARSUPIAL	NATURE GENETICS			English	Letter							SEX-DETERMINING REGION; Y-CHROMOSOME; MOUSE TESTIS; DIFFERENTIATION; ZFY	Total RNA was extracted from pooled tammar fetuses and neonatal gonads and analysed for SRY expression using reverse transcription and polymerase chain reaction (RT-PCR). In the tammar, the gonadal primordium is first apparent at day 21 of the 26.5 day gestation. By day 25 the cytoplasmic:nuclear ratio in male pre-Sertoli cells is greater than in female cells, but it is not until two days post-partum that seminiferous cords are obvious with putative Leydig cells appearing in the interstitium(9). We initially tested for the presence of SRY transcripts from the day after the genital ridge is established (day 22 of gestation) until two days after the development of seminiferous tubules (day 4 post partum). Surprisingly, SRY expression was detected throughout this entire developmental period in male fetal tissue and in gonads from male pouch young (Fig. 1a). We therefore extended our sampling period from day 19 of gestation (early head-fold; similar to 20 somites) to 40 days after birth and established that in the tammar SRY is expressed from at least 6 days before the appearance of Sertoli cells until long after the immature testis has bully differentiated (Fig. 1b). Thus, expression of the tammar SRY gene does not result in immediate Sertoli cell differentiation.	UNIV QUEENSLAND, CTR MOLEC BIOL & BIOTECHNOL, ST LUCIA, QLD 4072, AUSTRALIA; LA TROBE UNIV, DEPT GENET & HUMAN VARIAT, BUNDOORA, VIC 3083, AUSTRALIA	University of Queensland; La Trobe University	HARRY, JL (corresponding author), UNIV MELBOURNE, DEPT ZOOL, MELBOURNE, VIC 3052, AUSTRALIA.		Koopman, Peter A/C-9416-2009; Graves, Jennifer A.M./A-1387-2008	Koopman, Peter A/0000-0001-6939-0914; Graves, Jennifer/0000-0001-6480-7856; Renfree, Marilyn/0000-0002-4589-0436				Ao Asangla, 1994, Zygote, V2, P281; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; BOYER TR, 1994, BIOCHEM BIOPH RES CO, V198, P492, DOI 10.1006/bbrc.1994.1072; BURGOYNE PS, 1988, DEVELOPMENT, V102, P443; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; CLEPET C, 1993, HUM MOL GENET, V2, P2007, DOI 10.1093/hmg/2.12.2007; FIDDLER M, 1995, AM J MED GENET, V55, P80, DOI 10.1002/ajmg.1320550121; FOSTER JW, 1992, NATURE, V359, P531, DOI 10.1038/359531a0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KOOPMAN P, 1989, NATURE, V342, P940, DOI 10.1038/342940a0; LOVELLBADGE R, 1993, PHILOS T R SOC B, V339, P159, DOI 10.1098/rstb.1993.0012; O WS, 1988, NATURE, V331, P716; Renfree Marilyn B., 1994, P213; SHARMAN GB, 1970, J REPROD FERTIL, V21, P57; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; ZWINGMAN T, 1993, P NATL ACAD SCI USA, V90, P814, DOI 10.1073/pnas.90.3.814	18	86	86	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1995	11	3					347	349		10.1038/ng1195-347	http://dx.doi.org/10.1038/ng1195-347			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581465				2022-12-25	WOS:A1995TC63900030
J	LYNCH, AS; BRIGGS, D; HOPE, IA				LYNCH, AS; BRIGGS, D; HOPE, IA			DEVELOPMENTAL EXPRESSION PATTERN SCREEN FOR GENES PREDICTED IN THE C-ELEGANS GENOME SEQUENCING PROJECT	NATURE GENETICS			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; PROMOTER; EMBRYOGENESIS; NEURONS; SYSTEM; CELLS	Maximum use should be made of information generated in the genome sequencing projects. Toward this end, we have initiated a genome sequence-based, expression pattern screen of genes predicted from the Caenorhabditis elegans genome sequence data. We examined beta-galactosidase expression patterns in C. elegans lines transformed with lacZ reporter gene fusions constructed using predicted C. elegans gene promoter regions. Of the predicted genes in the cosmids analysed so far, 67% are amenable to the approach and 54% of examined genes yielded a developmental expression pattern. Expression pattern information is being made generally available using computer databases.	UNIV LEEDS,DEPT PURE & APPL BIOL,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND; UNIV LEEDS,DEPT GENET,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND	University of Leeds; University of Leeds			Hope, Ian/M-4186-2018	Hope, Ian/0000-0002-8990-3163				AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; BORK P, 1994, CURR OPIN STRUC BIOL, V4, P393, DOI 10.1016/S0959-440X(94)90109-0; BRENNER S, 1974, GENETICS, V77, P71; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; COWING DW, 1992, DEVELOPMENT, V116, P481; EVANS TC, 1994, CELL, V77, P183, DOI 10.1016/0092-8674(94)90311-5; FIELDS C, 1990, NUCLEIC ACIDS RES, V18, P1509, DOI 10.1093/nar/18.6.1509; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; HILL DP, 1993, CURR TOP DEV BIOL, V28, P181, DOI 10.1016/S0070-2153(08)60213-6; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; HOPE IA, 1991, DEVELOPMENT, V113, P399; KENYON C, 1988, SCIENCE, V240, P1448, DOI 10.1126/science.3287621; KRAUSE M, 1994, DEV BIOL, V166, P133, DOI 10.1006/dbio.1994.1302; KRAUSE M, 1990, CELL, V63, P907, DOI 10.1016/0092-8674(90)90494-Y; LAND M, 1994, J BIOL CHEM, V209, P9234; LINCKE CR, 1993, EMBO J, V12, P1615, DOI 10.1002/j.1460-2075.1993.tb05806.x; MACMORRIS M, 1992, MOL CELL BIOL, V12, P1652, DOI 10.1128/MCB.12.4.1652; MATSUBARA K, 1993, GENE, V135, P265, DOI 10.1016/0378-1119(93)90076-F; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; MITANI S, 1993, DEVELOPMENT, V119, P773; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; OKKEMA PG, 1993, GENETICS, V135, P385; ORR SL, 1994, P NATL ACAD SCI USA, V91, P11869, DOI 10.1073/pnas.91.25.11869; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; WAY JC, 1991, GENE DEV, V5, P2199, DOI 10.1101/gad.5.12a.2199; White J., 1988, NEMATODE CAENORHABDI, V17, P81; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; WOOD WB, 1994, TRENDS GENET, V10, P49, DOI 10.1016/0168-9525(94)90148-1; YOUNG JM, 1993, DEV DYNAM, V196, P124, DOI 10.1002/aja.1001960206; ZORIO DAR, 1994, NATURE, V372, P270, DOI 10.1038/372270a0; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	42	44	45	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					309	313		10.1038/ng1195-309	http://dx.doi.org/10.1038/ng1195-309			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581455				2022-12-25	WOS:A1995TC63900020
J	WESSON, DM; KROGSTAD, DJ				WESSON, DM; KROGSTAD, DJ			TRANSFECTION AND MALARIA	NATURE MEDICINE			English	Editorial Material							GENE; DNA; INTEGRATION; EXPRESSION	The introduction of novel genes into mosquitoes and malaria parasites is now feasible, raising hopes for an effective attack on malaria.			WESSON, DM (corresponding author), TULANE UNIV,SCH PUBL HLTH & TROP MED,DEPT TROP MED,NEW ORLEANS,LA 70112, USA.							BLOLAND PB, 1993, J INFECT DIS, V167, P932, DOI 10.1093/infdis/167.4.932; BRAIG HR, 1994, NATURE, V367, P453, DOI 10.1038/367453a0; COLLINS FH, 1995, ANNU REV ENTOMOL, V40, P195, DOI 10.1146/annurev.en.40.010195.001211; FALLON AM, 1991, NATURE, V352, P828, DOI 10.1038/352828a0; GOONEWARDENE R, 1993, P NATL ACAD SCI USA, V90, P5234, DOI 10.1073/pnas.90.11.5234; GUPTA S, 1994, SCIENCE, V263, P961, DOI 10.1126/science.8310293; KIM K, 1993, SCIENCE, V262, P911, DOI 10.1126/science.8235614; MCGRANE V, 1988, AM J TROP MED HYG, V39, P502, DOI 10.4269/ajtmh.1988.39.502; MILLER LH, 1987, SCIENCE, V237, P779, DOI 10.1126/science.3039658; MORRIS AC, 1989, MED VET ENTOMOL, V3, P1, DOI 10.1111/j.1365-2915.1989.tb00467.x; MORRIS AC, 1995, AM J TROP MED HYG, V52, P456, DOI 10.4269/ajtmh.1995.52.456; Robertson H.M., 1993, Insect Molecular Biology, V2, P125, DOI 10.1111/j.1365-2583.1993.tb00132.x; VADHEIM KL, 1994, MICROB PATHOGENESIS, V17, P339, DOI 10.1006/mpat.1994.1079; VANDIJK MR, 1995, SCIENCE, V268, P1358, DOI 10.1126/science.7761856; WALKERJONAH A, 1992, MOL BIOCHEM PARASIT, V51, P313, DOI 10.1016/0166-6851(92)90081-T; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	16	0	0	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1995	1	8					745	747		10.1038/nm0895-745	http://dx.doi.org/10.1038/nm0895-745			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585172				2022-12-25	WOS:A1995RM63500026
J	KATSUMATA, M; OKUDAIRA, T; SAMANTA, A; CLARK, DP; DREBIN, JA; JOLICOEUR, P; GREENE, MI				KATSUMATA, M; OKUDAIRA, T; SAMANTA, A; CLARK, DP; DREBIN, JA; JOLICOEUR, P; GREENE, MI			PREVENTION OF BREAST-TUMOR DEVELOPMENT IN-VIVO BY DOWN-REGULATION OF THE P185(NEU) RECEPTOR	NATURE MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; NEU ONCOGENE PRODUCT; MONOCLONAL-ANTIBODIES; MAMMARY-TUMORS; EFFECTS INVIVO; EXPRESSION; CANCER; PROTOONCOGENE; CELLS; P185NEU	Certain strains of transgenic mice that express the rat neu oncogene (neuT) in mammary epithelial cells develop breast tumours at an average of 44 weeks of age. in this study, intraperitoneal injection of a monoclonal anti-receptor antibody specific for the rat neuT oncogene product dramatically affected tumour development in these transgenic mice in a dose-dependent manner. A significant proportion (50%) of mice, when injected with anti-receptor antibodies, did not develop tumours even after 90 weeks of age. The phosphotyrosine levels of the membrane fraction of breast tissues in the anti-receptor antibody-treated mice were almost completely abolished when a higher dose of antibodies was used. This study demonstrates, for the first time, that immunologic manipulation of an oncogene product can effectively prevent the development of tumours in a rodent transgenic model.	WASHINGTON UNIV, SCH MED, DEPT SURG, ST LOUIS, MO 63110 USA; CLIN RES INST MONTREAL, MOLEC BIOL LAB, MONTREAL, PQ H2W 1R7, CANADA	Washington University (WUSTL); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	KATSUMATA, M (corresponding author), UNIV PENN, DEPT PATHOL & LAB MED, JOHN MORGAN BLDG, ROOM 288, PHILADELPHIA, PA 19104 USA.							BACUS SS, 1992, CANCER RES, V52, P2580; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BORG A, 1990, CANCER RES, V50, P4332; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; CHAZIN VR, 1992, ONCOGENE, V7, P1859; COHEN JA, 1992, J NEUROSCI RES, V31, P622, DOI 10.1002/jnr.490310406; COHEN JA, 1989, ONCOGENE, V4, P81; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; DEPOTTER CR, 1989, HISTOPATHOLOGY, V15, P351; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; DREBIN JA, 1988, ONCOGENE, V2, P273; DREBIN JA, 1988, ONCOGENE, V2, P387; GUERIN M, 1989, INT J CANCER, V43, P201, DOI 10.1002/ijc.2910430205; HARRIS AL, 1989, J STEROID BIOCHEM, V34, P123, DOI 10.1016/0022-4731(89)90072-1; KERN JA, 1990, CANCER RES, V50, P5184; KOKAI Y, 1989, CELL, V58, P287, DOI 10.1016/0092-8674(89)90843-X; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LESLIE KO, 1992, PATHOL ANNU, V27, P321; MAGUIRE HC, 1990, PATHOBIOLOGY, V58, P297; MAJORS J, 1983, P NATL ACAD SCI-BIOL, V80, P5866, DOI 10.1073/pnas.80.19.5866; MOOI WJ, 1992, EUR J CANCER, V28A, P623, DOI 10.1016/S0959-8049(05)80112-1; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; PRESS MF, 1990, ONCOGENE, V5, P953; QIAN XL, 1992, P NATL ACAD SCI USA, V89, P1330, DOI 10.1073/pnas.89.4.1330; SAMANTA A, 1994, P NATL ACAD SCI USA, V91, P1711, DOI 10.1073/pnas.91.5.1711; SARAGOVI HU, 1991, SCIENCE, V253, P792, DOI 10.1126/science.1876837; SHEPARD HM, 1991, J CLIN IMMUNOL, V11, P117, DOI 10.1007/BF00918679; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; TARAKHOVSKY AM, 1990, ONCOGENE, V5, P405; VANDEVIJVER MJ, 1988, NEW ENGL J MED, V319, P1239, DOI 10.1056/NEJM198811103191902; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; WADA T, 1990, ONCOGENE, V5, P489; WEINER DB, 1989, ONCOGENE, V4, P1175; WILLIAMS TM, 1991, PATHOBIOLOGY, V59, P46, DOI 10.1159/000163614; YU DH, 1991, ONCOGENE, V6, P1991; ZHAU HE, 1990, MOL CARCINOGEN, V3, P254, DOI 10.1002/mc.2940030503	40	103	113	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	1995	1	7					644	648		10.1038/nm0795-644	http://dx.doi.org/10.1038/nm0795-644			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585144				2022-12-25	WOS:A1995RQ06600037
J	SAH, VP; ATTARDI, LD; MULLIGAN, GJ; WILLIAMS, BO; BRONSON, RT; JACKS, T				SAH, VP; ATTARDI, LD; MULLIGAN, GJ; WILLIAMS, BO; BRONSON, RT; JACKS, T			A SUBSET OF P53-DEFICIENT EMBRYOS EXHIBIT EXENCEPHALY	NATURE GENETICS			English	Article							NEURAL-TUBE DEFECTS; WILD-TYPE P53; MOUSE; APOPTOSIS; MUTATION; PROTEIN; GENE; MICE; DELETION; TUMORS	Defects in neural tube formation are among the most common malformations leading to infant mortality. Although numerous genetic loci appear to contribute to the defects observed in humans and in animal model systems, few of the genes involved have been characterized at the molecular level, Mice lacking the p53 tumour suppressor gene are predisposed to tumours, but the viability of these animals indicates that p53 function is not essential for embryonic development. Here, we demonstrate that a fraction of p53-deficient embryos in fact do not develop normally. These animals display defects in neural tube closure resulting in an overgrowth of neural tissue in the region of the midbrain, a condition known as exencephaly.	MIT,CTR CANC RES,DEPT BIOL,CAMBRIDGE,MA 02139; TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111; TUFTS UNIV,SCH VET MED,DEPT PATHOL,BOSTON,MA 02111	Massachusetts Institute of Technology (MIT); Tufts University; Tufts University			Williams, Bart/A-3539-2013	Williams, Bart/0000-0002-5261-5301				BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; CAMPBELL LR, 1986, TERATOLOGY, V34, P171, DOI 10.1002/tera.1420340206; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; COPP AJ, 1990, PROG NEUROBIOL, V35, P363, DOI 10.1016/0301-0082(90)90037-H; COPP AJ, 1988, DEVELOPMENT, V104, P285; COPP AJ, 1993, TRENDS NEUROSCI, V16, P381, DOI 10.1016/0166-2236(93)90001-3; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GRUNEBERG H, 1954, J GENET, V52, P52, DOI 10.1007/BF02981490; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JCKS T, 1994, NAT GENET, V7, P353; JCKS T, 1994, CURR BIOL, V4, P1; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MACDONALD KB, 1989, TERATOLOGY, V39, P195, DOI 10.1002/tera.1420390211; MACLEOD K, IN PRESS GENES DEV; MCKAY IJ, 1994, DEVELOPMENT, V120, P2199; NEUMANN PE, 1994, NAT GENET, V6, P357, DOI 10.1038/ng0494-357; OLINER JD, 1993, BIOESSAYS, V15, P703, DOI 10.1002/bies.950151102; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PURDIE CA, 1994, ONCOGENE, V9, P603; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; SCHMID P, 1991, DEVELOPMENT, V113, P857; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; TSUKADA T, 1993, ONCOGENE, V8, P3313; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0	38	488	498	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					175	180		10.1038/ng0695-175	http://dx.doi.org/10.1038/ng0695-175			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663512				2022-12-25	WOS:A1995RA85700014
J	WANG, XW; YEH, H; SCHAEFFER, L; ROY, R; MONCOLLIN, V; EGLY, JM; WANG, Z; FRIEDBERG, EC; EVANS, MK; TAFFE, BG; BOHR, VA; WEEDA, G; HOEIJMAKERS, JHJ; FORRESTER, K; HARRIS, CC				WANG, XW; YEH, H; SCHAEFFER, L; ROY, R; MONCOLLIN, V; EGLY, JM; WANG, Z; FRIEDBERG, EC; EVANS, MK; TAFFE, BG; BOHR, VA; WEEDA, G; HOEIJMAKERS, JHJ; FORRESTER, K; HARRIS, CC			P53 MODULATION OF TFIIH-ASSOCIATED NUCLEOTIDE EXCISION-REPAIR ACTIVITY	NATURE GENETICS			English	Article							WILD-TYPE P53; COMPLEMENTATION GROUP-D; XERODERMA-PIGMENTOSUM; DNA-REPAIR; GENE AMPLIFICATION; COCKAYNE SYNDROME; PROTEIN; REPLICATION; HELICASE; TRANSCRIPTION	p53 has pleiotropic functions including control of genomic plasticity and integrity. Here we report that p53 can bind to several transcription factor IIH-associated factors, including transcription-repair factors, XPD (Rad3) and XPB, as well as CSB involved in strand-specific DNA repair, via its C-terminal domain. We also found that wild-type, but not Arg273His mutant p53 inhibits XPD (Rad3) and XPB DNA helicase activities. Moreover, repair of UV-induced dimers is slower in Li-Fraumeni syndrome cells (heterozygote p53 mutant) than in normal human cells. Our findings indicate that p53 may play a direct role in modulating nucleotide excision repair pathways.	NCI,HUMAN CARCINOGENESIS LAB,BETHESDA,MD 20892; FAC MED STRASBOURG,INSERM,U184,CNRS,UPR 6520,F-67085 STRASBOURG,FRANCE; UNIV TEXAS,SW MED CTR,DEPT PATHOL,MOLEC PATHOL LAB,DALLAS,TX 75235; NIA,MOLEC GENET LAB,BALTIMORE,MD 21224; ERASMUS UNIV ROTTERDAM,CTR MED GENET,DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Erasmus University Rotterdam			Wang, Xin Wei/B-6162-2009; MONCOLLIN, Vincent/R-1941-2017; Bohr, Vilhelm/AAP-5931-2020; Evans, Michele Kim/AAE-4776-2019; Hoeijmakers, Jan/AAX-6972-2021	Wang, Xin Wei/0000-0001-9735-606X; MONCOLLIN, Vincent/0000-0002-4163-0231; schaeffer, laurent/0000-0001-6600-503X; Evans, Michele/0000-0002-8546-2831				AMUNDSON SA, 1993, MUTAT RES, V286, P233, DOI 10.1016/0027-5107(93)90188-L; BAKALKIN G, 1994, P NATL ACAD SCI USA, V91, P413, DOI 10.1073/pnas.91.1.413; Bartek J, 1992, Eur J Cancer, V29A, P101; BOHR VA, 1988, DNA REPAIR LABORATOR, P347; BRAITHWAITE AW, 1987, NATURE, V329, P458, DOI 10.1038/329458a0; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; CLEAVER JE, 1994, METABOLIC BASIS INHE; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; DUTTA A, 1993, NATURE, V365, P79, DOI 10.1038/365079a0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; EVANS MK, 1993, J BIOL CHEM, V268, P4839; FISCHER L, 1992, SCIENCE, V257, P1392, DOI 10.1126/science.1529339; FLEJTER WL, 1992, P NATL ACAD SCI USA, V89, P261, DOI 10.1073/pnas.89.1.261; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; GREENBLATT MS, 1994, CANCER RES, V54, P4855; HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUMBERT S, 1994, EMBO J, V13, P2393, DOI 10.1002/j.1460-2075.1994.tb06523.x; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; HUPP TR, 1995, CURR BIOL, V4, P865; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KAWASHIMA K, 1995, INT J CANCER, V61, P76, DOI 10.1002/ijc.2910610113; KULESZMARTIN MF, 1994, MOL CELL BIOL, V14, P1698, DOI 10.1128/MCB.14.3.1698; LI L, 1994, P NATL ACAD SCI USA, V91, P5012, DOI 10.1073/pnas.91.11.5012; LITTLE JB, 1995, J BIOL CHEM, V270, P1; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LU X, 1993, CELL, V75, P765, DOI 10.1016/0092-8674(93)90496-D; MA LB, 1994, MOL CELL BIOL, V14, P4126, DOI 10.1128/MCB.14.6.4126; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; NAEGELI H, 1992, J BIOL CHEM, V267, P392; OBEROSLER P, 1993, EMBO J, V12, P2389, DOI 10.1002/j.1460-2075.1993.tb05893.x; OKAMOTO K, 1994, EMBO J, V13, P4816, DOI 10.1002/j.1460-2075.1994.tb06807.x; ROY R, 1994, J BIOL CHEM, V269, P9826; RUPPERT JM, 1993, MOL CELL BIOL, V13, P3811, DOI 10.1128/MCB.13.6.3811; SAKURAI T, 1994, EXP CELL RES, V215, P57, DOI 10.1006/excr.1994.1314; SATOH MS, 1993, P NATL ACAD SCI USA, V90, P6335, DOI 10.1073/pnas.90.13.6335; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SCHAEFFER L, 1994, EMBO J, V13, P2388, DOI 10.1002/j.1460-2075.1994.tb06522.x; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; SMITH ML, 1995, IN PRESS ONCOGENE; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; STAHL H, 1986, EMBO J, V5, P1939, DOI 10.1002/j.1460-2075.1986.tb04447.x; THUT CJ, 1995, SCIENCE, V267, P100, DOI 10.1126/science.7809597; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VERMEULEN W, 1991, MUTAT RES, V255, P201, DOI 10.1016/0921-8777(91)90054-S; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; WU L, 1995, MOL CELL BIOL, V15, P497, DOI 10.1128/MCB.15.1.497; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0; ZHAN QM, 1994, MOL CELL BIOL, V14, P2361, DOI 10.1128/MCB.14.4.2361	61	505	512	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					188	195		10.1038/ng0695-188	http://dx.doi.org/10.1038/ng0695-188			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663514	Green Published			2022-12-25	WOS:A1995RA85700016
J	WANG, SB; SUN, CE; WALCZAK, CA; ZIEGLE, JS; KIPPS, BR; GOLDIN, LR; DIEHL, SR				WANG, SB; SUN, CE; WALCZAK, CA; ZIEGLE, JS; KIPPS, BR; GOLDIN, LR; DIEHL, SR			EVIDENCE FOR A SUSCEPTIBILITY LOCUS FOR SCHIZOPHRENIA ON CHROMOSOME 6PTER-P22	NATURE GENETICS			English	Article							PEDIGREE-MEMBER METHOD; LINKAGE ANALYSIS; GENETIC-LINKAGE; ROSCOMMON FAMILY; RELATIVES; POLYMORPHISM; STRATEGIES; REGION	We have performed linkage analysis in 186 multiplex families to search for genes that predispose to schizophrenia. Under a model with partially dominant inheritance, moderately broad disease definition and assuming locus homogeneity, a lod score of 3.2 was obtained for D6S260 on chromosome 6p23. A multipoint lod score of 3.9 (P=2.3 x 10(-5)) was achieved when the F13A1 and D6S260 loci were analysed, allowing for locus heterogeneity. Adjusted for testing of multiple models, the multipoint lod score of 3.9 under heterogeneity has a genome wide significance of between 5-8%. The nonparametric affected pedigree member test provided. results (P=3 x 10(-4)) also supporting this finding. Our findings provide supportive evidence for a susceptibility locus for schizophrenia on distal chromosome 6p, and support a model of locus heterogeneity.	NIDR, MOLEC EPIDEMIOL & DIS INDICATORS BRANCH, BETHESDA, MD 20892 USA; NIMH, CLIN NEUROGENET BRANCH, BETHESDA, MD 20892 USA; PERKIN ELMER CORP, DIV APPL BIOSYST, FOSTER CITY, CA 94404 USA; VIRGINIA COMMONWEALTH UNIV, SCH DENT, CLIN PERIODONTAL DIS RES CTR, RICHMOND, VA 23298 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Thermo Fisher Scientific; Applied Biosystems; Virginia Commonwealth University					NCRR NIH HHS [RR03655] Funding Source: Medline; NIMH NIH HHS [MH41953, MH45390] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH041953, R01MH045390] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BABRON MC, 1993, GENET EPIDEMIOL, V10, P389, DOI 10.1002/gepi.1370100610; BARON M, 1990, BRIT J PSYCHIAT, V157, P645, DOI 10.1192/bjp.157.5.645; BARR CL, 1994, AM J MED GENET, V54, P51, DOI 10.1002/ajmg.1320540110; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; CLONINGER CR, 1994, AM J MED GENET, V54, P83, DOI 10.1002/ajmg.1320540202; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DIEHL SR, 1993, AM J HUM GENET, V53, P776; DIEHL SR, 1990, AM J HUM GENET, V47, pA177; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; GOTTESMAN II, 1991, SCHIZOPHRENIA GENETI; GUYER M, 1992, SCIENCE, V258, P67; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; KENDLER KS, 1994, AM J PSYCHIAT, V151, P27; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P781; KENDLER KS, 1993, SCHIZOPHRENIA BULL, V19, P261, DOI 10.1093/schbul/19.2.261; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P645; KENDLER KS, 1989, SCHIZOPHRENIA B, V15, P403; KOSTYU DD, CURR OPIN GENET DEV, V1, P40; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; NEDOSPASOV SA, 1991, J IMMUNOL, V147, P1053; OTT J, 1992, AM J HUM GENET, V51, P283; Ott J., 1991, ANAL HUMAN GENETIC L; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4306, DOI 10.1093/nar/19.15.4306-a; PULVER AE, 1994, AM J MED GENET, V54, P44, DOI 10.1002/ajmg.1320540109; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; RUTTER M, 1994, AM J MED GENET, V54, P185, DOI 10.1002/ajmg.1320540305; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHELLENBERG GD, 1993, AM J HUM GENET, V53, P619; STRAUB RE, 1994, NAT GENET, V8, P291, DOI 10.1038/ng1194-291; SU Y, 1993, ARCH GEN PSYCHIAT, V50, P205; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; SUAREZ BK, 1994, NEW GENETIC APPROACH, P23; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; TRAN LD, SIB PAL SIB PAIR LIN; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WEEKS DE, 1990, SCHIZOPHRENIA BULL, V16, P673, DOI 10.1093/schbul/16.4.673; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	44	224	233	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1995	10	1					41	46		10.1038/ng0595-41	http://dx.doi.org/10.1038/ng0595-41			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	QX573	7647789				2022-12-25	WOS:A1995QX57300014
J	LUNDBERG, JON; FARKASSZALLASI, T; WEITZBERG, E; RINDER, J; LIDHOLM, J; ANGGARD, A; HOKFELT, T; LUNDBERG, JM; ALVING, K				LUNDBERG, JON; FARKASSZALLASI, T; WEITZBERG, E; RINDER, J; LIDHOLM, J; ANGGARD, A; HOKFELT, T; LUNDBERG, JM; ALVING, K			HIGH NITRIC-OXIDE PRODUCTION IN HUMAN PARANASAL SINUSES	NATURE MEDICINE			English	Article							SYNTHASE; COLITIS	Nitric oxide (NO) is present in air derived from the nasal airways. However, the precise origin and physiological role of airway-derived NO ale unknown. We report that NO in humans is produced by epithelial cells in the paranasal sinuses and is present in sinus air tn very high concentrations, close to the highest permissible atmospheric pollution levels. In immunohistochemical and mRNA in situ hybridization studies we show that an NO synthase most closely resembling the inducible isoform is constitutively expressed apically in sinus epithelium. In contrast, only weak NO synthase activity was found in the epithelium of the nasal cavity. Our findings, together with the well-known bacteriostatic effects of NO, suggest a role for NO in the maintenance of sterility in the human paranasal sinuses.	KAROLINSKA INST, DEPT NEUROSCI, S-17177 STOCKHOLM, SWEDEN; KAROLINSKA HOSP, DEPT OTORHINOLARYNGOL, DEPT ANESTHESIOL & INTENS CARE, S-17176 STOCKHOLM, SWEDEN; PHARMACIA DIAGNOST AB, S-75182 UPPSALA, SWEDEN	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Pfizer; Pharmacia Corporation	LUNDBERG, JON (corresponding author), KAROLINSKA INST, DEPT PHYSIOL & PHARMACOL, S-17177 STOCKHOLM, SWEDEN.		Alving, Kjell/M-4579-2014	Alving, Kjell/0000-0003-0784-0443; Lundberg, Jon/0000-0002-0174-5210; Lidholm, Jonas/0000-0002-7779-3411				AFZELIUS B A, 1976, Science (Washington D C), V193, P317; ALVING K, 1993, EUR RESPIR J, V6, P1368; ASANO K, 1994, P NATL ACAD SCI USA, V91, P10089, DOI 10.1073/pnas.91.21.10089; BJORKWALL T, 1950, BACTERIOLOGICAL EXAM; CROEN KD, 1993, J CLIN INVEST, V91, P2446, DOI 10.1172/JCI116479; DAGERLIND A, 1992, HISTOCHEMISTRY, V98, P39, DOI 10.1007/BF00716936; GELLER DA, 1993, P NATL ACAD SCI USA, V90, P3491, DOI 10.1073/pnas.90.8.3491; HAMID Q, 1993, LANCET, V342, P1510, DOI 10.1016/S0140-6736(05)80083-2; JAIN B, 1993, BIOCHEM BIOPH RES CO, V191, P83, DOI 10.1006/bbrc.1993.1187; KNOPS JL, 1993, OTOLARYNG CLIN N AM, V26, P517; LUNDBERG JON, 1994, GUT, V35, P1543, DOI 10.1136/gut.35.11.1543; LUNDBERG JON, 1994, EUR RESPIR J, V7, P1501, DOI 10.1183/09031936.94.07081501; LUNDBERG JON, 1994, LANCET, V344, P1673, DOI 10.1016/S0140-6736(94)90460-X; MANCINELLI RL, 1983, APPL ENVIRON MICROB, V46, P198, DOI 10.1128/AEM.46.1.198-202.1983; MARSDEN PA, 1993, J BIOL CHEM, V268, P17478; MIDDLETON SJ, 1993, LANCET, V341, P465, DOI 10.1016/0140-6736(93)90211-X; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; PUYBASSET L, 1994, BRIT J ANAESTH, V72, P56; RACHMILEWITZ D, 1993, GASTROENTEROLOGY, V105, P1681, DOI 10.1016/0016-5085(93)91063-N; SHECHTMAN FG, 1993, OTOLARYNG CLIN N AM, V26, P509; Stein JJ, 1994, INTERNAL MED; 1988, MMWR-MORBID MORTAL W, V37, pS7	23	480	501	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	1995	1	4					370	373		10.1038/nm0495-370	http://dx.doi.org/10.1038/nm0495-370			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585069				2022-12-25	WOS:A1995RN09800035
J	CASTILLA, LH; COUCH, FJ; ERDOS, MR; HOSKINS, KF; CALZONE, K; GARBER, JE; BOYD, J; LUBIN, MB; DESHANO, ML; BRODY, LC; COLLINS, FS; WEBER, BL				CASTILLA, LH; COUCH, FJ; ERDOS, MR; HOSKINS, KF; CALZONE, K; GARBER, JE; BOYD, J; LUBIN, MB; DESHANO, ML; BRODY, LC; COLLINS, FS; WEBER, BL			MUTATIONS IN THE BRCA1 GENE IN FAMILIES WITH EARLY-ONSET BREAST AND OVARIAN-CANCER	NATURE GENETICS			English	Article							CHROMOSOME-17Q21; LINKAGE; REGION; DNA	We analysed 50 probands with a family history of breast and/or ovarian cancer for germline mutations in the coding region of the BRCA1 candidate gene, using single-strand conformation polymorphism (SSCP) analysis on PCR-amplified genomic DNA. A total Of eight putative disease-causing alterations were identified: four of these are frameshifts and two are nonsense mutations. In addition, we found two missense mutations, one of which changes the final cysteine of the BRCA1 zinc finger motif to glycine. These data are consistent with a tumour suppressor model, and support the notion that this candidate gene is in fact BRCA1. The heterogeneity of mutations, coupled with the large size of the gene, indicates that clinical application of BRCA1 mutation testing will be technically challenging.	UNIV PENN,DEPT INTERNAL MED,PHILADELPHIA,PA 19104; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; UNIV MICHIGAN,DEPT BIOL,ANN ARBOR,MI 48109; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CANC EPIDEMIOL & CONTROL,BOSTON,MA 02115; UNIV PENN,DEPT OBSTET & GYNECOL,PHILADELPHIA,PA 19104; STRANG CANC PREVENT CTR,NEW YORK,NY 10021; UNIV PENN,DEPT GENET,PHILADELPHIA,PA 19104	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Pennsylvania; University of Pennsylvania				Calzone, Kathleen/0000-0002-2354-6810	NATIONAL CANCER INSTITUTE [R01CA057601, R01CA061231] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-61231, R01-CA-57601] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; CHAMBERLAIN JS, 1993, AM J HUM GENET, V52, P792; CLAUS EB, 1991, AM J HUM GENET, V48, P232; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; LOVERING R, 1993, P NATL ACAD SCI USA, V90, P2112, DOI 10.1073/pnas.90.6.2112; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P1; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Sambrook J, 1989, MOL CLONING LABORATO; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; VIDALPUIG A, 1994, BIOTECHNIQUES, V17, P490; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; 1994, PRESYMPTOMATIC GENET; 1994, JAMA-J AM MED ASSOC, V271, P785; 1994, AM J HUM GENET, V55, pR1; 1993, CELL, V72, P971	26	365	386	1	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					387	391		10.1038/ng1294-387	http://dx.doi.org/10.1038/ng1294-387			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894491				2022-12-25	WOS:A1994PV68200021
J	NAGAFUCHI, S; YANAGISAWA, H; OHSAKI, E; SHIRAYAMA, T; TADOKORO, K; INOUE, T; YAMADA, M				NAGAFUCHI, S; YANAGISAWA, H; OHSAKI, E; SHIRAYAMA, T; TADOKORO, K; INOUE, T; YAMADA, M			STRUCTURE AND EXPRESSION OF THE GENE RESPONSIBLE FOR THE TRIPLET REPEAT DISORDER, DENTATORUBRAL AND PALLIDOLUYSIAN ATROPHY (DRPLA)	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR; MYOTONIC-DYSTROPHY; NUCLEAR-RNA; HUMAN BRAIN; CTG REPEAT; 3' END; PROTEIN; SEQUENCE; LOCALIZATION; CLONING	Dentatorubral and pallidoluysian atrophy is associated with expansion of an unstable CAG repeat on chromosome 12p. We have determined the nucleotide sequences of overlapping cDNA clones and deduced the gene structure. The gene is ubiquitously expressed to form a single 4.5 kb transcript and encoded by an open reading frame of 1184 amino acids (aa), in which a polyglutamine track with variable length starts at aa 484. Although the predicted amino acid sequence does not reveal any function, it does contain several interesting motifs consisting of a simple repeated amino acid sequence, a homo-proline track, two stretches of arginine-glutamic acid dipeptides and a stretch of alternative histidine residues. These results provide clues toward understanding neurodegenerative diseases associated with triplet repeat expansion.	NATL CHILDRENS MED RES CTR,TOKYO 154,JAPAN; NIHON UNIV,NUCLEIC ACID SCI LAB,FUJISAWA,KANAGAWA 252,JAPAN	National Center for Child Health & Development - Japan; Nihon University				Yanagisawa, Hiroko/0000-0002-6917-5218				ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; DICARLO M, 1992, J SUBMICR CYTOL PATH, V24, P467; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GIESER L, 1992, GENOMICS, V13, P873, DOI 10.1016/0888-7543(92)90173-P; HE WW, 1990, BIOCHEM BIOPH RES CO, V171, P697, DOI 10.1016/0006-291X(90)91202-4; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; KARLIN S, 1989, J MOL BIOL, V205, P165, DOI 10.1016/0022-2836(89)90373-2; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, GENOMICS, V16, P572, DOI 10.1006/geno.1993.1232; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MOWRY KL, 1987, SCIENCE, V238, P1682, DOI 10.1126/science.2825355; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PHILLIPS KL, 1993, HUM MOL GENET, V2, P1332, DOI 10.1093/hmg/2.8.1332-a; PHILLIPS SC, 1992, GENE, V116, P181, DOI 10.1016/0378-1119(92)90514-P; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; ROKEACH LA, 1989, J BIOL CHEM, V264, P5024; Sambrook J, 1989, MOL CLONING LABORATO; SANO A, 1994, HUM GENET, V93, P699; SMITH JK, 1958, NEUROLOGY, V8, P205, DOI 10.1212/WNL.8.3.205; SUROWY CS, 1990, GENE, V90, P299, DOI 10.1016/0378-1119(90)90194-V; TAKAHASHI H, 1988, NEUROLOGY, V38, P1065, DOI 10.1212/WNL.38.7.1065; TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; WARNER TT, 1994, NAT GENET, V6, P225, DOI 10.1038/ng0394-225a; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZHANG M, 1992, P NATL ACAD SCI USA, V89, P8769, DOI 10.1073/pnas.89.18.8769; 1993, CELL, V72, P971	37	182	188	1	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1994	8	2					177	182		10.1038/ng1094-177	http://dx.doi.org/10.1038/ng1094-177			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7842016				2022-12-25	WOS:A1994PL12300020
J	GYAPAY, G; MORISSETTE, J; VIGNAL, A; DIB, C; FIZAMES, C; MILLASSEAU, P; MARC, S; BERNARDI, G; LATHROP, M; WEISSENBACH, J				GYAPAY, G; MORISSETTE, J; VIGNAL, A; DIB, C; FIZAMES, C; MILLASSEAU, P; MARC, S; BERNARDI, G; LATHROP, M; WEISSENBACH, J			THE 1993-94 GENETHON HUMAN GENETIC-LINKAGE MAP	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; HUMAN GENOME; MOLECULAR-CLONING; RAT GENE; ASSIGNMENT; SEQUENCE; PROTEIN; LOCUS	In 1992, we described a second-generation genetic linkage map of the human genome. Using 1,267 new microsatellite markers, we now present a new genetic linkage map containing a total of 2,066 (AC)(n) short tandem repeats, 60% of which show a heterozygosity of over 0.7. Statistical linkage analysis based on the genotyping of eight large CEPH families placed these markers in the 23 linkage groups. The map includes 1,266 intervals and spans a total distance of 3690 centiMorgans (cM). A total of 1,041 markers could be ordered with odds ratios greater that 1000:1. About 56% of this map is at a distance of 1 cM or less from one of its markers.	CTR ETUD POLYMORPHISME HUMAIN,F-75010 PARIS,FRANCE; CHU LAVAL,RESEAU MED GENET,LAVAL,PQ,CANADA; INST JACQUES MONOD,GENET MOLEC LAB,F-75005 PARIS,FRANCE; INSERM,U358,F-75010 PARIS,FRANCE; INST PASTEUR,UNITE GENET MOLEC HUMAINE,CNRS,URA 1445,F-75724 PARIS,FRANCE	Laval University; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	GYAPAY, G (corresponding author), GENETHON,1 RUE INT,F-91000 EVRY,FRANCE.		Bernardi, Giorgio/G-1639-2011; Vignal, Alain/I-6253-2017	Vignal, Alain/0000-0002-6797-2125; Fizames, Cecile/0000-0002-0551-8250				BARBER TD, 1993, HUM MOL GENET, V2, P88, DOI 10.1093/hmg/2.1.88; BERNARDI G, 1993, GENE, V135, P57, DOI 10.1016/0378-1119(93)90049-9; BOSMA PJ, 1988, J BIOL CHEM, V263, P9129; BOWCOCK A, 1993, GENOMICS, V15, P376, DOI 10.1006/geno.1993.1071; BROPHY BK, 1992, BIOCHIM BIOPHYS ACTA, V1131, P119, DOI 10.1016/0167-4781(92)90110-L; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CASSARD AM, 1990, J CELL BIOCHEM, V43, P255, DOI 10.1002/jcb.240430306; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; DEITRICH W, 1992, GENETICS, V131, P423; GOOID RD, 1993, HUM MOL GENET, V2, P1271; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1991, HDB STAT, P81; LATHROP GM, 1988, GENOMICS, V2, P157; LINDSAY SJ, 1991, CYTOGENET CELL GENET, V58, P2075; LITT M, 1989, AM J HUM GENET, V44, P397; LITT M, 1989, CYTOGENET CELL GENET, V51, P104; MARTINGALLARDO A, 1992, NAT GENET, V1, P34, DOI 10.1038/ng0492-34; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; POLYMEROPOULOS MH, 1993, HUM MOL GENET, V2, P490, DOI 10.1093/hmg/2.4.490; REED KE, 1993, J CLIN INVEST, V91, P997, DOI 10.1172/JCI116321; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SERIKAWA T, 1992, GENETICS, V131, P701; SHARMA V, 1992, HUM MOL GENET, V1, P289; Shen Y., 1992, Human Molecular Genetics, V1, P773, DOI 10.1093/hmg/1.9.773; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILKIE PJ, 1992, GENOMICS, V12, P607, DOI 10.1016/0888-7543(92)90456-3	32	2152	2207	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1994	7	2			SI		246	339		10.1038/ng0694supp-246	http://dx.doi.org/10.1038/ng0694supp-246			94	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NQ898	7545953				2022-12-25	WOS:A1994NQ89800004
J	LI, CH; RAMJEESINGH, M; REYES, E; JENSEN, T; CHANG, XB; ROMMENS, JM; BEAR, CE				LI, CH; RAMJEESINGH, M; REYES, E; JENSEN, T; CHANG, XB; ROMMENS, JM; BEAR, CE			THE CYSTIC-FIBROSIS MUTATION (DELTA-F508) DOES NOT INFLUENCE THE CHLORIDE CHANNEL ACTIVITY OF CFTR	NATURE GENETICS			English	Article							GENE; CONDUCTANCE; PROTEINS; CELLS; IDENTIFICATION; TRANSPORT; FUSION	The cystic fibrosis transmembrane conductance regulator (CFTR) is a phosphorylation-regulated Cl- channel. In most mammalian cells, the functional consequences of the most common CF mutation, DELTAF508-CFTR, cannot be assessed as the mutant protein undergoes biosynthetic arrest. However, function can be studied in the baculovirus-insect cell expression system where DELTAF508-CFTR does not appear to undergo such arrest. Our results show that phosphorylation-regulated Cl- channel activity of DELTAF508-CFTR is similar to that of wild-type CFTR. This observation was confirmed in comparative studies of purified DELTAF508-CFTR and CFTR reconstituted in planar lipid bilayers. Therefore, we suggest that this common mutation does not result in a significant alteration in CFTR function.	UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A8,ONTARIO,CANADA; UNIV TORONTO,DEPT PHYSIOL,TORONTO M5S 1A8,ONTARIO,CANADA	University of Toronto; University of Toronto	LI, CH (corresponding author), HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA.		Rommens, Johanna/AAT-7465-2021					ANDERSON MP, 1991, CELL, V67, P775, DOI 10.1016/0092-8674(91)90072-7; BEAR C E, 1992, Biophysical Journal, V61, pA127; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BEAR CE, 1992, AM J PHYSIOL, V262, pC251, DOI 10.1152/ajpcell.1992.262.1.C251; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARTMAN J, 1992, J BIOL CHEM, V267, P6455; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KARTNER N, 1992, NAT GENET, V5, P321; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RIORDAN JR, 1989, SCIENCE, V245, P1066; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; THOMAS PJ, 1992, J BIOL CHEM, V267, P5727; VIALARD J, 1990, J VIROL, V64, P37, DOI 10.1128/JVI.64.1.37-50.1990; WELSH MJ, 1992, NEURON, V8, P821, DOI 10.1016/0896-6273(92)90196-K; WOODBURY DJ, 1990, BIOPHYS J, V58, P833, DOI 10.1016/S0006-3495(90)82429-2	26	158	162	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1993	3	4					311	316		10.1038/ng0493-311	http://dx.doi.org/10.1038/ng0493-311			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KW257	7526932				2022-12-25	WOS:A1993KW25700011
J	ZEMEL, S; BARTOLOMEI, MS; TILGHMAN, SM				ZEMEL, S; BARTOLOMEI, MS; TILGHMAN, SM			PHYSICAL LINKAGE OF 2 MAMMALIAN IMPRINTED GENES, H19 AND INSULIN-LIKE GROWTH FACTOR-II	NATURE GENETICS			English	Article							WIEDEMANN-BECKWITH SYNDROME; EARLY MOUSE EMBRYOGENESIS; FACTOR-II GENE; DOMINANT INHERITANCE; BETA-GLOBIN; EXPRESSION; YEAST; MICE; CHROMOSOME-11; GENOME	Parental imprinting is a phenomenon in mammals whereby the maternal and paternal alleles of a gene are differentially expressed. Three murine genes have been shown to display this type of allele-specific expression. Two of them, insulin-like growth factor-2 (Igf-2) and H19, map to the distal end of mouse chromosome 7, but are imprinted in opposite directions. Pulsed-field gel electrophoresis and large-fragment DNA cloning were utilized to establish a physical map that includes H19 and Igf-2. Igf-2 lies approximately 90 kilobases of DNA 5' to H19, in the same transcriptional orientation. This physical proximity is conserved in humans, based on pulsed-field gel analysis. We conclude that H19 and Igf-2 constitute an imprinted domain.	PRINCETON UNIV,HOWARD HUGHES MED INST,PRINCETON,NJ 08544; PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544	Howard Hughes Medical Institute; Princeton University; Princeton University								ALECK KA, 1989, AM J MED GENET, V33, P155, DOI 10.1002/ajmg.1320330202; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Bartolomei M.S., 1992, SEMIN DEV BIOL, V3, P107; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; BELL GI, 1985, P NATL ACAD SCI USA, V82, P6450, DOI 10.1073/pnas.82.19.6450; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BRUNKOW ME, 1991, GENE DEV, V5, P1092, DOI 10.1101/gad.5.6.1092; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CARLE GF, 1985, P NATL ACAD SCI USA, V82, P3756, DOI 10.1073/pnas.82.11.3756; CATTANACH BM, 1986, J EMBRYOL EXP MORPH, V97, P137; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CATTANACH BM, 1982, MOUSE NEWS LETT, V66, P62; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DECHIARA TM, 1991, CELL, V64; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LEE JE, 1990, DEVELOPMENT, V110, P151; LUBINSKY M, 1974, LANCET, V1, P983; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; NICKOL JM, 1988, P NATL ACAD SCI USA, V85, P2548, DOI 10.1073/pnas.85.8.2548; NIIKAWA N, 1986, AM J MED GENET, V24, P41, DOI 10.1002/ajmg.1320240107; OMALLEY KL, 1988, NUCLEIC ACIDS RES, V16, P4437; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; PING AJ, 1989, AM J HUM GENET, V44, P720; POIRIER F, 1991, DEVELOPMENT, V113, P1105; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; ROSSI JM, 1992, P NATL ACAD SCI USA, V89, P2456, DOI 10.1073/pnas.89.6.2456; ROTWEIN P, 1990, DNA CELL BIOL, V9, P725, DOI 10.1089/dna.1990.9.725; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; SOARES MB, 1986, J MOL BIOL, V192, P737, DOI 10.1016/0022-2836(86)90025-2; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TURLEAU C, 1984, HUM GENET, V67, P219, DOI 10.1007/BF00273006; WAZIRI M, 1983, J PEDIATR-US, V102, P873, DOI 10.1016/S0022-3476(83)80014-6; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	41	273	277	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					61	65		10.1038/ng0992-61	http://dx.doi.org/10.1038/ng0992-61			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303252				2022-12-25	WOS:A1992JM64600018
J	BONNE, G; CARRIER, L; BERCOVICI, J; CRUAUD, C; RICHARD, P; HAINQUE, B; GAUTEL, M; LABEIT, S; JAMES, M; BECKMANN, J; WEISSENBACH, J; VOSBERG, HP; FISZMAN, M; KOMAJDA, M; SCHWARTZ, K				BONNE, G; CARRIER, L; BERCOVICI, J; CRUAUD, C; RICHARD, P; HAINQUE, B; GAUTEL, M; LABEIT, S; JAMES, M; BECKMANN, J; WEISSENBACH, J; VOSBERG, HP; FISZMAN, M; KOMAJDA, M; SCHWARTZ, K			CARDIAC MYOSIN BINDING PROTEIN-C GENE SPLICE ACCEPTOR SITE MUTATION IS ASSOCIATED WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY	NATURE GENETICS			English	Note							HEAVY-CHAIN; MUSCLE; PURIFICATION; EXTRACTION; MYOCYTES; VELOCITY; LOCUS; ACTIN; MAPS; CDNA		GRP HOSP PITIE SALPETRIERE,INSERM,UR153,F-75651 PARIS 13,FRANCE; GENETHON SA,CNRS,URA 1922,EVRY,FRANCE; HOP LA PITIE SALPETRIERE,SERV BIOCHIM,PARIS,FRANCE; EUROPEAN MOLEC BIOL LAB,HEIDELBERG,GERMANY; WELLCOME TRUST CTR HUMAN GENET,NUFFIELD DEPT CLIN MED,OXFORD,ENGLAND; MAX PLANCK INST PHYSIOL & CLIN RES,BAD NAUHEIM,GERMANY; HOP LA PITIE SALPETRIERE,SERV CARDIOL,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; European Molecular Biology Laboratory (EMBL); University of Oxford; Wellcome Centre for Human Genetics; Max Planck Society; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite			Beckmann, Jacques S/A-9772-2008; Bonne, Gisèle/G-3121-2013; Gautel, Mathias/AAB-9860-2019	Beckmann, Jacques S/0000-0002-9741-1900; Bonne, Gisèle/0000-0002-2516-3258; Gautel, Mathias/0000-0003-4027-9803; Cruaud, Corinne/0000-0002-4752-7278	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BONNE G, 1995, J MED GENET, V32, P670, DOI 10.1136/jmg.32.8.670; CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; DETOMBE PP, 1992, J PHYSIOL-LONDON, V454, P619, DOI 10.1113/jphysiol.1992.sp019283; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; EINHEBER S, 1990, P NATL ACAD SCI USA, V87, P2157, DOI 10.1073/pnas.87.6.2157; FURST DO, 1992, J CELL SCI, V102, P769; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; GEISTERFERLOWRA.AA, 1990, CELL, V62, P999; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; HARTZELL HC, 1982, J BIOL CHEM, V257, P2111; HOFMANN PA, 1991, J GEN PHYSIOL, V97, P1141, DOI 10.1085/jgp.97.6.1141; JAMES MR, 1994, NAT GENET, V8, P70, DOI 10.1038/ng0994-70; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; KORETZ JF, 1982, BIOPHYS J, V37, P433, DOI 10.1016/S0006-3495(82)84689-4; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MOOS C, 1978, J MOL BIOL, V124, P571, DOI 10.1016/0022-2836(78)90172-9; MOOS C, 1980, BIOCHIM BIOPHYS ACTA, V632, P141, DOI 10.1016/0304-4165(80)90071-9; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; SCHWARTZ K, 1992, CIRC RES, V71, P3, DOI 10.1161/01.RES.71.1.3; STARR R, 1978, BIOCHEM J, V171, P813, DOI 10.1042/bj1710813; SWEITZER NK, 1993, CIRC RES, V73, P1150, DOI 10.1161/01.RES.73.6.1150; THIERFELDER L, 1993, P NATL ACAD SCI USA, V90, P6270, DOI 10.1073/pnas.90.13.6270; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; VIGNAL A, 1993, METHODS MOL GENETICS, V1, P211; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YAMAMOTO K, 1983, J BIOL CHEM, V258, P8395	29	364	372	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					438	440		10.1038/ng1295-438	http://dx.doi.org/10.1038/ng1295-438			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493026				2022-12-25	WOS:A1995TH62900023
J	CARLING, T; KINDMARK, A; HELLMAN, P; LUNDGREN, E; LJUNGHALL, S; RASTAD, J; AKERSTROM, G; MELHUS, H				CARLING, T; KINDMARK, A; HELLMAN, P; LUNDGREN, E; LJUNGHALL, S; RASTAD, J; AKERSTROM, G; MELHUS, H			VITAMIN-D-RECEPTOR GENOTYPES IN PRIMARY HYPERPARATHYROIDISM	NATURE MEDICINE			English	Article							PARATHYROID-HORMONE GENE; BOVINE; CELLS; 1,25-DIHYDROXYVITAMIN-D3; PROLIFERATION; CALCIUM	Vitamin D and parathyroid hormone (PTH) constitute the main regulators of systemic calcium homeostasis. As well as its calcaemic effects, active vitamin D-3 (1,25(OH)(2)D-3) has a direct regulatory role on parathyroid cells. Active vitamin D-3 acts via its receptor (VDR), and binding of the ligand-receptor complex to specific promotor regions of the PTH gene inhibits transcription(1). Active vitamin D-3 constitutes a principal regulator of parathyroid cell growth(2,3), and polymorphism in the VDR gene has recently been related to bone mineral density and suggested as predisposing to osteoporosis(4). Impaired effects of active vitamin D-3 may contribute to the relatively enhanced secretion and cell proliferation seen in hyperparathyroidism (HPT). Indeed, VDR dysfunction, of essentially unknown character, has been demonstrated in the pathological parathyroid tissue of primary HPT as well as HPT secondary to uraemia(5,6). Consistent with the essential role of active vitamin D-3 in parathyroid regulation, the VDR gene polymorphism was studied in 90 postmenopausal women with primary hyperparathyroidism. The VDR genotype bb was found in 60.0% of HPT patients and in 33.3% of the postmenopausal female controls (P < 0.001). As the b allele has been linked to decreased transcriptional activity or messenger RNA stability(4,7), reduced VDR expression may impede regulatory actions of vitamin D and may contribute to parathyroid tumorigenesis in these patients.	UNIV UPPSALA HOSP,DEPT INTERNAL MED,S-75185 UPPSALA,SWEDEN	Uppsala University; Uppsala University Hospital	CARLING, T (corresponding author), UNIV UPPSALA HOSP,DEPT SURG,S-75185 UPPSALA,SWEDEN.		Hellman, Per/AAL-9817-2021	Hellman, Per/0000-0002-5322-5073				AKERSTROM G, 1986, HUM PATHOL, V17, P520, DOI 10.1016/S0046-8177(86)80043-0; ARNOLD A, 1988, NEW ENGL J MED, V318, P658, DOI 10.1056/NEJM198803173181102; ARNOLD A, 1989, J CLIN INVEST, V83, P2034, DOI 10.1172/JCI114114; ARNOLD A, 1993, J CLIN ENDOCR METAB, V77, P1108, DOI 10.1210/jc.77.5.1108; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; DEMAY MB, 1992, P NATL ACAD SCI USA, V89, P8097, DOI 10.1073/pnas.89.17.8097; FARROW S, 1994, LANCET, V343, P1242, DOI 10.1016/S0140-6736(94)92147-4; FRIEDMAN E, 1992, CANCER RES, V52, P6804; FUKUDA N, 1993, J CLIN INVEST, V92, P1436, DOI 10.1172/JCI116720; HOWARD G, 1995, J CLIN ENDOCR METAB, V80, P2800, DOI 10.1210/jc.80.9.2800; HUSTMYER FG, 1994, J CLIN INVEST, V94, P2130, DOI 10.1172/JCI117568; KARMALI R, 1989, J ENDOCRINOL, V123, P137, DOI 10.1677/joe.0.1230137; KREMER R, 1989, ENDOCRINOLOGY, V125, P935, DOI 10.1210/endo-125-2-935; KROGER H, 1995, LANCET, V345, P1238, DOI 10.1016/S0140-6736(95)92019-6; MELHUS H, 1994, LANCET, V344, P949, DOI 10.1016/S0140-6736(94)92297-7; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; NYGREN P, 1988, CALCIFIED TISSUE INT, V43, P213, DOI 10.1007/BF02555137; PALMER M, 1988, EUR J CLIN INVEST, V18, P39, DOI 10.1111/j.1365-2362.1988.tb01163.x; RIGGS BL, 1995, J BONE MINER RES, V10, P991	19	173	176	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1309	1311		10.1038/nm1295-1309	http://dx.doi.org/10.1038/nm1295-1309			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489414				2022-12-25	WOS:A1995TH78600045
J	STRUEWING, JP; ABELIOVICH, D; PERETZ, T; AVISHAI, N; KABACK, MM; COLLINS, FS; BRODY, LC				STRUEWING, JP; ABELIOVICH, D; PERETZ, T; AVISHAI, N; KABACK, MM; COLLINS, FS; BRODY, LC			THE CARRIER FREQUENCY OF THE BRCA1 185DELAG MUTATION IS APPROXIMATELY 1 PERCENT IN ASHKENAZI-JEWISH INDIVIDUALS	NATURE GENETICS			English	Letter							BREAST-CANCER; FAMILIAL BREAST; OVARIAN-CANCER; RISK		NIH, NATL CTR HUMAN GENOME RES, GENE TRANSFER LAB, BETHESDA, MD 20892 USA; NCI, GENET EPIDEMIOL BRANCH, BETHESDA, MD 20892 USA; HEBREW UNIV JERUSALEM, HADASSAH UNIV HOSP,HADASSAH MED SCH,SHARETT INST, DEPT HUMAN GENET, JERUSALEM, ISRAEL; HEBREW UNIV JERUSALEM, HADASSAH UNIV HOSP,HADASSAH MED SCH,SHARETT INST, DEPT ONCOL, JERUSALEM, ISRAEL; UNIV CALIF SAN DIEGO, DEPT PEDIAT, SAN DIEGO, CA 92123 USA; UNIV CALIF SAN DIEGO, DEPT REPROD MED, SAN DIEGO, CA 92123 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of California System; University of California San Diego; University of California System; University of California San Diego			Struewing, Jeffery P/C-3221-2008; Struewing, Jeffery P/I-7502-2013	Struewing, Jeffery P/0000-0002-4848-3334				Bernstein T, 1994, RADON RENTAL HOUSING; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CLAUS EB, 1991, AM J HUM GENET, V48, P232; COHEN MM, 1994, AM J HUM GENET, V55, pR1; DELPERGOLA S, 1992, GENETIC DIVERSITY JE, P3; EASTON DF, 1993, AM J HUM GENET, V52, P678; FEUER EJ, 1993, J NATL CANCER I, V85, P892, DOI 10.1093/jnci/85.11.892; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HOGERVORST FBL, 1995, NAT GENET, V10, P208, DOI 10.1038/ng0695-208; HOSKINS KF, 1995, JAMA-J AM MED ASSOC, V273, P577, DOI 10.1001/jama.273.7.577; INOUE R, 1995, CANCER RES, V55, P3521; KELSEY JL, 1981, JNCI-J NATL CANCER I, V67, P327; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MILLER BA, 1993, NCI NIH9327B9 PUB; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; NAROD SA, 1995, AM J HUM GENET, V56, P254; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P3044, DOI 10.1073/pnas.85.9.3044; OTTMAN R, 1986, AM J EPIDEMIOL, V123, P15, DOI 10.1093/oxfordjournals.aje.a114209; RABEN N, 1993, J BIOL CHEM, V268, P4963; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1; TAKAHASHI H, 1995, CANCER RES, V55, P2998; TONIN P, 1995, AM J HUM GENET, V57, P189; WESTIN JB, 1990, ANN NY ACAD SCI, V609, P269, DOI 10.1111/j.1749-6632.1990.tb32074.x; WINGO PA, 1995, CA-CANCER J CLIN, V45, P8, DOI 10.3322/canjclin.45.1.8; 1994, JAMA-J AM MED ASSOC, V271, P785; 1994, JAMA-J AM MED ASSOC, V71, P785	34	542	558	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1995	11	2					198	200		10.1038/ng1095-198	http://dx.doi.org/10.1038/ng1095-198			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550349				2022-12-25	WOS:A1995RX80600023
J	BRIGGS, MD; HOFFMAN, SMG; KING, LM; OLSEN, AS; MOHRENWEISER, H; LEROY, JG; MORTIER, GR; RIMOIN, DL; LACHMAN, RS; GAINES, ES; CEKLENIAK, JA; KNOWLTON, RG; COHN, DH				BRIGGS, MD; HOFFMAN, SMG; KING, LM; OLSEN, AS; MOHRENWEISER, H; LEROY, JG; MORTIER, GR; RIMOIN, DL; LACHMAN, RS; GAINES, ES; CEKLENIAK, JA; KNOWLTON, RG; COHN, DH			PSEUDOACHONDROPLASIA AND MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO MUTATIONS IN THE CARTILAGE OLIGOMERIC MATRIX PROTEIN GENE	NATURE GENETICS			English	Article							V COLLAGEN; THROMBOSPONDIN; BINDING; HEPARIN; SITES	Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia (MED) are dominantly inherited chondrodysplasias characterized by short stature and early-onset osteoarthrosis. The disease genes in families with PSACH and MED have been localized to an 800 kilobase interval on the short arm of chromosome 19. Recently the gene for cartilage oligomeric matrix protein (COMP) was localized to chromosome 19p13.1. In three patients with these diseases, we identified COMP mutations in a region of the gene that encodes a CA(++) binding motif. Our data demonstrate that PSACH and some forms of MED are allelic and suggest an essential role for Ca++ binding in COMP structure and function.	CEDARS SINAI RES INST,STEVEN SPIELBERG PEDIAT RES CTR,AHMANSON DEPT PEDIAT,LOS ANGELES,CA 90048; UNIV CALIF LOS ANGELES,SCH MED,DEPT PEDIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT RADIOL,LOS ANGELES,CA 90024; LAWRENCE LIVERMORE NATL LAB,CTR HUMAN GENOME,BIOL & BIOTECHNOL RES PROGRAM,LIVERMORE,CA 94550; STATE UNIV GHENT,SCH MED,DEPT PEDIAT,B-9000 GHENT,BELGIUM; STATE UNIV GHENT,SCH MED,DEPT MED GENET,B-9000 GHENT,BELGIUM; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Ghent University; Ghent University; Jefferson University			Mortier, Geert/D-2542-2012; Hoffman, Susan/K-1995-2019	Mortier, Geert/0000-0001-9871-4578; 	NIAMS NIH HHS [AR43139, AR39740] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043139, P01AR039740] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BORNSTEIN P, 1993, GENOMICS, V15, P607, DOI 10.1006/geno.1993.1114; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; BRANDRIFF BF, 1994, GENOMICS, V23, P582, DOI 10.1006/geno.1994.1546; BRIGGS MD, 1993, GENOMICS, V18, P656, DOI 10.1016/S0888-7543(05)80369-6; BRIGGS MD, 1994, AM J HUM GENET, V55, P678; DEERE M, 1995, AM J HUM GENET, V56, P698; DICESARE P, 1994, FEBS LETT, V354, P237, DOI 10.1016/0014-5793(94)01134-6; DIXIT VM, 1984, J BIOL CHEM, V259, P100; EFIMOV VP, 1994, FEBS LETT, V341, P54, DOI 10.1016/0014-5793(94)80239-4; FAIRBANK T, 1947, BRIT J SURG, V34, P225, DOI 10.1002/bjs.18003413502; HALL JG, 1987, AM J MED GENET, V28, P143, DOI 10.1002/ajmg.1320280121; HECHT JT, 1993, GENOMICS, V18, P661, DOI 10.1016/S0888-7543(05)80370-2; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; HELLSTEN E, 1995, GENOMICS, V25, P404, DOI 10.1016/0888-7543(95)80040-S; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421; KNOWLTON RG, IN PRESS GENOMICS; LAHAV J, 1982, CELL, V31, P253, DOI 10.1016/0092-8674(82)90425-1; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; MAROTEAUX P, 1959, PRESSE MED, V67, P383; MAROTEAUX P, 1980, EUR J PEDIATR, V133, P227, DOI 10.1007/BF00496081; MAYNARD JA, 1972, LAB INVEST, V26, P40; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; MUMBY SM, 1984, J CELL BIOL, V98, P646, DOI 10.1083/jcb.98.2.646; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; OEHLMANN R, 1994, AM J HUM GENET, V54, P3; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Ribbing S, 1937, ACTA RADIOL S, V34, P1; RIMOIN DL, 1994, HUM GENET, V93, P236, DOI 10.1007/BF00212015; STANESCU R, 1993, AM J MED GENET, V45, P501, DOI 10.1002/ajmg.1320450420; STANESCU V, 1982, EUR J PEDIATR, V138, P221, DOI 10.1007/BF00441206; STANESCU V, 1977, ARCH FR PEDIATR   S3, V34, P1; TAKAGI J, 1993, J BIOL CHEM, V268, P15544; TYNAN K, 1993, GENOMICS, V17, P316, DOI 10.1006/geno.1993.1327; WARMAN ML, 1994, GENOMICS, V23, P158, DOI 10.1006/geno.1994.1472; 1992, AM J MED GENET, V44, P223	37	395	416	1	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					330	336		10.1038/ng0795-330	http://dx.doi.org/10.1038/ng0795-330			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670472				2022-12-25	WOS:A1995RG38600018
J	SCHALLING, M; EKMAN, M; KAAYA, EE; LINDE, A; BIBERFELD, P				SCHALLING, M; EKMAN, M; KAAYA, EE; LINDE, A; BIBERFELD, P			A ROLE FOR A NEW HERPES-VIRUS (KSHV) IN DIFFERENT FORMS OF KAPOSIS-SARCOMA	NATURE MEDICINE			English	Article								Kaposi's sarcoma (KS) is a previously rare, tumour-like lesion of controversial biological nature(1,2). KS has since the early 1980s become frequent in patients with AIDS, particularly in homosexuals(3). KS is also endemic in Central Africa predominantly in otherwise healthy men but also in women and children(1,4). Recently, evidence for the presence of novel, herpes virus DNA sequences in more than 90% of AIDS Kaposi lesions (AKS) was presented(5). This DNA was identified using representational difference analysis (RDA) generating short, unique sequences with variable homology to several herpes virus, but no intact virus was recovered. If these DNA-sequences are also present in other, non-HIV-associated forms of Kaposi's sarcoma this would strongly suggest a specific, aetiopathological involvement of this putative new herpes virus in the pathogenesis of Kaposi's sarcoma, rather than a contamination of yet another opportunistic virus in immunosuppressed AIDS patients.	KAROLINSKA HOSP & INST,DEPT MOLEC MED,NEUROGENET UNIT,S-17176 STOCKHOLM,SWEDEN; KAROLINSKA HOSP & INST,IMMUNOPATHOL LAB,S-17176 STOCKHOLM,SWEDEN; SWEDISH INST INFECT DIS CONTROL,DEPT VIROL,S-10521 STOCKHOLM,SWEDEN	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Swedish Institute for Infectious Disease Control	SCHALLING, M (corresponding author), KAROLINSKA INST,DEPT MOLEC MED,NEUROGENET UNIT,S-17176 STOCKHOLM,SWEDEN.		Schalling, Martin/F-1518-2015	Schalling, Martin/0000-0001-5011-2922				BAYLEY AC, 1991, CANCER SURV, V10, P53; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; ENSOLI B, 1994, AIDS UPDATES, V7, P1; FRIEDMANKIEN AE, 1981, J AM ACAD DERMATOL, V5, P468, DOI 10.1016/S0190-9622(81)80010-2; KAAYA EE, 1992, EUR J CANCER, V28A, P1890, DOI 10.1016/0959-8049(92)90030-6	5	259	271	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1995	1	7					707	708		10.1038/nm0795-707	http://dx.doi.org/10.1038/nm0795-707			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585156				2022-12-25	WOS:A1995RQ06600050
J	RENSEN, PCN; VANDIJK, MCM; HAVENAAR, EC; BIJSTERBOSCH, MK; KRUIJT, JK; VANBERKEL, TJC				RENSEN, PCN; VANDIJK, MCM; HAVENAAR, EC; BIJSTERBOSCH, MK; KRUIJT, JK; VANBERKEL, TJC			SELECTIVE LIVER TARGETING OF ANTIVIRALS BY RECOMBINANT CHYLOMICRONS - A NEW THERAPEUTIC APPROACH TO HEPATITIS-B	NATURE MEDICINE			English	Article							LOW-DENSITY LIPOPROTEIN; ADENINE-ARABINOSIDE MONOPHOSPHATE; APOLIPOPROTEIN-E; RAT-LIVER; HEPATOCELLULAR-CARCINOMA; PARENCHYMAL-CELLS; VIRUS-INFECTION; REPLICATION; PROTEIN; DISTINCT	Hepatitis B virus (HBV) infection is the world's most important chronic virus infection. No safe and effective treatment is available at present, and clinical exploration of promising antiviral agents, such as nucleoside analogues is hampered because of significant side-effects due to their aspecific body distribution. We are exploring the possibility of the selective delivery of antiviral active drugs to liver parenchymal cells, the main site of infection and replication of HBV. Chylomicrons, which transport dietary lipids into the liver via apolipoprotein E-specific receptors, could serve as drug carriers. However, their endogenous nature hampers their application as pharmaceutical drug carriers. We report here that incorporation of a derivative of the nucleoside analogue iododeoxyuridine into recombinant chylomicrons leads to selective targeting to liver parenchymal cells. Potentially effective intracellular drug concentrations of 700 nM can be achieved, and we therefore anticipate that these drug carrier complexes represent a conceptual advance in the development of an effective and safe therapy for hepatitis B.	LEIDEN UNIV,LEIDEN AMSTERDAM CTR DRUG RES,DIV BIOPHARMACEUT,SYLVIUS LABS,2300 RA LEIDEN,NETHERLANDS	Leiden University; Leiden University - Excl LUMC			Van Berkel, Theo/ABD-7677-2021; Rensen, Patrick C.N./D-7176-2018	Rensen, Patrick C.N./0000-0002-8455-4988				BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J; BEASLEY RP, 1981, LANCET, V2, P1129; BIJSTERBOSCH M K, 1990, Advanced Drug Delivery Reviews, V5, P231, DOI 10.1016/0169-409X(90)90018-N; BIJSTERBOSCH MK, 1994, BIOCHEMISTRY-US, V33, P14073, DOI 10.1021/bi00251a016; BIJSTERBOSCH MK, 1989, MOL PHARMACOL, V36, P484; BLOUIN A, 1977, J CELL BIOL, V72, P441, DOI 10.1083/jcb.72.2.441; CHEN ZM, 1993, BMJ-BRIT MED J, V306, P890, DOI 10.1136/bmj.306.6882.890; HOEG JM, 1985, SCIENCE, V227, P759, DOI 10.1126/science.2982214; HOOFNAGLE JH, 1984, GASTROENTEROLOGY, V86, P150; HUETTINGER M, 1988, CLIN BIOCHEM, V21, P87, DOI 10.1016/S0009-9120(88)80093-6; LIN TS, 1994, J MED CHEM, V37, P798, DOI 10.1021/jm00032a013; LOK ASF, 1984, J ANTIMICROB CHEMOTH, V14, P93, DOI 10.1093/jac/14.1.93; Mahley R. W., 1991, CURR OPIN LIPIDOL, V2, P170; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; NAGELKERKE JF, 1983, J BIOL CHEM, V258, P2221; PERIGAUD C, 1992, NUCLEOS NUCLEOT NUCL, V11, P903, DOI 10.1080/07328319208021748; PRICE PM, 1989, P NATL ACAD SCI USA, V86, P8543; REDGRAVE TG, 1985, BIOCHIM BIOPHYS ACTA, V835, P104, DOI 10.1016/0005-2760(85)90036-0; SACKS SL, 1982, ANTIMICROB AGENTS CH, V21, P93, DOI 10.1128/AAC.21.1.93; SACKS SL, 1979, JAMA-J AM MED ASSOC, V241, P28, DOI 10.1001/jama.1979.03290270020010; SEEGER C, 1986, SCIENCE, V232, P477, DOI 10.1126/science.3961490; Shaw J. M., 1991, LIPOPROTEINS CARRIER; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; SUMMERS J, 1978, P NATL ACAD SCI USA, V75, P4533, DOI 10.1073/pnas.75.9.4533; Tennant Bud C., 1994, P1455; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; UEDA K, 1989, VIROLOGY, V169, P213, DOI 10.1016/0042-6822(89)90057-3; VANBERKEL TJC, 1983, BIOCHEM J, V216, P71, DOI 10.1042/bj2160071; VANBERKEL TJC, 1987, BIOCHEM J, V243, P715, DOI 10.1042/bj2430715; VANDIJK MCM, 1991, BIOCHEM J, V279, P863, DOI 10.1042/bj2790863; VOGEL T, 1985, P NATL ACAD SCI USA, V82, P8696, DOI 10.1073/pnas.82.24.8696; WELLER IVD, 1983, J ANTIMICROB CHEMOTH, V11, P223, DOI 10.1093/jac/11.3.223; WINDLER E, 1980, J BIOL CHEM, V255, P8303; YOFFE B, 1992, DIGEST DIS SCI, V37, P1, DOI 10.1007/BF01308334	34	122	126	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1995	1	3					221	225		10.1038/nm0395-221	http://dx.doi.org/10.1038/nm0395-221			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX559	7585037				2022-12-25	WOS:A1995QX55900027
J	LAING, NG; WILTON, SD; AKKARI, PA; DOROSZ, S; BOUNDY, K; KNEEBONE, C; BLUMBERGS, P; WHITE, S; WATKINS, H; LOVE, DR; HAAN, E				LAING, NG; WILTON, SD; AKKARI, PA; DOROSZ, S; BOUNDY, K; KNEEBONE, C; BLUMBERGS, P; WHITE, S; WATKINS, H; LOVE, DR; HAAN, E			A MUTATION IN THE ALPHA-TROPOMYOSIN GENE TPM3 ASSOCIATED WITH AUTOSOMAL-DOMINANT NEMALINE MYOPATHY	NATURE GENETICS			English	Article								Nemaline myopathies are diseases characterized by the presence in muscle fibres of pathognomonic rod bodies. These are composed largely of alpha-actinin and actin. We have identified a missense mutation in the alpha-tropomyosin gene, TPM3, which segregates completely with the disease in a family whose autosomal dominant nemaline myopathy we had previously localized to chromosome 1p13-q25. The mutation substitutes an arginine residue for a highly conserved methionine in a putative actin-binding site near the N terminus of the alpha-tropomyosin. The mutation may strengthen tropomyosin - actin binding, leading to rod body formation, by adding a further basic residue to the postulated actin-binding motif.	CURTIN UNIV TECHNOL, SCH BIOMED SCI, BENTLEY, WA 6102, AUSTRALIA; ROYAL ADELAIDE HOSP, DEPT NEUROL, ADELAIDE, SA 5000, AUSTRALIA; INST MED & VET SCI, ADELAIDE, SA 5000, AUSTRALIA; WOMENS & CHILDRENS HOSP, CTR GENET MED, DEPT MED GENET, ADELAIDE, SA 5006, AUSTRALIA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; UNIV AUCKLAND, SCH BIOL SCI, AUCKLAND, NEW ZEALAND	Curtin University; Royal Adelaide Hospital; Institute Medical & Veterinary Science Australia; Womens & Childrens Hospital Australia; Harvard University; Harvard Medical School; University of Auckland	LAING, NG (corresponding author), UNIV WESTERN AUSTRALIA, AUSTRALIAN NEUROMUSCULAR RES INST, DEPT PATHOL, 4TH FLOOR, A BLOCK, NEDLANDS, WA 6009, AUSTRALIA.			Love, Donald/0000-0003-4669-8769; Watkins, Hugh/0000-0002-5287-9016; Laing, Nigel/0000-0001-5111-3732; Wilton, Steve/0000-0002-9400-893X				AKKARI PA, 1994, CYTOGENET CELL GENET, V65, P265, DOI 10.1159/000133644; BAADER CD, 1993, FEBS LETT, V328, P63, DOI 10.1016/0014-5793(93)80966-X; BEGGS AH, 1992, GENOMICS, V13, P1314, DOI 10.1016/0888-7543(92)90054-V; BODENSTEINER JB, 1994, MUSCLE NERVE, V17, P131, DOI 10.1002/mus.880170202; CHO YJ, 1990, J BIOL CHEM, V265, P538; CLAYTON L, 1988, J MOL BIOL, V201, P507, DOI 10.1016/0022-2836(88)90633-X; CONEN PE, 1963, CAN MED ASSOC J, V89, P983; EYRE H, IN PRESS CYTOGENET C; EYRE HJ, 1993, CYTOGENET CELL GENET, V62, P181, DOI 10.1159/000133467; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; GUNNING P, 1990, DEV BIOL, V138, P443, DOI 10.1016/0012-1606(90)90210-A; GUYER M, 1992, SCIENCE, V258, P67; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDY S, 1992, BIOCHIM BIOPHYS ACTA, V1131, P239, DOI 10.1016/0167-4781(92)90087-G; HARDY S, 1991, EUR J BIOCHEM, V202, P431, DOI 10.1111/j.1432-1033.1991.tb16392.x; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HELFMAN DM, 1984, J BIOL CHEM, V259, P4136; HITCHCOCKDEGREGORI SE, 1990, J MOL BIOL, V214, P885, DOI 10.1016/0022-2836(90)90343-K; KARLIK CC, 1984, CELL, V37, P469, DOI 10.1016/0092-8674(84)90377-5; LAING NG, 1992, AM J HUM GENET, V50, P576; MACLEOD AR, 1988, MOL CELL BIOL, V8, P433, DOI 10.1128/MCB.8.1.433; MAK AS, 1980, J BIOL CHEM, V255, P3647; MCALPINE PJ, 1993, GENOME PR R, P11; McKusick V.A., 1992, MENDELIAN INHERITANC; MEEDEL TH, 1993, J BIOL CHEM, V268, P6755; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; OTT J, 1974, AM J HUM GENET, V26, P588; PRICE HM, 1965, P NATL ACAD SCI USA, V54, P1398, DOI 10.1073/pnas.54.5.1398; RUIZOPAZO N, 1987, J BIOL CHEM, V262, P4755; SHY GM, 1963, BRAIN, V86, P793, DOI 10.1093/brain/86.4.793; TAHVANAINEN E, 1994, J MED GENET, V31, P79, DOI 10.1136/jmg.31.1.79; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; WIDADA JS, 1988, NUCLEIC ACIDS RES, V16, P3109, DOI 10.1093/nar/16.7.3109; WILTON SD, 1995, CYTOGENET CELL GENET, V68, P122, DOI 10.1159/000133905; WILTON SD, 1993, AM J MED GENET, V46, P563, DOI 10.1002/ajmg.1320460521; WOLFE SL, 1993, MOL CELL BIOL, P451; YONEZAWA N, 1989, EUR J BIOCHEM, V183, P235, DOI 10.1111/j.1432-1033.1989.tb14918.x	37	253	257	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					75	79		10.1038/ng0195-75	http://dx.doi.org/10.1038/ng0195-75			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704029				2022-12-25	WOS:A1995PZ91300018
J	MONCKTON, DG; NEUMANN, R; GURAM, T; FRETWELL, N; TAMAKI, K; MACLEOD, A; JEFFREYS, AJ				MONCKTON, DG; NEUMANN, R; GURAM, T; FRETWELL, N; TAMAKI, K; MACLEOD, A; JEFFREYS, AJ			MINISATELLITE MUTATION-RATE VARIATION ASSOCIATED WITH A FLANKING DNA-SEQUENCE POLYMORPHISM	NATURE GENETICS			English	Article							RECOMBINATION INITIATION SITE; INTERSPERSED REPEATS; MYOTONIC-DYSTROPHY; MVR-PCR; ALLELES; TANDEM; FAMILY; D1S8; LTR; EXPANSION	Human minisatellite mutation in the male germline frequently involves complex interallelic gene conversion events restricted to one end of the tandem repeat array. Some alleles at minisatellite MS32 show reduced variability in human populations and are associated with a G to C transversion upstream of the array. Analysis of single sperm demonstrated a frequently profound reduction in mutation rate at alleles carrying the C variant. This mutation suppression acts in cis, but does not affect the ability of an allele to act as sequence donor during gene conversion. This mutation rate polymorphism provides strong evidence for elements near the minisatellite that regulate tandem repeat instability.	UNIV LEICESTER, DEPT GENET, LEICESTER LE1 7RH, LEICS, ENGLAND; NAGOYA UNIV, SCH MED, DEPT LEGAL MED, NAGOYA, AICHI 466, JAPAN	University of Leicester; Nagoya University			Monckton, Darren/B-4943-2013	Monckton, Darren/0000-0002-8298-8264				ALLEN MJ, 1994, NUCLEIC ACIDS RES, V22, P2976, DOI 10.1093/nar/22.15.2976; ARMOUR JAL, 1993, HUM MOL GENET, V2, P1137, DOI 10.1093/hmg/2.8.1137; ARMOUR JAL, 1989, NUCLEIC ACIDS RES, V17, P4925, DOI 10.1093/nar/17.13.4925; BUARD J, IN PRESS EMBO J; CHUNG M, 1983, NAT GENET, V5, P254; EDELMANN W, 1989, CELL, V57, P937, DOI 10.1016/0092-8674(89)90332-2; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; FIELDS CA, 1992, GENOMICS, V13, P431, DOI 10.1016/0888-7543(92)90264-S; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; JEFFREYS AJ, 1993, EXS, V67, P1; JEFFREYS AJ, 1991, NATURE, V354, P204, DOI 10.1038/354204a0; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; KELLY R, 1991, P ROY SOC B-BIOL SCI, V245, P235, DOI 10.1098/rspb.1991.0115; KESHET E, 1991, ADV CANCER RES, V56, P215; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACPHERSON JN, 1994, HUM MOL GENET, V3, P399, DOI 10.1093/hmg/3.3.399; MAEDA N, 1985, J BIOL CHEM, V260, P6698; MASSEY B, 1993, EMBO J, V12, P1459; MERMER B, 1987, P NATL ACAD SCI USA, V84, P3320, DOI 10.1073/pnas.84.10.3320; MISRA R, 1987, J MOL BIOL, V196, P233, DOI 10.1016/0022-2836(87)90687-5; MONCKTON DG, 1993, HUM MOL GENET, V2, P513, DOI 10.1093/hmg/2.5.513; NEIL DL, 1993, HUM MOL GENET, V2, P1129; Oudet C., 1993, European Journal of Human Genetics, V1, P181; PIZZUTI A, 1992, GENOMICS, V13, P594, DOI 10.1016/0888-7543(92)90129-G; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; SAHA BK, 1993, MAMM GENOME, V4, P565, DOI 10.1007/BF00361386; SCHULTES NP, 1991, MOL CELL BIOL, V11, P322, DOI 10.1128/MCB.11.1.322; SMIT AFA, 1993, NUCLEIC ACIDS RES, V21, P1863, DOI 10.1093/nar/21.8.1863; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; SYLLA BS, 1984, GENE, V29, P343, DOI 10.1016/0378-1119(84)90063-5; TAMAKI K, 1993, HUM MOL GENET, V2, P1629, DOI 10.1093/hmg/2.10.1629; Tamaki Keiji, 1992, Human Molecular Genetics, V1, P401, DOI 10.1093/hmg/1.6.401; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; ZHONG N, 1993, NAT GENET, V5, P248, DOI 10.1038/ng1193-248	39	116	117	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1994	8	2					162	170		10.1038/ng1094-162	http://dx.doi.org/10.1038/ng1094-162			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7842015				2022-12-25	WOS:A1994PL12300018
J	EWART, AK; MORRIS, CA; ATKINSON, D; JIN, WS; STERNES, K; SPALLONE, P; STOCK, AD; LEPPERT, M; KEATING, MT				EWART, AK; MORRIS, CA; ATKINSON, D; JIN, WS; STERNES, K; SPALLONE, P; STOCK, AD; LEPPERT, M; KEATING, MT			HEMIZYGOSITY AT THE ELASTIN LOCUS IN A DEVELOPMENTAL DISORDER, WILLIAMS-SYNDROME	NATURE GENETICS			English	Article							INSITU HYBRIDIZATION; GENE; LOCALIZATION; MARKERS; DNA	Williams syndrome (WS) is a developmental disorder affecting connective tissue and the central nervous system. A common feature of WS, supravalvular aortic stenosis, is also a distinct autosomal dominant disorder caused by mutations in the elastin gene. In this study, we identified hemizygosity at the elastin locus using genetic analyses in four familial and five sporadic cases of WS. Fluorescent in situ hybridization and quantitative Southern analyses confirmed these findings, demonstrating inherited and de novo deletions of the elastin gene. These data indicate that deletions involving one elastin allele cause WS and implicate elastin hemizygosity in the pathogenesis of the disease.	UNIV NEVADA, SCH MED, DEPT MICROBIOL, RENO, NV 89502 USA; UNIV NEVADA, SCH MED, DEPT PATHOL & LAB MED, RENO, NV 89502 USA; UNIV NEVADA, SCH MED, DEPT GENET NETWORK, RENO, NV 89502 USA; UNIV UTAH, DIV CARDIOL, SALT LAKE CITY, UT 84112 USA; UNIV UTAH, HOWARD HUGHES MED INST, SALT LAKE CITY, UT 84112 USA; UNIV UTAH, ECCLES PROGRAM HUMAN MOLEC BIOL & GENET, SALT LAKE CITY, UT 84112 USA; UNIV NEVADA, SCH MED, DEPT PEDIAT, LAS VEGAS, NV 89102 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	EWART, AK (corresponding author), UNIV UTAH, DEPT HUMAN GENET, SALT LAKE CITY, UT 84112 USA.		Toland, Amanda Ewart/E-4202-2011		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR00064] Funding Source: Medline; NHLBI NIH HHS [R01HL4807] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELLUGI U, 1990, AM J MED GENET, P115; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BEUREN A J, 1972, Birth Defects Original Article Series, V8, P45; CHEVERS N, 1842, GUYS HOSP REP, V7, P387; CURRAN ME, 1993, CELL, V73, P159, DOI 10.1016/0092-8674(93)90168-P; CURRAN ME, 1992, GENOMICS, V12, P729, DOI 10.1016/0888-7543(92)90302-9; DILTS CV, 1990, AM J MED GENET, P126; EISENBERG R, 1964, AM J DIS CHILD, V108, P341, DOI 10.1001/archpedi.1964.02090010343002; EWART AK, 1993, P NATL ACAD SCI USA, V90, P3226, DOI 10.1073/pnas.90.8.3226; FAZIO MJ, 1991, AM J HUM GENET, V48, P696; GOODMAN BK, 1985, KARYOGRAM, V11, P65; KLEVER M, 1991, HUM GENET, V86, P484; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MORRIS CA, 1993, AM J MED GENET, V46, P737, DOI 10.1002/ajmg.1320460634; MORRIS CA, 1988, J PEDIATR-US, V113, P318, DOI 10.1016/S0022-3476(88)80272-5; MORRIS CA, IN PRESS AM J MED GE; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; OCONNELL P, 1989, GENOMICS, V5, P738, DOI 10.1016/0888-7543(89)90115-8; OCONNOR WN, 1985, ARCH PATHOL LAB MED, V109, P179; PEROU M, 1961, ARCH PATHOL, V71, P113; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; PREUS M, 1984, CLIN GENET, V24, P433; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TKACHUK DC, 1990, SCIENCE, V250, P559, DOI 10.1126/science.2237408; TROMP G, 1991, NUCLEIC ACIDS RES, V19, P4314, DOI 10.1093/nar/19.15.4314-a; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; WAHL GM, 1987, P NATL ACAD SCI USA, V84, P2160, DOI 10.1073/pnas.84.8.2160	28	846	872	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1993	5	1					11	16		10.1038/ng0993-11	http://dx.doi.org/10.1038/ng0993-11			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	7693128				2022-12-25	WOS:A1993LV56500008
J	OZCELIK, T; LEFF, S; ROBINSON, W; DONLON, T; LALANDE, M; SANJINES, E; SCHINZEL, A; FRANCKE, U				OZCELIK, T; LEFF, S; ROBINSON, W; DONLON, T; LALANDE, M; SANJINES, E; SCHINZEL, A; FRANCKE, U			SMALL NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE-N (SNRPN), AN EXPRESSED GENE IN THE PRADER-WILLI SYNDROME CRITICAL REGION	NATURE GENETICS			English	Article							POTENTIAL SM EPITOPE; ANGELMAN SYNDROME; CDNA SEQUENCE; PROTEIN-N; CHROMOSOME-15; HYBRIDIZATION; ASSIGNMENT; DELETION; B/B'; ARM	Prader-Willi syndrome (PWS) is associated with paternally derived chromosomal deletions in region 15q11-13 or with maternal disomy for chromosome 15. Therefore, loss of the expressed paternal alleles of maternally imprinted genes must be responsible for the PWS phenotype. We have mapped the gene encoding the small nuclear RNA associated polypeptide SmN (SNRPN) to human chromosome 15q12 and a processed pseudogene SNRPNP1 to chromosome region 6pter-p21. Furthermore, SNRPN was mapped to the minimal deletion interval that is critical for PWS. The fact that the mouse Snrpn gene is maternally imprinted in brain suggests that loss of the paternally derived SNRPN allele may be involved in the PWS phenotype.	STANFORD UNIV,MED CTR,SCH MED,DEPT PHARMACOL,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT GENET & PEDIAT,STANFORD,CA 94305; UNIV ZURICH,INST MED GENET,CH-8001 ZURICH,SWITZERLAND; CHILDRENS HOSP MED CTR,DIV GENET,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115; STANFORD UNIV,MED CTR,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305	Stanford University; Stanford University; Stanford University; University of Zurich; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Stanford University			Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174				BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTON DE, 1986, HUM GENET, V72, P221, DOI 10.1007/BF00291881; BUTLER MG, 1986, AM J MED GENET, V23, P793, DOI 10.1002/ajmg.1320230307; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; CHAILLET JR, 1991, GENOMICS, V11, P773, DOI 10.1016/0888-7543(91)90090-2; DONLON T, 1992, IN PRESS CYTOGENET C, P15; FRANCKE U, 1986, COLD SPRING HARB SYM, V51, P855, DOI 10.1101/SQB.1986.051.01.099; FRANCKE U, 1977, P NATL ACAD SCI USA, V74, P1147, DOI 10.1073/pnas.74.3.1147; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LI S, 1989, P NATL ACAD SCI USA, V86, P9778, DOI 10.1073/pnas.86.24.9778; MAGENIS RE, 1987, AM J MED GENET, V28, P829, DOI 10.1002/ajmg.1320280407; MAGENIS RE, 1990, AM J MED GENET, V35, P33; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MCALLISTER G, 1989, EMBO J, V8, P1177, DOI 10.1002/j.1460-2075.1989.tb03489.x; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OLIVER N, 1978, CYTOGENET CELL GENET, V22, P506, DOI 10.1159/000131009; Prader A., 1956, SCHWEIZ MED WSCHR, V86, P1260, DOI DOI 10.1007/978-3-642-47669-3_24; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROKEACH LA, 1989, J BIOL CHEM, V264, P5024; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; SCHMAUSS C, 1989, NUCLEIC ACIDS RES, V17, P1733, DOI 10.1093/nar/17.4.1733; SCHMAUSS C, 1990, J BIOL CHEM, V265, P10733; SCHMAUSS C, 1992, J BIOL CHEM, V267, P8521; SHARPE NG, 1990, MOL CELL BIOL, V10, P6817, DOI 10.1128/MCB.10.12.6817; SUNDARESAN S, 1989, SOMAT CELL MOLEC GEN, V15, P367, DOI 10.1007/BF01534975; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	33	232	233	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					265	269		10.1038/ng1292-265	http://dx.doi.org/10.1038/ng1292-265			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303277				2022-12-25	WOS:A1992KB49500008
J	MURRAY, JC; BENNETT, SR; KWITEK, AE; SMALL, KW; SCHINZEL, A; ALWARD, WLM; WEBER, JL; BELL, GI; BUETOW, KH				MURRAY, JC; BENNETT, SR; KWITEK, AE; SMALL, KW; SCHINZEL, A; ALWARD, WLM; WEBER, JL; BELL, GI; BUETOW, KH			LINKAGE OF RIEGER SYNDROME TO THE REGION OF THE EPIDERMAL GROWTH-FACTOR GENE ON CHROMOSOME-4	NATURE GENETICS			English	Article							DELETION; INVITRO; EGF; POLYMORPHISMS; EXPRESSION; SEQUENCE; TOOTH; ARM; 4Q	Rieger syndrome is an autosomal dominant disorder of morphogenesis in which previous cytogenetic arrangements have suggested chromosome 4 as a candidate chromosome. Using a group of highly polymorphic short tandem repeat polymorphisms (STRP), including a new tetranucleotide repeat for epidermal growth factor (EGF), significant linkage of Rieger syndrome to 4q markers has been identified. Tight linkage to EGF supports its role as a candidate gene, although a recombinant in an unaffected individual has been identified. This study demonstrates the utility of using polymorphic STRP markers when only a limited number of small families are available for study.	UNIV IOWA,DEPT OPHTHALMOL,IOWA CITY,IA 52242; VITREO RETINAL SURG,EDINA,MN 55435; INST MED GENET,ZURICH,SWITZERLAND; MARSHFIELD MED RES FDN,MARSHFIELD,WI 54449; UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637; FOX CHASE CANC CTR,PHILADELPHIA,PA 19111	University of Iowa; Howard Hughes Medical Institute; University of Chicago; Fox Chase Cancer Center	MURRAY, JC (corresponding author), UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242, USA.		Alward, Wallace/AAY-4149-2020	Alward, Wallace/0000-0001-6368-9018; Kwitek, Anne/0000-0003-1024-4116				ABBOTT BD, 1988, DEV BIOL, V128, P300, DOI 10.1016/0012-1606(88)90293-X; AKAZAWA K, 1981, JPN J OPHTHALMOL, V25, P321; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; FURGUSON JG, 1987, ARCH OPHTHALMOL-CHIC, V105, P323; HEINEMANN MH, 1979, BRIT J OPHTHALMOL, V63, P40, DOI 10.1136/bjo.63.1.40; HERVE J, 1984, ANN PEDIATR-PARIS, V31, P77; JORGENSON RJ, 1978, AM J MED GENET, V2, P307, DOI 10.1002/ajmg.1320020310; JUMBLATT MM, 1988, INVEST OPHTH VIS SCI, V29, P586; KRONMILLER JE, 1991, DEV BIOL, V147, P485, DOI 10.1016/0012-1606(91)90307-O; LIGUTIC I, 1981, CLIN GENET, V20, P323; MILLS KA, IN PRESS GENOMICS; MITCHELL JA, 1981, AM J MED GENET, V8, P73, DOI 10.1002/ajmg.1320080110; MOTEGI T, 1988, J MED GENET, V25, P628, DOI 10.1136/jmg.25.9.628; ORITA M, 1990, GENOMICS, V8, P271, DOI 10.1016/0888-7543(90)90282-Y; PARTANEN AM, 1985, DEV BIOL, V111, P84, DOI 10.1016/0012-1606(85)90437-3; RAYMOND GM, 1986, INVEST OPHTH VIS SCI, V27, P474; RHODES JA, 1987, DEV BIOL, V121, P247, DOI 10.1016/0012-1606(87)90156-4; SERVILLE F, 1977, HUM GENET, V39, P239, DOI 10.1007/BF00287019; SHIELDS MB, 1985, SURV OPHTHALMOL, V29, P387, DOI 10.1016/0039-6257(85)90205-X; SHIELDS MB, 1987, TXB GLAUCOMA, P199; Stathacopoulos R A, 1987, J Pediatr Ophthalmol Strabismus, V24, P198; TABBARA KF, 1973, CAN J OPHTHALMOL, V8, P488; VAUX C, 1992, J MED GENET, V29, P256, DOI 10.1136/jmg.29.4.256; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILCOX LM, 1978, AM J OPHTHALMOL, V86, P834, DOI 10.1016/0002-9394(78)90132-0	25	88	90	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					46	49		10.1038/ng0992-46	http://dx.doi.org/10.1038/ng0992-46			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303248				2022-12-25	WOS:A1992JM64600015
J	CHERVIN, RD; GUILLEMINAULT, C				CHERVIN, RD; GUILLEMINAULT, C			ASSESSMENT OF SLEEPINESS IN CLINICAL-PRACTICE	NATURE MEDICINE			English	Editorial Material							LATENCY TEST; DAYTIME SLEEPINESS; DISORDERS		UNIV MICHIGAN,MED CTR,CTR SLEEP DISORDERS,ANN ARBOR,MI 48109; STANFORD UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SLEEP DISORDERS CLIN,STANFORD,CA 94305	University of Michigan System; University of Michigan; Stanford University; Stanford University	CHERVIN, RD (corresponding author), UNIV MICHIGAN,MED CTR,DEPT NEUROL,ANN ARBOR,MI 48109, USA.							ALDRICH M, 1995, SLEEP RES, V24, P186; ALDRICH MS, 1989, SLEEP, V12, P487, DOI 10.1093/sleep/12.6.487; Carskadon M. A., 1977, SLEEP RES, V6, P200; CARSKADON MA, 1979, PERCEPT MOTOR SKILL, V48, P495, DOI 10.2466/pms.1979.48.2.495; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; CARSKADON MA, 1981, SLEEP, V4, P299; CARSKADON MA, 1981, PERCEPT MOTOR SKILL, V53, P103, DOI 10.2466/pms.1981.53.1.103; CARSKADON MA, 1982, SLEEP, V5, pS73, DOI 10.1093/sleep/5.S2.S73; CARSKADON MA, 1982, SLEEP, V5, pS67, DOI 10.1093/sleep/5.S2.S67; CHERVIN RD, 1995, ELECTROEN CLIN NEURO, V95, P147, DOI 10.1016/0013-4694(95)00075-A; Dement WC, 1978, SLEEP APNEA SYNDROME, P23; MOSCOVITCH A, 1993, NEUROLOGY, V43, P55, DOI 10.1212/WNL.43.1_Part_1.55; NAITOH P, 1995, SLEEP ONSET NORMAL A, P327; ROTH T, 1980, SLEEP, V3, P425; SANGAL RB, 1992, CHEST, V101, P898, DOI 10.1378/chest.101.4.898; SANGAL RB, 1992, CHEST, V102, P699, DOI 10.1378/chest.102.3.699	16	17	17	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1252	1253		10.1038/nm1295-1252	http://dx.doi.org/10.1038/nm1295-1252			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489403				2022-12-25	WOS:A1995TH78600034
J	LANDER, E; KRUGLYAK, L				LANDER, E; KRUGLYAK, L			GENETIC DISSECTION OF COMPLEX TRAITS - GUIDELINES FOR INTERPRETING AND REPORTING LINKAGE RESULTS	NATURE GENETICS			English	Article							X-CHROMOSOME MARKERS; SCHIZOPHRENIA; ILLNESS; MODELS; MAPS	Genetic studies are under way for many complex traits, spurred by the recent feasibility of whole genome scans. Clear guidelines for the interpretation of linkage results are needed to avoid a flood of false positive claims. At the same time, an overly cautious approach runs the risk of causing true hints of linkage to be missed. We address this problem by proposing specific standards designed to maintain rigor while also promoting communication.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139	Massachusetts Institute of Technology (MIT)	LANDER, E (corresponding author), WHITEHEAD INST BIOMED RES,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142, USA.							BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BROWN DL, 1994, AM J HUM GENET, V54, P544; CHOTAI J, 1984, ANN HUM GENET, V48, P359, DOI 10.1111/j.1469-1809.1984.tb00849.x; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; Cox DR, 1974, THEORETICAL STATISTI; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; ELSTON RC, 1992, 16TH P INT BIOM C HA, P39; EWENS WJ, 1995, AM J HUM GENET, V57, P455; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; FEINGOLD E, 1993, J APPL PROBAB, V30, P766, DOI 10.2307/3214511; GOUGH SCL, 1995, HUM MOL GENET, V4, P1609, DOI 10.1093/hmg/4.9.1609; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HOLMANS P, 1993, AM J HUM GENET, V52, P362; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; KENNEDY JL, 1988, NATURE, V336, P167, DOI 10.1038/336167a0; KRUGLYAK L, 1995, GENETICS, V139, P1421; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER ES, 1989, GENETICS, V121, P185; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LUO D, 1995, IN PRESS AUTOIMMUNIT; LUO DF, 1995, AM J HUM GENET, V57, P911; MCKUSICK VA, 1975, CYTOGENET CELL GENET, V14, P196, DOI 10.1159/000130344; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; TERWILLIGER JD, 1992, CYTOGENET CELL GENET, V59, P142, DOI 10.1159/000133228; THOMSON G, 1994, NAT GENET, V8, P108, DOI 10.1038/ng1094-108; THOMSON G, 1995, AM J HUM GENET, V57, P487; TODD JA, 1995, P NATL ACAD SCI USA, V92, P8560, DOI 10.1073/pnas.92.19.8560; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41	38	4386	4474	5	169	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					241	247		10.1038/ng1195-241	http://dx.doi.org/10.1038/ng1195-241			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581446				2022-12-25	WOS:A1995TC63900011
J	TILLER, GE; POLUMBO, PA; WEIS, MA; BOGAERT, R; LACHMAN, RS; COHN, DH; RIMOIN, DL; EYRE, DR				TILLER, GE; POLUMBO, PA; WEIS, MA; BOGAERT, R; LACHMAN, RS; COHN, DH; RIMOIN, DL; EYRE, DR			DOMINANT MUTATIONS IN THE TYPE-II COLLAGEN GENE, COL2A1, PRODUCE SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE	NATURE GENETICS			English	Letter							SPONDYLOMETEPIPHYSEAL DYSPLASIA; SUBSTITUTION		VANDERBILT UNIV, SCH MED, DEPT MED, NASHVILLE, TN 37232 USA; UNIV WASHINGTON, DEPT ORTHOPED, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT RADIOL, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT PEDIAT, LOS ANGELES, CA 90024 USA; CEDARS SINAI RES INST, STEVEN SPIELBERG PEDIAT RES CTR, AHMANSON DEPT PEDIAT, LOS ANGELES, CA 90048 USA	Vanderbilt University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	TILLER, GE (corresponding author), VANDERBILT UNIV, SCH MED, DEPT PEDIAT, 221 KIRKLAND HALL, NASHVILLE, TN 37232 USA.				NIAMS NIH HHS [AR37318, AR01925, R37 AR037318, R01 AR036794] Funding Source: Medline; NICHD NIH HHS [HD22657] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001925, R01AR036794, R01AR037318, R37AR037318] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALAKOKKO L, 1990, GENOMICS, V8, P454, DOI 10.1016/0888-7543(90)90031-O; ANDERSON CE, 1982, AM J MED GENET, V13, P243, DOI 10.1002/ajmg.1320130304; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BEIGHTON P, 1994, J MED GENET, V31, P136, DOI 10.1136/jmg.31.2.136; BOGAERT R, 1992, J BIOL CHEM, V267, P22522; COHN DH, 1990, AM J HUM GENET, V46, P591; COHN DH, 1993, AM J HUM GENET, V53, P208; ELANTRI S, 1993, J MOL BIOL, V230, P373, DOI 10.1006/jmbi.1993.1153; EYRE D, 1987, METHOD ENZYMOL, V144, P115; GAROFALO S, 1991, P NATL ACAD SCI USA, V88, P9648, DOI 10.1073/pnas.88.21.9648; HERNANDEZ A, 1980, AM J MED GENET, V5, P179, DOI 10.1002/ajmg.1320050212; KOUSSEFF BG, 1984, AM J MED GENET, V17, P547, DOI 10.1002/ajmg.1320170220; MCKUSICK VA, 1994, MENDELIAN INHERITANC, P1385; MILLER EJ, 1987, METHOD ENZYMOL, V144, P3; MORTIER GR, 1995, HUM MOL GENET, V4, P285, DOI 10.1093/hmg/4.2.285; MURDOCH J L, 1969, Birth Defects Original Article Series, V5, P368; MURRAY LW, 1989, AM J HUM GENET, V45, P5; RIMOLN DL, 1990, PRINCIPLES PRACTICE, P835; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SIBGHATULLAH, 1993, NUCLEIC ACIDS RES, V21, P1281, DOI 10.1093/nar/21.5.1281; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; TAYBI H, 1990, RADIOLOGY SYNDROMES, P795; TILLER GE, 1995, AM J HUM GENET, V56, P388; VIKKULA M, 1994, ANN MED, V26, P107; VIKKULA M, 1993, GENOMICS, V16, P82	25	71	74	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					87	89		10.1038/ng0995-87	http://dx.doi.org/10.1038/ng0995-87			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550321				2022-12-25	WOS:A1995RR72800021
J	COLLINS, S				COLLINS, S			THE LIMIT OF HUMAN ADAPTATION TO STARVATION	NATURE MEDICINE			English	Article							CHRONIC ENERGY DEFICIENCY; SOMALIA; MALNUTRITION; FAMINE	During the height of the 1992-93 famine in Somalia, data were collected from 573 inpatients at the Concern Worldwide Adult Therapeutic Centre in Baidoa, the town at the epicentre of the disaster. These data indicate that a body mass index (BMI, body weight in kilograms divided by height in metres squared) of less than 10 kg m(-2) can be compatible with life, so long as specialized care is provided. Such low levels of BMI may be explained, in part, by the high ambient temperature, the tall phenotype of the Somalis, the gradual reduction in food intake and previous exposure to chronic energy deficiency. Famine oedema occurred with the same prevalence in male and female patients, but male patients had more severe oedema and a poorer prognosis at any given degree of severity. Survival from these extremes of emaciation has never before been recorded, and many of the BMI values documented here are below the level of 12, previously thought to mark the limit of human adaptation to starvation.	INST CHILD HLTH,CTR INT CHILD HLTH,LONDON WC1N 1EH,ENGLAND; CONCERN WORLDWIDE,DUBLIN 2,IRELAND	University of London; University College London								AYKROID WR, 1974, CONQUEST FAMINE; BEATTIE J, 1948, BRIT J NUTR, V2, P47, DOI 10.1079/BJN19480008; BRANCA F, 1993, LANCET, V341, P1478, DOI 10.1016/0140-6736(93)90923-5; BURGER GCE, 1945, LANCET, P282; COLLINS S, 1993, JAMA-J AM MED ASSOC, V270, P637; Dallal GE, 1988, AM STAT, V42, P272; DEAN AG, 1990, EPI INFO VERSION 6 W; DEGOYET CD, 1978, MANAGEMENT NUTRITION; Eveleth P.B., 1976, WORLDWIDE VARIATION, V8; FERROLUZZI A, 1992, EUR J CLIN NUTR, V46, P173; FRIEDMAN PJ, 1991, NUTRITION, V7, P223; GOPALAN C, 1975, Progress in Food and Nutrition Science, V1, P207; HENRY CJK, 1990, EUR J CLIN NUTR, V44, P329; HENRY CJK, 1993, ANTHROPOMETRY INDIVI; JAMES WFT, 1992, BODY MASS INDEX OBJE; JAMES WPT, 1988, EUR J CLIN NUTR, V42, P969; JAMES WPT, 1994, EUR J CLIN NUTR, V49, P883; Keys A, 1950, BIOL HUMAN STARVATIO; Keys Ancel, 1946, JOUR AMER DIETETIC ASSOC, V22, P582; LEYTON GB, 1946, LANCET, V1, P73; LIPSCOMB FM, 1945, LANCET, V1, P313; MCCANCE RA, 1951, STUDIES UNDERNUTRITI; MOLLINSON PL, 1946, BRIT MED J, V5, P4; MOORE PS, 1993, LANCET, V341, P935, DOI 10.1016/0140-6736(93)91223-9; ROSS DA, 1990, INT J EPIDEMIOL, V19, P636, DOI 10.1093/ije/19.3.636; SHETTY PS, 1984, HUM NUTR-CLIN NUTR, V41, P287; WINICK M, 1979, HUNGER DISEASE; 1992, MMWR-MORBID MORTAL W, V41, P913; 1986, WHO B, V64, P929; 1993, FIGURES NUMBER UNCLA	30	39	39	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1995	1	8					810	814		10.1038/nm0895-810	http://dx.doi.org/10.1038/nm0895-810			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585185				2022-12-25	WOS:A1995RM63500039
J	HURFORD, RK; DRANOFF, G; MULLIGAN, RC; TEPPER, RI				HURFORD, RK; DRANOFF, G; MULLIGAN, RC; TEPPER, RI			GENE-THERAPY OF METASTATIC CANCER BY IN-VIVO RETROVIRAL GENE TARGETING	NATURE GENETICS			English	Article							BRAIN-TUMORS; CELLS; INTERLEUKIN-4; EXPRESSION; GENERATION; IMMUNITY; POTENT; INVIVO; IL-2	We have achieved efficient transduction of tumour metastases in vivo by the vascular delivery of retroviral producer cells. Experimental liver metastases in mice were created by intrasplenic injection of tumour cells into the portal venous circulation. Following the establishment of micrometastases, delivery of retroviral producer cells by the same route with a vector containing the Escherichia coli beta-galactosidase (lacZ) gene demonstrated selective in vivo gene transfer to tumour deposits. By this approach, two retroviral producer cell lines encoding cytokines (IL-4 and IL-2) directed tumoricidal inflammatory responses to established metastases. Cytokine gene targeting inhibited metastasis formation and caused significant overall reduction in tumour burden, These results suggest a novel therapeutic approach for the treatment of disseminated cancer.	MASSACHUSETTS GEN HOSP, BOSTON, MA 02129 USA; WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute			Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211				CARUSO M, 1993, P NATL ACAD SCI USA, V90, P7024, DOI 10.1073/pnas.90.15.7024; CHEN SH, 1994, P NATL ACAD SCI USA, V91, P3054, DOI 10.1073/pnas.91.8.3054; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; FEARON ER, 1990, CELL, V60, P397, DOI 10.1016/0092-8674(90)90591-2; GANSBACHER B, 1990, J EXP MED, V172, P1217, DOI 10.1084/jem.172.4.1217; HULI J, 1989, J IMMUNOL, V142, P800; KALEKO M, 1990, BLOOD, V75, P1733; KARP SE, 1993, J IMMUNOL, V150, P896; KAY MA, 1993, SCIENCE, V262, P117, DOI 10.1126/science.8211118; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239; NABEL GJ, 1993, P NATL ACAD SCI USA, V90, P11307, DOI 10.1073/pnas.90.23.11307; RAM Z, 1993, CANCER RES, V53, P83; TAKEUCHI Y, 1994, J VIROL, V68, P8001, DOI 10.1128/JVI.68.12.8001-8007.1994; TEPPER RI, 1989, CELL, V57, P503, DOI 10.1016/0092-8674(89)90925-2; TEPPER RI, 1994, HUM GENE THER, V5, P153, DOI 10.1089/hum.1994.5.2-153; TEPPER RI, 1992, SCIENCE, V257, P548, DOI 10.1126/science.1636093	18	68	81	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1995	10	4					430	435		10.1038/ng0895-430	http://dx.doi.org/10.1038/ng0895-430			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670493				2022-12-25	WOS:A1995RM37500016
J	FALO, LD; KOVACSOVICSBANKOWSKI, M; THOMPSON, K; ROCK, KL				FALO, LD; KOVACSOVICSBANKOWSKI, M; THOMPSON, K; ROCK, KL			TARGETING ANTIGEN INTO THE PHAGOCYTIC PATHWAY IN-VIVO INDUCES PROTECTIVE TUMOR-IMMUNITY	NATURE MEDICINE			English	Article							INFILTRATING LYMPHOCYTES; SOLUBLE-PROTEIN; T-CELLS; INVIVO; ASSOCIATION; MELANOMA; SURVIVAL	Cytotoxic T lymphocytes (CTLs) kill neoplastic or virally infected cells after recognizing on their surface antigenic peptides bound to major histocompatibility complex class molecules. These peptides are derived from antigens that are degraded in the cytosol of the affected cell. Because exogenous proteins cannot enter the cytosol, immunizations with killed pathogens or their proteins do not generally elicit CTLs. However, antigens that are internalized into phagocytic cells can enter the cytosol and be processed for class presentation. Here we show that immunization with a purified antigen on an avidly phagocytized particle primes CTLs, which in turn protect animals from subsequent challenge with tumours transfected with the antigen gene. Interestingly, these animals also become immune to other antigens expressed by the tumour. This approach could be exploited to develop tumour and viral vaccines.	UNIV PITTSBURGH,SCH MED,PITTSBURGH CANC INST,PITTSBURGH,PA 15213; DANA FARBER CANC INST,DIV LYMPHOCYTE BIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	FALO, LD (corresponding author), UNIV PITTSBURGH,SCH MED,DEPT DERMATOL,190 LOTHROP ST,PITTSBURGH,PA 15213, USA.		Falo, Louis/ABD-1499-2020		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020248, R01AI031337, R37AI020248] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 31337, AI 20248] Funding Source: Medline; PHS HHS [R01-1884] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AEBERSOLD P, 1991, JNCI-J NATL CANCER I, V83, P932, DOI 10.1093/jnci/83.13.932; AUCHINCLOSS H, 1988, TRANSPLANTATION, V45, P1118, DOI 10.1097/00007890-198806000-00024; BOON T, 1992, ADV CANCER RES, V58, P177, DOI 10.1016/S0065-230X(08)60295-X; CARBONE FR, 1990, J EXP MED, V171, P377, DOI 10.1084/jem.171.2.377; DOHERTY PC, 1984, ADV CANCER RES, V42, P1, DOI 10.1016/S0065-230X(08)60455-8; FIDLER IJ, 1976, CANCER RES, V36, P3160; HARDING CV, 1994, J IMMUNOL, V153, P4925; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; KAUFMANN SHE, 1988, IMMUNOL TODAY, V9, P168, DOI 10.1016/0167-5699(88)91292-3; KOVACSOVICSBANK.M, 1994, EUR J IMMUNOL, V24, P2421; KOVACSOVICSBANK.M, 1995, SCIENCE, V267, P243; KOVACSOVICSBANKOWS, 1993, P NATL ACAD SCI USA, V90, P4942; KUNDIG TM, 1993, J IMMUNOL, V150, P4450; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; PAN ZK, 1995, NAT MED, V1, P471, DOI 10.1038/nm0595-471; PARDOLL DM, 1994, NATURE, V369, P357, DOI 10.1038/369357a0; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; ROCK KL, 1990, J IMMUNOL, V145, P804; ROCK KL, 1993, J IMMUNOL, V150, P438; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; SINGLUFF CL, 1994, CURR OPIN IMMUNOL, V6, P733; Townsend A, 1993, Semin Cell Biol, V4, P53, DOI 10.1006/scel.1993.1007; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; WATSON J, 1979, J EXP MED, V150, P1510, DOI 10.1084/jem.150.6.1510; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5; ZHOU F, 1992, CANCER RES, V52, P6287	26	233	248	1	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1995	1	7					649	653		10.1038/nm0795-649	http://dx.doi.org/10.1038/nm0795-649			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585145				2022-12-25	WOS:A1995RQ06600038
J	WEILLER, C; MAY, A; LIMMROTH, V; JUPTNER, M; KAUBE, H; VONSCHAYCK, R; COENEN, HH; DIENER, HC				WEILLER, C; MAY, A; LIMMROTH, V; JUPTNER, M; KAUBE, H; VONSCHAYCK, R; COENEN, HH; DIENER, HC			BRAIN-STEM ACTIVATION IN SPONTANEOUS HUMAN MIGRAINE ATTACKS	NATURE MEDICINE			English	Article							PET IMAGES; PERIAQUEDUCTAL GRAY; LOCALIZATION; SUMATRIPTAN; HEADACHE; SITES; PAIN	Evidence from animal experiments shows that the brain stem is involved in the pathophysiology of migraine. To investigate human migraine, we used positron emission tomography to examine the changes in regional cerebral blood flow as an index of neuronal activity in the human brain during spontaneous migraine attacks. During the attacks, increased blood flow was found in the cerebral hemispheres in cingulate, auditory and visual association cortices and in the brain stem. However, only the brain stem activation persisted after the injection of sumatriptan had induced complete relief from headache and phono- and photophobia These findings support the idea that the pathogenesis of migraine is related to an imbalance in activity between brain stem nuclei regulating antinociception and vascular control.	UNIV ESSEN GESAMTHSCH,DEPT NEUROL,D-45122 ESSEN,GERMANY; UNIV ESSEN GESAMTHSCH,DEPT NUCL MED,RADIOPHARM SECT,D-45122 ESSEN,GERMANY	University of Duisburg Essen; University of Duisburg Essen			Diener, Hans-Christoph/AAF-7275-2019; Coenen, Heinz H./K-3078-2013	Coenen, Heinz H./0000-0002-3810-103X				BEHBEHANI MM, 1979, BRAIN RES, V170, P85, DOI 10.1016/0006-8993(79)90942-9; CASEY KL, 1994, J NEUROPHYSIOL, V71, P802, DOI 10.1152/jn.1994.71.2.802; FERRARI MD, 1995, ARCH NEUROL-CHICAGO, V52, P135, DOI 10.1001/archneur.1995.00540260037013; FOWLER PA, 1991, EUR NEUROL, V31, P291, DOI 10.1159/000116756; FOX PT, 1989, J NUCL MED, V30, P141; FRACKOWIAK RSJ, 1994, J ANAT, V184, P211; Friberg L, 1994, Eur J Neurol, V1, P35, DOI 10.1111/j.1468-1331.1994.tb00048.x; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; FRISTON KJ, 1991, J CEREBR BLOOD F MET, V11, P690, DOI 10.1038/jcbfm.1991.122; FRISTON KJ, 1991, J COMPUT ASSIST TOMO, V15, P634, DOI 10.1097/00004728-199107000-00020; GOADSBY PJ, 1991, ANN NEUROL, V29, P91, DOI 10.1002/ana.410290116; GOADSBY PJ, 1988, BASIC MECHANISMS HEA, P413; Headache Classification Committee of the International Headache Society, 1988, CEPHALALGIA S7, V8, P1; HEROLD S, 1985, J CEREB BLOOD FLO S1, V5, pS445; JENSEN TS, 1989, BRAIN RES, V476, P1, DOI 10.1016/0006-8993(89)91529-1; JONES AKP, 1992, SCIENCE, V255, P215, DOI 10.1126/science.1553549; KAUBE H, 1993, BRIT J PHARMACOL, V109, P788, DOI 10.1111/j.1476-5381.1993.tb13643.x; LAMMERTSMA AA, 1989, J CEREBR BLOOD F MET, V9, P461, DOI 10.1038/jcbfm.1989.69; LANCE JW, 1990, HEADACHE, V30, P17, DOI 10.1111/j.1526-4610.1990.hed30s1017.x; MOSKOWITZ MA, 1984, ANN NEUROL, V16, P157, DOI 10.1002/ana.410160202; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; OLESEN J, 1981, LANCET, V2, P438; OLESEN J, 1991, MIGRAINE OTHER HEADA; RASKIN NH, 1987, HEADACHE, V27, P416, DOI 10.1111/j.1526-4610.1987.hed2708416.x; ROSEN SD, 1994, LANCET, V344, P147, DOI 10.1016/S0140-6736(94)92755-3; Talairach J., 1988, COPLANAR STEREOTAXIC; WOODS RP, 1994, NEW ENGL J MED, V331, P1689, DOI 10.1056/NEJM199412223312505; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024	28	1011	1033	0	61	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1995	1	7					658	660		10.1038/nm0795-658	http://dx.doi.org/10.1038/nm0795-658			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585147				2022-12-25	WOS:A1995RQ06600040
J	RUDOLPH, U; FINEGOLD, MJ; RICH, SS; HARRIMAN, GR; SRINIVASAN, Y; BRABET, P; BOULAY, G; BRADLEY, A; BIRNBAUMER, L				RUDOLPH, U; FINEGOLD, MJ; RICH, SS; HARRIMAN, GR; SRINIVASAN, Y; BRABET, P; BOULAY, G; BRADLEY, A; BIRNBAUMER, L			ULCERATIVE-COLITIS AND ADENOCARCINOMA OF THE COLON IN G-ALPHA(I2)-DEFICIENT MICE	NATURE GENETICS			English	Article							INFLAMMATORY BOWEL-DISEASE; G-PROTEINS; ALPHA-SUBUNITS; ADENYLYL-CYCLASE; K+ CHANNELS; CELLS; MEMBRANES; TRANSFORMATION; INHIBITION; ONCOGENES	G proteins are involved in cellular signalling and regulate a variety of biological processes including differentiation and development. We have generated mice deficient for the G protein subunit alpha(i2) (G alpha(i2)) by homologous recombination in embryonic stem cells. G alpha(i2)-deficient mice display growth retardation and develop a lethal diffuse colitis with clinical and histopathological features closely resembling ulcerative colitis in humans, including the development of adenocarcinoma of the colon. Prior to clinical symptoms, the mice show profound alterations in thymocyte maturation and function. The study of these animals should provide important insights into the pathogenesis of ulcerative colitis as well as carcinogenesis.	BAYLOR COLL MED, DEPT CELL BIOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PHARMACOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT PATHOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MICROBIOL & IMMUNOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MED, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MOLEC PHYSIOL & BIOPHYS, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DIV NEUROSCI, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MOLEC & HUMAN GENET, HOUSTON, TX 77030 USA; BAYLOR COLL MED, HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute			Boulay, Guylain/D-9773-2010; Brabet, Philippe/AAO-8522-2020	Brabet, Philippe/0000-0003-2739-1622; Bradley, Allan/0000-0002-2349-8839				BARGATZE RF, 1993, J EXP MED, V178, P367, DOI 10.1084/jem.178.1.367; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; CODINA J, 1991, J RECEPTOR RES, V11, P587, DOI 10.3109/10799899109066429; ELSON CO, 1984, J IMMUNOL METHODS, V67, P101, DOI 10.1016/0022-1759(84)90089-9; FISCHER M, 1991, J IMMUNOL, V146, P3452; GUPTA SK, 1992, MOL CELL BIOL, V12, P190, DOI 10.1128/MCB.12.1.190; GUPTA SK, 1992, J BIOL CHEM, V267, P7987; HERMOUET S, 1991, P NATL ACAD SCI USA, V88, P10455, DOI 10.1073/pnas.88.23.10455; HSU WH, 1990, J BIOL CHEM, V265, P11220; KIRSCH GE, 1990, AM J PHYSIOL, V259, pH820, DOI 10.1152/ajpheart.1990.259.3.H820; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; MONTMAYEUR JP, 1994, SCIENCE, V263, P95, DOI 10.1126/science.8272874; MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237; MOXHAM CM, 1993, SCIENCE, V260, P991, DOI 10.1126/science.8493537; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; PACE AM, 1991, P NATL ACAD SCI USA, V88, P7031, DOI 10.1073/pnas.88.16.7031; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; RUDOLPH U, 1993, TRANSGENIC RES, V2, P345, DOI 10.1007/BF01976176; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; SCHERER NM, 1987, ARCH BIOCHEM BIOPHYS, V259, P431, DOI 10.1016/0003-9861(87)90509-1; SCHREIBER S, 1992, GASTROENTEROL CLIN N, V21, P451; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; WATKINS DC, 1992, SCIENCE, V258, P1373, DOI 10.1126/science.1455234; WONG YH, 1991, NATURE, V351, P63, DOI 10.1038/351063a0; YATANI A, 1987, MOL ENDOCRINOL, V1, P283, DOI 10.1210/mend-1-4-283; YATANI A, 1988, NATURE, V336, P680, DOI 10.1038/336680a0	31	351	362	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1995	10	2					143	150		10.1038/ng0695-143	http://dx.doi.org/10.1038/ng0695-143			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663509				2022-12-25	WOS:A1995RA85700010
J	TOURNAMILLE, C; COLIN, Y; CARTRON, JP; LEVANKIM, C				TOURNAMILLE, C; COLIN, Y; CARTRON, JP; LEVANKIM, C			DISRUPTION OF A GATA MOTIF IN THE DUFFY GENE PROMOTER ABOLISHES ERYTHROID GENE-EXPRESSION IN DUFFY NEGATIVE INDIVIDUALS	NATURE GENETICS			English	Article							PLASMODIUM-KNOWLESI MALARIA; TRANSCRIPTION FACTORS; PROTEIN 4.1; RECEPTOR; CELLS; VIVAX; INTERLEUKIN-8; PARASITES	The mRNA for the Duffy blood group antigen, the erythrocyte receptor for the Plasmodium vivax malaria parasite, has recently been cloned and shown to encode a widely expressed chemokine receptor. Here, we show that the Duffy antigen/chemokine receptor gene (DARC) is composed of a single exon and that most Duffy-negative blacks carry a silent FY*B allele with a single T to C substitution at nucleotide -46. This mutation impairs the promoter activity in erythroid cells by disrupting a binding site for the GATA1 erythroid transcription factor. With the recent characterization of the FY*A and FY*B alleles, these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid-specific repression of the DARC gene in Duffy-negative individuals.	INST NATL TRANSFUS SANGUINE,GIP,INSERM,U76,F-75015 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)			colin, yves/O-1910-2017; le van kim, caroline/O-7030-2017	colin, yves/0000-0001-5196-4254; le van kim, caroline/0000-0002-3251-1310				AHUJA SK, 1992, NAT GENET, V2, P31, DOI 10.1038/ng0992-31; BAMWELL JH, 1989, J EXP MED, V169, P1795; BENZ EJJ, 1991, BLOOD, V78, pA83; CHAUDHURI A, 1989, J BIOL CHEM, V264, P13770; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; CHAUDHURI A, 1993, P NATL ACAD SCI USA, V90, P10793, DOI 10.1073/pnas.90.22.10793; CHAUDHURI A, 1994, J BIOL CHEM, V269, P10793; CHERIFZAHAR B, 1994, GENOMICS, V19, P68, DOI 10.1006/geno.1994.1014; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; COLIN Y, 1990, J BIOL CHEM, V265, P16729; CONBOY JG, 1991, J BIOL CHEM, V266, P8273; CONBOY JG, 1993, J CLIN INVEST, V91, P77, DOI 10.1172/JCI116203; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; HADLEY TJ, 1986, ANNU REV MICROBIOL, V40, P451, DOI 10.1146/annurev.mi.40.100186.002315; HADLEY TJ, 1994, J CLIN INVEST, V88, P985; HORUK R, 1994, J BIOL CHEM, V269, P17730; IWAMOTO S, 1995, BLOOD, V85, P622, DOI 10.1182/blood.V85.3.622.bloodjournal853622; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MATSUDA M, 1992, BLOOD, V80, P1347; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; NEOTE K, 1994, BLOOD, V84, P44; ORKIN SH, 1992, BLOOD, V80, P575; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; Race RR., 1975, BLOOD GROUPS MAN; RAHUEL C, 1992, EMBO J, V11, P4095, DOI 10.1002/j.1460-2075.1992.tb05502.x; TOUMAMILLE C, 1995, HUM GENET, V85, P407; WASNIOWSKA K, 1994, TRANSFUS MED REV, V8, P281, DOI 10.1016/S0887-7963(94)70119-X	31	513	539	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					224	228		10.1038/ng0695-224	http://dx.doi.org/10.1038/ng0695-224			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663520				2022-12-25	WOS:A1995RA85700022
J	REYMER, PWA; GAGNE, E; GROENEMEYER, BE; ZHANG, HF; FORSYTH, I; JANSEN, H; SEIDELL, JC; KROMHOUT, D; LIE, KE; KASTELEIN, J; HAYDEN, MR				REYMER, PWA; GAGNE, E; GROENEMEYER, BE; ZHANG, HF; FORSYTH, I; JANSEN, H; SEIDELL, JC; KROMHOUT, D; LIE, KE; KASTELEIN, J; HAYDEN, MR			A LIPOPROTEIN-LIPASE MUTATION (ASN291SER) IS ASSOCIATED WITH REDUCED HDL CHOLESTEROL LEVELS IN PREMATURE ATHEROSCLEROSIS	NATURE GENETICS			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY HEART-DISEASE; POSTHEPARIN PLASMA; MISSENSE MUTATION; TRANSGENIC MICE; DEFICIENCY; ATHEROGENESIS; GENE; HYPERCHOLESTEROLEMIA; PROPRANOLOL	A reduction of high density lipoprotein cholesterol (HDC) is recognized as an important risk factor for coronary artery disease (CAD). We now show in approximately 1 in 20 males with proven atherosclerosis that an Asn291Ser mutation in the human lipoprotein lipase (LPL) gene is associated with significantly reduced HDL levels (P=0.001) and results in a significant decrease in LPL catalytic activity (P<0.0009), The relative frequency of this mutation increases in those patients with lower HDL cholesterol levels, In vitro mutagenesis and expression studies confirm that this change is associated with a significant reduction in LPL activity. Our data support the relationship between LPL activity and HDL-C levels, and suggest that a specific LPL mutation may be a factor in the development of atherosclerosis.	UNIV BRITISH COLUMBIA, DEPT MED GENET, VANCOUVER, BC V6T 1Z4, CANADA; UNIV AMSTERDAM, ACAD MED CTR, DEPT VASC MED, LIPID RES GRP, 1105 AZ AMSTERDAM, NETHERLANDS; ERASMUS UNIV ROTTERDAM, DEPT BIOCHEM, 3000 DR ROTTERDAM, NETHERLANDS; ERASMUS UNIV ROTTERDAM, DEPT INTERNAL MED, 3000 DR ROTTERDAM, NETHERLANDS; NATL INST PUBL HLTH & ENVIRONM PROTECT, DEPT CHRON DIS & ENVIRONM EPIDEMIOL, 3720 BA BILTHOVEN, NETHERLANDS; INTERUNIV CARDIOL INST NETHERLANDS, 3501 DG UTRECHT, NETHERLANDS	University of British Columbia; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus University Rotterdam; Netherlands National Institute for Public Health & the Environment; Interuniversity Cardiology Institute of the Netherlands; Utrecht University			Kastelein, John/AAF-7950-2020; Hayden, Michael R/D-8581-2011; seidell, jacob/AAF-5362-2019; seidell, jacob c/N-7427-2013; Kromhout, Daan/A-8566-2014	Hayden, Michael R/0000-0001-5159-1419; seidell, jacob/0000-0002-9262-9062; 				ALLAIN CC, 1974, CLIN CHEM, V20, P470; [Anonymous], 1993, NETH J CARDIOL; ANTONARAKIS SE, 1985, HUM GENET, V69, P1, DOI 10.1007/BF00295521; BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P326, DOI 10.1161/01.ATV.9.3.326; BLADES B, 1993, ARTERIOSCLER THROMB, V13, P1227, DOI 10.1161/01.ATV.13.8.1227; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; BRUIN T, 1991, NUCLEIC ACIDS RES, V19, P6346, DOI 10.1093/nar/19.22.6346-a; BRUNZELL JD, 1989, METABOLIC BASIS INHE, P1168; BUCOLO G, 1973, CLIN CHEM, V19, P476; CHAMBERLAIN JC, 1989, ATHEROSCLEROSIS, V79, P85, DOI 10.1016/0021-9150(89)90037-3; GARRISON RJ, 1983, AM HEART J, V105, P417; GARRLSON RJ, 1983, METABOLISM, V29, P1053; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HEIZMANN C, 1991, HUM GENET, V86, P578; HERTTUALA SY, 1991, P NATL ACAD SCI USA, V88, P10143; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; IVERIUS PH, 1985, AM J PHYSIOL, V249, pE107, DOI 10.1152/ajpendo.1985.249.1.E107; JOHNSON JP, 1990, NUCLEIC ACIDS RES, V18, P7469, DOI 10.1093/nar/18.24.7469; LIU MS, 1992, BIOCHIM BIOPHYS ACTA, V1128, P113, DOI 10.1016/0005-2760(92)90264-V; LIU MS, 1994, J BIOL CHEM, V269, P11417; MA Y, 1993, CIRCULATION, V88, P1; MA YH, 1994, J LIPID RES, V35, P1066; MA YH, 1992, J BIOL CHEM, V267, P1918; MIESENBOCK G, 1993, J CLIN INVEST, V91, P448, DOI 10.1172/JCI116222; MILLER NE, 1977, LANCET, V1, P965, DOI 10.1016/S0140-6736(77)92274-7; MULLENBACH R, 1989, TRENDS GENET, V5, P391; RONCAGLIONI MC, 1992, CIRCULATION, V85, P2065, DOI 10.1161/01.CIR.85.6.2065; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; SAXENA U, 1992, J CLIN INVEST, V89, P373, DOI 10.1172/JCI115595; SCHAUER I, 1980, ARTERY, V8, P146; SHIMADA M, 1993, J BIOL CHEM, V268, P17924; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; TANAKA N, 1976, METABOLISM, V25, P1071, DOI 10.1016/0026-0495(76)90014-7; TASKINEN MR, 1981, CLIN CHIM ACTA, V115, P63; TIKKANEN MJ, 1989, J LIPID RES, V30, P1117; TSUTSUMI K, 1993, J CLIN INVEST, V92, P411, DOI 10.1172/JCI116582; WARNICK GR, 1978, CLIN CHEM, V24, P900; WILSON DE, 1990, J CLIN INVEST, V86, P735, DOI 10.1172/JCI114770; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907; ZILVERSMIT DB, 1973, CIRC RES, V33, P633, DOI 10.1161/01.RES.33.6.633	41	223	240	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1995	10	1					28	34		10.1038/ng0595-28	http://dx.doi.org/10.1038/ng0595-28			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647785				2022-12-25	WOS:A1995QX57300012
J	YANG, NS; SUN, WH				YANG, NS; SUN, WH			GENE GUN AND OTHER NONVIRAL APPROACHES FOR CANCER GENE-THERAPY	NATURE MEDICINE			English	Editorial Material							PARTICLE BOMBARDMENT; CELLS; EXPRESSION; MELANOMA		NORTHWESTERN UNIV,CHILDRENS MEM HOSP,LURIE CANC CTR,DIV DERMATOL,CHICAGO,IL 60614	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	YANG, NS (corresponding author), AGRACETUS INC,DEPT CANC GENE THERAPY,8520 UNIV GREEN,MIDDLETON,WI 53562, USA.							ANDREE C, 1994, P NATL ACAD SCI USA, V91, P12188, DOI 10.1073/pnas.91.25.12188; BURKHOLDER JK, 1993, J IMMUNOL METHODS, V165, P149, DOI 10.1016/0022-1759(93)90340-D; CULVER KW, 1994, TRENDS GENET, V10, P174, DOI 10.1016/0168-9525(94)90095-7; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; FOA R, 1994, NAT IMMUN, V13, P65; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; HWU P, 1994, CANCER DETECT PREV, V18, P43; KERR WG, 1994, J LEUKOCYTE BIOL, V56, P210, DOI 10.1002/jlb.56.2.210; KLEIN TM, 1987, NATURE, V327, P70, DOI 10.1038/327070a0; NABEL GJ, 1994, HUM GENE THER, V5, P57, DOI 10.1089/hum.1994.5.1-57; NABEL GJ, 1993, P NATL ACAD SCI USA, V90, P11307, DOI 10.1073/pnas.90.23.11307; NABEL GJ, 1994, HUM GENE THER, V5, P79, DOI 10.1089/hum.1994.5.1-79; OGASAWARA M, 1993, CANCER RES, V53, P3561; ROSENBERG SA, 1993, JNCI-J NATL CANCER I, V85, P622, DOI 10.1093/jnci/85.8.622; SUN WH, 1995, P NATL ACAD SCI USA, V92, P2889, DOI 10.1073/pnas.92.7.2889; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; THOMPSON TA, 1993, IN VITRO CELL DEV-AN, V29, P165, DOI 10.1007/BF02630949; WOFFENDIN C, 1994, P NATL ACAD SCI USA, V91, P11581, DOI 10.1073/pnas.91.24.11581; YANG NS, 1990, P NATL ACAD SCI USA, V87, P9568, DOI 10.1073/pnas.87.24.9568; YANG NS, 1994, PARTICLE BOMBARDMENT, P39; YANG NS, 1994, PARTICLE BOMBARDMENT, P117; YANG NS, 1994, GENE THERAPEUTICS ME, P193	22	132	141	3	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1995	1	5					481	483		10.1038/nm0595-481	http://dx.doi.org/10.1038/nm0595-481			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585098				2022-12-25	WOS:A1995RN10000041
J	PLATT, OS				PLATT, OS			SICKLE-CELL PATHS CONVERGE ON HYDROXYUREA	NATURE MEDICINE			English	Editorial Material							FETAL-HEMOGLOBIN PRODUCTION; ANEMIA; AUGMENTATION				PLATT, OS (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,BOSTON,MA 02115, USA.							BRIDGES K, 1994, BLOOD, V84, pA413; CASTLE WB, 1976, SEMIN HEMATOL, V13, P159; CHARACHE S, 1992, BLOOD, V79, P2555; CHARACHE S, 1987, BLOOD, V69, P109; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; GOLDBERG MA, 1990, NEW ENGL J MED, V323, P366, DOI 10.1056/NEJM199008093230602; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; LETVIN NL, 1984, NEW ENGL J MED, V310, P869, DOI 10.1056/NEJM198404053101401; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; Orringer Eugene P., 1994, P861; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PAULING L, 1994, SICKLE CELL DISEASE; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; PLATT OS, 1987, J CLIN INVEST, V74, P652; WISHNER BC, 1975, J MOL BIOL, V98, P179, DOI 10.1016/S0022-2836(75)80108-2	15	11	11	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1995	1	4					307	308		10.1038/nm0495-307	http://dx.doi.org/10.1038/nm0495-307			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585059				2022-12-25	WOS:A1995RN09800025
J	BROOKCARTER, PT; PERAL, B; WARD, CJ; THOMPSON, P; HUGHES, J; MAHESHWAR, MM; NELLIST, M; GAMBLE, V; HARRIS, PC; SAMPSON, JR				BROOKCARTER, PT; PERAL, B; WARD, CJ; THOMPSON, P; HUGHES, J; MAHESHWAR, MM; NELLIST, M; GAMBLE, V; HARRIS, PC; SAMPSON, JR			DELETION OF THE TSC2 AND PKD1 GENES ASSOCIATED WITH SEVERE INFANTILE POLYCYSTIC KIDNEY-DISEASE - A CONTIGUOUS GENE SYNDROME	NATURE GENETICS			English	Article							TUBEROUS SCLEROSIS; INSITU HYBRIDIZATION	Major genes which cause tuberous sclerosis (TSC) and autosomal dominant polycystic kidney disease (ADPKD), known as TSC2 and PKD1 respectively, lie immediately adjacent to each other on chomosome 16p. Renal cysts are often found in TSC, but a specific renal phenotype, distinguished by the severity and infantile presentation of the cystic changes, is seen in a small proportion of cases. We have identified large deletions disrupting TSC2 and PKD1 in each of six such cases studied. Analysis of the deletions indicates that they inactivate PKD1, in contrast to the mutations reported in ADPKD patients, where in each case abnormal transcripts have been detected.	UNIV WALES COLL MED, INST MED GENET, CARDIFF CF4 4XN, S GLAM, WALES; JOHN RADCLIFFE HOSP, INST MOLEC MED, MRC, MOLEC HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND	Cardiff University; University of Oxford			Peral, Belén/F-4562-2015	Peral, Belén/0000-0003-4984-4020	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BERNSTEIN J, 1991, ANN NY ACAD SCI, V615, P36; COLE BR, 1987, J PEDIATR-US, V111, P693, DOI 10.1016/S0022-3476(87)80244-5; CREE JE, 1969, P ROY SOC MED, V62, P327, DOI 10.1177/003591576906200410; FINK GM, 1993, J AM SOC NEPHROL, V3, P1863; FINK GM, 1994, KIDNEY INT, V40, P1153; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Gomez MR, 1988, TUBEROUS SCLEROSIS; GREEN AJ, 1994, HUM MOL GENET, V3, P1833, DOI 10.1093/hmg/3.10.1833; GREEN AJ, 1994, NAT GENET, V6, P193, DOI 10.1038/ng0294-193; Hermann B. G., 1987, Cell, USA, V48, P813; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MANDEL JL, 1993, NAT GENET, V4, P8, DOI 10.1038/ng0593-8; NELLIST M, 1993, J MED GENET, V30, P224, DOI 10.1136/jmg.30.3.224; NELLIST M, 1993, CELL, V75, P1305; OCALLAGHAN TJ, 1975, ARCH INTERN MED, V135, P1082, DOI 10.1001/archinte.135.8.1082; PERAL B, 1994, AM J HUM GENET, V54, P899; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Sambrook J, 1989, MOL CLONING LABORATO; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SHEPHERD CW, 1991, MAYO CLIN PROC, V66, P792, DOI 10.1016/S0025-6196(12)61196-3; STAPLETON FB, 1980, J PEDIATR-US, V97, P574, DOI 10.1016/S0022-3476(80)80011-4; STILLWELL TJ, 1987, J UROLOGY, V138, P477, DOI 10.1016/S0022-5347(17)43234-4; VANBAAL JG, 1989, CLIN GENET, V35, P167; WARD CJ, 1994, CELL, V77, P881; WEBB DW, 1993, BMJ-BRIT MED J, V306, P1258, DOI 10.1136/bmj.306.6887.1258; WENZL JE, 1970, J PEDIATR-US, V77, P673, DOI 10.1016/S0022-3476(70)80211-6; ZERRES K, 1993, J MED GENET, V30, P583, DOI 10.1136/jmg.30.7.583; ZIMMERHACKL LB, IN PRESS PEDIAT NEPH	28	343	351	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1994	8	4					328	332		10.1038/ng1294-328	http://dx.doi.org/10.1038/ng1294-328			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894481				2022-12-25	WOS:A1994PV68200011
J	VAN MEIR, EG; POLVERINI, PJ; CHAZIN, VR; HUANG, HJS; DETRIBOLET, N; CAVENEE, WK				VAN MEIR, EG; POLVERINI, PJ; CHAZIN, VR; HUANG, HJS; DETRIBOLET, N; CAVENEE, WK			RELEASE OF AN INHIBITOR OF ANGIOGENESIS UPON INDUCTION OF WILD-TYPE P53 EXPRESSION IN GLIOBLASTOMA CELLS	NATURE GENETICS			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; GENE AMPLIFICATION; SUPPRESSOR GENE; CYCLE CONTROL; CANCER; PROGRESSION; MUTATIONS; PROTEIN; PROMOTERS	The earliest genetic alteration in human astrocytoma progression is mutation of the p53 tumour suppressor gene, while one of the earliest phenotypic changes is the stimulation of neovascularization. Here, we tested the role of p53 in the angiogenic process by introducing a tetracycline-regulated wild type p53 gene into null glioblastoma cells. The parental cells expressed strong angiogenic activity while upon induction of wild type, but not mutant, p53 expression, the cells secreted a factor able to neutralize the angiogenicity of the factors produced by the parental cells as well as of basic fibroblast growth factor.	UNIV CALIF SAN DIEGO, LUDWIG INST CANC RES, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT MED, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, CTR MOLEC GENET, LA JOLLA, CA 92093 USA; UNIV LAUSANNE HOSP, TUMOUR BIOL & GENET LAB, NEUROSURG SERV, CH-1011 LAUSANNE, SWITZERLAND; UNIV MICHIGAN, SCH DENT, ANN ARBOR, MI 48109 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Michigan System; University of Michigan			Polverini, Peter/AAJ-8392-2020	Van Meir, Erwin G./0000-0003-2444-7707	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039926] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL39926] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BREM S, 1972, J NATL CANCER I, V48, P347; CAVENEE WK, 1991, MUTAT RES, V247, P199, DOI 10.1016/0027-5107(91)90015-G; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FOLKMAN J, 1963, CANCER, V16, P453, DOI 10.1002/1097-0142(196304)16:4<453::AID-CNCR2820160407>3.0.CO;2-Y; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; GALL CM, 1991, ASTROCYTOMAS DIAGNOS, P241; GINSBERG D, 1991, P NATL ACAD SCI USA, V88, P9979, DOI 10.1073/pnas.88.22.9979; GLASER BM, 1980, NATURE, V288, P483, DOI 10.1038/288483a0; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; KASTAN MB, 1991, CANCER RES, V51, P6304; KEMP CJ, 1993, CELL, V74, P813, DOI 10.1016/0092-8674(93)90461-X; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KLAGSBRUN M, 1991, ANNU REV PHYSIOL, V53, P217, DOI 10.1146/annurev.physiol.53.1.217; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; RASTINEJAD F, 1989, CELL, V56, P345, DOI 10.1016/0092-8674(89)90238-9; Russell D., 1989, PATHOLOGY TUMORS NER; SCHWEIKI D, 1992, NATURE, V359, P843; SIDRANSKY D, 1992, NATURE, V355, P846, DOI 10.1038/355846a0; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; VAN MEIR EG, 1994, CANCER RES, V54, P649; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7	36	301	319	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	1994	8	2					171	176		10.1038/ng1094-171	http://dx.doi.org/10.1038/ng1094-171			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7531056				2022-12-25	WOS:A1994PL12300019
J	VANDENOUWELAND, AMW; DREESEN, JCFM; VERDIJK, M; KNOERS, NVAM; MONNENS, LAH; ROCCHI, M; VANOOST, BA				VANDENOUWELAND, AMW; DREESEN, JCFM; VERDIJK, M; KNOERS, NVAM; MONNENS, LAH; ROCCHI, M; VANOOST, BA			MUTATIONS IN THE VASOPRESSIN TYPE-2 RECEPTOR GENE (AVPR2) ASSOCIATED WITH NEPHROGENIC DIABETES-INSIPIDUS	NATURE GENETICS			English	Article							FRAGILE-X MUTATION; LINKAGE; MARKERS	Nephrogenic diabetes insipidus (DIR) is an X-linked disorder characterized by insensitivity of the distal nephron for the pituitary hormone, vasopressin. The genetic map location of the DIR gene on chromosome Xq28 coincides with the physical map location of the functional vasopressin renal V2-type receptor. Recently, the human and rat cDNAs for the vasopressin V2 receptor (AVPR2) have been identified. We show here that the structural AVPR2 gene is localized between DXS52 and G6PD, which is within the genetic map location of DIR. We also tested eight X-linked DIR probands and their families for mutations in one of the most conserved extracellular regions of AVPR2: in three of them, we have identified point mutations resulting in non-conservative amino acid substitutions which cosegregated with DIR in all families.	UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT PEDIAT,6500 HB NIJMEGEN,NETHERLANDS; INST GENET,I-70126 BARI,ITALY	Radboud University Nijmegen; Radboud University Nijmegen			Monnens, L.A.H./L-4526-2015					BICHET DG, 1988, NEW ENGL J MED, V318, P881, DOI 10.1056/NEJM198804073181403; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; DUSART D, 1992, AM J MED GENET, V42, P156, DOI 10.1002/ajmg.1320420204; JANS DA, 1990, J BIOL CHEM, V265, P15379; JARD S, 1985, FRONTIERS HORMONE RE, V13, P89; KIMURA T, 1992, NATURE, V356, P526, DOI 10.1038/356526a0; KNOERS N, 1988, HUM GENET, V80, P31, DOI 10.1007/BF00451451; KNOERS N, 1989, GENOMICS, V4, P434, DOI 10.1016/0888-7543(89)90352-2; KNOERS N, IN PRESS PEDIATR NEP; LOLAIT SJ, 1992, NATURE, V357, P336, DOI 10.1038/357336a0; MOREL A, 1992, NATURE, V356, P523, DOI 10.1038/356523a0; PAVO I, 1990, FEBS LETT, V272, P205, DOI 10.1016/0014-5793(90)80485-2; POUSTKA A, 1991, P NATL ACAD SCI USA, V88, P8302, DOI 10.1073/pnas.88.19.8302; REEVES WB, 1989, METABOLIC BASIS INHE, P1985; SHARIF M, 1992, NATURE, V357, P279, DOI 10.1038/357279a0; SUTHERS GK, 1990, AM J HUM GENET, V47, P187; TRAUPE H, 1992, GENOMICS, V13, P481, DOI 10.1016/0888-7543(92)90279-2; VANDENOUWELAND AMW, 1992, GENOMICS, V13, P1350, DOI 10.1016/0888-7543(92)90067-3; WILLIAMS RH, 1947, ANN INTERN MED, V27, P84, DOI 10.7326/0003-4819-27-1-84	19	150	153	1	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					99	102		10.1038/ng1092-99	http://dx.doi.org/10.1038/ng1092-99			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303271				2022-12-25	WOS:A1992JR08400006
J	JACOB, HJ; PETTERSSON, A; WILSON, D; MAO, Y; LERNMARK, A; LANDER, ES				JACOB, HJ; PETTERSSON, A; WILSON, D; MAO, Y; LERNMARK, A; LANDER, ES			GENETIC DISSECTION OF AUTOIMMUNE TYPE-I DIABETES IN THE BB RAT	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MELLITUS SYNDROME; SUSCEPTIBILITY; PRONE; MOUSE; LYMPHOPENIA; ASSOCIATION; MICE; MHC	The BB rat is among the best models of insulin-dependent diabetes mellitus - with onset and pathogenesis closely resembling the human disease. One unusual feature is a severe T-cell lymphopenia, which appears to be inherited as a recessive trait controlled by a single gene, Lyp. Based on genetic analysis of several crosses, we show that development of diabetes involves at least three genes: Lyp, which is tightly linked to the neuropeptide Y (Npy) gene on chromosome 4, a gene linked to the major histocompatibility complex (MHC) on chromosome 20, and a third unmapped gene for which the Fischer rat strain carries an allele conferring resistance.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139; MIT,CTR GENOME RES,CAMBRIDGE,MA 02139; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle	JACOB, HJ (corresponding author), WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142, USA.		Lernmark, Åke/F-8140-2015	Lernmark, Åke/0000-0003-1735-0499				BAHARY N, 1991, GENOMICS, V11, P33, DOI 10.1016/0888-7543(91)90099-Z; COLLE E, 1990, CLIN IMMUNOL IMMUNOP, V57, P1, DOI 10.1016/0090-1229(90)90017-K; COLLE E, 1983, METABOLISM, V32, P54, DOI 10.1016/S0026-0495(83)80012-2; COLLE E, 1981, J EXP MED, V154, P1237, DOI 10.1084/jem.154.4.1237; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; EKOE JM, 1988, DIABETES MELLITUS; ELDER ME, 1983, J IMMUNOL, V130, P1723; FUJII H, 1991, IMMUNOGENETICS, V33, P399, DOI 10.1007/BF00216701; GUNTHER E, 1991, J AUTOIMMUN, V4, P543, DOI 10.1016/0896-8411(91)90165-9; GUTTMANN RD, 1983, J IMMUNOL, V130, P1732; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; HEROLD KC, 1989, AUTOIMMUNITY, V3, P83, DOI 10.3109/08916938909019957; JACKSON R, 1981, DIABETES, V30, P887, DOI 10.2337/diabetes.30.10.887; JACKSON RA, 1984, J EXP MED, V159, P1629, DOI 10.1084/jem.159.6.1629; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LEITER EH, 1989, FASEB J, V3, P223; LEVAN G, 1991, GENOMICS, V10, P699, DOI 10.1016/0888-7543(91)90455-N; LIKE AA, 1991, DIABETES, V40, P259, DOI 10.2337/diabetes.40.2.259; LIKE AA, 1986, J IMMUNOL, V136, P3254; MARKHOLST H, 1991, J EXP MED, V174, P297, DOI 10.1084/jem.174.1.297; MORDES JP, 1987, DIABETES METAB REV, V3, P725, DOI 10.1002/dmr.5610030307; PLAMONDON C, 1990, J IMMUNOL, V144, P923; RIFKIN H, 1990, ELLENBERG RIFKINS DI; SAMBROOKE J, 1989, MOL CLONING LABORATO; SHYP S, 1990, IMMUNOLOGY, V69, P501; THOMAS VA, 1991, DIABETES, V40, P255, DOI 10.2337/diabetes.40.2.255; THOMSON G, 1988, AM J HUM GENET, V43, P799; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; WASSMUTH R, 1989, CLIN IMMUNOL IMMUNOP, V53, P358, DOI 10.1016/0090-1229(89)90002-0; YALE JF, 1985, DIABETES, V34, P955, DOI 10.2337/diabetes.34.10.955	31	235	235	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					56	60		10.1038/ng0992-56	http://dx.doi.org/10.1038/ng0992-56			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303251				2022-12-25	WOS:A1992JM64600017
J	CHARTIER, FL; KEER, JT; SUTCLIFFE, MJ; HENRIQUES, DA; MILEHAM, P; BROWN, SDM				CHARTIER, FL; KEER, JT; SUTCLIFFE, MJ; HENRIQUES, DA; MILEHAM, P; BROWN, SDM			CONSTRUCTION OF A MOUSE YEAST ARTIFICIAL CHROMOSOME LIBRARY IN A RECOMBINATION-DEFICIENT STRAIN OF YEAST	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENE; DNA; VECTORS; CLONES; REGION; REPAIR; RAD52	We have constructed a new generation yeast artificial chromosome (YAC) library from female C57BL/10 mice in a recombination-deficient strain of Saccharomyces cerevisiae carrying a mutation in the RAD52 gene. The YAC library contains 41,568 clones with an average insert size of 240 kilobases, representing a greater than threefold coverage of the mouse genome. Currently, the library can be screened by polymerase chain reaction and we have isolated positive clones at a number of loci in the mouse genome. This rad52 library should enable a long-term assessment of the effect of one of the yeast recombination pathway genes on both, genome-wide YAC clone stability and the frequency of chimaeric clones.	ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,NORFOLK PL,LONDON W2 1PG,ENGLAND	Imperial College London								ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; BROCKDORFF N, 1991, GENOMICS, V10, P17, DOI 10.1016/0888-7543(91)90478-W; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BURGERS PMJ, 1987, ANAL BIOCHEM, V163, P391, DOI 10.1016/0003-2697(87)90240-5; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURKE DT, 1991, MAMM GENOME, V65; CAVANNA JS, 1990, GENOMICS, V7, P12, DOI 10.1016/0888-7543(90)90513-T; CHEN DS, 1988, P NATL ACAD SCI USA, V85, P6821, DOI 10.1073/pnas.85.18.6821; CLARK GJ, 1992, IMMUNOGENETICS, V35, P54; DIETRICH A, 1991, NUCLEIC ACIDS RES, V19, P2567, DOI 10.1093/nar/19.10.2567; GREEN ED, 1991, GENOMICS, V11, P658, DOI 10.1016/0888-7543(91)90073-N; GREEN ED, 1990, SCIENCE, V250, P94, DOI 10.1126/science.2218515; HAMVAS RMJ, 1992, GENOMICS, V12, P363, DOI 10.1016/0888-7543(92)90386-7; IMAI T, 1990, GENOMICS, V8, P297, DOI 10.1016/0888-7543(90)90285-3; KAI T, 1990, FEBS LETT, V275, P77, DOI 10.1016/0014-5793(90)81443-R; KOZHINA TN, 1988, GENETIKA+, V24, P993; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; MALONE RE, 1980, P NATL ACAD SCI-BIOL, V77, P503, DOI 10.1073/pnas.77.1.503; NASIR J, 1990, P NATL ACAD SCI USA, V87, P399, DOI 10.1073/pnas.87.1.399; NEIL DL, 1990, NUCLEIC ACIDS RES, V18, P1421, DOI 10.1093/nar/18.6.1421; OZENBERGER BA, 1991, MOL CELL BIOL, V11, P1222, DOI 10.1128/MCB.11.3.1222; PAVAN WJ, 1991, P NATL ACAD SCI USA, V8, P7788; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; SCHIESTL RH, 1988, MOL CELL BIOL, V8, P3619, DOI 10.1128/MCB.8.9.3619; SILVERMAN GA, 1989, P NATL ACAD SCI USA, V86, P7485, DOI 10.1073/pnas.86.19.7485	27	79	82	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1992	1	2					132	136		10.1038/ng0592-132	http://dx.doi.org/10.1038/ng0592-132			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC980	1302006				2022-12-25	WOS:A1992JC98000012
J	SANDRIN, MS; FODOR, WL; MOUHTOURIS, E; OSMAN, N; COHNEY, S; ROLLINS, SA; GUILMETTE, ER; SETTER, E; SQUINTO, SP; MCKENZIE, IFC				SANDRIN, MS; FODOR, WL; MOUHTOURIS, E; OSMAN, N; COHNEY, S; ROLLINS, SA; GUILMETTE, ER; SETTER, E; SQUINTO, SP; MCKENZIE, IFC			ENZYMATIC REMODELING OF THE CARBOHYDRATE SURFACE OF A XENOGENIC CELL SUBSTANTIALLY REDUCES HUMAN-ANTIBODY BINDING AND COMPLEMENT-MEDIATED CYTOLYSIS	NATURE MEDICINE			English	Article							GDP-L-FUCOSE; XENOGRAFT SURVIVAL; CDNA; EXPRESSION; PRIMATES; ALPHA-1->3-GALACTOSYLTRANSFERASE; ALPHA-1,3-GALACTOSYLTRANSFERASE; TRANSPLANTATION; IDENTIFICATION; REJECTION	The major obstacle to successful discordant xenotransplantation is the phenomenon of hyperacute rejection (HAR). In the pig-to-primate discordant transplant setting, HAR results from the deposition of high-titre anti-alpha-galactosyl antibodies and complement activation leading to endothelial cell destruction and rapid graft failure. To overcome HAR, we developed an enzymatic carbohydrate remodelling strategy designed to replace expression of the Gal alpha-1,3-Gal xenoepitope on the surface of porcine cells with the nonantigenic universal donor human blood group O antigen, the alpha-1,2-fucosyl lactosamine moiety (H-epitope). Xenogenic cells expressing the human alpha-1,2-fucosyltransferase expressed high levels of the H-epitope and significantly reduced Gal alpha-1,3-Gal expression. As a result, these cells were shown to be resistant to human natural antibody binding and complement-mediated cytolysis.	ALEXION PHARMACEUT INC, NEW HAVEN, CT 06511 USA		SANDRIN, MS (corresponding author), AUSTIN RES INST, IMMUNOGENET MOLEC LAB, HEIDELBERG, VIC 3084, AUSTRALIA.			Osman, Narin/0000-0002-6738-6513	NICHD NIH HHS [R44 HD095784] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AUCHINCLOSS H, 1988, TRANSPLANTATION, V46, P1, DOI 10.1097/00007890-198807000-00001; AUCHINCLOSS H, 1990, TRANSPLANT REV, V4, P14; Ausubel FM, 1994, CURRENT PROTOCOLS MO; BOGMAN MJJT, 1982, AM J PATHOL, V109, P97; BOGMAN MJJT, 1980, AM J PATHOL, V100, P727; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; BREWER RJ, 1993, TRANSPLANT P, V25, P385; Cooper D K, 1993, Transpl Immunol, V1, P198, DOI 10.1016/0966-3274(93)90047-C; COOPER DKC, 1993, TRANSPLANT P, V25, P377; COOPER DKC, 1994, IMMUNOL REV, V141, P31, DOI 10.1111/j.1600-065X.1994.tb00871.x; DALMASSO AP, 1992, AM J PATHOL, V140, P1157; FISCHEL RJ, 1992, TRANSPLANT P, V24, P574; FODOR WL, 1994, P NATL ACAD SCI USA, V91, P11153, DOI 10.1073/pnas.91.23.11153; GALILI U, 1988, J BIOL CHEM, V263, P17755; GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369; GOOD AH, 1992, TRANSPL P, V24, P559; HAYES CE, 1974, J BIOL CHEM, V249, P1904; JOZIASSE DH, 1992, J BIOL CHEM, V267, P5534; JOZIASSE DH, 1991, J BIOL CHEM, V266, P6991; JOZIASSE DH, 1989, J BIOL CHEM, V264, P14290; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; LARSEN RD, 1990, J BIOL CHEM, V265, P7055; LARSEN RD, 1989, P NATL ACAD SCI USA, V86, P8227, DOI 10.1073/pnas.86.21.8227; LEVENTHAL JR, 1995, TRANSPLANTATION, V59, P294, DOI 10.1097/00007890-199501270-00024; LEVENTHAL JR, 1993, TRANSPLANT P, V25, P398; MATSUMOT.I, 1969, BIOCHIM BIOPHYS ACTA, V194, P180, DOI 10.1016/0005-2795(69)90193-7; MCCURRY KR, 1995, NAT MED, V1, P423, DOI 10.1038/nm0595-423; ORIOL R, 1993, TRANSPLANTATION, V56, P1433, DOI 10.1097/00007890-199312000-00031; PLATT JL, 1991, CURR OPIN IMMUNOL, V3, P735, DOI 10.1016/0952-7915(91)90105-A; PLATT JL, 1990, IMMUNOL TODAY, V11, P450, DOI 10.1016/0167-5699(90)90174-8; PRUITT SK, 1994, TRANSPLANTATION, V57, P363, DOI 10.1097/00007890-199402150-00009; RAJAN VP, 1989, J BIOL CHEM, V264, P11158; ROSENGARD AM, 1995, TRANSPLANTATION, V59, P1325, DOI 10.1097/00007890-199505150-00018; Sandrin Mauro S., 1994, Xenotransplantation, V1, P81, DOI 10.1111/j.1399-3089.1994.tb00053.x; SANDRIN MS, 1994, IMMUNOL REV, V141, P169, DOI 10.1111/j.1600-065X.1994.tb00877.x; SANDRIN MS, 1993, P NATL ACAD SCI USA, V90, P11391, DOI 10.1073/pnas.90.23.11391; SANDRIN MS, 1979, IMMUNOGENETICS, V8, P185, DOI 10.1007/BF01561429; SANDRIN MS, 1994, TRANSPLANT REV, V8, P134; Schachter H, 1991, CURR OPIN STRUC BIOL, V1, P755, DOI 10.1016/0959-440X(91)90175-S; SHAPER JH, 1992, CURR OPIN STRUC BIOL, V2, P701; VANDENEIJNDEN DH, 1983, EUR J BIOCHEM, V134, P523; VAUGHAN HA, 1991, IMMUNOGENETICS, V33, P113	43	266	284	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	1995	1	12					1261	1267		10.1038/nm1295-1261	http://dx.doi.org/10.1038/nm1295-1261			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489406				2022-12-25	WOS:A1995TH78600037
J	VALVERDE, P; HEALY, E; JACKSON, I; REES, JL; THODY, AJ				VALVERDE, P; HEALY, E; JACKSON, I; REES, JL; THODY, AJ			VARIANTS OF THE MELANOCYTE-STIMULATING HORMONE-RECEPTOR GENE ARE ASSOCIATED WITH RED HAIR AND FAIR SKIN IN HUMANS	NATURE GENETICS			English	Letter							CLONING; EXPRESSION; MOUSE	Melanin pigmentation protects the skin from the damaging effects of ultraviolet radiation (UVR). There are two types of melanin, the red phaeomelanin and the black eumelanin, both of which are present in human skin(1). Eumelanin is photoprotective whereas phaeomelanin, because of its potential to generate free radicals in response to UVR(2), may contribute to UV-induced skin damage. Individuals with red hair have a predominance of phaeomelain in hair and skin and/or a reduced ability to produce eumelanin, which may explain why they fail to tan and are at risk from UVR(1). In mammals the relative proportions of phaeomelanin and eumelanin are regulated by melanocyte stimulating hormone (MSH), which acts via its receptor (MC1R), on melanocytes, to increase the synthesis of eumelanin(3,4) and the product of the agouti locus which antagonises this action(5). In mice, mutations at either the MC1R gene or agouti affect the pattern of melanogenesis resulting in changes in coat colour(6,7). We now report the presence of MC1R gene sequence variants in humans. These were found in over 80% of individuals with red hair and/or fair skin that tans poorly but in fewer than 20% of individuals with brown or black hair and in less than 4% of those who showed a good tanning response. Our findings suggest that in humans, as in other mammals, the MC1R is a control point in the regulation of pigmentation phenotype and, more importantly, that variations in this protein are associated with a poor tanning response.	UNIV NEWCASTLE UPON TYNE,ROYAL VICTORIA INFIRM,DEPT DERMATOL,NEWCASTLE TYNE NE1 4LP,TYNE & WEAR,ENGLAND; WESTERN GEN HOSP,MRC HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	Newcastle University - UK; University of Edinburgh			Valverde, Paloma/A-9897-2008	Healy, Eugene/0000-0001-5591-6970				BURCHILL SA, 1993, J ENDOCRINOL, V137, P189, DOI 10.1677/joe.0.1370189; EILBERG H, 1987, CLIN GENET, V32, P125; FITZPATRICK TB, 1987, DERMATOLOGY GENERAL; FRYXELL KJ, 1987, EMBO J, V6, P443, DOI 10.1002/j.1460-2075.1987.tb04774.x; GANTZ I, 1993, J BIOL CHEM, V268, P8246; HUNT G, 1995, J INVEST DERMATOL, V104, P83, DOI 10.1111/1523-1747.ep12613565; JACKSON IJ, 1993, NATURE, V362, P587, DOI 10.1038/362587a0; JACKSON IJ, 1993, CURR BIOL, V3, P518, DOI 10.1016/0960-9822(93)90045-P; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; MONTELL C, 1987, J NEUROSCI, V7, P1158; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; RANADIVE NS, 1986, J INVEST DERMATOL, V86, P303, DOI 10.1111/1523-1747.ep12285496; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; Sambrook J, 1989, MOL CLONING LABORATO; SAVOV A, 1995, HUM MOL GENET, V4, P1169, DOI 10.1093/hmg/4.7.1169; THODY AJ, 1991, J INVEST DERMATOL, V97, P340, DOI 10.1111/1523-1747.ep12480680; TSUTSUMI M, 1992, MOL ENDOCRINOL, V6, P1163, DOI 10.1210/me.6.7.1163	18	768	798	1	76	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					328	330		10.1038/ng1195-328	http://dx.doi.org/10.1038/ng1195-328			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581459				2022-12-25	WOS:A1995TC63900024
J	MINETA, T; RABKIN, SD; YAZAKI, T; HUNTER, WD; MARTUZA, RL				MINETA, T; RABKIN, SD; YAZAKI, T; HUNTER, WD; MARTUZA, RL			ATTENUATED MULTI-MUTATED HERPES-SIMPLEX VIRUS-1 FOR THE TREATMENT OF MALIGNANT GLIOMAS	NATURE MEDICINE			English	Article							RIBONUCLEOTIDE REDUCTASE; DELETION MUTANT; TYPE-1; SEQUENCES; MICE; NEUROVIRULENCE; PATHOGENICITY; REPLICATION; COMPONENT; LATENCY	We have created a double mutant of the herpes simplex virus (HSV) type 1 (termed G207) with favourable properties for treating human malignant brain tumours: replication-competence in glioblastoma cells (and other dividing cells), attenuated neurovirulence, temperature sensitivity, ganciclovir hypersensitivity, and the presence of an easily detectable histochemical marker. G207 has deletions at both gamma 34.5 (RL1) loci and a lacZ gene insertion inactivating the ICP6 gene (UL39). G207 kills human glioma cells in monolayer cultures. In nude mice harbouring subcutaneous or intracerebral U-87MG gliomas, intraneoplastic inoculation with G207 causes decreased tumour growth and/or prolonged survival. G207 is avirulent upon intracerebral inoculation of mice and HSV-sensitive non-human primates. These results suggest that G207 should be considered for clinical evaluation in the treatment of glioblastomas.	GEORGETOWN UNIV,MED CTR,GEORGETOWN BRAIN TUMOR CTR,WASHINGTON,DC 20007; GEORGETOWN UNIV,MED CTR,DEPT NEUROSURG,WASHINGTON,DC 20007	Georgetown University; Georgetown University			rabkin, samuel/C-2443-2012	rabkin, samuel/0000-0003-2344-2795	NATIONAL CANCER INSTITUTE [P20CA060176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032677] Funding Source: NIH RePORTER; NCI NIH HHS [CA 60176] Funding Source: Medline; NINDS NIH HHS [NS 32677] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIKAWA M, 1988, ATLAS RENAL DISEASE; ASOU H, 1989, NEUROSCI RES, V6, P369, DOI 10.1016/0168-0102(89)90030-8; Ausubel FM., 2006, ENZYMATIC MANIPULATI; BARINGER JR, 1994, ANN NEUROL, V36, P823, DOI 10.1002/ana.410360605; BOLOVAN CA, 1994, J VIROL, V68, P48, DOI 10.1128/JVI.68.1.48-55.1994; BOVIATSIS EJ, 1994, GENE THER, V1, P323; CAMERON JM, 1988, J GEN VIROL, V69, P2607, DOI 10.1099/0022-1317-69-10-2607; CHOU J, 1986, J VIROL, V57, P629, DOI 10.1128/JVI.57.2.629-637.1986; CHOU J, 1990, SCIENCE, V250, P1262, DOI 10.1126/science.2173860; COEN DM, 1989, ANTIMICROB AGENTS CH, V33, P1395, DOI 10.1128/AAC.33.8.1395; COEN DM, 1989, P NATL ACAD SCI USA, V86, P4736, DOI 10.1073/pnas.86.12.4736; DOLAN A, 1992, J GEN VIROL, V73, P971, DOI 10.1099/0022-1317-73-4-971; GOLDSTEIN DJ, 1988, VIROLOGY, V166, P41, DOI 10.1016/0042-6822(88)90144-4; GOLDSTEIN DJ, 1988, J VIROL, V62, P196, DOI 10.1128/JVI.62.1.196-205.1988; HERSHKOVITZ P, 1983, AM J PRIMATOL, V4, P209, DOI 10.1002/ajp.1350040302; Hunt R. D., 1993, Nonhuman primates 1., P82; JACOBSON JG, 1989, VIROLOGY, V173, P276, DOI 10.1016/0042-6822(89)90244-4; JIA WWG, 1994, J NATL CANCER I, V86, P1209, DOI 10.1093/jnci/86.16.1209; KAPLITT M G, 1991, Molecular and Cellular Neuroscience, V2, P320, DOI 10.1016/1044-7431(91)90062-S; KAPLITT MG, 1994, J NEURO-ONCOL, V19, P137, DOI 10.1007/BF01306455; KATZIN DS, 1967, P SOC EXP BIOL MED, V125, P391, DOI 10.3181/00379727-125-32100; KNIPE DM, 1981, J VIROL, V38, P539, DOI 10.1128/JVI.38.2.539-547.1981; MACLEAN AR, 1991, J GEN VIROL, V72, P631, DOI 10.1099/0022-1317-72-3-631; MAHALEY MS, 1989, J NEUROSURG, V71, P826, DOI 10.3171/jns.1989.71.6.0826; MARKERT JM, 1993, NEUROSURGERY, V35, P597; MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MEIGNIER B, 1990, J INFECT DIS, V162, P313, DOI 10.1093/infdis/162.2.313; MELENDEZ LV, 1969, LAB ANIM CARE, V19, P38; MESSER A, 1977, BRAIN RES, V130, P12; MINETA T, 1994, CANCER RES, V54, P3963; PRESTON VG, 1984, J GEN VIROL, V65, P1457, DOI 10.1099/0022-1317-65-9-1457; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WHITLEY RJ, 1993, J CLIN INVEST, V91, P2837, DOI 10.1172/JCI116527; YAMADA Y, 1991, J INFECT DIS, V164, P1091, DOI 10.1093/infdis/164.6.1091	35	650	694	1	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	SEP	1995	1	9					938	943		10.1038/nm0995-938	http://dx.doi.org/10.1038/nm0995-938			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585221				2022-12-25	WOS:A1995RT30300049
J	PAPADOPOULOS, N; LEACH, FS; KINZLER, KW; VOGELSTEIN, B				PAPADOPOULOS, N; LEACH, FS; KINZLER, KW; VOGELSTEIN, B			MONOALLELIC MUTATION ANALYSIS (MAMA) FOR IDENTIFYING GERMLINE MUTATIONS	NATURE GENETICS			English	Letter							POLYPOSIS-COLI APC; GEL-ELECTROPHORESIS; STRUCTURAL GENE; HUMAN DNA; CELLS; POLYMORPHISMS		HOWARD HUGHES MED INST,BALTIMORE,MD 21231; JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21231	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine			Papadopoulos, Nickolas/K-7272-2012		NATIONAL CANCER INSTITUTE [R37CA057345, R01CA035494, R01CA057345, R37CA035494, P50CA062924] Funding Source: NIH RePORTER; NCI NIH HHS [CA62924, CA57345, CA35494] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARFIN SM, 1983, SOMAT CELL GENET, V9, P517, DOI 10.1007/BF01574256; BREUKEL C, 1991, NUCLEIC ACIDS RES, V19, P5804, DOI 10.1093/nar/19.20.5804; COTTON RGH, 1993, MUTAT RES, V285, P125, DOI 10.1016/0027-5107(93)90060-S; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; ISHIOKA C, 1993, NAT GENET, V5, P124, DOI 10.1038/ng1093-124; LEACH F, 1995, UNPUB; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LIU B, 1994, CANCER RES, V54, P4590; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NYSTROMLAHTI M, 1994, AM J HUM GENET, V55, P659; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PATTERSON D, 1983, SOMAT CELL GENET, V9, P359, DOI 10.1007/BF01539144; PATTERSON D, 1977, SOMAT CELL GENET, V3, P483, DOI 10.1007/BF01539120; POWELL SM, 1994, NEW ENGL J MED, V329, P1982; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; RUSTGI AK, 1994, NEW ENGL J MED, V331, P1694, DOI 10.1056/NEJM199412223312507; SMITH KJ, 1993, P NATL ACAD SCI USA, V90, P2846, DOI 10.1073/pnas.90.7.2846; SOEDJAK HS, 1994, ANAL BIOCHEM, V220, P142, DOI 10.1006/abio.1994.1310; SPIRIO L, 1991, NUCLEIC ACIDS RES, V19, P6348, DOI 10.1093/nar/19.22.6348; TALAVERA A, 1977, J CELL PHYSIOL, V92, P425, DOI 10.1002/jcp.1040920310; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WASMUTH JJ, 1980, J CELL BIOL, V87, P697, DOI 10.1083/jcb.87.3.697; WEBER JL, 1989, AM J HUM GENET, V44, P388	24	51	51	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					99	102		10.1038/ng0995-99	http://dx.doi.org/10.1038/ng0995-99			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550326				2022-12-25	WOS:A1995RR72800025
J	HALLAHAN, DE; MAUCERI, HJ; SEUNG, LP; DUNPHY, EJ; WAYNE, JD; HANNA, NN; TOLEDANO, A; HELLMAN, S; KUFE, DW; WEICHSELBAUM, RR				HALLAHAN, DE; MAUCERI, HJ; SEUNG, LP; DUNPHY, EJ; WAYNE, JD; HANNA, NN; TOLEDANO, A; HELLMAN, S; KUFE, DW; WEICHSELBAUM, RR			SPATIAL AND TEMPORAL CONTROL OF GENE-THERAPY USING IONIZING-RADIATION	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; ADENOVIRUS TYPE-5; CELLS; TNF	Activation of transcription of the Egr-1 gene by X-rays is regulated by the promoter region of this gene. We linked the radiation-inducible promoter region of the Egr-1 gene to the gene encoding the radiosensitizing and tumoricidal cytokine, tumour necrosis factor-alpha (TNF-alpha) and used a replication-deficient adenovirus to deliver the Egr-TNF construct to human tumours growing in nude mice. Combined treatment with AdS.EgrTNF and 5,000 cGy (rad) resulted in increased intratumoral TNF-a production and increased tumour control compared with treatment with Ad5.Egr-TNF alone or with radiation alone. The increase in tumour control was achieved without an increase in normal tissue damage when compared to tissue injury from radiation alone. Control of gene transcription by ionizing radiation in vivo represents a novel method of spatial and temporal regulation of gene-based medical treatments.	UNIV CHICAGO,DEPT RADIAT & CELLULAR ONCOL,CHICAGO,IL 60637; UNIV CHICAGO,PRITZKER SCH MED,CHICAGO,IL 60637; UNIV CHICAGO,DEPT SURG,CHICAGO,IL 60637; UNIV CHICAGO,DEPT ANESTHESIA & CRIT CARE,CHICAGO,IL 60637; DANA FARBER CANC INST,DIV CANC PHARMACOL,BOSTON,MA 02115	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Harvard University; Dana-Farber Cancer Institute					NATIONAL CANCER INSTITUTE [R01CA041068, R01CA037435, R29CA058508, R01CA058508] Funding Source: NIH RePORTER; NCI NIH HHS [CA37435, CA41068, CA58508] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMIN R, 1995, HUM GENE THER, V6, P145, DOI 10.1089/hum.1995.6.2-145; ANDERSON WF, 1994, HUM GENE THER, V5, P1, DOI 10.1089/hum.1994.5.1-1; BOOTHMAN DA, 1989, CANCER RES, V49, P2871; BRACH MA, 1991, J CLIN INVEST, V88, P691, DOI 10.1172/JCI115354; CULVER KW, 1994, TRENDS GENET, V10, P174, DOI 10.1016/0168-9525(94)90095-7; DATTA R, 1992, P NATL ACAD SCI USA, V89, P10149, DOI 10.1073/pnas.89.21.10149; GORCZYCA W, 1993, CANCER RES, V53, P1945; GRIDLEY DS, 1994, ANTICANCER RES, V14, P1107; HALLAHAN D, IN PRESS CANCER J; HALLAHAN DE, 1993, J BIOL CHEM, V268, P4903; HALLAHAN DE, 1989, P NATL ACAD SCI USA, V86, P10104, DOI 10.1073/pnas.86.24.10104; HALLAHAN DE, 1990, INT J RADIAT ONCOL, V19, P69, DOI 10.1016/0360-3016(90)90136-8; HALLAHAN DE, 1991, P NATL ACAD SCI USA, V88, P2152; HERRLICH P, 1992, REV PHYSIOL BIOCH P, V119, P187; HOLBROOK NJ, 1991, NEW BIOL, V3, P825; HUANG P, IN PRESS INT J RAD O; JONES N, 1979, CELL, V17, P683, DOI 10.1016/0092-8674(79)90275-7; KASAHARA N, 1994, SCIENCE, V266, P1373, DOI 10.1126/science.7973726; KASID U, 1989, SCIENCE, V243, P1354, DOI 10.1126/science.2466340; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LARRICK JW, 1990, FASEB J, V4, P3215, DOI 10.1096/fasebj.4.14.2172061; LASTER SM, 1988, J IMMUNOL, V141, P2629; MANOME Y, 1994, CANCER RES, V54, P5408; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; MEYN RE, 1993, RADIAT RES, V136, P327, DOI 10.2307/3578544; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; PATEL PM, 1993, J IMMUNOTHER, V14, P310, DOI 10.1097/00002371-199311000-00010; SERSA G, 1988, INT J CANCER, V42, P129, DOI 10.1002/ijc.2910420124; TAKAKU F, 1994, ONCOLOGY, V51, P123, DOI 10.1159/000227326; WEICHSELBAUM RR, 1985, P NATL ACAD SCI USA, V82, P4732, DOI 10.1073/pnas.82.14.4732; WEICHSELBAUM RR, 1994, CANCER RES, V54, P4266; WEICHSELBAUM RR, 1993, CANC MED, P539; WONG GHW, 1991, P NATL ACAD SCI USA, V88, P4372, DOI 10.1073/pnas.88.10.4372; WRIGHT SC, 1992, J CELL BIOCHEM, V48, P344, DOI 10.1002/jcb.240480403	34	288	323	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1995	1	8					786	791		10.1038/nm0895-786	http://dx.doi.org/10.1038/nm0895-786			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585181				2022-12-25	WOS:A1995RM63500035
J	KAMBOH, MI; SANGHERA, DK; FERRELL, RE; DEKOSKY, ST				KAMBOH, MI; SANGHERA, DK; FERRELL, RE; DEKOSKY, ST			APOE-ASTERISK-4-ASSOCIATED ALZHEIMERS-DISEASE RISK IS MODIFIED BY ALPHA-1-ANTICHYMOTRYPSIN POLYMORPHISM	NATURE GENETICS			English	Letter							PROTEASE INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN; APOLIPOPROTEIN-E; AMYLOID DEPOSITS; BETA-PROTEIN; BRAIN; EXPRESSION; DIAGNOSIS; PEPTIDES; SEQUENCE; BINDING							DeKosky, Steven/0000-0003-3743-2758; Sanghera, Dharambir/0000-0001-7203-8655; Kamboh, M. Ilyas/0000-0002-3453-1438	NIA NIH HHS [AG05133, AG09202, AG07562] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P50AG005133, R01AG009202, R01AG007562] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAHAM CR, 1990, NEUROBIOL AGING, V11, P123, DOI 10.1016/0197-4580(90)90045-2; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; DEKOSKY ST, 1994, NEUROLOGY, V44, pA354; EICHNER JE, 1990, ARTERIOSCLEROSIS, V10, P379, DOI 10.1161/01.ATV.10.3.379; FABER JP, 1993, J HEPATOL, V18, P313, DOI 10.1016/S0168-8278(05)80275-2; FRASER PE, 1993, J NEUROCHEM, V61, P298, DOI 10.1111/j.1471-4159.1993.tb03568.x; ISHIGURO K, 1993, VIRCHOWS ARCH B, V64, P221, DOI 10.1007/BF02915116; KAMBOH MI, 1995, HUM BIOL, V67, P195; KAMBOH MI, 1995, ATHEROSCLEROSIS, V112, P145, DOI 10.1016/0021-9150(94)05409-C; KHACHATURIAN ZS, 1985, ARCH NEUROL-CHICAGO, V42, P1097, DOI 10.1001/archneur.1985.04060100083029; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MATSUBARA E, 1990, ANN NEUROL, V28, P561, DOI 10.1002/ana.410280414; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; PICKEN MM, 1990, J NEUROPATH EXP NEUR, V49, P41, DOI 10.1097/00005072-199001000-00005; RANDALL LL, 1989, SCIENCE, V243, P1156, DOI 10.1126/science.2646712; RAYFORD A, 1992, J NEUROCHEM, V58, P88, DOI 10.1111/j.1471-4159.1992.tb09281.x; ROZEMULLER JM, 1991, ACTA NEUROPATHOL, V82, P200, DOI 10.1007/BF00294446; SANAN DA, 1994, J CLIN INVEST, V94, P880; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SHOJI M, 1991, AM J PATHOL, V138, P247; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019; WISNIEWSKI KE, 1990, EXP NEUROL, V110, P121, DOI 10.1016/0014-4886(90)90056-X; WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030; 1987, DIAGNOSTIC STATISTIC	26	308	312	1	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					486	488		10.1038/ng0895-486	http://dx.doi.org/10.1038/ng0895-486			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670501				2022-12-25	WOS:A1995RM37500026
J	PETRYLAK, DP				PETRYLAK, DP			METASTASES SUPPRESSORS AND PROSTATE-CANCER	NATURE MEDICINE			English	Editorial Material							RADICAL PROSTATECTOMY	Even though diagnosis of prostate cancer can be made earlier than in the past, prognosis is still difficult. The discovery of new metastatic markers should aid in treatment design.			PETRYLAK, DP (corresponding author), COLUMBIA PRESBYTERIAN MED CTR,COLL PHYS & SURG,NEW YORK,NY 10032, USA.							BORING CC, 1995, CA CANC J CLIN, V45, P8; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; FISHMAN JR, 1994, J UROLOGY, V152, P202, DOI 10.1016/S0022-5347(17)32862-8; PARTIN AW, 1995, UROLOGY, V45, P831, DOI 10.1016/S0090-4295(99)80091-0; PARTIN AW, 1993, UROL CLIN N AM, V20, P713; STAMEY TA, 1989, J UROLOGY, V141, P1076, DOI 10.1016/S0022-5347(17)41175-X; THOMPSON TC, 1990, CANCER CELL-MON REV, V2, P345	7	4	4	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1995	1	8					739	740		10.1038/nm0895-739	http://dx.doi.org/10.1038/nm0895-739			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585169				2022-12-25	WOS:A1995RM63500023
J	DUNCAN, C; DOUGALL, H; JOHNSTON, P; GREEN, S; BROGAN, R; LEIFERT, C; SMITH, L; GOLDEN, M; BENJAMIN, N				DUNCAN, C; DOUGALL, H; JOHNSTON, P; GREEN, S; BROGAN, R; LEIFERT, C; SMITH, L; GOLDEN, M; BENJAMIN, N			CHEMICAL GENERATION OF NITRIC-OXIDE IN THE MOUTH FROM THE ENTEROSALIVARY CIRCULATION OF DIETARY NITRATE	NATURE MEDICINE			English	Article							HUMAN SALIVA; GASTRIC-CANCER; STOMACH; SUPEROXIDE; PATHWAY; GENES	High concentrations of nitrite present in saliva (derived from dietary nitrate) may, upon acidification, generate nitrogen oxides in the stomach-in sufficient amounts to provide protection from swallowed pathogens. We now show that, in the rat, reduction of nitrate to nitrite is confined to a specialized area on the posterior surface of the tongue, which is heavily colonized by bacteria, and that nitrate reduction is absent in germ-free rats. We also show that in humans increased salivary nitrite production resulting from nitrate intake enhances oral nitric oxide production. We propose that the salivary generation of nitrite is accomplished by a symbiotic relationship involving nitrate-reducing bacteria on the tongue surface, which is designed to provide host defence against microbial pathogens in the mouth and lower gut. These results provide further evidence for beneficial effects of dietary nitrate.	UNIV ABERDEEN,SCH MED,DEPT MED & THERAPEUT,ABERDEEN AB9 2ZD,SCOTLAND; UNIV ABERDEEN,SCH MED,DEPT PATHOL,ABERDEEN AB9 2ZD,SCOTLAND; UNIV ABERDEEN,DEPT PLANT & SOIL SCI,ABERDEEN AB9 2UD,SCOTLAND	University of Aberdeen; University of Aberdeen; University of Aberdeen			Golden, Michael/AAB-8989-2020	Golden, Michael/0000-0002-4039-7538; Leifert, Carlo/0000-0002-2974-3612				BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BENJAMIN N, 1994, NATURE, V368, P502, DOI 10.1038/368502a0; BODIS S, 1993, BIOCHEM BIOPH RES CO, V194, P347, DOI 10.1006/bbrc.1993.1826; BRAUN C, 1991, J BIOL CHEM, V266, P22785; CALDWELL JR, 1974, JAMA-J AM MED ASSOC, V230, P77, DOI 10.1001/jama.230.1.77; DESAI KM, 1991, NATURE, V351, P477, DOI 10.1038/351477a0; DONAHOE WE, 1949, PEDIATRICS, V3, P308; DOUGALL HT, 1995, BRIT J CLIN PHARMACO, V39, P460, DOI 10.1111/j.1365-2125.1995.tb04479.x; EDWARDS DAW, 1954, LANCET, P498; FORMAN D, 1985, NATURE, V313, P620, DOI 10.1038/313620a0; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; GUNSALUS RP, 1992, J BACTERIOL, V174, P7069, DOI 10.1128/jb.174.22.7069-7074.1992; HADDOCK BA, 1977, BACTERIOL REV, V41, P47, DOI 10.1128/MMBR.41.1.47-99.1977; HEGESH E, 1982, CLIN CHIM ACTA, V125, P107, DOI 10.1016/0009-8981(82)90187-5; HOGG N, 1992, BIOCHEM J, V281, P419, DOI 10.1042/bj2810419; Ishiwata H., 1975, Journal of the Food Hygienic Society of Japan [Shokuhin Eiseigaku Zasshi], V16, P89; JENSEN ME, 1989, BRIT DENT J, V167, P204, DOI 10.1038/sj.bdj.4806971; KLEBANOFF SJ, 1993, FREE RADICAL BIO MED, V14, P351, DOI 10.1016/0891-5849(93)90084-8; KNIGHT TM, 1990, INT J EPIDEMIOL, V19, P510, DOI 10.1093/ije/19.3.510; LUNDBERG JON, 1994, GUT, V35, P1543, DOI 10.1136/gut.35.11.1543; MANCINELLI RL, 1983, APPL ENVIRON MICROB, V46, P198, DOI 10.1128/AEM.46.1.198-202.1983; NEAL KR, 1994, BRIT MED J, V308, P176; REDDY D, 1983, SCIENCE, V221, P769, DOI 10.1126/science.6308761; RIDER BF, 1946, IND ENG CHEM, V18, P96, DOI 10.1021/i560150a003; RUDDELL WSJ, 1976, GUT, V17, P401; Sasaki T, 1979, J FOOD HYG SOC JPN, V20, P363; SOBALA GM, 1989, GASTROENTEROLOGY, V97, P357, DOI 10.1016/0016-5085(89)90071-1; SPIEGELHALDER B, 1976, FOOD COSMET TOXICOL, V14, P545, DOI 10.1016/S0015-6264(76)80005-3; STEVENS A, 1990, THEORY PRACTICE HIST, P290; SUGIMURA T, 1970, CANCER RES, V30, P455; TANNENBAUM SR, 1976, FOOD COSMET TOXICOL, V14, P549, DOI 10.1016/S0015-6264(76)80006-5; TANNENBAUM SR, 1974, JNCI-J NATL CANCER I, V53, P79; WALKER AM, 1979, JAMA-J AM MED ASSOC, V242, P1273, DOI 10.1001/jama.242.12.1273; WENNERHOLM K, 1994, CARIES RES, V28, P48, DOI 10.1159/000261620; WHITTLE BJR, 1989, BRIT J PHARMACOL, V99, P607; Williams D. L. H., 1988, NITROSATION; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; 1987, 20 MIN AGR FISH FOOD, P7	38	487	511	6	54	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1995	1	6					546	551		10.1038/nm0695-546	http://dx.doi.org/10.1038/nm0695-546			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN101	7585121				2022-12-25	WOS:A1995RN10100038
J	HIROTSUNE, S; TAKAHARA, T; SASAKI, N; HIROSE, K; YOSHIKI, A; OHASHI, T; KUSAKABE, M; MURAKAMI, Y; MURAMATSU, M; WATANABE, S; NAKAO, K; KATSUKI, M; HAYASHIZAKI, Y				HIROTSUNE, S; TAKAHARA, T; SASAKI, N; HIROSE, K; YOSHIKI, A; OHASHI, T; KUSAKABE, M; MURAKAMI, Y; MURAMATSU, M; WATANABE, S; NAKAO, K; KATSUKI, M; HAYASHIZAKI, Y			THE REELER GENE ENCODES A PROTEIN WITH AN EGF-LIKE MOTIF EXPRESSED BY PIONEER NEURONS	NATURE GENETICS			English	Article							EPIDERMAL GROWTH-FACTOR; MOUSE CHROMOSOME-5; MUTANT MOUSE; LOCALIZATION; MUTATIONS; RESIDUES; DOMAINS; CELLS; MICE; LOCI	We have identified a strong candidate cDNA for the mouse reeler gene. This 5 kb transcript encodes a 99.4 kD protein consisting of 881 amino acids and possessing two EGF-like motifs. We assayed two independent mutant alleles - 'Jackson reeler', which has a deletion of the entire gene, and 'Orleans reeler' which exhibits a 220 bp deletion in the open reading frame, including the second EGF-like motif and resulting in a frame shift. In situ hybridization reveals that the transcript is detected exclusively in the pioneer neurons which guide neuronal cell migration along the radial array. Our findings offer an explanation for how the reeler mutant phenotype causes a disturbance of the complex architecture of the neuronal network.	INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,GENOME SCI LAB,CELL BIOL LAB,TSUKUBA,IBARAKI 305,JAPAN; INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,CELLULAR PHYSIOL LAB,TSUKUBA,IBARAKI 305,JAPAN; SHIONOGI & CO LTD,SHIONOGI INST MED SCI,SETTSU,OSAKA 566,JAPAN; KYUSHU UNIV,MED INST BIOREGULAT,HIGASHI KU,FUKUOKA 812,JAPAN	RIKEN; RIKEN; Shionogi & Company Limited; Kyushu University			Sasaki, Nobuya/F-6579-2012; Yoshiki, Atsushi/O-6162-2019	Yoshiki, Atsushi/0000-0002-9450-5151				BECKERS MC, 1994, GENOMICS, V23, P685, DOI 10.1006/geno.1994.1557; BIRNBOIM HC, 1988, NUCLEIC ACIDS RES, V16, P1487, DOI 10.1093/nar/16.4.1487; DERNONCOURT C, 1991, GENOMICS, V11, P1167, DOI 10.1016/0888-7543(91)90049-K; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1992, J CLIN INVEST, V89, P1674, DOI 10.1172/JCI115766; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; GOFFINET AM, 1991, MAMM GENOME, V1, P100, DOI 10.1007/BF02443785; GOFFINET AM, 1990, EXP BRAIN RES SER, V19, P135; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HANDFORD PA, 1990, EMBO J, V9, P475, DOI 10.1002/j.1460-2075.1990.tb08133.x; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; HAYASHIZAKI Y, 1994, GENETICS, V138, P1207; HIRAIWA N, 1993, J CELL SCI, V104, P289; HIROTSUNE S, 1993, BIOCHEM BIOPH RES CO, V194, P1406, DOI 10.1006/bbrc.1993.1981; KATARLINA K, 1994, NAT GENET, V6, P64; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; KOMORIYA A, 1984, P NATL ACAD SCI-BIOL, V81, P1351, DOI 10.1073/pnas.81.5.1351; MATUS A, 1988, ANNU REV NEUROSCI, V11, P29, DOI 10.1146/annurev.neuro.11.1.29; MEYERS WA, 1970, BEHAV GENET, V1, P225; MIAO GG, 1994, P NATL ACAD SCI USA, V91, P11050, DOI 10.1073/pnas.91.23.11050; MONTGOMERY JC, 1994, MAMM GENOME, V5, P756, DOI 10.1007/BF00292008; OHSUMI T, 1995, ELECTROPHORESIS, V16, P203, DOI 10.1002/elps.1150160135; OKAZAKI Y, IN PRESS P NATN ACAD; PINTOLORD MC, 1982, DEV BRAIN RES, V4, P379, DOI 10.1016/0165-3806(82)90181-X; STEINDLER DA, 1977, NEUROSCI LETT, V6, P293, DOI 10.1016/0304-3940(77)90087-8; STEINDLER DA, 1976, BRAIN RES, V113, P386, DOI 10.1016/0006-8993(76)90949-5; TERASHIMA T, 1986, J COMP NEUROL, V252, P264, DOI 10.1002/cne.902520209; YOSHIKI A, 27TH P ANN M JAP SOC, V169; 1990, EMBO PRACTICAL COURS	31	293	298	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					77	83		10.1038/ng0595-77	http://dx.doi.org/10.1038/ng0595-77			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647795				2022-12-25	WOS:A1995QX57300019
J	THURSZ, MR; KWIATKOWSKI, D; TOROK, ME; ALLSOPP, CEM; GREENWOOD, BM; WHITTLE, HC; THOMAS, HC; HILL, AVS				THURSZ, MR; KWIATKOWSKI, D; TOROK, ME; ALLSOPP, CEM; GREENWOOD, BM; WHITTLE, HC; THOMAS, HC; HILL, AVS			ASSOCIATION OF HEPATITIS-B SURFACE-ANTIGEN CARRIAGE WITH SEVERE MALARIA IN GAMBIAN CHILDREN	NATURE MEDICINE			English	Article							VIRUS	Severe malaria is a major cause of childhood mortality in sub-Saharan Africa but the factors predisposing children to Severe forms of malaria have not been fully elucidated. In a case-control study of over 1,200 Cambian children hepatitis B virus carriage was significantly increased amongst cases of severe malaria compared to matched controls. We suggest,that this association may relate to impaired clearance of liver stage parasites in the presence of the reduced level of HLA class l antigen expression on hepatocytes Infected by hepatitis B virus. If this association is causal and viral carriage predisposes to severe malaria, widespread vaccination against hepatitis B virus may reduce mortality from severe malaria.	ST MARYS HOSP,SCH MED,ACAD DEPT MED,HEPATOL UNIT,LONDON W2 1NY,ENGLAND; UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; MRC LABS,FAJARA,GAMBIA	Imperial College London; University of Oxford; MRC Laboratory Molecular Biology	THURSZ, MR (corresponding author), UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,HEPATOL UNIT,LONDON W2 1NY,ENGLAND.		HILL, Adrian V>S>/C-1306-2008; Thomas, Howard C/A-3152-2009	Torok, Mili Estee/0000-0001-9098-8590; Thursz, Mark/0000-0002-8218-192X; Kwiatkowski, Dominic/0000-0002-5023-0176	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALONSO PL, 1993, T ROY SOC TROP MED H, V87, P37, DOI 10.1016/0035-9203(93)90174-O; DECKER R, 1983, VIRAL HEPATITIS SCI; FOSTER GR, 1993, HEPATOLOGY, V17, P757, DOI 10.1002/hep.1840170502; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; GRUMAYER ER, 1989, J HEPATOL, V8, P232, DOI 10.1016/0168-8278(89)90012-3; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; IKEDA T, 1986, HEPATOLOGY, V6, P963; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; RYDER RW, 1984, LANCET, V2, P449; THURSZ MR, IN PRESS NEW ENGL J	11	43	47	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1995	1	4					374	375		10.1038/nm0495-374	http://dx.doi.org/10.1038/nm0495-374			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585070				2022-12-25	WOS:A1995RN09800036
J	GUILLEMOT, F; CASPARY, T; TILGHMAN, SM; COPELAND, NG; GILBERT, DJ; JENKINS, NA; ANDERSON, DJ; JOYNER, AL; ROSSANT, J; NAGY, A				GUILLEMOT, F; CASPARY, T; TILGHMAN, SM; COPELAND, NG; GILBERT, DJ; JENKINS, NA; ANDERSON, DJ; JOYNER, AL; ROSSANT, J; NAGY, A			GENOMIC IMPRINTING OF MASH2, A MOUSE GENE REQUIRED FOR TROPHOBLAST DEVELOPMENT	NATURE GENETICS			English	Article							GROWTH FACTOR-II; PATERNAL GENOMES; H19 GENE; EXPRESSION; CELLS; LINKAGE; ACHAETE; EMBRYOGENESIS; CHROMOSOME-7; DROSOPHILA	The mouse gene Mash2 encodes a transcription factor required for development of trophoblast progenitors. Mash2- homozygous mutant embryos die at 10 days post-coitum from placental failure. Here we show that Mash2 is genomically imprinted. First, Mash2+/- embryos inheriting a wild-type allele from their father die at the same stage as appears almost completely repressed by 8.5 days post-coitum. Finally, we have genetically and physically mapped Mash2 to the distal region of chromosome 7, within a The mouse gene Mash2 encodes a transcription factor required for development of cluster of imprinted genes, including insulin-2, insulin-like growth factor-2 and H19.	MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO,ON M5G 1X5,CANADA; PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544; PRINCETON UNIV,HOWARD HUGHES MED INST,PRINCETON,NJ 08544; NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702; CALTECH,HOWARD HUGHES MED INST,DIV BIOL,PASADENA,CA 91106; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON M5S 1A8,CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Princeton University; Howard Hughes Medical Institute; Princeton University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; California Institute of Technology; Howard Hughes Medical Institute; University of Toronto	GUILLEMOT, F (corresponding author), UNIV LOUIS PASTEUR STRASBOURG 1,CU STRASBOURG,INST GENET & BIOL MOLEC & CELLULAIRE,CNRS,INSERM,F-67404 ILLKIRCH GRAFFENS,FRANCE.		Nagy, Andras/G-6465-2013; Guillemot, Francois/AAV-1482-2021; Caspary, Tamara/AAH-5625-2020	Nagy, Andras/0000-0003-4311-0413; Caspary, Tamara/0000-0002-6579-7589	NCI NIH HHS [N0I-CO-46000] Funding Source: Medline; NIGMS NIH HHS [GM51460] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051460] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVRAHAM KB, 1994, GENOMICS, V21, P656, DOI 10.1006/geno.1994.1330; BARLOW DP, 1994, TRENDS GENET, V10, P194, DOI 10.1016/0168-9525(94)90255-0; Bartolomei M.S., 1992, SEMIN DEV BIOL, V3, P107; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; BARTON SC, 1985, J EMBRYOL EXP MORPH, V90, P267; BEECHEY CV, 1993, MOUSE GENOME, V91, P310; BEECHEY CV, 1993, MOUSE GENOME, V92, P108; BEECHEY CV, 1993, MOUSE GENOME, V91, P857; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CATTANACH BM, 1990, DEVELOPMENT, P63; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; CLARKE HJ, 1988, DEVELOPMENT, V104, P175; CLINE TW, 1993, TRENDS GENET, V9, P385, DOI 10.1016/0168-9525(93)90138-8; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FORONI L, 1992, J MOL BIOL, V226, P747, DOI 10.1016/0022-2836(92)90630-3; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; Green EL, 1981, GENETICS PROBABILITY, P77; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; HALL JG, 1990, AM J HUM GENET, V46, P857; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; JOHNSON JE, 1990, NATURE, V346, P868; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; LEE JE, 1990, DEVELOPMENT, V110, P151; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LESCISIN KR, 1989, GENE DEV, V2, P1639; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; MANN JR, 1984, NATURE, V310, P66, DOI 10.1038/310066a0; MARTINEZ C, 1991, SCIENCE, V251, P1485, DOI 10.1126/science.1900954; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MCLAUGHLIN KJ, IN PRESS GENES DEV; MOENS CB, 1993, DEVELOPMENT, V119, P485; NAGY A, 1987, DEVELOPMENT, V101, P67; POIRIER F, 1991, DEVELOPMENT, V113, P1105; SEARLE AG, 1990, GENET RES, V56, P237, DOI 10.1017/S0016672300035333; SOLTER D, 1988, ANNU REV GENET, V22, P127; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; THOMSON JA, 1988, GENE DEV, V2, P1344, DOI 10.1101/gad.2.10.1344; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61	50	326	337	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					235	242		10.1038/ng0395-235	http://dx.doi.org/10.1038/ng0395-235			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773285				2022-12-25	WOS:A1995QL23200011
J	LIU, SQ; SAIJO, K; TODOROKI, T; OHNO, T				LIU, SQ; SAIJO, K; TODOROKI, T; OHNO, T			INDUCTION OF HUMAN AUTOLOGOUS CYTOTOXIC T-LYMPHOCYTES ON FORMALIN-FIXED AND PARAFFIN-EMBEDDED TUMOR SECTIONS	NATURE MEDICINE			English	Article							ACTIVATED KILLER CELLS; CANCER; MELANOMA; IMMUNOTHERAPY; INTERLEUKIN-2; PROLIFERATION; RECOGNITION; GROWTH; MICE	Human autologous tumour-specific cytotoxic T lymphocytes (CTL) were generated from peripheral blood on small formalin-fixed paraffin-embedded sections of a gastric cancer. The CTL killed live target cells at an effector/target ratio of 1 within 24 hours and showed the same target specificity as those induced on live cancer cells, The killing activity of the CTL lasted for more than four months in culture and was inhibited by antibodies against CD8 and MHC-class I. These results suggest that adoptive immunotherapy of tumours will be possible with CTL induced on a stable source of tumour antigen.	UNIV TSUKUBA,SCH MED,INST PHYS & CHEM RES,RIKEN,CELL BANK,TSUKUBA,IBARAKI 305,JAPAN; UNIV TSUKUBA,SCH MED,DEPT SURG,TSUKUBA,IBARAKI 305,JAPAN	RIKEN; University of Tsukuba; University of Tsukuba			Saijo, Kaoru/N-5095-2015					AZUMA M, 1992, J IMMUNOL, V149, P1115; CONNORS M, 1992, J VIROL, V66, P7444, DOI 10.1128/JVI.66.12.7444-7451.1992; CROWLEY NJ, 1991, J IMMUNOL, V146, P1692; FISHER RI, 1988, ANN INTERN MED, V108, P518, DOI 10.7326/0003-4819-108-4-518; FUJINO T, 1994, CANCER RES, V54, P4294; Hay R. K. M, 1994, ATLAS HUMAN TUMOR CE; HEO DS, 1988, J IMMUNOL, V140, P4042; HOLDEN CA, 1986, J IMMUNOL METHODS, V91, P45, DOI 10.1016/0022-1759(86)90100-6; IKARASHI H, 1994, CANCER RES, V54, P190; IOANNIDES CG, 1993, CLIN IMMUNOL IMMUNOP, V66, P91, DOI 10.1006/clin.1993.1012; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LIU SQ, 1994, CANCER IMMUNOL IMMUN, V39, P279; MITRA AB, 1994, CANCER RES, V54, P4481; MONACO JJ, 1992, IMMUNOL TODAY, V13, P173, DOI 10.1016/0167-5699(92)90122-N; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MUUL LM, 1987, J IMMUNOL, V138, P989; NAKASHIMA M, 1994, CELL IMMUNOL, V155, P53, DOI 10.1006/cimm.1994.1101; PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171; POLLARD K, 1987, J IMMUNOL METHODS, V96, P145, DOI 10.1016/0022-1759(87)90379-6; Rees A D, 1989, Int Immunol, V1, P624, DOI 10.1093/intimm/1.6.624; ROSENBERG SA, 1987, NEW ENGL J MED, V316, P889, DOI 10.1056/NEJM198704093161501; ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904; SAOTOME K, 1989, TOXICOL IN VITRO, V3, P317, DOI 10.1016/0887-2333(89)90039-8; SLINGLUFF CL, 1994, CANCER RES, V54, P2731; TAKAHASHI H, 1993, SCIENCE, V259, P1460, DOI 10.1126/science.8451642; TJOA, 1994, CANCER RES, V54, P204; TOPALIAN SL, 1989, J IMMUNOL, V142, P3714; UCKER DS, 1992, MOL CELL BIOL, V12, P3060, DOI 10.1128/MCB.12.7.3060; WOLFEL T, 1993, INT J CANCER, V54, P636, DOI 10.1002/ijc.2910540419	30	88	94	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1995	1	3					267	271		10.1038/nm0395-267	http://dx.doi.org/10.1038/nm0395-267			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX559	7585045				2022-12-25	WOS:A1995QX55900035
J	SOMMER, N; LOSCHMANN, PA; NORTHOFF, GH; WELLER, M; STEINBRECHER, A; STEINBACH, JP; LICHTENFELS, R; MEYERMANN, R; RIETHMULLER, A; FONTANA, A; DICHGANS, J; MARTIN, R				SOMMER, N; LOSCHMANN, PA; NORTHOFF, GH; WELLER, M; STEINBRECHER, A; STEINBACH, JP; LICHTENFELS, R; MEYERMANN, R; RIETHMULLER, A; FONTANA, A; DICHGANS, J; MARTIN, R			THE ANTIDEPRESSANT ROLIPRAM SUPPRESSES CYTOKINE PRODUCTION AND PREVENTS AUTOIMMUNE ENCEPHALOMYELITIS	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; PHOSPHODIESTERASE INHIBITOR ROLIPRAM; MAJOR DEPRESSIVE DISORDER; FACTOR-ALPHA PRODUCTION; CENTRAL-NERVOUS-SYSTEM; T-CELL CLONES; MULTIPLE-SCLEROSIS; MYELIN; PROTEIN	In multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE) the cytokines tumour necrosis factor-alpha (TNF), lymphotoxin-alpha (LT), and interferon-gamma (IFN-gamma) are of central pathogenetic importance. A therapy capable of stopping neurological deterioration in MS patients is not yet available. Here, we report that rolipram, a selective type IV phosphodiesterase inhibitor, stereospecifically suppresses the production of TNF/LT and less strongly also IFN-gamma in human and rat autoreactive T cells. Moreover, we show that rolipram is an effective treatment for EAE. Rolipram has extensively been studied in humans for the treatment of depression, but has not yet been marketed. The data presented here identify rolipram as potential therapy for multiple sclerosis and provoke the immediate initiation of clinical trials.	UNIV TUBINGEN, DEPT TRANSFUS MED, D-72076 TUBINGEN, GERMANY; UNIV ZURICH HOSP, DEPT INTERNAL MED, CLIN IMMUNOL SECT, CH-8044 ZURICH, SWITZERLAND; UNIV TUBINGEN, INST BRAIN RES, D-72076 TUBINGEN, GERMANY; NINCDS, NEUROIMMUNOL BRANCH, BETHESDA, MD 20892 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; University Zurich Hospital; Eberhard Karls University of Tubingen; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	SOMMER, N (corresponding author), UNIV TUBINGEN, DEPT NEUROL, HOPPE SEYLER STR 3, D-72076 TUBINGEN, GERMANY.			Weller, Michael/0000-0002-1748-174X				BEAVO JA, 1990, TRENDS PHARMACOL SCI, V11, P150, DOI 10.1016/0165-6147(90)90066-H; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; CHUNG IY, 1991, J EXP MED, V173, P801, DOI 10.1084/jem.173.4.801; DAVIS CW, 1984, BIOCHIM BIOPHYS ACTA, V797, P354, DOI 10.1016/0304-4165(84)90257-5; DEZUBE BJ, 1993, J ACQ IMMUN DEF SYND, V6, P787; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; FLEISCHHACKER WW, 1992, NEUROPSYCHOBIOLOGY, V26, P59, DOI 10.1159/000118897; FREI K, 1987, EUR J IMMUNOL, V17, P1271, DOI 10.1002/eji.1830170909; HEBENSTREIT GF, 1989, PHARMACOPSYCHIATRY, V22, P156, DOI 10.1055/s-2007-1014599; HERVE P, 1992, BLOOD, V79, P3362; ICHIMURA M, 1993, BIOCHEM BIOPH RES CO, V193, P985, DOI 10.1006/bbrc.1993.1722; KAULEN P, 1989, BRAIN RES, V503, P229, DOI 10.1016/0006-8993(89)91669-7; KRAUSE W, 1989, XENOBIOTICA, V19, P683, DOI 10.3109/00498258909042306; KUCHROO VK, 1993, J IMMUNOL, V151, P4371; LINDSEY JW, 1994, ANN NEUROL, V36, P183; LININGTON C, 1993, EUR J IMMUNOL, V23, P1364, DOI 10.1002/eji.1830230627; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; MARTIN R, 1992, J IMMUNOL, V148, P1359; MCLAUGHLIN MM, 1993, J BIOL CHEM, V268, P6470; PANITCH HS, 1987, LANCET, V1, P893; PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z; POWELL MB, 1990, INT IMMUNOL, V2, P539, DOI 10.1093/intimm/2.6.539; RACKE MK, 1992, INT IMMUNOL, V4, P615, DOI 10.1093/intimm/4.5.615; RACKE MK, 1994, J EXP MED, V180, P1961, DOI 10.1084/jem.180.5.1961; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; SCHMIECHEN R, 1990, PSYCHOPHARMACOLOGY, V102, P17, DOI 10.1007/BF02245738; SCOTT AIF, 1991, EUR J CLIN PHARMACOL, V40, P127; SELMAJ K, 1991, J CLIN INVEST, V87, P949, DOI 10.1172/JCI115102; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; SEMMLER J, 1993, INT J IMMUNOPHARMACO, V15, P409, DOI 10.1016/0192-0561(93)90052-Z; SPENGLER RN, 1989, INFECT IMMUN, V57, P2837, DOI 10.1128/IAI.57.9.2837-2841.1989; STOLL G, 1993, J NEUROIMMUNOL, V45, P175, DOI 10.1016/0165-5728(93)90178-2; SUTTORP N, 1993, J CLIN INVEST, V91, P1421, DOI 10.1172/JCI116346; SWANBORG RH, 1988, METHOD ENZYMOL, V162, P413; UMEHARA F, 1990, LAB INVEST, V62, P147; WACHTEL H, 1986, NEUROPHARMACOLOGY, V25, P1119, DOI 10.1016/0028-3908(86)90159-0	36	308	325	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	1995	1	3					244	248		10.1038/nm0395-244	http://dx.doi.org/10.1038/nm0395-244			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX559	7585041				2022-12-25	WOS:A1995QX55900031
J	ESTRELA, JM; OBRADOR, E; NAVARRO, J; DELAVEGA, MCL; PELLICER, JA				ESTRELA, JM; OBRADOR, E; NAVARRO, J; DELAVEGA, MCL; PELLICER, JA			ELIMINATION OF EHRLICH TUMORS BY ATP-INDUCED GROWTH-INHIBITION, GLUTATHIONE DEPLETION AND X-RAYS	NATURE MEDICINE			English	Article							BUTHIONINE SULFOXIMINE; ADENINE-NUCLEOTIDES; PROTEIN-SYNTHESIS; MAMMALIAN-CELLS; ASCITES TUMOR; METABOLISM; ADENOSINE; MODULATION; TISSUES; INVIVO	ATP-induced tumour growth inhibition is accompanied by a selective decrease in the content of the tripeptide glutathione (GSH) within the cancer cells in vivo. Depletion of cellular GSH sensitizes tumours to chemotherapy and radiation, but the usefulness of this depletion depends on whether the levels of GSH can be reduced in the tumour relative to normal tissues. We report here that administration of ATP in combination with diethylmaleate and X-rays leads to complete regression of 95% of Ehrlich ascites tumours in mice. This shows that an aggressive tumour can be eliminated by using a therapy based on modulation of GSH levels in cancer cells.			ESTRELA, JM (corresponding author), UNIV VALENCIA,FAC MED,DEPT FISIOL,AV BLASCO IBANEZ 17,E-46010 VALENCIA,SPAIN.		OBRADOR, ELENA/H-4069-2015; Estrela, Jose/H-4449-2015; MARTINEZ, ANTONIO PELLICER/C-4832-2015	OBRADOR, ELENA/0000-0002-5934-5543; Estrela, Jose/0000-0002-2540-9190; 				Akerboom T P, 1981, Methods Enzymol, V77, P373; Apolant, 1905, BERL KLIN WSCHR, V42, P871; ARRICK BA, 1984, CANCER RES, V44, P4224; ASENSI M, 1994, ANAL BIOCHEM, V217, P323, DOI 10.1006/abio.1994.1126; BERGMEYER HU, 1985, METHODS ENZYMATIC AN; BUMP EA, 1990, PHARMACOL THERAPEUT, V47, P117, DOI 10.1016/0163-7258(90)90048-7; CHAHWALA SB, 1984, J BIOL CHEM, V259, P3717; DELAVEGA MCL, 1994, BIOCHEM J, V298, P99; DETHMERS JK, 1981, P NATL ACAD SCI-BIOL, V78, P7492, DOI 10.1073/pnas.78.12.7492; ESTRELA JM, 1992, BIOCHEM J, V286, P257, DOI 10.1042/bj2860257; FOX IH, 1978, ANNU REV BIOCHEM, V47, P655, DOI 10.1146/annurev.bi.47.070178.003255; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; HISATA T, 1980, EUR J BIOCHEM, V105, P155, DOI 10.1111/j.1432-1033.1980.tb04485.x; LEE FYF, 1987, BRIT J CANCER, V56, P33, DOI 10.1038/bjc.1987.148; LOPES MN, 1989, BIOCHEM J, V264, P713, DOI 10.1042/bj2640713; MCCLARD RW, 1980, BIOCHEMISTRY-US, V19, P4699, DOI 10.1021/bi00561a024; MEISTER A, 1991, PHARMACOL THERAPEUT, V51, P155, DOI 10.1016/0163-7258(91)90076-X; MEISTER A, 1983, SCIENCE, V220, P470; MISTRY P, 1991, PHARMACOL THERAPEUT, V49, P125, DOI 10.1016/0163-7258(91)90026-I; MITCHELL J B, 1987, British Journal of Cancer, V55, P96; MITCHELL JB, 1989, INT J RADIAT ONCOL, V16, P1289, DOI 10.1016/0360-3016(89)90301-5; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; PLANET G, 1976, J BIOL CHEM, V251, P583; RAPAPORT E, 1983, CANCER RES, V43, P4402; RAPAPORT E, 1989, P NATL ACAD SCI USA, V86, P1662, DOI 10.1073/pnas.86.5.1662; RAPAPORT E, 1988, EUR J CANCER CLIN ON, V24, P1491, DOI 10.1016/0277-5379(88)90340-9; Rottenberg H, 1979, Methods Enzymol, V55, P547; SNYDER FF, 1976, FEBS LETT, V66, P102, DOI 10.1016/0014-5793(76)80595-9; TERRADEZ P, 1993, BIOCHEM J, V292, P477, DOI 10.1042/bj2920477; WEISMAN GA, 1988, J BIOL CHEM, V263, P12367; YATES RA, 1956, J BIOL CHEM, V221, P743	31	66	68	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1995	1	1					84	88		10.1038/nm0195-84	http://dx.doi.org/10.1038/nm0195-84			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX557	7584960				2022-12-25	WOS:A1995QX55700032
J	RUGG, EL; MORLEY, SM; SMITH, FJD; BOXER, M; TIDMAN, MJ; NAVSARIA, H; LEIGH, IM; LANE, EB				RUGG, EL; MORLEY, SM; SMITH, FJD; BOXER, M; TIDMAN, MJ; NAVSARIA, H; LEIGH, IM; LANE, EB			MISSING LINKS - WEBER-COCKAYNE KERATIN MUTATIONS IMPLICATE THE L12 LINKER DOMAIN IN EFFECTIVE CYTOSKELETON FUNCTION	NATURE GENETICS			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; AMINO-ACID-SEQUENCE; POLYMORPHIC KERATINS; SECONDARY-STRUCTURE; EXPRESSION; PCR; HYPERKERATOSIS; AMPLIFICATION; SEGREGATION; PATTERNS	We have identified mutations in keratins K5 (Arg331Cys) and K14 (Val270Met) in two kinships affected by the dominantly-inherited skin blistering disease, Weber-Cockayne epidermolysis bullosa simplex (EBS-WC). Linkage analysis, DNA sequencing and clinical and ultrastructural analysis are combined to provide the first detailed description of classical EBS-WC. Both phenotypes show similar blistering on trauma, indicating that both mutations compromise the structural resilience of the basal keratinocytes by affecting the keratin cytoskeleton. The location of these mutations in the L12 linker, which bisects the alpha-helical rod region of intermediate filament proteins, identifies another keratin mutation cluster leading to hereditary skin fragility syndromes.	EDINBURGH ROYAL INFIRM,DEPT DERMATOL,EDINBURGH EH3 9YW,SCOTLAND; NINEWELLS HOSP,DEPT PATHOL,MED GENET GRP,DUNDEE DD1 9SY,SCOTLAND; ROYAL LONDON HOSP,COLL MED,EXPTL DERMATOL LABS,LONDON E1 6BL,ENGLAND	Royal Infirmary of Edinburgh; University of Dundee; Barts Health NHS Trust; Royal London Hospital	RUGG, EL (corresponding author), UNIV DUNDEE,INST MED SCI,DEPT ANAT & PHYSIOL,CANC RES CAMPAIGN LABS,CRC CELL STRUCT RES GRP,DUNDEE DD1 4HN,SCOTLAND.							ANTONLAMPRECHT I, 1982, DERMATOLOGICA, V164, P221, DOI 10.1159/000250096; BAKER R, 1991, NUCLEIC ACIDS RES, V19, P4315, DOI 10.1093/nar/19.15.4315; BARTEK J, 1990, INT J CANCER, V46, P839, DOI 10.1002/ijc.2910460515; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; BONIFAS JM, 1992, J INVEST DERMATOL, V98, pA573; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHIPEV CC, 1992, CELL, V70, P621; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CONWAY JF, 1988, INT J BIOL MACROMOL, V10, P79, DOI 10.1016/0141-8130(88)90015-3; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; COULOMBE PA, 1990, J CELL BIOL; DONG W, 1993, HUM MUTAT, V2, P94, DOI 10.1002/humu.1380020206; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEDDEDAHL T, 1990, MANAG BLISTERING DIS, V1, P189; GILL SR, 1990, J CELL BIOL, V111; HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485; HOVNANIAN A, 1993, NAT GENET, V3, P327, DOI 10.1038/ng0493-327; HOYHEIM B, 1992, J INVEST DERMATOL, V98, pA397; HUMPHRIES MM, 1993, HUM MUTAT, V2, P37, DOI 10.1002/humu.1380020107; KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910; KORGE BP, 1992, J INVEST DERMATOL, V99, P697, DOI 10.1111/1523-1747.ep12614149; Lane E B, 1990, Semin Cancer Biol, V1, P165; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181; MCCONNELL SJ, 1993, SCIENCE, V260, P687, DOI 10.1126/science.8480179; MCCORMICK MB, 1991, J CELL BIOL, V113, P1111, DOI 10.1083/jcb.113.5.1111; MCLEAN WHI, 1993, J INVEST DERMATOL, V100, P516; MCLEAN WHI, 1992, HUM MOL GENET, V1, P659, DOI 10.1093/hmg/1.8.659-a; MISCHKE D, 1987, J INVEST DERMATOL, V88, P191, DOI 10.1111/1523-1747.ep12525329; MISCHKE D, 1990, AM J HUM GENET, V46, P548; NIEMI KM, 1983, ARCH DERMATOL, V119, P138, DOI 10.1001/archderm.119.2.138; PRIESTLEY L, 1990, HUM GENET, V85, P525; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; RUGG E, IN PRESS BRIT J DERM; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Sambrook J, 1989, MOL CLONING LABORATO; SOMMER SS, 1992, BIOTECHNIQUES, V12, P82; STASIAK PC, 1989, J INVEST DERMATOL, V92, P707, DOI 10.1111/1523-1747.ep12721500; STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41; STEINERT PM, 1993, J MOL BIOL; WANNER R, 1993, J INVEST DERMATOL; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; WILD GA, 1986, EXP CELL RES, V162, P114, DOI 10.1016/0014-4827(86)90430-1	45	87	89	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					294	300		10.1038/ng1193-294	http://dx.doi.org/10.1038/ng1193-294			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	7506097				2022-12-25	WOS:A1993MF12200023
J	FARR, CJ; STEVANOVIC, M; THOMSON, EJ; GOODFELLOW, PN; COOKE, HJ				FARR, CJ; STEVANOVIC, M; THOMSON, EJ; GOODFELLOW, PN; COOKE, HJ			TELOMERE-ASSOCIATED CHROMOSOME FRAGMENTATION - APPLICATIONS IN GENOME MANIPULATION AND ANALYSIS	NATURE GENETICS			English	Article							SOMATIC-CELL HYBRIDS; HUMAN X-CHROMOSOME; DINUCLEOTIDE REPEAT; GENE-TRANSFER; PCR PRIMERS; LOCUS; DNA; SEQUENCE; REGION; PANEL	Telomere-associated chromosome fragmentation (TACF) is a new approach or chromosome mapping based on the non-targeted introduction of cloned telomeres into mammalian cells. TACF has been used to generate a panel of somatic cell hybrids with nested terminal deletions of the long arm of the human X chromosome, extending from Xq26 to the centromere. This panel has been characterized using a series of X chromosome loci. Recovery of the end clones by plasmid rescue produces a telomeric marker for each cell line and partial sequencing will allow the generation of sequence tagged sites (STSs). TACF provides a powerful and widely applicable method for genome analysis, a general way of manipulating mammalian chromosomes and a first step towards constructing artificial mammalian chromosomes.	IMPERIAL CANC RES FUND, LONDON WC2A 3PX, ENGLAND; INST MOLEC GENET & GENET ENGN, YU-11001 BELGRADE, YUGOSLAVIA; WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND	Cancer Research UK; University of Edinburgh				Farr, Christine/0000-0002-5357-5962; Stevanovic, Milena/0000-0003-4286-7334				ABBOTT C, 1991, GENOMICS, V9, P73, DOI 10.1016/0888-7543(91)90222-Z; BARSKI G, 1960, CR HEBD ACAD SCI, V251, P1825; BENHAM F, 1989, GENOMICS, V4, P509, DOI 10.1016/0888-7543(89)90274-7; BICKMORE W, 1988, NUCLEIC ACIDS RES, V16, P51, DOI 10.1093/nar/16.1.51; BROWN CJ, 1989, CYTOGENET CELL GENET, V51, P970; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CECCHERINI I, 1992, P NATL ACAD SCI USA, V89, P104, DOI 10.1073/pnas.89.1.104; COLE CG, 1991, GENOMICS, V10, P816, DOI 10.1016/0888-7543(91)90468-T; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; CREMERS FPM, 1990, NATURE, V347, P674, DOI 10.1038/347674a0; CROSS S, 1990, NUCLEIC ACIDS RES, V18, P6649, DOI 10.1093/nar/18.22.6649; FARR C, 1991, P NATL ACAD SCI USA, V88, P7006, DOI 10.1073/pnas.88.16.7006; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; GLASER T, 1990, GENOMICS, V6, P48, DOI 10.1016/0888-7543(90)90447-3; Goodfellow P N, 1991, Methods Mol Biol, V7, P53, DOI 10.1385/0-89603-178-0:53; GOODFELLOW PJ, 1990, SOMAT CELL MOLEC GEN, V16, P163, DOI 10.1007/BF01233046; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; GOSS SJ, 1977, J CELL SCI, V25, P17; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; HERRMANN BG, 1987, CELL, V48, P813, DOI 10.1016/0092-8674(87)90078-X; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; KASTER KR, 1983, NUCLEIC ACIDS RES, V11, P6895, DOI 10.1093/nar/11.19.6895; LITT M, 1989, AM J HUM GENET, V44, P397; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUTY JA, 1990, AM J HUM GENET, V46, P776; MANONI M, 1991, GENOMICS, V9, P551, DOI 10.1016/0888-7543(91)90424-D; MCBRIDE OW, 1973, P NATL ACAD SCI USA, V70, P1258, DOI 10.1073/pnas.70.4.1258; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McCLINTOCK B., 1938, MISSOURI AGRIC EXP STA RES BULL, V290, P1; MICHELSON AM, 1985, J BIOL CHEM, V260, P6982; NUSSBAUM RL, 1986, AM J MED GENET, V23, P457, DOI 10.1002/ajmg.1320230137; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PRITCHARD CA, 1987, GENE DEV, V1, P172, DOI 10.1101/gad.1.2.172; RAM KT, 1992, NUCLEIC ACIDS RES, V20, P1428, DOI 10.1093/nar/20.6.1428; RUDDLE FH, 1972, ADV HUM GENET, P173; Sambrook J, 1989, MOL CLONING LABORATO; SMEETS D, 1990, AM J HUM GENET, V47, P196; SMITH KA, 1992, P NATL ACAD SCI USA, V89, P5427, DOI 10.1073/pnas.89.12.5427; STANIER P, 1991, NUCLEIC ACIDS RES, V19, P4793, DOI 10.1093/nar/19.17.4793; THEUNE S, 1991, GENOMICS, V9, P511, DOI 10.1016/0888-7543(91)90418-E; TOLEDO F, 1992, EMBO J, V11, P2665, DOI 10.1002/j.1460-2075.1992.tb05332.x; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISS MC, 1967, P NATL ACAD SCI USA, V58, P1104, DOI 10.1073/pnas.58.3.1104; WIEACKER P, 1984, AM J HUM GENET, V36, P265; 1991, CYTOGENET CELL GENET, V58	48	106	109	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1992	2	4					275	282		10.1038/ng1292-275	http://dx.doi.org/10.1038/ng1292-275			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303279				2022-12-25	WOS:A1992KB49500010
J	DAVIS, AE; AULAK, K; PARAD, RB; STECKLEIN, HP; ELDERING, E; HACK, CE; KRAMER, J; STRUNK, RC; BISSLER, J; ROSEN, FS				DAVIS, AE; AULAK, K; PARAD, RB; STECKLEIN, HP; ELDERING, E; HACK, CE; KRAMER, J; STRUNK, RC; BISSLER, J; ROSEN, FS			C1 INHIBITOR HINGE REGION MUTATIONS PRODUCE DYSFUNCTION BY DIFFERENT MECHANISMS	NATURE GENETICS			English	Article							HEREDITARY ANGIONEUROTIC-EDEMA; POLYMERASE CHAIN-REACTION; HUMAN C1BAR INHIBITOR; STRUCTURAL CHARACTERIZATION; C1-INHIBITOR PROTEINS; PLASMA KALLIKREIN; CRYSTAL-STRUCTURE; ANTITHROMBIN; COMPLEMENT; MODEL	Heterozygosity for a mutant dysfunctional C1 inhibitor protein, a member of the serine proteinase inhibitor (serpin) superfamily, results in type II hereditary angioneurotic oedema. We identified a "hinge" region mutation in C1 inhibitor with a Val to Glu replacement at P14 Val-432. Recombinant C1 inhibitors P10 Ala --> Thr and P14 Val --> Glu did not form stable complexes with fluid phase C1s or kallikrein. The P14 Val --> Glu mutant, however, was cleaved to a 96K form by C1s, while the P10 Ala --> Thr mutant was not. The recombinant P10 mutant also did not complex with C1s, kallikrein or beta-factor XIIa-Sepharose. The two mutations, therefore, result in dysfunction by different mechanisms: in one (P14 Val --> Glu), the inhibitor is converted to a substrate, while in the other (P10 Ala --> Thr), interaction with target protease is blocked.	UNIV CINCINNATI,COLL MED,DEPT PEDIAT,CINCINNATI,OH 45229; CHILDRENS HOSP MED CTR,JOINT PROGRAM NEONATOL,BOSTON,MA 02115; WASHINGTON UNIV,SCH MED,DEPT PEDIAT,ST LOUIS,MO 63110; CTR BLOOD RES,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,DIV NEPHROL,BOSTON,MA 02115; NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,AMSTERDAM,NETHERLANDS; UNIV AMSTERDAM,EXPTL & CLIN IMMUNOL LAB,AMSTERDAM,NETHERLANDS	University System of Ohio; University of Cincinnati; Harvard University; Boston Children's Hospital; Washington University (WUSTL); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; University of Amsterdam	DAVIS, AE (corresponding author), CHILDRENS HOSP RES FDN,DIV NEPHROL,CINCINNATI,OH 45229, USA.		Levi, Marcel/AAZ-8559-2020; Parad, Richard/E-8559-2010; Parad, Richard B/AGX-7702-2022	Parad, Richard B/0000-0002-4326-0609; Bissler, John/0000-0001-9685-9183				AIACH M, 1985, THROMB RES, V39, P559, DOI 10.1016/0049-3848(85)90236-1; AULAK KS, 1988, BIOCHEM J, V253, P615, DOI 10.1042/bj2530615; AULAK KS, 1990, BIOCHEM J, V271, P565, DOI 10.1042/bj2710565; BING DH, 1980, PREP BIOCHEM, V10, P269, DOI 10.1080/10826068009412829; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; CARRELL RW, 1991, NATURE, V353, P576, DOI 10.1038/353576a0; CARROLL MC, 1990, P NATL ACAD SCI USA, V87, P6868, DOI 10.1073/pnas.87.17.6868; CASO R, 1991, BRIT J HAEMATOL, V77, P87, DOI 10.1111/j.1365-2141.1991.tb07953.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLE FS, 1985, J IMMUNOL, V134, P2610; CUGNO M, 1990, J CLIN INVEST, V85, P1215, DOI 10.1172/JCI114555; DEAGOSTINI A, 1988, J CLIN INVEST, V82, P700, DOI 10.1172/JCI113650; DEVRAJKIZUK R, 1988, BLOOD, V72, P1518; DONALDSON VH, 1985, J CLIN INVEST, V75, P124, DOI 10.1172/JCI111664; DONALDSON VH, 1987, BLOOD, V69, P1096; EINSTEIN LP, 1976, J EXP MED, V143, P114, DOI 10.1084/jem.143.1.114; ELDERING E, 1988, J BIOL CHEM, V263, P11776; ENGH RA, 1990, PROTEIN ENG, V3, P369; HARRISON RA, 1982, MOL IMMUNOL, V19, P1374, DOI 10.1016/0161-5890(82)90063-3; HARRISON RA, 1983, BIOCHEMISTRY-US, V22, P5001, DOI 10.1021/bi00290a019; HOLMES WE, 1987, SCIENCE, V238, P209, DOI 10.1126/science.2958938; KATZ Y, 1989, J IMMUNOL, V142, P2041; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVY NJ, 1990, P NATL ACAD SCI USA, V87, P265, DOI 10.1073/pnas.87.1.265; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MATHESON NR, 1991, J BIOL CHEM, V266, P13489; MOLHOSABATIER P, 1989, J CLIN INVEST, V84, P1236, DOI 10.1172/JCI114290; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; NUIJENS JH, 1987, IMMUNOLOGY, V61, P387; PARAD RB, 1990, P NATL ACAD SCI USA, V87, P6786, DOI 10.1073/pnas.87.17.6786; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; PEMBERTON PA, 1989, BIOCHEM J, V258, P193, DOI 10.1042/bj2580193; PERRY DJ, 1989, FEBS LETT, V254, P174, DOI 10.1016/0014-5793(89)81033-6; RIJKEN DC, 1988, BIOCHEM J, V255, P609; ROOS MH, 1982, NATURE, V298, P854, DOI 10.1038/298854a0; ROSEN FS, 1971, J CLIN INVEST, V50, P2143, DOI 10.1172/JCI106708; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SKRIVER K, 1989, J BIOL CHEM, V264, P3066; SKRIVER K, 1991, J BIOL CHEM, V266, P9216; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0	44	64	68	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1992	1	5					354	358		10.1038/ng0892-354	http://dx.doi.org/10.1038/ng0892-354			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	1363816				2022-12-25	WOS:A1992JJ12100014
J	CHUN, TW; FINZI, D; MARGOLICK, J; CHADWICK, K; SCHWARTZ, D; SILICIANO, RF				CHUN, TW; FINZI, D; MARGOLICK, J; CHADWICK, K; SCHWARTZ, D; SILICIANO, RF			IN-VIVO FATE OF HIV-1-INFECTED T-CELLS - QUANTITATIVE-ANALYSIS OF THE TRANSITION TO STABLE LATENCY	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD CELLS; INFECTED INDIVIDUALS; INSITU HYBRIDIZATION; MONONUCLEAR-CELLS; MESSENGER-RNA; LYMPH-NODES; HIV-1 DNA; HTLV-I; LYMPHOCYTES	Although it is presumed that the integration of HIV-1 into the genome of infected CD4(+) T lymphocytes allows viral persistence, there has been little direct evidence that CD4(+) T cells with integrated provirus function as a latent reservoir for HIV-1 in infected individuals. Using resting CD4(+) T-cell populations of extremely high purity and a novel assay that selectively and unambiguously detects integrated HIV-1, we show that resting CD4(+) T cells harbouring integrated provirus are present in some infected individuals. However, these cells do not accumulate within the circulating pool of resting CD4(+) T cells in the early stages of HIV-1 infection and do not accumulate even after prolonged periods in long-term survivors of HIV-1 infection. These results suggest that because of viral cytopathic effects and/or host effector mechanisms, productively infected CD4(+) T cells do not generally survive for long enough to revert to a resting memory state in vivo.	JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT MOLEC MICROBIOL & IMMUNOL,BALTIMORE,MD 21205	Johns Hopkins University	CHUN, TW (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205, USA.		Chun, Tae-Wook/AAC-3101-2020; Chun, Tae-Wook/W-9187-2019	Chun, Tae-Wook/0000-0001-5153-7340	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023871, R01AI028108, R37AI028108] Funding Source: NIH RePORTER; NIAID NIH HHS [AI23871, AI28108] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADAMS M, 1994, P NATL ACAD SCI USA, V91, P3862, DOI 10.1073/pnas.91.9.3862; BAGASRA O, 1992, NEW ENGL J MED, V326, P1385, DOI 10.1056/NEJM199205213262103; BELLO LJ, 1974, EXP CELL RES, V89, P263, DOI 10.1016/0014-4827(74)90790-3; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; COOMBS RW, 1989, NEW ENGL J MED, V321, P1626, DOI 10.1056/NEJM198912143212402; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; FOLKS T, 1986, J IMMUNOL, V136, P4049; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; GARCIABLANCO MA, 1991, SCIENCE, V254, P815, DOI 10.1126/science.1658933; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Mackay C R, 1992, Semin Immunol, V4, P51; MICHAEL NL, 1992, J VIROL, V66, P310, DOI 10.1128/JVI.66.1.310-316.1992; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; PANG S, 1990, NATURE, V343, P85, DOI 10.1038/343085a0; PANTALEO G, 1991, P NATL ACAD SCI USA, V88, P9838, DOI 10.1073/pnas.88.21.9838; PANTALEO G, 1994, NATURE, V370, P463, DOI 10.1038/370463a0; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PATTERSON BK, 1993, SCIENCE, V260, P976, DOI 10.1126/science.8493534; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; PSALLIDOPOULOS MC, 1989, J VIROL, V63, P4626, DOI 10.1128/JVI.63.11.4626-4631.1989; SAKSELA K, 1993, J VIROL, V67, P7423, DOI 10.1128/JVI.67.12.7423-7427.1993; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; SCHWARTZ D, 1994, AIDS RES HUM RETROV, V10, P1703, DOI 10.1089/aid.1994.10.1703; SESHAMMA T, 1992, P NATL ACAD SCI USA, V89, P10663, DOI 10.1073/pnas.89.22.10663; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; TONGSTARKSEN SE, 1987, P NATL ACAD SCI USA, V84, P6845, DOI 10.1073/pnas.84.19.6845; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WITHERSWARD ES, 1994, GENE DEV, V8, P1473, DOI 10.1101/gad.8.12.1473; YASUTOMI Y, 1993, J VIROL, V67, P1707, DOI 10.1128/JVI.67.3.1707-1711.1993; ZACK JA, 1988, SCIENCE, V240, P1026, DOI 10.1126/science.2835813; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	38	580	598	0	37	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1284	1290		10.1038/nm1295-1284	http://dx.doi.org/10.1038/nm1295-1284			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489410				2022-12-25	WOS:A1995TH78600041
J	FREDERICH, RC; HAMANN, A; ANDERSON, S; LOLLMANN, B; LOWELL, BB; FLIER, JS				FREDERICH, RC; HAMANN, A; ANDERSON, S; LOLLMANN, B; LOWELL, BB; FLIER, JS			LEPTIN LEVELS REFLECT BODY LIPID-CONTENT IN MICE - EVIDENCE FOR DIET-INDUCED RESISTANCE TO LEPTIN ACTION	NATURE MEDICINE			English	Article							OBESITY; FAT	The regulation of body weight and composition involves input from genes(1,2) and the environment(3,4), demonstrated, for example, by the variable susceptibility of inbred strains of mice to obesity when offered a high-fat diets. The identification of the gene responsible for obesity in the ob/ob mouse(6) provides a new approach to defining links between diet and genetics in the regulation of body weight. The ob gene protein product, leptin(7), is an adipocyte-derived circulating protein(6,8). Administration of recombinant leptin reduces food intake and increases energy expenditure in ob/ob mice(7,9,10), suggesting that it signals to the brain the magnitude of fat stores. Information on the regulation of this protein is limited. In several rodent models of obesity including db/db(6,8,11), fa/fa(12), yellow (Ay/a)(13) VMH-lesioned(14) and those induced by gold thioglucose(11), monosodium glutamate(8), and transgenic ablation of brown adipose tissues, leptin mRNA expression(6,8,11-14) and the level of circulating leptin(6,8) are increased, suggesting resistance to one or more of its actions. We have assessed the impact of increased dietary fat on circulating leptin levels in normal FVB mice and FVB mice with transgene-induced ablation of brown adipose tissue(15,16). We find that high-fat diet evokes a sustained increase in circulating leptin in both normal and transgenic mice, with leptin levels accurately reflecting the amount of body lipid across a broad range of body fat. However, despite increased leptin levels, animals fed a high-fat diet became obese without decreasing their caloric intake, suggesting that a high content of dietary fat changes the 'set point(17) for body weight, at least in part by limiting the action of leptin.			FREDERICH, RC (corresponding author), BETH ISRAEL HOSP RES N,DIV ENDOCRINOL,330 BROOKLINE AVE,BOSTON,MA 02215, USA.		Flier, jeffrey/AAG-6223-2019		NIDDK NIH HHS [R01 DK43051, P30 DK46200, R37 DK28082] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK028082, R01DK043051, P30DK046200] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bouchard C, 1994, GENETICS OBESITY; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CONSIDINE RV, 1995, J CLIN INVEST, V95, P2986, DOI 10.1172/JCI118007; DUBUC PU, 1977, HORM METAB RES, V9, P95, DOI 10.1055/s-0028-1095550; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; FRIEDMAN JM, 1992, CELL, V69, P217, DOI 10.1016/0092-8674(92)90402-X; FUNAHASHI T, 1995, BIOCHEM BIOPH RES CO, V211, P469, DOI 10.1006/bbrc.1995.1837; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HAMANN A, 1995, DIABETES, V44, P1266, DOI 10.2337/diabetes.44.11.1266; HAMANN A, IN PRESS ENDOCRINOLO; HILL JO, 1991, AM J CLIN NUTR, V54, P10, DOI 10.1093/ajcn/54.1.10; HILL JO, 1992, INT J OBESITY, V16, P321; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MAFFEI M, 1995, P NATL ACAD SCI USA, V92, P6957, DOI 10.1073/pnas.92.15.6957; MIZUNO T, 1995, END SOC ABSTR, P174; OGAWA Y, 1995, J CLIN INVEST, V96, P1647, DOI 10.1172/JCI118204; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; SALMON DMW, 1985, INT J OBESITY, V9, P443; WEIGLE DS, 1994, FASEB J, V8, P302, DOI 10.1096/fasebj.8.3.8143936; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	21	1331	1361	0	125	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1311	1314		10.1038/nm1295-1311	http://dx.doi.org/10.1038/nm1295-1311			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489415				2022-12-25	WOS:A1995TH78600046
J	MORRIS, DL; ADAMS, WJ				MORRIS, DL; ADAMS, WJ			CIMETIDINE AND COLORECTAL-CANCER - OLD DRUG, NEW USE	NATURE MEDICINE			English	Editorial Material							CELLS				MORRIS, DL (corresponding author), UNIV NEW S WALES,ST GEORGE HOSP,DEPT SURG,SYDNEY,NSW 2217,AUSTRALIA.							ADAMS WJ, 1994, LANCET, V344, P1768, DOI 10.1016/S0140-6736(94)92907-6; ADAMS WJ, 1994, AUST NZ J SURG, V64, P847, DOI 10.1111/j.1445-2197.1994.tb04562.x; ADAMS WJ, 1994, GUT, V35, P1632, DOI 10.1136/gut.35.11.1632; FISHER ER, 1989, HUM PATHOL, V20, P159, DOI 10.1016/0046-8177(89)90180-9; GARCIACABALLERO M, 1993, ADV BIOSCI, V89, P273; HANSBROUGH JF, 1986, AM J SURG, V151, P249, DOI 10.1016/0002-9610(86)90080-2; HARRISON JC, 1994, HUM PATHOL, V25, P498, DOI 10.1016/0046-8177(94)90122-8; JEZLORSKA M, 1993, GUT, V34, pS5; LAWSON J, 1994, AUST NZ J SURG, V64, P361; LINKS M, IN PRESS EUR J SURG; MATSUMOTO S, 1995, LANCET, V346, P115, DOI 10.1016/S0140-6736(95)92136-2; SVENDSEN LB, 1995, DIS COLON RECTUM, V38, P514, DOI 10.1007/BF02148852; TSUNODA T, 1992, INT J IMMUNOPHARMACO, V14, P75; UCHIDA A, 1993, CANCER IMMUNOL IMMUN, V37, P75, DOI 10.1007/BF01517038; WEESE JL, 1986, SURGERY, V100, P273	15	39	40	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1243	1244		10.1038/nm1295-1243	http://dx.doi.org/10.1038/nm1295-1243			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489398				2022-12-25	WOS:A1995TH78600029
J	SCOTT, HS; BLANCH, L; GUO, XH; FREEMAN, C; ORSBORN, A; BAKER, E; SUTHERLAND, GR; MORRIS, CP; HOPWOOD, JJ				SCOTT, HS; BLANCH, L; GUO, XH; FREEMAN, C; ORSBORN, A; BAKER, E; SUTHERLAND, GR; MORRIS, CP; HOPWOOD, JJ			CLONING OF THE SULFAMIDASE GENE AND IDENTIFICATION OF MUTATIONS IN SANFILIPPO-A-SYNDROME	NATURE GENETICS			English	Note							CDNA CLONE; SEQUENCE; EXPRESSION		WOMENS & CHILDRENS HOSP,DEPT CHEM PATHOL,LYSOSOMAL DIS RES UNIT,ADELAIDE,SA 5006,AUSTRALIA; AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,DIV CELL BIOL,CANBERRA,ACT 2601,AUSTRALIA; WOMENS & CHILDRENS HOSP,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA	Womens & Childrens Hospital Australia; Australian National University; John Curtin School of Medical Research; Womens & Childrens Hospital Australia			Sutherland, Grant Robert/D-2606-2012; Scott, Hamish/B-2122-2009	Scott, Hamish/0000-0002-5813-631X; Morris, Phillip/0000-0001-8976-619X				CALLEN DF, 1990, ANN GENET-PARIS, V33, P219; CHEN YQ, 1993, HUM MOL GENET, V2, P1841, DOI 10.1093/hmg/2.11.1841; FREEMAN C, 1986, BIOCHEM J, V234, P83, DOI 10.1042/bj2340083; HOPWOOD JJ, 1989, HEPARIN CHEM BIOL PR, P190; LEE CC, 1988, SCIENCE, V239, P1288, DOI 10.1126/science.3344434; MATALON R, 1980, PEDIATR RES, V14, P524; MIDRO AT, 1993, CLIN GENET, V44, P53; Neufeld EF, 1995, METABOLIC MOL BASES, P2465; ROBERTSON DA, 1988, BIOCHEM BIOPH RES CO, V157, P218, DOI 10.1016/S0006-291X(88)80035-4; ROBERTSON DA, 1992, BIOCHEM J, V288, P539, DOI 10.1042/bj2880539; RODEWALD A, 1980, CYTOGENET CELL GENET, V27, P267, DOI 10.1159/000131495; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; SANFILIPPO SJ, 1963, J PEDIATR, V631, P837; SCHUCHMAN EH, 1990, GENOMICS, V6, P149, DOI 10.1016/0888-7543(90)90460-C; SCOTT HS, 1991, P NATL ACAD SCI USA, V88, P9695, DOI 10.1073/pnas.88.21.9695; VANDEKAMP JJP, 1981, CLIN GENET, V20, P152; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WHITEMAN P, 1977, CLIN CHIM ACTA, V76, P139, DOI 10.1016/0009-8981(77)90126-7; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; ZHAO HG, 1994, AM J HUM GENET, V55, pA1473	20	117	130	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					465	467		10.1038/ng1295-465	http://dx.doi.org/10.1038/ng1295-465			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493035				2022-12-25	WOS:A1995TH62900032
J	STRAUSS, M; LUKAS, J; BARTEK, J				STRAUSS, M; LUKAS, J; BARTEK, J			UNRESTRICTED CELL CYCLING AND CANCER	NATURE MEDICINE			English	Editorial Material							PROLIFERATION		DANISH CANC SOC,DIV CANC BIOL,DK-2100 COPENHAGEN O,DENMARK	Danish Cancer Society	STRAUSS, M (corresponding author), HUMBOLDT UNIV BERLIN,MAX DELBRUCK CTR MOLEC MED,D-13122 BERLIN,GERMANY.		Bartek, Jiri/G-5870-2014	Lukas, Jiri/0000-0001-9087-506X				BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BATES S, 1995, SEMIN CANCER BIOL, V6, P73, DOI 10.1006/scbi.1995.0010; KOH J, 1995, NATURE, V375, P506, DOI 10.1038/375506a0; LUKAS J, 1995, MOL CELL BIOL, V15, P2600; LUKAS J, 1995, CANCER RES, V55, P4818; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; SCHMIDT EE, 1994, CANCER RES, V54, P6321; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577	14	159	162	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1245	1246		10.1038/nm1295-1245	http://dx.doi.org/10.1038/nm1295-1245			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489399				2022-12-25	WOS:A1995TH78600030
J	HANSSON, JH; NELSONWILLIAMS, C; SUZUKI, H; SCHILD, L; SHIMKETS, R; LU, Y; CANESSA, C; IWASAKI, T; ROSSIER, B; LIFTON, RP				HANSSON, JH; NELSONWILLIAMS, C; SUZUKI, H; SCHILD, L; SHIMKETS, R; LU, Y; CANESSA, C; IWASAKI, T; ROSSIER, B; LIFTON, RP			HYPERTENSION CAUSED BY A TRUNCATED EPITHELIAL SODIUM-CHANNEL GAMMA-SUBUNIT - GENETIC-HETEROGENEITY OF LIDDLE SYNDROME	NATURE GENETICS			English	Article							ALDOSTERONE SYNTHASE; MOLECULAR-GENETICS; DIABETES-MELLITUS; BLOOD-PRESSURE; DNA; COSEGREGATION; GLUCOKINASE; MUTATIONS; LINKAGE; HOMOLOG	Sensitivity of blood pressure to dietary salt is a common feature in subjects with hypertension. These features are exemplified by the mendelian disorder, Liddle's syndrome, previously shown to arise from constitutive activation of the renal epithelial sodium channel due to mutation in the beta subunit of this channel. We now demonstrate that this disease can also result from a mutation truncating the carboxy terminus of the gamma subunit of this channel; this truncated subunit also activates channel activity. These findings demonstrate genetic heterogeneity of Liddle's syndrome, indicate independent roles of beta and gamma subunits in the negative regulation of channel activity, and identify a new gene in which mutation causes a salt-sensitive form of human hypertension.	YALE UNIV, SCH MED, BOYER CTR MOLEC MED, HOWARD HUGHES MED INST, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, BOYER CTR MOLEC MED, DEPT MED, NEW HAVEN, CT 06510 USA; YALE UNIV, SCH MED, BOYER CTR MOLEC MED, DEPT GENET, NEW HAVEN, CT 06510 USA; HYOGO MED UNIV, DEPT INTERNAL MED 1, NISHINOMIYA, HYOGO 663, JAPAN; UNIV LAUSANNE, INST PHARMACOL & TOXICOL, CH-1005 LAUSANNE, SWITZERLAND; YALE UNIV, SCH MED, DEPT PHYSIOL, NEW HAVEN, CT 06520 USA; YALE UNIV, SCH MED, DEPT MED, NEW HAVEN, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Hyogo College of Medicine; University of Hyogo; University of Lausanne; Yale University; Yale University								BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; CANESSA CM, 1993, NATURE, V361, P467, DOI 10.1038/361467a0; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; EVANS GA, 1987, METHOD ENZYMOL, V152, P604; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; FUKUTAKE N, 1988, J JAP SOC INT MED, V77, P441; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARRIS EL, 1993, AM J HYPERTENS, V6, P330, DOI 10.1093/ajh/6.4.330; HATA A, 1990, NUCLEIC ACIDS RES, V18, P5407, DOI 10.1093/nar/18.18.5407; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LIDDLE GW, 1963, T ASSOC AM PHYSICIAN, V76, P199; Lifton Richard P., 1995, P2163; LIFTON RP, 1993, J HYPERTENS, V11, P231, DOI 10.1097/00004872-199303000-00002; LIFTON RP, 1992, NAT GENET, V2, P66, DOI 10.1038/ng0992-66; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; LINDPAINTNER K, 1993, J HYPERTENS, V11, P19, DOI 10.1097/00004872-199301000-00004; MANIATIS T, 1980, ANNU REV GENET, V14, P145, DOI 10.1146/annurev.ge.14.120180.001045; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MUNE T, 1995, NAT GENET, V10, P394, DOI 10.1038/ng0895-394; NABLKA T, 1995, HYPERTENSION, V25, P6; NATHANS J, 1992, J GEN PHYSIOL, V47, P110; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; RENARD S, 1994, J BIOL CHEM, V269, P12981; SAMANI NJ, 1993, J CLIN INVEST, V92, P1099, DOI 10.1172/JCI116616; Sambrook J, 1989, MOL CLONING LABORATO; SCHILD L, 1995, P NATL ACAD SCI USA, V92, P5699, DOI 10.1073/pnas.92.12.5699; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X	35	639	658	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1995	11	1					76	82		10.1038/ng0995-76	http://dx.doi.org/10.1038/ng0995-76			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550319				2022-12-25	WOS:A1995RR72800019
J	SRIWATANAWONGSA, V; DAVIES, HFS; CALNE, RY				SRIWATANAWONGSA, V; DAVIES, HFS; CALNE, RY			THE ESSENTIAL ROLES OF PARENCHYMAL TISSUES AND PASSENGER LEUKOCYTES IN THE TOLERANCE INDUCED BY LIVER GRAFTING IN RATS	NATURE MEDICINE			English	Article							I MHC MOLECULES; TRANSPLANTATION ANTIGENS; ALLOGRAFT-REJECTION; KIDNEY ALLOGRAFTS; RECIPIENTS; NONREACTIVITY; SUPPRESSION; CHIMERISM; RESPONSES	Liver allografts in pigs and rodents are uniquely capable of inducing tolerance to themselves and to other grafts of donor tissues, instead of succumbing to the acute rejection that follows transplantation of other allogeneic tissues. We demonstrate here, using normal and chimaeric rat liver grafts, that both the allogeneic liver parenchyma and the intrahepatic leukocytes of donor type contribute to the establishment of long-term tolerance, each component being essential and complementary. The essential role of hepatic parenchyma may be related to its continuous release of soluble transplantation antigens that facilitate tolerogenesis. We suggest that clinical attempts at tolerance induction by the infusion of donor bone marrow-derived leukocytes may likewise be facilitated by the coadministration of soluble transplantation antigens of donor type.	UNIV CAMBRIDGE, ADDENBROOKES HOSP, DEPT SURG, CAMBRIDGE CB2 2QQ, ENGLAND	Addenbrooke's Hospital; University of Cambridge	SRIWATANAWONGSA, V (corresponding author), CHULALONGKORN UNIV, FAC MED, DEPT SURG, BANGKOK 10330, THAILAND.							BATCHELOR JR, 1979, J EXP MED, V150, P455, DOI 10.1084/jem.150.3.455; BUTCHER GW, 1987, J IMMUNOGENET, V14, P163; CALNE R, 1994, LANCET, V343, P67, DOI 10.1016/S0140-6736(94)90809-5; CALNE R, 1991, CLIN TRANSPLANT, V5, P544; CALNE RY, 1969, NATURE, V223, P472, DOI 10.1038/223472a0; CALNE RY, 1994, TRANSPLANTATION, V57, P1433; DAHMEN U, 1994, TRANSPLANTATION, V58, P1, DOI 10.1097/00007890-199407150-00001; DAVIES HFS, 1989, TRANSPLANTATION, V47, P524; DAVIES HFS, 1983, TRANSPLANT P, V15, P831; DAVIES HFS, 1991, TRANSPLANT P, V23, P2248; DEMETRIS AJ, 1994, TRANSP CL IMMUN SFMM, V25, P325; FONTES P, 1994, LANCET, V344, P151, DOI 10.1016/S0140-6736(94)92756-1; KAMADA N, 1983, SURGERY, V93, P64; KAMADA N, 1981, NATURE, V292, P840, DOI 10.1038/292840a0; KAMADA N, 1983, TRANSPLANTATION, V35, P304, DOI 10.1097/00007890-198304000-00008; KAMADA N, 1980, TRANSPLANTATION, V29, P429, DOI 10.1097/00007890-198005000-00021; LECHLER RI, 1982, J EXP MED, V155, P31, DOI 10.1084/jem.155.1.31; MILLARD PR, 1971, TRANSPLANT P, V3, P505; PRIESTLEY CA, 1989, TRANSPLANTATION, V48, P1031, DOI 10.1097/00007890-198912000-00028; QIAN SW, 1994, HEPATOLOGY, V19, P916, DOI 10.1002/hep.1840190418; RASMUSSEN A, IN PRESS TRANSPLANTA; SETTAF A, 1988, TRANSPLANTATION, V46, P32, DOI 10.1097/00007890-198807000-00005; SINGH PB, 1988, J EXP MED, V168, P195, DOI 10.1084/jem.168.1.195; SPENCER SC, 1987, IMMUNOGENETICS, V25, P91, DOI 10.1007/BF00364273; SRIWATANAWONGSA V, 1993, TRANSPLANT P, V25, P371; SRIWATANAWONGSA V, IN PRESS TRANSPLANTA; STARZL TE, 1993, TRANSPLANTATION, V55, P1272, DOI 10.1097/00007890-199306000-00012; STARZL TE, 1992, LANCET, V339, P1579, DOI 10.1016/0140-6736(92)91840-5; STARZL TE, 1993, IMMUNOL TODAY, V14, P326, DOI 10.1016/0167-5699(93)90054-O; SUMIMOTO R, 1990, TRANSPLANTATION, V50, P678, DOI 10.1097/00007890-199010000-00029; ZAVAZAVA N, 1992, TRANSPLANT INT, V5, pS606; ZIMMERMANN FA, 1979, TRANSPLANT P, V11, P571; ZIMMERMANN FA, 1984, TRANSPLANTATION, V37, P406, DOI 10.1097/00007890-198404000-00019	33	117	118	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	1995	1	5					428	432		10.1038/nm0595-428	http://dx.doi.org/10.1038/nm0595-428			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585089				2022-12-25	WOS:A1995RN10000032
J	WALGENBACH, KJ; GRATAS, C; SHESTAK, KC; BECKER, D				WALGENBACH, KJ; GRATAS, C; SHESTAK, KC; BECKER, D			ISCHEMIA-INDUCED EXPRESSION OF BFGF IN NORMAL SKELETAL-MUSCLE - A POTENTIAL PARACRINE MECHANISM FOR MEDIATING ANGIOGENESIS IN ISCHEMIC SKELETAL-MUSCLE	NATURE MEDICINE			English	Article							FIBROBLAST GROWTH-FACTOR; NUCLEOTIDE-SEQUENCE; ENDOTHELIAL-CELLS; RABBIT MODEL; INVIVO; DIFFERENTIATION; PROLIFERATION; ISCHEMIA; RECEPTOR; LIMB	To test the hypothesis that induction of endogenous bFGF can lead to angiogenesis in ischaemic skeletal muscle, we studied the expression of bFGF after transposition of a well-vascularized muscle flap onto an ischaemic hindlimb in the rabbit. The results indicated a marked induction of bFGF mRNA throughout the myoblasts of the well-perfused muscle flap but not the myoblasts of the ischaemic muscle. bFGF protein was detected in the muscle flap, particularly in the myoblasts located closest to a newly formed, adjacent interface, and in the interface itself. In contrast, bFGF expression was not induced after transposition of a well-perfused muscle flap onto healthy muscle tissue. These data provide evidence that the juxtaposition of ischaemic skeletal muscle with healthy mesenchymal tissue triggers an increased expression of bFGF in the myoblasts of the well-perfused muscle. This paracrine induction of bFGF, in turn, leads to increased angiogenesis and regeneration of the ischaemic skeletal muscle.	UNIV PITTSBURGH,DEPT MED,PITTSBURGH,PA 15213; UNIV PITTSBURGH,DEPT SURG,DIV PLAST SURG,PITTSBURGH,PA 15213	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			Gratas-Rabbia-Ré, Catherine/K-9280-2015	Gratas-Rabbia-Ré, Catherine/0000-0002-9155-6906				ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; BAFFOUR R, 1992, J VASC SURG, V16, P181, DOI 10.1016/0741-5214(92)90106-I; BECKER D, 1989, GENOMICS, V4, P97, DOI 10.1016/0888-7543(89)90320-0; BECKER D, 1992, ONCOGENE, V7, P2303; CHLEBOUN JO, 1992, BIOCHEM BIOPH RES CO, V185, P510, DOI 10.1016/0006-291X(92)91654-9; FOLKMAN J, 1979, P NATL ACAD SCI USA, V76, P5217, DOI 10.1073/pnas.76.10.5217; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; GOSPODAROWICZ D, 1986, CELL DIFFER DEV, V19, P1, DOI 10.1016/0045-6039(86)90021-7; GOSPODAROWICZ D, 1989, J INVEST DERMATOL, V93, P39; GROTENDORST GR, 1985, J CLIN INVEST, V76, P2323, DOI 10.1172/JCI112243; HENDRICKS DL, 1990, J SURG RES, V49, P453, DOI 10.1016/0022-4804(90)90195-8; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297; NAKAJIMAIIJIMA S, 1985, P NATL ACAD SCI USA, V82, P6133, DOI 10.1073/pnas.82.18.6133; NICKOLOFF BJ, 1993, ARCH DERMATOL, V129, P250, DOI 10.1001/archderm.129.2.250; PARUMS DV, 1990, J CLIN PATHOL, V43, P752, DOI 10.1136/jcp.43.9.752; PEVEC WC, 1991, J VASC SURG, V13, P385, DOI 10.1067/mva.1991.24915; PIERCE GF, 1989, J CELL BIOL, V109, P429, DOI 10.1083/jcb.109.1.429; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Pu L Q, 1994, J Invest Surg, V7, P49, DOI 10.3109/08941939409018282; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952; VIGNOVICH J, 1993, INT J ONCOL, V2, P637; WILCOX JN, 1988, J CLIN INVEST, V82, P1134, DOI 10.1172/JCI113671; YANAGISAWAMIWA A, 1992, SCIENCE, V257, P1401, DOI 10.1126/science.1382313	27	50	50	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1995	1	5					453	459		10.1038/nm0595-453	http://dx.doi.org/10.1038/nm0595-453			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585094				2022-12-25	WOS:A1995RN10000037
J	DAVIDSON, DJ; DORIN, JR; MCLACHLAN, G; RANALDI, V; LAMB, D; DOHERTY, C; GOVAN, J; PORTEOUS, DJ				DAVIDSON, DJ; DORIN, JR; MCLACHLAN, G; RANALDI, V; LAMB, D; DOHERTY, C; GOVAN, J; PORTEOUS, DJ			LUNG-DISEASE IN THE CYSTIC-FIBROSIS MOUSE EXPOSED TO BACTERIAL PATHOGENS	NATURE GENETICS			English	Article							PSEUDOMONAS-CEPACIA; GENE; MICE; IDENTIFICATION; MICROBIOLOGY; COLONIZATION; INFECTION; TRANSPORT	Lung disease is the major cause of death in cystic fibrosis (CF), but there is no evidence for overt lung involvement at birth. We show here that the same is true for the gene targeted cftr(m1HGU) mutant mouse. Furthermore, this CF mouse model demonstrates an impaired capacity to clear Staphylococcus aureus and Burkholderia (Pseudomonas) cepacia, two opportunistic lung pathogens closely associated with lung disease in CF subjects. The cftr(m1HGU) homozygotes display mucus retention and frank lung disease in response to repeated microbial exposure. Thus, lung disease in the cftr(m1HGU) mouse develops in response to bacterial infection, establishing a model to dissect the pathogenesis of CF pulmonary disease and providing a clinically relevant end point to assess the efficacy of pharmacologic or genetic interventions.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; WESTERN GEN HOSP,BIOMED RES FACIL,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,SCH MED,DEPT PATHOL,EDINBURGH,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,SCH MED,DEPT MED MICROBIOL,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh			Porteous, David J/C-7289-2013; Porteous, David/AAA-3446-2021	Porteous, David J/0000-0003-1249-6106; Porteous, David/0000-0003-1249-6106; McLachlan, Gerry/0000-0001-5362-9804				ALTON EWFW, 1992, THORAX, V47, P1010, DOI 10.1136/thx.47.12.1010; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CAPLEN NJ, 1995, NAT MED, V1, P39, DOI 10.1038/nm0195-39; DORIN JR, 1994, MAMM GENOME, V5, P465, DOI 10.1007/BF00369314; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; DORIN JR, 1994, CYSTIC FIBROSIS CURR, V2, P3; Editorial, 1992, LANCET, V339, P1385; ENGLEHARDT JF, 1992, NAT GENET, V2, P240; GILLIGAN PH, 1991, CLIN MICROBIOL REV, V4, P35, DOI 10.1128/CMR.4.1.35-51.1991; GOVAN JR, 1993, J R SOC MED, V20, P11; GOVAN JRW, 1993, LANCET, V342, P15, DOI 10.1016/0140-6736(93)91881-L; GOVAN JRW, 1992, BRIT MED BULL, V48, P912, DOI 10.1093/oxfordjournals.bmb.a072585; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; HYDE SC, 1993, NATURE, V362, P250, DOI 10.1038/362250a0; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KUBESCH P, 1993, LANCET, V341, P189, DOI 10.1016/0140-6736(93)90062-L; MEARNS M, 1992, CYSTIC FIBROSIS CURR, V1, P217; NELSON JW, 1994, FEMS IMMUNOL MED MIC, V8, P89, DOI 10.1111/j.1574-695X.1994.tb00430.x; ONEAL WK, 1993, HUM MOL GENET, V2, P1561, DOI 10.1093/hmg/2.10.1561; OPPENHEIMER EH, 1976, PERSPECT PEDIAT PATH, V2, P241; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; RIORDAN JR, 1989, SCIENCE, V245, P1066; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; SMITHS, IN PRESS AM J PHYSL; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; TABLAN OC, 1987, CHEST, V91, P527, DOI 10.1378/chest.91.4.527; WOOD RE, 1974, PEDIATR RES, V8, P471, DOI 10.1203/00006450-197404000-00788; YEATES DB, 1976, ARCH DIS CHILD, V51, P28, DOI 10.1136/adc.51.1.28; 1993, NEW ENGL J MED, V329, P1308	31	115	122	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1995	9	4					351	357		10.1038/ng0495-351	http://dx.doi.org/10.1038/ng0495-351			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7540910				2022-12-25	WOS:A1995QQ75300011
J	FRAZER, KA; NARLA, G; ZHANG, JL; RUBIN, EM				FRAZER, KA; NARLA, G; ZHANG, JL; RUBIN, EM			THE APOLIPOPROTEIN(A) GENE IS REGULATED BY SEX-HORMONES AND ACUTE-PHASE INDUCERS IN YAC TRANSGENIC MICE	NATURE GENETICS			English	Article							LP(A) GLYCOPROTEIN PHENOTYPES; LIPOPROTEIN TRAIT; SIZE POLYMORPHISM; PLASMA; SEQUENCE; PLASMINOGEN	High plasma concentrations of apolipoprotein (a) (apo(a)) have been implicated as a major independent risk factor for atherosclerosis in humans. Apo(a) is a large, evolutionarily new gene (present primarily in primates) for which considerable controversy exists concerning the factors that regulate its expression. To investigate the in vivo regulation of apo(a), we have created several lines of YAC transgenic mice containing a 110-kb human apo(a) gene surrounded by greater than 60 kb of 5' and 3' flanking DNA. Studies in humans have suggested that acute-phase inducers increase and sex steroids decrease apo(a) concentrations, but these results are controversial. Analysis of the YAC transgenic mice conclusively supports the hypothesized role of sex steroids and refutes the suggested role of acute-phase inducers in regulating the apo(a) gene.	GRAD THEOL UNION,LAWRENCE BERKELEY LAB,CTR HUMAN GENOME,BERKELEY,CA 94720	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory			Narla, Goutham/AAZ-5710-2020	Narla, Goutham/0000-0003-4098-4203; Frazer, Kelly/0000-0002-6060-8902	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018574] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-18574] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOERWINKLE E, 1989, HUM GENET, V82, P73, DOI 10.1007/BF00288277; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BYRNE CD, 1994, ARTERIOSCLER THROMB, V14, P534, DOI 10.1161/01.ATV.14.4.534; CALLOW MJ, 1994, P NATL ACAD SCI USA, V92, P21130; CHLESA G, 1992, J BIOL CHEM, V287, P24369; COHEN JC, 1993, J CLIN INVEST, V91, P1630, DOI 10.1172/JCI116370; GRAINGER DJ, 1993, SCIENCE, V260, P1655, DOI 10.1126/science.8503012; HAFFNER SM, 1994, ARTERIOSCLER THROMB, V14, P19, DOI 10.1161/01.ATV.14.1.19; HENRIKSSON P, 1992, J CLIN INVEST, V89; KRAFT HG, 1989, J CLIN INVEST, V83, P137, DOI 10.1172/JCI113849; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; LAWN RM, 1982, NATURE, V360, P670; LINTON MF, 1993, J CLIN INVEST, V92, P3029, DOI 10.1172/JCI116927; MAEDA S, 1989, ATHEROSCLEROSIS, V78, P145, DOI 10.1016/0021-9150(89)90218-9; MAGNAGHI P, 1994, HUM MOL GENET, V3, P437, DOI 10.1093/hmg/3.3.437; MALGARETTI N, 1992, P NATL ACAD SCI USA, V69, P11584; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; NACHMAN RL, 1992, BLOOD, V79, P1897, DOI 10.1182/blood.V79.8.1897.bloodjournal7981897; PEROMBELON YFN, 1994, J CLIN INVEST, V93, P1481, DOI 10.1172/JCI117126; SANDHOLZER C, 1991, HUM GENET, V86, P607; SCANU AM, 1991, ANN INTERN MED, V115, P209, DOI 10.7326/0003-4819-115-3-209; SCHEDL A, 1993, NUCLEIC ACIDS RES, V21, P4783, DOI 10.1093/nar/21.20.4783; SIUNGA L, 1992, SCAND J CLIN LAB INV, V52, P95; SOMA MR, 1994, CHEM PHYS LIPIDS, V678, P345; TANG JJ, 1991, J LIPID RES, V32, P1571; TOMLINSON JE, 1989, J BIOL CHEM, V264, P5957; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; UTERMANN G, 1988, HUM GENET, V78, P47, DOI 10.1007/BF00291233; UTERMANN G, 1988, HUM GENET, V78, P41, DOI 10.1007/BF00291232; WADE DP, 1993, P NATL ACAD SCI USA, V90, P1369, DOI 10.1073/pnas.90.4.1369; YANG FM, 1993, GENOMICS, V18, P374, DOI 10.1006/geno.1993.1478	33	105	109	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1995	9	4					424	431		10.1038/ng0495-424	http://dx.doi.org/10.1038/ng0495-424			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795650				2022-12-25	WOS:A1995QQ75300022
J	LIU, B; FARRINGTON, SM; PETERSEN, GM; HAMILTON, SR; PARSONS, R; PAPADOPOULOS, N; FUJIWARA, T; JEN, J; KINZLER, KW; WYLLIE, AH; VOGELSTEN, B; DUNLOP, MG				LIU, B; FARRINGTON, SM; PETERSEN, GM; HAMILTON, SR; PARSONS, R; PAPADOPOULOS, N; FUJIWARA, T; JEN, J; KINZLER, KW; WYLLIE, AH; VOGELSTEN, B; DUNLOP, MG			GENETIC INSTABILITY OCCURS IN THE MAJORITY OF YOUNG-PATIENTS WITH COLORECTAL-CANCER	NATURE MEDICINE			English	Article							NONPOLYPOSIS COLON-CANCER; MICROSATELLITE INSTABILITY; NATURAL-HISTORY; MUTATIONS; CARCINOMA; POLYPOSIS; HOMOLOG	Replication errors (RER) associated with genetic instability have been found in cancers of several different types and particularly in the tumours of patients with hereditary non-polyposis colorectal cancer (HNPCC). We have here determined the prevalence of such instability in relation to age among patients without HNPCC. Colorectal cancers (CRCs) in the majority of patients 35 years of age or younger exhibited instability (58% of 31 patients), whereas CRCs from patients older than 35 uncommonly did (12% of 158, P < 0.0001). Twelve of the patients under 35 with instability were evaluated for alterations of mismatch repair genes, and five were found to harbour germline mutations. These data suggest that the mechanisms underlying tumour development in young CRC patients differ from those in most order patients, regardless of HNPCC status. The results have important implications for genetic testing and management of young CRC patients and their families.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,DEPT PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,DEPT ONCOL,BALTIMORE,MD 21205; UNIV EDINBURGH,SCH MED,DEPT PATHOL,CANC RES CAMPAIGN LABS,EDINBURGH EH8 9AG,MIDLOTHIAN,SCOTLAND; UNIV EDINBURGH,ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND	University of Edinburgh; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	LIU, B (corresponding author), JOHNS HOPKINS ONCOL CTR,424 N BOND ST,BALTIMORE,MD 21231, USA.		Dunlop, Malcolm G/F-1973-2011; Farrington, Susan M/Q-2710-2019; Farrington, Susan M/C-7319-2013; Papadopoulos, Nickolas/K-7272-2012	Dunlop, Malcolm G/0000-0002-3033-5851; Farrington, Susan M/0000-0001-5955-7389; Parsons, Ramon/0000-0002-6656-3514	NATIONAL CANCER INSTITUTE [R37CA035494, P50CA062924, R01CA035494, R01CA047527] Funding Source: NIH RePORTER; NCI NIH HHS [CA35494, CA62924, CA47527] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BURKS RT, 1994, ONCOGENE, V9, P1163; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; COSTA LT, 1995, NAT GENET, V9, P9; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; HAN HJ, 1993, CANCER RES, V53, P5087; HARTWELL L, 1991, ORIGINS OF HUMAN CANCER, P45; HEMMINKI A, 1994, NAT GENET, V8, P405, DOI 10.1038/ng1294-405; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; KIM H, 1994, AM J PATHOL, V145, P1; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; LIU B, 1994, CANCER RES, V54, P4590; LOEB LA, 1974, CANCER RES, V34, P2311; LOTHE RA, 1993, CANCER RES, V53, P5849; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; MERLO A, 1994, CANCER RES, V54, P2098; MILLER BA, 1993, NIH932789 NATL CANC; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; ORTH K, 1994, P NATL ACAD SCI USA, V91, P9495, DOI 10.1073/pnas.91.20.9495; PALOMBO F, 1994, NATURE, V367, P417, DOI 10.1038/367417a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PELTOMAKI P, 1993, CANCER RES, V53, P5853; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; RISINGER JI, 1993, CANCER RES, V53, P5100; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; UMAR A, 1994, J BIOL CHEM, V269, P14367; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152; 1990, CANCER REGISTRATION	39	322	328	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1995	1	4					348	352		10.1038/nm0495-348	http://dx.doi.org/10.1038/nm0495-348			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585065				2022-12-25	WOS:A1995RN09800031
J	SMITH, MA; SIEDLAK, SL; RICHEY, PL; MULVIHILL, P; GHISO, J; FRANGIONE, B; TAGLIAVINI, F; GIACCONE, G; BUGIANI, O; PRAPROTNIK, D; KALARIA, RN; PERRY, G				SMITH, MA; SIEDLAK, SL; RICHEY, PL; MULVIHILL, P; GHISO, J; FRANGIONE, B; TAGLIAVINI, F; GIACCONE, G; BUGIANI, O; PRAPROTNIK, D; KALARIA, RN; PERRY, G			TAU-PROTEIN DIRECTLY INTERACTS WITH THE AMYLOID BETA-PROTEIN PRECURSOR - IMPLICATIONS FOR ALZHEIMERS-DISEASE	NATURE MEDICINE			English	Article							PAIRED HELICAL FILAMENTS; NEUROFIBRILLARY TANGLES; BRAIN; PHOSPHORYLATION; DEPOSITION; PLAQUES; INVITRO; BINDING; ALPHA-1-ANTICHYMOTRYPSIN; PATHOLOGY	The simultaneous presence of intracellular neurofibrillary tangles (NFT) and extracellular senile plaques in Alzheimer's disease (AD) suggests that the two lesions could be synergistically interrelated. However, although the main protein components of NFT and senile plaques, (tau) and amyloid beta-protein, respectively, are well characterized, the molecular mechanisms responsible for their deposition in lesions are unknown. We demonstrate, using four independent techniques, that tau directly interacts with a conformation-dependent domain of the amyloid beta-protein precursor (beta PP) encompassing residues beta PP714-723. The putative tau-binding domain includes beta PP717 mutation sites that are associated with familial forms of AD. Our findings strongly suggest that NFT and senile plaques, often thought of as independent structures, may play a role in each other's formation during the pathogenesis of AD.	NYU,MED CTR,DEPT PATHOL,NEW YORK,NY 10016; IST NAZL NEUROL CARLO BESTA,DIV NEUROPATHOL,I-20133 MILAN,ITALY	New York University; IRCCS Istituto Neurologico Besta	SMITH, MA (corresponding author), CASE WESTERN RESERVE UNIV,INST PATHOL,2085 ADELBERT RD,CLEVELAND,OH 44106, USA.		Tagliavini, Fabrizio/AAO-7891-2021; giaccone, giorgio/AAB-9978-2019; Giaccone, Giorgio/J-6212-2012; Smith, Mark A/A-9053-2009; Perry, George/A-8611-2009; Kalaria, Raj/AAX-2630-2020	Tagliavini, Fabrizio/0000-0003-1039-7315; giaccone, giorgio/0000-0002-4803-0802; Perry, George/0000-0002-6547-0172; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG005891, R37AG005891, R01AG007552] Funding Source: NIH RePORTER; NIA NIH HHS [AG05891, AG07552] Funding Source: Medline; NINDS NIH HHS [NS 30455] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALZHEIMER A, 1907, ZENTRALBL NERVENHEIL, V18, P177; AUTILIOGAMBETTI L, 1988, FEBS LETT, V241, P94, DOI 10.1016/0014-5793(88)81038-X; CAPUTO CB, 1992, BRAIN RES, V597, P227, DOI 10.1016/0006-8993(92)91478-W; CONNOLLY JA, 1977, P NATL ACAD SCI USA, V74, P2437, DOI 10.1073/pnas.74.6.2437; CRAS P, 1990, AM J PATHOL, V137, P241; DAVIES L, 1988, NEUROLOGY, V38, P1688, DOI 10.1212/WNL.38.11.1688; ELLISMAN M, 1987, ALTERATIONS NEURONAL, P61; FRASER PE, 1993, J NEUROCHEM, V61, P298, DOI 10.1111/j.1471-4159.1993.tb03568.x; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; KALARIA RN, 1991, NEUROPATH APPL NEURO, V17, P189, DOI 10.1111/j.1365-2990.1991.tb00714.x; KALARIA RN, 1992, BRAIN RES, V585, P87, DOI 10.1016/0006-8993(92)91193-I; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWAI M, 1993, BRAIN RES, V623, P142, DOI 10.1016/0006-8993(93)90021-E; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LINDWALL G, 1984, J BIOL CHEM, V259, P2241; MAGGIO JE, 1992, P NATL ACAD SCI USA, V89, P5462, DOI 10.1073/pnas.89.12.5462; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MIYATA Y, 1986, J BIOL CHEM, V261, P3026; PERRY G, 1993, AM J PATHOL, V143, P1586; PERRY G, 1988, LANCET, V2, P746; PERRY G, 1993, MED HYPOTHESES, V40, P257, DOI 10.1016/0306-9877(93)90051-Q; PERRY G, 1982, MUSCLE CELL MOTILITY, V2; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; REFOLO LM, 1991, J NEUROSCI, V11, P3888; ROHER AE, 1993, J NEUROCHEM, V61, P1916, DOI 10.1111/j.1471-4159.1993.tb09834.x; SELDEN SC, 1983, J BIOL CHEM, V258, P7064; SHIN RW, 1993, P NATL ACAD SCI USA, V90, P6825, DOI 10.1073/pnas.90.14.6825; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SMITH MA, 1994, P NATL ACAD SCI USA, V91, P5710, DOI 10.1073/pnas.91.12.5710; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573	35	78	81	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1995	1	4					365	369		10.1038/nm0495-365	http://dx.doi.org/10.1038/nm0495-365			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585068				2022-12-25	WOS:A1995RN09800034
J	MALHOTRA, R; WORMALD, MR; RUDD, PM; FISCHER, PB; DWEK, RA; SIM, RB				MALHOTRA, R; WORMALD, MR; RUDD, PM; FISCHER, PB; DWEK, RA; SIM, RB			GLYCOSYLATION CHANGES OF IGG ASSOCIATED WITH RHEUMATOID-ARTHRITIS CAN ACTIVATE COMPLEMENT VIA THE MANNOSE-BINDING PROTEIN	NATURE MEDICINE			English	Article							SERUM IGG; LECTIN; SITE; OLIGOSACCHARIDE; RECOGNITION; DOMAINS; C1Q	The glycosylation of the circulating immunoglobulin-gamma (IgC) antibody molecules changes in rheumatoid arthritis. The extent of the changes correlates with the disease severity and reverses in remission. We demonstrate here that the alteration in glycosylation associated with rheumatoid arthritis can create a new mode for the interaction of IgC with complement through binding to the collagenous lectin mannose-binding protein (MBP). Rheumatoid arthritis is associated with a marked increase in IgC glycoforms that lack galactose (referred to as CO glycoforms) in the Fc region of the molecule and that terminate in N-acetyl glucosamine (GlcNAc). We show, using nuclear magnetic resonance (NMR) and X-ray data, that these terminal GlcNAc residues become accessible for MBP binding. We further demonstrate that multiple presentation of IgG-GO glycoforms to MBP results in activation of the complement. This suggests that a contribution to the chronic inflammation of the synovial membrane could arise from the localization of the IgG-GO glycoforms in the affected joint and from resulting activation of complement.	UNIV OXFORD, DEPT BIOCHEM, INST GLYCOBIOL, OXFORD OX1 3QU, ENGLAND; UNIV OXFORD, DEPT BIOCHEM, MRC, IMMUNOCHEM UNIT, OXFORD OX1 3QU, ENGLAND	University of Oxford; University of Oxford			Sim, Bob/A-1354-2008; Wormald, Mark R/G-2785-2011	Sim, Bob/0000-0002-2855-7455; Wormald, Mark R/0000-0002-4853-2773				ASHFORD D, 1987, EUR J BIOCHEM, V166, P311, DOI 10.1111/j.1432-1033.1987.tb13516.x; BURTON DR, 1980, NATURE, V288, P338, DOI 10.1038/288338a0; CHANG SC, 1993, THESIS OXFORD; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; DWEK RA, 1984, BIOCHEM SOC SYMP, P123; IKEDA K, 1987, J BIOL CHEM, V262, P7451; IOBST ST, 1994, J BIOL CHEM, V269, P15505; KIYOHARA T, 1976, J BIOCHEM, V80, P9, DOI 10.1093/oxfordjournals.jbchem.a131263; MALHOTRA R, 1994, IMMUNOLOGY, V82, P439; MALHOTRA R, 1990, J EXP MED, V172, P955, DOI 10.1084/jem.172.3.955; Malhotra R, 1994, Clin Exp Immunol, V97 Suppl 2, P4; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Morgan B, 1990, COMPLEMENT CLIN ASPE; PAREKH R, 1988, J EXP MED, V167, P1731, DOI 10.1084/jem.167.5.1731; PAREKH R, 1989, J AUTOIMMUN, V2, P101, DOI 10.1016/0896-8411(89)90148-0; PAREKH RB, 1987, EMBO J, V6, P1233, DOI 10.1002/j.1460-2075.1987.tb02359.x; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; PAREKH RB, 1987, THESIS OXFORD U; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; RADEMACHER TW, 1986, BIOCHEM SOC SYMP, P131; RADEMACHER TW, 1994, P NATL ACAD SCI USA, V91, P6123, DOI 10.1073/pnas.91.13.6123; RADEMACHER TW, 1988, SPRINGER SEMIN IMMUN, V10, P231, DOI 10.1007/BF01857227; ROOK GAW, 1991, J AUTOIMMUN, V4, P779, DOI 10.1016/0896-8411(91)90173-A; SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789; SJOHOLM AG, 1991, APMIS, V99, P1120; SUPER M, 1992, NAT GENET, V2, P50, DOI 10.1038/ng0992-50; TSUCHIYA N, 1993, J IMMUNOL, V151, P1137; VANZEBEN D, 1994, BRIT J RHEUMATOL, V33, P36; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3	32	636	696	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	1995	1	3					237	243		10.1038/nm0395-237	http://dx.doi.org/10.1038/nm0395-237			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX559	7585040				2022-12-25	WOS:A1995QX55900030
J	KREMER, H; KRAAIJ, R; TOLEDO, SPA; POST, M; FRIDMAN, JB; HAYASHIDA, CY; VANREEN, M; MILGROM, E; ROPERS, HH; MARIMAN, E; THEMMEN, APN; BRUNNER, HG				KREMER, H; KRAAIJ, R; TOLEDO, SPA; POST, M; FRIDMAN, JB; HAYASHIDA, CY; VANREEN, M; MILGROM, E; ROPERS, HH; MARIMAN, E; THEMMEN, APN; BRUNNER, HG			MALE PSEUDOHERMAPHRODITISM DUE TO A HOMOZYGOUS MISSENSE MUTATION OF THE LUTEINIZING-HORMONE RECEPTOR GENE	NATURE GENETICS			English	Article							LEYDIG-CELL HYPOPLASIA; NEONATAL RAT TESTIS; GONADOTROPIN RECEPTORS; PRECOCIOUS PUBERTY; FETAL; EXPRESSION; DNA; LH; STIMULATION; PROTEIN	Leydig cell hypoplasia is a rare autosomal recessive condition that interferes with normal development of male external genitalia in 46,XY individuals. We have studied two Leydig cell hypoplasia patients (siblings born to consanguineous parents), and found them to be homozygous for a missense mutation (Ala593Pro) in the sixth transmembrane domain of the luteinizing hormone (LH) receptor gene. In vitro expression studies showed that this mutated receptor binds human choriogonadotropin with a normal K-D, but the ligand binding does not result in increased production of cAMP. We conclude that a homozygous LH receptor gene mutation underlies the syndrome of autosomal recessive congenital Leydig cell hypoplasia in this family. These results have implications for the understanding of the development of the male genitalia.	ERASMUS UNIV ROTTERDAM, DEPT ENDOCRINOL & REPROD, 3000 DR ROTTERDAM, NETHERLANDS; UNIV NIJMEGEN HOSP, DEPT HUMAN GENET, 6500 HB NIJMEGEN, NETHERLANDS; UNIV SAO PAULO, SCH MED,DEPT MED,DIV ENDOCRINE, ENDOCRINE GENET UNIT, BR-05508 SAO PAULO, BRAZIL; UNIV PARIS, FAC MED BICETRE,INSERM,U135, UNITE RECH HORMONES & REPROD, PARIS, FRANCE	Erasmus University Rotterdam; Radboud University Nijmegen; Universidade de Sao Paulo; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Reen, M.M.M./L-4593-2015; Kremer, Hannie/F-5126-2010; Brunner, Han/C-9928-2013; Toledo, Sergio P. A./S-9291-2018	Kremer, Hannie/0000-0002-0841-8693; Toledo, Sergio P. A./0000-0002-2590-3519				ARNHOLD I J P, 1987, Revista do Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo, V42, P227; BLOK LJ, 1992, MOL CELL ENDOCRINOL, V88, P153, DOI 10.1016/0303-7207(92)90020-7; BRAUN T, 1991, EMBO J, V10, P1885, DOI 10.1002/j.1460-2075.1991.tb07714.x; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CLEMENTS JA, 1976, J CLIN ENDOCR METAB, V42, P9, DOI 10.1210/jcem-42-1-9; ELAWADY MK, 1987, HUM HERED, V37, P36, DOI 10.1159/000153675; GEORGE FW, 1978, ENDOCRINOLOGY, V102, P665, DOI 10.1210/endo-102-3-665; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HUHTANIEMI I, 1994, EUR J ENDOCRINOL, V130, P25, DOI 10.1530/eje.0.1300025; HUHTANIEMI I, 1992, P SOC EXP BIOL MED, V201, P125, DOI 10.3181/00379727-201-43493; HUHTANIEMI IT, 1977, J CLIN ENDOCR METAB, V44, P963, DOI 10.1210/jcem-44-5-963; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; KETELSLEGERS JM, 1978, BIOCHIM BIOPHYS ACTA, V541, P360, DOI 10.1016/0304-4165(78)90195-2; KREMER H, 1993, HUM MOL GENET, V2, P1779, DOI 10.1093/hmg/2.11.1779; KUOPIO T, 1989, BIOL REPROD, V40, P135, DOI 10.1095/biolreprod40.1.135; LEE PA, 1982, FERTIL STERIL, V37, P675; MARTINEZMORA J, 1991, CLIN ENDOCRINOL, V34, P485, DOI 10.1111/j.1365-2265.1991.tb00329.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MINEGISH T, 1990, BIOCHEM BIOPH RES CO, V172, P1049, DOI 10.1016/0006-291X(90)91552-4; MOLENAAR R, 1986, ENDOCRINOLOGY, V118, P2546, DOI 10.1210/endo-118-6-2546; MURONO EP, 1994, J STEROID BIOCHEM, V48, P377, DOI 10.1016/0960-0760(94)90078-7; NORDQVIST K, 1994, NAT GENET, V7, P7, DOI 10.1038/ng0594-7; PATSAVOUDI E, 1985, J ENDOCRINOL, V105, P235, DOI 10.1677/joe.0.1050235; PEREZPALACIOS G, 1981, ACTA ENDOCRINOL-COP, V98, P148, DOI 10.1530/acta.0.0980148; SALDANHA PH, 1987, AM J MED GENET, V26, P337, DOI 10.1002/ajmg.1320260212; SCHWARTZ M, 1981, J CLIN ENDOCR METAB, V53, P123, DOI 10.1210/jcem-53-1-123; SHENKER A, 1993, NATURE, V365, P652, DOI 10.1038/365652a0; STOOF JC, 1987, BRAIN RES, V423, P364, DOI 10.1016/0006-8993(87)90864-X; THEMMEN APN, 1991, MOL CELL ENDOCRINOL, V78, pR7, DOI 10.1016/0303-7207(91)90130-K; Toledo S P, 1985, Prog Clin Biol Res, V200, P311; TOLEDO SPA, 1992, CLIN ENDOCRINOL, V36, P521, DOI 10.1111/j.1365-2265.1992.tb02256.x; VANDIJK MA, 1991, MOL CELL ENDOCRINOL, V81, P81, DOI 10.1016/0303-7207(91)90207-9; WARREN DW, 1984, ENDOCRINOLOGY, V114, P470, DOI 10.1210/endo-114-2-470; ZHANG FP, 1994, ENDOCRINOLOGY, V134, P2206, DOI 10.1210/en.134.5.2206	35	227	236	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1995	9	2					160	164		10.1038/ng0295-160	http://dx.doi.org/10.1038/ng0295-160			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719343	Green Submitted			2022-12-25	WOS:A1995QE67200017
J	GRAINGER, DJ; KEMP, BR; METCALFE, JC; LIU, AC; LAWN, RM; WILLIAMS, NR; GRACE, AA; SCHOFIELD, PM; CHAUHAN, A				GRAINGER, DJ; KEMP, BR; METCALFE, JC; LIU, AC; LAWN, RM; WILLIAMS, NR; GRACE, AA; SCHOFIELD, PM; CHAUHAN, A			THE SERUM CONCENTRATION OF ACTIVE TRANSFORMING GROWTH-FACTOR-BETA IS SEVERELY DEPRESSED IN ADVANCED ATHEROSCLEROSIS	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE CELLS; MYOCARDIAL-INFARCTION; TGF-BETA; LIPOPROTEIN; ACTIVATION; PROLIFERATION; PATHOGENESIS; PLASMINOGEN; INHIBITOR; CULTURE	Recent evidence has led us to propose that transforming growth factor-beta (TGF-beta) is a key inhibitor of atherosclerosis. We show here that a population of patients with advanced atherosclerosis all have less active TGF-beta in their sera than patients with normal coronary arteries, with a fivefold difference in average concentration between the two groups. This correlation with atherosclerosis is much stronger than for other known major risk factors and it may therefore have important diagnostic and prognostic significance. Aspirin medication correlates with an increase in active TGF-beta concentration, indicating that therapeutic interventions for TGF-beta are possible.	STANFORD UNIV, SCH MED, FALK CARDIOVASC RES CTR, STANFORD, CA 94305 USA; PAPWORTH HOSP NHS TRUST, DEPT CARDIOL, CAMBRIDGE CB3 8RE, ENGLAND	Stanford University; Papworth Hospital	GRAINGER, DJ (corresponding author), UNIV CAMBRIDGE, DEPT BIOCHEM, TENNIS COURT RD, CAMBRIDGE CB2 1QW, ENGLAND.		WILLIAMS, Norman/C-2002-2008	WILLIAMS, Norman/0000-0001-6496-312X; Kemp, Paul/0000-0001-8975-7293				BUTTA A, 1992, CANCER RES, V52, P4261; COLLETTA AA, 1990, BRIT J CANCER, V62, P405, DOI 10.1038/bjc.1990.307; DEBONO D, 1994, BRIT HEART J, V71, P504; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GRAINGER D, IN PRESS CLIN CHIM A; GRAINGER DJ, 1993, BIOCHEM J, V294, P109, DOI 10.1042/bj2940109; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; GRAINGER DJ, 1993, SCIENCE, V260, P1655, DOI 10.1126/science.8503012; HAMSTEN A, 1985, NEW ENGL J MED, V313, P1557, DOI 10.1056/NEJM198512193132501; KANNEL WB, 1983, AM J CARDIOL, V52, pB9, DOI 10.1016/0002-9149(83)90649-5; KIRSCHENLOHR HL, 1993, AM J PHYSIOL, V265, pC571, DOI 10.1152/ajpcell.1993.265.2.C571; KOJIMA S, 1991, J CELL BIOL, V113, P1439, DOI 10.1083/jcb.113.6.1439; LAW MR, 1994, BRIT MED J, V308, P373, DOI 10.1136/bmj.308.6925.373; LAWRENCE DA, 1991, METHOD ENZYMOL, V198, P327; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; MCDONALD CC, 1991, BRIT MED J, V303, P435, DOI 10.1136/bmj.303.6800.435; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; ROSS R, 1976, NEW ENGL J MED, V295, P369, DOI 10.1056/NEJM197608122950707; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SCHREINER PJ, 1993, ARTERIOSCLER THROMB, V13, P826, DOI 10.1161/01.ATV.13.6.826; SYTKOWSKI PA, 1990, NEW ENGL J MED, V322, P1635, DOI 10.1056/NEJM199006073222304; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1	26	357	374	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	1995	1	1					74	79		10.1038/nm0195-74	http://dx.doi.org/10.1038/nm0195-74			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX557	7584958				2022-12-25	WOS:A1995QX55700030
J	WRIGHT, E; HARGRAVE, MR; CHRISTIANSEN, J; COOPER, L; KUN, J; EVANS, T; GANGADHARAN, U; GREENFIELD, A; KOOPMAN, P				WRIGHT, E; HARGRAVE, MR; CHRISTIANSEN, J; COOPER, L; KUN, J; EVANS, T; GANGADHARAN, U; GREENFIELD, A; KOOPMAN, P			THE SRY-RELATED GENE SOX9 IS EXPRESSED DURING CHONDROGENESIS IN MOUSE EMBRYOS	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR; CAMPOMELIC SYNDROME; SEX REVERSAL; HMG BOX; PROTEIN; DNA; ACTIVATION; CONTAINS; DOMAINS; FAMILY	Mutations in the human SRY-related gene, SOX9, located on chromosome 17, have recently been associated with the sex reversal and skeletal dysmorphology syndrome, campomelic dysplasia. In order to clarify the role of this gene in skeletal development, we have studied the expression of mouse Sox9 during embryogenesis. Sox9 is expressed predominantly in mesenchymal condensations throughout the embryo before and during the deposition of cartilage, consistent with a primary role in skeletal formation. Interspecific backcross mapping has localized mouse Sox9 to distal chromosome 11. The expression pattern and chromosomal location of Sox9 suggest that it may be the gene defective in the mouse skeletal mutant. Tail-short, a potential animal model for campomelic dysplasia.	UNIV QUEENSLAND,CTR MOLEC & CELLULAR BIOL,BRISBANE,QLD 4072,AUSTRALIA; ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON W2 1PG,ENGLAND	University of Queensland; Imperial College London			Koopman, Peter A/C-9416-2009; Greenfield, Andy/F-5099-2017	Koopman, Peter A/0000-0001-6939-0914; Evans, Timothy/0000-0001-7962-6863; Greenfield, Andy/0000-0002-1477-1776; Christiansen, Jeff/0000-0002-8146-1225; Hargrave, Murray/0000-0001-5797-9377				BUCHBERG AM, 1993, MAMM GENOME, V4, pS164, DOI 10.1007/BF00360837; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; DEOL MS, 1961, PROC R SOC SER B-BIO, V155, P78, DOI 10.1098/rspb.1961.0058; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; HOUSTON CS, 1983, AM J MED GENET, V15, P3, DOI 10.1002/ajmg.1320150103; HOVMOLLER ML, 1977, HEREDITAS, V86, P51; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LEE FA, 1972, AM J DIS CHILD, V124, P485, DOI 10.1001/archpedi.1972.02110160023002; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MORGAN WC, 1950, J HERED, V41, P208, DOI 10.1093/oxfordjournals.jhered.a106131; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; OJEDA JL, 1970, STAIN TECHNOL, V45, P137; RODRIGUEZ JI, 1993, AM J MED GENET, V46, P185, DOI 10.1002/ajmg.1320460218; Sambrook J, 1989, MOL CLONING LABORATO; SCHEIDEREIT C, 1988, NATURE, V338, P551; TOMMERUP N, 1993, NAT GENET, V4, P170, DOI 10.1038/ng0693-170; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WRIGHT EM, 1993, NUCLEIC ACIDS RES, V21, P744, DOI 10.1093/nar/21.3.744; 1994, HUM MOL GENET, V3, P621; 1993, MIM211970 J HOPK U	35	555	585	0	27	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					15	20		10.1038/ng0195-15	http://dx.doi.org/10.1038/ng0195-15			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704017				2022-12-25	WOS:A1995PZ91300009
J	ZABNER, J; PETERSEN, DM; PUGA, AP; GRAHAM, SM; COUTURE, LA; KEYES, LD; LUKASON, MJ; STGEORGE, JA; GREGORY, RJ; SMITH, AE; WELSH, MJ				ZABNER, J; PETERSEN, DM; PUGA, AP; GRAHAM, SM; COUTURE, LA; KEYES, LD; LUKASON, MJ; STGEORGE, JA; GREGORY, RJ; SMITH, AE; WELSH, MJ			SAFETY AND EFFICACY OF REPETITIVE ADENOVIRUS-MEDIATED TRANSFER OF CFTR CDNA TO AIRWAY EPITHELIA OF PRIMATES AND COTTON RATS	NATURE GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; ELECTROLYTE TRANSPORT; CHLORIDE CHANNEL; IDENTIFICATION; PATHOGENESIS; EXPRESSION; DISEASE; CELLS; INVIVO	Gene therapy for cystic fibrosis (CF) will require the safe transfer of CFTR cDNA to airway epithelia in vivo. We showed previously that a recombinant adenovirus, Ad2/CFTR-1, expresses CFTR in vitro. As adenovirus rarely integrates, treatment will require repeated vector administration. We applied Ad2/CFTR-1 to intrapulmonary airway epithelia of cotton rats and nasal epithelia of Rhesus monkeys. In both species we detected CFTR mRNA and protein after repeated administration and in monkeys, protein was detected six weeks after repeat administration. The vector did not replicate and was rapidly cleared. Despite an antibody response, there was no evidence of a local or systemic inflammatory response after repeat administration. These data indicate that repetitive administration of Ad2/CFTR-1 is both safe and efficacious.	UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT INTERNAL MED,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,DEPT OTOLARYNGOL,IOWA CITY,IA 52242; GENZYME CORP,FRAMINGHAM,MA 01701	Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Sanofi-Aventis; Genzyme Corporation				Welsh, Michael/0000-0002-1646-6206; Zabner, Joseph/0000-0002-9606-1339; Graham, Scott/0000-0003-2969-2998	NHLBI NIH HHS [HL42385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL042385] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BOUCHER RC, 1983, LUNG, V161, P1, DOI 10.1007/BF02713837; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; GINSBERG HS, 1989, P NATL ACAD SCI USA, V86, P3823, DOI 10.1073/pnas.86.10.3823; GINSBERG HS, 1991, P NATL ACAD SCI USA, V88, P1651, DOI 10.1073/pnas.88.5.1651; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Graham FL, 1992, VACCINES NEW APPROAC; HANSON CA, 1990, AM J PATHOL, V137, P1; HARKEMA JR, 1987, AM J ANAT, V180, P266, DOI 10.1002/aja.1001800308; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES M, 1983, J CLIN INVEST, V71, P1410, DOI 10.1172/JCI110894; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MCINTOSH I, 1992, FASEB J, V6, P2775, DOI 10.1096/fasebj.6.10.1378801; PRINCE GA, 1993, J VIROL, V67, P101, DOI 10.1128/JVI.67.1.101-111.1993; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RICH DP, 1993, HUM GENE THER, V4, P461, DOI 10.1089/hum.1993.4.4-461; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIORDAN JR, 1993, ANNU REV PHYSIOL, V55, P609, DOI 10.1146/annurev.ph.55.030193.003141; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; Sambrook J, 1989, MOL CLONING LABORATO; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; WELSH MJ, 1987, PHYSIOL REV, V67, P1143, DOI 10.1152/physrev.1987.67.4.1143; WELSH MJ, 1992, NEURON, V8, P821, DOI 10.1016/0896-6273(92)90196-K; YANKASKAS JR, 1985, AM REV RESPIR DIS, V132, P1281	36	216	268	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1994	6	1					75	83		10.1038/ng0194-75	http://dx.doi.org/10.1038/ng0194-75			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MQ177	7511023				2022-12-25	WOS:A1994MQ17700018
J	ALTON, EWFW; MIDDLETON, PG; CAPLEN, NJ; SMITH, SN; STEEL, DM; MUNKONGE, FM; JEFFERY, PK; GEDDES, DM; HART, SL; WILLIAMSON, R; FASOLD, KI; MILLER, AD; DICKINSON, P; STEVENSON, BJ; MCLACHLAN, G; DORIN, JR; PORTEOUS, DJ				ALTON, EWFW; MIDDLETON, PG; CAPLEN, NJ; SMITH, SN; STEEL, DM; MUNKONGE, FM; JEFFERY, PK; GEDDES, DM; HART, SL; WILLIAMSON, R; FASOLD, KI; MILLER, AD; DICKINSON, P; STEVENSON, BJ; MCLACHLAN, G; DORIN, JR; PORTEOUS, DJ			NONINVASIVE LIPOSOME-MEDIATED GENE DELIVERY CAN CORRECT THE ION-TRANSPORT DEFECT IN CYSTIC-FIBROSIS MUTANT MICE	NATURE GENETICS			English	Article							CONDUCTANCE REGULATOR GENE; POTENTIAL DIFFERENCE; EPITHELIAL-CELLS; MAMMALIAN-CELLS; MOUSE; INVIVO; EXPRESSION; CLONING; LUNG	We report gene transfer to the Edinburgh insertional mutant mouse (cf/cf), delivering CFTR cDNA-liposome complexes into the airways by nebulization. We show full restoration of cAMP related chloride responses in some animals and demonstrate, in the same tissues, human CFTR cDNA expression. Overall, a range of correction was seen with restoration of about 50% of the deficit between wild type mice and untreated cf/cf controls. We report modest correction in the intestinal tract following direct instillation and provide initial encouraging safety data for both the respiratory and intestinal tract following the liposome mediated gene delivery. The non-viral nature and potentially lower immunogenicity of DNA-liposomes suggest that this may offer a therapeutic alternative to adenoviral therapies.	NATL HEART & LUNG INST,DEPT LUNG PATHOL,LONDON SW3 6LR,ENGLAND; ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON W2 1PG,ENGLAND; UNIV LONDON IMPERIAL COLL SCI & TECHNOL,DEPT CHEM,LONDON SW7 1NA,ENGLAND; WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	Imperial College London; Imperial College London; Imperial College London; University of Edinburgh	ALTON, EWFW (corresponding author), NATL HEART & LUNG INST,ION TRANSPORT LAB,LONDON SW3 6LR,ENGLAND.		Dickinson, Paul/B-7598-2014; Caplen, Natasha J/H-2768-2016; Porteous, David/AAA-3446-2021; Middleton, Peter G/ABC-5138-2020; Miller, Andrew/G-8291-2019; Hart, Stephen L/C-1615-2008; Porteous, David J/C-7289-2013	Caplen, Natasha J/0000-0002-0001-9460; Porteous, David/0000-0003-1249-6106; Middleton, Peter G/0000-0003-3361-4941; Miller, Andrew/0000-0003-0661-249X; Hart, Stephen L/0000-0001-8254-376X; Porteous, David J/0000-0003-1249-6106				ALTON EWFW, 1990, EUR RESPIR J, V3, P922; ALTON EWFW, 1992, THORAX, V47, P1010, DOI 10.1136/thx.47.12.1010; BOUCHER RC, 1982, FLUID ELECTROLYTE AB, P271; DORIN JR, 1989, SCIENCE, V243, P1357; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; Dorin Julia R., 1992, Transgenic Research, V1, P101, DOI 10.1007/BF02513027; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; FELDMAN C, 1991, AM J RESP CELL MOL, V5, P416, DOI 10.1165/ajrcmb/5.5.416; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; GAO X, 1991, BIOCHEM BIOPH RES CO, V179, P280, DOI 10.1016/0006-291X(91)91366-K; GEDDES DM, 1991, RECENT ADV RESPIRATO, P203; HAZINSKI TA, 1992, SEMIN PERINATOL, V15, P200; HYDE SC, 1993, NATURE, V362, P250, DOI 10.1038/362250a0; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MENTZ WM, 1986, AM REV RESPIR DIS, V134, P938, DOI 10.1164/arrd.1986.134.5.938; Nabel G. J., 1992, HUM GENE THER, V3, P399; PORTEOUS DJ, 1993, HUM MOL GENET, V2, P211, DOI 10.1093/hmg/2.3.211; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; SAMBROOK J, 1988, MOL CLONING LABORATO; SMITH SN, 1992, CLIN SCI, V82, P667, DOI 10.1042/cs0820667; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; STRIBLING R, 1992, P NATL ACAD SCI USA, V89, P11277, DOI 10.1073/pnas.89.23.11277; TATA F, 1991, GENOMICS, V10, P301, DOI 10.1016/0888-7543(91)90312-3; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; WHITSETT JA, 1992, NAT GENET, V2, P13, DOI 10.1038/ng0992-13; WIDDICOMBE JH, 1985, P NATL ACAD SCI USA, V82, P6167, DOI 10.1073/pnas.82.18.6167; YAMAGUCHI M, 1991, NUCLEIC ACIDS RES, V19, P2403, DOI 10.1093/nar/19.9.2403; YOSHIMURA K, 1992, NUCLEIC ACIDS RES, V20, P3233, DOI 10.1093/nar/20.12.3233	33	387	416	0	29	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					135	142		10.1038/ng1093-135	http://dx.doi.org/10.1038/ng1093-135			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	7504552				2022-12-25	WOS:A1993MA05600010
J	STGEORGEHYSLOP, P; HAINES, J; ROGAEV, E; MORTILLA, M; VAULA, G; PERICAKVANCE, M; FONCIN, JF; MONTESI, M; BRUNI, A; SORBI, S; RAINERO, I; PINESSI, L; POLLEN, D; POLINSKY, R; NEE, L; KENNEDY, J; MACCIARDI, F; ROGAEVA, E; LIANG, Y; ALEXANDROVA, N; LUKIW, W; SCHLUMPF, K; TANZI, R; TSUDA, T; FARRER, L; CANTU, JM; DUARA, R; AMADUCCI, L; BERGAMINI, L; GUSELLA, J; ROSES, A; MCLACHLAN, DC				STGEORGEHYSLOP, P; HAINES, J; ROGAEV, E; MORTILLA, M; VAULA, G; PERICAKVANCE, M; FONCIN, JF; MONTESI, M; BRUNI, A; SORBI, S; RAINERO, I; PINESSI, L; POLLEN, D; POLINSKY, R; NEE, L; KENNEDY, J; MACCIARDI, F; ROGAEVA, E; LIANG, Y; ALEXANDROVA, N; LUKIW, W; SCHLUMPF, K; TANZI, R; TSUDA, T; FARRER, L; CANTU, JM; DUARA, R; AMADUCCI, L; BERGAMINI, L; GUSELLA, J; ROSES, A; MCLACHLAN, DC			GENETIC-EVIDENCE FOR A NOVEL FAMILIAL ALZHEIMERS-DISEASE LOCUS ON CHROMOSOME-14	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; MARKERS; RECOMBINATION; MUTATION; REGION	Familial Alzheimer's disease (FAD) has been shown to be genetically heterogeneous, with a very small proportion of early onset pedigrees being associated with mutations in the amyloid precursor protein (APP) gene on chromosome 21, and some late onset pedigrees showing associations with markers on chromosome 19. We now provide evidence for a major early onset FAD locus on the long arm of chromosome 14 near the markers D14S43 and D14S53 (multipoint lod score z = 23.4) and suggest that the inheritance of FAD may be more complex than had initially been suspected.	UNIV TORONTO, CTR RES NEURODEGENERAT DIS, DEPT PHYSIOL, TORONTO M5S 1A8, ONTARIO, CANADA; MASSACHUSETTS GEN HOSP, MOLEC NEUROGENET LAB, BOSTON, MA 02129 USA; ACAD MED SCI, NATL RES CTR MENT HLTH, MOLEC BRAIN GENET LAB, MOSCOW 113152, USSR; UNIV FLORENCE, DEPT NEUROL, I-50121 FLORENCE, ITALY; UNIV TURIN, DEPT NEUROL, I-10126 TURIN, ITALY; DUKE UNIV, MED CTR, BRYAN ALZHEIMERS DIS RES CTR, DURHAM, NC 27710 USA; UNIV MILANO, SCH MED, DEPT NEUROSCI, I-20127 MILAN, ITALY; TOHOKU UNIV, SCH MED, DEPT NEUROL, SENDAI, MIYAGI 980, JAPAN; BOSTON UNIV, SCH MED, NEUROGENET LAB, BOSTON, MA 02118 USA; IST MEXICANO SEGURO SOCIAL, DEPT GENET, GUADALAJARA, MEXICO; ECOLE PRAT HAUTES ETUD, NEUROHISTOL LAB, F-75651 PARIS 13, FRANCE; CNR, SERV NEUROL, USSL 17, I-88046 LAMEZIA TERME, ITALY; UNIV MASSACHUSETTS, MED CTR, DEPT NEUROL, WORCESTER, MA 01655 USA; SANDOZ PHARMACEUT CORP, SANDOZ RES INST, E HANOVER, NJ 07936 USA; NINCDS, CLIN NEUROPHARMACOL SECT, BETHESDA, MD 20892 USA; UNIV TORONTO, CLARKE INST PSYCHIAT, DEPT PSYCHIAT, NEUROGENET SECT, TORONTO M5T 1R8, ONTARIO, CANADA; MT SINAI MED CTR, WEIN CTR, MIAMI BEACH, FL 33140 USA	University of Toronto; Harvard University; Massachusetts General Hospital; Russian Academy of Medical Sciences; University of Florence; University of Turin; Duke University; University of Milan; Tohoku University; Boston University; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Consiglio Nazionale delle Ricerche (CNR); University of Massachusetts System; University of Massachusetts Worcester; Novartis; Sandoz; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Mount Sinai Medical Center	STGEORGEHYSLOP, P (corresponding author), UNIV TORONTO, CTR RES NEURODEGENERAT DIS, DEPT MED, DIV NEUROL, TORONTO M5S 1A8, ONTARIO, CANADA.		Farrer, Lindsay/AAS-1035-2020; Macciardi, Fabio/N-3768-2014; Rogaev, Evgeny/AAN-7662-2020; Tanzi, Rudolph/AAE-9622-2019; Mortilla, Marzia/AAV-5525-2020; Haines, Jonathan/C-3374-2012; Bruni, Amalia/K-5038-2016	Macciardi, Fabio/0000-0003-0537-4266; Tanzi, Rudolph/0000-0002-7032-1454; Haines, Jonathan/0000-0002-4351-4728; Farrer, Lindsay/0000-0001-5533-4225; sorbi, sandro/0000-0002-0380-6670; Bruni, Amalia/0000-0003-3471-3343; St George-Hyslop, Peter/0000-0003-0796-7209				BEYREUTHER K, 1991, ANN NY ACAD SCI, V640, P129; CARTER DA, 1992, NATURE GNET, V2; COX DW, 1990, CYTOGENET CELL GENET, V55, P183, DOI 10.1159/000133010; GADJUSEK DC, 1991, BRAIN RES BRAIN RES, V16, P83; Glenner G G, 1989, Prog Clin Biol Res, V317, P857; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOATE AM, 1989, LANCET, V1, P352; HAINES JL, 1991, AM J HUM GENET, V48, P1021; HARDY J, 1992, AM J HUM GENET, V50, P648; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HESTON LL, 1991, AM J MED GENET, V40, P449, DOI 10.1002/ajmg.1320400415; HEYMAN A, 1983, ANN NEUROL, V14, P507, DOI 10.1002/ana.410140503; HOFKER MH, 1990, GENOMICS, V6, P33, DOI 10.1016/0888-7543(90)90445-Z; JOACHIM CL, 1992, ALZ DIS ASSOC DIS, V6, P7, DOI 10.1097/00002093-199205000-00003; KARLINSKY H, 1992, NEUROLOGY, V42, P1445, DOI 10.1212/WNL.42.8.1445; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; LAFAUCI G, 1989, BIOCHEM BIOPH RES CO, V159, P297, DOI 10.1016/0006-291X(89)92437-6; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PERICAKVANCE MA, 1988, EXP NEUROL, V102, P271, DOI 10.1016/0014-4886(88)90220-8; POLLWEIN P, 1992, NUCLEIC ACIDS RES, V20, P63, DOI 10.1093/nar/20.1.63; ROSES AD, IN PRESS HETEROGENEI; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; SEFTON L, 1990, GENOMICS, V7, P382, DOI 10.1016/0888-7543(90)90172-Q; STGEORGEHYSLOP PH, 1989, NEUROBIOL AGING, V10, P417, DOI 10.1016/0197-4580(89)90082-1; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P85; TANZI RE, 1992, AM J HUM GENET, V51, P273; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WISNIEWSKI HM, 1988, IMMUNOLOGY ALZHEIMER, P1	33	404	419	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1992	2	4					330	334		10.1038/ng1292-330	http://dx.doi.org/10.1038/ng1292-330			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303289	Green Published			2022-12-25	WOS:A1992KB49500020
J	RICHLER, C; SOREQ, H; WAHRMAN, J				RICHLER, C; SOREQ, H; WAHRMAN, J			X-INACTIVATION IN MAMMALIAN TESTIS IS CORRELATED WITH INACTIVE X-SPECIFIC TRANSCRIPTION	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; CHROMATIN CONFORMATION; ACTIVE CHROMATIN; SEX-CHROMOSOMES; GERM-CELLS; GENE; EXPRESSION; MOUSE; MICE; DNA	X chromosome inactivation occurs twice during the mammalian life cycle. In females one of the two X chromosomes of somatic nuclei is inactive, while in males the solitary X chromosome is inactivated during germ cell development. Despite the different properties of the inactivated chromosomes of females and males, the molecular initiation of inactivation may be the same. X inactive-specific transcripts, XIST, are produced from somatic inactivated X chromosomes. We demonstrate here the existence of XIST transcripts in testes of man and mouse. Inactivation of X chromosomes in males, as in females, may thus be mediated through XIST. Conceivably, the silencing of X-linked genes is the price paid for the evolution of successful mechanisms of chromosomal sex determination.	HEBREW UNIV JERUSALEM,DEPT GENET,IL-91904 JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,DEPT BIOL CHEM,IL-91904 JERUSALEM,ISRAEL	Hebrew University of Jerusalem; Hebrew University of Jerusalem				Soreq, Hermona/0000-0002-0955-526X				BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROSANI G, 1991, NATURE, V351, P325; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; CHANDLEY AC, 1987, CYTOGENET CELL GENET, V44, P22, DOI 10.1159/000132336; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; DAVIES K, 1991, NATURE, V349, P15, DOI 10.1038/349015a0; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; FLETCHER JM, 1979, CHROMOSOMA, V72, P241, DOI 10.1007/BF00293237; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; HANNAH-ALAVA ALOHA, 1965, ADVANCE GENET, V13, P157, DOI 10.1016/S0065-2660(08)60049-8; HENDERSON SA, 1964, CHROMOSOMA, V15, P345, DOI 10.1007/BF00368137; HOTTA Y, 1982, GAMETE RES, V6, P65, DOI 10.1002/mrd.1120060108; HOTTA Y, 1979, CHROMOSOMA, V73, P287, DOI 10.1007/BF00288693; JABLONKA E, 1988, J THEOR BIOL, V133, P23, DOI 10.1016/S0022-5193(88)80022-5; KEREM BS, 1983, NATURE, V304, P88, DOI 10.1038/304088a0; KIM E, 1989, MOL CELL BIOL, V9, P1875, DOI 10.1128/MCB.9.5.1875; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; LYON MF, 1989, PROG NUCLEIC ACID RE, V36, P119; MARTIN GR, 1982, CELL, V29, P721, DOI 10.1016/0092-8674(82)90432-9; MESSTHALER H, 1975, CARYOLOGIA, V28, P501, DOI 10.1080/00087114.1975.10796638; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; NUR U, 1981, CHROMOSOMA, V82, P353, DOI 10.1007/BF00285761; RICHLER C, 1989, CHROMOSOMA, V97, P465, DOI 10.1007/BF00295031; RICHLER C, 1987, CHROMOSOMA, V95, P167, DOI 10.1007/BF00330346; ROSENMANN A, 1985, CYTOGENET CELL GENET, V39, P19, DOI 10.1159/000132098; SCARBROUGH K, 1984, MOL CELL BIOL, V4, P599, DOI 10.1128/MCB.4.4.599; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P1255, DOI 10.1093/nar/18.5.1255; SOLARI AJ, 1974, INT REV CYTOL, V38, P273, DOI 10.1016/S0074-7696(08)60928-6; Tres L. L., 1981, Bioregulators of reproduction., P229; VENOLIA L, 1983, NATURE, V302, P82, DOI 10.1038/302082a0; VENOLIA L, 1984, CHROMOSOMA, V90, P185, DOI 10.1007/BF00292395; WEISBROD S, 1982, NATURE, V297, P289, DOI 10.1038/297289a0; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; 1992, LANCET, V339, P1328	35	139	139	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1992	2	3					192	195		10.1038/ng1192-192	http://dx.doi.org/10.1038/ng1192-192			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345167				2022-12-25	WOS:A1992JW16500007
J	CARTIER, M; BREITMAN, ML; TSUI, LC				CARTIER, M; BREITMAN, ML; TSUI, LC			A FRAMESHIFT MUTATION IN THE GAMMA-E-CRYSTALLIN GENE OF THE ELO MOUSE	NATURE GENETICS			English	Article							EYE LENS OBSOLESCENCE; LINKAGE ANALYSIS; LOCUS; PROTEINS; CATARACT	The murine Elo (eye lens obsolesence) mutation confers a dominant phenotype characterized by malformation of the eye lens. The mutation maps to chromosome 1, in close proximity to the gamma-E-crystallin gene which is the 3'-most member of the gamma-crystallin gene cluster. We have analysed the sequence of this gene from the Elo mouse and identified a single nucleotide deletion which destroys the fourth and last "Greek key" motif of the protein. This mutation is tightly associated with the phenotype, as no recombination was detected in 274 meioses. In addition, the mutant mRNA is present in the affected lens, providing further support for our hypothesis that the deletion is responsible for the dominant Elo phenotype.	HOSP SICK CHILDREN,RES INST,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO M5G 1X5,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A8,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto			Tsui, Lap-chee/A-1081-2010					BLUNDELL T, 1981, NATURE, V289, P771, DOI 10.1038/289771a0; CHAMBERS C, 1991, J BIOL CHEM, V266, P6742; DAVIS LG, 1986, BASIC METHODS MOL BI, P130; DELAYE M, 1983, NATURE, V302, P415, DOI 10.1038/302415a0; GORING DR, 1992, EXP EYE RES, V54, P785, DOI 10.1016/0014-4835(92)90034-P; GRAW J, 1991, GENE, V104, P265, DOI 10.1016/0378-1119(91)90260-I; HOGAN B, 1986, MANIPULATING MOUSE E, P175; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; MASAKI S, 1988, EXP EYE RES, V47, P727, DOI 10.1016/0014-4835(88)90040-1; MASAKI S, 1989, GENOMICS, V5, P259, DOI 10.1016/0888-7543(89)90055-4; MCAVOY JW, 1980, DIFFERENTIATION, V17, P137, DOI 10.1111/j.1432-0436.1980.tb01091.x; ODA SI, 1980, EXP EYE RES, V31, P673, DOI 10.1016/S0014-4835(80)80051-0; ODA SI, 1980, JPN J GENET, V55, P71, DOI 10.1266/jjg.55.71; PARMELEE JT, 1988, J CELL PHYSIOL, V134, P491, DOI 10.1002/jcp.1041340323; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2; QUINLAN P, 1987, GENE DEV, V1, P637, DOI 10.1101/gad.1.7.637; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SKOW LC, 1988, BIOCHEM GENET, V26, P557, DOI 10.1007/BF02399601; WATANABE K, 1980, EXP EYE RES, V31, P683, DOI 10.1016/S0014-4835(80)80052-2; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669; YOSHIKI A, 1991, DEVELOPMENT, V113, P1293; ZIGLER JS, 1981, OPHTHALMIC RES, V13, P237, DOI 10.1159/000265154	25	84	85	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					42	45		10.1038/ng0992-42	http://dx.doi.org/10.1038/ng0992-42			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303247				2022-12-25	WOS:A1992JM64600014
J	JOHNSON, R; JACKSON, IJ				JOHNSON, R; JACKSON, IJ			LIGHT IS A DOMINANT MOUSE MUTATION RESULTING IN PREMATURE CELL-DEATH	NATURE GENETICS			English	Article							MOLECULAR-BASIS; BROWN LOCUS; TYROSINASE; EXPRESSION	Light is a dominant mutant allele of the mouse brown locus which results in hairs pigmented only at their tips. The phenotype is due to premature melanocyte death. We have sequenced the tyrosinase-related protein-1 cDNA encoded at this locus from Light mice and found that it contains a single base alteration from wild-type, causing an Arg to Cys change in the protein. To further elucidate the mutant phenotype, we studied the expression of melanocyte specific genes in the skin of Light mice. We have demonstrated premature melanocyte death, but only in pigmented mice, indicating that the cell death is mediated through the inherent cytotoxicity of pigment production.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND	University of Edinburgh				Jackson, Ian/0000-0001-6526-0688				ABBOTT C, 1991, GENOMICS, V11, P471, DOI 10.1016/0888-7543(91)90160-G; ECKERT KA, 1991, PCR PRACTICAL APPROA, P225; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; JACKSON IJ, 1991, BIOESSAYS, V13, P439, DOI 10.1002/bies.950130903; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; JACKSON IJ, 1992, EMBO J, V11, P527, DOI 10.1002/j.1460-2075.1992.tb05083.x; JACKSON IJ, 1990, GENETICS, V91, P451; KING RA, 1991, MOL BIOL MED, V8, P19; KWON BS, 1989, BIOCHEM BIOPH RES CO, V161, P252, DOI 10.1016/0006-291X(89)91588-X; KWON BS, 1991, P NATL ACAD SCI USA, V88, P9228, DOI 10.1073/pnas.88.20.9228; LERNER AB, 1978, JAMA-J AM MED ASSOC, V239, P1183, DOI 10.1001/jama.239.12.1183; MACDOWELL EC, 1950, J HERED, V41, P35, DOI 10.1093/oxfordjournals.jhered.a106079; MINTY AJ, 1981, J BIOL CHEM, V256, P1006; MORSE HC, 1985, CELL, V41, P439, DOI 10.1016/S0092-8674(85)80017-9; Muller H.J, 1932, P 6 INT C GEN, V1, P213; PAWELEK J, 1980, NATURE, V286, P617, DOI 10.1038/286617a0; PAWELEK JM, 1978, NATURE, V276, P627, DOI 10.1038/276627a0; QUEVEDO WC, 1981, PIGMENT CELL 1981 PH, P177; SHIBAHARA S, 1986, NUCLEIC ACIDS RES, V14, P2413, DOI 10.1093/nar/14.6.2413; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; VIJAYASARADHI S, 1990, J EXP MED, V171, P1375, DOI 10.1084/jem.171.4.1375; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; ZDARSKY E, 1990, GENETICS, V126, P443	24	81	83	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					226	229		10.1038/ng0692-226	http://dx.doi.org/10.1038/ng0692-226			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303241				2022-12-25	WOS:A1992JC98200019
J	WEINSTATSASLOW, D; MERINO, MJ; MANROW, RE; LAWRENCE, JA; BLUTH, RF; WITTENBEL, KD; SIMPSON, JF; PAGE, DL; STEEG, PS				WEINSTATSASLOW, D; MERINO, MJ; MANROW, RE; LAWRENCE, JA; BLUTH, RF; WITTENBEL, KD; SIMPSON, JF; PAGE, DL; STEEG, PS			OVEREXPRESSION OF CYCLIN-D MESSENGER-RNA DISTINGUISHES INVASIVE AND IN-SITU BREAST CARCINOMAS FROM NONMALIGNANT LESIONS	NATURE MEDICINE			English	Article							ATYPICAL HYPERPLASIAS; ESTROGEN-RECEPTOR; EXPRESSION; CANCER; INSITU; AMPLIFICATION; DISEASE; RISK	The elucidation of molecular alterations that occur during human breast cancer progression may contribute to the development of preventative strategies. Using in situ hybridizations on a cohort of 94 biopsy lesions, quantitatively increased cyclin D mRNA expression levels were observed in only 18% of benign lesions, which confer no or slightly increased breast cancer risk, and 18% of premalignant atypical ductal hyperplasias, which confer a four to fivefold increase in breast cancer risk. The transition to carcinoma was accompanied by frequent cyclin D mRNA overexpression in 76% of low-grade ductal carcinomas in situ, 87% of higher grade comedo ductal carcinomas in situ and 83% of infiltrating ductal breast carcinomas. The data identify a molecular event that may separate benign and premalignant human breast lesions from any form of breast carcinoma.	NCI, DIV CLIN SCI, PATHOL LAB, SURG PATHOL SECT, BETHESDA, MD 20892 USA; VANDERBILT UNIV, SCH MED, DEPT PATHOL, MCN, NASHVILLE, TN 37232 USA; CITY HOPE NATL MED CTR, DIV PATHOL, DUARTE, CA 91010 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; City of Hope	WEINSTATSASLOW, D (corresponding author), NCI, DIV CLIN SCI,PATHOL LAB,WOMENS CANC SECT,BLDG 10, ROOM 2A33, BETHESDA, MD 20892 USA.							BARTKOVA J, 1994, INT J CANCER, V57, P353, DOI 10.1002/ijc.2910570311; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; BUR ME, 1992, CANCER-AM CANCER SOC, V69, P1174; CARPENTER R, 1987, BRIT J SURG, V74, P905, DOI 10.1002/bjs.1800741011; CRISSMAN JD, 1990, ARCH PATHOL LAB MED, V114, P1249; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; GILLETT C, 1994, CANCER RES, V54, P1812; GIRI DD, 1989, HISTOPATHOLOGY, V15, P575, DOI 10.1111/j.1365-2559.1989.tb01623.x; HAN EKH, 1995, ONCOGENE, V10, P953; KEYOMARSI K, 1993, P NATL ACAD SCI USA, V90, P1112, DOI 10.1073/pnas.90.3.1112; LODATO RF, 1990, MODERN PATHOL, V3, P449; LUKAS J, 1994, ONCOGENE, V9, P707; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; OCONNELL P, 1994, BREAST CANCER RES TR, V32, P5, DOI 10.1007/BF00666201; OHUCHI N, 1987, J NATL CANCER I, V79, P109; OMALLEY FP, 1994, LAB INVEST, V71, P67; PAGE DL, 1990, CANCER, V66, P1326, DOI 10.1002/1097-0142(19900915)66:14+<1326::AID-CNCR2820661405>3.0.CO;2-P; PAGE DL, 1993, BREAST CANCER RES TR, V28, P157, DOI 10.1007/BF00666428; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; POLLER DN, 1993, HUM PATHOL, V24, P463, DOI 10.1016/0046-8177(93)90157-C; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; TSUDA H, 1993, JPN J CANCER RES, V84, P394, DOI 10.1111/j.1349-7006.1993.tb00149.x; UMEKITA Y, 1994, VIRCHOWS ARCH, V424, P491; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D; ZHANG SY, 1994, AM J CLIN PATHOL, V102, P695, DOI 10.1093/ajcp/102.5.695	26	268	272	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	1995	1	12					1257	1260		10.1038/nm1295-1257	http://dx.doi.org/10.1038/nm1295-1257			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489405				2022-12-25	WOS:A1995TH78600036
J	BUSSAGLIA, E; CLERMONT, O; TIZZANO, E; LEFEBVRE, S; BURGLEN, L; CRUAUD, C; URTIZBEREA, JA; COLOMER, J; MUNNICH, A; BAIGET, M; MELKI, J				BUSSAGLIA, E; CLERMONT, O; TIZZANO, E; LEFEBVRE, S; BURGLEN, L; CRUAUD, C; URTIZBEREA, JA; COLOMER, J; MUNNICH, A; BAIGET, M; MELKI, J			A FRAME-SHIFT DELETION IN THE SURVIVAL MOTOR-NEURON GENE IN SPANISH SPINAL MUSCULAR-ATROPHY PATIENTS	NATURE GENETICS			English	Letter							FREQUENCY	Spinal muscular atrophy (SMA) is a frequent autosomal recessive disease characterized by degeneration of the motor neurons of the spinal cord causing proximal paralysis with muscle atrophy(1,2). The region on chromosome 5q13 encompassing the disease gene is particularly unstable and prone to large-scale deletions whose characterization recently led to the identification of the survival motor neuron (SMN) gene(3,4). We now present a genetic analysis of 54 unrelated Spanish SMA families that has revealed a 4-basepair (bp) deletion (AGAG) in exon 3 of SMN in four unrelated patients. This deletion, which results in a frameshift and a premature stop codon, occurs on the same haplotype background, suggesting that a single mutational event is involved in the four families. The other patients showed either deletions of the SMN gene (49/54) or a gene conversion event changing SMN exon 7 into its highly homologous copy ((C)BCD541, 1/54). This observation gives strong support to the view that mutations of the SMN gene are responsible for the SMA phenotype as it is the first frameshift mutation reported in SMA.	HOSP SANTA CRUZ & SAN PABLO,MOLEC GENET UNIT,E-08025 BARCELONA,SPAIN; HOP NECKER ENFANTS MALAD,INSERM,U393,UNITE RECH HANDICAPS GENET ENFANT,F-75743 PARIS,FRANCE; GENETHON SA,EVRY,FRANCE; HOP RAY POINCARE,GARCHES,FRANCE; HOSP ST JOAN DE DEU,SERV NEUROL,BARCELONA,SPAIN	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; University of Barcelona			Lefebvre, Suzie/D-5092-2017	Cruaud, Corinne/0000-0002-4752-7278				BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LEWIN B, 1995, CELL, V80, P1, DOI 10.1016/0092-8674(95)90442-5; MAHADEVAN MS, 1995, NAT GENET, V9, P112, DOI 10.1038/ng0295-112; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; Munsat TL., 1991, NEUROMUSCUL DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-t, DOI 10.1016/0960-8966(91)90052-T]; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; PEARN JH, 1973, J MED GENET, V10, P260, DOI 10.1136/jmg.10.3.260; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; THOMPSON TG, 1995, NAT GENET, V9, P56, DOI 10.1038/ng0195-56; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7	15	207	210	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					335	337		10.1038/ng1195-335	http://dx.doi.org/10.1038/ng1195-335			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581461				2022-12-25	WOS:A1995TC63900026
J	NYSTROMLAHTI, M; KRISTO, P; NICOLAIDES, NC; CHANG, SY; AALTONEN, LA; MOISIO, AL; JARVINEN, HJ; MECKLIN, JP; KINZLER, KW; VOGELSTEIN, B; DELACHAPELLE, A; PELTOMAKI, P				NYSTROMLAHTI, M; KRISTO, P; NICOLAIDES, NC; CHANG, SY; AALTONEN, LA; MOISIO, AL; JARVINEN, HJ; MECKLIN, JP; KINZLER, KW; VOGELSTEIN, B; DELACHAPELLE, A; PELTOMAKI, P			FOUNDING MUTATIONS AND ALU-MEDIATED RECOMBINATION IN HEREDITARY COLON-CANCER	NATURE MEDICINE			English	Article							COLORECTAL-CANCER	By screening members of Finnish families displaying hereditary nonpolyposis colorectal cancer (HNPCC) for predisposing germline mutations in MSH2 and MLH1, we show that two mutations in MLH1 together account for 63% (19/30) of kindreds meeting international diagnostic criteria. Mutation 1, originally detected as a 165-base pair deletion in MLH1 cDNA comprising exon 16, was shown to consist of a 3.5-kilobase genomic deletion most likely resulting from Alu-mediated recombination. Mutation 2 destroys the splice acceptor site of exon 6. A simple diagnostic test based on polymerase chain reaction was designed for both mutations. Our results show that these two ancestral founding mutations account for a majority of Finnish HNPCC kindreds and represent the first report of Alu-mediated recombination causing a prevalent, dominantly inherited predisposition to cancer.	UNIV HELSINKI,DEPT MED GENET,SF-00014 HELSINKI,FINLAND; JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21231; HOWARD HUGHES MED INST,BALTIMORE,MD 21231; ROCHE MOLEC SYST INC,ALAMEDA,CA 94501; UNIV HELSINKI,CENT HOSP,DEPT SURG 2,SF-00290 HELSINKI,FINLAND; JYVASKYLA CENT HOSP,SF-40620 JYVASKYLA,FINLAND	University of Helsinki; Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; University of Helsinki; Helsinki University Central Hospital; Central Finland Central Hospital			Mecklin, Jukka-Pekka/AAC-9650-2019; Aaltonen, Lauri/A-5375-2010; Mecklin, Jukka-Pekka/AAB-5378-2020	Aaltonen, Lauri/0000-0001-6839-4286; Mecklin, Jukka-Pekka/0000-0003-4895-2249; Peltomaki, Paivi/0000-0001-8819-2980; Nystrom, Minna/0000-0003-0827-0243	NCI NIH HHS [CA 35494, CA 62924] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA062924, R37CA035494, R01CA035494] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; CHISSOE SL, 1995, GENOMICS, V27, P67, DOI 10.1006/geno.1995.1008; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; FROGGATT NJ, 1995, LANCET, V345, P727, DOI 10.1016/S0140-6736(95)90900-1; HEMMINKI A, 1994, NAT GENET, V8, P405, DOI 10.1038/ng1294-405; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; JARVINEN HJ, 1995, GASTROENTEROLOGY, V108, P1405, DOI 10.1016/0016-5085(95)90688-6; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LIU B, 1994, CANCER RES, V54, P4590; MURRAY V, 1989, NUCLEIC ACIDS RES, V17, P8889, DOI 10.1093/nar/17.21.8889; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; NYSTROMLAHTI M, 1994, AM J HUM GENET, V55, P659; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; TYCKO B, 1991, J EXP MED, V174, P867, DOI 10.1084/jem.174.4.867; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699	20	257	262	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1203	1206		10.1038/nm1195-1203	http://dx.doi.org/10.1038/nm1195-1203			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584997				2022-12-25	WOS:A1995TC53700049
J	KOHL, NE; OMER, CA; CONNER, MW; ANTHONY, NJ; DAVIDE, JP; DESOLMS, SJ; GIULIANI, EA; GOMEZ, RP; GRAHAM, SL; HAMILTON, K; HANDT, LK; HARTMAN, GD; KOBLAN, KS; KRAL, AM; MILLER, PJ; MOSSER, SD; ONEILL, TJ; RANDS, E; SCHABER, MD; GIBBS, JB; OLIFF, A				KOHL, NE; OMER, CA; CONNER, MW; ANTHONY, NJ; DAVIDE, JP; DESOLMS, SJ; GIULIANI, EA; GOMEZ, RP; GRAHAM, SL; HAMILTON, K; HANDT, LK; HARTMAN, GD; KOBLAN, KS; KRAL, AM; MILLER, PJ; MOSSER, SD; ONEILL, TJ; RANDS, E; SCHABER, MD; GIBBS, JB; OLIFF, A			INHIBITION OF FARNESYLTRANSFERASE INDUCES REGRESSION OF MAMMARY AND SALIVARY CARCINOMAS IN RAS TRANSGENIC MICE	NATURE MEDICINE			English	Article							ONCOGENES; CANCER; MYC	For Ras oncoproteins to transform mammalian cells, they must be post-translationally modified with a farnesyl group in a reaction catalysed by the enzyme farnesyl-protein transferase (FPTase). Inhibitors of FPTase have therefore been proposed as anti-cancer agents. We show that L-744,832, which mimics the CaaX motif to which the farnesyl group is added, is a potent and selective inhibitor of FPTase. In MMTV-v-Ha-ras mice bearing palpable tumours, daily administration of L-744,832 caused tumour regression. Following cessation of treatment, tumours reappeared, the majority of which regressed upon retreatment. No systemic toxicity was found upon necropsy of L-744,832-treated mice. This first demonstration of anti-FPTase-mediated tumour regression suggests that FPTase inhibitors may be safe and effective anti-tumour agents in some cancers.	MERCK SHARP & DOHME RES LABS,DEPT SAFETY ASSESSMENT,W POINT,PA 19486; MERCK SHARP & DOHME RES LABS,DEPT MED CHEM,W POINT,PA 19486; MERCK SHARP & DOHME RES LABS,ANIM RESOURCES LAB,W POINT,PA 19486	Merck & Company; Merck & Company; Merck & Company	KOHL, NE (corresponding author), MERCK SHARP & DOHME RES LABS,DEPT CANC RES,W POINT,PA 19486, USA.							ADAMS JM, 1991, SCIENCE, V254, P1161, DOI 10.1126/science.1957168; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1989, CANCER RES, V49, P4682; Clark Geoffrey J., 1995, P17; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; DEXTER DL, 1993, INVEST NEW DRUG, V11, P161, DOI 10.1007/BF00874150; GIBBS JB, 1991, CELL, V65, P1, DOI 10.1016/0092-8674(91)90352-Y; GIBBS JB, 1994, CELL, V77, P175, DOI 10.1016/0092-8674(94)90308-5; JAMES GL, 1993, SCIENCE, V260, P1937, DOI 10.1126/science.8316834; JAMES GL, 1994, J BIOL CHEM, V269, P14182; KOHL NE, 1994, P NATL ACAD SCI USA, V91, P9141, DOI 10.1073/pnas.91.19.9141; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; PATEL DV, 1995, J MED CHEM, V38, P435, DOI 10.1021/jm00003a006; PRENDERGAST GC, 1994, MOL CELL BIOL, V14, P4193, DOI 10.1128/MCB.14.6.4193; SINN E, 1987, CELL, V49, P465, DOI 10.1016/0092-8674(87)90449-1; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; YAMADA H, 1986, BIOCHEM BIOPH RES CO, V140, P167, DOI 10.1016/0006-291X(86)91072-7	17	486	570	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1995	1	8					792	797		10.1038/nm0895-792	http://dx.doi.org/10.1038/nm0895-792			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585182				2022-12-25	WOS:A1995RM63500036
J	LANNFELT, L; BASUN, H; WAHLUND, LO; ROWE, BA; WAGNER, SL				LANNFELT, L; BASUN, H; WAHLUND, LO; ROWE, BA; WAGNER, SL			DECREASED ALPHA-SECRETASE-CLEAVED AMYLOID PRECURSOR PROTEIN AS A DIAGNOSTIC MARKER FOR ALZHEIMERS-DISEASE	NATURE MEDICINE			English	Article							BETA-PROTEIN; CEREBROSPINAL-FLUID; MUTATION	The neuropathologic hallmarks of Alzheimer's disease (AD) are extracellular plaques and intracellular neurofibrillary tangles. A constituent of senile plaques in AD is beta-amyloid, a hydrophobic peptide of 39-43 amino acids(1) and a fragment of the amyloid precursor protein (APP). APP can be metabolized by at least two pathways, one of which involves generation of soluble APP by an unidentified enzyme named alpha-secretase. This cleavage generates alpha-secretase-cleaved, soluble APP (alpha-sAPP), which in this investigation was measured by a new assay in cerebrospinal fluid (CSF) from members of a Swedish AD family with a pathogenic mutation at APP(670/671) (ref. 2). Family members who carry the mutation and are diagnosed with AD had low levels of alpha-sAPP (160 +/- 48 ng ml(-1)), with no overlap compared with non-carriers (257 +/- 48 ng ml(-1)). Carriers of the presymptomatic mutation showed intermediate alpha-sAPP levels. Today there exists no antemortem marker in AD with sufficient sensitivity and specificity, but measurement of alpha-sAPP represents a new and promising diagnostic marker.	SIBIA,LA JOLLA,CA 92037		LANNFELT, L (corresponding author), HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT CLIN NEUROSCI GERIATR MED,S-14186 HUDDINGE,SWEDEN.							AXELMAN K, 1994, ARCH NEUROL-CHICAGO, V51, P1193, DOI 10.1001/archneur.1994.00540240037013; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; FELSENSTEIN KM, 1994, NAT GENET, V6, P251, DOI 10.1038/ng0394-251; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; HARDY J, 1992, NEUROSCI FACTS, V3, P65; HENRIKSSON T, 1991, J NEUROCHEM, V56, P1037, DOI 10.1111/j.1471-4159.1991.tb02026.x; JOHNSTON JA, 1994, FEBS LETT, V354, P274, DOI 10.1016/0014-5793(94)01137-0; LANNFELT L, 1993, NEUROSCI LETT, V153, P85, DOI 10.1016/0304-3940(93)90083-W; LANNFELT L, 1994, NEUROSCI LETT, V168, P254, DOI 10.1016/0304-3940(94)90463-4; LEVY E, 1991, SCIENCE, V49, P511; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; VANNOSTRAND WE, 1992, ANN NEUROL, V32, P215, DOI 10.1002/ana.410320214; VANNOSTRAND WE, 1992, P NATL ACAD SCI USA, V89, P2551, DOI 10.1073/pnas.89.7.2551; WAGNER SL, 1994, ANN NEUROL, V36, P215, DOI 10.1002/ana.410360214	20	142	152	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1995	1	8					829	832		10.1038/nm0895-829	http://dx.doi.org/10.1038/nm0895-829			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585189				2022-12-25	WOS:A1995RM63500043
J	PALMER, S; PERRY, J; ASHWORTH, A				PALMER, S; PERRY, J; ASHWORTH, A			A CONTRAVENTION OF OHNOS LAW IN MICE	NATURE GENETICS			English	Article							HYBRID STERILITY; GENETIC-BASIS; HALDANE RULE; DISORDERS; DOMINANT; MYOTONIA; CHANNEL; DISEASE	The chloride channel gene, CLCN4, has been previously mapped to the X chromosome in humans. We isolated a cDNA clone for mouse Clcn4 and used this to map the gene in an interspecific backcross. This revealed the surprising finding that the gene maps to the X chromosome in Mus spretus but to chromosome 7 in C57BL/6 mice. This is the first example of a gene that contravenes Ohno's law - it is a gene unique to the X chromosome in one eutherian species but autosomal in another. The consequence of this chromosomal rearrangement is that the gene is lost by mendelian segregation in a subset of the male progeny of a (C57BL/6 x Mus spretus) x Mus spretus backcross.	INST CANC RES, CRC, CTR CELL & MOLEC BIOL, CHESTER BEATTY LABS, LONDON SW3 6JB, ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK			Palmer, Stephen/F-2822-2013	Palmer, Stephen/0000-0002-4907-4719; Perry, Jo/0000-0002-4418-947X				ASHWORTH A, 1991, NATURE, V351, P406, DOI 10.1038/351406a0; BIDDLE FG, 1994, GENOME, V37, P198, DOI 10.1139/g94-027; BREEN M, 1994, HUM MOL GENET, V3, P621, DOI 10.1093/hmg/3.4.621; CALDWELL JH, 1992, NAT GENET, V2, P87, DOI 10.1038/ng1092-87; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COYNE JA, 1985, NATURE, V314, P736, DOI 10.1038/314736a0; DISTECHE CM, 1992, NAT GENET, V1, P333, DOI 10.1038/ng0892-333; ELLIS N, 1989, TRENDS GENET, V5, P406, DOI 10.1016/0168-9525(89)90199-6; FISHER SE, 1994, HUM MOL GENET, V3, P2053; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; GUENET JL, 1990, GENET RES, V56, P163, DOI 10.1017/S0016672300035254; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; HALE DW, 1993, CYTOGENET CELL GENET, V63, P221, DOI 10.1159/000133539; HERMAN GE, 1994, MAMM GENOME, V5, pS276; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; LYON MF, 1992, ANNU REV GENET, V26, P17, DOI 10.1146/annurev.ge.26.120192.000313; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MATSUDA Y, 1991, P NATL ACAD SCI USA, V88, P4850, DOI 10.1073/pnas.88.11.4850; MEINDL A, 1993, J MED GENET, V30, P838, DOI 10.1136/jmg.30.10.838; MIYAJIMA I, 1995, BLOOD, V85, P1246, DOI 10.1182/blood.V85.5.1246.bloodjournal8551246; Ohno S., 1967, SEX CHROMOSOMES SEX; PTACEK LJ, 1993, NEW ENGL J MED, V328, P482; Salido E. C., 1994, American Journal of Human Genetics, V55, pA138; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547; WILLISON KR, 1986, CELL, V44, P727, DOI 10.1016/0092-8674(86)90839-1	25	51	51	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1995	10	4					472	476		10.1038/ng0895-472	http://dx.doi.org/10.1038/ng0895-472			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670497				2022-12-25	WOS:A1995RM37500022
J	ROSENBERG, C; FLORIJN, RJ; VANDERIJKE, FM; BLONDEN, LAJ; RAAP, TK; VANOMMEN, GJB; DENDUNNEN, JT				ROSENBERG, C; FLORIJN, RJ; VANDERIJKE, FM; BLONDEN, LAJ; RAAP, TK; VANOMMEN, GJB; DENDUNNEN, JT			HIGH-RESOLUTION DNA FIBER-FISH ON YEAST ARTIFICIAL CHROMOSOMES - DIRECT VISUALIZATION OF DNA-REPLICATION	NATURE GENETICS			English	Letter							INSITU HYBRIDIZATION; DMD-GENE; SACCHAROMYCES-CEREVISIAE; DELINEATION; SEQUENCES						rosenberg, carla/N-4148-2015; dunnen, johan den/ABH-4228-2020	rosenberg, carla/0000-0003-3253-4448; dunnen, johan den/0000-0002-6304-1710				BLONDEN LAJ, 1991, GENOMICS, V10, P631, DOI 10.1016/0888-7543(91)90445-K; DENDUNNEN JT, 1992, HUM MOL GENET, V1, P19; EDENBERG HJ, 1975, ANNU REV GENET, V9, P245, DOI 10.1146/annurev.ge.09.120175.001333; FLORIJN RJ, 1995, HUM MOL GENET, V4, P831, DOI 10.1093/hmg/4.5.831; HAAF T, 1994, HUM MOL GENET, V3, P629, DOI 10.1093/hmg/3.4.629; HELSKANEN M, 1994, BIOTECHNIQUES, V17, P928; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; KIEVITS T, 1990, CYTOGENET CELL GENET, V53, P134, DOI 10.1159/000132913; KITSBERG D, 1993, NATURE, V366, P588, DOI 10.1038/366588a0; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MONTIEL JF, 1984, NUCLEIC ACIDS RES, V12, P1049, DOI 10.1093/nar/12.2.1049; NEWLON CS, 1988, MICROBIOL REV, V52, P568, DOI 10.1128/MMBR.52.4.568-601.1988; PARRA I, 1993, NAT GENET, V5, P17, DOI 10.1038/ng0993-17; ROTH GE, 1983, MOL CELL BIOL, V3, P1898, DOI 10.1128/MCB.3.11.1898; SCHERTHAN H, 1993, TRENDS GENET, V9, P41; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; WIEGANT J, 1992, HUM MOL GENET, V1, P587, DOI 10.1093/hmg/1.8.587	17	32	33	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					477	479		10.1038/ng0895-477	http://dx.doi.org/10.1038/ng0895-477			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670498				2022-12-25	WOS:A1995RM37500023
J	LI, LN; HOFFMAN, RM				LI, LN; HOFFMAN, RM			THE FEASIBILITY OF TARGETED SELECTIVE GENE-THERAPY OF THE HAIR FOLLICLE	NATURE MEDICINE			English	Article							SKIN; HISTOCULTURE; TYROSINASE	Loss of hair and hair colour is associated with ageing, and when it involves the scalp hair, it can be distressing to both sexes. Hair loss resulting from cancer chemotherapy is particularly distressing. However, safe, effective therapies directed to hair have only just started to be developed. The hair follicle is a complex skin appendage composed of epidermal and dermal tissue, with specialized keratinocytes, the hair matrix cells, forming the hair shaft. Specific therapy of the hair follicle depends on selective targeting of specific cells of the hair follicle. We have developed the histoculture of intact hair-growing skin on sponge-gel matrices(1-6). We have recently found in histocultured skin that liposomes can selectively target hair follicles to deliver both small and large molecules(3-6). That liposomes can target the hair follicle for delivery has been confirmed independently(7). Two decades ago we introduced the technique of entrapping DNA in liposomes for use in gene therapy(8). In this report we describe the selective targeting of the lacZ reporter gene to the hair follicles in mice after topical application of the gene entrapped in liposomes. These results demonstrate that highly selective, safe gene therapy for the hair process is feasible.	ANTICANC INC,SAN DIEGO,CA 92111	AntiCancer, Inc.								CAPLEN NJ, 1995, NAT MED, V1, P39, DOI 10.1038/nm0195-39; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; HOFFMAN RM, 1978, FEBS LETT, V93, P365, DOI 10.1016/0014-5793(78)81141-7; LI LG, 1993, IN VITRO CELL DEV-AN, V29A, P192; LI LN, 1994, IN VITRO CELL DEV-AN, V30A, P135; LI LN, 1993, IN VITRO CELL DEV-AN, V29A, P258; LI LN, 1992, IN VITRO CELL DEV-AN, V28A, P679; LI LN, 1992, P NATL ACAD SCI USA, V89, P8764, DOI 10.1073/pnas.89.18.8764; LI LN, 1991, P NATL ACAD SCI USA, V88, P1908, DOI 10.1073/pnas.88.5.1908; SHIBAHARA S, 1988, TOHOKU J EXP MED, V156, P403, DOI 10.1620/tjem.156.403; TANAKA S, 1990, DEVELOPMENT, V108, P223; YAROSH D, 1994, J INVEST DERMATOL, V103, P461, DOI 10.1111/1523-1747.ep12395551	12	156	169	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1995	1	7					705	706		10.1038/nm0795-705	http://dx.doi.org/10.1038/nm0795-705			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585157				2022-12-25	WOS:A1995RQ06600049
J	CHRISTOFORI, G; NAIK, P; HANAHAN, D				CHRISTOFORI, G; NAIK, P; HANAHAN, D			DEREGULATION OF BOTH IMPRINTED AND EXPRESSED ALLELES OF THE INSULIN-LIKE GROWTH-FACTOR-2 GENE DURING BETA-CELL TUMORIGENESIS	NATURE GENETICS			English	Article							FACTOR-II GENE; MOUSE H19 GENE; PANCREATIC-ISLETS; RELAXATION; CANCER	In a mouse model of multistage carcinogenesis elicited by the SV40 large T-antigen (Tag) oncogene in pancreatic beta cells, the gene for insulin-like growth factor IGF2 is focally up-regulated and functionally implicated in tumour development. The IGF2 gene is differentially regulated in normal tissues: the paternal allele is transiently expressed during embryogenesis, whereas the maternal allele is genomically imprinted and inactive. Crossbred mice carrying the Tag oncogene and a disruption of either the paternal or maternal allele of IGF2 reveal that both alleles are co-activated early during tumour development, and that each contributes to malignant hyperproliferation and consequent tumour volume.	UNIV CALIF SAN FRANCISCO,HORMONE RES INST,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco								ALPERT S, 1988, CELL, V53, P295, DOI 10.1016/0092-8674(88)90391-1; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DECHIARA TM, 1990, NATURE, V345, P75; DIETRICH WF, 1994, P NATL ACAD SCI USA, V91, P9451, DOI 10.1073/pnas.91.20.9451; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; FERGUSONSMITH AC, 1990, CANCER SURV, V9, P487; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; KANDEL J, 1991, CELL, V66, P1095, DOI 10.1016/0092-8674(91)90033-U; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RAPPOLEE DA, 1992, GENE DEV, V6, P939, DOI 10.1101/gad.6.6.939; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; SCHOFIELD PN, 1992, INSULIN LIKE GROWTH; SMITH KM, 1990, J LIPID RES, V31, P995; SOLTER D, 1990, ANNU REV GENET, V22, P127; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; SZABO P, 1994, DEVELOPMENT, V120, P1651; TEITELMAN G, 1988, CELL, V52, P97, DOI 10.1016/0092-8674(88)90534-X; VILLAR AJ, 1994, NAT GENET, V8, P373, DOI 10.1038/ng1294-373	34	105	107	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					196	201		10.1038/ng0695-196	http://dx.doi.org/10.1038/ng0695-196			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663515				2022-12-25	WOS:A1995RA85700017
J	GOODY, RS				GOODY, RS			RATIONAL DRUG DESIGN AND HIV - HOPES AND LIMITATIONS	NATURE MEDICINE			English	Editorial Material							REVERSE-TRANSCRIPTASE; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; INHIBITORS; INVITRO				GOODY, RS (corresponding author), MAX PLANCK INST MOLEK PHYSIOL, D-44026 DORTMUND, GERMANY.		Goody, Roger S/J-8845-2014	Goody, Roger S/0000-0002-0772-0444				ABDELMEGUID SS, 1993, MED RES REV, V13, P731, DOI 10.1002/med.2610130605; BUSHMAN F, 1995, SCIENCE, V267, P1443, DOI 10.1126/science.7878462; CASPAR DLD, 1995, STRUCTURE, V3, P327, DOI 10.1016/S0969-2126(01)00163-0; COLLINS JR, 1995, NAT STRUCT BIOL, V2, P334, DOI 10.1038/nsb0495-334; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; DING J, 1995, STRUCTURE, V3, P365, DOI 10.1016/S0969-2126(01)00168-X; DIVITA G, 1994, J BIOL CHEM, V269, P13080; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LASIC DD, 1995, SCIENCE, V267, P1275, DOI 10.1126/science.7871422; LIUZZI M, 1994, NATURE, V372, P695, DOI 10.1038/372695a0; PAUWELS R, 1990, NATURE, V343, P470, DOI 10.1038/343470a0; REN JS, 1995, NAT STRUCT BIOL, V2, P293, DOI 10.1038/nsb0495-293; RITTINGER K, IN PRESS P NATN ACAD; RODGERS DW, 1995, P NATL ACAD SCI USA, V92, P1222, DOI 10.1073/pnas.92.4.1222; SMERDON SJ, 1994, P NATL ACAD SCI USA, V91, P3911, DOI 10.1073/pnas.91.9.3911; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; TISDALE M, 1993, P NATL ACAD SCI USA, V90, P5653, DOI 10.1073/pnas.90.12.5653	19	5	5	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	1995	1	6					519	520		10.1038/nm0695-519	http://dx.doi.org/10.1038/nm0695-519			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN101	7585113				2022-12-25	WOS:A1995RN10100030
J	NICOL, CJ; HARRISON, ML; LAPOSA, RR; GIMELSHTEIN, IL; WELLS, PG				NICOL, CJ; HARRISON, ML; LAPOSA, RR; GIMELSHTEIN, IL; WELLS, PG			A TERATOLOGIC SUPPRESSOR ROLE FOR P53 IN BENZO[A]PYRENE-TREATED TRANSGENIC P53-DEFICIENT MICE	NATURE GENETICS			English	Article							FETAL HYDANTOIN SYNDROME; DNA-DAMAGING AGENTS; MOUSE; METABOLISM; INDUCTION; 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN; EMBRYOGENESIS; ACTIVATION; APOPTOSIS; MUTATIONS	DNA damage may mediate birth defects caused by many drugs and environmental chemicals, therefore p53, a tumour suppressor gene that facilitates DNA repair, may be critically embryoprotective. We have studied the effects of the environmental teratogen, benzo[a]pyrene, on pregnant heterozygous p53-deficient mice. Such mice exhibited between 2- to 4-fold higher embryotoxicity and teratogenicity than normal p53-controls. Fetal resorptions reflecting in utero death were genotyped using the polymerase chain reaction and found to be increased 2.6-fold and 3.6-fold respectively with heterozygous and homozygous p53-deficient embryos. These results provide the first direct evidence that p53 may be an important teratological suppressor gene which protects the embryo from DNA-damaging chemicals and developmental oxidative stress.	UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON M5S 2S2,CANADA; UNIV TORONTO,FAC PHARM,TORONTO,ON M5S 2S2,CANADA	University of Toronto; University of Toronto								BIRNBAUM LS, 1985, TOXICOL APPL PHARM, V77, P292, DOI 10.1016/0041-008X(85)90329-1; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; CLEAVER JE, 1994, CELL, V76, P1, DOI 10.1016/0092-8674(94)90165-1; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; FINNELL RH, 1984, AM J MED GENET, V19, P463, DOI 10.1002/ajmg.1320190307; FRITSCHE M, 1993, ONCOGENE, V8, P307; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; GUPTA RC, 1984, P NATL ACAD SCI-BIOL, V81, P6943, DOI 10.1073/pnas.81.22.6943; HANSON JW, 1975, J PEDIATR-US, V87, P285, DOI 10.1016/S0022-3476(75)80604-4; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; JONES KL, 1975, TERATOLOGY, V12, P1, DOI 10.1002/tera.1420120102; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; LIU L, IN PRESS FREE RAD BI; LOUIS JM, 1988, BIOCHIM BIOPHYS ACTA, V950, P395, DOI 10.1016/0167-4781(88)90136-4; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MANSON JM, 1994, PRINCIPLES METHODS T, V3, P989; MANSON JM, 1980, BIOCH BASIS CHEM TER, P95; MARNETT LJ, 1978, BIOCHEM BIOPH RES CO, V82, P210, DOI 10.1016/0006-291X(78)90597-1; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; MERRITT AJ, 1994, CANCER RES, V54, P614; OKEY AB, 1994, TRENDS PHARMACOL SCI, V15, P226, DOI 10.1016/0165-6147(94)90316-6; PHILLIPS DH, 1983, NATURE, V303, P468, DOI 10.1038/303468a0; PURDIE CA, 1994, ONCOGENE, V9, P603; ROBERTS CJ, 1975, LANCET, V1, P498; ROLFE BE, 1982, FERTIL STERIL, V37, P655; SAH VP, 1995, NATURE GENET, V10; SANDS A, 1994, MUTAT RES, V307, P557, DOI 10.1016/0027-5107(94)90266-6; SCHMID P, 1991, DEVELOPMENT, V113, P857; SCOLNIK D, 1994, JAMA-J AM MED ASSOC, V271, P767, DOI 10.1001/jama.271.10.767; SHEN ES, 1989, BIOCHEM PHARMACOL, V38, P4075, DOI 10.1016/0006-2952(89)90689-8; SHUM S, 1979, TERATOLOGY, V20, P365, DOI 10.1002/tera.1420200307; Smart Y C, 1982, Clin Reprod Fertil, V1, P177; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; STRICKLER SM, 1985, LANCET, V2, P746; TIMME TL, 1994, BIOTECHNIQUES, V17, P461; VANDENBERG M, 1994, CRIT REV TOXICOL, V24, P1; WINN LM, IN PRESS MOL PHARM; WRIGHTON SA, 1992, CRIT REV TOXICOL, V22, P1, DOI 10.3109/10408449209145319; ZHAN QM, 1993, MOL CELL BIOL, V13, P4242, DOI 10.1128/MCB.13.7.4242	45	199	205	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					181	187		10.1038/ng0695-181	http://dx.doi.org/10.1038/ng0695-181			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663513				2022-12-25	WOS:A1995RA85700015
J	BECK, MA; SHI, Q; MORRIS, VC; LEVANDER, OA				BECK, MA; SHI, Q; MORRIS, VC; LEVANDER, OA			RAPID GENOMIC EVOLUTION OF A NONVIRULENT COXSACKIEVIRUS B3 IN SELENIUM-DEFICIENT MICE RESULTS IN SELECTION OF IDENTICAL VIRULENT ISOLATES	NATURE MEDICINE			English	Article							TYPE-3 VACCINE STRAIN; POLIOVIRUS; ATTENUATION; MUTATION	Previous work from our laboratory demonstrated that selenium deficiency in the mouse allows a normally benign (amyocarditic) cloned and sequenced Coxsackievirus to cause significant heart damage. Furthermore, Coxsackievirus recovered from the hearts of selenium-deficient mice inoculated into selenium-adequate mice still induced significant heart damage, suggesting that the amyocarditic Coxsackievirus had mutated to a virulent phenotype. Here we report that sequence analysis revealed six nucleotide changes between the virulent virus recovered from the selenium-deficient host and the avirulent input virus. These nucleotide changes are consistent with known differences in base composition between virulent and avirulent strains of Coxsackievirus. To the best of our knowledge, this is the first report of a specific nutritional deficiency driving changes in a viral genome, permitting an avirulent virus to acquire virulence due to genetic mutation.	USDA ARS,BELTSVILLE HUMAN NUTR RES CTR,NUTRIENT REQUIREMENTS & FUNCT LAB,BELTSVILLE,MD 20705	United States Department of Agriculture (USDA)	BECK, MA (corresponding author), UNIV N CAROLINA,FRANK PORTER GRAHAM CHILD DEV CTR,CB 8180,105 SMITH LEVEL RD,CHAPEL HILL,NC 27599, USA.							ALMOND JW, 1987, ANNU REV MICROBIOL, V41, P153; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BAI J, 1984, ACTA ACAD MED SIN, V2, P29; BECK MA, 1994, J MED VIROL, V43, P166, DOI 10.1002/jmv.1890430213; BURK RF, 1994, J NUTR, V124, P1891, DOI 10.1093/jn/124.10.1891; CAGGANA M, 1993, J VIROL, V67, P4797, DOI 10.1128/JVI.67.8.4797-4803.1993; CHAPMAN NM, 1994, ARCH VIROL, V135, P115, DOI 10.1007/BF01309769; GU BQ, 1983, CHINESE MED J-PEKING, V96, P251; HALL BG, 1990, GENETICS, V126, P5; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; KHUMP WM, 1990, J VIROL, V64, P1573; LEVANDER OA, 1985, FED PROC, V44, P2579; MACADAM AJ, 1991, J VIROL, V65, P5225, DOI 10.1128/JVI.65.10.5225-5231.1991; MINOR PD, 1989, J GEN VIROL, V70, P1117, DOI 10.1099/0022-1317-70-5-1117; MINOR PD, 1986, J GEN VIROL, V67, P693, DOI 10.1099/0022-1317-67-4-693; OCONNELL JB, 1985, POSTGRAD MED J, V61, P1127, DOI 10.1136/pgmj.61.722.1127; Su C, 1979, CHIN MED J, V59, P466; TRACY S, 1993, ARCH VIROL, V122, P399; VANDERPAS JB, 1990, AM J CLIN NUTR, V52, P1087, DOI 10.1093/ajcn/52.6.1087; WOODRUFF JF, 1980, AM J PATHOL, V101, P426; Yang G Q, 1988, World Rev Nutr Diet, V55, P98; ZHANG HY, 1993, J MED VIROL, V41, P129, DOI 10.1002/jmv.1890410208	22	290	306	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1995	1	5					433	436		10.1038/nm0595-433	http://dx.doi.org/10.1038/nm0595-433			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585090				2022-12-25	WOS:A1995RN10000033
J	HAGER, J; HANSEN, L; VAISSE, C; VIONNET, N; PHILIPPI, A; POLLER, W; VELHO, G; CARCASSI, C; CONTU, L; JULIER, C; CAMBIEN, F; PASSA, P; LATHROP, M; KINDSVOGEL, W; DEMENAIS, F; NISHIMURA, E; FROGUEL, P				HAGER, J; HANSEN, L; VAISSE, C; VIONNET, N; PHILIPPI, A; POLLER, W; VELHO, G; CARCASSI, C; CONTU, L; JULIER, C; CAMBIEN, F; PASSA, P; LATHROP, M; KINDSVOGEL, W; DEMENAIS, F; NISHIMURA, E; FROGUEL, P			A MISSENSE MUTATION IN THE GLUCAGON RECEPTOR GENE IS ASSOCIATED WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS	NATURE GENETICS			English	Article							GLUCOKINASE; LINKAGE; HYPERGLUCAGONEMIA; SUBTYPE; LESSONS; REGION; LOCUS; CELL	Non-insulin-dependent diabetes mellitus (NIDDM) affects about 5% of the world population. The disease presents a polygenic mode of inheritance, but mechanisms and genes involved in late-onset NIDDM are largely unknown. We report the association of a single heterozygous Gly to Ser missense mutation in the glucagon receptor gene with late-onset NIDDM. This mutation was highly associated with NIDDM in a pooled set of French and Sardinian patients (chi(2)=14.4, P=0.0001) and showed some evidence for linkage to diabetes in 18 sibships from 9 French pedigrees (chi(2)=6.63, P<0.01). Receptor binding studies using cultured cells expressing the Gly40Ser mutation demonstrate that this mutation results in a receptor which binds glucagon with a three-fold lower affinity compared to the wild type receptor.	HOP ST LOUIS,CTR ETUD POLYMORPHISME HUMAIN,CNRS,EP 10,INSERM,U358,F-75010 PARIS,FRANCE; HOP ST LOUIS,SERV ENDOCRINOL,F-75010 PARIS,FRANCE; ZYMO GENET INC,SEATTLE,WA; UNIV WURZBURG,MED KLIN,INST BIOCHEM,W-8700 WURZBURG,GERMANY; CATTEDRA GENET MED,CAGLIARI,ITALY; HAGEDORN RES INST,GENTOFTE,DENMARK; INSERM,SC7,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Zymogenet Inc.; University of Wurzburg; Novo Nordisk; Hagedorn Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm)			Vionnet, Nathalie/N-6302-2017; Poller, Wolfgang/AAB-2185-2021; JULIER, Cécile/M-9824-2017; Philippi, Anne/M-9853-2017; Demenais, Florence/G-3298-2013; FROGUEL, Philippe/O-6799-2017; Vaisse, Christian/F-1067-2011; Velho, Gilberto/Q-6724-2017; Cambien, Francois/AAP-9751-2020	JULIER, Cécile/0000-0002-1538-0240; Philippi, Anne/0000-0003-2184-6008; Demenais, Florence/0000-0001-8361-0936; FROGUEL, Philippe/0000-0003-2972-0784; Velho, Gilberto/0000-0001-8811-363X; Poller, Wolfgang/0000-0002-2805-6634; Nishimura, Erica/0000-0001-5741-3648; Carcassi, Carlo/0000-0002-9533-1579				BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; CHERRINGTON A D, 1987, Diabetes Metabolism Reviews, V3, P307; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; ELSTON RC, 1986, 7TH INT C HUM GEN BE; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; GALLUS G, 1991, EPIDEMIOL PREVENZ, V48, P55; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JELINEK LJ, 1993, SCIENCE, V259, P1614, DOI 10.1126/science.8384375; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; LEVEBRE P, 1991, NEW DIRECTIONS RES C, P25; LOK S, 1994, GENE, V140, P203, DOI 10.1016/0378-1119(94)90545-2; PARSIAN A, 1991, ARCH GEN PSYCHIAT, V48, P655; RASKIN P, 1978, NEW ENGL J MED, V299, P433, DOI 10.1056/NEJM197808312990901; SAMOLS E, 1965, LANCET, V2, P415; SEGRE GV, 1993, TRENDS ENDOCRIN MET, V4, P309, DOI 10.1016/1043-2760(93)90071-L; SPIEGEL AM, 1993, J CLIN INVEST, V92, P1119, DOI 10.1172/JCI116680; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEINER DF, 1990, DIABETES CARE, V13, P600, DOI 10.2337/diacare.13.6.600; TAYLOR SI, 1992, DIABETES, V41, P1473, DOI 10.2337/diabetes.41.11.1473; UNGER RH, 1970, J CLIN INVEST, V49, P837, DOI 10.1172/JCI106297; VANDENOUWELAND JMW, 1993, NAT GENET, V1, P368; VANEYLL B, 1994, DIABETES, V43, pA178; VANSCHRAVENDIJK CFH, 1985, ENDOCRINOLOGY, V117, P841; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; VIONNET N, 1993, LANCET, V342, P1429, DOI 10.1016/0140-6736(93)92792-R	27	158	164	0	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					299	304		10.1038/ng0395-299	http://dx.doi.org/10.1038/ng0395-299			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773293				2022-12-25	WOS:A1995QL23200021
J	LAFERLA, FM; TINKLE, BT; BIEBERICH, CJ; HAUDENSCHILD, CC; JAY, G				LAFERLA, FM; TINKLE, BT; BIEBERICH, CJ; HAUDENSCHILD, CC; JAY, G			THE ALZHEIMERS A-BETA PEPTIDE INDUCES NEURODEGENERATION AND APOPTOTIC CELL-DEATH IN TRANSGENIC MICE	NATURE GENETICS			English	Article								To test whether the hypothesis that the Alzheimer's A beta peptide is neurotoxic, we introduced a transgene into mice to direct expression of this peptide to neurons. We show that the transgene is expressed in brain regions which are severely affected in Alzheimer's disease resulting in extensive neuronal degeneration. Morphological and biochemical evidence indicates that the eventual death of these cells occurs by apoptosis. Coincident with the cell degeneration and cell death is the presence of a striking reactive gliosis. Over 50% of the transgenic mice die by 12 months of age, half the normal life span of control mice. These data show that A beta is neurotoxic in vivo and suggest that apoptosis may be responsible for the accompanying neuronal loss, the principal underlying cellular feature of Alzheimer's disease.	AMER RED CROSS, JEROME H HOLLAND LAB BIOMED SCI, DEPT VIROL, ROCKVILLE, MD 20855 USA; AMER RED CROSS, JEROME H HOLLAND LAB BIOMED SCI, DEPT EXPTL PATHOL, ROCKVILLE, MD 20855 USA	American Red Cross; American Red Cross			Christian, Haudenschild C/D-1602-2009; Jay, Gregory/C-6346-2013					BEGEMANN M, 1990, P NATL ACAD SCI USA, V87, P9042, DOI 10.1073/pnas.87.22.9042; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BYRNE GW, 1989, P NATL ACAD SCI USA, V86, P5473, DOI 10.1073/pnas.86.14.5473; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CARSON DA, 1993, LANCET, V341, P1251, DOI 10.1016/0140-6736(93)91154-E; CARSWELL S, 1989, MOL CELL BIOL, V9, P4248, DOI 10.1128/MCB.9.10.4248; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6; COTMAN CW, 1992, NEUROBIOL AGING, V13, P587, DOI 10.1016/0197-4580(92)90060-B; DELACOURTE A, 1990, NEUROLOGY, V40, P33, DOI 10.1212/WNL.40.1.33; DUFFY P, 1988, ARCH NEUROL-CHICAGO, V45, P1097, DOI 10.1001/archneur.1988.00520340051011; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; FARLOW M, 1994, NEUROLOGY, V44, P105, DOI 10.1212/WNL.44.1.105; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; FREDERICKSON RCA, 1992, NEUROBIOL AGING, V13, P239, DOI 10.1016/0197-4580(92)90036-W; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GREEN JE, 1989, NATURE, V341, P72, DOI 10.1038/341072a0; GRUNDKEIQBAL I, 1989, P NATL ACAD SCI USA, V86, P2853, DOI 10.1073/pnas.86.8.2853; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAUSER WA, 1986, NEUROLOGY, V36, P1226, DOI 10.1212/WNL.36.9.1226; HAYASHI Y, 1992, BIOCHEM BIOPH RES CO, V187, P1249, DOI 10.1016/0006-291X(92)90437-P; HILBICH C, 1991, EUR J BIOCHEM, V201, P61, DOI 10.1111/j.1432-1033.1991.tb16256.x; HINRICHS SH, 1987, SCIENCE, V237, P1340, DOI 10.1126/science.2888191; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; JUCKER M, 1992, SCIENCE, V255, P1443, DOI 10.1126/science.1542796; JULIEN JP, 1986, MOL BRAIN RES, V1, P243, DOI 10.1016/0169-328X(86)90030-6; JULIEN JP, 1992, J PHYSIOL-PARIS, V84, P50; KAMMESHEIDT A, 1992, P NATL ACAD SCI USA, V89, P10857, DOI 10.1073/pnas.89.22.10857; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KAWABATA S, 1991, NATURE, V354, P476, DOI 10.1038/354476a0; KAWABATA S, 1992, NATURE, V356, P23, DOI 10.1038/356023b0; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; MANDYBUR TI, 1990, NEUROLOGY, V40, P635, DOI 10.1212/WNL.40.4.635; MARUYAMA K, 1990, NATURE, V347, P566, DOI 10.1038/347566a0; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MONTEIRO MJ, 1989, J CELL BIOL, V108, P579, DOI 10.1083/jcb.108.2.579; MONTEIRO MJ, 1990, J CELL BIOL, V111, P1543, DOI 10.1083/jcb.111.4.1543; MUCKE L, 1991, NEW BIOL, V3, P465; MURPHY GM, 1994, AM J PATHOL, V144, P1082; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; PEARSON BE, 1993, P NATL ACAD SCI USA, V90, P10578, DOI 10.1073/pnas.90.22.10578; PERRY G, 1992, AM J PATHOL, V140, P283; POLLOCK RA, 1992, CELL, V71, P911, DOI 10.1016/0092-8674(92)90388-S; PONTE P, 1988, NATURE, V331, P525, DOI 10.1038/331525a0; PRICE DL, 1992, NEUROBIOL AGING, V13, P623, DOI 10.1016/0197-4580(92)90069-A; PRICE DL, 1993, P NATL ACAD SCI USA, V90, P6381, DOI 10.1073/pnas.90.14.6381; QUON D, 1991, NATURE, V352, P239, DOI 10.1038/352239a0; RISSE S C, 1990, Alzheimer Disease and Associated Disorders, V4, P217, DOI 10.1097/00002093-199040400-00003; ROMANELLI MF, 1990, ARCH NEUROL-CHICAGO, V47, P847, DOI 10.1001/archneur.1990.00530080029006; SANDHU FA, 1991, J BIOL CHEM, V266, P21331; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; VIJAYAN VK, 1991, EXP NEUROL, V112, P72, DOI 10.1016/0014-4886(91)90115-S; VOGEL J, 1988, NATURE, V335, P606, DOI 10.1038/335606a0; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; WIRAK D, 1992, SCIENCE, V255, P1445, DOI 10.1126/science.255.5050.1445; WIRAK DO, 1991, SCIENCE, V253, P323, DOI 10.1126/science.1857970; WYLLIE AH, 1987, INT REV CYTOL, P755; YAMAGUCHI F, 1991, NEUROREPORT, V2, P781, DOI 10.1097/00001756-199112000-00013; YOSHIKAWA K, 1992, NATURE, V359, P64, DOI 10.1038/359064a0; 1990, MMWR-MORBID MORTAL W, V39, P785	69	478	498	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1995	9	1					21	30		10.1038/ng0195-21	http://dx.doi.org/10.1038/ng0195-21			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704018				2022-12-25	WOS:A1995PZ91300010
J	SKINNER, MP; YUAN, C; MITSUMORI, L; HAYES, CE; RAINES, EW; NELSON, JA; ROSS, R				SKINNER, MP; YUAN, C; MITSUMORI, L; HAYES, CE; RAINES, EW; NELSON, JA; ROSS, R			SERIAL MAGNETIC-RESONANCE-IMAGING OF EXPERIMENTAL ATHEROSCLEROSIS DETECTS LESION FINE-STRUCTURE, PROGRESSION AND COMPLICATIONS IN-VIVO	NATURE MEDICINE			English	Article							ACUTE CORONARY SYNDROMES; LOW-LEVEL HYPERCHOLESTEROLEMIA; FATTY STREAK CONVERSION; NONHUMAN PRIMATE; MEDICAL PROGRESS; FIBROUS PLAQUE; ARTERY DISEASE; FOAM CELLS; ATHEROGENESIS; PATHOGENESIS	A major problem in the study of lesions of atherosclerosis is the difficulty of imaging noninvasively the lesions and following their progression in vivo. To address this problem, we have developed advanced magnetic resonance techniques to noninvasively and serially image advanced lesions of atherosclerosis in the rabbit abdominal aorta. Both lumen and wail were imaged with high resolution. Progression of disease, resulting in increase in lesion mass, decrease in arterial lumen, or stenosis, and intralesion complications, can be detected. Images acquired in vivo correlate with the fine structure of the lesions of atherosclerosis, including the fibrous cap, necrotic core, and lesion fissures, as verified by gross examination, dissection microscopy, and histology. The ability to noninvasively identify the features of atherosclerotic plaques, has significant implications for determining risks and benefits associated with different therapeutic approaches.	UNIV WASHINGTON, DEPT PATHOL SM30, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT RADIOL SB05, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle					PHS HHS [18645] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CONSTANT.P, 1966, J ATHEROSCLER RES, V6, P1, DOI 10.1016/S0368-1319(66)80056-X; DAVIES MJ, 1993, BRIT HEART J, V69, pS3; DAVIES MJ, 1984, NEW ENGL J MED, V310, P137; EDELMAN RR, 1993, NEW ENGL J MED, V328, P785, DOI 10.1056/NEJM199303183281109; EDELMAN RR, 1993, NEW ENGL J MED, V328, P708, DOI 10.1056/NEJM199303113281008; FALK E, 1985, CIRCULATION, V71, P699, DOI 10.1161/01.CIR.71.4.699; FORRESTER JS, 1991, ANNU REV MED, V42, P35, DOI 10.1146/annurev.med.42.1.35; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; FUSTER V, 1992, NEW ENGL J MED, V326, P310; GERRITY RG, 1981, AM J PATHOL, V103, P191; GERRITY RG, 1981, AM J PATHOL, V103, P181; GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018; GOLD GE, 1993, JMRI-J MAGN RESON IM, V3, P399, DOI 10.1002/jmri.1880030216; HAYES C, IN PRESS J MAGN RESO; HERFKENS RJ, 1983, RADIOLOGY, V148, P161, DOI 10.1148/radiology.148.1.6856827; MANNING WJ, 1993, NEW ENGL J MED, V328, P828, DOI 10.1056/NEJM199303253281202; MASUDA J, 1990, ARTERIOSCLEROSIS, V10, P178, DOI 10.1161/01.ATV.10.2.178; MASUDA J, 1990, ARTERIOSCLEROSIS, V10, P164, DOI 10.1161/01.ATV.10.2.164; MATWIYOFF NA, 1990, MAGN RESON IMAGING, V8, P295, DOI 10.1016/0730-725X(90)90102-8; MAYNOR CH, 1989, INVEST RADIOL, V24, P52, DOI 10.1097/00004424-198901000-00012; MERICKEL MB, 1993, ARTERIOSCLER THROMB, V13, P1180, DOI 10.1161/01.ATV.13.8.1180; MERICKEL MB, 1988, COMPUT BIOL MED, V18, P89, DOI 10.1016/0010-4825(88)90035-2; MIZUNO K, 1992, NEW ENGL J MED, V326, P287, DOI 10.1056/NEJM199201303260502; MOHIADDIN RH, 1993, CIRCULATION, V88, P264, DOI 10.1161/01.CIR.88.1.264; MOHIADDIN RH, 1989, BRIT MED BULL, V45, P968, DOI 10.1093/oxfordjournals.bmb.a072377; PEARLMAN JD, 1988, MAGN RESON MED, V7, P262, DOI 10.1002/mrm.1910070303; PEARLMAN JD, 1991, ANGIOLOGY, V42, P726, DOI 10.1177/000331979104200906; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Stary HC, 1989, ARTERIOSCLER, V99, pI19; Topol EJ., 1994, TXB INTERVENTIONAL C, V1; VINITSKI S, 1991, INVEST RADIOL, V26, P703, DOI 10.1097/00004424-199108000-00001	33	162	165	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1995	1	1					69	73		10.1038/nm0195-69	http://dx.doi.org/10.1038/nm0195-69			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX557	7584956				2022-12-25	WOS:A1995QX55700029
J	KURATA, N; NAGAMURA, Y; YAMAMOTO, K; HARUSHIMA, Y; SUE, N; WU, J; ANTONIO, BA; SHOMURA, A; SHIMIZU, T; LIN, SY; INOUE, T; FUKUDA, A; SHIMANO, T; KUBOKI, Y; TOYAMA, T; MIYAMOTO, Y; KIRIHARA, T; HAYASAKA, K; MIYAO, A; MONNA, L; ZHONG, HS; TAMURA, Y; WANG, ZX; MOMMA, T; UMEHARA, Y; YANO, M; SASAKI, T; MINOBE, Y				KURATA, N; NAGAMURA, Y; YAMAMOTO, K; HARUSHIMA, Y; SUE, N; WU, J; ANTONIO, BA; SHOMURA, A; SHIMIZU, T; LIN, SY; INOUE, T; FUKUDA, A; SHIMANO, T; KUBOKI, Y; TOYAMA, T; MIYAMOTO, Y; KIRIHARA, T; HAYASAKA, K; MIYAO, A; MONNA, L; ZHONG, HS; TAMURA, Y; WANG, ZX; MOMMA, T; UMEHARA, Y; YANO, M; SASAKI, T; MINOBE, Y			A 300 KILOBASE INTERVAL GENETIC-MAP OF RICE INCLUDING 883 EXPRESSED SEQUENCES	NATURE GENETICS			English	Article							LINKAGE MAPS; GENOMES; DNA	We have constructed a high resolution rice genetic map containing 1,383 DNA markers at an average interval of 300 kilobases (kb). The markers, distributed along 1,575 cM on 12 linkage groups, comprise 883 cDNAs, 265 genomic DNAs, 147 randomly amplified polymorphic DNAs (RAPD) and 88 other DNAs. cDNAs were derived from rice root and callus, analysed by single-run sequencing and searched for similarities with known proteins. Nearly 260 rice genes are newly identified and mapped, and genomic DNA and cloned RAPD fragments were also sequenced to generate STSs. Our map is the first significant gene expression map in plants. It is also the densest genetic map available in plants and the first to be backed up comprehensively by clone sequence data.	AICHI KEN AGR RES CTR, NAGAKUTE, AICHI 48011, JAPAN; WAKAYAMA AGR EXPT STN, WAKAYAMA 64004, JAPAN; IBARAKI AGR CTR, INST PLANT BIOTECHNOL, IWAMA, IBARAKI 31902, JAPAN; MIYAGI PREFECTURAL FURUKAWA AGR EXPT STN, FURUKAWA, MIYAGI, JAPAN		KURATA, N (corresponding author), NATL INST AGROBIOL RESOURCES, INST SOC TECHNOINNOVAT AGR FORESTRY & FISHERIES, TSUKUBA, IBARAKI 305, JAPAN.		Ding, Cheng-Qiang/B-6287-2011; Miyao, Akio/V-7306-2019	Miyao, Akio/0000-0002-2822-2866				AHN S, 1993, P NATL ACAD SCI USA, V90, P7980, DOI 10.1073/pnas.90.17.7980; Ashikawa I, 1994, DNA Res, V1, P67, DOI 10.1093/dnares/1.2.67; BURR B, 1993, GENETIC MAPS; DEVOS KM, 1992, OUTLOOK AGR, V22, P93; INOUE T, IN PRESS THEOR APPL; Kinoshita T., 1990, RICE GENET NEWSLETT, V7, P16; KURATA N, 1994, BIO-TECHNOL, V12, P276, DOI 10.1038/nbt0394-276; KURATA N, 1993, RICE GENET NEWS, V9, P130; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; MACKILL DJ, 1993, THEOR APPL GENET, V85, P536, DOI 10.1007/BF00220910; MOCHIZUKI K, 1992, JPN J GENET, V67, P155, DOI 10.1266/jjg.67.155; MOHAN M, 1994, THEOR APPL GENET, V87, P782, DOI 10.1007/BF00221129; Monna L, 1994, DNA Res, V1, P139, DOI 10.1093/dnares/1.3.139; MOORE G, 1993, BIO-TECHNOL, V11, P584, DOI 10.1038/nbt0593-584; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; RONALD PC, 1991, RICE GENET NEWSL, V8, P142; SAITO A, 1991, JPN J BREED, V41, P665; SASAKI T, 1994, PLANT J, V6, P615, DOI 10.1046/j.1365-313X.1994.6040615.x; STEPHENS JC, 1992, GENETIC MAPS; TANKSLEY SD, 1992, GENETICS, V132, P1141; TANKSLEY SD, 1993, GENETIC MAPS; UMEDA M, 1991, JPN J GENET, V66, P569, DOI 10.1266/jjg.66.569; UMEHARA Y, IN PRESS PLANT BREED; Xiao J., 1992, RICE GENET NEWSL, V9, P124; 1993, PLANT MOL BIOL REPOR, V11, P291	26	445	499	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					365	372		10.1038/ng1294-365	http://dx.doi.org/10.1038/ng1294-365			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894488				2022-12-25	WOS:A1994PV68200018
J	COLLOD, G; BABRON, MC; JONDEAU, G; COULON, M; WEISSENBACH, J; DUBOURG, O; BOURDARIAS, JP; BONAITIPELLIE, C; JUNIEN, C; BOILEAU, C				COLLOD, G; BABRON, MC; JONDEAU, G; COULON, M; WEISSENBACH, J; DUBOURG, O; BOURDARIAS, JP; BONAITIPELLIE, C; JUNIEN, C; BOILEAU, C			A 2ND LOCUS FOR MARFAN-SYNDROME MAPS TO CHROMOSOME-3P24.2-P25	NATURE GENETICS			English	Article							DYSTROPHIC EPIDERMOLYSIS-BULLOSA; VII COLLAGEN GENE; MITRAL-VALVE PROLAPSE; CONNECTIVE-TISSUE; FIBRILLIN GENES; MISSENSE MUTATION; LINKAGE ANALYSIS; COL7A1; DIAGNOSIS; DISORDER	Marfan syndrome (MFS) is an autosomal dominant connective-tissue disorder characterized by skeletal, ocular and cardiovascular defects of highly variable expressivity. The diagnosis relies solely on clinical criteria requiring anomalies in at least two systems. By excluding the chromosome 15 disease locus, fibrillin 1 (FBN1), in a large French family with typical cardiovascular and skeletal anomalies, we raised the issue of genetic heterogeneity in MFS and the implication of a second locus (MFS2). Linkage analyses, performed in this family, have localized MFS2 to a region of 9 centiMorgans between D3S1293 and D3S1283, at 3p24.2-p25. In this region, the highest lod score was found with D3S2336, of 4.89 (theta=0.05). By LINKMAP analyses, the most probable position for the second locus in MFS was at D3S2335.	UNIV PARIS 05,HOP NECKER ENFANTS MALAD,INSERM,U383,F-75743 PARIS 15,FRANCE; INSERM,U155,F-75016 PARIS,FRANCE; CHU AMBROISE PARE,SERV CARDIOL,F-92104 BOULOGNE,FRANCE; GENETHON,F-91002 EVRY,FRANCE; CHU AMBROSIE PARE,CENT BIOCHIM & GENET LAB,F-92104 BOULOGNE,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP			COLLOD-BEROUD, Gwenaëlle/A-8342-2008; boileau, catherine/M-4482-2017	COLLOD-BEROUD, Gwenaëlle/0000-0003-4098-6161; boileau, catherine/0000-0002-0371-7539; Babron, Marie-Claude/0000-0002-4100-0299				ALIMARA L, 1992, J MED GENET, V29, P381, DOI 10.1136/jmg.29.6.381; AOYAMA T, 1994, J CLIN INVEST, V94, P130, DOI 10.1172/JCI117298; ARNASINO RM, 1986, ANAL BIOCHEM, V152, P304; BEIGHTON P, 1988, AM J MED GENET, V29, P581, DOI 10.1002/ajmg.1320290316; BLANTON SH, 1990, J MED GENET, V27, P73, DOI 10.1136/jmg.27.2.73; BOILEAU C, 1994, AM J HUM GENET, V54, P554; BOILEAU C, 1990, J MED GENET, V27, P78, DOI 10.1136/jmg.27.2.78; BOILEAU C, 1993, AM J HUM GENET, V53, P46; CHRISTIANO AM, 1993, NAT GENET, V4, P62, DOI 10.1038/ng0593-62; CHRISTIANO AM, 1992, GENOMICS, V14, P827, DOI 10.1016/S0888-7543(05)80204-6; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; DEVEREUX RB, 1987, AM HEART J, V113, P1265, DOI 10.1016/0002-8703(87)90955-0; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; GILCHRIST DM, 1994, AM J HUM GENET, V54, P553; GLESBY MJ, 1989, JAMA-J AM MED ASSOC, V262, P523, DOI 10.1001/jama.262.4.523; HENRY I, 1984, AM J HUM GENET, V36, P760; HILAL L, 1993, NAT GENET, V5, P287, DOI 10.1038/ng1193-287; HOVNANIAN A, 1992, J CLIN INVEST, V90, P1032, DOI 10.1172/JCI115916; KAINULAINEN K, 1992, P NATL ACAD SCI USA, V89, P5917, DOI 10.1073/pnas.89.13.5917; KAINULAINEN K, 1990, NEW ENGL J MED, V323, P935, DOI 10.1056/NEJM199010043231402; KAINULAINEN K, 1991, AM J HUM GENET, V49, P662; KINGSLEY DM, 1993, MAMM GENOME, V4, P135; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEE B, 1991, NATURE, V352, P330, DOI 10.1038/352330a0; MCKUSICK VA, 1955, CIRCULATION, V11, P321, DOI 10.1161/01.CIR.11.3.321; MCKUSICK VA, 1988, MENDELIAN INHERITANC; MOORE KJ, 1993, MAMM GENOME, V4, P88; NAYLOR SL, 1994, CYTOGENET CELL GENET, V65, P1; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; REEVES RH, 1993, MAMMALIAN GENOME S, V4, P223; SARFARAZI M, 1992, J MED GENET, V29, P75, DOI 10.1136/jmg.29.2.75; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; TYNAN K, 1993, HUM MOL GENET, V2, P1813, DOI 10.1093/hmg/2.11.1813; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; 1994, AM J HUM GENET, V54, P553	37	120	122	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					264	268		10.1038/ng1194-264	http://dx.doi.org/10.1038/ng1194-264			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7632217	Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:A1994PP76500016
J	MUENKE, M; SCHELL, U; HEHR, A; ROBIN, NH; LOSKEN, HW; SCHINZEL, A; PULLEYN, LJ; RUTLAND, P; REARDON, W; MALCOLM, S; WINTER, RM				MUENKE, M; SCHELL, U; HEHR, A; ROBIN, NH; LOSKEN, HW; SCHINZEL, A; PULLEYN, LJ; RUTLAND, P; REARDON, W; MALCOLM, S; WINTER, RM			A COMMON MUTATION IN THE FIBROBLAST GROWTH-FACTOR RECEPTOR-1 GENE IN PFEIFFER-SYNDROME	NATURE GENETICS			English	Article							PROTEIN-TYROSINE KINASE; SIGNAL TRANSDUCTION; EXPRESSION; FORMS; FGF	Pfeiffer syndrome (PS) is one of the classic autosomal dominant craniosynostosis syndromes with craniofacial anomalies and characteristic broad thumbs and big toes. We have previously mapped one of the genes for PS to the centromeric region of chromosome 8 by linkage analysis. Here we present evidence that mutations in the fibroblast growth factor receptor-1 (FGFR1) gene, which maps to 8p, cause one form of familiar Pfeiffer syndrome. A C to G transversion in exon 5, predicting a proline to arginine substitution in the putative extracellular domain, was identified in all affected members of five unrelated PS families but not in any unaffected individuals. FGFR1 therefore becomes the third fibroblast growth factor receptor to be associated with an autosomal dominant skeletal disorder.	UNIV PENN,SCH MED,DEPT PEDIAT,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104; UNIV PITTSBURGH,DEPT PLAST SURG,PITTSBURGH,PA 15261; INST MED GENET,ZURICH,SWITZERLAND; INST CHILD HLTH,MOTHERCARE UNIT CLIN GENET,LONDON WC1N 1EH,ENGLAND; INST CHILD HLTH,GENET UNIT,LONDON WC1N 1EH,ENGLAND	University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; University College London; University of London; University College London	MUENKE, M (corresponding author), UNIV PENN,SCH MED,CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104, USA.			Reardon, Willie/0000-0001-7329-9179; Muenke, Maximilian/0000-0002-7719-6545	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD028732, T32HD007107] Funding Source: NIH RePORTER; NICHD NIH HHS [5T32HD07107, R29HD28732] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BARAITSER M, 1980, J MED GENET, V17, P250, DOI 10.1136/jmg.17.4.250; COHEN M M JR, 1986, P413; COHEN MM, 1993, AM J MED GENET, V45, P300, DOI 10.1002/ajmg.1320450305; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; HOUSSAINT E, 1990, P NATL ACAD SCI USA, V87, P8180, DOI 10.1073/pnas.87.20.8180; ISACCHI A, 1990, NUCLEIC ACIDS RES, V18, P1906, DOI 10.1093/nar/18.7.1906; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LI XA, 1994, GENOMICS, V22, P418, DOI 10.1006/geno.1994.1403; MANSUKHANI A, 1990, P NATL ACAD SCI USA, V87, P4378, DOI 10.1073/pnas.87.11.4378; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PASQUALE EB, 1989, P NATL ACAD SCI USA, V86, P5449, DOI 10.1073/pnas.86.14.5449; PETERS KG, 1992, DEVELOPMENT, V114, P233; PFEIFFER R A, 1964, Z Kinderheilkd, V90, P301, DOI 10.1007/BF00447500; PRESTON RA, 1994, NAT GENET, V7, P149, DOI 10.1038/ng0694-149; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; ROBIN NH, IN PRESS HUM MOL GEN; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUTA M, 1988, ONCOGENE, V3, P9; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; YAZAKI N, 1993, BIOCHIM BIOPHYS ACTA, V1172, P37, DOI 10.1016/0167-4781(93)90266-G; ZIPPEL H, 1969, FORTSCHR RONTG NEUEN, V110, P234, DOI 10.1055/s-0029-1228557	29	508	523	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					269	274		10.1038/ng1194-269	http://dx.doi.org/10.1038/ng1194-269			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874169				2022-12-25	WOS:A1994PP76500017
J	ROSATI, R; HORAN, GSB; PINERO, GJ; GAROFALO, S; KEENE, DR; HORTON, WA; VUORIO, E; DECROMBRUGGHE, B; BEHRINGER, RR				ROSATI, R; HORAN, GSB; PINERO, GJ; GAROFALO, S; KEENE, DR; HORTON, WA; VUORIO, E; DECROMBRUGGHE, B; BEHRINGER, RR			NORMAL LONG-BONE GROWTH AND DEVELOPMENT IN TYPE-X COLLAGEN NULL MICE	NATURE GENETICS			English	Article							CARTILAGE MATRIX; GENE-EXPRESSION; MUTATION; PROTOONCOGENE; ASSOCIATION; DISRUPTION; PROTEIN; ENCODES	To investigate the role of type X collagen in skeletal development, we have generated type X collagen-null mice. Surprisingly, mice without type X collagen were viable and fertile and had no gross abnormalities in long bone growth or development. No differences were detected between the type X collagen-null mice and controls when growth plates of both newborn and 3-week old mice were examined by histology and by immunostaining for extracellular matrix components of bone including osteopontin, osteocalcin and type II collagen. Our results suggest that type X collagen is not required for long bone development. However, mice and humans with dominant acting type X collagen mutations have bone abnormalities, suggesting that only the presence of abnormal type X collagen can modify bone growth and development.	UNIV TEXAS, MD ANDERSON CANC CTR, DEPT MOLEC GENET, HOUSTON, TX 77030 USA; FDN G PASCALE, IST STUDIO CURA TUMORI, NAPLES, ITALY; UNIV TEXAS, HLTH SCI CTR, DEPT BASIC SCI, DENT BRANCH, HOUSTON, TX 77030 USA; SHRINERS HOSP CRIPPLED CHILDRENS, PORTLAND, OR 97201 USA; TURKU UNIV, DEPT MOLEC BIOL & MED BIOCHEM, TURKU, FINLAND	University of Texas System; UTMD Anderson Cancer Center; IRCCS Fondazione Pascale; University of Texas System; University of Texas Health Science Center Houston; University of Turku				Vuorio, Eero/0000-0003-3404-2439; GAROFALO, SILVIO/0000-0001-7460-3179	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD031568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040335] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR40335] Funding Source: Medline; NICHD NIH HHS [HD 31568] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; CHEN Q, 1990, P NATL ACAD SCI USA, V87, P8046, DOI 10.1073/pnas.87.20.8046; Culling C. F. A., 1985, CELLULAR PATHOLOGY T, P642; DHARMAVARAM RM, 1994, HUM MOL GENET, V3, P507, DOI 10.1093/hmg/3.3.507; ELIMA K, 1993, BIOCHEM J, V289, P247, DOI 10.1042/bj2890247; FITCH JM, 1988, DEV BIOL, V128, P396, DOI 10.1016/0012-1606(88)90301-6; GAROFALO S, 1991, P NATL ACAD SCI USA, V88, P9648, DOI 10.1073/pnas.88.21.9648; GERSTENFELD LC, 1991, J CELL BIOL, V112, P501, DOI 10.1083/jcb.112.3.501; HAUSCHKA PV, 1989, PHYSIOL REV, V69, P990, DOI 10.1152/physrev.1989.69.3.990; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; KIRSCH T, 1991, EUR J BIOCHEM, V196, P575, DOI 10.1111/j.1432-1033.1991.tb15852.x; KRAMER JM, 1988, CELL, V55, P555, DOI 10.1016/0092-8674(88)90214-0; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; KWAN APL, 1991, J CELL BIOL, V114, P597, DOI 10.1083/jcb.114.3.597; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARK MP, 1987, J HISTOCHEM CYTOCHEM, V35, P707, DOI 10.1177/35.7.3295029; MCINTOSH I, 1994, HUM MOL GENET, V3, P303, DOI 10.1093/hmg/3.2.303; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MURAGAKI Y, 1991, J BIOL CHEM, V266, P7721; POOLE AR, 1989, J CELL BIOL, V109, P2547, DOI 10.1083/jcb.109.5.2547; POOLE R, 1991, CARTILAGE MOL ASPECT, V6, P179; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; Sambrook J, 1989, MOL CLONING LABORATO; SCHMID TM, 1990, ANN NY ACAD SCI, V580, P64, DOI 10.1111/j.1749-6632.1990.tb17918.x; SCHMID TM, 1985, J CELL BIOL, V100, P598, DOI 10.1083/jcb.100.2.598; SCHMID TM, 1990, DEV BIOL, V138, P53, DOI 10.1016/0012-1606(90)90176-J; SCHMID TM, 1987, STRUCTURE FUNCTION C, P223; SEARLE AG, 1954, J GENET, V52, P68, DOI 10.1007/BF02981491; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; THOMAS JT, 1990, J CELL SCI, V95, P639; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; WALLIS GA, 1994, AM J HUM GENET, V54, P169; WARMAN ML, 1993, NAT GENET, V5, P79, DOI 10.1038/ng0993-79; WU LNY, 1989, J BIOL CHEM, V264, P21346; YAMAGUCHI N, 1991, J BIOL CHEM, V266, P4508	38	132	135	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1994	8	2					129	135		10.1038/ng1094-129	http://dx.doi.org/10.1038/ng1094-129			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7842010				2022-12-25	WOS:A1994PL12300013
J	ENGELHARDT, JF; YANKASKAS, JR; ERNST, SA; YANG, YP; MARINO, CR; BOUCHER, RC; COHN, JA; WILSON, JM				ENGELHARDT, JF; YANKASKAS, JR; ERNST, SA; YANG, YP; MARINO, CR; BOUCHER, RC; COHN, JA; WILSON, JM			SUBMUCOSAL GLANDS ARE THE PREDOMINANT SITE OF CFTR EXPRESSION IN THE HUMAN BRONCHUS	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS GENE; TRANSMEMBRANE CONDUCTANCE REGULATOR; DOGFISH SQUALUS-ACANTHIAS; CHLORIDE CHANNELS; RECTAL GLAND; CYCLIC-AMP; TRANSPORT; IDENTIFICATION; LOCALIZATION; EPITHELIA	We have used in situ hybridization and immunocytochemistry to characterize the cellular distribution of cystic fibrosis (CF) gene expression in human bronchus. The cystic fibrosis transmembrane conductance regulator (CFTR) was primarily localized to cells of submucosal glands in bronchial tissues from non-CF individuals notably in the serous component of the secretory tubules as well as a subpopulation of cells in ducts. Normal distribution of CFTR mRNA was found in CF tissues while expression of CFTR protein was genotype specific, with AF508 homozygotes demonstrating no detectable protein and compound heterozygotes expressing decreased levels of normally distributed protein. Our data suggest mechanisms whereby defects in CFTR expression could lead to abnormal production of mucus in human lung.	UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT ANAT & CELL BIOL,ANN ARBOR,MI 48109; UNIV N CAROLINA,DIV PULM DIS,CHAPEL HILL,NC 27599; YALE UNIV,DEPT INTERNAL MED,NEW HAVEN,CT 06510; DUKE UNIV,DEPT MED,DURHAM,NC 27706; VET ADM MED CTR,DURHAM,NC 27705	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; Yale University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)			Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131; Engelhardt, John/0000-0003-2389-9277				ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; BASBAUM CB, 1990, ANNU REV PHYSIOL, V52, P97; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; COHN JA, 1991, BIOCHEM BIOPH RES CO, V181, P36, DOI 10.1016/S0006-291X(05)81378-6; COHN JA, 1992, P NATL ACAD SCI USA, V89, P2340, DOI 10.1073/pnas.89.6.2340; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; FRIZZELL RA, 1979, AM J PHYSIOL, V236, P1; GREGER R, 1987, PFLUG ARCH EUR J PHY, V409, P114, DOI 10.1007/BF00584757; GREGER R, 1984, PFLUG ARCH EUR J PHY, V402, P376, DOI 10.1007/BF00583938; HARKEMA JR, 1990, AIRWAY EPITHELIUM PH, P3; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; KATZ SM, 1980, AM J CLIN PATHOL, V73, P682, DOI 10.1093/ajcp/73.5.682; KATZ U, 1986, BIOCHIM BIOPHYS ACTA, V861, P480, DOI 10.1016/0005-2736(86)90457-8; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LARSEN EH, 1991, PHYSIOL REV, V71, P235, DOI 10.1152/physrev.1991.71.1.235; LEIKAUF GD, 1984, J APPL PHYSIOL, V56, P426, DOI 10.1152/jappl.1984.56.2.426; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; LIEDTKE CM, 1989, ANNU REV PHYSIOL, V51, P143, DOI 10.1146/annurev.physiol.51.1.143; MARINO CR, 1991, J CLIN INVEST, V88, P712, DOI 10.1172/JCI115358; MARTINEZ J R, 1990, Critical Reviews in Oral Biology and Medicine, V1, P67; MEYRICK B, 1970, J ANAT, V107, P281; MEYRICK B, 1969, THORAX, V24, P729, DOI 10.1136/thx.24.6.729; NATHANSON I, 1984, LUNG, V162, P125, DOI 10.1007/BF02715640; Oppenheimer E H, 1975, Perspect Pediatr Pathol, V2, P241; Phipps R J, 1981, Int Rev Physiol, V23, P213; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; REID LYNNE, 1960, THORAX, V15, P132, DOI 10.1136/thx.15.2.132; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; RUTLAND J, 1981, THORAX, V36, P654, DOI 10.1136/thx.36.9.654; RUTTEN AAJJL, 1988, VIRCHOWS ARCH B, V56, P111, DOI 10.1007/BF02890009; SATO K, 1991, ADV EXP MED BIOL, V290, P145; SILVA P, 1977, AM J PHYSIOL, V233, P298; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; TAM PY, 1981, NATURE, V292, P340, DOI 10.1038/292340a0; THOMPSON IG, 1983, AM PHYSL SOC, P221; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; UMEKI S, 1988, RESPIRATION, V54, P220, DOI 10.1159/000195528; VERDUGO P, 1990, BIORHEOLOGY, V27, P465; YAMAYA M, 1991, AM J PHYSIOL, V261, pL491, DOI 10.1152/ajplung.1991.261.6.L491; YAMAYA M, 1991, AM J PHYSIOL, V261, pL485, DOI 10.1152/ajplung.1991.261.6.L485; ZEITLIN PL, 1992, P NATL ACAD SCI USA, V89, P344, DOI 10.1073/pnas.89.1.344	47	554	562	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1992	2	3					240	248		10.1038/ng1192-240	http://dx.doi.org/10.1038/ng1192-240			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1285365				2022-12-25	WOS:A1992JW16500016
J	MORAES, CT; RICCI, E; PETRUZZELLA, V; SHANSKE, S; DIMAURO, S; SCHON, EA; BONILLA, E				MORAES, CT; RICCI, E; PETRUZZELLA, V; SHANSKE, S; DIMAURO, S; SCHON, EA; BONILLA, E			MOLECULAR ANALYSIS OF THE MUSCLE PATHOLOGY ASSOCIATED WITH MITOCHONDRIAL-DNA DELETIONS	NATURE GENETICS			English	Article								Large-scale deletions of mitochondrial DNA (mtDNA) are associated with a subgroup of mitochondrial encephalomyopathies. We studied seven patients with Kearns-Sayre syndrome or isolated ocular myopathy who harboured a sub-population of partially-deleted mitochondrial genomes in skeletal muscle. Variable cytochrome c oxidase (COX) deficiencies and reduction of mitochondrially-encoded polypeptides were found in affected muscle fibres, but while many COX-deficient fibres had increased levels of mutant mtDNA, they almost invariably had reduced levels of normal mtDNA. Our results suggest that a specific ratio between mutant and wild-type mitochondrial genomes is the most important determinant of a focal respiratory chain deficiency, even though absolute copy numbers may vary widely.	COLUMBIA UNIV COLL PHYS & SURG, DEPT NEUROL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, NEW YORK, NY 10032 USA	Columbia University; Columbia University			Moraes, Carlos/AAT-3818-2021; Ricci, Enzo/AAC-4448-2020	RICCI, Enzo/0000-0003-3092-3597	Telethon [231] Funding Source: Medline	Telethon(Fondazione Telethon)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ATTARDI B, 1971, J MOL BIOL, V55, P231, DOI 10.1016/0022-2836(71)90194-X; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; COLLINS S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P309, DOI 10.1016/0925-4439(91)90086-O; Dubowitz V., 1973, MUSCLE BIOPSY MODERN; GELFAND R, 1981, MOL CELL BIOL, V1, P497, DOI 10.1128/MCB.1.6.497; GERBITZ KD, 1990, J NEUROL, V237, P5, DOI 10.1007/BF00319660; GOTO Y, 1990, J NEUROL SCI, V100, P63, DOI 10.1016/0022-510X(90)90014-E; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAMMANS SR, 1992, J NEUROL SCI, V107, P87, DOI 10.1016/0022-510X(92)90213-5; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9; KNIGHT E, 1969, BIOCHEMISTRY-US, V8, P5089, DOI 10.1021/bi00840a062; KOBAYASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P816, DOI 10.1016/S0006-291X(05)80860-5; MITA S, 1989, P NATL ACAD SCI USA, V86, P9509, DOI 10.1073/pnas.86.23.9509; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MORAES CT, 1992, AM J HUM GENET, V50, P934; MORAES CT, 1991, MOL CELL BIOL, V11, P1631, DOI 10.1128/MCB.11.3.1631; OLIVER NA, 1982, MOL CELL BIOL, V2, P30, DOI 10.1128/MCB.2.1.30; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SHOUBRIDGE EA, 1990, CELL, V62, P43, DOI 10.1016/0092-8674(90)90238-A; SJOSTROM M, 1982, MUSCLE NERVE, V5, P538, DOI 10.1002/mus.880050708; TRITSCHLER HJ, 1991, NEUROLOGY, V41, P300, DOI 10.1212/WNL.41.2_Part_1.300; WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41, DOI 10.1007/BF01560726; YAMAMOTO M, 1991, NEUROLOGY, V41, P1822, DOI 10.1212/WNL.41.11.1822; YONEDA M, 1990, BIOCHEM INT, V21, P789; ZEVIANI M, 1988, NEUROLOGY, V38, P1339	35	138	139	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	1992	1	5					359	367		10.1038/ng0892-359	http://dx.doi.org/10.1038/ng0892-359			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	1284549				2022-12-25	WOS:A1992JJ12100015
J	CULIAT, CT; STUBBS, LJ; WOYCHIK, RP; RUSSELL, LB; JOHNSON, DK; RINCHIK, EM				CULIAT, CT; STUBBS, LJ; WOYCHIK, RP; RUSSELL, LB; JOHNSON, DK; RINCHIK, EM			DEFICIENCY OF THE BETA-3 SUBUNIT OF THE TYPE-A GAMMA-AMINOBUTYRIC-ACID RECEPTOR CAUSES CLEFT-PALATE IN MICE	NATURE GENETICS			English	Letter							PRADER-WILLI SYNDROME; POSTNATAL-DEVELOPMENT; ANGELMAN SYNDROME; MESSENGER-RNAS; MOUSE STRAINS; GABA; EXPRESSION; DIAZEPAM; REGION	In addition to its function in the nervous system gamma-aminobutyric acid (GABA) has been implicated in mouse craniofacial development by the results of both teratological(1-3), and genetic studies(4). We previously reported that disruption of the cleft palate 1 (cp1) locus, closely linked to the pink-eyed dilution (p) locus on mouse chromosome 7, causes a 95% penetrant, recessive, neonatally-lethal cleft palate (CP) in mice homozygous for the p(4THO-II) deletion(4). We proposed that the beta 3 subunit gene (Gabrb3) of the GABA(A) receptor might be a candidate for cp1 (ref. 4); our earlier studies(4,5) had localized cp1 to an interval beginning distal to the gene for the GABA(A) receptor alpha 5 subunit (Gabra5) and ending within the Gabrb3 coding region. To test the hypothesis that deletion of Gabrb3, and not another gene in the interval, causes CP, we performed an experiment to rescue the CP phenotype by introducing a Gabrb3 transgene into p(4THO-II) homozygotes. We now show that such transgenic mice are phenotypically normal, indicating that Gabrb3 is indeed the cp1 locus.	OAK RIDGE NATL LAB,DIV BIOL,OAK RIDGE,TN 37831; UNIV TENNESSEE,OAK RIDGE GRAD SCH BIOMED SCI,OAK RIDGE NATL LAB,OAK RIDGE,TN 37831	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville			Woychik, Richard P/C-8345-2019	Woychik, Richard P/0000-0001-8196-1732; Stubbs, Lisa/0000-0002-9556-1972	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010896] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE10896] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BRILLIANT MH, 1992, MAMM GENOME, V3, P187, DOI 10.1007/BF00355717; BUTLER MG, 1990, AM J MED GENET, V35, P319, DOI 10.1002/ajmg.1320350306; CULIAT CT, 1993, P NATL ACAD SCI USA, V90, P5105, DOI 10.1073/pnas.90.11.5105; CULIAT CT, 1994, P NATL ACAD SCI USA, V91, P2815, DOI 10.1073/pnas.91.7.2815; GREGER V, 1993, HUM MOL GENET, V2, P921, DOI 10.1093/hmg/2.7.921; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HOGAN B, 1986, MANIPULATING MOUSE E; KIRKNESS EF, 1993, J BIOL CHEM, V268, P4420; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; MILLER RP, 1975, TOXICOL APPL PHARM, V32, P53, DOI 10.1016/0041-008X(75)90194-5; NICHOLLS RD, 1993, P NATL ACAD SCI USA, V90, P2050, DOI 10.1073/pnas.90.5.2050; SMITH JC, 1992, J MED GENET, V29, P412; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330; WEE EL, 1986, J CRAN GENET DEV BIO, V6, P53; WEE EL, 1983, TERATOLOGY, V28, P15, DOI 10.1002/tera.1420280104; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x; ZHANG JH, 1991, J COMP NEUROL, V308, P586, DOI 10.1002/cne.903080407; Zimmerman E F, 1985, Prog Clin Biol Res, V171, P283; ZIMMERMAN EF, 1984, CURR TOP DEV BIOL, V19, P37, DOI 10.1016/S0070-2153(08)60394-4	19	102	104	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					344	346		10.1038/ng1195-344	http://dx.doi.org/10.1038/ng1195-344			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581464				2022-12-25	WOS:A1995TC63900029
J	ZANGENBERG, G; HUANG, MM; ARNHEIM, N; ERLICH, H				ZANGENBERG, G; HUANG, MM; ARNHEIM, N; ERLICH, H			NEW HLA-DPB1 ALLELES GENERATED BY INTERALLELIC GENE CONVERSION DETECTED BY ANALYSIS OF SPERM	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; HLA-B ALLELES; H-2 GENES; SEQUENCE; MUTANT; LOCI; MHC; POLYMORPHISM; EVOLUTION; DIVERSITY	The rate at which allelic diversity at the HLA loci evolves has been the subject of considerable controversy. The patchwork pattern of sequence polymorphism within the second exon of the HLA class II loci, particularly in the DPB1 locus, may have been generated by segmental exchange (gene conversion). We have analysed the frequency of variant DPB1 sequences that have been created by interallelic gene conversion in the germline by screening pools of sperm using PCR amplification and oligonucleotide probe typing. Our results indicate that-about 1/10,000 sperm represents a new DPB1 sequence generated by short tracts of segmental exchange (gene conversion) within the second exon, suggesting that interallelic gene conversion may have an important role in generating the extensive allelic diversity at the HLA loci.	ROCHE MOLEC SYST,DEPT HUMAN GENET,ALAMEDA,CA 94501; UNIV SO CALIF,DEPT BIOL SCI,LOS ANGELES,CA 90089	Roche Holding; University of Southern California				Arnheim, Norman/0000-0003-1247-1347				APPLE RJ, 1992, TISSUE ANTIGENS, V40, P69, DOI 10.1111/j.1399-0039.1992.tb01962.x; AYALA FJ, 1994, P NATL ACAD SCI USA, V91, P6787, DOI 10.1073/pnas.91.15.6787; BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; BELICH MP, 1992, NATURE, V357, P326, DOI 10.1038/357326a0; BODMER JG, 1994, TISSUE ANTIGENS, V44, P1, DOI 10.1111/j.1399-0039.1994.tb02351.x; BUGAWAN TL, 1988, J IMMUNOL, V141, P4024; BUGAWAN TL, 1990, IMMUNOGENETICS, V32, P231; DENARO M, 1984, EMBO J, V3, P2029, DOI 10.1002/j.1460-2075.1984.tb02086.x; ERLICH HA, 1992, 11TH P INT HIST WORK, V1, P38; ERLICH HA, 1991, IMMUNOL TODAY, V11, P411; GYLLENSTEN U, 1991, J IMMUNOL, V146, P4368; GYLLENSTEN U, 1990, P NATL ACAD SCI USA, V86, P9986; GYLLENSTEN UB, 1991, P NATL ACAD SCI USA, V88, P3686, DOI 10.1073/pnas.88.9.3686; GYLLENSTEN UB, 1991, J IMMUNOL, V156, P4368; HOGSTRAND K, 1994, P NATL ACAD SCI USA, V91, P9921, DOI 10.1073/pnas.91.21.9921; HUANG MM, IN PRESS HUM MUTATIO; KLEIN J, 1986, CRC CR REV IMMUNOL, V6, P295; KLEIN J, 1984, TRANSPLANTATION, V38, P327, DOI 10.1097/00007890-198410000-00002; KLEIN J, 1991, MOL EVOLUTION MAJOR, P261; LAWLOR DA, 1988, NATURE, V335, P268, DOI 10.1038/335268a0; LETSOU A, 1987, GENETICS, V117, P759; LI H, 1991, Methods (Orlando), V2, P49, DOI 10.1016/S1046-2023(05)80125-2; MCINTYRE KR, 1984, NATURE, V308, P551, DOI 10.1038/308551a0; MENGLEGAW L, 1984, J EXP MED, V160, P1184, DOI 10.1084/jem.160.4.1184; MOONSAMY PV, 1994, TISSUE ANTIGENS, V43, P249, DOI 10.1111/j.1399-0039.1994.tb02333.x; MURTI JR, 1992, MOL CELL BIOL, V12, P2545, DOI 10.1128/MCB.12.6.2545; NAIRN R, 1980, ANNU REV GENET, V14, P241, DOI 10.1146/annurev.ge.14.120180.001325; RADDING CM, 1978, ANNU REV BIOCHEM, V47, P847, DOI 10.1146/annurev.bi.47.070178.004215; SCHULZE DH, 1983, P NATL ACAD SCI-BIOL, V80, P2007, DOI 10.1073/pnas.80.7.2007; SLIGHTOM JL, 1980, CELL, V21, P627, DOI 10.1016/0092-8674(80)90426-2; TITUSTRACHTENBE.EA, 1994, AM J HUM GENET, V55, P160; WATKINS DI, 1992, NATURE, V357, P329, DOI 10.1038/357329a0; WEISS EH, 1983, NATURE, V301, P671, DOI 10.1038/301671a0; WHEELER CJ, 1990, NATURE, V347, P192, DOI 10.1038/347192a0	34	120	123	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					407	414		10.1038/ng0895-407	http://dx.doi.org/10.1038/ng0895-407			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670490				2022-12-25	WOS:A1995RM37500013
J	FUCHS, S; NAKAZAWA, M; MAW, M; TAMAI, M; OGUCHI, Y; GAL, A				FUCHS, S; NAKAZAWA, M; MAW, M; TAMAI, M; OGUCHI, Y; GAL, A			A HOMOZYGOUS 1-BASE PAIR DELETION IN THE ARRESTIN GENE IS A FREQUENT CAUSE OF OGUCHI DISEASE IN JAPANESE	NATURE GENETICS			English	Letter							RETINITIS-PIGMENTOSA; 48-KDA PROTEIN; RHODOPSIN GENE; PHOSPHODIESTERASE; POLYMORPHISMS; MUTATIONS		UNIV HAMBURG, KRANKENHAUS EPPENDORF, INST HUMANGENET, D-22529 HAMBURG, GERMANY; TOHOKU UNIV, SCH MED, DEPT OPHTHALMOL, SENDAI, MIYAGI 980, JAPAN; UNIV OTAGO, DEPT BIOCHEM, DUNEDIN, NEW ZEALAND; KEIO UNIV, SCH MED, DEPT OPHTHALMOL, TOKYO 160, JAPAN	University of Hamburg; Tohoku University; University of Otago; Keio University			Nakazawa, Mitsuru/ABI-7897-2020	Nakazawa, Mitsuru/0000-0001-6095-5712				BUDOWLE B, 1991, AM J HUM GENET, V48, P137; CARR RE, 1965, ARCH OPHTHALMOL-CHIC, V73, P646; CARR RE, 1991, INVEST OPHTHALMOL, V6, P426; DEJONG PTVM, 1991, ARCH OPHTHALMOL-CHIC, V109, P1104, DOI 10.1001/archopht.1991.01080080064029; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; HECKENLIVELY JR, 1986, ARCH OPHTHALMOL-CHIC, V104, P1322, DOI 10.1001/archopht.1986.01050210076029; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; KUO JL, 1993, GENOMICS, V16, P173, DOI 10.1006/geno.1993.1155; MAW MA, 1995, J MED GENET, V32, P396, DOI 10.1136/jmg.32.5.396; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Mizuo G., 1913, ACTA SOC OPHTH JAPON, V17, P1148; Oguchi C., 1907, NIPPON GANKA GAKKAI, V11, P123; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; PALCZEWSKI K, 1992, NEURON, V8, P117, DOI 10.1016/0896-6273(92)90113-R; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; SHEFFIELD VC, 1992, AM J HUM GENET, V50, P567; VALVERDE D, 1994, HUM GENET, V94, P193; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; YAMAKI K, 1988, FEBS LETT, V234, P39, DOI 10.1016/0014-5793(88)81298-5; YAMAKI K, 1990, J BIOL CHEM, V265, P20757	23	216	220	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1995	10	3					360	362		10.1038/ng0795-360	http://dx.doi.org/10.1038/ng0795-360			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670478				2022-12-25	WOS:A1995RG38600024
J	WANG, W; FISHER, EMC; JIA, Q; DUNN, JM; PORFIRI, E; DOWNWARD, J; EGAN, SE				WANG, W; FISHER, EMC; JIA, Q; DUNN, JM; PORFIRI, E; DOWNWARD, J; EGAN, SE			THE GRB2 BINDING DOMAIN OF MSOS1 IS NOT REQUIRED FOR DOWNSTREAM SIGNAL-TRANSDUCTION	NATURE GENETICS			English	Article							NUCLEOTIDE EXCHANGE FACTOR; RECEPTOR TYROSINE KINASES; SH3 DOMAINS; ADAPTER PROTEIN; SEVENLESS GENE; EGF RECEPTOR; RAS; SOS; ACTIVATION; PATHWAY	Cellular Ras proteins are activated primarily by specific guanine-nucleotide releasing factors such as the Son of Sevenless (Sos) proteins. This activation event is thought to occur in response to plasma membrane localization of a complex containing Sos and a small adapter protein Grb2. We have isolated a dominant mutant allele of mSos1 which transforms Rat1 cells, yet is no longer able to bind Grb2. Biochemical experiments reveal that the subcellular distribution of this truncated Sos protein is not altered with respect to the wild type Sos protein. These data argue against a role for Grb2 in the direct recruitment of Sos proteins to the plasma membrane and suggest that Grb2 may function to overcome negative regulation of Sos by its C terminus.	HOSP SICK CHILDREN,DIV IMMUNOL & CANC RES,TORONTO,ON M5G 1X8,CANADA; ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON W2 1PG,ENGLAND; EYE RES INST CANADA,TORONTO,ON M5T 2S8,CANADA; ONYX PHARMACEUT,RICHMOND,CA 94806; IMPERIAL CANC RES FUND,SIGNAL TRANSDUCT LAB,LONDON WC2A 3PX,ENGLAND	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Imperial College London; Cancer Research UK			Downward, Julian/A-3251-2012; Fisher, Elizabeth MC/C-2168-2008	Fisher, Elizabeth MC/0000-0003-2850-9936; Downward, Julian/0000-0002-2331-4729				ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; BASU T, 1994, ONCOGENE, V9, P3483; BONFINI L, 1992, SCIENCE, V255, P603, DOI 10.1126/science.1736363; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; BROEK D, 1987, CELL, V48, P789, DOI 10.1016/0092-8674(87)90076-6; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; BURGERING BMT, 1993, EMBO J, V12, P4211, DOI 10.1002/j.1460-2075.1993.tb06105.x; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CHEMIACK AD, 1994, J BIOL CHEM, V269, P4717; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; GRUSSENMEYER T, 1985, P NATL ACAD SCI USA, V82, P7952, DOI 10.1073/pnas.82.23.7952; HORVITZ HR, 1991, NATURE, V351, P535, DOI 10.1038/351535a0; HUANG DCS, 1993, MOL CELL BIOL, V13, P2420, DOI 10.1128/MCB.13.4.2420; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; MARENGERE LEM, 1994, NATURE, V369, P502, DOI 10.1038/369502a0; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MATUOKA K, 1992, P NATL ACAD SCI USA, V89, P9015, DOI 10.1073/pnas.89.19.9015; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; MOSTELLER RD, 1994, MOL CELL BIOL, V14, P1104, DOI 10.1128/MCB.14.2.1104; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PORFIRI E, 1994, J BIOL CHEM, V269, P22672; Powers S, 1992, Semin Cancer Biol, V3, P209; PRONK GJ, 1994, MOL CELL BIOL, V14, P1575, DOI 10.1128/MCB.14.3.1575; QULLIAM LA, 1994, P NATL ACAD SCI USA, V91, P8512; ROGGE RD, 1991, CELL, V64, P39, DOI 10.1016/0092-8674(91)90207-F; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Sambrook J, 1989, MOL CLONING LABORATO; SHOEMAKER C, 1981, J VIROL, V40, P164, DOI 10.1128/JVI.40.1.164-172.1981; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; TEMPLETON DJ, 1991, P NATL ACAD SCI USA, V88, P3033, DOI 10.1073/pnas.88.8.3033; WELHAM MJ, 1994, J BIOL CHEM, V269, P21165; YOSHIMURA A, 1990, NATURE, V348, P647, DOI 10.1038/348647a0	44	59	60	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					294	300		10.1038/ng0795-294	http://dx.doi.org/10.1038/ng0795-294			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670467				2022-12-25	WOS:A1995RG38600012
J	MIKECZ, K; BRENNAN, FR; KIM, JH; GLANT, TT				MIKECZ, K; BRENNAN, FR; KIM, JH; GLANT, TT			ANTI-CD44 TREATMENT ABROGATES TISSUE EDEMA AND LEUKOCYTE INFILTRATION IN MURINE ARTHRITIS	NATURE MEDICINE			English	Article							HYALURONIC-ACID BINDING; ADHESION MOLECULE; MONOCLONAL-ANTIBODIES; RHEUMATOID-ARTHRITIS; CD44; RECEPTOR; CELLS; GLYCOPROTEINS; CARTILAGE; EPITOPES	A ubiquitous cell adhesion receptor, CD44 preferentially binds hyaluronan, a polysaccharide macromolecule that is present in most extracellular matrices. Hyaluronan molecules have large hydrodynamic volumes that entrap substantial amounts of water and can therefore control tissue hydration (swelling). CD44 Is overexpressed by jynovial cells and leukocytes, and hyaluronan is overproduced in the rheumatoid synovial and in other inflammatory sites. Nevertheless, the role of the CD44-hyaluronan interaction during inflammation is unclear. Our evidence shows that the CD44 receptor plays a critical role in governing the migration of inflammatory leukocytes into the extravascular compartment of the synovium in murine arthritis. An anti-CD44 antibody induces a rapid loss of CD44 from both leukocytes and synovial cells and displays an inhibitory effect on cell-extracellular matrix interactions In the synovium. As a result, the administration of such an antibody abrogates tissue swelling and leukocyte infiltration, two major components of inflammation.	RUSH PRESBYTERIAN ST LUKES MED CTR, RUSH MED COLL, DEPT BIOCHEM, CHICAGO, IL 60612 USA; RUSH PRESBYTERIAN ST LUKES MED CTR, RUSH MED COLL, RUSH ARTHRITIS & ORTHOPED INST, CHICAGO, IL 60612 USA	Rush University; Rush University	MIKECZ, K (corresponding author), RUSH PRESBYTERIAN ST LUKES MED CTR, RUSH MED COLL, DEPT ORTHOPED SURG, CHICAGO, IL 60612 USA.			Mikecz, Katalin/0000-0003-1506-4296	NIAMS NIH HHS [AR 40310] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040310] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BARTOLAZZI A, 1994, J EXP MED, V180, P53, DOI 10.1084/jem.180.1.53; BAZIL V, 1992, J IMMUNOL, V149, P747; BRENNAN FR, 1995, CLIN EXP IMMUNOL, V100, P104; BUZAS EI, 1994, CELL IMMUNOL, V158, P292, DOI 10.1006/cimm.1994.1277; CAMP RL, 1993, J EXP MED, V178, P497, DOI 10.1084/jem.178.2.497; CAMPBELL RD, 1982, INFLAMMATION, V6, P235, DOI 10.1007/BF00916405; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; CULTY M, 1990, J CELL BIOL, V111, P2765, DOI 10.1083/jcb.111.6.2765; ENGSTROMLAURENT A, 1987, ARTHRITIS RHEUM, V30, P1333, DOI 10.1002/art.1780301203; GLANT TT, 1987, ARTHRITIS RHEUM-US, V30, P201, DOI 10.1002/art.1780300211; GLANT TT, 1982, BIOCHEM BIOPH RES CO, V106, P158, DOI 10.1016/0006-291X(82)92071-X; GLANT TT, 1986, BIOCHEM J, V234, P31, DOI 10.1042/bj2340031; Gunthert U, 1993, Curr Top Microbiol Immunol, V184, P47; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HATHCOCK KS, 1993, J IMMUNOL, V151, P6712; HAYNES BF, 1991, ARTHRITIS RHEUM, V34, P1434; HERRLICH P, 1993, IMMUNOL TODAY, V14, P395, DOI 10.1016/0167-5699(93)90141-7; KAKIMOTO K, 1992, CELL IMMUNOL, V142, P326, DOI 10.1016/0008-8749(92)90294-Y; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LESLEY J, 1992, J EXP MED, V175, P257, DOI 10.1084/jem.175.1.257; LESLEY J, 1990, EXP CELL RES, V187, P224, DOI 10.1016/0014-4827(90)90085-O; MACKAY CR, 1994, J CELL BIOL, V124, P71, DOI 10.1083/jcb.124.1.71; MIKECZ K, 1994, ARTHRITIS RHEUM-US, V37, P1395, DOI 10.1002/art.1780370919; MIYAKE K, 1990, J EXP MED, V172, P69, DOI 10.1084/jem.172.1.69; NETTELBLADT O, 1989, AM J PHYSIOL, V257, pL379, DOI 10.1152/ajplung.1989.257.6.L379; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; PITSILLIDES AA, 1994, BRIT J RHEUMATOL, V33, P5; SANCHEZMADRID F, 1983, J EXP MED, V158, P586, DOI 10.1084/jem.158.2.586; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; SZABO GC, IN PRESS ARTHRITIS R; THOMAS L, 1992, J CELL BIOL, V118, P971, DOI 10.1083/jcb.118.4.971; Toole B. P., 1991, CELL BIOL EXTRACELLU, P305; TROWBRIDGE IS, 1982, IMMUNOGENETICS, V15, P299, DOI 10.1007/BF00364338; UNDERHILL C, 1992, J CELL SCI, V103, P293; WILLIAMS JM, 1993, J ORTHOPAED RES, V11, P172, DOI 10.1002/jor.1100110204; 1985, SAS USERS GUIDE STAT, P113	38	257	266	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	1995	1	6					558	563		10.1038/nm0695-558	http://dx.doi.org/10.1038/nm0695-558			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN101	7585123				2022-12-25	WOS:A1995RN10100040
J	ELLIS, JRM; KEATING, PJ; BAIRD, J; HOUNSELL, EF; RENOUF, DV; ROWE, M; HOPKINS, D; DUGGANKEEN, MF; BARTHOLOMEW, JS; YOUNG, LS; STERN, PL				ELLIS, JRM; KEATING, PJ; BAIRD, J; HOUNSELL, EF; RENOUF, DV; ROWE, M; HOPKINS, D; DUGGANKEEN, MF; BARTHOLOMEW, JS; YOUNG, LS; STERN, PL			THE ASSOCIATION OF AN HPV16 ONCOGENE VARIANT WITH HLA-B7 HAS IMPLICATIONS FOR VACCINE DESIGN IN CERVICAL-CANCER	NATURE MEDICINE			English	Article							PAPILLOMAVIRUS INFECTION; MHC MOLECULES; PEPTIDES; BINDING; RECOGNITION; CARCINOMA; ANTIGENS; EPITOPES; RISK	HLA-restricted cytotoxic T-lymphocyte (CTL) recognition of human papillomavirus (HPV) oncogene products may be important in the control of the HPV infections associated with the development of cervical cancer. We have identified, in HLA-B7 individuals, a consistent variation in the HPV16 E6 oncoprotein sequence, which alters an HLA-B7 peptide binding epitope in a way likely to influence immune recognition by CTLs. These results illustrate a biologically relevant mechanism for escape from immune surveillance of HPV16 in HLA-B7 individuals. Thus, both HLA type and HPV16 strain variation need to be considered in the screening of at-risk individuals and for the rational design of anti-HPV vaccines.	UNIV BIRMINGHAM, SCH MED, CRC, INST CANC STUDIES, BIRMINGHAM B15 2TJ, W MIDLANDS, ENGLAND; CHRISTIE HOSP NATL HLTH SERV TRUST, PATERSON INST CANC RES, CRC, DEPT IMMUNOL, MANCHESTER M20 9BX, LANCS, ENGLAND; UCL, DEPT BIOCHEM & MOLEC BIOL, LONDON, ENGLAND	University of Birmingham; Christie NHS Foundation Trust; Christie Hospital; Paterson Institute for Cancer Research; University of London; University College London			Young, Lawrence S/B-7213-2009; Rowe, Martin/B-2880-2009; Hounsell, Elizabeth F/C-5177-2008	Young, Lawrence S/0000-0003-3919-4298; Rowe, Martin/0000-0003-4139-7326; 				APPLE RJ, 1994, NAT GENET, V6, P157, DOI 10.1038/ng0294-157; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; BARTHOLOMEW JS, 1994, EUR J IMMUNOL, V24, P3175, DOI 10.1002/eji.1830241239; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; BRINTON LA, 1992, EPIDEMIOLOGY CERVICA, P3; BURROWS SR, 1990, J EXP MED, V171, P345, DOI 10.1084/jem.171.1.345; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; ELLIS SA, 1982, HUM IMMUNOL, V5, P49, DOI 10.1016/0198-8859(82)90030-1; ELVIN J, 1993, J IMMUNOL METHODS, V158, P161, DOI 10.1016/0022-1759(93)90210-X; Engelhard V H, 1993, Chem Immunol, V57, P39; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; GARRIDO F, 1993, IMMUNOL TODAY, V14, P491, DOI 10.1016/0167-5699(93)90264-L; GAVIOLI R, 1993, J VIROL, V67, P1572, DOI 10.1128/JVI.67.3.1572-1578.1993; GLEW SS, 1992, NATURE, V356, P22, DOI 10.1038/356022a0; HAN R, 1992, NATURE, V356, P66, DOI 10.1038/356066a0; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; HELLAND A, 1992, NATURE, V356, P23, DOI 10.1038/356023a0; HILL A, 1995, EUR J IMMUNOL, V25, P18, DOI 10.1002/eji.1830250105; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HONMA S, 1994, INT J CANCER, V57, P650, DOI 10.1002/ijc.2910570507; HUCZKO EL, 1993, J IMMUNOL, V151, P2572; KEATING PJ, IN PRESS BR J CANCER; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; KOUTSKY LA, 1992, NEW ENGL J MED, V327, P1272, DOI 10.1056/NEJM199210293271804; LORINCZ AT, 1990, AM J OBSTET GYNECOL, V162, P645, DOI 10.1016/0002-9378(90)90974-C; MADDEN DR, 1992, CELL, V70, P1035, DOI 10.1016/0092-8674(92)90252-8; MAIER R, 1994, IMMUNOGENETICS, V40, P306, DOI 10.1007/BF00189978; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; PIRISI L, 1987, J VIROL, V61, P1061, DOI 10.1128/JVI.61.4.1061-1066.1987; SADOVNIKOVA E, 1994, INT IMMUNOL, V6, P289, DOI 10.1093/intimm/6.2.289; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; WANK R, 1991, NATURE, V352, P723, DOI 10.1038/352723a0	33	163	164	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	1995	1	5					464	470		10.1038/nm0595-464	http://dx.doi.org/10.1038/nm0595-464			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585096				2022-12-25	WOS:A1995RN10000039
J	MCLEAN, M; BISITS, A; DAVIES, J; WOODS, R; LOWRY, P; SMITH, R				MCLEAN, M; BISITS, A; DAVIES, J; WOODS, R; LOWRY, P; SMITH, R			A PLACENTAL CLOCK CONTROLLING THE LENGTH OF HUMAN-PREGNANCY	NATURE MEDICINE			English	Article							CORTICOTROPIN-RELEASING HORMONE; HUMAN-FETAL MEMBRANES; BETA-ENDORPHIN; PRETERM LABOR; PLASMA; PARTURITION; MODULATE; CORTISOL; CELLS	We report the existence of a 'placental clock', which is active from an early stage in human pregnancy and determines the length of gestation and the timing of parturition and delivery. Using a prospective, longitudinal cohort study of 485 pregnant women we have demonstrated that placental secretion of corticotropin-releasing hormone (CRH) is a marker of this process and that measurement of the maternal plasma CRH concentration as early as 16-20 weeks of gestation identifies groups of women who ale destined to experience normal term, preterm or post-term delivery. Further, we report that the exponential rise in maternal plasma CRH concentrations with advancing pregnancy is associated with a concomitant fall in concentrations of the specific CRH binding protein in late pregnancy, leading to a rapid increase in circulating levels of bioavailable CRH at a time that coincides with the onset of parturition, suggesting that CRH may ad directly as a trigger for parturition in humans.	JOHN HUNTER HOSP,MATERNAL HLTH RES CTR,NEWCASTLE,NSW 2310,AUSTRALIA; UNIV READING,SCH ANIM & MICROBIAL SCI,READING RG6 2AJ,BERKS,ENGLAND	John Hunter Hospital; University of Reading				Smith, Roger/0000-0003-4720-0280				BALDUCCI J, 1993, AM J OBSTET GYNECOL, V168, P1609, DOI 10.1016/S0002-9378(11)90806-0; BENEDETTO C, 1994, AM J OBSTET GYNECOL, V171, P126, DOI 10.1016/0002-9378(94)90457-X; CAMPBELL EA, 1987, J CLIN ENDOCR METAB, V64, P1054, DOI 10.1210/jcem-64-5-1054; CHALLIS JRG, 1989, BAILLIERE CLIN ENDOC, V3, P781, DOI 10.1016/S0950-351X(89)80053-9; CHAN EC, 1993, ACTA ENDOCRINOL-COP, V128, P339, DOI 10.1530/acta.0.1280339; Cunningham F., 1993, WILLIAMS OBSTETRICS, P297; HILLHOUSE EW, 1993, J CLIN ENDOCR METAB, V76, P736, DOI 10.1210/jc.76.3.736; JONES SA, 1989, BIOCHEM BIOPH RES CO, V159, P192, DOI 10.1016/0006-291X(89)92422-4; JONES SA, 1989, J CLIN ENDOCR METAB, V68, P825, DOI 10.1210/jcem-68-4-825; KLEINBAUM DG, 1988, APPL REGRESSION ANAL, P263; KURKI T, 1991, BRIT J OBSTET GYNAEC, V98, P685, DOI 10.1111/j.1471-0528.1991.tb13456.x; LINTON EA, 1993, J CLIN ENDOCR METAB, V76, P260, DOI 10.1210/jc.76.1.260; MCLEAN M, 1994, EUR J ENDOCRINOL, V131, P167, DOI 10.1530/eje.0.1310167; MCNUTT CM, 1994, J ENDOCRINOL, V141, P195, DOI 10.1677/joe.0.1410195; PETRAGLIA F, 1989, AM J OBSTET GYNECOL, V160, P247, DOI 10.1016/0002-9378(89)90130-0; PETRAGLIA F, 1990, OBSTET GYNECOL, V75, P784; PETRAGLIA F, 1990, AM J OBSTET GYNECOL, V163, P1307, DOI 10.1016/0002-9378(90)90711-F; POTTER E, 1991, NATURE, V349, P423, DOI 10.1038/349423a0; QUARTERO HWP, 1989, PLACENTA, V10, P439, DOI 10.1016/0143-4004(89)90054-4; ROBINSON BG, 1988, P NATL ACAD SCI USA, V85, P5244, DOI 10.1073/pnas.85.14.5244; SANGHA RK, 1994, J CLIN ENDOCR METAB, V78, P982, DOI 10.1210/jc.78.4.982; SASAKI A, 1987, J CLIN ENDOCR METAB, V64, P224, DOI 10.1210/jcem-64-2-224; SMITH R, 1993, J CLIN ENDOCR METAB, V76, P1063, DOI 10.1210/jc.76.4.1063; SMITH R, 1990, J PSYCHOSOM RES, V34, P53, DOI 10.1016/0022-3999(90)90008-R; SUN K, 1994, J CLIN ENDOCR METAB, V79, P519, DOI 10.1210/jc.79.2.519; THORBURN GD, 1991, REPROD FERT DEVELOP, V3, P277, DOI 10.1071/RD9910277; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; VANWAGENEN G, 1943, SURG GYNECOL OBSTET, V77, P539; WARREN WB, 1992, AM J OBSTET GYNECOL, V166, P1198, DOI 10.1016/S0002-9378(11)90606-1; WOLFE CDA, 1988, BRIT J OBSTET GYNAEC, V95, P1003, DOI 10.1111/j.1471-0528.1988.tb06504.x; WOODS RJ, 1994, J CLIN ENDOCR METAB, V78, P73, DOI 10.1210/jc.78.1.73	31	692	713	2	42	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1995	1	5					460	463		10.1038/nm0595-460	http://dx.doi.org/10.1038/nm0595-460			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585095				2022-12-25	WOS:A1995RN10000038
J	TENNYSON, CN; KLAMUT, HJ; WORTON, RG				TENNYSON, CN; KLAMUT, HJ; WORTON, RG			THE HUMAN DYSTROPHIN GENE REQUIRES 16 HOURS TO BE TRANSCRIBED AND IS COTRANSCRIPTIONALLY SPLICED	NATURE GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; MESSENGER-RNA; NASCENT TRANSCRIPTS; NONMUSCLE TISSUES; POLY(A) ADDITION; SITE SELECTION; MAJOR PRODUCT; BRAIN; EXPRESSION	The largest known gene is the human dystrophin gene, which has 79 exons spanning at least 2,300 kilobases (kb). Transcript accumulation was monitored from four regions of the gene following induction of expression in muscle cell cultures. Quantitative reverse transcription-polymerase chain reaction (RT-PCR) results indicate that approximately 12 h are required for transcription of 1,770 kb (at an average elongation rate of 2.4 kb min(-1)), extrapolating to a transcription time of 16 h for the complete gene. Accumulation profiles for spliced and total transcript demonstrated that transcripts are spliced at the 5' end before transcription is complete providing strong evidence for cotranscriptional splicing. The rate of transcript accumulation was reduced at the 3' end of the gene relative to the 5' end, perhaps due to premature termination of transcription complexes.	HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON M5G 1X8,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	TENNYSON, CN (corresponding author), HOSP SICK CHILDREN,DEPT GENET,555 UNIV AVE,TORONTO,ON M5G 1X8,CANADA.							ABEI M, 1987, TRENDS GENET, V3, P102; BAR S, 1990, BIOCHEM J, V272, P557, DOI 10.1042/bj2720557; BAUREN G, 1994, CELL, V76, P183, DOI 10.1016/0092-8674(94)90182-1; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; BIES RD, 1992, NUCLEIC ACIDS RES, V20, P1725, DOI 10.1093/nar/20.7.1725; BLAU HM, 1985, ADV EXP MED BIOL, V182, P85; BYERS TJ, 1993, NAT GENET, V4, P77, DOI 10.1038/ng0593-77; CHELLY J, 1990, EUR J BIOCHEM, V187, P691, DOI 10.1111/j.1432-1033.1990.tb15355.x; COFFEY AJ, 1992, GENOMICS, V12, P474, DOI 10.1016/0888-7543(92)90437-W; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; FORD JP, 1978, J VIROL, V28, P795, DOI 10.1128/JVI.28.3.795-801.1978; GALLI G, 1988, P NATL ACAD SCI USA, V85, P2439, DOI 10.1073/pnas.85.8.2439; GORECKI DC, 1992, HUM MOL GENET, V1, P505, DOI 10.1093/hmg/1.7.505; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; KLAMUT HJ, 1990, MOL CELL BIOL, V10, P193, DOI 10.1128/MCB.10.1.193; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LEDERFEIN D, 1993, HUM MOL GENET, V2, P1883, DOI 10.1093/hmg/2.11.1883; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; LEMAIRE MF, 1990, MOL CELL BIOL, V10, P6059, DOI 10.1128/MCB.10.11.6059; LEV AA, 1987, J BIOL CHEM, V262, P15817; LONDON L, 1991, MOL CELL BIOL, V11, P4599, DOI 10.1128/MCB.11.9.4599; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; Maniatis T, 1989, DECONTAMINATION DILU; MONACO AP, 1992, GENOMICS, V12, P465, DOI 10.1016/0888-7543(92)90436-V; NEVINS JR, 1978, CELL, V15, P1477, DOI 10.1016/0092-8674(78)90071-5; NUDEL U, 1988, NATURE, V331, P635, DOI 10.1038/331635a0; REED R, 1986, CELL, V46, P681, DOI 10.1016/0092-8674(86)90343-0; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D; SEHGAL PB, 1976, SCIENCE, V194, P431, DOI 10.1126/science.982026; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; SOLNICK D, 1985, CELL, V43, P667, DOI 10.1016/0092-8674(85)90239-9; SPENCER CA, 1990, ONCOGENE, V5, P777; THUMMEL CS, 1990, CELL, V61, P101, DOI 10.1016/0092-8674(90)90218-4; UCKER DS, 1984, J BIOL CHEM, V259, P7416; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WEBER J, 1980, J VIROL, V33, P286, DOI 10.1128/JVI.33.1.286-291.1980; ZEEVI M, 1981, CELL, V26, P39, DOI 10.1016/0092-8674(81)90031-3	42	261	275	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					184	190		10.1038/ng0295-184	http://dx.doi.org/10.1038/ng0295-184			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719347				2022-12-25	WOS:A1995QE67200021
J	LEFF, SE; BRANNAN, CI; REED, ML; OZCELIK, T; FRANCKE, U; COPELAND, NG; JENKINS, NA				LEFF, SE; BRANNAN, CI; REED, ML; OZCELIK, T; FRANCKE, U; COPELAND, NG; JENKINS, NA			MATERNAL IMPRINTING OF THE MOUSE SNRPN GENE AND CONSERVED LINKAGE HOMOLOGY WITH THE HUMAN PRADER-WILLI SYNDROME REGION	NATURE GENETICS			English	Article							CALCITONIN GENE; CDNA; RIBONUCLEOPROTEIN; CHROMOSOME-7; EXPRESSION; RECEPTOR; NEUROPEPTIDE; ANTIBODIES; PROTEINS; SUBUNIT	Prader-Willi syndrome (PWS) is associated with paternal gene deficiencies in human chromosome 1511-13, suggesting that PWS is caused by a deficiency in one or more maternally imprinted genes. We have now mapped a gene, Snrpn, encoding a brain-enriched small nuclear ribonucleoprotein (snRNP)-associated polypeptide SmN, to mouse chromosome 7 in a region of homology with human chromosome 1511-13 and demonstrated that Snrpn is a maternally imprinted gene in mouse. These studies, in combination with the accompanying human mapping studies showing that SNRPN maps in the Prader-Willi critical region, identify SNRPN as a candidate gene involved in PWS and suggest that PWS may be caused, in part, by defects in mRNA processing.	NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702; STANFORD UNIV,MED CTR,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT GENET & PEDIAT,STANFORD,CA 94305	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Howard Hughes Medical Institute; Stanford University; Stanford University	LEFF, SE (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT PHARMACOL,STANFORD,CA 94305, USA.				OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Bartolomei M.S., 1992, SEMIN DEV BIOL, V3, P107; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BRILLIANT MH, 1991, SCIENCE, V252, P566, DOI 10.1126/science.1673574; CATTANACH BM, 1990, DEVELOPMENT, P63; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; CECI JD, 1990, GENOMICS, V6, P673, DOI 10.1016/0888-7543(90)90503-M; CHAILLET JR, 1991, GENOMICS, V11, P773, DOI 10.1016/0888-7543(91)90090-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; COPELAND NG, 1992, GENOMICS, V13, P1356, DOI 10.1016/0888-7543(92)90069-5; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DELSERT CD, 1992, J BIOL CHEM, V267, P14573; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; GOODMAN EC, 1986, LIFE SCI, V38, P2169, DOI 10.1016/0024-3205(86)90568-0; Green E., 1981, GENETICS PROBABILITY, DOI 10.1007/978-1-349-04904-2; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; HAEFLIGER JA, 1992, J BIOL CHEM, V267, P2057; HALL JG, 1990, AM J HUM GENET, V46, P857; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; KRAHN DD, 1984, PEPTIDES, V5, P861, DOI 10.1016/0196-9781(84)90107-4; LALAND M, 1989, MOUSE NEWS LETT, V84, P87; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; LI S, 1989, P NATL ACAD SCI USA, V86, P9778, DOI 10.1073/pnas.86.24.9778; LUHRMANN R, 1990, BIOCHIM BIOPHYS ACTA, V1087, P265, DOI 10.1016/0167-4781(90)90001-I; MCALLISTER G, 1989, EMBO J, V8, P1177, DOI 10.1002/j.1460-2075.1989.tb03489.x; MCALLISTER G, 1988, P NATL ACAD SCI USA, V85, P5296, DOI 10.1073/pnas.85.14.5296; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; NAKATSU Y, 1992, MAMM GENOME, V2, P69, DOI 10.1007/BF00570442; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Nicholls RD, 1991, MOUSE GENOME, V89, P254; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; Prader A., 1956, SCHWEIZ MED WSCHR, V86, P1260, DOI DOI 10.1007/978-3-642-47669-3_24; PRITCHARD MA, 1991, GENOMICS, V10, P801, DOI 10.1016/0888-7543(91)90466-R; ROSENFELD MG, 1983, NATURE, V304, P129, DOI 10.1038/304129a0; SAITOH S, 1992, LANCET, V339, P366, DOI 10.1016/0140-6736(92)91686-3; SCHMAUSS C, 1989, NUCLEIC ACIDS RES, V17, P1733, DOI 10.1093/nar/17.4.1733; SCHMAUSS C, 1990, J BIOL CHEM, V265, P10733; SCHMAUSS C, 1992, J BIOL CHEM, V267, P8521; SHARPE NG, 1990, MOL CELL BIOL, V10, P6817, DOI 10.1128/MCB.10.12.6817; STEITZ JA, 1990, STRUCTURE FUNCTION M, P115; TANTRAVAHI U, 1989, AM J MED GENET, V33, P78, DOI 10.1002/ajmg.1320330110; WAGSTAFF J, 1992, NAT GENET, V1, P291, DOI 10.1038/ng0792-291; WAGSTAFF J, 1991, AM J HUM GENET, V49, P330; WAGSTAFF J, 1991, GENOMICS, V11, P1071, DOI 10.1016/0888-7543(91)90034-C; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575; ZEMEL S, 1992, NAT GENET, V2, P61, DOI 10.1038/ng0992-61	52	245	249	1	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					259	264		10.1038/ng1292-259	http://dx.doi.org/10.1038/ng1292-259			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303276				2022-12-25	WOS:A1992KB49500007
J	HASTBACKA, J; DELACHAPELLE, A; KAITILA, I; SISTONEN, P; WEAVER, A; LANDER, E				HASTBACKA, J; DELACHAPELLE, A; KAITILA, I; SISTONEN, P; WEAVER, A; LANDER, E			LINKAGE DISEQUILIBRIUM MAPPING IN ISOLATED FOUNDER POPULATIONS - DIASTROPHIC DYSPLASIA IN FINLAND	NATURE GENETICS			English	Article							FMS PROTO-ONCOGENE; C-FMS; RECEPTOR; GENE; POLYMORPHISM; ALLELES; MAP	Linkage disequilibrium mapping in isolated populations provides a powerful tool for fine structure localization of disease genes. Here, Luria and Delbruck's classical methods for analysing bacterial cultures are adapted to the study of human isolated founder populations in order to estimate (i) the recombination fraction between a disease locus and a marker; (ii) the expected degree of allelic homogeneity in a population; and (iii) the mutation rate of marker loci. Using these methods, we report striking linkage disequilibrium for diastrophic dysplasia (DTD) in Finland indicating that the DTD gene should lie within 0.06 centimorgans (or about 60 kilobases) of the CSF1R gene. Predictions about allelic homogeneity in Finland and mutation rates in simple sequence repeats are confirmed by independent observations.	UNIV HELSINKI, DEPT MED GENET, SF-00290 HELSINKI 29, FINLAND; FOLKHALSAN INST GENET, SF-00290 HELSINKI, FINLAND; UNIV HELSINKI, CENT HOSP, DEPT MED GENET, SF-00100 HELSINKI 10, FINLAND; FINNISH RED CROSS & BLOOD TRANSFUS SERV, BLOOD TRANSFUS SERV, HELSINKI, FINLAND; WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, CTR GENOME RES, CAMBRIDGE, MA 02139 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)								BRODY LC, 1992, J BIOL CHEM, V267, P3302; CAVALLISFORZA LL, 1971, GNETICS HUMAN POPULA, P71; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; DIETRICH W, 1992, GENETICS, V131, P423; GEDDEDAHL T, 1992, FINSKA LAKRESALLSKAP, V135, P199; GOODMAN RM, 1980, POPULATION STRUCTURE, P337; HAMPE A, 1989, ONCOGENE RES, V4, P9; HASTBACKA J, 1990, P NATL ACAD SCI USA, V87, P8056, DOI 10.1073/pnas.87.20.8056; HASTBACKA J, 1991, GENOMICS, V11, P968, DOI 10.1016/0888-7543(91)90021-6; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; KAPLAN N, 1992, AM J HUM GENET, V51, P333; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIRK RL, 1980, POPULATION STRUCTURE, P13; KLEIN D, 1980, POPULATION STRUCTURE, P367; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; Luria SE, 1943, GENETICS, V28, P491; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; MONONEN T, 1991, HUM GENET, V87, P266; Morton Newton E., 1980, POPULATION STRUCTURE, P43; NEVANLINNA HR, 1972, HEREDITAS-GENETISK A, V71, P195; NORIO R, 1973, ANN CLIN RES, V5, P109; Norio R., 1981, BIOCULTURAL ASPECTS, P359; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P1160, DOI 10.1093/nar/19.5.1160-a; ROBERTS WM, 1988, CELL, V55, P655, DOI 10.1016/0092-8674(88)90224-3; SAHORTA S, 1991, GENETICS, V127, P257; Sambrook J, 1989, MOL CLONING LABORATO; SHERR CJ, 1990, BLOOD, V75, P1; SIRUGO G, 1992, AM J HUM GENET, V50, P559; STEVENSON AC, 1967, MUTAT RES, V4, P339, DOI 10.1016/0027-5107(67)90029-2; SYVANEN AC, 1992, GENOMICS, V12, P590, DOI 10.1016/0888-7543(92)90452-X; VERBEEK JS, 1985, MOL CELL BIOL, V5, P422, DOI 10.1128/MCB.5.2.422; WALKER BA, 1972, MEDICINE, V51, P41, DOI 10.1097/00005792-197201000-00003; Weir BS, 1990, GENETIC DATA ANAL; XU DQ, 1985, P NATL ACAD SCI USA, V82, P2862, DOI 10.1073/pnas.82.9.2862	35	472	490	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1992	2	3					204	211		10.1038/ng1192-204	http://dx.doi.org/10.1038/ng1192-204			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345170				2022-12-25	WOS:A1992JW16500010
J	CHUMAKOV, IM; LEGALL, I; BILLAULT, A; OUGEN, P; SOULARUE, P; GUILLOU, S; RIGAULT, P; BUI, H; DETAND, MF; BARILLOT, E; ABDERRAHIM, H; CHERIF, D; BERGER, R; LEPASLIER, D; COHEN, D				CHUMAKOV, IM; LEGALL, I; BILLAULT, A; OUGEN, P; SOULARUE, P; GUILLOU, S; RIGAULT, P; BUI, H; DETAND, MF; BARILLOT, E; ABDERRAHIM, H; CHERIF, D; BERGER, R; LEPASLIER, D; COHEN, D			ISOLATION OF CHROMOSOME-21-SPECIFIC YEAST ARTIFICIAL CHROMOSOMES FROM A TOTAL HUMAN GENOME LIBRARY	NATURE GENETICS			English	Article							CONSTRUCTION; DNA; VECTORS	A new approach for the isolation of chromosome-specific subsets from a human genomic yeast artificial chromosome (YAC) library is described. It is based on the hybridization with an Alu polymerase chain reaction (PCR) probe. We screened a 1.5 genome equivalent YAC library of megabase insert size with Alu PCR products amplified from hybrid cell lines containing human chromosome 21, and identified a subset of 63 clones representative of this chromosome. The majority of clones were assigned to chromosome 21 by the presence of specific STSs and in situ hybridization. Twenty-nine of 36 STSs that we tested were detected in the subset, and a contig spanning 20 centimorgans in the genetic map and containing 8 STSs in 4 YACs was identified. The proposed approach can greatly speed efforts to construct physical maps of the human genome.	GENETHON,F-91002 EVRY,FRANCE; INSERM,U307,F-75010 PARIS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm)	CHUMAKOV, IM (corresponding author), CTR ETUD POLYMORPHISME HUMAIN,27 RUE JULIETTE DODU,F-75010 PARIS,FRANCE.			BARILLOT, Emmanuel/0000-0003-2724-2002; Le Paslier, Denis/0000-0003-4335-9956				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; BICKNELL DC, 1991, GENOMICS, V10, P186, DOI 10.1016/0888-7543(91)90499-5; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GREEN ED, 1991, GENOMICS, V11, P658, DOI 10.1016/0888-7543(91)90073-N; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEDBETTER SA, 1990, GENOMICS, V8, P614, DOI 10.1016/0888-7543(90)90247-R; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MCCORMICK MK, 1989, P NATL ACAD SCI USA, V86, P9991, DOI 10.1073/pnas.86.24.9991; MONACO AP, 1991, NUCLEIC ACIDS RES, V19, P3315, DOI 10.1093/nar/19.12.3315; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; WADA M, 1990, AM J HUM GENET, V46, P95; WILLARD C, 1987, J MOL EVOL, V26, P180, DOI 10.1007/BF02099850	21	112	114	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					222	225		10.1038/ng0692-222	http://dx.doi.org/10.1038/ng0692-222			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303240				2022-12-25	WOS:A1992JC98200018
J	FEREC, C; AUDREZET, MP; MERCIER, B; GUILLERMIT, H; MOULLIER, P; QUERE, I; VERLINGUE, C				FEREC, C; AUDREZET, MP; MERCIER, B; GUILLERMIT, H; MOULLIER, P; QUERE, I; VERLINGUE, C			DETECTION OF OVER 98-PERCENT CYSTIC-FIBROSIS MUTATIONS IN A CELTIC POPULATION	NATURE GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE CHAIN-REACTION; SINGLE-BASE CHANGES; 3 POINT MUTATIONS; DNA FRAGMENTS; CFTR GENE; IDENTIFICATION; MISMATCHES; CLUSTER	We have conducted a large systematic study of 365 cystic fibrosis (CF) chromosomes in a Celtic population from Brittany, France, in which we have been able to identify more than 98% of the cystic fibrosis gene mutations. We detected 19 different CFTR mutations located in 9 exons. Eleven of these mutations have not been described previously and nine of them are presented in this study. The denaturing gradient gel electrophoresis strategy we have used, can be applied to other populations suggesting that population screening for CF on a large scale might be possible.			FEREC, C (corresponding author), CTR DEPT TRANSFUS SANGUINE,CTR BIOGENET,BP 454,F-29275 BREST,FRANCE.		Ferec, Claude/ABG-9699-2020	Ferec, Claude/0000-0002-2325-0710				ATTREE O, 1989, GENOMICS, V4, P266, DOI 10.1016/0888-7543(89)90330-3; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BEAUDET AL, 1990, AM J HUM GENET, V47, P603; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BOIS E, 1978, CLIN GENET, V14, P73; BROCK D, 1990, AM J HUM GENET, V47, P164; BROCK DJH, 1991, PEDIAT PULMONOL, V59, P239; CASKEY CT, 1990, AM J HUM GENET, V46, P393; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; CUTTING GR, 1990, NEW ENGL J MED, V323, P1517; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEVOTO M, 1991, AM J HUM GENET, V48, P1127; FEREC C, 1991, PATHOL BIOL, V39, P577; GASPARINI P, 1991, GENOMICS, V10, P193, DOI 10.1016/0888-7543(91)90500-E; GILBERT F, 1990, AM J HUM GENET, V46, P394; GUILLERMIT H, 1990, HUM GENET, V85, P450, DOI 10.1007/BF02428306; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HIGHSMITH WE, 1991, PEDIATR PULMONOL A S, V11; HIGHSMITH WE, 1991, PEDIATR PULMONOL S, V5; HIGUCHI M, 1991, P NATL ACAD SCI USA, V88, P8307, DOI 10.1073/pnas.88.19.8307; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; IVASCHENKO TE, 1991, GENOMICS, V10, P298, DOI 10.1016/0888-7543(91)90517-I; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOBAYASHI K, 1990, AM J HUM GENET, V47, P611; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; MYERS RM, 1985, SCIENCE, V230, P1242, DOI 10.1126/science.4071043; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OSBORNE L, 1991, AM J HUM GENET, V48, P608; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROBERTS L, 1990, SCIENCE, V247, P1296, DOI 10.1126/science.2315698; ROMMENS JM, 1991, P NATL ACAD SCI USA, V88, P7500, DOI 10.1073/pnas.88.17.7500; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSATELLI MC, 1992, AM J HUM GENET, V50, P422; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEFFIELD VC, 1991, AM J HUM GENET, V49, P699; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SHOSHANI T, 1991, N AM CYSTIC FIBROSIS, V74, P242; SUPER M, 1992, EUR J PEDIATR, V151, P108, DOI 10.1007/BF01958953; SUPER M, 1989, NATURE, V344, P113; TENKATE LP, 1990, AM J HUM GENET, V47, P359; VIDAUD M, 1989, P NATL ACAD SCI USA, V86, P1041, DOI 10.1073/pnas.86.3.1041; VIDAUD M, 1990, HUM GENET, V85, P446, DOI 10.1007/BF02428305; WATSON EK, 1991, BRIT MED J, V303, P504, DOI 10.1136/bmj.303.6801.504; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8	52	176	176	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					188	191		10.1038/ng0692-188	http://dx.doi.org/10.1038/ng0692-188			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1284639				2022-12-25	WOS:A1992JC98200010
J	MATSUNAMI, N; SMITH, B; BALLARD, L; LENSCH, MW; ROBERTSON, M; ALBERTSEN, H; HANEMANN, CO; MULLER, HW; BIRD, TD; WHITE, R; CHANCE, PF				MATSUNAMI, N; SMITH, B; BALLARD, L; LENSCH, MW; ROBERTSON, M; ALBERTSEN, H; HANEMANN, CO; MULLER, HW; BIRD, TD; WHITE, R; CHANCE, PF			PERIPHERAL MYELIN PROTEIN-22 GENE MAPS IN THE DUPLICATION IN CHROMOSOME-17P11.2 ASSOCIATED WITH CHARCOT-MARIE-TOOTH-1A	NATURE GENETICS			English	Article							MARIE-TOOTH NEUROPATHY; HEREDITARY MOTOR; LINKAGE; DISEASE	Charcot-Marie-Tooth disease 1A (CMT1A) is a hereditary demyelinating peripheral neuropathy, associated with a DNA duplication on chromosome 17p11.2. A related disorder in the mouse, trembler (Tr), maps to mouse chromosome 11 which has syntenic homology to human chromosome 17p. Recently, the peripheral myelin protein-22 (pmp-22) gene was identified as the likely Tr locus. We have constructed a partial yeast artificial chromosome contig spanning the CMT1A gene region and mapped the PMP-22 gene to the duplicated region. These observations further implicate PMP-22 as a candidate gene for CMT1A, and suggest that over-expression of this gene may be one mechanism that produces the CMT1A phenotype.	UNIV UTAH,MED CTR,DEPT PEDIAT,DIV MED GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,MED CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV DUSSELDORF,DEPT NEUROL,MOLEC NEUROBIOL LAB,W-4000 DUSSELDORF 1,GERMANY; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112; UNIV WASHINGTON,SCH MED,DIV NEUROL,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DIV PEDIAT,SEATTLE,WA 98195	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Heinrich Heine University Dusseldorf; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle			Chance, Phillip/AAX-5826-2020; Hanemann, C Oliver/AAV-6257-2020	Hanemann, C Oliver/0000-0002-1951-1025				AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BIRD TD, 1982, AM J HUM GENET, V34, P388; CHANCE PF, 1990, AM J HUM GENET, V47, P915; CHANCE PF, IN PRESS NEUROLOGY; DAVISSON MT, 1978, CYTOGENET CELL GENET, V22, P552, DOI 10.1159/000131022; DYCK PJ, 1984, DISEASES PERIPHERAL, P1609; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; GAL A, 1985, HUM GENET, V70, P38, DOI 10.1007/BF00389456; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HENRY EW, 1988, SCIENCE, V241, P344, DOI 10.1126/science.3388045; LEBO RV, 1992, AM J HUM GENET, V50, P42; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MUNKE M, 1987, J MOL EVOL, V25, P134, DOI 10.1007/BF02101755; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195	23	331	332	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					176	179		10.1038/ng0692-176	http://dx.doi.org/10.1038/ng0692-176			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303231				2022-12-25	WOS:A1992JC98200008
J	PARKINSON, DB; THAKKER, RV				PARKINSON, DB; THAKKER, RV			A DONOR SPLICE SITE MUTATION IN THE PARATHYROID-HORMONE GENE IS ASSOCIATED WITH AUTOSOMAL RECESSIVE HYPOPARATHYROIDISM	NATURE GENETICS			English	Article							FAMILIAL ISOLATED HYPOPARATHYROIDISM; MESSENGER-RNA; IDIOPATHIC HYPOPARATHYROIDISM; TRANSCRIPTION; SEQUENCE; DNA; INTRON	Investigation of one kindred with autosomal recessive isolated hypoparathyroidism, which had resulted from a consanguineous marriage, has identified a g to c substitution in the first nucleotide of intron 2 of the parathyroid hormone (PTH) gene. This donor splice mutation could be detected by restriction enzyme cleavage with Ddel, and this revealed that the patients were homozygous for the mutant alleles, the unaffected relatives were heterozygous, and unrelated normals were homozygous for the wild type alleles. Defects in messenger RNA splicing were investigated by the detection of illegitimate transcription of the PTH gene in lymphoblastoid cells. The mutation resulted in exon skipping with a loss of exon 2, which encodes the initiation codon and the signal peptide, thereby causing parathyroid hormone deficiency.	MRC,CLIN RES CTR,DIV MOLEC MED,WATFORD RD,HARROW HA1 3UJ,MIDDX,ENGLAND	Medical Research Council Clinical Trials Unit				Thakker, Rajesh/0000-0002-1438-3220				AHN TG, 1986, MEDICINE, V65, P73, DOI 10.1097/00005792-198603000-00001; ARNOLD A, 1990, J CLIN INVEST, V86, P1084, DOI 10.1172/JCI114811; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BARR DGD, 1971, HELV PAEDIATR ACTA, V26, P507; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; BRG LP, 1990, HUM GENET, V85, P655; BRONSKY D, 1968, J CLIN ENDOCR METAB, V28, P61, DOI 10.1210/jcem-28-1-61; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; EMR SD, 1980, J CELL BIOL, V86, P701, DOI 10.1083/jcb.86.3.701; KEUTMANN HT, 1978, BIOCHEMISTRY-US, V12, P5723; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUO HC, 1991, SCIENCE, V251, P1045, DOI 10.1126/science.1825520; LOVELLBADGE RH, 1987, TERATOCARCINOMAS EMB, P153; MCKUSICK VA, 1988, MENDELIAN INHERITANC; NAYLOR SL, 1983, SOMAT CELL GENET, V9, P609, DOI 10.1007/BF01574261; NICHOLLS AC, 1991, HUM GENET, V87, P193, DOI 10.1007/BF00204180; NUSSBAUM SR, 1987, CLIN CHEM, V33, P1364; OHNO K, 1988, J BIOL CHEM, V263, P18563; ROELEN DL, 1989, EUR J CLIN INVEST, V19, P311, DOI 10.1111/j.1365-2362.1989.tb00235.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; SCHMIDTKE J, 1984, HUM GENET, V67, P427; TALERICO M, 1990, MOL CELL BIOL, V10, P6299, DOI 10.1128/MCB.10.12.6299; THAKKER RV, 1990, J CLIN INVEST, V86, P40, DOI 10.1172/JCI114712; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; VASICEK TJ, 1983, P NATL ACAD SCI-BIOL, V80, P2127, DOI 10.1073/pnas.80.8.2127; WHYTE MP, 1981, J PEDIATR-US, V99, P608, DOI 10.1016/S0022-3476(81)80272-7	28	147	150	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1992	1	2					149	152		10.1038/ng0592-149	http://dx.doi.org/10.1038/ng0592-149			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC980	1302009				2022-12-25	WOS:A1992JC98000015
J	MANDELBOIM, O; VADAI, E; FRIDKIN, M; KATZHILLEL, A; FELDMAN, M; BERKE, G; EISENBACH, L				MANDELBOIM, O; VADAI, E; FRIDKIN, M; KATZHILLEL, A; FELDMAN, M; BERKE, G; EISENBACH, L			REGRESSION OF ESTABLISHED MURINE CARCINOMA METASTASES FOLLOWING VACCINATION WITH TUMOR-ASSOCIATED ANTIGEN PEPTIDES	NATURE MEDICINE			English	Article							SUPPRESSOR T-CELLS; ANTIVIRAL PROTECTION; LYMPHOCYTES	The cure of micrometastases following surgery is the major goal of cancer immunotherapy. We have recently isolated tumour-associated antigen (TAA) peptides, MUT 1 and MUT 2, derived from a mutated connexin 37 gap-junction protein, from the malignant 3LL-D122 murine lung carcinoma. We now report that synthetic MUT 1 or MUT 2 induces effective antitumour cytoxic T lymphocytes. Peptide vaccines protect mice from spontaneous metastases of 3LL-D122 tumours. Moreover, peptide vaccines reduce metastatic loads in mice carrying pre-established micrometastases. Tumour-specific immunity was primarily mediated by CD8(+) T cells. This is the first evidence that peptide therapy may be effective in treatment of residual tumours and provides a rationale for the development of peptide vaccines as a modality for cancer therapy.	WEIZMANN INST SCI,DEPT CELL BIOL,IL-76100 REHOVOT,ISRAEL; WEIZMANN INST SCI,DEPT ORGAN CHEM,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science; Weizmann Institute of Science				Eisenbach, Lea R/0000-0002-4816-1968; Mandelboim, Ofer/0000-0002-9354-1855				AWWAD M, 1989, CANCER RES, V49, P1649; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; GELBER C, 1992, CANCER RES, V52, P6507; KAST WM, 1993, EUR J IMMUNOL, V23, P1189, DOI 10.1002/eji.1830230534; KOVACSOVICSBANK.M, 1995, SCIENCE, V267, P243; KUNDIG TM, 1995, SCIENCE, V268, P1343, DOI 10.1126/science.7761853; LEVITSKY HI, 1994, J EXP MED, V179, P1215, DOI 10.1084/jem.179.4.1215; MANDELBOIM O, 1994, NATURE, V369, P67, DOI 10.1038/369067a0; MELIEF CJM, 1992, ADV CANCER RES, V58, P143, DOI 10.1016/S0065-230X(08)60294-8; NORTH RJ, 1990, IMMUNOLOGY, V71, P90; PLAKSIN D, 1988, P NATL ACAD SCI USA, V85, P4463, DOI 10.1073/pnas.85.12.4463; POWRIE F, 1993, IMMUNOL TODAY, V14, P270, DOI 10.1016/0167-5699(93)90044-L; RAKMILEVICH AL, 1994, CANCER IMMUNOL IMMUN, V38, P197; RAKMILLEVICH AL, 1993, INT J CANCER, V53, P338; ROCK KL, 1993, J IMMUNOL, V150, P438; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; SCHULZ M, 1991, P NATL ACAD SCI USA, V88, P991, DOI 10.1073/pnas.88.3.991; SETTE A, 1994, ANNU REV IMMUNOL, V12, P413, DOI 10.1146/annurev.immunol.12.1.413; URBAN JL, 1992, ANNU REV IMMUNOL, V10, P617, DOI 10.1146/annurev.iy.10.040192.003153	21	134	154	0	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1179	1183		10.1038/nm1195-1179	http://dx.doi.org/10.1038/nm1195-1179			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584991				2022-12-25	WOS:A1995TC53700043
J	CUMMINGS, CW				CUMMINGS, CW			THE HYPOCRISY OF US TOBACCO POLICY	NATURE MEDICINE			English	Editorial Material											CUMMINGS, CW (corresponding author), JOHNS HOPKINS MED INST,DEPT OTOLARYNGOL HEAD & NECK SURG,BOX 41402,BALTIMORE,MD 21203, USA.							BOYD JW, 1995, LANCET, V346, P64, DOI 10.1016/S0140-6736(95)92104-4; BRENNAN JA, 1995, ENGL J MED, V332, P712; MACKENZIE TD, 1994, NEW ENGL J MED, V330, P975, DOI 10.1056/NEJM199404073301406; MACKENZIE TD, 1994, NEW ENGL J MED, V330, P907; THUN MJ, 1995, AM J PUBLIC HEALTH, V85, P1223, DOI 10.2105/AJPH.85.9.1223; 1995, JAMA-J AM MED ASSOC, V274, P528	6	1	1	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	OCT	1995	1	10					989	990		10.1038/nm1095-989	http://dx.doi.org/10.1038/nm1095-989			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489380				2022-12-25	WOS:A1995RX95100029
J	HEISS, MM; ALLGAYER, H; GRUETZNER, KU; FUNKE, I; BABIC, R; JAUCH, KW; SCHILDBERG, FW				HEISS, MM; ALLGAYER, H; GRUETZNER, KU; FUNKE, I; BABIC, R; JAUCH, KW; SCHILDBERG, FW			INDIVIDUAL DEVELOPMENT AND UPA-RECEPTOR EXPRESSION OF DISSEMINATED TUMOR-CELLS IN BONE-MARROW - A REFERENCE TO EARLY SYSTEMIC-DISEASE IN SOLID CANCER	NATURE MEDICINE			English	Article							MONOCLONAL-ANTIBODIES; BREAST-CANCER; ALKALINE-PHOSPHATASE; MICRO-METASTESES; UROKINASE; CYTOKERATIN; METASTASIS; INVASION	It is unclear whether disseminated tumour cells detected in bone marrow in early stages of solid cancers indicate a subclinical systemic disease component determining the patient's fate or simply represent mainly irrelevant shed cells. Moreover, characteristics differentiating high and low metastatic potential of disseminated tumour cells are not defined. We performed repeated serial bone marrow biopsies during follow-up in operated gastric cancer patients. Most patients with later tumour relapse revealed either an increase or a constantly high number of tumour cells. In contrast, in patients without recurrence, either clearance of tumour cells or negative or low cell counts were seen. Urokinase plasminogen activator (uPA)-receptor expression on disseminated tumour cells was significantly correlated with increasing tumour cell counts and clinical prognosis. These results demonstrate a systemic component in early solid cancer, indicated by early systemically disseminated tumour cells, which may predict individual disease development.	UNIV MUNICH, DEPT PATHOL, D-81377 MUNICH, GERMANY	University of Munich	HEISS, MM (corresponding author), UNIV MUNICH, KLINIKUM GROSSHADERN, DEPT SURG, MARCHIONINISTR 15, D-81377 MUNICH, GERMANY.							BERGER U, 1988, AM J CLIN PATHOL, V90, P1; BLASI F, 1993, BIOESSAYS, V15, P105, DOI 10.1002/bies.950150206; BREIMANN L, 1984, CLASSIFICATION REGRE; BRISCO MJ, 1994, LANCET, V343, P196, DOI 10.1016/S0140-6736(94)90988-1; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; COTE RJ, 1991, J CLIN ONCOL, V9, P1749, DOI 10.1200/JCO.1991.9.10.1749; COX DR, 1972, J R STAT SOC B, V34, P187; DIXON WJ, 1985, BMDP STATISTICAL SOF; DUFFY MJ, 1992, CLIN EXP METASTAS, V10, P145, DOI 10.1007/BF00132746; DUFFY MJ, 1990, CANCER RES, V50, P6827; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; FAZIOLI F, 1994, TRENDS PHARMACOL SCI, V15, P25, DOI 10.1016/0165-6147(94)90130-9; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; FROST P, 1989, Cancer Bulletin (Houston), V41, P139; GHOSH AK, 1985, BRIT J HAEMATOL, V61, P21, DOI 10.1111/j.1365-2141.1985.tb04056.x; HEISS MM, 1995, J CLIN ONCOL, V13, P2084, DOI 10.1200/JCO.1995.13.8.2084; HEISS MM, 1992, TUMOR ASS ANTIGENS O, P471; JAUCH KW, 1995, 1ST INT GASTR CANC C; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LINDEMANN F, 1992, LANCET, V340, P685, DOI 10.1016/0140-6736(92)92230-D; MANSI JL, 1989, J CLIN ONCOL, V7, P445, DOI 10.1200/JCO.1989.7.4.445; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MOSS TJ, 1991, NEW ENGL J MED, V324, P219, DOI 10.1056/NEJM199101243240403; NEKARDA H, 1994, CANCER RES, V54, P2900; Osborne M P, 1994, Oncology (Williston Park), V8, P25; OSSOWSKI L, 1991, J CELL BIOL, V115, P1107, DOI 10.1083/jcb.115.4.1107; Paget S, 1889, LANCET, V133, P571, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; PANTEL K, 1993, JNCI-J NATL CANCER I, V85, P1419, DOI 10.1093/jnci/85.17.1419; RIESENBERG R, 1993, HISTOCHEMISTRY, V99, P61, DOI 10.1007/BF00268022; RIETHMULLER G, 1992, CURR OPIN IMMUNOL, V4, P647, DOI 10.1016/0952-7915(92)90041-C; SCHLIMOK G, 1987, P NATL ACAD SCI USA, V84, P8672, DOI 10.1073/pnas.84.23.8672; WONG KF, 1993, HEMATOL ONCOL, V11, P35, DOI 10.1002/hon.2900110105; YOKOTA S, 1991, BLOOD, V77, P331	33	226	230	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	1995	1	10					1035	1039		10.1038/nm1095-1035	http://dx.doi.org/10.1038/nm1095-1035			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489359				2022-12-25	WOS:A1995RX95100043
J	JESKE, YWA; BOWLES, J; GREENFIELD, A; KOOPMAN, P				JESKE, YWA; BOWLES, J; GREENFIELD, A; KOOPMAN, P			EXPRESSION OF A LINEAR SRY TRANSCRIPT IN THE MOUSE GENITAL RIDGE	NATURE GENETICS			English	Letter							TESTIS-DETERMINING GENE; SEX-DETERMINING REGION; MICE; DIFFERENTIATION; LOCUS; CELLS; XY		UNIV QUEENSLAND,CTR MOLEC & CELLULAR BIOL,BRISBANE,QLD 4072,AUSTRALIA; UNIV QUEENSLAND,DEPT ANAT SCI,BRISBANE,QLD 4072,AUSTRALIA	University of Queensland; University of Queensland			Bowles, Josephine/B-6583-2013; Bowles, Josephine/AAG-4903-2020; Koopman, Peter A/C-9416-2009; Greenfield, Andy/F-5099-2017	Bowles, Josephine/0000-0003-2867-7438; Bowles, Josephine/0000-0003-2867-7438; Koopman, Peter A/0000-0001-6939-0914; Greenfield, Andy/0000-0002-1477-1776				BUEHR M, 1993, DEVELOPMENT, V117, P273; BURGOYNE PS, 1988, DEVELOPMENT, V102, P443; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEPET C, 1993, HUM MOL GENET, V2, P2007, DOI 10.1093/hmg/2.12.2007; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; GUBBAY J, 1992, P NATL ACAD SCI USA, V89, P7953, DOI 10.1073/pnas.89.17.7953; HACKER A, 1995, DEVELOPMENT, V121, P1603; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; MCLAREN A, 1990, CELL DIFFER DEV, V31, P185, DOI 10.1016/0922-3371(90)90131-F; PALMER SJ, 1991, DEVELOPMENT, V113, P709; RUGH R, 1968, MOUSE ITS REPRODUCTI; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; TUCKER PK, 1993, NATURE, V364, P715, DOI 10.1038/364715a0	17	149	157	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					480	482		10.1038/ng0895-480	http://dx.doi.org/10.1038/ng0895-480			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670499				2022-12-25	WOS:A1995RM37500024
J	REIJO, R; LEE, TY; SALO, P; ALAGAPPAN, R; BROWN, LG; ROSENBERG, M; ROZEN, S; JAFFE, T; STRAUS, D; HOVATTA, O; DELACHAPELLE, A; SILBER, S; PAGE, DC				REIJO, R; LEE, TY; SALO, P; ALAGAPPAN, R; BROWN, LG; ROSENBERG, M; ROZEN, S; JAFFE, T; STRAUS, D; HOVATTA, O; DELACHAPELLE, A; SILBER, S; PAGE, DC			DIVERSE SPERMATOGENIC DEFECTS IN HUMANS CAUSED BY Y-CHROMOSOME DELETIONS ENCOMPASSING A NOVEL RNA-BINDING PROTEIN GENE	NATURE GENETICS			English	Article							SEX-DETERMINING REGION; HUMAN X-CHROMOSOME; LONG ARM; DNA; ENCODES; MICRODELETIONS; LOCALIZATION; INTERVAL-6; FERTILITY; STERILITY	We have detected deletions of portions of the Y chromosome long arm in 12 of 89 men with azoospermia (no sperm in semen), No Y deletions were detected in their male relatives or in 90 other fertile males, The 12 deletions overlap, defining a region likely to contain one or more genes required for spermatogenesis (the Azoospermia Factor, AZF). Deletion of the AZF region is associated with highly variable testicular defects, ranging from complete absence of germ cells to spermatogenic arrest with occasional production of condensed spermatids. We find no evidence of YRRM genes, recently proposed as AZF candidates, in the AZF region. The region contains a single-copy gene, DAZ (Deleted in AZoospermia), which is transcribed in the adult testis and appears to encode an RNA binding protein. The possibility that DAZ is AZF should now be explored.	MIT,WHITEHEAD INST,CTR GENOME RES,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02142; HELSINKI UNIV,DEPT MED GENET,HELSINKI,FINLAND; BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254; FAMILY FEDERAT FINLAND,HELSINKI,FINLAND; ST LUKES HOSP,IN VITRO FERTILIZAT PROGRAM,ST LOUIS,MO 63017	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Helsinki; Brandeis University; Family Federation of Finland; Saint Luke's Hospital - Missouri	REIJO, R (corresponding author), MIT,HOWARD HUGHES MED INST,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142, USA.		; Rozen, Steven G./J-5939-2013	Reijo Pera, Renee/0000-0002-6487-1329; Rozen, Steven G./0000-0002-4288-0056				ANDERSSON M, 1988, HUM GENET, V79, P2, DOI 10.1007/BF00291700; BORGAONKAR DS, 1971, NATURE, V230, P52, DOI 10.1038/230052a0; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; BUTLER MG, 1991, AM J MED GENET, V38, P260, DOI 10.1002/ajmg.1320380220; CARR DH, 1968, AM J CLIN PATHOL, V49, P521; CLERMONT Y, 1966, AM J ANAT, V118, P509, DOI 10.1002/aja.1001180211; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; DYM M, 1994, P NATL ACAD SCI USA, V91, P11287, DOI 10.1073/pnas.91.24.11287; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FITCH N, 1985, AM J MED GENET, V20, P31, DOI 10.1002/ajmg.1320200106; FOOTE S, 1992, SCIENCE, V258, P60, DOI 10.1126/science.1359640; HALDI M, 1995, GENOMICS, V24, P478; HARTUNG M, 1988, ANN GENET-PARIS, V31, P21; Hecht N. B., 1993, CELL MOL BIOL TESTIS, P400; HOLLAND J, 1993, GENOMICS, V15, P297, DOI 10.1006/geno.1993.1060; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; JOHNSON MD, 1989, AM J OBSTET GYNECOL, V161, P1732, DOI 10.1016/0002-9378(89)90959-9; KARSCHMIZRACHI I, 1993, NUCLEIC ACIDS RES, V21, P2229, DOI 10.1093/nar/21.9.2229; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; KOBAYASHI K, 1994, HUM MOL GENET, V3, P1965, DOI 10.1093/hmg/3.11.1965; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KWON YK, 1993, DEV BIOL, V158, P90, DOI 10.1006/dbio.1993.1170; LAMAR EE, 1984, CELL, V37, P171, DOI 10.1016/0092-8674(84)90312-X; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; LINDSLEY DL, 1980, GENETICS BIOL DROSOP, P226; LUCOTTE G, 1985, NUCLEIC ACIDS RES, V13, P8285, DOI 10.1093/nar/13.22.8285; MA K, 1993, CELL, V75, P1287, DOI 10.1016/0092-8674(93)90616-X; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; MAGRAM J, 1991, P NATL ACAD SCI USA, V88, P10327, DOI 10.1073/pnas.88.22.10327; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PAGE DC, 1990, NATURE, V346, P279, DOI 10.1038/346279a0; ROSENBERG M, 1994, P NATL ACAD SCI USA, V91, P6113, DOI 10.1073/pnas.91.13.6113; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; SILBER SJ, 1989, HUM REPROD, V4, P947, DOI 10.1093/oxfordjournals.humrep.a137018; SILBER SJ, 1995, HUM REPROD, V10, P131; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SKARE J, 1990, AM J MED GENET, V36, P394, DOI 10.1002/ajmg.1320360405; STRAUS D, 1990, P NATL ACAD SCI USA, V87, P1889, DOI 10.1073/pnas.87.5.1889; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; VOGT P, 1992, HUM GENET, V89, P491; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	43	995	1064	1	46	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					383	393		10.1038/ng0895-383	http://dx.doi.org/10.1038/ng0895-383			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670487				2022-12-25	WOS:A1995RM37500010
J	COOPER, DL; DOUGHERTY, GJ				COOPER, DL; DOUGHERTY, GJ			TO METASTASIZE OR NOT - SELECTION OF CD44 SPLICE SITES	NATURE MEDICINE			English	Editorial Material							ADHESION MOLECULE; HYALURONATE; RECEPTOR; CELLS; EXONS; FORM		BRITISH COLUMBIA CANC AGCY,TERRY FOX LAB,VANCOUVER,BC V5Z 1L3,CANADA	British Columbia Cancer Agency	COOPER, DL (corresponding author), UNIV PITTSBURGH,SCH MED,DEPT PATHOL,PITTSBURGH,PA 15261, USA.							ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; ASMAN DC, IN PRESS J NEUROONCO; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; COOPER DL, 1992, BIOCHEM BIOPH RES CO, V182, P569, DOI 10.1016/0006-291X(92)91770-Q; DOUGHERTY G J, 1992, Proceedings of the American Association for Cancer Research Annual Meeting, V33, P35; DOUGHERTY GJ, 1991, J EXP MED, V174, P1, DOI 10.1084/jem.174.1.1; DOUGHERTY GJ, 1994, J BIOL CHEM, V269, P9074; DROLL A, 1995, J BIOL CHEM, V270, P11567, DOI 10.1074/jbc.270.19.11567; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; HOFMANN M, 1991, CANCER RES, V51, P5295; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; LABARRIERE N, 1994, CANCER RES, V54, P6275; MATSUMURA Y, 1992, LANCET, V340, P1053, DOI 10.1016/0140-6736(92)93077-Z; MERZAK A, 1994, CANCER RES, V54, P3988; MIYAKE K, 1990, J EXP MED, V172, P69, DOI 10.1084/jem.172.1.69; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; SEITER S, 1993, J EXP MED, V177, P443, DOI 10.1084/jem.177.2.443; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; TANABE KK, 1993, LANCET, V341, P725, DOI 10.1016/0140-6736(93)90490-8; TARIN D, IN PRESS J NEUROONCO; TOYAMASORIMACHI N, 1995, J BIOL CHEM, V270, P7437, DOI 10.1074/jbc.270.13.7437; IN PRESS J NEUROONCO	23	84	84	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1995	1	7					635	637		10.1038/nm0795-635	http://dx.doi.org/10.1038/nm0795-635			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585142				2022-12-25	WOS:A1995RQ06600035
J	GELB, BD; EDELSON, JG; DESNICK, RJ				GELB, BD; EDELSON, JG; DESNICK, RJ			LINKAGE OF PYCNODYSOSTOSIS TO CHROMOSOME 1Q21 BY HOMOZYGOSITY MAPPING	NATURE GENETICS			English	Note							RECEPTOR; GENE; INTERLEUKIN-6; ILLNESS		MT SINAI SCH MED,DEPT HUMAN GENET,NEW YORK,NY 10029; MT SINAI SCH MED,DEPT PEDIAT,NEW YORK,NY 10029; PORIYA GOVT HOSP,DEPT ORTHOPED,TIBERIAS,ISRAEL	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031775] Funding Source: NIH RePORTER; NCRR NIH HHS [5 M01 RR00071] Funding Source: Medline; NICHD NIH HHS [5 P30 HD 28822] Funding Source: Medline; NIDDK NIH HHS [R01 DK 31775] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ANDREN L., 1962, ACTA CHIR SCAND, V124, P496; BALENA R, 1994, EMBO J, V13, P1189; CRAIG RW, 1994, GENOMICS, V23, P457, DOI 10.1006/geno.1994.1523; EDELSON JG, 1992, CLIN ORTHOPAEDICS, V280, P263; FREY JB, 1994, TOULOUSELAUTREC LIFE; GREENSPAN A, 1991, SKELETAL RADIOL, V20, P561, DOI 10.1007/BF01106087; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Herrmann J, 1975, Birth Defects Orig Artic Ser, V11, P76; HOGGARD N, 1994, CYTOGENET CELL GENET, V67, P168; HOYLAND JA, 1994, J BONE MINER RES, V9, P75; KISHIMOTO T, 1992, INT J IMMUNOPHARMACO, V14, P431; KLUCK PMC, 1993, HUM GENET, V90, P542; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LOFTUS LS, 1991, BRIT MED J, V303, P1589, DOI 10.1136/bmj.303.6817.1589; MACALPINE I, 1968, BMJ-BRIT MED J, V1, P7, DOI 10.1136/bmj.1.5583.7; MAROTEAUX P, 1962, PRESSE MED, V70, P999; MAROTEAUX P, 1965, J AMER MED ASSOC, V191, P715, DOI 10.1001/jama.1965.03080090029007; MAROTEAUX P, 1993, PRESSE MED, V23, P1635; MCKUSICK VA, 1991, NATURE, V352, P280; MCKUSICK VA, 1965, SCI AM, V213, P88, DOI 10.1038/scientificamerican0865-88; OSHEA JG, 1987, MED J AUSTRALIA, V147, P586; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VERMA RS, 1995, HUMAN CHROMOSOMES PR, P134; WOLF PL, 1994, CLIN CHEM, V40, P328	30	81	83	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					235	237		10.1038/ng0695-235	http://dx.doi.org/10.1038/ng0695-235			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663521				2022-12-25	WOS:A1995RA85700024
J	INDOLFI, C; AVVEDIMENTO, EV; RAPACCIUOLO, A; DILORENZO, E; ESPOSITO, G; STABILE, E; FELICIELLO, A; MELE, E; GIULIANO, P; CONDORELLI, G; CHIARIELLO, M				INDOLFI, C; AVVEDIMENTO, EV; RAPACCIUOLO, A; DILORENZO, E; ESPOSITO, G; STABILE, E; FELICIELLO, A; MELE, E; GIULIANO, P; CONDORELLI, G; CHIARIELLO, M			INHIBITION OF CELLULAR RAS PREVENTS SMOOTH-MUSCLE CELL-PROLIFERATION AFTER VASCULAR INJURY IN-VIVO	NATURE MEDICINE			English	Article							SUCCESSFUL CORONARY ANGIOPLASTY; H-RAS; GROWTH; RESTENOSIS; PROTEIN; PHOSPHORYLATION; MICROINJECTION; NIH-3T3-CELLS; MUTANTS	Proliferation of smooth muscle cells of the arterial wall in response to local injury is an important aetiologic factor of vascular proliferative disorders such as atherosclerosis and restenosis after angioplasty. Ras proteins are key transducers of mitogenic signals from membrane to nucleus in many cell types. We investigated the role of ros proteins in the vascular response to arterial injury by inactivating cellular ras of rats in which the common carotid artery was subjected to balloon injury. DNA vectors expressing ros transdominant negative mutants, which interfere with ros function, reduced neointimal formation after injury. Our results indicate a key role for ras in smooth muscle cell proliferation and show that the local delivery of transdominant negative mutants of ras in vivo might prevent some of the acute vascular injury caused by balloon injury.	UNIV NAPLES FEDERICO II,CNR,CTR ENDOCRINOL & ONCOL SPERIMENTALE,I-80131 NAPLES,ITALY; FAC MED & CHIRURG CATANZARO,DIPARTIMENTO MED SPERIMENTALE CLIN,I-88100 CANTANZARO,ITALY; THOMAS JEFFERSON UNIV,JEFFERSON CANC INST,PHILADELPHIA,PA 19107	Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Jefferson University	INDOLFI, C (corresponding author), UNIV NAPLES FEDERICO II,CNR,CTR ENDOCRINOL & ONCOL SPERIMENTALE,CATTEDRA CARDIOL,VIA PANSINI 5,I-80131 NAPLES,ITALY.		Esposito, Giovanni/F-2880-2010; Rapacciuolo, Antonio/AAR-8012-2020; Condorelli, Gianluigi/Q-6736-2017	Esposito, Giovanni/0000-0003-0565-7127; Rapacciuolo, Antonio/0000-0002-4739-7004; stabile, eugenio/0000-0002-4544-3142; Condorelli, Gianluigi/0000-0003-0481-6843; INDOLFI, Ciro/0000-0003-1241-6487; stabile, eugenio/0000-0001-9763-6010				BENDITT EP, 1973, P NATL ACAD SCI USA, V70, P1753, DOI 10.1073/pnas.70.6.1753; BLUMER KJ, 1994, TRENDS BIOCHEM SCI, V19, P236, DOI 10.1016/0968-0004(94)90147-3; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOLLAG G, 1991, ANNU REV CELL BIOL, V7, P601, DOI 10.1146/annurev.cellbio.7.1.601; BOURASSA MG, 1992, J AM COLL CARDIOL, V19, P1410, DOI 10.1016/0735-1097(92)90595-E; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CAI H, 1990, MOL CELL BIOL, V10, P5314, DOI 10.1128/MCB.10.10.5314; CARNEY WP, 1989, HUMAN TUMOR ANTIGENS, P53; CLOWES AW, 1983, LAB INVEST, V49, P327; DIXON WJ, 1969, INTRO STATISTICAL AN; EDELMAN ER, 1992, J CLIN INVEST, V89, P465, DOI 10.1172/JCI115607; EPSTEIN SE, 1993, CIRCULATION, V88, P1351, DOI 10.1161/01.CIR.88.3.1351; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FERAMISCO JR, 1984, CELL, V38, P109, DOI 10.1016/0092-8674(84)90531-2; GIBBS JB, 1989, P NATL ACAD SCI USA, V86, P6630, DOI 10.1073/pnas.86.17.6630; HALLBERG B, 1994, J BIOL CHEM, V269, P3913; HERRMAN JPR, 1993, DRUGS, V46, P249, DOI 10.2165/00003495-199346020-00003; HOLMES DR, 1984, AM J CARDIOL, V53, pC77, DOI 10.1016/0002-9149(84)90752-5; INDOLFI C, 1995, IN PRESS CIRCULATION; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; MADRI JA, 1989, LAB INVEST, V60, P755; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MCBRIDE W, 1988, NEW ENGL J MED, V318, P1734, DOI 10.1056/NEJM198806303182606; MEDEMA RH, 1991, MOL CELL BIOL, V11, P5963, DOI 10.1128/MCB.11.12.5963; MICHAELI T, 1989, EMBO J, V8, P3039, DOI 10.1002/j.1460-2075.1989.tb08454.x; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; PORRAS A, 1994, J BIOL CHEM, V269, P12741; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; SERRUYS PW, 1988, CIRCULATION, V77, P361, DOI 10.1161/01.CIR.77.2.361; SIMONS M, 1992, NATURE, V359, P67, DOI 10.1038/359067a0; SPEIR E, 1994, SCIENCE, V265, P391, DOI 10.1126/science.8023160; STACEY DW, 1984, NATURE, V310, P508, DOI 10.1038/310508a0; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; VIRMANI R, 1994, AM HEART J, V127, P163, DOI 10.1016/0002-8703(94)90522-3; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WILLUMSEN BM, 1984, EMBO J, V3, P2581, DOI 10.1002/j.1460-2075.1984.tb02177.x; 1991, CIRCULATION, V86, P100	40	219	238	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1995	1	6					541	545		10.1038/nm0695-541	http://dx.doi.org/10.1038/nm0695-541			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN101	7585120				2022-12-25	WOS:A1995RN10100037
J	MCCURRY, KR; KOOYMAN, DL; ALVARADO, CG; COTTERELL, AH; MARTIN, MJ; LOGAN, JS; PLATT, JL				MCCURRY, KR; KOOYMAN, DL; ALVARADO, CG; COTTERELL, AH; MARTIN, MJ; LOGAN, JS; PLATT, JL			HUMAN-COMPLEMENT REGULATORY PROTEINS PROTECT SWINE-TO-PRIMATE CARDIAC XENOGRAFTS FROM HUMORAL INJURY	NATURE MEDICINE			English	Article							HYPERACUTE REJECTION; ACTIVATION; ANTIBODIES; MECHANISM; CELLS; CD59; C8; C9	The susceptibility of xenografts to hyperacute rejection is postulated to reflect in part failure of complement regulatory proteins (CRPs) to control activation of heterologous complement on graft endothelium. To test this concept, transgenic swine expressing the human CRP decay accelerating factor and CD59 were developed using a novel expression system involving transfer of the proteins from erythrocytes to endothelial cells. Hearts from transgenic swine transplanted into baboons had markedly less vascular injury and functioned for prolonged periods compared to hearts from nontransgenic swine. These results indicate that expression of human CRPs in xenogeneic organs may contribute to successful xenografting and suggest that intercellular protein transfer might be a useful approach for expression of heterologous proteins in endothelial cells.	DUKE UNIV, MED CTR, DEPT SURG, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT PEDIAT, DURHAM, NC 27710 USA; DUKE UNIV, MED CTR, DEPT IMMUNOL, DURHAM, NC 27710 USA; NEXTRAN, PRINCETON, NJ 08540 USA	Duke University; Duke University; Duke University			Platt, Jeffrey/AHB-0480-2022	Platt, Jeffrey/0000-0002-4915-0419	NHLBI NIH HHS [HL 52297, HL 50985, HL 46810] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL050985, R37HL052297, R01HL052297, R01HL046810] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALEXANDRE GPJ, 1985, TRANSPLANT P, V17, P138; CHARREAU B, 1994, TRANSPLANTATION, V58, P1222, DOI 10.1097/00007890-199412150-00015; COOPER DKC, 1991, XENOTRANSPLANTATION, pR11; DALMASSO AP, 1992, AM J PATHOL, V140, P1157; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; FALK RJ, 1983, J CLIN INVEST, V72, P560, DOI 10.1172/JCI111004; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; KAPLON RJ, 1995, TRANSPLANTATION, V59, P1, DOI 10.1097/00007890-199501150-00001; KOOYMAN D, 1994, TRANSPLANT P, V26, P1241; LEVENTHAL JR, 1993, TRANSPLANTATION, V55, P857, DOI 10.1097/00007890-199304000-00033; LOGAN JS, 1994, METHOD ENZYMOL, V231, P435; MCCURRY KR, IN PRESS TRANSPLANTA; MICHLER RE, 1985, J MED PRIMATOL, V14, P357; MIYAGAWA S, 1988, TRANSPLANTATION, V46, P825, DOI 10.1097/00007890-198812000-00007; PLATT JL, 1982, J EXP MED, V155, P17, DOI 10.1084/jem.155.1.17; PLATT JL, 1991, TRANSPLANTATION, V52, P214, DOI 10.1097/00007890-199108000-00006; PLATT JL, 1990, J EXP MED, V171, P1363, DOI 10.1084/jem.171.4.1363; PLATT JL, 1990, IMMUNOL TODAY, V11, P450, DOI 10.1016/0167-5699(90)90174-8; PLATT JL, 1990, TRANSPLANTATION, V49, P1000, DOI 10.1097/00007890-199005000-00033; PLATT JL, 1995, HYPERACUTE XENOGRAFT; PRUITT SK, 1994, TRANSPLANTATION, V57, P363, DOI 10.1097/00007890-199402150-00009; ROLLINS SA, 1991, J IMMUNOL, V146, P2345; SHIN ML, 1986, J IMMUNOL, V136, P1777; TOWNES TM, 1985, EMBO J, V4, P1715, DOI 10.1002/j.1460-2075.1985.tb03841.x; WHITE D, 1993, LANCET, V342, P879, DOI 10.1016/0140-6736(93)91939-J	25	459	475	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	1995	1	5					423	427		10.1038/nm0595-423	http://dx.doi.org/10.1038/nm0595-423			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585088				2022-12-25	WOS:A1995RN10000031
J	OTTMAN, R; RISCH, N; HAUSER, WA; PEDLEY, TA; LEE, JH; BARKERCUMMINGS, C; LUSTENBERGER, A; NAGLE, KJ; LEE, KS; SCHEUER, ML; NEYSTAT, M; SUSSER, M; WILHELMSEN, KC				OTTMAN, R; RISCH, N; HAUSER, WA; PEDLEY, TA; LEE, JH; BARKERCUMMINGS, C; LUSTENBERGER, A; NAGLE, KJ; LEE, KS; SCHEUER, ML; NEYSTAT, M; SUSSER, M; WILHELMSEN, KC			LOCALIZATION OF A GENE FOR PARTIAL EPILEPSY TO CHROMOSOME 10Q	NATURE GENETICS			English	Article							JUVENILE MYOCLONIC EPILEPSY; IDIOPATHIC GENERALIZED EPILEPSY; FAMILIAL NEONATAL CONVULSIONS; LINKAGE ANALYSIS; HLA REGION; LOCUS; COMPUTATIONS; MARKERS	There is strong evidence for a genetic contribution to epilepsy, but it is commonly assumed that this genetic contribution is limited to 'generalized' epilepsies, and that most forms of 'partial' epilepsy are nongenetic. In a linkage analysis of a single family containing 11 affected individuals, we obtained strong evidence for localization of a gene for partial epilepsy. This susceptibility gene maps to chromosome 10q, with a maximum two-point lod score for D10S192 of 3.99 at theta=0.0. All affected individuals share a single haplotype for seven tightly linked contiguous markers; the maximum rod score for this haplotype is 4.83 at theta=0.0. Key recombinants place the susceptibility locus within a 10 centimorgan interval.	COLUMBIA UNIV,SCH PUBL HLTH,DIV EPIDEMIOL,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT NEUROL,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,DEPT EPIDEMIOL BRAIN DISORDERS RES,NEW YORK,NY 10032; STANFORD UNIV,SCH MED,DEPT GENET,STANFORD,CA 94305	Columbia University; Columbia University; New York State Psychiatry Institute; Stanford University	OTTMAN, R (corresponding author), COLUMBIA UNIV,GH SERGIEVSKY CTR,NEW YORK,NY 10032, USA.		Hauser, W Allen/AAB-5277-2020; Lee, Joseph H/D-2441-2012; Ottman, Ruth/O-2371-2013; Renieri, Alessandra/K-5950-2016	Lee, Joseph H/0000-0002-2000-4821; Ottman, Ruth/0000-0001-7074-242X; Bergen, Arthur/0000-0002-6333-9576; Renieri, Alessandra/0000-0002-0846-9220	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020656] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS020656-13, 2RO1-NS20656, R01 NS020656] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1981, EPILEPSIA, V22, P489; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HAUSER WA, 1991, EPILEPSIA, V31, P429; HEIJBEL J, 1975, EPILEPSIA, V16, P285, DOI 10.1111/j.1528-1157.1975.tb06059.x; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LEHESJOKI AE, 1991, P NATL ACAD SCI USA, V88, P3696, DOI 10.1073/pnas.88.9.3696; LEPPERT M, 1989, NATURE, V337, P647, DOI 10.1038/337647a0; LEWIS TB, 1993, AM J HUM GENET, V53, P670; OTTMAN R, 1989, EPILEPSIA, V30, P107, DOI 10.1111/j.1528-1157.1989.tb05290.x; OTTMAN R, 1989, EPILEPSIA, V30, P157, DOI 10.1111/j.1528-1157.1989.tb05448.x; OTTMAN R, 1992, J CLIN EPIDEMIOL, V45, P721, DOI 10.1016/0895-4356(92)90049-S; OTTMAN R, IN PRESS AM J EPIDEM; OTTMAN R, 1990, EPILEPSIA, V31, P611; SCHEFFER IE, 1994, LANCET, V343, P515, DOI 10.1016/S0140-6736(94)91463-X; STEINLEIN O, 1994, GENOMICS, V22, P493, DOI 10.1006/geno.1994.1420; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; WHITEHOUSE WP, 1993, AM J HUM GENET, V53, P652; 1989, EPILEPSIA, V30, P268	25	290	299	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					56	60		10.1038/ng0595-56	http://dx.doi.org/10.1038/ng0595-56			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647791	Green Accepted			2022-12-25	WOS:A1995QX57300016
J	GERHAUSER, C; MAR, W; LEE, SK; SUH, N; LUO, YD; KOSMEDER, J; LUYENGI, L; FONG, HHS; KINGHORN, AD; MORIARTY, RM; MEHTA, RG; CONSTANTINOU, A; MOON, RC; PEZZUTO, JM				GERHAUSER, C; MAR, W; LEE, SK; SUH, N; LUO, YD; KOSMEDER, J; LUYENGI, L; FONG, HHS; KINGHORN, AD; MORIARTY, RM; MEHTA, RG; CONSTANTINOU, A; MOON, RC; PEZZUTO, JM			ROTENOIDS MEDIATE POTENT CANCER CHEMOPREVENTIVE ACTIVITY THROUGH TRANSCRIPTIONAL REGULATION OF ORNITHINE DECARBOXYLASE	NATURE MEDICINE			English	Article							SKIN TUMOR PROMOTION; PROTEIN KINASE-C; MESSENGER-RNA; RAT-BRAIN; INHIBITION; ACTIVATION; EXPRESSION; CELLS; GENE; ACID	For the discovery of new cancer chemopreventive agents, we have studied the potential of plant extracts to inhibit phorbol ester-induced ornithine decarboxylase (ODC) activity in cell culture. Four active rotenoids were obtained from the African plant Mundulea sericea (Leguminosae). These isolates were highly potent when evaluated for inhibition of chemically induced preneoplastic lesions in mammary organ culture and inhibition of papillomas in the two-stage mouse skin model, and they appear to function by a unique mechanism at the level of ODC messenger RNA expression. Based on our findings, rotenoids can be regarded as promising new chemopreventive OF anticancer agents.	UNIV ILLINOIS, COLL PHARM, DEPT MED CHEM & PHARMACOGNOSY, CHICAGO, IL 60612 USA; UNIV ILLINOIS, COLL LIBERAL ARTS & SCI, DEPT CHEM, CHICAGO, IL 60612 USA; UNIV ILLINOIS, COLL MED, DEPT SURG ONCOL, CHICAGO, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital				Kinghorn, A. Douglas/0000-0002-6647-8707; Constantinou, Andreas/0000-0003-0365-1821	NCI NIH HHS [R01 CA48112] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANZEVENO PB, 1979, J ORG CHEM, V44, P2578, DOI 10.1021/jo01328a056; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; Bello-Fernandez C, 1992, Curr Top Microbiol Immunol, V182, P445; Boutwel R. K., 1978, CARCINOGENESIS, V2, P49; BURGOS J, 1965, BIOCHIM BIOPHYS ACTA, V110, P475, DOI 10.1016/S0926-6593(65)80060-1; CHEN IS, 1994, J NAT PROD, V57, P1206, DOI 10.1021/np50111a003; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DASILVA C, 1990, CANCER RES, V50, P2081; DEVRIES DJ, 1988, BIOCHEM PHARMACOL, V37, P4069, DOI 10.1016/0006-2952(88)90097-4; Fukami H, 1971, NATURALLY OCCURRING, P71; KAKAR SS, 1994, CANCER LETT, V87, P85, DOI 10.1016/0304-3835(94)90413-8; KELLOFF GJ, 1994, CANCER EPIDEM BIOMAR, V3, P85; KONOSHIMA T, 1993, J NAT PROD, V56, P843, DOI 10.1021/np50096a006; KROCZEK RA, 1990, ANAL BIOCHEM, V184, P90, DOI 10.1016/0003-2697(90)90017-4; LICHTI U, 1982, J CELL PHYSIOL, V113, P433, DOI 10.1002/jcp.1041130312; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LU YP, 1993, CARCINOGENESIS, V14, P293, DOI 10.1093/carcin/14.2.293; LUYENGI L, 1994, PHYTOCHEMISTRY, V36, P1523, DOI 10.1016/S0031-9422(00)89755-1; MARSHALL LE, 1978, BIOCHIM BIOPHYS ACTA, V543, P590, DOI 10.1016/0304-4165(78)90315-X; MCCANN PP, 1992, PHARMACOL THERAPEUT, V54, P195, DOI 10.1016/0163-7258(92)90032-U; MCCORMICK DL, 1986, CANCER LETT, V31, P133, DOI 10.1016/0304-3835(86)90003-0; MEHTA RG, 1991, ANTICANCER RES, V11, P587; O'Brien RD., 1967, INSECTICIDES ACTION, P159; OBRIEN TG, 1976, CANCER RES, V36, P2644; PEFIA A, 1993, J BIOL CHEM, V268, P27277; PEZZUTO JM, 1993, ACS SYM SER, V534, P205; PEZZUTO JM, IN PRESS RECENT ADV, V29; SPORN MB, 1979, FED PROC, V38, P2528; SZARKA CE, 1994, CURR PROB CANCER, V18, P1; TALALAY P, 1992, CANCER CHEMOPREVENTION, P469; VERMA AK, 1988, CANCER RES, V48, P2168; VERMA AK, 1986, CANCER RES, V46, P6149; WAGNER AJ, 1993, CELL GROWTH DIFFER, V4, P879; WATTENBERG LW, 1985, CANCER RES, V45, P1; WETTERS TV, 1989, NUCLEIC ACIDS RES, V17, P9843, DOI 10.1093/nar/17.23.9843	35	129	132	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	1995	1	3					260	266		10.1038/nm0395-260	http://dx.doi.org/10.1038/nm0395-260			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX559	7585044				2022-12-25	WOS:A1995QX55900034
J	GOLDMAN, MJ; YANG, YP; WILSON, JM				GOLDMAN, MJ; YANG, YP; WILSON, JM			GENE-THERAPY IN A XENOGRAFT MODEL OF CYSTIC-FIBROSIS LUNG CORRECTS CHLORIDE TRANSPORT MORE EFFECTIVELY THAN THE SODIUM DEFECT	NATURE GENETICS			English	Article							HUMAN BRONCHIAL EPITHELIA; INVIVO; CFTR	We have developed a model of gene therapy for cystic fibrosis (CF) lung disease, based on growth of human CF bronchial xenografts in nu/nu mice. We now report an evaluation of the primary abnormalities in CF lung epithelia - defective CI secretion and Na hyperabsorption - in xenografts following adenovirus-mediated gene transfer. In vivo infection of CF xenografts with a cystic fibrosis transmembrane regulator (CFTR) recombinant adenovirus, at a multiplicity of infection equal to 100, was sufficient to reconstitute near normal levels of cAMP-stimulated CI transport, despite transducing only 5% of cells in the pseudostratified epithelium. Correction in sodium hyperabsorption was partial and variable. These experiments define aspects of adenovirus-mediated gene therapy relevant to CF protocols based on intrapulmonary genetic reconstitution.	UNIV PENN,MED CTR,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104; UNIV PENN,MED CTR,DEPT MED,PHILADELPHIA,PA 19104; UNIV PENN,MED CTR,DEPT MOLEC & CELLULAR ENGN,PHILADELPHIA,PA 19104; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; The Wistar Institute			Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131				Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BOUCHER RC, 1994, HUM GENE THER, V5, P615, DOI 10.1089/hum.1994.5.5-615; BOUCHER RC, 1980, J APPL PHYSIOL, V48, P169, DOI 10.1152/jappl.1980.48.1.169; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; CRYSTAL RG, 1994, NAT GENET, V8, P42, DOI 10.1038/ng0994-42; ENGELHARDT JF, 1994, J CLIN INVEST, V93, P737, DOI 10.1172/JCI117028; ENGELHARDT JF, 1992, J CLIN INVEST, V90, P2598, DOI 10.1172/JCI116155; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; GINSBERG HS, 1991, P NATL ACAD SCI USA, V88, P1651, DOI 10.1073/pnas.88.5.1651; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; KOZARSKY KF, 1994, J BIOL CHEM, V269, P13695; OLSEN JC, 1992, HUM GENE THER, V3, P253, DOI 10.1089/hum.1992.3.3-253; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; WELSH MJ, 1987, J CLIN INVEST, V80, P1523, DOI 10.1172/JCI113237; WHITSETT JA, 1994, HUM GENE THERA, V5, P1019; WILLUMSEN NJ, 1991, AM J PHYSIOL, V30, pC332; WILSON JM, 1994, HUM GENE THER, V5, P501, DOI 10.1089/hum.1994.5.4-501; YANG YP, 1994, NAT GENET, V7, P362, DOI 10.1038/ng0794-362; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K	22	74	78	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					126	131		10.1038/ng0295-126	http://dx.doi.org/10.1038/ng0295-126			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719338				2022-12-25	WOS:A1995QE67200012
J	YANG, YP; NUNES, FA; BERENCSI, K; GONCZOL, E; ENGELHARDT, JF; WILSON, JM				YANG, YP; NUNES, FA; BERENCSI, K; GONCZOL, E; ENGELHARDT, JF; WILSON, JM			INACTIVATION OF E2A IN RECOMBINANT ADENOVIRUSES IMPROVES THE PROSPECT FOR GENE-THERAPY IN CYSTIC-FIBROSIS	NATURE GENETICS			English	Article							TYPE-5; PATHOGENESIS; PNEUMONIA; INVIVO; TRANSCRIPTION; TRANSLATION; EPITHELIUM; TRANSPORT; INFECTION	Although first generation recombinant adenoviruses, deleted of sequences spanning E1a and E1b, have been useful for in vivo applications of gene therapy, expression of the recombinant gene has been transient and often associated with the development of inflammation. We show that with first generation adenovirus-mediated gene transfer to the mouse lung, viral proteins are expressed leading to destructive cellular immune responses and repopulation of the lung with nontransgene containing cells. Second generation E1 deleted viruses further crippled by a temperature sensitive mutation in the E2a gene were associated with substantially longer recombinant gene expression and less inflammation. Stable expression of human CF transmembrane conductance regulator has been achieved in lungs of CF mice instilled with a second generation virus.	UNIV PENN,MED CTR,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104; UNIV PENN,MED CTR,DEPT MOLEC & CELLULAR ENGN,PHILADELPHIA,PA 19104; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; The Wistar Institute			Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131; Engelhardt, John/0000-0003-2389-9277	NIDDK NIH HHS [R01 DK047967] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047967] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BABBISS LE, 1984, J VIROL, V50, P202; BABISS LE, 1985, MOL CELL BIOL, V5, P2552, DOI 10.1128/MCB.5.10.2552; BERENCSI K, IN PRESS J GEN VIROL; BROUGH DE, 1993, VIROLOGY, V196, P269, DOI 10.1006/viro.1993.1475; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; DUNCAN SJ, 1978, J GEN VIROL, V40, P45, DOI 10.1099/0022-1317-40-1-45; ENGELHARDT JF, 1993, HUM GENE THER, V4, P759, DOI 10.1089/hum.1993.4.6-759; ENGELHARDT JF, 1993, NAT GENET, V4, P27, DOI 10.1038/ng0593-27; ENGELHARDT JF, IN PRESS P NATN ACAD; ENSINGER MJ, 1972, J VIROL, V10, P328, DOI 10.1128/JVI.10.3.328-339.1972; GAYNOR RB, 1983, CELL, V33, P683, DOI 10.1016/0092-8674(83)90011-9; GINSBERG HS, 1990, P NATL ACAD SCI USA, V87, P6191, DOI 10.1073/pnas.87.16.6191; GINSBERG HS, 1991, P NATL ACAD SCI USA, V88, P1651, DOI 10.1073/pnas.88.5.1651; HORWITZ MS, 1990, VIROLOGY, P01679; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P867, DOI 10.1128/MCB.4.5.867; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; LOGAN J, 1984, P NATL ACAD SCI-BIOL, V81, P3655, DOI 10.1073/pnas.81.12.3655; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; MULLBACHER A, 1989, IMMUNOL CELL BIOL, V67, P31, DOI 10.1038/icb.1989.4; NEVINS JR, 1981, CELL, V26, P213, DOI 10.1016/0092-8674(81)90304-4; PRINCE GA, 1993, J VIROL, V67, P101, DOI 10.1128/JVI.67.1.101-111.1993; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SIMON RH, 1993, HUM GENE THER, V4, P771, DOI 10.1089/hum.1993.4.6-771; SMITH TAG, 1993, NAT GENET, V5, P397, DOI 10.1038/ng1293-397; SNOUWAERT JN, 1992, SCIENCE, V257, P1803; SPERGEL JM, 1992, J VIROL, V66, P1021, DOI 10.1128/JVI.66.2.1021-1030.1992; WILSON JM, 1993, NATURE, V365, P691, DOI 10.1038/365691a0; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; ZABNER J, 1993, CELL, V75, P207, DOI 10.1016/0092-8674(93)80063-K; ZABNER J, 1994, NAT GENET, V6, P75, DOI 10.1038/ng0194-75	31	452	477	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1994	7	3					362	369		10.1038/ng0794-362	http://dx.doi.org/10.1038/ng0794-362			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NU306	7522742				2022-12-25	WOS:A1994NU30600009
J	ROGAEV, EI; ROGAEVA, EA; GINTER, EK; KOROVAITSEVA, GI; FARRER, LA; SHLENSKY, AB; PRITKOV, AN; MORDOVTSEV, VN; STGEORGEHYSLOP, PH				ROGAEV, EI; ROGAEVA, EA; GINTER, EK; KOROVAITSEVA, GI; FARRER, LA; SHLENSKY, AB; PRITKOV, AN; MORDOVTSEV, VN; STGEORGEHYSLOP, PH			IDENTIFICATION OF THE GENETIC-LOCUS FOR KERATOSIS-PALMARIS-ET-PLANTARIS ON CHROMOSOME-17 NEAR THE RARA AND KERATIN TYPE-I GENES	NATURE GENETICS			English	Article							EPIDERMOLYTIC PALMOPLANTAR KERATODERMA; ALZHEIMERS-DISEASE; BULLOSA SIMPLEX; GLYCINE LOOPS; HYPERKERATOSIS; EXPRESSION; MUTATION; LINKAGE; CLUSTER; REGION	Familial keratosis palmaris et plantaris (KPPF) is characterized by extreme keratinization and desquamation of the skin of the palmar and plantar surfaces of the hands and feet. We have mapped the causative genetic defect to an 8 cM interval on 17q12-24 in or close to the acidic keratin (type 1) gene cluster. We show that KPPF co-segregates with a rare, high molecular weight allele of an insertion-deletion polymorphism in the C-terminal coding region of the keratin 10 gene (Z = 8.36 at theta = 0.00) and segregates as a true autosomal dominant trait. Some pedigrees with familial hyperkeratosis of the palms and soles have co-inherited diseases such as congenital malformations and familial cancers. Our analyses provide a region which should be investigated for contiguous gene syndromes in such pedigrees.	ACAD MED SCI MOSCOW,NATL RES CTR MENTAL HLTH,MOLEC BRAUN GENET LAB,MOSCOW 113152,RUSSIA; ACAD MED SCI MOSCOW,NATL RES CTR MED GENET,MOSCOW,RUSSIA; BOSTON UNIV,SCH MED,DEPT EPIDEMIOL,BOSTON,MA 02118; BOSTON UNIV,SCH MED,DEPT BIOSTAT,BOSTON,MA 02118; BOSTON UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02118; CENT DERMATOVENEROL INST,DEPT HEREDITARY SKIN DIS,MOSCOW 107076,RUSSIA	Research Centre for Medical Genetics; Boston University; Boston University; Boston University	ROGAEV, EI (corresponding author), UNIV TORONTO,DEPT MED,TORONTO M5S 1A8,ONTARIO,CANADA.		Korovaitseva, Galina/J-7965-2017; Farrer, Lindsay/AAS-1035-2020; Rogaev, Evgeny/AAN-7662-2020	Korovaitseva, Galina/0000-0001-7653-4242; Farrer, Lindsay/0000-0001-5533-4225				ANDERSON IF, 1961, BMJ-BRIT MED J, V1, P1293, DOI 10.1136/bmj.1.5235.1293; BLANCHETBARDON C, 1987, BRIT J DERMATOL, V117, P363, DOI 10.1111/j.1365-2133.1987.tb04144.x; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; BOWCOCK AM, 1987, AM J HUM GENET, V41, P27; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V18, P24, DOI 10.1016/0010-4809(85)90004-7; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; COMPTON JG, 1992, NAT GENET, V1, P301, DOI 10.1038/ng0792-301; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; ECKERT RL, 1986, CELL, V46, P583, DOI 10.1016/0092-8674(86)90884-6; FAIN PR, 1992, CYTOGENET CELL GENET, V60, P178; FRED ML, 1964, ARCH INTERN MED, V113, P866; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; GINTER EK, 1977, GENETIKA+, V13, P2207; GREITHER A, 1952, Hautarzt, V3, P198; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HALL JM, 1992, NUCLEIC ACIDS RES, V50, P1235; HARPER PS, 1970, Q J MED, V39, P317; HOHN D, 1991, J BIOL CHEM, V226, P6626; KIM IG, 1992, J BIOL CHEM, V267, P7710; KLINTWORTH G K, 1961, S Afr Med J, V35, P170; KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEMONS RS, 1990, GENE CHROMOSOME CANC, V2, P79, DOI 10.1002/gcc.2870020202; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MOLL R, 1982, J CELL BIOL, V95, P285, DOI 10.1083/jcb.95.1.285; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; NIELSEN PG, 1985, CLIN GENET, V28, P361; NOJI S, 1989, FEBS LETT, V259, P86, DOI 10.1016/0014-5793(89)81501-7; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; REIGER M, 1988, J MOL BIOL, V204, P841; REIS A, 1992, HUM GENET, V90, P113; ROMANO V, 1987, CYTOGENET CELL GENET, V46, P683; ROSENBERG M, 1988, MOL CELL BIOL, V8, P722, DOI 10.1128/MCB.8.2.722; ROSENBERG M, 1991, CYTOGENET CELL GENET, V57, P33, DOI 10.1159/000133109; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; STEINERT PM, 1991, INT J BIOL MACROMOL, V13, P130, DOI 10.1016/0141-8130(91)90037-U; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STGEORGEHYSLOP PH, 1987, SCIENCE, V238, P664, DOI 10.1126/science.2890206; VAULA G, 1992, NEUROSCI LETT, V144, P46, DOI 10.1016/0304-3940(92)90712-G; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; 1993, CELL, V72, P971	45	38	40	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1993	5	2					158	162		10.1038/ng1093-158	http://dx.doi.org/10.1038/ng1093-158			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MA056	7504553				2022-12-25	WOS:A1993MA05600013
J	DISTECHE, CM; BRANNAN, CI; LARSEN, A; ADLER, DA; SCHORDERET, DF; GEARING, D; COPELAND, NG; JENKINS, NA; PARK, LS				DISTECHE, CM; BRANNAN, CI; LARSEN, A; ADLER, DA; SCHORDERET, DF; GEARING, D; COPELAND, NG; JENKINS, NA; PARK, LS			THE HUMAN PSEUDOAUTOSOMAL GM-CSF RECEPTOR ALPHA-SUBUNIT GENE IS AUTOSOMAL IN MOUSE	NATURE GENETICS			English	Article							COLONY-STIMULATING FACTOR; HUMAN X-CHROMOSOME; AFFINITY INTERLEUKIN-5 RECEPTOR; Y-CHROMOSOME; EXPRESSION CLONING; 2ND SUBUNIT; INACTIVATION; REGION; PROTEIN; DNA	The gene encoding the granulocyte macrophage colony stimulating factor receptor alpha-subunit (CSF2RA) has previously been mapped to the pseudoautosomal region of the human sex chromosomes. In contrast, we report that the murine locus, Csf2ra, maps to an autosome in the laboratory mouse. By in situ hybridization and genetic mapping, Csf2ra maps at telomeric band D2 of mouse chromosome 19. This first instance of a pseudoautosomal locus in human being autosomal in mouse, indicates incomplete conservation between the human and mouse X chromosomes and suggests that the genetic content of the pseudoautosomal region may differ between species of eutherian mammals due to chromosomal rearrangements.	UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702; IMMUNEX CORP,SEATTLE,WA 98101	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Immunex Corporation	DISTECHE, CM (corresponding author), UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195, USA.							ADLER DA, 1991, P NATL ACAD SCI USA, V88, P4592, DOI 10.1073/pnas.88.11.4592; ASHWORTH A, 1991, NATURE, V351, P406, DOI 10.1038/351406a0; BENOVIC JL, 1991, J BIOL CHEM, V266, P14939; BROWN CJ, 1989, AM J HUM GENET, V45, P592; BROWN WRA, 1990, CELL, V63, P119, DOI 10.1016/0092-8674(90)90293-N; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DAVISSON MT, 1989, LINKAGE MAP GENETIC, P416; DEVOS R, 1991, EMBO J, V10, P2133, DOI 10.1002/j.1460-2075.1991.tb07747.x; DISTECHE CM, 1992, MAMM GENOME, V3, P156, DOI 10.1007/BF00352460; ELLIS N, 1989, TRENDS GENET, V5, P406, DOI 10.1016/0168-9525(89)90199-6; ELLIS N, 1990, CELL, V63, P977, DOI 10.1016/0092-8674(90)90501-5; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; GOODFELLOW P, 1984, AM J HUM GENET, V36, P777; GORMAN DM, 1990, P NATL ACAD SCI USA, V87, P5459, DOI 10.1073/pnas.87.14.5459; GOUGH NM, 1990, NATURE, V345, P734, DOI 10.1038/345734a0; GROMPE M, 1992, GENOMICS, V12, P755, DOI 10.1016/0888-7543(92)90306-D; HARBERS K, 1990, CYTOGENET CELL GENET, V53, P129, DOI 10.1159/000132912; HARBERS K, 1986, NATURE, V324, P682, DOI 10.1038/324682a0; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; JONES J, 1989, GENET RES, V53, P193, DOI 10.1017/S0016672300028160; KAY GF, 1991, NATURE, V354, P486, DOI 10.1038/354486a0; KEITGES E, 1986, AM J HUM GENET, V39, P470; KEITGES E, 1985, NATURE, V315, P226, DOI 10.1038/315226a0; KITAMURA T, 1991, CELL, V66, P1165, DOI 10.1016/0092-8674(91)90039-2; KITAMURA T, 1991, P NATL ACAD SCI USA, V88, P5082, DOI 10.1073/pnas.88.12.5082; KOOPMAN P, 1989, NATURE, V342, P940, DOI 10.1038/342940a0; LYON MF, 1988, AM J HUM GENET, V42, P8; MARDON G, 1989, CELL, V56, P765, DOI 10.1016/0092-8674(89)90680-6; MITCHELL MJ, 1991, NATURE, V354, P483, DOI 10.1038/354483a0; OHNO S, 1967, SEX CHROMOSOMES SEX, P140; PALMER MS, 1990, P NATL ACAD SCI USA, V87, P1681, DOI 10.1073/pnas.87.5.1681; PARK LS, IN PRESS P NATN ACAD; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SPENCER JA, 1991, GENOMICS, V9, P598, DOI 10.1016/0888-7543(91)90352-F; SPENCER JA, 1991, GENOMICS, V11, P339, DOI 10.1016/0888-7543(91)90141-Z; TAKAKI S, 1991, EMBO J, V10, P2833, DOI 10.1002/j.1460-2075.1991.tb07832.x; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6; TEDDER TF, 1988, J IMMUNOL, V141, P4388; TUCKER PK, 1992, MAMM GENOME, V3, P28, DOI 10.1007/BF00355838; WATSON JM, 1991, P NATL ACAD SCI USA, V88, P11256, DOI 10.1073/pnas.88.24.11256; ZINN AR, 1991, GENOMICS, V11, P1097, DOI 10.1016/0888-7543(91)90037-F	45	69	69	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1992	1	5					333	336		10.1038/ng0892-333	http://dx.doi.org/10.1038/ng0892-333			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	1363815				2022-12-25	WOS:A1992JJ12100009
J	GARTNER, J; MOSER, H; VALLE, D				GARTNER, J; MOSER, H; VALLE, D			MUTATIONS IN THE 70K PEROXISOMAL MEMBRANE-PROTEIN GENE IN ZELLWEGER SYNDROME	NATURE GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISMS; POLYMERASE CHAIN-REACTION; BETA-OXIDATION ENZYMES; CYSTIC-FIBROSIS GENE; COMPLEMENTATION ANALYSIS; GEL-ELECTROPHORESIS; PRENATAL-DIAGNOSIS; SPLICING MUTATION; MOLECULAR-BASIS; HUMAN DNA	The peroxisomal membrane protein, with a relative molecular mass of 70,000 (M(r)70K) (PMP70), is an important component of peroxisomal membranes and an ATP-binding cassette protein. To investigate its possible involvement in Zellweger syndrome (ZS), an inborn error of peroxisome assembly, we cloned and sequenced cDNAs for human PMP70 and mapped the gene to chromosome 1. Amongst 32 probands with ZS or related disorders, we found two mutant PMP70 alleles in single ZS probands from the same complementation group. One allele has a donor splice site mutation and the second a missense mutation. Our results suggest that PMP70 plays an important role in peroxisome biogenesis and that mutations in PMP70 may be responsible for a subset of ZS patients.	KENNEDY KRIEGER INST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205	Kennedy Krieger Institute; Howard Hughes Medical Institute; Johns Hopkins University	GARTNER, J (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205, USA.							ATTAYA M, 1992, NATURE, V355, P646; BORST P, 1986, BIOCHIM BIOPHYS ACTA, V866, P179, DOI 10.1016/0167-4781(86)90044-8; BOTTO M, 1990, J CLIN INVEST, V86, P1158, DOI 10.1172/JCI114821; BRUL S, 1988, J CLIN INVEST, V81, P1710, DOI 10.1172/JCI113510; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; FOJO SS, 1988, J CLIN INVEST, V82, P1489, DOI 10.1172/JCI113756; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GARTNER J, 1991, PEDIATR RES, V29, P141; GOLDFISCHER S, 1973, SCIENCE, V182, P62, DOI 10.1126/science.182.4107.62; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; GRANDCHAMP B, 1989, P NATL ACAD SCI USA, V86, P661, DOI 10.1073/pnas.86.2.661; HIGGINS C, 1989, NATURE, V340, P342, DOI 10.1038/340342a0; HIGGINS CF, 1988, BIOESSAYS, V8, P111, DOI 10.1002/bies.950080406; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; IMANAKA T, 1987, J CELL BIOL, V105, P2915, DOI 10.1083/jcb.105.6.2915; KAFATOS FC, 1979, NUCLEIC ACIDS RES, V7, P1541, DOI 10.1093/nar/7.6.1541; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KAZAZIAN HH, 1990, SEMIN HEMATOL, V27, P209; KELLEY RI, 1983, AM J MED GENET, V16, P503, DOI 10.1002/ajmg.1320160409; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; Lazarow P. B., 1989, METABOLIC BASIS INHE, P1479; LAZAROW PB, 1985, PEDIATR RES, V19, P1356, DOI 10.1203/00006450-198512000-00030; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; MCGUINNESS MC, 1990, BIOCHEM BIOPH RES CO, V172, P364, DOI 10.1016/S0006-291X(05)80218-9; MICHAUD J, IN PRESS GENOMICS; MITCHELL GA, 1988, J BIOL CHEM, V263, P14288; MITCHELL GA, 1991, P NATL ACAD SCI USA, V88, P815, DOI 10.1073/pnas.88.3.815; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORKIN SH, 1983, J CLIN INVEST, V71, P775, DOI 10.1172/JCI110826; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSCHER AA, 1989, PEDIATR RES, V26, P67, DOI 10.1203/00006450-198907000-00019; SANTOS MJ, 1988, J BIOL CHEM, V263, P10502; SCHRAM AW, 1986, P NATL ACAD SCI USA, V83, P6156, DOI 10.1073/pnas.83.16.6156; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SPIES T, 1992, NATURE, V355, P644, DOI 10.1038/355644a0; SUZUKI Y, 1986, CLIN CHIM ACTA, V156, P191, DOI 10.1016/0009-8981(86)90152-X; SUZUKI Y, 1987, J BIOCHEM-TOKYO, V101, P491, DOI 10.1093/oxfordjournals.jbchem.a121935; TREISMAN R, 1982, CELL, V29, P903, DOI 10.1016/0092-8674(82)90452-4; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4636, DOI 10.1093/nar/18.15.4636-a; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4038, DOI 10.1093/nar/18.13.4038; WEINSTEIN LS, 1990, P NATL ACAD SCI USA, V87, P8287, DOI 10.1073/pnas.87.21.8287; WIEMER EAC, 1989, EUR J CELL BIOL, V50, P407	57	213	214	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1992	1	1					16	23		10.1038/ng0492-16	http://dx.doi.org/10.1038/ng0492-16			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1301993				2022-12-25	WOS:A1992JC97800006
J	BACHARLUSTIG, E; RACHAMIM, N; LI, HW; LAN, FS; REISNER, Y				BACHARLUSTIG, E; RACHAMIM, N; LI, HW; LAN, FS; REISNER, Y			MEGADOSE OF T-CELL-DEPLETED BONE-MARROW OVERCOMES MHC BARRIERS IN SUBLETHALLY IRRADIATED MICE	NATURE MEDICINE			English	Article							CLASSICAL TRANSPLANTATION TOLERANCE; LYMPHOID RADIATION CHIMERAS; ALLOGRAFT TOLERANCE; GRAFT-REJECTION; HOST DISEASE; SPLEEN-CELLS; ADULT MICE; VETO CELLS; NUDE-MICE; ENGRAFTMENT	Graft-versus-host disease (GVHD) is uniformly lethal in recipients of HLA-mismatched marrow. In patients with severe combined immunodeficiency disease, this major obstacle can be overcome by rigorous T-cell depletion before transplantation. In leukaemia patients, however, the benefit of preventing GVHD is offset by graft rejection or graft failure, Very recently, this problem was overcome by supplementing T cell-depleted bone marrow transplants with megadoses of peripheral blood stem cells collected by leukapheresis after mobilization of the donor stem cells with granulocyte colony-stimulating factor (G-CSF). In the present study, we further demonstrate in a mouse model (C57BL/6-->C3H/HeJ) that escalation of bone marrow doses by four- to fivefold leads to full donor-type chimerism in sublethally irradiated (6.5 Gy) recipients. Thus, the new source of G-CSF mobilized human haematopoietic stem cells may enable extending the use of mismatched bone marrow transplants to patients with non-malignant diseases for whom supralethal conditioning is not a prerequisite.			BACHARLUSTIG, E (corresponding author), WEIZMANN INST SCI,DEPT MEMBRANE RES & BIOPHYS,IL-76100 REHOVOT,ISRAEL.		Reisner, Yair/AAA-4772-2019	Reisner, Yair/0000-0002-3354-6945				AVERSA F, 1994, BLOOD, V84, P3948, DOI 10.1182/blood.V84.11.3948.bloodjournal84113948; COBBOLD SP, 1986, NATURE, V323, P164, DOI 10.1038/323164a0; FAKTOROWICH Y, 1993, BONE MARROW TRANSPL, V12, P15; FERRARA J, 1987, TRANSPLANTATION, V43, P461, DOI 10.1097/00007890-198704000-00001; GALE RP, 1986, LANCET, V1, P1468; GENGOZIAN N, 1969, TRANSPLANTATION, V7, P259, DOI 10.1097/00007890-196904000-00004; GIANNI AM, 1989, LANCET, V2, P580; KAUFMAN CL, 1994, BLOOD, V84, P2436; KIKUYA S, 1988, P NATL ACAD SCI USA, V85, P4824; KIYOSHI H, 1992, J EXP MED, V175, P863; LAPIDOT T, 1990, P NATL ACAD SCI USA, V87, P4595, DOI 10.1073/pnas.87.12.4595; LAPIDOT T, 1989, BLOOD, V73, P2025; LAPIDOT T, 1987, BLOOD, V70, pA309; LEONG LYW, 1992, EUR J IMMUNOL, V22, P2825, DOI 10.1002/eji.1830221111; MARTIN PJ, 1993, J EXP MED, V178, P703, DOI 10.1084/jem.178.2.703; MAYUMI H, 1989, J EXP MED, V169, P213, DOI 10.1084/jem.169.1.213; NAVARRO J, 1989, TRANSPLANTATION, V47, P871, DOI 10.1097/00007890-198905000-00024; PIERCE GE, 1993, TRANSPLANTATION, V55, P882, DOI 10.1097/00007890-199304000-00037; PIERCE GE, 1993, TRANSPLANT P, V25, P331; PIERCE GE, 1985, TRANSPLANTATION, V40, P702, DOI 10.1097/00007890-198512000-00026; QIN SX, 1989, J EXP MED, V169, P779, DOI 10.1084/jem.169.3.779; RAMSDELL F, 1992, SCIENCE, V257, P1130, DOI 10.1126/science.257.5073.1130; REISNER Y, 1983, BLOOD, V61, P341; REISNER Y, 1978, P NATL ACAD SCI USA, V75, P2933, DOI 10.1073/pnas.75.6.2933; ROCHA B, 1993, J EXP MED, V177, P1517, DOI 10.1084/jem.177.5.1517; RYSER JE, 1979, J IMMUNOL, V122, P1691; SCHWARTZ E, 1987, J IMMUNOL, V138, P460; SHARABI Y, 1989, J EXP MED, V169, P493, DOI 10.1084/jem.169.2.493; SLAVIN S, 1977, J EXP MED, V146, P34, DOI 10.1084/jem.146.1.34; SODERLING CCB, 1985, J IMMUNOL, V135, P941; STROBER S, 1987, J IMMUNOL, V138, P699; SYKES M, 1988, J IMMUNOL, V141, P2282; TSCHERNING T, 1991, IMMUNOL LETT, V29, P223, DOI 10.1016/0165-2478(91)90174-9; UHAREK L, 1992, BLOOD, V79, P1612; VRIESENDORP HM, 1985, BONE MARROW TRANSPL, P73	35	268	283	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1268	1273		10.1038/nm1295-1268	http://dx.doi.org/10.1038/nm1295-1268			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489407				2022-12-25	WOS:A1995TH78600038
J	BOSHOFF, C; SCHULZ, TF; KENNEDY, MM; GRAHAM, AK; FISHER, C; THOMAS, A; MCGEE, JO; WEISS, RA; OLEARY, JJ				BOSHOFF, C; SCHULZ, TF; KENNEDY, MM; GRAHAM, AK; FISHER, C; THOMAS, A; MCGEE, JO; WEISS, RA; OLEARY, JJ			KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS INFECTS ENDOTHELIAL AND SPINDLE CELLS	NATURE MEDICINE			English	Article							CULTURE; GROWTH	Kaposi's sarcoma (KS), a vascular tumour that contains characteristic spindle cells forming slit-like spaces, may have an infectious aetiology. Recently, sequences of a new human herpesvirus, KSHV/HHV-8, have been identified in both HIV-associated and classical KS. We sought to identify the target cell of this virus in KS tumour tissue. Using PCR in situ hybridization (PCR-ISH) we show that KSHV/HHV-8 is present in the flat endothelial cells lining vascular spaces of KS lesions as well as in typical KS spindle cells. These findings show that KSHV/HHV-8 is present in the cell types thought to represent neoplastic cells in these lesions.	ROYAL MARSDEN HOSP,INST CANC RES,VIROL LAB,LONDON SW3 3BJ,ENGLAND; ROYAL MARSDEN HOSP,DEPT HISTOPATHOL,LONDON SW3 6BJ,ENGLAND; JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL & BACTERIOL,OXFORD OX3 9DU,ENGLAND; LONDON SCH HYG & TROP MED,LONDON WC1,ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of Oxford; University of London; London School of Hygiene & Tropical Medicine			Schulz, Thomas/AAA-1634-2019	Schulz, Thomas/0000-0001-8792-5345				AMBROZIAK JA, 1995, SCIENCE, V268, P582, DOI 10.1126/science.7725108; BAYLEY AC, 1991, CANCER SURV, V10, P53; BERAL V, 1991, CANCER SURV, V10, P5; BOSHOFF C, 1995, LANCET, V345, P1043; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; CHANG Y, IN PRESS ARCH INTERN; COCKERELL CJ, 1991, CANCER SURV, V10, P73; COHEN J, 1995, SCIENCE, V268, P1847, DOI 10.1126/science.7604255; CORBEIL J, 1991, J IMMUNOL, V146, P2972; DUPIN N, 1995, LANCET, V345, P761, DOI 10.1016/S0140-6736(95)90642-8; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1989, SCIENCE, V243, P223, DOI 10.1126/science.2643161; HERNDIER BG, 1994, AIDS, V8, P575, DOI 10.1097/00002030-199405000-00002; HERRINGTON CS, 1991, J CLIN PATHOL, V44, P33, DOI 10.1136/jcp.44.1.33; HUANG YQ, 1995, LANCET, V345, P759, DOI 10.1016/S0140-6736(95)90641-X; IOCHIM HL, 1995, CANCER, V75, P1376; LEBBE C, 1995, LANCET, V345, P1180, DOI 10.1016/S0140-6736(95)91011-5; LUNARDIISKANDAR Y, 1995, NATURE, V375, P64, DOI 10.1038/375064a0; MILES SA, 1990, P NATL ACAD SCI USA, V87, P4068, DOI 10.1073/pnas.87.11.4068; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Nuovo J, 1994, PCR IN SITU HYBRIDIZ, V2nd; OLEARY JJ, IN PRESS J PATH; RABKIN CS, 1995, CLIN CANCER RES, V1, P257; RADY PL, 1995, LANCET, V345, P1339, DOI 10.1016/S0140-6736(95)92538-4; REDI GC, 1995, NATURE MED, V1, P65; ROTH WK, 1989, ONCOGENE, V4, P483; RUSZCZAK Z, 1987, DERMATOLOGICA, V175, P270, DOI 10.1159/000248833; SALAHUDDIN SZ, 1988, SCIENCE, V242, P430, DOI 10.1126/science.2459779; SCHALLING M, 1995, NAT MED, V1, P707, DOI 10.1038/nm0795-707; SCHULZ TF, 1995, NATURE, V373, P17, DOI 10.1038/373017a0; SCIACCA FL, 1994, J IMMUNOL, V153, P4816; SLAVIN G, 1969, BRIT J CANCER, V23, P349, DOI 10.1038/bjc.1969.45; STURZL M, 1992, P NATL ACAD SCI USA, V85, P7046; WALTER PR, 1984, HUM PATHOL, V15, P1145, DOI 10.1016/S0046-8177(84)80309-3; WHITBY D, IN PRESS LANCET	35	599	612	1	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1274	1278		10.1038/nm1295-1274	http://dx.doi.org/10.1038/nm1295-1274			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489408				2022-12-25	WOS:A1995TH78600039
J	REISS, AL; FREUND, LS; BAUMGARDNER, TL; ABRAMS, MT; DENCKLA, MB				REISS, AL; FREUND, LS; BAUMGARDNER, TL; ABRAMS, MT; DENCKLA, MB			CONTRIBUTION OF THE FMR1 GENE MUTATION TO HUMAN INTELLECTUAL DYSFUNCTION	NATURE GENETICS			English	Letter							FRAGILE-X-SYNDROME; MARTIN-BELL SYNDROME; FEMALE CARRIERS; CGG REPEAT; METHYLATION; EXPRESSION; PHENOTYPE; CELLS	The degree to which genetic factors influence human intelligence remains a matter of some controversy. However, there is little doubt that single gene mutations can significantly alter brain development and function. For example, mutations affecting the FMR1 gene cause the fragile X syndrome, the most prevalent known inherited cause of intellectual dysfunction. The most common mutation occurring in the FMR1 locus involves expansion of a trinucleotide (CGG), repeat sequence within the promoter region of the gene(1). Between 6 and 54 repeats are typically observed in individuals from the general population(2). When greater than or equal to 200 CGG repeats are present, the expanded repeat sequence and an adjacent CpG island are usually hypermethylated, a phenomenon associated with transcriptional silencing of the gene and commonly referred to as the FMR1 full mutation(3-5). The intermediate range of repeats (approximately 50 to 200 CGGs), referred to as the premutation, is characterized by the absence of hypermethylation within the promoter region and normal phenotype(6,7). Some individuals have a combination of a methylated and unmethylated alleles of differing size and are referred to as having mosaic status. Most males with the FMR1 full mutation function in the mentally retarded range of intelligence; in contrast, females with the FMR1 full mutation show a broader range of intelligence, from mental retardation to normal IQ(8). The wider spectrum of cognitive functioning in females with the full mutation is likely to be due, in part, to variation in cellular X chromosome inactivation patterns and consequent FMR1 protein (FMRP) production in the brain. Despite differences in severity of intellectual dysfunction, both males and females with the FMR1 full mutation manifest a similar cognitive profile with weakness in the visual-spatial and attentional-organizational domains and relatively preserved verbal abilities(9,10). Here, we show that the variance in child IQ predicted by mean parental IQ is decreased in 29 girls with the FMR1 full mutation compared to a non-fragile X group of 50 girls of similar age. We also show that activation status of the FMR1 gene, but not repeat size, is strongly correlated with intellectual function in girls with the full mutation, particularly for cognitive measures which distinguish fragile X from non-fragile X groups. These data indicate that FMR1 activation status is directly associated with the severity of intellectual dysfunction in girls with the fragile X syndrome.	JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,DIV CHILD PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	REISS, AL (corresponding author), KENNEDY KRIEGER INST,707 N BROADWAY,BALTIMORE,MD 21205, USA.		Freund, Lisa/ABD-8855-2020	Freund, Lisa/0000-0003-2095-4023	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD025806] Funding Source: NIH RePORTER; NICHD NIH HHS [HD2406, HD25806] Funding Source: Medline; NIMH NIH HHS [MH01142] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAMS MT, 1994, AM J MED GENET, V51, P317, DOI 10.1002/ajmg.1320510407; DANIELS JK, 1994, INTELLIGENCE, V19, P45, DOI 10.1016/0160-2896(94)90052-3; FREUND LS, IN PRESS DEV NEUROPS; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Hagerman R, 1991, FRAGILE X SYNDROME D, P3; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; KEMPER MB, 1986, AM J MED GENET, V23, P139, DOI 10.1002/ajmg.1320230109; LOESCH DZ, 1993, AM J HUM GENET, V53, P1064; MAZZOCCO MMM, 1993, J DEV BEHAV PEDIATR, V14, P328; MCCONKIEROSELL A, 1993, AM J HUM GENET, V53, P800; MIEZEJESKI CM, 1986, NEUROPSYCHOLOGIA, V24, P405, DOI 10.1016/0028-3932(86)90026-6; PAI JT, 1994, HUM GENET, V93, P488; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; PLOMIN R, 1990, BEHAVIORAL GENETICS; REISS AL, 1993, AM J HUM GENET, V52, P884; REISS AL, 1995, NAT MED, V1, P159, DOI 10.1038/nm0295-159; ROCHICCIOLI P, 1994, ACTA PAEDIATR, V83, P305, DOI 10.1111/j.1651-2227.1994.tb18099.x; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; ROUSSEAU F, 1994, AM J HUM GENET, V55, P225; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SATTLER JM, 1988, ASSESSMENT CHILDRENS; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037/0022-006X.50.3.415; Taylor A. K., 1994, American Journal of Human Genetics, V55, pA18; TAYLOR AK, 1994, JAMA-J AM MED ASSOC, V271, P507, DOI 10.1001/jama.271.7.507; TUCKERMAN E, 1989, CLIN GENET, V36, P25; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBB T, 1990, J MED GENET, V27, P627, DOI 10.1136/jmg.27.10.627; Wechsler D, 1974, WECHSLER ADULT INTEL; WOHRLE D, 1993, NAT GENET, V4, P140, DOI 10.1038/ng0693-140	29	113	113	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					331	334		10.1038/ng1195-331	http://dx.doi.org/10.1038/ng1195-331			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581460				2022-12-25	WOS:A1995TC63900025
J	SCHWAB, SG; ALBUS, M; HALLMAYER, J; HONIG, S; BORRMANN, M; LICHTERMANN, D; EBSTEIN, RP; ACKENHEIL, M; LERER, B; RISCH, N; MAIER, W; WILDENAUER, DB				SCHWAB, SG; ALBUS, M; HALLMAYER, J; HONIG, S; BORRMANN, M; LICHTERMANN, D; EBSTEIN, RP; ACKENHEIL, M; LERER, B; RISCH, N; MAIER, W; WILDENAUER, DB			EVALUATION OF A SUSCEPTIBILITY GENE FOR SCHIZOPHRENIA ON CHROMOSOME 6P BY MULTIPOINT AFFECTED SIB-PAIR LINKAGE ANALYSIS	NATURE GENETICS			English	Letter							DISORDERS	The influence of genetic factors in schizophrenia has been convincingly demonstrated by family, twin and adoption studies(1-3), but the mode of transmission remains uncertain. The reported pattern of recurrence risks suggests a set of interacting loci(4). Based on prior evidence for linkage on chromosome 6p (K. Kendler, pers. comm.), we have scanned the short arm of chromosome 6 in 54 families for loci predisposing to schizophrenia, using 25 microsatellite markers spanning 60 centiMorgans (cM). Allele sharing identity by descent was examined in affected sib-pairs from these families, followed by multipoint sib-pair linkage analysis. Positive lod scores were obtained over a wide region (D6S470 to D6S271), with a maximum lod score of 2.2 occuring near D6S274, located in 6p22. However, we obtained a lod score of -2 at D6S296, the locus found by others to provide the greatest linkage evidence(5). At D6S274, we report a positive lod score as do Straub et al.(5) (individually non-significant). A combined total lod of 3.6-4.0 suggests the possibility of a susceptibility locus in this region. However, methodological differences between our studies makes a firm conclusion difficult.	UNIV MUNICH,HOSP PSYCHIAT,NEUROCHEM UNIT,D-80336 MUNICH,GERMANY; STATE MENTAL HOSP,D-85529 HAAR,GERMANY; STANFORD UNIV,DEPT GENET,STANFORD,CA 94305; UNIV MAINZ,HOSP PSYCHIAT,D-55131 MAINZ,GERMANY; SARAH HERZOG HOSP,JERUSALEM,ISRAEL; HEBREW UNIV JERUSALEM,HADASSAH MED CTR,JERUSALEM,ISRAEL	University of Munich; Stanford University; Johannes Gutenberg University of Mainz; Hebrew University of Jerusalem; Herzog Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center				Ebstein, Richard/0000-0002-3626-541X	NHGRI NIH HHS [HG00348] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000348] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BERTELSEN A, 1985, ACTA PSYCHIAT SCAND, V71, P61, DOI 10.1111/j.1600-0447.1985.tb08523.x; GOTTESMAN II, 1989, ARCH GEN PSYCHIAT, V46, P867; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; KENDLER KS, 1988, ARCH GEN PSYCHIAT, V45, P377; KNAPP M, 1994, HUM HERED, V44, P37, DOI 10.1159/000154187; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MACAUBAS C, 1995, HUM IMMUNOL, V42, P209, DOI 10.1016/0198-8859(94)00101-U; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; PENROSE LS, 1953, ANN EUGENIC, V18, P120; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4306, DOI 10.1093/nar/19.15.4306-a; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1993, AM J HUM GENET, V53, pA185; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41	16	237	244	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					325	327		10.1038/ng1195-325	http://dx.doi.org/10.1038/ng1195-325			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581458				2022-12-25	WOS:A1995TC63900023
J	JACOBSON, SG; CIDECIYAN, AV; REGUNATH, G; RODRIGUEZ, FJ; VANDENBURGH, K; SHEFFIELD, VC; STONE, EM				JACOBSON, SG; CIDECIYAN, AV; REGUNATH, G; RODRIGUEZ, FJ; VANDENBURGH, K; SHEFFIELD, VC; STONE, EM			NIGHT BLINDNESS IN SORSBYS-FUNDUS-DYSTROPHY REVERSED BY VITAMIN-A	NATURE GENETICS			English	Article							RETINITIS-PIGMENTOSA; RHODOPSIN LEVELS; A-DEFICIENCY; MACULAR DYSTROPHY; RETINAL FUNCTION; RECOVERY	Sorsby's fundus dystrophy (SFD) is an autosomal dominant retinal degeneration caused by mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) gene, Mechanisms of the visual loss in SFD, however, remain unknown. In a SFD family with a novel TIMP3 point mutation, we tested a hypothesis that their night blindness is due to a chronic deprivation of vitamin A at the level of the photoreceptors caused by a thickened membrane barrier between the photoreceptor layer and its blood supply. Vitamin A at 50,000 IU/d was administered orally. Within a week, the night blindness disappeared in patients at early stages of disease. Nutritional night blindness is thus part of the pathophysiology of this genetic disease and vitamin A supplementation can lead to dramatic restoration of photoreceptor function.	UNIV MIAMI,SCH MED,BASCOM PALMER EYE INST,DEPT OPHTHALMOL,MIAMI,FL 33136; UNIV IOWA HOSP & CLIN,DEPT OPHTHALMOL,IOWA CITY,IA 52242; UNIV IOWA HOSP & CLIN,DEPT PEDIAT,IOWA CITY,IA 52242	Bascom Palmer Eye Institute; University of Miami; University of Iowa; University of Iowa			Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Jacobson, Samuel/0000-0003-2122-169X; Stone, Edwin M./0000-0003-3343-4414	NATIONAL EYE INSTITUTE [R01EY010539, R01EY010564] Funding Source: NIH RePORTER; NEI NIH HHS [EY10564, EY05627, EY10539] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BENDICH A, 1989, AM J CLIN NUTR, V49, P358, DOI 10.1093/ajcn/49.2.358; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; CAPON MRC, 1988, EYE, V2, P114, DOI 10.1038/eye.1988.23; CAPON MRC, 1989, OPHTHALMOLOGY, V96, P1760; DOWLING JE, 1958, P NATL ACAD SCI USA, V44, P648, DOI 10.1073/pnas.44.7.648; FRENCH J, 1971, MATH STATISTICS; GOURAS P, 1971, INVEST OPHTH VISUAL, V10, P784; HAMILTON WK, 1989, OPHTHALMOLOGY, V96, P1755; HOOD DC, 1994, INVEST OPHTH VIS SCI, V35, P2477; HOSKIN A, 1981, BRIT J OPHTHALMOL, V65, P859, DOI 10.1136/bjo.65.12.859; JACOBSON SG, 1991, AM J OPHTHALMOL, V112, P256, DOI 10.1016/S0002-9394(14)76726-1; JACOBSON SG, 1994, INVEST OPHTH VIS SCI, V35, P2521; JACOBSON SG, 1991, HDB CLIN VISION TEST, P475; KATZ ML, 1993, EXP EYE RES, V56, P671, DOI 10.1006/exer.1993.1084; KEMP CM, 1994, INVEST OPHTH VIS SCI, V35, P3154; KEMP CM, 1988, EXP EYE RES, V46, P185, DOI 10.1016/S0014-4835(88)80076-9; KEMP CM, 1989, EXP EYE RES, V49, P49; NICHOLS BE, 1994, AM J HUM GENET, V54, P95; POLKINGHORNE PJ, 1989, OPHTHALMOLOGY, V96, P1763; PULIDO JS, 1990, EYE SYSTEMIC DISEASE, P344; SAARI JC, 1990, PROGR RETINAL RES, P368; SANDBERG MA, 1977, AM J OPHTHALMOL, V84, P658, DOI 10.1016/0002-9394(77)90381-6; SEARLE SR, 1992, VARIANCE COMPONENTS, P78; SORSBY A, 1949, BRIT J OPHTHALMOL, V33, P67, DOI 10.1136/bjo.33.2.67; STEINMETZ RL, 1993, BRIT J OPHTHALMOL, V77, P549, DOI 10.1136/bjo.77.9.549; STEINMETZ RL, 1995, INVEST OPHTH VIS SCI, V33, P633; WALT RP, 1984, BRIT MED J, V288, P1030, DOI 10.1136/bmj.288.6423.1030; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WU G, 1991, AM J OPHTHALMOL, V111, P294, DOI 10.1016/S0002-9394(14)72312-8	30	147	156	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					27	32		10.1038/ng0995-27	http://dx.doi.org/10.1038/ng0995-27			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550309				2022-12-25	WOS:A1995RR72800011
J	ENRIQUEZ, JA; CHOMYN, A; ATTARDI, G				ENRIQUEZ, JA; CHOMYN, A; ATTARDI, G			MTDNA MUTATION IN MERRF-SYNDROME CAUSES DEFECTIVE AMINOACYLATION OF TRNA(LYS) AND PREMATURE TRANSLATION TERMINATION	NATURE GENETICS			English	Article							MITOCHONDRIAL-DNA; HELA-CELLS; MYOCLONIC EPILEPSY; RNALYS MUTATION; TRANSFER-RNAS; DISEASE; EXPRESSION; INVIVO	We have investigated the pathogenetic mechanism of the mitochondrial tRNA(Lys) gene mutation (position 8344) associated with MERRF encephalomyopathy in several mitochondrial DNA (mtDNA)-less cell transformants carrying the mutation and in control cells. A decrease of 50-60% in the specific tRNA(Lys) aminoacylation capacity per cell was found in mutant cells. Furthermore, several lines of evidence reveal that the severe protein synthesis impairment in MERRF mutation-carrying cells is due to premature termination of translation at each or near each lysine codon, with the deficiency of aminoacylated tRNA(Lys) being the most likely cause of this phenomenon.	CALTECH,DIV BIOL,PASADENA,CA 91125	California Institute of Technology			Enríquez, J.A./M-8468-2016	Enríquez, J.A./0000-0002-3671-2961	NIGMS NIH HHS [GM-11726] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMALDI F, 1968, J MOL BIOL, V33, P737, DOI 10.1016/0022-2836(68)90317-3; ANDERSON S, 1981, NATURE, V290, P427; ATTARDI B, 1969, J MOL BIOL, V44, P47, DOI 10.1016/0022-2836(69)90404-5; ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; ATTARDI G, 1985, ACHIEVEMENTS PERSPEC, V2, P145; ATTARDI G, 1971, NATURE-NEW BIOL, V228, P133; BOULET L, 1992, AM J HUM GENET, V51, P1187; CHOMYN A, 1991, MOL CELL BIOL, V11, P2236, DOI 10.1128/MCB.11.4.2236; CHOMYN A, P NATL ACAD SCI USA, V89, P4221; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAINES G, 1984, MOL CELL BIOL, V4, P1605, DOI 10.1128/MCB.4.8.1605; GIEGE R, 1993, PROG NUCLEIC ACID RE, V45, P129, DOI 10.1016/S0079-6603(08)60869-7; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; KING MP, 1993, J BIOL CHEM, V268, P10228; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; KURLAND CG, 1986, ACCURACY MOL PROCESS, P127; LYNCH DC, 1976, J MOL BIOL, V102, P125, DOI 10.1016/0022-2836(76)90077-2; MARIOTTINI P, 1986, P NATL ACAD SCI USA, V83, P1563, DOI 10.1073/pnas.83.6.1563; NIERHAUS KH, 1993, TRANSLATION APPARATU; NORMANLY J, 1989, ANNU REV BIOCHEM, V58, P1029, DOI 10.1146/annurev.bi.58.070189.005121; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OJALA D, 1972, J MOL BIOL, V65, P273, DOI 10.1016/0022-2836(72)90282-3; SAKS ME, 1994, SCIENCE, V263, P191, DOI 10.1126/science.7506844; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; YONEDA M, 1994, MOL CELL BIOL, V14, P2699, DOI 10.1128/MCB.14.4.2699	31	250	254	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					47	55		10.1038/ng0595-47	http://dx.doi.org/10.1038/ng0595-47			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647790				2022-12-25	WOS:A1995QX57300015
J	TROTTIER, Y; DEVYS, D; IMBERT, G; SAUDOU, F; AN, I; LUTZ, Y; WEBER, C; AGID, Y; HIRSCH, EC; MANDEL, JL				TROTTIER, Y; DEVYS, D; IMBERT, G; SAUDOU, F; AN, I; LUTZ, Y; WEBER, C; AGID, Y; HIRSCH, EC; MANDEL, JL			CELLULAR-LOCALIZATION OF THE HUNTINGTONS-DISEASE PROTEIN AND DISCRIMINATION OF THE NORMAL AND MUTATED FORM	NATURE GENETICS			English	Article							TRINUCLEOTIDE CAG REPEAT; GENE; NEURONS; EXPRESSION; EXPANSION; MECHANISM; TISSUES; LENGTH	Huntington's disease (HD) results from the expansion of a polyglutamine encoding CAG repeat in a gene of unknown function. The wide expression of this transcript does not correlate with the pattern of neuropathology in HD. To study the HD gene product (huntingtin), we have developed monoclonal antibodies raised against four different regions of the protein. On western blots, these monoclonals detect the similar to 350 kD huntingtin protein in various human cell lines and in neural and non-neural rodent tissues. In cell lines from HD patients, a doublet protein is detected corresponding to the mutated and normal huntingtin. Immunohistochemical studies in the human brain using two of these antibodies detects the huntingtin in perikarya of some neurons, neuropiles, varicosities and as punctate staining likely to be nerve endings.	UNIV STRASBOURG 1,INST GENET & BIOL MOLEC & CELLULAIRE,CNRS,INSERM,F-67404 ILLKIRCH GRAFFENS,FRANCE; CTR UNIV STRASBOURG,STRASBOURG,FRANCE; HOP LA PITIE SALPETRIERE,INSERM,U289,F-75651 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite			Hirsch, Etienne/AAC-7655-2019; Trottier, Yvon/H-8852-2016; SAUDOU, Frédéric/L-3454-2014	Hirsch, Etienne/0000-0003-4823-276X; SAUDOU, Frédéric/0000-0001-6107-1046; Trottier, Yvon/0000-0001-7230-4810; Devys, Didier/0000-0001-9655-3512				ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; BARNES GT, 1994, SOMAT CELL MOLEC GEN, V20, P87, DOI 10.1007/BF02290678; CHAMBERLAIN NL, 1994, NUCLEIC ACIDS RES, V22, P3181, DOI 10.1093/nar/22.15.3181; CHATRE AN, 1993, NAT GENET, V5, P84; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; FERRANTE RJ, 1985, SCIENCE, V230, P561, DOI 10.1126/science.2931802; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GORMAN CM, 1984, PHILOS T ROY SOC B, V307, P343, DOI 10.1098/rstb.1984.0137; GRAYBIEL AM, 1987, P NATL ACAD SCI USA, V84, P303, DOI 10.1073/pnas.84.1.303; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GUSELLA JF, 1994, NEW ENGL J MED, V330, P1450, DOI 10.1056/NEJM199405193302011; HARPER PS, 1992, HUM GENET, V89, P365; Harper PS, 1991, HUNTINGTONS DISEASE; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; IMBERT G, 1994, GENOMICS, V21, P667, DOI 10.1006/geno.1994.1335; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; KAWAGUCHI Y, 1995, NAT GENET, V8, P221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KREMER B, 1994, NEW ENGL J MED, V330, P1402; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; LIN BY, 1994, HUM MOL GENET, V3, P85, DOI 10.1093/hmg/3.1.85; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAGAFUCHI S, 1994, NAT GENET, V8, P177, DOI 10.1038/ng1094-177; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; 1993, CELL, V72, P971	39	368	388	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					104	110		10.1038/ng0595-104	http://dx.doi.org/10.1038/ng0595-104			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647777				2022-12-25	WOS:A1995QX57300024
J	AKHTAR, S; JAMES, H; GIBSON, I				AKHTAR, S; JAMES, H; GIBSON, I			MOLECULAR DIY WITH HAIRPINS AND HAMMERHEADS	NATURE MEDICINE			English	Editorial Material									UNIV E ANGLIA,SCH BIOL SCI,NORWICH NR4 7TJ,NORFOLK,ENGLAND	University of East Anglia	AKHTAR, S (corresponding author), UNIV ASTON,INST PHARMACEUT SCI,BIRMINGHAM B4 7ET,W MIDLANDS,ENGLAND.			Akhtar, Saghir/0000-0003-3177-946X				Akhtar S, 1992, Trends Cell Biol, V2, P139, DOI 10.1016/0962-8924(92)90100-2; ELKINS DA, 1995, DELIVERY STRATEGIES; PLEY HW, 1994, NATURE, V372, P68, DOI 10.1038/372068a0	3	5	7	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1995	1	4					300	302		10.1038/nm0495-300	http://dx.doi.org/10.1038/nm0495-300			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585055				2022-12-25	WOS:A1995RN09800021
J	NAKAO, N; FRODL, EM; WIDNER, H; CARLSON, E; EGGERDING, FA; EPSTEIN, CJ; BRUNDIN, P				NAKAO, N; FRODL, EM; WIDNER, H; CARLSON, E; EGGERDING, FA; EPSTEIN, CJ; BRUNDIN, P			OVEREXPRESSING CU/ZN SUPEROXIDE-DISMUTASE ENHANCES SURVIVAL OF TRANSPLANTED NEURONS IN A RAT MODEL OF PARKINSONS-DISEASE	NATURE MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MICE; LIPID-PEROXIDATION; SUBSTANTIA-NIGRA; NERVOUS-SYSTEM; NITRIC-OXIDE; GLUTATHIONE; BRAINS; IRON	A high survival rate of grafted dopamine neurons is crucial for reversing neurological deficits following brain tissue transplantation in Parkinson's disease. For unknown rea-sons the survival rate of transplanted dopamine neurons is only around 10% in experimental animals. The hypothesis that oxidative stress causes the loss of transplanted neurons was tested by grafting neurons from transgenic mice that overexpress Cu/Zn superoxide dismutase. Compared with the survival of those taken from non-transgenic littermates, the survival was 4 times higher for the transgenic dopamine neurons with a concomitant more extensive functional recovery. The results provide direct support for the free radical hypothesis of dopaminergic neuron death in brain tissue grafting.	WAKAYAMA MED COLL,DEPT NEUROL SURG,WAKAYAMA,JAPAN; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143	Wakayama Medical University; University of California System; University of California San Francisco	NAKAO, N (corresponding author), LUND UNIV,DEPT MED CELL RES,NEURONAL SURVIVAL SECT,BISKOPSGATAN 5,LUND,SWEDEN.				NATIONAL INSTITUTE ON AGING [P01AG008938] Funding Source: NIH RePORTER; NIA NIH HHS [AG-08938] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; BAKER H, 1980, P NATL ACAD SCI-BIOL, V77, P4369, DOI 10.1073/pnas.77.7.4369; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BRUNDIN P, 1988, EXP BRAIN RES, V70, P192; BRUNDIN P, 1985, BRAIN RES, V331, P251, DOI 10.1016/0006-8993(85)91550-1; CADET JL, 1994, J NEUROCHEM, V62, P380; CHADI G, 1993, EXP BRAIN RES, V97, P145; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; DEXTER DT, 1994, ANN NEUROL, V35, P298, DOI 10.1002/ana.410350309; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; DEXTER DT, 1994, NEUROREPORT, V5, P1773, DOI 10.1097/00001756-199409080-00022; DUAN WM, IN PRESS EXP BRAIN R; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; FRODL EM, 1994, BRAIN RES, V647, P286, DOI 10.1016/0006-8993(94)91328-5; GERMAN DC, 1983, J NEURAL TRANSM, V57, P243, DOI 10.1007/BF01248996; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; KINOUCHI H, 1992, P NATL ACAD SCI USA, V88, P11158; LIEMANHURWITZ J, 1982, P NATL ACAD SCI-BIOL, V79, P2808, DOI 10.1073/pnas.79.9.2808; LINDVALL O, 1994, FUNCTIONAL NEURAL TR, P103; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MAHALIK TJ, 1994, EXP NEUROL, V129, P27, DOI 10.1006/exnr.1994.1144; NAKAO N, 1994, P NATL ACAD SCI USA, V91, P12408, DOI 10.1073/pnas.91.26.12408; OLANOW CW, 1994, TRENDS NEUROSCI, V16, P439; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PRZEDBORSKI S, 1992, J NEUROCHEM, V58, P1760, DOI 10.1111/j.1471-4159.1992.tb10051.x; PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658; RIEDERER P, 1989, J NEUROCHEM, V52, P515, DOI 10.1111/j.1471-4159.1989.tb09150.x; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SAUER H, 1991, RESTOR NEUROL NEUROS, V2, P123, DOI 10.3233/RNN-1991-2302; SCHMIDT RH, 1983, ACTA PHYSL SCAND S, V522, P19; SIAN J, 1994, ANN NEUROL, V36, P348, DOI 10.1002/ana.410360305; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; TRIARHOU LC, 1988, EXP BRAIN RES, V70, P256; UNGERSTEDT U, 1970, BRAIN RES, V24, P486	40	123	136	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1995	1	3					226	231		10.1038/nm0395-226	http://dx.doi.org/10.1038/nm0395-226			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX559	7585038				2022-12-25	WOS:A1995QX55900028
J	ANAND, P; PARRETT, A; MARTIN, J; ZEMAN, S; FOLEY, P; SWASH, M; LEIGH, PN; CEDARBAUM, JM; LINDSAY, RM; WILLIAMSCHESTNUT, RE; SINICROPI, DV				ANAND, P; PARRETT, A; MARTIN, J; ZEMAN, S; FOLEY, P; SWASH, M; LEIGH, PN; CEDARBAUM, JM; LINDSAY, RM; WILLIAMSCHESTNUT, RE; SINICROPI, DV			REGIONAL CHANGES OF CILIARY NEUROTROPHIC FACTOR AND NERVE GROWTH-FACTOR LEVELS IN POST-MORTEM SPINAL-CORD AND CEREBRAL-CORTEX FROM PATIENTS WITH MOTOR DISEASE	NATURE MEDICINE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ADULT-RAT BRAIN; CHOLINERGIC PHENOTYPE; FACTOR PREVENTS; MESSENGER-RNA; SCIATIC-NERVE; NEURONS; DEGENERATION; INJURY; INVIVO	Ciliary neurotrophic factor (CNTF) rescues motor neurons in animal models of injury and neurodegeneration, and disruption of the mouse CNTF gene results in motor neuron degeneration in mature adults. Glial cells increase nerve growth factor (NGF) expression in neuropathological conditions, and the sensory system can be affected in the amyotrophic lateral sclerosis (ALS) type of motor neuronic disease. We therefore studied CNTF and NGF levels in post mortem spinal cord and cerebral cortex from patients with ALS and matched controls. We report a marked decrease of CNTF in the ventral horn of spinal cord in ALS, with no change in cerebral motor cortex. In contrast NGF levels were decreased in ALS cerebral motor cortex, where the corticospinal tract originates, but increased in the lateral column of spinal cord, which includes the region of corticospinal tract degeneration in ALS. Both CNTF and NGF levels were decreased in ALS dorsal spinal cord.	ROYAL LONDON HOSP, COLL MED, DEPT MORBID ANAT, LONDON E1 1BB, ENGLAND; INST PSYCHIAT, LONDON, ENGLAND; REGENERON PHARMACEUT INC, TARRYTOWN, NY USA; GENENTECH INC, DEPT MED & ANALYT CHEM, San Francisco, CA USA	Barts Health NHS Trust; Royal London Hospital; University of London; King's College London; Regeneron; Roche Holding; Genentech	ANAND, P (corresponding author), ROYAL LONDON HOSP, COLL MED, DEPT NEUROL, WHITECHAPEL, LONDON E1 1BB, ENGLAND.		Lindsay, Ronald/GQP-8001-2022; Leigh, Peter/AAD-5638-2019	Swash, Michael/0000-0002-8717-8914	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTAR CA, 1992, J NEUROCHEM, V59, P2167; ANAND P, 1983, NATURE, V305, P143, DOI 10.1038/305143a0; BAKHIT C, 1991, BRAIN RES, V554, P264, DOI 10.1016/0006-8993(91)90199-6; CURTIS R, 1993, NATURE, V365, P253, DOI 10.1038/365253a0; Davison C, 1941, ARCH NEURO PSYCHIATR, V46, P1039, DOI 10.1001/archneurpsyc.1941.02280240094006; DYCK PJ, 1975, NEUROLOGY, V25, P781, DOI 10.1212/WNL.25.8.781; FERNANDEZ E, 1993, NEUROSURGERY, V33, P889; FRIEDMAN B, 1992, NEURON, V9, P295, DOI 10.1016/0896-6273(92)90168-D; GREGORY R, 1993, J NEUROL, V240, P309, DOI 10.1007/BF00838169; GURNEY ME, 1992, J NEUROSCI, V12, P3241, DOI 10.1523/JNEUROSCI.12-08-03241.1992; HELGREN ME, 1994, CELL, V76, P493, DOI 10.1016/0092-8674(94)90113-9; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; Hughes J T, 1982, Adv Neurol, V36, P61; IKEDA K, IN PRESS ANN NEUROL; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; LOREZ H, 1989, NEUROSCI LETT, V98, P339, DOI 10.1016/0304-3940(89)90425-4; MAGAL E, 1993, NEUROREPORT, V4, P779, DOI 10.1097/00001756-199306000-00046; MALESSA S, 1991, J NEUROL NEUROSUR PS, V54, P984, DOI 10.1136/jnnp.54.11.984; Manthorpe M, 1993, NEUROTROPHIC FACTORS, P443; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MITSUMOTO H, 1994, ANN NEUROL, V36, P142, DOI 10.1002/ana.410360205; MITSUMOTO H, 1994, SCIENCE, V265, P1107, DOI 10.1126/science.8066451; OPPENHEIM RW, 1991, SCIENCE, V251, P1616, DOI 10.1126/science.2011743; RENDE M, 1992, GLIA, V5, P25, DOI 10.1002/glia.440050105; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SENDTNER M, 1990, NATURE, V345, P440, DOI 10.1038/345440a0; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; SWASH M, 1988, J NEUROL NEUROSUR PS, V51, P785, DOI 10.1136/jnnp.51.6.785; TAKAHASHI R, 1994, NAT GENET, V7, P79, DOI 10.1038/ng0594-79; TANDAN R, 1985, ANN NEUROL, V18, P271, DOI 10.1002/ana.410180302; WONG V, 1993, EUR J NEUROSCI, V5, P466, DOI 10.1111/j.1460-9568.1993.tb00513.x	34	63	64	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	1995	1	2					168	172		10.1038/nm0295-168	http://dx.doi.org/10.1038/nm0295-168			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX558	7585015				2022-12-25	WOS:A1995QX55800029
J	COX, GA; SUNADA, Y; CAMPBELL, KP; CHAMBERLAIN, JS				COX, GA; SUNADA, Y; CAMPBELL, KP; CHAMBERLAIN, JS			DP71 CAN RESTORE THE DYSTROPHIN-ASSOCIATED GLYCOPROTEIN COMPLEX IN MUSCLE BUT FAILS TO PREVENT DYSTROPHY	NATURE GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MDX MICE; TERMINAL DOMAIN; MOLECULAR-BASIS; CELL-MEMBRANE; PROTEIN; EXPRESSION; GENE; KINASE	Two lines of transgenic mdx mice have been generated that express a 71 kD non-muscle isoform of dystrophin (Dp71) in skeletal muscle, This isoform contains the cysteine-rich and C-terminal domains of dystrophin, but lacks the N-terminal actin-binding and central spectrin-like repeat domains. Dp71 was associated with the sarcolemma membrane, where it restored normal expression and localization of all members of the dystrophin-associated glycoprotein complex. However, the skeletal muscle pathology of the transgenic mdx mice remained severe. These results indicate that the dystrophin C terminus cannot function independently to prevent dystrophic symptoms and confirms predictions based on patient data that both the N and C-terminal domains are required for normal dystrophin function.	UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, SCH MED, CTR HUMAN GENOME, ANN ARBOR, MI 48109 USA; UNIV IOWA, COLL MED, HOWARD HUGHES MED INST, IOWA CITY, IA 52242 USA; UNIV IOWA, COLL MED, DEPT PHYSIOL & BIOPHYS, IOWA CITY, IA 52242 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Iowa; University of Iowa				Chamberlain, Jeffrey/0000-0001-5299-0059; Campbell, Kevin/0000-0003-2066-5889	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040864, P60AR020557] Funding Source: NIH RePORTER; NIAMS NIH HHS [P60AR20557, R01AR40864] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BENNETT V, 1990, PHYSIOL REV, V70, P1029, DOI 10.1152/physrev.1990.70.4.1029; BIES RD, 1992, NUCLEIC ACIDS RES, V20, P1725, DOI 10.1093/nar/20.7.1725; BULMAN DE, 1991, AM J HUM GENET, V48, P295; BYERS TJ, 1993, NAT GENET, V4, P77, DOI 10.1038/ng0593-77; CHAMBERLAIN JS, 1993, MOL CELL BIOL MUSCUL, P167; CHAMBERLAIN JS, M68859 GENB ACC; CORRADO K, 1994, FEBS LETT, V344, P255, DOI 10.1016/0014-5793(94)00397-1; COX GA, 1993, NAT GENET, V4, P87, DOI 10.1038/ng0593-87; COX GA, 1993, NATURE, V364, P725, DOI 10.1038/364725a0; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; GREENBERG DS, 1994, NAT GENET, V8, P340, DOI 10.1038/ng1294-340; HARLOW E, 1988, ANTIBODIES LABORATOR; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1991, ANN NEUROL, V30, P605, DOI 10.1002/ana.410300414; HOGAN B, 1986, MANIPULATING MOUSE E; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JAYNES JB, 1986, MOL CELL BIOL, V6, P2855, DOI 10.1128/MCB.6.8.2855; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; LEE CC, 1991, NATURE, V349, P334, DOI 10.1038/349334a0; LUISE M, 1993, BIOCHEM J, V293, P243, DOI 10.1042/bj2930243; LYONS PR, 1991, J NEUROCYTOL, V20, P969, DOI 10.1007/BF01187915; MADHAVAN R, 1994, BIOCHEMISTRY-US, V33, P5797, DOI 10.1021/bi00185a018; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; MATSUMURA K, 1993, J CLIN INVEST, V92, P866, DOI 10.1172/JCI116661; MEISENHELDER J, 1991, METHOD ENZYMOL, V197, P288; MIIKE T, 1989, BRAIN DEV-JPN, V11, P344, DOI 10.1016/S0387-7604(89)80067-1; MILNER RE, 1993, J BIOL CHEM, V268, P21901; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; OHLENDIECK K, 1991, FEBS LETT, V283, P230, DOI 10.1016/0014-5793(91)80595-T; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PARTRIDGE T, 1991, NEUROPATH APPL NEURO, V17, P353, DOI 10.1111/j.1365-2990.1991.tb00735.x; PASSOSBUENO MR, 1994, HUM MOL GENET, V3, P919, DOI 10.1093/hmg/3.6.919; PASSOSBUENO MR, 1993, HUM MOL GENET, V2, P1945, DOI 10.1093/hmg/2.11.1945; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; RAPAPORT D, 1992, DIFFERENTIATION, V49, P187, DOI 10.1111/j.1432-0436.1992.tb00666.x; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; Sambrook J, 1989, MOL CLONING LABORATO; SENTER L, 1993, BIOCHEM BIOPH RES CO, V192, P899, DOI 10.1006/bbrc.1993.1500; SHIMIZU T, 1989, BIOMED RES-TOKYO, V10, P405, DOI 10.2220/biomedres.10.405; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; TANAKA H, 1991, HISTOCHEMISTRY, V96, P1, DOI 10.1007/BF00266753; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; WAGNER KR, 1993, NEURON, V10, P511, DOI 10.1016/0896-6273(93)90338-R; WAY M, 1992, FEBS LETT, V301, P243, DOI 10.1016/0014-5793(92)80249-G	60	152	160	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1994	8	4					333	339		10.1038/ng1294-333	http://dx.doi.org/10.1038/ng1294-333			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894482				2022-12-25	WOS:A1994PV68200012
J	WEBER, BHF; VOGT, G; PRUETT, RC; STOHR, H; FELBOR, U				WEBER, BHF; VOGT, G; PRUETT, RC; STOHR, H; FELBOR, U			MUTATIONS IN THE TISSUE INHIBITOR OF METALLOPROTEINASES-3 (TIMP3) IN PATIENTS WITH SORSBYS FUNDUS DYSTROPHY	NATURE GENETICS			English	Article							DOMINANT RETINITIS PIGMENTOSA; MATRIX METALLOPROTEINASES; EXPRESSION; GENE; LOCALIZATION; MEMBRANE; CHICKEN	The hereditary macular dystrophies are progressive degenerations of the central retina and contribute significantly to irreversible visual loss in developed countries. Among these disorders, Sorsby's fundus dystrophy (SFD), an autosomal dominant condition, provides an excellent mendelian model for the study of the genetically complex age-related macular degeneration (AMD), the most common maculopathy in the elderly. Recently, we mapped the SFD locus to 22q13-qter. This same region contains the gene for tissue inhibitor of metalloproteinases-3 (TIMP3), which is known to play a pivotal role in extracellular matrix remodeling. We have now identified point mutations in the TIMP3 gene in affected members of two SFD pedigrees. These mutations are predicted to disrupt the tertiary structure and thus the functional properties of the mature protein.	SCHEPENS EYE RES INST,BOSTON,MA 02114	Harvard University; Schepens Eye Research Institute	WEBER, BHF (corresponding author), BIOZENTRUM,INST HUMANGENET,D-97074 WURZBURG,GERMANY.			Weber, Bernhard H.F./0000-0002-8808-7723				APTE SS, 1994, GENOMICS, V19, P86, DOI 10.1006/geno.1994.1016; BERTAUX B, 1991, J INVEST DERMATOL, V97, P679, DOI 10.1111/1523-1747.ep12483956; BOONE TC, 1990, P NATL ACAD SCI USA, V87, P2800, DOI 10.1073/pnas.87.7.2800; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; CAPON MRC, 1989, OPHTHALMOLOGY, V96, P1769; DARMIENTO J, 1992, CELL, V71, P955, DOI 10.1016/0092-8674(92)90391-O; DECLERCK Y, 1992, GENOMICS, V14, P782, DOI 10.1016/S0888-7543(05)80186-7; DERRY JMJ, 1992, GENOMICS, V12, P632, DOI 10.1016/0888-7543(92)90286-2; DOCHERTY AJP, 1992, TRENDS BIOTECHNOL, V10, P200, DOI 10.1016/0167-7799(92)90214-G; DUVALL J, 1986, GRAEF ARCH CLIN EXP, V224, P299, DOI 10.1007/BF02143075; GASSON JC, 1985, NATURE, V315, P768, DOI 10.1038/315768a0; HAMILTON WK, 1989, OPHTHALMOLOGY, V96, P1755; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; KHOKHA R, 1989, INVAS METAST, V9, P391; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; LECO KJ, 1994, J BIOL CHEM, V269, P9352; LIN WL, 1989, CURR EYE RES, V8, P1171, DOI 10.3109/02713688909000042; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MEYER KT, 1982, OPHTHALMOLOGY, V89, P1414; MILANI S, 1994, AM J PATHOL, V144, P528; MOSES MA, 1990, SCIENCE, V248, P1408, DOI 10.1126/science.1694043; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAULEIKHOFF D, 1990, AM J OPHTHALMOL, V109, P211, DOI 10.1016/S0002-9394(14)75989-6; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; PELLETIER JP, 1990, ARTHRITIS RHEUM, V33, P1486; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SANTOSANDERSON RM, 1982, OPHTHALMIC PAED GEN, V1, P151, DOI 10.3109/13816818209036028; SILBIGER SM, 1994, GENE, V141, P293, DOI 10.1016/0378-1119(94)90588-6; SORSBY A, 1949, BRIT J OPHTHALMOL, V33, P67, DOI 10.1136/bjo.33.2.67; WEBER BHF, 1994, NAT GENET, V7, P158, DOI 10.1038/ng0694-158; WILLIAMSON RA, 1990, BIOCHEM J, V268, P267, DOI 10.1042/bj2680267; WU G, 1991, AM J OPHTHALMOL, V111, P294, DOI 10.1016/S0002-9394(14)72312-8; YANG TT, 1992, P NATL ACAD SCI USA, V89, P10676, DOI 10.1073/pnas.89.22.10676	33	504	517	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					352	356		10.1038/ng1294-352	http://dx.doi.org/10.1038/ng1294-352			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894485				2022-12-25	WOS:A1994PV68200015
J	ENGELHARDT, JF; YANG, YP; STRATFORDPERRICAUDET, LD; ALLEN, ED; KOZARSKY, K; PERRICAUDET, M; YANKASKAS, JR; WILSON, JM				ENGELHARDT, JF; YANG, YP; STRATFORDPERRICAUDET, LD; ALLEN, ED; KOZARSKY, K; PERRICAUDET, M; YANKASKAS, JR; WILSON, JM			DIRECT GENE-TRANSFER OF HUMAN CFTR INTO HUMAN BRONCHIAL EPITHELIA OF XENOGRAFTS WITH E1-DELETED ADENOVIRUSES	NATURE GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; EXPRESSION; CELLS; IDENTIFICATION; INVITRO; MONKEY; LUNG	We describe the use of a human bronchial xenograft model for studying the efficiency and biology of in vivo gene transfer into human bronchial epithelia with recombinant E1 deleted adenoviruses. All cell types in the surface epithelium except basal cells efficiently expressed the adenoviral transduced recombinant genes, lacZ and CFTR, for 3-5 weeks. Stable transgene expression was associated with high level expression of the early adenoviral gene, E2a, in a subset of transgene expressing cells and virtually undetectable expression of the late adenoviral genes encoding the structural proteins, hexon and fiber. These studies begin to address important issues that relate to safety and in vivo efficacy of recombinant adenoviruses for gene delivery into the human airway.	UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109; INST GUSTAVE ROUSSY,CNRS,UA 1301,F-94805 VILLEJUIF,FRANCE; UNIV N CAROLINA,DIV PULM DIS,CHAPEL HILL,NC 27599; WISTAR INST ANAT & BIOL,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); UNICANCER; Gustave Roussy; University of North Carolina; University of North Carolina Chapel Hill; The Wistar Institute			Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131; Engelhardt, John/0000-0003-2389-9277	NHLBI NIH HHS [HL34322] Funding Source: Medline; NIDDK NIH HHS [R01 DK047967] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047967] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AYERS MM, 1988, EUR RESPIR J, V1, P58; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BLENKINSOPP WK, 1967, EXP CELL RES, V46, P144, DOI 10.1016/0014-4827(67)90416-8; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BREEZE RG, 1977, AM REV RESPIR DIS, V116, P705, DOI 10.1164/arrd.1977.116.4.705; COTTON CU, 1987, J CLIN INVEST, V79, P80, DOI 10.1172/JCI112812; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; ENGELHARDT JF, 1991, P NATL ACAD SCI USA, V88, P11192, DOI 10.1073/pnas.88.24.11192; ENGELHARDT JF, 1992, J CLIN INVEST, V90, P2598, DOI 10.1172/JCI116155; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109; GREEN M, 1961, VIROLOGY, V13, P169, DOI 10.1016/0042-6822(61)90051-4; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; HAZINSKI TA, 1991, AM J RESP CELL MOL, V4, P206, DOI 10.1165/ajrcmb/4.3.206; HORWITZ MS, 1990, VIROLOGY, P01679; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; PLOPPER CG, 1989, AM J ANAT, V184, P31, DOI 10.1002/aja.1001840104; RANDELL SH, 1991, AM J RESP CELL MOL, V4, P544, DOI 10.1165/ajrcmb/4.6.544; REICHEL R, 1987, CELL, V48, P501, DOI 10.1016/0092-8674(87)90200-5; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; RUTTEN AAJJL, 1988, VIRCHOWS ARCH B CELL, V56, P117; SARKADI B, 1992, J BIOL CHEM, V267, P2087; STRATFORDPERRICAUDET LD, 1992, J CLIN INVEST, V90, P626, DOI 10.1172/JCI115902; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; WILSON DW, 1984, AM J ANAT, V171, P25, DOI 10.1002/aja.1001710104; YANKASKAS JR, 1985, LANCET, V1, P954; YOSHIMURA K, 1992, NUCLEIC ACIDS RES, V20, P3233, DOI 10.1093/nar/20.12.3233; ZEITLIN PL, 1992, P NATL ACAD SCI USA, V89, P344, DOI 10.1073/pnas.89.1.344	34	289	324	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1993	4	1					27	34		10.1038/ng0593-27	http://dx.doi.org/10.1038/ng0593-27			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LA337	7685651				2022-12-25	WOS:A1993LA33700008
J	CHU, CS; TRAPNELL, BC; CURRISTIN, S; CUTTING, GR; CRYSTAL, RG				CHU, CS; TRAPNELL, BC; CURRISTIN, S; CUTTING, GR; CRYSTAL, RG			GENETIC-BASIS OF VARIABLE EXON-9 SKIPPING IN CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MESSENGER-RNA	NATURE GENETICS			English	Article							3' SPLICE-SITE; MAMMALIAN INTRONS; XENOPUS OOCYTES; CL CHANNEL; CFTR GENE; IDENTIFICATION; SEQUENCES; CELLS; DNA; MUTATIONS	Variable in-frame skipping of exon 9 in cystic fibrosis transmembrane conductance regulator (CFTR) mRNA transcripts (exon 9-) occurs in the respiratory epithelium. To explore the genetic basis of this event, we evaluated respiratory epithelial cells and blood leukocytes from 124 individuals (38 with cystic fibrosis (CF), 86 without CF). We found an inverse relationship between the length of the polythymidine tract at the exon 9 splice branch/acceptor site and the proportion of exon 9- CFTR mRNA transcripts. These results strongly indicate a genetic basis in vivo modulating post-transcriptional processing of CFTR mRNA transcripts.	JOHNS HOPKINS UNIV HOSP, DEPT PEDIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV HOSP, CTR MED GENET, BALTIMORE, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	CHU, CS (corresponding author), NHLBI, PULM BRANCH, BETHESDA, MD 20892 USA.							ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BARGON J, 1992, MOL CELL BIOL, V12, P1872, DOI 10.1128/MCB.12.4.1872; BARGON J, 1992, J BIOL CHEM, V267, P16056; BARINAGA M, 1992, SCIENCE, V256, P444, DOI 10.1126/science.1373905; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BEAR CE, 1991, J BIOL CHEM, V266, P19142; BINDEREIF A, 1986, MOL CELL BIOL, V6, P2582, DOI 10.1128/MCB.6.7.2582; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CHEHAB FF, 1991, AM J HUM GENET, V48, P223; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; CUPPENS H, 1990, J MED GENET, V27, P717, DOI 10.1136/jmg.27.11.717; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTVILL X, NATURE, V326, P840; FRENDEWEY D, 1985, CELL, V42, P355, DOI 10.1016/S0092-8674(85)80131-8; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; GUTHRIE C, 1991, SCIENCE, V253, P157, DOI 10.1126/science.1853200; JIN W, 1990, NUCLEIC ACIDS RES, V18, P5995, DOI 10.1093/nar/18.20.5995; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; Krainer AR, 1988, TRANSCRIPTION SPLICI, P131; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PATTERSON B, 1991, CELL, V64, P181, DOI 10.1016/0092-8674(91)90219-O; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; REED R, 1985, CELL, V41, P95, DOI 10.1016/0092-8674(85)90064-9; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; RUBY SW, 1991, TRENDS GENET, V7, P79; RUSKIN B, 1985, NATURE, V317, P732, DOI 10.1038/317732a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; TRAPNELL BC, 1991, P NATL ACAD SCI USA, V88, P6565, DOI 10.1073/pnas.88.15.6565; TRAPNELL BC, 1991, J BIOL CHEM, V266, P10319; WELSH MJ, 1987, J CLIN INVEST, V80, P1523, DOI 10.1172/JCI113237; YOSHIMURA K, 1991, NUCLEIC ACIDS RES, V19, P5417, DOI 10.1093/nar/19.19.5417; YOSHIMURA K, 1991, J BIOL CHEM, V266, P9140; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	51	418	429	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1993	3	2					151	156		10.1038/ng0293-151	http://dx.doi.org/10.1038/ng0293-151			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	7684646				2022-12-25	WOS:A1993KL01000013
J	KHAN, AS; WILCOX, AS; POLYMEROPOULOS, MH; HOPKINS, JA; STEVENS, TJ; ROBINSON, M; ORPANA, AK; SIKELA, JM				KHAN, AS; WILCOX, AS; POLYMEROPOULOS, MH; HOPKINS, JA; STEVENS, TJ; ROBINSON, M; ORPANA, AK; SIKELA, JM			SINGLE PASS SEQUENCING AND PHYSICAL AND GENETIC-MAPPING OF HUMAN BRAIN CDNAS	NATURE GENETICS			English	Article							HUMAN GENOME; DNA; REPEAT; AMPLIFICATION; POLYMORPHISMS; POLYMERASE	We have performed single pass sequencing of 1,024 human brain cDNAs, over 900 of which seem to represent new human genes. Library prescreening with total brain cDNA significantly reduced repeated sequencing of highly represented cDNAs. A subset of sequenced cDNAs were physically mapped to their chromosomal locations using gene-specific STS primers derived from 3' untranslated regions. We have also determined that human brain cDNAs represent a rich source of gene-associated polymorphic markers. Microsatellite-containing cDNAs can be physically mapped and converted to highly informative genetic markers, thus facilitating integration of the human physical, expression and genetic maps.	VET ADM SCHIZOPHRENIA CTR,MOLEC BIOL LAB,DENVER,CO 80220; NIMH,BIOCHEM GENET LAB,WASHINGTON,DC 20032	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	KHAN, AS (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT PHARMACOL,DENVER,CO 80262, USA.							ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; EDWARDS A, 1991, AM J HUM GENET, V49, P746; FU YH, 1991, CELL, V67, P1; HAMADA H, 1984, MOL CELL BIOL, V4, P2610, DOI 10.1128/MCB.4.12.2610; KHAN AS, 1991, NUCLEIC ACIDS RES, V19, P1715, DOI 10.1093/nar/19.7.1715; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LEVITT RC, 1991, GENOMICS, V11, P484, DOI 10.1016/0888-7543(91)90168-E; LITT M, 1989, AM J HUM GENET, V44, P397; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P689, DOI 10.1093/nar/19.3.689; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SUTCLIFFE JG, 1988, ANNU REV NEUROSCI, V11, P157, DOI 10.1146/annurev.ne.11.030188.001105; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILCOX AS, 1991, NUCLEIC ACIDS RES, V19, P1837, DOI 10.1093/nar/19.8.1837; WILCOX AS, 1992, P NATL ACAD SCI USA, V89, P5857, DOI 10.1073/pnas.89.13.5857; 1991, HUM GENOME NEWS, V2, P9; 1992, GENOMICS, V12, P492; 1990, UNDERSTANDING OUR GE	25	160	185	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1992	2	3					180	185		10.1038/ng1192-180	http://dx.doi.org/10.1038/ng1192-180			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345165				2022-12-25	WOS:A1992JW16500005
J	DENG, YL; RAPP, JP				DENG, YL; RAPP, JP			COSEGREGATION OF BLOOD-PRESSURE WITH ANGIOTENSIN CONVERTING ENZYME AND ATRIAL-NATRIURETIC-PEPTIDE RECEPTOR GENES USING DAHL SALT-SENSITIVE RATS	NATURE GENETICS			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; WISTAR-KYOTO RATS; RENIN GENE; LINKAGE; HYPERTENSION; ALLELES; HETEROGENEITY; ASSOCIATION; VARIABILITY; INGESTION	We have evaluated the genes for angiotensin converting enzyme (ACE) and guanylyl cyclase A/atrial natriuretic peptide receptor (GCA) for genetic effects on blood pressure response to high salt diet. In F2 rats derived from Milan normotensive and Dahl salt-hypertension sensitive (S) rats, both ACE and GCA cosegregated with blood pressure, and rats that were homozygous for the S allele at both the ACE and GCA loci had inordinately high blood pressure. In F2 derived from Wistar Kyoto (WKY) and S rats, GCA revealed positive cosegregation with blood pressure, but ACE did not. We conclude that certain alleles at the GCA and ACE loci (or at loci closely linked to them) have a significant genetic impact on blood pressure response to high salt in specific rat strains.	MED COLL OHIO, DEPT MED, TOLEDO, OH 43699 USA; MED COLL OHIO, DEPT PATHOL, TOLEDO, OH 43699 USA									BARLEY J, 1991, J HYPERTENS, V9, P993, DOI 10.1097/00004872-199111000-00003; Bianchi G., 1984, HDB HYPERTENSION, V4, P328; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BUNAG RD, 1982, HYPERTENSION, V4, P898, DOI 10.1161/01.HYP.4.6.898; DAHL LK, 1962, J EXP MED, V115, P1173, DOI 10.1084/jem.115.6.1173; FRIEDMAN M, 1949, P SOC EXP BIOL MED, V70, P670; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HIRATA Y, 1984, HYPERTENSION, V6, pI148, DOI 10.1161/01.HYP.6.2_Pt_2.I148; HOWARD TE, 1990, MOL CELL BIOL, V10, P4294, DOI 10.1128/MCB.10.8.4294; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JEUNEMAITRE X, 1992, HUM GENET, V88, P301; JEUNEMAITRE X, 1992, NAT GENET, V1, P72, DOI 10.1038/ng0492-72; KLEINERT HD, 1984, HYPERTENSION, V6, pI143, DOI 10.1161/01.HYP.6.2_Pt_2.I143; KNUDSEN KD, 1970, J EXP MED, V132, P976, DOI 10.1084/jem.132.5.976; KURTZ TW, 1989, HYPERTENSION, V13, P188, DOI 10.1161/01.HYP.13.2.188; KURTZ TW, 1987, HYPERTENSION, V10, P127, DOI 10.1161/01.HYP.10.1.127; MATSUMOTO K, 1991, CLIN EXP HYPERTENS A, V13, P925, DOI 10.3109/10641969109042098; MORRIS BJ, 1988, BIOCHEM BIOPH RES CO, V150, P219, DOI 10.1016/0006-291X(88)90508-6; NABIKA T, 1991, HYPERTENSION, V18, P12, DOI 10.1161/01.HYP.18.1.12; NAFTILAN AJ, 1989, HYPERTENSION, V14, P614, DOI 10.1161/01.HYP.14.6.614; NARA Y, 1991, BIOCHEM BIOPH RES CO, V181, P941, DOI 10.1016/0006-291X(91)92027-H; PRAVENEC M, 1991, GENOMICS, V9, P466, DOI 10.1016/0888-7543(91)90412-8; RAPP JP, 1985, HYPERTENSION, V7, P340, DOI 10.1161/01.HYP.7.3_Pt_1.340; RAPP JP, 1989, SCIENCE, V243, P542, DOI 10.1126/science.2563177; RAPP JP, 1991, HYPERTENSION, V18, P18, DOI 10.1161/01.HYP.18.3_Suppl.I18; RAPP JP, 1990, J HYPERTENS, V8, P457, DOI 10.1097/00004872-199005000-00010; RAPP JP, 1990, AM J HYPERTENS, V3, P391, DOI 10.1093/ajh/3.5.391; RAPP JP, 1983, HYPERTENSION PHYSIOP, P582; SAMANI NJ, 1989, J HYPERTENS, V7, P809, DOI 10.1097/00004872-198910000-00006; SNAJDAR RM, 1985, HYPERTENSION, V7, P775, DOI 10.1161/01.HYP.7.5.775; SOUBRIER F, 1990, HYPERTENSION, V16, P712, DOI 10.1161/01.HYP.16.6.712; Ward R, 1990, HYPERTENSION PATHOPH; YAMAGUCHI M, 1990, J BIOL CHEM, V265, P20414; ZEE RYL, 1991, J HYPERTENS, V9, P825, DOI 10.1097/00004872-199109000-00009	34	164	167	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1992	1	4					267	272		10.1038/ng0792-267	http://dx.doi.org/10.1038/ng0792-267			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1363813				2022-12-25	WOS:A1992JC98400010
J	ROSS, MT; NIZETIC, D; NGUYEN, C; KNIGHTS, C; VATCHEVA, R; BURDEN, N; DOUGLAS, C; ZEHETNER, G; WARD, DC; BALDINI, A; LEHRACH, H				ROSS, MT; NIZETIC, D; NGUYEN, C; KNIGHTS, C; VATCHEVA, R; BURDEN, N; DOUGLAS, C; ZEHETNER, G; WARD, DC; BALDINI, A; LEHRACH, H			SELECTION OF A HUMAN CHROMOSOME-21 ENRICHED YAC SUB-LIBRARY USING A CHROMOSOME-SPECIFIC COMPOSITE PROBE	NATURE GENETICS			English	Article							YEAST ARTIFICIAL CHROMOSOMES; HUMAN ACROCENTRIC CHROMOSOMES; DNA-SEQUENCES; PERICENTROMERIC REGIONS; HUMAN GENOME; CONSTRUCTION; HYBRIDIZATION; CLONES; MAPS	The subdivision Of total genomic human yeast artificial chromosome (YAC) libraries into specific chromosome clone collections will greatly facilitate the construction of an integrated genetic, physical and transcriptional map of the genome. We report the isolation of 388 YAC clones from a human library with an average insert size of 620 kilobases (kb) by the hybridization of a composite chromosome 21 probe to a high-density array of YAC clones. Roughly half of these clones hybridize to chromosome 21 by fluorescence in situ hybridization. These clones represent a twofold coverage of the chromosome. The technique offers the potential of sub-dividing whole genomic YAC libraries into their chromosomal elements to produce high-resolution tools for genome mapping.	CTR IMMUNOL MARSEILLE LUMINY,F-13288 MARSEILLE 09,FRANCE; YALE UNIV,SCH MED,NEW HAVEN,CT 06510	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Yale University	ROSS, MT (corresponding author), IMPERIAL CANC RES FUND,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.		Nguyen, Catherine/M-4119-2016; Nizetic, Dean/F-9509-2015; genes, anthony/F-2541-2012; Baldini, Antonio/M-2355-2015	Nguyen, Catherine/0000-0001-9376-6360; Baldini, Antonio/0000-0002-5330-0256; Nizetic, Dean/0000-0001-5486-5761				ABIDI FE, 1990, GENOMICS, V7, P363, DOI 10.1016/0888-7543(90)90170-Y; ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BALDINI A, 1991, GENOMICS, V9, P770, DOI 10.1016/0888-7543(91)90374-N; BALDINI A, IN PRESS GENOMICS; BAXENDALE S, 1991, NUCLEIC ACIDS RES, V19, P6651, DOI 10.1093/nar/19.23.6651; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; CHUMAKOV IM, 1992, NAT GENET, V1, P222, DOI 10.1038/ng0692-222; COLLINS C, 1991, GENOMICS, V11, P997, DOI 10.1016/0888-7543(91)90025-A; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; COX DR, 1991, CYTOGENET CELL GENET, V58, P800, DOI 10.1159/000133181; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; KORENBERG JR, 1985, CYTOGENET CELL GENET, V40, P673; KURNIT DM, 1986, CYTOGENET CELL GENET, V43, P109, DOI 10.1159/000132305; KURNIT DM, 1984, CYTOGENET CELL GENET, V38, P99, DOI 10.1159/000132039; LARIN Z, 1990, GENET RES, V56, P203, DOI 10.1017/S0016672300035308; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEHRACH H., 1990, GENOME ANAL, P39; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; MAIER E, 1992, NAT GENET, V1, P273, DOI 10.1038/ng0792-273; MCCORMICK MK, 1989, P NATL ACAD SCI USA, V86, P9991, DOI 10.1073/pnas.86.24.9991; MILLINGTONWARD A, 1985, CYTOGENET CELL GENET, V40, P699; MONACO AP, 1991, NUCLEIC ACIDS RES, V19, P3315, DOI 10.1093/nar/19.12.3315; NIZETIC D, 1991, P NATL ACAD SCI USA, V88, P3233, DOI 10.1073/pnas.88.8.3233; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PATTERSON D, 1991, CYTOGENET CELL GENET, V57, P167; RIED T, 1992, P NATL ACAD SCI USA, V89, P1388, DOI 10.1073/pnas.89.4.1388; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Ross M. T., 1992, Techniques for the analysis of complex genomes., P137; SCHLESSINGER D, 1991, GENOMICS, V11, P783, DOI 10.1016/0888-7543(91)90001-U; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; TANTRAVAHI U, 1988, HUM GENET, V79, P196, DOI 10.1007/BF00366237; VANCAMP G, 1991, HUM GENET, V87, P649, DOI 10.1007/BF00201718; VANDILLA M, 1989, FLOW CYTOGENETICS, P257; VANDILLA MA, 1986, BIO-TECHNOL, V4, P537, DOI 10.1038/nbt0686-537; VANHUL W, 1991, CYTOGENET CELL GENET, V58, P2041	38	22	26	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1992	1	4					284	290		10.1038/ng0792-284	http://dx.doi.org/10.1038/ng0792-284			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1302025				2022-12-25	WOS:A1992JC98400013
J	TSILFIDIS, C; MACKENZIE, AE; METTLER, G; BARCELO, J; KORNELUK, RG				TSILFIDIS, C; MACKENZIE, AE; METTLER, G; BARCELO, J; KORNELUK, RG			CORRELATION BETWEEN CTG TRINUCLEOTIDE REPEAT LENGTH AND FREQUENCY OF SEVERE CONGENITAL MYOTONIC-DYSTROPHY	NATURE GENETICS			English	Article							BRITAIN	The myotonic dystrophy (DM) mutation has recently been identified as an unstable trinucleotide CTG repeat which is present 5-30 times in the normal population but which is amplified up to 2,000 times in DM. We have determined the status of the CTG repeat in 272 DM individuals. Infants with severe congenital DM, as well as their mothers, are shown to have on average a greater amplification of the CTG repeat than is seen in the noncongenital DM population. This fact, when viewed in conjunction with the tendency to increased CTG repeat length in our DM kindreds, provides evidence for the existence of genetic anticipation in the transmission of DM.	UNIV OTTAWA,DEPT MICROBIOL & IMMUNOL,OTTAWA K1H 8M5,ONTARIO,CANADA; UNIV OTTAWA,DEPT BIOCHEM,OTTAWA K1H 8M5,ONTARIO,CANADA; CHILDRENS HOSP EASTERN ONTARIO,OTTAWA K1H 8L1,ONTARIO,CANADA	University of Ottawa; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario								ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; DODGE PR, 1965, PEDIATRICS, V365, P3; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GLANZ A, 1984, J MED GENET, V21, P186, DOI 10.1136/jmg.21.3.186; GRIGGS RC, 1989, NEUROLOGY, V39, P420, DOI 10.1212/WNL.39.3.420; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; Harper P.S., 1989, MYOTONIC DYSTROPHY; HARPER PS, 1975, ARCH DIS CHILD, V50, P514, DOI 10.1136/adc.50.7.514; HARPER PS, 1975, ARCH DIS CHILD, V50, P505, DOI 10.1136/adc.50.7.505; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; KOCH MC, 1991, AM J HUM GENET, V48, P1084; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACKENZIE AE, 1989, AM J HUM GENET, V44, P140; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MATHIEU J, 1990, NEUROLOGY, V40, P839, DOI 10.1212/WNL.40.5.839; MCCOMAS AJ, 1978, J NEUROL NEUROSUR PS, V41, P882, DOI 10.1136/jnnp.41.10.882; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; TSILFIDIS C, 1991, AM J HUM GENET, V49, P961; VANIER TM, 1960, BRIT MED J, V2, P1284, DOI 10.1136/bmj.2.5208.1284; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	24	304	313	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					192	195		10.1038/ng0692-192	http://dx.doi.org/10.1038/ng0692-192			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303233				2022-12-25	WOS:A1992JC98200011
J	BEAUMONT, C; LENEUVE, P; DEVAUX, I; SCOAZEC, JY; BERTHIER, M; LOISEAU, MN; GRANDCHAMP, B; BONNEAU, D				BEAUMONT, C; LENEUVE, P; DEVAUX, I; SCOAZEC, JY; BERTHIER, M; LOISEAU, MN; GRANDCHAMP, B; BONNEAU, D			MUTATION IN THE IRON-RESPONSIVE ELEMENT OF THE L-FERRITIN MESSENGER-RNA IN A FAMILY WITH DOMINANT HYPERFERRITINEMIA AND CATARACT	NATURE GENETICS			English	Note							MESSENGER-RNA; UNTRANSLATED REGION; BINDING-PROTEIN; SEQUENCE		FAC XAVIER BICHAT,INSERM,U327,F-75870 PARIS 18,FRANCE; HOP JEAN BERNARD,UNITE GENET,F-86021 POITIERS,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers	BEAUMONT, C (corresponding author), FAC XAVIER BICHAT,INSERM,U409,BP 416,F-75870 PARIS 18,FRANCE.		Bonneau, Dominique/K-6110-2015					ARMITAGE MM, 1995, NAT GENET, V9, P37, DOI 10.1038/ng0195-37; BEAUMONT C, 1994, J BIOL CHEM, V269, P20281; BONNEAU D, 1995, J MED GENET, V32, P778, DOI 10.1136/jmg.32.10.778; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; CASEY JL, 1989, EMBO J, V8, P3693, DOI 10.1002/j.1460-2075.1989.tb08544.x; EIKEN HG, 1991, NUCLEIC ACIDS RES, V19, P1427, DOI 10.1093/nar/19.7.1427; ELBERG H, 1988, CLIN GENET, V34, P272; GIRELLI D, 1995, BRIT J HAEMATOL, V90, P931, DOI 10.1111/j.1365-2141.1995.tb05218.x; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; HERTZE MW, 1987, SCIENCE, V238, P1570; JAFFREY SR, 1993, NUCLEIC ACIDS RES, V21, P4627, DOI 10.1093/nar/21.19.4627; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; MCGILL JR, 1987, HUM GENET, V76, P66; MELEFORS O, 1993, J BIOL CHEM, V268, P5974; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; THEIL EC, 1994, BIOCHEM J, V304, P1	20	243	246	1	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					444	446		10.1038/ng1295-444	http://dx.doi.org/10.1038/ng1295-444			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493028				2022-12-25	WOS:A1995TH62900025
J	TSUKAMOTO, T; MIURA, S; NAKAI, T; YOKOTA, S; SHIMOZAWA, N; SUZUKI, Y; ORII, T; FUJIKI, Y; SAKAI, F; BOGAKI, A; YASUMO, H; OSUMI, T				TSUKAMOTO, T; MIURA, S; NAKAI, T; YOKOTA, S; SHIMOZAWA, N; SUZUKI, Y; ORII, T; FUJIKI, Y; SAKAI, F; BOGAKI, A; YASUMO, H; OSUMI, T			PEROXISOME ASSEMBLY FACTOR-II, A PUTATIVE ATPASE CLONED BY FUNCTIONAL COMPLEMENTATION ON A PEROXISOME-DEFICIENT MAMMALIAN-CELL MUTANT	NATURE GENETICS			English	Article							AMINO-ACID SEQUENCE; ACYL-COA OXIDASE; SACCHAROMYCES-CEREVISIAE; ZELLWEGER SYNDROME; PROTEIN IMPORT; 3-KETOACYL-COA THIOLASE; ESCHERICHIA-COLI; TARGETING SIGNAL; CDNA CLONE; GENE	Rat peroxisome assembly factor-2 (PAF-2) cDNA was isolated by functional complementation of peroxisome deficiency of a mutant CHO cell line, ZP92, using transient transfection assay. This cDNA encodes a 978-amino acid protein with two putative ATP-binding sites. PAF-2 is a member of a putative ATPase family, including two yeast gene products essential for peroxisome assembly. A stable transformant of ZP92 with the cDNA was morphologically and biochemically restored for peroxisome biogenesis. Fibroblasts derived from patients deficient in peroxisome biogenesis (complementation group C) were also complemented with PAF-2 cDNA, indicating that PAF-2 is a strong candidate for the pathogenic gene of group C peroxisome deficiency.	GIFU UNIV,SCH MED,DEPT PEDIAT,GIFU 500,JAPAN; HIMEJI INST TECHNOL,DEPT LIFE SCI,KAMIGORI,HYOGO 67812,JAPAN; YOKOHAMA CITY UNIV,SCH MED,RADIOISOTOPE RES CTR,YOKOHAMA,KANAGAWA 236,JAPAN; YAMANASKI MED COLL,DEPT ANAT,TAMAHO,YAMANASHI 40938,JAPAN; KYUSHU UNIV,FAC SCI,DEPT BIOL,FUKUOKA 81281,JAPAN	Gifu University; University of Hyogo; Yokohama City University; University of Yamanashi; Kyushu University				Shimozawa, Nobuyuki/0000-0003-3040-5458				BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIN DT, 1988, J BIOL CHEM, V263, P11718; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; DUBIEL W, 1992, J BIOL CHEM, V267, P22699; ERDMANN R, 1991, CELL, V64, P499, DOI 10.1016/0092-8674(91)90234-P; FROLICH KU, 1991, J CELL BIOL, V114, P443; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; HEYMAN JA, 1994, J CELL BIOL, V127, P1259, DOI 10.1083/jcb.127.5.1259; HIJIKATA M, 1987, J BIOL CHEM, V262, P8151; IMANAKA T, 1987, J CELL BIOL, V105, P2915, DOI 10.1083/jcb.105.6.2915; KOLLER KJ, 1987, NATURE, V325, P542, DOI 10.1038/325542a0; KRAUSE T, 1994, YEAST, V10, P1613, DOI 10.1002/yea.320101210; KUNAU WH, 1993, BIOCHIMIE, V75, P209, DOI 10.1016/0300-9084(93)90079-8; MIURA S, 1992, J BIOL CHEM, V267, P14405; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; MIYAZAWA S, 1987, J BIOL CHEM, V262, P8131; MORAND OH, 1990, BIOCHIM BIOPHYS ACTA, V1034, P132, DOI 10.1016/0304-4165(90)90066-6; NAKAI T, 1995, MOL CELL BIOL, V15, P4441; NELBOCK P, 1990, SCIENCE, V248, P1650, DOI 10.1126/science.2194290; NUTTLEY WM, 1994, J BIOL CHEM, V269, P556; OGAWA H, 1987, EUR J BIOCHEM, V168, P141, DOI 10.1111/j.1432-1033.1987.tb13398.x; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; OSUMI T, 1991, BIOCHEM BIOPH RES CO, V181, P947, DOI 10.1016/0006-291X(91)92028-I; PETERS JM, 1990, EMBO J, V9, P175; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHUTGENS RBH, 1986, EUR J PEDIATR, V144, P430, DOI 10.1007/BF00441734; SHIMOZAWA N, 1992, J CLIN INVEST, V90, P1864, DOI 10.1172/JCI116063; SHIMOZAWA N, 1993, AM J HUM GENET, V52, P843; SHIMOZAWA N, 1988, PEDIATR RES, V24, P723, DOI 10.1203/00006450-198812000-00015; SHIMOZAWA N, 1992, SCIENCE, V255, P1132, DOI 10.1126/science.1546315; SPONG AP, 1993, J CELL BIOL, V123, P535, DOI 10.1083/jcb.123.3.535; SUBRAMANI S, 1993, ANNU REV CELL BIOL, V9, P445, DOI 10.1146/annurev.cb.09.110193.002305; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; THORSNESS PE, 1993, MOL CELL BIOL, V13, P5418, DOI 10.1128/MCB.13.9.5418; TOMOYASU T, 1993, J BACTERIOL, V175, P1344, DOI 10.1128/JB.175.5.1344-1351.1993; TSUKAMOTO T, 1994, MOL CELL BIOL, V14, P5458, DOI 10.1128/MCB.14.8.5458; TSUKAMOTO T, 1990, J CELL BIOL, V110, P651, DOI 10.1083/jcb.110.3.651; TSUKAMOTO T, 1991, NATURE, V350, P77, DOI 10.1038/350077a0; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VOOMBROUWER T, 1993, BIOCHIM BIOPHYS ACTA, V1216, P325; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WENDLAND M, 1993, J CLIN INVEST, V92, P2462, DOI 10.1172/JCI116854; WENDLAND M, 1993, J CELL BIOL, V120, P675, DOI 10.1083/jcb.120.3.675; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	48	99	102	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					395	401		10.1038/ng1295-395	http://dx.doi.org/10.1038/ng1295-395			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493019				2022-12-25	WOS:A1995TH62900016
J	BERGH, J; NORBERG, T; SJOGREN, S; LINDGREN, A; HOLMBERG, L				BERGH, J; NORBERG, T; SJOGREN, S; LINDGREN, A; HOLMBERG, L			COMPLETE SEQUENCING OF THE P53 GENE PROVIDES PROGNOSTIC INFORMATION IN BREAST-CANCER PATIENTS, PARTICULARLY IN RELATION TO ADJUVANT SYSTEMIC THERAPY AND RADIOTHERAPY	NATURE MEDICINE			English	Article							TUMOR-SUPPRESSOR GENE; CELL-LINES; EXPRESSION	The complete coding region of the p53 gene was sequenced from 316 consecutively presented breast cancers, of which 97 were lymph node positive and 206 were node negative. The p53 status was related to prognosis and effect of adjuvant therapy. In all, 69 individual mutations, 29 in node-positive tumours, were demonstrated throughout the whole coding sequence. The mutation sites were partly different for node-positive and node-negative patients. p53 mutations in the evolutionary conserved regions II and V were associated with significantly worse prognosis. Adjuvant systemic therapy, especially with tamoxifen, along with radiotherapy seemed to be of less value to p53 mutation- and lymph node-positive tumours.	UNIV UPPSALA,AKAD SJUKHUSET,DEPT PATHOL,S-75185 UPPSALA,SWEDEN; UNIV UPPSALA,AKAD SJUKHUSET,DEPT SURG,S-75185 UPPSALA,SWEDEN; UNIV UPPSALA,AKAD SJUKHUSET,DEPT CANC EPIDEMIOL,S-75185 UPPSALA,SWEDEN; PHARMACIA AB,S-75182 UPPSALA,SWEDEN	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Pfizer; Pharmacia Corporation	BERGH, J (corresponding author), UNIV UPPSALA,AKAD SJUKHUSET,DEPT ONCOL,S-75185 UPPSALA,SWEDEN.			Bergh, Jonas/0000-0001-5526-1847				BANKS L, 1986, EUR J BIOCHEM, V159, P529, DOI 10.1111/j.1432-1033.1986.tb09919.x; BARTEK J, 1990, ONCOGENE, V5, P893; BARTEK J, 1990, INT J CANCER, V46, P839, DOI 10.1002/ijc.2910460515; CATTORETTI G, 1988, INT J CANCER, V41, P178, DOI 10.1002/ijc.2910410204; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; COX DR, 1972, J R STAT SOC B, V34, P187; DAVIDOFF AM, 1991, SURGERY, V110, P259; Early Breast Cancer Trialists' Collaborative Group, 1992, LANCET, V339, P1; ELLEDGE RM, 1993, BREAST CANCER RES TR, V26, P225, DOI 10.1007/BF00665800; FREBOURG T, 1993, J NATL CANCER I, V85, P1554, DOI 10.1093/jnci/85.19.1554; FUJIWARA T, 1994, CANCER RES, V54, P2287; LAGERKVIST A, 1994, P NATL ACAD SCI USA, V91, P2245, DOI 10.1073/pnas.91.6.2245; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LILJEGREN G, 1994, JNCI-J NATL CANCER I, V86, P717, DOI 10.1093/jnci/86.9.717; LIM JS, 1994, P ANN M AM ASS CANCE; LOWE SW, 1994, SCIENCE, V266, P807, DOI 10.1126/science.7973635; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; OCONNOR PM, 1993, CANCER RES, V53, P4776; ORY K, 1994, EMBO J, V13, P3496, DOI 10.1002/j.1460-2075.1994.tb06656.x; OSTROWSKI JL, 1991, J PATHOL, V164, P75, DOI 10.1002/path.1711640113; STAHL S, 1988, NUCLEIC ACIDS RES, V16, P3025, DOI 10.1093/nar/16.7.3025; THOR AD, 1992, JNCI-J NATL CANCER I, V84, P845, DOI 10.1093/jnci/84.11.845; THORLACIUS S, 1993, CANCER RES, V53, P1637; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WILSON AC, 1992, P ANN M AM ASS CANCE; 1992, LANCET, V339, P71	27	378	388	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	OCT	1995	1	10					1029	1034		10.1038/nm1095-1029	http://dx.doi.org/10.1038/nm1095-1029			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489358				2022-12-25	WOS:A1995RX95100042
J	ZWEIER, JL; WANG, PH; SAMOUILOV, A; KUPPUSAMY, P				ZWEIER, JL; WANG, PH; SAMOUILOV, A; KUPPUSAMY, P			ENZYME-INDEPENDENT FORMATION OF NITRIC-OXIDE IN BIOLOGICAL TISSUES	NATURE MEDICINE			English	Article							RELAXING FACTOR; PERFUSED HEART; L-ARGININE; SUPEROXIDE; SYNTHASE; NITRATE; INJURY	The gaseous free radical nitric oxide (NO.) is an important regulator of a variety of biological functions and also has a role in the pathogenesis of cellular injury. It has been generally accepted that NO. is solely generated in biological tissues by specific nitric oxide synthases, NOSs, which metabolize arginine to citrulline with the formation of NO.. We report that NO. can also be generated in the ischaemic heart by direct reduction of nitrite to NO. under the acidotic and highly reduced conditions that occur. This NO. formation is not blocked by NOS inhibitors, and with long periods of ischaemia progressing to necrosis, this mechanism of NO. formation predominates. We observe that enzyme-independent NO. generation results in myocardial injury with a loss of contractile function. The existence of this enzyme-independent mechanism of NO. formation has important implications in our understanding of the pathogenesis and treatment of tissue injury.	JOHNS HOPKINS MED INST,JOHNS HOPKINS BAYVIEW MED CTR,DEPT MED,DIV CARDIOL,BALTIMORE,MD 21224	Johns Hopkins University; Johns Hopkins Medicine	ZWEIER, JL (corresponding author), JOHNS HOPKINS MED INST,JOHNS HOPKINS BAYVIEW MED CTR,CTR ELECTRON PARAMAGNET RESONANACE,BALTIMORE,MD 21224, USA.		Samouilov, Alexandre/B-5824-2014; Samouilov, Alexandre/E-4010-2011		NHLBI NIH HHS [HL-17655, HL-38324] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038324, R01HL038324, P50HL017655] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; CHZHAN M, 1993, J MAGN RESON SER A, V105, P49, DOI 10.1006/jmra.1993.1246; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; FURFINE ES, 1993, BIOCHEMISTRY-US, V32, P8512, DOI 10.1021/bi00084a017; GARSIDE C, 1982, MAR CHEM, V11, P159, DOI 10.1016/0304-4203(82)90039-1; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; IGNARRO LJ, 1987, CIRC RES, V61, P866, DOI 10.1161/01.RES.61.6.866; LAI CS, 1994, FEBS LETT, V345, P120, DOI 10.1016/0014-5793(94)00422-6; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; LANGREHR JM, 1993, TRANSPLANTATION, V55, P1205, DOI 10.1097/00007890-199306000-00001; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; MONCADA S, 1989, BIOCHEM PHARMACOL, V38, P1709, DOI 10.1016/0006-2952(89)90403-6; MONCADA S, 1991, PHARMACOL REV, V43, P109; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; SHINOBU LA, 1984, ACTA PHARMACOL TOX, V54, P189; ZWEIER JL, 1987, J BIOL CHEM, V262, P8015; ZWEIER JL, 1988, J BIOL CHEM, V263, P1353; ZWEIER JL, 1995, J BIOL CHEM, V270, P304, DOI 10.1074/jbc.270.1.304; ZWEIER JL, 1989, J BIOL CHEM, V264, P18890	22	657	679	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1995	1	8					804	809		10.1038/nm0895-804	http://dx.doi.org/10.1038/nm0895-804			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585184				2022-12-25	WOS:A1995RM63500038
J	GRUIS, NA; VANDERVELDEN, PA; SANDKUIJL, LA; PRINS, DE; WEAVERFELDHAUS, J; KAMB, A; BERGMAN, W; FRANTS, RR				GRUIS, NA; VANDERVELDEN, PA; SANDKUIJL, LA; PRINS, DE; WEAVERFELDHAUS, J; KAMB, A; BERGMAN, W; FRANTS, RR			HOMOZYGOTES FOR CDKN2 (P16) GERMLINE MUTATION IN DUTCH FAMILIAL MELANOMA KINDREDS	NATURE GENETICS			English	Letter							DNA		LEIDEN UNIV,MGC DEPT HUMAN GENET,LEIDEN,NETHERLANDS; UNIV LEIDEN HOSP,DEPT DERMATOL,LEIDEN,NETHERLANDS; MYRIAD GENET INC,SALT LAKE CITY,UT	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Myriad Genetics, Inc				van der Velden, Pieter/0000-0002-5710-9256; Gruis, Nelleke/0000-0002-5210-9150; Orr, Harry/0000-0001-6118-741X				BERGMAN W, 1994, J INVEST DERMATOL, V103, pS122; BERGMAN W, 1992, CYTOGENET CELL GENET, V59, P161, DOI 10.1159/000133232; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; GRULS NA, 1993, MELANOMA RES, V3, P271; GUAN KL, 1994, GENE DEV, V8, P2939, DOI 10.1101/gad.8.24.2939; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; Maniatis T, 1989, DECONTAMINATION DILU; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0	17	268	273	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					351	353		10.1038/ng0795-351	http://dx.doi.org/10.1038/ng0795-351			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670475				2022-12-25	WOS:A1995RG38600021
J	ROWE, RE; WAPELHORST, B; BELL, GI; RISCH, N; SPIELMAN, RS; CONCANNON, P				ROWE, RE; WAPELHORST, B; BELL, GI; RISCH, N; SPIELMAN, RS; CONCANNON, P			LINKAGE AND ASSOCIATION BETWEEN INSULIN-DEPENDENT DIABETES-MELLITUS (IDDM) SUSCEPTIBILITY AND MARKERS NEAR THE GLUCOKINASE GENE ON CHROMOSOME-7	NATURE GENETICS			English	Note							POLYMORPHISM; REGION		VIRGINIA MASON RES CTR,SEATTLE,WA 98101; WASHINGTON UNIV,DEPT IMMUNOL,SEATTLE,WA; UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637; STANFORD UNIV,SCH MED,STANFORD,CA 94305; UNIV PENN,SCH MED,PHILADELPHIA,PA 19104	Virginia Mason Medical Center; Howard Hughes Medical Institute; University of Chicago; Stanford University; University of Pennsylvania				Martin, Beth/0000-0002-9661-014X; Concannon, Patrick/0000-0002-5801-1859	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046618, R01DK046627, R01DK046635] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK046635, DK46618, DK46627, DK46635] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAIN SC, 1992, LANCET, V340, P54, DOI 10.1016/0140-6736(92)92469-V; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; CHARMLEY P, 1993, IMMUNOGENETICS, V38, P92; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; KRETZ KA, 1989, NUCLEIC ACIDS RES, V17, P5864, DOI 10.1093/nar/17.14.5864; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; OLMOS P, 1988, DIABETOLOGIA, V31, P747, DOI 10.1007/BF00274777; RISCH N, 1987, AM J HUM GENET, V40, P1; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STOFFEL M, 1992, P NATL ACAD SCI USA, V89, P7698, DOI 10.1073/pnas.89.16.7698; STOFFEL M, 1993, DIABETOLOGIA, V36, P170, DOI 10.1007/BF00400700	17	56	57	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					240	242		10.1038/ng0695-240	http://dx.doi.org/10.1038/ng0695-240			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663523				2022-12-25	WOS:A1995RA85700026
J	SERVADIO, A; KOSHY, B; ARMSTRONG, D; ANTALFFY, B; ORR, HT; ZOGHBI, HY				SERVADIO, A; KOSHY, B; ARMSTRONG, D; ANTALFFY, B; ORR, HT; ZOGHBI, HY			EXPRESSION ANALYSIS OF THE ATAXIN-1 PROTEIN IN TISSUES FROM NORMAL AND SPINOCEREBELLAR ATAXIA TYPE-1 INDIVIDUALS	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; HUNTINGTONS-DISEASE GENE; BULBAR MUSCULAR-ATROPHY; DELETION; DOMAINS	Spinocerebellar ataxia type 1 (SCA1) is an autosomal dominant neurodegenerative disorder caused by expansion of a CAG trinucleotide repeat which codes for glutamine in the protein ataxin-1. We have investigated the effect of this expansion on ataxin-1 by immunoblot analysis. The wild-type protein is detected in both normal and affected individuals; however, a mutant protein which varies in its migration properties according to the size of the CAG repeat is detected in cultured cells and tissues from SCA1 individuals. The protein has a nuclear localization in ail normal and SCA1 brain regions examined but a cytoplasmic localization of ataxin-1 was also observed in cerebellar Purkinje cells. Our data show that in SCAI, the expanded alleles are faithfully translated into proteins of apparently normal stability and distribution.	BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030; UNIV MINNESOTA,INST HUMAN GENET,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,DEPT BIOCHEM,MINNEAPOLIS,MN 55455	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities				Zoghbi, Huda/0000-0002-0700-3349; Orr, Harry/0000-0001-6118-741X				BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; CATTORETTI G, 1993, J PATHOL, V171, P83, DOI 10.1002/path.1711710205; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; GREEN H, 1993, CELL, V74, P955, DOI 10.1016/0092-8674(93)90718-6; GUSELLA JF, 1985, NATURE, V318, P75, DOI 10.1038/318075a0; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; MATILLA T, IN PRESS ANN NEUROL; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PASCAL E, 1991, GENE DEV, V5, P1646, DOI 10.1101/gad.5.9.1646; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; QUIGLEY CA, 1992, J CLIN ENDOCR METAB, V74, P927, DOI 10.1210/jc.74.4.927; RANUM LPW, 1994, AM J HUM GENET, V55, P244; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; TRIFIRO M, 1991, MOL CELL ENDOCRINOL, V75, P37, DOI 10.1016/0303-7207(91)90243-L; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213; ZOGHBI HY, 1993, CURRENT NEUROLOGY, P87; 1993, CELL, V72, P971	26	245	251	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					94	98		10.1038/ng0595-94	http://dx.doi.org/10.1038/ng0595-94			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647801				2022-12-25	WOS:A1995QX57300022
J	HIYAMA, E; HIYAMA, K; YOKOYAMA, T; MATSUURA, Y; PIATYSZEK, MA; SHAY, JW				HIYAMA, E; HIYAMA, K; YOKOYAMA, T; MATSUURA, Y; PIATYSZEK, MA; SHAY, JW			CORRELATING TELOMERASE ACTIVITY LEVELS WITH HUMAN NEUROBLASTOMA OUTCOMES	NATURE MEDICINE			English	Article							NEURO-BLASTOMA; HUMAN FIBROBLASTS; N-MYC; CELLULAR SENESCENCE; CHILDRENS CANCER; PROGNOSIS; STAGE; CELLS; DNA; IMMORTALIZATION	Telomerase activity was analysed in 100 neuroblastoma cases. Although telomerase activity was not detected in normal adrenal tissues or benign ganglioneuromas, almost all neuroblastomas (94%) did express it, suggesting an important role for telomerase in neuroblastoma development. Neuroblastomas with high telomerase activity had other genetic changes (for example, N-myc amplification) and an unfavourable prognosis, whereas tumours with low telomerase activity were devoid of such genetic alterations and were associated with a favourable prognosis. Three neuroblastomas lacking telomerase activity regressed (stage IVS). Thus telomerase expression may be required as a critical step in the multigenetic process of tumorigenesis, and two different pathways may exist for the development of neuroblastoma.	UNIV TEXAS,SW MED CTR,DEPT CELL BIOL & NEUROSCI,DALLAS,TX 75235; HIROSHIMA UNIV,SCH MED,DEPT GEN MED,HIROSHIMA 734,JAPAN; HIROSHIMA UNIV,SCH MED,DEPT INTERNAL MED 2,HIROSHIMA 734,JAPAN; HIROSHIMA UNIV,SCH MED,DEPT SURG 1,HIROSHIMA 734,JAPAN	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Hiroshima University; Hiroshima University; Hiroshima University			Shay, Jerry W/F-7878-2011; Piatyszek, Mieczyslaw A./F-9365-2015; Hiyama, Eiso/A-2013-2019	Piatyszek, Mieczyslaw A./0000-0003-0502-3239; Hiyama, Eiso/0000-0001-9179-5037	NATIONAL INSTITUTE ON AGING [R01AG007992] Funding Source: NIH RePORTER; NIA NIH HHS [AG 07992] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; COUNTER CM, 1994, J VIROL, V68, P3410, DOI 10.1128/JVI.68.5.3410-3414.1994; DANGIO GJ, 1971, LANCET, V1, P1046; DELANGE T, 1994, P NATL ACAD SCI USA, V91, P2882, DOI 10.1073/pnas.91.8.2882; Evans A E, 1976, Natl Cancer Inst Monogr, V44, P49; EVANS AE, 1981, ARCH DIS CHILD, V56, P271, DOI 10.1136/adc.56.4.271; EVANS AE, 1971, CANCER, V27, P374, DOI 10.1002/1097-0142(197102)27:2<374::AID-CNCR2820270221>3.0.CO;2-G; FINKLESTEIN JZ, 1979, MED PEDIATR ONCOL, V6, P179, DOI 10.1002/mpo.2950060211; FONG CT, 1989, P NATL ACAD SCI USA, V86, P3753, DOI 10.1073/pnas.86.10.3753; GREIDER CW, 1990, BIOESSAYS, V12, P363, DOI 10.1002/bies.950120803; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HAYASHI Y, 1989, CANCER, V63, P126, DOI 10.1002/1097-0142(19890101)63:1<126::AID-CNCR2820630120>3.0.CO;2-Z; HELLSTROM IE, 1968, P NATL ACAD SCI USA, V60, P1231, DOI 10.1073/pnas.60.4.1231; HIYAMA E, 1992, JPN J CANCER RES, V83, P159, DOI 10.1111/j.1349-7006.1992.tb00081.x; HIYAMA E, 1995, INT J ONCOL, V6, P13; IKEDA Y, 1981, J PEDIATR SURG, V16, P636, DOI 10.1016/0022-3468(81)90019-1; JAMES DH, 1965, J AMER MED ASSOC, V194, P123, DOI 10.1001/jama.1965.03090150015003; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; KRETSCHMAR CS, 1984, J CLIN ONCOL, V2, P799, DOI 10.1200/JCO.1984.2.7.799; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7; MANTELL LL, 1994, EMBO J, V13, P3211, DOI 10.1002/j.1460-2075.1994.tb06620.x; MEHLE C, 1994, CANCER RES, V54, P236; MOTIN GB, 1989, CELL, V59, P521; NURNBERG P, 1993, HUM GENET, V91, P190; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; PRICHARD J, 1994, LANCET, V344, P869; RANGECROFT L, 1978, ARCH DIS CHILD, V52, P815; SAWADA T, 1991, AM J PEDIAT HEMATOL, V13, P3; SAWAGUCHI S, 1990, CANCER, V66, P1879, DOI 10.1002/1097-0142(19901101)66:9<1879::AID-CNCR2820660905>3.0.CO;2-L; SCHMITT H, 1994, GENE CHROMOSOME CANC, V11, P171, DOI 10.1002/gcc.2870110306; SCHWARTZ HS, 1993, CANCER GENET CYTOGEN, V71, P132, DOI 10.1016/0165-4608(93)90018-H; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SHAY JW, 1995, MOL CELL BIOL, V15, P425, DOI 10.1128/MCB.15.1.425; SHAY JW, 1993, ONCOGENE, V8, P1407; SHAY JW, 1993, INT J ONCOL, V3, P559; SHAY JW, 1993, BREAST CANCER RES TR, V25, P83, DOI 10.1007/BF00662404; SHAY JW, 1994, CELL DIFFER, V2, P1; SHIMADA H, 1984, J NATL CANCER I, V73, P405, DOI 10.1093/jnci/73.2.405; TURKEL SB, 1974, AM J PATHOL, V76, P225; VAZIRI H, 1993, AM J HUM GENET, V52, P661; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; WOODS WG, 1992, PEDIATRICS, V89, P114; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C; WRIGHT WE, 1992, TRENDS GENET, V8, P193, DOI 10.1016/0168-9525(92)90232-S; YOUNG JL, 1986, CANCER, V56, P598; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	56	608	631	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAR	1995	1	3					249	255		10.1038/nm0395-249	http://dx.doi.org/10.1038/nm0395-249			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX559	7585042				2022-12-25	WOS:A1995QX55900032
J	REIS, A; HENNIES, HC; LANGBEIN, L; DIGWEED, M; MISCHKE, D; DRECHSLER, M; SCHROCK, E; ROYERPOKORA, B; FRANKE, WW; SPERLING, K; KUSTER, W				REIS, A; HENNIES, HC; LANGBEIN, L; DIGWEED, M; MISCHKE, D; DRECHSLER, M; SCHROCK, E; ROYERPOKORA, B; FRANKE, WW; SPERLING, K; KUSTER, W			KERATIN-9 GENE-MUTATIONS IN EPIDERMOLYTIC PALMOPLANTAR KERATODERMA (EPPK)	NATURE GENETICS			English	Article							POINT MUTATIONS; HYPERKERATOSIS; EXPRESSION; POLYMORPHISMS; SUBDOMAIN; LINKAGE; DISEASE	We have isolated the gene for human type l keratin 9(KRT9) and localised it to chromosome 17q21. Patients with epidermolytic palmoplantar keratoderma (EPPK), an autosomal dominant skin disease, were investigated. Three KRT9 mutations, N160K, R162Q, and R162W, were identified. All the mutations are in the highly conserved coil 1A of the rod domain, thought to be important for heterodimerisation. R162W was detected in five unrelated families and affects the corresponding residue in the keratin 14 and keratin 10 genes that is also altered in cases of epidermolysis bullosa simplex and generalised epidermolytic hyperkeratosis, respectively. These findings provide further evidence that mutations in keratin genes may cause epidermolysis and hyperkeratosis and that hyperkeratosis of palms and soles may be caused by different mutations in the KRT9 gene.	GERMAN CANC RES CTR,DIV CELL BIOL,D-69120 HEIDELBERG,GERMANY; FREE UNIV BERLIN,DEPT EXPTL ONCOL & TRANSPLANTAT MED,D-14050 BERLIN,GERMANY; UNIV HEIDELBERG,INST HUMAN GENET,D-69120 HEIDELBERG,GERMANY; UNIV MARBURG,DEPT DERMATOL,D-35037 MARBURG,GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Ruprecht Karls University Heidelberg; Philipps University Marburg	REIS, A (corresponding author), FREE UNIV BERLIN,INST HUMAN GENET,HEUBNERWEG 6,D-14059 BERLIN,GERMANY.		Hennies, Hans C/G-9424-2014; Reis, André/D-2309-2009	Hennies, Hans C/0000-0001-7210-2389; Reis, André/0000-0002-6301-6363; Franke, Werner W./0000-0002-4873-8448				BONLFAS JM, 1991, SCIENCE, V254, P1202; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; COMPTON JG, 1992, NAT GENET, V1, P301, DOI 10.1038/ng0792-301; COOPER DN, 1985, HUM GENET, V69, P201, DOI 10.1007/BF00293024; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; DONG W, 1993, HUM MUTAT, V2, P94, DOI 10.1002/humu.1380020206; FUCHS E, 1992, P NATL ACAD SCI USA, V89, P6906, DOI 10.1073/pnas.89.15.6906; HENNIES HC, 1993, HUM MOL GENET, V2, P87, DOI 10.1093/hmg/2.1.87; HOVNANIAN A, 1993, NAT GENET, V3, P327, DOI 10.1038/ng0493-327; KNAPP AC, 1986, J CELL BIOL, V103, P657, DOI 10.1083/jcb.103.2.657; KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910; KORGE BP, 1992, J INVEST DERMATOL, V99, P687; KUSTER W, 1992, ACTA DERM-VENEREOL, V72, P120; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LANGBEIN L, 1993, DIFFERENTIATION, V55, P57, DOI 10.1111/j.1432-0436.1993.tb00033.x; LESSIN SR, 1988, J INVEST DERMATOL, V91, P572, DOI 10.1111/1523-1747.ep12477087; LICHTER P, 1992, HUMAN CYTOGENETICS P, P157; McKusick V.A., 1992, MENDELIAN INHERITANC; MISCHKE D, 1993, HUM MOL GENET, V2, P618, DOI 10.1093/hmg/2.5.618; MOLL I, 1987, DIFFERENTIATION, V33, P254, DOI 10.1111/j.1432-0436.1987.tb01565.x; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PARRY DAD, 1977, J MOL BIOL, V113, P449, DOI 10.1016/0022-2836(77)90153-X; REID T, 1992, P NATL ACAD SCI USA, V89, P1388; RELS A, 1992, HUM GENET, V90, P113; ROMANO V, 1988, CYTOGENET CELL GENET, V46, P683; ROSENBERG M, 1988, MOL CELL BIOL, V8, P722, DOI 10.1128/MCB.8.2.722; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; Sambrook J, 1989, MOL CLONING LABORATO; STEINERT PM, 1993, J INVEST DERMATOL, V100, P729, DOI 10.1111/1523-1747.ep12475665; STEINERT PM, 1993, J BIOL CHEM, V268, P2878; THOST A, 1880, THESIS HELDELBERG; UNNA PG, 1883, ARCH DERMATOL SYPHIL, V15, P231; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; VERMA AS, 1989, HUMAN CHROMOSOMES MA; Vorner H, 1901, ARCH DERMATOL SYPH-G, V56, P3; WANNER R, 1993, J INVEST DERMATOL, V100, P735, DOI 10.1111/1523-1747.ep12475671; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z	41	220	235	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					174	179		10.1038/ng0294-174	http://dx.doi.org/10.1038/ng0294-174			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	7512862				2022-12-25	WOS:A1994MU76300013
J	HAYASAKA, K; HIMORO, M; SATO, W; TAKADA, G; UYEMURA, K; SHIMIZU, N; BIRD, TD; CONNEALLY, PM; CHANCE, PF				HAYASAKA, K; HIMORO, M; SATO, W; TAKADA, G; UYEMURA, K; SHIMIZU, N; BIRD, TD; CONNEALLY, PM; CHANCE, PF			CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-1B IS ASSOCIATED WITH MUTATIONS OF THE MYELIN-P(0) GENE	NATURE GENETICS			English	Article							MAJOR STRUCTURAL PROTEIN; PERIPHERAL MYELIN; DISEASE TYPE-1A; HEREDITARY MOTOR; DUFFY LOCUS; LINKAGE; DNA; CHROMOSOME-1; SEQUENCE; DUPLICATION	P0, a major structural protein of peripheral myelin, is a homophilic adhesion molecule and maps to chromosome 1q22-q23, in the region of the locus for Charcot-Marie-Tooth neuropathy type 1B (CMT1B). We have investigated P0 as a candidate gene in two pedigrees with CMT1B and found point mutations which are completely linked with the disease (Z=5.5, theta=0). The mutations, glutamate substitution for lysine 96 or aspartate 90, are located in the extracellular domain, which plays a significant role in myelin membrane adhesion. Individuals with CMT1B are heterozygous for the normal allele and the mutant allele. Our results indicate that P0 is a gene responsible for CMT1B.	UNIV WASHINGTON,SCH MED,DIV MED GENET & NEUROL,SEATTLE,WA 98195; AKITA UNIV,SCH MED,DEPT DENT,AKITA 010,JAPAN; KEIO UNIV,SCH MED,DEPT PHYSIOL,TOKYO 160,JAPAN; KEIO UNIV,SCH MED,DEPT MOLEC BIOL,TOKYO 160,JAPAN; INDIANA UNIV,DEPT MED GENET,INDIANAPOLIS,IN 46202; CHILDRENS HOSP PHILADELPHIA,DIV NEUROL RES,PHILADELPHIA,PA 19104	University of Washington; University of Washington Seattle; Akita University; Keio University; Keio University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	HAYASAKA, K (corresponding author), AKITA UNIV,SCH MED,DEPT PEDIAT,AKITA 010,JAPAN.		Chance, Phillip/AAX-5826-2020; Hayasaka, Kiyoshi/H-5340-2012	Hayasaka, Kiyoshi/0000-0003-3621-8901				BARBU M, 1990, J NEUROSCI RES, V25, P143, DOI 10.1002/jnr.490250119; BIRD TD, 1982, AM J HUM GENET, V34, P388; CHANCE PF, 1990, AM J HUM GENET, V47, P915; CHANCE PF, 1992, NEUROLOGY, V42, P2037, DOI 10.1212/WNL.42.10.2037; DEFESCHE JC, 1990, NEUROLOGY, V40, P1450, DOI 10.1212/WNL.40.9.1450; Dyck P.J, 1993, PNP, P1094; ESPELUND M, 1990, NUCLEIC ACIDS RES, V18, P6157, DOI 10.1093/nar/18.20.6157; FISCHBECK KH, 1986, ANN NEUROL, V20, P527, DOI 10.1002/ana.410200414; GAL A, 1985, HUM GENET, V70, P38, DOI 10.1007/BF00389456; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HARDING AE, 1980, J MED GENET, V17, P329, DOI 10.1136/jmg.17.5.329; HAYASAKA K, 1991, BIOCHEM BIOPH RES CO, V180, P515, DOI 10.1016/S0006-291X(05)81094-0; HAYASAKA K, IN PRESS GENOMICS; IONASESCU VV, 1992, AM J MED GENET, V42, P728, DOI 10.1002/ajmg.1320420521; KULKENS, IN PRESS NATURE GENE; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEBO RV, 1991, HUM GENET, V88, P1, DOI 10.1007/BF00204921; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MISIURA K, 1990, NUCLEIC ACIDS RES, V18, P4345, DOI 10.1093/nar/18.15.4345; OAKEY RJ, 1992, HUM MOL GENET, V1, P613, DOI 10.1093/hmg/1.8.613; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; SAKAMOTO Y, 1987, J BIOL CHEM, V262, P4208; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STEBBINS NB, 1982, AM J HUM GENET, V34, pA195; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; Uyemura Keiichi, 1992, P481; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VANCE JM, 1989, EXP NEUROL, V104, P186, DOI 10.1016/S0014-4886(89)80013-5	33	350	359	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1993	5	1					31	34		10.1038/ng0993-31	http://dx.doi.org/10.1038/ng0993-31			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LV565	7693129				2022-12-25	WOS:A1993LV56500011
J	BENOTHMANE, K; BENHAMIDA, M; PERICAKVANCE, MA; BENHAMIDA, C; BLEL, S; CARTER, SC; BOWCOCK, AM; PETRUKHIN, K; GILLIAM, TC; ROSES, AD; HENTATI, F; VANCE, JM				BENOTHMANE, K; BENHAMIDA, M; PERICAKVANCE, MA; BENHAMIDA, C; BLEL, S; CARTER, SC; BOWCOCK, AM; PETRUKHIN, K; GILLIAM, TC; ROSES, AD; HENTATI, F; VANCE, JM			LINKAGE OF TUNISIAN AUTOSOMAL RECESSIVE DUCHENNE-LIKE MUSCULAR-DYSTROPHY TO THE PERICENTROMERIC REGION OF CHROMOSOME 13Q	NATURE GENETICS			English	Article							SKELETAL-MUSCLE; LIKELIHOOD; PEDIGREES; COMPLEX; GENE	Autosomal recessive Duchenne-like muscular dystrophy (DLMD) is a severe dystrophic myopathy. The incidence is unknown because of its clinical similarity to Duchenne muscular dystrophy (DMD). Three highly inbred DLMD families from Tunisia were analysed for chromosomal linkage using 135 polymorphic microsatellite markers. A significant lod score of z = 9.15 at theta = 0.03 was found with the 13q12 locus D13S115. Two additional 13q12 markers, D13S143 and D13S120, also gave significant lod scores. Therefore, the primary DLMD defect gene lies in the pericentrometric region of chromosome 13q.	INST NATL NEUROL, TUNIS, TUNISIA; UNIV TEXAS, SW MED CTR, DEPT PEDIAT, DALLAS, TX 75235 USA; COLUMBIA UNIV, NEW YORK, NY 10032 USA	Universite de Tunis-El-Manar; Institut National de Neurologie; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Columbia University	BENOTHMANE, K (corresponding author), DUKE UNIV, MED CTR, DEPT MED, DIV NEUROL, DURHAM, NC 27710 USA.			Vance, Jeffery/0000-0003-3815-8199; Bowcock, Anne/0000-0001-8691-9090				AZII K, 1991, CYTOGENET CELL GENET, V58, P1907; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BENHAMIDA M, 1980, ADV NEW TRENDS, V527, P43; BENJELLOUNDELLAGI S, 1990, NEUROLOGY, V40, P1903; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DUBOWITZ V, 1960, BRAIN, V83, P432, DOI 10.1093/brain/83.3.432; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; EMERY AEH, 1987, OXFORD MONOGRAPHS ME, V15, P75; FARAG TI, 1990, AM J MED GENET, V37, P290, DOI 10.1002/ajmg.1320370229; FRYDMAN M, 1985, P NATL ACAD SCI USA, V82, P1819, DOI 10.1073/pnas.82.6.1819; HAMIDA MB, 1983, MUSCLE NERVE, V6, P469, DOI 10.1002/mus.880060702; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; MATSUMURA K, IN PRESS NATURE; MCGUIRE SA, 1991, MUSCLE NERVE, V14, P1209, DOI 10.1002/mus.880141212; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; OTT J, 1974, AM J HUM GENET, V26, P588; Ott J., 1991, ANAL HUMAN GENETIC L; PERICAKVANCE MA, 1988, AUST PAEDIATR J S, V87; SPEER MC, 1992, AM J HUM GENET, V50, P1211; WALTON JN, 1956, ANN HUM GENET, V21, P40, DOI 10.1111/j.1469-1809.1971.tb00264.x; WEBER JL, 1989, AM J HUM GENET, V44, P388; ZATZ M, 1989, AM J MED GENET, V32, P407, DOI 10.1002/ajmg.1320320328	25	180	184	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1992	2	4					315	317		10.1038/ng1292-315	http://dx.doi.org/10.1038/ng1292-315			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303286				2022-12-25	WOS:A1992KB49500017
J	RICHARDS, RI; HOLMAN, K; FRIEND, K; KREMER, E; HILLEN, D; STAPLES, A; BROWN, WT; GOONEWARDENA, P; TARLETON, J; SCHWARTZ, C; SUTHERLAND, GR				RICHARDS, RI; HOLMAN, K; FRIEND, K; KREMER, E; HILLEN, D; STAPLES, A; BROWN, WT; GOONEWARDENA, P; TARLETON, J; SCHWARTZ, C; SUTHERLAND, GR			EVIDENCE OF FOUNDER CHROMOSOMES IN FRAGILE-X SYNDROME	NATURE GENETICS			English	Article								The mutation responsible for fragile X syndrome and myotonic dystrophy involves the amplification of a simple trinucleotide repeat sequence, which increases in successive generations of affected pedigrees accounting for increasing penetrance of both disorders. This common molecular basis suggests that the two diseases may share other genetic features, but whereas myotonic dystrophy exhibits a significant founder chromosome effect, fragile X syndrome apparently has a very high mutation frequency. By haplotype analysis of microsatellite markers which flank the fragile X unstable element, we have uncovered evidence of founder chromosomes of the fragile X 'mutation'. Disorders caused by heritable unstable elements may therefore exhibit common genetic properties including anticipation and founder chromosomes.	ADELAIDE CHILDRENS HOSP INC,DEPT MED GENET & EPIDEMIOL,ADELAIDE,SA 5006,AUSTRALIA; NEW YORK STATE INST BASIC RES DEV DISABILITIES,DEPT HUMAN GENET,STATEN ISL,NY 10314; N SHORE UNIV HOSP,DEPT PEDIAT,MANHASSET,NY 11030; GREENWOOD GENET CTR,GREENWOOD,SC 29646	Institute for Basic Research in Developmental Disabilities; Northwell Health; North Shore University Hospital; Greenwood Genetic Center	RICHARDS, RI (corresponding author), ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA.		Kremer, EJ/P-9838-2019; Kremer, Eric J/D-3734-2013; Richards, Robert/ABE-6423-2020; Brown, William/GXN-2777-2022; Sutherland, Grant Robert/D-2606-2012	Kremer, EJ/0000-0001-6114-7530; Richards, Robert Ian/0000-0002-5978-6453				ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; DRUGGE U, 1991, AM J MED GENET, V38, P363, DOI 10.1002/ajmg.1320380240; FU YH, 1991, CELL, V67, P1; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; RICHARDS RI, 1991, J MED GENET, V28, P818, DOI 10.1136/jmg.28.12.818; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; RICHARDS RI, IN PRESS TRENDS GENE; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Sherman S., 1991, FRAGILE X SYNDROME D, P69; SUTHERLAND GR, 1991, LANCET, V338, P289, DOI 10.1016/0140-6736(91)90426-P; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; YU S, 1992, AM J HUM GENET, V50, P968; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	20	173	176	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1992	1	4					257	260		10.1038/ng0792-257	http://dx.doi.org/10.1038/ng0792-257			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1302021				2022-12-25	WOS:A1992JC98400008
J	CHEN, ZY; HENDRIKS, RW; JOBLING, MA; POWELL, JF; BREAKEFIELD, XO; SIMS, KB; CRAIG, IW				CHEN, ZY; HENDRIKS, RW; JOBLING, MA; POWELL, JF; BREAKEFIELD, XO; SIMS, KB; CRAIG, IW			ISOLATION AND CHARACTERIZATION OF A CANDIDATE GENE FOR NORRIE DISEASE	NATURE GENETICS			English	Article							PRENATAL-DIAGNOSIS; DNA; SEQUENCES; DELETION; FAMILY; LOCUS	Previous analysis has refined the location of the gene for Norrie disease, a severe, X-linked, recessive neurodevelopmental disorder, to a yeast artificial chromosome subfragment of 160 kilobases (kb). This fragment was used to screen cDNA libraries from human fetal and adult retina. As a result, we have identified an evolutionarily conserved cDNA, which is expressed in fetal and adult brain and encodes a predicted protein of 133 amino acids. The cDNA detects genomic sequences which span a maximum of 50 kb, and which are partly deleted in several typical Norrie disease patients. An EcoRI polymorphism with a calculated heterozygosity value of 43% was observed. The locus identified is a strong candidate for the Norrie disease gene.	UNIV OXFORD,DEPT BIOCHEM,GENET LAB,S PARKS RD,OXFORD OX1 3QU,ENGLAND; INST PSYCHIAT,DEPT NEUROSCI,LONDON SE5 8AF,ENGLAND; MASSACHUSETTS GEN HOSP,CTR NEUROSCI,MOLEC NEUROGENET LAB,BOSTON,MA 02114	University of Oxford; University of London; King's College London; Harvard University; Massachusetts General Hospital			Craig, Ian/AAF-9167-2019; Powell, John F/G-4412-2011	Powell, John F/0000-0001-6124-439X; Craig, Ian/0000-0002-4063-1005; Jobling, Mark/0000-0002-8061-1308	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHEN ZY, 1991, CYTOGENET CELL GENET, V58, P2059; CHEN ZY, 1991, CYTOGENET CELL GENET, V58, P2060; CHEN ZY, IN PRESS HUM MOL GEN; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; DAVIES KE, 1991, CYTOGENET CELL GENET, V58, P853, DOI 10.1159/000133183; DELACHAPELLE A, 1985, CLIN GENET, V28, P317; DONNAI D, 1988, J MED GENET, V25, P73, DOI 10.1136/jmg.25.2.73; DUDOV KP, 1984, CELL, V37, P457, DOI 10.1016/0092-8674(84)90376-3; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5311; GAL A, 1986, CYTOGENET CELL GENET, V42, P219, DOI 10.1159/000132282; KATAYAMA S, 1988, J MED GENET, V30, P967; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAN NC, 1989, GENOMICS, V4, P552, DOI 10.1016/0888-7543(89)90279-6; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEFF SE, 1986, ANN REV BIOCH, V55, P1092; LINDSAY S, 1992, HUM GENET, V88, P349; LUND E, 1983, MOL CELL BIOL, V3, P2211, DOI 10.1128/MCB.3.12.2211; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NGO JT, 1988, CLIN GENET, V34, P43; NORRIE G, 1927, ACTA OPHTHALMOL, V5, P3578; POVEY S, 1980, ANN HUM GENET, V43, P241, DOI 10.1111/j.1469-1809.1980.tb01557.x; ROSS MT, 1990, GENOMICS, V6, P528, DOI 10.1016/0888-7543(90)90482-A; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SIMS KB, 1989, AM J HUM GENET, V45, P424; SIMS KB, IN PRESS HUM MOL GEN; SOUTHERN EM, 1987, NUCLEIC ACIDS RES, V15, P5925, DOI 10.1093/nar/15.15.5925; Warburg M., 1966, ACTA OPHTHALMOL SCAN, V89, P1; ZHU DP, 1989, AM J MED GENET, V33, P485, DOI 10.1002/ajmg.1320330415	34	170	181	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					204	208		10.1038/ng0692-204	http://dx.doi.org/10.1038/ng0692-204			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303236				2022-12-25	WOS:A1992JC98200014
J	AMADORI, A; ZAMARCHI, R; DESILVESTRO, G; FORZA, G; CAVATTON, G; DANIELI, GA; CLEMENTI, M; CHIECOBIANCHI, L				AMADORI, A; ZAMARCHI, R; DESILVESTRO, G; FORZA, G; CAVATTON, G; DANIELI, GA; CLEMENTI, M; CHIECOBIANCHI, L			GENETIC-CONTROL OF THE CD4/CD8 T-CELL RATIO IN HUMANS	NATURE MEDICINE			English	Article							LYMPHOCYTE SUBPOPULATIONS; IMMUNE FUNCTION; SUBSETS; THERAPY; MODEL; MICE; CRYOPRECIPITATE; HEMOPHILIACS; MECHANISM	We studied the genetic pattern of inheritance of the ratio between circulating CD4(+) and CD8(+) T lymphocytes in a population of healthy donors. The distribution of the CD4/CD8 ratio in males and females was significantly different and was significantly affected by age. In 46 randomly selected families, the parental CD4/CD8 ratio significantly influenced the ratio in offspring. Complex segregation analysis of the data rejected the non-genetic hypothesis; among the genetic models tested, a major recessive gene with a polygenic component and random environmental effects was the most parsimonious model. These findings indicate that the ratio of CD4(+) and CD8(+) T cells is genetically controlled in humans.	AZIENDA OSPED,BLOOD TRANSFUS UNIT,I-35128 PADUA,ITALY; ULSS 7,SERT,I-31015 CONEGLIANO,ITALY; UNIV PADUA,DEPT BIOL,CHAIR GENET,I-35121 PADUA,ITALY; UNIV PADUA,DEPT PEDIAT,CHAIR MED GENET,I-35128 PADUA,ITALY	University of Padua; Azienda Ospedaliera - Universita di Padova; ULSS 7 Pedemontana; University of Padua; University of Padua	AMADORI, A (corresponding author), UNIV PADUA,OSPED BUSONETA,INTERUNIV CTR RES CANC,INST ONCOL,VIA GATTAMELATA 64,I-35128 PADUA,ITALY.		Zamarchi, Rita/K-4517-2016	Zamarchi, Rita/0000-0001-6435-2257				AMADORI A, 1992, J IMMUNOL, V148, P2709; CALLAHAN JE, 1993, J IMMUNOL, V151, P6657; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CUTHBERT RJG, 1992, BRIT J HAEMATOL, V80, P364, DOI 10.1111/j.1365-2141.1992.tb08146.x; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617; GRATAMA JW, 1986, BONE MARROW TRANSPL, V1, P141; HANNET I, 1992, IMMUNOL TODAY, V13, P215, DOI 10.1016/0167-5699(92)90157-3; HASSETT J, 1993, BLOOD, V82, P1351; KRAAL G, 1983, IMMUNOGENETICS, V18, P585, DOI 10.1007/BF00345966; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LANGLADEDEMOYEN P, 1988, J IMMUNOL, V141, P1949; MENITOVE JE, 1983, NEW ENGL J MED, V308, P83, DOI 10.1056/NEJM198301133080206; MICELI MC, 1993, ADV IMMUNOL, V53, P59, DOI 10.1016/S0065-2776(08)60498-8; Morton N.E., 1983, METHODS GENETIC EPID; MORTON NE, 1974, AM J HUM GENET, V26, P318; Mossmann TR, 1986, J IMMUNOL, V136, P2348; POLLACK S, 1985, AM J HEMATOL, V20, P1, DOI 10.1002/ajh.2830200102; RITCHIE AWS, 1983, BRIT MED J, V286, P1773, DOI 10.1136/bmj.286.6380.1773; ROMAGNANI S, 1991, IMMUNOL TODAY, V12, P256, DOI 10.1016/0167-5699(91)90120-I; ROWLANDJONES SL, 1993, LANCET, V341, P860, DOI 10.1016/0140-6736(93)93063-7; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; TEITEL JM, 1989, AM J HEMATOL, V32, P262, DOI 10.1002/ajh.2830320406; UTSUYAMA M, 1987, MECH AGEING DEV, V40, P89, DOI 10.1016/0047-6374(87)90037-6; ZANDER AR, 1985, TRANSPLANTATION, V40, P177, DOI 10.1097/00007890-198508000-00014	26	316	323	0	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1279	1283		10.1038/nm1295-1279	http://dx.doi.org/10.1038/nm1295-1279			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489409				2022-12-25	WOS:A1995TH78600040
J	IMBEAUD, S; FAURE, E; LAMARRE, I; MATTEI, MG; DICLEMENTE, N; TIZARD, R; CARREEUSEBE, D; BELVILLE, C; TRAGETHON, L; TONKIN, C; NELSON, J; MCAULIFFE, M; BIDART, JM; LABABIDI, A; JOSSO, N; CATE, RL; PICARD, JY				IMBEAUD, S; FAURE, E; LAMARRE, I; MATTEI, MG; DICLEMENTE, N; TIZARD, R; CARREEUSEBE, D; BELVILLE, C; TRAGETHON, L; TONKIN, C; NELSON, J; MCAULIFFE, M; BIDART, JM; LABABIDI, A; JOSSO, N; CATE, RL; PICARD, JY			INSENSITIVITY TO ANTI-MULLERIAN HORMONE DUE TO A MUTATION IN THE HUMAN ANTI-MULLERIAN HORMONE-RECEPTOR	NATURE GENETICS			English	Article							SERINE THREONINE KINASE; INHIBITING SUBSTANCE; MESSENGER-RNA; DUCT SYNDROME; SPLICE SITE; BIOLOGICAL-ACTIVITY; RIBONUCLEIC-ACID; GENE; DNA; ASSAY	Anti-Mullerian hormone (AMH) and its receptor are involved in the regression of Mullerian ducts in male fetuses. We have now cloned and mapped the human AMH receptor gene and provide genetic proof that it is required for AMH signalling, by identifying a mutation in the AMH receptor in a patient with persistent Mullerian duct syndrome. The mutation destroys the invariant dinucleotide at the 5' end of the second intron, generating two abnormal mRNAs, one missing the second exon, required for ligand binding, and the other incorporating the first 12 bases of the second intron. The similar phenotypes observed in AMH-deficient and AMH receptor-deficient individuals indicate that the AMH signalling machinery is remarkably simple, consisting of one ligand and one type II receptor.	ECOLE NORMALE SUPER,DEPT BIOL,INSERM,UNITE RECH ENDOCRINOL DEV,F-92120 MONTROUGE,FRANCE; INSERM,UNITE RECH GENET MED & DEV,F-13385 MARSEILLE 5,FRANCE; BIOGEN INC,CAMBRIDGE,MA 02142; INST GUSTAVE ROUSSY,SERV IMMUNOL CLIN,F-94805 VILLEJUIF,FRANCE; HOP BICETRE,SERV CHIRURG PEDIAT,F-94276 LE KREMLIN BICETR,FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Biogen; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP			; Imbeaud, Sandrine/P-8780-2017	belville, corinne/0000-0002-7841-214X; di Clemente, Nathalie/0000-0001-9087-3486; Imbeaud, Sandrine/0000-0001-8439-6732				ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; BAARENDS WM, 1994, DEVELOPMENT, V120, P189; BARSOUM J, 1990, DNA CELL BIOL, V9, P293, DOI 10.1089/dna.1990.9.293; BEHRINGER RR, 1994, CELL, V79, P415, DOI 10.1016/0092-8674(94)90251-8; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BRAND T, 1995, J BIOL CHEM, V270, P8274, DOI 10.1074/jbc.270.14.8274; BURKE JF, 1984, GENE, V30, P63, DOI 10.1016/0378-1119(84)90105-7; CARCAMO J, 1995, MOL CELL BIOL, V15, P1573; CARREEUSEBE D, 1992, HUM GENET, V90, P389; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DICLEMENTE N, 1994, ENDOCRINE, V2, P553; DICLEMENTE N, 1992, DEVELOPMENT, V114, P721; DICLEMENTE N, 1994, MOL ENDOCRINOL, V8, P1006, DOI 10.1210/me.8.8.1006; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GUERRIER D, 1989, J CLIN ENDOCR METAB, V68, P46, DOI 10.1210/jcem-68-1-46; GUSTAFSON ML, 1992, NEW ENGL J MED, V326, P466, DOI 10.1056/NEJM199202133260707; HARADA N, 1992, J BIOL CHEM, V267, P4781; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; HUMPHRIES DE, 1994, BIOCHEM BIOPH RES CO, V203, P1020, DOI 10.1006/bbrc.1994.2284; IMBEAUD S, 1994, HUM MOL GENET, V3, P125, DOI 10.1093/hmg/3.1.125; JOSSO N, 1993, RECENT PROG HORM RES, V48, P1; JOST A, 1953, RECENT PROG HORM RES, V8, P379; KARIYA Y, 1987, GENE, V53, P1, DOI 10.1016/0378-1119(87)90087-4; KNEBELMANN B, 1991, P NATL ACAD SCI USA, V88, P3767, DOI 10.1073/pnas.88.9.3767; KOENIG BB, 1994, MOL CELL BIOL, V14, P5961, DOI 10.1128/MCB.14.9.5961; KRAWCZAK M, 1992, HUM GENET, V90, P41; LIN HY, 1992, CELL, V68, P775, DOI 10.1016/0092-8674(92)90152-3; LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341; MASSAGUE J, 1992, CELL, V69, P1067, DOI 10.1016/0092-8674(92)90627-O; MATZUK MM, 1992, BIOCHEM BIOPH RES CO, V185, P404, DOI 10.1016/S0006-291X(05)81000-9; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PARKINSON DB, 1992, NAT GENET, V1, P149, DOI 10.1038/ng0592-149; PEPINSKY RB, 1988, J BIOL CHEM, V263, P18961; PICON R, 1969, ARCH ANAT MICROSC MO, V58, P1; REDINBAUGH MG, 1986, ANAL BIOCHEM, V153, P267, DOI 10.1016/0003-2697(86)90091-6; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEN WH, 1994, CELL, V77, P651, DOI 10.1016/0092-8674(94)90050-7; STOVER ML, 1993, J CLIN INVEST, V92, P1994, DOI 10.1172/JCI116794; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; TALERICO M, 1990, MOL CELL BIOL, V10, P6299, DOI 10.1128/MCB.10.12.6299; TREISMAN R, 1982, CELL, V29, P903, DOI 10.1016/0092-8674(82)90452-4; WALI L, 1988, GENE DEV, V2, P1089; WILSON CA, 1993, MOL ENDOCRINOL, V7, P247, DOI 10.1210/me.7.2.247; WRANA JL, 1994, MOL CELL BIOL, V14, P944, DOI 10.1128/MCB.14.2.944; YEN PM, 1994, MOL ENDOCRINOL, V8, P1450, DOI 10.1210/me.8.11.1450	49	173	193	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					382	388		10.1038/ng1295-382	http://dx.doi.org/10.1038/ng1295-382			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493017				2022-12-25	WOS:A1995TH62900014
J	HELWIG, U; IMAI, K; SCHMAHL, W; THOMAS, BE; VARNUM, DS; NADEAU, JH; BALLING, R				HELWIG, U; IMAI, K; SCHMAHL, W; THOMAS, BE; VARNUM, DS; NADEAU, JH; BALLING, R			INTERACTION BETWEEN UNDULATED AND PATCH LEADS TO AN EXTREME FORM OF SPINA-BIFIDA IN DOUBLE-MUTANT MICE	NATURE GENETICS			English	Article							NEURAL-TUBE DEFECTS; EMBRYONIC-DEVELOPMENT; MUTATION; EXPRESSION; RECEPTOR; PAX-1; EMERGENESIS; MODEL; CELLS	The aetiology of spina bifida involves genetic and environmental factors, which may be why major genes contributing to pathogenesis have not been identified. Here we report that undulated-Patch double-mutant mice have a phenotype reminiscent of an extreme form of spina bifida occulta in humans. This unexpected phenotype in double-mutant but not single-mutant mice shows that novel congenital anomalies such as spina bifida can result from interaction between products of independently segregating loci. This example of digenic inheritance may explain the often sporadic nature of spina bifida in humans.	JACKSON LAB,BAR HARBOR,ME 04609; GSF FORSCHUNGSZENTRUM UNWELT & GESUNDHEIT GMBH,INST SAUGETIERGENET,D-85758 OBERSCHLEISSHEIM,GERMANY; GSF FORSCHUNGSZENTRUM UNWELT & GESUNDHEIT GMBH,INST PATHOL,D-85758 OBERSCHLEISSHEIM,GERMANY; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ H3G 1A4,CANADA; MONTREAL GEN HOSP,DEPT MED,MONTREAL,PQ H3G 1A4,CANADA	Jackson Laboratory; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; McGill University; McGill University			Balling, Rudi/E-9680-2010	Balling, Rudi/0000-0003-2902-5650	NICHD NIH HHS [HD25389] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025389] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLES AJ, 1990, DEVELOPMENT, V108, P73; BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BESMER P, 1993, DEVELOPMENT, P125; BRUNKOW ME, IN PRESS GENOMICS; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; COPP AJ, 1990, PROG NEUROBIOL, V35, P363, DOI 10.1016/0301-0082(90)90037-H; DIMMERICK JE, 1992, DEV PATHOLOGY; DIZIER MH, 1994, AM J HUM GENET, V55, P1042; DUTTLINGER R, 1995, P NATL ACAD SCI USA, V92, P3754, DOI 10.1073/pnas.92.9.3754; EHLERS K, 1992, TERATOLOGY, V45, P145, DOI 10.1002/tera.1420450208; Elwood J. M., 1992, EPIDEMIOLOGY CONTROL, P10; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; ESSIEN FB, 1990, TERATOLOGY, V42, P183, DOI 10.1002/tera.1420420209; ESTIBEIRO JP, 1993, DEVELOPMENT, V119, P113; GRUNEBERG H, 1960, GENET RES, V1, P69, DOI 10.1017/S0016672300000094; GRUNEBERG H, 1954, J GENET, V52, P441, DOI 10.1007/BF02981536; GRUNEBERG H, 1950, J GENET, V50, P142, DOI 10.1007/BF02986800; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; KNAPP M, 1994, AM J HUM GENET, V55, P1030; KOSEKI H, 1993, DEVELOPMENT, V119, P649; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LI CC, 1987, AM J HUM GENET, V41, P517; LYKKEN DT, 1982, PSYCHOPHYSIOLOGY, V19, P361, DOI 10.1111/j.1469-8986.1982.tb02489.x; MARINPADILLA M, 1991, CAN J NEUROL SCI, V18, P153, DOI 10.1017/S0317167100031632; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORRISONGRAHAM K, 1992, DEVELOPMENT, V115, P133; NAGEL DL, 1994, P NATL ACAD SCI USA, V91, P7237; NEUMANN PE, 1994, NAT GENET, V6, P357, DOI 10.1038/ng0494-357; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; SCHATTEMAN GC, 1992, DEVELOPMENT, V115, P123; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; STEPHENSON DA, 1991, P NATL ACAD SCI USA, V86, P6; STRONG LC, 1949, J HERED, V40, P329, DOI 10.1093/oxfordjournals.jhered.a105976; TAKAHASHI Y, 1992, P NATL ACAD SCI USA, V89, P10237, DOI 10.1073/pnas.89.21.10237; WALLIN J, 1994, DEVELOPMENT, V120, P1109	35	59	59	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					60	63		10.1038/ng0995-60	http://dx.doi.org/10.1038/ng0995-60			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550316				2022-12-25	WOS:A1995RR72800016
J	PANDOLFI, PP; ROTH, ME; KARIS, A; LEONARD, MW; DZIERZAK, E; GROSVELD, FG; ENGEL, JD; LINDENBAUM, MH				PANDOLFI, PP; ROTH, ME; KARIS, A; LEONARD, MW; DZIERZAK, E; GROSVELD, FG; ENGEL, JD; LINDENBAUM, MH			TARGETED DISRUPTION OF THE GATA3 GENE CAUSES SEVERE ABNORMALITIES IN THE NERVOUS-SYSTEM AND IN FETAL LIVER HEMATOPOIESIS	NATURE GENETICS			English	Article							ERYTHROID TRANSCRIPTION FACTOR; DNA-BINDING SPECIFICITIES; EMBRYONIC STEM-CELLS; MOUSE; EXPRESSION; FAMILY; PROTEIN; IDENTIFICATION; LINEAGES; ENHANCER	GATA-3 is one member of a growing family of related transcription factors which share a strongly conserved expression pattern in all vertebrate organisms. In order to elucidate GATA-3 function using a direct genetic approach, we have disrupted the murine gene by homologous recombination in embryonic stem cells. Mice heterozygous for the GATA3 mutation are fertile and appear in all respects to be normal, whereas homozygous mutant embryos die between days 11 and 12 postcoitum (p.c.) and display massive internal bleeding, marked growth retardation, severe deformities of the brain and spinal cord, and gross aberrations in fetal liver haematopoiesis.	NORTHWESTERN UNIV,DEPT BIOCHEM MOLEC BIOL & CELL BIOL,EVANSTON,IL 60208; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HAEMATOL,LONDON W12 0HS,ENGLAND; NATL INST MED RES,GENE STRUCT & EXPRESS LAB,LONDON NW7 1AA,ENGLAND; ERASMUS UNIV ROTTERDAM,MGC DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS	Northwestern University; Imperial College London; MRC National Institute for Medical Research; Erasmus University Rotterdam					NIGMS NIH HHS [GM28896] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028896] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; BARIBAULT H, GENE DEV, V7, P1191; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; HAMBOR JE, 1993, MOL CELL BIOL, V13, P7056, DOI 10.1128/MCB.13.11.7056; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; JOULIN V, 1991, EMBO J, V10, P1809, DOI 10.1002/j.1460-2075.1991.tb07706.x; KELLEY C, 1993, DEVELOPMENT, V118, P817; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; KO LJ, 1993, MOL CELL BIOL, V13, P7056; KORNHAUSER JM, 1994, MOL BRAIN RES, V23, P100, DOI 10.1016/0169-328X(94)90216-X; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; LINDENBAUM MH, 1990, GENE DEV, V4, P2075, DOI 10.1101/gad.4.12a.2075; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; NG A, 1994, DEVELOPMENT, V120, P3257; OOSTERWEGEL M, 1992, DEV IMMUNOL, V3, P1, DOI 10.1155/1992/27903; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; REDONDO JM, 1991, MOL CELL BIOL, V11, P5671, DOI 10.1128/MCB.11.11.5671; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; Sambrook J, 1989, MOL CLONING LABORATO; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; STEGER DJ, 1994, MOL CELL BIOL, V14, P5592, DOI 10.1128/MCB.14.8.5592; TAMURA S, 1993, P NATL ACAD SCI USA, V90, P10876, DOI 10.1073/pnas.90.22.10876; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; WHYATT DJ, 1993, EMBO J, V12, P4993, DOI 10.1002/j.1460-2075.1993.tb06193.x; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759	33	483	489	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					40	44		10.1038/ng0995-40	http://dx.doi.org/10.1038/ng0995-40			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550312				2022-12-25	WOS:A1995RR72800013
J	POMPONIO, RJ; REYNOLDS, TR; COLE, H; BUCK, GA; WOLF, B				POMPONIO, RJ; REYNOLDS, TR; COLE, H; BUCK, GA; WOLF, B			MUTATIONAL HOTSPOT IN THE HUMAN BIOTINIDASE GENE CAUSES PROFOUND BIOTINIDASE DEFICIENCY	NATURE GENETICS			English	Letter							CARBOXYLASE; POLYMORPHISMS; DIAGNOSIS; DELETION; DNA		VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT HUMAN GENET,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT MICROBIOL & IMMUNOL,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PEDIAT,RICHMOND,VA 23298	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University					NICHD NIH HHS [HD48258] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		COLE H, 1994, J BIOL CHEM, V269, P6566; COLE H, 1994, GENOMICS, V22, P662, DOI 10.1006/geno.1994.1449; HANDELIN B, 1994, CURRENT PROTOCOLS HU; HART PS, 1992, AM J HUM GENET, V50, P126; HART PS, 1992, BIOCHEM MED METAB B, V48, P41, DOI 10.1016/0885-4505(92)90046-2; MOSKOWITZ SM, 1993, HUM MUTAT, V2, P71, DOI 10.1002/humu.1380020113; MUTTER GL, 1991, NUCLEIC ACIDS RES, V19, P4203, DOI 10.1093/nar/19.15.4203; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PISPA J, 1965, ANN MED EXP BIOL F S, V43, P1; SAILD RK, 1985, NUCLEIC ACIDS RES, V230, P1350; TAHARA T, 1990, P NATL ACAD SCI USA, V87, P1372, DOI 10.1073/pnas.87.4.1372; WOLF B, 1983, J PEDIATR-US, V103, P233, DOI 10.1016/S0022-3476(83)80351-5; WOLF B, 1983, CLIN CHIM ACTA, V131, P273, DOI 10.1016/0009-8981(83)90096-7; WOLF B, 1985, ANN NEUROL, V18, P614, DOI 10.1002/ana.410180517; WOLF B, 1991, J INHERIT METAB DIS, V14, P923, DOI 10.1007/BF01800475; WOLF B, 1982, AM J HUM GENET, V34, P699; WOLF B, 1995, METABOLIC MOL BASIS, V7, P3151	19	64	66	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					96	98		10.1038/ng0995-96	http://dx.doi.org/10.1038/ng0995-96			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550325				2022-12-25	WOS:A1995RR72800024
J	TOTH, M; GRIMSBY, J; BUZSAKI, G; DONOVAN, GP				TOTH, M; GRIMSBY, J; BUZSAKI, G; DONOVAN, GP			EPILEPTIC SEIZURES CAUSED BY INACTIVATION OF A NOVEL GENE, JERKY, RELATED TO CENTROMERE-BINDING PROTEIN-B IN TRANSGENIC MICE	NATURE GENETICS			English	Article							MYOCLONIC EPILEPSY; CENP-B; LINKAGE; CHROMOSOME-15; LOCUS; MOUSE	Epidemiological data and genetic studies indicate that certain forms of human epilepsy are inherited. Based on the similarity between the human and mouse genomes, mouse models of epilepsy could facilitate the discovery of genes associated with epilepsy syndromes. Here, we report an insertional murine mutation that inactivates a novel gene and results in whole body jerks, generalized clonic seizures, and epileptic brain activity in transgenic mice. The gene, named jerky, encodes a putative 41.7 kD protein displaying homology to a number of nuclear regulatory proteins, suggesting that perhaps the jerky protein is able to bind DNA.	UNIV SO CALIF,DEPT MOLEC PHARMACOL & TOXICOL,LOS ANGELES,CA 90033; RUTGERS STATE UNIV,CTR MOLEC & BEHAV NEUROSCI,NEWARK,NJ 07102	University of Southern California; Rutgers State University Newark; Rutgers State University New Brunswick	TOTH, M (corresponding author), CORNELL UNIV,COLL MED,DEPT PHARMACOL,NEW YORK,NY 10021, USA.		Toth, Miklos/O-3343-2017	Buzsaki, Gyorgy/0000-0002-3100-4800				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beck C, 1994, Neurobiol Dis, V1, P95, DOI 10.1006/nbdi.1994.0012; Delgado-Escueta A V, 1986, Adv Neurol, V44, P3; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; GAREY CE, 1994, NAT GENET, V6, P426, DOI 10.1038/ng0494-426; GREENBERG DA, 1993, EPILEPSIA, V34, pS12; HOHMANN S, 1993, MOL GEN GENET, V241, P657, DOI 10.1007/BF00279908; LABOW MA, 1990, MOL CELL BIOL, V10, P3343, DOI 10.1128/MCB.10.7.3343; LEHESJOKI AE, 1992, NEUROLOGY, V42, P1545, DOI 10.1212/WNL.42.8.1545; LOSSIE AC, 1993, MAMM GENOME, V4, P621, DOI 10.1007/BF00361398; MCNAMARA JO, 1994, J NEUROSCI, V14, P3413; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; NOEBELS JL, 1984, NATURE, V310, P409, DOI 10.1038/310409a0; OTTMAN R, 1995, NAT GENET, V10, P56, DOI 10.1038/ng0595-56; PHILLIPS HA, 1995, NAT GENET, V10, P117, DOI 10.1038/ng0595-117; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; TOTH M, IN PRESS J NEUROSCI, V41; TUDOR M, 1992, MOL GEN GENET, V232, P126, DOI 10.1007/BF00299145; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; YODA K, 1992, J CELL BIOL, V119, P1413, DOI 10.1083/jcb.119.6.1413	23	75	78	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					71	75		10.1038/ng0995-71	http://dx.doi.org/10.1038/ng0995-71			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550318				2022-12-25	WOS:A1995RR72800018
J	NOAKES, PG; MINER, JH; GAUTAM, M; CUNNINGHAM, JM; SANES, JR; MERLIE, JP				NOAKES, PG; MINER, JH; GAUTAM, M; CUNNINGHAM, JM; SANES, JR; MERLIE, JP			THE RENAL GLOMERULUS OF MICE LACKING S-LAMININ LAMININ BETA-2 - NEPHROSIS DESPITE MOLECULAR COMPENSATION BY LAMININ BETA-1	NATURE GENETICS			English	Article							BASEMENT-MEMBRANE; ALPORT SYNDROME; IV COLLAGEN; NEUROMUSCULAR-JUNCTION; MONOCLONAL-ANTIBODIES; SYNAPTIC CLEFT; KIDNEY; GENE; IDENTIFICATION; PATHOGENESIS	S-laminin/laminin beta 2, a homologue of the widely distributed laminin B1/beta 1 chain, is a major component of adult renal glomerular basement membrane (GEM). Immature GEM bears beta 1, which is replaced by beta 2 as development proceeds. In mutant mice that lack beta 2, the GEM remains rich in beta 1, suggesting that a feedback mechanism normally regulates GEM maturation. The beta 2-deficient GEM is structurally intact and contains normal complements of several collagenous acid noncollagenous glycoproteins. However, mutant mice develop massive proteinuria due to failure of the glomerular filtration barrier. These results support the idea that laminin beta chains are functionally distinct although they assemble to form similar structures. Laminin beta 2-deficient mice may provide a model for human congenital or idiopathic nephrotic syndromes.	WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC BIOL & PHARMACOL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)			Noakes, Peter/X-9825-2019	Noakes, Peter/0000-0001-9821-8478; Gautam, Medha/0000-0002-5418-4322				ABERDAM D, 1994, NAT GENET, V6, P299, DOI 10.1038/ng0394-299; ABRAHAMSON DR, 1992, J HISTOCHEM CYTOCHEM, V40, P1943, DOI 10.1177/40.12.1280666; ABRAHAMSON DR, 1989, J CELL BIOL, V109, P3477, DOI 10.1083/jcb.109.6.3477; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; BENDER BL, 1981, AM J PATHOL, V103, P419; BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8; CARLSON JA, 1993, DISEASES KIDNEY, P383; COUSER WG, 1993, KIDNEY INT, V44, pS19; DANIELS BS, 1994, J LAB CLIN MED, V124, P224; DESJARDINS M, 1991, J CELL BIOL, V113, P689, DOI 10.1083/jcb.113.3.689; EDDY A, 1992, PEDIATRIC KIDNEY DIS, P329; EKBLOM P, 1992, KIDNEY PHYSL PATHOPH, P475; FALKON JR, 1994, TRENDS NEUROSCI, V17, P469; FRENK S, 1955, P SOC EXP BIOL MED, V89, P424; GREEN TL, 1992, J BIOL CHEM, V267, P2014; HONG X, 1994, NAT GENET, V8, P297; HOSTIKKA SL, 1990, P NATL ACAD SCI USA, V87, P1606, DOI 10.1073/pnas.87.4.1606; HUDSON BG, 1992, KIDNEY INT, V42, P179, DOI 10.1038/ki.1992.276; HUDSON BG, 1993, J BIOL CHEM, V268, P26033; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; KASHTAN CE, 1992, KIDNEY INT, V42, P115, DOI 10.1038/ki.1992.269; Kashtan CE, 1994, RENAL PATHOLOGY, P1239; KATO M, 1988, J CELL BIOL, V106, P2203, DOI 10.1083/jcb.106.6.2203; KATZ A, 1991, KIDNEY INT, V40, P643, DOI 10.1038/ki.1991.256; KESTILA M, 1994, AM J HUM GENET, V54, P757; KLEPPEL MM, 1989, LAB INVEST, V61, P278; MARTIN PT, IN PRESS SCIENCE; MCCLUSKEY RT, 1992, PATHOLOGY KIDNEY, P169; MINER JH, 1994, J CELL BIOL, V127, P879, DOI 10.1083/jcb.127.3.879; MOCHIZUKI T, 1994, NAT GENET, V8, P77, DOI 10.1038/ng0994-77; NASH MA, 1992, PEDIAT KIDNEY DIS, P1247; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; OGURA A, 1994, NEPHRON, V68, P239, DOI 10.1159/000188264; OLSON JL, 1992, PATHOLOGY KIDNEY, P779; PULKKINEN L, 1994, NAT GENET, V6, P293, DOI 10.1038/ng0394-293; REEVES WH, 1980, J CELL BIOL, V85, P735, DOI 10.1083/jcb.85.3.735; Rohrbach DH, 1993, MOL CELLULAR ASPECTS; SANES JR, 1982, J CELL BIOL, V93, P442, DOI 10.1083/jcb.93.2.442; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SANES JR, 1989, ANNU REV NEUROSCI, V12, P491, DOI 10.1146/annurev.ne.12.030189.002423; SARIOLA H, 1984, DEV BIOL, V101, P86, DOI 10.1016/0012-1606(84)90119-2; SCHARER K, 1992, PEDIATRIC KIDNEY DIS, P593; Schnaper HW, 1993, DIS KIDNEY, P1731; SOROKIN L, 1992, KIDNEY INT, V41, P657, DOI 10.1038/ki.1992.101; SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9; TIMPL R, 1993, EXPERIENTIA, V49, P417, DOI 10.1007/BF01923586; Vehaskari VM, 1992, PEDIAT KIDNEY DIS, P531; WEWER UM, 1994, GENOMICS, V24, P243, DOI 10.1006/geno.1994.1612; ZHOU J, 1993, SCIENCE, V261, P1167, DOI 10.1126/science.8356449	51	323	332	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					400	406		10.1038/ng0895-400	http://dx.doi.org/10.1038/ng0895-400			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670489				2022-12-25	WOS:A1995RM37500012
J	BENOMAR, A; KROLS, L; STEVANIN, G; CANCEL, G; LEGUERN, E; DAVID, G; OUHABI, H; MARTIN, JJ; DURR, A; ZAIM, A; RAVISE, N; BUSQUE, C; PENET, C; VANREGEMORTER, N; WEISSENBACH, J; YAHYAOUI, M; CHKILI, T; AGID, Y; Van Broeckhoven, C; BRICE, A				BENOMAR, A; KROLS, L; STEVANIN, G; CANCEL, G; LEGUERN, E; DAVID, G; OUHABI, H; MARTIN, JJ; DURR, A; ZAIM, A; RAVISE, N; BUSQUE, C; PENET, C; VANREGEMORTER, N; WEISSENBACH, J; YAHYAOUI, M; CHKILI, T; AGID, Y; Van Broeckhoven, C; BRICE, A			THE GENE FOR AUTOSOMAL-DOMINANT CEREBELLAR-ATAXIA WITH PIGMENTARY MACULAR DYSTROPHY MAPS TO CHROMOSOME 3P12-P21.1	NATURE GENETICS			English	Article							LINKAGE ANALYSIS	Autosomal dominant cerebellar ataxia with pigmentary macular dystrophy (ADCA type II) is a rare neurodegenerative disorder with marked anticipation. We have mapped the ADCA type II locus to chromosome 3 by linkage analysis in a genome-wide search and found no evidence for genetic heterogeneity among four families of different geographic origins. Haplotype reconstruction initially restricted the locus to the 33 cM interval flanked by D3S1300 and D3S1276 located at 3p12-p21.1. Combined multipoint analysis, using the Z(max-1) method, further reduced the candidate interval to an 8 cM region around D3S1285. Our results show that ADCA type II is a genetically homogenous disorder, independent of the heterogeneous group of type I cerebellar ataxias.	HOP LA PITIE SALPETRIERE, INSERM, U289, PARIS, FRANCE; CHU RABAT, HOP SPECIALITES, SERV NEUROL, RABAT, MOROCCO; UNIV ANTWERP, BORN BUNGE FDN, DEPT MED, NEUROPATHOL LAB, ANTWERP, BELGIUM; UNIV ANTWERP, BORN BUNGE FDN, DEPT BIOCHEM, NEUROGENET LAB, ANTWERP, BELGIUM; UNIV BRUSSELS, CTR MED GENET, DEPT MED, BRUSSELS, BELGIUM; GENETHON, F-91000 EVRY, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; University of Antwerp; University of Antwerp			brice, alexis/AAE-8275-2019; yahyaoui, mohamed/AAP-9047-2020; Brice, Alexis/A-2170-2009; Stevanin, Giovanni/E-5038-2016; Van Broeckhoven, Christine/M-7853-2019	brice, alexis/0000-0002-0941-3990; Stevanin, Giovanni/0000-0001-9368-8657; Van Broeckhoven, Christine/0000-0003-0183-7665; Cancel-Tassin, Geraldine/0000-0002-9583-6382				BENOMAR A, 1994, ANN NEUROL, V35, P439, DOI 10.1002/ana.410350411; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DUBOURG O, 1995, ANN NEUROL, V37, P176, DOI 10.1002/ana.410370207; DURR A, 1993, BRAIN, V116, P1497, DOI 10.1093/brain/116.6.1497; ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445; FARRER LA, 1992, AM J HUM GENET, V50, P528; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1993, ADV NEUROL, V61, P1; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OTT J, 1991, ANAL HUMAN GENETIC L, P1; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; STEVANIN G, 1994, AM J HUM GENET, V54, P11; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; 1993, CELL, V72, P971	26	160	168	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1995	10	1					84	88		10.1038/ng0595-84	http://dx.doi.org/10.1038/ng0595-84			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647798				2022-12-25	WOS:A1995QX57300020
J	ABIMIKU, AG; FRANCHINI, G; TARTAGLIA, J; ALDRICH, K; MYAGKIKH, M; MARKHAM, PD; CHONG, PL; KLEIN, M; KIENY, MP; PAOLETTI, E; GALLO, RC; ROBERTGUROFF, M				ABIMIKU, AG; FRANCHINI, G; TARTAGLIA, J; ALDRICH, K; MYAGKIKH, M; MARKHAM, PD; CHONG, PL; KLEIN, M; KIENY, MP; PAOLETTI, E; GALLO, RC; ROBERTGUROFF, M			HIV-1 RECOMBINANT POXVIRUS VACCINE INDUCES CROSS-PROTECTION AGAINST HIV-2 CHALLENGE IN RHESUS MACAQUES	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TOXIC LYMPHOCYTES-T; ENVELOPE GLYCOPROTEIN; SYNTHETIC PEPTIDES; INFECTION; TYPE-1; NEUTRALIZATION; ANTIBODIES; EXPRESSION; EPITOPE	Rhesus macaques were immunized with attenuated vaccinia or canarypox human immunodeficiency virus type 1 (HIV-1) recombinants and boosted with HIV-1 protein subunits formulated in alum. Following challenge with HIV-2(SBL6669), three out of eight immunized macaques resisted infection for six months and another exhibited significantly delayed infection, whereas all three naive controls became infected. Immunizations elicited both humoral and cellular immune responses; however, no clear correlates of protection were discerned. Although more extensive studies are now called for, this first demonstration of cross-protection between HIV-1 and -2 suggests that viral variability may not be an insurmountable problem in the design of a global AIDS vaccine.	VIROGENET CORP,TROY,NY 12180; ADV BIOSCI LABS INC,KENSINGTON,MD 20895; CONNAUGHT LABS,N YORK,ON M2R 3T4,CANADA; TRANSGENE SA,F-67082 STRASBOURG,FRANCE	Transgene SA	ABIMIKU, AG (corresponding author), NCI,TUMOR CELL BIOL LAB,BLDG 37,ROOM 6A09,37 CONVENT DR MSC 4255,BETHESDA,MD 20892, USA.		Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019; Chong, Pele/E-3855-2010	Kieny, Marie-Paule/0000-0002-5943-6488; 				ABIMIKU AG, 1995, AIDS RES HUM RETROV, V11, P383, DOI 10.1089/aid.1995.11.383; ACHOUR A, 1990, P NATL ACAD SCI USA, V87, P7045, DOI 10.1073/pnas.87.18.7045; AGY MB, 1992, SCIENCE, V257, P103, DOI 10.1126/science.1621083; BERZOFSKY JA, 1991, J ACQ IMMUN DEF SYND, V4, P451; BOTTIGER B, 1990, J VIROL, V64, P3492; BOTTIGER B, 1990, AIDS RES HUM RETROV, V5, P525; CADOZ M, 1992, LANCET, V339, P1429, DOI 10.1016/0140-6736(92)92027-D; CARLSON JR, 1990, AIDS RES HUM RETROV, V6, P1239, DOI 10.1089/aid.1990.6.1239; CEASE KB, 1987, P NATL ACAD SCI USA, V84, P4249, DOI 10.1073/pnas.84.12.4249; CHONG P, 1990, FEBS LETT, V264, P231, DOI 10.1016/0014-5793(90)80255-H; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; COX WI, 1993, VIROLOGY, V195, P845, DOI 10.1006/viro.1993.1442; DONNELLY C, 1993, B MATH BIOL, V55, P731, DOI 10.1007/BF02460671; DORMONT D, 1989, INTERVIROLOGY, V30, P59, DOI 10.1159/000150125; FRANCHINI G, 1990, J VIROL, V64, P4462, DOI 10.1128/JVI.64.9.4462-4467.1990; FRANCHINI G, 1995, AIDS RES HUM RETROV, V11, P307, DOI 10.1089/aid.1995.11.307; GOUDSMIT J, 1988, P NATL ACAD SCI USA, V85, P4478, DOI 10.1073/pnas.85.12.4478; GUO HG, 1990, VIROLOGY, V174, P217, DOI 10.1016/0042-6822(90)90070-8; GUYADER M, 1987, NATURE, V326, P662, DOI 10.1038/326662a0; Hale P M, 1989, Int Immunol, V1, P409, DOI 10.1093/intimm/1.4.409; JAVAHERIAN K, 1989, P NATL ACAD SCI USA, V86, P6768, DOI 10.1073/pnas.86.17.6768; KALYANARAMAN VS, 1990, AIDS RES HUM RETROV, V6, P371, DOI 10.1089/aid.1990.6.371; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; MYERS G, 1994, HUMAN RETROVIRUSES A; NAIR BC, 1994, J CLIN MICROBIOL, V32, P1449, DOI 10.1128/JCM.32.6.1449-1456.1994; NICOL I, 1989, INTERVIROLOGY, V30, P258, DOI 10.1159/000150101; NISHANIAN PG, 1988, J IMMUNOL METHODS, V107, P261, DOI 10.1016/0022-1759(88)90227-X; NIXON DF, 1990, AIDS, V4, P841, DOI 10.1097/00002030-199009000-00002; NORLEY SG, 1990, J IMMUNOL, V145, P1700; PALKER TJ, 1988, P NATL ACAD SCI USA, V85, P1932, DOI 10.1073/pnas.85.6.1932; PERKUS ME, 1989, J VIROL, V63, P3829, DOI 10.1128/JVI.63.9.3829-3836.1989; PICCINI A, 1987, METHOD ENZYMOL, V153, P545; PUTKONEN P, 1989, J ACQ IMMUN DEF SYND, V2, P366; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; ROBERTGUROFF M, 1992, J VIROL, V66, P3602, DOI 10.1128/JVI.66.6.3602-3608.1992; ROBERTGUROFF M, 1990, TECHNIQUES HIV RES, P179; ROMIEU I, 1990, J ACQ IMMUN DEF SYND, V3, P220; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; RUSCHE JR, 1988, P NATL ACAD SCI USA, V85, P3198, DOI 10.1073/pnas.85.9.3198; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; SUTJIPTO S, 1990, J VIROL, V64, P2290, DOI 10.1128/JVI.64.5.2290-2297.1990; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B; TARTAGLIA J, 1993, J VIROL, V67, P2370, DOI 10.1128/JVI.67.4.2370-2375.1993; TARTAGLIA J, 1993, AIDS RES REV, V3, P361; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; VOS JC, 1988, EMBO J, V7, P3487, DOI 10.1002/j.1460-2075.1988.tb03224.x; WANG CY, 1991, SCIENCE, V254, P285, DOI 10.1126/science.1925584; WEISS RA, 1988, AIDS, V2, P95, DOI 10.1097/00002030-198804000-00004	50	63	66	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1995	1	4					321	329		10.1038/nm0495-321	http://dx.doi.org/10.1038/nm0495-321			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585061				2022-12-25	WOS:A1995RN09800027
J	JIANG, CA; ATKINSON, D; TOWBIN, JA; SPLAWSKI, I; LEHMANN, MH; LI, H; TIMOTHY, K; TAGGART, RT; SCHWARTZ, PJ; VINCENT, GM; MOSS, AJ; KEATING, MT				JIANG, CA; ATKINSON, D; TOWBIN, JA; SPLAWSKI, I; LEHMANN, MH; LI, H; TIMOTHY, K; TAGGART, RT; SCHWARTZ, PJ; VINCENT, GM; MOSS, AJ; KEATING, MT			2 LONG QT SYNDROME LOCI MAP TO CHROMOSOME-3 AND CHROMOSOME-7 WITH EVIDENCE FOR FURTHER HETEROGENEITY	NATURE GENETICS			English	Article							SUDDEN CARDIAC DEATH; LINKAGE ANALYSIS; EARLY AFTERDEPOLARIZATIONS; VENTRICULAR TACHYARRHYTHMIAS; ANTIARRHYTHMIC DRUGS; ALPHA-1 SUBUNIT; CHANNEL; GENE; POTASSIUM; HEART	Cardiac arrhythmias cause sudden death in 300,000 United States citizens every year. In this study, We describe two new loci for an inherited cardiac arrhythmia, long QT syndrome (LQT). In 1991 we reported linkage of LQT to chromosome 11p15.5. In this study we demonstrate further linkage to D7S483 in nine families with a combined lod score of 19.41 and to D3S1100 in three families with a combined score of 6.72. These findings localize major LQT genes to chromosomes 7q35-36 and 3p21-24, respectively. Linkage to any known locus was excluded in three families indicating that additional heterogeneity exists. Proteins encoded by different LQT genes may interact to modulate cardiac repolarization and arrhythmia risk.	UNIV UTAH,HLTH SCI CTR,DIV CARDIOL,SALT LAKE CITY,UT 84112; UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,HLTH SCI CTR,ECCLES PROGRAM HUMAN MOLEC BIOL & GENET,SALT LAKE CITY,UT 84112; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT HUMAN MOLEC GENET,HOUSTON,TX 77030; WAYNE STATE UNIV,DEPT MED,DIV CARDIOL,DETROIT,MI 48235; LDS HOSP,DEPT MED,SALT LAKE CITY,UT 84037; CAROLINAS MED CTR,DEPT OBSTET & GYNECOL,CHARLOTTE,NC 28203; UNIV PAVIA,DEPT CARDIOL,I-20122 PAVIA,ITALY; UNIV ROCHESTER,MED CTR,DEPT MED,ROCHESTER,NY 14627	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Baylor College of Medicine; Baylor College of Medicine; Wayne State University; Carolinas Medical Center; University of Pavia; University of Rochester			Towbin, Jeffrey A./J-5595-2019; Schwartz, Peter J/J-4267-2016	Towbin, Jeffrey A./0000-0002-6585-714X; Schwartz, Peter J/0000-0003-0367-1048	NHLBI NIH HHS [R01 HL51618, R01 HL48074, R01 HL33843] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033843, R01HL051618] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARR CS, 1994, LANCET, V343, P327, DOI 10.1016/S0140-6736(94)91164-9; BENHORIN J, 1993, SCIENCE, V260, P1960, DOI 10.1126/science.8316839; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1991, CYTOGENET CELL GENET, V58, P1850; BROOKS CM, 1960, AM J PHYSIOL, V198, P1143, DOI 10.1152/ajplegacy.1960.198.6.1143; CHIN H, 1991, GENOMICS, V11, P914, DOI 10.1016/0888-7543(91)90014-6; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; CURRAN M, 1993, J CLIN INVEST, V92, P799, DOI 10.1172/JCI116653; DAVIDENKO JM, 1989, CIRCULATION, V79, P674, DOI 10.1161/01.CIR.79.3.674; DAY CP, 1990, BRIT HEART J, V63, P342; DOWNAR E, 1977, CIRCULATION, V56, P217, DOI 10.1161/01.CIR.56.2.217; GARCIA DK, 1991, CYTOGENET CELL GENET, V58, P1877; GEOGE AL, 1993, NAT GENET, V3, P305; GOYAL RK, 1989, NEW ENGL J MED, V321, P1022; GREEN ED, 1994, HUM MOL GENET, V3, P489, DOI 10.1093/hmg/3.3.489; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEUTINK P, 1994, NAT GENET, V6, P287, DOI 10.1038/ng0394-287; JANUARY CT, 1988, CIRC RES, V62, P563, DOI 10.1161/01.RES.62.3.563; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; JERVELL A, 1957, AM HEART J, V54, P59, DOI 10.1016/0002-8703(57)90079-0; KANNEL WB, 1987, AM HEART J, V113, P799, DOI 10.1016/0002-8703(87)90722-8; KEATING M, 1991, AM J HUM GENET, V49, P1335; KEATING M, 1994, J CARDIOVASC ELECTR, V5, P146, DOI 10.1111/j.1540-8167.1994.tb01155.x; KEATING M, 1992, CIRCULATION, V85, P1973, DOI 10.1161/01.CIR.85.6.1973; KEATING M, 1991, SCIENCE, V252, P704, DOI 10.1126/science.1673802; KEATING M, 1993, SCIENCE, V260, P1960; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KRAMER P, 1992, SCIENCE, V258, P67; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEHMANN M, IN PRESS J AM COLL C; MARKS ML, IN PRESS J AM COLL C; MASON JW, 1993, NEW ENGL J MED, V329, P452, DOI 10.1056/NEJM199308123290702; MASON JW, 1993, NEW ENGL J MED, V329, P445, DOI 10.1056/NEJM199308123290701; MYERBURG RJ, 1993, ANN INTERN MED, V119, P1187, DOI 10.7326/0003-4819-119-12-199312150-00006; OTT J, 1983, ANN HUM GENET, V47, P311, DOI 10.1111/j.1469-1809.1983.tb01001.x; PENKOSKE PA, 1978, CIRCULATION, V58, P1023, DOI 10.1161/01.CIR.58.6.1023; PETRONIS A, 1993, GENOMICS, V18, P161, DOI 10.1006/geno.1993.1445; PHILIPSON LH, 1993, GENOMICS, V15, P463, DOI 10.1006/geno.1993.1094; RIED T, 1993, GENOMICS, V15, P405, DOI 10.1006/geno.1993.1075; ROMANO C, 1963, Clin Pediatr (Bologna), V45, P656; SCHWARTZ PJ, 1975, AM HEART J, V89, P378, DOI 10.1016/0002-8703(75)90089-7; SCHWARTZ PJ, 1978, CIRCULATION, V57, P1074, DOI 10.1161/01.CIR.57.6.1074; SEINO S, 1992, GENOMICS, V13, P1375, DOI 10.1016/0888-7543(92)90078-7; SEINO S, 1992, P NATL ACAD SCI USA, V89, P584, DOI 10.1073/pnas.89.2.584; TOWBIN JA, IN PRESS CIRCULATION; TSUKUROV O, 1994, NAT GENET, V6, P282, DOI 10.1038/ng0394-282; VINCENT G M, 1974, Progress in Cardiovascular Diseases, V16, P523; VINCENT GM, 1992, NEW ENGL J MED, V327, P846, DOI 10.1056/NEJM199209173271204; WARD O C, 1964, J Ir Med Assoc, V54, P103; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; WILLICH SN, 1987, AM J CARDIOL, V60, P801, DOI 10.1016/0002-9149(87)91027-7; YATANI A, 1990, CELL, V61, P769, DOI 10.1016/0092-8674(90)90187-J; ZIPES DP, 1987, AM J CARDIOL, V59, pE26, DOI 10.1016/0002-9149(87)90198-6	55	221	229	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1994	8	2					141	147		10.1038/ng1094-141	http://dx.doi.org/10.1038/ng1094-141			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7842012				2022-12-25	WOS:A1994PL12300015
J	KIESEWETTER, S; MACEK, M; DAVIS, C; CURRISTIN, SM; CHU, CS; GRAHAM, C; SHRIMPTON, AE; CASHMAN, SM; TSUI, LC; MICKLE, J; AMOS, J; HIGHSMITH, WE; SHUBER, A; WITT, DR; CRYSTAL, RG; CUTTING, GR				KIESEWETTER, S; MACEK, M; DAVIS, C; CURRISTIN, SM; CHU, CS; GRAHAM, C; SHRIMPTON, AE; CASHMAN, SM; TSUI, LC; MICKLE, J; AMOS, J; HIGHSMITH, WE; SHUBER, A; WITT, DR; CRYSTAL, RG; CUTTING, GR			A MUTATION IN CFTR PRODUCES DIFFERENT PHENOTYPES DEPENDING ON CHROMOSOMAL BACKGROUND	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS GENE; CONDUCTANCE REGULATOR GENE; LINKAGE DISEQUILIBRIUM; DELTA-F508 MUTATION; IDENTIFICATION; MARKER	Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR) gene but the association between mutation (genotype) and disease presentation (phenotype) is not straightforward. We have been investigating whether variants in the CFTR gene that alter splicing efficiency of exon 9 can affect the phenotype produced by a mutation. A missense mutation, R117H, which has been observed in three phenotypes, was found to occur on two chromosome backgrounds with intron 8 variants that have profoundly different effects upon splicing efficiency. A close association is shown between chromosome background of the R117H mutation and phenotype. These findings demonstrate that the genetic context in which a mutation occurs can play a significant role in determining the type of illness produced.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PEDIAT & MED,BALTIMORE,MD 21287; HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA; NHLBI,PULM BRANCH,BETHESDA,MD 20892; UNIV EDINBURGH,HUMAN GENET UNIT,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND; UNIV DUBLIN TRINITY COLL,DEPT GENET,DUBLIN 2,IRELAND; REG GENET CTR,BELFAST,NORTH IRELAND; BOSTON UNIV,SCH MED,CTR HUMAN GENET,BOSTON,MA 02118; UNIV N CAROLINA,DEPT PATHOL,CHAPEL HILL,NC 27599; INTEGRATED GENET INC,FRAMINGHAM,MA 01701; KAISER PERMANENTE,DEPT GENET,SAN JOSE,CA 95119; JOHNS HOPKINS UNIV HOSP,BALTIMORE,MD 21287	Johns Hopkins University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Edinburgh; Trinity College Dublin; Boston University; University of North Carolina; University of North Carolina Chapel Hill; Kaiser Permanente; Johns Hopkins University; Johns Hopkins Medicine			Tsui, Lap-chee/A-1081-2010; Highsmith, William E/B-6175-2008					AMOS JA, 1992, PEDIAT PULMON S, V8, P142; AUDREZET MP, 1993, HUM MOL GENET, V2, P51, DOI 10.1093/hmg/2.1.51; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CARROLL TP, IN PRESS CELL PHYSL; CHEHAB FF, 1991, AM J HUM GENET, V48, P223; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DORK T, 1991, HUM GENET, V87, P441; DORK T, 1992, HUM GENET, V88, P417, DOI 10.1007/BF00215676; ESTIVILL X, 1989, AM J HUM GENET, V44, P704; HAMOSH A, 1992, AM J HUM GENET, V51, P245; HAMOSH A, 1992, PEDIATR PULM S, V8, P144; Hamosh Ada, 1993, P69; Handelin B. L., 1992, American Journal of Human Genetics, V51, pA218; HORN GT, 1990, CLIN CHEM, V36, P1614; KALIN N, 1993, HUM MUT, V1, P204; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KRISTIDIS P, 1992, AM J HUM GENET, V50, P1178; LATHAM T, 1990, AM J HUM GENET, V47, P79; Lee R., 1992, American Journal of Human Genetics, V51, pA32; OSBORNE L, 1992, HUM GENET, V89, P653, DOI 10.1007/BF00221957; REISS J, 1991, HUM GENET, V87, P457; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; STRONG TV, 1993, HUM MOL GENET, V2, P225, DOI 10.1093/hmg/2.3.225; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; Witt D. R., 1992, American Journal of Human Genetics, V51, pA16; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	34	362	368	1	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					274	278		10.1038/ng1193-274	http://dx.doi.org/10.1038/ng1193-274			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	7506096				2022-12-25	WOS:A1993MF12200019
J	YANAGISAWA, K; ODAKA, A; SUZUKI, N; IHARA, Y				YANAGISAWA, K; ODAKA, A; SUZUKI, N; IHARA, Y			GM1 GANGLOSIDE-BOUND AMYLOID BETA-PROTEIN (AB) - A POSSIBLE FORM OF PREAMYLOID IN ALZHEIMERS-DISEASE	NATURE MEDICINE			English	Article							DIFFUSE PLAQUES; CORE PROTEIN; RECEPTOR; PEPTIDE; LOCALIZATION; DEMENTIA; CELLS	The earliest event so far known that occurs in the brain affected with Alzheimer's disease (AD) is the deposition and fibril formation of amyloid beta-protein (A beta). A beta is cleaved from a glycosylated membrane protein, called beta-amyloid protein precursor, and normally secreted into the extracellular space. Here we report on the presence of membrane-bound A beta that tightly binds GM1 ganglioside. This suggests that this novel A beta species, rather than secreted A beta, may act as a 'seed' for amyloid and further that intracellular abnormalities in the membrane recycling already exist at the stage of amyloidogenesis.	UNIV TOKYO,FAC MED,INST BRAIN RES,DEPT NEUROPATHOL,BUNKYO KU,TOKYO 113,JAPAN; TAKEDA CHEM IND LTD,DIV DISCOVERY RES,TSUKUBA,IBARAKI 30042,JAPAN	University of Tokyo; Takeda Chemical Industries								BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; DAVIES CA, 1993, AM J PATHOL, V143, P1594; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HANSSON HA, 1977, P NATL ACAD SCI USA, V74, P3782, DOI 10.1073/pnas.74.9.3782; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; LHERNAULT SW, 1992, J CELL BIOL, V119, P55, DOI 10.1083/jcb.119.1.55; MANN DMA, 1989, NEUROBIOL AGING, V10, P397, DOI 10.1016/0197-4580(89)90073-0; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MORI H, 1992, J BIOL CHEM, V267, P17082; MULLAN M, 1993, TRENDS NEUROSCI, V16, P398, DOI 10.1016/0166-2236(93)90007-9; PAN BT, 1983, CELL, V33, P967, DOI 10.1016/0092-8674(83)90040-5; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; PIKE CJ, 1994, BRAIN RES, V563, P311; ROHER AE, 1993, J BIOL CHEM, V268, P3072; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; SUZUKI N, 1994, AM J PATHOL, V145, P452; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V76, P541, DOI 10.1007/BF00689591; YAMAGUCHI H, 1990, BRAIN RES, V508, P320, DOI 10.1016/0006-8993(90)90416-9; YAMAGUCHI H, 1989, AM J PATHOL, V135, P593; YAMAZAKI T, 1992, J NEUROPATH EXP NEUR, V51, P281, DOI 10.1097/00005072-199205000-00006	27	455	473	0	50	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	OCT	1995	1	10					1062	1066		10.1038/nm1095-1062	http://dx.doi.org/10.1038/nm1095-1062			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489364				2022-12-25	WOS:A1995RX95100048
J	MARQUIS, ST; RAJAN, JV; WYNSHAWBORIS, A; XU, TJ; YIN, GY; ABEL, KJ; WEBER, BL; CHODOSH, LA				MARQUIS, ST; RAJAN, JV; WYNSHAWBORIS, A; XU, TJ; YIN, GY; ABEL, KJ; WEBER, BL; CHODOSH, LA			THE DEVELOPMENTAL PATTERN OF BRCA1 EXPRESSION IMPLIES A ROLE IN DIFFERENTIATION OF THE BREAST AND OTHER TISSUES	NATURE GENETICS			English	Article							CELLULAR TUMOR-ANTIGEN; FAMILIAL BREAST; GENE-EXPRESSION; OVARIAN-CANCER; P53; LACTOFERRIN	We have examined the developmental expression of the murine breast and ovarian cancer susceptibility gene, Brca1, to investigate its role in the control of cell growth and differentiation. Specifically, we have analysed Brca1 expression during embryonic development, in adult tissues, and during postnatal mammary gland development, particularly in response to ovarian hormones. Our results suggest that Brca1 is expressed in rapidly proliferating cell types undergoing differentiation. In the mammary gland, Brca1 expression is induced during puberty, pregnancy, and following treatment of ovariectomized animals with 17 beta-estradiol and progesterone. These observations imply that Brca1 is involved in the processes of proliferation and differentiation in multiple tissues, notably in the mammary gland in response to ovarian hormones.	UNIV PENN, SCH MED, DEPT MOLEC & CELLULAR ENGN, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, INST HUMAN GENE THERAPY, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT INTERNAL MED, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DEPT GENET, PHILADELPHIA, PA 19104 USA; UNIV PENN, SCH MED, DIV ENDOCRINOL DIABET & METAB, PHILADELPHIA, PA 19104 USA; NIH, NATL CTR HUMAN GENOME RES, GENET DIS RES LAB, BETHESDA, MD 20892 USA; UNIV MICHIGAN, SCH MED, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan					NCI NIH HHS [CA57601, 1P20CA66179] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P20CA066179, R01CA057601] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; BOICE JD, 1977, J NATL CANCER I, V59, P823, DOI 10.1093/jnci/59.3.823; BUHLER TA, 1993, DEV BIOL, V155, P87, DOI 10.1006/dbio.1993.1009; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; EASTON DF, 1993, AM J HUM GENET, V52, P678; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; HOBBS AA, 1982, J BIOL CHEM, V257, P3598; HOSKING L, 1995, NAT GENET, V9, P343, DOI 10.1038/ng0495-343; LANE DP, 1994, BRIT MED BULL, V50, P582, DOI 10.1093/oxfordjournals.bmb.a072911; MACMAHON B, 1970, B WORLD HEALTH ORGAN, V43, P209; MCGREGOR DH, 1977, J NATL CANCER I, V59, P799, DOI 10.1093/jnci/59.3.799; MCMASTER MT, 1992, MOL ENDOCRINOL, V6, P101, DOI 10.1210/me.6.1.101; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MERCER WE, 1984, MOL CELL BIOL, V4, P276, DOI 10.1128/MCB.4.2.276; MERRITT AJ, 1994, CANCER RES, V54, P614; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MORRISON BW, 1994, ONCOGENE, V9, P3417; REICH NC, 1984, NATURE, V308, P199, DOI 10.1038/308199a0; ROGEL A, 1985, MOL CELL BIOL, V5, P2851, DOI 10.1128/MCB.5.10.2851; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; Russo J, 1993, Eur J Cancer Prev, V2 Suppl 3, P85; SCHMID P, 1991, DEVELOPMENT, V113, P857; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; THOMPSON ME, 1995, NAT GENET, V9, P444, DOI 10.1038/ng0495-444; WALMER DK, 1992, ENDOCRINOLOGY, V131, P1458, DOI 10.1210/en.131.3.1458; WILKINSON DG, 1992, INSITUHYBRIDIZATION	29	315	328	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	1995	11	1					17	26		10.1038/ng0995-17	http://dx.doi.org/10.1038/ng0995-17			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550308				2022-12-25	WOS:A1995RR72800010
J	KANG, S; JAWORSKI, A; OHSHIMA, K; WELLS, RD				KANG, S; JAWORSKI, A; OHSHIMA, K; WELLS, RD			EXPANSION AND DELETION OF CTG REPEATS FROM HUMAN-DISEASE GENES ARE DETERMINED BY THE DIRECTION OF REPLICATION IN ESCHERICHIA-COLI	NATURE GENETICS			English	Article							UNUSUAL DNA STRUCTURES; MYOTONIC-DYSTROPHY; ESCHERICHIA-COLI; TYPE-1	Several human hereditary neurological and neurodegenerative disease genes are associated with the expansion of CTG repeats. Here we show that the frequency of genetic expansions or deletions in Escherichia coli depends on the direction of replication. Large expansions occur predominantly when the CTGs are in the leading strand template rather than the lagging strand. However, deletions are more prominant when the CTGs are in the opposite orientation. Most deletions generated products of defined size classes. Strand slippage coupled with non-classical DNA structures may account for these observations and relate to expansion-deletion mechanisms in eukaryotic chromosomes for disease genes.	TEXAS A&M UNIV, MED CTR, INST BIOSCI & TECHNOL, HOUSTON, TX 77030 USA	Texas A&M University System					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030822] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30822] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BINGHAM PM, 1995, NAT GENET, V9, P191, DOI 10.1038/ng0295-191; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; COVERLEY D, 1994, ANNU REV BIOCHEM, V63, P745, DOI 10.1146/annurev.bi.63.070194.003525; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; KANG S, 1992, J BIOL CHEM, V267, P19435; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PODHAJSKA AJ, 1985, GENE, V40, P163, DOI 10.1016/0378-1119(85)90038-1; RICHARDS RI, 1994, NAT GENET, V6, P114, DOI 10.1038/ng0294-114; TRINH TQ, 1991, NATURE, V352, P544, DOI 10.1038/352544a0; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; WELLS RD, 1988, J BIOL CHEM, V263, P1095; WELLS RD, 1993, GENOME ANAL, V7, P107; WELLS RD, 1988, FASEB J, V2, P2939, DOI 10.1096/fasebj.2.14.3053307; WIERINGA B, 1994, HUM MOL GENET, V3, P1, DOI 10.1093/hmg/3.1.1-a; WOHLRAB F, 1987, J BIOL CHEM, V262, P6407	25	311	315	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1995	10	2					213	218		10.1038/ng0695-213	http://dx.doi.org/10.1038/ng0695-213			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663518				2022-12-25	WOS:A1995RA85700020
J	PASINI, B; BORRELLO, MG; GRECO, A; BONGARZONE, I; LUO, Y; MONDELLINI, P; ALBERTI, L; MIRANDA, C; ARIGHI, E; BOCCIARDI, R; SERI, M; BARONE, V; RADICE, MT; ROMEO, G; PIEROTTI, MA				PASINI, B; BORRELLO, MG; GRECO, A; BONGARZONE, I; LUO, Y; MONDELLINI, P; ALBERTI, L; MIRANDA, C; ARIGHI, E; BOCCIARDI, R; SERI, M; BARONE, V; RADICE, MT; ROMEO, G; PIEROTTI, MA			LOSS OF FUNCTION EFFECT OF RET MUTATIONS CAUSING HIRSCHSPRUNG DISEASE	NATURE GENETICS			English	Article							THYROID PAPILLARY CARCINOMAS; PROTO-ONCOGENE; REGULATORY SUBUNIT; TYROSINE KINASE; PROTOONCOGENE; SEQUENCE; DOMAINS; CELLS; EXPRESSION; GENE	We have introduced three Hirschsprung (HSCR) mutations localized in the tyrosine kinase domain of RET into the RET/PTC2 chimaeric oncogene which is capable of transforming NIH3T3 mouse fibroblasts and of differentiating pC12 rat pheochromocytoma cells. The three HSCR mutations abolished the biological activity of RET/PTC2 in both cell types and significantly decreased its tyrosine phosphorylation. By contrast, a rare polymorphism in exon 18 does not alter the transforming capability of RET/PTC2 or its tyrosine phosphorylation. These data suggest a loss of function effect of HSCR mutations which might act through a dominant negative mechanism. Our model system is therefore capable of discriminating between causative HSCR mutations and rare polymorphisms in the tyrosine kinase domain of RET.	IST NAZL TUMORI,DIV ONCOL SPERIMENTALE A,I-20133 MILAN,ITALY; IST GIANNINA GASLINI,GENET MOLEC LAB,I-16147 GENOA,ITALY	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Genoa; IRCCS Istituto Giannina Gaslini			Pierotti, Marco Alessandro/AAC-4728-2022; Borrello, Maria Grazia/C-3161-2017; Barone, Virginia/K-8782-2015; Greco, Angela/C-1953-2017; Bongarzone, Italia/B-9544-2017; Pasini, Barbara/AHI-2004-2022; Bocciardi, Renata/J-8577-2016; Seri, Marco/A-4339-2014	Pierotti, Marco Alessandro/0000-0002-7431-8332; Borrello, Maria Grazia/0000-0002-6854-2848; Barone, Virginia/0000-0001-8794-9291; Greco, Angela/0000-0003-2994-0349; Bongarzone, Italia/0000-0003-2530-9170; Pasini, Barbara/0000-0002-4373-1212; Bocciardi, Renata/0000-0001-8415-3802; Seri, Marco/0000-0003-2425-2176				BONGARZONE I, 1993, MOL CELL BIOL, V13, P358, DOI 10.1128/MCB.13.1.358; BONGARZONE I, 1994, CANCER RES, V54, P2979; BORRELLO MG, 1994, ONCOGENE, V9, P1661; CARLSON KM, 1994, P NATL ACAD SCI USA, V91, P1579, DOI 10.1073/pnas.91.4.1579; CECCHERINI I, 1993, BIOCHEM BIOPH RES CO, V196, P1288, DOI 10.1006/bbrc.1993.2392; DONISKELLER H, 1993, HUM MOL GENET, V2, P851, DOI 10.1093/hmg/2.7.851; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; ENG C, 1994, HUM MOL GENET, V3, P237, DOI 10.1093/hmg/3.2.237; FANTL WJ, 1993, ANNU REV BIOCHEM, V62, P453, DOI 10.1146/annurev.bi.62.070193.002321; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; GRECO A, 1993, CELL GROWTH DIFFER, V4, P539; GRIECO M, 1990, CELL, V60, P557, DOI 10.1016/0092-8674(90)90659-3; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; LONGATI P, 1994, ONCOGENE, V9, P49; Luo Y, 1994, EUR J HUM GENET, V2, P272; MINOLETTI F, 1994, GENE CHROMOSOME CANC, V11, P51, DOI 10.1002/gcc.2870110108; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; MULLIGAN LM, 1994, HUM MOL GENET, V3, P2163, DOI 10.1093/hmg/3.12.2163; MULLIGAN LM, 1994, NAT GENET, V6, P70, DOI 10.1038/ng0194-70; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; OHMICHI M, 1991, J BIOL CHEM, V266, P14858; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PIEROTTI MA, 1992, P NATL ACAD SCI USA, V89, P1616, DOI 10.1073/pnas.89.5.1616; RODRIGUES CA, 1994, CURR OPIN GENET DEV, V4, P15, DOI 10.1016/0959-437X(94)90086-8; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; SANTORO M, 1994, ONCOGENE, V9, P509; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; SOZZI G, 1994, GENE CHROMOSOME CANC, V9, P244, DOI 10.1002/gcc.2870090404; TAKAHASHI M, 1985, CELL, V42, P581, DOI 10.1016/0092-8674(85)90115-1; TAKAHASHI M, 1993, ONCOGENE, V8, P2925; TAKAHASHI M, 1989, ONCOGENE, V4, P805; TAKAHASHI M, 1988, ONCOGENE, V3, P571; VANHEYNINGEN V, 1994, NATURE, V367, P319, DOI 10.1038/367319a0; WIGLER M, 1977, CELL, V11, P223, DOI 10.1016/0092-8674(77)90333-6; ZHEN Z, 1994, ONCOGENE, V9, P1691; ZICK SK, 1982, J BIOL CHEM, V257, P2287	40	174	177	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					35	40		10.1038/ng0595-35	http://dx.doi.org/10.1038/ng0595-35			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647787				2022-12-25	WOS:A1995QX57300013
J	MCLEAN, WHI; RUGG, EL; LUNNY, DP; MORLEY, SM; LANE, EB; SWENSSON, O; DOPPINGHEPENSTAL, PJC; GRIFFITHS, WAD; EADY, RAJ; HIGGINS, C; NAVSARIA, HA; LEIGH, IM; STRACHAN, T; KUNKELER, L; MUNRO, CS				MCLEAN, WHI; RUGG, EL; LUNNY, DP; MORLEY, SM; LANE, EB; SWENSSON, O; DOPPINGHEPENSTAL, PJC; GRIFFITHS, WAD; EADY, RAJ; HIGGINS, C; NAVSARIA, HA; LEIGH, IM; STRACHAN, T; KUNKELER, L; MUNRO, CS			KERATIN-16 AND KERATIN-17 MUTATIONS CAUSE PACHYONYCHIA-CONGENITA	NATURE GENETICS			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; EPIDERMOLYSIS-BULLOSA SIMPLEX; INTERMEDIATE FILAMENTS; HAIR-FOLLICLES; COILED-COIL; EXPRESSION; CELLS; GENES; CYTOKERATIN; PATTERNS	Pachyonychia congenita (PC) is a group of autosomal dominant disorders characterized by dystrophic nails and other ectodermal aberrations. A gene for Jackson-Lawler PC was recently mapped to the type I keratin cluster on 17q. Here, we show that a heterozygous missense mutation in the helix initiation motif of K17 (Asn92Asp) cosegregates with the disease in this kindred. We also show that Jadassohn-Lewandowsky PC is caused by a heterozygous missense mutation in the helix initiation peptide of K16 (Leu130Pro). The known expression patterns of these keratins in epidermal structures correlates with the specific abnormalities observed in each form of PC.	UNITED MED & DENT SCH, ST THOMAS HOSP, ST JOHNS INST DERMATOL, LONDON SE1 7EH, ENGLAND; ROYAL LONDON HOSP, COLL MED, EXPTL DERMATOL LABS, LONDON E1 6BL, ENGLAND; UNIV NEWCASTLE UPON TYNE, DEPT HUMAN GENET, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND; SO GEN HOSP, DEPT DERMATOL, GLASGOW G51 4TF, LANARK, SCOTLAND	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Barts Health NHS Trust; Royal London Hospital; Newcastle University - UK; University of Glasgow	MCLEAN, WHI (corresponding author), UNIV DUNDEE, INST MED SCI, DEPT ANAT & PHYSIOL, CANC RES CAMPAIGN LABS, CELL STRUCT RES GRP, DUNDEE DD1 4HN, SCOTLAND.		McLean, William HI/C-6352-2009	McLean, William Henry Irwin/0000-0001-5539-5757	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALBERS K, 1987, J CELL BIOL, V105, P791, DOI 10.1083/jcb.105.2.791; ALBERS K, 1989, J CELL BIOL, V108, P1477, DOI 10.1083/jcb.108.4.1477; ALBERTSEN HM, 1994, NAT GENET, V7, P472, DOI 10.1038/ng0894-472; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; CHENG J, 1992, CELL, V70, P811, DOI 10.1016/0092-8674(92)90314-3; CHIPEV CC, 1992, CELL, V70, P821, DOI 10.1016/0092-8674(92)90315-4; COLLIN C, 1992, EXP CELL RES, V202, P132, DOI 10.1016/0014-4827(92)90412-2; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199; HEID HW, 1988, DIFFERENTIATION, V37, P215, DOI 10.1111/j.1432-0436.1988.tb00724.x; HOROVITZ A, 1992, J MOL BIOL, V227, P560, DOI 10.1016/0022-2836(92)90907-2; JACKSON ADM, 1951, ANN EUGENIC, V16, P142, DOI 10.1111/j.1469-1809.1951.tb02468.x; JADASSOHN J, 1906, JACOBS IKONOGRAPHIA, V1, P29; KORGE BP, 1992, P NATL ACAD SCI USA, V89, P910, DOI 10.1073/pnas.89.3.910; KREMER H, 1994, J INVEST DERMATOL, V103, P286, DOI 10.1111/1523-1747.ep12394414; LANE EB, 1991, ANN NY ACAD SCI, V642, P197; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LANE EB, 1994, CURR OPIN GENET DEV, V4, P412, DOI 10.1016/0959-437X(94)90030-2; LANGBEIN L, 1993, DIFFERENTIATION, V55, P57, DOI 10.1111/j.1432-0436.1993.tb00033.x; MCKUSICK VA, 1994, OMIM LINE MENDELIAN; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, 1994, J INVEST DERMATOL, V103, P277, DOI 10.1111/1523-1747.ep12394307; MCLEAN WHI, 1994, J INVEST DERMATOL, V102, P24, DOI 10.1111/1523-1747.ep12371726; MOLL R, 1982, J CELL BIOL, V95, P285, DOI 10.1083/jcb.95.1.285; MOLL R, 1982, DIFFERENTIATION, V23, P170, DOI 10.1111/j.1432-0436.1982.tb01280.x; MUNRO CS, 1994, J MED GENET, V31, P675, DOI 10.1136/jmg.31.9.675; QUINLAN RA, 1994, INTERMEDIATE FILAMEN; REIS A, 1994, NAT GENET, V6, P174, DOI 10.1038/ng0294-174; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; ROMANO V, 1987, CYTOGENET CELL GENET, V46, P683; ROMANO V, 1988, CYTOGENET CELL GENET, V48, P148, DOI 10.1159/000132612; ROSENBERG M, 1988, MOL CELL BIOL, V8, P722, DOI 10.1128/MCB.8.2.722; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; ROTHNAGEL JA, 1994, NAT GENET, V7, P485, DOI 10.1038/ng0894-485; SERRANO L, 1992, J MOL BIOL, V227, P544, DOI 10.1016/0022-2836(92)90906-Z; SMEDTS F, 1990, AM J PATHOL, V136, P657; SMEDTS F, 1992, AM J PATHOL, V140, P601; STARK HJ, 1987, DIFFERENTIATION, V35, P236, DOI 10.1111/j.1432-0436.1987.tb00174.x; STEINERT PM, 1990, J BIOL CHEM, V265, P8766; STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161; STOOF TJ, 1994, KERATINOCYTE HDB, P365; TROYANOVSKY SM, 1989, J CELL SCI, V93, P419; TROYANOVSKY SM, 1992, EUR J CELL BIOL, V59, P127; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; WETZELS RHW, 1991, AM J PATHOL, V138, P751; WILSON CL, 1994, BRIT J DERMATOL, V131, P191	48	259	281	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1995	9	3					273	278		10.1038/ng0395-273	http://dx.doi.org/10.1038/ng0395-273			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7539673				2022-12-25	WOS:A1995QL23200017
J	YOSHIDA, K; FURIHATA, K; TAKEDA, S; NAKAMURA, A; YAMAMOTO, K; MORITA, H; HIYAMUTA, S; IKEDA, S; SHIMIZU, N; YANAGISAWA, N				YOSHIDA, K; FURIHATA, K; TAKEDA, S; NAKAMURA, A; YAMAMOTO, K; MORITA, H; HIYAMUTA, S; IKEDA, S; SHIMIZU, N; YANAGISAWA, N			A MUTATION IN THE CERULOPLASMIN GENE IS ASSOCIATED WITH SYSTEMIC HEMOSIDEROSIS IN HUMANS	NATURE GENETICS			English	Article							WILSON DISEASE GENE; COPPER-TRANSPORTING ATPASE; AMINO-ACID-SEQUENCE; CANDIDATE GENE; MENKES DISEASE; NONSENSE MUTATIONS; INTERNAL TRIPLICATION; IRON METABOLISM; DEFICIENCY; CDNA	We identified a mutation in the ceruloplasmin (Cp) gene in a Japanese family with aceruloplasminemia, some of whose members showed extrapyramidal disorders, cerebellar ataxia, and diabetes mellitus. A post-mortem study of the proband revealed excessive iron deposition mainly in the brain, liver and pancreas. The G to A transition at the splice acceptor site introduces a premature termination codon at the amino acid position 991 by defective splicing, thereby truncating the carboxyl terminus of Cp in affected individuals. We conclude that the mutation in the Cp gene is associated with systemic hemosiderosis in humans.	SHINSHU UNIV,SCH MED,DEPT LAB MED,MATSUMOTO,NAGANO 390,JAPAN; SHINSHU UNIV,SCH MED,DEPT MED NEUROL,MATSUMOTO,NAGANO 390,JAPAN; NATL CTR NEUROL & PSYCHIAT,NATL INST NEUROSCI,KODAIRA,TOKYO 187,JAPAN; IDEMITSU KOSAN CO LTD,CENT RES LABS,SODEGAURA,CHIBA 29902,JAPAN; TOHO UNIV,SCH MED,DEPT PEDIAT,MEGURO KU,TOKYO 153,JAPAN	Shinshu University; Shinshu University; National Center for Neurology & Psychiatry - Japan; Idemitsu Kosan; Toho University	YOSHIDA, K (corresponding author), NINCDS,DEV & METAB NEUROL BRANCH,BLDG 10,ROOM 3D-04,BETHESDA,MD 20892, USA.							ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; CHENG J, 1990, Molecular and Cellular Biology, V10, P5215; COUSINS RJ, 1985, PHYSIOL REV, V65, P238, DOI 10.1152/physrev.1985.65.2.238; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; Danks DM, 1989, METABOLIC BASIS INHE, P1411; DWULET FE, 1981, P NATL ACAD SCI-BIOL, V78, P2805, DOI 10.1073/pnas.78.5.2805; FOJO SS, 1989, J CLIN INVEST, V84, P1215, DOI 10.1172/JCI114287; FRIEDEN E, 1981, MET IONS BIOL SYST, V13, P117; GAREY CE, 1994, NAT GENET, V6, P426, DOI 10.1038/ng0494-426; HAMOSH A, 1991, J CLIN INVEST, V88, P1880, DOI 10.1172/JCI115510; HIYAMUTA S, 1994, HYBRIDOMA, V13, P139, DOI 10.1089/hyb.1994.13.139; HIYAMUTA S, 1993, BIOCHEM BIOPH RES CO, V197, P1140, DOI 10.1006/bbrc.1993.2596; KINGSTON IB, 1977, P NATL ACAD SCI USA, V74, P5377, DOI 10.1073/pnas.74.12.5377; KINGSTON IB, 1979, P NATL ACAD SCI USA, V76, P1668, DOI 10.1073/pnas.76.4.1668; KINGSTON IB, 1980, J BIOL CHEM, V255, P2886; KINGSTON IB, 1980, J BIOL CHEM, V255, P2878; KOSCHINSKY ML, 1986, P NATL ACAD SCI USA, V83, P5086, DOI 10.1073/pnas.83.14.5086; KOSCHINSKY ML, 1987, BIOCHEMISTRY-US, V26, P7760, DOI 10.1021/bi00398a034; LEE GR, 1968, J CLIN INVEST, V47, P2058, DOI 10.1172/JCI105891; LOGAN JI, 1994, Q J MED, V87, P663; MCINTOSH I, 1993, NAT GENET, V4, P219, DOI 10.1038/ng0793-219; MERCER JFB, 1986, FEBS LETT, V203, P185, DOI 10.1016/0014-5793(86)80739-6; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MIYAJIMA H, 1987, NEUROLOGY, V37, P761, DOI 10.1212/WNL.37.5.761; MORITA H, IN PRESS ANN NEUROL; MORITA H, 1992, CLIN NEUROL TOKYO, V32, P483; NOYER M, 1981, BIOCHEMISTRY-US, V20, P3536, DOI 10.1021/bi00515a036; ORTEL TL, 1984, P NATL ACAD SCI-BIOL, V81, P4761, DOI 10.1073/pnas.81.15.4761; OSAKI S, 1971, J BIOL CHEM, V246, P3018; OSAKI S, 1966, J BIOL CHEM, V241, P2746; OWEN CA, 1973, AM J PHYSIOL, V224, P514; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; Poulik M. D., 1975, PLASMA PROTEINS, V2, P51; RAGAN HA, 1969, AM J PHYSIOL, V217, P1320, DOI 10.1152/ajplegacy.1969.217.5.1320; ROESER HP, 1970, J CLIN INVEST, V49, P2408, DOI 10.1172/JCI106460; RYDEN L, 1982, P NATL ACAD SCI-BIOL, V79, P6767, DOI 10.1073/pnas.79.22.6767; SATO M, 1991, J BIOL CHEM, V266, P5128; TAKAHASHI N, 1984, P NATL ACAD SCI-BIOL, V81, P390, DOI 10.1073/pnas.81.2.390; TAKAHASHI N, 1983, P NATL ACAD SCI-BIOL, V80, P115, DOI 10.1073/pnas.80.1.115; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; YAMAGUCHI Y, 1993, BIOCHEM BIOPH RES CO, V197, P271, DOI 10.1006/bbrc.1993.2471; YANG F, 1986, P NATL ACAD SCI USA, V83, P3257, DOI 10.1073/pnas.83.10.3257	47	402	410	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					267	272		10.1038/ng0395-267	http://dx.doi.org/10.1038/ng0395-267			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7539672				2022-12-25	WOS:A1995QL23200016
J	HOLMGREN, L; OREILLY, MS; FOLKMAN, J				HOLMGREN, L; OREILLY, MS; FOLKMAN, J			DORMANCY OF MICROMETASTASES - BALANCED PROLIFERATION AND APOPTOSIS IN THE PRESENCE OF ANGIOGENESIS SUPPRESSION	NATURE MEDICINE			English	Article							TUMOR-GROWTH; MONOCLONAL-ANTIBODY; CELL-DEATH; METASTASIS; INDUCTION; SURVIVAL; PROTEIN; CANCER; RATS; MICE	In cancer patients, dormant micrometastases are often asymptomatic and clinically undetectable, for months or years, until relapse. We have studied dormant lung metastases under angiogenesis suppression in mice. The metastases exhibited rapid growth when the inhibition of angiogenesis was removed. Tumour cell proliferation, as measured by bromodeoxyuridine incorporation and immunohistochemical staining proliferating cell nuclear antigen, was not significantly different in dormant and growing metastases. However, tumour cells of dormant metastases exhibited a more than threefold higher incidence of apoptosis. These data show that metastases remain dormant when tumour cell proliferation is balanced by an equivalent rate of cell death and suggest that angiogenesis inhibitors control metastatic growth by indirectly increasing apoptosis in tumour cells.	HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School	HOLMGREN, L (corresponding author), HARVARD UNIV,CHILDRENS HOSP,DEPT SURG,300 LONGWOOD AVE,BOSTON,MA 02115, USA.							ANTOINE N, 1994, CANCER RES, V54, P2073; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BREM H, 1993, J PEDIATR SURG, V28, P445, DOI 10.1016/0022-3468(93)90246-H; BURSCH W, 1990, CARCINOGENESIS, V11, P847, DOI 10.1093/carcin/11.5.847; CROWLEY NJ, 1992, ARCH SURG-CHICAGO, V127, P1303; DEDERA DA, 1993, CELL, V74, P833, DOI 10.1016/0092-8674(93)90463-Z; DEMICHELI R, 1994, J NATL CANCER I, V86, P45; DEVITA VT, 1993, CANCER PRINCIPLES PR, P134; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; FIDLER IJ, 1991, BRIT MED BULL, V47, P157, DOI 10.1093/oxfordjournals.bmb.a072453; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1994, J CLIN ONCOL, V12, P441, DOI 10.1200/JCO.1994.12.3.441; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; HAMADA J, 1992, BRIT J CANCER, V66, P349, DOI 10.1038/bjc.1992.269; HARRINGTON EA, 1994, CURR OPIN GENET DEV, V4, P120, DOI 10.1016/0959-437X(94)90100-7; HORI A, 1991, CANCER RES, V51, P6180; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; MELTZER A, 1990, J SURG ONCOL, V43, P181, DOI 10.1002/jso.2930430312; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; NICOSIA RF, 1983, CANCER RES, V43, P2159; NOBLE RL, 1975, CANCER RES, V35, P2935; O'Reilly Michael, 1993, Surgical Forum, V44, P474; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; POTTEN CS, 1992, CANCER METAST REV, V11, P179, DOI 10.1007/BF00048063; RAFFMC, 1992, NATURE, V356, P397; WEINSTATSASLOW D, 1994, FASEB J, V8, P401, DOI 10.1096/fasebj.8.6.7513289; Wheelock E F, 1981, Adv Cancer Res, V34, P107; WHITE E, 1991, J VIROL, V65, P2968, DOI 10.1128/JVI.65.6.2968-2978.1991; WOODRUFF M, 1982, BRIT J CANCER, V46, P313, DOI 10.1038/bjc.1982.206; WYLLIE AH, 1992, CANCER METAST REV, V11, P95, DOI 10.1007/BF00048057	37	1535	1602	2	41	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1995	1	2					149	153		10.1038/nm0295-149	http://dx.doi.org/10.1038/nm0295-149			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX558	7585012				2022-12-25	WOS:A1995QX55800026
J	LICHTENBERGER, LM; WANG, ZM; ROMERO, JJ; ULLOA, C; PEREZ, JC; GIRAUD, MN; BARRETO, JC				LICHTENBERGER, LM; WANG, ZM; ROMERO, JJ; ULLOA, C; PEREZ, JC; GIRAUD, MN; BARRETO, JC			NONSTEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDS) ASSOCIATE WITH ZWITTERIONIC PHOSPHOLIPIDS - INSIGHT INTO THE MECHANISM AND REVERSAL OF NSAID-INDUCED GASTROINTESTINAL INJURY	NATURE MEDICINE			English	Article							CANINE GASTRIC-MUCOSA; SURFACE HYDROPHOBICITY; RAT; ASPIRIN; PROSTAGLANDIN; ABSORPTION; INHIBITION; ORGANELLES; CELLS	The molecular basis of the injurious actions of non-steroidal anti-inflammatory drugs (NSAIDs) on the gastrointestinal (GI) tract is only partly understood. In this study we have obtained evidence, employing both in vitro and in vivo systems, that five NSAIDs have the ability to form a chemical association with zwitterionic phospholipids. Since this same class of phospholipids line the luminal aspects of the mucus gel layer to provide it with non-wettable properties, this intermolecular association may be the mechanism by which NSAIDs attenuate the hydrophobic barrier properties of the upper GI tract. Preassociating a number of NSAIDs with exogenous zwitterionic phospholipids prevented this increase in surface wettability of the mucus gel layer and protected rats against the injurious GI side-effects of these drugs, while enhancing their lipid permeability, antipyretic and anti-inflammatory activity.	UNIV TEXAS,SCH MED,DEPT SURG,HOUSTON,TX 77030	University of Texas System	LICHTENBERGER, LM (corresponding author), UNIV TEXAS,SCH MED,DEPT PHYSIOL & CELL BIOL,HOUSTON,TX 77030, USA.		gf, mn/N-1593-2016	gf, mn/0000-0003-3228-6827	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033239] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK33239] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADAMS SS, 1968, J PHARM PHARMACOL, V20, P305, DOI 10.1111/j.2042-7158.1968.tb09744.x; ALEXANDER AM, 1985, J CLIN HOSP PHARM, V10, P89; ALLISON MC, 1992, NEW ENGL J MED, V32, P749; ALPSTEN M, 1982, EUR J CLIN PHARMACOL, V22, P57, DOI 10.1007/BF00606426; CASTRO GA, 1980, J PARASITOL, V66, P407, DOI 10.2307/3280739; CHEN, 1993, GASTROENTEROLOGY, V104, pA53; CLATWORTHY AL, 1994, J NEUROSCI, V14, P3263; GODDARD PJ, 1987, AM J PHYSIOL, V252, pG421, DOI 10.1152/ajpgi.1987.252.3.G421; GODDARD PJ, 1990, GASTROENTEROLOGY, V98, P361, DOI 10.1016/0016-5085(90)90826-M; GRAHAM DY, 1989, GASTROENTEROLOGY, V96, P675, DOI 10.1016/S0016-5085(89)80064-2; HILLS BA, 1983, AM J PHYSIOL, V244, pG561, DOI 10.1152/ajpgi.1983.244.5.G561; JOLOBE OMP, 1984, DIGESTION, V29, P164, DOI 10.1159/000199027; KAO YCJ, 1991, GASTROENTEROLOGY, V101, P7, DOI 10.1016/0016-5085(91)90454-S; KAO YCJ, 1990, GASTROENTEROLOGY, V98, P592, DOI 10.1016/0016-5085(90)90278-9; KAO YCJ, 1993, GASTROENTEROLOGY, V104, P103, DOI 10.1016/0016-5085(93)90841-Y; LICHTENBERGER LM, 1983, SCIENCE, V219, P1327, DOI 10.1126/science.6828859; LIGUMSKY M, 1982, AM J PHYSIOL, V242, pG337, DOI 10.1152/ajpgi.1982.242.4.G337; MCCORMACK K, 1987, ARCH TOXICOL, V60, P261, DOI 10.1007/BF01234664; MOJAVERIAN P, 1987, CLIN PHARMACOL THER, V41, P11, DOI 10.1038/clpt.1987.3; RAINSFORD KD, 1989, SCAND J GASTROENTERO, V24, P9, DOI 10.3109/00365528909091169; RAINSFORDKD, 1985, ANTI INFLAMMATORY AN, V1; UCELAY M, 1988, ARZNEIMITTELFORSCH, V38-1, P546; WHITTLE BJR, 1980, NATURE, V284, P271, DOI 10.1038/284271a0; WHITTLE BJR, 1981, GASTROENTEROLOGY, V80, P94	24	259	276	2	14	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1995	1	2					154	158		10.1038/nm0295-154	http://dx.doi.org/10.1038/nm0295-154			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX558	7585013				2022-12-25	WOS:A1995QX55800027
J	SIMERLY, C; WU, GJ; ZORAN, S; ORD, T; RAWLINS, R; JONES, J; NAVARA, C; GERRITY, M; RINEHART, J; BINOR, Z; ASCH, R; SCHATTEN, G				SIMERLY, C; WU, GJ; ZORAN, S; ORD, T; RAWLINS, R; JONES, J; NAVARA, C; GERRITY, M; RINEHART, J; BINOR, Z; ASCH, R; SCHATTEN, G			THE PATERNAL INHERITANCE OF THE CENTROSOME, THE CELLS MICROTUBULE-ORGANIZING CENTER, IN HUMANS, AND THE IMPLICATIONS FOR INFERTILITY	NATURE MEDICINE			English	Article							GAMMA-TUBULIN; MOUSE OOCYTES; SEA-URCHIN; FERTILIZATION; CENTRIOLES; RABBIT; CYCLE	Successful fertilization in humans, achieved when parental chromosomes intermix at first mitosis, requires centrosome restoration and microtubule-mediated motility. Imaging of inseminated human oocytes reveals that the sperm introduces the centrosome. The centrosome then nucleates the new microtubule assembly to form the sperm aster - a step essential for successful fertilization. Oocytes from some infertile patients failed to complete fertilization because of defects in uniting the sperm and egg nuclei, indicating that failure to properly effect the cytoplasmic motions uniting the nuclei results in human infertility. These discoveries have important implications for infertility diagnosis and managing reproduction.	UNIV WISCONSIN,DEPT ZOOL,MADISON,WI 53706; UNIV WISCONSIN,WISCONSIN REG PRIMATE RES CTR,MADISON,WI 53706; UNIV WISCONSIN,DEPT OBSTET & GYNECOL,MADISON,WI 53706; UNIV CALIF IRVINE,IRVINE MED CTR,CTR REPROD HLTH,ORANGE,CA 92668; RUSH UNIV,REPROD ENDOCRINOL & INFERTIL SECT,CHICAGO,IL 60612; GLENBROOK HOSP,ASSISTED REPROD TECHNOL PROGRAM,GLENVIEW,IL 60025	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; Rush University; NorthShore University Health System			simerly, Calvin/AAC-9564-2021; Navara, Christopher/C-2813-2011; Schatten, Gerald/B-3253-2009	Schatten, Gerald/0000-0001-5206-7782				ARCHER J, 1994, CELL, V76, P589, DOI 10.1016/0092-8674(94)90496-0; BORRERO C, 1989, HUM REPROD, V4, P275, DOI 10.1093/oxfordjournals.humrep.a136887; BOVERI T, 1901, ZELIEN STUDIEN NATUR, V4; BREED W, 1994, DEV BIOL B, P230; BRINKLEY BR, 1985, ANNU REV CELL BIOL, V1, P145, DOI 10.1146/annurev.cellbio.1.1.145; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; FELIX MA, 1994, J CELL BIOL, V124, P19, DOI 10.1083/jcb.124.1.19; FUKUI Y, 1988, J REPROD FERTIL, V82, P337, DOI 10.1530/jrf.0.0820337; HILL DP, 1993, DEV BIOL, V1136, P154; KIMBLE M, 1992, INT REV CYTOL, V136, P1, DOI 10.1016/S0074-7696(08)62049-5; LEGUEN P, 1989, EUR J CELL BIOL, V48, P239; LONG CR, 1993, MOL REPROD DEV, V36, P23, DOI 10.1002/mrd.1080360105; LONGO FJ, 1976, J CELL BIOL, V69, P539, DOI 10.1083/jcb.69.3.539; MARO B, 1985, J CELL BIOL, V101, P1665, DOI 10.1083/jcb.101.5.1665; MAZIA D, 1987, INT REV CYTOL, V100, P49; NAVARA CS, 1994, DEV BIOL, V162, P29, DOI 10.1006/dbio.1994.1064; PALACIOS MJ, 1993, J CELL SCI, V104, P383; PALERMO G, 1994, HUM REPROD, V9, P1220, DOI 10.1093/oxfordjournals.humrep.a138682; PICKERING SJ, 1988, HUM REPROD, V3, P978, DOI 10.1093/oxfordjournals.humrep.a136828; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Rose MD, 1993, CURR OPIN CELL BIOL, V5, P105, DOI 10.1016/S0955-0674(05)80015-8; SATHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806, DOI 10.1073/pnas.88.11.4806; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4152, DOI 10.1073/pnas.82.12.4152; SCHATTEN H, 1989, GAMETE RES, V23, P309, DOI 10.1002/mrd.1120230308; SCHATTEN H, 1986, P NATL ACAD SCI USA, V83, P105, DOI 10.1073/pnas.83.1.105; SIMERLY C, 1993, METHOD ENZYMOL, V225, P516; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; SZOLLOSI D, 1991, BIOL CELL, V72, P61, DOI 10.1016/0248-4900(91)90079-3; VANSTEIRTEGHEM AC, 1993, HUM REPROD, V8, P1061, DOI 10.1093/oxfordjournals.humrep.a138192; WHEATLEY DN, 1982, CENTRIOLE CENTRAL EN; Wilson EB., 1925, CELL DEV HEREDITY, V3rd edition; WINSTON N, 1991, FERTIL STERIL, V56, P204; YLLERAFERNANDEZ MD, 1992, MOL REPROD DEV, V32, P271, DOI 10.1002/mrd.1080320313; ZHENG YX, 1991, CELL, V65, P817, DOI 10.1016/0092-8674(91)90389-G	36	214	222	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1995	1	1					47	52		10.1038/nm0195-47	http://dx.doi.org/10.1038/nm0195-47			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX557	7584952				2022-12-25	WOS:A1995QX55700025
J	THOMPSON, TG; DIDONATO, CJ; SIMARD, LR; INGRAHAM, SE; BURGHES, AHM; CRAWFORD, TO; ROCHETTE, C; MENDELL, JR; WASMUTH, JJ				THOMPSON, TG; DIDONATO, CJ; SIMARD, LR; INGRAHAM, SE; BURGHES, AHM; CRAWFORD, TO; ROCHETTE, C; MENDELL, JR; WASMUTH, JJ			A NOVEL CDNA DETECTS HOMOZYGOUS MICRODELETIONS IN GREATER-THAN 50-PERCENT OF TYPE-I SPINAL MUSCULAR-ATROPHY PATIENTS	NATURE GENETICS			English	Article							21-HYDROXYLASE DEFICIENCY; CELL-CYCLE; GENE; REGION; CHROMOSOME-5; ASSIGNMENT; DELETION; LINKAGE; FORMS; MAP	Spinal muscular atrophy (SMA) is the second most common lethal, autosomal recessive disease in Caucasians (after cystic fibrosis). Childhood SMAs are divided into three groups (type I, II and III), which are allelic variants of the same locus in a region of similar to 850 kb in chromosome 5q12-q13, containing multiple copies of a novel, chromosome 5-specific repeat as well as many atypical pseudogenes. This has hampered the identification of candidate genes. We have identified several coding sequences unique to the SMA region. A genomic fragment detected by one cDNA is homozygously deleted in 17/29 (58%) of type I SMA patients. Of 235 unaffected individuals examined, only two showed the deletion and both are carriers of SMA. Our results suggest that deletion of at least part of this novel gene is directly related to the phenotype of SMA.	UNIV CALIF IRVINE,COLL MED,DEPT BIOL CHEM,IRVINE,CA 92717; OHIO STATE UNIV,DEPT MOLEC GENET,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT NEUROL,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT BIOCHEM MED,COLUMBUS,OH 43210; HOP ST JUSTINE,MONTREAL,PQ H3T 1C5,CANADA; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205	University of California System; University of California Irvine; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Universite de Montreal; Johns Hopkins University			Ingraham, Susan/B-4565-2012; Crawford, Thomas/E-6307-2012	Burghes, Arthur/0000-0001-9031-1555; Simard, Louise/0000-0003-0391-8821	NICHD NIH HHS [HD 24061] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARREDONDOVEGA FX, 1984, CYTOGENET CELL GENET, V37, P403; BEIT KT, 1984, CELL, V36, P907; BRETON C, 1993, MOL BRAIN RES, V18, P297, DOI 10.1016/0169-328X(93)90093-5; BRISTOW J, 1993, J CELL BIOL, V122, P265, DOI 10.1083/jcb.122.1.265; BRUNSTOWICZ L, 1990, NATURE, V344, P540; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BURGHES AHM, 1994, GENOMICS, V21, P394, DOI 10.1006/geno.1994.1282; CARROLL MC, 1985, EMBO J, V4, P2547, DOI 10.1002/j.1460-2075.1985.tb03969.x; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DANESINO C, 1981, HUM GENET, V56, P371, DOI 10.1007/BF00274695; DANIELS RJ, 1992, GENOMICS, V12, P335, DOI 10.1016/0888-7543(92)90382-3; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; FRANCIS MJ, 1993, HUM MOL GENET, V2, P1161, DOI 10.1093/hmg/2.8.1161; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; GILLIAM TC, 1989, GENOMICS, V5, P940, DOI 10.1016/0888-7543(89)90138-9; KLYEN PW, 1993, P NATL ACAD SCI USA, V90, P6801; MEIKI J, 1994, SCIENCE, V264, P1474; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MILLER WL, 1989, ANNU REV GENET, V23, P371, DOI 10.1146/annurev.ge.23.120189.002103; MOREL Y, 1989, P NATL ACAD SCI USA, V86, P6582, DOI 10.1073/pnas.86.17.6582; MOREL Y, 1989, J CLIN ENDOCR METAB, V68, P592, DOI 10.1210/jcem-68-3-592; PANG S, 1988, PEDIATRICS, V81, P866; PEARN J, 1980, LANCET, V1, P919; PEARN JH, 1982, ADV NEUROL, P121; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PREDEUTOUR F, 1994, GENOMICS, V19, P31; SARGENT CA, 1991, CYTOGENET CELL GENET, V56, P1901; SARTOR H, 1992, GENOMICS, V13, P911, DOI 10.1016/0888-7543(92)90190-4; SELIG S, IN PRESS EMBO J; SHEN LM, 1994, J BIOL CHEM, V269, P8466; SHIPLEY JM, 1993, AM J HUM GENET, V52, P517; SIMARD LR, 1994, HUM MOL GENET, V3, P459, DOI 10.1093/hmg/3.3.459; SIMARD LR, 1992, GENOMICS, V14, P188, DOI 10.1016/S0888-7543(05)80305-2; TAKAHASHI M, 1992, J BIOL CHEM, V267, P17864; THOMPSON TG, 1993, HUM MOL GENET, V2, P1169, DOI 10.1093/hmg/2.8.1169; WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M; WIRTH B, 1994, GENOMICS, V20, P84, DOI 10.1006/geno.1994.1130; Wirth B., 1994, American Journal of Human Genetics, V55, pA207; [No title captured]	40	84	84	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					56	62		10.1038/ng0195-56	http://dx.doi.org/10.1038/ng0195-56			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704025				2022-12-25	WOS:A1995PZ91300015
J	SIMARD, J; TONIN, P; DUROCHER, F; MORGAN, K; ROMMENS, J; GINGRAS, S; SAMSON, C; LEBLANC, JF; BELANGER, C; DION, F; LIU, Q; SKOLNICK, M; GOLDGAR, D; SHATTUCKEIDENS, D; LABRIE, F; NAROD, SA				SIMARD, J; TONIN, P; DUROCHER, F; MORGAN, K; ROMMENS, J; GINGRAS, S; SAMSON, C; LEBLANC, JF; BELANGER, C; DION, F; LIU, Q; SKOLNICK, M; GOLDGAR, D; SHATTUCKEIDENS, D; LABRIE, F; NAROD, SA			COMMON ORIGINS OF BRCA1 MUTATIONS IN CANADIAN BREAST AND OVARIAN-CANCER FAMILIES	NATURE GENETICS			English	Article							CHROMOSOME-17Q21; LINKAGE	Women who carry mutations in the BRCA1 gene on chromosome 17q have an 85% lifetime risk of breast cancer, and a 60% risk of ovarian cancer, We have identified BRCA1 mutations in 12 of 30 (40%) Canadian families with breast and/or ovarian cancer, including six of the eight families (75%) that contained two cases of early-onset breast cancer and two cases of ovarian cancer, Six frameshift mutations account for all 12 mutant alleles, including nucleotide insertions (two mutations) and deletions (four mutations), Four independent families carried the same 1 basepair (bp) insertion mutation in codon 1755 and four other families shared a 2 bp deletion mutation in codons 22-23. These families were not known to be related, but haplotype analysis suggests that the carriers of each of these mutations have common ancestors.	MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL H3G 1A4,PQ,CANADA; MCGILL UNIV,DEPT HUMAN GENET,MONTREAL H3G 1A4,PQ,CANADA; MCGILL UNIV,DEPT BIOSTAT & EPIDEMIOL,MONTREAL H3G 1A4,PQ,CANADA; CHU LAVAL,RES CTR,MOLEC ENDOCRINOL LAB,QUEBEC CITY G1V 4G2,PQ,CANADA; UNIV LAVAL,QUEBEC CITY G1V 4G2,PQ,CANADA; HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ON,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; MYRIAD GENET INC,SALT LAKE CITY,UT; UNIV UTAH,DEPT MED INFORMAT,SALT LAKE CITY,UT 84112	McGill University; McGill University; McGill University; Laval University; Laval University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Myriad Genetics, Inc; Utah System of Higher Education; University of Utah			Narod, Steven A/AAA-6112-2022	Leblanc, Jean-Francois/0000-0003-4568-2335; Durocher, Francine/0000-0001-8012-4641; Simard, Jacques/0000-0001-6906-3390				ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; EASTON DF, 1993, AM J HUM GENET, V52, P678; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; GOLDGAR DE, 1994, J NATL CANCER I, V86, P200, DOI 10.1093/jnci/86.3.200; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1991, LANCET, V338, P82; NAROD SA, IN PRESS AM J HUM GE; NEUHAUSEN SL, 1994, HUM MOL GENET, V3, P1919, DOI 10.1093/hmg/3.11.1919; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; TONIN P, IN PRESS HUM GENET; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	14	304	319	1	9	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					392	398		10.1038/ng1294-392	http://dx.doi.org/10.1038/ng1294-392			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894492				2022-12-25	WOS:A1994PV68200022
J	MOISES, HW; YANG, L; KRISTBJARNARSON, H; WIESE, C; BYERLEY, W; MACCIARDI, F; AROLT, V; BLACKWOOD, D; LIU, X; SJOGREN, S; ASCHAUER, HN; HWU, HG; JANG, K; LIVESLEY, WJ; KENNEDY, JL; ZOEGA, T; IVARSSON, O; BUI, MT; YU, MH; HAVSTEEN, B; COMMENGES, D; WEISSENBACH, J; SCHWINGER, E; GOTTESMAN, II; PAKSTIS, AJ; WETTERBERG, L; KIDD, KK; HELGASON, T				MOISES, HW; YANG, L; KRISTBJARNARSON, H; WIESE, C; BYERLEY, W; MACCIARDI, F; AROLT, V; BLACKWOOD, D; LIU, X; SJOGREN, S; ASCHAUER, HN; HWU, HG; JANG, K; LIVESLEY, WJ; KENNEDY, JL; ZOEGA, T; IVARSSON, O; BUI, MT; YU, MH; HAVSTEEN, B; COMMENGES, D; WEISSENBACH, J; SCHWINGER, E; GOTTESMAN, II; PAKSTIS, AJ; WETTERBERG, L; KIDD, KK; HELGASON, T			AN INTERNATIONAL 2-STAGE GENOME-WIDE SEARCH FOR SCHIZOPHRENIA SUSCEPTIBILITY GENES	NATURE GENETICS			English	Letter							LINKAGE	Schizophrenia is thought to be a multifactorial disease with complex mode of inheritance (1,2). Using a two-stage strategy for another complex disorder, a number of putative IDDM-susceptibility genes have recently been mapped(3). We now report the results of a two-stage genome-wide search for genes conferring susceptibility to schizophrenia. In stage I, model-free linkage analyses of large pedigrees from Iceland, a geographical isolate, revealed 26 loci suggestive of linkage. In stage II, ten of these were followed-up in a second international collaborative study comprising families from Austria, Canada, Germany, Italy, Scotland, Sweden, Taiwan and the United States. Potential linkage findings of stage I on chromosomes 6p, 9 and 20 were observed again in the second sample. Furthermore, in a third sample from China, fine mapping of the 6p region by association studies also showed evidence for linkage or linkage disequilibrium. Combining our results with other recent findings(4,5) revealed significant evidence for linkage to an area distal of the HLA region on chromosome 6p. However, in a fourth sample from Europe, the 6p fine mapping finding observed in the Chinese sample could not be replicated. Finally evidence suggestive of locus heterogeneity and oligogenic transmission in schizophrenia was obtained.	NATL UNIV HOSP REYKJAVIK,DEPT PSYCH,IS-121 REYKJAVIK,ICELAND; UNIV UTAH,DEPT PSYCH,SALT LAKE CITY,UT 84132; UNIV MILAN,SCI INST HOSP ST RAFFAEL,DEPT NEUROSCI,I-20127 MILAN,ITALY; UNIV LUBECK,DEPT PSYCH,D-23538 LUBECK,GERMANY; UNIV EDINBURGH,DEPT PSYCH,EDINBURGH EH10 5HF,MIDLOTHIAN,SCOTLAND; W CHINA UNIV MED SCI,DEPT PSYCH RES,CHENGDU 610041,PEOPLES R CHINA; KAROLINSKA INST,ST GORANS HOSP,DEPT PSYCH,S-11281 STOCKHOLM,SWEDEN; UNIV HOSP VIENNA,DEPT GEN PSYCH,A-1090 VIENNA,AUSTRIA; NATL TAIWAN UNIV HOSP,DEPT PSYCH,TAIPEI 100,TAIWAN; UNIV BRITISH COLUMBIA,DEPT PSYCH,VANCOUVER,BC V6T 2A1,CANADA; UNIV TORONTO,CLARKE INST PSYCH,TORONTO,ON M5T 1R8,CANADA; CHRISTIAN ALBRECHTS UNIV KIEL,DEPT BIOCHEM,D-24118 KIEL,GERMANY; UNIV BORDEAUX 2,INSERM,F-33077 BORDEAUX,FRANCE; GENETHON SA,F-91000 EVRY,FRANCE; UNIV LUBECK,DEPT HUMAN GENET,D-23538 LUBECK,GERMANY; UNIV VIRGINIA,DEPT PSYCH,CHARLOTTESVILLE,VA 22903; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510	Landspitali National University Hospital; Utah System of Higher Education; University of Utah; University of Milan; University of Lubeck; University of Edinburgh; Sichuan University; Karolinska Institutet; Saint Goran's Hospital; University Hospital Vienna; National Taiwan University; National Taiwan University Hospital; University of British Columbia; University of Toronto; University of Kiel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Lubeck; University of Virginia; Yale University	MOISES, HW (corresponding author), UNIV HOSP KIEL,DEPT PSYCH,NIEMANNSWEG 147,D-24105 KIEL,GERMANY.		Commenges, Daniel/T-6536-2019; Macciardi, Fabio/N-3768-2014; G, I/D-8042-2011; Aschauer, Harald/G-8850-2016; Kennedy, James Lowery/AAZ-6947-2020	Macciardi, Fabio/0000-0003-0537-4266; Aschauer, Harald/0000-0002-4449-372X; Kennedy, James Lowery/0000-0002-8733-3806; HWU, HAI-GWO/0000-0002-2582-2807; Moises, Hans/0000-0003-1522-3226				BLOSSEY H, 1993, GENET EPIDEMIOL, V10, P377, DOI 10.1002/gepi.1370100608; BROWN DL, 1994, AM J HUM GENET, V54, P544; COMMENGES D, 1994, GENET EPIDEMIOL, V11, P201, DOI 10.1002/gepi.1370110209; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; ELSTON RC, 1992, 16TH P INT BIOM C HA, P39; GOTTESMAN II, 1991, SCHIZOPHRENIA GENETI; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; LASSETER VK, 1995, AM J MED GENET, V60, P172, DOI 10.1002/ajmg.1320600217; MOISES HW, IN PRESS AM J MED GE; MOISES HW, 1995, ADV NEUROBIOLOGY SCH, P59; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SPITZER RL, 1988, SCHEDULE AFFECTIVE D; Spitzer RL, 1978, RES DIAGNOSTIC CRITE; STRAUB RE, NATURE GENET, V11; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; VALLADA HP, 1995, AM J MED GENET, V60, P139, DOI 10.1002/ajmg.1320600210; VINOGRADOV S, 1991, SCHIZOPHRENIA BULL, V17, P669, DOI 10.1093/schbul/17.4.669; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	20	320	332	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					321	324		10.1038/ng1195-321	http://dx.doi.org/10.1038/ng1195-321			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581457				2022-12-25	WOS:A1995TC63900022
J	CAIRNS, P; POLASCIK, TJ; EBY, Y; TOKINO, K; CALIFANO, J; MERLO, A; MAO, L; HERATH, J; JENKINS, R; WESTRA, W; RUTTER, JL; BUCKLER, A; GABRIELSON, E; TOCKMAN, M; CHO, KR; HEDRICK, L; BOVA, GS; ISAACS, W; KOCH, W; SCHWAB, D; SIDRANSKY, D				CAIRNS, P; POLASCIK, TJ; EBY, Y; TOKINO, K; CALIFANO, J; MERLO, A; MAO, L; HERATH, J; JENKINS, R; WESTRA, W; RUTTER, JL; BUCKLER, A; GABRIELSON, E; TOCKMAN, M; CHO, KR; HEDRICK, L; BOVA, GS; ISAACS, W; KOCH, W; SCHWAB, D; SIDRANSKY, D			FREQUENCY OF HOMOZYGOUS DELETION AT P16/CDKN2 IN PRIMARY HUMAN TUMORS	NATURE GENETICS			English	Letter							CANCER; GENE		JOHNS HOPKINS UNIV,SCH MED,DEPT OTOLARYNGOL HEAD & NECK SURG,DIV HEAD & NECK CANC RES,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV HOSP,DEPT UROL,BALTIMORE,MD 21287; MAYO CLIN,ROCHESTER,MN 55905; JOHNS HOPKINS UNIV HOSP,DEPT PATHOL,BALTIMORE,MD 21287; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,BOSTON,MA 02129; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT ENVIRONM HLTH SCI,DIV OCCUPAT HLTH,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University			Mao, Li/C-7570-2011	Mao, Li/0000-0001-7263-3358; Rutter, Joni/0000-0002-6502-2361; Bova, George/0000-0003-1639-3104; Cho, Kathleen/0000-0003-0500-9998	NATIONAL CANCER INSTITUTE [P50CA058184, P20CA066204] Funding Source: NIH RePORTER; NCI NIH HHS [P20-CA-ES 66204, CA-58184-01,NCI] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CAIRNS P, 1994, SCIENCE, V265, P415, DOI 10.1126/science.8023167; CAIRNS P, 1994, CANCER RES, V54, P1422; CAIRNS P, 1993, ONCOGENE, V8, P1083; CALDAS C, 1994, NAT GENET, V8, P27, DOI 10.1038/ng0994-27; DIAZ MO, 1990, NEW ENGL J MED, V332, P77; FOUNTAIN JW, 1992, P NATL ACAD SCI USA, V89, P10557, DOI 10.1073/pnas.89.21.10557; HAYASHI N, 1994, BIOCHEM BIOPH RES CO, V202, P1426, DOI 10.1006/bbrc.1994.2090; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; JAMES CD, 1991, CANCER RES, V51, P1684; JEN J, 1994, CANCER RES, V54, P6353; Kamb A, 1994, Nat Genet, V8, P23; KAMB A, 1994, SCIENCE, V265, P416, DOI 10.1126/science.265.5170.416; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KNUDSON AG, 1975, P NATL ACAD SCI USA, V72, P5116, DOI 10.1073/pnas.72.12.5116; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; MIDDLETONPRICE H, 1988, ANN HUM GENET B, P189; MORI T, 1994, CANCER RES, V54, P3396; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; OKAMOTO A, 1995, CANCER RES, V55, P1448; OLOPADE OI, 1993, CANCER RES, V53, P2410; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; SAUTER G, 1995, INT J CANCER, V64, P99, DOI 10.1002/ijc.2910640205; VANDERRIET P, 1994, CANCER RES, V54, P1156; WEAVERFELDHAUS J, 1994, P NATL ACAD SCI USA, V91, P7563, DOI 10.1073/pnas.91.16.7563; XU L, 1994, CANCER RES, V54, P5262; XU L, 1994, CANCER RES, V54, P5269; ZHANG J, 1993, BLOOD, V81, P3365; ZHOU XL, 1994, ONCOGENE, V9, P3737	29	634	652	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					210	212		10.1038/ng1095-210	http://dx.doi.org/10.1038/ng1095-210			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550353				2022-12-25	WOS:A1995RX80600027
J	RUIZOPAZO, N; AKIMOTO, K; HERRERA, VLM				RUIZOPAZO, N; AKIMOTO, K; HERRERA, VLM			IDENTIFICATION OF A NOVEL DUAL ANGIOTENSIN-II VASOPRESSIN RECEPTOR ON THE BASIS OF MOLECULAR RECOGNITION THEORY	NATURE MEDICINE			English	Article							HYDROPATHIC COMPLEMENTARITY APPROACH; DENSITY-LIPOPROTEIN RECEPTOR; MESSENGER-RNA; BINDING-SITE; AMINO-ACIDS; PEPTIDE; CLONING; ANTIBODY; PROTEIN; EXPRESSION	The molecular recognition theory suggests that binding sites of interacting proteins, for example, peptide hormone and its receptor binding site, were originally encoded by and evolved from complementary strands of genomic DNA. To test this theory, we screened a rat kidney complementary DNA library twice: first with the angiotensin II (All) followed by the vasopressin (AVP) antisense oligonucleotide probe, expecting to isolate cDNA clones of the respective receptors. Surprisingly, the identical cDNA clone was isolated twice independently. Structural analysis revealed a single receptor polypeptide with seven predicted transmembrane regions, distinct All and AVP putative binding domains, a G(s) protein-activation motif, and an internalization recognition sequence. Functional analysis revealed specific binding to both All and AVP as well as All- and AVP-induced coupling to the adenylate cyclase second messenger system. Site-directed mutagenesis of the predicted AII binding domain obliterates All binding but preserves AVP binding. This corroborates the dual nature of the receptor and provides direct molecular genetic evidence for the molecular recognition theory.	BOSTON UNIV, SCH MED, WHITAKER CARDIOVASC INST, CARDIOL SECT, BOSTON, MA 02118 USA	Boston University	RUIZOPAZO, N (corresponding author), BOSTON UNIV, SCH MED, WHITAKER CARDIOVASC INST, MOLEC GENET SECT, 80 E CONCORD ST, BOSTON, MA 02118 USA.			Herrera, Victoria/0000-0001-8991-2134; Ruiz-Opazo, Nelson/0000-0001-8234-1332				ABOOD LG, 1989, J RECEPTOR RES, V9, P19, DOI 10.3109/10799898909066042; BARANYI L, 1995, NAT MED, V1, P894, DOI 10.1038/nm0995-894; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; BLACKSHEAR PJ, 1988, FASEB J, V2, P2957, DOI 10.1096/fasebj.2.14.2972578; BLALOCK JE, 1984, BIOCHEM BIOPH RES CO, V121, P203, DOI 10.1016/0006-291X(84)90707-1; BOST KL, 1985, P NATL ACAD SCI USA, V82, P1372, DOI 10.1073/pnas.82.5.1372; BRENTANI RR, 1988, P NATL ACAD SCI USA, V85, P364, DOI 10.1073/pnas.85.2.364; BUDISAVLJEVIC M, 1992, HYPERTENSION, V19, P345, DOI 10.1161/01.HYP.19.4.345; CALVETE JJ, 1991, BIOCHEM J, V274, P457, DOI 10.1042/bj2740457; CARR DJJ, 1986, J NEUROIMMUNOL, V12, P329, DOI 10.1016/0165-5728(86)90039-1; CASTRONOVO V, 1991, CANCER RES, V51, P5672; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; DESOUZA SJ, 1992, J BIOL CHEM, V267, P13763; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; DOUGLAS JG, 1987, AM J PHYSIOL, V253, pF1, DOI 10.1152/ajprenal.1987.253.1.F1; ELTON TS, 1988, P NATL ACAD SCI USA, V85, P2518, DOI 10.1073/pnas.85.8.2518; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; GHISO J, 1990, P NATL ACAD SCI USA, V87, P1288, DOI 10.1073/pnas.87.4.1288; GORCS TJ, 1986, PEPTIDES, V7, P1137, DOI 10.1016/0196-9781(86)90144-0; HERRERA VLM, 1988, SCIENCE, V241, P221, DOI 10.1126/science.2838907; IVELL R, 1984, P NATL ACAD SCI-BIOL, V81, P2006, DOI 10.1073/pnas.81.7.2006; JARD S, 1983, CURR TOP MEMBR TRANS, V18, P255; Jard S, 1987, Adv Nephrol Necker Hosp, V16, P1; KANG CY, 1988, SCIENCE, V240, P1034, DOI 10.1126/science.3368787; KHOSLA MC, 1972, J MED CHEM, V15, P792, DOI 10.1021/jm00278a003; KNUTSON VP, 1988, J BIOL CHEM, V263, P14146; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOLAIT SJ, 1992, NATURE, V357, P336, DOI 10.1038/357336a0; MANNING M, 1984, J MED CHEM, V27, P423, DOI 10.1021/jm00370a002; MOORE GJ, 1989, BIOCHEM BIOPH RES CO, V160, P1387, DOI 10.1016/S0006-291X(89)80157-3; MOREL A, 1992, NATURE, V356, P523, DOI 10.1038/356523a0; MOREL F, 1987, KIDNEY INT, V31, P512, DOI 10.1038/ki.1987.30; MULCHAHEY JJ, 1986, P NATL ACAD SCI USA, V83, P9714, DOI 10.1073/pnas.83.24.9714; MUNOZRAMIREZ H, 1976, RES COMMUN CHEM PATH, V13, P649; MURPHY TJ, 1991, NATURE, V351, P233, DOI 10.1038/351233a0; OHKUBO H, 1983, P NATL ACAD SCI-BIOL, V80, P2196, DOI 10.1073/pnas.80.8.2196; OKAMOTO T, 1991, CELL, V67, P723, DOI 10.1016/0092-8674(91)90067-9; PALS DT, 1971, CIRC RES, V29, P673, DOI 10.1161/01.RES.29.6.673; PASQUALINI R, 1989, J BIOL CHEM, V264, P14566; PHILLIPSON OT, 1983, BRAIN RES, V258, P33, DOI 10.1016/0006-8993(83)91223-4; ROGERS TB, 1986, J PHARMACOL EXP THER, V236, P438; SANDBERG K, 1992, J BIOL CHEM, V267, P9455; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; SUGIMOTO T, 1994, J BIOL CHEM, V269, P27088; SWORDS BH, 1990, NEUROENDOCRINOLOGY, V51, P487, DOI 10.1159/000125379; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; Trowbridge IS, 1991, CURR OPIN CELL BIOL, V3, P1062, DOI 10.1016/0955-0674(91)90130-Q	49	60	63	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	1995	1	10					1074	1081		10.1038/nm1095-1074	http://dx.doi.org/10.1038/nm1095-1074			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489366				2022-12-25	WOS:A1995RX95100050
J	RUGARLI, EI; ADLER, DA; BORSANI, G; TSUCHIYA, K; FRANCO, B; HAUGE, X; DISTECHE, C; CHAPMAN, V; BALLABIO, A				RUGARLI, EI; ADLER, DA; BORSANI, G; TSUCHIYA, K; FRANCO, B; HAUGE, X; DISTECHE, C; CHAPMAN, V; BALLABIO, A			DIFFERENT CHROMOSOMAL LOCALIZATION OF THE CLCN4 GENE IN MUS-SPRETUS AND C57BL/6J MICE	NATURE GENETICS			English	Article							HUMAN SEX-CHROMOSOMES; MOUSE X-CHROMOSOME; PSEUDOAUTOSOMAL REGION; CHLORIDE CHANNEL; INTERSPECIFIC HYBRIDS; ALPHA-SUBUNIT; HALDANE RULE; MALE MEIOSIS; DNA; EXPRESSION	We report the unprecedented finding of a gene with a different map position in two mouse strains. The Clcn4 gene was found to map to the X chromosome in the wild Mediterrean mouse, Mus spretus but to chromosome 7 in the inbred strain of laboratory mouse C57BL/6J. These data indicate that a recent evolutionary rearrangement occurred on the mouse sex chromosomes, very close to the pseudoautosomal region, Our data provide molecular evidence for a major divergence near the pseudoautosomal region, consistent with the hypothesis that hybrid sterility in these species results from abnormal pairing of sex chromosomes during male meiosis.	TELETHON INST GENET & MED,MILAN,ITALY; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030; ROSWELL PK CANC INST,DEPT MOLEC & CELL BIOL,BUFFALO,NY 14263; UNIV SIENA,DEPT MOLEC BIOL,SIENA,ITALY	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Washington; University of Washington Seattle; Baylor College of Medicine; Roswell Park Cancer Institute; University of Siena			Borsani, Giuseppe/B-1709-2010; BALLABIO, Andrea/AAL-2672-2020; FRANCO, Brunella/S-2882-2018	Borsani, Giuseppe/0000-0003-0110-1148; BALLABIO, Andrea/0000-0003-1381-4604; Rugarli, Elena/0000-0002-5782-1067; FRANCO, Brunella/0000-0001-5588-4569	Telethon [TGM94000, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		ADLER DA, 1991, P NATL ACAD SCI USA, V88, P4592, DOI 10.1073/pnas.88.11.4592; BORSANI G, 1995, GENOMICS, V27, P131, DOI 10.1006/geno.1995.1015; CHAPMAN VM, 1991, GENOMICS, V10, P23, DOI 10.1016/0888-7543(91)90479-X; COYNE JA, 1985, NATURE, V314, P736, DOI 10.1038/314736a0; DISTECHE CM, 1992, NAT GENET, V1, P333, DOI 10.1038/ng0892-333; EICHER EM, 1992, P NATL ACAD SCI USA, V89, P2160, DOI 10.1073/pnas.89.6.2160; FERRIS SD, 1983, GENETICS, V107, P681; FISHER SE, 1994, HUM MOL GENET, V3, P2053; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; HALE DW, 1993, CYTOGENET CELL GENET, V63, P221, DOI 10.1159/000133539; HARBERS K, 1990, CYTOGENET CELL GENET, V53, P129, DOI 10.1159/000132912; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LEE K, 1994, MAMM GENOME, V5, P612, DOI 10.1007/BF00411455; LYON MF, 1964, CYTOGENETICS, V3, P306, DOI 10.1159/000129820; Maniatis T., 1982, MOL CLONING; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MATSUDA Y, 1991, P NATL ACAD SCI USA, V88, P4850, DOI 10.1073/pnas.88.11.4850; MATSUDA Y, 1992, CHROMOSOMA, V101, P483, DOI 10.1007/BF00352471; MILATOVICH A, 1993, AM J HUM GENET, V53, P1146; MOHANDAS TK, 1992, AM J HUM GENET, V51, P526; Ohno S., 1967, SEX CHROMOSOMES SEX, DOI [10.1007/978-3-642-88178-7, DOI 10.1007/978-3-642-88178-7]; RAPPOLD GA, 1993, HUM GENET, V92, P315, DOI 10.1007/BF01247327; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; SORIANO P, 1987, P NATL ACAD SCI USA, V84, P7218, DOI 10.1073/pnas.84.20.7218; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547	31	75	77	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					466	471		10.1038/ng0895-466	http://dx.doi.org/10.1038/ng0895-466			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670496				2022-12-25	WOS:A1995RM37500021
J	RUBY, J; BLUETHMANN, H; AGUET, M; RAMSHAW, IA				RUBY, J; BLUETHMANN, H; AGUET, M; RAMSHAW, IA			CD40 LIGAND HAS POTENT ANTIVIRAL ACTIVITY	NATURE MEDICINE			English	Article							RECOMBINANT VACCINIA VIRUS; B-CELL PROLIFERATION; INTERFERON-GAMMA; T-CELLS; DEPENDENT ACTIVATION; VIRAL REPLICATION; IMMUNE-RESPONSE; GENE FAMILY; MICE; EXPRESSION	For B cells to make antibodies against most antigens, they require help from T cells. T cell help is delivered as two signals to the B cell, one of which is via CD40 and the other can be through receptors for any of a variety of soluble cytokines. We have constructed recombinant vaccinia viruses that express the ligand for CD40 and have shown that the growth of these viruses is dramatically controlled in vivo, even in mice that lack T or B cells. In this paper, we also describe our attempts to analyse the CD40 ligand-mediated antiviral activity by studying the clearance of these viruses in mice that are deficient in important antiviral mechanisms. Thus, the antiviral activity of CD40L may represent a surprising and potent effector mechanism of T cells activated during a virus infection.	F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES NEW TECHNOL,DEPT BIOL,CH-1002 BASEL,SWITZERLAND; GENENTECH INC,S SAN FRANCISCO,CA 94080	Roche Holding; Roche Holding; Genentech	RUBY, J (corresponding author), JOHN CURTIN SCH MED RES,DIV CELL BIOL,VIRAL ENGN & CYTOKINES GRP,POB 334,CANBERRA,ACT 2601,AUSTRALIA.							ALDERSON MR, 1993, J EXP MED, V178, P669, DOI 10.1084/jem.178.2.669; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; BRIAN AA, 1988, P NATL ACAD SCI USA, V85, P564, DOI 10.1073/pnas.85.2.564; CALLARD RE, 1993, IMMUNOL TODAY, V14, P559, DOI 10.1016/0167-5699(93)90188-Q; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; GALY AHM, 1992, J IMMUNOL, V149, P775; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; HODGKIN PD, 1990, J IMMUNOL, V145, P2025; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; KARUPIAH G, 1990, J EXP MED, V172, P1495, DOI 10.1084/jem.172.5.1495; KARUPIAH G, 1990, J IMMUNOL, V144, P290; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; LANE P, 1992, EUR J IMMUNOL, V22, P2573, DOI 10.1002/eji.1830221016; LANE P, 1993, J EXP MED, V177, P1209, DOI 10.1084/jem.177.4.1209; LEDERMAN S, 1993, CURR OPIN IMMUNOL, V5, P439, DOI 10.1016/0952-7915(93)90066-2; MOHLER KM, 1993, J IMMUNOL, V151, P1548; NOTARANGELO L D, 1992, Immunodeficiency Reviews, V3, P101; PAULIE S, 1989, J IMMUNOL, V142, P590; RAMSHAW I, 1992, IMMUNOL REV, V127, P157, DOI 10.1111/j.1600-065X.1992.tb01413.x; RAMSHAW IA, 1987, NATURE, V329, P545, DOI 10.1038/329545a0; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; RUBY J, 1991, CYTOKINE, V3, P92, DOI 10.1016/1043-4666(91)90028-C; RUBY J, 1991, LYMPHOKINE CYTOK RES, V10, P353; SAMBHI SK, 1991, P NATL ACAD SCI USA, V88, P4025, DOI 10.1073/pnas.88.9.4025; SCHRIEVER F, 1989, J EXP MED, V169, P2043, DOI 10.1084/jem.169.6.2043; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TAO X, 1993, EUR J IMMUNOL, V23, P2916, DOI 10.1002/eji.1830231128; UPTON C, 1991, VIROLOGY, V184, P370, DOI 10.1016/0042-6822(91)90853-4; WONG GHW, 1986, NATURE, V323, P819, DOI 10.1038/323819a0	33	48	54	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1995	1	5					437	441		10.1038/nm0595-437	http://dx.doi.org/10.1038/nm0595-437			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585091				2022-12-25	WOS:A1995RN10000034
J	FINKEL, TH; TUDORWILLIAMS, G; BANDA, NK; COTTON, MF; CURIEL, T; MONKS, C; BABA, TW; RUPRECHT, RM; KUPFER, A				FINKEL, TH; TUDORWILLIAMS, G; BANDA, NK; COTTON, MF; CURIEL, T; MONKS, C; BABA, TW; RUPRECHT, RM; KUPFER, A			APOPTOSIS OCCURS PREDOMINANTLY IN BYSTANDER CELLS AND NOT IN PRODUCTIVELY INFECTED-CELLS OF HIV-INFECTED AND SIV-INFECTED LYMPH-NODES	NATURE MEDICINE			English	Article							CD4+ T-CELLS; ENVELOPE GLYCOPROTEIN; DEATH; AIDS; MECHANISM; DNA; LYMPHOCYTES; DEPLETION; RNA; PCR	Although 13 years have passed since identification of human immunodeficiency virus-1 (HIV-1) as the cause of AIDS, we do not yet know how HIV kills its primary target, the T cell that carries the CD4 antigen. We and others have shown an increase in the percentage of apoptotic cells among circulating CD4(+) (and CD8(+)) T cells of HIV-seropositive individuals and an increase in frequency of apoptosis with disease progression. However, it is not known if this apoptosis occurs in infected or uninfected T cells. We show here, using in situ labelling of lymph nodes from HIV-infected children and SIV-infected macaques, that apoptosis occurs predominantly in bystander cells and not in the productively infected cells themselves. These data have implications for pathogenesis and therapy, namely, arguing that rational drug therapy may involve combination agents targeting viral replication in infected cells and apoptosis of uninfected cells.	UNIV COLORADO, HLTH SCI CTR, DEPT PEDIAT, DENVER, CO 80262 USA; UNIV COLORADO, HLTH SCI CTR, DEPT IMMUNOL, DENVER, CO 80262 USA; UNIV COLORADO, HLTH SCI CTR, DEPT BIOCHEM BIOPHYS & GENET, DENVER, CO 80262 USA; UNIV COLORADO, HLTH SCI CTR, DEPT INFECT DIS, DENVER, CO 80262 USA; UNIV COLORADO, HLTH SCI CTR, DEPT CELL & STRUCT BIOL, DENVER, CO 80262 USA; NCI, PEDIAT BRANCH, BETHESDA, MD 20892 USA; HARVARD UNIV, SCH MED, DANA FARBER CANC INST, VIRAL PATHOGENESIS LAB, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA; TUFTS UNIV, SCH MED, DIV NEWBORN MED, DEPT PEDIAT, BOSTON, MA 02111 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Tufts University	FINKEL, TH (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED, DIV BASIC SCI, DEPT PEDIAT, 1400 JACKSON ST, DENVER, CO 80206 USA.		Serei, Virian D/B-4616-2015; Cotton, Mark/AAQ-9936-2020	Cotton, Mark/0000-0003-2559-6034	NIAID NIH HHS [P01-AI29903A, R01-AI35513] Funding Source: Medline; PHS HHS [R01-A130575A] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035513, P01AI029903] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDROVANDI GM, 1993, NATURE, V363, P732, DOI 10.1038/363732a0; BABA TW, 1994, AIDS RES HUM RETROV, V10, P351, DOI 10.1089/aid.1994.10.351; BANDA NK, 1992, J EXP MED, V176, P1099, DOI 10.1084/jem.176.4.1099; BONYHADI ML, 1993, NATURE, V363, P728, DOI 10.1038/363728a0; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; COHEN JJ, 1993, HOSP PRACT, V28, P35, DOI 10.1080/21548331.1993.11442887; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; FINKEL TH, 1994, CURR OPIN IMMUNOL, V6, P605, DOI 10.1016/0952-7915(94)90149-X; FOX CH, 1994, CURR PROT IMMUN; GOEBEL WS, 1992, FASEB J, V6, pA1335; GORCZYCA W, 1992, INT J ONCOL, V1, P639; GOUGEON ML, 1993, AIDS RES HUM RETROV, V9, P553, DOI 10.1089/aid.1993.9.553; GRAY D, 1991, INT IMMUNOL, V3, P141, DOI 10.1093/intimm/3.2.141; GREENE WC, 1993, SCI AM, V269, P98, DOI 10.1038/scientificamerican0993-98; GROUX H, 1992, J EXP MED, V175, P331, DOI 10.1084/jem.175.2.331; KOWALSKI M, 1991, J VIROL, V65, P281, DOI 10.1128/JVI.65.1.281-291.1991; Kuby J., 1994, IMMUNOLOGY; LAURENTCRAWFORD AG, 1991, VIROLOGY, V185, P829, DOI 10.1016/0042-6822(91)90554-O; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; LEWIS DE, 1994, J IMMUNOL, V153, P412; LIU YJ, 1992, IMMUNOL TODAY, V13, P17, DOI 10.1016/0167-5699(92)90199-H; LYERLY HK, 1987, P NATL ACAD SCI USA, V84, P4601, DOI 10.1073/pnas.84.13.4601; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; MOSIER DE, 1993, SCIENCE, V260, P689, DOI 10.1126/science.8097595; OYAIZU N, 1993, BLOOD, V82, P3392; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PATTERSON BK, 1993, SCIENCE, V260, P976, DOI 10.1126/science.8493534; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; SCHWARTZ LM, 1993, IMMUNOL TODAY, V14, P582, DOI 10.1016/0167-5699(93)90197-S; SILICIANO RF, 1988, CELL, V54, P561, DOI 10.1016/0092-8674(88)90078-5; STEIN H, 1982, CLIN HAEMATOL, V11, P531; STEVENSON M, 1988, CELL, V53, P483, DOI 10.1016/0092-8674(88)90168-7; TERAI C, 1991, J CLIN INVEST, V87, P1710, DOI 10.1172/JCI115188; WEINHOLD KJ, 1989, J IMMUNOL, V142, P3091	34	782	804	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	1995	1	2					129	134		10.1038/nm0295-129	http://dx.doi.org/10.1038/nm0295-129			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX558	7585008				2022-12-25	WOS:A1995QX55800022
J	WHITTINGTON, MA; SIDLE, KCL; GOWLAND, I; MEADS, J; HILL, AF; PALMER, MS; JEFFERYS, JGR; COLLINGE, J				WHITTINGTON, MA; SIDLE, KCL; GOWLAND, I; MEADS, J; HILL, AF; PALMER, MS; JEFFERYS, JGR; COLLINGE, J			RESCUE OF NEUROPHYSIOLOGICAL PHENOTYPE SEEN IN PRP NULL MICE BY TRANSGENE ENCODING HUMAN PRION PROTEIN	NATURE GENETICS			English	Article							CREUTZFELDT-JAKOB DISEASE; SCRAPIE; GENE; LACKING	The prion protein (PrP) is central to the aetiology of the prion diseases, transmissible neurodegenerative conditions of humans and animals. PrP null mice show abnormalities of synaptic neurophysiology, in particular weakened GABA(A) receptor-mediated fast inhibition and impaired long-term potentiation in the hippocampus. Here we demonstrate that this PrP null phenotype is rescued in mice with a high copy number of a transgene encoding human PrP but not in low copy number mice, confirming the specificity of the phenotype for loss of function of PrP. The ability of human PrP to compensate for loss of murine PrP will allow direct study of the functional consequences of the 18 human PrP mutations, which cause the inherited prion diseases; this phenotype can now form the basis of the first functional assay for PrP.	UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,LONDON W2 1PG,ENGLAND; UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,DEPT PHYSIOL & BIOPHYS,LONDON W2 1PG,ENGLAND; ST MARYS HOSP,DEPT NEUROL,LONDON W2 1NY,ENGLAND	Imperial College London; Imperial College London; Imperial College London			Hill, Andrew F./AAH-2854-2020; Hill, Andrew F/B-4527-2009; Jefferys, John G R/AAF-1164-2021; Hill, Andrew F./GZL-4124-2022; Jefferys, John/E-6132-2012	Hill, Andrew F/0000-0001-5581-2354; Jefferys, John G R/0000-0003-0106-4412; Hill, Andrew F./0000-0001-5581-2354; Jefferys, John/0000-0003-0106-4412; Whittington, Miles Adrian/0000-0002-0247-1362	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAKER HF, 1991, LANCET, V337, P1286, DOI 10.1016/0140-6736(91)92953-Y; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BRENNER HR, 1992, P ROY SOC B-BIOL SCI, V250, P151, DOI 10.1098/rspb.1992.0143; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CATHALA F, 1987, P467; CLINTON J, 1993, NEUROREPORT, V4, P65, DOI 10.1097/00001756-199301000-00017; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; COLLINGE J, 1990, LANCET, V336, P7, DOI 10.1016/0140-6736(90)91518-F; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Collinge J, 1992, CURR OPIN GENET DEV, V2, P448, DOI 10.1016/S0959-437X(05)80156-X; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; GABRIEL J, 1992, PRION DISEASES HUMAN; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; HARRIS DA, 1993, P NATL ACAD SCI USA, V90, P4309, DOI 10.1073/pnas.90.9.4309; HARRIS DA, 1991, P NATL ACAD SCI USA, V88, P7664, DOI 10.1073/pnas.88.17.7664; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; JEFFERYS JGR, 1994, J PHYSIOL-LONDON, V476P, pP9; JEFFERYS JGR, 1994, NEUROBIOL DIS, V1, P3; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANSON J, 1992, DEVELOPMENT, V115, P117; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; STAHL N, 1990, BIOCHEMISTRY-US, V29, P5405, DOI 10.1021/bi00474a028; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; WEISSMANN C, 1991, NATURE, V349, P569, DOI 10.1038/349569a0; WELLER RO, 1989, PSYCHOL MED, V19, P1, DOI 10.1017/S0033291700010965; WESTAWAY D, 1986, NUCLEIC ACIDS RES, V14, P2035, DOI 10.1093/nar/14.5.2035	33	130	131	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					197	201		10.1038/ng0295-197	http://dx.doi.org/10.1038/ng0295-197			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719349				2022-12-25	WOS:A1995QE67200023
J	JAMIESON, CR; VANDERBURGT, I; BRADY, AF; VANREEN, M; ELSAWI, MM; HOL, F; JEFFERY, S; PATTON, MA; MARIMAN, E				JAMIESON, CR; VANDERBURGT, I; BRADY, AF; VANREEN, M; ELSAWI, MM; HOL, F; JEFFERY, S; PATTON, MA; MARIMAN, E			MAPPING A GENE FOR NOONAN-SYNDROME TO THE LONG ARM OF CHROMOSOME-12	NATURE GENETICS			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; LOCUS; LINKAGE; TYPE-1	Noonan syndrome is characterized by typical facies, short stature and congenital cardiac defects. Approximately half of all cases are sporadic, but autosomal dominant inheritance with variable expression is well established. We have performed a genome-wide linkage analysis in a large Dutch kindred with autosomal dominant Noonan syndrome, and localized the Noonan syndrome gene to chromosome 12 (Z(max)=4.04 at theta=0.0). Linkage analysis using chromosome 12 markers in 20 smaller, two-generation families gave Z(max)=2.89 at theta=0.07, but haplotype analysis showed non-linkage in one family. These data imply that a gene for Noonan syndrome is located on chromosome 12q, between D12S84 and D12S366.	ST GEORGE HOSP,SCH MED,MED GENET UNIT,LONDON SW17 0RE,ENGLAND; UNIV NIJMEGEN HOSP,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS	St Georges University London; Radboud University Nijmegen								ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; BERTELSON CJ, 1988, AM J HUM GENET, V42, P703; BONNET D, 1994, NAT GENET, V6, P405, DOI 10.1038/ng0494-405; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; CABALLIN MR, 1981, CLIN GENET, V20, P428; CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; Chery M., 1993, Genetic Counseling, V4, P113; COXMATISE T, 1994, NAT GENET, V6, P384; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; FLINTOFF WF, 1993, AM J MED GENET, V46, P700, DOI 10.1002/ajmg.1320460621; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; JARCHO JA, 1984, NEW ENGL J MED, V20, P1372; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEGIUS E, 1994, EUR SOC HUM GENET, pA174; NOONAN JA, 1963, J PEDIATR-US, V63, P468; ONUFER CN, 1993, ANN GENET-PARIS, V30, P236; OTT J, 1985, ANAL HUMAN GENETIC L, P112; SHARLAND M, 1992, J MED GENET, V29, P188, DOI 10.1136/jmg.29.3.188; TERRETT JA, 1994, NAT GENET, V6, P401, DOI 10.1038/ng0494-401; THIERFELDER L, 1993, P NATL ACAD SCI USA, V90, P6270, DOI 10.1073/pnas.90.13.6270; VANDERBURGT I, 1994, AM J MED GENET, V53, P1; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WILSON DI, 1993, ARCH DIS CHILD, V68, P187, DOI 10.1136/adc.68.2.187; ZINN AR, 1993, TRENDS GENET, V9, P90, DOI 10.1016/0168-9525(93)90230-F	25	206	217	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					357	360		10.1038/ng1294-357	http://dx.doi.org/10.1038/ng1294-357			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894486				2022-12-25	WOS:A1994PV68200016
J	FIELD, LL; TOBIAS, R; MAGNUS, T				FIELD, LL; TOBIAS, R; MAGNUS, T			A LOCUS ON CHROMOSOME 15Q26 (IDDM3) PRODUCES SUSCEPTIBILITY TO INSULIN-DEPENDENT DIABETES-MELLITUS	NATURE GENETICS			English	Article							RESPONSES UNDERLYING ASTHMA; LINKAGE ANALYSIS; GENETIC-LINKAGE; IGE RESPONSES; HLA; DISEASE; POLYMORPHISMS; DETERMINANTS; RHINITIS; ATOPY	To identify new loci predisposing to insulin-dependent diabetes mellitus (IDDM), we have investigated 250 families with more than one diabetic child. Affected sibling pair linkage analysis revealed strong evidence for an IDDM susceptibility locus near D15S107 on chromosome 15q26 (P=0.0010) termed IDDM3. Families less predisposed through genes in the HLA region provided most of the evidence for linkage. In these families, discordant sibling pairs also showed linkage (P=0.0052), and sibling pair disease concordance or discordance was strongly related to the proportion of genes the pair shared at D15S107 (P=0.0003). Our study also revealed evidence for an IDDM locus on chromosome 11q13 (IDDM4) using affected siblings (P=0.0043), but no evidence using discordant siblings.			FIELD, LL (corresponding author), UNIV CALGARY, DEPT MED GENET, 3330 HOSP DR NW, CALGARY T2N 4N1, AB, CANADA.				NCRR NIH HHS [1-P41-RR03655] Funding Source: Medline; NICHD NIH HHS [HD12731] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012731] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; BECKMANN JS, 1993, HUM MOL GENET, V2, P2019, DOI 10.1093/hmg/2.12.2019; BELL GI, 1984, DIABETES, V33, P1504; BERTRAMS J, 1984, HISTOCOMPATIBILITY T, P348; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BOWCOCK AM, 1992, SCIENCE, V258, P67; CHEETHAM TD, 1993, DIABETOLOGIA, V36, P678, DOI 10.1007/BF00404081; COOKSON WOCM, 1989, LANCET, V1, P1292; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; COX NJ, 1988, AM J HUM GENET, V43, P954; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; ELSTON RC, 1992, STATISTICAL ANAL GEN; FIELD LL, 1991, BAILLIERE CLIN ENDOC, V5, P413, DOI 10.1016/S0950-351X(05)80139-9; FIELD LL, 1986, GENET EPIDEMIOL, P323; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HYER RN, 1991, AM J HUM GENET, V48, P243; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; MACLEAN CJ, 1992, AM J HUM GENET, V50, P1259; MORTON NE, 1983, AM J HUM GENET, V35, P201; OTT J, 1991, ANALHUMAN GENETIC LI, P79; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7468, DOI 10.1093/nar/18.24.7468-a; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1987, AM J HUM GENET, V40, P1; ROSENSHINE S, 1986, IMMUNOGENETICS, V23, P187, DOI 10.1007/BF00373820; SANDFORD AJ, 1993, LANCET, V341, P332, DOI 10.1016/0140-6736(93)90136-5; SHIRAKAWA T, 1994, NAT GENET, V7, P125, DOI 10.1038/ng0694-125; SHIRAKAWA T, 1991, CYTOGENET CELL GENET, V58, P1970; TERASAKI PI, 1978, AM J CLIN PATHOL, V69, P103; THOMSON G, 1988, ANNU REV GENET, V22, P31; THOMSON G, IN PRESS AM J HUM GE; TODD JA, 1992, DIABETES, V41, P1029, DOI 10.2337/diabetes.41.9.1029; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; YOUNG RP, 1992, J MED GENET, V29, P236, DOI 10.1136/jmg.29.4.236	36	170	170	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1994	8	2					189	194		10.1038/ng1094-189	http://dx.doi.org/10.1038/ng1094-189			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PL123	7842018				2022-12-25	WOS:A1994PL12300022
J	TREZISE, AEO; LINDER, CC; GRIEGER, D; THOMPSON, EW; MEUNIER, H; GRISWOLD, MD; BUCHWALD, M				TREZISE, AEO; LINDER, CC; GRIEGER, D; THOMPSON, EW; MEUNIER, H; GRISWOLD, MD; BUCHWALD, M			CFTR EXPRESSION IS REGULATED DURING BOTH THE CYCLE OF THE SEMINIFEROUS EPITHELIUM AND THE ESTROUS-CYCLE OF RODENTS	NATURE GENETICS			English	Article							CYSTIC-FIBROSIS GENE; MESSENGER-RNAS; IDENTIFICATION; CELLS; SPERMATOGENESIS; LOCALIZATION; CONDUCTANCE; SPERMATIDS; TRANSPORT; TESTES	Severely reduced, fertility is a common finding in cystic fibrosis (CF). We used in situ hybridization to examine the cell-specific expression of CFTR in the reproductive organs of rodents. In males CFTR mRNA is found in the round spermatids (spermatogenic stages V-X) and in the principal cells that line the initial segment of the epididymis. In both the testis and the epididymis, CFTR expression is developmentally regulated suggesting that the defect in the genital tract of male CF patients is of developmental origin. CFTR expression in the luminal and glandular epithelium of the uterus is regulated during the oestrous cycle and is maximal at pro-oestrus. Our results provide a biological rationale for the reduced fertility of CF patients, and suggest a possible cause for the comparatively poorer prognosis for women with CF.	HOSP SICK CHILDREN, RES INST, DEPT GENET, TORONTO M5G 1X8, ONTARIO, CANADA; HOSP SICK CHILDREN, RES INST, DIV ENDOCRINOL, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV TORONTO, DEPT CLIN BIOCHEM, TORONTO M5G 1X8, ON, CANADA; UNIV TORONTO, DEPT MOLEC & MED GENET, TORONTO M5G 1X8, ON, CANADA; WASHINGTON STATE UNIV, BIOCHEM & BIOPHYS PROGRAM, PULLMAN, WA 99164 USA; GEORGETOWN UNIV, MED CTR, VINCENT T LOMBARDI CANC RES CTR, WASHINGTON, DC 20007 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Washington State University; Georgetown University			Thompson, Erik W/A-1425-2009; Thompson, Erik/GPK-2067-2022	Thompson, Erik W/0000-0002-9723-4924; Thompson, Erik/0000-0002-9723-4924				ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; ARCECI RJ, 1988, P NATL ACAD SCI USA, V85, P4350, DOI 10.1073/pnas.85.12.4350; BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BRAUN RE, 1989, NATURE, V337, P373, DOI 10.1038/337373a0; BRUGMAN SM, 1987, CYSTIC FIBROSIS, P323; CALDWELL KA, 1991, P NATL ACAD SCI USA, V88, P2407, DOI 10.1073/pnas.88.6.2407; CHALON J, 1971, J AMER MED ASSOC, V218, P1928, DOI 10.1001/jama.218.13.1928; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; COHN JA, 1991, BIOCHEM BIOPH RES CO, V181, P36, DOI 10.1016/S0006-291X(05)81378-6; COLLEDGE WH, 1992, LANCET, V340, P680, DOI 10.1016/0140-6736(92)92223-3; COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; ERICKSON RP, 1990, TRENDS GENET, V6, P264, DOI 10.1016/0168-9525(90)90209-O; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOTTLIEB C, 1991, INT J ANDROL, V14, P437, DOI 10.1111/j.1365-2605.1991.tb01272.x; Harper M.J.K., 1988, P103; HARRIS A, 1991, DEVELOPMENT, V113, P305; HEATON ND, 1990, BRIT J UROL, V66, P538, DOI 10.1111/j.1464-410X.1990.tb15006.x; HESS RA, 1990, BIOL REPROD, V43, P525, DOI 10.1095/biolreprod43.3.525; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LEBLOND CP, 1952, ANN NY ACAD SCI, V55, P548, DOI 10.1111/j.1749-6632.1952.tb26576.x; MORALES CR, 1989, MOL ENDOCRINOL, V3, P725, DOI 10.1210/mend-3-4-725; MURTI JR, 1992, MOL CELL BIOL, V12, P2545, DOI 10.1128/MCB.12.6.2545; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; PHILLIPS DM, 1970, J CELL BIOL, V44, P243, DOI 10.1083/jcb.44.2.243; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RIORDAN JR, 1989, SCIENCE, V245, P1066; Robaire B., 1988, P999; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; RUSSELL LD, 1987, ENDOCRINOLOGY, V120, P1615, DOI 10.1210/endo-120-4-1615; SCHIMENTI J, 1988, CELL, V55, P71, DOI 10.1016/0092-8674(88)90010-4; Setchell B.P., 1988, P753; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; SPRANDO RL, 1987, AM J ANAT, V178, P72, DOI 10.1002/aja.1001780109; STALLARD BJ, 1991, MOL CELL BIOL, V11, P1448, DOI 10.1128/MCB.11.3.1448; TREZISE AEO, 1991, NATURE, V353, P434, DOI 10.1038/353434a0; TREZISE AEO, 1992, GENOMICS, V14, P869, DOI 10.1016/S0888-7543(05)80107-7; TREZISE AEO, 1992, EMBO J, V11, P4291, DOI 10.1002/j.1460-2075.1992.tb05528.x; Tsui L C, 1991, Adv Hum Genet, V20, P153; VALVERDE MA, 1992, NATURE, V355, P830, DOI 10.1038/355830a0; WONG PYD, 1978, INT J ANDROL, P608, DOI 10.1111/j.1365-2605.1978.tb00512.x; WONG PYD, 1978, J PHYSIOL-LONDON, V275, P13, DOI 10.1113/jphysiol.1978.sp012174	49	123	126	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1993	3	2					157	164		10.1038/ng0293-157	http://dx.doi.org/10.1038/ng0293-157			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KL010	7684647				2022-12-25	WOS:A1993KL01000014
J	LASPADA, AR; ROLING, DB; HARDING, AE; WARNER, CL; SPIEGEL, R; HAUSMANOWAPETRUSEWICZ, I; YEE, WC; FISCHBECK, KH				LASPADA, AR; ROLING, DB; HARDING, AE; WARNER, CL; SPIEGEL, R; HAUSMANOWAPETRUSEWICZ, I; YEE, WC; FISCHBECK, KH			MEIOTIC STABILITY AND GENOTYPE-PHENOTYPE CORRELATION OF THE TRINUCLEOTIDE REPEAT IN X-LINKED SPINAL AND BULBAR MUSCULAR-ATROPHY	NATURE GENETICS			English	Article							FRAGILE-X; GENE; LOCALIZATION	Expansion of the trinucleotide repeat (CAG)n in the first exon of the androgen receptor gene is associated with a rare motor neuron disorder, X-linked spinal and bulbar muscular atrophy. We have found that expanded (CAG)n alleles undergo alteration in length when transmitted from parent to offspring. Of 45 meioses examined, 12 (27%) demonstrated a change in CAG repeat number. Both expansions and contractions were observed, although their magnitude was small. There was a greater rate of instability in male meiosis than in female meiosis. We also found evidence for a correlation between disease severity and CAG repeat length, but other factors seem to contribute to the phenotypic variability in this disorder.	NATL HOSP,INST NEUROL,LONDON WC1N 3BG,ENGLAND; MILLARD FILLMORE HOSP,INST DENT NEUROL,BUFFALO,NY 14209; UNIV ZURICH,INST MED GENET,CH-8001 ZURICH,SWITZERLAND; POLISH ACAD SCI,NEUROMUSCULAR UNIT,PL-02097 WARSAW,POLAND; WASHINGTON UNIV,SCH MED,DEPT NEUROL,ST LOUIS,MO 63110	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; State University of New York (SUNY) System; University of Zurich; Polish Academy of Sciences; Washington University (WUSTL)	LASPADA, AR (corresponding author), UNIV PENN,SCH MED,DEPT NEUROL,CRB 250,U22 CURIE BLVD,PHILADELPHIA,PA 19104, USA.		La Spada, Albert/AAG-8809-2020					ARBIZU T, 1983, J NEUROL SCI, V59, P371, DOI 10.1016/0022-510X(83)90022-9; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BROWN CJ, 1989, AM J HUM GENET, V44, P264; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; FISCHBECK KH, 1991, ADV NEUROL, V56, P209; FISCHBECK KH, 1986, NEUROLOGY, V36, P1595, DOI 10.1212/WNL.36.12.1595; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; HARDING AE, 1982, J NEUROL NEUROSUR PS, V45, P1012, DOI 10.1136/jnnp.45.11.1012; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; RICHARDS RI, 1992, NAT GENET, V1, P7, DOI 10.1038/ng0492-7; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H	21	312	317	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					301	304		10.1038/ng1292-301	http://dx.doi.org/10.1038/ng1292-301			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303283				2022-12-25	WOS:A1992KB49500014
J	MCCOMBIE, WR; MARTINGALLARDO, A; GOCAYNE, JD; FITZGERALD, M; DUBNICK, M; KELLEY, JM; CASTILLA, L; LIU, LI; WALLACE, S; TRAPP, S; TAGLE, D; WHALEY, WL; CHENG, S; GUSELLA, J; FRISCHAUF, AM; POUSTKA, A; LEHRACH, H; COLLINS, FS; KERLAVAGE, AR; FIELDS, C; VENTER, JC				MCCOMBIE, WR; MARTINGALLARDO, A; GOCAYNE, JD; FITZGERALD, M; DUBNICK, M; KELLEY, JM; CASTILLA, L; LIU, LI; WALLACE, S; TRAPP, S; TAGLE, D; WHALEY, WL; CHENG, S; GUSELLA, J; FRISCHAUF, AM; POUSTKA, A; LEHRACH, H; COLLINS, FS; KERLAVAGE, AR; FIELDS, C; VENTER, JC			EXPRESSED GENES, ALU REPEATS AND POLYMORPHISMS IN COSMIDS SEQUENCED FROM CHROMOSOME-4P16.3	NATURE GENETICS			English	Article							HUNTINGTON DISEASE GENE; PROTEIN-CODING REGIONS; HUMAN GENOME; DNA-SEQUENCES; NEUROFIBROMATOSIS TYPE-1; RETINOBLASTOMA; SUBFAMILY; DELETION; CLUSTER; FAMILY	The sequences of three cosmids (90 kilobases) from the Huntington's disease region in chromosome 4p16.3 have been determined. A 30,837 base overlap of DNA sequenced from two individuals was found to contain 72 DNA sequence polymorphisms, an average of 2.3 polymorphisms per kilobase (kb). The assembled 58 kb contig contains 62 Alu repeats, and eleven predicted exons representing at least three expressed genes that encode previously unidentified proteins. Each of these genes is associated with a CpG island. The structure of one of the new genes, hda1-1, has been determined by characterizing cDNAs from a placental library. This gene is expressed in a variety of tissues and may encode a novel housekeeping gene.	NINCDS,RECEPTOR BIOCHEM & MOLEC BIOL SECT,BETHESDA,MD 20892; IMPERIAL CANC RES FUND,DEPT GENOME ANAL,LONDON WC2A 3PX,ENGLAND; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; HARVARD UNIV,DEPT GENET,BOSTON,MA 02129; DEUTSCH KREBSFORSCHUNGSZENTRUM,W-6900 HEIDELBERG,GERMANY; MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET LAB,BOSTON,MA 02114	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Cancer Research UK; The Genome Analysis Centre (TGAC); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Harvard University; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Massachusetts General Hospital				Fields, Chris/0000-0002-4812-0744; McCombie, W. Richard/0000-0003-1899-0682; Kerlavage, Anthony/0000-0002-3954-9653				ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANTONARAKIS SE, 1988, HUM GENET, V80, P265, DOI 10.1007/BF01790095; BAILEY WJ, 1991, MOL BIOL EVOL, V8, P155; BATES GP, 1991, AM J HUM GENET, V49, P7; BATES GP, 1992, NAT GENET, V1, P180, DOI 10.1038/ng0692-180; BATZER MA, 1991, GENOMICS, V9, P481, DOI 10.1016/0888-7543(91)90414-A; BERNARDI G, 1989, ANNU REV GENET, V23, P637, DOI 10.1146/annurev.genet.23.1.637; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BUCAN M, 1990, GENOMICS, V6, P1; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; CHAKRAVARTI A, 1984, P NATL ACAD SCI-BIOL, V81, P6085, DOI 10.1073/pnas.81.19.6085; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUBNICK M, IN PRESS COMP APPL B; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; EDWARDS A, 1990, GENOMICS, V6, P593, DOI 10.1016/0888-7543(90)90493-E; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; FIELDS CA, 1990, COMPUT APPL BIOSCI, V6, P263; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GOCAYNE J, 1987, P NATL ACAD SCI USA, V84, P8296, DOI 10.1073/pnas.84.23.8296; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HIGUCHI M, 1990, GENOMICS, V6, P65, DOI 10.1016/0888-7543(90)90448-4; HOFKER MH, 1986, AM J HUM GENET, V39, P438; HOOG C, 1991, NUCLEIC ACIDS RES, V19, P6123, DOI 10.1093/nar/19.22.6123; JURKA J, 1991, J MOL EVOL, V32, P105, DOI 10.1007/BF02515383; KIMURA M, 1991, EVOLUTION OF LIFE, P67; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; LAIRD CD, 1990, TRENDS GENET, V6, P242, DOI 10.1016/0168-9525(90)90206-L; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MARTINGALLARDO A, 1992, NAT GENET, V1, P34, DOI 10.1038/ng0492-34; MATERA AG, 1990, MOL CELL BIOL, V10, P5424, DOI 10.1128/MCB.10.10.5424; MCCOMBIE W R, 1991, Methods (Orlando), V3, P33; McCombie W R, 1992, DNA Seq, V2, P289, DOI 10.3109/10425179209030961; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; MOYZIS RK, 1989, GENOMICS, V4, P273, DOI 10.1016/0888-7543(89)90331-5; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; ORYE E, 1971, LANCET, V2, P1376; ORYE E, 1974, CLIN GENET, V5, P457; PAULSON KE, 1985, NATURE, V316, P359, DOI 10.1038/316359a0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PERRINPECONTAL P, 1992, J MOL EVOL, V34, P17, DOI 10.1007/BF00163849; Sambrook J, 1989, MOL CLONING LABORATO; SCHMID CW, 1982, SCIENCE, V216, P1065, DOI 10.1126/science.6281889; SCHMIDT MA, 1987, AM J MED GENET, V28, P771, DOI 10.1002/ajmg.1320280333; SCHWABE JWR, 1991, TRENDS BIOCHEM SCI, V16, P291, DOI 10.1016/0968-0004(91)90121-B; SLAGEL V, 1987, MOL BIOL EVOL, V4, P19; SNELL R, IN PRESS AM J HUM GE; SODERLUND C, 1992, P HAWAII INT C SYSTE, P653; SPARKES RS, 1979, SCIENCE, V203, P1027, DOI 10.1126/science.424728; SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; WASMUTH JJ, 1986, AM J HUM GENET, V39, P397; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WHALEY WL, 1991, SOMAT CELL MOLEC GEN, V17, P83, DOI 10.1007/BF01233207; WILSON RK, 1990, BIOTECHNIQUES, V8, P184	72	47	49	1	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1992	1	5					348	353		10.1038/ng0892-348	http://dx.doi.org/10.1038/ng0892-348			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	1338771				2022-12-25	WOS:A1992JJ12100013
J	AVRAHAM, KB; HASSON, T; STEEL, KP; KINGSLEY, DM; RUSSELL, LB; MOOSEKER, MS; COPELAND, NG; JENKINS, NA				AVRAHAM, KB; HASSON, T; STEEL, KP; KINGSLEY, DM; RUSSELL, LB; MOOSEKER, MS; COPELAND, NG; JENKINS, NA			THE MOUSE SNELLS WALTZER DEAFNESS GENE ENCODES AN UNCONVENTIONAL MYOSIN REQUIRED FOR STRUCTURAL INTEGRITY OF INNER-EAR HAIR-CELLS	NATURE GENETICS			English	Article							SUPERFAMILY; SEQUENCES; HEARING; CLONES; LOCUS	The mouse represents an excellent model system for the study of genetic deafness in humans. Many mouse deafness mutants have been identified and the anatomy of the mouse and human ear is similar. Here we report the use of a positional cloning approach to identify the gene encoded by the mouse recessive deafness mutation, Snell's waltzer (sv). We show that sv encodes an unconventional myosin heavy chain, myosin VI, which is expressed within the sensory hair cells of the inner ear, and appears to be required for maintaining their structural integrity. The requirement for myosin VI in hearing makes this gene an excellent candidate for a human deafness disorder.	YALE UNIV,DEPT CELL BIOL,NEW HAVEN,CT 06511; YALE UNIV,DEPT PATHOL,NEW HAVEN,CT 06511; MRC,INST HEARING RES,NOTTINGHAM NG7 2RD,ENGLAND; STANFORD UNIV,SCH MED,DEPT DEV BIOL,STANFORD,CA 94305; OAK RIDGE NATL LAB,DIV BIOL,OAK RIDGE,TN 37831; YALE UNIV,DEPT BIOL,NEW HAVEN,CT 06511	Yale University; Yale University; Stanford University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Yale University	AVRAHAM, KB (corresponding author), NCI,FREDERICK CANC RES & DEV CTR,ABL,BASIC RES PROGRAM,MAMMALIAN GENET LAB,FREDERICK,MD 21702, USA.			HASSON, TAMA/0000-0002-5405-662X; Avraham, Karen B/0000-0002-4913-251X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038979, R01DK025387, R37DK025387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015909] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-25387, DK-38979] Funding Source: Medline; NIGMS NIH HHS [5F32GM15909-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANAND R, 1989, NUCLEIC ACIDS RES, V17, P3425, DOI 10.1093/nar/17.9.3425; BEDELL MA, 1995, GENE DEV, V9, P455, DOI 10.1101/gad.9.4.455; BURKE DT, 1991, MAMM GENOME, V1, P65, DOI 10.1007/BF00350849; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; Deol M S, 1968, J Med Genet, V5, P137, DOI 10.1136/jmg.5.2.137; DEOL MS, 1966, GENET RES, V8, P339, DOI 10.1017/S0016672300010193; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; HARVEY D, 1992, HEARING RES, V61, P137, DOI 10.1016/0378-5955(92)90044-N; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; LEHRACH H., 1990, GENOME ANAL, P39; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MERMALL V, 1994, NATURE, V369, P560, DOI 10.1038/369560a0; MERMALL V, 1995, J CELL BIOL, V129, P1575, DOI 10.1083/jcb.129.6.1575; NADOL JB, 1993, NEW ENGL J MED, V329, P1092, DOI 10.1056/NEJM199310073291507; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; RUSSELL LB, 1971, MUTAT RES, V11, P107, DOI 10.1016/0027-5107(71)90036-4; SPOENDLIN H, 1976, EFFECTS NOISE HEARIN; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; STEEL KP, 1994, TRENDS GENET, V10, P428, DOI 10.1016/0168-9525(94)90113-9; Titus MA, 1993, CURR OPIN CELL BIOL, V5, P77, DOI 10.1016/S0955-0674(05)80011-0	28	402	407	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					369	375		10.1038/ng1295-369	http://dx.doi.org/10.1038/ng1295-369			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493015				2022-12-25	WOS:A1995TH62900012
J	SEKHON, HS; LARSON, JE				SEKHON, HS; LARSON, JE			IN-UTERO GENE-TRANSFER INTO THE PULMONARY EPITHELIUM	NATURE MEDICINE			English	Article							RAT LUNG	In early gestation the internal surface of the lung is structurally simple and an ideal target for somatic gene transfer(1-3). The transfer of genes into the growing lung would be particularly useful in the prenatal correction of cystic fibrosis, which has devastating pulmonary complications. In addition, in utero gene therapy has the potential to immunotolerize the individual, and thereby to avoid the immune reactions now seen with the current generation of adenoviral vectors(4,5). We injected a replication-defective adenoviral vector containing the lacZ reporter gene (Ad5.CMVlacZ) into the amniotic fluid of rat pups on the 16th day of gestation(6-9). At 16 days of gestation, rat lungs are equivalent in maturity to those of a 22-week human fetus as their airways are lined with undifferentiated multipotential stem cells. The pups showed high-level reporter gene expression in their airways a week following birth (13 days following infection). The expression was maintained during a time when the lung volume increased approximately 20-fold, alveolarization occurred, and the epithelial cells differentiated(2,3). These data establish gene targeting of undifferentiated fetal cells as an effective means of gene therapy.	TULANE UNIV,MED CTR,NEW ORLEANS,LA 70121; ALTON OCHSNER MED FDN & OCHSNER CLIN,MOLEC GENET LAB,NEW ORLEANS,LA 70121	Tulane University; Ochsner Health System					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000880] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 00880] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMSON IYR, 1975, LAB INVEST, V32, P736; ADAMSON IYR, 1984, LAB INVEST, V50, P456; ADAMSON IYR, 1984, AM REV RESPIR DIS, V129, P130; ADAMSON IYR, 1991, LUNG SCI F, P663; BOLDUC P, 1976, AM REV RESPIR DIS, V114, P1121; CRYSTAL RG, 1994, NAT GENET, V8, P42, DOI 10.1038/ng0994-42; HISLOP A, 1974, THORAX, V29, P90, DOI 10.1136/thx.29.1.90; Kauffman S L, 1980, Int Rev Exp Pathol, V22, P131; KOLLS J, 1994, P NATL ACAD SCI USA, V91, P215, DOI 10.1073/pnas.91.1.215; MASTRANGELI A, 1993, J CLIN INVEST, V91, P225, DOI 10.1172/JCI116175; STRATFORDPERRIC.LD, 1992, J CLIN INVEST, V90, P626; TENHAVEOPBROEK AAW, 1981, AM J ANAT, V162, P201, DOI 10.1002/aja.1001620303; WINICK M, 1965, DEV BIOL, V12, P451, DOI 10.1016/0012-1606(65)90009-6; YANG YP, 1994, NAT GENET, V7, P362, DOI 10.1038/ng0794-362; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407	15	82	84	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1201	1203		10.1038/nm1195-1201	http://dx.doi.org/10.1038/nm1195-1201			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584996				2022-12-25	WOS:A1995TC53700048
J	WHITNEY, M; THAYER, M; REIFSTECK, C; OLSON, S; SMITH, L; JAKOBS, PM; LEACH, R; NAYLOR, S; JOENJE, H; GROMPE, M				WHITNEY, M; THAYER, M; REIFSTECK, C; OLSON, S; SMITH, L; JAKOBS, PM; LEACH, R; NAYLOR, S; JOENJE, H; GROMPE, M			MICROCELL MEDIATED CHROMOSOME TRANSFER MAPS THE FANCONI-ANEMIA-GROUP-D GENE TO CHROMOSOME-3P	NATURE GENETICS			English	Letter							CELL-CYCLE; ANEMIA; HYBRIDS; OXYGEN; DNA	Fanconi anaemia (FA) is an autosomal recessive disorder characterized by progressive pancytopenia, short stature, radial ray defects, skin hyperpigmentation and a predisposition to cancer(1,2). Cells from FA patients are hypersensitive to cell killing and chromosome breakage induced by DNA cross-linking agents such as mitomycin C (MMC) and diepoxybutane (DEB)(3,4). Consequently, the defect in FA is thought to be in DNA crosslink repair. Additional cellular phenotypes of FA include oxygen sensitivity(5,6), poor cell growth(7) and a G2 cell cycle delay(8,9). At least 5 complementation groups for Fanconi anaemia exist, termed A through E(10,11). One of the five FA genes, FA(C), has been identified by cDNA complementation(12), but no other FA genes have been mapped or cloned until now. The strategy of cDNA complementation, which was successful for identifying the FA(C) gene has not yet been successful for cloning additional FA genes. The alternative approach of linkage analysis, followed by positional cloning, is hindered in FA by genetic heterogeneity and the lack of a simple assay for determining complementation groups. In contrast to genetic linkage studies, microcell mediated chromosome transfer utilizes functional complementation to identify the disease bearing chromosome(13). Here we report the successful use of this technique to map the gene for the rare FA complementation group D (FA(D)).	OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT PEDIAT,PORTLAND,OR 97201; UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284; FREE UNIV AMSTERDAM,DEPT HUMAN GENET,1081 BT AMSTERDAM,NETHERLANDS	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Texas System; University of Texas Health San Antonio; Vrije Universiteit Amsterdam				Leach, Robin/0000-0002-3201-5579; Grompe, Markus/0000-0002-6616-4345	NHLBI NIH HHS [1PO1HL48546-01A2] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048546] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERGER R, 1993, CANCER GENET CYTOGEN, V69, P13, DOI 10.1016/0165-4608(93)90104-T; BILLARDON B, 1986, MUTAT RES, V174, P241, DOI 10.1016/0165-7992(86)90158-2; CARMICHAEL J, 1987, CANCER RES, V47, P936; COHEN MM, 1982, CYTOGENET CELL GENET, V34, P230, DOI 10.1159/000131810; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; FOURNIER REK, 1983, SOMAT CELL GENET, V9, P69, DOI 10.1007/BF01544049; FOURNIER REK, 1981, P NATL ACAD SCI-BIOL, V78, P6349, DOI 10.1073/pnas.78.10.6349; GORDONSMITH EC, 1991, SEMIN HEMATOL, V28, P104; JOANJE H, IN PRESS BLOOD; LEACH RJ, 1989, GENOMICS, V5, P167, DOI 10.1016/0888-7543(89)90043-8; LEGERSKI R, 1992, NATURE, V359, P70, DOI 10.1038/359070a0; LEGERSKI RJ, 1994, GENOMICS, V21, P266, DOI 10.1006/geno.1994.1256; MASUTANI C, 1994, EMBO J, V13, P1831, DOI 10.1002/j.1460-2075.1994.tb06452.x; MERCER WE, 1979, EXP CELL RES, V120, P417, DOI 10.1016/0014-4827(79)90403-8; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; SAITO H, 1993, MUTAT RES, V294, P255, DOI 10.1016/0921-8777(93)90008-5; SCHINDLER D, 1988, AM J HUM GENET, V43, P429; SEYSCHAB H, 1993, HUM GENET, V92, P61, DOI 10.1007/BF00216146; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; STRATHDEE CA, 1992, NATURE, V358, P434, DOI 10.1038/358434a0; WEKSBERG R, 1979, J CELL PHYSIOL, V101, P311, DOI 10.1002/jcp.1041010211	21	109	110	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					341	343		10.1038/ng1195-341	http://dx.doi.org/10.1038/ng1195-341			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581463				2022-12-25	WOS:A1995TC63900028
J	SCHROEDER, SA; GAUGHAN, DM; SWIFT, M				SCHROEDER, SA; GAUGHAN, DM; SWIFT, M			PROTECTION AGAINST BRONCHIAL-ASTHMA BY CFTR DELTA-F508 MUTATION - A HETEROZYGOTE ADVANTAGE IN CYSTIC-FIBROSIS	NATURE MEDICINE			English	Article							DISEASE; GENE	Cystic fibrosis (CF) is a multisystem autosomal recessive disorder caused by mutations of the cystic fibrosis transmembrane regulator (CFTR), a protein that regulates cyclic-AMP-mediated chloride conductance at the apical membrane of secretory epithelia(1). Mutations in the CFTR gene are common in many populations. In North America, 4-5% Of the general population are heterozygous for a CFTR mutation(2). Although there are over 400 known CFTR mutations, a single mutation, a deletion of the phenylalanine at position 508 (Delta F508) in exon 10, accounts for about 70% of all CF chromosomes worldwide(3). The reasons for the high frequency of the Delta F508 CFTR allele - the selective advantage associated with CF heterozygosity - are unknown(1). Many physiological abnormalities have been observed in CF heterozygotes(4-6), although the clinical significance of these observations is unknown. Preliminary unpublished data and anecdotal information from CF families suggested that, remarkably, the Delta F508 allele might protect heterozygotes against bronchial asthma prompted us to further investigate this possibility. Here we present evidence that the Delta F508 CF allele protects against asthma in childhood and early adult life.	NEW YORK MED COLL,INST GENET ANAL COMMON DIS,HAWTHORNE,NY 10523; NEW YORK MED COLL,DEPT PEDIAT,DIV PULM DIS,HAWTHORNE,NY 10523; NEW YORK MED COLL,DEPT PEDIAT,DIV HUMAN MOLEC GENET,HAWTHORNE,NY 10523	New York Medical College; New York Medical College; New York Medical College								BAXTER PS, 1988, NATURE, V335, P211, DOI 10.1038/335211a0; BONFORTE RJ, 1993, PEDIATRIC RESPIRATOR, P263; COUNAHAN R, 1975, ARCH DIS CHILD, V50, P477, DOI 10.1136/adc.50.6.477; DAVIS PB, 1989, J APPL PHYSIOL, V66, P2124, DOI 10.1152/jappl.1989.66.5.2124; DAVIS PB, 1987, THORAX, V42, P120, DOI 10.1136/thx.42.2.120; FRIEDMAN KJ, 1991, CLIN CHEM, V37, P753; GYURKOVITS K, 1977, LANCET, V1, P203; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; MORRAL N, 1994, NAT GENET, V7, P169, DOI 10.1038/ng0694-169; PIGNATTI PF, 1995, HUM MOL GENET, V4, P635, DOI 10.1093/hmg/4.4.635; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; SWIFT M, 1990, AM J HUM GENET, V47, P266; TIZZANO EF, 1992, J PEDIATR-US, V120, P337, DOI 10.1016/S0022-3476(05)80895-9; 1977, AM REV RESPIR DIS, V136, P225; 1991, DHMS NIH913042 PUBL	15	106	108	0	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1995	1	7					703	705		10.1038/nm0795-703	http://dx.doi.org/10.1038/nm0795-703			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585155				2022-12-25	WOS:A1995RQ06600048
J	CLARK, SJ; HARRISON, J; FROMMER, M				CLARK, SJ; HARRISON, J; FROMMER, M			CPNPG METHYLATION IN MAMMALIAN-CELLS	NATURE GENETICS			English	Article							DNA METHYLTRANSFERASE; SEQUENCE SPECIFICITY; HIGHER EUKARYOTES; ENZYMES; BINDING; DOMAIN; MOUSE; CPG	In vertebrate DNA, 3% to 5% of cytosine residues are present as 5-methylcytosine, and it is generally accepted that essentially all of this methylation occurs at cytosines which are contained in the symmetrical dinucleotide CpG. In this report we demonstrate, using bisulphite genomic sequencing, that the methylation machinery of mammalian cells is capable of both maintenance and de novo methylation at CpNpG sites. The existence of inherited CpNpG methylation in mammalian cells has important implications in gene regulation and in the aetiology of disease.	CSIRO, DIV BIOMOLEC ENGN, SYDNEY LAB, POB 184, N RYDE, NSW 2113, AUSTRALIA; UNIV SYDNEY, SCH BIOL SCI, SYDNEY, NSW 2006, AUSTRALIA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Sydney	CLARK, SJ (corresponding author), ROYAL PRINCE ALFRED HOSP, KANEMATSU LABS, MISSENDEN RD, CAMPERDOWN, NSW 2050, AUSTRALIA.		Clark, Susan J/U-7365-2019; Clark, Susan J/B-2272-2008	Clark, Susan J/0000-0001-5925-5030; Clark, Susan J/0000-0001-5925-5030				BATES G, 1994, BIOESSAYS, V16, P277, DOI 10.1002/bies.950160411; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; BESTOR TH, 1983, P NATL ACAD SCI-BIOL, V80, P5559, DOI 10.1073/pnas.80.18.5559; BIRD AP, 1978, J MOL BIOL, V118, P27, DOI 10.1016/0022-2836(78)90242-5; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Graessmann M, 1993, EXS, V64, P404; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; GRUENBAUM Y, 1981, NATURE, V292, P860, DOI 10.1038/292860a0; HARRISON J, 1994, ANAL BIOCHEM, V216, P235, DOI 10.1006/abio.1994.1033; Leonhardt H., 1993, DNA methylation: molecular biology and biological significance., P109; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MEYER P, 1994, EMBO J, V13, P2084, DOI 10.1002/j.1460-2075.1994.tb06483.x; MONK M, 1991, DEVELOPMENT, V112, P189; NOYERWEIDNER M, 1993, DNA METHYLATION MOL, P39; PFEIFER GP, 1989, SCIENCE, V246, P810, DOI 10.1126/science.2814502; ROSENSTRAUS MJ, 1979, CELL, V17, P337, DOI 10.1016/0092-8674(79)90160-0; SALUZ H, 1989, P NATL ACAD SCI USA, V86, P2602, DOI 10.1073/pnas.86.8.2602; Sambrook J, 1989, MOL CLONING LABORATO; Sasaki H., 1993, DNA methylation: molecular biology and biological significance., P469; SCHEIDT G, 1994, NUCLEIC ACIDS RES, V22, P953, DOI 10.1093/nar/22.6.953; SELKER EU, 1993, DNA METHYLATION MOL, P212; SIMON D, 1983, NATURE, V304, P275, DOI 10.1038/304275a0; SPRUCK CH, 1993, DNA METHYLATION MOL, P487; TASHEVA ES, 1994, MOL CELL BIOL, V14, P5636, DOI 10.1128/MCB.14.9.5636; TOMMASI S, 1993, SOMAT CELL MOLEC GEN, V19, P529, DOI 10.1007/BF01233380; TOTH M, 1990, J MOL BIOL, V214, P673, DOI 10.1016/0022-2836(90)90285-T; WALTER J, 1992, EMBO J, V11, P4445, DOI 10.1002/j.1460-2075.1992.tb05545.x; WOODCOCK DM, 1987, BIOCHEM BIOPH RES CO, V145, P888, DOI 10.1016/0006-291X(87)91048-5; YEN RWC, 1992, NUCLEIC ACIDS RES, V20, P2287, DOI 10.1093/nar/20.9.2287	34	224	237	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1995	10	1					20	27		10.1038/ng0595-20	http://dx.doi.org/10.1038/ng0595-20			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647784				2022-12-25	WOS:A1995QX57300011
J	HARVEY, M; VOGEL, H; MORRIS, D; BRADLEY, A; BERNSTEIN, A; DONEHOWER, LA				HARVEY, M; VOGEL, H; MORRIS, D; BRADLEY, A; BERNSTEIN, A; DONEHOWER, LA			A MUTANT P53 TRANSGENE ACCELERATES TUMOR-DEVELOPMENT IN HETEROZYGOUS BUT NOT NULLIZYGOUS P53 DEFICIENT MICE	NATURE GENETICS			English	Article							WILD-TYPE P53; LI-FRAUMENI SYNDROME; P53-DEFICIENT MICE; SUPPRESSOR GENE; FRIEND-VIRUS; MUTATIONS; APOPTOSIS; CELLS; EXPRESSION; PROTEIN	To test the behaviour of a mutant form of p53 in the presence and absence of wild-type p53 in vivo, we mated p53-deficient mice containing a p53 null allele to transgenic mice containing multiple copies of a mutant p53 gene (Val 135). Animals hemizygous for the endogenous wild-type p53 gene with the mutant transgene exhibited accelerated tumour development and an altered tumour spectrum compared to their non-transgenic counterparts. In contrast, transgenic and non-transgenic animals nullizygous for endogenous p53 developed tumours at the same rate. Thus, the mutant Val-135 p53 allele may act in vivo in a dominant negative manner in the presence of wild-type p53 but does not display gain of function activity in the absence of wild-type p53.	BAYLOR COLL MED,DIV MOLEC VIROL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT HUMAN & MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030; MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO,ON M5G 1X5,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON M5G 1X5,CANADA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto				Bradley, Allan/0000-0002-2349-8839; Morris, Danna/0000-0003-3812-6584; Vogel, Otto Hannes/0000-0002-0960-3508	NATIONAL CANCER INSTITUTE [R01CA054897] Funding Source: NIH RePORTER; NCI NIH HHS [CA54897] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENDAVID Y, 1991, CELL, V66, P831, DOI 10.1016/0092-8674(91)90428-2; CHIN KV, 1992, SCIENCE, V255, P459, DOI 10.1126/science.1346476; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; DEB S, 1992, J VIROL, V66, P6164, DOI 10.1128/JVI.66.10.6164-6170.1992; DEFROMENTEL CC, 1992, GENE CHROMOSOME CANC, V4, P1; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FARMER G, 1992, NATURE, V358, P83, DOI 10.1038/358083a0; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FINLAY C, CELL, V57, P1083; GREENBLATT MS, 1994, CANCER RES, V54, P4855; HALEVY O, 1990, SCIENCE, V250, P113, DOI 10.1126/science.2218501; HARPER JW, 1993, CELL, V75, P805; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, ONCOGENE, V8, P2457; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1990, CELL GROWTH DIFFER, V1, P571; HOLLSTEIN M, 1991, SCIENCE, V252, P49; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; KEMP CJ, 1994, NAT GENET, V8, P66, DOI 10.1038/ng0994-66; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; LANE DP, 1994, MED B, V50, P582; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; LI BL, 1994, CELL GROWTH DIFFER, V5, P711; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALKIN D, 1993, CANCER GENET CYTOGEN, V66, P83, DOI 10.1016/0165-4608(93)90233-C; MARTINEZ J, 1991, GENE DEV, V5, P151, DOI 10.1101/gad.5.2.151; MASUDA H, 1987, P NATL ACAD SCI USA, V84, P7716, DOI 10.1073/pnas.84.21.7716; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; MILNER J, 1991, MOL CELL BIOL, V11, P12, DOI 10.1128/MCB.11.1.12; MOWAT M, 1985, NATURE, V314, P633, DOI 10.1038/314633a0; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; ORY K, 1994, EMBO J, V13, P3496, DOI 10.1002/j.1460-2075.1994.tb06656.x; PROSSER J, 1990, ONCOGENE, V5, P1573; PURDIE CA, 1994, ONCOGENE, V9, P603; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; SEHGAL PB, 1993, ONCOGENE, V8, P3417; SHAULSKY G, 1991, CANCER RES, V51, P5232; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; WOLF D, 1984, CELL, V38, P119, DOI 10.1016/0092-8674(84)90532-4; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0	50	222	225	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					305	311		10.1038/ng0395-305	http://dx.doi.org/10.1038/ng0395-305			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773294				2022-12-25	WOS:A1995QL23200022
J	PALABRICA, TM; LIU, AC; ARONOVITZ, MJ; FURIE, B; LAWN, RM; FURIE, BC				PALABRICA, TM; LIU, AC; ARONOVITZ, MJ; FURIE, B; LAWN, RM; FURIE, BC			ANTIFIBRINOLYTIC ACTIVITY OF APOLIPOPROTEIN(A) IN-VIVO - HUMAN APOLIPOPROTEIN(A) TRANSGENIC MICE ARE RESISTANT TO TISSUE-PLASMINOGEN ACTIVATOR-MEDIATED THROMBOLYSIS	NATURE MEDICINE			English	Article							EXPRESSING HUMAN APOLIPOPROTEIN(A); PLASMA LIPOPROTEIN(A); MYOCARDIAL-INFARCTION; MONOCLONAL-ANTIBODY; FIBRIN BINDING; ATHEROSCLEROSIS; HETEROGENEITY; HEMOSTASIS; THROMBOSIS; INHIBITION	The extensive homology between apolipoprotein(a) and plasminogen has led to the hypothesis that the increased risk for atherosclerosis, cardiac disease and stroke associated with elevated levels of apolipoprotein(a) may reflect modulation of fibrinolysis. We have investigated the role of apolipoprotein(a) on clot lysis in transgenic mice expressing the human apolipoprotein(a) gene. These mice develop fatty streak lesions resembling early lesions of human atherosclerosis. Pulmonary emboli were generated in mice by injection, through the right jugular vein, of a human platelet-rich plasma clot radiolabelled with technetium-99m-labelled antifibrin antibodies. Tissue plasminogen activator was introduced continuously via the right jugular vein. Clot lysis, determined by ex vivo imaging, was depressed in mice carrying the apolipoprotein(a) transgene relative to their sex-matched normal littermates. These results directly demonstrate an in vivo effect of apolipoprotein(a) on fibrinolysis, an effect that may contribute to the pathology associated with elevated levels of this protein.	TUFTS UNIV NEW ENGLAND MED CTR, CTR HEMOSTASIS & THROMBOSIS RES, DIV HEMATOL ONCOL, BOSTON, MA 02111 USA; TUFTS UNIV, SCH MED, DEPT MED, BOSTON, MA 02111 USA; TUFTS UNIV, SCH MED, DEPT BIOCHEM, BOSTON, MA 02111 USA; TUFTS UNIV NEW ENGLAND MED CTR, DIV CARDIOL, BOSTON, MA 02111 USA; STANFORD UNIV, SCH MED, FALK CARDIOVASC RES CTR, DIV CARDIOVASC MED, STANFORD, CA 94305 USA	Tufts Medical Center; Tufts University; Tufts University; Tufts Medical Center; Stanford University								CARMELIET P, 1993, J CLIN INVEST, V92, P2756, DOI 10.1172/JCI116893; CHIESA G, 1992, J BIOL CHEM, V267, P24369; EDELBERG JM, 1990, THROMB RES, V57, P155, DOI 10.1016/0049-3848(90)90203-O; FRADE LJG, 1991, THROMB RES, V63, P407, DOI 10.1016/0049-3848(91)90227-N; GLUECK CJ, 1993, METABOLISM, V42, P236, DOI 10.1016/0026-0495(93)90042-M; HAJJAR KA, 1989, NATURE, V339, P303, DOI 10.1038/339303a0; HALVORSEN S, 1992, THROMB RES, V68, P223, DOI 10.1016/0049-3848(92)90080-T; HEINRICH J, 1991, CLIN CHEM, V37, P1950; KUDRYK B, 1984, MOL IMMUNOL, V21, P89, DOI 10.1016/0161-5890(84)90093-2; LAWN RM, 1992, NATURE, V360, P670, DOI 10.1038/360670a0; LEERINK CB, 1992, THROMB HAEMOSTASIS, V68, P185; LIU JN, 1993, BIOCHEMISTRY-US, V32, P9694, DOI 10.1021/bi00088a022; LOSCALZO J, 1990, ARTERIOSCLEROSIS, V10, P240, DOI 10.1161/01.ATV.10.2.240; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MILES LA, 1989, NATURE, V339, P301, DOI 10.1038/339301a0; MOLITERNO DJ, 1993, CIRCULATION, V88, P935, DOI 10.1161/01.CIR.88.3.935; OSHIMA S, 1991, ARTERIOSCLER THROMB, V11, P1772, DOI 10.1161/01.ATV.11.6.1772; ROSEBROUGH SF, 1988, J NUCL MED, V29, P1212; SCANU AM, 1994, BBA-MOL BASIS DIS, V1227, P41, DOI 10.1016/0925-4439(94)90104-X; SCANU AM, 1990, J CLIN INVEST, V85, P1709, DOI 10.1172/JCI114625; SCANU AM, 1991, ANN INTERN MED, V115, P209, DOI 10.7326/0003-4819-115-3-209; STASSEN JM, 1991, CIRCULATION, V83, P65; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; VONHODENBERG E, 1991, AM J CARDIOL, V67, P1349, DOI 10.1016/0002-9149(91)90464-V; Zysow Bernice R., 1993, Current Opinion in Lipidology, V4, P484, DOI 10.1097/00041433-199312000-00010	25	126	128	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	1995	1	3					256	259		10.1038/nm0395-256	http://dx.doi.org/10.1038/nm0395-256			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX559	7585043				2022-12-25	WOS:A1995QX55900033
J	THOMAS, GR; FORBES, JR; ROBERTS, EA; WALSHE, JM; COX, DW				THOMAS, GR; FORBES, JR; ROBERTS, EA; WALSHE, JM; COX, DW			THE WILSON-DISEASE GENE - SPECTRUM OF MUTATIONS AND THEIR CONSEQUENCES	NATURE GENETICS			English	Article							COPPER-TRANSPORTING ATPASE; MENKES DISEASE; CANDIDATE GENE; DNA MARKERS; ENCODES	We have previously reported the cloning of a gene that encodes a copper transporting P-type ATPase (ATP7B) which is defective in Wilson disease. We have now identified in 58 WND patients, 20 new mutations as well as three of five previously published mutations: 11 small insertions and deletions, seven missense, two nonsense and three splice site mutations, Two of the mutations are relatively frequent, representing 38% of the mutations in patients of European origin. Our findings suggest a wider spectrum of age of onset than is considered typical of Wilson disease: mutations that completely disrupt the gene can produce liver disease in early childhood when Wilson disease may not typically considered in the differential diagnosis. The mutations identified provide an explanation for at least part of the wide phenotypic variation observed in Wilson disease.	HOSP SICK CHILDREN,RES INST,TORONTO,ON M5G 1X8,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO,ON,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO,ON M5S 1A1,CANADA; MIDDLESEX HOSP,LONDON,ENGLAND	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of London; University College London								BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; BULL PC, 1994, TRENDS GENET, V10, P246, DOI 10.1016/0168-9525(94)90172-4; BYTH BC, 1994, NUCLEIC ACIDS RES, V22, P1766, DOI 10.1093/nar/22.9.1766; CHELLY J, 1993, NAT GENET, V3, P14, DOI 10.1038/ng0193-14; COX DW, 1972, AM J HUM GENET, V24, P646; Danks DM, 1989, METABOLIC BASIS INHE, P1411; DAS S, 1994, AM J HUM GENET, V55, P883; FARRER LA, 1991, NEUROLOGY, V41, P992, DOI 10.1212/WNL.41.7.992; HOUWEN RHJ, 1993, J HEPATOL, V17, P269, DOI 10.1016/S0168-8278(05)80204-1; KALER SG, 1994, NAT GENET, V8, P195, DOI 10.1038/ng1094-195; MACLENNAN DH, 1992, ACTA PHYSIOL SCAND, V146, P141; MERCER JFB, 1993, NAT GENET, V3, P20, DOI 10.1038/ng0193-20; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; RAD MR, 1994, YEAST, V10, P1217, DOI 10.1002/yea.320100910; TANNER MS, 1981, ARCH DIS CHILD, V56, P4, DOI 10.1136/adc.56.1.4; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; THOMAS GR, 1993, HUM MOL GENET, V2, P1401, DOI 10.1093/hmg/2.9.1401; THOMAS GR, 1994, AM J HUM GENET, V54, P71; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541	21	434	470	0	24	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					210	217		10.1038/ng0295-210	http://dx.doi.org/10.1038/ng0295-210			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7626145				2022-12-25	WOS:A1995QE67200025
J	LIU, B; NICOLAIDES, NC; MARKOWITZ, S; WILLSON, JKV; PARSONS, RE; JEN, J; PAPADOPOLOUS, N; PELTOMAKI, P; DELACHAPELLE, A; HAMILTON, SR; KINZLER, KW; VOGELSTEIN, B				LIU, B; NICOLAIDES, NC; MARKOWITZ, S; WILLSON, JKV; PARSONS, RE; JEN, J; PAPADOPOLOUS, N; PELTOMAKI, P; DELACHAPELLE, A; HAMILTON, SR; KINZLER, KW; VOGELSTEIN, B			MISMATCH REPAIR GENE DEFECTS IN SPORADIC COLORECTAL CANCERS WITH MICROSATELLITE INSTABILITY	NATURE GENETICS			English	Article							NONPOLYPOSIS COLON-CANCER; HEREDITARY; MUTATIONS; CARCINOMA; POLYPOSIS; HOMOLOG; HISTORY	Microsatellite instability has been observed in both sporadic and hereditary forms of colorectal cancer. In the hereditary form, this instability is generally due to germline mutations in mismatch repair (MMR) genes. However, only one in ten patients with sporadic tumours exhibiting microsatellite instability had a detectable germline mutation. Moreover, only three of seven sporadic tumour cell lines with microsatellite instability had mutations in a MMR gene, and these mutations could occur somatically. These results demonstrate that tumours can acquire somatic mutations that presumably do not directly affect cell growth but result only in genetic instability. They also suggest that many sporadic tumours with microsatellite instability have alterations in genes other than the four now known to participate in MMR.	JOHNS HOPKINS ONCOL CTR,BALTIMORE,MD 21231; CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106; UNIV CLEVELAND HOSP,DEPT MED,CLEVELAND,OH 44106; UNIV CLEVELAND HOSP,IRELAND CANC CTR,CLEVELAND,OH 44106; UNIV HELSINKI,DEPT MED GENET,SF-00290 HELSINKI,FINLAND; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine; Case Western Reserve University; University of Helsinki; Johns Hopkins University				Parsons, Ramon/0000-0002-6656-3514; Peltomaki, Paivi/0000-0001-8819-2980	NATIONAL CANCER INSTITUTE [P01CA051183, R29CA051504] Funding Source: NIH RePORTER; NCI NIH HHS [CA57208, CA51504, CA51183] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BURKS RT, 1994, ONCOGENE, V9, P1163; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; GIANNELLI F, 1994, NUCLEIC ACIDS RES, V22, P3534, DOI 10.1093/nar/22.17.3534; GLEBOV OK, 1994, CANCER RES, V54, P3703; HAN HJ, 1993, CANCER RES, V53, P5087; HEMMINKI A, 1994, NAT GENET, V8, P405, DOI 10.1038/ng1294-405; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JEN J, 1994, NEW ENGL J MED, V331, P213, DOI 10.1056/NEJM199407283310401; KIM H, 1994, AM J PATHOL, V145, P1; KNUDSON AG, 1985, CANCER RES, V45, P1437; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LIU B, 1994, CANCER RES, V54, P4590; LOTHE RA, 1993, CANCER RES, V53, P5849; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; MERLO A, 1994, CANCER RES, V54, P2098; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; ORTH K, 1994, P NATL ACAD SCI USA, V91, P9495, DOI 10.1073/pnas.91.20.9495; PALOMBO F, 1994, NATURE, V367, P417, DOI 10.1038/367417a0; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PELTOMAKI P, 1993, CANCER RES, V53, P5853; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; RISINGER JI, 1993, CANCER RES, V53, P5100; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; TUDDENHAM EGD, 1994, NUCLEIC ACIDS RES, V22, P3511, DOI 10.1093/nar/22.17.3511; UMAR A, 1994, J BIOL CHEM, V269, P14367; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; WILLSON JKV, 1987, CANCER RES, V47, P2704; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152	37	746	768	0	22	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					48	55		10.1038/ng0195-48	http://dx.doi.org/10.1038/ng0195-48			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704024				2022-12-25	WOS:A1995PZ91300014
J	HAYASAKA, K; HIMORO, M; SAWAISHI, Y; NANAO, K; TAKAHASHI, T; TAKADA, G; NICHOLSON, GA; OUVRIER, RA; TACHI, N				HAYASAKA, K; HIMORO, M; SAWAISHI, Y; NANAO, K; TAKAHASHI, T; TAKADA, G; NICHOLSON, GA; OUVRIER, RA; TACHI, N			DE-NOVO MUTATION OF THE MYELIN P(O) GENE IN DEJERINE-SOTTAS DISEASE (HEREDITARY MOTOR AND SENSORY NEUROPATHY TYPE-III)	NATURE GENETICS			English	Article							MARIE-TOOTH NEUROPATHY; MAJOR STRUCTURAL PROTEIN; PERIPHERAL MYELIN; HOMOZYGOUS EXPRESSION; DUFFY LOCUS; SEQUENCE; DNA; HYPOMYELINATION; LINKAGE; MOUSE	We have investigated the myelin P(o) gene on chromosome 1 as a candidate gene in two sporadic cases with Dejerine-Sottas disease or hereditary motor and sensory neuropathy (HMSN) type III. We found different mutations, a cysteine substitution for serine 63 in the extracellular domain and an arginine substitution for glycine 167 in the transmembrane domain. The patients were genetically heterozygous for the normal allele and the mutant allele, which was absent in their parents and in one hundred unrelated, healthy controls. The results strongly suggest that a de novo dominant mutation of the P(o) gene is responsible for at least some sporadic cases of Dejerine-Sottas disease.	SAPPORO MED COLL,DEPT PEDIAT,SAPPORO,HOKKAIDO 060,JAPAN; AKITA UNIV,SCH MED,DEPT DENT,AKITA 010,JAPAN; UNIV SYDNEY,DEPT MED,SYDNEY,NSW 2139,AUSTRALIA	Sapporo Medical University; Akita University; University of Sydney	HAYASAKA, K (corresponding author), AKITA UNIV,SCH MED,DEPT PEDIAT,AKITA 010,JAPAN.		Hayasaka, Kiyoshi/H-5340-2012	Hayasaka, Kiyoshi/0000-0003-3621-8901				BARBU M, 1990, J NEUROSCI RES, V25, P143, DOI 10.1002/jnr.490250119; BIRD TD, 1982, AM J HUM GENET, V34, P388; Dyck P.J, 1993, PNP, P1094; ESPELUND M, 1990, NUCLEIC ACIDS RES, V18, P6157, DOI 10.1093/nar/18.20.6157; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HAYASAKA K, 1991, BIOCHEM BIOPH RES CO, V180, P515, DOI 10.1016/S0006-291X(05)81094-0; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; HAYASAKA K, IN PRESS GENOMICS; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; KILLIAN JM, 1979, ANN NEUROL, V5, P515, DOI 10.1002/ana.410050604; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MISIURA K, 1990, NUCLEIC ACIDS RES, V18, P4345, DOI 10.1093/nar/18.15.4345; OAKEY RJ, 1992, HUM MOL GENET, V1, P613, DOI 10.1093/hmg/1.8.613; OUVRIER RA, 1987, BRAIN, V110, P121, DOI 10.1093/brain/110.1.121; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; SAAVEDRA RA, 1989, J MOL EVOL, V29, P149, DOI 10.1007/BF02100113; SAKAMOTO Y, 1987, J BIOL CHEM, V262, P4208; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SGHIRLANZONI A, 1992, NEUROLOGY, V42, P2201, DOI 10.1212/WNL.42.11.2201; STEBBINS NB, 1982, AM J HUM GENET, V34, pA195; TACHI N, 1984, BRAIN DEV-JPN, V6, P560, DOI 10.1016/S0387-7604(84)80101-1; Uyemura Keiichi, 1992, P481; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166	27	204	207	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1993	5	3					266	268		10.1038/ng1193-266	http://dx.doi.org/10.1038/ng1193-266			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MF122	7506095				2022-12-25	WOS:A1993MF12200017
J	PENTAO, L; WISE, CA; CHINAULT, AC; PATEL, PI; LUPSKI, JR				PENTAO, L; WISE, CA; CHINAULT, AC; PATEL, PI; LUPSKI, JR			CHARCOT-MARIE-TOOTH TYPE-1A DUPLICATION APPEARS TO ARISE FROM RECOMBINATION AT REPEAT SEQUENCES FLANKING THE 1.5 MB MONOMER UNIT	NATURE GENETICS			English	Article							HEREDITARY HYPERTROPHIC NEUROPATHY; ARTIFICIAL CHROMOSOME CLONES; TREMBLER MOUSE; MUSCULAR-DYSTROPHY; ALU-PCR; DISEASE; YEAST; DNA; DELETIONS; IDENTIFICATION	We have constructed a 3.1 megabase (Mb) physical map of chromosome 17p11.2-p12, which contains a submicroscopic duplication in patients with Charcot-Marie-Tooth disease type 1A (CMT1A). We find that the CMT1A duplication is a tandem repeat of 1.5 Mb of DNA. A YAC contig encompassing the CMT1A duplication and spanning the endpoints was also developed. Several low copy repeats in 17p11.2-p12 were identified including the large (> 17 kb) CMT1A-REP unit which may be part of a mosaic repeat. CMT1A-REP flanks the 1.5 Mb CMT1A monomer unit on normal chromosome 17 and is present in an additional copy on the CMT1A duplicated chromosome. We propose that the de novo CMT1A duplication arises from unequal crossing over due to misalignment these CMT1A-REP repeat sequences during meiosis.	BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT BIOCHEM,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine			Patel, Pragna/H-9129-2017	Patel, Pragna/0000-0003-3584-1072; Wise, Carol/0000-0002-6790-2194				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; BIRD A, 1987, TRENDS GENET, V3, P341; BREUKEL C, 1990, NUCLEIC ACIDS RES, V18, P3097, DOI 10.1093/nar/18.10.3097; BROWNSTEIN BH, 1989, SCIENCE, V244, P1348, DOI 10.1126/science.2544027; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; Charcot JM, 1886, REV MED-PARIS, V6, P97; DARRAS BT, 1988, AM J HUM GENET, V43, P620; EDWARDS A, 1991, AM J HUM GENET, V49, P746; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; GUZZETTA V, 1992, GENOMICS, V13, P551, DOI 10.1016/0888-7543(92)90124-B; HALLAM PJ, 1992, ANN NEUROL, V31, P570, DOI 10.1002/ana.410310518; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; Hu Xiuyuan, 1992, Human Mutation, V1, P3, DOI 10.1002/humu.1380010103; HU XY, 1990, AM J HUM GENET, V46, P682; KWIATKOWSKI TJ, 1990, NUCLEIC ACIDS RES, V18, P7191, DOI 10.1093/nar/18.23.7191; LOW PA, 1977, NEUROPATH APPL NEURO, V3, P81, DOI 10.1111/j.1365-2990.1977.tb00572.x; LOW PA, 1976, J NEUROL SCI, V30, P343, DOI 10.1016/0022-510X(76)90139-8; LOW PA, 1976, J NEUROL SCI, V30, P327, DOI 10.1016/0022-510X(76)90138-6; LOW PA, 1975, J NEUROL SCI, V26, P565, DOI 10.1016/0022-510X(75)90057-X; LOW PA, 1978, J NEUROL SCI, V35, P93, DOI 10.1016/0022-510X(78)90104-1; LOW PA, 1977, J NEUROL NEUROSUR PS, V40, P434, DOI 10.1136/jnnp.40.5.434; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, AM J MED GENET, V40, P354, DOI 10.1002/ajmg.1320400323; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1900, IN PRESS AM J MED GE; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; MACMILLAN JC, 1992, J MED GENET, V29, P12, DOI 10.1136/jmg.29.1.12; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; PATEL PI, 1990, AM J HUM GENET, V47, P926; PATEL PI, 1990, AM J HUM GENET, V46, P801; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TIMEMRMAN V, 1992, NATUER GENET, V1, P171; Tooth HH, 1886, PERONEAL TYPE PROGRE; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; VANCE JM, 1991, J MED GENET, V28, P1, DOI 10.1136/jmg.28.1.1; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	51	335	339	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					292	300		10.1038/ng1292-292	http://dx.doi.org/10.1038/ng1292-292			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303282				2022-12-25	WOS:A1992KB49500013
J	ROSENTHAL, A; JOUET, M; KENWRICK, S				ROSENTHAL, A; JOUET, M; KENWRICK, S			ABERRANT SPLICING OF NEURAL CELL-ADHESION MOLECULE L1 MESSENGER-RNA IN A FAMILY WITH X-LINKED HYDROCEPHALUS	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; MASA SYNDROME; OUTGROWTH; GENE	A locus for X-linked hydrocephalus (HSAS), which is characterized by mental retardation and enlarged brain ventricles, maps to the same subchromosomal region (Xq28) as the gene for neural cell adhesion molecule L1. We have found novel L1 mRNA species in cells from affected members of a HSAS family containing deletions and insertions produced by the utilization of alternative 3' splice sites. A point mutation at a potential branch point signal in an intron segregates with the disease and is likely to be responsible for the abnormal RNA processing. These results suggest that HSAS is a disorder of neuronal cell migration due to disruption of L1 protein function.	UNIV CAMBRIDGE,ADDENBROOKES HOSP,DEPT MED,CAMBRIDGE CB2 2QQ,ENGLAND	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	KENWRICK, S (corresponding author), UNIV CAMBRIDGE,ADDENBROOKES HOSP,MRC,MOLEC GENET GRP,CAMBRIDGE CB2 2QQ,ENGLAND.							BACH I, 1992, AM J HUM GENET, V50, P38; Grumet M, 1991, Curr Opin Neurobiol, V1, P370, DOI 10.1016/0959-4388(91)90055-C; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; KOWITZ A, 1992, EUR J IMMUNOL, V22, P1199, DOI 10.1002/eji.1830220514; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; LANDMESSER L, 1988, DEV BIOL, V130, P645, DOI 10.1016/0012-1606(88)90358-2; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; MCKUSICK VA, 1988, MENDELIAN INHERITANC; POUSTKA A, 1991, P NATL ACAD SCI USA, V88, P8302, DOI 10.1073/pnas.88.19.8302; ROSENTHAL A, 1991, NUCLEIC ACIDS RES, V19, P5395, DOI 10.1093/nar/19.19.5395; ROSENTHAL A, IN PRESS DNA SEQUENC; SCHRANDERSTUMPEL C, 1990, J MED GENET, V27, P688, DOI 10.1136/jmg.27.11.688; SHARP P, 1987, SCIENCE, V235, P767; SMITH SB, 1989, SCIENCE, V243, P203, DOI 10.1126/science.2911733; VANOOST BA, 1992, MAPPING GENES DNA MA, V1; WILLEMS PJ, 1987, AM J MED GENET, V27, P921, DOI 10.1002/ajmg.1320270419; WILLEMS PJ, 1990, GENOMICS, V8, P367, DOI 10.1016/0888-7543(90)90294-5; WILLEMS PJ, 1991, CYTOGENET CELL GENET, V58, P2090; WINTER RM, 1989, HUM GENET, V82, P367	20	255	259	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					107	112		10.1038/ng1092-107	http://dx.doi.org/10.1038/ng1092-107			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303258				2022-12-25	WOS:A1992JR08400008
J	PATEL, PI; ROA, BB; WELCHER, AA; SCHOENERSCOTT, R; TRASK, BJ; PENTAO, L; SNIPES, GJ; GARCIA, CA; FRANCKE, U; SHOOTER, EM; LUPSKI, JR; SUTER, U				PATEL, PI; ROA, BB; WELCHER, AA; SCHOENERSCOTT, R; TRASK, BJ; PENTAO, L; SNIPES, GJ; GARCIA, CA; FRANCKE, U; SHOOTER, EM; LUPSKI, JR; SUTER, U			THE GENE FOR THE PERIPHERAL MYELIN PROTEIN-PMP-22 IS A CANDIDATE FOR CHARCOT-MARIE-TOOTH DISEASE TYPE-1A	NATURE GENETICS			English	Article							HEREDITARY HYPERTROPHIC NEUROPATHY; TREMBLER MOUSE; SENSORY NEUROPATHY; MICROSCOPY; MOTOR; MICE; ACID; MAP	Charcot-Marie-Tooth disease type 1A (CMT1A) is an autosomal dominant peripheral neuropathy associated with a large DNA duplication on the short arm of human chromosome 17. The trembler (Tr) mouse serves as a model for CMT1A because of phenotypic similarities and because the Tr locus maps to mouse chromosome 11 in a region of conserved synteny with human chromosome 17. Recently, the peripheral myelin gene Pmp-22 was found to carry a point mutation in Tr mice. We have isolated cDNA and genomic clones for human PMP-22. The gene maps to human chromosome 17p11.2-17p2, is expressed at high levels in peripheral nervous tissue and is duplicated, but not disrupted, in CMT1A patients. Thus, we suggest that a gene dosage effect involving PMP-22 is at least partially responsible for the demyelinating neuropathy seen in CMT1A.	BAYLOR COLL MED,CTR HUMAN GENOME,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; AMGEN INC,AMGEN CTR,THOUSAND OAKS,CA 91320; STANFORD UNIV,MED CTR,SCH MED,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROBIOL,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT NEUROPATHOL,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT GENET & PEDIAT,STANFORD,CA 94305; LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,LIVERMORE,CA 94550; LOUISIANA STATE UNIV,MED CTR,DEPT NEUROL,NEW ORLEANS,LA 70112; LOUISIANA STATE UNIV,MED CTR,DEPT PATHOL,NEW ORLEANS,LA 70112	Baylor College of Medicine; Baylor College of Medicine; Amgen; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Louisiana State University System; Louisiana State University System	PATEL, PI (corresponding author), BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030, USA.		Suter, Ueli/A-1624-2010; Patel, Pragna/H-9129-2017	Patel, Pragna/0000-0003-3584-1072				AGUAYO AJ, 1977, NATURE, V265, P753; BUCHBERG AM, 1989, GENETICS, V122, P153; BUCHBERG AM, 1991, MAMM GENOME, V1, P5158; Charcot JM, 1886, REV MED-PARIS, V6, P97; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVISSON MT, 1977, CYTOGENET CELL GENET, V22, P5852; DELEON M, 1991, J NEUROSCI RES, V29, P437; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dyck P.J., 1984, PERIPHERAL NEUROPATH, P1600; ELDER FFB, 1985, AM J MED GENET, V20, P519, DOI 10.1002/ajmg.1320200312; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; FRANCKE U, 1975, CYTOGENET CELL GENET, V14, P313, DOI 10.1159/000130371; FRANCKE U, 1986, COLD SPRING HARB SYM, V51, P855, DOI 10.1101/SQB.1986.051.01.099; FUQUA SAW, 1990, BIOTECHNIQUES, V9, P206; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; GUZZETTA V, IN PRESS GENOMICS; HENRY EW, 1988, SCIENCE, V241, P344, DOI 10.1126/science.3388045; HENRY EW, 1983, J NEUROPATH EXP NEUR, V42, P688, DOI 10.1097/00005072-198311000-00008; HOOGENDIJK JE, 1991, HUM GENET, V88, P215, DOI 10.1007/BF00206075; KITAMURA K, 1981, 6TH P INT S GLYC, P273; LOW PA, 1977, NEUROPATH APPL NEURO, V3, P81, DOI 10.1111/j.1365-2990.1977.tb00572.x; LOW PA, 1976, J NEUROL SCI, V30, P343, DOI 10.1016/0022-510X(76)90139-8; LOW PA, 1976, J NEUROL SCI, V30, P327, DOI 10.1016/0022-510X(76)90138-6; LOW PA, 1975, J NEUROL SCI, V26, P565, DOI 10.1016/0022-510X(75)90057-X; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1991, CURRENT NEUROLOGY, P1; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; NUKADA H, 1984, ANN NEUROL, V16, P238, DOI 10.1002/ana.410160213; NUKADA H, 1983, ANN NEUROL, V14, P648, DOI 10.1002/ana.410140608; PATEL PI, 1990, AM J HUM GENET, V47, P926; PERKINS CS, 1981, NEUROPATH APPL NEURO, V7, P115, DOI 10.1111/j.1365-2990.1981.tb00081.x; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TRASK BJ, 1991, AM J HUM GENET, V48, P1; van Tuinen P, 1987, Genomics, V1, P374, DOI 10.1016/0888-7543(87)90042-5; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195; WRIGHT EC, 1990, GENOMICS, V7, P103, DOI 10.1016/0888-7543(90)90524-X	46	476	481	0	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					159	165		10.1038/ng0692-159	http://dx.doi.org/10.1038/ng0692-159			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303228				2022-12-25	WOS:A1992JC98200005
J	VALENTIJN, LJ; BOLHUIS, PA; ZORN, I; HOOGENDIJK, JE; VANDENBOSCH, N; HENSELS, GW; STANTON, VP; HOUSMAN, DE; FISCHBECK, KH; ROSS, DA; NICHOLSON, GA; MEERSHOEK, EJ; DAUWERSE, HG; VANOMMEN, GJB; BAAS, F				VALENTIJN, LJ; BOLHUIS, PA; ZORN, I; HOOGENDIJK, JE; VANDENBOSCH, N; HENSELS, GW; STANTON, VP; HOUSMAN, DE; FISCHBECK, KH; ROSS, DA; NICHOLSON, GA; MEERSHOEK, EJ; DAUWERSE, HG; VANOMMEN, GJB; BAAS, F			THE PERIPHERAL MYELIN GENE PMP-22/GAS-3 IS DUPLICATED IN CHARCOT-MARIE-TOOTH DISEASE TYPE-1A	NATURE GENETICS			English	Article							GROWTH ARREST; DNA-MOLECULES; SEPARATION; LINKAGE; LOCUS; YEAST	Charcot-Marie-Tooth disease type 1A (CMT1A) is associated with a DNA duplication at chromosome 17p11.2. In view of the point mutation in the gene for peripheral myelin protein pmp-22/gas-3 in Trembler mice, a murine model for CMT1A, we have analysed whether this gene is altered in CMT1A. Here we show that the human homologue of the murine pmp-22 gene is located within the CMT1A DNA duplication, which is a direct repeat and does not interrupt the coding region of PMP-22. Expression of PMP-22 in CMT1A fibroblasts is similar to expression in control fibroblasts. Increased gene dosage or altered PMP-22 expression in the peripheral nervous system are therefore possible mechanisms by which PMP-22 is involved in CMT1A.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104; UNIV SYDNEY,CONCORD HOSP,DEPT MED,SYDNEY,NSW 2006,AUSTRALIA; LEIDEN UNIV,SYLVIUS LABS,DEPT HUMAN GENET,2333 AL LEIDEN,NETHERLANDS	Massachusetts Institute of Technology (MIT); University of Pennsylvania; Concord Repatriation General Hospital; University of Sydney; Leiden University; Leiden University - Excl LUMC	VALENTIJN, LJ (corresponding author), UNIV AMSTERDAM,ACAD MED CTR,DEPT NEUROL K2206,MEIBERGDREEF 9,1105 AZ AMSTERDAM,NETHERLANDS.		Baas, Frank/F-9574-2010	Baas, Frank/0000-0003-3912-5428; Stanton, Vincent/0000-0002-2205-6000				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BAAS F, 1984, HUM GENET, V67, P301, DOI 10.1007/BF00291357; BIRD TD, 1982, AM J HUM GENET, V34, P388; CARLE GF, 1984, NUCLEIC ACIDS RES, V12, P5647, DOI 10.1093/nar/12.14.5647; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; DAUWERSE JG, IN PRESS BLOOD, V79; DEFESCHE JC, 1990, NEUROLOGY, V40, P1450, DOI 10.1212/WNL.40.9.1450; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; HOOGENDIJK JE, 1991, HUM GENET, V88, P215, DOI 10.1007/BF00206075; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; HOOGENDIJK JE, 1991, HDB CLIN NEUROLOGY; HULSEBOS TJM, 1991, CYTOGENET CELL GENET, V56, P171, DOI 10.1159/000133080; LEBO RV, 1991, HUM GENET, V88, P1, DOI 10.1007/BF00204921; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; LUPSKI JR, 1992, NATURE GENET, V1; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; RAEYMAEKERS P, 1992, J MED GENET, V29, P5, DOI 10.1136/jmg.29.1.5; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Sambrook J, 1989, MOL CLONING LABORATO; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sherman F., 1986, METHODS YEAST GENETI; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; VANCE JM, 1991, GENOMICS, V9, P623, DOI 10.1016/0888-7543(91)90355-I; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195	26	330	332	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					166	170		10.1038/ng0692-166	http://dx.doi.org/10.1038/ng0692-166			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303229				2022-12-25	WOS:A1992JC98200006
J	MELTZER, PS; GUAN, XY; BURGESS, A; TRENT, JM				MELTZER, PS; GUAN, XY; BURGESS, A; TRENT, JM			RAPID GENERATION OF REGION SPECIFIC PROBES BY CHROMOSOME MICRODISSECTION AND THEIR APPLICATION	NATURE GENETICS			English	Article							HUMAN-MALIGNANT MELANOMA; INSITU HYBRIDIZATION; CELL-LINES; TRANSLOCATIONS; ABNORMALITIES; INVOLVEMENT; LIBRARIES; LECTURE; DNA	The strategy presented here to identify unequivocally cryptic chromosomal rearrangements has relevance to both prenatal and postnatal cytogenetic analysis as well as the analysis of tumour-associated chromosome rearrangements. Microdissection and in vitro amplification of specific chromosomal regions are performed, followed by labelling for fluorescent in situ hybridization (FISH) to normal metaphase chromosomes (Micro-FISH). Micro-FISH probes have been used successfully to determine the derivation of chromosome segments unidentifiable by standard chromosome banding analysis. Micro-FISH probes (created in less than 24 hours) now make it possible to identify explicitly the chromosome constitution of virtually all cytologically visible chromosome rearrangements.	UNIV MICHIGAN,DEPT RADIAT ONCOL,MED SCI RES BLDG 2,RM C560B,1150 W MED CTR DR,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT HUMAN GENET,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan			Guan, Xin-Yuan/A-3639-2009; /A-3639-2009	Guan, Xin-Yuan/0000-0002-4485-6017; /0000-0003-1874-9805				CALLEN DF, 1991, AM J HUM GENET, V48, P769; de Grouchy J., 1984, CLIN ATLAS HUMAN CHR; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FOUNTAIN JW, 1989, SCIENCE, V244, P1085, DOI 10.1126/science.2543076; Gardner R. J. M., 1989, CHROMOSOME ABNORMALI; GELEHRTER TD, 1990, PRINCIPLES MED GENET, P159; HALUSKA FG, 1987, ANNU REV GENET, V21, P321, DOI 10.1146/annurev.ge.21.120187.001541; HAMPTON G, 1991, GENOMICS, V11, P247, DOI 10.1016/0888-7543(91)90130-7; HASSOLD TJ, 1986, TRENDS GENET, V2, P105, DOI 10.1016/0168-9525(86)90194-0; HEIM S, 1987, CANCER CYTOGENETICS; JOHNSON DH, 1990, GENOMICS, V6, P243, DOI 10.1016/0888-7543(90)90563-A; KUO WL, 1991, AM J HUM GENET, V49, P112; KUWANO A, 1991, AM J HUM GENET, V49, P707; LENGAUER C, 1991, CYTOGENET CELL GENET, V56, P27, DOI 10.1159/000133039; LICHTER P, 1988, HUM GENET, V80, P224, DOI 10.1007/BF01790090; MEESE EU, 1992, GENOMICS, V12, P542, DOI 10.1016/0888-7543(92)90446-Y; MILLIKIN D, 1991, CANCER RES, V51, P5449; MITELMAN F, 1991, CYTOGENET CELL GENET, V58, P1053, DOI 10.1159/000133721; MITELMAN F, 1991, CATALOG CHROMOSOME A; NOWELL PC, 1990, AM J CLIN PATHOL, V94, P229, DOI 10.1093/ajcp/94.2.229; PATHAK S, 1983, CYTOGENET CELL GENET, V36, P573, DOI 10.1159/000131975; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; ROWLEY JD, 1990, CANCER RES, V50, P3816; SANDBERG AA, 1990, CHROMOSOMES HUMAN CA; TKACHUK DC, 1990, SCIENCE, V250, P559, DOI 10.1126/science.2237408; TRAUTMANN U, 1991, HUM GENET, V87, P495; TRENT JM, 1990, NEW ENGL J MED, V322, P1508, DOI 10.1056/NEJM199005243222107; TRENT JM, 1990, SCIENCE, V247, P568, DOI 10.1126/science.2300817; TRENT JM, 1983, CANCER GENET CYTOGEN, V9, P177, DOI 10.1016/0165-4608(83)90039-0; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WEINBERG RA, 1991, J NIH RES, V3, P45	31	241	254	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1992	1	1					24	28		10.1038/ng0492-24	http://dx.doi.org/10.1038/ng0492-24			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1301994				2022-12-25	WOS:A1992JC97800007
J	DESOUZA, AT; HANKINS, GR; WASHINGTON, MK; ORTON, TC; JIRTLE, RL				DESOUZA, AT; HANKINS, GR; WASHINGTON, MK; ORTON, TC; JIRTLE, RL			M6P/IGF2R GENE IS MUTATED IN HUMAN HEPATOCELLULAR CARCINOMAS WITH LOSS OF HETEROZYGOSITY	NATURE GENETICS			English	Note							FACTOR-II RECEPTOR; MANNOSE 6-PHOSPHATE BINDING; FACTOR TYPE-2 RECEPTOR; GROWTH-FACTOR; IGF-II; MOUSE		DUKE UNIV,MED CTR,DEPT RADIAT ONCOL,DURHAM,NC 27710; ZENECA PHARMACEUT,DEPT SAFETY MED,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND; DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710	Duke University; Duke University								BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; CAUSIN C, 1988, BIOCHEM J, V252, P795, DOI 10.1042/bj2520795; CHRISTOFORI G, 1994, NATURE, V369, P414, DOI 10.1038/369414a0; DAHMS NM, 1993, J BIOL CHEM, V268, P5457; DAHMS NM, 1994, J BIOL CHEM, V269, P3802; DENNIS PA, 1991, P NATL ACAD SCI USA, V88, P580, DOI 10.1073/pnas.88.2.580; DESOUZA AT, 1995, ONCOGENE, V10, P1725; HARTSHORN MA, 1988, J ENDOCRINOL, V121, P221; HOROWITZ DS, 1994, TRENDS GENET, V10, P100, DOI 10.1016/0168-9525(94)90233-X; JIRTLE RL, 1994, CARCINOGENESIS, V15, P1473, DOI 10.1093/carcin/15.8.1473; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; LAUREYS G, 1988, GENOMICS, V3, P224, DOI 10.1016/0888-7543(88)90083-3; OGAWA O, 1993, HUM MOL GENET, V2, P2163, DOI 10.1093/hmg/2.12.2163; OSBORNE CK, 1989, MOL ENDOCRINOL, V3, P1701, DOI 10.1210/mend-3-11-1701; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; SINGER C, 1995, CANCER RES, V55, P2448; SZEBENYI G, 1994, GENOMICS, V19, P120, DOI 10.1006/geno.1994.1021; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; WESTLUND B, 1991, J BIOL CHEM, V266, P23233; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; YANG DY, 1991, CARCINOGENESIS, V12, P1893, DOI 10.1093/carcin/12.10.1893	22	324	330	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					447	449		10.1038/ng1295-447	http://dx.doi.org/10.1038/ng1295-447			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493029				2022-12-25	WOS:A1995TH62900026
J	HU, S; PATTATUCCI, AML; PATTERSON, C; LI, L; FULKER, DW; CHERNY, SS; KRUGLYAK, L; HAMER, DH				HU, S; PATTATUCCI, AML; PATTERSON, C; LI, L; FULKER, DW; CHERNY, SS; KRUGLYAK, L; HAMER, DH			LINKAGE BETWEEN SEXUAL ORIENTATION AND CHROMOSOME XQ28 IN MALES BUT NOT IN FEMALES	NATURE GENETICS			English	Article							MALE HOMOSEXUALITY	We have extended our analysis of the role of the long arm of the X chromosome (Xq28) in sexual orientation by DNA linkage analyses of two newly ascertained series of families that contained either two gay brothers or two lesbian sisters as well as heterosexual siblings. Linkage between the Xq28 markers and sexual orientation was detected for the gay male families but not for the lesbian families or for families that failed to meet defined inclusion criteria for the study of sex-linked sexual orientation. Our results corroborate the previously reported linkage between Xq28 and male homosexuality in selected kinships and suggest that this region contains a locus that influences individual variations in sexual orientation in men but not in women.	NCI, BIOCHEM LAB, BETHESDA, MD 20892 USA; UNIV COLORADO, INST BEHAV GENET, BOULDER, CO 80309 USA; MIT, WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Colorado System; University of Colorado Boulder; Massachusetts Institute of Technology (MIT); Whitehead Institute			Cherny, Stacey S/B-3315-2008; Hamer, Dean H/L-1248-2015	Cherny, Stacey S/0000-0002-0269-3352; Hamer, Dean H/0000-0002-6211-5781	NICHD NIH HHS [HD-27802, HD-11681] Funding Source: Medline; NIMH NIH HHS [MH-43899] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD027802] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD011681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043899] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAILEY JM, 1993, AM J PSYCHIAT, V150, P272; BAILEY JM, 1993, BEHAV GENET, V23, P313, DOI 10.1007/BF01067431; BAILEY JM, 1993, ARCH GEN PSYCHIAT, V50, P217; BAILEY JM, 1991, ARCH GEN PSYCHIAT, V48, P1089; Bell Alan P., 1981, SEXUAL PREFERENCE IT; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; CARDON LR, 1994, AM J HUM GENET, V55, P825; FISHER RA, 1954, STATISTICAL METHODS; FREIJE D, 1992, SCIENCE, V258, P1784, DOI 10.1126/science.1465614; FULKER DW, 1995, AM J HUM GENET, V56, P1224; FULKER DW, 1994, AM J HUM GENET, V54, P1092; Hamer D., 1994, SCI DESIRE; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; HAQQ CM, 1994, SCIENCE, V266, P1494, DOI 10.1126/science.7985018; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; KINSEY AC, 1948, SEXUAL BEHAVIOR HUMA; KINSEY AC, 1953, SEXUAL BEHAVIOR HUMA; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; KRUGLYAK L, 1995, AM J HUM GENET, V56, P1212; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; KVALOY K, 1994, HUM MOL GENET, V3, P771, DOI 10.1093/hmg/3.5.771; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LeVay Simon, 1993, SEXUAL BRAIN; PATTATUCCI AML, 1995, BEHAV GENET, V25, P407, DOI 10.1007/BF02253370; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PILLARD RC, 1986, ARCH GEN PSYCHIAT, V43, P808; PILLARD RC, 1990, KINSEY INST, V2, P88; RUTTER M, 1994, AM J MED GENET, V54, P185, DOI 10.1002/ajmg.1320540305; TRAN LD, 1994, SAGE USERS GUIDE REL; Tripp C. A., 1975, HOMOSEXUAL MATRIX; WANG LH, 1994, GENOMICS, V22, P590, DOI 10.1006/geno.1994.1432	32	195	199	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					248	256		10.1038/ng1195-248	http://dx.doi.org/10.1038/ng1195-248			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581447	Green Published			2022-12-25	WOS:A1995TC63900012
J	MUNDY, GR				MUNDY, GR			NO BONES ABOUT FLUORIDE	NATURE MEDICINE			English	Editorial Material							OSTEOPOROSIS				MUNDY, GR (corresponding author), UNIV TEXAS, HLTH SCI CTR, DEPT MED ENDOCRINOL & METAB, SAN ANTONIO, TX 78284 USA.							CHAVASSIEUX PM, 1985, CALCIFIED TISSUE INT, V37, P345, DOI 10.1007/BF02553699; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Kleerekoper M, 1991, Osteoporos Int, V1, P155, DOI 10.1007/BF01625446; LAU KHW, 1989, METABOLISM, V38, P858; PAK CYC, 1995, ANN INTERN MED, V123, P401, DOI 10.7326/0003-4819-123-6-199509150-00001; REEVE J, 1980, BMJ-BRIT MED J, V280, P1340, DOI 10.1136/bmj.280.6228.1340; RIGGS BL, 1990, NEW ENGL J MED, V322, P802, DOI 10.1056/NEJM199003223221203; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O	8	8	8	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	1995	1	11					1130	1131		10.1038/nm1195-1130	http://dx.doi.org/10.1038/nm1195-1130			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584977				2022-12-25	WOS:A1995TC53700029
J	GRAINGER, DJ; WITCHELL, CM; METCALFE, JC				GRAINGER, DJ; WITCHELL, CM; METCALFE, JC			TAMOXIFEN ELEVATES TRANSFORMING GROWTH-FACTOR-BETA AND SUPPRESSES DIET-INDUCED FORMATION OF LIPID LESIONS IN MOUSE AORTA	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE CELLS; HIGH-DENSITY LIPOPROTEIN; BREAST-CANCER; ATHEROSCLEROSIS SUSCEPTIBILITY; MICE; HYPERCHOLESTEROLEMIA; PROLIFERATION; CHOLESTEROL; OSTEOPONTIN; INHIBITION	When C57B16 male mice are fed a high-fat diet, they develop significant fatty streak lesions in the aorta. Addition of tamoxifen (TMX) to a high-fat diet, equivalent to a dose of approximately 1 mg TMX per kg body weight per day, suppressed the diet-induced increase in the area of lipid staining in the aortic sinus of the mice by 88% and in the average number of lesions by 86%. The TMX-treated mice had 11% +/- 5% less total plasma cholesterol, with most of the reduction in the high density lipoprotein fraction, whereas plasma triglycerides were significantly elevated, and circulating concentrations of 17 beta-estradiol and testosterone were unaffected. Both circulating and aortic concentrations of active and latent transforming growth factor-beta (TGF-beta) were substantially elevated by TMX. The inhibition of lesion formation may be due, at least in part, to cardiovascular protection by TGF-beta.			GRAINGER, DJ (corresponding author), UNIV CAMBRIDGE,DEPT BIOCHEM,TENNIS COURT RD,CAMBRIDGE CB2 1QW,ENGLAND.							ALLAIN CC, 1974, CLIN CHEM, V20, P470; BERTELLI G, 1988, BREAST CANCER RES TR, V12, P307, DOI 10.1007/BF01811244; BUTTA A, 1992, CANCER RES, V52, P4261; CALEFFI M, 1988, J ENDOCRINOL, V119, P335, DOI 10.1677/joe.0.1190335; COLLETTA AA, 1991, J CLIN INVEST, V87, P277, DOI 10.1172/JCI114983; COLLETTA AA, 1990, BRIT J CANCER, V62, P405, DOI 10.1038/bjc.1990.307; EMESON EE, 1993, AM J PATHOL, V142, P1906; FURR BJA, 1984, PHARMACOL THERAPEUT, V25, P127, DOI 10.1016/0163-7258(84)90043-3; GIACHELLI C, 1991, BIOCHEM BIOPH RES CO, V177, P867, DOI 10.1016/0006-291X(91)91870-I; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GRAINGER DJ, 1993, BIOCHEM J, V294, P109, DOI 10.1042/bj2940109; GRAINGER DJ, 1995, NAT MED, V1, P74, DOI 10.1038/nm0195-74; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; GRAINGER DJ, 1995, CLIN CHIM ACTA, V235, P11, DOI 10.1016/0009-8981(94)05995-4; GRAINGER DJ, 1993, SCIENCE, V260, P1655, DOI 10.1126/science.8503012; GRAINGER DJ, IN PRESS BIOL REV; HURSTING SD, 1994, P NATL ACAD SCI USA, V91, P7035; KIRSCHENLOHR HL, 1993, AM J PHYSIOL, V265, pC571, DOI 10.1152/ajpcell.1993.265.2.C571; KOJIMA S, 1991, J CELL BIOL, V113, P1439, DOI 10.1083/jcb.113.6.1439; KUBO C, 1992, P SOC EXP BIOL MED, V201, P192, DOI 10.3181/00379727-201-43498; LOVE RR, 1990, JNCI-J NATL CANCER I, V82, P1327, DOI 10.1093/jnci/82.16.1327; MACDONALD CC, 1991, BRIT MED J, V303, P435; OBRIAN CA, 1986, J NATL CANCER I, V76, P1243; PAIGEN B, 1985, CANCER RES, V45, P3850; PAIGEN B, 1987, ATHEROSCLEROSIS, V64, P215, DOI 10.1016/0021-9150(87)90249-8; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; PAIGEN B, 1990, ARTERIOSCLEROSIS, V10, P316, DOI 10.1161/01.ATV.10.2.316; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P313; PASZTY C, 1994, J CLIN INVEST, V94, P899, DOI 10.1172/JCI117412; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; ROWLANDS MG, 1990, BIOCHEM PHARMACOL, V40, P283, DOI 10.1016/0006-2952(90)90689-I; SHANAHAN CM, 1994, J CLIN INVEST, V93, P2393, DOI 10.1172/JCI117246; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; SHEWMON DA, 1994, ARTERIOSCLER THROMB, V14, P1586, DOI 10.1161/01.ATV.14.10.1586; STEWARTPHILLIPS JL, 1991, ATHEROSCLEROSIS, V90, P211, DOI 10.1016/0021-9150(91)90117-L; VANLEEUWEN FE, 1994, LANCET, V343, P448, DOI 10.1016/S0140-6736(94)92692-1; WILLIAMS PT, 1994, METABOLISM, V43, P655, DOI 10.1016/0026-0495(94)90210-0; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210	40	121	135	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	OCT	1995	1	10					1067	1073		10.1038/nm1095-1067	http://dx.doi.org/10.1038/nm1095-1067			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489365				2022-12-25	WOS:A1995RX95100049
J	LYNCH, SA; BOND, PM; COPP, AJ; KIRWAN, WO; NOUR, S; BALLING, R; MARIMAN, E; BURN, J; STRACHAN, T				LYNCH, SA; BOND, PM; COPP, AJ; KIRWAN, WO; NOUR, S; BALLING, R; MARIMAN, E; BURN, J; STRACHAN, T			A GENE FOR AUTOSOMAL-DOMINANT SACRAL AGENESIS MAPS TO THE HOLOPROSENCEPHALY REGION AT 7Q36	NATURE GENETICS			English	Letter							SPINA-BIFIDA; MALFORMATIONS; MOUSE; ABNORMALITIES; FAMILY		UNIV LONDON,INST CHILD HLTH,LONDON WC1N 1EH,ENGLAND; CORK REG HOSP,DEPT PAEDIAT,CORK,IRELAND; GSF FORSCHUNGSZENTRUM UNWELT & GESUNDHEIT GMBH,INST SAUGETIERGENET,D-85764 OBERSCHLEISSHEIM,GERMANY; CATHOLIC UNIV NIJMEGEN,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS	University of London; University College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Radboud University Nijmegen	LYNCH, SA (corresponding author), UNIV NEWCASTLE UPON TYNE,DEPT HUMAN GENET,NEWCASTLE TYNE NE2 4AA,TYNE & WEAR,ENGLAND.		Copp, Andrew/C-4174-2008; Balling, Rudi/E-9680-2010	Copp, Andrew/0000-0002-2544-9117; Balling, Rudi/0000-0003-2902-5650; Lynch, Sally Ann/0000-0003-3540-1333; Burn, John/0000-0002-9823-2322				ALLES AJ, 1990, DEVELOPMENT, V108, P73; ATTWOOD J, 1988, ANN HUM GENET, V52, P259, DOI 10.1111/j.1469-1809.1988.tb01103.x; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CASEY B, 1993, NAT GENET, V5, P403, DOI 10.1038/ng1293-403; CHATKUPT S, 1994, AM J MED GENET, V52, P1, DOI 10.1002/ajmg.1320520102; Chesley P, 1935, J EXP ZOOL, V70, P429, DOI 10.1002/jez.1400700306; COHEN MM, 1992, J CRAN GENET DEV BIO, V12, P196; COPP AJ, 1989, J MED GENET, V26, P160, DOI 10.1136/jmg.26.3.160; CURRARINO G, 1981, AM J ROENTGENOL, V137, P395, DOI 10.2214/ajr.137.2.395; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; FELLOUS M, 1982, AM J MED GENET, V12, P465, DOI 10.1002/ajmg.1320120410; GREEN ED, 1994, HUM MOL GENET, V3, P489, DOI 10.1093/hmg/3.3.489; GURRIERI F, 1993, NAT GENET, V3, P247, DOI 10.1038/ng0393-247; HEUTINK P, 1994, NAT GENET, V6, P287, DOI 10.1038/ng0394-287; KALTER H, 1993, CLIN GENET, V43, P174, DOI 10.1111/j.1399-0004.1993.tb04443.x; KOSEKI H, 1993, DEVELOPMENT, V119, P649; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; MARTIN AO, 1977, CLIN GENET, V12, P65; MORICHONDELVALL.N, 1993, J MED GENET, V30, P521; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; Muenke Maximilian, 1994, Seminars in Developmental Biology, V5, P293, DOI 10.1006/sedb.1994.1038; MULLER F, 1987, ANAT EMBRYOL, V176, P413, DOI 10.1007/BF00310083; NOUR S, 1989, ARCH DIS CHILD, V64, P1618, DOI 10.1136/adc.64.11.1618; ORIORDAIN DS, 1991, BRIT J SURG, V78, P536, DOI 10.1002/bjs.1800780507; PANG D, 1993, NEUROSURGERY, V32, P755, DOI 10.1227/00006123-199305000-00009; SAY B, 1975, HUMANGENETIK, V27, P231, DOI 10.1007/BF00278350; SAY B, 1968, LANCET, V2, P688; TAM PPL, 1984, J EMBRYOL EXP MORPH, V82, P253; TSUI LC, 1995, CYTOGENET CELL GENET, V71, P1, DOI 10.1159/000134055; TSUKUROV O, 1994, NAT GENET, V6, P282, DOI 10.1038/ng0394-282; 1995, COOPERATIVE HUMAN LI; 1995, ENCY MOUSE GENOME EL; 1994, HUMAN CYTOGENETICS D	34	114	119	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					93	95		10.1038/ng0995-93	http://dx.doi.org/10.1038/ng0995-93			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550324	Green Submitted			2022-12-25	WOS:A1995RR72800023
J	MUNE, T; ROGERSON, FM; NIKKILA, H; AGARWAL, AK; WHITE, PC				MUNE, T; ROGERSON, FM; NIKKILA, H; AGARWAL, AK; WHITE, PC			HUMAN HYPERTENSION CAUSED BY MUTATIONS IN THE KIDNEY ISOZYME OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE	NATURE GENETICS			English	Article							APPARENT MINERALOCORTICOID EXCESS; 11 BETA-DEHYDROGENASE; CORTICOSTEROID 11-BETA-DEHYDROGENASE; DIMETHYL-SULFOXIDE; MOLECULAR-BASIS; DEFICIENCY; EXPRESSION; METABOLISM; CORTISOL; GENE	The syndrome of apparent mineralocorticoid excess (AME) is an inherited form of human hypertension thought to result from a deficiency of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD). This enzyme normally converts cortisol to inactive cortisone and is postulated to thus confer specificity for aldosterone upon the mineralocorticoid receptor. We have analysed the gene encoding the kidney isozyme of 11 beta HSD and found mutations on both alleles in nine of 11 AME patients (eight of nine kindreds). These mutations markedly affect enzymatic activity. They thus permit cortisol to occupy the renal mineralocorticoid receptor and thereby cause sodium retention and hypertension.	UNIV TEXAS,SW MED CTR,DIV PEDIAT ENDOCRINOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034400, R01DK042169] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42169, DK34400] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGARWAL AK, 1995, BBA-PROTEIN STRUCT M, V1248, P70, DOI 10.1016/0167-4838(95)00005-F; AGARWAL AK, 1994, J BIOL CHEM, V269, P25959; AGARWAL AK, 1990, MOL ENDOCRINOL, V4, P1827, DOI 10.1210/mend-4-12-1827; AGARWAL AK, 1989, J BIOL CHEM, V264, P18939; AGARWAL AK, IN PRESS GENOMICS; ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, pR11, DOI 10.1016/0303-7207(94)90176-7; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; BALVAY L, 1993, BIOESSAYS, V15, P165, DOI 10.1002/bies.950150304; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; BENNEDIKTSSON R, 1993, LANCET, V341, P339; BROWN RW, 1993, ENDOCRINOLOGY, V132, P2614, DOI 10.1210/en.132.6.2614; DIMARTINONARDI J, 1987, CLIN ENDOCRINOL, V27, P49, DOI 10.1111/j.1365-2265.1987.tb00838.x; EDWARDS CRW, 1988, LANCET, V2, P986, DOI 10.1016/S0140-6736(88)90742-8; FILICHKIN SA, 1992, BIOTECHNIQUES, V12, P828; FUNDER JW, 1988, SCIENCE, V242, P583, DOI 10.1126/science.2845584; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; HANSSON JH, IN PRESS NATURE GENE; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KAGIMOTO M, 1988, MOL ENDOCRINOL, V2, P564, DOI 10.1210/mend-2-6-564; KORNEL L, 1969, J CLIN ENDOCR METAB, V29, P1608, DOI 10.1210/jcem-29-12-1608; KROZOWSKI Z, 1990, ENDOCRINOLOGY, V127, P3009, DOI 10.1210/endo-127-6-3009; KROZOWSKI ZS, 1983, P NATL ACAD SCI-BIOL, V80, P6056, DOI 10.1073/pnas.80.19.6056; LAKSHMI V, 1988, ENDOCRINOLOGY, V123, P2390, DOI 10.1210/endo-123-5-2390; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; MONDER C, 1986, J CLIN ENDOCR METAB, V63, P550, DOI 10.1210/jcem-63-3-550; MONDER C, 1990, ENDOCRINOLOGY, V126, P2435, DOI 10.1210/endo-126-5-2435; MONDER C, 1993, VITAM HORM, V47, P187, DOI 10.1016/S0083-6729(08)60447-1; NEW MI, 1977, J CLIN ENDOCR METAB, V44, P924, DOI 10.1210/jcem-44-5-924; NIKKILA H, 1993, J CLIN ENDOCR METAB, V77, P687, DOI 10.1210/jc.77.3.687; OBEID J, 1992, BIOCHEM BIOPH RES CO, V188, P222, DOI 10.1016/0006-291X(92)92373-6; OBERFIELD SE, 1983, J CLIN ENDOCR METAB, V56, P332, DOI 10.1210/jcem-56-2-332; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P8327, DOI 10.1073/pnas.89.17.8327; RUSVAI E, 1993, J BIOL CHEM, V268, P10717; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANN L, 1976, J CLIN ENDOCR METAB, V43, P265, DOI 10.1210/jcem-43-2-265; SHACKLETON CHL, 1980, J CLIN ENDOCR METAB, V50, P786, DOI 10.1210/jcem-50-4-786; SHACKLETON CHL, 1985, CLIN ENDOCRINOL, V22, P701, DOI 10.1111/j.1365-2265.1985.tb00160.x; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; SORO A, 1995, HYPERTENSION, V25, P67, DOI 10.1161/01.HYP.25.1.67; SPEISER PW, 1992, J CLIN INVEST, V90, P584, DOI 10.1172/JCI115897; STEWART PM, 1988, J CLIN INVEST, V82, P340, DOI 10.1172/JCI113592; STEWART PM, 1987, LANCET, V2, P821; STEWART PM, 1995, J CLIN ENDOCR METAB, V80, P885, DOI 10.1210/jc.80.3.885; TANNIN GM, 1991, J BIOL CHEM, V266, P16653; ULICK S, 1979, J CLIN ENDOCR METAB, V49, P757, DOI 10.1210/jcem-49-5-757; ULICK S, 1977, J CLIN ENDOCR METAB, V44, P799, DOI 10.1210/jcem-44-4-799; ULICK S, 1992, J CLIN ENDOCR METAB, V74, P593, DOI 10.1210/jc.74.3.593; ULICK S, 1989, J STEROID BIOCHEM, V32, P209, DOI 10.1016/0022-4731(89)90166-0; WALKER BR, 1993, CLIN ENDOCRINOL, V39, P221, DOI 10.1111/j.1365-2265.1993.tb01778.x; Ward Ryk, 1995, P67; WERDER E, 1974, RES STEROIDS, V6, P385; WHITE PC, 1991, J CLIN INVEST, V87, P1664, DOI 10.1172/JCI115182; WINSHIP PR, 1989, NUCLEIC ACIDS RES, V17, P1266, DOI 10.1093/nar/17.3.1266; WINTER JSD, 1977, JUVENILE HYPERTENSIO, P123; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	57	519	528	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					394	399		10.1038/ng0895-394	http://dx.doi.org/10.1038/ng0895-394			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670488				2022-12-25	WOS:A1995RM37500011
J	HECHT, JT; NELSON, LD; CROWDER, E; WANG, Y; ELDER, FFB; HARRISON, WR; FRANCOMANO, CA; PRANGE, CK; LENNON, GG; DEERE, M; LAWLER, J				HECHT, JT; NELSON, LD; CROWDER, E; WANG, Y; ELDER, FFB; HARRISON, WR; FRANCOMANO, CA; PRANGE, CK; LENNON, GG; DEERE, M; LAWLER, J			MUTATIONS IN EXON 17B OF CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) CAUSE PSEUDOACHONDROPLASIA	NATURE GENETICS			English	Article							THROMBOSPONDIN; EXPRESSION; DYSPLASIA; DOMINANT; COLLAGEN; BINDING; GENE	Pseudoachondroplasia (PSACH) is a well characterized dwarfing condition mapping to chromosome 19p12-13.1. Cartilage oligomeric matrix protein (COMP), a cartilage specific protein, maps to the same location within a contig that spans the PSACH locus. Using single strand conformation polymorphism (SSCP) analysis and nucleotide sequencing we have identified COMP mutations in eight familiar and isolated PSACH cases. All mutations involve either a single base-pair change or a three base-pair deletion in exon 17B. Six mutations delete or change a well conserved aspartic acid residue within the calcium-binding type 3 repeats. These results demonstrate that mutations in the COMP gene cause pseudochondroplasia.	UNIV TEXAS,SCH MED,DEPT PATHOL,HOUSTON,TX 77225; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892; LAWRENCE LIVERMORE NATL LAB,CTR HUMAN GENOME,LIVERMORE,CA 94551; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT PATHOL,DIV VASC RES,BOSTON,MA 02115	University of Texas System; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Harvard University; Brigham & Women's Hospital; Harvard Medical School	HECHT, JT (corresponding author), UNIV TEXAS,SCH MED,DEPT PEDIAT,POB 20708,HOUSTON,TX 77225, USA.		Lawler, Jack/AAJ-1379-2020; Lennon, Greg/T-4717-2019		NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049081] Funding Source: NIH RePORTER; NCI NIH HHS [CA16672] Funding Source: Medline; NHLBI NIH HHS [HL49081] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS J, 1993, CURR BIOL, V3, P188, DOI 10.1016/0960-9822(93)90270-X; BORNSTEIN P, 1993, GENOMICS, V15, P607, DOI 10.1006/geno.1993.1114; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; BRIGGS MD, 1993, GENOMICS, V18, P656, DOI 10.1016/S0888-7543(05)80369-6; COOPER RR, 1973, J BONE JOINT SURG AM, VA 55, P475, DOI 10.2106/00004623-197355030-00003; DICESAREPE, 1994, EUR J BIOCHEM, V223, P927; ELLARD JT, 1989, TEX SOC EL MICR; FINKELSTEIN JE, 1991, AM J HUM GENET, V48, P97; GELLIS SS, 1974, AM J DIS CHILD, V128, P833, DOI 10.1001/archpedi.1974.02110310081015; GUO NH, 1992, J BIOL CHEM, V267, P19349; HALL JG, 1987, AM J MED GENET, V28, P143, DOI 10.1002/ajmg.1320280121; HECHT JT, 1993, GENOMICS, V18, P661, DOI 10.1016/S0888-7543(05)80370-2; HECHT JT, 1992, AM J MED GENET, V44, P420, DOI 10.1002/ajmg.1320440406; HEDBOM E, 1992, J BIOL CHEM, V267, P6132; Heinegard Dick, 1993, P189; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; Knowlton R. G., 1994, American Journal of Human Genetics, V55, pA190; KNOWLTON RG, 1994, AM J HUM GENET, V55, P1106; Kretsinger R H, 1980, Ann N Y Acad Sci, V356, P14, DOI 10.1111/j.1749-6632.1980.tb29594.x; LAWLER J, 1983, J BIOL CHEM, V258, P2098; LAWLER J, 1992, BIOCHEMISTRY-US, V31, P1173, DOI 10.1021/bi00119a029; LAWLER J, 1995, MOL BASIS THROMBOSIS; MAYNARD JA, 1972, LAB INVEST, V26, P40; MEWAR R, 1993, CYTOGENET CELL GENET, V64, P1, DOI 10.1159/000133547; MISENHEIMER TM, 1995, J BIOL CHEM, V270, P1729, DOI 10.1074/jbc.270.4.1729; MORGELIN M, 1992, J BIOL CHEM, V267, P6137; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; PEDRINIMILLE A, 1984, J BONE JOINT SURG AM, V66A, P1408, DOI 10.2106/00004623-198466090-00014; PROCKOP DJ, 1984, AM J HUM GENET, V36, P499; QABAR AN, 1994, J BIOL CHEM, V269, P1262; SAGE EH, 1991, J BIOL CHEM, V266, P14831; Sambrook J, 1989, MOL CLONING LABORATO; SPRANGER J, 1974, BONE DYSPLASIA ATLAS; STANESCU R, 1993, AM J MED GENET, V45, P501, DOI 10.1002/ajmg.1320450420; STANESCU V, 1994, AM J MED GENET, V51, P22, DOI 10.1002/ajmg.1320510106; WYNNEDAVIES R, 1986, J MED GENET, V23, P425, DOI 10.1136/jmg.23.5.425	37	297	304	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					325	329		10.1038/ng0795-325	http://dx.doi.org/10.1038/ng0795-325			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670471				2022-12-25	WOS:A1995RG38600017
J	MIGCHIELSEN, AAJ; BREUER, ML; VANROON, MA; RIELE, HT; ZURCHER, C; OSSENDORP, F; TOUTAIN, S; HERSHFIELD, MS; BERNS, A; VALERIO, D				MIGCHIELSEN, AAJ; BREUER, ML; VANROON, MA; RIELE, HT; ZURCHER, C; OSSENDORP, F; TOUTAIN, S; HERSHFIELD, MS; BERNS, A; VALERIO, D			ADENOSINE-DEAMINASE-DEFICIENT MICE DIE PERINATALLY AND EXHIBIT LIVER-CELL DEGENERATION, ATELECTASIS AND SMALL-INTESTINAL CELL-DEATH	NATURE GENETICS			English	Article							S-ADENOSYLHOMOCYSTEINE HYDROLASE; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOMA CELLS; DEOXYADENOSINE METABOLISM; HOMOCYSTEINE HYDROLASE; PATHOLOGIC FINDINGS; TISSUE ALTERATIONS; MOUSE; EXPRESSION; 2'-DEOXYCOFORMYCIN	We report the generation and characterization of mice lacking adenosine deaminase (ADA). in humans, absence of ADA causes severe combined immunodeficiency. In contrast, ADA-deficient mice die perinatally with marked liver-cell degeneration, but lack abnormalities in the thymus. The ADA substrates, adenosine and deoxyadenosine, are increased in ADA-deficient mice. Adenine deoxyribonucleotides are only modestly elevated, whereas S-adenosylhomocysteine hydrolase activity is reduced more than 85%. Consequently, the ratio of S-adenosylhomocysteine (AdoMet) to S-adenosyl homocysteine (AdoHcy) is reduced threefold in liver. We conclude that ADA plays a more critical role in murine than human fetal development. me murine liver pathology may be due to AdoHcy-mediated inhibition of AdoMet-dependent transmethylation reactions.	LEIDEN UNIV, SYLVIUS LABS, MOLEC CARCINOGENESIS LAB, GENE THERAPY WORKING GRP, 2300 RA LEIDEN, NETHERLANDS; NETHERLANDS CANC INST, DIV MOLEC GENET, 1066 CX AMSTERDAM, NETHERLANDS; TNO, BIOMED PRIMATE RES CTR, 2280 HV RIJSWIJK, NETHERLANDS; ACAD HOSP LEIDEN, IMMUNOHEMATOL & BLOODBANK, LEIDEN, NETHERLANDS; DUKE UNIV, MED CTR, DEPT RHEUMATOL & IMMUNOL, DURHAM, NC 27710 USA; INTROGENE BV, 2280 GG RYSWIJK, NETHERLANDS	Leiden University; Leiden University - Excl LUMC; Netherlands Cancer Institute; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Duke University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020902] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK20902] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; AKESON AL, 1988, J BIOL CHEM, V263, P16291; ARONOW B, 1989, GENE DEV, V3, P1384, DOI 10.1101/gad.3.9.1384; ARREDONDOVEGA FX, 1990, J CLIN INVEST, V86, P444, DOI 10.1172/JCI114730; BERKVENS TM, 1990, GENOMICS, V7, P486, DOI 10.1016/0888-7543(90)90190-6; BONTEMPS F, 1993, BIOCHEM J, V290, P671, DOI 10.1042/bj2900671; BUCHOU T, 1993, ONCOGENE, V8, P1765; CARSON DA, 1980, J IMMUNOL, V124, P8; CHINSKY JM, 1990, DIFFERENTIATION, V42, P172, DOI 10.1111/j.1432-0436.1990.tb00759.x; COHEN A, 1978, P NATL ACAD SCI USA, V75, P472, DOI 10.1073/pnas.75.1.472; COLEMAN MS, 1978, J BIOL CHEM, V253, P1619; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207, DOI 10.1016/S0065-2776(08)60643-4; GAO X, 1994, TERATOLOGY, V49, P1, DOI 10.1002/tera.1420490103; GIBLETT ER, 1972, LANCET, V2, P1067; GREENBERG ML, 1989, J BIOL CHEM, V264, P795; GROSVELD FG, 1982, NUCLEIC ACIDS RES, V10, P6715, DOI 10.1093/nar/10.21.6715; HELLAND S, 1983, CANCER RES, V43, P4142; HERSHFIELD MS, 1980, P NATL ACAD SCI-BIOL, V77, P4292, DOI 10.1073/pnas.77.7.4292; HERSHFIELD MS, 1979, J CLIN INVEST, V63, P807, DOI 10.1172/JCI109367; HERSHFIELD MS, 1979, J BIOL CHEM, V254, P22; HERSHFIELD MS, 1984, P NATL ACAD SCI-BIOL, V81, P253, DOI 10.1073/pnas.81.1.253; HERSHFIELD MS, 1985, BIOCHEM J, V230, P43, DOI 10.1042/bj2300043; HERSHFIELD MS, 1983, CANCER RES, V43, P3451; HERSHFIELD MS, 1982, J BIOL CHEM, V257, P6380; HERSHFIELD MS, 1994, MOL METABOLIC BASIS, P1725; HIRSCHHORN R, 1993, PEDIATR RES, V33, pS35; HIRSCHHORN R, 1990, Immunodeficiency Reviews, V2, P175; HIRSCHHORN R, 1980, J CLIN INVEST, V65, P768, DOI 10.1172/JCI109725; HOOGERBRUGGE PM, 1995, BRIT MED BULL, V51, P72, DOI 10.1093/oxfordjournals.bmb.a072954; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; KARLSSON A, 1994, J BIOL CHEM; KHAN PM, 1971, ARCH BIOCHEM BIOPHYS, V145, P470, DOI 10.1016/S0003-9861(71)80007-3; KIZAKI H, 1988, J IMMUNOL, V141, P1652; KREDICH NM, 1977, CELL, V12, P931, DOI 10.1016/0092-8674(77)90157-X; KREDICH NM, 1979, INBORN ERRORS SPECIF, P261; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LINCH DC, 1984, CLIN EXP IMMUNOL, V56, P223; Maniatis T., 1982, MOL CLONING; MARKERT ML, 1988, J CLIN INVEST, V81, P1323, DOI 10.1172/JCI113458; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; OLSSON RA, 1990, PHYSIOL REV, V70, P761, DOI 10.1152/physrev.1990.70.3.761; OSSENDORP F, 1992, J IMMUNOL, V148, P3714; RAMAMURTHY V, 1989, MOL CELLULAR MECHANI, P125; RATECH H, 1985, AM J PATHOL, V119, P65; RATECH H, 1985, AM J PATHOL, V120, P157; RATECH H, 1989, AM J PATHOL, V135, P1145; RIELE HT, 1990, NATURE, V348, P649, DOI 10.1038/348649a0; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; SANTISTEBAN I, 1993, J CLIN INVEST, V92, P2291, DOI 10.1172/JCI116833; SETO S, 1985, J CLIN INVEST, V75, P377, DOI 10.1172/JCI111710; SHOVLIN CL, 1994, J IMMUNOL, V153, P2331; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; STEWART CL, 1993, METHOD ENZYMOL, V225, P823; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; TEDDE A, 1980, P NATL ACAD SCI-BIOL, V77, P4899, DOI 10.1073/pnas.77.8.4899; ULLMAN B, 1981, J BIOL CHEM, V256, P848; ULLMAN B, 1978, CELL, V14, P365, DOI 10.1016/0092-8674(78)90122-8; WAINFAN E, 1992, CANCER RES, V52, pS2071; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; WITTE DP, 1991, J CELL BIOL, V115, P179, DOI 10.1083/jcb.115.1.179; WOLOS JA, 1993, J IMMUNOL, V150, P3264	61	102	106	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1995	10	3					279	287		10.1038/ng0795-279	http://dx.doi.org/10.1038/ng0795-279			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670465				2022-12-25	WOS:A1995RG38600010
J	TAKAYAMA, H; RAY, J; RAYMON, HK; BAIRD, A; HOGG, J; FISHER, LJ; GAGE, FH				TAKAYAMA, H; RAY, J; RAYMON, HK; BAIRD, A; HOGG, J; FISHER, LJ; GAGE, FH			BASIC FIBROBLAST GROWTH-FACTOR INCREASES DOPAMINERGIC GRAFT-SURVIVAL AND FUNCTION IN A RAT MODEL OF PARKINSONS-DISEASE	NATURE MEDICINE			English	Article							EXTRACELLULAR-MATRIX; NIGRAL TRANSPLANTS; FACTOR PROMOTES; NEURONS; ASTROCYTES; SECRETION; INVITRO; STIMULATION; PROSPECTS; TISSUE	The clinical use of fetal neural grafts as an intracerebral source of dopamine for patients with Parkinson's disease has, met with limited success. Since basic fibroblast growth factor (bFGF) enhances the survival and growth of dopaminergic neurons in vitro, we explored whether cells genetically modified to produce bFGF would improve the functional efficacy of dopaminergic neurons implanted into rats with experimental Parkinson's disease. Results show that bFGF-producing cells grafted together with fetal dopamine neurons have potent growth-promoting effects on the implanted neurons in vivo. Moreover, rats implanted with such co-grafts display the most pronounced behavioural improvements post-grafting. These findings not only provide insight into the function of bFGF in situ, but also suggest an approach for enhancing the survival and function of dopamine neurons grafted into the damaged brain.	UNIV CALIF SAN DIEGO, DEPT NEUROSCI, LA JOLLA, CA 92093 USA; WHITTIER INST DIABET & ENDOCRINOL, LA JOLLA, CA 92037 USA	University of California System; University of California San Diego				Baird, Andrew/0000-0003-0027-9905	NIA NIH HHS [AG10435, AG08514] Funding Source: Medline; NIDDK NIH HHS [DK18811] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK018811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008514, P01AG010435, R37AG008514] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; AHLSKOG JE, 1993, MAYO CLIN PROC, V68, P578, DOI 10.1016/S0025-6196(12)60373-5; BAIRD A, 1987, BIOCHEM BIOPH RES CO, V142, P428, DOI 10.1016/0006-291X(87)90292-0; Baird A., 1991, PEPTIDE GROWTH FACTO, V1, P369; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; BLAM SB, 1988, ONCOGENE, V3, P129; BRUNDIN P, 1985, BRAIN RES, V331, P251, DOI 10.1016/0006-8993(85)91550-1; Brundin P, 1987, PROG BRAIN RES <D>, V71, P293; ENGELE J, 1991, J NEUROSCI, V11, P3070; FINGER S, 1989, EXP NEUROL, V104, P1, DOI 10.1016/0014-4886(89)90001-0; FLAUMENHAFT R, 1989, J CELL PHYSIOL, V140, P75, DOI 10.1002/jcp.1041400110; GONZALEZ AM, IN PRESS BRAIN RES; KAWAJA MD, 1992, J COMP NEUROL, V317, P102, DOI 10.1002/cne.903170108; KAWAJA MD, 1992, NEURAL TRANSPLANTATI, P21; KNUSEL B, 1990, J NEUROSCI, V10, P558; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDVALL O, 1991, TRENDS NEUROSCI, V14, P376, DOI 10.1016/0166-2236(91)90167-S; MATSUDA S, 1992, JAPAN J PHARM, V69, P365; MAYER E, 1993, NEUROSCIENCE, V56, P389, DOI 10.1016/0306-4522(93)90340-L; MAYER E, 1993, NEUROSCIENCE, V56, P379, DOI 10.1016/0306-4522(93)90339-H; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; RAY J, 1995, J NEUROCHEM, V64, P503; REDMOND DE, 1990, LANCET, V336, P820, DOI 10.1016/0140-6736(90)93294-Y; SAWLE GV, 1992, ANN NEUROL, V31, P166, DOI 10.1002/ana.410310207; SCHMIDT RH, 1983, ACTA PHYSIOL SCAND, P19; SHIMASAKI S, 1988, BIOCHEM BIOPH RES CO, V157, P256, DOI 10.1016/S0006-291X(88)80041-X; STEINBUSCH HWM, 1990, PROG BRAIN RES, V82, P81; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; YOSHIDA K, 1992, J NEUROCHEM, V59, P919, DOI 10.1111/j.1471-4159.1992.tb08331.x; YOSHIDA K, 1991, BRAIN RES, V538, P118, DOI 10.1016/0006-8993(91)90385-9; YOSHIDA K, 1992, BRAIN RES, V569, P14, DOI 10.1016/0006-8993(92)90364-F	31	175	185	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	1995	1	1					53	58		10.1038/nm0195-53	http://dx.doi.org/10.1038/nm0195-53			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX557	7584953				2022-12-25	WOS:A1995QX55700026
J	FRIEDMAN, LS; OSTERMEYER, EA; SZABO, CI; DOWD, P; LYNCH, ED; ROWELL, SE; KING, MC				FRIEDMAN, LS; OSTERMEYER, EA; SZABO, CI; DOWD, P; LYNCH, ED; ROWELL, SE; KING, MC			CONFIRMATION OF BRCA1 LAY ANALYSIS OF GERMLINE MUTATIONS LINKED TO BREAST AND OVARIAN-CANCER IN 10 FAMILIES	NATURE GENETICS			English	Article								We provide genetic evidence supporting the identity of the candidate gene for BRCA1 through the characterization of germline mutations in 63 breast cancer patients and 10 ovarian cancer patients in ten families with cancer linked to chromosome 17g21. Nine different mutations were detected by screening BRCA1 DNA and RNA by single-strand conformation polymorphism analysis and direct sequencing. Seven mutations lead to protein truncations at sites throughout the gene. One missense mutation (which occurred independently in two families) leads to loss of a cysteine in the zinc binding domain. An intronic single basepair substitution destroys an acceptor site and activates a cryptic splice site, leading to a 59 basepair insertion and chain termination. The four families with both breast and ovarian cancer had chain termination mutations in the N-terminal half of the protein.	UNIV CALIF BERKELEY,SCH PUBL HLTH,BERKELEY,CA 94720	University of California System; University of California Berkeley	FRIEDMAN, LS (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,229 STANLEY HALL,BERKELEY,CA 94720, USA.			King, Mary-Claire/0000-0001-9426-1743	NCI NIH HHS [R01 CA27632] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALBERTSEN HM, 1994, NAT GENET, V7, P472, DOI 10.1038/ng0894-472; ARENA JF, IN PRESS J AM MED AS; FRIEDMAN LS, IN PRESS CANCER RES; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; ROWELL S, 1994, AM J HUM GENET, V55, P861; SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9; 1994, AM J HUM GENET, V55, P860	8	562	593	0	34	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					399	404		10.1038/ng1294-399	http://dx.doi.org/10.1038/ng1294-399			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894493				2022-12-25	WOS:A1994PV68200023
J	PIGG, M; JAGELL, S; SILLEN, A; WEISSENBACH, J; GUSTAVSON, KH; WADELIUS, C				PIGG, M; JAGELL, S; SILLEN, A; WEISSENBACH, J; GUSTAVSON, KH; WADELIUS, C			THE SJOGREN-LARSSON SYNDROME GENE IS CLOSE TO D17S805 AS DETERMINED BY LINKAGE ANALYSIS AND ALLELIC ASSOCIATION	NATURE GENETICS			English	Article							NEUROFIBROMATOSIS; SWEDEN; CELLS	Sjogren-Larsson Syndrome (SLS) is characterized by congenital ichthyosis, spastic di- or tetraplegia and mental retardation. It is an autosomal recessive trait that is frequent in the northern part of Sweden. Based on linkage analysis and allelic association, the disorder has now been mapped to chromosome 17. Meiotic recombinations suggest that the gene is flanked by D17S805 on the centromeric and D17S783, D17S959, D17S842 and D17S925 on the telomeric side. These markers map to the same location in reference pedigrees. Strong allelic association (chi-square 60.28, p<0.0003) to D17S805 suggests that the mutation is located close to this marker.	UNIV UPPSALA HOSP,DEPT CLIN GENET,S-75185 UPPSALA,SWEDEN; GENETHON,F-91000 EVRY,FRANCE	Uppsala University; Uppsala University Hospital								BARKER D, 1987, SCIENCE, V236, P1100, DOI 10.1126/science.3107130; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; DURSO M, 1990, GENOMICS, V7, P531, DOI 10.1016/0888-7543(90)90196-2; GNIRKE A, 1993, GENOMICS, V15, P659, DOI 10.1006/geno.1993.1121; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; ISELIUS L, 1989, CLIN GENET, V35, P272; JAGELL S, 1981, CLIN GENET, V19, P233; JAGELL S, 1981, SJOGREN LARSSON SYND; KELSON TL, 1992, J INHERIT METAB DIS, V15, P105, DOI 10.1007/BF01800352; LATHROP GM, 1988, GENOMICS, V2, P157; LAZARO C, 1993, HUM GENET, V92, P429, DOI 10.1007/BF01247353; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; MORTON NE, 1981, HUM GENET, V57, P420, DOI 10.1007/BF00281696; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; RIZZO WB, 1989, J PEDIATR-US, V115, P228, DOI 10.1016/S0022-3476(89)80070-8; RIZZO WB, 1991, J CLIN INVEST, V88, P1643, DOI 10.1172/JCI115478; Sjogren T, 1957, ACTA PSYCHIAT NEUROL, V32, P1	18	57	58	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					361	364		10.1038/ng1294-361	http://dx.doi.org/10.1038/ng1294-361			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894487				2022-12-25	WOS:A1994PV68200017
J	MULLAN, M; HOULDEN, H; WINDELSPECHT, M; FIDANI, L; LOMBARDI, C; DIAZ, P; ROSSOR, M; CROOK, R; HARDY, J; DUFF, K; CRAWFORD, F				MULLAN, M; HOULDEN, H; WINDELSPECHT, M; FIDANI, L; LOMBARDI, C; DIAZ, P; ROSSOR, M; CROOK, R; HARDY, J; DUFF, K; CRAWFORD, F			A LOCUS FOR FAMILIAL EARLY-ONSET ALZHEIMERS-DISEASE ON THE LONG ARM OF CHROMOSOME 14, PROXIMAL TO THE ALPHA-1-ANTICHYMOTRYPSIN GENE	NATURE GENETICS			English	Article							PROTEIN; MUTATION	Although mutations in the beta-amyloid precursor protein gene (APP) on chromosome 21 cause some cases of early-onset Alzheimer's disease (AD), most cases evidently do not have mutations in APP. We analysed ten early-onset families for linkage to APP and markers elsewhere in the genome. One family (F172) was consistent with linkage to chromosome 21 and was subsequently found to have an APP Val to Ile mutation. Of the others, all but one were consistent with linkage to markers in the middle long arm of chromosome 14. However, no family showed independent evidence of linkage with two point analysis and only one showed independent evidence of linkage on multipoint analysis. Therefore, we cannot rule out heterogeneity at these loci although tests for heterogeneity were not significant.	ST MARYS HOSP,SCH MED,DEPT BIOCHEM,LONDON W2 1PG,ENGLAND; ST MARYS HOSP,SCH MED,DEPT NEUROL,LONDON W2 1PG,ENGLAND	Imperial College London; Imperial College London	MULLAN, M (corresponding author), UNIV S FLORIDA,CTR PSYCHIAT,ALZHEIMERS DIS RES LABS,3515 E FLETCHER AVE,TAMPA,FL 33613, USA.		Hardy, John/C-2451-2009; Houlden, Henry J/C-1532-2008; Rossor, Martin/C-1598-2008	Hardy, John/0000-0002-3122-0423; Houlden, Henry J/0000-0002-2866-7777; Rossor, Martin/0000-0001-8215-3120; Mullan, Michael/0000-0002-1473-7527; Duff, Karen/0000-0002-6177-868X				ABE K, 1991, NEUROSCI LETT, V125, P169, DOI 10.1016/0304-3940(91)90019-P; ABRAHAM CR, 1988, CELL, V52, P487, DOI 10.1016/0092-8674(88)90462-X; COX DW, 1990, CYTOGENET CELL GENET, V55, P183, DOI 10.1159/000133010; FIDANI L, 1992, HUM MOL GENET, V1, P165, DOI 10.1093/hmg/1.3.165; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLENNER GG, 1989, J NEUROL SCI, V94, P1, DOI 10.1016/0022-510X(89)90214-1; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HARLIN MCC, 1991, NATURE, V353, P844; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; Ott J., 1991, ANAL HUMAN GENETIC L; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WEITKAMP LR, 1983, AM J HUM GENET, V35, P443; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729	20	257	276	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					340	342		10.1038/ng1292-340	http://dx.doi.org/10.1038/ng1292-340			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303291				2022-12-25	WOS:A1992KB49500022
J	OKUBO, K; HORI, N; MATOBA, R; NIIYAMA, T; FUKUSHIMA, A; KOJIMA, Y; MATSUBARA, K				OKUBO, K; HORI, N; MATOBA, R; NIIYAMA, T; FUKUSHIMA, A; KOJIMA, Y; MATSUBARA, K			LARGE-SCALE CDNA SEQUENCING FOR ANALYSIS OF QUANTITATIVE AND QUALITATIVE ASPECTS OF GENE-EXPRESSION	NATURE GENETICS			English	Article							CONSTRUCTION; LIBRARY; CLONING	Large scale sequencing of cDNAs provides a complementary approach to structural analysis of the human genome by generating expressed sequence tags (ESTs). We have initiated the large-scale sequencing of a 3'-directed cDNA library from the human liver cell line HepG2, that is a non-biased representation of the mRNA population. 982 random cDNA clones were sequenced yielding more than 270 kilobases. A significant portion of the identified genes encoded secretable proteins and components for protein-synthesis. The abundance of cDNA species varied from 2.2% to less than 0.004%. Fifty two percent of the mRNA were abundant species consisting of 173 genes and the rest were non-abundant, consisting of about 6,600 genes.	OSAKA UNIV,INST MOLEC & CELLULAR BIOL,1-3 YAMADA OKA,SUITA,OSAKA 565,JAPAN	Osaka University								ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; ALBERTS B, 1983, MOL BIOL CELL, P33; BISHOP JO, 1974, NATURE, V250, P199, DOI 10.1038/250199a0; DARLINGTON GJ, 1987, METHOD ENZYMOL, V151, P38; EHLERS MRW, 1989, P NATL ACAD SCI USA, V86, P7741, DOI 10.1073/pnas.86.20.7741; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; JAISWAL AK, 1988, J BIOL CHEM, V263, P13572; KO MSH, 1990, NUCLEIC ACIDS RES, V18, P5705, DOI 10.1093/nar/18.19.5705; KOLLER M, 1990, BIOCHIM BIOPHYS ACTA, V1087, P180, DOI 10.1016/0167-4781(90)90203-E; LEWIN B, 1980, GENE EXPRESSION, V2, P719; NAKAYAMA K, 1989, TRENDS GENET, V5, P325; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; Okubo K, 1991, DNA Seq, V2, P137, DOI 10.3109/10425179109039684; PATANJALI SR, 1991, P NATL ACAD SCI USA, V88, P1943, DOI 10.1073/pnas.88.5.1943; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SUKEGAWA J, 1987, MOL CELL BIOL, V7, P41, DOI 10.1128/MCB.7.1.41	19	454	498	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1992	2	3					173	179		10.1038/ng1192-173	http://dx.doi.org/10.1038/ng1192-173			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345164				2022-12-25	WOS:A1992JW16500004
J	AHUJA, SK; OZCELIK, T; MILATOVITCH, A; FRANCKE, U; MURPHY, PM				AHUJA, SK; OZCELIK, T; MILATOVITCH, A; FRANCKE, U; MURPHY, PM			MOLECULAR EVOLUTION OF THE HUMAN INTERLEUKIN-8 RECEPTOR GENE-CLUSTER	NATURE GENETICS			English	Article							PLATELET FACTOR-4; HUMAN-NEUTROPHILS; IL-1 RECEPTOR; EXPRESSION; CLONING; FAMILY; SUPERFAMILY; NUCLEOTIDE; PROTEINS; CYTOKINE	Interleukin-8 (IL-8) is the prototype for a family of at least eight neutrophil chemoattractants whose genes map to human chromosome 4q13-q21. Two human IL-8 receptors, IL8RA and IL8RB, are known from cDNA cloning; IL8RA is a promiscuous receptor for at least two other related ligands, GRO-alpha and NAP-2. We now report cloning of the genes for IL8RA, IL8RB and a recently inactivated pseudogene of receptor A (IL8RAP). These form a cluster of only three genes in the superfamily of G protein-coupled receptors (GPCRs) and map to 2q34-q35. The coevolutionary diversity displayed by the IL-8 ligand-receptor complex - ligand promiscuity for IL-8, receptor promiscuity for IL8RA, gene duplication for both ligands and receptors and gene extinction in the case of IL8RAP - is unprecedented for the GPCR superfamily.	NIAID,HOST DEF LAB,BETHESDA,MD 20892; STANFORD UNIV,MED CTR,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,MED CTR,DEPT GENET,STANFORD,CA 94305; STANFORD UNIV,MED CTR,DEPT PEDIAT,STANFORD,CA 94305	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University								BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; BAO L, 1992, Genomics, V13, P437, DOI 10.1016/0888-7543(92)90265-T; BATZER MA, 1991, GENOMICS, V9, P481, DOI 10.1016/0888-7543(91)90414-A; BROOKS JE, 1987, METHOD ENZYMOL, V152, P113; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; FARGIN A, 1988, NATURE, V335, P358, DOI 10.1038/335358a0; FRANCKE U, 1986, COLD SPRING HARB SYM, V51, P855, DOI 10.1101/SQB.1986.051.01.099; GRANDY DK, 1991, P NATL ACAD SCI USA, V88, P9175, DOI 10.1073/pnas.88.20.9175; GRIFFIN CA, 1987, CYTOGENET CELL GENET, V45, P67, DOI 10.1159/000132431; HASKILL S, 1990, P NATL ACAD SCI USA, V87, P7732, DOI 10.1073/pnas.87.19.7732; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HSIEH CL, 1989, SOMAT CELL MOLEC GEN, V15, P579, DOI 10.1007/BF01534919; KOBILKA BK, 1987, NATURE, V329, P75, DOI 10.1038/329075a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE J, 1992, J IMMUNOL, V148, P1261; LEONARD EJ, 1991, J LEUKOCYTE BIOL, V49, P258, DOI 10.1002/jlb.49.3.258; LI WH, 1985, MOL BIOL EVOL, V2, P150; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; LUSTER AD, 1987, P NATL ACAD SCI USA, V84, P2868, DOI 10.1073/pnas.84.9.2868; MANSUKHANI A, 1992, P NATL ACAD SCI USA, V89, P3305, DOI 10.1073/pnas.89.8.3305; MATTEI MG, 1992, MAMM GENOME, V2, P135, DOI 10.1007/BF00353862; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; MILATOVICH A, 1991, GENOMICS, V11, P1040, DOI 10.1016/0888-7543(91)90030-I; MODI WS, 1990, HUM GENET, V84, P185; MUKAIDA N, 1991, ADV EXP MED BIOL, V305, P31; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; NEI M, 1986, MOL BIOL EVOL, V3, P418; NGUYEN T, 1991, GENE, V109, P211, DOI 10.1016/0378-1119(91)90611-E; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; RICHMOND A, 1988, EMBO J, V7, P2025, DOI 10.1002/j.1460-2075.1988.tb03042.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNITZEL W, 1991, BIOCHEM BIOPH RES CO, V180, P301, DOI 10.1016/S0006-291X(05)81292-6; SEN GC, 1992, J BIOL CHEM, V267, P5017; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; STROSBERG AD, 1991, EUR J BIOCHEM, V196, P1, DOI 10.1111/j.1432-1033.1991.tb15778.x; TEKAMPOLSON P, 1990, J EXP MED, V172, P911, DOI 10.1084/jem.172.3.911; WALZ A, 1989, J EXP MED, V170, P1745, DOI 10.1084/jem.170.5.1745; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; WEISHANK RL, 1991, J BIOL CHEM, V266, P22427; WOLPE SD, 1989, FASEB J, V3, P2565, DOI 10.1096/fasebj.3.14.2687068; YANGFENG TL, 1990, P NATL ACAD SCI USA, V87, P1516, DOI 10.1073/pnas.87.4.1516; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	46	111	121	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					31	36		10.1038/ng0992-31	http://dx.doi.org/10.1038/ng0992-31			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303245	Green Published			2022-12-25	WOS:A1992JM64600012
J	WHITE, RA; PETERS, LL; ADKISON, LR; KORSGREN, C; COHEN, CM; LUX, SE				WHITE, RA; PETERS, LL; ADKISON, LR; KORSGREN, C; COHEN, CM; LUX, SE			THE MURINE PALLID MUTATION IS A PLATELET STORAGE POOL DISEASE ASSOCIATED WITH THE PROTEIN 42 (PALLIDIN) GENE	NATURE GENETICS			English	Article							HUMAN-ERYTHROCYTE-MEMBRANE; CYTOPLASMIC DOMAIN; BAND 4.2; MOUSE MODEL; DEFICIENCY; ANKYRIN; CELLS; MICE	Pallid is one of 12 independent murine mutations with a prolonged bleeding time that are models for human platelet storage pool deficiencies in which several intracellular organelles are abnormal. We have mapped the murine gene for protein 4.2 (Epb4.2) to chromosome 2 where it co-localizes with pallid. Southern blot analyses suggest that pallid is a mutation in the Epb4.2 gene. Northern blot analyses demonstrate a smaller than normal Epb4.2 transcript in affected pallid tissues, such as kidney and skin. This is the first gene defect to be associated with a platelet storage pool deficiency, and may allow the identification of a novel structure or biological pathway that influences granulogenesis.	HARVARD UNIV,CHILDRENS HOSP,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; MERCER UNIV,SCH MED,DEPT HUMAN GENET,MACON,GA 31207; TUFTS UNIV,SCH MED,BOSTON,MA 02115; ST ELIZABETH HOSP,DEPT BIOMED RES,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Mercer University; Tufts University	WHITE, RA (corresponding author), HARVARD UNIV,CHILDRENS HOSP,SCH MED,DIV HEMATOL ONCOL,BOSTON,MA 02115, USA.			Peters, Luanne/0000-0002-0784-0534				ABO T, 1982, J CLIN INVEST, V70, P193, DOI 10.1172/JCI110592; AHMED F, 1989, EXPERIENTIA, V45, P1133, DOI 10.1007/BF01950180; BENNETT V, 1980, J BIOL CHEM, V255, P6424; BENNETT V, 1990, PHYSIOL REV, V70, P1029, DOI 10.1152/physrev.1990.70.4.1029; BOXER GJ, 1977, BRIT J HAEMATOL, V35, P521; CLARK EA, 1981, IMMUNOGENETICS, V12, P601, DOI 10.1007/BF01561700; CONBOY J, 1990, J CLIN INVEST, V86, P524, DOI 10.1172/JCI114739; CONBOY JG, 1991, J BIOL CHEM, V266, P8273; DEPINHO RA, 1985, MEDICINE, V64, P192, DOI 10.1097/00005792-198505000-00004; Flaherty L, 1981, MOUSE BIOMEDICAL RES, P215; FRIEDRICHS B, 1989, EUR J CELL BIOL, V48, P121; GHANEM A, 1990, BRIT J HAEMATOL, V75, P414, DOI 10.1111/j.1365-2141.1990.tb04357.x; IDEGUCHI H, 1990, BRIT J HAEMATOL, V74, P347, DOI 10.1111/j.1365-2141.1990.tb02594.x; KORSGREN C, 1986, J BIOL CHEM, V261, P5536; KORSGREN C, 1991, P NATL ACAD SCI USA, V88, P4840, DOI 10.1073/pnas.88.11.4840; KORSGREN C, 1990, P NATL ACAD SCI USA, V87, P613, DOI 10.1073/pnas.87.2.613; KORSGREN C, 1988, J BIOL CHEM, V263, P10212; LANE PW, 1989, GENETIC VARIANTS STR, P825; LYON MF, 1953, J GENET, V51, P638, DOI 10.1007/BF02982950; Lyon ML, 1989, GENETIC VARIANTS STR, P773; MCCLUER RH, 1981, J BIOL CHEM, V256, P3112; MEISLER MH, 1978, J BIOL CHEM, V253, P3129; NOVAK EK, 1988, BRIT J HAEMATOL, V69, P371, DOI 10.1111/j.1365-2141.1988.tb02376.x; NOVAK EK, 1984, BLOOD, V63, P536; NOVAK EK, 1980, BIOCHEM GENET, V18, P549, DOI 10.1007/BF00484401; NOVAK EK, 1979, GENETICS, V92, P189; NOVAK EK, 1980, GENET RES, V35, P195, DOI 10.1017/S001667230001404X; ORN A, 1982, SCAND J IMMUNOL, V15, P305, DOI 10.1111/j.1365-3083.1982.tb00653.x; PETERS LL, 1991, J CELL BIOL, V114, P114; PHILLIPS MA, 1990, P NATL ACAD SCI USA, V87, P9333, DOI 10.1073/pnas.87.23.9333; PHILLIPS MA, 1992, J BIOL CHEM, V267, P2282; REDDINGTON M, 1987, BLOOD, V69, P1300; RISINGER MA, 1992, J BIOL CHEM, V267, P5680; Roberts E, 1931, SCIENCE, V74, P569, DOI 10.1126/science.74.1927.569; RODER J, 1979, NATURE, V278, P451, DOI 10.1038/278451a0; RYBICKI AC, 1988, J CLIN INVEST, V81, P893, DOI 10.1172/JCI113400; SILVER J, 1985, J HERED, V76, P436, DOI 10.1093/oxfordjournals.jhered.a110140; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUNG LA, 1990, P NATL ACAD SCI USA, V87, P955, DOI 10.1073/pnas.87.3.955; SWANK RT, 1991, GENET RES, V58, P51, DOI 10.1017/S0016672300029608; SWANK RT, 1991, BLOOD, V78, P2036, DOI 10.1182/blood.V78.8.2036.bloodjournal7882036; THERIAULT LL, 1970, DEV BIOL, V23, P261, DOI 10.1016/0012-1606(70)90098-9; WHITE RA, 1992, MAMM GENOME, V3, P281, DOI 10.1007/BF00292156	43	94	95	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					80	83		10.1038/ng0992-80	http://dx.doi.org/10.1038/ng0992-80			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1284644				2022-12-25	WOS:A1992JM64600021
J	HAASS, C; LEMERE, CA; CAPELL, A; CITRON, M; SEUBERT, P; SCHENK, D; LANNFELT, L; SELKOE, DJ				HAASS, C; LEMERE, CA; CAPELL, A; CITRON, M; SEUBERT, P; SCHENK, D; LANNFELT, L; SELKOE, DJ			THE SWEDISH MUTATION CAUSES EARLY-ONSET ALZHEIMERS-DISEASE BY BETA-SECRETASE CLEAVAGE WITHIN THE SECRETORY PATHWAY	NATURE MEDICINE			English	Article							AMYLOID PRECURSOR PROTEIN; CELL-SURFACE; PEPTIDE; IDENTIFICATION	Several missense mutations causing early-onset Alzheimer's disease (AD) have been described in the gene coding for the beta-amyloid precursor protein (beta APP). A double mutation found in a Swedish family is located before the amyloid beta-peptide (A beta) region of beta APP and results in the increased production and secretion of A beta. Here we show that the increased production of A beta results from a cellular mechanism, which differs substantially from that responsible for the production of A beta from wild-type beta APP. In the latter case, A beta generation requires reinternalization and recycling of beta APP. In the case of the Swedish mutation the N-terminal beta-secretase cleavage of A beta occurs in Golgi-derived vesicles, most likely within secretory vesicles. Therefore, this cleavage occurs in the same compartment as the alpha-secretase cleavage, which normally prevents A beta production,explaining the increased A beta generation by a competition between alpha- and beta-secretase.	UNIV HEIDELBERG,CENT INST MENTAL HLTH,DEPT MOLEC BIOL,D-68159 MANNHEIM,GERMANY; ATHENA NEUROSCI INC,S SAN FRANCISCO,CA 94080; KAROLINSKA INST,DEPT GERIATR MED B56,S-14186 HUDDINGE,SWEDEN	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Karolinska Institutet	HAASS, C (corresponding author), HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,CTR NEUROL DIS,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE ON AGING [R01AG012749, R01AG006173, R37AG006173] Funding Source: NIH RePORTER; NIA NIH HHS [AG12749, AG06173] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CHEN JW, 1985, J CELL BIOL, V101, P85, DOI 10.1083/jcb.101.1.85; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; DESTROOPER B, 1995, J BIOL CHEM, V270, P4058, DOI 10.1074/jbc.270.8.4058; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; FELSENSTEIN KM, 1994, NAT GENET, V6, P251, DOI 10.1038/ng0394-251; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAASS C, 1995, J BIOL CHEM, V270, P6186, DOI 10.1074/jbc.270.11.6186; HAASS C, 1994, J BIOL CHEM, V269, P17741; HAASS C, 1992, NATURE, V357, P500, DOI 10.1038/357500a0; HUNG A, 1993, J BIOL CHEM, V268, P22956; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KELLY RB, 1990, CELL, V61, P5, DOI 10.1016/0092-8674(90)90206-T; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; KOO EH, 1994, J BIOL CHEM, V269, P17386; KUENTZEL SL, 1993, BIOCHEM J, V295, P367, DOI 10.1042/bj2950367; LAI A, 1995, J BIOL CHEM, V270, P3565, DOI 10.1074/jbc.270.8.3565; LO ACY, 1994, J BIOL CHEM, V269, P30966; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; MULLAN M, 1993, TRENDS NEUROSCI, V16, P398, DOI 10.1016/0166-2236(93)90007-9; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; YAMAZAKI T, 1995, J CELL BIOL, V129, P431, DOI 10.1083/jcb.129.2.431	33	429	456	0	43	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1291	1296		10.1038/nm1295-1291	http://dx.doi.org/10.1038/nm1295-1291			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489411				2022-12-25	WOS:A1995TH78600042
J	ROBIN, NH; FELDMAN, GJ; ARONSON, AL; MITCHELL, HF; WEKSBERG, R; LEONARD, CO; BURTON, BK; JOSEPHSON, KD; LAXOVA, R; ALECK, KA; ALLANSON, JE; GUIONALMEIDA, ML; MARTIN, RA; LEICHTMAN, LG; PRICE, RA; OPITZ, JM; MUENKE, M				ROBIN, NH; FELDMAN, GJ; ARONSON, AL; MITCHELL, HF; WEKSBERG, R; LEONARD, CO; BURTON, BK; JOSEPHSON, KD; LAXOVA, R; ALECK, KA; ALLANSON, JE; GUIONALMEIDA, ML; MARTIN, RA; LEICHTMAN, LG; PRICE, RA; OPITZ, JM; MUENKE, M			OPITZ-SYNDROME IS GENETICALLY HETEROGENEOUS, WITH ONE LOCUS ON XP22, AND A 2ND LOCUS ON 22Q11.2	NATURE GENETICS			English	Note							MICRODELETIONS; GENE; DELETIONS		UNIV PENN,CHILDRENS HOSP PHILADELPHIA,SCH MED,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PSYCHIAT,PHILADELPHIA,PA 19104; HOSP SICK CHILDREN,DEPT GENET,TORONTO,ON M5G 1X8,CANADA; UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112; MICHAEL REESE HOSP & MED CTR,CHICAGO,IL 60616; GUNDERSON CLIN LTD,LA CROSSE REG GENET SERV,LA CROSSE,WI 54601; UNIV WISCONSIN,WAISMAN CTR MENTAL RETARDAT,MADISON,WI 53705; UNIV ARIZONA,DEPT PEDIAT,PHOENIX,AZ 85010; UNIV ARIZONA,DEPT GENET,PHOENIX,AZ 85010; CHILDRENS HOSP EASTERN ONTARIO,DEPT GENET,OTTAWA,ON K1H 8L1,CANADA; UNIV SAO PAULO,HOSP PESQUISA & REABILITACAO LESOES LABIO PALATAI,BAURU,SP,BRAZIL; UNIV CALIF IRVINE,MED CTR,DEPT PEDIAT,ORANGE,CA 92613; EASTERN VIRGINIA MED SCH,DEPT PEDIAT,DIV GENET,NORFOLK,VA 23507; FDN DEV & MED GENET,HELENA,MT 59601	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Utah System of Higher Education; University of Utah; Michael Reese Hospital & Medical Center; University of Wisconsin System; University of Wisconsin Madison; University of Arizona; University of Arizona; University of Ottawa; Children's Hospital of Eastern Ontario; Universidade de Sao Paulo; University of California System; University of California Irvine; Eastern Virginia Medical School				Muenke, Maximilian/0000-0002-7719-6545	NICHD NIH HHS [R29HD28732, 5T32HD07107] Funding Source: Medline; NIDDK NIH HHS [R01DK44073] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007107, R29HD028732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044073] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLANSON JE, 1988, AM J MED GENET, V31, P637, DOI 10.1002/ajmg.1320310319; AUBRY M, 1992, GENOMICS, V13, P641, DOI 10.1016/0888-7543(92)90135-F; BROOKS JK, 1992, AM J MED GENET, V43, P595, DOI 10.1002/ajmg.1320430318; Cohen M M Jr, 1979, Birth Defects Orig Artic Ser, V15, P85; CORDERO JF, 1978, AM J MED GENET, V2, P145, DOI 10.1002/ajmg.1320020205; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; FARDON PA, 1983, CLIN GENET, V24, P446; FRANZE A, 1991, GENOMICS, V7, P728; GOLDMUNTZ E, 1993, J MED GENET, V30, P807, DOI 10.1136/jmg.30.10.807; GUIONALMEIDA ML, 1992, AM J MED GENET, V43, P918, DOI 10.1002/ajmg.1320430603; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MACPHERSON E, 1991, AM J HUM GENET S, V49, pA774; MARINO M, 1993, MAMM GENOME, V4, P252, DOI 10.1007/BF00417431; MCKUSICK VA, 1994, MENDELIAN INHERITANC, P759; OPITZ J M, 1969, Birth Defects Original Article Series, V5, P95; OPITZ J M, 1969, Birth Defects Original Article Series, V5, P86; OPITZ JM, 1987, AM J MED GENET, V28, P275, DOI 10.1002/ajmg.1320280203; PAGE DC, 1990, GENOMICS, V7, P37, DOI 10.1016/0888-7543(90)90516-W; STOLL C, 1978, AM J MED GENET, V20, P221; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; WITTWER B, 1994, AM J HUM GENET, V55, pA1207; [No title captured]	23	91	93	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					459	461		10.1038/ng1295-459	http://dx.doi.org/10.1038/ng1295-459			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493033				2022-12-25	WOS:A1995TH62900030
J	KRAMER, R; ZHANG, YP; GEHRMANN, J; GOLD, R; THOENEN, H; WEKERLE, H				KRAMER, R; ZHANG, YP; GEHRMANN, J; GOLD, R; THOENEN, H; WEKERLE, H			GENE-TRANSFER THROUGH THE BLOOD-NERVE BARRIER - NGF-ENGINEERED NEURITOGENIC T-LYMPHOCYTES ATTENUATE EXPERIMENTAL AUTOIMMUNE NEURITIS	NATURE MEDICINE			English	Article							EXPERIMENTAL ALLERGIC NEURITIS; GROWTH-FACTOR; CELL LINE; MESSENGER-RNA; EXPRESSION; RAT; INVIVO; SYSTEM; CDNA; TRK	Nerve-specific autoimmune T lymphocytes were used as vehicles to deliver therapeutically useful neurotrophic factors across the endothelial blood-nerve barrier. P-2 protein-reactive T-lymphocyte lines from Lewis rats were transduced with a recombinant retrovirus containing the mouse nerve growth factor (NGF) gene. The engineered T cells released high amounts of NGF dependent on antigenic stimulation in vitro. After intravenous injection, the T cells infiltrated the rat peripheral nervous system and persisted there for at least two weeks. Local release of NGF from engineered T cells was demonstrable by immunocytochemistry and by an anti-inflammatory effect on infiltrating macrophages.	MAX PLANCK INST PSYCHIAT,D-82152 MARTINSRIED,GERMANY; UNIV ZURICH HOSP,DEPT PATHOL,CH-8091 ZURICH,SWITZERLAND	Max Planck Society; University of Zurich; University Zurich Hospital								CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COUMOYER D, 1993, ANNU REV IMMUNOL, V11, P297; EHRHARD PB, 1993, P NATL ACAD SCI USA, V90, P5423, DOI 10.1073/pnas.90.12.5423; EHRHARD PB, 1993, P NATL ACAD SCI USA, V90, P10984, DOI 10.1073/pnas.90.23.10984; GEHRMANN J, 1992, LAB INVEST, V67, P100; HARTUNG HP, 1993, PERIPHERAL NEUROPATH, P418; HEININGER K, 1988, ANN NEUROL, V23, P326, DOI 10.1002/ana.410230403; HEININGER K, 1986, ANN NEUROL, V19, P44, DOI 10.1002/ana.410190109; HWU P, 1993, J IMMUNOL, V150, P4104; IZUMO S, 1985, LAB INVEST, V53, P209; KAWAJA MD, 1992, J NEUROSCI, V12, P2849; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; LAMPERT P, 1977, ACTA NEUROPATHOL, V40, P103, DOI 10.1007/BF00688697; LININGTON C, 1993, EUR J IMMUNOL, V23, P1364, DOI 10.1002/eji.1830230627; LININGTON C, 1984, J IMMUNOL, V133, P1946; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; SCOTT J, 1983, NATURE, V302, P538, DOI 10.1038/302538a0; SEBERT ME, 1993, J NEUROSCI RES, V36, P357, DOI 10.1002/jnr.490360402; SPRANGER M, 1990, EUR J NEUROSCI, V2, P69, DOI 10.1111/j.1460-9568.1990.tb00382.x; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9	22	70	76	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1162	1166		10.1038/nm1195-1162	http://dx.doi.org/10.1038/nm1195-1162			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584988				2022-12-25	WOS:A1995TC53700040
J	TAMADA, JA; BOHANNON, NJV; POTTS, RO				TAMADA, JA; BOHANNON, NJV; POTTS, RO			MEASUREMENT OF GLUCOSE IN DIABETIC SUBJECTS USING NONINVASIVE TRANSDERMAL EXTRACTION	NATURE MEDICINE			English	Article							SUBCUTANEOUS TISSUE	Results from the Diabetes Care and Complications Trial show that tight blood glucose control significantly reduces the long-term complications of diabetes mellitus(1). In that study, frequent self-testing of glucose and insulin administration resulted in a significant reduction in long-term complications. This protocol, however, also resulted in a threefold increase in the frequency of hypoglycaemic incidents. Currently, self-testing requires a drop of blood for each measurement. The pain and inconvenience of self-testing, along with the fear and danger of hypoglycaemia has led to poor patient acceptance of a tight control regimen, despite the clear long-term advantages. A continuously worn, noninvasive method to periodically measure glucose would provide a convenient and comfortable means of frequent self-testing(2,3). A continuously worn device could also alert the user of low glucose levels, thereby reducing the incidence of hypoglycaemia(4,5). Guy et al. demonstrated a noninvasive method to transport glucose through the skin using low-level electrical current(6,7). To provide a quantitative measurement, the flux of glucose extracted across the skin must correlate with serum glucose in a predictive manner. The results presented here show a quantitative relationship between serum and transdermally extracted glucose in diabetics.	MONTEAGLE MED CTR,SAN FRANCISCO,CA 94110		TAMADA, JA (corresponding author), CYGNUS THERAPEUT SYST,400 PENOBSCOT DR,REDWOOD CITY,CA 94063, USA.							CLARKE WL, 1987, DIABETES CARE, V10, P622, DOI 10.2337/diacare.10.5.622; GLIKFELD P, 1989, PHARMACEUT RES, V6, P988, DOI 10.1023/A:1015957816254; MEYERHOFF C, 1992, DIABETOLOGIA, V35, P1087, DOI 10.1007/BF02221686; MOATTISIRAT D, 1992, DIABETOLOGIA, V35, P224, DOI 10.1007/BF00400921; OSHEA TJ, 1992, ANAL CHEM, V64, P381; RAO G, IN PRESS PHARM RES; REACH G, 1992, Analytical Chemistry, V64, P381; REACH G, 1993, DIABETES ANN, P332; 1993, NEW ENGL J MED, V329, P977	9	146	156	1	20	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1198	1201		10.1038/nm1195-1198	http://dx.doi.org/10.1038/nm1195-1198			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584995				2022-12-25	WOS:A1995TC53700047
J	BURGESS, DL; KOHRMAN, DC; GALT, J; PLUMMER, NW; JONES, JM; SPEAR, B; MEISLER, MH				BURGESS, DL; KOHRMAN, DC; GALT, J; PLUMMER, NW; JONES, JM; SPEAR, B; MEISLER, MH			MUTATION OF A NEW SODIUM-CHANNEL GENE, SCN8A, IN THE MOUSE MUTANT MOTOR END-PLATE DISEASE	NATURE GENETICS			English	Article							REGION	The mouse neurological mutant 'motor endplate disease' (med) is characterized by early onset progressive paralysis of the hind limbs, severe muscle atrophy, degeneration of Purkinje cells and juvenile lethality. We have isolated a voltage-gated sodium channel gene, Scn8a, from the flanking region of a transgene-induced allele of med. Scn8a is expressed in brain and spinal cord but not in skeletal muscle or heart, and encodes a predicted protein of 1,732 amino acids. An intragenic deletion at the transgene insertion site results in loss of expression. Scn8a is closely related to other sodium channel alpha subunits, with greatest similarity to a brain transcript from the pufferfish Fugu rubripes. The human homologue, SCN8A, maps to chromosome 12q13 and is a candidate gene for inherited neurodegenerative disease.	UNIV MICHIGAN,SCH MED,DEPT HUMAN GENET,ANN ARBOR,MI 48109; UNIV KENTUCKY,DEPT MICROBIOL & IMMUNOL & PATHOL,LEXINGTON,KY 40536	University of Michigan System; University of Michigan; University of Kentucky				Spear, Brett/0000-0002-4343-9393; /0000-0003-2971-814X				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANGAUTPETIT D, 1982, PROC R SOC SER B-BIO, V215, P117, DOI 10.1098/rspb.1982.0031; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DICK DJ, 1985, NEUROPATH APPL NEURO, V11, P141; DUCHEN LW, 1970, J NEUROL NEUROSUR PS, V33, P238, DOI 10.1136/jnnp.33.2.238; DUCHEN LW, 1987, J PHYSL, V189, pP4; GOLDSTEIN LA, IN PRESS J COMP NEUR; GREEN MC, 1989, CATALOG MUTANT GENES; HANASH SM, 1993, GENE CHROMOSOME CANC, V8, P34, DOI 10.1002/gcc.2870080107; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HERNANDEZ A, 1995, GENOMICS, V25, P433, DOI 10.1016/0888-7543(95)80043-L; JOCKUSCH H, 1980, CELL TISSUE RES, V207, P241; JONES JM, 1989, NUCLEIC ACIDS RES, V17, P6613, DOI 10.1093/nar/17.16.6613; KALLEN RG, 1993, MOL NEUROBIOL, V7, P383, DOI 10.1007/BF02769184; KOHRMAN DC, 1995, GENOMICS, V26, P171, DOI 10.1016/0888-7543(95)80198-U; MACRAE AD, 1995, GENOMICS, V25, P436, DOI 10.1016/0888-7543(95)80044-M; MOCK BA, 1994, MAMM GENOME, V15, pS217; NAKAZAWA A, 1994, DNA DATABASE JAPAN; PIERCE JC, 1992, MAMM GENOME, V3, P550, DOI 10.1007/BF00350620; ROMMENS JM, 1993, HUM MOL GENET, V2, P901, DOI 10.1093/hmg/2.7.901; SHEPHERD NS, 1994, P NATL ACAD SCI USA, V91, P2629, DOI 10.1073/pnas.91.7.2629; TAGLE DA, 1993, NATURE, V361, P751, DOI 10.1038/361751a0; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3	26	247	260	1	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					461	465		10.1038/ng0895-461	http://dx.doi.org/10.1038/ng0895-461			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670495				2022-12-25	WOS:A1995RM37500020
J	COLLEDGE, WH; ABELLA, BS; SOUTHERN, KW; RATCLIFF, R; JIANG, CW; CHENG, SH; MACVINISH, LJ; ANDERSON, JR; CUTHBERT, AW; EVANS, MJ				COLLEDGE, WH; ABELLA, BS; SOUTHERN, KW; RATCLIFF, R; JIANG, CW; CHENG, SH; MACVINISH, LJ; ANDERSON, JR; CUTHBERT, AW; EVANS, MJ			GENERATION AND CHARACTERIZATION OF A DELTA-F508 CYSTIC-FIBROSIS MOUSE MODEL	NATURE GENETICS			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ION-TRANSPORT DEFECT; CHLORIDE TRANSPORT; ANIMAL-MODEL; GENE; MICE; MUTATION; CFTR; CHANNEL; IDENTIFICATION	We have generated mice carrying the most common mutation in cystic fibrosis (CF), Delta F508, within the cystic fibrosis (Cftr) gene. Mutant animals show pathological and electrophysiological changes consistent with a CF phenotype. Delta F508(-/-) mice die from peritonitis and show deficiencies in cAMP-activated electrogenic Cl- transport. These mice produce Delta F508 transcripts and show the temperature-dependent trafficking defect first described for the human Delta F508 CFTR protein. A functional CFTR Cl- channel not demonstrated by null CF mice or present at 37 degrees C was detected following incubation of epithelial cells at 27 degrees C. Thus, these mice are an accurate Delta F508 model and will be valuable for testing drugs aimed at overcoming the Delta F508 trafficking defect.	UNIV CAMBRIDGE,WELLCOME INST CANC & DEV BIOL,CRC,CAMBRIDGE CB2 1QR,ENGLAND; UNIV CAMBRIDGE,DEPT GENET,CAMBRIDGE CB2 1QR,ENGLAND; UNIV CAMBRIDGE,DEPT PHARMACOL,CAMBRIDGE CB2 1QJ,ENGLAND; GENZYME CORP,FRAMINGHAM,MA 01710; ADDENBROOKES HOSP,DEPT HISTOPATHOL,CAMBRIDGE CB2 2QQ,ENGLAND	University of Cambridge; University of Cambridge; University of Cambridge; Sanofi-Aventis; Genzyme Corporation; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge			Cheng, Seng H/AAC-6564-2022; Colledge, William/X-4976-2019	Colledge, William/0000-0002-9603-4429; Abella, Benjamin/0000-0003-2521-0891	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTON EWFW, 1993, NAT GENET, V5, P135, DOI 10.1038/ng1093-135; ANDERSON MP, 1991, SCIENCE, V253, P202, DOI 10.1126/science.1712984; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; CHENG SH, 1995, AM J PHYSIOL-LUNG C, V268, pL615, DOI 10.1152/ajplung.1995.268.4.L615; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; CUTHBERT AW, 1995, J PHYSIOL-LONDON, V482, P449, DOI 10.1113/jphysiol.1995.sp020531; CUTHBERT AW, 1994, PFLUG ARCH EUR J PHY, V428, P508, DOI 10.1007/BF00374572; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; DELANEY SJ, 1993, NAT GENET, V4, P426, DOI 10.1038/ng0893-426; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; DORIN JR, 1994, GENOME, V5, P465; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; GRAY MA, 1994, AM J PHYSIOL, V266, P213; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; GRUBB BR, 1994, AM J PHYSIOL, V267, P293; HYDE SC, 1993, NATURE, V362, P250, DOI 10.1038/362250a0; ILLSLEY NP, 1987, BIOCHEMISTRY-US, V26, P1215, DOI 10.1021/bi00379a002; JACKSON ADM, 1989, NATURAL HIST CYSTIC; JOHNSON LG, 1992, NAT GENET, V2, P21, DOI 10.1038/ng0992-21; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KIM HS, 1988, NUCLEIC ACIDS RES, V15, P8887; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; LI CH, 1993, NAT GENET, V3, P311, DOI 10.1038/ng0493-311; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; MACLEOD RJ, 1993, PEDIATR RES, V35, P45; MARSHALL J, 1994, J BIOL CHEM, V269, P29897; MEAMS MB, 1993, CYSTIC FIBROSIS 1ST; ONEAL WK, 1993, HUM MOL GENET, V2, P1561, DOI 10.1093/hmg/2.10.1561; PIND S, 1994, J BIOL CHEM, V269, P12784; RATCLIFF R, 1993, NAT GENET, V4, P35, DOI 10.1038/ng0593-35; REID LH, 1990, P NATL ACAD SCI USA, V87, P4299, DOI 10.1073/pnas.87.11.4299; RICH DP, 1993, J BIOL CHEM, V268, P20259; RIORDAN JR, 1989, SCIENCE, V245, P1066; SHERRY AM, 1994, AM J PHYSIOL, V266, P870; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; THOMAS PJ, 1993, J BIOENERG BIOMEMBR, V25, P11, DOI 10.1007/BF00768063; TSUI LC, 1993, CYSTIC FIBROSIS CURR, V1, P27; YANG YP, 1993, P NATL ACAD SCI USA, V90, P9480, DOI 10.1073/pnas.90.20.9480	43	185	189	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					445	452		10.1038/ng0895-445	http://dx.doi.org/10.1038/ng0895-445			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7545494				2022-12-25	WOS:A1995RM37500018
J	POLYMEROPOULOS, MH; DELUNA, RIO; IDE, SE; TORRES, R; RUBENSTEIN, J; FRANCOMANO, CA				POLYMEROPOULOS, MH; DELUNA, RIO; IDE, SE; TORRES, R; RUBENSTEIN, J; FRANCOMANO, CA			THE GENE FOR PYCNODYSOSTOSIS MAPS TO HUMAN-CHROMOSOME 1CEN-Q21	NATURE GENETICS			English	Note									NIH,NATL CTR HUMAN GENOME RES,MED GENET BRANCH,BETHESDA,MD 20892; HOSP INFANTIL MEXICO DR FEDERICO GOMEZ,MEXICO CITY,DF,MEXICO	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Hospital Infantil de Mexico Federico Gomez	POLYMEROPOULOS, MH (corresponding author), NIH,NATL CTR HUMAN GENOME RES,GENET DIS RES LAB,BETHESDA,MD 20892, USA.							CARMI R, 1995, HUM MOL GENET, V4, P9, DOI 10.1093/hmg/4.1.9; EDELSON JG, 1992, CLIN ORTHOPAEDICS, V280, P273; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; LADNER MB, 1987, EMBO J, V6, P2693, DOI 10.1002/j.1460-2075.1987.tb02561.x; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOZANO GEC, 1990, THESIS MEXICO; MAROTEAUX P, 1962, PRESSE MED, V70, P999; MAROTEAUX P, 1965, J AMER MED ASSOC, V191, P715, DOI 10.1001/jama.1965.03080090029007; SEDANO HD, 1968, AM J DIS CHILD, V116, P70, DOI 10.1001/archpedi.1968.02100020072010; SUGIURA Y, 1974, BIRTH DEFECTS ORIGIN, V10; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	11	46	49	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					238	239		10.1038/ng0695-238	http://dx.doi.org/10.1038/ng0695-238			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663522	Green Published			2022-12-25	WOS:A1995RA85700025
J	TREMBLAY, KD; SAAM, JR; INGRAM, RS; TILGHMAN, SM; BARTOLOMEI, MS				TREMBLAY, KD; SAAM, JR; INGRAM, RS; TILGHMAN, SM; BARTOLOMEI, MS			A PATERNAL-SPECIFIC METHYLATION IMPRINT MARKS THE ALLELES OF THE MOUSE H19 GENE	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; DNA METHYLATION; EXPRESSION; TRANSGENE; LOCUS	Imprinting, the differential expression of the two alleles of a gene based on their parental origin, requires that the alleles be distinguished or marked. A candidate for the differentiating mark is DNA methylation. The maternally expressed H19 gene is hypermethylated on the inactive paternal allele in somatic tissues and sperm, but to serve as the mark that designates the imprint, differential methylation must also be present in the gametes and the pre-implantation embryo. We now show that the pattern of differential methylation in the 5' portion of H19 is established in the gametes and a subset is maintained in the pre-implanation embryo. That subset is sufficient to confer monoallelic expression to the gene in blastocysts. We propose that paternal-specific methylation of the far 5' region is the mark that distinguishes the two alleles of H19.	UNIV PENN,SCH MED,DEPT DEV & CELL BIOL,PHILADELPHIA,PA 19104; PRINCETON UNIV,HOWARD HUGHES MED INST,PRINCETON,NJ 08544; PRINCETON UNIV,DEPT BIOL MOLEC,PRINCETON,NJ 08544	University of Pennsylvania; Howard Hughes Medical Institute; Princeton University; Princeton University				Tremblay, Kimberly/0000-0002-3059-9910	NCI NIH HHS [CA44976] Funding Source: Medline; NIGMS NIH HHS [GM51279, GM51460] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA044976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051460, R01GM051279] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARLOW DP, 1994, TRENDS GENET, V10, P194, DOI 10.1016/0168-9525(94)90255-0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BESTOR TH, 1983, P NATL ACAD SCI USA, V82, P2674; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; BUSSLINGER M, 1983, CELL, V34, P197, DOI 10.1016/0092-8674(83)90150-2; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; FEIL R, 1994, DEVELOPMENT, V120, P2933; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; HATADA I, 1993, NUCLEIC ACIDS RES, V21, P5577, DOI 10.1093/nar/21.24.5577; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; LATHAM KE, 1994, GENE DEV, V8, P290, DOI 10.1101/gad.8.3.290; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MONK M, 1987, DEVELOPMENT, V99, P371; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SINGERSAM J, 1990, MOL CELL BIOL, V10, P4987, DOI 10.1128/MCB.10.9.4987; SINGERSAM J, 1989, NUCLEIC ACIDS RES, V18, P687; SOLTER D, 1988, ANNU REV GENET, V22, P127; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; SZABO P, 1994, DEVELOPMENT, V120, P1651; VILLAR AJ, 1994, NAT GENET, V8, P373, DOI 10.1038/ng1294-373; WAHL GM, P NATN ACAD SCI US, V76; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; ZHANG YH, 1993, AM J HUM GENET, V53, P113	40	367	374	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1995	9	4					407	413		10.1038/ng0495-407	http://dx.doi.org/10.1038/ng0495-407			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795647				2022-12-25	WOS:A1995QQ75300019
J	BENNETT, ST; LUCASSEN, AM; GOUGH, SCL; POWELL, EE; UNDLIEN, DE; PRITCHARD, LE; MERRIMAN, ME; KAWAGUCHI, Y; DRONSFIELD, MJ; POCIOT, F; NERUP, J; BOUZEKRI, N; CAMBONTHOMSEN, A; RONNINGEN, KS; BARNETT, AH; BAIN, SC; TODD, JA				BENNETT, ST; LUCASSEN, AM; GOUGH, SCL; POWELL, EE; UNDLIEN, DE; PRITCHARD, LE; MERRIMAN, ME; KAWAGUCHI, Y; DRONSFIELD, MJ; POCIOT, F; NERUP, J; BOUZEKRI, N; CAMBONTHOMSEN, A; RONNINGEN, KS; BARNETT, AH; BAIN, SC; TODD, JA			SUSCEPTIBILITY TO HUMAN TYPE-1 DIABETES AT IDDM2 IS DETERMINED BY TANDEM REPEAT VARIATION AT THE INSULIN GENE MINISATELLITE LOCUS	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; 5'-FLANKING REGION; HRAS1 MINISATELLITE; NEGATIVE REGULATION; POLYMORPHIC REGION; MELLITUS; INDIVIDUALS; EXPRESSION; SEQUENCES; RISK	The IDDM2 locus encoding susceptibility to type 1 diabetes was mapped previously to a 4.1-kb region spanning the insulin gene and a minisatellite or variable number of tandem repeats (VNTR) locus on human chromosome 11p15.5. By 'cross-match' haplotype analysis and linkage disequilibrium mapping, we have mapped the mutation IDDM2 to within the VNTR itself. Other polymorphisms were systematically excluded as primary disease determinants. Transmission of IDDM2 may be influenced by parent-of-origin phenomena. Although we show that the insulin gene is expressed biallelically in the adult pancreas, we present preliminary evidence that the level of transcription in vivo is correlated with allelic variation within the VNTR. Allelic variation at VNTRs may play an important general role in human disease.	UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; NATL HOSP NORWAY,INST TRANSPLANTAT IMMUNOL,N-0027 OSLO,NORWAY; UNIV BIRMINGHAM,BIRMINGHAM HEARTLANDS HOSP,DEPT MED DIABET ENDOCRINOL,BIRMINGHAM B9 5SS,W MIDLANDS,ENGLAND; STENO DIABET CTR,DK-2820 GENTOFTE,DENMARK; HOP PURPAN,CTR IMMUNOPATHOL & GENET HUMAINE,CNRS,UPR 8291,F-31300 TOULOUSE,FRANCE	University of Oxford; University of Oslo; National Hospital Norway; Heart of England NHS Foundation Trust; University of Birmingham; Steno Diabetes Center; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse	BENNETT, ST (corresponding author), UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,NUFFIELD DEPT SURG,WINDMILL RD,OXFORD OX3 7BN,ENGLAND.		Powell, Elizabeth/B-4455-2011; Todd, John A/A-3542-2010; Lucassen, Anneke/D-7764-2017	Powell, Elizabeth/0000-0001-5008-8061; Todd, John A/0000-0003-2740-8148; Pociot, Flemming/0000-0003-3274-5448; Lucassen, Anneke/0000-0003-3324-4338	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BOAM DSW, 1990, J BIOL CHEM, V265, P8285; BUI MM, 1993, DIABETES, V42, pA63; COCCOZA S, 1988, EUR J CLIN INVEST, V18, P582; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; COX NJ, 1988, AM J HUM GENET, V43, P495; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GIDDINGS SJ, 1994, NAT GENET, V6, P310, DOI 10.1038/ng0394-310; GREEN M, 1993, GENOMICS, V17, P429, DOI 10.1006/geno.1993.1343; HAMMONDKOSACK MCU, 1992, NUCLEIC ACIDS RES, V20, P231, DOI 10.1093/nar/20.2.231; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; KELLER MA, 1993, PCR METH APPL, V3, P32; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; LUCASSEN AM, IN PRESS HUM MOL GEN; MARTINSON JJ, 1994, AM J HUM GENET, V55, P513; MCGINNIS RE, 1994, AM J HUM GENET, V55, P526; NEUMANN B, 1995, NAT GENET, V9, P12, DOI 10.1038/ng0195-12; OUDET C, 1993, AM J HUM GENET, V52, P297; OUDET C, 1991, AM J HUM GENET, V49, P311; OWERBACH D, 1982, LANCET, V1, P880; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; PERMUTT MA, 1985, DIABETES, V34, P311, DOI 10.2337/diabetes.34.4.311; PRITCHARD LE, 1995, HUM MOL GENET, V4, P197, DOI 10.1093/hmg/4.2.197; PUGLIESE A, 1994, J AUTOIMMUN, V7, P687, DOI 10.1006/jaut.1994.1053; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; RENGES HH, 1992, ANN HUM GENET, V56, P11, DOI 10.1111/j.1469-1809.1992.tb01126.x; ROYCE NJ, 1988, GENOMICS, V3, P352; SHEEHY MJ, 1992, DIABETES, V41, P123, DOI 10.2337/diabetes.41.2.123; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; TAKEDA J, 1989, FEBS LETT, V247, P41, DOI 10.1016/0014-5793(89)81236-0; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; TODD JA, 1994, DIABETIC MED, V11, P6, DOI 10.1111/j.1464-5491.1994.tb00222.x; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WEAVER JU, 1992, EUR J CLIN INVEST, V22, P265, DOI 10.1111/j.1365-2362.1992.tb01461.x; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	51	639	655	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					284	292		10.1038/ng0395-284	http://dx.doi.org/10.1038/ng0395-284			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773291				2022-12-25	WOS:A1995QL23200019
J	KENNEDY, GC; GERMAN, MS; RUTTER, WJ				KENNEDY, GC; GERMAN, MS; RUTTER, WJ			THE MINISATELLITE IN THE DIABETES SUSCEPTIBILITY LOCUS IDDM2 REGULATES INSULIN TRANSCRIPTION	NATURE GENETICS			English	Article							POLYMORPHIC REGION ADOPTS; HLA-DR; GENETIC-ANALYSIS; BINDING-PROTEIN; DNA; MELLITUS; EXPRESSION; SEQUENCES; CELLS; INDIVIDUALS	Genetic susceptibility to insulin-dependent diabetes mellitus (IDDM) is inherited as a polygenic trait. One of the loci implicated in IDDM is a polymorphic minisatellite 5' of the human insulin (INS) gene on chromosome 11. This insulin-linked polymorphic region (ILPR) is composed of tandemly repeated sequences, which fall into three size classes: IDDM is strongly associated with short ILPR alleles. We now show that the ILPR is capable of transducing a transcriptional signal in pancreatic beta-cells, with a long ILPR possessing greater activity than a short ILPR. The ILPR contains numerous high-affinity binding sites for the transcription factor Pur-1, and transcriptional activation by Pur-1 is modulated by naturally occurring sequences in the ILPR. Our results demonstrate a possible function for this unique minisatellite, which may have implications for type 1 diabetes.	UNIV CALIF SAN FRANCISCO,HORMONE RES INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco					NIDDK NIH HHS [R01 DK021344] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021344] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BELL GI, 1982, NATURE, V295, P31, DOI 10.1038/295031a0; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; COLLICK A, 1991, NUCLEIC ACIDS RES, V19, P6399, DOI 10.1093/nar/19.23.6399; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DAVIES K, 1993, NATURE, V364, P88, DOI 10.1038/364088a0; GERMAN MS, 1990, J BIOL CHEM, V265, P22063; HAMMONDKOSACK MCU, 1993, J MOL ENDOCRINOL, V10, P121, DOI 10.1677/jme.0.0100121; HAMMONDKOSACK MCU, 1992, FEBS LETT, V301, P79, DOI 10.1016/0014-5793(92)80214-2; HAMMONDKOSACK MCU, 1992, NUCLEIC ACIDS RES, V20, P231, DOI 10.1093/nar/20.2.231; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KENNEDY GC, 1993, BIOCHEM SOC T, V21, P178, DOI 10.1042/bst0210178; KENNEDY GC, 1992, P NATL ACAD SCI USA, V89, P11498, DOI 10.1073/pnas.89.23.11498; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; MADDOX J, 1994, NATURE, V368, P685, DOI 10.1038/368685a0; MADSEN OD, 1991, MOL ENDOCRINOL, V5, P143, DOI 10.1210/mend-5-1-143; OWERBACH D, 1993, DIABETES, V42, P1708, DOI 10.2337/diabetes.42.12.1708; OWERBACH D, 1989, DIABETES, V38, P942, DOI 10.2337/diabetes.38.7.942; OWERBACH D, 1983, NATURE, V303, P815, DOI 10.1038/303815a0; OWERBACH D, 1984, GENE, V32, P475, DOI 10.1016/0378-1119(84)90021-0; OWERBACH D, 1988, DIABETOLOGIA, V31, P751, DOI 10.1007/BF00274778; PLATZ P, 1981, DIABETOLOGIA, V21, P108; ROTWEIN P, 1986, AM J HUM GENET, V39, P291; SEINO S, 1992, MOL BIOL EVOL, V9, P193; SHEEHY MJ, 1989, J CLIN INVEST, V83, P830, DOI 10.1172/JCI113965; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; TAUTZ D, 1993, EXS, V67, P21; THOMSON G, 1988, AM J HUM GENET, V43, P799; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TREPICCHIO WL, 1992, NUCLEIC ACIDS RES, V20, P2427, DOI 10.1093/nar/20.10.2427; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; WAHLS WP, 1991, NUCLEIC ACIDS RES, V19, P3269, DOI 10.1093/nar/19.12.3269; WALKER MD, 1983, NATURE, V306, P557, DOI 10.1038/306557a0; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; YAMAZAKI H, 1992, J BIOL CHEM, V267, P12311	37	344	350	0	16	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					293	298		10.1038/ng0395-293	http://dx.doi.org/10.1038/ng0395-293			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773292				2022-12-25	WOS:A1995QL23200020
J	JACOB, HJ; BROWN, DM; BUNKER, RK; DALY, MJ; DZAU, VJ; GOODMAN, A; KOIKE, G; KREN, V; KURTZ, T; LERNMARK, A; LEVAN, G; MAO, YP; PETTERSSON, A; PRAVENEC, M; SIMON, JS; SZPIRER, C; SZPIRER, J; TROLLIET, MR; WINER, ES; LANDER, ES				JACOB, HJ; BROWN, DM; BUNKER, RK; DALY, MJ; DZAU, VJ; GOODMAN, A; KOIKE, G; KREN, V; KURTZ, T; LERNMARK, A; LEVAN, G; MAO, YP; PETTERSSON, A; PRAVENEC, M; SIMON, JS; SZPIRER, C; SZPIRER, J; TROLLIET, MR; WINER, ES; LANDER, ES			A GENETIC-LINKAGE MAP OF THE LABORATORY RAT, RATTUS-NORVEGICUS	NATURE GENETICS			English	Article								We report the construction of the first complete genetic linkage map of the laboratory rat. By testing 1171 simple sequence length polymorphisms (SSLPs), we have identified 432 markers that show polymorphisms between the SHR and BN rat strains and mapped them in a single (SHR x BN) F-2 intercross. The loci define 21 large linkage groups corresponding to the 21 rat chromosomes, together with a pair of nearby markers on chromosome 9 that are not linked to the rest of the map. Because 99.5% of the markers fall into one of the 21 large linkage groups, the maps appear to cover the vast majority of the rat genome. The availability of the map should facilitate whole genome scans for genes underlying qualitative and quantitative traits relevant to mammalian physiology and pathobiology.	MIT, WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA USA; STANFORD UNIV, CARDIOVASC RES CTR, PALO ALTO, CA USA; UNIV CALIF SAN FRANCISCO, DEPT LAB MED, SAN FRANCISCO, CA 94143 USA; GOTHENBURG UNIV, GOTHENBURG, SWEDEN; KAROLINSKA INST, DEPT MOLEC MED, STOCKHOLM, SWEDEN; FREE UNIV BRUSSELS, BRUSSELS, BELGIUM; CHARLES UNIV, DEPT BIOL, PRAGUE, CZECH REPUBLIC; ACAD SCI CZECH REPUBL, INST PHYSIOL, PRAGUE, CZECH REPUBLIC; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Stanford University; University of California System; University of California San Francisco; University of Gothenburg; Karolinska Institutet; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Massachusetts Institute of Technology (MIT)	JACOB, HJ (corresponding author), MASSACHUSETTS GEN HOSP, CARDIOVASC RES CTR, BOSTON, MA USA.		Lernmark, Åke/F-8140-2015; Pravenec, Michal/B-1666-2012; Daly, Mark J/B-2453-2017	Lernmark, Åke/0000-0003-1735-0499; Pravenec, Michal/0000-0001-9197-5871; Daly, Mark J/0000-0002-0949-8752; Brown, Donna/0000-0002-8805-7225				BARGOU RCEF, 1991, GENE, V99, P197, DOI 10.1016/0378-1119(91)90127-W; BUARD J, 1994, EMBO J, V13, P3203, DOI 10.1002/j.1460-2075.1994.tb06619.x; CHING GY, 1991, J BIOL CHEM, V266, P19459; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; COX JL, 1992, GENE, V110, P175, DOI 10.1016/0378-1119(92)90645-6; CROW JF, 1993, ENVIRON MOL MUTAGEN, V21, P122, DOI 10.1002/em.2850210205; CROW JF, 1993, ENVIRON MOL MUTAGEN, V21, P389; DAMBROSIO E, 1986, MOL CELL BIOL, V6, P411, DOI 10.1128/MCB.6.2.411; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; DAS AT, 1993, EUR J BIOCHEM, V211, P795, DOI 10.1111/j.1432-1033.1993.tb17611.x; DEUCHARS KL, 1992, BIOCHIM BIOPHYS ACTA, V1130, P157, DOI 10.1016/0167-4781(92)90523-3; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH WF, 1994, NAT GENET, V7, P220, DOI 10.1038/ng0694supp-220; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; GILGOMEZ G, 1993, EUR J BIOCHEM, V213, P773, DOI 10.1111/j.1432-1033.1993.tb17819.x; GOLDMUNTZ EA, 1993, GENOMICS, V16, P761, DOI 10.1006/geno.1993.1261; GREENHOUSE DD, 1990, GENETIC MONITORING I; HOFKER MH, 1986, AM J HUM GENET, V39, P438; HOLLOWAY MP, 1993, THESIS SUNY STONY BR; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; KURAMOTO T, 1994, GENOMICS, V19, P358, DOI 10.1006/geno.1994.1069; KURTZ TW, 1991, GENETIC APPROACHES C, P38; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LEESMILLER JP, 1990, J MOL BIOL, V213, P399, DOI 10.1016/S0022-2836(05)80202-5; LEVAN G, 1990, LOCUS MAPS COMPLEX G; LEVAN G, 1992, LOCUS MAPS COMPLEX G; LEVIN MS, 1987, J BIOL CHEM, V262, P7118; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; Lindsey J. R., 1979, The laboratory rat. Volume I. Biology and diseases., P1; MATSUYAMA M, 1990, NEPHRON, V54, P334, DOI 10.1159/000185890; MOTOJIMA K, 1990, FEBS LETT, V264, P156, DOI 10.1016/0014-5793(90)80789-L; OZER J, 1993, GENE, V133, P187, DOI 10.1016/0378-1119(93)90637-I; PETTERSSON S, 1990, NATURE, V344, P165, DOI 10.1038/344165a0; PRAVENEC M, 1989, J HYPERTENS, V7, P217; RICHTER G, 1990, Cytokine, V2, P221, DOI 10.1016/1043-4666(90)90020-T; Robinson R., 1965, GENETICS NORWAY RAT; Sambrook J, 1989, MOL CLONING LABORATO; SERIKAWA T, 1992, GENETICS, V131, P701; SHIER P, 1992, MOL ENDOCRINOL, V6, P723, DOI 10.1210/me.6.5.723; SPRENGEL R, 1989, J BIOL CHEM, V264, P20415; SZPIRER J, 1984, CYTOGENET CELL GENET, V38, P142, DOI 10.1159/000132047; TAY A, IN PRESS GENOMICS; WATANABE N, 1988, EUR J BIOCHEM, V174, P125, DOI 10.1111/j.1432-1033.1988.tb14071.x; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; YAMADA J, 1994, MAMM GENOME, V5, P63, DOI 10.1007/BF00292332; YOKOYAMA T, 1993, SCIENCE, V260, P679, DOI 10.1126/science.8480178; ZHA H, 1993, CYTOGENET CELL GENET, V63, P117, DOI 10.1159/000133514; 1993, ILAR NEWS, V34, pS1	49	441	449	0	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	1995	9	1					63	69		10.1038/ng0195-63	http://dx.doi.org/10.1038/ng0195-63			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704027				2022-12-25	WOS:A1995PZ91300016
J	UEDA, H; ULLRICH, SJ; GANGEMI, JD; KAPPEL, CA; NGO, L; FEITELSON, MA; JAY, G				UEDA, H; ULLRICH, SJ; GANGEMI, JD; KAPPEL, CA; NGO, L; FEITELSON, MA; JAY, G			FUNCTIONAL INACTIVATION BUT NOT STRUCTURAL MUTATION OF P53 CAUSES LIVER-CANCER	NATURE GENETICS			English	Article							HEPATITIS-B VIRUS; PRIMARY HEPATOCELLULAR CARCINOMAS; TRANSFORMATION-RELATED PROTEIN; TUMOR-SUPPRESSOR GENE; ALPHA-B/D HYBRID; X-PROTEIN; SV40-TRANSFORMED CELLS; MONOCLONAL-ANTIBODY; TRANS-ACTIVATION; HOST PROTEIN	Structural mutations in the p53 gene are seen in virtually every form of human cancer. To determine whether such mutations are important for initiating tumorigenesis, we have been studying hepatocellular carcinoma, in which most cases are associated with chronic hepatitis B virus infections. Using a transgenic mouse model where expression of a single HBV gene product, the HBx protein, induces progressive changes in the liver, we show that tumour development correlates precisely with p53 binding to HBx in the cytoplasm and complete blockage of p53 entry into the nucleus. Analysis of tumour cell DNA shows no evidence for p53 mutation, except in advanced tumours where a small proportion of cells may have acquired specific base substitutions. Our results suggest that genetic changes in p53 are late events which may contribute to tumour progression.	AMER RED CROSS,JEROME H HOLLAND LAB,DEPT VIROL,ROCKVILLE,MD 20855; CLEMSON UNIV,GREENVILLE HOSP SYST,CLEMSON,SC 29634; THOMAS JEFFERSON UNIV,DEPT PATHOL & CELL BIOL,PHILADELPHIA,PA 19107	American Red Cross; Clemson University; Jefferson University			Jay, Gregory/C-6346-2013	Jay, Gregory/0000-0003-1517-8488				BARAK Y, 1992, EMBO J, V11, P2115, DOI 10.1002/j.1460-2075.1992.tb05270.x; Beasley R.P., 1984, VIRAL HEPATITIS LIVE, P209; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; BUETOW KH, 1992, P NATL ACAD SCI USA, V89, P9622, DOI 10.1073/pnas.89.20.9622; COLGROVE R, 1989, J VIROL, V63, P4019, DOI 10.1128/JVI.63.9.4019-4026.1989; CRAWFORD LV, 1981, P NATL ACAD SCI-BIOL, V78, P41, DOI 10.1073/pnas.78.1.41; CROSS JC, 1993, P NATL ACAD SCI USA, V90, P8078, DOI 10.1073/pnas.90.17.8078; DELEO AB, 1979, P NATL ACAD SCI USA, V76, P2420, DOI 10.1073/pnas.76.5.2420; DIPPOLD WG, 1981, P NATL ACAD SCI-BIOL, V78, P1695, DOI 10.1073/pnas.78.3.1695; FEITELSON MA, 1993, ONCOGENE, V8, P1109; FELTELSON MA, 1990, VIROLOGY, V177, P367; FUJIYAMA A, 1983, NUCLEIC ACIDS RES, V11, P4601, DOI 10.1093/nar/11.13.4601; GANGEMI JD, 1989, J INTERFERON RES, V9, P227, DOI 10.1089/jir.1989.9.227; GREENBLATT MS, 1994, CANCER RES, V54, P4855; GUTIERREZ MI, 1992, CANCER RES, V52, P1032; HALEVY O, 1991, ONCOGENE, V6, P1593; HARLOW E, 1981, J VIROL, V39, P861, DOI 10.1128/JVI.39.3.861-869.1981; HARRIS CC, 1993, NEW ENGL J MED, V329, P1318, DOI 10.1056/NEJM199310283291807; HORISBERGER MA, 1987, J GEN VIROL, V68, P945, DOI 10.1099/0022-1317-68-3-945; HOSONO S, 1991, ONCOGENE, V6, P237; HSU HC, 1993, CANCER RES, V53, P4691; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; JAY G, 1979, COLD SPRING HARB SYM, V44, P659; JAY G, 1981, P NATL ACAD SCI USA, V78, P2931; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEE TH, 1990, J VIROL, V64, P5939, DOI 10.1128/JVI.64.12.5939-5947.1990; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; NISHIDA N, 1993, CANCER RES, V53, P358; ODA T, 1992, CANCER RES, V52, P6358; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PERRILLO RP, 1993, DIGEST DIS SCI, V38, P577, DOI 10.1007/BF01316785; PIETENPOL JA, 1993, NATURE, V365, P17, DOI 10.1038/365017a0; POPPER H, 1987, HEPATOLOGY, V7, P764, DOI 10.1002/hep.1840070425; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SCHEK N, 1991, ONCOGENE, V6, P1735; SETO E, 1988, P NATL ACAD SCI USA, V85, P8286, DOI 10.1073/pnas.85.21.8286; SHEU JC, 1992, CANCER RES, V52, P6098; SPANDAU DF, 1988, J VIROL, V62, P427, DOI 10.1128/JVI.62.2.427-434.1988; SZEKELY L, 1993, P NATL ACAD SCI USA, V90, P5455, DOI 10.1073/pnas.90.12.5455; TANAKA S, 1993, CANCER RES, V53, P2884; TERAMOTO T, 1994, CANCER RES, V54, P231; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; TURKASPA R, 1990, J VIROL, V64, P1821, DOI 10.1128/JVI.64.4.1821-1824.1990; TWU JS, 1987, J VIROL, V61, P3448, DOI 10.1128/JVI.61.11.3448-3453.1987; ULLRICH SJ, 1992, J BIOL CHEM, V267, P15259; ULLRICH SJ, 1993, P NATL ACAD SCI USA, V90, P5954, DOI 10.1073/pnas.90.13.5954; UNSAL H, 1994, P NATL ACAD SCI USA, V91, P822, DOI 10.1073/pnas.91.2.822; WANG XW, 1994, P NATL ACAD SCI USA, V91, P2230, DOI 10.1073/pnas.91.6.2230; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286	53	338	343	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					41	47		10.1038/ng0195-41	http://dx.doi.org/10.1038/ng0195-41			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704023				2022-12-25	WOS:A1995PZ91300013
J	STOFFEL, M; PATEL, P; LO, YMD; HATTERSLEY, AT; LUCASSEN, AM; PAGE, R; BELL, JI; BELL, GI; TURNER, RC; WAINSCOAT, JS				STOFFEL, M; PATEL, P; LO, YMD; HATTERSLEY, AT; LUCASSEN, AM; PAGE, R; BELL, JI; BELL, GI; TURNER, RC; WAINSCOAT, JS			MISSENSE GLUCOKINASE MUTATION IN MATURITY-ONSET DIABETES OF THE YOUNG AND MUTATION SCREENING IN LATE-ONSET DIABETES	NATURE GENETICS			English	Article							GENE; HEXOKINASE; MELLITUS; SEQUENCE; CLONING; FAMILY; CDNA	We describe a codon 299 mutation in the glucokinase gene in a British pedigree with maturity-onset diabetes of the young (MODY) resulting in a substitution of glycine to arginine. One out of fifty patients diagnosed with classical late-onset type 2 diabetes mellitus was also found to have this mutation. All nine relatives of this patient who have inherited the mutation have type 2 diabetes, although six others without the mutation are also present with diabetes. The discovery that glucokinase mutations can cause MODY and was also found in ten affected members of a pedigree with type 2 diabetes in which MODY had not previously been considered indicates that diagnosis based on molecular pathology will be helpful in understanding the aetiology of type 2 diabetes.	UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637; RADCLIFFE INFIRM,DIABET RES LABS,OXFORD OX2 6HE,ENGLAND; JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL & BACTERIOL,OXFORD OX3 9DU,ENGLAND; JOHN RADCLIFFE HOSP,DEPT HAEMATOL,OXFORD OX3 9DU,ENGLAND; UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,CHICAGO,IL 60637; UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637	Howard Hughes Medical Institute; University of Chicago; Radcliffe Infirmary; University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Chicago; University of Chicago			Lo, Yuk Ming Dennis/D-4468-2011; Lucassen, Anneke/D-7764-2017	Lo, Yuk Ming Dennis/0000-0001-8746-0293; Stoffel, Markus/0000-0003-1304-5817; Hattersley, Andrew/0000-0001-5620-473X; Lucassen, Anneke/0000-0003-3324-4338	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDREONE TL, 1989, J BIOL CHEM, V264, P363; ARORA KK, 1990, J BIOL CHEM, V265, P6481; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; FAJANS SS, 1990, DIABETES CARE, V13, P49, DOI 10.2337/diacare.13.1.49; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LO YMD, 1992, NUCLEIC ACIDS RES, V20, P1005, DOI 10.1093/nar/20.5.1005; MEGLASSON MD, 1984, AM J PHYSIOL, V246, pE1, DOI 10.1152/ajpendo.1984.246.1.E1; NISHI S, 1988, BIOCHEM BIOPH RES CO, V157, P937, DOI 10.1016/S0006-291X(88)80964-1; ORAHILLY S, 1988, DIABETOLOGIA, V31, P792; ORAHILLY S, 1989, DIABETOLOGIA, V32, P266, DOI 10.1007/BF00285296; ORAHILLY S, 1988, DIABETOLOGIA, V31, P407, DOI 10.1007/BF00271584; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; Prospective U. K., 1991, DIABETOLOGIA, V34, P877; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STOFFEL M, IN PRESS P NATN ACAD; TANIZAWA Y, 1991, P NATL ACAD SCI USA, V88, P7294, DOI 10.1073/pnas.88.16.7294; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0	20	121	122	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					153	156		10.1038/ng1092-153	http://dx.doi.org/10.1038/ng1092-153			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303265				2022-12-25	WOS:A1992JR08400017
J	SUPER, M; GILLIES, SD; FOLEY, S; SASTRY, K; SCHWEINLE, JE; SILVERMAN, VJ; EZEKOWITZ, RAB				SUPER, M; GILLIES, SD; FOLEY, S; SASTRY, K; SCHWEINLE, JE; SILVERMAN, VJ; EZEKOWITZ, RAB			DISTINCT AND OVERLAPPING FUNCTIONS OF ALLELIC FORMS OF HUMAN MANNOSE BINDING-PROTEIN	NATURE GENETICS			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; CLASSICAL PATHWAY; HUMAN-SERUM; MANNAN; COMPLEMENT; IMMUNODEFICIENCY; SEQUENCE; LECTINS; ZYMOSAN; DEFECT	Human mannose binding protein (MBP) is a C-type serum lectin involved in first-line host defense against a variety of bacterial, fungal and viral pathogens. Recently an association was found between low levels of serum MBP and an increased frequency of recurrent infections in infants. A particular genotype, in which glycine is substituted by aspartic acid at codon 54 of MBP in the fifth collagen repeat, shows apparent concordance with the clinical phenotype. We report, however, that this genotype occurs in 5% of the population and encodes a functional protein. Our results indicate that the Gly54Asp allele does not account for a deficiency state, but instead suggest that MBP may have two predominant allelic forms that have overlapping function and differ only in their ability to activate the classical pathway of complement.	HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; ABBOTT BIOTECH INC,NEEDHAM,MA; YALE UNIV,SCH MED,DEPT INTERNAL MED,DIV INFECT DIS,NEW HAVEN,CT 06510; BOSTON UNIV,SCH MED,DIV HEMATOL ONCOL,BOSTON,MA 02118	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Yale University; Boston University	SUPER, M (corresponding author), HARVARD UNIV,CHILDRENS HOSP,DEPT PEDIAT,DIV HEMATOL ONCOL,BOSTON,MA 02115, USA.		Super, Michael/AAW-7952-2021					BENSON B, 1985, P NATL ACAD SCI USA, V82, P6379, DOI 10.1073/pnas.82.19.6379; CHILDS RA, 1990, J BIOL CHEM, V265, P20770; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; EZEKOWITZ R A B, 1991, Current Biology, V1, P60; EZEKOWITZ R A B, 1992, Current Biology, V2, P147, DOI 10.1016/0960-9822(92)90266-D; EZEKOWITZ RAB, 1988, J EXP MED, V167, P1034, DOI 10.1084/jem.167.3.1034; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; FLOROS J, 1986, J BIOL CHEM, V261, P9029; GILLIES SD, 1989, BIO-TECHNOL, V7, P799, DOI 10.1038/nbt0889-799; HAMMARSTROM L, 1986, IMMUNOGLOBULIN SUBCL, P50; HIGUCHI R, 1989, AMPLIFICATIONS, V2, P1; IKEDA K, 1987, J BIOL CHEM, V262, P7451; JACENKO O, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P327; JANEWAY CA, 1989, APPROACHING ASYMPTOT, P1; KAWASAKI N, 1983, J BIOCHEM, V94, P937, DOI 10.1093/oxfordjournals.jbchem.a134437; KAWASAKI T, 1978, BIOCHEM BIOPH RES CO, V81, P1018, DOI 10.1016/0006-291X(78)91452-3; KOZUTSUMI Y, 1980, BIOCHEM BIOPH RES CO, V95, P658, DOI 10.1016/0006-291X(80)90836-0; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LU J, 1990, J IMMUNOL, V144, P2287; MALHOTRA R, 1990, J EXP MED, V172, P955, DOI 10.1084/jem.172.3.955; MIZUNO Y, 1981, J BIOL CHEM, V256, P4247; OHTA M, 1990, J BIOL CHEM, V265, P1980; REID KBM, 1985, BIOCHEM J, V231, P729, DOI 10.1042/bj2310729; SCHWEINLE JE, 1989, J CLIN INVEST, V84, P1821, DOI 10.1172/JCI114367; SHYUR SD, 1991, PEDIATR INFECT DIS J, V10, P595, DOI 10.1097/00006454-199108000-00009; SUMIYA M, 1991, LANCET, V337, P1569, DOI 10.1016/0140-6736(91)93263-9; SUPER M, 1989, LANCET, V2, P1236; SUPER M, 1990, CLIN EXP IMMUNOL, V79, P144; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241	30	136	139	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1992	2	1					50	55		10.1038/ng0992-50	http://dx.doi.org/10.1038/ng0992-50			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JM646	1303250				2022-12-25	WOS:A1992JM64600016
J	LI, YB; HUANG, TT; CARLSON, EJ; MELOV, S; URSELL, PC; OLSON, TL; NOBLE, LJ; YOSHIMURA, MP; BERGER, C; CHAN, PH; WALLACE, DC; EPSTEIN, CJ				LI, YB; HUANG, TT; CARLSON, EJ; MELOV, S; URSELL, PC; OLSON, TL; NOBLE, LJ; YOSHIMURA, MP; BERGER, C; CHAN, PH; WALLACE, DC; EPSTEIN, CJ			DILATED CARDIOMYOPATHY AND NEONATAL LETHALITY IN MUTANT MICE LACKING MANGANESE SUPEROXIDE-DISMUTASE	NATURE GENETICS			English	Article							SUCCINATE-DEHYDROGENASE; MITOCHONDRIAL; MYOPATHY; EXPRESSION; DISEASE; INJURY	The Sod2 gene for Mn-superoxide dismutase (MnSOD), an intramitochondrial free radical scavenging enzyme that is the first line of defense against superoxide produced as a byproduct of oxidative phosphorylation, was inactivated by homologous recombination. Homozygous mutant mice die within the first 10 days of life with a dilated cardiomyopathy, accumulation of lipid in liver and skeletal muscle, and metabolic acidosis. Cytochemical analysis revealed a severe reduction in succinate dehydrogenase (complex II) and aconitase (a TCA cycle enzyme) activities in the heart and, to a lesser extent, in other organs. These findings indicate that MnSOD is required for normal biological function of tissues by maintaining the integrity of mitochondrial enzymes susceptible to direct inactivation by superoxide.	UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT NEUROSURG,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143; EMORY UNIV,SCH MED,DEPT GENET & MOLEC MED,ATLANTA,GA 30322	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Emory University			Melov, Simon/AAC-9469-2020	Melov, Simon/0000-0001-8554-2834	NIA NIH HHS [AG10130, AG13154, AG08938] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG010130, P01AG008938, R01AG013154] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKASHI M, 1995, J BIOL CHEM, V270, P15864, DOI 10.1074/jbc.270.26.15864; BORGSTAHL GEO, 1992, CELL, V71, P107, DOI 10.1016/0092-8674(92)90270-M; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; CHAN PH, 1994, BRAIN PATHOL, V4, P59; CHEN S, 1993, PCR PROTOCOLS CURREN, V15, P75; CHEN Y, 1994, FREE RADICAL BIO MED, V17, P529, DOI 10.1016/0891-5849(94)90092-2; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; DAVIS JM, 1993, J APPL PHYSIOL, V74, P2234, DOI 10.1152/jappl.1993.74.5.2234; DEROSA G, 1979, BIOCHIM BIOPHYS ACTA, V566, P32, DOI 10.1016/0005-2744(79)90245-6; EULER DE, 1995, AM J PHYSIOL-HEART C, V268, pH295, DOI 10.1152/ajpheart.1995.268.1.H295; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; Fridovich I., 1982, SUPEROXIDE DISMUTASE, V1, P69; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; HALLIWELL B, 1993, HAEMOSTASIS, V1, P118; HARRIS CA, 1991, J IMMUNOL, V147, P149; JENNER P, 1994, LANCET, V344, P796, DOI 10.1016/S0140-6736(94)92347-7; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LINDERHOLM H, 1990, J INTERN MED, V228, P43, DOI 10.1111/j.1365-2796.1990.tb00191.x; MULLERHOCKER J, 1991, VIRCHOWS ARCH A, V419, P355, DOI 10.1007/BF01606527; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; REICHMANN H, 1994, EUR NEUROL, V34, P95; RIFAI Z, 1995, ANN NEUROL, V37, P24, DOI 10.1002/ana.410370107; SARNAJA M, 1994, FREE RADICAL BIO MED, V16, P255; SATO M, 1995, ARCH BIOCHEM BIOPHYS, V316, P738, DOI 10.1006/abbi.1995.1098; STCLAIR DK, 1994, FREE RADICAL BIO MED, V16, P275, DOI 10.1016/0891-5849(94)90153-8; ZHANG Y, 1990, J BIOL CHEM, V265, P16330; ZHENG X, 1989, NEUROLOGY, V39, P1203, DOI 10.1212/WNL.39.9.1203	31	1350	1391	0	76	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					376	381		10.1038/ng1295-376	http://dx.doi.org/10.1038/ng1295-376			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493016				2022-12-25	WOS:A1995TH62900013
J	LISMAN, J; FAIN, G				LISMAN, J; FAIN, G			SUPPORT FOR THE EQUIVALENT LIGHT HYPOTHESIS FOR RP	NATURE MEDICINE			English	Editorial Material							RETINITIS-PIGMENTOSA; RETINAL DEGENERATION		BRANDEIS UNIV,CTR COMPLEX SYST,WALTHAM,MA 02254; UNIV CALIF LOS ANGELES,DEPT PHYS SCI,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,DEPT OPHTHALMOL,LOS ANGELES,CA 90024	Brandeis University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	LISMAN, J (corresponding author), BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254, USA.			Fain, Gordon/0000-0002-9813-0342				BAUER PJ, 1988, J PHYSIOL-LONDON, V401, P309, DOI 10.1113/jphysiol.1988.sp017164; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; CARETTA A, 1989, J CELL BIOL, V108, P1517, DOI 10.1083/jcb.108.4.1517; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; FAIN GL, 1993, EXP EYE RES, V57, P335, DOI 10.1006/exer.1993.1132; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; LI ZY, 1995, J NEUROSCI, V15, P5429; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Noell W K, 1966, Invest Ophthalmol, V5, P450; PAPERMASTER DS, 1995, NAT MED, V1, P874, DOI 10.1038/nm0995-874; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; RAPP LM, 1980, EFFECTS CONSTANT LIG, P135; SIEVING PA, 1995, P NATL ACAD SCI USA, V92, P880, DOI 10.1073/pnas.92.3.880; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; TRAVIS GH, 1991, NEURON, V6, P61, DOI 10.1016/0896-6273(91)90122-G; ZHUKOVSKY EA, 1991, SCIENCE, V251, P558, DOI 10.1126/science.1990431	17	58	60	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1254	1255		10.1038/nm1295-1254	http://dx.doi.org/10.1038/nm1295-1254			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489404				2022-12-25	WOS:A1995TH78600035
J	GALLIMORE, A; CRANAGE, M; COOK, N; ALMOND, N; BOOTMAN, J; RUD, E; SILVERA, P; DENNIS, M; CORCORAN, T; STOTT, J; MCMICHAEL, A; GOTCH, F				GALLIMORE, A; CRANAGE, M; COOK, N; ALMOND, N; BOOTMAN, J; RUD, E; SILVERA, P; DENNIS, M; CORCORAN, T; STOTT, J; MCMICHAEL, A; GOTCH, F			EARLY SUPPRESSION OF SIV REPLICATION BY CD8+ NEF-SPECIFIC CYTOTOXIC T-CELLS IN VACCINATED MACAQUES	NATURE MEDICINE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; LYMPHOCYTES-T; MONKEYS; GENE; INVITRO; PROTEIN; AIDS	In order to develop a successful subunit vaccine against infection with the human immunodeficiency virus (HIV), protective immune effector functions must be identified. Until now, there has been only indirect evidence that HIV-specific cytotoxic T lymphocytes (CTLs) fulfill this role. Using the macaque simian immunodeficiency virus (SIV) model, the protective potential of nef-specific CTLs, stimulated by vaccination, was examined in animals challenged with a high intravenous dose of the pathogenic simian immunodeficiency virus, SIVmac251(32H)(pJ5). An inverse correlation was found between the vaccine-induced nef-specific CTL precursor frequency and virus load measured after challenge. In addition, the early decline in viraemia, observed in both vaccinated and unvaccinated control animals was associated with the development of virus-specific CTL activity and not with the presence of virus-specific neutralizing; antibodies. The results imply that vaccines that stimulate strong CTL responses could protect against HIV infection.	JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC IMMUNOL GRP,OXFORD OX3 9DU,ENGLAND; CTR APPL MICROBIOL & RES,SALISBURY SP4 0JG,WILTS,ENGLAND; NATL INST BIOL STAND & CONTROLS,AIDS COLLABORATING CTR,POTTERS BAR EN6 3QG,HERTS,ENGLAND; NATL INST BIOL STAND & CONTROLS,DIV IMMUNOBIOL,POTTERS BAR EN6 3QG,HERTS,ENGLAND; DEPT HLTH & WELF,LAB CTR DIS CONTROL,BUR HIV AIDS,OTTAWA,ON K1A 0L2,CANADA	University of Oxford; National Institute for Biological Standards & Control; National Institute for Biological Standards & Control			Rud, Erling/P-5359-2016	Rud, Erling/0000-0001-8615-0277; Gallimore, Awen/0000-0001-6675-7004; Almond, Neil/0000-0001-6105-0616				ABIMIKU AG, 1995, NAT MED, V1, P321, DOI 10.1038/nm0495-321; AN SF, 1992, MOL CELL PROBE, V6, P193, DOI 10.1016/0890-8508(92)90016-Q; ARIYOSHI K, 1995, AIDS, V9, P555, DOI 10.1097/00002030-199506000-00004; BACHMANN MF, 1994, EUR J IMMUNOL, V24, P2228, DOI 10.1002/eji.1830240944; BANGHAM CRM, 1989, T CELLS; BOOTMAN JS, 1992, J VIROL METHODS, V37, P23, DOI 10.1016/0166-0934(92)90018-9; BOOTMAN JS, 1994, J VIROL METHODS, V49, P1, DOI 10.1016/0166-0934(94)90050-7; BOURGAULT I, 1994, J IMMUNOL, V152, P2530; BRINCHMANN JE, 1990, J IMMUNOL, V144, P2961; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CHAKRABARTI L, 1987, NATURE, V328, P543, DOI 10.1038/328543a0; CULMANN B, 1991, J IMMUNOL, V146, P1560; CULMANNPENCIOLE.B, 1994, J VIROL, V68, P7336; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; GOTCH FM, 1990, INT IMMUNOL, V2, P707, DOI 10.1093/intimm/2.8.707; GOTCH FM, 1991, AIDS, V5, P317, DOI 10.1097/00002030-199103000-00012; KANNAGI M, 1988, J IMMUNOL, V140, P2237; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; LAMHAMEDICHERRA.S, 1992, AIDS, V6, P1249; LEFKOVITS I, 1979, LIMITING DILUTION AN; LETVIN NL, 1985, SCIENCE, V230, P71, DOI 10.1126/science.2412295; LUKACHER AE, 1984, J EXP MED, V160, P814, DOI 10.1084/jem.160.3.814; MACKEWICZ CE, 1991, J CLIN INVEST, V87, P1462, DOI 10.1172/JCI115153; MCMICHAEL AJ, 1994, AIDS S1, V8, pS155; NORUSIS MJ, 1988, SPSS PCPLUS V2 0; NOWAK MA, IN PRESS NATURE; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; ROBERTGUROFF M, 1990, J VIROL, V64, P3391, DOI 10.1128/JVI.64.7.3391-3398.1990; ROSE J, 1995, J VIROL METHODS, V51, P229, DOI 10.1016/0166-0934(94)00109-T; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; ROWLANDJONES S, IN PRESS CURR TOPICS; RUD E, 1994, VACCINES 92 MODERN A, V75, P529; SALUZ H, 1989, P NATL ACAD SCI USA, V86, P2602, DOI 10.1073/pnas.86.8.2602; Sambrook J, 1989, MOL CLONING LABORATO; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; TSUBOTA H, 1989, J EXP MED, V169, P1421, DOI 10.1084/jem.169.4.1421; WALKER CM, 1986, SCIENCE, V234, P1563, DOI 10.1126/science.2431484; YASUTOMI Y, 1993, J VIROL, V67, P1707, DOI 10.1128/JVI.67.3.1707-1711.1993	39	182	187	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1167	1173		10.1038/nm1195-1167	http://dx.doi.org/10.1038/nm1195-1167			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584989				2022-12-25	WOS:A1995TC53700041
J	COYLE, JT				COYLE, JT			FOOD FOR THOUGHT	NATURE MEDICINE			English	Editorial Material							MEMORY				COYLE, JT (corresponding author), HARVARD UNIV,SCH MED,DEPT PSYCHIAT,BOSTON,MA 02178, USA.							BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; COHEN BM, IN PRESS JAMA; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; DRACHMAN DA, 1974, ARCH NEUROL-CHICAGO, V30, P113, DOI 10.1001/archneur.1974.00490320001001; WALD LL, 1995, MAGNET RESON MED, V34, P440, DOI 10.1002/mrm.1910340322; WURTMAN RJ, 1992, TRENDS NEUROSCI, V15, P117, DOI 10.1016/0166-2236(92)90351-8	6	0	0	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	OCT	1995	1	10					1006	1007		10.1038/nm1095-1006	http://dx.doi.org/10.1038/nm1095-1006			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489354				2022-12-25	WOS:A1995RX95100038
J	OSBORN, JE				OSBORN, JE			HIV - THE MORE THINGS CHANGE, THE MORE THEY STAY THE SAME	NATURE MEDICINE			English	Editorial Material											OSBORN, JE (corresponding author), UNIV MICHIGAN,SCH PUBL HLTH,ANN ARBOR,MI 48109, USA.							ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; COUTOFERNANDEZ JC, 1994, AIDS RES HUM RETROV, V10, P1157, DOI 10.1089/aid.1994.10.1157; DIAZ RS, 1995, J VIROL, V69, P3273, DOI 10.1128/JVI.69.6.3273-3281.1995; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8; LOUWAGIE J, 1995, J VIROL, V69, P263, DOI 10.1128/JVI.69.1.263-271.1995; MACHADO AA, 1995, VACCINE, V13, P321, DOI 10.1016/0264-410X(95)93321-Y; SAAG MS, 1988, NATURE, V334, P440, DOI 10.1038/334440a0; SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994; TRAVERS K, 1995, SCIENCE, V268, P1612, DOI 10.1126/science.7539936	10	4	4	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	OCT	1995	1	10					991	993		10.1038/nm1095-991	http://dx.doi.org/10.1038/nm1095-991			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489381				2022-12-25	WOS:A1995RX95100031
J	WANG, T; LAWLER, AM; STEEL, G; SIPILA, I; MILAM, AH; VALLE, D				WANG, T; LAWLER, AM; STEEL, G; SIPILA, I; MILAM, AH; VALLE, D			MICE LACKING ORNITHINE-DELTA-AMINO-TRANSFERASE HAVE PARADOXICAL NEONATAL HYPOORNITHINAEMIA AND RETINAL DEGENERATION	NATURE GENETICS			English	Article							GYRATE ATROPHY; MOUSE INTESTINE; ARGININE; AMINOTRANSFERASE; MUTATIONS; GLUTAMATE; GENE; PYRROLINE-5-CARBOXYLATE; METABOLISM; ACID	Deficiency of ornithine-delta-aminotransferase (OAT) in humans causes hyperornithinaemia and gyrate atrophy (GA), a blinding chorioretinal degeneration. Surprisingly, OAT-deficient mice produced by gene targeting exhibit neonatal hypoornithinaemia and lethality, rescuable by short-term arginine supplementation. Post-weaning, these mice develop hyperornithinaemia similar to human GA patients. Subsequent studies in one human GA infant also showed transient hypoornithinaemia. Thus, the OAT reaction plays opposite roles in neonatal and adult mammals. Over several months, OAT-deficient mice develop a retinal degeneration with involvement of photoreceptors and pigment epithelium. OAT-deficient mice appear to be an excellent model of human GA.	JOHNS HOPKINS UNIV, SCH MED, HOWARD HUGHES MED INST, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT OBSTET & GYNECOL, BALTIMORE, MD 21205 USA; AURORA HOSP, DEPT PEDIAT, SF-00250 HELSINKI, FINLAND; UNIV WASHINGTON, SCH MED, DEPT OPHTHALMOL, SEATTLE, WA 98195 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Washington; University of Washington Seattle					NEI NIH HHS [EY01730, EY01311, EY02948] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY001311, R01EY002948, P30EY001730] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALTMAN PL, 1972, BIOL DATA BOOK, P195; BRODY LC, 1992, J BIOL CHEM, V267, P3302; Brusilow SW, 1991, TECHNIQUES DIAGNOSTI, P345; CAREY GP, 1987, J NUTR, V117, P1734, DOI 10.1093/jn/117.10.1734; DAVIS TA, 1993, J NUTR, V123, P947, DOI 10.1093/jn/123.5.947; HAUSER ER, 1990, NEW ENGL J MED, V322, P1641, DOI 10.1056/NEJM199006073222305; HURWITZ R, 1986, AM J PHYSIOL, V251, pG103, DOI 10.1152/ajpgi.1986.251.1.G103; JONES ME, 1985, J NUTR, V115, P509, DOI 10.1093/jn/115.4.509; KERWIN JF, 1994, MED RES REV, V14, P23, DOI 10.1002/med.2610140103; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; MIGCHIELSEN AAJ, 1995, NAT GENET, V10, P279, DOI 10.1038/ng0795-279; MITCHELL GA, 1988, J CLIN INVEST, V81, P630, DOI 10.1172/JCI113365; MITCHELL GA, 1988, J BIOL CHEM, V263, P14288; MITCHELL GA, 1989, P NATL ACAD SCI USA, V86, P197, DOI 10.1073/pnas.86.1.197; MORRIS JG, 1978, SCIENCE, V199, P431, DOI 10.1126/science.619464; MORRIS JG, 1978, J NUTR, V108, P1944, DOI 10.1093/jn/108.12.1944; PATEJUNAS G, 1994, SOMAT CELL MOLEC GEN, V20, P55, DOI 10.1007/BF02257486; RAMIREZSOLIS R, 1992, ANAL BIOCHEM, V201, P331, DOI 10.1016/0003-2697(92)90347-A; RIBY JE, 1990, PEDIATR RES, V28, P261, DOI 10.1203/00006450-199009000-00022; STEWART PM, 1981, AM J PHYSIOL, V241, pE310, DOI 10.1152/ajpendo.1981.241.4.E310; Valle D, 1995, METABOLIC MOL BASES, V1, P1147; WAKABAYASHI Y, 1991, ARCH BIOCHEM BIOPHYS, V291, P1, DOI 10.1016/0003-9861(91)90097-3; WAKAMIYA M, 1995, P NATL ACAD SCI USA, V92, P3673, DOI 10.1073/pnas.92.9.3673; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; WILSON DJ, 1991, AM J OPHTHALMOL, V111, P24, DOI 10.1016/S0002-9394(14)76892-8; WINDMUELLER HG, 1975, ARCH BIOCHEM BIOPHYS, V171, P662, DOI 10.1016/0003-9861(75)90078-8	29	72	74	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1995	11	2					185	190		10.1038/ng1095-185	http://dx.doi.org/10.1038/ng1095-185			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550347				2022-12-25	WOS:A1995RX80600021
J	HORINOUCHI, K; ERLICH, S; PERL, DP; FERLINZ, K; BISGAIER, CL; SANDHOFF, K; DESNICK, RJ; STEWART, CL; SCHUCHMAN, EH				HORINOUCHI, K; ERLICH, S; PERL, DP; FERLINZ, K; BISGAIER, CL; SANDHOFF, K; DESNICK, RJ; STEWART, CL; SCHUCHMAN, EH			ACID SPHINGOMYELINASE DEFICIENT MICE - A MODEL OF TYPE-A AND TYPE-B NIEMANN-PICK DISEASE	NATURE GENETICS			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; STEM-CELLS; RAT-BRAIN; GENE; MOUSE; ORGANIZATION; EXPRESSION; SMPD1	Types A and B Niemann-Pick disease (NPD) result from the deficient activity of acid sphingomyelinase (ASM). An animal model of NPD has been created by gene targeting. In affected animals, the disease followed a severe, neurodegenerative course and death occurred by eight months of age. Analysis of these animals showed their tissues had no detectable ASM activity, the blood cholesterol levels and sphingomyelin in the liver and brain were elevated, and atrophy of the cerebellum and marked deficiency of Purkinje cells was evident. Microscopic analysis revealed 'NPD cells' in reticuloendothelial organs and characteristic NPD lesions in the brain. Thus, the ASM deficient mice should be of great value for studying the pathogenesis and treatment of NPD, and for investigations into the role of ASM in signal transduction and apoptosis.	MT SINAI SCH MED, DEPT HUMAN GENET, NEW YORK, NY 10029 USA; MT SINAI SCH MED, DEPT PATHOL, NEW YORK, NY 10029 USA; UNIV BONN, INST ORGAN CHEM & BIOCHEM, W-5300 BONN, GERMANY; PARKE DAVIS PHARMACEUT RES, DEPT ATHEROSCLEROSIS THERAPEUT, ANN ARBOR, MI 48105 USA; ROCHE INST MOLEC BIOL, ROCHE RES CTR, DEPT CELL BIOL & DEV BIOL, NUTLEY, NJ 07110 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Bonn; Pfizer; Roche Holding			Perl, Daniel/GPS-9879-2022		NICHD NIH HHS [1 R01 HD28607] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028607] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AALTOSETALA K, 1994, J CLIN INVEST, V93, P1776, DOI 10.1172/JCI117163; ALTAIN CC, 1974, CLIN CHEM, V20, P470; BISHOP DF, 1981, J BIOL CHEM, V256, P1307; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; DINUR T, 1992, HUM GENE THER, V3, P633, DOI 10.1089/hum.1992.3.6-633; GATT S, 1978, J NEUROCHEM, V31, P547, DOI 10.1111/j.1471-4159.1978.tb02671.x; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HORINOUCHI K, 1993, GENOMICS, V18, P450, DOI 10.1006/geno.1993.1497; KANFER JN, 1966, J BIOL CHEM, V241, P1081; KIEFT KA, 1991, J LIPID RES, V32, P859; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; KONTGEN F, 1993, METHOD ENZYMOL, V225, P878; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARUYAMA EN, 1989, J NEUROCHEM, V52, P611, DOI 10.1111/j.1471-4159.1989.tb09163.x; NEWRZELLA D, 1992, BIOL CHEM H-S, V373, P1233, DOI 10.1515/bchm3.1992.373.2.1233; PEREIRA LD, 1991, GENOMICS, V9, P229, DOI 10.1016/0888-7543(91)90246-B; QUINTERN LE, 1991, METHOD ENZYMOL, V197, P536; RAO BG, 1976, J LIPID RES, V17, P506; SALKI RK, 1988, SCIENCE, V239, P487; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER PB, 1967, J LIPID RES, V8, P202; SCHUCHMAN EH, 1992, GENOMICS, V12, P197, DOI 10.1016/0888-7543(92)90366-Z; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; SCHUCHMAN EH, 1994, METABOLIC MOL BASES, P2601; STEWART CL, 1987, EMBO J, V6, P383, DOI 10.1002/j.1460-2075.1987.tb04766.x; STEWART CL, 1993, METHOD ENZYMOL, V225, P825; SUCHI M, 1992, P NATL ACAD SCI USA, V89, P3227, DOI 10.1073/pnas.89.8.3227; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; YEDGAR S, 1976, BIOCHEMISTRY-US, V15, P2570, DOI 10.1021/bi00657a013	31	393	415	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1995	10	3					288	293		10.1038/ng0795-288	http://dx.doi.org/10.1038/ng0795-288			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670466				2022-12-25	WOS:A1995RG38600011
J	MARGOLICK, JB; MUNOZ, A; DONNENBERG, AD; PARK, LP; GALAI, N; GIORGI, JV; OGORMAN, MRG; FERBAS, J				MARGOLICK, JB; MUNOZ, A; DONNENBERG, AD; PARK, LP; GALAI, N; GIORGI, JV; OGORMAN, MRG; FERBAS, J			FAILURE OF T-CELL HOMEOSTASIS PRECEDING AIDS IN HIV-1 INFECTION	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PERIPHERAL-BLOOD; LYMPHOCYTES-T; DISEASE; SEROCONVERSION; PROGRESSION; RESPONSES	We and others have postulated that a constant number of T lymphocytes is normally maintained without regard to CD4(+) or CD8(+) phenotype ('blind' T-cell homeostasis). Here we confirm essentially constant T-cell levels (despite marked decline in CD4(+) T cells and increase in CD8(+) T cells) in homosexual men with incident human immunodeficiency virus, type 1 (HIV-1), infection who remained free of acquired immunodeficiency syndrome (AIDS) for up to eight years after seroconversion. In contrast, seroconverters who developed AIDS exhibited rapidly declining T cells (both CD4(+) and CD8(+)) for approximately two years before AIDS, independent of the time between seroconversion and AIDS, suggesting that homeostasis failure is an important landmark in HIV disease progression. Given the high rate of T-cell turnover in HIV-1 infection, blind T-cell homeostasis may contribute to HIV pathogenesis through a CD8(+) T lymphocytosis that interferes with regeneration of lost CD4(+) T cells.	JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,BALTIMORE,MD 21205; MONTEFIORE UNIV HOSP,PITTSBURGH,PA 15213; HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT ECOL MED,IL-91120 JERUSALEM,ISRAEL; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024; NORTHWESTERN UNIV,DEPT PEDIAT,CHICAGO,IL 60614	Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University	MARGOLICK, JB (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT MOLEC BIOL & IMMUNOL,ROOM 7032,615 N WOLFE ST,BALTIMORE,MD 21205, USA.		Galai, Noya/HII-8086-2022; Gange, Stephen/AGY-5004-2022	Gange, Stephen/0000-0001-7842-512X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI072631, N01AI072634, N01AI032535] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 32535, AI 72631, AI 72634] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALDEMAN LM, 1993, J ACQ IMMUN DEF SYND, V6, P144; ALDEMAN LM, 1993, 1ST NATN C HUM RETR; ASCHER MS, 1990, J ACQ IMMUN DEF SYND, V3, P177; DONNENBERG AD, 1995, RES IMMUNOL, V146, P11, DOI 10.1016/0923-2494(96)80236-7; DONNENBERG AD, IN PRESS ANN NY ACAD; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; GALAI N, 1993, STAT MED, V12, P2133, DOI 10.1002/sim.4780122207; GIORGI JV, 1994, AIDS S1, V8, pS183; GIORGI JV, 1900, CLIN IMMUNOL IMMUNOP, V55, P173; GOUGEON ML, 1993, SCIENCE, V260, P1269, DOI 10.1126/science.8098552; HAUSNER MA, 1993, J IMMUNOL METHODS, V157, P181, DOI 10.1016/0022-1759(93)90085-L; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HO HN, 1993, J IMMUNOL, V150, P3070; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; HOOVER DR, 1992, AM J PUBLIC HEALTH, V82, P1538, DOI 10.2105/AJPH.82.11.1538; KOENIG S, 1988, P NATL ACAD SCI USA, V85, P8638, DOI 10.1073/pnas.85.22.8638; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; LANG W, 1989, J ACQ IMMUN DEF SYND, V2, P63; MACKEWICZ CE, 1991, J CLIN INVEST, V87, P1462, DOI 10.1172/JCI115153; MARGOLICK JB, 1993, J ACQ IMMUN DEF SYND, V6, P153; MARGOLICK JB, 1994, J ACQUIR IMMUN DEFIC, V8, P415; MEUER SC, 1982, J IMMUNOL, V129, P1076; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; SCHENKER EL, 1993, CYTOMETRY, V14, P307, DOI 10.1002/cyto.990140311; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; ZOLLAPAZNER S, 1987, P NATL ACAD SCI USA, V84, P5404, DOI 10.1073/pnas.84.15.5404; 1987, MMWR-MORBID MORTAL W, V36, pS3	29	211	226	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1995	1	7					674	680		10.1038/nm0795-674	http://dx.doi.org/10.1038/nm0795-674			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585150	Bronze			2022-12-25	WOS:A1995RQ06600043
J	JONESCARSON, J; VAZQUEZTORRES, A; VANDERHEYDE, HC; WARNER, T; WAGNER, RD; BALISH, E				JONESCARSON, J; VAZQUEZTORRES, A; VANDERHEYDE, HC; WARNER, T; WAGNER, RD; BALISH, E			GAMMA-DELTA T-CELL-INDUCED NITRIC-OXIDE PRODUCTION ENHANCES RESISTANCE TO MUCOSAL CANDIDIASIS	NATURE MEDICINE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; BLOOD-STAGE MALARIA; GASTROINTESTINAL CANDIDIASIS; LISTERIA-MONOCYTOGENES; MACROPHAGE ACTIVATION; SYSTEMIC CANDIDIASIS; GNOTOBIOTIC MICE; INFECTED MICE; ALPHA-BETA; SCID MICE	Despite the prevalence of gamma delta T cells in mucosae that are typically colonized by Candida albicans, little is known of the possible role of these cells in resistance to candidiasis. A sharp increase in the number of gamma delta T cells and macrophages following intraperitoneal inoculation of mice with C. albicons led us to examine the role of these cells in the immune response to C, albicans. We show that the gamma delta T cells enhance macrophage nitric oxide (NO) production and anti-candida activity, in vitro. We also propose that the gamma delta T cells regulate macrophage function during candidiasis in vivo as well, because depletion of these cells abrogated inducible NO synthase expression in mucosae and enhanced murine susceptibility to candidiasis.	UNIV WISCONSIN,SCH MED,DEPT SURG,MADISON,WI 53706; UNIV WISCONSIN,SCH MED,DEPT MED MICROBIOL,MADISON,WI 53706; UNIV WISCONSIN,SCH MED,DEPT IMMUNOL,MADISON,WI 53706; UNIV WISCONSIN,SCH MED,DEPT SURG PATHOL,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison					NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009659] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE-09659] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BALISH E, 1993, J MED VET MYCOL, V31, P143; BALISH E, 1990, INFECT IMMUN, V58, P107, DOI 10.1128/IAI.58.1.107-113.1990; BECKERMAN KP, 1993, J IMMUNOL, V150, P888; BISTONI F, 1993, J INFECT DIS, V168, P1449, DOI 10.1093/infdis/168.6.1449; BODEY GP, 1992, SEMIN HEMATOL, V19, P196; BOOCKVAR KS, 1994, INFECT IMMUN, V62, P1089, DOI 10.1128/IAI.62.3.1089-1100.1994; CANTORNA M, 1990, INFECT IMMUN, V58, P3813, DOI 10.1128/IAI.58.11.3813-3815.1990; CANTORNA MT, 1991, INFECT IMMUN, V59, P2447, DOI 10.1128/IAI.59.7.2447-2455.1991; CENCI E, 1993, EUR J IMMUNOL, V23, P1034, DOI 10.1002/eji.1830230508; CHAKIR J, 1994, ORAL MICROBIOL IMMUN, V9, P88, DOI 10.1111/j.1399-302X.1994.tb00040.x; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; CHEN JZ, 1993, INT IMMUNOL, V5, P647, DOI 10.1093/intimm/5.6.647; COLE GT, 1992, INFECT IMMUN, V60, P4168, DOI 10.1128/IAI.60.10.4168-4178.1992; CUTLER JE, 1976, J RETICULOENDOTH SOC, V19, P121; Di Rosa R, 1991, Boll Ist Sieroter Milan, V70, P499; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; FIDEL PL, 1994, INFECT IMMUN, V62, P1032, DOI 10.1128/IAI.62.3.1032-1038.1994; FOLLOWS GA, 1992, INFECT IMMUN, V60, P1229, DOI 10.1128/IAI.60.3.1229-1231.1992; FU YX, 1994, J IMMUNOL, V153, P3101; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GREENFIELD RA, 1993, INFECT IMMUN, V61, P2520, DOI 10.1128/IAI.61.6.2520-2525.1993; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; JENSEN J, 1992, INFECT IMMUN, V60, P4549, DOI 10.1128/IAI.60.11.4549-4557.1992; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; LEFRANCOIS L, 1989, SCIENCE, V243, P1716, DOI 10.1126/science.2564701; LORSBACH RB, 1992, INFECT IMMUN, V60, P2133, DOI 10.1128/IAI.60.5.2133-2135.1992; LUNDQVIST C, 1994, J IMMUNOL, V153, P2302; MARODI L, 1993, J CLIN INVEST, V91, P2596, DOI 10.1172/JCI116498; MCMENAMIN C, 1994, SCIENCE, V265, P1869, DOI 10.1126/science.7916481; MIXTER PF, 1994, INFECT IMMUN, V62, P4618, DOI 10.1128/IAI.62.10.4618-4621.1994; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; NARAYANAN R, 1991, INFECT IMMUN, V59, P2116, DOI 10.1128/IAI.59.6.2116-2119.1991; ROMANI L, 1994, J IMMUNOL, V152, P3514; ROMANI L, 1993, INFECT IMMUN, V61, P3769, DOI 10.1128/IAI.61.9.3769-3774.1993; ROSAT JP, 1993, J IMMUNOL, V150, P550; SKEEN MJ, 1993, J EXP MED, V178, P985, DOI 10.1084/jem.178.3.985; STENGER S, 1994, J EXP MED, V180, P783, DOI 10.1084/jem.180.3.783; STERNBERG S, 1994, SCIENCE, V266, P1632, DOI 10.1126/science.7702654; TANOWITZ HB, 1992, MED CLIN N AM, V76, P45, DOI 10.1016/S0025-7125(16)30370-4; TAO X, 1993, EUR J IMMUNOL, V23, P2916, DOI 10.1002/eji.1830231128; VANDERHEYDE HC, 1993, EUR J IMMUNOL, V23, P1846, DOI 10.1002/eji.1830230817; VANDERHEYDE HC, 1993, J IMMUNOL, V151, P6311; VASQUEZTORRES A, IN PRESS J INFECT DI; VAZQUEZTORRES A, 1994, J INFECT DIS, V170, P180, DOI 10.1093/infdis/170.1.180; YAMAMOTO S, 1993, INFECT IMMUN, V61, P2154, DOI 10.1128/IAI.61.5.2154-2161.1993	46	102	104	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1995	1	6					552	557		10.1038/nm0695-552	http://dx.doi.org/10.1038/nm0695-552			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN101	7585122				2022-12-25	WOS:A1995RN10100039
J	THOMPSON, VP				THOMPSON, VP			ANATOMICAL RESEARCH LIVES	NATURE MEDICINE			English	Editorial Material											THOMPSON, VP (corresponding author), UNIV MARYLAND,SCH DENT,DEPT RESTORAT DENT,BALTIMORE,MD 21201, USA.							BOGDUK N, 1992, J MANIP PHYSIOL THER, V15, P67; KIMMEL DL, 1960, NEUROLOGY, V10, P800; RAY BS, 1942, ARCH SURG-CHICAGO, V41, P813	3	7	7	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1995	1	4					297	298		10.1038/nm0495-297	http://dx.doi.org/10.1038/nm0495-297			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585053				2022-12-25	WOS:A1995RN09800019
J	ZUCCOTTI, M; MONK, M				ZUCCOTTI, M; MONK, M			METHYLATION OF THE MOUSE XIST GENE IN SPERM AND EGGS CORRELATES WITH IMPRINTED XIST EXPRESSION AND PATERNAL X-INACTIVATION	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; DNA METHYLATION; EMBRYOS; MECHANISMS	Preferential paternal X-inactivation in the extra-embryonic tissues of the female mouse embryo is correlated with imprinted expression of the paternal allele of the Xist gene in pre-implantation development. Here we examine 11 CpG sites in Xist to determine whether differential methylation might be the molecular basis for imprinting. We find that three sites in the promoter region are methylated in eggs but not in sperm and that this differential methylation is maintained to the blastocyst stage when the paternal X-inactivation occurs. This is the first example of a primary gametic methylation imprint governing differential expression of parental alleles in pre-implantation embryos.	UNIV PAVIA,DIPARTIMENTO BIOL ANIM,I-27100 PAVIA,ITALY; UNIV PAVIA,CNR,CTR STUDI ISTOCHIM,I-27100 PAVIA,ITALY	University of Pavia; Consiglio Nazionale delle Ricerche (CNR); University of Pavia	ZUCCOTTI, M (corresponding author), UNIV LONDON,INST CHILD HLTH,MOLEC EMBRYOL UNIT,30 GUILDFORD ST,LONDON WC1N 1EH,ENGLAND.		Conti, Bice/AAC-7792-2022	Conti, Bice/0000-0002-0034-2815				BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; GRANT M, 1992, NAT GENET, V2, P161, DOI 10.1038/ng1092-161; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; HARPER MI, 1982, J EMBRYOL EXP MORPH, V67, P127; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; LYON MF, 1961, NATURE, V190, P373; MCCARREY JR, 1992, NAT GENET, V2, P200, DOI 10.1038/ng1192-200; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; MONK M, 1987, DEVELOPMENT, V99, P371; MONK M, 1986, BIOESSAYS, V2, P204; MONK M, 1987, MAMMALIAN DEV PRACTI; NORRIS DP, 1994, CELL, V7, P41; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; SALIDO EC, 1992, NAT GENET, V2, P196, DOI 10.1038/ng1192-196; SINGERSAM J, 1990, MOL CELL BIOL, V10, P4987, DOI 10.1128/MCB.10.9.4987; SINGERSAM J, 1989, UCLA S MOL CELL BIOL, P128; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; ZUCCOTTI M, 1993, METHOD ENZYMOL, V225, P557	31	132	135	1	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					316	320		10.1038/ng0395-316	http://dx.doi.org/10.1038/ng0395-316			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773296				2022-12-25	WOS:A1995QL23200024
J	KINGSTON, IB; CASTRO, MJM; ANDERSON, S				KINGSTON, IB; CASTRO, MJM; ANDERSON, S			IN-VITRO STIMULATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY ALZHEIMER AMYLOID BETA-PEPTIDE ANALOGS	NATURE MEDICINE			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; DISEASE; PROTEIN; ANGIOPATHY; BRAIN; PRECURSOR; FIBRIN; CHAIN	We have studied the effects of amyloid beta-peptide analogues on the activity of tissue-type plasminogen activator (t-PA) in vitro. We have found that these peptides have a marked stimulatory effect upon plasminogen activation by t-PA, comparable to that of known stimulators of t-PA. This stimulatory activity appears to increase when beta-peptides form aggregated fibrillar structures similar to those found in amyloid deposits. This finding is significant in that it may provide insights into the pathogenesis of hereditary cerebral haemorrhage with amyloidosis-Dutch type (HCHWA-D) and cerebral amyloid angiopathy-related cerebral haemorrhage. It may also provide an explanation for the deaths resulting from intracerebral haemorrhage that have occurred in patients undergoing t-PA treatment for acute myocardial infarction.	UNIV CAMBRIDGE, DEPT PATHOL, CAMBRIDGE CB2 1QP, ENGLAND; RUTGERS STATE UNIV, DEPT MICROBIOL, NEW BRUNSWICK, NJ 08903 USA; RUTGERS STATE UNIV, DEPT MOLEC BIOL & BIOCHEM, NEW BRUNSWICK, NJ 08903 USA	University of Cambridge; Rutgers State University New Brunswick; Rutgers State University New Brunswick	KINGSTON, IB (corresponding author), CTR ADV BIOTECHNOL & MED, 679 HOES LANE, PISCATAWAY, NJ 08854 USA.				NIA NIH HHS [R01-AG10462, R01-AG11525] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG010462, R01AG011525] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CASTRO MJM, IN PRESS ANAL BIOCH; CHIEN TT, 1984, BLOOD, V63, P1331; CORIA F, 1987, AM J PATHOL, V129, P422; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; GIACCONE G, 1989, NEUROSCI LETT, V97, P232, DOI 10.1016/0304-3940(89)90169-9; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOUST JM, 1984, J NEUROPATH EXP NEUR, V43, P481, DOI 10.1097/00005072-198409000-00003; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HIGGINS DL, 1990, THROMB RES, V57, P527, DOI 10.1016/0049-3848(90)90070-S; HOYLAERTS M, 1982, J BIOL CHEM, V257, P2912; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KASE CS, 1990, ANN INTERN MED, V112, P17, DOI 10.7326/0003-4819-112-1-17; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LIJNEN HR, 1982, SEMIN THROMB HEMOST, V8, P2, DOI 10.1055/s-2007-1005038; LUYENDIJK W, 1988, J NEUROL SCI, V85, P267, DOI 10.1016/0022-510X(88)90186-4; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; NIEUWENHUIZEN W, 1988, EUR J BIOCHEM, V174, P163, DOI 10.1111/j.1432-1033.1988.tb14077.x; PENDLEBURY WW, 1991, ANN NEUROL, V29, P210, DOI 10.1002/ana.410290216; PIKE CJ, 1993, J NEUROSCI, V13, P1676; POWERS JM, 1981, J NEUROPATH EXP NEUR, V40, P592, DOI 10.1097/00005072-198111000-00002; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; SCHIELEN WJG, 1993, FIBRINOLYSIS, V7, P63, DOI 10.1016/0268-9499(93)90057-3; SELKOE DJ, 1989, NEUROBIOL AGING, V10, P387, DOI 10.1016/0197-4580(89)90072-9; SIMMONS LK, 1994, MOL PHARMACOL, V45, P373; STERN RA, 1990, FEBS LETT, V264, P43; TAGLIAVINI F, 1990, LAB INVEST, V62, P761; Tomlinson B.E., 1992, GREENFIELDS NEUROPAT, P1284; TORACK RM, 1975, AM J PATHOL, V81, P349; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503; WATTENDORFF AR, 1982, J NEUROL SCI, V55, P121, DOI 10.1016/0022-510X(82)90094-6; WIJDICKS EFM, 1993, STROKE, V24, P554, DOI 10.1161/01.STR.24.4.554; YAMAGUCHI H, 1992, AM J PATHOL, V141, P249	36	101	108	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	1995	1	2					138	142						5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX558	7585010				2022-12-25	WOS:A1995QX55800024
J	NICOLL, JAR; ROBERTS, GW; GRAHAM, DI				NICOLL, JAR; ROBERTS, GW; GRAHAM, DI			APOLIPOPROTEIN-E EPSILON-4 ALLELE IS ASSOCIATED WITH DEPOSITION OF AMYLOID BETA-PROTEIN FOLLOWING HEAD-INJURY	NATURE MEDICINE			English	Article							ALZHEIMERS-DISEASE; TYPE-4 ALLELE; BRAIN; BINDING; STAGE; RISK; PCR	Deposition of amyloid beta-protein (A beta) in the brain plays a key role in the pathogenesis of Alzheimer's disease. Apolipoprotein E epsilon 4 allele (apo E-epsilon 4) is a strong risk factor for Alzheimer's disease, and there is in vitro evidence that apo E is directly involved in A beta deposition. Head injury is an epidemiological risk factor for Alzheimer's disease and deposition of A beta occurs in approximately one-third of individuals dying after a severe head injury. We report here that the frequency of apo E-epsilon 4 in those individuals with A beta deposition following head injury (0.52) is higher than in most studies of Alzheimer's disease, while in those head-injured individuals without A beta deposition the apo E-epsilon 4 frequency (0.16) is similar to controls without Alzheimer's disease (P < 0.00001). This finding provides further evidence linking apo E-epsilon 4 with A beta deposition in vivo and suggests that known environmental and genetic risk factors for Alzheimer's disease may act additively. In addition our finding indicates a genetic susceptibility to the effects of a head injury.	SMITHKLINE BEECHAM PHARMACEUT,DEPT MOLEC NEUROPATHOL,HARLOW CM19 5AW,ESSEX,ENGLAND	GlaxoSmithKline	NICOLL, JAR (corresponding author), SO GEN HOSP,INST NEUROL SCI,DEPT NEUROPATHOL,GLASGOW G51 4TF,LANARK,SCOTLAND.		Nicoll, James/I-9253-2017	Nicoll, James/0000-0002-9444-7246				ABE K, 1991, NEUROSCI LETT, V125, P172, DOI 10.1016/0304-3940(91)90020-T; Adams JH, 1992, GREENFIELDS NEUROPAT, P106; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; MA JY, 1994, NATURE, V372, P92, DOI 10.1038/372092a0; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; MAYEUX R, 1994, NEUROBIOL AGING, pS73; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; NICOLL JAR, 1992, J NEUROL SCI, V113, P144, DOI 10.1016/0022-510X(92)90242-D; PEACOCK ML, 1994, NEUROLOGY, V44, P339, DOI 10.1212/WNL.44.2.339; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SELKOE DJ, 1994, J NEUROPATH EXP NEUR, V53, P438, DOI 10.1097/00005072-199409000-00003; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019; TSAI MS, 1994, AM J HUM GENET, V54, P643; WENHAM PR, 1991, LANCET, V337, P1158, DOI 10.1016/0140-6736(91)92823-K; Younkin SG, 1991, BRAIN PATHOL, V1, P253, DOI 10.1111/j.1750-3639.1991.tb00668.x	26	416	429	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1995	1	2					135	137		10.1038/nm0295-135	http://dx.doi.org/10.1038/nm0295-135			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX558	7585009				2022-12-25	WOS:A1995QX55800023
J	SHORT, N				SHORT, N			A FIGHT TO THE DEATH	NATURE MEDICINE			English	Editorial Material							INFECTION; HIV	Examination of the effects of three new drugs shows that the destruction of the immune system in AIDS reflects fulminant HIV production, which eventually overwhelms the immune system's prodigious powers of regeneration.			SHORT, N (corresponding author), NATURE,4 LITTLE ESSEX ST,LONDON WCZR 3LF,ENGLAND.							CAO Y, NEWENGL J MED   0126, P332; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; FINKEL TF, 1995, NATURE MED, P1; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; KEMPF D, IN PRESS P NATN ACAD; MERLUZZI VJ, 1990, SCIENCE, V250, P1411, DOI 10.1126/science.1701568; NAJERA I, 1995, J VIROL, V69, P23; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; PANTALEO G, NEW ENGL J MED  0126, P332; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; VACCA JP, 1994, P NATL ACAD SCI USA, V91, P4096, DOI 10.1073/pnas.91.9.4096; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; ZINKERNAGEL RM, 1994, IMMUNOL TODAY, V15, P262, DOI 10.1016/0167-5699(94)90005-1	13	4	4	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1995	1	2					122	124		10.1038/nm0295-122	http://dx.doi.org/10.1038/nm0295-122			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX558	7585006				2022-12-25	WOS:A1995QX55800020
J	GREENBERG, DS; SUNADA, Y; CAMPBELL, KP; YAFFE, D; NUDEL, U				GREENBERG, DS; SUNADA, Y; CAMPBELL, KP; YAFFE, D; NUDEL, U			EXOGENOUS DP71 RESTORES THE LEVELS OF DYSTROPHIN-ASSOCIATED PROTEINS BUT DOES NOT ALLEVIATE MUSCLE DAMAGE IN MDX MICE	NATURE GENETICS			English	Article							BECKER MUSCULAR-DYSTROPHY; GLYCOPROTEIN COMPLEX; SKELETAL-MUSCLE; NEUROMUSCULAR-JUNCTIONS; NONMUSCLE TISSUES; MAJOR PRODUCT; GENE; EXPRESSION; TRANSCRIPT; DEFICIENCY	Dp71 is a non-muscle product of the Duchenne muscular dystrophy gene. It consists of the cysteine-rich and C-terminal domains of dystrophin. We have generated transgenic mdx mice which do not have dystrophin but express Dp71 in their muscle. In these mice, Dp71 was localized to the plasma membrane and restored normal levels of dystrophin associated protiens (DAPs), indicating that Dp71 is capable of interacting with the DAPs in a similar manner to dystrophin. However, the presence of Dp71 and DAPs in the muscle fibres of mdx mice was not sufficient to alleviate symptoms of muscle degeneration.	WEIZMANN INST SCI,DEPT CELL BIOL,IL-76100 REHOVOT,ISRAEL; UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242	Weizmann Institute of Science; Howard Hughes Medical Institute; University of Iowa; University of Iowa				Campbell, Kevin/0000-0003-2066-5889; Greenberg, David/0000-0001-8959-8640				AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; BAR S, 1990, BIOCHEM J, V272, P557, DOI 10.1042/bj2720557; Blake Derek J., 1992, Human Molecular Genetics, V1, P103, DOI 10.1093/hmg/1.2.103; COX GA, 1994, NAT GENET, V8, P334; ELLIS JM, 1990, LANCET, V336, P881, DOI 10.1016/0140-6736(90)92392-U; EMERY AEH, 1987, OXFORD MONOGRAPHS ME; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; HOGAN B, 1986, MANIPULATING MOUSE E; HUGNOT JP, 1992, P NATL ACAD SCI USA, V89, P7506, DOI 10.1073/pnas.89.16.7506; KRAMARCY NR, 1994, J BIOL CHEM, V269, P2870; LEDERFEIN D, 1993, HUM MOL GENET, V2, P1883, DOI 10.1093/hmg/2.11.1883; LEDERFEIN D, 1992, P NATL ACAD SCI USA, V89, P5346, DOI 10.1073/pnas.89.12.5346; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; NICHOLSON LVB, 1993, NEUROPEDIATRICS, V24, P93, DOI 10.1055/s-2008-1071521; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; PONS F, 1991, FEBS LETT, V282, P161, DOI 10.1016/0014-5793(91)80468-I; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; RAPAPORT D, 1993, FEBS LETT, V328, P197, DOI 10.1016/0014-5793(93)80992-4; RAPAPORT D, 1992, DIFFERENTIATION, V49, P187, DOI 10.1111/j.1432-0436.1992.tb00666.x; RAPAPORT D, 1992, J BIOL CHEM, V267, P21289; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; SAMBROOK J, 1992, MOL CLONING LABORATO; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; SUZUKI A, 1992, FEBS LETT, V308, P154, DOI 10.1016/0014-5793(92)81265-N; VAINZOF M, 1993, HUM MOL GENET, V2, P39, DOI 10.1093/hmg/2.1.39; WINNARD AV, 1993, HUM MOL GENET, V2, P737, DOI 10.1093/hmg/2.6.737; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	33	108	114	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					340	344		10.1038/ng1294-340	http://dx.doi.org/10.1038/ng1294-340			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894483				2022-12-25	WOS:A1994PV68200013
J	CORRALDEBRINSKI, M; HORTON, T; LOTT, MT; SHOFFNER, JM; BEAL, MF; WALLACE, DC				CORRALDEBRINSKI, M; HORTON, T; LOTT, MT; SHOFFNER, JM; BEAL, MF; WALLACE, DC			MITOCHONDRIAL-DNA DELETIONS IN HUMAN BRAIN - REGIONAL VARIABILITY AND INCREASE WITH ADVANCED AGE	NATURE GENETICS			English	Article							ALZHEIMERS-DISEASE; SKELETAL-MUSCLE; NUCLEAR-DNA; HUMAN-HEART; DAMAGE; CARDIOMYOCYTES; METABOLISM; DECLINE; TISSUES	We have examined the role of somatic mitochondrial DNA (mtDNA) mutations in human ageing by quantitating the accumulation of the common 4977 nucleotide pair (np) deletion (mtDNA4977) in the cortex, putamen and cerebellum. A significant increase in the mtDNA4977 deletion was seen in elderly individuals. In the cortex, the deleted to total mtDNA ratio ranged from 0.00023 to 0.012 in 67-77 year old brains and up to 0.034 in subjects over 80. In the putamen, the deletion level ranged from 0.0016 to 0.010 in 67 to 77 years old up to 0.12 in individuals over the age of 80. The cerebellum remained relatively devoid of mtDNA deletions. Similar changes were observed with a different 7436 np deletion. These changes suggest that somatic mtDNA deletions might contribute to the neurological impairment often associated with ageing.	EMORY UNIV,SCH MED,DEPT GENET & MOLEC MED,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT NEUROL,ATLANTA,GA 30322; MASSACHUSETTS GEN HOSP,DEPT NEUROL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,BOSTON,MA 02114	Emory University; Emory University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School				Lott, Marie/0000-0003-2035-479X				AMES BN, 1989, MUTAT RES, V214, P41, DOI 10.1016/0027-5107(89)90196-6; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; CHAWLUK JB, 1987, J CEREB BLOOD FLO S1, V7, pS411; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; DITTER SM, 1987, NEUROLOGY, V37, P754, DOI 10.1212/WNL.37.5.754; DRAYER B, 1986, AM J NEURORADIOL, V7, P373; DRAYER BP, 1988, RADIOLOGY, V166, P785, DOI 10.1148/radiology.166.3.3277247; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; FRACKOWIAK RSJ, 1984, ANN NEUROL, V15, pS112; FUKUNAGA M, 1979, BIOCHEM BIOPH RES CO, V90, P582, DOI 10.1016/0006-291X(79)91275-0; GOLDSTEIN S, 1991, CLIN NEUROPHARMACOL, V14, pS34, DOI 10.1097/00002826-199114001-00006; Harman D, 1986, FREE RADICALS AGING, P3; HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I; KATAYAMA M, 1991, BIOCHEM INT, V25, P47; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; MCCORD JM, 1988, FREE RADICAL BIO MED, V4, P9, DOI 10.1016/0891-5849(88)90005-6; MCGEER PL, 1977, ARCH NEUROL-CHICAGO, V34, P33, DOI 10.1001/archneur.1977.00500130053010; MIQUEL J, 1991, ARCH GERONTOL GERIAT, V12, P99, DOI 10.1016/0167-4943(91)90022-I; MIQUEL J, 1986, FREE RADICALS AGING, V51; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORRIS JC, 1991, GERIATRICS, V46, P47; MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9; MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167; OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W; PARKER WD, 1992, ANN NY ACAD SCI, V640, P59; PIKO L, 1988, MECH AGEING DEV, V43, P279, DOI 10.1016/0047-6374(88)90037-1; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SOKAL RR, 1969, BIOMETRY, P387; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; UAMAGUCHI T, 1986, STROKE I, V17, P220; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WALLACE DC, 1991, CYTOGENET CELL GENET, V58, P1103, DOI 10.1159/000133724; YEN TC, 1991, BIOCHEM BIOPH RES CO, V178, P124, DOI 10.1016/0006-291X(91)91788-E; YEN TC, 1989, BIOCHEM BIOPH RES CO, V165, P994, DOI 10.1016/0006-291X(89)92701-0; YOSHII F, 1988, J CEREBR BLOOD F MET, V8, P654, DOI 10.1038/jcbfm.1988.112; ZHANG C, 1992, FEBS LETT, V297, P34, DOI 10.1016/0014-5793(92)80321-7	40	723	739	1	28	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					324	329		10.1038/ng1292-324	http://dx.doi.org/10.1038/ng1292-324			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303288				2022-12-25	WOS:A1992KB49500019
J	RIGGINS, GJ; LOKEY, LK; CHASTAIN, JL; LEINER, HA; SHERMAN, SL; WILKINSON, KD; WARREN, ST				RIGGINS, GJ; LOKEY, LK; CHASTAIN, JL; LEINER, HA; SHERMAN, SL; WILKINSON, KD; WARREN, ST			HUMAN GENES CONTAINING POLYMORPHIC TRINUCLEOTIDE REPEATS	NATURE GENETICS			English	Article							FRAGILE-X-SYNDROME; SODIUM-POTASSIUM-ATPASE; PROTECTIVE PROTEIN; BETA-GALACTOSIDASE; N-CADHERIN; GALACTOSIALIDOSIS; EXPRESSION; SUBUNIT; OBESITY; ORGANIZATION	Expansions of trinucleotide repeats within gene transcripts are responsible for fragile X syndrome, myotonic dystrophy and spinal and bulbar muscular atrophy. To identify other human genes with similar features as candidates for triplet repeat expansion mutations, we screened human cDNA libraries with repeat probes and searched databases for transcribed genes with repeats. From both strategies, 40 genes were identified and 14 characterized. Five were found to contain repeats which are highly polymorphic including the N-cadherin, BCR, glutathione-S-transferase and Na+/K+ ATPase (beta-subunit) genes. These data demonstrate the occurrence of other human loci which may undergo this novel mechanism of mutagenesis giving rise to genetic disease.	EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322; EMORY UNIV,SCH MED,DEPT PEDIAT,DIV MED GENET,ATLANTA,GA 30322; EMORY UNIV,SCH MED,HOWARD HUGHES MED INST,ATLANTA,GA 30322	Emory University; Emory University; Emory University; Howard Hughes Medical Institute			Warren, Stephen T/A-2498-2012					BELL MV, 1991, CELL, V64, P861, DOI 10.1016/0092-8674(91)90514-Y; BEUTLER E, 1983, NEW ENGL J MED, V309, P756, DOI 10.1056/NEJM198309293091303; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; FENG TLY, 1988, GENOMICS, V2, P128; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GALJART NJ, 1988, CELL, V54, P755, DOI 10.1016/S0092-8674(88)90999-3; GONZALEZ IL, 1985, P NATL ACAD SCI USA, V82, P7666, DOI 10.1073/pnas.82.22.7666; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; HARPER PS, 1992, AM J HUM GENET, V51, P10; HOSHINO S, 1989, EMBO J, V8, P3807, DOI 10.1002/j.1460-2075.1989.tb08558.x; IDLE JR, 1991, MUTAT RES, V247, P259, DOI 10.1016/0027-5107(91)90021-F; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; LANE LK, 1989, GENOMICS, V5, P445, DOI 10.1016/0888-7543(89)90008-6; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LASPADA AR, IN PRESS NATURE GENE; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MCDONOUGH AA, 1990, FASEB J, V4, P1598, DOI 10.1096/fasebj.4.6.2156741; MCKUSICK VA, 1992, GENETIC MAPS; MIR MA, 1981, NEW ENGL J MED, V305, P1264, DOI 10.1056/NEJM198111193052107; MIR MA, 1984, NEW ENGL J MED, V310, P528; MIYAJIMA N, 1988, NUCLEIC ACIDS RES, V16, P11057, DOI 10.1093/nar/16.23.11057; MIYAKE S, 1986, NUCLEIC ACIDS RES, V14, P8805, DOI 10.1093/nar/14.22.8805; NANBA E, 1988, HUM GENET, V80, P329, DOI 10.1007/BF00273645; NOWELL PC, 1960, SCIENCE, V132, P1497; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OHNO S, 1990, CYTOGENET CELL GENET, V53, P225, DOI 10.1159/000132937; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4307, DOI 10.1093/nar/19.15.4307; REID RA, 1990, NUCLEIC ACIDS RES, V18, P5896, DOI 10.1093/nar/18.19.5896; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; Sambrook J, 1989, MOL CLONING LABORATO; SHAH NP, 1991, MOL CELL BIOL, V11, P1854, DOI 10.1128/MCB.11.4.1854; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; SHERMAN SL, 1984, ANN HUM GENET, V48, P21, DOI 10.1111/j.1469-1809.1984.tb00830.x; STRANGE RC, 1991, CARCINOGENESIS, V12, P25, DOI 10.1093/carcin/12.1.25; STRISCIUGLIO P, 1988, HUM GENET, V80, P304, DOI 10.1007/BF01790104; SUTCLIFFE JS, IN PRESS HUM MOL GEN; SUTHERLAND GR, 1989, CYTOGENET CELL GENET, V51, P452, DOI 10.1159/000132804; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VINCENT A, 1991, NATURE, V349, P624, DOI 10.1038/349624a0; WALSH FS, 1990, J NEUROCHEM, V55, P805, DOI 10.1111/j.1471-4159.1990.tb04563.x; WIEGANT J, 1991, GENOMICS, V10, P345, DOI 10.1016/0888-7543(91)90318-9; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; ZHOU XY, 1991, EMBO J, V10, P4041, DOI 10.1002/j.1460-2075.1991.tb04980.x; ZHU QS, 1990, NUCLEIC ACIDS RES, V18, P7119, DOI 10.1093/nar/18.23.7119	49	170	176	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1992	2	3					186	191		10.1038/ng1192-186	http://dx.doi.org/10.1038/ng1192-186			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345166				2022-12-25	WOS:A1992JW16500006
J	SALIDO, EC; YEN, PH; MOHANDAS, TK; SHAPIRO, LJ				SALIDO, EC; YEN, PH; MOHANDAS, TK; SHAPIRO, LJ			EXPRESSION OF THE X-INACTIVATION-ASSOCIATED GENE XIST DURING SPERMATOGENESIS	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; MEIOTIC PROPHASE; MOUSE	Mammalian X-chromosome inactivation is thought to be controlled by the X inactivation centre (XIC, X-controlling element -Xce- in mice). A human gene, XIST and its mouse counterpart, Xist, which map to the XIC/Xce, are expressed exclusively from inactive X chromosomes, suggesting their involvement in the process of X-inactivation. We now report the presence of Xist/XIST transcripts in newborn and adult mouse testes, and in human testicular tissue with normal spermatogenesis, but not in the testes of patients who lack germ cells. Our results indicate that while the X chromosome in males is active in somatic cells, it undergoes inactivation during spermatogenesis.	UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,SCH MED,DEPT PEDIAT,TORRANCE,CA 90509; UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,SCH MED,DEPT BIOL CHEM,TORRANCE,CA 90509; UNIV LA LAGUNA,SCH MED,DEPT PATHOL,E-38071 TENERIFE,SPAIN	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidad de la Laguna	SALIDO, EC (corresponding author), UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,SCH MED,HOWARD HUGHES MED INST,TORRANCE,CA 90509, USA.		Salido, Eduardo C/I-2232-2015	Salido, Eduardo C/0000-0001-9599-9854				BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CATTANACH B, 1961, GENET RES, V2, P156, DOI 10.1017/S001667230000063X; CATTANACH BM, 1971, CYTOGENETICS, V10, P318, DOI 10.1159/000130151; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; HANDEL MA, 1987, SPERMATOGENESIS GENE, P1; HENDERSON SA, 1964, CHROMOSOMA, V15, P345, DOI 10.1007/BF00368137; KIERSZEN.AL, 1974, J CELL BIOL, V63, P923, DOI 10.1083/jcb.63.3.923; KIERSZENBAUM AL, 1974, J CELL BIOL, V60, P39, DOI 10.1083/jcb.60.1.39; Klinefelter HF, 1942, J CLIN ENDOCRINOL, V2, P615, DOI 10.1210/jcem-2-11-615; KOFMANALFARO S, 1970, CHROMOSOMA, V31, P404, DOI 10.1007/BF00285832; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1974, NATURE, V250, P651, DOI 10.1038/250651a0; MATSUDA Y, 1991, P NATL ACAD SCI USA, V88, P4850, DOI 10.1073/pnas.88.11.4850; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; ODARTCHE.N, 1970, SCIENCE, V167, P1133, DOI 10.1126/science.167.3921.1133; OHNO S., 1963, CYTOGENETICS [BASEL], V2, P232, DOI 10.1159/000129781; PATHAK S, 1980, HU MGENET, P171; RICHLER C, 1992, NAT GENET, V2, P192, DOI 10.1038/ng1192-192; SAMBOOK J, 1989, MOL CLONING LABORATO; SEARLE AG, 1962, HEREDITY, V17, P297; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P1255, DOI 10.1093/nar/18.5.1255; VANDYKE DL, 1986, AM J HUM GENET, V39, P88; [No title captured]	29	127	127	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1992	2	3					196	199		10.1038/ng1192-196	http://dx.doi.org/10.1038/ng1192-196			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345168				2022-12-25	WOS:A1992JW16500008
J	DELACHAPELLE, A; TOLVANEN, R; BOYSEN, G; SANTAVY, J; BLEEKERWAGEMAKERS, L; MAURY, CPJ; KERE, J				DELACHAPELLE, A; TOLVANEN, R; BOYSEN, G; SANTAVY, J; BLEEKERWAGEMAKERS, L; MAURY, CPJ; KERE, J			GELSOLIN-DERIVED FAMILIAL AMYLOIDOSIS CAUSED BY ASPARAGINE OR TYROSINE SUBSTITUTION FOR ASPARTIC-ACID AT RESIDUE 187	NATURE GENETICS			English	Article							FINNISH HEREDITARY AMYLOIDOSIS; LATTICE CORNEAL-DYSTROPHY; PRECURSOR PROTEIN GENE; ALZHEIMERS-DISEASE; CEREBRAL-HEMORRHAGE; SECONDARY-STRUCTURE; CRANIAL NEUROPATHY; VARIANT GELSOLIN; DUTCH TYPE; MUTATION	Dominantly inherited familial amyloidosis, Finnish type (FAF) is caused by the accumulation of a 71-amino acid amyloidogenic fragment of mutant gelsolin (GSN). FAF is common in Finland but is very rare elsewhere. In Finland and in two American families, the mutation is a G654A transition leading to an Asp to Asn substitution at residue 187. We found the same mutation in a Dutch family but a Danish FAF family had a G654T mutation, predicting Asp to Tyr at residue 187. We also found the G654T transversion in a Czech family. Using GSN polymorphisms, different haplotypes were found in the Danish and Czech families. We conclude that substitution of the uncharged Asn or Tyr for the acidic Asp at residue 187 creates a conformation that may be preferentially amyloidogenic for GSN.	FOLKHALSAN INST GENET, SF-00290 HELSINKI, FINLAND; RIGSHOSP, DEPT NEUROL, DK-2100 COPENHAGEN, DENMARK; UNIV HOSP OLOMOUC, DEPT MED GENET, CS-77500 OLOMOUC, CZECHOSLOVAKIA; NETHERLANDS OPHTHALM RES INST, 1100 AC AMSTERDAM, NETHERLANDS; UNIV HELSINKI, DEPT MED 4, SF-00170 HELSINKI 17, FINLAND; WASHINGTON UNIV, SCH MED, DEPT MED MICROBIOL, ST LOUIS, MO 63110 USA	Rigshospitalet; University of Copenhagen; University Hospital Olomouc; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Helsinki; Washington University (WUSTL)	DELACHAPELLE, A (corresponding author), UNIV HELSINKI, DEPT MED GENET, SF-00290 HELSINKI 29, FINLAND.		Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271				BAKKER E, 1991, AM J HUM GENET, V49, P518; BENSON MD, 1991, J MED GENET, V28, P73, DOI 10.1136/jmg.28.2.73; Benson MD, 1989, METABOLIC BASIS INHE, P2439; BOYSEN G, 1979, J NEUROL NEUROSUR PS, V42, P1020, DOI 10.1136/jnnp.42.11.1020; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DARRAS BT, 1986, NEUROLOGY, V36, P432, DOI 10.1212/WNL.36.3.432; DELACHAPELLE A, 1992, GENOMICS, V13, P898, DOI 10.1016/0888-7543(92)90182-R; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONDERS PC, 1979, OPHTHALMOLOGICA, V178, P173, DOI 10.1159/000308818; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GHISO J, 1990, BIOCHEM J, V272, P827, DOI 10.1042/bj2720827; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOREVIC PD, 1991, NEW ENGL J MED, V325, P1780, DOI 10.1056/NEJM199112193252505; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; HILTUNEN T, 1991, AM J HUM GENET, V49, P522; KLAUS EDMUND, 1959, PSYCHIAT ET NEUROL, V138, P79; KWIATKOWSKI DJ, 1989, NUCLEIC ACIDS RES, V17, P4425, DOI 10.1093/nar/17.11.4425; KWIATKOWSKI DJ, 1988, J CELL BIOL, V106, P375, DOI 10.1083/jcb.106.2.375; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; KWIATKOWSKI DJ, 1991, NUCLEIC ACIDS RES, V19, P967, DOI 10.1093/nar/19.4.967; LEVY E, 1990, J EXP MED, V172, P1865, DOI 10.1084/jem.172.6.1865; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MAURY CPJ, 1991, J CLIN INVEST, V87, P1195, DOI 10.1172/JCI115118; MAURY CPJ, 1992, GENOMICS, V13, P902, DOI 10.1016/0888-7543(92)90183-S; MAURY CPJ, 1990, BIOCHIM BIOPHYS ACTA, V1096, P84, DOI 10.1016/0925-4439(90)90016-I; MAURY CPJ, 1990, FEBS LETT, V276, P75, DOI 10.1016/0014-5793(90)80510-P; MAURY CPJ, 1992, BIOCHEM BIOPH RES CO, V183, P227, DOI 10.1016/0006-291X(92)91632-Z; MAURY CPJ, 1990, FEBS LETT, V260, P85, DOI 10.1016/0014-5793(90)80072-Q; MCKUSICK VA, 1990, MENDELIAN INHERITANC, P58; MERETOJA J, 1969, Annals of Clinical Research, V1, P314; Meretoja J, 1976, J FINN MED ASS, V31, P2234; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; PAUNIO T, 1992, GENOMICS, V13, P237, DOI 10.1016/0888-7543(92)90235-K; PURCELL JJ, 1983, OPHTHALMOLOGY, V90, P1512; SACK GH, 1981, JOHNS HOPKINS MED J, V149, P239; SCHELLENBERG GD, 1991, AM J HUM GENET, V48, P563; Srivastava A K, 1992, PCR Methods Appl, V1, P255; STARCK T, 1991, OPHTHALMOLOGY, V98, P1197; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; TANZI RE, 1991, AM J HUM GENET, V49, P507; VRABEC F, 1957, Ophthalmologica, V133, P160; WAY M, 1988, J MOL BIOL, V203, P1127, DOI 10.1016/0022-2836(88)90132-5; WINKELMAN J E, 1971, Klinische Monatsblaetter fuer Augenheilkunde, V159, P618	45	152	154	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	1992	2	2					157	160		10.1038/ng1092-157	http://dx.doi.org/10.1038/ng1092-157			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1338910				2022-12-25	WOS:A1992JR08400018
J	JEUNEMAITRE, X; LIFTON, RP; HUNT, SC; WILLIAMS, RR; LALOUEL, JM				JEUNEMAITRE, X; LIFTON, RP; HUNT, SC; WILLIAMS, RR; LALOUEL, JM			ABSENCE OF LINKAGE BETWEEN THE ANGIOTENSIN CONVERTING ENZYME LOCUS AND HUMAN ESSENTIAL-HYPERTENSION	NATURE GENETICS			English	Article							BLOOD-PRESSURE; GROWTH-HORMONE; INSULIN RESISTANCE; GENE; UTAH	The angiotensin converting enzyme (ACE) is a key component of the renin angiotensin system that contributes to the regulation of blood pressure (BP). Recent demonstration of linkage between the ACE locus and elevated BP in a rat model of hypertension has further emphasized ACE as a candidate gene in human hypertension1,2,3. We report the localization of the ACF gene on the genetic map of chromosome 17, and identify an extremely polymorphic marker at the human growth hormone (hGH) locus which shows no recombination with ACE. We have found no evidence to support linkage between the ACE locus and hypertension, which suggests that mutations at the ACE locus do not commonly contribute to the pathogenesis of hypertension in our test population.	UNIV UTAH,HLTH SCI CTR,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; BRIGHAM & WOMENS HOSP,DIV ENDOCRINE HYPERTENS,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; UNIV UTAH,CARDIOVASC GENET RES CLIN,SALT LAKE CITY,UT 84112	Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah	JEUNEMAITRE, X (corresponding author), UNIV UTAH,HLTH SCI CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112, USA.		JEUNEMAITRE, Xavier/AAQ-4853-2021	JEUNEMAITRE, Xavier/0000-0001-5925-381X				ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33; BISHOP DT, 1990, AM J HUM GENET, V46, P254; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; BRATUSCHMARRAIN PR, 1982, J CLIN ENDOCR METAB, V55, P973, DOI 10.1210/jcem-55-5-973; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; ERDOS EG, 1987, LAB INVEST, V56, P346; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; GOLDSTEIN JL, 1979, ANNU REV GENET, V13, P259, DOI 10.1146/annurev.ge.13.120179.001355; HARPER ME, 1982, AM J HUM GENET, V34, P227; HARRAP SB, 1990, HYPERTENSION, V16, P603, DOI 10.1161/01.HYP.16.6.603; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; HYER RN, 1991, AM J HUM GENET, V48, P243; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JEUNEMAITRE X, 1992, HUM GENET, V88, P301; KURTZ T, 1991, NATURE, V353, P499, DOI 10.1038/353499a0; LANDER ES, 1989, GENETICS, V121, P185; LANGE K, 1986, ANN HUM GENET, V50, P283, DOI 10.1111/j.1469-1809.1986.tb01049.x; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LIFTON RP, 1991, HYPERTENSION, V17, P8, DOI 10.1161/01.HYP.17.1.8; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; MACGREGOR GA, 1981, NATURE, V291, P329, DOI 10.1038/291329a0; MATTEI MG, 1989, CYTOGENET CELL GENET, V51, P1041; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; POLLARE T, 1990, METABOLISM, V39, P167, DOI 10.1016/0026-0495(90)90071-J; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P689, DOI 10.1093/nar/19.3.689; PTACEK LJ, 1991, AM J HUM GENET, V49, P378; REAVEN GM, 1991, AM J HYPERTENS, V4, P34, DOI 10.1093/ajh/4.1.34; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; RIGAT B, IN PRESS NUCL ACIDS; SASSANO P, 1987, AM J MED, V83, P227, DOI 10.1016/0002-9343(87)90690-5; SEGAL KR, 1985, J APPL PHYSIOL, V58, P1565, DOI 10.1152/jappl.1985.58.5.1565; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; WARD R, 1990, HYPERTENSION PATHOPH, P81; WEINBERGER MH, 1986, HYPERTENSION, V8, P127, DOI 10.1161/01.HYP.8.6_Pt_2.II127; WILLIAMS RR, 1988, JAMA-J AM MED ASSOC, V259, P3579, DOI 10.1001/jama.259.24.3579; WILLIAMS RR, 1988, AM J PUBLIC HEALTH, V78, P1283, DOI 10.2105/AJPH.78.10.1283	40	379	395	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1992	1	1					72	75		10.1038/ng0492-72	http://dx.doi.org/10.1038/ng0492-72			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1338766				2022-12-25	WOS:A1992JC97800017
J	OCONNELL, JR; WEEKS, DE				OCONNELL, JR; WEEKS, DE			THE VITESSE ALGORITHM FOR RAPID EXACT MULTILOCUS LINKAGE ANALYSIS VIA GENOTYPE SET-RECODING AND FUZZY INHERITANCE	NATURE GENETICS			English	Article							LOD SCORES; LIKELIHOOD CALCULATIONS; PEDIGREES; HUMANS; MAP; CONSTRUCTION; COMPUTATIONS; ELIMINATION; LOCUS	As genetic marker maps have improved, multipoint linkage analysis has become a crucial part of all disease mapping studies. Paradoxically, multipoint rod scores become increasingly difficult to compute, particularly as the numbers of markers, marker alleles and untyped people increase. We have solved this problem by using a novel set-recoding scheme to recode each person's genotype and 'fuzzy inheritance' to infer transmission probabilities. Our approach is implemented in a memory-efficient computer program, VITESSE, for extremely rapid computation of exact multipoint likelihoods. VITESSE enables fast and precise multipoint mapping of disease loci with highly polymorphic markers.	UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7BN,ENGLAND	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oxford; Wellcome Centre for Human Genetics			Weeks, Daniel E/B-2995-2012	Weeks, Daniel E/0000-0001-9410-7228	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000932] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00932] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission)		BAMSHAD M, 1994, AM J HUM GENET, V55, P1153; BOEHNKE M, 1986, AM J HUM GENET, V39, P513; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V18, P24, DOI 10.1016/0010-4809(85)90004-7; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CURTIS D, 1993, HUM HERED, V43, P173, DOI 10.1159/000154174; DEMENAIS F, 1994, GENET EPIDEMIOL, V11, P291; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FOROUD T, 1991, AM J HUM GENET, V49, P1263; GUO SW, 1992, AM J HUM GENET, V51, P1111; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; IRWIN M, 1994, P NATL ACAD SCI USA, V91, P11684, DOI 10.1073/pnas.91.24.11684; KASS S, 1994, NAT GENET, V7, P546, DOI 10.1038/ng0894-546; KONG A, 1993, GENET EPIDEMIOL, V10, P483, DOI 10.1002/gepi.1370100626; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANGE K, 1991, AM J HUM GENET, V49, P1320; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; LANGE K, 1989, ANN HUM GENET, V53, P67, DOI 10.1111/j.1469-1809.1989.tb01122.x; LANGE K, 1987, AM J HUM GENET, V40, P250; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; MAMELKA PM, 1988, PEDIGREE DRAW APPLE; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; McNeill D., 1993, FUZZY LOGIC; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NYGAARD TG, 1993, NAT GENET, V5, P386, DOI 10.1038/ng1293-386; OTT J, 1978, ANN HUM GENET, V42, P255, DOI 10.1111/j.1469-1809.1978.tb00657.x; OTT J, 1976, AM J HUM GENET, V28, P528; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; PERICAKVANCE MA, 1993, GENET EPIDEMIOL, V10, P361, DOI 10.1002/gepi.1370100605; ROTHSCHILD CB, 1993, AM J HUM GENET, V52, P110; SOBEL E, 1995, GENETIC MAPPING DNA; THOMAS DC, 1992, HUM HERED, V42, P63, DOI 10.1159/000154046; Thomas J.M., 1984, 8TH P INT C CAT BERL, V1, P31; WEEKS DE, 1993, HUM HERED, V43, P86, DOI 10.1159/000154123; WEEKS DE, 1994, GENETICS, V136, P1217; WEEKS DE, 1995, AM J HUM GENET, V56, P1506; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEISSENBACH J, 1993, GENE, V135, P275, DOI 10.1016/0378-1119(93)90077-G; WORTHINGTON J, 1994, BRIT J RHEUMATOL, V33, P970	48	430	436	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					402	408		10.1038/ng1295-402	http://dx.doi.org/10.1038/ng1295-402			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493020				2022-12-25	WOS:A1995TH62900017
J	KAY, MA; HOLTERMAN, AX; MEUSE, L; GOWN, A; OCHS, HD; LINSLEY, PS; WILSON, CB				KAY, MA; HOLTERMAN, AX; MEUSE, L; GOWN, A; OCHS, HD; LINSLEY, PS; WILSON, CB			LONG-TERM HEPATIC ADENOVIRUS-MEDIATED GENE-EXPRESSION IN MICE FOLLOWING CTLA4LG ADMINISTRATION	NATURE GENETICS			English	Article							CELL ACTIVATION; RECEPTOR; ANTIGEN; CTLA-4; DELIVERY; THERAPY; LIGAND; SYSTEM; CD28	Recombinant adenovirus vectors are efficient at transferring genes into somatic tissues but are limited for use in clinical gene therapy by immunologic factors that result in the vapid loss of gene expression and inhibit secondary gene transfer. This study demonstrates that systemic coadministration of recombinant adenovirus with soluble CTLA41g, which is known to block co-stimulatory signals between T cells and antigen presenting cells, leads to persistent adenoviral gene expression in mice without longterm immunosuppression. This form of immunotherapy greatly enhances the likelihood that recombinant adenovirus vectors will be useful for human gene therapy.	UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Bristol-Myers Squibb	KAY, MA (corresponding author), UNIV WASHINGTON,DEPT MED,DIV MED GENET,BOX 357720,SEATTLE,WA 98195, USA.			Kay, Mark/0000-0002-2799-2615	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017427, R37HD017427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047754, R01DK049022] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 17427] Funding Source: Medline; NIDDK NIH HHS [DK 47754, DK 49022] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; BARR D, 1995, GENE THER, V2, P151; BLUESTONE JA, 1995, IMMUNITY, V2, P555, DOI 10.1016/1074-7613(95)90000-4; DAI YF, 1995, P NATL ACAD SCI USA, V92, P1401, DOI 10.1073/pnas.92.5.1401; ENGLEHARDT JF, 1994, P NATL ACAD SCI USA, V91, P6196; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; INCK BK, 1994, SCIENCE, V265, P1225; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; KAY MA, 1994, TRENDS GENET, V10, P253, DOI 10.1016/0168-9525(94)90173-2; KAY MA, 1994, P NATL ACAD SCI USA, V91, P2353, DOI 10.1073/pnas.91.6.2353; KAY MA, 1995, HEPATOLOGY, V21, P815, DOI 10.1002/hep.1840210331; KAY MA, 1992, HUM GENE THER, V3, P641, DOI 10.1089/hum.1992.3.6-641; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; KOZARSKY KF, 1994, J BIOL CHEM, V269, P13695; LENSCHOW DJ, SCIENCE, V257, P789; LEWIS DB, 1994, J EXP MED, V173, P89; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; NGUYEN L, 1994, J IMMUNOL, V152, P478; NONOYAMA S, 1993, J EXP MED, V178, P1097, DOI 10.1084/jem.178.3.1097; NONOYAMA S, 1993, J IMMUNOL, V150, P3817; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; RAWLE FC, 1991, J IMMUNOL, V146, P3977; Rinaldo C R Jr, 1993, Immunodeficiency, V5, P33; SCARIA A, 1995, GENE THER, V2, P295; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; SMITH TAG, 1993, NAT GENET, V5, P397, DOI 10.1038/ng1293-397; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4	33	256	262	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					191	197		10.1038/ng1095-191	http://dx.doi.org/10.1038/ng1095-191			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550348				2022-12-25	WOS:A1995RX80600022
J	LEWIS, DL; ARENS, M				LEWIS, DL; ARENS, M			RESISTANCE OF MICROORGANISMS TO DISINFECTION IN DENTAL AND MEDICAL DEVICES	NATURE MEDICINE			English	Article							INFECTION; STERILIZATION; ENDOSCOPES	The U.S. Centers for Disease Control and Prevention (CDC) recommends that only heat sterilization be used for all reusable devices entering the oral cavity(1). However, chemical disinfection is still employed for reprocessing dental devices in many areas of the world. In an analysis of a Florida dental practice responsible for nosocomial human immunodeficiency virus (HIV) transmissions, the possible role of contaminated devices was deemed unlikely in part because they were subjected to high-level disinfection with 2% glutaraldehyde(2). Disease transmissions have, however, been documented for endoscopes used in diagnostic and surgical procedures even after this treatment(3). In some dental devices, lubricants mix with potentially infectious patient materials, and organic debris has been observed in endoscopes after cleaning(4-6). We have investigated whether lubricants can render high-level chemical disinfection procedures ineffective and have addressed the role that some common devices may play in disease transmission. We report here that HIV in whole-blood samples and Pseudomonas aeruginosa in blood and plasma survived high-level disinfection when entrapped in lubricants used in dental handpieces and endoscopes. We also found that lubricated dental devices used to clean and polish teeth (prophylaxis angles) have the potential to transfer sufficient amounts of blood to infect human lymphocyte cultures with HIV. These results emphasize the need to subject reusable dental devices to a heat-sterilization protocol that penetrates the lubricant(7).	UNIV GEORGIA, DEPT ECOL, ATHENS, GA 30602 USA; WASHINGTON UNIV, SCH MED, DEPT PEDIAT, ST LOUIS, MO 63110 USA	University System of Georgia; University of Georgia; Washington University (WUSTL)				Lewis, David/0000-0003-0777-2460				[Anonymous], 1993, MMWR Recomm Rep, V42, P1; Barnes Caren M., 1994, General Dentistry, V42, P456; BOND WW, 1991, DISINFECTION STERILI, P1097; ERICE A, 1992, J CLIN MICROBIOL, V30, P444, DOI 10.1128/JCM.30.2.444-448.1992; FAVERO MS, 1991, INFECT CONT HOSP EP, V12, P279; GERBERDING JL, 1991, HOSP PRACT, V26, P103; GOOCH B, 1993, J AM DENT ASSOC, V124, P38, DOI 10.14219/jada.archive.1993.0006; Lewis D L, 1995, Trends Tech Contemp Dent Lab, V12, P30; LEWIS DL, 1992, LANCET, V340, P1252, DOI 10.1016/0140-6736(92)92950-K; LEWIS DL, 1995, ANN INTERN MED, V122, P960, DOI 10.7326/0003-4819-122-12-199506150-00015; LEWIS DL, 1992, J CLIN MICROBIOL, V30, P401, DOI 10.1128/JCM.30.2.401-406.1992; MARTIN E, 1995, AGD IMPACT, V23, P6; SPACH DH, 1993, ANN INTERN MED, V118, P117, DOI 10.7326/0003-4819-118-2-199301150-00008; VESLEY D, 1992, AM J INFECT CONTROL, V20, P291, DOI 10.1016/S0196-6553(05)80232-9	14	25	25	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	SEP	1995	1	9					956	958		10.1038/nm0995-956	http://dx.doi.org/10.1038/nm0995-956			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585225				2022-12-25	WOS:A1995RT30300053
J	REITMAIR, AH; SCHMITS, R; EWEL, A; BAPAT, B; REDSTON, M; MITRI, A; WATERHOUSE, P; MITTRUCKER, HW; WAKEHAM, A; LIU, B; THOMASON, A; GRIESSER, H; GALLINGER, S; BALLHAUSEN, WG; FISHEL, R; MAK, TW				REITMAIR, AH; SCHMITS, R; EWEL, A; BAPAT, B; REDSTON, M; MITRI, A; WATERHOUSE, P; MITTRUCKER, HW; WAKEHAM, A; LIU, B; THOMASON, A; GRIESSER, H; GALLINGER, S; BALLHAUSEN, WG; FISHEL, R; MAK, TW			MSH2 DEFICIENT MICE ARE VIABLE AND SUSCEPTIBLE TO LYMPHOID TUMORS	NATURE GENETICS			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH-REPAIR; ESCHERICHIA-COLI; MICROSATELLITE INSTABILITY; STEM-CELLS; GENETIC INSTABILITY; MUTATIONS; CARCINOGENESIS; RECOMBINATION; CARCINOMA	Alterations of the human MSH2 gene, a homologue of the bacterial MutS mismatch repair gene, co-segregate with the majority of hereditary non-polyposis colon cancer (HNPCC) cases. We have generated homozygous MSH2(+) mice. Surprisingly, these mice were found to be viable, produced offspring in a mendelian ratio and bred through at least two generations. Starting at two months of age homozygous -/- mice began, with high frequency, to develop lymphoid tumours that contained microsatellite instabilities. These data establish a direct link between MSH2 deficiency and the pathogenesis of cancer, These mutant mice should be good models to study the progression of tumours and also to screen carcinogenic and anti-cancer agents.	ONTARIO CANC INST,AMGEN INST,DEPT MED BIOPHYS,TORONTO,ON M4X 1K9,CANADA; ONTARIO CANC INST,AMGEN INST,DEPT IMMUNOL,TORONTO,ON M4X 1K9,CANADA; UNIV VERMONT,SCH MED,MARKEY CTR MOLEC GENET,DEPT MOLEC GENET & MICROBIOL,BURLINGTON,VT 05405; UNIV TORONTO,MT SINAI HOSP,SAMUEL LUNENFELD RES INST,DEPT PATHOL & LAB MED,TORONTO,ON M5G 1X5,CANADA; UNIV TORONTO,MT SINAI HOSP,SAMUEL LUNENFELD RES INST,DEPT SURG,TORONTO,ON M5G 1X5,CANADA; AMGEN INC,DEPT BIOL MOLEC,THOUSAND OAKS,CA 91320; UNIV TORONTO,ONTARIO CANC INST,DEPT PATHOL,TORONTO,ON M4X 1K9,CANADA; UNIV ERLANGEN NURNBERG,INST HUMANGENET,D-91054 ERLANGEN,GERMANY	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Vermont; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Amgen; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Erlangen Nuremberg			Gallinger, Steven/E-4575-2013; Bapat, Bharati/B-5839-2014	Waterhouse, Paul/0000-0001-8745-5224	NCI NIH HHS [CA56542, CA67007] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA067007, R01CA056542] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; ALANI E, 1994, GENETICS, V137, P19; ALBRIGHT LAC, 1988, NEW ENGL J MED, V319, P533; BAKER SM, 1995, CELL, V82, P302; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; BISHOP DT, 1990, CANCER SURV, V9, P585; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; BRADLEY A, 1986, CURR TOP DEV BIOL, V20, P357, DOI 10.1016/S0070-2153(08)60675-4; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BURKS RT, 1994, ONCOGENE, V9, P1163; COHEN PR, 1992, AM J HEMATOL, V40, P64, DOI 10.1002/ajh.2830400114; CROCE CM, 1987, CELL, V49, P155, DOI 10.1016/0092-8674(87)90552-6; DELEON MP, 1993, CANCER, V71, P3493, DOI 10.1002/1097-0142(19930601)71:11<3493::AID-CNCR2820711106>3.0.CO;2-H; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; FEINSTEIN SI, 1986, GENETICS, V113, P13; FISHEL R, 1994, CANCER RES, V54, P5539; FISHEL R, 1994, SCIENCE, V266, P1403, DOI 10.1126/science.7973733; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHEL RA, 1986, J MOL BIOL, V188, P147, DOI 10.1016/0022-2836(86)90300-1; GONZALEZZULUETA M, 1993, CANCER RES, V53, P5620; HAMILTON SR, 1995, NEW ENGL J MED, V332, P839, DOI 10.1056/NEJM199503303321302; HAN HJ, 1993, CANCER RES, V53, P5087; HONCHEL R, 1994, CANCER RES, V54, P1159; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; JONES M, 1987, CELL, V50, P621, DOI 10.1016/0092-8674(87)90035-3; KEE F, 1991, GUT, V32, P509, DOI 10.1136/gut.32.5.509; KUNKEL TA, 1993, NATURE, V365, P207, DOI 10.1038/365207a0; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LEUNG WPF, 1991, CELL, V65, P443; LEVINSON G, 1987, NUCLEIC ACIDS RES, V15, P5323, DOI 10.1093/nar/15.13.5323; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LOEB LA, 1991, CANCER RES, V51, P3075; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; LYNCH HT, 1991, SEMIN ONCOL, V18, P337; Maniatis T., 1982, MOL CLONING; MERLO A, 1994, CANCER RES, V54, P2098; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; NICOLAIDES NC, 1994, NATURE, V371, P75, DOI 10.1038/371075a0; NYSTROMLAHTI M, 1994, AM J HUM GENET, V55, P659; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; PARSONS R, 1995, SCIENCE, V268, P738, DOI 10.1126/science.7632227; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; PELTOMAKI P, 1993, CANCER RES, V53, P5853; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; RHYU MG, 1994, ONCOGENE, V9, P29; RISINGER JI, 1993, CANCER RES, V53, P5100; SCHOENBERG MP, 1994, BIOCHEM BIOPH RES CO, V198, P74, DOI 10.1006/bbrc.1994.1011; SELVA EM, 1995, GENETICS, V139; SHIBATA D, 1994, NAT GENET, V6, P273, DOI 10.1038/ng0394-273; SHRIDHAR V, 1994, CANCER RES, V54, P2084; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; TEICH N, 1984, PATHOGENESIS RETROVI, P785; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; WADA C, 1994, BLOOD, V83, P3449, DOI 10.1182/blood.V83.12.3449.bloodjournal83123449; WOOSTER R, 1994, NAT GENET, V6, P152, DOI 10.1038/ng0294-152; YEE CJ, 1994, CANCER RES, V54, P1641; YOUNG J, 1993, HUM MUTAT, V2, P351, DOI 10.1002/humu.1380020505	65	349	358	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					64	70		10.1038/ng0995-64	http://dx.doi.org/10.1038/ng0995-64			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550317				2022-12-25	WOS:A1995RR72800017
J	WAYMIRE, KG; MAHUREN, JD; JAJE, JM; GUILARTE, TR; COBURN, SP; MACGREGOR, GR				WAYMIRE, KG; MAHUREN, JD; JAJE, JM; GUILARTE, TR; COBURN, SP; MACGREGOR, GR			MICE LACKING TISSUE NONSPECIFIC ALKALINE-PHOSPHATASE DIE FROM SEIZURES DUE TO DEFECTIVE METABOLISM OF VITAMIN-B-6	NATURE GENETICS			English	Article							DEVELOPING RAT-BRAIN; CENTRAL-NERVOUS-SYSTEM; ADULT HYPOPHOSPHATASIA; GENE; PYRIDOXAL-5'-PHOSPHATE; DEFICIENCY; SEQUENCE; PROTEIN	In humans, deficiency of the tissue non-specific alkaline phosphatase (TNAP) gene is associated with defective skeletal mineralization. In contrast, mice lacking TNAP generated by homologous recombination using embryonic stem (ES) cells have normal skeletal development. However, at approximately two weeks after birth, homozygous mutant mice develop seizures which are subsequently fatal. Defective metabolism of pyridoxal 5'-phosphate (PLP), characterized by elevated serum PLP levels, results in reduced levels of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the brain. The mutant seizure phenotype can be rescued by the administration of pyridoxal and a semi-solid diet. Rescued animals subsequently develop defective dentition. This study reveals essential physiological functions of TNAP in the mouse.	EMORY UNIV,SCH MED,DEPT MOLEC & MED GENET,ATLANTA,GA 30322; FT WAYNE STATE DEV CTR,FT WAYNE,IN 46835; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT ENVIRONM HLTH SCI,BALTIMORE,MD 21205	Emory University; Johns Hopkins University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020939] Funding Source: NIH RePORTER; NICHD NIH HHS [HD20939] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBIN RL, 1987, NEUROLOGY, V37, P1729, DOI 10.1212/WNL.37.11.1729; BAYOUMI RA, 1972, J NEUROCHEM, V19, P1883, DOI 10.1111/j.1471-4159.1972.tb01477.x; BELL RR, 1971, ARCH BIOCHEM BIOPHYS, V147, P588, DOI 10.1016/0003-9861(71)90417-6; BRUCKNER R. J. N. H. RICKLES, 1962, ORAL SURG ORAL MED AND ORAL PATHOL, V15, P1351, DOI 10.1016/0030-4220(62)90356-0; BUKIN YV, 1976, BIOKHIMIYA, V41, P81; CASWELL AM, 1991, CRIT REV CL LAB SCI, V28, P175, DOI 10.3109/10408369109106862; DAKSHINAMURTI K, 1969, J NEUROCHEM, V16, P1515, DOI 10.1111/j.1471-4159.1969.tb09906.x; EASTMAN CL, 1992, J NUTR BIOCHEM, V3, P618, DOI 10.1016/0955-2863(92)90081-S; EBADI M, 1981, Neurochemistry International, V3, P181, DOI 10.1016/0197-0186(81)90001-2; FEDDE KN, 1990, AM J HUM GENET, V47, P776; FEDDE KN, 1990, AM J HUM GENET, V47, P767; FONDA ML, 1980, EXP GERONTOL, V15, P473, DOI 10.1016/0531-5565(80)90055-8; FRIEDRICH GA, 1990, GENE DEV, V5, P1513; Gould Bernard S., 1944, ARCH BIOCHEM, V4, P175; GUILARTE TR, 1989, NEUROCHEM RES, V14, P889, DOI 10.1007/BF00964820; HAHNEL AC, 1990, DEVELOPMENT, V110, P555; HAHNEL AC, 1989, CLIN CHIM ACTA, V186, P171; HENTHORN PS, 1988, J BIOL CHEM, V263, P12011; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; HOUPT MI, 1970, J DENT CHILD, V27, P126; KNOLL BJ, 1988, J BIOL CHEM, V263, P12020; KRINKE G, 1985, J NEUROPATH EXP NEUR, V44, P117, DOI 10.1097/00005072-198503000-00001; KRINKE G, 1980, NEUROTOXICOLOGY, V2, P13; LANGMAN MJS, 1966, NATURE, V212, P41, DOI 10.1038/212041a0; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; MACFARLANE JD, 1992, AM J MED GENET, V42, P117, DOI 10.1002/ajmg.1320420124; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; MAHUREN JD, 1990, J NUTR BIOCHEM, V1, P659, DOI 10.1016/0955-2863(90)90028-J; MANES T, 1990, GENOMICS, V8, P541, DOI 10.1016/0888-7543(90)90042-S; McComb Jr RB, 1979, ALKALINE PHOSPHATASE, DOI 10.1007/978-1-4613-2970-1_4; Meldrum B S, 1975, Int Rev Neurobiol, V17, P1, DOI 10.1016/S0074-7742(08)60205-6; MILLAN JL, 1988, P NATL ACAD SCI USA, V85, P3024, DOI 10.1073/pnas.85.9.3024; ORNOY A, 1985, AM J MED GENET, V22, P743, DOI 10.1002/ajmg.1320220410; RASMUSSEN K, 1968, DANISH MED B, V15, P1; RITCHIE GM, 1964, ARCH DIS CHILD, V39, P584, DOI 10.1136/adc.39.208.584; ROXBURGH STD, 1983, T OPHTHAL SOC UK, V103, P513; SALHANY JM, 1993, J BIOL CHEM, V268, P7643; SALHANY JM, 1987, J BIOL CHEM, V262, P15965; SASAKI T, 1990, CELL BIOL TOOTH ENAM, P1; SHIDELER CE, 1983, AM J MED TECHNOL, V49, P17; Slocum RH, 1991, TECHNIQUES DIAGNOSTI, P87; SNELL EE, 1971, COMPREHENSIVE BIOCH, P47; STEPHENS MC, 1971, J NEUROCHEM, V18, P2407, DOI 10.1111/j.1471-4159.1971.tb00196.x; TAKAHASHI T, 1984, ENDOCRINE CONTROL BO, P93; TERAO M, 1987, P NATL ACAD SCI USA, V84, P7051, DOI 10.1073/pnas.84.20.7051; Voet D VJ, 1990, BIOCHEMISTRY; WADA H, 1961, J BIOL CHEM, V236, P2089; WARSHAW JB, 1971, J CLIN INVEST, V50, P2137, DOI 10.1172/JCI106707; WASYNCZUK A, 1983, J NUTR, V113, P746, DOI 10.1093/jn/113.4.746; WEISS MJ, 1988, J BIOL CHEM, V263, P12002; Whyte M, 1995, METABOLIC MOL BASES, P4095; WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814; WHYTE MP, 1988, J CLIN INVEST, V81, P1234, DOI 10.1172/JCI113440; WHYTE MP, 1979, MEDICINE, V58, P329, DOI 10.1097/00005792-197909000-00001; WHYTE MP, 1982, AM J MED, V72, P631, DOI 10.1016/0002-9343(82)90474-0; WHYTE MP, 1985, J CLIN INVEST, V76, P752, DOI 10.1172/JCI112031	56	306	328	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					45	51		10.1038/ng0995-45	http://dx.doi.org/10.1038/ng0995-45			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550313				2022-12-25	WOS:A1995RR72800014
J	RICHARDS, JR				RICHARDS, JR			EUTHANASIA	NATURE MEDICINE			English	Editorial Material											RICHARDS, JR (corresponding author), OPEN UNIV,DEPT PHILOSOPHY,MILTON KEYNES MK7 6AA,BUCKS,ENGLAND.								0	0	0	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUL	1995	1	7					618	620		10.1038/nm0795-618	http://dx.doi.org/10.1038/nm0795-618			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585133				2022-12-25	WOS:A1995RQ06600026
J	SPIEGEL, AM				SPIEGEL, AM			G-PROTEIN GENE KNOCKOUT HITS THE GUT	NATURE MEDICINE			English	Editorial Material							MUTATIONS				SPIEGEL, AM (corresponding author), NIDDKD,BETHESDA,MD 20892, USA.							BICHET DG, 1994, AM J HUM GENET, V55, P278; CHAFFIN KE, 1991, EUR J IMMUNOL, V21, P2565, DOI 10.1002/eji.1830211038; ELSON CO, 1994, INFLAMM BOWEL DIS, P81; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; IISMA TP, 1995, PROTEIN COUPLED RECE; LYONS J, 1990, SCIENCE, V249, P655, DOI 10.1126/science.2116665; MONTMAYEUR JP, 1994, SCIENCE, V263, P95, DOI 10.1126/science.8272874; MOXHAM CM, 1993, SCIENCE, V260, P991, DOI 10.1126/science.8493537; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; RAYMOND JR, 1994, J BIOL CHEM, V269, P13073; RUDOLPH U, 1995, NAT GENET, V10, P141; SPIEGEL AM, 1993, J CLIN INVEST, V92, P1119, DOI 10.1172/JCI116680; SPIEGEL AM, 1994, PROTEINS; STROBER W, 1993, CELL, V75, P203, DOI 10.1016/0092-8674(93)80062-J; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403	17	7	8	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1995	1	6					522	524		10.1038/nm0695-522	http://dx.doi.org/10.1038/nm0695-522			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN101	7585115				2022-12-25	WOS:A1995RN10100032
J	RABBITTS, P; IMPEY, H; HEPPELLPARTON, A; LANGFORD, C; TEASE, C; LOWE, N; BAILEY, D; FERGUSONSMITH, M; CARTER, N				RABBITTS, P; IMPEY, H; HEPPELLPARTON, A; LANGFORD, C; TEASE, C; LOWE, N; BAILEY, D; FERGUSONSMITH, M; CARTER, N			CHROMOSOME-SPECIFIC PAINTS FROM A HIGH-RESOLUTION FLOW KARYOTYPE OF THE MOUSE	NATURE GENETICS			English	Article							DNA; HYBRIDIZATION; PCR	Chromosomes from antigen stimulated B-cells from spleens of inbred mice have been separated using flow cytometry into 18 distinguishable peaks. Using locus-specific oligonucleotides and fluorescence in situ hybridization to banded metaphase spreads, 15 individual chromosomes were identified: 1, 2, 3, 6, 7, 8, 9, 11, 12, 16, 17, 18, 19, X and Y. The remaining six chromosomes, occurring as pairs in three peaks, 4 with 5, 10 with 13, and 14 with 15, were resolved by flow sorting chromosomes from mice carrying an appropriate homozygous translocation and 4, 5 and 14 have been isolated in this way. This is the first demonstration of how a complete set of mouse chromosome plaints can be produced.	UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE CB2 1QP,ENGLAND; MRC,RADIOBIOL UNIT,DIDCOT OX11 ORD,OXON,ENGLAND	University of Cambridge	RABBITTS, P (corresponding author), UNIV CAMBRIDGE,CTR MRC,CLIN ONCOL & MRC RADIOTHERAPEUT UNIT,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.							BRENEMAN JW, 1993, CHROMOSOMA, V102, P591, DOI 10.1007/BF00352306; CARTER NP, 1994, CYTOMETRY, V18, P2, DOI 10.1002/cyto.990180103; CARTER NP, 1994, CELL BIOL LAB HDB, P442; CARTER NP, 1994, CHROMOSOME ANAL PROT; CORNALL RJ, 1992, MAMM GENOME, V3, P620, DOI 10.1007/BF00352478; COWELL JK, 1984, CHROMOSOMA, V89, P294, DOI 10.1007/BF00292478; DAVISSON MT, 1989, GENETIC VARIANTS STR, P617; DIETRICH W, 1992, GENETICS MAPS; EVANS E P, 1987, P93; HOEBEE B, 1994, CYTOGENET CELL GENET, V66, P277, DOI 10.1159/000133712; KENTER AL, 1986, EXP CELL RES, V167, P241, DOI 10.1016/0014-4827(86)90220-X; LANGFORD CF, 1993, ANIM GENET, V24, P261, DOI 10.1111/j.1365-2052.1993.tb00309.x; MAYALL BH, 1984, CYTOMETRY, V5, P376, DOI 10.1002/cyto.990050414; MIYASHITA K, 1994, CYTOGENET CELL GENET, V66, P54, DOI 10.1159/000133664; SCHERTHAN H, 1994, NAT GENET, V6, P342, DOI 10.1038/ng0494-342; SILLAR R, 1981, J HISTOCHEM CYTOCHEM, V29, P74, DOI 10.1177/29.1.6162882; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; VERMA RS, 1989, HUMAN CHROMOSOMES MA; WEIER HUG, 1994, GENOMICS, V21, P641, DOI 10.1006/geno.1994.1326; WIENBERG J, 1990, GENOMICS, V8, P347, DOI 10.1016/0888-7543(90)90292-3; YERLE M, 1993, GENOMICS, V16, P97, DOI 10.1006/geno.1993.1146	21	120	124	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1995	9	4					369	375		10.1038/ng0495-369	http://dx.doi.org/10.1038/ng0495-369			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795642				2022-12-25	WOS:A1995QQ75300014
J	THOMPSON, ME; JENSEN, RA; OBERMILLER, PS; PAGE, DL; HOLT, JT				THOMPSON, ME; JENSEN, RA; OBERMILLER, PS; PAGE, DL; HOLT, JT			DECREASED EXPRESSION OF BRCA1 ACCELERATES GROWTH AND IS OFTEN PRESENT DURING SPORADIC BREAST-CANCER PROGRESSION	NATURE GENETICS			English	Article							INTRADUCTAL CARCINOMA; FOLLOW-UP; CELLS; PROLIFERATION; OVARIAN; BIOPSY; TUMORS	We have characterized expression of the familial breast and ovarian cancer gene, BRCA1, in cases of non-hereditary (sporadic) breast cancer and analyzed the effect of antisense inhibition of BRCA1 on the proliferative rate of mammary epithelial cells. BRCA1 mRNA levels are markedly decreased during the transition from carcinoma in situ to invasive cancer. Experimental inhibition of BRCA1 expression with antisense oligonucleotides produced accelerated growth of normal and malignant mammary cells, but had no effect on non-mammary epithelial cells. These studies suggest that BRCA1 may normally serve as a negative regulator of mammary epithelial cell growth whose function is compromised in breast cancer either by direct mutation or alterations in gene expression.	VANDERBILT UNIV, SCH MED, DEPT CELL BIOL, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, SCH MED, DEPT PATHOL, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, SCH MED, DEPT PREVENT MED, NASHVILLE, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University			Jensen, Roy A/B-9739-2011	Jensen, Roy A/0000-0003-4430-2281	NATIONAL CANCER INSTITUTE [R29CA062161] Funding Source: NIH RePORTER; NCI NIH HHS [CA62161] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BETSILL WL, 1978, JAMA-J AM MED ASSOC, V239, P1863, DOI 10.1001/jama.239.18.1863; CASTILLA LH, 1994, NAT GENET, V8, P387, DOI 10.1038/ng1294-387; CROPP CS, 1994, CANCER RES, V54, P2548; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; HOLT JT, 1993, CANCER SURV, V18, P115; JACOBS IJ, 1993, CANCER RES, V53, P1218; JENSEN RA, 1994, P NATL ACAD SCI USA, V91, P9257, DOI 10.1073/pnas.91.20.9257; Marcus J N, 1994, J Natl Cancer Inst Monogr, P23; MERAJVER SD, 1995, NAT GENET, V9, P439, DOI 10.1038/ng0495-439; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1995, AM J HUM GENET, V56, P254; NEUHAUSEN SL, 1994, CANCER RES, V54, P6069; PAGE DL, 1982, CANCER, V49, P751, DOI 10.1002/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y; PAGE DL, 1990, CANCER, V66, P1326, DOI 10.1002/1097-0142(19900915)66:14+<1326::AID-CNCR2820661405>3.0.CO;2-P; PAGE DL, 1993, BREAST CANCER RES TR, V28, P157, DOI 10.1007/BF00666428; REUTER R, 1990, DEVELOPMENT, V110, P1031; ROBINSONBENION C, IN PRESS METHODS ENZ; SAITO H, 1993, CANCER RES, V53, P3382; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; SOULE HD, 1980, CANCER LETT, V10, P177, DOI 10.1016/0304-3835(80)90042-7; STAMPFER M, 1980, IN VITRO CELL DEV B, V16, P415; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239	24	532	571	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1995	9	4					444	450		10.1038/ng0495-444	http://dx.doi.org/10.1038/ng0495-444			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795653				2022-12-25	WOS:A1995QQ75300025
J	VAXILLAIRE, M; BOCCIO, V; PHILIPPI, A; VIGOUROUX, C; TERWILLIGER, J; PASSA, P; BECKMANN, JS; VELHO, G; LATHROP, GM; FROGUEL, P				VAXILLAIRE, M; BOCCIO, V; PHILIPPI, A; VIGOUROUX, C; TERWILLIGER, J; PASSA, P; BECKMANN, JS; VELHO, G; LATHROP, GM; FROGUEL, P			A GENE FOR MATURITY-ONSET DIABETES OF THE YOUNG (MODY) MAPS TO CHROMOSOME 12Q	NATURE GENETICS			English	Article							MELLITUS; GLUCOKINASE; MUTATIONS; SUBTYPE; LINKAGE	Maturity-onset diabetes of the young (MODY) is a subtype of non-insulin dependent diabetes mellitus, with early age of onset. MODY is genetically heterogeneous, associated with glucokinase mutations and a locus on chromosome 20q; in about 50% of cases, its genetic background is unknown. We have studied 12 families in which MODY is unlinked to either glucokinase or chromosome 20q markers, and find significant evidence for linkage with microsatellite markers on chromosome 12q, most likely within a 7 centimorgan interval bracketed by D12S86 and D12S342. The disease was estimated to be linked to this chromosome region in approximately 50% of families in a heterogeneity analysis. These MODY patients exhibit major hyperglycaemia with a severe insulin secretory defect, suggesting that the causal gene is implicated in pancreatic beta-cell function.	INST PASTEUR,CNRS,EP10,F-59019 LILLE,FRANCE; WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7BN,ENGLAND; HOP ST LOUIS,SERV ENDOCRINOL,F-75010 PARIS,FRANCE; GENETHON,F-91002 EVRY,FRANCE; INSERM,U358,F-75010 PARIS,FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Oxford; Wellcome Centre for Human Genetics; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)			Philippi, Anne/M-9853-2017; FROGUEL, Philippe/O-6799-2017; Beckmann, Jacques S/A-9772-2008; Velho, Gilberto/Q-6724-2017	Philippi, Anne/0000-0003-2184-6008; FROGUEL, Philippe/0000-0003-2972-0784; Beckmann, Jacques S/0000-0002-9741-1900; Velho, Gilberto/0000-0001-8811-363X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BELL GI, 1991, P NATL ACAD SCI USA, V88, P1484, DOI 10.1073/pnas.88.4.1484; FEJANS SS, 1990, DIABETES CARE, V13, P49; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; FROGUEL P, 1991, DIABETOLOGIA, V34, P685, DOI 10.1007/BF00401001; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; GIDHJAIN M, 1993, P NATL ACAD SCI USA, V90, P1932, DOI 10.1073/pnas.90.5.1932; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HERMAN WH, 1994, DIABETES, V43, P40, DOI 10.2337/diabetes.43.1.40; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Snedecor G. W, 1989, STAT METHODS, V8th; VAXILLAIRE M, 1994, DIABETES, V43, P389, DOI 10.2337/diabetes.43.3.389; VELHO G, 1992, LANCET, V340, P444, DOI 10.1016/0140-6736(92)91768-4; Vignal Alain, 1993, V1, P211; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; [No title captured]; [No title captured]	16	183	191	0	8	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1995	9	4					418	423		10.1038/ng0495-418	http://dx.doi.org/10.1038/ng0495-418			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795649				2022-12-25	WOS:A1995QQ75300021
J	REISS, AL; ABRAMS, MT; GREENLAW, R; FREUND, L; DENCKLA, MB				REISS, AL; ABRAMS, MT; GREENLAW, R; FREUND, L; DENCKLA, MB			NEURODEVELOPMENTAL EFFECTS OF THE FMR-1 FULL MUTATION IN HUMANS	NATURE MEDICINE			English	Article							FRAGILE-X-SYNDROME; FRA(X) SYNDROME; CAENORHABDITIS-ELEGANS; COGNITIVE PROFILES; POSTERIOR-FOSSA; CGG-REPEAT; CELL-DEATH; MALES; GENE; BEHAVIOR	Brain dysfunction is the most important sequelae of the fragile X (FMR-1) mutation, the most common heritable cause of developmental disability. Using magnetic-resonance imaging (MRI) and quantitative morphometry, we have compared the neuroanatomy of 51 individuals with an FMR-1 mutation with matched controls and showed that subjects with an FMR-1 mutation have increased volume of the caudate nucleus and, in males, the lateral ventricle. Both caudate and lateral ventricular volumes are correlated with IQ. Caudate volume is also correlated with the methylation status of the FMR-1 gene. Neuroanatomical differences between two monozygotic twins with an FMR-1 mutation who are discordant for mental retardation are localized to the cerebellum, lateral ventricles and subcortical nuclei. These findings suggest that the FMR-1 mutation causing the fragile X syndrome leads to observable changes in neuroanatomy that may be relevant to the neurodevelopmental disability and behavioural problems observed in affected individuals.	JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT NEUROL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	REISS, AL (corresponding author), KENNEDY KRIEGER INST,707 N BROADWAY,BALTIMORE,MD 21205, USA.		Freund, Lisa/ABD-8855-2020	Freund, Lisa/0000-0003-2095-4023	NICHD NIH HHS [HD24061, HD25806] Funding Source: Medline; NIMH NIH HHS [MH01142] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD025806] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABRAMS MT, 1994, AM J MED GENET, V51, P317, DOI 10.1002/ajmg.1320510407; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; BAMGARDNER T, IN PRESS PEDIATRICS; BAUMGARDNER T, 1992, Current Opinion in Pediatrics, V4, P609, DOI 10.1097/00008480-199208000-00008; Bayley N, 1993, BAYLEY SCALES INFANT; BREGMAN JD, 1988, J AUTISM DEV DISORD, V18, P343, DOI 10.1007/BF02212191; COHEN IL, 1988, AM J MENT RETARD, V92, P436; COHEN IL, 1991, AM J HUM GENET, V48, P195; COTE L, 1991, PRINCIPLES NEURAL SC, P647; CROWE SF, 1990, NEUROPSYCHOLOGIA, V28, P9, DOI 10.1016/0028-3932(90)90082-Y; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; CURFS LMG, 1989, J MED GENET, V26, P443, DOI 10.1136/jmg.26.7.443; D'MELLO SR, 1994, EXP CELL RES, V211, P332, DOI 10.1006/excr.1994.1095; DRISCOLL M, 1992, J NEUROBIOL, V23, P1327, DOI 10.1002/neu.480230919; DYKENS EM, 1989, J AM ACAD CHILD PSY, V28, P422, DOI 10.1097/00004583-198905000-00020; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; FILIPEK PA, IN PRESS CEREBRAL CO; FISCH GS, 1994, AM J MED GENET, V51, P353, DOI 10.1002/ajmg.1320510411; FREUND LS, 1993, PEDIATRICS, V91, P321; FREUND LS, 1991, AM J MED GENET, V38, P542, DOI 10.1002/ajmg.1320380409; FREUND LS, IN PRESS DEVNEUROPSY; GIBSON TJ, 1993, TRENDS BIOCHEM SCI, V18, P331, DOI 10.1016/0968-0004(93)90068-X; Hagerman R, 1991, FRAGILE X SYNDROME D, P3; Hagerman R. J., 1991, FRAGILE X SYNDROME D, P173; HAGERMAN RJ, 1989, AM J MED GENET, V33, P513, DOI 10.1002/ajmg.1320330422; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; HODAPP RM, 1990, J AM ACAD CHILD PSY, V29, P214, DOI 10.1097/00004583-199003000-00009; JACK CR, 1994, EPILEPSIA, V35, pS21, DOI 10.1111/j.1528-1157.1994.tb05986.x; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; KEMPER MB, 1988, AM J MED GENET, V30, P191, DOI 10.1002/ajmg.1320300118; LACHIEWICZ AM, 1987, AM J MENT RETARD, V92, P272; LACHIEWICZ AM, 1994, AM J MED GENET, V51, P364, DOI 10.1002/ajmg.1320510413; MARGOLIS RL, 1994, BIOL PSYCHIAT, V35, P946, DOI 10.1016/0006-3223(94)91241-6; Mesulam M. M., 1985, PRINCIPLES BEHAVIORA, P1; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; PROUTY LA, 1988, AM J MED GENET, V30, P123, DOI 10.1002/ajmg.1320300111; REISS A L, 1990, Brain Dysfunction, V3, P9; REISS AL, 1992, AM J MED GENET, V43, P35, DOI 10.1002/ajmg.1320430106; REISS AL, 1994, HUM MOL GENET, V3, P393, DOI 10.1093/hmg/3.3.393; REISS AL, 1994, NEUROLOGY, V44, P1317, DOI 10.1212/WNL.44.7.1317; REISS AL, 1991, AM J HUM GENET, V49, P279; REISS AL, 1991, ANN NEUROL, V29, P26, DOI 10.1002/ana.410290107; REISS AL, ANN NEUROL, V34; ROUSSEAU F, 1991, J MED GENET, V28, P830, DOI 10.1136/jmg.28.12.830; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; Sherman S., 1991, FRAGILE X SYNDROME D, P69; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SUDHALTER V, 1991, AM J MED GENET, V38, P493, DOI 10.1002/ajmg.1320380270; SUGIMOTO A, 1994, EMBO J, V13, P2023, DOI 10.1002/j.1460-2075.1994.tb06475.x; TAYLOR A E, 1990, Alzheimer Disease and Associated Disorders, V4, P150, DOI 10.1097/00002093-199040300-00003; THEOBALD TM, 1987, AM J MED GENET, V28, P1, DOI 10.1002/ajmg.1320280102; THORNDIKE R, 1986, GUIDE ADM SCORING 4T; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; VERHEIJ C, 1993, NATURE, V363, P722, DOI 10.1038/363722a0; VERKERK AJMH, 1993, HUM MOL GENET, V2, P399, DOI 10.1093/hmg/2.4.399; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wechsler D, 1974, WECHSLER ADULT INTEL	60	179	179	1	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1995	1	2					159	167		10.1038/nm0295-159	http://dx.doi.org/10.1038/nm0295-159			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX558	7585014				2022-12-25	WOS:A1995QX55800028
J	ARMITAGE, MM; KIVLIN, JD; FERRELL, RE				ARMITAGE, MM; KIVLIN, JD; FERRELL, RE			A PROGRESSIVE EARLY-ONSET CATARACT GENE MAPS TO HUMAN-CHROMOSOME 17Q24	NATURE GENETICS			English	Article							INTRINSIC POLYPEPTIDE MIP; LINKAGE ANALYSIS; LENS; GALACTOKINASE; ENZYMES; FAMILY; LOCUS	Cerulean cataract is an autosomal dominant, early onset, progressive cataract characterized by blue or white opacifications in the nucleus and cortex of the lens. A large four-generation pedigree in which cerulean cataract segregates was studied for linkage analysis. A genome wide search was undertaken after the plausible candidate genes were excluded and the cerulean cataract phenotype was mapped to chromosome 17q24. The three markers closest to the disease gene are D17S802 (Z(theta)=9.46 at (theta)=0.085), D17S836 (Z(theta)=5.26 at (theta)=0.031) and AFMa238yb5 (Z(theta)=7.11 at (theta)=0.032). Multipoint linkage analyses yielded a maximum lod score of Z(theta)=13.71, placing the cerulean cataract gene between D17S802 and D17S836 at (theta)=0.048 and (theta)=0.013, respectively.	UNIV PITTSBURGH,GRAD SCH PUBL HLTH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; MED COLL WISCONSIN,INST EYE,MILWAUKEE,WI 53226	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical College of Wisconsin								BEUTLER E, 1973, New England Journal of Medicine, V288, P1203, DOI 10.1056/NEJM197306072882303; BODKER FS, 1990, AM J MED GENET, V37, P54, DOI 10.1002/ajmg.1320370113; BRAKENHOFF RH, 1994, HUM MOL GENET, V3, P279, DOI 10.1093/hmg/3.2.279; BROEKHUYSE RM, 1976, EXP EYE RES, V23, P365, DOI 10.1016/0014-4835(76)90135-4; EIBERG H, 1988, CLIN GENET, V34, P272; ELSEVIER SM, 1974, NATURE, V251, P633, DOI 10.1038/251633a0; GORIN MB, 1984, CELL, V39, P49, DOI 10.1016/0092-8674(84)90190-9; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; KIVLIN J, 1985, CYTOGENET CELL GENET, V40, P669; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; MAUMENEE IH, 1979, OPHTHALMOLOGY, V86, P1554; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; REESE PD, 1987, ARCH OPHTHALMOL-CHIC, V105, P1382; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SKALKA HW, 1980, ARCH OPHTHALMOL-CHIC, V98, P269; STAMBOLIAN D, 1986, INVEST OPHTH VIS SCI, V27, P429; TOMAREV SI, 1988, NATURE, V336, P86, DOI 10.1038/336086a0; VOGT A, 1922, A VONGRAEFES ARCH CL, V108, P219; WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669; YANCEY SB, 1988, J CELL BIOL, V106, P705, DOI 10.1083/jcb.106.3.705	22	77	80	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JAN	1995	9	1					37	40		10.1038/ng0195-37	http://dx.doi.org/10.1038/ng0195-37			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PZ913	7704021				2022-12-25	WOS:A1995PZ91300012
J	REED, ML; LEFF, SE				REED, ML; LEFF, SE			MATERNAL IMPRINTING OF HUMAN SNRPN, A GENE DELETED IN PRADER-WILLI-SYNDROME	NATURE GENETICS			English	Article							NUCLEAR RIBONUCLEOPROTEIN POLYPEPTIDE; PARENTAL ORIGIN; TME LOCUS; CHROMOSOME-15; DELETIONS; ANGELMAN; REGION; DNA	Prader-Willi syndrome (PWS), a human neuroendocrine disorder, is associated with deficiencies of paternal chromosome 15q12. Small nuclear ribonucleoprotein polypeptide N (SNRPN) is the first expressed gene identified in the PWS critically deleted region. Following our demonstration that the murine homologue of SNRPN is imprinted, we have characterized a sequence polymorphism within expressed portions of human SNRPN and show that human SNRPN is monoallelically expressed in fetal brain and heart and in adult brain. Analysis of maternal DNA and SNRPN cDNA confirmed that the maternal allele of SNRPN is not expressed in fetal brain and heart. Maternal imprinting of SNRPN supports the hypothesis that paternal absence of SNRPN is responsible for the PWS phenotype.	STANFORD UNIV,SCH MED,DEPT MOLEC PHARMACOL,STANFORD,CA 94305	Stanford University								BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Cassidy S B, 1984, Curr Probl Pediatr, V14, P1; CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; FEENEY RJ, 1989, J BIOL CHEM, V264, P5576; FOREJT J, 1992, CELL, V70, P443, DOI 10.1016/0092-8674(92)90168-C; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; GRIMALDI K, 1993, DEV BIOL, V156, P319, DOI 10.1006/dbio.1993.1080; HAMM J, 1990, CELL, V62, P569, DOI 10.1016/0092-8674(90)90021-6; Hayashi K, 1991, PCR Methods Appl, V1, P34; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; NAKATSU Y, 1993, NATURE, V364, P448, DOI 10.1038/364448a0; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OGAWA O, 1993, NAT GENET, V5, P408, DOI 10.1038/ng1293-408; OHLSSON R, 1993, NAT GENET, V4, P94, DOI 10.1038/ng0593-94; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; Prader A., 1956, SCHWEIZ MED WSCHR, V86, P1260, DOI DOI 10.1007/978-3-642-47669-3_24; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; ROKEACH LA, 1989, J BIOL CHEM, V264, P5024; SCHMAUSS C, 1989, NUCLEIC ACIDS RES, V17, P1733, DOI 10.1093/nar/17.4.1733; STELTZ JA, 1987, STRUCTURE FUNCTION M, P115; ZHANG YH, 1993, AM J HUM GENET, V53, P113; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40; ZIEVE GW, 1990, CRIT REV BIOCHEM MOL, V25, P1, DOI 10.3109/10409239009090604	32	141	144	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1994	6	2					163	167		10.1038/ng0294-163	http://dx.doi.org/10.1038/ng0294-163			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MU763	7512861				2022-12-25	WOS:A1994MU76300011
J	DELCASTILLO, I; COHENSALMON, M; BLANCHARD, S; LUTFALLA, G; PETIT, C				DELCASTILLO, I; COHENSALMON, M; BLANCHARD, S; LUTFALLA, G; PETIT, C			STRUCTURE OF THE X-LINKED KALLMANN SYNDROME GENE AND ITS HOMOLOGOUS PSEUDOGENE ON THE Y-CHROMOSOME	NATURE GENETICS			English	Article							HYDROPHOBIC CLUSTER-ANALYSIS; STEROID SULFATASE GENE; NEURAL CELL-ADHESION; MESSENGER-RNA; PROTEIN GENES; SEQUENCE; INACTIVATION; EVOLUTION; MOUSE; FIBRONECTIN	The gene for the X-linked Kallmann syndrome (KAL), a developmental disorder characterized by hypogonadotropic hypogonadism and anosmia, maps to Xp22.3 and has a homologous locus, KALP, on Yq11. We show here that KAL consists of 14 exons spanning 120-200 kilobases that correlate with the distribution of domains in the predicted protein including four fibronectin type III repeats. The KALP locus reveals several large deletions and a number of small insertions, deletions and base substitutions which indicate it is a non-processed pseudogene. The sequence divergence between KAL and KALP in humans, and the chromosomal location of KAL homologous sequences in other primates, suggest that KALP and the steroid sulphatase pseudogene on Yq11 were involved in the same rearrangement event on the Y chromosome during primate evolution.	INST PASTEUR, CNRS, URA 1445, UNITE GENET MOLEC HUMAINE, F-75724 PARIS 15, FRANCE; CNRS, UNITE ONCOL VIRALE, F-94801 VILLEJUIF, FRANCE	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)			del Castillo, Ignacio/B-4314-2013; Lutfalla, Georges/AAW-9386-2021	del Castillo, Ignacio/0000-0003-1188-3665; LUTFALLA, Georges/0000-0002-6591-7894; Cohen-Salmon, Martine/0000-0002-5312-8476; Petit, Christine/0000-0002-9069-002X				ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; BALLABIO A, 1987, HUM GENET, V77, P338, DOI 10.1007/BF00291422; BICK D, 1992, NEW ENGL J MED, V326, P1752, DOI 10.1056/NEJM199206253262606; CAMPBELL SM, 1984, NUCLEIC ACIDS RES, V12, P8685, DOI 10.1093/nar/12.22.8685; De Morster G, 1954, SCHWEIZ ARCH NEUROL, V74, P309; DEAR TN, 1991, BIOCHEM BIOPH RES CO, V176, P247, DOI 10.1016/0006-291X(91)90916-U; DESSEN P, 1990, COMPUT APPL BIOSCI, V6, P355; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; Engel J, 1991, CURR OPIN CELL BIOL, V3, P779, DOI 10.1016/0955-0674(91)90050-9; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; HARDELIN JP, 1992, P NATL ACAD SCI USA, V89, P8190, DOI 10.1073/pnas.89.17.8190; HEMPERLY JJ, 1986, P NATL ACAD SCI USA, V83, P3037, DOI 10.1073/pnas.83.9.3037; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; Jones J R, 1976, Obstet Gynecol Annu, V5, P443; Kallmann FJ, 1944, AM J MENT DEF, V48, P203; KEITGES E, 1985, NATURE, V315, P226, DOI 10.1038/315226a0; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEMESLEVARLOOT L, 1990, BIOCHIMIE, V72, P555, DOI 10.1016/0300-9084(90)90120-6; Maestre de San Juan A., 1856, SIGLO MED, V3, P211; MALES JL, 1973, ARCH INTERN MED, V131, P501, DOI 10.1001/archinte.131.4.501; McKusick VA, 1990, MENDELIAN INHERITANC; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; OLDBERG A, 1986, J BIOL CHEM, V261, P2113; PETIT C, 1990, P NATL ACAD SCI USA, V87, P3680, DOI 10.1073/pnas.87.10.3680; RONNEKLEIV OK, 1990, ENDOCRINOLOGY, V126, P498, DOI 10.1210/endo-126-1-498; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SALIDO EC, 1992, AM J HUM GENET, V50, P303; SAMBROOK J, 1989, MOL CLONIGN LABORATO; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; SCHWANZELFUKUDA M, 1992, J COMP NEUROL, V321, P1, DOI 10.1002/cne.903210102; SCHWANZELFUKUDA M, 1989, NATURE, V338, P161, DOI 10.1038/338161a0; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SPARKES RS, 1968, ARCH INTERN MED, V121, P534, DOI 10.1001/archinte.121.6.534; STETLER G, 1986, NUCLEIC ACIDS RES, V14, P7883, DOI 10.1093/nar/14.20.7883; THEPOT D, 1990, NUCLEIC ACIDS RES, V18, P3641, DOI 10.1093/nar/18.12.3641; THOREAU E, 1991, FEBS LETT, V282, P26, DOI 10.1016/0014-5793(91)80437-8; WRAY S, 1989, P NATL ACAD SCI USA, V86, P8132, DOI 10.1073/pnas.86.20.8132; YEN PH, 1988, CELL, V55, P1123, DOI 10.1016/0092-8674(88)90257-7; YEN PH, 1992, HUM MOL GENET, V1, P47	46	106	108	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1992	2	4					305	310		10.1038/ng1292-305	http://dx.doi.org/10.1038/ng1292-305			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303284				2022-12-25	WOS:A1992KB49500015
J	ITZHAKI, JE; BARNETT, MA; MACCARTHY, AB; BUCKLE, VJ; BROWN, WRA; PORTER, ACG				ITZHAKI, JE; BARNETT, MA; MACCARTHY, AB; BUCKLE, VJ; BROWN, WRA; PORTER, ACG			TARGETED BREAKAGE OF A HUMAN-CHROMOSOME MEDIATED BY CLONED HUMAN TELOMERIC DNA	NATURE GENETICS			English	Article							RECOMBINATION; CELLS; AMPLIFICATION	Novel approaches to the structural and functional analysis of mammalian chromosomes would be possible if the gross structure of the chromosomes in living cells could be engineered. Controlled modifications can be engineered by conventional targeting techniques based on homologous recombination. Large but uncontrolled modifications can be made by the integration of cloned human telomeric DNA. We describe here the combined use of gene targeting and telomere-mediated chromosome breakage to generate a defined truncation of a human chromosome. Telomeric DNA was targeted to the 6-16 gene on the short arm of chromosome 1 in a human cell line. Molecular and cytogenetic analyses showed that, of eight targeted clones that were isolated, one clone had the predicted truncation of chromosome 1.	JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND	University of Oxford	ITZHAKI, JE (corresponding author), UNIV OXFORD,DEPT BIOCHEM,S PARKS RD,OXFORD OX1 3QU,ENGLAND.			Brown, William RA/0000-0001-5340-3645				BLACKBURN EH, 1984, CELL, V36, P447, DOI 10.1016/0092-8674(84)90238-1; Brown WRA, 1992, CURR OPIN GENET DEV, V2, P479, DOI 10.1016/S0959-437X(05)80161-3; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CLAUSS IM, 1990, CYTOGENET CELL GENET, V53, P66; COOKE HJ, 1979, NUCLEIC ACIDS RES, V6, P3177, DOI 10.1093/nar/6.10.3177; FARR C, 1991, P NATL ACAD SCI USA, V88, P7006, DOI 10.1073/pnas.88.16.7006; ITZHAKI JE, 1991, NUCLEIC ACIDS RES, V19, P3835, DOI 10.1093/nar/19.14.3835; KELLY JM, 1986, EMBO J, V5, P1601, DOI 10.1002/j.1460-2075.1986.tb04402.x; MORRISON KE, 1992, AM J HUM GENET, V50, P520; Porter A. C. G., 1989, Technique, A Journal of Methods in Cell and Molecular Biology, V1, P53; PORTER ACG, 1988, EMBO J, V7, P85, DOI 10.1002/j.1460-2075.1988.tb02786.x; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; SMITH KA, 1990, CELL, V63, P1219, DOI 10.1016/0092-8674(90)90417-D; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; TEREILE H, 1992, P NATL ACAD SCI USA, V89, P5128; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027; WINDLE B, 1991, GENE DEV, V5, P160, DOI 10.1101/gad.5.2.160; YEN PH, 1991, P NATL ACAD SCI USA, V88, P8944, DOI 10.1073/pnas.88.20.8944	20	67	73	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1992	2	4					283	287		10.1038/ng1292-283	http://dx.doi.org/10.1038/ng1292-283			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303280				2022-12-25	WOS:A1992KB49500011
J	TAYLOR, SAM; SNELL, RG; BUCKLER, A; AMBROSE, C; DUYAO, M; CHURCH, D; LIN, CS; ALTHERR, M; BATES, GP; GROOT, N; BARNES, G; SHAW, DJ; LEHRACH, H; WASMUTH, JJ; HARPER, PS; HOUSMAN, DE; MACDONALD, ME; GUSELLA, JF				TAYLOR, SAM; SNELL, RG; BUCKLER, A; AMBROSE, C; DUYAO, M; CHURCH, D; LIN, CS; ALTHERR, M; BATES, GP; GROOT, N; BARNES, G; SHAW, DJ; LEHRACH, H; WASMUTH, JJ; HARPER, PS; HOUSMAN, DE; MACDONALD, ME; GUSELLA, JF			CLONING OF THE ALPHA-ADDUCIN GENE FROM THE HUNTINGTONS-DISEASE CANDIDATE REGION OF CHROMOSOME-4 BY EXON AMPLIFICATION	NATURE GENETICS			English	Article							PROTEIN KINASE-C; ERYTHROCYTE ADDUCIN; LINKAGE DISEQUILIBRIUM; PHOSPHORYLATION; MEMBRANE; SITES; IDENTIFICATION; ASSOCIATION; SUBSTRATE; RATS	We have applied the technique of exon amplification to the isolation of genes from the chromosome 4p16.3 Huntington's disease (HD) candidate region. Exons recovered from cosmid Y24 identified cDNA clones corresponding to the alpha-subunit of adducin, a calmodulin-binding protein that is thought to promote assembly of spectrin-actin complexes in the formation of the membrane cytoskeleton. Alpha-adducin is widely expressed and, at least in brain, is encoded by alternatively spliced mRNAs. The alpha-adducin gene maps immediately telomeric to D4S95, in a region likely to contain the HD defect, and must be scrutinized to establish whether it is the site of the HD mutation.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND; UNIV WALES COLL MED,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES; MIT,CTR CANC RES,CAMBRIDGE,MA 02139; UNIV CALIF IRVINE,DEPT BIOL CHEM,IRVINE,CA 92717	Harvard University; Harvard Medical School; Cancer Research UK; Cardiff University; Massachusetts Institute of Technology (MIT); University of California System; University of California Irvine	TAYLOR, SAM (corresponding author), MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET UNIT,BOSTON,MA 02114, USA.		Bates, Gillian P/E-1146-2012	Bates, Gillian P/0000-0002-4041-6305; Snell, Russell/0000-0002-8166-4014				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASEEM A, 1988, EUR J BIOCHEM, V178, P563; BATES GP, 1991, AM J HUM GENET, V49, P7; BATES GP, 1992, NAT GENET, V1, P180, DOI 10.1038/ng0692-180; BENNETT V, 1988, J BIOL CHEM, V263, P5860; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; COHEN CM, 1986, J BIOL CHEM, V261, P7701; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; GARDNER K, 1986, J BIOL CHEM, V261, P1339; GRAFF JM, 1989, J BIOL CHEM, V264, P11912; Gusella J F, 1991, Adv Hum Genet, V20, P125; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; JOSHI R, 1990, J BIOL CHEM, V265, P13130; JOSHI R, 1991, J CELL BIOL, V115, P665, DOI 10.1083/jcb.115.3.665; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; LIN CS, 1991, CELL MOL GENET, V17, P481; LING E, 1986, J BIOL CHEM, V261, P13875; MACDONALD ME, 1992, NAT GENET, V1, P99, DOI 10.1038/ng0592-99; MACDONALD ME, 1991, AM J HUM GENET, V49, P723; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; Maniatis T., 1982, MOL CLONING; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; MISCHE S, 1987, J CELL BIOL, V105, P2387; NEHLS V, 1991, BLOOD, V78, P1692; PALFREY HC, 1985, J BIOL CHEM, V260, P6021; PETERS LL, 1991, J CELL BIOL, V114, P1233, DOI 10.1083/jcb.114.6.1233; SALARDI S, 1989, AM J HYPERTENS, V2, P229, DOI 10.1093/ajh/2.4.229; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH B, 1988, AM J HUM GENET, V42, P335; SNELL RG, 1989, J MED GENET, V26, P673, DOI 10.1136/jmg.26.11.673; SNELL RG, 1992, AM J HUM GENET, V51, P357; THEILMANN J, 1989, J MED GENET, V26, P676, DOI 10.1136/jmg.26.11.676; WASEEM A, 1990, J CELL SCI, V96, P93; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0	35	43	47	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1992	2	3					223	227		10.1038/ng1192-223	http://dx.doi.org/10.1038/ng1192-223			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345173				2022-12-25	WOS:A1992JW16500013
J	WOLFE, JH; DESHMANE, SL; FRASER, NW				WOLFE, JH; DESHMANE, SL; FRASER, NW			HERPESVIRUS VECTOR GENE-TRANSFER AND EXPRESSION OF BETA-GLUCURONIDASE IN THE CENTRAL-NERVOUS-SYSTEM OF MPS-VII MICE	NATURE GENETICS			English	Article							SIMPLEX VIRUS TYPE-1; LATENCY-ASSOCIATED TRANSCRIPT; MUCOPOLYSACCHARIDOSIS TYPE-VII; TRIGEMINAL GANGLIA; MESSENGER-RNA; MOUSE; CELLS; INFECTION; GALACTOSIDASE; DEFICIENCY	Genetic disorders affecting the central nervous system (CNS) can potentially be treated by gene transfer using vectors which infect and express genes in post-mitotic neurons. Herpesviruses establish latent infections in neurons during which only one viral gene (LAT) is expressed, thus the LAT promoter may express foreign genes in latently infected CNS cells. Expression of a beta-glucuronidase gene driven by the LAT promoter was tested in mice lacking this enzyme, which are a model for a human genetic disease affecting the CNS (mucopolysaccharidosis VII, Sly disease). Cells expressing the missing enzymatic activity were present in the trigeminal ganglia and brainstems of latently infected animals, up to four months post-inoculation, demonstrating the potential of this approach for the long-term expression of foreign genes in the CNS.	WISTAR INST,PHILADELPHIA,PA 19104	The Wistar Institute	WOLFE, JH (corresponding author), UNIV PENN,SCH VET MED,3800 SPRUCE ST,PHILADELPHIA,PA 19104, USA.							BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; BIRKENMEIER EH, 1991, BLOOD, V78, P3081; BLOCK TM, 1990, J VIROL, V64, P3417, DOI 10.1128/JVI.64.7.3417-3426.1990; DEATLY AM, 1988, J VIROL, V62, P749, DOI 10.1128/JVI.62.3.749-756.1988; DEATLY AM, 1987, P NATL ACAD SCI USA, V84, P3204, DOI 10.1073/pnas.84.10.3204; DESHMANE SL, 1989, J VIROL, V63, P943, DOI 10.1128/JVI.63.2.943-947.1989; DOBSON AT, 1989, J VIROL, V63, P3844, DOI 10.1128/JVI.63.9.3844-3851.1989; DOBSON AT, 1990, NEURON, V5, P353, DOI 10.1016/0896-6273(90)90171-B; FARRELL MJ, 1991, P NATL ACAD SCI USA, V88, P790, DOI 10.1073/pnas.88.3.790; FISHMAN WH, 1967, NATURE, V213, P457, DOI 10.1038/213457a0; FRASER NW, 1991, CURR EYE RES, V10, P1, DOI 10.3109/02713689109020352; FRIEDMANN T, 1989, SCIENCE, V244, P1275, DOI 10.1126/science.2660259; GELLER AI, 1988, SCIENCE, V241, P1667, DOI 10.1126/science.2843986; HASKINS ME, 1984, PEDIATR RES, V18, P980, DOI 10.1203/00006450-198418100-00014; HO DY, 1988, VIROLOGY, V167, P279, DOI 10.1016/0042-6822(88)90079-7; HO DY, 1989, P NATL ACAD SCI USA, V86, P7596, DOI 10.1073/pnas.86.19.7596; IZUMI KM, 1989, MICROB PATHOGENESIS, V7, P121, DOI 10.1016/0882-4010(89)90031-4; LEIB DA, 1989, J VIROL, V63, P2893, DOI 10.1128/JVI.63.7.2893-2900.1989; MITCHELL WJ, 1990, J GEN VIROL, V71, P953, DOI 10.1099/0022-1317-71-4-953; Neufeld EF, 1989, METABOLIC BASIS INHE, P1565; NISHIMURA Y, 1986, P NATL ACAD SCI USA, V83, P7292, DOI 10.1073/pnas.83.19.7292; OLSEN I, 1981, NATURE, V291, P244, DOI 10.1038/291244a0; PALELLA TD, 1988, MOL CELL BIOL, V8, P457, DOI 10.1128/MCB.8.1.457; PERRY LJ, 1988, J GEN VIROL, V69, P2831, DOI 10.1099/0022-1317-69-11-2831; PIGNATTI PF, 1979, VIROLOGY, V93, P260, DOI 10.1016/0042-6822(79)90295-2; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; ROIZMAN B, 1979, CELL, V16, P481, DOI 10.1016/0092-8674(79)90023-0; ROSENBERG MB, 1988, SCIENCE, V242, P1575, DOI 10.1126/science.3201248; SCHULL RM, 1988, PEDIATR RES, V24, P347; SLY WS, 1973, J PEDIATR-US, V82, P249, DOI 10.1016/S0022-3476(73)80162-3; SMITH BF, 1990, MOL CELL BIOL, V10, P3268, DOI 10.1128/MCB.10.6.3268; SPIVACK JG, 1988, J VIROL, V62, P1479, DOI 10.1128/JVI.62.5.1479-1485.1988; STEINER I, 1988, J VIROL, V62, P3493, DOI 10.1128/JVI.62.9.3493-3496.1988; STEINER I, 1989, EMBO J, V8, P505, DOI 10.1002/j.1460-2075.1989.tb03404.x; STEVENS JG, 1987, SCIENCE, V235, P1056, DOI 10.1126/science.2434993; STEVENS JG, 1989, MICROBIOL REV, V53, P318, DOI 10.1128/MMBR.53.3.318-332.1989; STRAMM LE, 1990, EXP EYE RES, V50, P521, DOI 10.1016/0014-4835(90)90041-R; WOLFE JH, 1990, P NATL ACAD SCI USA, V87, P2877, DOI 10.1073/pnas.87.8.2877	38	163	173	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1992	1	5					379	384		10.1038/ng0892-379	http://dx.doi.org/10.1038/ng0892-379			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ121	1338772				2022-12-25	WOS:A1992JJ12100018
J	ELDEIRY, WS; KERN, SE; PIETENPOL, JA; KINZLER, KW; VOGELSTEIN, B				ELDEIRY, WS; KERN, SE; PIETENPOL, JA; KINZLER, KW; VOGELSTEIN, B			DEFINITION OF A CONSENSUS BINDING-SITE FOR P53	NATURE GENETICS			English	Article							WILD-TYPE; PROTEIN; SEQUENCES; ANTIGEN; GENOME; DNA	Recent experiments have suggested that p53 action may be mediated through its interaction with DNA. We have now identified 18 human genomic clones that bind to p53 in vitro. Precise mapping of the binding sequences within these clones revealed a consensus binding site with a striking internal symmetry, consisting of two copies of the 10 base pair motif 5'-PuPuPuC(A/T)(T/A)GPyPyPy-3' separated by 0-13 base pairs. One copy of the motif was insufficient for binding, and subtle alterations of the motif, even when present in multiple copies, resulted in loss of affinity for p53. Mutants of p53, representing each of the four "hot spots" frequently altered in human cancers, failed to bind to the consensus dimer. These results define the DNA sequence elements with which p53 interacts in vitro and which may be important for p53 action in vivo.	JOHNS HOPKINS UNIV,SCH MED,CTR ONCOL,424 N BOND ST,BALTIMORE,MD 21231; JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21231	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University			El-Deiry, Wafik/AAJ-6080-2020	El-Deiry, Wafik/0000-0002-9577-8266				BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; FRIEDMAN PN, 1990, P NATL ACAD SCI USA, V87, P9275, DOI 10.1073/pnas.87.23.9275; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; KERN SE, 1991, ONCOGENE, V6, P131; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KINZLER KW, 1990, MOL CELL BIOL, V10, P634, DOI 10.1128/MCB.10.2.634; KINZLER KW, 1989, NUCLEIC ACIDS RES, V17, P3645, DOI 10.1093/nar/17.10.3645; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; MCKAY RDG, 1981, J MOL BIOL, V145, P471, DOI 10.1016/0022-2836(81)90540-4; MICHALOVITZ D, 1991, J CELL BIOCHEM, V45, P22, DOI 10.1002/jcb.240450108; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; RAYCROFT L, 1990, SCIENCE, V249, P1049, DOI 10.1126/science.2144364; STEINMEYER K, 1988, ONCOGENE, V3, P501; VOGELSTEIN B, 1990, NATURE, V348, P681, DOI 10.1038/348681a0; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WEINTRAUB H, 1991, P NATL ACAD SCI USA, V88, P4570, DOI 10.1073/pnas.88.11.4570	20	1849	1897	0	54	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1992	1	1					45	49		10.1038/ng0492-45	http://dx.doi.org/10.1038/ng0492-45			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1301998				2022-12-25	WOS:A1992JC97800011
J	RUGG, EL; MCLEAN, WHI; ALLISON, WE; LUNNY, DP; MACLEOD, RI; FELIX, DH; LANE, EB; MUNRO, CS				RUGG, EL; MCLEAN, WHI; ALLISON, WE; LUNNY, DP; MACLEOD, RI; FELIX, DH; LANE, EB; MUNRO, CS			A MUTATION IN THE MUCOSAL KERATIN K4 IS ASSOCIATED WITH ORAL WHITE SPONGE NEVUS	NATURE GENETICS			English	Note							EXPRESSION		EDINBURGH DENT HOSP,DEPT ORAL MED,EDINBURGH EH3 9YW,MIDLOTHIAN,SCOTLAND; GLASGOW DENT HOSP,DEPT ORAL MED,GLASGOW G2 3JZ,LANARK,SCOTLAND; SO GEN HOSP,DEPT DERMATOL,GLASGOW G51 4TF,LANARK,SCOTLAND	University of Edinburgh; University of Glasgow; University of Glasgow	RUGG, EL (corresponding author), UNIV DUNDEE,INST MED SCI,CANC RES CAMPAIGN LABS,DEPT ANAT & PHYSIOL,CANC RES CAMPAIGN,DUNDEE DD1 4HN,SCOTLAND.		McLean, William HI/C-6352-2009	McLean, William Henry Irwin/0000-0001-5539-5757	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALOI FG, 1988, DERMATOLOGICA, V177, P323, DOI 10.1159/000248588; BOWDEN PE, 1995, NAT GENET, V10, P363, DOI 10.1038/ng0795-363; COOPER DN, 1993, HUM GENE MUTAT; FRITHIOF L, 1976, ORAL SURG ORAL MED O, V41, P607, DOI 10.1016/0030-4220(76)90313-3; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HATZFELD M, 1991, J CELL SCI, V99, P351; JORGENSON RJ, 1981, ARCH DERMATOL, V117, P73, DOI 10.1001/archderm.117.2.73; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; LANE EB, 1994, CURR OPIN GENET DEV, V4, P412, DOI 10.1016/0959-437X(94)90030-2; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; LEUBE RE, 1988, J CELL BIOL, V106, P1249, DOI 10.1083/jcb.106.4.1249; MCDONAGH AJG, 1990, CLIN EXP DERMATOL, V15, P152, DOI 10.1111/j.1365-2230.1990.tb02056.x; MCGINNIS JP, 1975, ORAL SURG ORAL MED O, V40, P644, DOI 10.1016/0030-4220(75)90374-6; MCKUSICK VA, 1995, OMIM ON LINE MENDELI; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; MCLEAN WHI, 1994, HUM MOL GENET, V3, P1031, DOI 10.1093/hmg/3.6.1031; MISCHKE D, 1989, NUCLEIC ACIDS RES, V17, P7984, DOI 10.1093/nar/17.19.7984; RICHARD G, 1995, NAT GENET, V11, P453, DOI 10.1038/ng1295-453; VANMUIJEN GNP, 1986, EXP CELL RES, V162, P97, DOI 10.1016/0014-4827(86)90429-5; YOON SJ, 1994, GENOMICS, V24, P502, DOI 10.1006/geno.1994.1659	21	95	97	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					450	452		10.1038/ng1295-450	http://dx.doi.org/10.1038/ng1295-450			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493030				2022-12-25	WOS:A1995TH62900027
J	ISACSON, O; DEACON, TW; PAKZABAN, P; GALPERN, WR; DINSMORE, J; BURNS, LH				ISACSON, O; DEACON, TW; PAKZABAN, P; GALPERN, WR; DINSMORE, J; BURNS, LH			TRANSPLANTED XENOGENEIC NEURAL CELLS IN NEURODEGENERATIVE DISEASE-MODELS EXHIBIT REMARKABLE AXONAL TARGET SPECIFICITY AND DISTINCT GROWTH-PATTERNS OF GLIAL AND AXONAL FIBERS	NATURE MEDICINE			English	Article							CD44 EXPRESSION; NERVOUS-SYSTEM; NEUROBLASTS; ASTROCYTES; NEURONS; OLIGODENDROCYTES; GLYCOPROTEIN; SURVIVAL; PATHWAYS; SUBSETS	Clinical trials are under way using fetal cells to repair damaged neuronal circuitry. However, little is known about how transplanted immature neurons can grow anatomically correct connections in the adult central nervous system (CNS). We transplanted embryonic porcine neural cells in vivo into adult rat brains with neuronal and axonal loss typical of Parkinson's or Huntington's disease. Using complementary species-specific cellular markers, we found donor axons and CD44(+) astroglial fibres in host white matter tracts up to 8 mm from CNS transplant sites, although only donor axons were capable of reaching correct gray matter target regions. This work demonstrates that adult host brain can orient growth of transplanted neurons and that there are differences in transplant donor glial and axonal growth patterns in cellular repair of the mature CNS.	MCLEAN HOSP,NEUROGENERAT LAB,BELMONT,MA 02178; MASSACHUSETTS GEN HOSP,DEPT NEUROL,BELMONT,MA 02178; MASSACHUSETTS GEN HOSP,DEPT NEUROSURG,BELMONT,MA 02178; DIACRIN INC,BOSTON,MA 02129	Harvard University; McLean Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	ISACSON, O (corresponding author), HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115, USA.			Pakzaban, Peyman/0000-0001-7541-2286; Isacson, Ole/0000-0001-8091-8302	NINDS NIH HHS [NS29178, 5T32 NS07340, NS30064] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS029178, T32NS007340, R01NS030064] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGUAYO AJ, 1984, NEUROSCI LETT, V45, P53, DOI 10.1016/0304-3940(84)90328-8; ASHER R, 1992, EXP CELL RES, V203, P80, DOI 10.1016/0014-4827(92)90042-7; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; Bjorklund A, 1988, Adv Neurol, V47, P455; BRUNDIN P, 1985, BRAIN RES, V331, P251, DOI 10.1016/0006-8993(85)91550-1; BURDENGULLEY SM, 1995, J NEUROSCI, V15, P4370; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; COON HG, 1989, P NATL ACAD SCI USA, V86, P1703, DOI 10.1073/pnas.86.5.1703; DAVIES SJA, 1993, EUR J NEUROSCI, V5, P95, DOI 10.1111/j.1460-9568.1993.tb00474.x; DAVIES SJA, 1994, J NEUROSCI, V14, P1596, DOI 10.1523/JNEUROSCI.14-03-01596.1994; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; DEACON TW, 1994, EXP NEUROL, V130, P151, DOI 10.1006/exnr.1994.1194; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FORSSMAN J, 1898, THESIS LUND U; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; GALPERN WR, 1995, J NEUROSURG P AANS, P38; GIRGRAH N, 1991, J NEUROPATH EXP NEUR, V50, P779, DOI 10.1097/00005072-199111000-00009; GIRGRAH N, 1992, EXP CELL RES, V203, P80; GOODMAN CS, 1993, CELL S, V10, P77; HAMBURGER V, 1939, J EXP ZOOL, V80, P147; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Keynes R J, 1992, Curr Opin Neurobiol, V2, P55, DOI 10.1016/0959-4388(92)90162-E; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MORETTO G, 1993, J NEUROPATH EXP NEUR, V52, P419, DOI 10.1097/00005072-199307000-00009; PAKZABAN P, 1993, EXP BRAIN RES, V97, P13; PATTERSON PH, 1988, NEURON, V1, P263, DOI 10.1016/0896-6273(88)90074-8; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; SNOW MHL, 1980, NATURE, V286, P107, DOI 10.1038/286107a0; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; WICTORIN K, 1990, NATURE, V347, P556, DOI 10.1038/347556a0; WICTORIN K, 1992, J COMP NEUROL, V323, P475, DOI 10.1002/cne.903230403; ZHOU HF, 1993, EXP NEUROL, V122, P155, DOI 10.1006/exnr.1993.1116	37	179	184	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1189	1194		10.1038/nm1195-1189	http://dx.doi.org/10.1038/nm1195-1189			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584993				2022-12-25	WOS:A1995TC53700045
J	LIM, LE; DUCLOS, F; BROUX, O; BOURG, N; SUNADA, Y; ALLAMAND, V; MEYER, J; RICHARD, IZ; MOOMAW, C; SLAUGHTER, C; TOME, FMS; FARDEAU, M; JACKSON, CE; BECKMANN, JS; CAMPBELL, KP				LIM, LE; DUCLOS, F; BROUX, O; BOURG, N; SUNADA, Y; ALLAMAND, V; MEYER, J; RICHARD, IZ; MOOMAW, C; SLAUGHTER, C; TOME, FMS; FARDEAU, M; JACKSON, CE; BECKMANN, JS; CAMPBELL, KP			BETA-SARCOGLYCAN - CHARACTERIZATION AND ROLE IN LIMB-GIRDLE MUSCULAR-DYSTROPHY LINKED TO 4Q12	NATURE GENETICS			English	Article							GLYCOPROTEIN COMPLEX; SKELETAL-MUSCLE; BINDING DOMAIN; LINKAGE; DEFICIENCY; SARCOLEMMA; PROTEINS; MAPS; PURIFICATION; LAMININ	beta-sarcoglycan, a 43 kDa dystrophin-associated glycoprotein, is an integral component of the dystrophin-glycoprotein complex. We have cloned human beta-sarcoglycan cDNA and mapped the beta-sarcoglycan gene to chromosome 4q12. Pericentromeric markers and an intragenic polymorphic CA repeat cosegregated perfectly with autosomal recessive limb-girdle muscular dystrophy in several Amish families. A Thr-to-Arg missense mutation was identified within the beta-sarcoglycan gene that leads to a dramatically reduced expression of beta-sarcoglycan in the sarcolemma and a concomitant loss of adhalin and 35 DAG, which may represent a disruption of a functional subcomplex within the dystrophin-glycoprotein complex. Thus, the beta-sarcoglycan gene is the fifth locus identified (LGMD2E) that is involved in autosomal recessive limb-girdle muscular dystrophy.	UNIV IOWA,COLL MED,HOWARD HUGHES MED INST,IOWA CITY,IA 52242; UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; CTR ETUD POLYMORPHISME HUMAIN,FDN JEAN DAUSSET,F-75010 PARIS,FRANCE; GENETHON SA,F-91000 EVRY,FRANCE; UNIV TEXAS,HOWARD HUGHES MED INST,BIOPOLYMER FACIL,DALLAS,TX 75235; INSERM,U153,F-75005 PARIS,FRANCE; HENRY FORD HOSP,DIV CLIN & MOLEC GENET,DETROIT,MI 48202	Howard Hughes Medical Institute; University of Iowa; University of Iowa; Foundation Jean Dausset-CEPH; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); Henry Ford Health System; Henry Ford Hospital			Beckmann, Jacques S/A-9772-2008; Richard, isabelle/J-8298-2013; Allamand, Valérie/AAH-6272-2021; Allamand, Valerie/M-4333-2017	Beckmann, Jacques S/0000-0002-9741-1900; Allamand, Valérie/0000-0001-8997-9742; Campbell, Kevin/0000-0003-2066-5889				ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; ALLAMAND V, 1995, HUM MOL GENET, V4, P459, DOI 10.1093/hmg/4.3.459; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AZIBI K, 1993, HUM MOL GENET, V2, P1423; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FARDEAU M, IN PRESS BRAIN; FOUGEROUSSE F, 1994, HUM MOL GENET, V3, P285, DOI 10.1093/hmg/3.2.285; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GEE SH, 1993, J BIOL CHEM, V268, P14972; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEMMINGS L, 1992, J CELL BIOL, V116, P1369, DOI 10.1083/jcb.116.6.1369; HILLAIRE D, 1994, HUM MOL GENET, V3, P1657, DOI 10.1093/hmg/3.9.1657; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; IBRAGHINOVBESKR, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JACKSON CE, 1961, PEDIATRICS, V28, P77; JACKSON CE, 1968, PEDIATRICS, V41, P495; JORGENSEN AO, 1990, J CELL BIOL, V110, P1173, DOI 10.1083/jcb.110.4.1173; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MILLS KA, 1992, GENOMICS, V14, P209, DOI 10.1016/S0888-7543(05)80208-3; MIZUNO Y, 1995, AM J PATHOL, V146, P530; MIZUNO Y, 1994, BIOCHEM BIOPH RES CO, V203, P979, DOI 10.1006/bbrc.1994.2278; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; PICCOLO F, 1995, NAT GENET, V10, P243, DOI 10.1038/ng0695-243; RICHARD I, 1995, CELL, V87, P27; ROBERDS SL, 1995, FEBS LETT, V364, P245, DOI 10.1016/0014-5793(95)00395-P; ROBERDS SL, 1993, J BIOL CHEM, V268, P11496; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SMITH DB, 1987, CURRENT PROTOCOLS MO; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; SPEER MC, 1992, AM J HUM GENET, V50, P1211; STEVENSON AC, 1953, ANN EUGENIC, V18, P50; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALTON JN, 1954, BRAIN, V77, P169, DOI 10.1093/brain/77.2.169; YANG B, 1994, J BIOL CHEM, V269, P6040; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	59	428	436	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					257	265		10.1038/ng1195-257	http://dx.doi.org/10.1038/ng1195-257			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581448				2022-12-25	WOS:A1995TC63900013
J	KOHN, DB; WEINBERG, KI; NOLTA, JA; HEISS, LN; LENARSKY, C; CROOKS, GM; HANLEY, ME; ANNETT, G; BROOKS, JS; ELKHOUREIY, A; LAWRENCE, K; WELLS, S; MOEN, RC; BASTIAN, J; WILLIAMSHERMAN, DE; ELDER, M; WARA, D; BOWEN, T; HERSHFIELD, MS; MULLEN, CA; BLAESE, RM; PARKMAN, R				KOHN, DB; WEINBERG, KI; NOLTA, JA; HEISS, LN; LENARSKY, C; CROOKS, GM; HANLEY, ME; ANNETT, G; BROOKS, JS; ELKHOUREIY, A; LAWRENCE, K; WELLS, S; MOEN, RC; BASTIAN, J; WILLIAMSHERMAN, DE; ELDER, M; WARA, D; BOWEN, T; HERSHFIELD, MS; MULLEN, CA; BLAESE, RM; PARKMAN, R			ENGRAFTMENT OF GENE-MODIFIED UMBILICAL-CORD BLOOD-CELLS IN NEONATES WITH ADENOSINE-DEAMINASE DEFICIENCY	NATURE MEDICINE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; LONG-TERM HEMATOPOIESIS; PROGENITOR CELLS; EXPRESSION; MARROW; MOUSE; LINES; VIRUS; STEM	Haematopoietic stem cells in umbilical cord blood are an attractive target for gene therapy of inborn errors of metabolism. Three neonates with severe combined immunodeficiency were treated by retroviral-mediated transduction of the CD34+ cells from their umbilical cord blood with a normal human adenosine deaminase complementary DNA followed by autologous transplantation. The continued presence and expression of the introduced gene in leukocytes from bone marrow and peripheral blood for 18 months demonstrates that umbilical cord blood cells may be genetically modified with retroviral vectors and engrafted in neonates for gene therapy.	GENET THERAPY INC,GAITHERSBURG,MD 20878; CHILDRENS HOSP & HLTH CTR,SAN DIEGO,CA 92123; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892	Novartis; University of California System; University of California San Francisco; Duke University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	KOHN, DB (corresponding author), UNIV SO CALIF,CHILDRENS HOSP,SCH MED,DIV RES IMMUNOL BONE MARROW TRANSPLANTAT,4650 SUNSET BLVD,LOS ANGELES,CA 90027, USA.		Kohn, Donald/N-5085-2016	Kohn, Donald/0000-0003-1840-6087; Nolta, Jan/0000-0003-4576-8542	NIDDK NIH HHS [R55 DK053041, R55 DK053041-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R55DK053041] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARREDONDOVEGA FX, 1990, J CLIN INVEST, V86, P444, DOI 10.1172/JCI114730; BASSIN RH, 1970, INT J CANCER, V6, P95, DOI 10.1002/ijc.2910060114; BLAESE RM, 1993, PEDIATR RES, V33, pS49, DOI 10.1203/00006450-199304001-00010; BODINE DM, 1993, BLOOD, V82, P1975; BRENNER MK, 1993, LANCET, V342, P1134, DOI 10.1016/0140-6736(93)92122-A; BROXMEYER HE, 1992, CURR TOP MICROBIOL, V177, P195; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; GIBLETT ER, 1972, LANCET, V2, P1067; HANLEY ME, 1994, BLOOD CELLS, V20, P539; HARRISON DE, 1993, BLOOD, V81, P2473; HERSHFIELD MS, 1993, PEDIATR RES, V33, pS42; HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005; HERSHFIELD MS, 1994, MOL METABOLIC BASIS, P1725; HOCK RA, 1989, BLOOD, V74, P876; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; NOLTA JA, 1990, HUM GENE THER, V1, P257, DOI 10.1089/hum.1990.1.3-257; NOLTA JA, 1992, J CLIN INVEST, V90, P343; OCHMAN H, 1988, GENETICS, V120, P621; PARKMAN R, 1975, NEW ENGL J MED, V292, P714, DOI 10.1056/NEJM197504032921402; RILL DR, 1994, BLOOD, V84, P380; STEWART FM, 1993, BLOOD, V81, P2566; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; VALERA A, 1994, HUM GENE THER, V5, P449, DOI 10.1089/hum.1994.5.4-449; VANBEUSECHEM VW, 1992, P NATL ACAD SCI USA, V79, P7640; VONMELCHNER H, 1988, ONCOGENE, V2, P137; WAGNER JE, 1992, BLOOD, V79, P1874; WEINBERG K, 1990, NEW ENGL J MED, V322, P1718, DOI 10.1056/NEJM199006143222406; WEINBERG KI, 1995, SOMATIC GENE THERAPY, P31; WILLIAMS DA, 1984, NATURE, V310, P476, DOI 10.1038/310476a0; WU DD, 1993, EXP HEMATOL, V21, P251	31	476	538	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	OCT	1995	1	10					1017	1023		10.1038/nm1095-1017	http://dx.doi.org/10.1038/nm1095-1017			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489356	Green Accepted			2022-12-25	WOS:A1995RX95100040
J	SCHOENMAKERS, EFPM; WANSCHURA, S; MOLS, R; BULLERDIEK, J; VANDENBERGHE, H; VANDEVEN, WJM				SCHOENMAKERS, EFPM; WANSCHURA, S; MOLS, R; BULLERDIEK, J; VANDENBERGHE, H; VANDEVEN, WJM			RECURRENT REARRANGEMENTS IN THE HIGH-MOBILITY GROUP PROTEIN GENE, HMGI-C, IN BENIGN MESENCHYMAL TUMORS	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; DNA; TRANSLOCATION; LOCALIZATION; INVITRO; HYBRIDIZATION; LIBRARIES; HMG-I(Y); COSMIDS; FUSION	We recently showed that the 1.7 megabase multiple aberration region (MAR) on human chromosome 12q15 harbours recurrent breakpoints frequently found in a variety of benign solid tumours. We now report a candidate gene within MAR suspected to be of pathogenetical relevance. Using positional cloning, we have identified the high mobility group protein gene HMGI-C within a 175 kilobase segment of MAR and characterized its genomic organization. By FISH analysis, we show the majority of the breakpoints of eight different benign solid tumour types fall within this gene, By Southern blot and 3'-RACE analysis, we demonstrate consistent rearrangements in HMGI-C and/or expression of altered HMGI-C transcripts. These results suggest a link between a member of the HMG gene family and benign solid tumour development.	CATHOLIC UNIV LEUVEN,CTR HUMAN GENET,MOLEC ONCOL LAB,B-3000 LOUVAIN,BELGIUM; FLANDERS INST BIOTECHNOL,B-3000 LOUVAIN,BELGIUM; UNIV BREMEN,CTR HUMAN GENET,D-28359 BREMEN,GERMANY	KU Leuven; Flanders Institute for Biotechnology (VIB); University of Bremen								AIZAWA S, 1994, BIOCHEMISTRY-US, V33, P14690, DOI 10.1021/bi00253a006; ALBERTSEN HM, 1990, P NATL ACAD SCI USA, V87, P4256, DOI 10.1073/pnas.87.11.4256; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; BUSTIN M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P231, DOI 10.1016/0167-4781(90)90092-G; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CRAMER DW, 1992, SEMIN REPROD ENDOCR, V10, P320, DOI 10.1055/s-2007-1018889; DU W, 1994, P NATL ACAD SCI USA, V91, P11318, DOI 10.1073/pnas.91.24.11318; FEJZO MS, 1995, GENOMICS, V26, P265, DOI 10.1016/0888-7543(95)80210-D; FLETCHER JA, 1992, GENE CHROMOSOME CANC, V5, P184, DOI 10.1002/gcc.2870050214; FRIEDMANN M, 1993, NUCLEIC ACIDS RES, V21, P4259, DOI 10.1093/nar/21.18.4259; GEURTS JMW, 1994, METHOD MOL CELL BIOL, V4, P257; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; KAZMIERCZAK B, 1990, CYTOGENET CELL GENET, V53, P37, DOI 10.1159/000132891; KIEVITS T, 1990, CYTOGENET CELL GENET, V53, P134, DOI 10.1159/000132913; KOOLS PFJ, 1995, CANCER GENET CYTOGEN, V79, P1, DOI 10.1016/0165-4608(94)00137-Z; MANFIOLETTI G, 1991, NUCLEIC ACIDS RES, V19, P6793, DOI 10.1093/nar/19.24.6793; MILES JH, 1984, AM J MED GENET, V19, P225, DOI 10.1002/ajmg.1320190204; MITELMAN F, 1994, CATALOG CHROMOSOME A; MONTGOMERY KT, 1993, GENOMICS, V17, P682, DOI 10.1006/geno.1993.1390; NELSON DL, 1989, P NATL ACAD SCI USA, V86, P6686, DOI 10.1073/pnas.86.17.6686; PATEL UA, 1994, BIOCHEM BIOPH RES CO, V201, P63, DOI 10.1006/bbrc.1994.1669; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; REEVES R, 1991, P NATL ACAD SCI USA, V88, P1671, DOI 10.1073/pnas.88.5.1671; ROBERTS P, 1992, CANCER GENET CYTOGEN, V60, P135, DOI 10.1016/0165-4608(92)90005-S; ROHEN C, IN PRESS GENES CHROM; RYCHLIK W, 1989, NUCLEIC ACIDS RES, V17, P8543, DOI 10.1093/nar/17.21.8543; SCHOENMAKERS EFP, IN PRESS GENOMICS; SCHOENMAKERS EFPM, 1994, GENE CHROMOSOME CANC, V11, P106, DOI 10.1002/gcc.2870110207; SCHOENMAKERS EFPM, 1994, GENOMICS, V20, P210, DOI 10.1006/geno.1994.1155; SMITH MW, 1994, NAT GENET, V7, P40, DOI 10.1038/ng0594-40; THANOS D, 1992, CELL, V71, P777, DOI 10.1016/0092-8674(92)90554-P; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V23, P291; VANDEVEN WJM, 1995, GENE CHROMOSOME CANC, V12, P296; WAGNER MJ, 1991, GENOMICS, V10, P114, DOI 10.1016/0888-7543(91)90491-V; YANGYEN HF, 1988, MOL CELL BIOL, V8, P3406, DOI 10.1128/MCB.8.8.3406; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341; [No title captured]	39	500	513	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					436	444		10.1038/ng0895-436	http://dx.doi.org/10.1038/ng0895-436			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670494				2022-12-25	WOS:A1995RM37500017
J	BELLUS, GA; MCINTOSH, I; SMITH, EA; AYLSWORTH, AS; KAITILA, I; HORTON, WA; GREENHAW, GA; HECHT, JT; FRANCOMANO, CA				BELLUS, GA; MCINTOSH, I; SMITH, EA; AYLSWORTH, AS; KAITILA, I; HORTON, WA; GREENHAW, GA; HECHT, JT; FRANCOMANO, CA			A RECURRENT MUTATION IN THE TYROSINE KINASE DOMAIN OF FIBROBLAST GROWTH-FACTOR RECEPTOR-3 CAUSES HYPOCHONDROPLASIA	NATURE GENETICS			English	Letter							DIVERSITY; FAMILY; GENE		JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,BALTIMORE,MD 21205; NIH,NATL CTR HUMAN GENOME RES,MED GENET BRANCH,BETHESDA,MD 20892; UNIV N CAROLINA,DEPT PEDIAT,CHAPEL HILL,NC 27599; UNIV N CAROLINA,BRAIN & DEV RES CTR,CHAPEL HILL,NC 27599; HELSINKI UNIV HOSP,DEPT CLIN GENET,SF-00290 HELSINKI,FINLAND; SHRINERS HOSP CRIPPLED CHILDREN,DEPT RES,PORTLAND,OR 97201; UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX 77225	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Helsinki; Helsinki University Central Hospital; University of Texas System				Bellus, Gary/0000-0001-7492-3324	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010293] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR41135] Funding Source: Medline; NICHD NIH HHS [HD24061] Funding Source: Medline; NIDCR NIH HHS [DE10293] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; BELUS GA, 1995, AM J HUM GENET, V56, P368; FRANCOMANO CA, 1994, HUM MOL GENET, V3, P787, DOI 10.1093/hmg/3.5.787; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; HALL BD, 1979, RADIOLOGY, V133, P95, DOI 10.1148/133.1.95; HECHT JT, IN PRESS J MED GENET; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; JONES CT, 1992, HUM MOL GENET, V1, P11, DOI 10.1093/hmg/1.1.11; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; LEMERRER M, 1994, NAT GENET, V6, P318; MAROTEAUX P, 1988, ARCH FR PEDIATR, V45, P105; MCKUSICK VA, 1973, J MED GENET, V10, P11, DOI 10.1136/jmg.10.1.11; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MULLIS PE, 1991, CLIN ENDOCRINOL, V34, P265, DOI 10.1111/j.1365-2265.1991.tb03765.x; PAULI RM, 1995, AM J HUM GENET, V56, P732; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; ROUSSEAU F, 1995, NAT GENET, V10, P11, DOI 10.1038/ng0595-11; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; STOILOV I, 1995, AM J MED GENET, V55, P127, DOI 10.1002/ajmg.1320550132; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; VELLNOV M, 1994, NAT GENET, V6, P314; WALKER BA, 1971, AM J DIS CHILD, V122, P95, DOI 10.1001/archpedi.1971.02110020029001; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; WYNNEDAVIES R, 1981, J BONE JOINT SURG BR, V63, P508, DOI 10.1302/0301-620X.63B4.7298674	28	331	344	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					357	359		10.1038/ng0795-357	http://dx.doi.org/10.1038/ng0795-357			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670477				2022-12-25	WOS:A1995RG38600023
J	NESTEROVA, M; CHOCHUNG, YS				NESTEROVA, M; CHOCHUNG, YS			A SINGLE-INJECTION PROTEIN-KINASE A-DIRECTED ANTISENSE TREATMENT TO INHIBIT TUMOR-GROWTH	NATURE MEDICINE			English	Article							I REGULATORY SUBUNIT; HL-60 LEUKEMIA-CELLS; AMINO-ACID SEQUENCE; RI-ALPHA-SUBUNIT; CATALYTIC SUBUNIT; MOLECULAR-CLONING; HUMAN TESTIS; MESSENGER-RNA; CANCER-CELLS; CAMP	Expression of the RI(alpha) subunit of cAMP-dependent protein kinase type I is enhanced in human cancer cell lines, in primary tumours, in cells after transformation and in cells upon stimulation of growth. We have investigated the effect of sequence-specific inhibition of RI(alpha) gene expression on in vivo tumour growth. We report that single injection RI(alpha) antisense treatment results in a reduction in RI(alpha) expression and inhibition of tumour growth. Tumour cells behaved like untransformed cells by making less protein kinase type I. The RI(alpha) antisense, which produces a biochemical imprint for growth control, requires infrequent dosing to halt neoplastic growth in vivo.	NCI, TUMOR IMMUNOL & BIOL LAB, CELLULAR BIOCHEM SECT, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; BEEBE SJ, 1986, ENZYMES, V17, P43; CADD GG, 1990, J BIOL CHEM, V265, P19502; CHOCHUNG YS, 1990, CANCER RES, V50, P7093; CLEGG CH, 1988, P NATL ACAD SCI USA, V85, P3703, DOI 10.1073/pnas.85.11.3703; COBB CE, 1987, J BIOL CHEM, V262, P16566; CONNELLY PA, 1986, J BIOL CHEM, V261, P2325; IVERSEN P, 1991, ANTI-CANCER DRUG DES, V6, P531; KAPOOR CL, 1983, CANCER RES, V43, P295; Krebs E G, 1972, Curr Top Cell Regul, V5, P99; LEVY FO, 1988, MOL ENDOCRINOL, V2, P1364, DOI 10.1210/mend-2-12-1364; LOHMANN SM, 1984, ADV CYCLIC NUCL PROT, V18, P63; MCKNIGHT GS, 1988, RECENT PROG HORM RES, V44, P307; NESTEROVA M, 1994, FASEB J, V8, pA1328; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; OTTEN AD, 1991, J BIOL CHEM, V266, P23074; OYEN O, 1988, FEBS LETT, V229, P391, DOI 10.1016/0014-5793(88)81163-3; ROHLFF C, 1993, J BIOL CHEM, V268, P5774; ROSEN OM, 1975, J BIOL CHEM, V250, P7788; SANDBERG M, 1987, BIOCHEM BIOPH RES CO, V149, P939, DOI 10.1016/0006-291X(87)90499-2; SHOWERS MO, 1986, J BIOL CHEM, V261, P6288; SRIVASTAVA AK, 1978, J BIOL CHEM, V253, P1752; TAGLIAFERRI P, 1988, J BIOL CHEM, V263, P409; TAYLOR SS, 1988, FASEB J, V2, P2677, DOI 10.1096/fasebj.2.11.3294077; TORTORA G, 1991, P NATL ACAD SCI USA, V88, P2011, DOI 10.1073/pnas.88.5.2011; TORTORA G, 1990, P NATL ACAD SCI USA, V87, P705, DOI 10.1073/pnas.87.2.705; UHLER MD, 1986, J BIOL CHEM, V261, P5360; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WAGNER RW, 1994, NATURE, V372, P333, DOI 10.1038/372333a0; WEBER W, 1986, BIOCHEMISTRY-US, V25, P5661, DOI 10.1021/bi00367a047; YOKOZAKI H, 1993, CANCER RES, V53, P868	31	130	139	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	1995	1	6					528	533		10.1038/nm0695-528	http://dx.doi.org/10.1038/nm0695-528			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN101	7585118				2022-12-25	WOS:A1995RN10100035
J	ANDERSEN, PM; NILSSON, P; ALAHURULA, V; KERANEN, ML; TARVAINEN, I; HALTIA, T; NILSSON, L; BINZER, M; FORSGREN, L; MARKLUND, SL				ANDERSEN, PM; NILSSON, P; ALAHURULA, V; KERANEN, ML; TARVAINEN, I; HALTIA, T; NILSSON, L; BINZER, M; FORSGREN, L; MARKLUND, SL			AMYOTROPHIC-LATERAL-SCLEROSIS ASSOCIATED WITH HOMOZYGOSITY FOR AN ASP90ALA MUTATION IN CUZN-SUPEROXIDE DISMUTASE	NATURE GENETICS			English	Article							NORTHERN SWEDEN; COPPER; POPULATION; ALS; SOD	Recent reports have shown heterozygosity for some twenty different mutations in the CuZn-superoxide dismutase (CuZn-SOD) gene in familial amyotrophic lateral sclerosis (FALS), and analysed samples from patients have shown decreased enzymic activity. Here we report homozygosity for an exon 4 mutation, Asp90Ala in fourteen patients among four unrelated ALS families and four apparently sporadic ALS patients from Sweden and Finland. The erythrocyte CuZn-SOD activity is essentially normal. Our findings suggest that this CuZn-SOD mutation causes ALS by a gain of function rather than by loss, and that the Asp90Ala mutation is less detrimental than previously reported mutations.	UMEA UNIV HOSP, DEPT CLIN CHEM, S-90185 UMEA, SWEDEN; UMEA UNIV HOSP, DEPT NEUROL, S-90185 UMEA, SWEDEN; CENT LASARETTET KEMI, DEPT NEUROL, SF-94100 KEMI, FINLAND; LAPIN KESKUSSAIRAALA, DEPT NEUROL, SF-96101 ROVANIEMI, FINLAND; MIKKELIN KESKUSSAIRAALA, DEPT NEUROL, SF-50100 MIKKELI, FINLAND; KAUNIALA SJUKHUS KRIGSINVALIDER, SF-02700 KAUNIAINEN, FINLAND	Umea University; Umea University								BECKMAN G, 1973, HEREDITAS, V73, P305; BECKMAN G, 1973, HUM HERED, V23, P346, DOI 10.1159/000152595; BECKMAN G, 1975, HEREDITAS, V79, P43; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; BORDO D, 1994, J MOL BIOL, V238, P366, DOI 10.1006/jmbi.1994.1298; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; CHIO A, 1987, ACTA NEUROL SCAND, V75, P277, DOI 10.1111/j.1600-0404.1987.tb07933.x; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; DUMON J, 1971, J MED GENET, V8, P113, DOI 10.1136/jmg.8.1.113; ERIKSSON AW, 1973, ISRAEL J MED SCI, V9, P1156; FORSGREN L, 1983, ACTA NEUROL SCAND, V68, P20, DOI 10.1111/j.1600-0404.1983.tb04810.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; ILSHAFEY A, 1994, HUM MOL GENET, V3, P363; JONES CT, 1994, HUM MOL GENET, V3, P649, DOI 10.1093/hmg/3.4.649; KURLAND LT, 1955, NEUROLOGY, V5, P182, DOI 10.1212/WNL.5.3.182; KURLAND LT, 1955, NEUROLOGY, V5, P249, DOI 10.1212/WNL.5.4.249; LEVANON D, 1985, EMBO J, V4, P77, DOI 10.1002/j.1460-2075.1985.tb02320.x; MARKLUND S, 1976, J BIOL CHEM, V251, P7504; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MARKLUND SL, 1985, CRC HDB METHODS OXYG, P249; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MIETTINEN OS, 1974, AM J EPIDEMIOL, V100, P515; MYLLYLA VV, 1979, ACTA NEUROL SCAND, V60, P170; NAKANO R, 1994, BIOCHEM BIOPH RES CO, V200, P695, DOI 10.1006/bbrc.1994.1506; OGASAWARA M, 1993, NAT GENET, V5, P323, DOI 10.1038/ng1293-323; OHMAN M, 1986, CLIN SCI, V70, P365; PRAMATAROVA A, 1995, AM J HUM GENET, V56, P592; RAINERO I, 1994, NEUROLOGY, V44, P347, DOI 10.1212/WNL.44.2.347; ROBBERECHT W, 1994, J NEUROCHEM, V62, P384; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIDDIQUE T, 1994, AM J HUM GENET, V55, pA1419; SJALANDER A, IN PRESS HUM MOL GEN; SWASH M, 1992, NEUROMUSCULAR DISORD, V2, P7, DOI 10.1016/0960-8966(92)90020-7; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; TANDAN R, 1985, ANN NEUROL, V18, P271, DOI 10.1002/ana.410180302; TSUDA T, 1994, NEURON, V13, P727, DOI 10.1016/0896-6273(94)90039-6; WEISIGER RA, 1973, J BIOL CHEM, V248, P4793; YIM MB, 1993, J BIOL CHEM, V268, P4099	40	274	279	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1995	10	1					61	66		10.1038/ng0595-61	http://dx.doi.org/10.1038/ng0595-61			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647793				2022-12-25	WOS:A1995QX57300017
J	NORTH, TW; LACASSE, RA				NORTH, TW; LACASSE, RA			TESTING ANTI-HIV DRUGS IN THE FIV MODEL	NATURE MEDICINE			English	Editorial Material							FELINE IMMUNODEFICIENCY VIRUS; CATS; INFECTION; AIDS	Viral resistance is a major problem with current AIDS drugs. The feline immunodeficiency virus model may provide a way to test new drugs and strategies before human trials.			NORTH, TW (corresponding author), UNIV MONTANA,DIV BIOL SCI,MISSOULA,MT 59812, USA.							ACKLEY CD, 1990, J VIROL, V64, P5652, DOI 10.1128/JVI.64.11.5652-5655.1990; BARLOUGH JE, 1991, J ACQ IMMUN DEF SYND, V4, P219; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; DAVIDSON MG, 1993, AM J PATHOL, V143, P1486; ENGLISH RV, 1994, J INFECT DIS, V120, P543; GOBERT JM, 1994, ANTIMICROB AGENTS CH, V38, P861, DOI 10.1128/AAC.38.4.861; ISHIDA T, 1990, JPN J VET SCI, V52, P645; NOWAK MA, 1991, SCIENCE, V254, P963, DOI 10.1126/science.1683006; Pedersen N. C., 1993, The Retroviridae, volume 2., P181; PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; PHILLIPS TR, 1994, J GEN VIROL, V75, P979, DOI 10.1099/0022-1317-75-5-979; PODELL M, 1993, J ACQ IMMUN DEF SYND, V6, P758; REMINGTON KM, 1991, J VIROL, V65, P308, DOI 10.1128/JVI.65.1.308-312.1991; RICHMAN DD, 1993, ANTIMICROB AGENTS CH, V37, P1207, DOI 10.1128/AAC.37.6.1207; WAINBERG MA, 1993, J ACQ IMMUN DEF SYND, V6, pS36; 1990, RETROVIR PACKAGE INS	16	20	20	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1995	1	5					410	411		10.1038/nm0595-410	http://dx.doi.org/10.1038/nm0595-410			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585083				2022-12-25	WOS:A1995RN10000026
J	ROTH, GS; INGRAM, DK; LANE, MA				ROTH, GS; INGRAM, DK; LANE, MA			SLOWING AGING BY CALORIC RESTRICTION	NATURE MEDICINE			English	Editorial Material							DIETARY RESTRICTION	Dietary caloric restriction is the only intervention conclusively shown to slow ageing, delay the onset of age-related diseases, maintain function and extend both median and maximal life span in mammals.			ROTH, GS (corresponding author), JOHNS HOPKINS UNIV,NIA,GERONTOL RES CTR,BAYVIEW CAMPUS,BALTIMORE,MD 21224, USA.							BEREGI E, 1990, CENTENARIANS HUNGARY; BODKIN N, IN PRESS J GERONT BI; DARK J, 1994, AM J PHYSIOL, V267, pR496, DOI 10.1152/ajpregu.1994.267.2.R496; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HEYDARI AR, IN PRESS J NUTR; INGRAM DK, 1990, J GERONTOL, V45, pB148, DOI 10.1093/geronj/45.5.B148; KEMITZ JW, 1993, J GERONTOL A-BIOL, V48, pB17; LANE MA, IN PRESS J NUTR; LEE AS, 1983, J BIOL CHEM, V258, P597; MASORO EJ, 1992, J GERONTOL, V47, pB202, DOI 10.1093/geronj/47.6.B202; PAHLAVANI MA, 1994, MODULATION AGING PRO, P143; REISER KM, 1994, J GERONTOL, V49, pB71, DOI 10.1093/geronj/49.2.B71; ROTH GS, 1994, AGING-CLIN EXP RES, V6, P139, DOI 10.1007/BF03324227; SABATINO F, 1991, J GERONTOL, V46, pB171, DOI 10.1093/geronj/46.5.B171; WEINDRUCH R, 1988, RETARDATION AGING DI; Yu BP, 1993, FREE RADICALS AGING; [No title captured]	17	44	48	1	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1995	1	5					414	415		10.1038/nm0595-414	http://dx.doi.org/10.1038/nm0595-414			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585085				2022-12-25	WOS:A1995RN10000028
J	VISAKORPI, T; HYYTINEN, E; KOIVISTO, P; TANNER, M; KEINANEN, R; PALMBERG, C; PALOTIE, A; TAMMELA, T; ISOLA, J; KALLIONIEMI, OP				VISAKORPI, T; HYYTINEN, E; KOIVISTO, P; TANNER, M; KEINANEN, R; PALMBERG, C; PALOTIE, A; TAMMELA, T; ISOLA, J; KALLIONIEMI, OP			IN-VIVO AMPLIFICATION OF THE ANDROGEN RECEPTOR GENE AND PROGRESSION OF HUMAN PROSTATE-CANCER	NATURE GENETICS			English	Article							CARCINOMA	Overexpression of amplified genes is often associated with the acquisition of resistance to cancer therapeutic agents in vitro. We have identified a similar molecular mechanism in vivo for endocrine treatment failure in human prostate cancer which involves amplification of the androgen receptor (AR) gene. Comparative genomic hybridization shows that amplification of the Xq11-q13 region (the location), is common in tumours recurring during androgen deprivation therapy. We found high-level AR amplification in seven of 23 (30%) recurrent tumours, but in none of the specimens taken from the same patients prior to therapy. Our results suggest that AR amplification emerges during androgen deprivation therapy by facilitating tumour cell growth in low androgen concentrations.	INST MED TECHNOL,SF-33521 TAMPERE,FINLAND; NIH,NATL CTR HUMAN GENOME RES,CANC GENET LAB,BETHESDA,MD 20892; TAMPERE UNIV HOSP,DEPT SURG,DIV UROL,SF-33521 TAMPERE,FINLAND; TAMPERE UNIV,DEPT CLIN SCI,SF-33521 TAMPERE,FINLAND; UNIV HELSINKI,CENT HOSP,DEPT CLIN CHEM,SF-00290 HELSINKI,FINLAND	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Tampere University; Tampere University Hospital; Tampere University; University of Helsinki; Helsinki University Central Hospital	VISAKORPI, T (corresponding author), TAMPERE UNIV HOSP,CANC GENET LAB,POB 2000,SF-33521 TAMPERE,FINLAND.		Kallioniemi, Olli P/H-5111-2011	Kallioniemi, Olli P/0000-0002-3231-0332				BERGES RR, 1993, P NATL ACAD SCI USA, V90, P8910, DOI 10.1073/pnas.90.19.8910; BORING CC, 1993, CA-CANCER J CLIN, V43, P7, DOI 10.3322/canjclin.43.1.7; CHER ML, 1994, GENE CHROMOSOME CANC, V11, P153, DOI 10.1002/gcc.2870110304; CORVI R, 1994, P NATL ACAD SCI USA, V91, P5523, DOI 10.1073/pnas.91.12.5523; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; CULIG Z, 1993, MOL ENDOCRINOL, V7, P1541, DOI 10.1210/me.7.12.1541; DENNIS L, 1994, PROSTATE S, V5, P17; DIXON WJ, 1981, BMDP STATISTICAL SOF; GADDIPATI JP, 1994, CANCER RES, V54, P2861; GITTES RF, 1991, NEW ENGL J MED, V324, P236, DOI 10.1056/NEJM199101243240406; HYTINEN E, 1994, CYTOMETRY, V16, P93; IHALAINEN J, 1994, BIOTECHNIQUES, V6, P938; ISAACS WB, 1994, SEMIN ONCOL, V21, P514; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; KELLENS RE, 1993, GENE AMPLIFICATION M; LABRIE F, 1993, CLIN INVEST MED, V16, P475; LAFRENIERE RG, 1991, GENOMICS, V11, P352, DOI 10.1016/0888-7543(91)90143-3; MACOSKA JA, 1993, GENE CHROMOSOME CANC, V8, P88, DOI 10.1002/gcc.2870080205; NOWELL PC, 1986, CANCER RES, V46, P2203; RINKERSCHAEFFER CW, 1994, CANCER RES, V54, P6249; Sambrook J, 1989, MOL CLONING LABORATO; SANDBERG AA, 1992, HUM PATHOL, V23, P368, DOI 10.1016/0046-8177(92)90083-F; SCHOENBERG MP, 1994, BIOCHEM BIOPH RES CO, V198, P74, DOI 10.1006/bbrc.1994.1011; STEARNS ME, 1992, LAB INVEST, V67, P540; TANNER M, 1994, CANCER RES, V54, P2457; THOMPSON TC, 1990, CANCER CELL-MON REV, V2, P345; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; VISAKORPI T, 1995, CANCER RES, V55, P342	30	1175	1233	1	61	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	APR	1995	9	4					401	406		10.1038/ng0495-401	http://dx.doi.org/10.1038/ng0495-401			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795646				2022-12-25	WOS:A1995QQ75300018
J	WILKIE, AOM; SLANEY, SF; OLDRIDGE, M; POOLE, MD; ASHWORTH, GJ; HOCKLEY, AD; HAYWARD, RD; DAVID, DJ; PULLEYN, LJ; RUTLAND, P; MALCOLM, S; WINTER, RM; REARDON, W				WILKIE, AOM; SLANEY, SF; OLDRIDGE, M; POOLE, MD; ASHWORTH, GJ; HOCKLEY, AD; HAYWARD, RD; DAVID, DJ; PULLEYN, LJ; RUTLAND, P; MALCOLM, S; WINTER, RM; REARDON, W			APERT SYNDROME RESULTS FROM LOCALIZED MUTATIONS OF FGFR2 AND IS ALLELIC WITH CROUZON SYNDROME	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTORS; POINT MUTATIONS; LIGAND-BINDING; HUMAN GENOME; LINKAGE MAP; EXPRESSION; GENE; SPECIFICITY; MARKERS; MOUSE	Apert syndrome is a distinctive human malformation comprising craniosynostosis and severe syndactyly of the hands and feet. We have identified specific missense substitutions involving adjacent amino acids (Ser252Trp and Pro253Arg) in the linker between the second and third extracellular immunoglobulin (Ig) domains of fibroblast growth factor receptor 2 (FGFR2) in all 40 unrelated cases of Apert syndrome studied. Crouzon syndrome, characterized by craniosynostosis but normal limbs, was previously shown to result from allelic mutations of the third Ig domain of FGFR2. The contrasting effects of these mutations provide a genetic resource for dissecting the complex effects of signal transduction through FGFRs in cranial and limb morphogenesis.	CHURCHILL HOSP,DEPT CLIN GENET,OXFORD OX3 7LJ,ENGLAND; RADCLIFFE INFIRM NHS TRUST,OXFORD CRANIOFACIAL UNIT,OXFORD OX2 6HE,ENGLAND; QUEEN ELIZABETH HOSP,W MIDLANDS CRANIOFACIAL UNIT,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND; CHILDRENS HOSP,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND; GREAT ORMOND ST HOSP CHILDREN NHS TRUST,CRANIOFACIAL UNIT,LONDON WC1N 3JH,ENGLAND; WOMENS & CHILDRENS HOSP,AUSTRALIAN CRANIOFACIAL UNIT,ADELAIDE,SA 5006,AUSTRALIA; INST CHILD HLTH,GENET & FETAL MED CLIN,MOTHERCARE UNIT,LONDON WC1N 1EH,ENGLAND; INST CHILD HLTH,MOLEC GENET UNIT,LONDON WC1N 1EH,ENGLAND	University of Oxford; Radcliffe Infirmary; University of Birmingham; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Womens & Childrens Hospital Australia; University of London; University College London; University of London; University College London	WILKIE, AOM (corresponding author), JOHN RADCLIFFE HOSP,INST MOLEC MED,HEADINGTON,OXFORD OX3 9DU,ENGLAND.		Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481; Reardon, Willie/0000-0001-7329-9179	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON R, 1993, DEVELOPMENT, V117, P1421; Apert E., 1906, B SOC MED PARIS, V23, P1310; AVRAHAM KB, 1994, GENOMICS, V21, P656, DOI 10.1006/geno.1994.1330; BLANK CE, 1960, ANN HUM GENET, V24, P151; CAMPIS LB, 1991, CLIN PLAST SURG, V18, P409; CARLSON KM, 1994, P NATL ACAD SCI USA, V91, P1579, DOI 10.1073/pnas.91.4.1579; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN MM, 1993, AM J MED GENET, V47, P624, DOI 10.1002/ajmg.1320470509; COHEN MM, 1992, AM J MED GENET, V42, P655, DOI 10.1002/ajmg.1320420505; COHEN MM, 1990, AM J MED GENET, V35, P36, DOI 10.1002/ajmg.1320350108; COHEN MM, 1993, AM J MED GENET, V45, P758, DOI 10.1002/ajmg.1320450618; COOPER DN, 1990, HUM GENET, V85, P55; DAVIDSON DR, 1991, NATURE, V352, P429, DOI 10.1038/352429a0; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; DIONNE CA, 1992, CYTOGENET CELL GENET, V60, P34, DOI 10.1159/000133290; ERICKSON JD, 1974, ANN HUM GENET, V38, P89, DOI 10.1111/j.1469-1809.1974.tb01996.x; FALLON JF, 1994, SCIENCE, V264, P104, DOI 10.1126/science.7908145; FRANCOMANO CA, 1994, HUM MOL GENET, V3, P787, DOI 10.1093/hmg/3.5.787; GIVOL D, 1992, FASEB J, V6, P3362, DOI 10.1096/fasebj.6.15.1464370; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; GRUNEBERG H, 1962, GENET RES, V3, P157, DOI 10.1017/S0016672300003153; Gruneberg H., 1956, Journal of Genetics, V54, P113, DOI 10.1007/BF02981706; GRUNEBERG H, 1960, GENET RES, V1, P196; GRUNEBERG HANS, 1961, GENET RES, V2, P33, DOI 10.1017/S0016672300000525; HAZAN J, 1992, GENOMICS, V12, P183, DOI 10.1016/0888-7543(92)90364-X; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; HOU JZ, 1992, J BIOL CHEM, V267, P17804; HOUSSAINT E, 1990, P NATL ACAD SCI USA, V87, P8180, DOI 10.1073/pnas.87.20.8180; JABS EW, 1993, CELL, V75, P43; JARVIK GP, 1994, AM J HUM GENET, V55, P710; JOHNSON DE, 1991, MOL CELL BIOL, V11, P4627, DOI 10.1128/MCB.11.9.4627; JOHNSON DE, 1993, ADV CANCER RES, V6, P1; JOHNSON RL, 1994, CURR OPIN GENET DEV, V4, P535, DOI 10.1016/0959-437X(94)90069-F; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; KETTERLING RP, 1994, AM J HUM GENET, V54, P831; LEWANDA AF, 1993, AM J DIS CHILD, V147, P1306, DOI 10.1001/archpedi.1993.02160360048016; LI XA, 1994, GENOMICS, V22, P418, DOI 10.1006/geno.1994.1403; MACDONALD ME, 1989, J CLIN INVEST, V84, P1013, DOI 10.1172/JCI114222; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; MATTEI MG, 1991, HUM GENET, V87, P84, DOI 10.1007/BF01213098; MIKI T, 1992, P NATL ACAD SCI USA, V89, P246, DOI 10.1073/pnas.89.1.246; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; NISWANDER L, 1993, CELL, V75, P759; ORRURTREGER A, 1993, DEV BIOL, V158, P475, DOI 10.1006/dbio.1993.1205; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; Padanilam B. J., 1992, Human Molecular Genetics, V1, P407, DOI 10.1093/hmg/1.6.407; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; PATTON MA, 1988, J MED GENET, V25, P164, DOI 10.1136/jmg.25.3.164; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; PETERS KG, 1992, DEVELOPMENT, V114, P233; PRESTON RA, 1994, NAT GENET, V7, P149, DOI 10.1038/ng0694-149; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; ROBERT B, 1991, GENE DEV, V5, P2363, DOI 10.1101/gad.5.12b.2363; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; Sambrook J, 1989, MOL CLONING LABORATO; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; SPINARDI L, 1991, NUCLEIC ACIDS RES, V19, P4009, DOI 10.1093/nar/19.14.4009; Taylor S. A. M., 1992, Human Molecular Genetics, V1, P142, DOI 10.1093/hmg/1.2.142-a; THEIN SL, 1991, BRIT J HAEMATOL, V79, P113, DOI 10.1111/j.1365-2141.1991.tb08016.x; UPTON J, 1991, CLIN PLAST SURG, V18, P321; UPTON J, 1991, CLIN PLAST SURG, V18, P1; VELINOV M, 1994, NAT GENET, V6, P314, DOI 10.1038/ng0394-314; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WERNER S, 1993, EMBO J, V12, P2635, DOI 10.1002/j.1460-2075.1993.tb05924.x; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; XU JM, 1992, J BIOL CHEM, V267, P17792; YAYON A, 1992, EMBO J, V11, P1885, DOI 10.1002/j.1460-2075.1992.tb05240.x; YU CE, 1994, HUM MOL GENET, V3, P212, DOI 10.1093/hmg/3.1.212; ZIMMER Y, 1993, J BIOL CHEM, V268, P7899	70	705	727	1	86	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					165	172		10.1038/ng0295-165	http://dx.doi.org/10.1038/ng0295-165			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719344				2022-12-25	WOS:A1995QE67200018
J	SOLIMENA, M; DECAMILLI, P				SOLIMENA, M; DECAMILLI, P			COXSACKIEVIRUSES AND DIABETES	NATURE MEDICINE			English	Editorial Material							GLUTAMIC-ACID DECARBOXYLASE; MELLITUS	Two recent reports provide further evidence for a link between coxsackieviruses and the onset of IDDM, although a careful examination suggests it is still too early to conclude a definitive role.	YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT CELL BIOL,NEW HAVEN,CT 06510	Howard Hughes Medical Institute; Yale University	SOLIMENA, M (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT INTERNAL MED,ENDOCRINOL SECT,NEW HAVEN,CT 06510, USA.		Solimena, Michele/GVS-5990-2022; Solimena, Michele/E-1275-2011					ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; ATKINSON MA, 1994, J CLIN INVEST, V94, P2125, DOI 10.1172/JCI117567; BAEKKESKOV S, 1990, NATURE, V347, P130; BANATVALA JE, 1985, LANCET, V1, P149; DALESSIO DJ, 1992, AM J EPIDEMIOL, V135, P1331, DOI 10.1093/oxfordjournals.aje.a116244; FRISK G, 1985, J MED VIROL, V17, P219, DOI 10.1002/jmv.1890170303; KAUFMAN DL, 1992, J CLIN INVEST, V89, P283, DOI 10.1172/JCI115573; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; SCHMIDT WAK, 1978, MED MICROBIOL IMMUN, V164, P291, DOI 10.1007/BF02125498; SOLIMENA M, 1990, NEW ENGL J MED, V322, P1555, DOI 10.1056/NEJM199005313222202; SOLIMENA M, 1994, NATURE, V366, P15; TIAN J, 1994, J EXP MED, V180, P1979, DOI 10.1084/jem.180.5.1979; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0	14	20	21	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1995	1	1					25	26		10.1038/nm0195-25	http://dx.doi.org/10.1038/nm0195-25			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX557	7584948				2022-12-25	WOS:A1995QX55700021
J	CALDAS, C; HAHN, SA; DACOSTA, LT; REDSTON, MS; SCHUTTE, M; SEYMOUR, AB; WEINSTEIN, CL; HRUBAN, RH; YEO, CJ; KERN, SE				CALDAS, C; HAHN, SA; DACOSTA, LT; REDSTON, MS; SCHUTTE, M; SEYMOUR, AB; WEINSTEIN, CL; HRUBAN, RH; YEO, CJ; KERN, SE			FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA	NATURE GENETICS			English	Article							POLYMERASE CHAIN-REACTION; RAS ONCOGENE ACTIVATION; CARCINOMAS; INHIBITOR; KINASES; CANCER; P53; P21	The MTS1 gene on chromosome 9p21 encodes the p16 inhibitor of cyclinD/Cdk-4 complexes, and is deleted or mutated in a variety of tumour types. We found allelic deletions of 9p21-p22 in 85% of pancreatic adenocarcinomas. Analysis of MTS1 in pancreatic carcinomas (27 xenografts and 10 cell lines) showed homozygous deletions in 15(41%) and sequence changes in 14 (38%). These included eight point mutations (four nonsense, two missense and two splice site mutations) and six deletions/ insertions, all accompanied by loss of the wild-type allele. Sequencing of MTS1 from primary tumours confirmed the mutations. Coexistent inactivations of both MTS1 and p53 was common and suggests that abnormal regulation of cyclin-dependent kinases may play an important role in the biology of pancreatic carcinoma.	JOHNS HOPKINS MED INST,DEPT ONCOL,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DEPT PATHOL,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DEPT SURG,BALTIMORE,MD 21205; JOHNS HOPKINS MED INST,DIV TOXICOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine			Hahn, Stephan A./AAV-6062-2021; Caldas, Carlos/U-7250-2019; Caldas, Carlos/A-7543-2008; Hahn, Stephan/E-3880-2010	Hahn, Stephan A./0000-0003-0855-9741; Caldas, Carlos/0000-0003-3547-1489; Hahn, Stephan/0000-0003-0855-9741	NCI NIH HHS [CA56130, CA62924] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA062924, R01CA056130] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; BORING CC, 1993, CA-CANCER J CLIN, V43, P7, DOI 10.3322/canjclin.43.1.7; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; CAIRNS P, 1994, SCIENCE, V265, P415, DOI 10.1126/science.8023167; CALDAS C, 1994, CANCER RES, V54, P3568; CAMERON JL, 1991, AM J SURG, V161, P120, DOI 10.1016/0002-9610(91)90371-J; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; HARPER JW, 1993, CELL, V75, P805; HRUBAN RH, 1993, AM J PATHOL, V143, P545; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KWAITKOWSKI KW, 1993, CYTOGENET CELL GENET, V64, P94; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; OKAMOTO A, IN PRESS P NATN ACAD; PELLEGATA S, 1994, CANCER RES, V54, P1556; REDSTON MS, 1994, CANCER RES, V54, P3025; RUGGERI B, 1992, ONCOGENE, V7, P1503; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SEYMOUR AB, 1994, CANCER RES, V54, P2761; SPRUCK CH, 1994, NATURE, V370, P183, DOI 10.1038/370183a0; WEBER JL, 1989, AM J HUM GENET, V44, P388; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YANAGISAWA A, 1993, CANCER RES, V53, P953	25	1070	1115	1	25	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1994	8	1					27	32		10.1038/ng0994-27	http://dx.doi.org/10.1038/ng0994-27			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PE157	7726912				2022-12-25	WOS:A1994PE15700012
J	GRANT, M; ZUCCOTTI, M; MONK, M				GRANT, M; ZUCCOTTI, M; MONK, M			METHYLATION OF CPG SITES OF 2 X-LINKED GENES COINCIDES WITH X-INACTIVATION IN THE FEMALE MOUSE EMBRYO BUT NOT IN THE GERM LINE	NATURE GENETICS			English	Article							CHROMOSOME INACTIVATION; DNA METHYLATION; CELLS; EXPRESSION; ISLAND; MICE	To further our understanding of initiation and imprinting of X-chromosome inactivation, we have examined methylation of specific CpG sites of X-linked Pgk-1 and G6pd genes throughout female mouse development. Methylation occurs around the time of inactivation and earlier for Pgk-1, which is closer to the X-inactivation centre. In female primordial germ cells, the inactive X chromosome escapes methylation; this may underly the reversibility of inactivation at meiosis. Similarly, the genes are unmethylated on the inactive X chromosome in sperm; hence, the imprint specifying preferential X-inactivation in extra-embryonic tissues must reside elsewhere.	UNIV PAVIA,CNR,CTR STUDIO ISTOCHIM,I-27100 PAVIA,ITALY; UNIV PAVIA,DIPARTIMENTO BIOL ANIM,I-27100 PAVIA,ITALY	Consiglio Nazionale delle Ricerche (CNR); University of Pavia; University of Pavia	GRANT, M (corresponding author), UNIV LONDON UNIV COLL,MRC,MAMMALIAN DEV UNIT,STEPHENSON WAY,LONDON NW1 2HE,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARLETT MH, 1991, SOMAT CELL MOLEC GEN, V17, P35; BECK BN, 1988, NUCLEIC ACIDS RES, V16, P9051, DOI 10.1093/nar/16.18.9051; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BRADLEY A, 1986, CURR TOP DEV BIOL, V20, P357, DOI 10.1016/S0070-2153(08)60675-4; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; CATTANACH BM, 1981, GENET RES, V38, P57, DOI 10.1017/S0016672300020401; CHIQUOINE AD, 1954, ANAT REC, V118, P135, DOI 10.1002/ar.1091180202; DRISCOLL DJ, 1990, SOMAT CELL MOLEC GEN, V16, P267, DOI 10.1007/BF01233363; GARTLER SM, 1980, CYTOGENET CELL GENET, V28, P203, DOI 10.1159/000131531; GINSBURG M, 1990, DEVELOPMENT, V110, P521; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; HANSEN RS, 1988, MOL CELL BIOL, V8, P4962; HARPER MI, 1982, J EMBRYOL EXP MORPH, V67, P127; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P964; JOHNSTON PG, 1981, GENET RES, V37, P317, DOI 10.1017/S0016672300020322; KRATZER PG, 1981, P NATL ACAD SCI-BIOL, V78, P3093, DOI 10.1073/pnas.78.5.3093; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MCCLELLAND M, 1988, NUCLEIC ACIDS RES, V16, P364, DOI 10.1093/nar/16.1.364; MCMAHON A, 1983, J EMBRYOL EXP MORPH, V74, P207; MCMAHON A, 1981, J EMBRYOL EXP MORPH, V64, P251; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; MONK M, 1986, BIOESSAYS, V4, P204, DOI 10.1002/bies.950040505; MONK M, 1987, DEVELOPMENT, V99, P371; MONK M, 1987, MAMMALIAN DEV PRACTI; MONK M, 1990, GENOMIC IMPRINTING D, P55; PAPAIOANNOU VE, 1981, DEV GENET, V2, P305, DOI 10.1002/dvg.1020020308; PFEIFER GP, 1990, P NATL ACAD SCI USA, V87, P8252, DOI 10.1073/pnas.87.21.8252; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; SINGERSAM J, 1990, MOL CELL BIOL, V10, P4987, DOI 10.1128/MCB.10.9.4987; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P1413, DOI 10.1073/pnas.89.4.1413; SINGERSAM J, 1989, UCLA S MOL CELLULAR, V128; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TONIOLO D, 1991, GENE, V102, P197, DOI 10.1016/0378-1119(91)90078-P; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9	37	78	78	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1992	2	2					161	166		10.1038/ng1092-161	http://dx.doi.org/10.1038/ng1092-161			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JR084	1303266				2022-12-25	WOS:A1992JR08400019
J	CHOU, YHW; BROWN, EM; LEVI, T; CROWE, G; ATKINSON, AB; ARNQVIST, HJ; TOSS, G; EL-HAJJ FULEIHAN, G; SEIDMAN, JG; SEIDMAN, CE				CHOU, YHW; BROWN, EM; LEVI, T; CROWE, G; ATKINSON, AB; ARNQVIST, HJ; TOSS, G; EL-HAJJ FULEIHAN, G; SEIDMAN, JG; SEIDMAN, CE			THE GENE RESPONSIBLE FOR FAMILIAL HYPOCALCIURIC HYPERCALCEMIA MAPS TO CHROMOSOME-3Q IN 4 UNRELATED FAMILIES	NATURE GENETICS			English	Article							BENIGN HYPERCALCEMIA; DNA POLYMORPHISMS; LINKAGE; RHODOPSIN; KINDREDS; LOCUS; CHAIN	Familial hypocalciuric hypercalcemia (FHH) is an autosomal dominant syndrome of unknown aetiology characterized by lifelong elevation in serum calcium concentration and low urinary calcium excretion. These features suggest that the causal gene is important for maintenance of extracellular calcium homeostasis by the parathyroid gland and kidney. To identify the chromosomal location of FHH gene(s), we clinically evaluated 114 individuals in four unrelated affected families and performed linkage analyses. The disease gene mapped to the long arm of chromosome 3 in each family (combined maximum multipoint lod score = 20.67). We suggest that this is the predominant FHH locus and anticipate that identification of the FHH gene will improve our understanding of the molecular basis for physiologic and pathologic regulation of calcium.	BRIGHAM & WOMENS HOSP, DIV CARDIOL, BOSTON, MA 02115 USA; HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DIV ENDOCRINOL HYPERTENS, BOSTON, MA 02115 USA; ROYAL VICTORIA HOSP, SIR GEORGE E CLARK METAB UNIT, BELFAST BT12 6BA, NORTH IRELAND; LINKOPING UNIV, DEPT INTERNAL MED, S-58185 LINKOPING, SWEDEN	Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Linkoping University								ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; ATTIE MF, 1983, J CLIN INVEST, V72, P667, DOI 10.1172/JCI111016; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; CATTERALL WA, 1988, J BIOL CHEM, V263, P3535; CHIN H, 1991, GENOMICS, V11, P914, DOI 10.1016/0888-7543(91)90014-6; DOAK S, 1991, NUC ACID RES, V19, P4017; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FARRAR GJ, 1990, GENOMICS, V8, P35; FOLEY TP, 1972, J PEDIATR-US, V81, P1060, DOI 10.1016/S0022-3476(72)80232-4; GARCIA D, 1991, 8TH P INT C HUM GEN, P352; GRANGVIST M, 1991, NUCLEIC ACIDS RES, V19, P4017; HEATH H, 1991, J BONE MINER RES, pS176; LAMHONWAH AM, 1986, P NATL ACAD SCI USA, V83, P4864, DOI 10.1073/pnas.83.13.4864; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAW WM, 1985, ANN INTERN MED, V102, P511, DOI 10.7326/0003-4819-102-4-511; LEVY ER, GENOME DATA BASE VER; LYONS TJ, 1986, BRIT J SURG, V73, P188, DOI 10.1002/bjs.1800730310; MARX SJ, 1978, AM J MED, V65, P235, DOI 10.1016/0002-9343(78)90814-8; MARX SJ, 1981, MEDICINE, V60, P397, DOI 10.1097/00005792-198111000-00002; MCALPINE PJ, 1987, CYTOGENET CELL GENET, V46, P659; MENKO FH, 1984, HUM GENET, V67, P452, DOI 10.1007/BF00291409; NEMETH EF, 1986, FEBS LETT, V203, P15, DOI 10.1016/0014-5793(86)81427-2; NUSSBAUM SR, 1987, CLIN CHEM, V33, P1364; OTT J, 1983, ANAL HUMAN LINKAGE; RICHARDS E, 1987, CURRENT PROTOCOLS MO; SPARKES RS, 1986, CURR EYE RES, V5, P797, DOI 10.3109/02713688609000021; TONOKI H, 1991, CYTOGENET CELL GENET, V56, P103, DOI 10.1159/000133059; TOSS G, 1989, J INTERN MED, V225, P201, DOI 10.1111/j.1365-2796.1989.tb00064.x; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4635, DOI 10.1093/nar/18.15.4635-a; WEBER JL, 1989, AM J HUM GENET, V44, P388	30	126	131	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	1992	1	4					295	300		10.1038/ng0792-295	http://dx.doi.org/10.1038/ng0792-295			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC984	1302026				2022-12-25	WOS:A1992JC98400015
J	WATERSTON, R; MARTIN, C; CRAXTON, M; HUYNH, C; COULSON, A; HILLIER, L; DURBIN, R; GREEN, P; SHOWNKEEN, R; HALLORAN, N; METZSTEIN, M; HAWKINS, T; WILSON, R; BERKS, M; DU, Z; THOMAS, K; THIERRYMIEG, J; SULSTON, J				WATERSTON, R; MARTIN, C; CRAXTON, M; HUYNH, C; COULSON, A; HILLIER, L; DURBIN, R; GREEN, P; SHOWNKEEN, R; HALLORAN, N; METZSTEIN, M; HAWKINS, T; WILSON, R; BERKS, M; DU, Z; THOMAS, K; THIERRYMIEG, J; SULSTON, J			A SURVEY OF EXPRESSED GENES IN CAENORHABDITIS-ELEGANS	NATURE GENETICS			English	Article							CHROMOSOME; DNA; MUTATIONS; SEQUENCE; GENOME	As an adjunct to the genomic sequencing of Caenorhabditis elegans, we have investigated a representative cDNA library of 1,517 clones. A single sequence read has been obtained from the 5' end of each clone, allowing its characterization with respect to the public databases, and the clones are being localized on the genome map. The result is the identification of about 1,200 of the estimated 15,000 genes of C. elegans. More than 30% of the inferred protein sequences have significant similarity to existing sequences in the databases, providing a route towards in vivo analysis of known genes in the nematode. These clones also provide material for assessing the accuracy of predicted exons and splicing patterns and will lead to a more accurate estimate of the total number of genes in the organism than has hitherto been available.	LAWRENCE LIVERMORE NATL LAB, CTR HUMAN GENOME, LIVERMORE, CA 94550 USA; MRC, MOLEC BIOL LAB, CAMBRIDGE CB2 2QH, ENGLAND; CTR RECH BIOL MOLEC & PHYS MATH, CNRS, F-34044 MONTPELLIER, FRANCE	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; MRC Laboratory Molecular Biology; Centre National de la Recherche Scientifique (CNRS)	WATERSTON, R (corresponding author), WASHINGTON UNIV, SCH MED, DEPT GENET, BOX 8232, 4566 SCOTT AVE, ST LOUIS, MO 63110 USA.		Wilson, Richard K./AAF-4139-2019; Durbin, Richard/AAE-7178-2019; THIERRY-MIEG, Jean/F-1975-2017	Wilson, Richard K./0000-0002-1992-1358; Durbin, Richard/0000-0002-9130-1006; THIERRY-MIEG, Jean/0000-0002-0396-6789				ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BOSSY B, 1984, EMBO J, V3, P2537, DOI 10.1002/j.1460-2075.1984.tb02169.x; BRENNER S, 1974, GENETICS, V77, P71; CLARK DV, 1988, GENETICS, V119, P345; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; COULSON A, 1991, BIOESSAYS, V13, P413, DOI 10.1002/bies.950130809; Coulson Alan, 1988, P19; CRAXTON M, 1991, Methods (Orlando), V3, P20, DOI 10.1016/S1046-2023(05)80159-8; DEAR S, 1991, NUCLEIC ACIDS RES, V19, P3907, DOI 10.1093/nar/19.14.3907; EDGLEY ML, 1990, GENETIC MAPS, V5, P3; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GIBSON TJ, 1987, GENE ANAL TECH, V4, P41, DOI 10.1016/0735-0651(87)90016-1; GLEESON T, 1991, NUCLEIC ACIDS RES, V19, P6481, DOI 10.1093/nar/19.23.6481; GREEN ED, 1990, P NATL ACAD SCI USA, V87, P1213, DOI 10.1073/pnas.87.3.1213; HALL LMC, 1983, J MOL BIOL, V169, P83, DOI 10.1016/S0022-2836(83)80176-4; HALLORAN N, IN PRESS METHODS MOL, V10; HERMAN RK, 1988, NEMATODE CAENORHABDI, P17; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LEESMILLER JP, 1992, P NATL ACAD SCI USA, V89, P80, DOI 10.1073/pnas.89.1.80; MCCOMBIE WR, 1992, NATRUE GENET, V1; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; OLSON M, 1991, GENOME DYNAMICS PROT, P1; PALAZZOLO MJ, 1990, GENE, V88, P25, DOI 10.1016/0378-1119(90)90056-W; PARK EC, 1986, GENETICS, V113, P821; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SCHWOB E, 1992, NATURE, V355, P179, DOI 10.1038/355179a0; STADEN R, 1990, METHOD ENZYMOL, V183, P163; STATES DJ, 1991, P NATL ACAD SCI USA, V88, P5518, DOI 10.1073/pnas.88.13.5518; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0	32	348	358	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1992	1	2					114	123		10.1038/ng0592-114	http://dx.doi.org/10.1038/ng0592-114			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC980	1302004				2022-12-25	WOS:A1992JC98000010
J	ZHANG, YH; TYCKO, B				ZHANG, YH; TYCKO, B			MONOALLELIC EXPRESSION OF THE HUMAN H19 GENE	NATURE GENETICS			English	Article							SPORADIC WILMS-TUMOR; LOCUS; MOUSE; MAP; CHROMOSOME-11; ANTICIPATION; METHYLATION; MECHANISM; MODEL	Monoallelic expression of several genes has been observed in mice in which transcripts from parental homologues are distinguishable, but this phenomenon has not been demonstrated in humans. One monoallelically expressed murine gene, H19, encodes an abundant fetal RNA. We have found restriction site polymorphisms in the human H19 gene, located on chromosome 11p15, and examined the representation of these polymorphisms in cDNAs from fetal organs. Expression of H19 is largely or exclusively from a single allele; a similar analysis of the WT1 gene, on 11p13, shows biallelic expression. In the context of previous studies of 11p15 allelic losses in human embryonal tumours, our findings support the possibility of single-step inactivation of monoallelically expressed growth-regulating genes in human oncogenesis.	COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, DIV NEUROPATHOL, NEW YORK, NY 10032 USA	Columbia University	ZHANG, YH (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, DIV ONCOL, NEW YORK, NY 10032 USA.							BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BRUNKOW ME, 1991, GENE DEV, V5, P1092, DOI 10.1101/gad.5.6.1092; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; Eldridge R, 1981, Adv Neurol, V29, P57; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; HABER DA, 1991, CELL, V64, P5, DOI 10.1016/0092-8674(91)90200-I; HAIG D, 1991, CELL, V64, P1045; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HOVAN PR, 1990, NUCLEIC ACIDS RES, V19, P1164; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; KITTUR SD, 1985, P NATL ACAD SCI USA, V82, P5064, DOI 10.1073/pnas.82.15.5064; KOUFOS A, 1989, AM J HUM GENET, V44, P711; LEIBOVITCH MP, 1991, BIOCHEM BIOPH RES CO, V180, P1241, DOI 10.1016/S0006-291X(05)81329-4; LITTLE M, 1991, NATURE, V351, P609, DOI 10.1038/351609a0; Maniatis T., 1982, MOL CLONING; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; PACHNIS V, 1988, EMBO J, V7, P673, DOI 10.1002/j.1460-2075.1988.tb02862.x; PACHNIS V, 1984, P NATL ACAD SCI-BIOL, V81, P5523, DOI 10.1073/pnas.81.17.5523; PAL N, 1990, ONCOGENE, V5, P1665; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; REEVE AE, 1989, MOL CELL BIOL, V9, P1799, DOI 10.1128/MCB.9.4.1799; REIK W, 1988, J MED GENET, V25, P805, DOI 10.1136/jmg.25.12.805; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; SAPIENZA C, 1989, PROG NUCLEIC ACID RE, V36, P145; SCHROEDER WT, 1987, AM J HUM GENET, V53, P89; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; SWAIN JL, 1987, CELL, V50, P719, DOI 10.1016/0092-8674(87)90330-8; TYCKO B, 1989, SCIENCE, V245, P1242, DOI 10.1126/science.2551037; VANDERMEY AGL, 1989, LANCET, V2, P1291; VOGELSTEIN B, 1979, P NATL ACAD SCI USA, V76, P615, DOI 10.1073/pnas.76.2.615; WILES MV, 1988, DEVELOPMENT, V104, P403	35	384	391	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1992	1	1					40	44		10.1038/ng0492-40	http://dx.doi.org/10.1038/ng0492-40			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC978	1363808				2022-12-25	WOS:A1992JC97800010
J	RICHARD, G; DELAURENZI, V; DIDONA, B; BALE, SJ; COMPTON, JG				RICHARD, G; DELAURENZI, V; DIDONA, B; BALE, SJ; COMPTON, JG			KERATIN-13 POINT MUTATION UNDERLIES THE HEREDITARY MUCOSAL EPITHELIA DISORDER WHITE SPONGE NEVUS	NATURE GENETICS			English	Note							EXPRESSION; PATTERNS		NIAMSD,SKIN BIOL LAB,BETHESDA,MD 20892; UNIV ROMA TOR VERGATA,DEPT EXPTL MED,BIOCHEM LAB,IRCCS,IST DERMOPATICO IMMACOLATA,I-00167 ROME,ITALY; IRCCS,IST DERMOPATICO IMMACOLATA,I-00167 ROME,ITALY	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Rome Tor Vergata; IRCCS Istituto Dermopatico dell'Immacolata (IDI)			; De Laurenzi, Vincenzo/K-7471-2016	Didona, Biagio/0000-0001-6635-0490; De Laurenzi, Vincenzo/0000-0002-7506-1743				ALBERTSEN HM, 1994, NAT GENET, V7, P472, DOI 10.1038/ng0894-472; ANNEROTH G, 1975, ACTA DERM-VENEREOL, V55, P387; BOWDEN PE, 1995, NAT GENET, V10, P363, DOI 10.1038/ng0795-363; FRITHIOF L, 1976, ORAL SURG ORAL MED O, V41, P607, DOI 10.1016/0030-4220(76)90313-3; JORGENSON RJ, 1981, ARCH DERMATOL, V117, P73, DOI 10.1001/archderm.117.2.73; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; LINDBERG K, 1990, DIFFERENTIATION, V45, P230, DOI 10.1111/j.1432-0436.1990.tb00477.x; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MCLEAN WHI, 1995, NAT GENET, V9, P273, DOI 10.1038/ng0395-273; Metz J, 1979, Z Hautkr, V54, P604; MISCHKE D, 1989, NUCLEIC ACIDS RES, V17, P7984, DOI 10.1093/nar/17.19.7984; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MORRIS R, 1988, ACTA CYTOL, V32, P357; OTT J, 1985, ANAL HUMAN GENETIC L; PARRY DAD, 1995, INTERMEDIATE FILAMEN; RICHARD G, 1994, J INVEST DERMATOL, V103, P665, DOI 10.1111/1523-1747.ep12398429; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; ROMANO V, 1992, GENOMICS, V14, P495, DOI 10.1016/S0888-7543(05)80250-2; ROSENBERG M, 1988, MOL CELL BIOL, V8, P722, DOI 10.1128/MCB.8.2.722; ROTHNAGEL JA, 1995, J INVEST DERMATOL, V104, P430, DOI 10.1111/1523-1747.ep12666018; ROTHNAGEL JA, 1990, SCIENCE, V257, P1128; RUGG EL, NAT GENET, V11, P450; STEINERT PM, 1993, BIOCHEM BIOPH RES CO, V197, P840, DOI 10.1006/bbrc.1993.2555; STEINERT PM, 1990, CELLULAR MOL BIOL IN, P353; YOON SJ, 1994, GENOMICS, V24, P502, DOI 10.1006/geno.1994.1659	25	87	89	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					453	455		10.1038/ng1295-453	http://dx.doi.org/10.1038/ng1295-453			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493031	Green Published			2022-12-25	WOS:A1995TH62900028
J	ADACHI, M; SUEMATSU, S; KONDO, T; OGASAWARA, J; TANAKA, T; YOSHIDA, N; NAGATA, S				ADACHI, M; SUEMATSU, S; KONDO, T; OGASAWARA, J; TANAKA, T; YOSHIDA, N; NAGATA, S			TARGETED MUTATION IN THE FAS GENE CAUSES HYPERPLASIA IN PERIPHERAL LYMPHOID ORGANS AND LIVER	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; CELL-SURFACE ANTIGEN; LPR MICE; MONOCLONAL-ANTIBODY; MOLECULAR-CLONING; APOPTOTIC BODIES; MESSENGER-RNA; STEM-CELLS; RAT-LIVER; EXPRESSION	Fas, a type I membrane protein that transduces an apoptotic signal, is expressed in lymphocytes as well as in various tissues such as the liver, lung and heart. The mouse lymphoproliferation (lpr) mutation is a leaky mutation in Fas. By means of gene targeting, we generated a mouse strain which is completely deficient in Fas. In addition to the massive production of lymphocytes, the Fas-null mice showed substantial liver hyperplasia, which was accompanied by the enlargement of nuclei in hepatocytes. The Fas system seems to play a role in the apoptotic process to maintain homeostasis of the liver as well as the peripheral lymphoid organs.	OSAKA BIOSCI INST,SUITA,OSAKA 565,JAPAN; OSAKA MED CTR MATERNAL & CHILD HLTH,IZUMI,OSAKA 59002,JAPAN				Nagata, Shigekazu/AAG-3203-2019; Tanaka, Takashi/O-8254-2015; Kondo, Toru/F-9420-2012	Nagata, Shigekazu/0000-0001-9758-8426; 				ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; Andrew W, 1943, AM J ANAT, V72, P199, DOI 10.1002/aja.1000720204; ARBER N, 1988, LIVER, V8, P80; BENEDETTI A, 1988, J HEPATOL, V7, P319, DOI 10.1016/S0168-8278(88)80004-7; BENEDETTI A, 1988, LIVER, V8, P172; CHU JL, 1993, J EXP MED, V178, P723, DOI 10.1084/jem.178.2.723; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; EPSTEIN CJ, 1967, NATURE, V214, P1050, DOI 10.1038/2141050a0; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; ITOH N, 1993, J BIOL CHEM, V268, P10932; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; IZUI S, 1984, J IMMUNOL, V133, P227; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAGI D, 1994, SCIENCE, V265, P5287; KOBAYASHI S, 1993, BIOCHEM BIOPH RES CO, V191, P617, DOI 10.1006/bbrc.1993.1262; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LOWIN B, 1994, NATURE, V370, P650, DOI 10.1038/370650a0; MACMAHON AP, 1990, CELL, V62, P1037; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARIANI SM, 1994, EUR J IMMUNOL, V24, P3119, DOI 10.1002/eji.1830241231; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; NI R, 1995, EXP CELL RES, V215, P332; OEHM A, 1992, J BIOL CHEM, V267, P10709; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; SUDA T, 1995, J IMMUNOL, V154, P3806; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TANAKA M, 1995, EMBO J, V14, P1129, DOI 10.1002/j.1460-2075.1995.tb07096.x; TANAKA T, 1995, CELL, P353; TRAUTH BC, 1989, SCIENCE, V245, P301, DOI 10.1126/science.2787530; VIGNAUX F, 1995, J EXP MED, V181, P781, DOI 10.1084/jem.181.2.781; Watanabe T., 1994, J TOXICOL PATHOL, V7, P353; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WU JG, 1993, J EXP MED, V178, P461, DOI 10.1084/jem.178.2.461; YAGI T, 1993, ANAL BIOCHEM, V214, P77, DOI 10.1006/abio.1993.1459; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	50	327	329	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					294	300		10.1038/ng1195-294	http://dx.doi.org/10.1038/ng1195-294			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581453				2022-12-25	WOS:A1995TC63900018
J	EVERALL, IP; HUDSON, L; ALSARRAJ, S; HONAVAR, M; LANTOS, P; KERWIN, R				EVERALL, IP; HUDSON, L; ALSARRAJ, S; HONAVAR, M; LANTOS, P; KERWIN, R			DECREASED EXPRESSION OF AMPA RECEPTOR MESSENGER-RNA AND PROTEIN IN AIDS - A MODEL FOR HIV-ASSOCIATED NEUROTOXICITY	NATURE MEDICINE			English	Article							ENVELOPE PROTEIN; NEURONAL LOSS; GLUTAMATE; CHANNELS; INFECTION; DAMAGE; FAMILY	HIV infection can cause extensive neuronal loss and clinically a severe dementia. The cause of the neurotoxicity remains unclear as neurons are not infected, but disturbance of glutamate-linked calcium entry has been implicated. In this study, we have shown a decrease in HIV-infected brain of the expression of mRNA and protein of the GluR-A flop subtype of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) glutamate receptor in cerebellar Purkinje cells. Although Purkinje cells are relatively resistant to loss, the observed disturbance of AMPA receptors may contribute to the neurotoxic process in other vulnerable brain regions and clinically to the development of dementia.			EVERALL, IP (corresponding author), INST PSYCHIAT,DE CRESPIGNY PK,LONDON SE5 8AF,ENGLAND.							BAUDE A, 1994, J NEUROSCI, V14, P2830; BENKE TA, 1993, P NATL ACAD SCI USA, V90, P7819, DOI 10.1073/pnas.90.16.7819; BRENNEMAN DE, 1988, NATURE, V335, P639, DOI 10.1038/335639a0; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; DAY NC, 1995, MOL BRAIN RES, V31, P17, DOI 10.1016/0169-328X(95)00021-J; DIOP AG, 1994, NEUROSCI LETT, V165, P187, DOI 10.1016/0304-3940(94)90741-2; DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; EVERALL I, 1992, LANCET, V340, P1413, DOI 10.1016/0140-6736(92)92603-D; EVERALL IP, 1994, ACTA NEUROPATHOL, V88, P538; EVERALL IP, 1991, LANCET, V337, P1119, DOI 10.1016/0140-6736(91)92786-2; EVERALL IP, 1993, J NEUROL NEUROSUR PS, V56, P481, DOI 10.1136/jnnp.56.5.481; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; GARCIALADONA FJ, 1994, MOL BRAIN RES, V21, P75, DOI 10.1016/0169-328X(94)90380-8; GARRY RF, 1991, AIDS, V5, P1381, DOI 10.1097/00002030-199111000-00017; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; HALL TC, 1975, NEUROPATH APPL NEURO, V1, P267, DOI 10.1111/j.1365-2990.1975.tb00652.x; HEYES MP, 1991, ANN NEUROL, V29, P202, DOI 10.1002/ana.410290215; HILL JM, 1993, BRAIN RES, V603, P222, DOI 10.1016/0006-8993(93)91241-J; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; LIPTON SA, 1991, ANN NEUROL, V30, P111; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; MASLIAH E, 1992, J NEUROPATH EXP NEUR, V51, P585; SAITO Y, 1994, NEUROLOGY, V44, P474, DOI 10.1212/WNL.44.3_Part_1.474; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; WERNER T, 1991, AIDS, V5, P1301, DOI 10.1097/00002030-199111000-00003; WILEY CA, 1991, ANN NEUROL, V29, P651, DOI 10.1002/ana.410290613	30	35	35	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1174	1178		10.1038/nm1195-1174	http://dx.doi.org/10.1038/nm1195-1174			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584990				2022-12-25	WOS:A1995TC53700042
J	YANG, ZY; PERKINS, ND; OHNO, T; NABEL, EG; NABEL, GJ				YANG, ZY; PERKINS, ND; OHNO, T; NABEL, EG; NABEL, GJ			THE P21 CYCLIN-DEPENDENT KINASE INHIBITOR SUPPRESSES TUMORIGENICITY IN-VIVO	NATURE MEDICINE			English	Article							RETINOBLASTOMA GENE-PRODUCT; CELL-CYCLE; CYTO-TOXICITY; CDC2 KINASE; G1 CYCLIN; DIFFERENTIATION; PROTEIN; PHOSPHORYLATION; 5-AZACYTIDINE; GROWTH	The p21 gene encodes a cyclin-dependent kinase inhibitor that affects cell-cycle progression, but the potential of this gene product to serve as a tumour suppressor in vivo has not been established. In this report, we show that the growth of malignant cells in vitro and in vivo is inhibited by expression of p21. Expression of p21 resulted in an accumulation of cells in G0/G1, altered morphology, and cell differentiation, but apoptosis was not induced. Introduction of p21 with adenoviral vectors into malignant cells completely suppressed their growth in vivo and also reduced the growth of established pre-existing tumours. Gene transfer of p21 may provide a molecular genetic approach to arresting cancer cell growth by committing malignant cells irreversibly to a pathway of terminal differentiation.	HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,DEPT BIOL CHEM,ANN ARBOR,MI 48109	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					NCI NIH HHS [P01 CA59327] Funding Source: Medline; NHLBI NIH HHS [HL43757] Funding Source: Medline; NIDDK NIH HHS [DK42760] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA059327] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043757] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CHANG F, 1990, CELL, V63, P999, DOI 10.1016/0092-8674(90)90503-7; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; CHEN SH, 1995, P NATL ACAD SCI USA, V92, P2577, DOI 10.1073/pnas.92.7.2577; CHRISTMAN JK, 1983, CANCER RES, V43, P763; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; DYNLACHT BD, 1994, GENE DEV, V8, P1722; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; GORCZYCA W, 1993, LEUKEMIA, V7, P659; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; HARPER JW, 1993, CELL, V75, P805; HEICHMAN KA, 1994, CELL, V79, P557, DOI 10.1016/0092-8674(94)90541-X; HU Q, 1992, MOL CELL BIOL, V12, P971, DOI 10.1128/MCB.12.3.971; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; ITO S, 1993, ANAL BIOCHEM, V215, P273, DOI 10.1006/abio.1993.1586; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; KATO J, 1993, GENE DEV, V7, P331; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; LEFTWICH JA, 1986, CANCER RES, V46, P3789; LI CY, 1995, J BIOL CHEM, V270, P4971, DOI 10.1074/jbc.270.10.4971; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; LI Y, 1994, ONCOGENE, V9, P2261; LIN BTY, 1991, EMBO J, V10, P857, DOI 10.1002/j.1460-2075.1991.tb08018.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; PETER M, 1994, CELL, V79, P181, DOI 10.1016/0092-8674(94)90186-4; PIERCE GB, 1988, CANCER RES, V48, P1996; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; RILEY DJ, 1994, ANNU REV CELL BIOL, V10, P1, DOI 10.1146/annurev.cb.10.110194.000245; SAMID D, 1992, CANCER RES, V52, P1988; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750	44	204	206	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	OCT	1995	1	10					1052	1056		10.1038/nm1095-1052	http://dx.doi.org/10.1038/nm1095-1052			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489362				2022-12-25	WOS:A1995RX95100046
J	COLMAN, SD; WILLIAMS, CA; WALLACE, MR				COLMAN, SD; WILLIAMS, CA; WALLACE, MR			BENIGN NEUROFIBROMAS IN TYPE-1 NEUROFIBROMATOSIS (NF1) SHOW SOMATIC DELETIONS OF THE NF1 GENE	NATURE GENETICS			English	Letter							POLYMORPHIC CDNA PROBE; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; REPEAT; CHROMOSOME-17; MUTATIONS; ORIGIN; REGION		UNIV FLORIDA,DEPT MED,DIV GENET,GAINESVILLE,FL 32610; UNIV FLORIDA,DEPT BIOCHEM & MOLEC BIOL,GAINESVILLE,FL 32610; UNIV FLORIDA,DEPT PATHOL & LAB MED,GAINESVILLE,FL 32610; UNIV FLORIDA,CTR MAMMALIAN GENET,GAINESVILLE,FL 32610	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida					NCI NIH HHS [T32CA09126] Funding Source: Medline; NINDS NIH HHS [R29NS31550] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS031550] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERNATHY C, 1994, CLIN GENET, V45, P313; ANDERSEN LB, 1993, HUM MOL GENET, V2, P1083, DOI 10.1093/hmg/2.7.1083-a; ANDERSEN LB, 1991, NUCLEIC ACIDS RES, V19, P3754, DOI 10.1093/nar/19.13.3754; ANDERSEN LB, 1991, NUCLEIC ACIDS RES, V19, P197, DOI 10.1093/nar/19.1.197-a; COLMAN SD, 1995, MOL GENETICS CANC, P43; FAIN P R, 1987, Genomics, V1, P340, DOI 10.1016/0888-7543(87)90034-6; FAIN PR, 1989, AM J HUM GENET, V45, P721; FUTREAL PA, 1991, NUCLEIC ACIDS RES, V19, P6977, DOI 10.1093/nar/19.24.6977; GLOVER TW, 1991, GENE CHROMOSOME CANC, V3, P62, DOI 10.1002/gcc.2870030111; HOFF M, 1988, NUCLEIC ACIDS RES, V16, P781, DOI 10.1093/nar/16.2.781; HOFFMEYER S, 1994, HUM GENET, V93, P481; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; JORDE LB, 1993, AM J HUM GENET, V53, P1038; KAYES LM, 1992, GENOMICS, V14, P369, DOI 10.1016/S0888-7543(05)80228-9; KONDOLEON S, 1987, NUCLEIC ACIDS RES, V15, P9096, DOI 10.1093/nar/15.21.9096; LAZARO C, 1993, HUM GENET, V92, P429, DOI 10.1007/BF01247353; LAZARO C, 1994, HUM GENET, V93, P351, DOI 10.1007/BF00212039; LOTHE RA, 1995, J NEUROPATH EXP NEUR, V54, P65, DOI 10.1097/00005072-199501000-00008; MADISEN L, 1989, AM J MED GENET, V27, P379; MATSUI I, 1993, CANCER-AM CANCER SOC, V72, P2746, DOI 10.1002/1097-0142(19931101)72:9<2746::AID-CNCR2820720936>3.0.CO;2-W; MCDANIEL T, 1991, NUCLEIC ACIDS RES, V19, P4796, DOI 10.1093/nar/19.17.4796-a; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P3598, DOI 10.1093/nar/16.8.3598; PURANDARE SM, 1994, HUM MOL GENET, V3, P1109, DOI 10.1093/hmg/3.7.1109; REYNIERS E, 1993, HUM GENET, V92, P631, DOI 10.1007/BF00420953; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; Sambrook J, 1989, MOL CLONING LABORATO; SKUSE GR, 1991, AM J HUM GENET, V49, P600; SORENSEN SA, 1986, NEW ENGL J MED, V314, P1010, DOI 10.1056/NEJM198604173141603; STEPHENS K, 1992, HUM GENET, V88, P279; UPADHYAYA M, 1994, HUM MUTAT, V4, P83, DOI 10.1002/humu.1380040202; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; XU W, 1991, NUCLEIC ACIDS RES, V19, P2520, DOI 10.1093/nar/19.9.2520	33	179	181	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					90	92		10.1038/ng0995-90	http://dx.doi.org/10.1038/ng0995-90			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550323				2022-12-25	WOS:A1995RR72800022
J	PUTKONEN, P; WALTHER, L; ZHANG, YJ; LI, SL; NILSSON, C; ALBERT, J; BIBERFELD, P; THORSTENSSON, R; BIBERFELD, G				PUTKONEN, P; WALTHER, L; ZHANG, YJ; LI, SL; NILSSON, C; ALBERT, J; BIBERFELD, P; THORSTENSSON, R; BIBERFELD, G			LONG-TERM PROTECTION AGAINST SIV-INDUCED DISEASE IN MACAQUES VACCINATED WITH A LIVE ATTENUATED HIV-2 VACCINE	NATURE MEDICINE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; CYNOMOLGUS MONKEYS; INFECTION; IMMUNIZATION	The aim of this study was to test the ability of a live attenuated human immunodeficiency virus type 2 (HIV-2) vaccine to protect cynomolgus monkeys against superinfection with a pathogenic simian immunodeficiency virus (SIVsm) This report is an update on our previously reported observation period of nine months. The new data here show that three of four monkeys vaccinated with live HIV-2 were protected against immunosuppression and SIV-induced disease during more than five years of follow-up. The quality of the immunity was permissive for infection, but monkeys that survived showed restricted viral replication in peripheral blood and lymph nodes. This study shows that it is possible to induce protection against a pathogenic heterologous primate lentivirus and to prevent disease in vaccinated monkeys even if infection is not prevented. These findings provide evidence that protection against AIDS can be achieved by immunization.	KAROLINSKA INST,CTR MICROBIOL & TUMOURBIOL,S-17177 STOCKHOLM,SWEDEN; KAROLINSKA HOSP,IMMUNOPATHOL LAB,S-17176 STOCKHOLM,SWEDEN; KAROLINSKA INST,SWEDISH INST INFECT DIS CONTROL,DEPT VIROL,S-10521 STOCKHOLM,SWEDEN	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Swedish Institute for Infectious Disease Control	PUTKONEN, P (corresponding author), KAROLINSKA INST,SWEDISH INST INFECT DIS CONTROL,DEPT IMMUNOL,S-10521 STOCKHOLM,SWEDEN.			Walther-Jallow, Lilian/0000-0001-8731-1917				ADA GL, 1990, LANCET, V335, P523, DOI 10.1016/0140-6736(90)90748-T; AHMAD S, 1994, AIDS RES HUM RETROV, V10, P195, DOI 10.1089/aid.1994.10.195; ALBERT J, 1987, AIDS RES HUM RETROV, V3, P3, DOI 10.1089/aid.1987.3.3; ALBERT J, 1990, J CLIN MICROBIOL, V28, P1560, DOI 10.1128/JCM.28.7.1560-1564.1990; BABA TW, 1995, SCIENCE, V267, P1820, DOI 10.1126/science.7892606; BOTTIGER B, 1989, AIDS RES HUM RETROV, V5, P511; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; GAO F, 1994, J VIROL, V68, P7433, DOI 10.1128/JVI.68.11.7433-7447.1994; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; HIRSCH VM, 1994, J INFECT DIS, V170, P51, DOI 10.1093/infdis/170.1.51; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; ISRAEL ZR, 1994, J VIROL, V68, P1843, DOI 10.1128/JVI.68.3.1843-1853.1994; MARTHAS ML, 1990, J VIROL, V64, P3694, DOI 10.1128/JVI.64.8.3694-3700.1990; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; PUTKONEN P, 1991, NATURE, V352, P436, DOI 10.1038/352436a0; PUTKONEN P, 1992, AIDS, V6, P257, DOI 10.1097/00002030-199203000-00001; PUTKONEN P, 1989, J ACQ IMMUN DEF SYND, V2, P359; PUTKONEN P, 1990, AIDS, V4, P783, DOI 10.1097/00002030-199008000-00010; PUTKONEN P, 1989, J ACQ IMMUN DEF SYND, V2, P368; SCHAFERMAN A, 1993, VACCINE, V11, P848; SCHULTZ AM, 1994, AIDS S1, V8, P203; STOTT EJ, 1991, NATURE, V353, P393, DOI 10.1038/353393a0; SUJIPTO S, 1990, J VIROL, V64, P2290; WIGZELL H, 1991, FASEB J, V5, P2406, DOI 10.1096/fasebj.5.10.2065889; ZHANG YJ, 1994, VIROLOGY, V200, P583, DOI 10.1006/viro.1994.1221	26	62	63	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	SEP	1995	1	9					914	918		10.1038/nm0995-914	http://dx.doi.org/10.1038/nm0995-914			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585217				2022-12-25	WOS:A1995RT30300045
J	GROMPE, M; LINDSTEDT, S; ALDHALIMY, M; KENNAWAY, NG; PAPACONSTANTINOU, J; TORRESRAMOS, CA; OU, CN; FINEGOLD, M				GROMPE, M; LINDSTEDT, S; ALDHALIMY, M; KENNAWAY, NG; PAPACONSTANTINOU, J; TORRESRAMOS, CA; OU, CN; FINEGOLD, M			PHARMACOLOGICAL CORRECTION OF NEONATAL LETHAL HEPATIC-DYSFUNCTION IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I	NATURE GENETICS			English	Article							TYROSINEMIA TYPE-I; FUMARYLACETOACETATE HYDROLASE; ALBINO DELETIONS; TRANSCRIPTIONAL CONTROL; LIVER-TRANSPLANTATION; MOUSE CHROMOSOME-7; NEWBORN LIVER; ANIMAL-MODEL; GENE; MICE	Hereditary tyrosinaemia type I, a severe autosomal recessive metabolic disease, affects the liver and kidneys and is caused by deficiency of fumarylacetoacetate hydrolase (FAH). Mice homozygous for a FAH gene disruption have a neonatal lethal phenotype caused by liver dysfunction and do not represent an adequate model of the human disease. Here we demonstrate that treatment of affected animals with 2-(2-nitro-4-trifluoro-methylbenzyol)-1,3-cyclohexanedione abolished neonatal lethality, corrected liver function and partially normalized the altered expression pattern of hepatic mRNAs. The prolonged lifespan of affected animals resulted in a phenotype analogous to human tyrosinaemia type I including hepatocellular carcinoma. The adult FAH(-/-) mouse will serve as useful model for studies of the pathophysiology and treatment of hereditary tyrosinaemia type I as well as hepatic cancer.	OREGON HLTH SCI UNIV,DEPT PEDIAT,PORTLAND,OR 97201; GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT CLIN CHEM,S-41345 GOTHENBURG,SWEDEN; UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77555; TEXAS CHILDRENS HOSP,DEPT PATHOL,HOUSTON,TX 77030	Oregon Health & Science University; Sahlgrenska University Hospital; University of Gothenburg; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine	GROMPE, M (corresponding author), OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,PORTLAND,OR 97201, USA.		Papaconstantinou, John/E-3312-2010	Grompe, Markus/0000-0002-6616-4345	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048252] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK48252-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BISGAARD HC, 1994, J CELL PHYSIOL, V159, P475, DOI 10.1002/jcp.1041590312; BLANCHARD H, 1989, J PEDIATR SURG, V24, P1009, DOI 10.1016/S0022-3468(89)80204-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEFRANCO D, 1988, P NATL ACAD SCI USA, V85, P1161, DOI 10.1073/pnas.85.4.1161; EDWARDS MA, 1987, LANCET, V1, P1437; GERIN JL, 1990, GASTROENTEROL JPN S, V2, P38; GIOMETTI CS, 1992, P NATL ACAD SCI USA, V89, P2448, DOI 10.1073/pnas.89.6.2448; GLUECKSOHNWAELS.S, 1979, CELL, V16, P225; GLUECKSOHNWAELS.S, 1974, P NATL ACAD SCI USA, V71, P825; GRENIER A, 1985, METHOD ENZYMAT AN, P73; GROMPE M, 1992, BIOCHEM MED METAB B, V48, P26, DOI 10.1016/0885-4505(92)90044-Y; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; KALAYOGLU M, 1989, J PEDIATR SURG, V24, P70, DOI 10.1016/S0022-3468(89)80305-7; KELSEY G, 1993, GENE DEV, V7, P2285, DOI 10.1101/gad.7.12a.2285; KLEBIG ML, 1992, P NATL ACAD SCI USA, V89, P1363, DOI 10.1073/pnas.89.4.1363; KVITTINGEN EA, 1986, SCAND J CLIN LAB INV, V46, P27; LEM J, 1988, P NATL ACAD SCI USA, V85, P7302, DOI 10.1073/pnas.85.19.7302; LINDSTEDT S, 1992, LANCET, V340, P813, DOI 10.1016/0140-6736(92)92685-9; LOOSE DS, 1986, P NATL ACAD SCI USA, V83, P5184, DOI 10.1073/pnas.83.14.5184; MAUAD TH, 1994, AM J PATHOL, V145, P1237; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITCHELL G, 1990, NEW ENGL J MED, V322, P432, DOI 10.1056/NEJM199002153220704; MITCHELL GA, 1994, METABOLIC MOL BASIS, P1077; MORI M, 1994, AM J PATHOL, V144, P200; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; PERRY TL, 1967, CAN MED ASSOC J, V97, P1067; Piantino P, 1989, J Nucl Med Allied Sci, V33, P34; PITKANEN S, 1994, PEDIATR RES, V35, P205, DOI 10.1203/00006450-199402000-00016; RABEK JP, 1990, NUCLEIC ACIDS RES, V18, P6677, DOI 10.1093/nar/18.22.6677; REZNIK GK, 1991, J CANCER RES CLIN, V117, P123, DOI 10.1007/BF01613135; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; RUPPERT S, 1992, GENE DEV, V6, P1430, DOI 10.1101/gad.6.8.1430; RUPPERT S, 1990, CELL, V61, P895, DOI 10.1016/0092-8674(90)90200-X; RUSSO P, 1990, AM J HUM GENET, V47, P317; SALATREPAT JM, 1985, P NATL ACAD SCI USA, V82, P2442, DOI 10.1073/pnas.82.8.2442; Sambrook J, 1989, MOL CLONING LABORATO; SMITH I, 1969, CHROMATOGR ELECTROPH, P104; STURMAN JA, 1985, NEUROMETHODS; SURH LC, 1991, GENE, V99, P181, DOI 10.1016/0378-1119(91)90125-U; TONJES RR, 1992, EMBO J, V11, P127, DOI 10.1002/j.1460-2075.1992.tb05035.x; ULLRICH SJ, 1994, SEMIN CANCER BIOL, V5, P61; VACHER J, 1992, MOL CELL BIOL, V12, P856, DOI 10.1128/MCB.12.2.856; VERES G, 1987, SCIENCE, V237, P415, DOI 10.1126/science.3603027; WINSTON SE, 1993, CURRENT PROTOCOLS MO; WYSS PA, 1992, CLIN SCI, V83, P81, DOI 10.1042/cs0830081; ZARET KS, 1992, P NATL ACAD SCI USA, V89, P6540, DOI 10.1073/pnas.89.14.6540	48	242	260	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					453	460		10.1038/ng0895-453	http://dx.doi.org/10.1038/ng0895-453			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7545495				2022-12-25	WOS:A1995RM37500019
J	ILIOPOULOS, O; KIBEL, A; GRAY, S; KAELIN, WG				ILIOPOULOS, O; KIBEL, A; GRAY, S; KAELIN, WG			TUMOR SUPPRESSION BY THE HUMAN VON HIPPEL-LINDAU GENE-PRODUCT	NATURE MEDICINE			English	Article							RETINOBLASTOMA SUSCEPTIBILITY GENE; BINDING; DNA; IDENTIFICATION; TRANSLATION; COMPLEX; DOMAIN	A partial cDNA sequence for the gene linked to the von Hippel-Lindau (VHL) syndrome was reported in 1993. Mutation or loss of both VHL alleles has been documented in sporadic renal cell carcinomas and in the neoplasms that arise in von Hippel-Lindau kindreds. We have determined that the protein product of the VHL gene is an approximately 30 kilodalton cytoplasmic protein. The renal carcinoma cell line 786-0 is known to harbour a VHL mutation and, as shown here, fails to produce a wild-type VHL protein. Reintroduction of wild-type, but not mutant, VHL into these cells had no demonstrable effect on their growth in vitro but inhibited their ability to form tumours in nude mice.	DANA FARBER CANC INST, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School								CHEN F, 1995, HUM MUTAT, V5, P66, DOI 10.1002/humu.1380050109; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; GOLDE DW, 1981, ANN INTERN MED, V95, P71, DOI 10.7326/0003-4819-95-1-71; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HARLOW E, 1988, ANTIBODIES LABORATOR; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; KAELIN WG, 1990, MOL CELL BIOL, V10, P3761, DOI 10.1128/MCB.10.7.3761; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KANNO H, 1994, CANCER RES, V54, P4845; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KREK W, 1993, SCIENCE, V262, P1557, DOI 10.1126/science.8248803; KUZMIN I, IN PRESS ONCOGENE; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; LEE WH, 1987, NATURE, V329, P642, DOI 10.1038/329642a0; LINEHAN WM, 1995, JAMA-J AM MED ASSOC, V273, P564; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; McKusick V.A., 1992, MENDELIAN INHERITANC; QIN XQ, 1995, MOL CELL BIOL, V15, P742; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; RADKE K, 1983, J CELL BIOL, V97, P1601, DOI 10.1083/jcb.97.5.1601; SHIMIZU M, 1990, ONCOGENE, V5, P185; SHUIN T, 1994, CANCER RES, V54, P2852; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; YOSHIDA MA, 1994, MOL CARCINOGEN, V9, P114, DOI 10.1002/mc.2940090303	30	555	567	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	1995	1	8					822	826		10.1038/nm0895-822	http://dx.doi.org/10.1038/nm0895-822			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585187				2022-12-25	WOS:A1995RM63500041
J	BASSI, MT; SCHIAFFINO, MV; RENIERI, A; DENIGRIS, F; GALLI, L; BRUTTINI, M; GEBBIA, M; BERGEN, AAB; LEWIS, RA; BALLABIO, A				BASSI, MT; SCHIAFFINO, MV; RENIERI, A; DENIGRIS, F; GALLI, L; BRUTTINI, M; GEBBIA, M; BERGEN, AAB; LEWIS, RA; BALLABIO, A			CLONING OF THE GENE FOR OCULAR ALBINISM TYPE-1 FROM THE DISTAL SHORT ARM OF THE X-CHROMOSOME	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; DELETIONS; MACROMELANOSOMES; SEQUENCES; PROTEIN; FEMALE; DNA	Ocular albinism type 1 (OA1) is an X-linked disorder characterized by severe impairment of visual acuity, retinal hypopigmentation and the presence of macromelanosomes. We isolated a novel transcript from the OA1 critical region in Xp22.3-22.2 which is expressed at high levels in RNA samples from retina, including the retinal pigment epithelium, and from melanoma. This gene encodes a protein of 424 amino acids displaying several putative transmembrane domains and sharing no similarities with previously identified molecules. Five intragenic deletions and a 2 bp insertion resulting in a premature stop codon were identified from DNA analysis of patients with OA1, indicating that we have identified the OA1 gene.	UNIV SIENA,DEPT MOLEC BIOL,I-53100 SIENA,ITALY; TELETHON INST GENET & MED,I-20132 MILAN,ITALY; NETHERLANDS OPHTHALM RES INST,1100 AC AMSTERDAM,NETHERLANDS; BAYLOR COLL MED,DEPT OPHTHALMOL & MOLEC & HUMAN GENET,HOUSTON,TX 77030	University of Siena; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Baylor College of Medicine			Bergen, Arthur/J-3637-2013; Bassi, Maria Teresa T/A-3517-2014; Renieri, Alessandra/K-5950-2016; BALLABIO, Andrea/AAL-2672-2020; Schiaffino, Maria Vittoria/AAN-3313-2020	Bassi, Maria Teresa T/0000-0002-8236-1197; Renieri, Alessandra/0000-0002-0846-9220; BALLABIO, Andrea/0000-0003-1381-4604; Schiaffino, Maria Vittoria/0000-0001-9744-7025; de nigris, filomena/0000-0002-2322-1557; Bergen, Arthur/0000-0002-6333-9576	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031367] Funding Source: NIH RePORTER; NINDS NIH HHS [NS31367-01] Funding Source: Medline; Telethon [TGM94000, TGM06S01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		BALLABIO A, 1987, P NATL ACAD SCI USA, V84, P4519, DOI 10.1073/pnas.84.13.4519; Ballabio Andrea, 1992, Human Molecular Genetics, V1, P221, DOI 10.1093/hmg/1.4.221; BASSI MT, 1994, HUM MOL GENET, V3, P647, DOI 10.1093/hmg/3.4.647; BERGEN AA, 1991, GENOMICS, V9, P605; BERGEN AAB, 1993, GENOMICS, V16, P272, DOI 10.1006/geno.1993.1176; BERGEN AAB, 1991, HUM GENET, V88, P162, DOI 10.1007/BF00206065; BERGEN AAB, 1990, OPHTHALMIC PAEDIATR, V3, P165; CHARLES SJ, 1992, J MED GENET, V29, P552, DOI 10.1136/jmg.29.8.552; CHARLES SJ, 1993, GENOMICS, V16, P259, DOI 10.1006/geno.1993.1171; COOPER DN, 1991, HUM GENET, V87, P409; CREEL DJ, 1990, OPHTHALMIC PAED GEN, V11, P193, DOI 10.3109/13816819009020979; FALLS HF, 1951, AM J OPHTHALMOL, V34, P41, DOI 10.1016/0002-9394(51)90007-4; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; FRANCO B, 1995, CELL, V81, P1; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GARNER A, 1980, HISTOPATHOLOGY, V4, P243, DOI 10.1111/j.1365-2559.1980.tb02919.x; JOHNSON GJ, 1971, CAN J OPHTHALMOLOGY, V6, P237; King R., 1995, METABOLIC MOL BASES, P4353; KRISS A, 1992, OPHTHALMIC PAED GEN, V13, P89, DOI 10.3109/13816819209087609; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANG GE, 1990, OPHTHALMIC PAED GEN, V11, P265, DOI 10.3109/13816819009015712; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; McKusick V.A., 1992, MENDELIAN INHERITANC; NISHIMURA S, 1991, AM J MED GENET, V40, P260, DOI 10.1002/ajmg.1320400303; ODONNELL FE, 1976, ARCH OPHTHALMOL-CHIC, V94, P1883, DOI 10.1001/archopht.1976.03910040593001; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAGE DC, 1990, NATURE, V346, P279, DOI 10.1038/346279a0; PEISSEL B, 1994, HUM MUTAT, V3, P386, DOI 10.1002/humu.1380030410; RENIERI A, 1993, HUM GENET, V92, P417, DOI 10.1007/BF01247348; Sambrook J, 1989, MOL CLONING LABORATO; SCHAEFER L, 1993, NAT GENET, V4, P272, DOI 10.1038/ng0793-272; SCHIAFFINO MV, 1995, HUM MOL GENET, V4, P373, DOI 10.1093/hmg/4.3.373; SCHNUR RE, 1991, GENOMICS, V9, P605, DOI 10.1016/0888-7543(91)90353-G; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; WAPENAAR MC, 1990, CYTOGENET CELL GENET, V54, P10, DOI 10.1159/000132945; WAPENAAR MC, 1994, HUM MOL GENET, V3, P1155, DOI 10.1093/hmg/3.7.1155; WAPENAAR MC, 1993, HUM MOL GENET, V2, P947, DOI 10.1093/hmg/2.7.947; WONG L, 1983, OPHTHALMIC PAED GEN, V2, P47, DOI 10.3109/13816818309007149; YOSHIIKE T, 1985, ACTA DERM-VENEREOL, V65, P66	39	174	181	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					13	19		10.1038/ng0595-13	http://dx.doi.org/10.1038/ng0595-13			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647783				2022-12-25	WOS:A1995QX57300010
J	GOUW, LG; KAPLAN, CD; HAINES, JH; DIGRE, KB; RUTLEDGE, SL; MATILLA, A; LEPPERT, M; ZOGHBI, HY; PTACEK, LJ				GOUW, LG; KAPLAN, CD; HAINES, JH; DIGRE, KB; RUTLEDGE, SL; MATILLA, A; LEPPERT, M; ZOGHBI, HY; PTACEK, LJ			RETINAL DEGENERATION CHARACTERIZES A SPINOCEREBELLAR ATAXIA MAPPING TO CHROMOSOME 3P	NATURE GENETICS			English	Article							LARGE KINDREDS; GENE; LOCUS; MAPS; MUTATIONS; LINKAGE; ATROPHY; REPEAT	A heterogeneous group of neurological disorders known as the spinocerebellar ataxias (SCA) are characterized by degeneration of the cerebellum, spinal cord and brainstem. We describe linkage analysis in four unusual SCA families revealing a distinct disease locus on chromosome 3p14-21.1. The disease in these families is distinguished from other forms of SCA by concomitant retinal degeneration. Initial visual problems leading to blindness, disabling ataxia and anticipation are seen in all kindreds. The anticipation in these families suggests a dynamic mutation at this locus. Eventual molecular characterization of this disease may provide valuable insights into the processes of both neural and retinal degeneration.	UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT NEUROL,SALT LAKE CITY,UT 84112; UNIV UTAH,DEPT OPHTHALMOL,SALT LAKE CITY,UT 84112; OREGON EYE ASSOCIATES,EUGENE,OR 97401; UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL 35233; BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham; Baylor College of Medicine; Baylor College of Medicine			MATILLA-DUEÑAS, ANTONI/C-7980-2011; Kaplan, Craig/AAO-4500-2021	MATILLA-DUEÑAS, ANTONI/0000-0002-3514-4181; Kaplan, Craig/0000-0002-7518-695X; Zoghbi, Huda/0000-0002-0700-3349	NICHD NIH HHS [HD00940] Funding Source: Medline; NINDS NIH HHS [NS27699, NS32711] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K11HD000940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032711, R01NS027699] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BENOMAR A, 1994, ANN NEUROL, V35, P439, DOI 10.1002/ana.410350411; BURKE JR, 1994, NAT GENET, V7, P521, DOI 10.1038/ng0894-521; GARDNER K, 1994, NEUROLOGY, V44, pA361; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1993, CLIN FEATURES CLASSI; JACKSON JF, 1977, NEW ENGL J MED, V296, P1138, DOI 10.1056/NEJM197705192962003; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KONIGSMARK BW, 1970, MEDICINE, V49, P227, DOI 10.1097/00005792-197005000-00003; KWIATKOWSKI TJ, 1993, AM J HUM GENET, V53, P391; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOPESCENDES I, 1994, GENOMICS, V21, P270, DOI 10.1006/geno.1994.1257; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Ott J., 1991, ANAL HUMAN GENETIC L; PTACEK LJ, 1993, ANN NEUROL, V33, P300, DOI 10.1002/ana.410330312; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; RANUM LPW, 1992, NEUROLOGY, V42, P344, DOI 10.1212/WNL.42.2.344; RICH SS, 1987, AM J HUM GENET, V41, P524; STEVANIN G, 1994, AM J HUM GENET, V54, P11; STGEORGEHYSLOP P, 1994, AM J HUM GENET, V55, P120; TAKIYAMA Y, 1993, NAT GENET, V4, P300, DOI 10.1038/ng0793-300; TO KW, 1993, OPHTHALMOLOGY, V100, P15; TWELLS R, 1994, HUM MOL GENET, V3, P177, DOI 10.1093/hmg/3.1.177; VOIZ A, 1992, CELL GENETICS, V60, P37; YAKURA H, 1974, NEW ENGL J MED, V291, P154; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23; 1993, CELL, V72, P971	34	134	141	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAY	1995	10	1					89	93		10.1038/ng0595-89	http://dx.doi.org/10.1038/ng0595-89			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QX573	7647799				2022-12-25	WOS:A1995QX57300021
J	ELLIS, NA; TIPPETT, P; PETTY, A; REID, M; WELLER, PA; YE, TZ; GERMAN, J; GOODFELLOW, PN; THOMAS, S; BANTING, G				ELLIS, NA; TIPPETT, P; PETTY, A; REID, M; WELLER, PA; YE, TZ; GERMAN, J; GOODFELLOW, PN; THOMAS, S; BANTING, G			PBDX IS THE XG BLOOD-GROUP GENE	NATURE GENETICS			English	Article							HUMAN SEX-CHROMOSOMES; PSEUDOAUTOSOMAL BOUNDARY; MIC2; ANTIGEN; LOCUS; REGION; IDENTIFICATION; TRANSLOCATION; ANTIBODIES; PRODUCT	We have identified the Xg(a) antigen, encoded by the XG blood group gene, by employing rabbit polyclonal and mouse monoclonal antibodies raised against a peptide derived from the N-terminal domain of a candidate gene, referred to earlier as PBDX. in indirect haemagglutination assays, these anti-peptide antibodies react with Xg(a+) but not Xg(a-) erythrocytes. In antibody-specific immobilization of antigen (ASIA) and immunoblot assays, the anti-peptide antibodies react with the same molecule as does human anti-Xg(a). Therefore, by its identity with PBDX, Xg(a) is identified as a cell-surface protein that is 48% homologous to CD99 (previously designated the 12E7 antigen), the product of MIC2 which is tightly linked to XG. PBDX is renamed here XG.	MRC, BLOOD GRP UNIT, LONDON NW1 2HE, ENGLAND; UNIV CAMBRIDGE, DEPT GENET, CAMBRIDGE CB2 3EH, ENGLAND; UNIV BRISTOL, SCH MED SCI, DEPT BIOCHEM, BRISTOL 1TD, AVON, ENGLAND; UNIV BRISTOL, SCH MED SCI, DEPT SCI, BRISTOL 1TD, AVON, ENGLAND; UNIV BRISTOL, SCH MED SCI, CTR MOLEC RECOGNIT, ENGN RES COUNCIL, BRISTOL 1TD, AVON, ENGLAND	University of Cambridge; University of Bristol; University of Bristol; University of Bristol	ELLIS, NA (corresponding author), NEW YORK BLOOD CTR, 310 E 67TH ST, NEW YORK, NY 10021 USA.		Thomas, Steve/HCI-4063-2022	Banting, George/0000-0001-8249-1621	NIGMS NIH HHS [GM47890] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047890] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOROS IM, 1991, CANCER, V67, P1886; AUBRIT F, 1989, EUR J IMMUNOL, V19, P1431, DOI 10.1002/eji.1830190813; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; BANTING GS, 1989, MOL IMMUNOL, V26, P181, DOI 10.1016/0161-5890(89)90100-4; BANTING GS, 1985, EMBO J, V4, P1967, DOI 10.1002/j.1460-2075.1985.tb03879.x; BODGER MP, 1987, EXP HEMATOL, V15, P869; BUCKLE V, 1985, NATURE, V317, P739, DOI 10.1038/317739a0; BUCKTON KE, 1971, ANN HUM GENET, V35, P171, DOI 10.1111/j.1469-1809.1956.tb01390.x; CAMPANA T, 1978, CYTOGENET CELL GENET, V22, P524, DOI 10.1159/000131015; CLEPET C, 1993, HUM MOL GENET, V2, P2007, DOI 10.1093/hmg/2.12.2007; DARLING SM, 1986, P NATL ACAD SCI USA, V83, P135, DOI 10.1073/pnas.83.1.135; DWORZAK MN, 1994, BLOOD, V83, P415, DOI 10.1182/blood.V83.2.415.bloodjournal832415; ELLIS N, 1990, NATURE, V344, P663, DOI 10.1038/344663a0; ELLIS N, 1989, TRENDS GENET, V5, P406, DOI 10.1016/0168-9525(89)90199-6; ELLIS NA, 1994, NAT GENET, V6, P394, DOI 10.1038/ng0494-394; ELLIS NA, 1989, NATURE, V337, P81, DOI 10.1038/337081a0; FELLOUS M, 1974, ANN HUM GENET, V37, P421, DOI 10.1111/j.1469-1809.1974.tb01847.x; FERGUSONSMITH MA, 1982, CYTOGENET CELL GENET, V32, P273; FIALKOW PJ, 1970, AM J HUM GENET, V22, P460; FIALKOW PT, 1970, NATURE, V226, P367, DOI 10.1038/226367a0; GELIN C, 1989, EMBO J, V8, P3253, DOI 10.1002/j.1460-2075.1989.tb08485.x; Goodfellow P.N., 1988, P1; GOODFELLOW PJ, 1987, ANN HUM GENET, V51, P161, DOI 10.1111/j.1469-1809.1987.tb01058.x; GOODFELLOW PN, 1981, NATURE, V289, P404, DOI 10.1038/289404a0; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; HABIBI B, 1979, VOX SANG, V36, P367, DOI 10.1111/j.1423-0410.1979.tb04513.x; HARLOW E, 1988, ANTIBODIES LABORATOR; HERRON R, 1989, BIOCHEM J, V262, P369, DOI 10.1042/bj2620369; HSU SH, 1976, CYTOGENET CELL GENET, V16, P382, DOI 10.1159/000130638; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOVAR H, 1990, ONCOGENE, V5, P1067; LAWLER SD, 1970, LANCET, V1, P584; LEVY R, 1979, P NATL ACAD SCI USA, V76, P6552, DOI 10.1073/pnas.76.12.6552; MALLINSON G, 1986, BIOCHEM J, V234, P649, DOI 10.1042/bj2340649; MANN JD, 1962, LANCET, V1, P8; PETTY AC, 1993, J IMMUNOL METHODS, V161, P91, DOI 10.1016/0022-1759(93)90200-Q; RACE RR, 1975, BLOOD GROUPS MAN, P578; SCHLOSSMAN SF, 1994, J IMMUNOL, V152, P1; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; SMITH MJ, 1993, HUM MOL GENET, V2, P417, DOI 10.1093/hmg/2.4.417; TIPPETT P, 1986, ANN HUM GENET, V50, P339, DOI 10.1111/j.1469-1809.1986.tb01755.x; YATES J R W, 1987, Genomics, V1, P52, DOI 10.1016/0888-7543(87)90104-2	42	55	60	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1994	8	3					285	290		10.1038/ng1194-285	http://dx.doi.org/10.1038/ng1194-285			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7533029				2022-12-25	WOS:A1994PP76500020
J	TASSABEHJI, M; NEWTON, VE; READ, AP				TASSABEHJI, M; NEWTON, VE; READ, AP			WAARDENBURG SYNDROME TYPE-2 CAUSED BY MUTATIONS IN THE HUMAN MICROPHTHALMIA (MITF) GENE	NATURE GENETICS			English	Article							MOUSE	Waardenburg syndrome type 2 (WS2) is a dominantly inherited syndrome of hearing loss and pigmentary disturbances. We recently mapped a WS2 gene to chromosome 3p12.3-p14.1 and proposed as a candidate gene MITF, the human homologue of the mouse microphthalmia (mi) gene. This encodes a putative basic-helix-loop-helix-leucine zipper transcription factor expressed in adult skin and in embryonic retina, otic vesicle and hair follicles. Mice carrying mi mutations show reduced pigmentation of the eyes and coat, and with some alleles, microphthalmia, hearing loss, osteopetrosis and mast cell defects. Here we show that affected individuals in two WS2 families have mutations affecting splice sites in the MITF gene.	ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND; UNIV MANCHESTER,CTR AUDIOL,MANCHESTER M13 9PL,LANCS,ENGLAND	University of Manchester; University of Manchester					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANAND R, 1990, NUCLEIC ACIDS RES, V18, P1951, DOI 10.1093/nar/18.8.1951; ARIAS S, 1978, J GENET HUM, V26, P101; ASHER JH, 1990, J MED GENET, V27, P618, DOI 10.1136/jmg.27.10.618; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; FARRER LA, IN PRESS AM J HUM GE; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HUGHES AE, 1994, NAT GENET, V7, P509, DOI 10.1038/ng0894-509; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lyon M., 1989, GENETIC VARIANTS STR; NAYLOR SL, 1993, CYTOGENET CELL GENET, V65, P1; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; TACHIBANA M, 1994, HUM MOL GENET, V3, P553, DOI 10.1093/hmg/3.4.553; TASSABEHJI M, 1994, HUM MOL GENET, V3, P1069, DOI 10.1093/hmg/3.7.1069; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195	15	516	553	1	27	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					251	255		10.1038/ng1194-251	http://dx.doi.org/10.1038/ng1194-251			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874167				2022-12-25	WOS:A1994PP76500014
J	GIACALONE, J; FRIEDES, J; FRANCKE, U				GIACALONE, J; FRIEDES, J; FRANCKE, U			A NOVEL GC-RICH HUMAN MACROSATELLITE VNTR IN XQ24 IS DIFFERENTIALLY METHYLATED ON ACTIVE AND INACTIVE X-CHROMOSOMES	NATURE GENETICS			English	Article							CHRONIC GRANULOMATOUS-DISEASE; DUCHENNE MUSCULAR-DYSTROPHY; REPETITIVE DNA-SEQUENCE; SATELLITE DNA; CELL HYBRIDS; HUMAN GENOME; ALU FAMILY; SHORT ARM; ORGANIZATION; MAP	A new X chromosome-specific repetitive sequence, a 3 kilobase HindIII clone with a base composition of 63% C+G, has been isolated. The sequence is organized as a hypervariable tandem repeat cluster ranging in size from 150-350 kilobases, with outlying single copies. This locus, designated DXZ4 and mapped to chromosome band Xq24, may consist of as many as 50 variable-length alleles. It represents a class of variable number of tandem repeat polymorphism which may be termed 'macrosatellite'. The cluster is highly methylated on the active X chromosome and hypomethylated on the inactive X.	STANFORD UNIV, MED CTR, SCH MED, DEPT GENET, STANFORD, CA 94305 USA; STANFORD UNIV, MED CTR, SCH MED, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA; UNIV CALIF SAN FRANCISCO, DEPT OBSTET GYNECOL & REPROD SCI, SAN FRANCISCO, CA 94143 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Francisco								BONNER TI, 1982, P NATL ACAD SCI-BIOL, V79, P4709, DOI 10.1073/pnas.79.15.4709; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BUROKER N, 1987, HUM GENET, V77, P175, DOI 10.1007/BF00272388; DEMARTINVILLE B, 1985, AM J HUM GENET, V37, P235; DEVILEE P, 1988, CANCER RES, V48, P5825; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; EDWARDS A, 1991, AM J HUM GENET, V49, P746; EPSTEIN ND, 1987, NUCLEIC ACIDS RES, V15, P2327, DOI 10.1093/nar/15.5.2327; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1981, CYTOGENET CELL GENET, V31, P24, DOI 10.1159/000131622; FRANCKE U, 1984, CYTOGENET CELL GENET, V38, P298, DOI 10.1159/000132078; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; GIACALONE J, IN PRESS AM J HUM GE; GRIFO JA, 1990, AM J OBSTET GYNECOL, V163, P2013, DOI 10.1016/0002-9378(90)90789-A; HAGELBERG E, 1991, NATURE, V352, P427, DOI 10.1038/352427a0; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; HERRMANN BG, 1987, CELL, V48, P813, DOI 10.1016/0092-8674(87)90078-X; HOUCK CM, 1979, J MOL BIOL, V132, P289, DOI 10.1016/0022-2836(79)90261-4; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; LICHTER P, 1990, PROG CLIN BIOL RES, V360, P69; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; LINDGREN V, 1985, NATURE, V314, P115, DOI 10.1038/314115a0; MAGER DL, 1984, P NATL ACAD SCI-BIOL, V81, P7510, DOI 10.1073/pnas.81.23.7510; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; MILATOVICH A, 1991, GENOMICS, V11, P1040, DOI 10.1016/0888-7543(91)90030-I; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; MULLER U, 1986, HUM GENET, V74, P24; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P2537, DOI 10.1093/nar/15.6.2537; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; PEARSON SJ, 1983, SOMAT CELL GENET, V9, P567, DOI 10.1007/BF01574259; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMID CW, 1982, SCIENCE, V216, P1065, DOI 10.1126/science.6281889; SCHMID CW, 1975, CELL, V6, P345, DOI 10.1016/0092-8674(75)90184-1; SUN L, 1984, NUCLEIC ACIDS RES, V12, P2669, DOI 10.1093/nar/12.6.2669; TYLERSMITH C, 1988, J MOL BIOL, V203, P837, DOI 10.1016/0022-2836(88)90110-6; VIEGASPEQUIGNOT E, 1988, P NATL ACAD SCI USA, V85, P7657, DOI 10.1073/pnas.85.20.7657; WAYE JS, 1989, P NATL ACAD SCI USA, V86, P6250, DOI 10.1073/pnas.86.16.6250; WEBER JL, 1989, AM J HUM GENET, V44, P388; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WILLARD HF, 1987, TRENDS GENET, V3, P192, DOI 10.1016/0168-9525(87)90232-0; YANGFENG TL, 1986, P NATL ACAD SCI USA, V83, P8679, DOI 10.1073/pnas.83.22.8679; YANGFENG TL, 1985, AM J HUM GENET, V37, P1117	46	71	73	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1992	1	2					137	143		10.1038/ng0592-137	http://dx.doi.org/10.1038/ng0592-137			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC980	1302007				2022-12-25	WOS:A1992JC98000013
J	BANERJEE, S; LIVANOS, E; VOS, JMH				BANERJEE, S; LIVANOS, E; VOS, JMH			THERAPEUTIC GENE DELIVERY IN HUMAN BETA-LYMPHOBLASTOID CELLS BY ENGINEERED NON-TRANSFORMING INFECTIOUS EPSTEIN-BARR-VIRUS	NATURE MEDICINE			English	Article							FANCONIS ANEMIA; REPLICATION; DNA	The B-lymphotrophic human herpes Epstein-Barr virus (EBV) is a 160-kilobase double-stranded DNA episomal virus carried in a persistent asymptomatic state by more than 90% of the worldwide adult population. We engineered a helper-dependent mini-EBV, with the minimal cis-EBV elements for episomal replication, viral amplification and packaging, for use as a gene delivery system. The therapeutic potential of this system was established by stably transducing B-lymphoblastoid cells from a Fanconi anaemia group C (FA-C) patient with a mini-EBV constitutively expressing the normal FACC cDNA and showing in vitro correction of the FA phenotype. In the absence of selective pressure, episomal expression persisted with a half-life of 30 days in actively growing transduced cells, indicating a retention rate of 98% expression per cell doubling. This work demonstrates the generation of an infectious non-transforming viral vector that can potentially deliver large therapeutic genes efficiently and selectively into human B cells.	UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT BIOCHEM & BIOPHYS,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051818] Funding Source: NIH RePORTER; NHLBI NIH HHS [1-POI-HL51818-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BLAESE RM, 1990, HUM GENE THER, V1, P327; BLOSS TA, 1994, J VIROL, V68, P8217, DOI 10.1128/JVI.68.12.8217-8222.1994; CHEN F, 1995, J VIROL, V69, P3752, DOI 10.1128/JVI.69.6.3752-3758.1995; COHEN JI, 1992, J VIROL, V66, P7555, DOI 10.1128/JVI.66.12.7555-7559.1992; CULVER KW, 1991, HUM GENE THER, V2, P107, DOI 10.1089/hum.1991.2.2-107; DILLON N, 1994, CURR OPIN GENET DEV, V4, P260, DOI 10.1016/S0959-437X(05)80053-X; DUNBAR CE, 1994, STEM CELLS, V12, P563, DOI 10.1002/stem.5530120604; EDVARDSMITH CI, 1994, IMMUNOL REV, V138, P159; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; FARELL PJ, 1989, ADV VIRAL ONCOL, V8, P103; HESTON L, 1982, NATURE, V295, P160, DOI 10.1038/295160a0; KELLEHER ZT, 1994, BIOTECHNIQUES, V17, P1110; KEMPKES B, 1995, P NATL ACAD SCI USA, V92, P5875, DOI 10.1073/pnas.92.13.5875; KEMPKES B, 1995, J VIROL, V69, P231, DOI 10.1128/JVI.69.1.231-238.1995; KIEFF E, 1990, VIROLOGY, P1889; KINCADE PW, 1992, FUNDAMENTAL IMMUNOLO, P41; KRAUSS JC, 1992, BIOCHIM BIOPHYS ACTA, V1114, P193, DOI 10.1016/0304-419X(92)90015-Q; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; MATSUMOTO A, 1989, MUTAT RES, V217, P185, DOI 10.1016/0921-8777(89)90070-0; MILLER G, 1990, VIROLOGY, P1921; MIYASHITA EM, 1995, CELL, V80, P593, DOI 10.1016/0092-8674(95)90513-8; MORGAN RA, 1994, ANN REV BIOCH, V62, P191; REISMAN D, 1985, MOL CELL BIOL, V5, P1822, DOI 10.1128/MCB.5.8.1822; ROBERTSON E, 1995, J VIROL, V69, P983, DOI 10.1128/JVI.69.2.983-993.1995; SPRENT J, 1994, CELL, V76, P315, DOI 10.1016/0092-8674(94)90338-7; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; STRATHDEE CA, 1992, AM J PEDIAT HEMATOL, V5, P177; SUN TQ, 1994, NAT GENET, V8, P33, DOI 10.1038/ng0994-33; SUN TQ, 1992, INT J GENOME RES, V1, P45; VOS JM, 1994, VIRUSES HUMAN GENE T, P108; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604	33	62	64	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1303	1308		10.1038/nm1295-1303	http://dx.doi.org/10.1038/nm1295-1303			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489413				2022-12-25	WOS:A1995TH78600044
J	HUANG, SH; PITTLER, SJ; HUANG, XH; OLIVEIRA, L; BERSON, EL; DRYJA, TP				HUANG, SH; PITTLER, SJ; HUANG, XH; OLIVEIRA, L; BERSON, EL; DRYJA, TP			AUTOSOMAL RECESSIVE RETINITIS-PIGMENTOSA CAUSED BY MUTATIONS IN THE ALPHA-SUBUNIT OF ROD CGMP PHOSPHODIESTERASE	NATURE GENETICS			English	Note							CYCLIC-GMP ACCUMULATION; BETA-SUBUNIT; PHOTORECEPTOR CELLS; RHODOPSIN GENE; CONE DYSPLASIA; MOUSE RETINA; DEGENERATION; CDNA; PHOTOTRANSDUCTION; IDENTIFICATION		HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,BERMAN GUND LAB STUDY RETINAL DEGENERAT,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,TAYLOR SMITH LAB,BOSTON,MA 02114; UNIV SO ALABAMA,COLL MED,DEPT BIOCHEM,MOBILE,AL 36688; UNIV SO ALABAMA,COLL MED,DEPT MOLEC BIOL,MOBILE,AL 36688; UNIV SO ALABAMA,COLL MED,DEPT OPHTHALMOL,MOBILE,AL 36688	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of South Alabama; University of South Alabama; University of South Alabama			; Pittler, Steven/J-7091-2013	Chen, Sherleen/0000-0003-1254-4171; Pittler, Steven/0000-0002-8464-9303	NEI NIH HHS [EY08683, EY00169, EY09924] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY000169, R01EY008683, R01EY009924, R37EY000169] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AGUIRRE G, 1978, SCIENCE, V201, P1133, DOI 10.1126/science.210508; BAEHR W, 1991, FEBS LETT, V278, P107, DOI 10.1016/0014-5793(91)80095-K; BAYES M, 1995, HUM MUTAT, V5, P228, DOI 10.1002/humu.1380050307; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOWES C, 1990, NATURE, V347, P877; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; CHARBONNEAU H, 1986, P NATL ACAD SCI USA, V83, P9308, DOI 10.1073/pnas.83.24.9308; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1995, P NATL ACAD SCI USA, V92, P10177, DOI 10.1073/pnas.92.22.10177; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; FARBER DB, 1976, J CYCLIC NUCL PROT, V2, P139; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LI T, 1990, P NATL ACAD SCI USA, V87, P293, DOI 10.1073/pnas.87.1.293; LIPKIN VM, 1990, J BIOL CHEM, V265, P12955; LOLLEY RN, 1977, SCIENCE, V196, P664, DOI 10.1126/science.193183; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; MEYERTHOLEN EP, 1987, J COMP PHYSIOL A, V161, P793, DOI 10.1007/BF00610221; ONG OC, 1989, P NATL ACAD SCI USA, V86, P9238, DOI 10.1073/pnas.86.23.9238; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OVCHINNIKOV YA, 1987, FEBS LETT, V223, P169, DOI 10.1016/0014-5793(87)80530-6; PITTLER SJ, 1990, GENOMICS, V6, P272, DOI 10.1016/0888-7543(90)90567-E; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; REICHEL E, 1989, AM J OPHTHALMOL, V108, P540, DOI 10.1016/0002-9394(89)90431-5; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; SUBER ML, 1993, P NATL ACAD SCI USA, V90, P3968, DOI 10.1073/pnas.90.9.3968; ULSHAFER RJ, 1980, INVEST OPHTH VIS SCI, V19, P1236; WEBER B, 1991, NUCLEIC ACIDS RES, V19, P6263, DOI 10.1093/nar/19.22.6263; YANDELL DW, 1989, CANCER CEL, V7, P223	32	205	208	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					468	471		10.1038/ng1295-468	http://dx.doi.org/10.1038/ng1295-468			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493036				2022-12-25	WOS:A1995TH62900033
J	KAARTINEN, V; VONCKEN, JW; SHULER, C; WARBURTON, D; BU, D; HEISTERKAMP, N; GROFFEN, J				KAARTINEN, V; VONCKEN, JW; SHULER, C; WARBURTON, D; BU, D; HEISTERKAMP, N; GROFFEN, J			ABNORMAL LUNG DEVELOPMENT AND CLEFT-PALATE IN MICE LACKING TGF-BETA-3 INDICATES DEFECTS OF EPITHELIAL-MESENCHYMAL INTERACTION	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; DIFFERENTIAL EXPRESSION; IMMUNOHISTOCHEMICAL LOCALIZATION; ADULT TISSUES; TGF BETA-1; CELL DEATH; MOUSE; GENES; TRANSFORMATION; EMBRYOGENESIS	A broad spectrum of biological activities has been proposed for transforming growth factor-beta 3 (TGF-beta 3). To study TGF-beta 3 function in development, TGF-beta 3 null mutant mice were generated by gene-targeting. Within 20 hours of birth, homozygous TGF-beta 3 -/- mice die with unique and consistent phenotypic features including delayed pulmonary development and defective palatogenesis. Unlike other null mutants with cleft palate, TGF-beta 3 -/- mice lack other concomitant craniofacial abnormalities. This study demonstrates an essential function for TGF-beta 3 in the normal morphogenesis of palate and lung, and directly implicates this cytokine in mechanisms of epithelial-mesenchymal interaction.	CHILDRENS HOSP LOS ANGELES,RES INST,DEPT SURG & PEDIAT 3,LOS ANGELES,CA 90027; UNIV SO CALIF,SCH DENT,CTR CRANIOFACIAL MOLEC BIOL,LOS ANGELES,CA 90033	Children's Hospital Los Angeles; University of Southern California	KAARTINEN, V (corresponding author), CHILDRENS HOSP LOS ANGELES,RES INST,DEPT PATHOL,4650 SUNSET BLVD,LOS ANGELES,CA 90027, USA.		Heisterkamp, Nora/C-1698-2012; Kaartinen, Vesa/AAU-5396-2021; Warburton, David/AAD-5709-2020	Heisterkamp, Nora/0000-0003-2769-2273; Kaartinen, Vesa/0000-0002-9432-510X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044060, R01HL044977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE009165] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL44060, HL44977] Funding Source: Medline; NIDCR NIH HHS [P50 DE-09165] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABBOTT BD, 1994, TOXICOL APPL PHARM, V126, P16, DOI 10.1006/taap.1994.1085; ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; CARETTE MJM, 1992, DEVELOPMENT, V114, P379; COUTURE LA, 1990, TERATOLOGY, V42, P619, DOI 10.1002/tera.1420420606; DENHOLM EM, 1993, AM J PHYSIOL, V264, pL36, DOI 10.1152/ajplung.1993.264.1.L36; DERYNCK R, 1988, EMBO J, V7, P3737, DOI 10.1002/j.1460-2075.1988.tb03257.x; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FITCHETT JE, 1989, DEV BIOL, V131, P455, DOI 10.1016/S0012-1606(89)80017-X; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; GREENE RM, 1989, CRIT REV TOXICOL, V20, P137, DOI 10.3109/10408448909017907; HUDSON CD, 1973, ARCH ORAL BIOL, V18, P77, DOI 10.1016/0003-9969(73)90022-8; JETTEN AM, 1990, AM REV RESPIR DIS, V142, pS36, DOI 10.1164/ajrccm/142.6_Pt_2.S36; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; MATZUK MM, 1994, NATURE, V374, P354; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; MILLAN FA, 1991, DEVELOPMENT, V111, P131; MILLER DA, 1990, ANN NY ACAD SCI, V593, P208, DOI 10.1111/j.1749-6632.1990.tb16113.x; MILLER DA, 1989, MOL ENDOCRINOL, V3, P1926, DOI 10.1210/mend-3-12-1926; MINOO P, 1994, ANNU REV PHYSIOL, V56, P13; MUGLIA L, 1995, NATURE, V373, P427, DOI 10.1038/373427a0; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Papaioannou V., 1993, Gene targeting: a practical approach., P107; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; PELTON RW, 1990, DEV BIOL, V141, P456, DOI 10.1016/0012-1606(90)90401-4; POTTS JD, 1991, P NATL ACAD SCI USA, V88, P1516, DOI 10.1073/pnas.88.4.1516; POURTOIS M, 1966, J EMBRYOL EXP MORPH, V16, P171; PRATT RM, 1975, P NATL ACAD SCI USA, V72, P874, DOI 10.1073/pnas.72.3.874; PRATT RM, 1984, TERATOGEN CARCIN MUT, V4, P427, DOI 10.1002/tcm.1770040505; PRATT RM, 1976, DEV BIOL, V54, P135, DOI 10.1016/0012-1606(76)90292-X; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Roberts A.B., 1990, HDB EXPT PHARM PEPTI, V95, P419; ROBERTS AB, 1992, MOL REPROD DEV, V32, P91, DOI 10.1002/mrd.1080320203; SATOKATA I, 1995, NAT GENET, V6, P348; SCHMID P, 1991, DEVELOPMENT, V111, P117; SERRA R, 1994, DEVELOPMENT, V120, P2153; SHANNON JM, 1994, DEV BIOL, V166, P600, DOI 10.1006/dbio.1994.1340; SHAPIRO BL, 1969, J DENT RES, V48, P652, DOI 10.1177/00220345690480050801; SHARPE PM, 1980, J CELL SCI, V10, P195; SHULER C F, 1991, International Journal of Developmental Biology, V35, P463; SHULER CF, 1992, DEV BIOL, V154, P318, DOI 10.1016/0012-1606(92)90071-N; SMITH BT, 1991, TISSUE INTERACTIONS, V1, P671; TENDIJKE P, 1988, P NATL ACAD SCI USA, V85, P4715; VONCKEN JW, 1995, CELL, V80, P719, DOI 10.1016/0092-8674(95)90350-X; VORBROKER DK, 1995, AM J PHYSIOL-LUNG C, V268, pL647, DOI 10.1152/ajplung.1995.268.4.L647; WANG JX, 1995, J BIOL CHEM, V270, P2722, DOI 10.1074/jbc.270.36.21326; WARBURTON D, 1992, DEV BIOL, V149, P123, DOI 10.1016/0012-1606(92)90269-M; WURST W, 1993, GENE TARGETING PRACT, P31; 1981, AM J OBSTET GYNECOL, V141, P276	54	847	881	0	15	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					415	421		10.1038/ng1295-415	http://dx.doi.org/10.1038/ng1295-415			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493022				2022-12-25	WOS:A1995TH62900019
J	RAMALINGASWAMI, V				RAMALINGASWAMI, V			PLAGUE IN INDIA	NATURE MEDICINE			English	Editorial Material											RAMALINGASWAMI, V (corresponding author), ALL INDIA INST MED SCI,DEPT PATHOL,NEW DELHI 110029,INDIA.								0	19	23	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	DEC	1995	1	12					1237	1239		10.1038/nm1295-1237	http://dx.doi.org/10.1038/nm1295-1237			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489395				2022-12-25	WOS:A1995TH78600026
J	HILLEMAN, MR				HILLEMAN, MR			WHETHER AND WHEN AN AIDS VACCINE	NATURE MEDICINE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS INFECTION				HILLEMAN, MR (corresponding author), MERCK SHARP & DOHME RES LABS,THERAPEUT RES INST,WP26-331,W POINT,PA 19486, USA.							BABA TW, 1995, SCIENCE, V427, P1820; CLERICI M, 1993, IMMUNOL TODAY, V114, P107; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; DONNELLY JJ, 1995, NAT MED, V1, P583, DOI 10.1038/nm0695-583; ENNEN J, 1994, P NATL ACAD SCI USA, V91, P7207, DOI 10.1073/pnas.91.15.7207; FIELDS BN, 1994, NATURE, V369, P95, DOI 10.1038/369095a0; GRIFFIN DE, 1994, J INFECT DIS, V170, pS24, DOI 10.1093/infdis/170.Supplement_1.S24; HILLEMAN MR, 1994, AIDS RES HUM RETROV, V10, P1409, DOI 10.1089/aid.1994.10.1409; HILLEMAN MR, 1992, VACCINE, V10, P1053, DOI 10.1016/0264-410X(92)90115-Z; HILLEMAN MR, 1994, AIDS RES HUM RETROV, V10, P3, DOI 10.1089/aid.1994.10.3; HILLEMAN MR, IN PRESS VACCINE; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Kurth Reinhard, 1993, P39; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; MOSMANN TR, 1994, SCIENCE, V265, P193, DOI 10.1126/science.8023139; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; PAUL WE, 1995, SCIENCE, V267, P633, DOI 10.1126/science.7839138; RIMMELZWAAN GF, 1995, VACCINE, V13, P703; SIMONMOFFAT A, 1995, SCIENCE, V268, P658; 1995, AIDS, V9, pWHO1	20	12	12	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1126	1129		10.1038/nm1195-1126	http://dx.doi.org/10.1038/nm1195-1126			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584976	Bronze			2022-12-25	WOS:A1995TC53700028
J	ORAVECZ, T; RODERIQUEZ, G; KOFFI, J; WANG, JH; DITTO, M; BOUHABIB, DC; LUSSO, P; NORCROSS, MA				ORAVECZ, T; RODERIQUEZ, G; KOFFI, J; WANG, JH; DITTO, M; BOUHABIB, DC; LUSSO, P; NORCROSS, MA			CD26 EXPRESSION CORRELATES WITH ENTRY, REPLICATION AND CYTOPATHICITY OF MONOCYTOTROPIC HIV-1 STRAINS IN A T-CELL LINE	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DIPEPTIDYL PEPTIDASE-IV; ACTIVATION ANTIGEN; BIOLOGICAL PHENOTYPE; AIDS VIRUS; HTLV-III; INFECTION; SURFACE; CD4; INDIVIDUALS	Experiments to identify cell determinants involved in HIV-1 tropism revealed a specific decrease in the expression of the T-cell activation antigen CD26 after monocytotropic (M-tropic) but not T-cell line-tropic (T-tropic) virus infection of the PM1 T-cell line. The level of CD26 expression in single-cell clones of PM1 correlated with the entry rate and cytopathicity of M-tropic HIV-1 variants, resulting in preferential survival of cells with low CD26 levels after infection. Experiments with recombinant viruses showed that the third hypervariable region of the envelope gp120 plays an important role in this selection process. This study identifies CD26 as a key marker for M-tropic human immunodeficiency virus type 1 (HIV-1) infection and suggests a mechanism for the early loss of CD26-expressing cells in HIV-1-infected individuals.	NIH,FOOD & DRUG ADM,CTR BIOL EVALUAT & RES,DIV HEMATOL PROD,BETHESDA,MD 20892; UNIV MILAN,OSPED L SACCO,INST MALATTIE INFETT,I-20132 MILAN,ITALY	National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA); University of Milan; Luigi Sacco Hospital				Bou-Habib, Dumith/0000-0003-0552-9045				ANSORGE S, 1987, ADV BIOSCI, P3; BEDNARCZYK JL, 1991, J CELL BIOCHEM, V46, P206, DOI 10.1002/jcb.240460304; BLAZQUEZ MV, 1992, J IMMUNOL, V149, P3073; BOUHABIB DC, 1994, J VIROL, V68, P6006, DOI 10.1128/JVI.68.9.6006-6013.1994; BRODER CC, 1994, SCIENCE, V264, P1156, DOI 10.1126/science.7909959; CALLEBAUT C, 1993, SCIENCE, V262, P2045, DOI 10.1126/science.7903479; CALLEBAUT C, 1994, SCIENCE, V264, P1162, DOI 10.1126/science.264.5162.1162; CANN AJ, 1992, J VIROL, V66, P305, DOI 10.1128/JVI.66.1.305-309.1992; CANN AJ, 1990, J VIROL, V64, P4735, DOI 10.1128/JVI.64.10.4735-4742.1990; CHENGMAYER C, 1990, J VIROL, V64, P4390, DOI 10.1128/JVI.64.9.4390-4398.1990; CLEMENTS GJ, 1991, AIDS RES HUM RETROV, V7, P3, DOI 10.1089/aid.1991.7.3; CLERICI M, 1993, SCIENCE, V262, P1721, DOI 10.1126/science.7903123; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; DRAGIC T, 1992, J VIROL, V66, P4794, DOI 10.1128/JVI.66.8.4794-4802.1992; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GRUTERS RA, 1991, AIDS, V5, P837, DOI 10.1097/00002030-199107000-00007; GUTHEIL WG, 1994, P NATL ACAD SCI USA, V91, P6594, DOI 10.1073/pnas.91.14.6594; HAFLER DA, 1986, J IMMUNOL, V137, P414; HILDRETH JEK, 1989, SCIENCE, V244, P1075, DOI 10.1126/science.2543075; HOXIE JA, 1986, SCIENCE, V234, P1123, DOI 10.1126/science.3095925; KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391; KIDO H, 1990, J BIOL CHEM, V265, P21979; KOOT M, 1992, AIDS, V6, P49, DOI 10.1097/00002030-199201000-00006; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; LAZARO I, 1994, J VIROL, V68, P6535, DOI 10.1128/JVI.68.10.6535-6546.1994; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; Maniatis T., 1982, MOL CLONING; MEERLOO T, 1992, AIDS, V6, P1105, DOI 10.1097/00002030-199210000-00007; MORIMOTO C, 1994, P NATL ACAD SCI USA, V91, P9960, DOI 10.1073/pnas.91.21.9960; ORAVECZ T, 1991, SCAND J IMMUNOL, V34, P531, DOI 10.1111/j.1365-3083.1991.tb01576.x; ORAVECZ T, 1994, IMMUNOL LETT, V40, P7, DOI 10.1016/0165-2478(94)90198-8; ORAVECZ T, 1993, AIDS RES HUM RETROV, V9, P945, DOI 10.1089/aid.1993.9.945; PATEL M, 1993, AIDS RES HUM RETROV, V9, P167, DOI 10.1089/aid.1993.9.167; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RODERIQUEZ G, 1995, J VIROL, V69, P2233, DOI 10.1128/JVI.69.4.2233-2239.1995; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; SERPENTE N, 1993, INT IMMUNOL, V5, P939, DOI 10.1093/intimm/5.8.939; SKINNER MA, 1988, J VIROL, V62, P4195, DOI 10.1128/JVI.62.11.4195-4200.1988; TANAKA T, 1992, J IMMUNOL, V149, P481; TORIMOTO Y, 1991, J IMMUNOL, V147, P2514; VANHAM G, 1993, J ACQ IMMUN DEF SYND, V6, P749; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	45	61	62	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	SEP	1995	1	9					919	926		10.1038/nm0995-919	http://dx.doi.org/10.1038/nm0995-919			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585218				2022-12-25	WOS:A1995RT30300046
J	PASZTY, C; MOHANDAS, N; STEVENS, ME; LORING, JF; LIEBHABER, SA; BRION, CM; RUBIN, EM				PASZTY, C; MOHANDAS, N; STEVENS, ME; LORING, JF; LIEBHABER, SA; BRION, CM; RUBIN, EM			LETHAL ALPHA-THALASSEMIA CREATED BY GENE TARGETING IN MICE AND ITS GENETIC RESCUE	NATURE GENETICS			English	Article							HUMAN BETA-S; TRANSGENIC MOUSE MODEL; LONG-TERM SURVIVAL; GLOBIN GENES; HOMOZYGOUS ALPHA-THALASSEMIA-1; INTERVENING SEQUENCES; HIGH EXPRESSION; HEMOGLOBIN; POLYMERIZATION; PROTOONCOGENE	Mutations at the alpha-globin locus are the most common class of mutations in humans, with deletion of all four adult alpha-globin genes resulting in the perinatal lethal condition haemoglobin Bart's hydrops fetalis. Using gene targeting in mice, we have deleted a 16 kilobase region encompassing both adult alpha-globin genes. Animals homozygous for this deletion become hydropic and die late in gestation mimicking humans with hydrops fetalis. Introduction of a human alpha-globin transgene rescued these animals from perinatal death thus demonstrating the utility of this murine model in the development of cellular and gene based approaches for treating this human genetic disease.	UNIV CALIF BERKELEY,LAWRENCE BERKELEY LAB,CTR HUMAN GENOME,BERKELEY,CA 94720; GENPHARM INT,MT VIEW,CA 94043; UNIV PENN,SCH MED,HOWARD HUGHES MED INST,PHILADELPHIA,PA 19104	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Pennsylvania			Loring, Jeanne F/A-1620-2011	Loring, Jeanne F/0000-0001-6226-9767				ALBITAR M, 1991, MOL CELL BIOL, V11, P3786, DOI 10.1128/MCB.11.7.3786; BEAUDRY MA, 1986, J PEDIATR-US, V108, P713, DOI 10.1016/S0022-3476(86)81048-4; BEHRINGER RR, 1989, SCIENCE, V245, P971, DOI 10.1126/science.2772649; BIANCHI DW, 1986, J PEDIATR-US, V108, P716, DOI 10.1016/S0022-3476(86)81049-6; BRADLEY A, 1984, NATURE, V330, P255; CRAIG ML, 1964, DEV BIOL, V10, P191, DOI 10.1016/0012-1606(64)90040-5; CRAIG ML, 1967, DEV BIOL, V16, P331, DOI 10.1016/0012-1606(67)90046-2; FABRY ME, 1992, P NATL ACAD SCI USA, V89, P12150, DOI 10.1073/pnas.89.24.12150; FABRY ME, 1992, P NATL ACAD SCI USA, V89, P12155, DOI 10.1073/pnas.89.24.12155; FANTONI A, 1967, SCIENCE, V157, P1327, DOI 10.1126/science.157.3794.1327; GREAVES DR, 1990, NATURE, V343, P183, DOI 10.1038/343183a0; HIGGS DR, 1989, BLOOD, V73, P1081; LAM TK, 1992, ACTA HAEMATOL-BASEL, V88, P198; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LEDER A, 1981, NATURE, V293, P196, DOI 10.1038/293196a0; LIEBHABER SA, 1989, HEMOGLOBIN, V13, P685, DOI 10.3109/03630268908998845; Livingstone F. B., 1985, FREQUENCIES HEMOGLOB; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; NISHIOKA Y, 1980, P NATL ACAD SCI-BIOL, V77, P2806, DOI 10.1073/pnas.77.5.2806; POPP RA, 1980, DIFFERENTIATION, V17, P205, DOI 10.1111/j.1432-0436.1980.tb01098.x; RHODA MD, 1988, BIOCHIM BIOPHYS ACTA, V952, P208, DOI 10.1016/0167-4838(88)90117-3; ROY RP, 1993, J BIOL CHEM, V268, P16406; RUBIN EM, 1991, J CLIN INVEST, V87, P639, DOI 10.1172/JCI115041; RUSSELL LB, 1976, P NATL ACAD SCI USA, V73, P2843, DOI 10.1073/pnas.73.8.2843; RYAN TM, 1990, SCIENCE, V247, P566, DOI 10.1126/science.2154033; SMITH RD, 1990, ANAL CHEM, V62, P882, DOI 10.1021/ac00208a002; TALBOT D, 1989, NATURE, V338, P352, DOI 10.1038/338352a0; TANPHAICLTR VS, 1988, THALASSEMIA PATHOP A, P15; TRUDEL M, 1994, BLOOD, V84, P3189; TRUDEL M, 1991, EMBO J, V10, P3157, DOI 10.1002/j.1460-2075.1991.tb04877.x; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANIN EF, 1980, NATURE, V286, P222, DOI 10.1038/286222a0; WHITNEY JB, 1985, P NATL ACAD SCI USA, V82, P7646, DOI 10.1073/pnas.82.22.7646; WHITNEY JB, 1980, P NATL ACAD SCI-BIOL, V77, P1087, DOI 10.1073/pnas.77.2.1087	35	62	63	0	5	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	SEP	1995	11	1					33	39		10.1038/ng0995-33	http://dx.doi.org/10.1038/ng0995-33			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR728	7550311				2022-12-25	WOS:A1995RR72800012
J	JINNO, Y; IKEDA, Y; YUN, K; MAW, M; MASUZAKI, H; FUKUDA, H; INUZUKA, K; FUJISHITA, A; OHTANI, Y; OKIMOTO, T; ISHIMARU, TS; NIIKAWA, N				JINNO, Y; IKEDA, Y; YUN, K; MAW, M; MASUZAKI, H; FUKUDA, H; INUZUKA, K; FUJISHITA, A; OHTANI, Y; OKIMOTO, T; ISHIMARU, TS; NIIKAWA, N			ESTABLISHMENT OF FUNCTIONAL IMPRINTING OF THE H19 GENE IN HUMAN DEVELOPING PLACENTAE	NATURE GENETICS			English	Article							GROWTH-FACTOR-II; WILMS-TUMOR; MOUSE; METHYLATION; RELAXATION; H19-GENE; RNA	We have found that the imprinted H19 gene can be expressed either biallelically or monoallelically in the developing human placentae. H19 biallelic expression is confined to the placenta until 10 weeks of gestation, after which it becomes exclusively maternal, and does not affect allele-specificity or levels of IGF2 expression. The promoter region of H19 is hypomethylated at all stages of placental development, while the 3' portion shows progressive methylation of the paternal allele with gestation. Our observations demonstrate that the establishment of functional H19 imprinting occurs during the early development of the placenta and provide and opportunity to understand the mechanism by which the H19 primary imprint is manifested in somatic cells.	NAGASAKI UNIV,SCH MED,DEPT OBSTET & GYNECOL,NAGASAKI 852,JAPAN; UNIV OTAGO,SCH MED,DEPT PATHOL,DUNEDIN,NEW ZEALAND; UNIV OTAGO,DEPT BIOCHEM,DUNEDIN,NEW ZEALAND; KUMAMOTO UNIV,SCH MED,DEPT CHILD DEV,KUMAMOTO 860,JAPAN; NAGASAKI UNIV,SCH MED,DEPT PATHOL 1,NAGASAKI 852,JAPAN	Nagasaki University; University of Otago; University of Otago; Kumamoto University; Nagasaki University	JINNO, Y (corresponding author), NAGASAKI UNIV,SCH MED,DEPT HUMAN GENET,NAGASAKI 852,JAPAN.							BARLOW DP, 1994, TRENDS GENET, V10, P194, DOI 10.1016/0168-9525(94)90255-0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; CATTANACH BM, 1990, DEVELOPMENT, P63; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; EKSTROM TJ, 1995, DEVELOPMENT, V121, P309; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; JINNO Y, 1988, NUCLEIC ACIDS RES, V16, P4957, DOI 10.1093/nar/16.11.4957; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; MUTTER GL, 1993, AM J HUM GENET, V53, P1096; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; OGAWA O, 1993, NAT GENET, V5, P408, DOI 10.1038/ng1293-408; OHLSSON R, 1994, DEVELOPMENT, V120, P361; POIRIER F, 1991, DEVELOPMENT, V113, P1105; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; TADOKORO K, 1991, NUCLEIC ACIDS RES, V19, P6967, DOI 10.1093/nar/19.24.6967; TANIGUCHI T, 1995, P NATL ACAD SCI USA, V92, P2159, DOI 10.1073/pnas.92.6.2159; WALSH C, 1995, CANCER RES, V55, P1111; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; YOOWARREN H, 1988, MOL CELL BIOL, V8, P4707, DOI 10.1128/MCB.8.11.4707; YUN K, 1993, LAB INVEST, V69, P603; ZHANG YH, 1993, AM J HUM GENET, V53, P113; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	32	96	98	0	3	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUL	1995	10	3					318	324		10.1038/ng0795-318	http://dx.doi.org/10.1038/ng0795-318			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RG386	7670470				2022-12-25	WOS:A1995RG38600016
J	HOGERVORST, FBL; CORNELIS, RS; BOUT, M; VANVLIET, M; OOSTERWIJK, JC; OLMER, R; BAKKER, B; KLIJN, JGM; VASEN, HFA; MEIJERSHEIJBOER, H; MENKO, FH; CORNELISSE, CJ; DENDUNNEN, JT; DEVILEE, P; VANOMMEN, GJB				HOGERVORST, FBL; CORNELIS, RS; BOUT, M; VANVLIET, M; OOSTERWIJK, JC; OLMER, R; BAKKER, B; KLIJN, JGM; VASEN, HFA; MEIJERSHEIJBOER, H; MENKO, FH; CORNELISSE, CJ; DENDUNNEN, JT; DEVILEE, P; VANOMMEN, GJB			RAPID DETECTION OF BRCA1 MUTATIONS BY THE PROTEIN TRUNCATION TEST	NATURE GENETICS			English	Article							FAMILIAL BREAST; LINKAGE; CANCER	More than 75% of the reported mutations in the hereditary breast and ovarian cancer gene, BRCA1, result in truncated proteins, We have used the protein truncation test (PTT) to screen for mutations in exon 11, which encodes 61% of BRCA1. In 45 patients from breast and/or ovarian cancer families we found six novel mutations: two single nucleotide insertions, three small deletions (1-5 bp) and a nonsense mutation identified two unrelated families, Furthermore, we were able to amplify the remaining coding region by RT-PCR using lymphocyte RNA. Combined with PTT, we detected aberrantly spliced products affecting exons 5 and 6 in one of two BRCA1-linked families examined. The protein truncation test promises to become a valuable technique in detecting BRCA1 mutations.	LEIDEN UNIV,DEPT PATHOL,2333 AL LEIDEN,NETHERLANDS; UNIV LEIDEN HOSP,DEPT CLIN GENET,2333 AA LEIDEN,NETHERLANDS; FDN DETECT HEREDITARY TUMOURS,2333 AA LEIDEN,NETHERLANDS; DANIEL DEN HOED HOSP,3075 EA ROTTERDAM,NETHERLANDS; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,3015 GE ROTTERDAM,NETHERLANDS; FREE UNIV AMSTERDAM HOSP,DEPT CLIN GENET,1081 HV AMSTERDAM,NETHERLANDS	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Erasmus University Rotterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	HOGERVORST, FBL (corresponding author), LEIDEN UNIV,DEPT HUMAN GENET,MGC,WASSENAARSEWEG 72,2333 AL LEIDEN,NETHERLANDS.		DEVILEE, PETER/ABR-2140-2022; dunnen, johan den/ABH-4228-2020; Oosterwijk, Jan C./G-5770-2011; Bakker, Egbert/D-3525-2009	dunnen, johan den/0000-0002-6304-1710; Bakker, Egbert/0000-0002-2843-7357; Vasen, Hans/0000-0003-2682-2603				CASTILLA, 1994, NAT GENET, V8, P387; CORNELIS RS, IN PRESS HUM GENET, V119; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; LYNCH HT, 1989, GENETIC EPIDEMIOLOGY, P289; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NAROD SA, 1995, AM J HUM GENET, V56, P254; NOWAK R, 1994, SCIENCE, V266, P1470, DOI 10.1126/science.7985008; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; ROBERTS RG, 1991, AM J HUM GENET, V49, P298; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; VANDERLUIJT R, 1994, GENOMICS, V20, P1, DOI 10.1006/geno.1994.1119; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	19	280	302	1	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					208	212		10.1038/ng0695-208	http://dx.doi.org/10.1038/ng0695-208			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7663517	Green Published			2022-12-25	WOS:A1995RA85700019
J	VANOMMEN, GJ				VANOMMEN, GJ			A FOUNDATION FOR LIMB-GIRDLE MUSCULAR-DYSTROPHY	NATURE MEDICINE			English	Editorial Material							GENETIC-HETEROGENEITY; MOLECULAR-CLONING; LINKAGE; CALPAIN; CHROMOSOME-15; CONFIRMATION; AUTOLYSIS; SUBUNIT; MUSCLE	Recent work suggests that the molecular basis for one form of limb-girdle muscular dystrophy is neither a single gene nor many genes: Enter the digenic model.			VANOMMEN, GJ (corresponding author), LEIDEN UNIV, DEPT HUMAN GENET, 2300 RA LEIDEN, NETHERLANDS.							ALLAMAND V, IN PRESS AM J HUM GE; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; Bushby K.M.D., 1994, DIAGNOSTIC CRITERIA, P25; BUSHBY KMD, IN PRESS NEUROMUSC D; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; FOUGEROUSSE F, 1994, HUM MOL GENET, V3, P285, DOI 10.1093/hmg/3.2.285; HIRAI S, 1991, FEBS LETT, V287, P57, DOI 10.1016/0014-5793(91)80015-U; IMAJOH S, 1986, J BIOCHEM-TOKYO, V100, P633, DOI 10.1093/oxfordjournals.jbchem.a121755; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; PASSOSBUENO MR, 1993, J MED GENET, V30, P385, DOI 10.1136/jmg.30.5.385; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SAKIHAMA T, 1985, P NATL ACAD SCI USA, V82, P6075, DOI 10.1073/pnas.82.18.6075; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; SPEER MC, 1992, AM J HUM GENET, V50, P1211; YOUNG K, 1992, GENOMICS, V13, P1370, DOI 10.1016/0888-7543(92)90074-3	18	16	16	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	1995	1	5					412	414						3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585084				2022-12-25	WOS:A1995RN10000027
J	LYNCH, HT; MARCUS, JN				LYNCH, HT; MARCUS, JN			GENETICS AND ENVIRONMENT IN HODGKINS-DISEASE	NATURE MEDICINE			English	Editorial Material							NONPOLYPOSIS COLORECTAL-CANCER; COLON-CANCER; LOCUS; CHROMOSOME-5Q21; MUTATIONS; HOMOLOG; FAMILY; GENES; FAP		ST LUKES HOSP,DEPT PATHOL,ST LOUIS,MO 63017	Saint Luke's Hospital - Missouri	LYNCH, HT (corresponding author), CREIGHTON UNIV,SCH MED,DEPT PREVENT MED,OMAHA,NE 68178, USA.							Anderson Robert J., 1993, Current Opinion in Oncology, V5, P75; BJERRUM OW, 1986, SCAND J HAEMATOL, V46, P398; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; BUEHLER SK, 1975, LANCET, V1, P195; CIMINO G, 1988, EUR J CANCER CLIN ON, V24, P1595, DOI 10.1016/0277-5379(88)90051-X; CREAGAN ET, 1972, LANCET, V2, P547; DONHUIJSENANT R, 1988, ANN INTERN MED, V109, P946, DOI 10.7326/0003-4819-109-12-946; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FRAUMENI JF, 1974, CANCER RES, V34, P1164; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; LYNCH HT, 1989, BRIT J CANCER, V59, P622, DOI 10.1038/bjc.1989.126; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; LYNCH HT, 1990, BREAST COMPREHENSIVE, P262; MACK TM, 1995, NEW ENGL J MED, V332, P413, DOI 10.1056/NEJM199502163320701; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAKAMURA Y, 1988, AM J HUM GENET, V43, P638; NAROD SA, 1991, LANCET, V338, P82; NICOLAIDES NC, 1994, NATURE, V271, P75; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; PAPADOPOULOS N, 1994, SCIENCE, V262, P1625; PYRIESLER A, 1926, VIRCHOWS ARCH PATH A, V262, P749; SALIMONU LS, 1980, INT ARCH ALLER A IMM, V63, P52, DOI 10.1159/000232609	24	2	2	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	APR	1995	1	4					298	300		10.1038/nm0495-298	http://dx.doi.org/10.1038/nm0495-298			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN098	7585054				2022-12-25	WOS:A1995RN09800020
J	ARIEL, M; ROBINSON, E; MCCARREY, JR; CEDAR, H				ARIEL, M; ROBINSON, E; MCCARREY, JR; CEDAR, H			GAMETE-SPECIFIC METHYLATION CORRELATES WITH IMPRINTING OF THE MURINE XIST GENE	NATURE GENETICS			English	Article							X-CHROMOSOME INACTIVATION; DNA METHYLATION; MOUSE EMBRYO; GERM-CELLS; EXPRESSION	We have investigated the potential role of DNA methylation as a regulator of imprinted Xist expression in mouse preimplantation embryos. The active paternal allele was found to be unmodified in sperm at CpG loci near the 5' end of the gene transcription unit. In contrast, on the inactive maternal allele, these same sites are initially methylated in the oocyte and then remain modified in the early embryo. In the male germ line, these methyl moieties are removed during spermatogenesis, and this occurs before the programmed reactivation of Xist in the testis. This represents a clear-cut example of a potential methylation imprinting signal that is reprogrammable and gamete derived.	SW FDN BIOMED RES,DEPT GENET,SAN ANTONIO,TX 78228	Texas Biomedical Research Institute	ARIEL, M (corresponding author), HEBREW UNIV JERUSALEM,SCH MED,DEPT CELLULAR BIOCHEM,IL-91010 JERUSALEM,ISRAEL.							ARIEL M, 1994, NAT GENET, V7, P59, DOI 10.1038/ng0594-59; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; KRATZER PG, 1981, P NATL ACAD SCI-BIOL, V78, P3093, DOI 10.1073/pnas.78.5.3093; KUNIEDA T, 1992, BIOL REPROD, V46, P692, DOI 10.1095/biolreprod46.4.692; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MCCARREY JR, 1992, NAT GENET, V2, P200, DOI 10.1038/ng1192-200; MCMAHON A, 1981, J EMBRYOL EXP MORPH, V64, P251; MONK M, 1987, DEVELOPMENT, V99, P371; NORRIS DP, 1991, MAMM GENOME, V1, P78, DOI 10.1007/BF02443782; NORRIS DP, 1994, CELL, V77, P41, DOI 10.1016/0092-8674(94)90233-X; RAZIN A, 1994, CELL, V77, P473, DOI 10.1016/0092-8674(94)90208-9; RICHLER C, 1992, NAT GENET, V2, P192, DOI 10.1038/ng1192-192; RIGGS AD, 1992, TRENDS GENET, V8, P169, DOI 10.1016/0168-9525(92)90219-T; SALIDO EC, 1992, NAT GENET, V2, P196, DOI 10.1038/ng1192-196; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R	23	98	100	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					312	315		10.1038/ng0395-312	http://dx.doi.org/10.1038/ng0395-312			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773295				2022-12-25	WOS:A1995QL23200023
J	TAVORMINA, PL; SHIANG, R; THOMPSON, LM; ZHU, YZ; WILKIN, DJ; LACHMAN, RS; WILCOX, WR; RIMOIN, DL; COHN, DH; WASMUTH, JJ				TAVORMINA, PL; SHIANG, R; THOMPSON, LM; ZHU, YZ; WILKIN, DJ; LACHMAN, RS; WILCOX, WR; RIMOIN, DL; COHN, DH; WASMUTH, JJ			THANATOPHORIC DYSPLASIA (TYPE-I AND TYPE-II) CAUSED BY DISTINCT MUTATIONS IN FIBROBLAST GROWTH-FACTOR RECEPTOR-3	NATURE GENETICS			English	Article							SKELETAL DYSPLASIAS; SIGNAL TRANSDUCTION; EXPRESSION PATTERN; PRENATAL-DIAGNOSIS; MONOZYGOTIC TWINS; CLOVERLEAF SKULL; ABNORMALITIES; DWARFISM; FAMILY; GENE	Thanatophoric dysplasia (TD), the most common neonatal lethal skeletal dysplasia, affects one out of 20,000 live births. Affected individuals display features similar to those seen in homozygous achondroplasia. Mutations causing achondroplasia are in FGFR3, suggesting that mutations in this gene may cause TD. A sporadic mutation causing a Lys650Glu change in the tyrosine kinase domain of FGFR3 was found in 16 of 16 individuals with one type of TD. Of 39 individuals with a second type of TD, 22 had a mutation causing an Arg248Cys change and one had a Ser371Cys substitution, both in the extracellular region of the protein. None of these mutations were found in 50 controls showing that mutations affecting different functional domains of FGFR3 cause different forms of this lethal disorder.	UNIV CALIF IRVINE, DEPT BIOL CHEM, IRVINE, CA 92717 USA; UNIV CALIF IRVINE, HUMAN GENOME RES CTR, IRVINE, CA 92717 USA; UNIV CALIF LOS ANGELES, SCH MED, DEPT PEDIAT, LOS ANGELES, CA 90048 USA; UNIV CALIF LOS ANGELES, SCH MED, CEDARS SINAI RES INST, LOS ANGELES, CA 90048 USA	University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025631] Funding Source: NIH RePORTER; NICHD NIH HHS [HD22657] Funding Source: Medline; NINDS NIH HHS [NS25631] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; CORSELLO G, 1992, AM J MED GENET, V42, P122, DOI 10.1002/ajmg.1320420125; COULTER CL, 1991, CHILD NERV SYST, V7, P21, DOI 10.1007/BF00263828; DIONNE CA, 1990, EMBO J, V9, P2685, DOI 10.1002/j.1460-2075.1990.tb07454.x; ESCOBAR LF, 1993, AM J MED GENET, V45, P25, DOI 10.1002/ajmg.1320450109; HECHT JT, 1987, AM J HUM GENET, V41, P454; HORTON WA, 1983, AM J MED GENET, V15, P97, DOI 10.1002/ajmg.1320150113; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; JOHNSON DE, 1990, MOL CELL BIOL, V10, P4728, DOI 10.1128/MCB.10.9.4728; KAUFMAN RL, 1970, AM J DIS CHILD, V120, P53, DOI 10.1001/archpedi.1970.02100060087013; KEEGAN K, 1991, P NATL ACAD SCI USA, V88, P1095, DOI 10.1073/pnas.88.4.1095; KNISELY AS, 1988, PEDIATR NEUROSCI, V14, P169, DOI 10.1159/000120384; Langer L O Jr, 1987, Am J Med Genet Suppl, V3, P167; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; MACDONALD IM, 1989, AM J MED GENET, V33, P508, DOI 10.1002/ajmg.1320330420; Maroteaux P, 1967, Presse Med, V75, P2519; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Norman A M, 1992, Clin Dysmorphol, V1, P115; ORIOLI IM, 1986, J MED GENET, V23, P328, DOI 10.1136/jmg.23.4.328; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; RIMOIN DL, 1993, MCKUSICKS HERITABLE, P557; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SHAH K, 1973, J MED GENET, V10, P243, DOI 10.1136/jmg.10.3.243; SHARONY R, 1993, AM J OBSTET GYNECOL, V169, P668, DOI 10.1016/0002-9378(93)90641-U; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; STENSVOLD K, 1986, CLIN GENET, V29, P157; THOMPSON LM, 1991, GENOMICS, V11, P1133, DOI 10.1016/0888-7543(91)90041-C; TONOKI H, 1987, CLIN GENET, V32, P415; UENO H, 1992, J BIOL CHEM, V267, P1470; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WEINER CP, 1986, J CLIN ULTRASOUND, V14, P463, DOI 10.1002/jcu.1870140612; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; WONGMONGKOLRIT T, 1983, ARCH PATHOL LAB MED, V107, P132	37	482	503	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	1995	9	3					321	328		10.1038/ng0395-321	http://dx.doi.org/10.1038/ng0395-321			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773297				2022-12-25	WOS:A1995QL23200025
J	BINGHAM, PM; SCOTT, MO; WANG, SP; MCPHAUL, MJ; WILSON, EM; GARBERN, JY; MERRY, DE; FISCHBECK, KH				BINGHAM, PM; SCOTT, MO; WANG, SP; MCPHAUL, MJ; WILSON, EM; GARBERN, JY; MERRY, DE; FISCHBECK, KH			STABILITY OF AN EXPANDED TRINUCLEOTIDE REPEAT IN THE ANDROGEN RECEPTOR GENE IN TRANSGENIC MICE	NATURE GENETICS			English	Article							BULBAR MUSCULAR-ATROPHY; RECESSIVE BULBOSPINAL NEURONOPATHY; SPINAL NUCLEUS; CAG REPEAT; BULBOCAVERNOSUS; MUTATIONS; NEURONS; MOUSE; SIZE; RAT	The expansion of trinucleotide repeat sequences underlies a number of hereditary neurological disorders. To study the stability of a trinucleotide repeat and to develop an animal model of one of these disorders, spinal and bulbar muscular atrophy (SBMA), we have generated transgenic mice carrying either the normal or expanded repeat human androgen receptor (AR) gene. Unlike the disease allele in humans, the AR cDNA containing the expanded repeat in transgenic mice showed no change in repeat length with transmission. Expression of the SBMA AR was,found in transgenic mice, but at a lower level than normal endogenous expression. The lack of a physiological pattern of expression may explain why no phenotypic effects of the transgene were observed.	CHILDRENS HOSP PHILADELPHIA,DEPT NEUROL,PHILADELPHIA,PA 19104; HOSP UNIV PENN,DEPT NEUROL,PHILADELPHIA,PA 19104; UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235; UNIV N CAROLINA,DEPT BIOCHEM,REPROD BIOL LAB,CHAPEL HILL,NC 27599	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill	BINGHAM, PM (corresponding author), CHILDRENS HOSP PHILADELPHIA,DIV NEUROL,PHILADELPHIA,PA 19104, USA.		McPhaul, Michael/AAC-7124-2020					ARAKI I, 1991, J NEUROSCI, V11, P3025; ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; Biancalana V., 1992, Human Molecular Genetics, V1, P255, DOI 10.1093/hmg/1.4.255; DOYU M, 1992, ANN NEUROL, V32, P707, DOI 10.1002/ana.410320517; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; FISHMAN RB, 1992, DEV BRAIN RES, V70, P283, DOI 10.1016/0165-3806(92)90208-E; FORGER NG, 1992, J NEUROBIOL, V23, P1192, DOI 10.1002/neu.480230910; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; HE WW, 1990, BIOCHEM BIOPH RES CO, V171, P697, DOI 10.1016/0006-291X(90)91202-4; HE WW, 1991, NUCLEIC ACIDS RES, V19, P2373, DOI 10.1093/nar/19.9.2373; HUSMANN DA, 1990, ENDOCRINOLOGY, V126, P2359, DOI 10.1210/endo-126-5-2359; IGARASHI S, 1992, NEUROLOGY, V42, P2300, DOI 10.1212/WNL.42.12.2300; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MHATRE AN, 1993, NAT GENET, V5, P184, DOI 10.1038/ng1093-184; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; RICHARDS RI, 1993, HUM MOL GENET, V2, P1429, DOI 10.1093/hmg/2.9.1429; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAR M, 1977, SCIENCE, V197, P77, DOI 10.1126/science.867053; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; SOBUE G, 1989, BRAIN, V112, P209, DOI 10.1093/brain/112.1.209; STRAND M, 1993, NATURE, V365, P274, DOI 10.1038/365274a0; WILLEMS PJ, 1994, NAT GENET, V8, P213, DOI 10.1038/ng1194-213	26	116	121	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	FEB	1995	9	2					191	196		10.1038/ng0295-191	http://dx.doi.org/10.1038/ng0295-191			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719348				2022-12-25	WOS:A1995QE67200022
J	RUTKOWSKI, JL; KIRK, CJ; LERNER, MA; TENNEKOON, GI				RUTKOWSKI, JL; KIRK, CJ; LERNER, MA; TENNEKOON, GI			PURIFICATION AND EXPANSION OF HUMAN SCHWANN-CELLS IN-VITRO	NATURE MEDICINE			English	Article							PERIPHERAL-NERVE REGENERATION; GLIAL GROWTH-FACTOR; WALLERIAN DEGENERATION; TISSUE-CULTURE; PROLIFERATION; SYSTEM	The ability to culture cells from the human nervous system provides new insight into the pathophysiology of neurological diseases and could be crucial to the development of gene replacement therapies and neural transplantation. We report that the proliferation of human Schwann cells isolated from paediatric and adult nerves is sustained in vitro by recombinant glial growth factor. Agents that increase intracellular cyclic cAMP were also mitogenic towards Schwann cells but suppress growth of contaminating fibroblasts. As the lifespan of highly enriched cultures can be extended for up to twelve population doublings, large numbers of cells can be generated from nerve biopsies.	CAMBRIDGE NEUROSCI INC,CAMBRIDGE,MA 02139		RUTKOWSKI, JL (corresponding author), UNIV MICHIGAN,DIV PEDIAT NEUROL,ANN ARBOR,MI 48109, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029710] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS-29710] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AICARDI J, 1993, J INHERIT METAB DIS, V16, P733, DOI 10.1007/BF00711905; ASKANAS V, 1980, ARCH NEUROL-CHICAGO, V37, P329, DOI 10.1001/archneur.1980.00500550031001; BOLIN LM, 1992, J NEUROSCI RES, V33, P231, DOI 10.1002/jnr.490330206; BOYER PJ, 1994, EXP NEUROL, V130, P53, DOI 10.1006/exnr.1994.1184; BROCKES JP, 1987, METHOD ENZYMOL, V147, P217; BUNGE RP, 1988, PROG BRAIN RES, V78, P312; CARRAWAY KL, 1994, CELL, V78, P5, DOI 10.1016/0092-8674(94)90564-9; CHANCE PF, 1993, ARCH NEUROL-CHICAGO, V50, P1180, DOI 10.1001/archneur.1993.00540110060006; COHEN JA, 1992, J NEUROSCI RES, V31, P622, DOI 10.1002/jnr.490310406; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; ESPINOZA B, 1986, AM J PHYSIOL, V251, pC238, DOI 10.1152/ajpcell.1986.251.2.C238; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; FISHER LJ, 1993, PHYSIOL REV, V73, P583, DOI 10.1152/physrev.1993.73.3.583; GOODEARL ADJ, 1993, J BIOL CHEM, V268, P18095; GUTMANN DH, 1994, CURR OPIN NEUROL, V7, P166, DOI 10.1097/00019052-199404000-00014; HUGHES RAC, 1994, ACTA NEUROL BELG, V94, P128; KIM SU, 1989, J NEUROSCI RES, V22, P50, DOI 10.1002/jnr.490220107; LEVI ADO, 1994, J NEUROSCI, V14, P1309, DOI 10.1523/JNEUROSCI.14-03-01309.1994; MARCHIONNI MA, 1993, NATURE, V362, P312, DOI 10.1038/362312a0; MORETTO G, 1984, ACTA NEUROPATHOL, V64, P15, DOI 10.1007/BF00695601; MUIR D, 1990, J CELL BIOL, V111, P2663, DOI 10.1083/jcb.111.6.2663; PELES E, 1993, BIOESSAYS, V15, P815, DOI 10.1002/bies.950151207; PORTER S, 1987, P NATL ACAD SCI USA, V84, P7768, DOI 10.1073/pnas.84.21.7768; RAFF MC, 1978, CELL, V15, P813, DOI 10.1016/0092-8674(78)90266-0; RAIVICH G, 1993, INT J DEV NEUROSCI, V11, P311, DOI 10.1016/0736-5748(93)90003-V; RUTKOWSKI JL, 1992, ANN NEUROL, V31, P580, DOI 10.1002/ana.410310603; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; SCARPINI E, 1988, BRAIN RES, V440, P261, DOI 10.1016/0006-8993(88)90994-8; ZAGER EL, 1988, SURG NEUROL, V29, P350, DOI 10.1016/0090-3019(88)90044-4	29	130	132	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1995	1	1					80	83		10.1038/nm0195-80	http://dx.doi.org/10.1038/nm0195-80			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX557	7584959				2022-12-25	WOS:A1995QX55700031
J	STRAUB, RE; LEHNER, T; LUO, Y; LOTH, JE; SHAO, W; SHARPE, L; ALEXANDER, JR; DAS, K; SIMON, R; FIEVE, RR; LERER, B; ENDICOTT, J; OTT, J; GILLIAM, TC; BARON, M				STRAUB, RE; LEHNER, T; LUO, Y; LOTH, JE; SHAO, W; SHARPE, L; ALEXANDER, JR; DAS, K; SIMON, R; FIEVE, RR; LERER, B; ENDICOTT, J; OTT, J; GILLIAM, TC; BARON, M			A POSSIBLE VULNERABILITY LOCUS FOR BIPOLAR AFFECTIVE-DISORDER ON CHROMOSOME 21Q22.3	NATURE GENETICS			English	Article							PEDIGREE-MEMBER METHOD; LINKAGE ANALYSIS; GENETIC-LINKAGE; ALZHEIMERS-DISEASE; MENTAL-ILLNESS; LOD SCORES; MARKERS; DNA; STRATEGIES	In a preliminary genome scan of 47 bipolar disorder families, we detected in one family a lod score of 3.41 at the PFKL locus on chromosome 21q22.3. The lod score is robust to marker allele frequencies, phenocopy rates and age-dependent penetrance, and remains strongly positive with changes in affection status. Fourteen other markers in 21q22.3 were tested on this family, with largely positive lod scores. Five of the other 46 families also show positive, but modest lod scores with PFKL. When all 47 families are analysed together, there is little support for linkage to PFKL under homogeneity or heterogeneity using lod score analysis, but the model-free affected-pedigree-member method yields statistically significant results (p<0.0003). Our results are consistent with the presence of a gene in 21q22.3 predisposing at least one family to bipolar disorder.	NEW YORK STATE PSYCHIAT INST & HOSP,DEPT MED GENET,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,DEPT STAT GENET,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,DEPT RES ASSESSMENT & TRAINING,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,DEPT LITHIUM STUDIES,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT GENET & DEV,NEW YORK,NY 10032; HEBREW UNIV JERUSALEM,DEPT PSYCHIAT,IL-91120 JERUSALEM,ISRAEL	New York State Psychiatry Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; New York State Psychiatry Institute; Columbia University; Columbia University; Hebrew University of Jerusalem					NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH044292, R01MH043979, R01MH042535, R01MH044292] Funding Source: NIH RePORTER; NIMH NIH HHS [MH44292, MH42535, MH43979] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P129; BABRON MC, 1993, GENET EPIDEMIOL, V10, P389, DOI 10.1002/gepi.1370100610; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BARON M, 1990, BRIT J PSYCHIAT, V157, P645, DOI 10.1192/bjp.157.5.645; BARON M, 1994, PSYCHIATR GENET, V4, P43, DOI 10.1097/00041444-199421000-00007; Baron M, 1994, GENETIC APPROACHES M, P253; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; DELABAR JM, 1993, GENOMICS, V18, P735, DOI 10.1016/S0888-7543(05)80390-8; EASTON DF, 1989, GENET EPIDEMIOL, V6, P83, DOI 10.1002/gepi.1370060116; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HODGE SE, 1992, AM J HUM GENET, V50, P1053; KEISOE JR, 1989, NATURE, V342, P238; LANDER ES, 1993, NAT GENET, V4, P5, DOI 10.1038/ng0593-5; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; ODONOVAN MC, 1992, ANN MED, V24, P171, DOI 10.3109/07853899209147816; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OTT J, 1992, AM J HUM GENET, V51, P283; Ott J., 1991, ANAL HUMAN GENETIC L; OWERBACH D, 1994, AM J HUM GENET, V54, P909; PAULS DL, 1993, NAT GENET, V3, P4, DOI 10.1038/ng0193-4; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1987, AM J HUM GENET, V40, P1; RISCH N, 1992, SCIENCE, V255, P803, DOI 10.1126/science.1536004; SANDKUYL LA, 1989, PROG CLIN BIOL RES, V329, P117; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WICKING C, 1991, TRENDS GENET, V7, P288, DOI 10.1016/0168-9525(91)90177-R; XIE X, 1990, AM J HUM GENET, V47, pA205	42	236	251	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1994	8	3					291	296		10.1038/ng1194-291	http://dx.doi.org/10.1038/ng1194-291			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PP765	7874172				2022-12-25	WOS:A1994PP76500021
J	STRATHDEE, CA; DUNCAN, AMV; BUCHWALD, M				STRATHDEE, CA; DUNCAN, AMV; BUCHWALD, M			EVIDENCE FOR AT LEAST 4 FANCONI ANEMIA GENES INCLUDING FACC ON CHROMOSOME-9	NATURE GENETICS			English	Article							INSITU HYBRIDIZATION; ANEMIA CELLS; COMPLEMENTATION; SUSCEPTIBILITY; LOCALIZATION; BREAKAGE; MARKERS; AGENTS	Fanconi anaemia (FA) is a DNA repair disorder characterized by cellular hypersensitivity to DNA cross-linking agents and extensive phenotypic heterogeneity. To determine the extent of genetic heterogeneity present in FA, a panel of somatic cell hybrids was constructed using polyethylene glycol-mediated cell fusion. Three new complementation groups were identified, designated FA(B), FA(C) and FA(D), and the gene defective in FA(C) which we have recently cloned was localized to chromosome 9q22.3 through in situ hybridization. These results suggest that mutations in at least four different genes lead to FA, a degree of genetic heterogeneity comparable to that of other DNA repair disorders.	HOSP SICK CHILDREN,RES INST,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; QUEENS UNIV,DEPT PATHOL,KINGSTON K7L 2V7,ONTARIO,CANADA; KINGSTON GEN HOSP,CYTOGENET LAB,KINGSTON K7L 2V7,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Queens University - Canada; Queens University - Canada								AUERBACH AD, 1989, BLOOD, V73, P391; BUCHWALD M, 1989, FANCONI ANEMIA CLIN, P226; DUCKWORTHRYSIECKI G, 1985, SOMAT CELL MOLEC GEN, V11, P35, DOI 10.1007/BF01534732; FANCONI G., 1967, SEMINARS HAMATOL, V4, P233; GLANZ A, 1982, J MED GENET, V19, P412, DOI 10.1136/jmg.19.6.412; GORDONSMITH EC, 1991, SEMIN HEMATOL, V28, P104; HARPER ME, 1981, CHROMOSOMA, V83, P431, DOI 10.1007/BF00327364; ISHIDA R, 1982, CANCER RES, V42, P4000; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; LEEDER JS, 1989, ANAL BIOCHEM, V177, P364, DOI 10.1016/0003-2697(89)90067-5; LIN CC, 1985, CYTOGENET CELL GENET, V39, P269, DOI 10.1159/000132156; MANN WR, 1991, GENOMICS, V9, P329, DOI 10.1016/0888-7543(91)90261-C; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; PAPADOPOULO D, 1990, P NATL ACAD SCI USA, V87, P8383, DOI 10.1073/pnas.87.21.8383; SANTERRE RF, 1984, GENE, V30, P147, DOI 10.1016/0378-1119(84)90115-X; SASAKI MS, 1973, CANCER RES, V33, P1829; SCHROEDER TM, 1976, HUM GENET, V32, P257, DOI 10.1007/BF00295817; SCHROEDER TM, 1964, HUM GENET, V1, P1694; SETLOW RB, 1978, NATURE, V271, P713, DOI 10.1038/271713a0; SOUTHERN PJ, 1982, J MOL APPL GENET, V1, P3027; STRATHDEE CA, IN PRESS NATURE; STRATHDEE CA, IN PRESS AM J PEDIAT; TANAKA K, 1990, NATURE, V348, P73, DOI 10.1038/348073a0; TSUI LC, 1991, GENES PHENOTYPES, P1; VERMEULEN W, 1991, MUTAT RES, V255, P201, DOI 10.1016/0921-8777(91)90054-S; WEKSBERG R, 1979, J CELL PHYSIOL, V101, P311, DOI 10.1002/jcp.1041010211; ZAKRZEWSKI S, 1982, HUM GENET, V62, P321, DOI 10.1007/BF00304547; ZAKRZEWSKI S, 1983, HUM GENET, V64, P55, DOI 10.1007/BF00289479	28	284	288	0	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1992	1	3					196	198		10.1038/ng0692-196	http://dx.doi.org/10.1038/ng0692-196			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC982	1303234				2022-12-25	WOS:A1992JC98200012
J	BIGGS, PJ; WOOSTER, R; FORD, D; CHAPMAN, P; MANGION, J; QUIRK, Y; EASTON, DF; BURN, J; STRATTON, MR				BIGGS, PJ; WOOSTER, R; FORD, D; CHAPMAN, P; MANGION, J; QUIRK, Y; EASTON, DF; BURN, J; STRATTON, MR			FAMILIAL CYLINDROMATOSIS (TURBAN TUMOR SYNDROME) GENE LOCALIZED TO CHROMOSOME 16Q12-Q13 - EVIDENCE FOR ITS ROLE AS A TUMOR-SUPPRESSOR GENE	NATURE GENETICS			English	Note							DERMAL ECCRINE CYLINDROMA; PAROTID-GLAND; RETINOBLASTOMA; PATIENT; CLONING; CANCER; REGION; BREAST		INST CANC RES,HADDOW LABS,MOLEC CARCINOGENESIS SECT,SUTTON SM2 5NG,SURREY,ENGLAND; INST CANC RES,HADDOW LABS,EPIDEMIOL SECT,SUTTON SM2 5NG,SURREY,ENGLAND; UNIV NEWCASTLE,DIV HUMAN GENET,NEWCASTLE TYNE NE2 4AA,TYNE & WEAR,ENGLAND	University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Newcastle University - UK			Biggs, Patrick Jon/H-3355-2014	Biggs, Patrick Jon/0000-0002-0285-4101; Burn, John/0000-0002-9823-2322				ABENOZA P, 1990, NEOPLASMS ECCRINE DI; ALAWI MH, 1982, BRIT J PLAST SURG, V35, P167, DOI 10.1016/0007-1226(82)90157-6; AUTIOHARMAINEN H, 1988, CANCER-AM CANCER SOC, V61, P161, DOI 10.1002/1097-0142(19880101)61:1<161::AID-CNCR2820610127>3.0.CO;2-1; CAVENEE WK, 1985, SCIENCE, V228, P501, DOI 10.1126/science.3983638; CLAUDIO PP, 1994, CANCER RES, V54, P5556; COLLINS N, 1995, ONCOGENE, V10, P1673; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CRAIN RC, 1961, AM J CLIN PATHOL, V6, P504; FABIAN RL, 1981, HEAD NECK SURG, V4, P165, DOI 10.1002/hed.2890040214; FERRANDIZ C, 1985, J CUTAN PATHOL, V12, P72, DOI 10.1111/j.1600-0560.1985.tb00432.x; FREEDMAN AM, 1989, ANN PLAS SURG, V22, P50, DOI 10.1097/00000637-198901000-00010; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HYMAN BA, 1988, ARCH PATHOL LAB MED, V112; IRWIN LR, 1990, BRIT J PLAST SURG, V43, P702, DOI 10.1016/0007-1226(90)90194-5; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lever W. F., 1990, HISTOPATHOLOGY SKIN; MAYOL X, 1993, ONCOGENE, V8, P2561; MURTAGH JJ, 1991, MOL CELL BIOL, V11, P1146, DOI 10.1128/MCB.11.2.1146; PINGITORE R, 1984, TUMORI, V70, P385, DOI 10.1177/030089168407000415; REINGOLD IM, 1977, CANCER, V40, P1702, DOI 10.1002/1097-0142(197710)40:4<1702::AID-CNCR2820400446>3.0.CO;2-A; SHAPIRO PE, 1991, ARCH DERMATOL, V127, P83, DOI 10.1001/archderm.127.1.83; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; STENN KS, 1983, HISTOLOGY CELL TISSU, P569; TSUJI S, 1992, EMBO J, V11, P4843, DOI 10.1002/j.1460-2075.1992.tb05590.x; VERNON HJ, 1988, J AM ACAD DERMATOL, V19, P397, DOI 10.1016/S0190-9622(88)70186-3; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; YEUNG RS, 1993, ONCOGENE, V8, P3465	29	120	124	1	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					441	443		10.1038/ng1295-441	http://dx.doi.org/10.1038/ng1295-441			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493027				2022-12-25	WOS:A1995TH62900024
J	PROETZEL, G; PAWLOWSKI, SA; WILES, MV; YIN, MY; BOIVIN, GP; HOWLES, PN; DING, JX; FERGUSON, MWJ; DOETSCHMAN, T				PROETZEL, G; PAWLOWSKI, SA; WILES, MV; YIN, MY; BOIVIN, GP; HOWLES, PN; DING, JX; FERGUSON, MWJ; DOETSCHMAN, T			TRANSFORMING GROWTH FACTOR-BETA-3 IS REQUIRED FOR SECONDARY PALATE FUSION	NATURE GENETICS			English	Article							EPITHELIAL-MESENCHYMAL TRANSFORMATION; FACTOR-ALPHA-GENE; DIFFERENTIAL EXPRESSION; MEDIAL EDGE; FACTOR-BETA; CELL DIFFERENTIATION; MOUSE EMBRYO; CLEFT-PALATE; TGF BETA-1; CULTURE	Mice lacking IGF-beta 3 exhibit an incompletely penetrant failure of the palatal shelves to fuse leading to cleft palate. The defect appears to result from impaired adhesion of the apposing medial edge epithelia of the palatal shelves and subsequent elimination of the mid-line epithelial seam. No craniofacial abnormalities were observed. This result demonstrates that TGF-beta 3 affects palatal shelf fusion by an intrinsic, primary mechanism rather than by effects secondary to craniofacial defects.	UNIV CINCINNATI,COLL MED,DEPT MOLEC GENET BIOCHEM & MICROBIOL,CINCINNATI,OH 45267; UNIV CINCINNATI,COLL MED,DEPT PATHOL,CINCINNATI,OH 45267; BASEL INST IMMUNOL,CH-4005 BASEL,SWITZERLAND; UNIV MANCHESTER,SCH BIOL SCI,MANCHESTER,LANCS,ENGLAND	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Manchester				wiles, michael/0000-0002-3620-8386	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026471] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046826, P01HL041496] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL41496, HL46826] Funding Source: Medline; NICHD NIH HHS [HD26471, R01 HD026471] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANSCHER MS, 1994, INT J RADIAT ONCOL, V30, P671, DOI 10.1016/0360-3016(92)90954-G; ARDINGER HH, 1989, AM J HUM GENET, V45, P348; BOIVIN GP, 1995, AM J PATHOL, V146, P276; Brown K S, 1980, Prog Clin Biol Res, V46, P77; BRUNET CL, 1995, INT J DEV BIOL, V39, P345; CARETTE MJM, 1992, DEVELOPMENT, V114, P379; CARETTE MJM, 1991, DIFFERENTIATION, V47, P149, DOI 10.1111/j.1432-0436.1991.tb00233.x; CHAI Y, 1994, DEV BIOL, V162, P85, DOI 10.1006/dbio.1994.1069; CHENEVIXTRENCH G, 1992, AM J HUM GENET, V51, P1377; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DANGELO M, 1994, J EXP ZOOL, V270, P189, DOI 10.1002/jez.1402700208; DIXON MJ, 1992, ARCH ORAL BIOL, V37, P395, DOI 10.1016/0003-9969(92)90024-3; FERGUSON MWJ, 1987, IRISH J MED SCI, V156, P309, DOI 10.1007/BF02951261; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FERGUSON MWJ, 1994, NAT GENET, V6, P329, DOI 10.1038/ng0494-329; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; GEHRIS AL, 1992, DIFFERENTIATION, V49, P167, DOI 10.1111/j.1432-0436.1992.tb00664.x; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; GREENE RM, 1976, J EMBRYOL EXP MORPH, V36, P225; GRIFFITH CM, 1992, DEVELOPMENT, V116, P1087; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; KULKARNI AB, 1995, AM J PATHOL, V146, P264; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; MARTIN JF, 1995, GENE DEV, V9, P1237, DOI 10.1101/gad.9.10.1237; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MATZUK MM, 1995, NATURE, V374, P354, DOI 10.1038/374354a0; MATZUK MM, 1995, NATURE, V374, P360, DOI 10.1038/374360a0; MATZUK MM, 1995, NATURE, V374, P356, DOI 10.1038/374356a0; MILLAN FA, 1991, DEVELOPMENT, V111, P131; MORRISWIMAN J, 1992, ANAT RECORD, V234, P575, DOI 10.1002/ar.1092340413; PELTON RW, 1991, J CELL BIOL, V115, P1091, DOI 10.1083/jcb.115.4.1091; PELTON RW, 1990, DEVELOPMENT, V110, P609; PELTON RW, 1990, DEV BIOL, V141, P456, DOI 10.1016/0012-1606(90)90401-4; PROETZEL G, 1994, THESIS U CINCINNATI, P1; RIJLI FM, 1993, CELL, V75, P1333, DOI 10.1016/0092-8674(93)90620-6; Roberts A.B., 1990, HDB EXPT PHARM PEPTI, V95, P419; ROBINSON SD, 1991, DEVELOPMENT, V113, P867; RUNYAN RB, 1992, MOL REPROD DEV, V32, P152, DOI 10.1002/mrd.1080320211; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SCHMID P, 1991, DEVELOPMENT, V111, P117; SHAH M, 1995, J CELL SCI, V108, P985; SHIANG R, 1993, AM J HUM GENET, V53, P836; SHULER CF, 1992, DEV BIOL, V154, P318, DOI 10.1016/0012-1606(92)90071-N; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; WAHL SM, 1992, J CLIN IMMUNOL, V12, P61, DOI 10.1007/BF00918135; Wilson J.G., 1965, TERATOLOGY PRINCIPLE, P262	53	735	759	0	19	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					409	414		10.1038/ng1295-409	http://dx.doi.org/10.1038/ng1295-409			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493021	Green Accepted			2022-12-25	WOS:A1995TH62900018
J	TARGAN, SR; MURPHY, LK				TARGAN, SR; MURPHY, LK			CLARIFYING THE CAUSES OF CROHNS	NATURE MEDICINE			English	Editorial Material							MICE; DISEASE				TARGAN, SR (corresponding author), CEDARS SINAI INFLAMMATORY BOWEL DIS CTR, LOS ANGELES, CA 90048 USA.							ARANDA R, 1995, GASTROENTEROLOGY, V108, pA773, DOI 10.1016/0016-5085(95)27402-2; BERBERIAN LS, 1994, J IMMUNOL, V153, P3756; Castro R., 1995, American Journal of Human Genetics, V57, pA161; INA K, 1995, GASTROENTEROLOGY, V108, pA841; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; LIFRAK ET, 1995, GASTROENTEROLOGY, V108, pA149; MA A, 1995, GASTROENTEROLOGY, V108, pA867, DOI 10.1016/0016-5085(95)27774-9; MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q; PLEVY SE, 1995, GASTROENTEROLOGY, V108, pA895; PLEVY SE, 1994, GASTROENTEROLOGY, V106, pA754; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; VASILIAUSKAS EA, 1995, GASTROENTEROLOGY, V108, pA935; Yang H., 1995, American Journal of Human Genetics, V57, pA233; YANG HY, 1995, GASTROENTEROLOGY, V109, P440, DOI 10.1016/0016-5085(95)90331-3	17	52	63	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	1995	1	12					1241	1243		10.1038/nm1295-1241	http://dx.doi.org/10.1038/nm1295-1241			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TH786	7489397				2022-12-25	WOS:A1995TH78600028
J	PEARLMAN, JD; HIBBERD, MG; CHUANG, ML; HARADA, K; LOPEZ, JJ; GLADSTONE, SR; FRIEDMAN, M; SELLKE, FW; SIMONS, M				PEARLMAN, JD; HIBBERD, MG; CHUANG, ML; HARADA, K; LOPEZ, JJ; GLADSTONE, SR; FRIEDMAN, M; SELLKE, FW; SIMONS, M			MAGNETIC-RESONANCE MAPPING DEMONSTRATES BENEFITS OF VEGF INDUCED MYOCARDIAL ANGIOGENESIS	NATURE MEDICINE			English	Article							PERFUSION; EXPRESSION; 1ST-PASS; HYPOXIA	Coronary occlusive disease is the leading cause of death in industrial nations and affects one in four adults. Although heart. attacks are caused by occlusion of a coronary artery, some patients have occlusions without infarction because they have sufficient collateral vessels providing an alternate pathway for blood supply. Vascular endothelial growth factor (VEGF) is an angiogenic peptide that can stimulate collateral vessel development in the ischaemic myocardium(1-6). We used magnetic resonance imaging (MRI) and image processing to identify and quantify non-invasively the benefits related to VEGF infusion on collateral development in the heart. This was accomplished as a placebo-controlled study in the porcine model of chronic ischaemia(7,8) that most closely mimics the human pathophysiology of progressive coronary occlusion(9). Image series converted to a space-time map demonstrated that with treatment the ischaemic zone was smaller and the contrast arrival delay was less, which resulted in better ejection fraction and regional wall thickening, These findings demonstrate in a manner applicable to humans, that VEGF improves collateral blood supply, resulting in improved cardiac global and regional function after and in spite of coronary artery occlusion.	HARVARD UNIV,SCH MED,HARVARD THORNDIKE LAB,BOSTON,MA 02215; HARVARD UNIV,SCH MED,DEPT RADIOL,BOSTON,MA 02215; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02215; HARVARD UNIV,SCH MED,DEPT SURG,BOSTON,MA 02215; BETH ISRAEL HOSP,BOSTON,MA 02215	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	PEARLMAN, JD (corresponding author), HARVARD UNIV,SCH MED,CHARLES A DANA RES INST,BOSTON,MA 02215, USA.		Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	NHLBI NIH HHS [HL-46716] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046716, R29HL046716] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATKINSON DJ, 1990, RADIOLOGY, V174, P757, DOI 10.1148/radiology.174.3.2305058; BANAI S, 1994, CIRCULATION, V89, P2183, DOI 10.1161/01.CIR.89.5.2183; BURSTEIN D, 1991, MAGNET RESON MED, V20, P299, DOI 10.1002/mrm.1910200212; CHUANG M, 1994, COMPUTER APPLICATION; HARADA K, 1994, J CLIN INVEST, V94, P623, DOI 10.1172/JCI117378; JAKEMAN LB, 1993, ENDOCRINOLOGY, V133, P848, DOI 10.1210/en.133.2.848; LADOUX A, 1993, BIOCHEM BIOPH RES CO, V195, P1005, DOI 10.1006/bbrc.1993.2144; LAUB G, 1993, P SOC MAGN RESON MED, V1, P478; LEBIHAN D, 1990, MAGNET RESON MED, V14, P283, DOI 10.1002/mrm.1910140213; PEARLMAN JD, 1990, J AM COLL CARDIOL, V16, P986, DOI 10.1016/S0735-1097(10)80352-3; PEARLMAN JD, 1991, P SOC MAGN RESON MED, V2, P780; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; ROTH DM, 1987, AM J PHYSIOL, V253, pH1279, DOI 10.1152/ajpheart.1987.253.5.H1279; SCHAEFER S, 1992, RADIOLOGY, V185, P795, DOI 10.1148/radiology.185.3.1438765; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SHWEIKI D, 1993, J CLIN INVEST, V91, P2235, DOI 10.1172/JCI116450; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; VANRUGGE FP, 1991, J COMPUT ASSIST TOMO, V15, P959, DOI 10.1097/00004728-199111000-00010; WENDLAND MF, 1993, RADIOLOGY, V186, P535, DOI 10.1148/radiology.186.2.8421761; WHITE FC, 1986, LAB ANIM SCI, V36, P351	20	285	298	0	6	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	OCT	1995	1	10					1085	1089		10.1038/nm1095-1085	http://dx.doi.org/10.1038/nm1095-1085			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489368				2022-12-25	WOS:A1995RX95100052
J	PISHA, E; CHAI, H; LEE, IS; CHAGWEDERA, TE; FARNSWORTH, NR; CORDELL, GA; BEECHER, CWW; FONG, HHS; KINGHORN, AD; BROWN, DM; WANI, MC; WALL, ME; HIEKEN, TJ; DASGUPTA, TK; PEZZUTO, JM				PISHA, E; CHAI, H; LEE, IS; CHAGWEDERA, TE; FARNSWORTH, NR; CORDELL, GA; BEECHER, CWW; FONG, HHS; KINGHORN, AD; BROWN, DM; WANI, MC; WALL, ME; HIEKEN, TJ; DASGUPTA, TK; PEZZUTO, JM			DISCOVERY OF BETULINIC ACID AS A SELECTIVE INHIBITOR OF HUMAN-MELANOMA THAT FUNCTIONS BY INDUCTION OF APOPTOSIS	NATURE MEDICINE			English	Article							MALIGNANT-MELANOMA; TUMORS; AGENTS; LUPEOL	As a result of bioassay-guided fractionation, betulinic acid, a pentacyclic triterpene, was identified as a melanoma-specific cytotoxic agent. In follow-up studies conducted with athymic mice carrying human melanomas, tumour growth was completely inhibited without toxicity. As judged by a variety of cellular responses, antitumour activity was mediated by the induction of apoptosis. Betulinic acid is inexpensive and available in abundant supply from common natural sources, notably the bark of white birch trees. The compound is currently undergoing preclinical development for the treatment or prevention of malignant melanoma.	UNIV ILLINOIS, COLL PHARM, DEPT MED CHEM & PHARMACOGNOSY, PROGRAM COLLABORAT RES PHARMACEUT SCI, CHICAGO, IL 60612 USA; UNIV ZIMBABWE, DEPT PHARM, HARARE, ZIMBABWE; RES TRIANGLE INST, DIV CHEM & LIFE SCI, RES TRIANGLE PK, NC 27709 USA; UNIV ILLINOIS, COLL MED, DEPT SURG ONCOL, CHICAGO, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Zimbabwe; Research Triangle Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital				Kinghorn, A. Douglas/0000-0002-6647-8707	NATIONAL CANCER INSTITUTE [U01CA052956] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA 52956] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BORING CC, 1994, CA-CANCER J CLIN, V44, P7, DOI 10.3322/canjclin.44.1.7; BROZENA SJ, 1993, SEMIN SURG ONCOL, V9, P165; COHEN GM, 1994, J IMMUNOL, V153, P507; COMIS RL, 1976, CANCER TREAT REP, V60, P165; CORDELL GA, 1993, ACS SYM SER, V534, P191; Cragg G. M., 1993, ACS S SERIES, V534; FUJIOKA T, 1994, J NAT PROD, V57, P243, DOI 10.1021/np50104a008; GERAN RI, 1972, CANC CHEMOTHER REP, V3, P1; HOTZ MA, 1994, CYTOMETRY, V15, P237, DOI 10.1002/cyto.990150309; KINGSTON DGI, 1978, LLOYDIA, V41, P499; LIKHITWITAYWUID K, 1993, J NAT PROD, V56, P1468, DOI 10.1021/np50099a005; MASTRANGELO MJ, 1995, MALIGNANT MELANOMA M, P295; MCCLAY EF, 1994, J CLIN ONCOL, V12, P617, DOI 10.1200/JCO.1994.12.3.617; MILES DH, 1974, J PHARM SCI, V63, P613, DOI 10.1002/jps.2600630427; OCONNELL MM, 1988, PHYTOCHEMISTRY, V27, P2175, DOI 10.1016/0031-9422(88)80120-1; PEZZUTO JM, 1988, SEMIN ONCOL, V15, P578; RICHARDS JM, 1990, CLIN RES, V38, pA844; RICHARDS JM, 1992, J CLIN ONCOL, V10, P1338, DOI 10.1200/JCO.1992.10.8.1338; RIES LA, NIH902789 NCI DIV CA; Robertson A, 1939, J CHEM SOC, P1267, DOI 10.1039/jr9390001267; ROBINSON FP, 1970, PHYTOCHEMISTRY, V9, P907, DOI 10.1016/S0031-9422(00)85205-X; Ruzicka L, 1938, HELV CHIM ACTA, V21, P1706, DOI 10.1002/hlca.193802101208; SANDBERG F, 1987, ACTA PHARM SUEC, V24, P253; SHETH K, 1972, J PHARM SCI, V61, P1819, DOI 10.1002/jps.2600611129; SHOLICHIN M, 1980, CHEM PHARM BULL, V28, P1006, DOI 10.1248/cpb.28.1006; SIDDIQUI S, 1988, J NAT PROD, V51, P229, DOI 10.1021/np50056a006; SUFFNESS M, 1995, INT J PHARMACOGN, V33, P5, DOI 10.3109/13880209509067083; THOMPSON HJ, 1992, CANCER EPIDEM BIOMAR, V1, P597; TRUMBULL ER, 1976, J PHARM SCI, V65, P1407, DOI 10.1002/jps.2600650938; WALKER PR, 1993, BIOTECHNIQUES, V15, P1032; WALL ME, 1993, ACS SYM SER, V534, P149; WALLER DP, 1980, CONTRACEPTION, V22, P183, DOI 10.1016/0010-7824(80)90062-1; WYLLIE AH, 1985, ANTICANCER RES, V5, P131; STUDIES CONDUCTED LA	34	705	802	2	112	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	1995	1	10					1046	1051		10.1038/nm1095-1046	http://dx.doi.org/10.1038/nm1095-1046			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489361				2022-12-25	WOS:A1995RX95100045
J	NAGASE, H; BRYSON, S; CORDELL, H; KEMP, CJ; FEE, F; BALMAIN, A				NAGASE, H; BRYSON, S; CORDELL, H; KEMP, CJ; FEE, F; BALMAIN, A			DISTINCT GENETIC-LOCI CONTROL DEVELOPMENT OF BENIGN AND MALIGNANT SKIN TUMORS IN MICE	NATURE GENETICS			English	Article							MOUSE GENOME; INBRED MICE; HA-RAS; CHROMOSOME-7; CARCINOGENESIS; CANCER; TUMORS; MAP; MICROSATELLITES; HETEROZYGOSITY	Genetic susceptibility to chemically induced skin cancer in mice is controlled by multiple unlinked genetic loci. Mus spretus mice have dominant resistance genes which confer resistance to interspecific F-1 hybrids with susceptible Mus musculus strains. We have mapped three major resistance loci using a combination of Mapmaker/QTL analysis and multiple regression analysis to mouse chromosomes 5 and 7. At least two independent loci on chromosome 7 exert their effects primarily during benign tumour development and have very little influence on tumour progression. On the other hand, probably a single locus on chromosome 5 affects both early and late stages of malignancy. The results indicate that benign and malignant tumours are largely under independent genetic control.	UNIV GLASGOW,DEPT MED ONCOL,CRC,BEATSON LABS,GLASGOW,LANARK,SCOTLAND; BEATSON INST CANC RES,GLASGOW G61 1BD,LANARK,SCOTLAND; UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,NUFFIELD DEPT SURG,OXFORD OX3 7BN,ENGLAND; FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104	Beatson Institute; University of Glasgow; Beatson Institute; University of Oxford; Wellcome Centre for Human Genetics; Fred Hutchinson Cancer Center				Cordell, Heather/0000-0002-1879-5572	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALARID ET, 1994, P NATL ACAD SCI USA, V91, P1074, DOI 10.1073/pnas.91.3.1074; ALDAZ CM, 1989, MOL CARCINOGEN, V2, P22, DOI 10.1002/mc.2940020104; BALMAIN A, 1992, MULTISTAGE CARCINOGE, P97; BANGRAZI C, 1990, CARCINOGENESIS, V11, P1711, DOI 10.1093/carcin/11.10.1711; BIANCHI AB, 1990, P NATL ACAD SCI USA, V87, P6902, DOI 10.1073/pnas.87.17.6902; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BREMNER R, 1994, MOL CARCINOGEN, V11, P90, DOI 10.1002/mc.2940110206; BREMNER R, 1990, CELL, V61, P407, DOI 10.1016/0092-8674(90)90523-H; BURNS PA, 1991, ONCOGENE, V6, P2363; CARTER BS, 1990, P NATL ACAD SCI USA, V87, P8771; CHEN B, 1994, P NATL ACAD SCI USA, V91, P1589, DOI 10.1073/pnas.91.4.1589; CHENG C, 1993, CELL GROWTH DIFFER, V4, P317; CORNALL RJ, 1991, GENOMICS, V10, P874, DOI 10.1016/0888-7543(91)90175-E; Demant P, 1992, Semin Cancer Biol, V3, P159; DIETRICH W, 1992, GENETICS, V131, P423; DRINKWATER NR, 1986, CARCINOGENESIS, V7, P1701, DOI 10.1093/carcin/7.10.1701; FISCHER SM, 1987, CARCINOGENESIS, V8, P421, DOI 10.1093/carcin/8.3.421; GARIBODI M, 1994, CANCER RES, V53, P209; GARIBOLDI M, 1993, NAT GENET, V3, P132, DOI 10.1038/ng0293-132; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; GIMENEZCONTI IB, 1992, CANCER RES, V52, P3432; GROOT PC, 1992, RES COMM, P2826; HEARNE CM, 1991, MAMM GENOME, V1, P273, DOI 10.1007/BF00352339; HENNINGS H, 1985, CARCINOGENESIS, V6, P1607, DOI 10.1093/carcin/6.11.1607; KEMP CJ, 1993, CANCER RES, V53, P6022; KEMP CJ, IN PRESS COLD SPRING; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; KRONTIRIS TG, 1993, NEW ENGL J MED, V329, P517, DOI 10.1056/NEJM199308193290801; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEE CC, 1993, CELL ADHES COMMUN, V1, P101, DOI 10.3109/15419069309095686; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; MANENTI G, 1994, GENOMICS, V23, P118, DOI 10.1006/geno.1994.1466; MOCK BA, 1993, P NATL ACAD SCI USA, V99, P9499; NAITO M, 1991, CANCER RES, V15, P639; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PETO J, 1980, BANBURY REPORT, V4, P203; PONDER BAJ, 1990, TRENDS GENET, V6, P213, DOI 10.1016/0168-9525(90)90181-5; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; RINCHIK EM, 1992, MAMM GENOME, V3, pS104, DOI 10.1007/BF00648425; RYAN J, 1987, J NATL CANCER I, V79, P1351; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; VASSAR R, 1992, MOL CELL BIOL, V12, P4643, DOI 10.1128/MCB.12.10.4643; WEIDNER KM, 1990, J CELL BIOL, V11, P2097; YUSPA SH, 1994, CANCER RES, V54, P1178; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	46	113	114	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	AUG	1995	10	4					424	429		10.1038/ng0895-424	http://dx.doi.org/10.1038/ng0895-424			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RM375	7670492				2022-12-25	WOS:A1995RM37500015
J	GOTTLIEB, SL; GILLEAUDEAU, P; JOHNSON, R; ESTES, L; WOODWORTH, TG; GOTTLIEB, AB; KRUEGER, JG				GOTTLIEB, SL; GILLEAUDEAU, P; JOHNSON, R; ESTES, L; WOODWORTH, TG; GOTTLIEB, AB; KRUEGER, JG			RESPONSE OF PSORIASIS TO A LYMPHOCYTE-SELECTIVE TOXIN (DAB(389)IL-2) SUGGESTS A PRIMARY IMMUNE, BUT NOT KERATINOCYTE, PATHOGENIC BASIS	NATURE MEDICINE			English	Article							GROWTH FACTOR-ALPHA; INTERLEUKIN-2 FUSION PROTEIN; RECEPTOR; CYCLOSPORINE; EXPRESSION; CELLS; MATURATION; PLAQUES; MODEL; SKIN	Psoriasis is a hyperproliferative and inflammatory skin disorder of unknown aetiology. A fusion protein composed of human interleukin-2 and fragments of diphtheria toxin (DAB(389)IL-2), which selectively blocks the growth of activated lymphocytes but not keratinocytes, was administered systemically to ten patients to gauge the contribution of activated T cells to the disease. Four patients showed striking clinical improvement and four moderate improvement, after two cycles of low dose IL-2-toxin. The reversal of several molecular markers of epidermal dysfunction was associated with a marked reduction in intraepidermal CD3(-) and CD8(+) T cells, suggesting a primary immunological basis for this widespread disorder.	ROCKEFELLER UNIV,INVEST DERMATOL LAB,NEW YORK,NY 10021; SERAGEN INC,HOPKINTON,MA 01748	Rockefeller University					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007525] Funding Source: NIH RePORTER; NCI NIH HHS [CA 54215] Funding Source: Medline; NCRR NIH HHS [RR 00102] Funding Source: Medline; NIAMS NIH HHS [AR 07525] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ACKERMAN C, 1991, J INVEST DERMATOL, V96, P536; BAADSGARD O, 1990, J INVEST DERMATOL, V95, P325; BACHA PA, 1991, INT J CANCER, V49, P96, DOI 10.1002/ijc.2910490118; BAKER BS, 1987, BRIT J DERMATOL, V116, P503, DOI 10.1111/j.1365-2133.1987.tb05869.x; BATACSORGO Z, 1995, J CLIN INVEST, V95, P317, DOI 10.1172/JCI117659; BOS JD, 1989, ARCH DERMATOL RES, V281, P24, DOI 10.1007/BF00424268; CARNAUD C, 1993, IMMUNOL RES, V12, P131, DOI 10.1007/BF02918300; CHANG JCC, 1994, P NATL ACAD SCI USA, V91, P9282, DOI 10.1073/pnas.91.20.9282; ELDER JT, 1989, SCIENCE, V243, P811, DOI 10.1126/science.2916128; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; GOTTLIEB AB, 1988, J EXP MED, V167, P670, DOI 10.1084/jem.167.2.670; GOTTLIEB AB, 1986, J EXP MED, V164, P1013, DOI 10.1084/jem.164.4.1013; GOTTLIEB AB, 1992, J INVEST DERMATOL, V98, P302, DOI 10.1111/1523-1747.ep12499782; GOTTLIEB AB, 1994, PSORIASIS, P63; GOTTLIEB SI, IN PRESS J AM ACAD D; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; KHANDKE L, 1991, ARCH DERMATOL, V127, P1172, DOI 10.1001/archderm.127.8.1172; KRANE JF, 1991, J INVEST DERMATOL, V96, P983, DOI 10.1111/1523-1747.ep12476485; KRUEGER JG, 1994, PSORIASIS, P18; LEMAISTRE CF, 1992, BLOOD, V79, P2547; MANSBRIDGE JN, 1987, J INVEST DERMATOL, V89, P253, DOI 10.1111/1523-1747.ep12471216; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; ONUMA A, 1994, J DERMATOL, V21, P223; PAUKKONEN K, 1992, ARCH DERMATOL RES, V284, P375, DOI 10.1007/BF00372065; PETZELBAUER P, 1991, J INVEST DERMATOL, V96, P362, DOI 10.1111/1523-1747.ep12465404; PRINZ JC, 1994, EUR J IMMUNOL, V24, P593, DOI 10.1002/eji.1830240315; Rizova Helena, 1994, Journal of Dermatological Science, V7, P1, DOI 10.1016/0923-1811(94)90016-7; SHAW JP, 1991, J BIOL CHEM, V266, P21118; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; VALDIMARSSON H, 1995, IMMUNOL TODAY, V16, P145, DOI 10.1016/0167-5699(95)80132-4; VALLAT VP, 1994, J EXP MED, V180, P283, DOI 10.1084/jem.180.1.283; WALDMANN TA, 1993, IMMUNOL TODAY, V14, P264, DOI 10.1016/0167-5699(93)90043-K; WATERS CA, 1990, EUR J IMMUNOL, V20, P785, DOI 10.1002/eji.1830200412; Weinstein GD, 1993, THERAPY OF MODERATE-TO-SEVERE PSORIASIS, P1; WILLIAMS DP, 1987, PROTEIN ENG, V1, P493, DOI 10.1093/protein/1.6.493	36	507	534	0	12	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	MAY	1995	1	5					442	447		10.1038/nm0595-442	http://dx.doi.org/10.1038/nm0595-442			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN100	7585092				2022-12-25	WOS:A1995RN10000035
J	SMITH, AJH; DESOUSA, MA; KWABIADDO, B; HEPPELLPARTON, A; IMPEY, H; RABBITTS, P				SMITH, AJH; DESOUSA, MA; KWABIADDO, B; HEPPELLPARTON, A; IMPEY, H; RABBITTS, P			A SITE-DIRECTED CHROMOSOMAL TRANSLOCATION INDUCED IN EMBRYONIC STEM-CELLS BY CRE-LOXP RECOMBINATION	NATURE GENETICS			English	Article							BACTERIOPHAGE-P1 RECOMBINASE; SACCHAROMYCES-CEREVISIAE; YEAST PLASMID; SYSTEM; GENE; EXPRESSION; GENOME; DISRUPTION; MECHANISM; MUTATIONS	We have developed a strategy for chromosome engineering in embryonic stem (ES) cells that relies on sequential gene targeting and Cre-loxP site-specific recombination. Gene targeting was first used to integrate loxP sites at the desired positions in the genome. Transient expression of Cre recombinase was then used to mediate the chromosomal rearrangement. A genetic selection relying on reconstruction of a selectable marker from sequences co-integrated with the loxP sites allowed detection of cells containing the Cre-mediated rearrangement. A programmed translocation between the c-myc and immunoglobulin heavy chain genes on chromosomes 15 and 12 was created by this method. This strategy will allow the design of a variety of chromosome rearrangements that can be selected and verified in ES cells or activated in ES cell-derived mice.	UNIV CAMBRIDGE, CTR MRC, MRC, CLIN ONCOL & RADIOTHERAPEUT UNIT, CAMBRIDGE CB2 2QH, ENGLAND	University of Cambridge	SMITH, AJH (corresponding author), UNIV CAMBRIDGE, CTR MRC, MRC, MOLEC BIOL LAB, HILLS RD, CAMBRIDGE CB2 2QH, ENGLAND.		Kwabi-Addo, Bernard/A-6993-2016	Kwabi-Addo, Bernard/0000-0003-3692-6350; de sousa, maria/0000-0002-4552-185X				ABREMSKI K, 1983, CELL, V32, P1301, DOI 10.1016/0092-8674(83)90311-2; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CORY S, 1986, ADV CANCER RES, V47, P189, DOI 10.1016/S0065-230X(08)60200-6; COX MM, 1988, GENETIC RECOMBINATIO, P429; CRAIG NL, 1988, ANNU REV GENET, V22, P77; DALE EC, 1990, GENE, V91, P79, DOI 10.1016/0378-1119(90)90165-N; ELLEDGE SJ, 1991, P NATL ACAD SCI USA, V88, P1731, DOI 10.1073/pnas.88.5.1731; EVANS MJ, 1989, MOL BIOL MED, V6, P557; GAGE PJ, 1992, J VIROL, V66, P5509, DOI 10.1128/JVI.66.9.5509-5515.1992; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HOESS RH, 1985, J MOL BIOL, V181, P351, DOI 10.1016/0022-2836(85)90224-4; HOESS RH, 1984, P NATL ACAD SCI-BIOL, V81, P1026, DOI 10.1073/pnas.81.4.1026; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; KOTTER BH, 1992, ANNU REV IMMUNOL, V10, P705; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATSUZAKI H, 1990, J BACTERIOL, V172, P610, DOI 10.1128/jb.172.2.610-618.1990; MATSUZAKI H, 1988, MOL CELL BIOL, V8, P955, DOI 10.1128/MCB.8.2.955; NEHLS M, 1994, BIOTECHNIQUES, V17, P770; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; QIN MM, 1994, P NATL ACAD SCI USA, V91, P1706, DOI 10.1073/pnas.91.5.1706; RABBITTS P, 1995, NAT GENET, V9, P369, DOI 10.1038/ng0495-369; REID LH, 1990, P NATL ACAD SCI USA, V87, P4299, DOI 10.1073/pnas.87.11.4299; RIELE HT, 1990, NATURE, V348, P649, DOI 10.1038/348649a0; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; SAUER B, 1990, New Biologist, V2, P441; STARK WM, 1992, TRENDS GENET, V8, P432, DOI 10.1016/0168-9525(92)90176-5; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; YARMOLINSKY MB, 1988, BACTERIOPHAGES, V1, P291; YEN PH, 1991, P NATL ACAD SCI USA, V88, P8944, DOI 10.1073/pnas.88.20.8944; YENOFSKY RL, 1990, P NATL ACAD SCI USA, V87, P3435, DOI 10.1073/pnas.87.9.3435	38	210	243	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	1995	9	4					376	385		10.1038/ng0495-376	http://dx.doi.org/10.1038/ng0495-376			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QQ753	7795643				2022-12-25	WOS:A1995QQ75300015
J	OUAHCHI, K; ARITA, M; KAYDEN, H; HENTATI, F; BENHAMIDA, M; SOKOL, R; ARAI, H; INOUE, K; MANDEL, JL; KOENIG, M				OUAHCHI, K; ARITA, M; KAYDEN, H; HENTATI, F; BENHAMIDA, M; SOKOL, R; ARAI, H; INOUE, K; MANDEL, JL; KOENIG, M			ATAXIA WITH ISOLATED VITAMIN-E-DEFICIENCY IS CAUSED BY MUTATIONS IN THE ALPHA-TOCOPHEROL TRANSFER PROTEIN	NATURE GENETICS			English	Article							RAT-LIVER; FRIEDREICH ATAXIA; BINDING-PROTEIN; ABSORPTION; GENE	Ataxia with isolated vitamin E deficiency (AVED) is an autosomal recessive neurodegenerative disease which maps to chromosome 8q13. AVED patients have an impaired ability to incorporate a-tocopherol into lipoproteins secreted by the liver, a function putatively attributable to the a-tocopherol transfer protein (alpha-TTP). Here we report the identification of three frame-shift mutations in the alpha TTP gene. A 744delA mutation accounts for 68% of the mutant alleles in the 17 families analysed and appears to have spread in North Africa and Italy. This mutation correlates with a severe phenotype but alters only the C-terminal tenth of the protein. Two other mutations were found in single families. The finding of alpha TTP gene mutations in AVED patients substantiates the therapeutic role of vitamin E as a protective agent against neurological damage in this disease.	UNIV TOKYO, FAC PHARMACEUT SCI, DEPT HLTH CHEM, BUNKYO KU, TOKYO 113, JAPAN; NYU, MED CTR, DEPT MED, NEW YORK, NY 10016 USA; INST NATL NEUROL, TUNIS 1007, TUNISIA; UNIV COLORADO, SCH MED, PEDIAT GASTROENTEROL & NUTR SECT, DENVER, CO 80218 USA; CHU STRASBOURG, F-67000 STRASBOURG, FRANCE; FAC MED STRASBOURG, STRASBOURG, FRANCE	University of Tokyo; New York University; Universite de Tunis-El-Manar; Institut National de Neurologie; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	OUAHCHI, K (corresponding author), UNIV STRASBOURG 1, INST GENET & BIOL MOLEC & CELLULAIRE,CNRS,INSERM, 1 RUE LAURENT FRIES, BP 163, F-67404 ILLKIRCH GRAFFENSTADEN, FRANCE.			Arita, Makoto/0000-0001-9902-0463	NCRR NIH HHS [RR00069] Funding Source: Medline; NIADDK NIH HHS [AM34914] Funding Source: Medline; NIDDK NIH HHS [DK38446] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [P30AM034914] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038446, R01DK038446] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMIEL J, IN PRESS J INHER MET; ARITA M, IN PRESS BIOCH J; BEHRENS WA, 1982, NUTR RES, V2, P611, DOI 10.1016/S0271-5317(82)80073-0; BENHAMIDA C, 1993, NAT GENET, V5, P195, DOI 10.1038/ng1093-195; BENHAMIDA M, 1993, NEUROLOGY, V43, P2179, DOI 10.1212/WNL.43.11.2179; BURCK U, 1981, NEUROPEDIATRICS, V12, P267, DOI 10.1055/s-2008-1059657; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; DI MASCIO P, 1991, AM J CLIN NUTR, V53, pS194, DOI 10.1093/ajcn/53.1.194S; DOERFLINGER N, IN PRESS AM J HUM GE; DUCLOS F, 1994, HUM MOL GENET, V3, P909, DOI 10.1093/hmg/3.6.909; HARDING AE, 1985, NEW ENGL J MED, V313, P32, DOI 10.1056/NEJM198507043130107; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; KAYDEN HJ, 1993, NEUROLOGY, V43, P2167, DOI 10.1212/WNL.43.11.2167; KAYDEN HJ, 1993, J LIPID RES, V34, P343; KOHLSCHUTTER A, 1988, J INHERIT METAB DIS, V11, P149, DOI 10.1007/BF01804221; KRENDEL DA, 1987, NEUROLOGY, V37, P538, DOI 10.1212/WNL.37.3.538; LAPLANTE P, 1984, CAN J NEUROL SCI, V11, P561, DOI 10.1017/S0317167100035046; MOWRI H, 1981, EUR J BIOCHEM, V117, P537; MULLER DPR, 1983, LANCET, V1, P225; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SATO Y, 1993, J BIOL CHEM, V268, P17705; SATO Y, 1991, FEBS LETT, V288, P41, DOI 10.1016/0014-5793(91)80999-J; SCHUBERT D, 1992, P NATL ACAD SCI USA, V89, P8264, DOI 10.1073/pnas.89.17.8264; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SIRUGO G, 1992, AM J HUM GENET, V50, P559; SOKOL RJ, 1988, J LAB CLIN MED, V111, P548; STUMPF DA, 1987, NEUROLOGY, V37, P68, DOI 10.1212/WNL.37.1.68; TRABER MG, 1990, J CLIN INVEST, V85, P397, DOI 10.1172/JCI114452; TRABER MG, 1994, P NATL ACAD SCI USA, V91, P10005, DOI 10.1073/pnas.91.21.10005; TRABER MG, 1993, J LIPID RES, V34, P201; TRABERT W, 1989, FORTSCHR NEUROL PSYC, V57, P495, DOI 10.1055/s-2007-1001146; YOKOTA T, 1987, ANN NEUROL, V22, P84, DOI 10.1002/ana.410220119	32	453	467	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	1995	9	2					141	145		10.1038/ng0295-141	http://dx.doi.org/10.1038/ng0295-141			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QE672	7719340				2022-12-25	WOS:A1995QE67200014
J	ROWLANDJONES, S; SUTTON, J; ARIYOSHI, K; DONG, T; GOTCH, F; MCADAM, S; WHITBY, D; SABALLY, S; GALLIMORE, A; CORRAH, T; TAKIGUCHI, M; SCHULTZ, T; MCMICHAEL, A; WHITTLE, H				ROWLANDJONES, S; SUTTON, J; ARIYOSHI, K; DONG, T; GOTCH, F; MCADAM, S; WHITBY, D; SABALLY, S; GALLIMORE, A; CORRAH, T; TAKIGUCHI, M; SCHULTZ, T; MCMICHAEL, A; WHITTLE, H			HIV-SPECIFIC CYTOTOXIC T-CELLS IN HIV-EXPOSED BUT UNINFECTED GAMBIAN WOMEN	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TOXIC LYMPHOCYTES-T; POLYMERASE CHAIN-REACTION; CLASS-I ANTIGENS; CONSERVED REGION; COTE-DIVOIRE; INFECTION; AIDS; RESPONSES; PEPTIDE	A crucial requirement in the rational design of a prophylactic vaccine against the huuman immunodeficiency virus (HIV) is to establish whether or not protective immunity can occur following natural infection. The immune response to HIV infection is characterized by very vigorous HIV-specific cytotoxic T-lymphocyte (CTL) activity. We have identified four HIV-1 and HIV-2 cross-reactive peptide epitopes, presented to CTL from HIV-infected Gambians by HLA-B35 (the most common Gambian class I HLA molecule). These peptides were used to elicit HIV-specific CTLs from three out of six repeatedly exposed but HIV-seronegative female prostitutes with HLA-B35. These women remain seronegative with no evidence of HIV infection by polymerase chain reaction or viral culture. Their CTL activity may represent protective immunity against HIV infection.	MRC LABS,FAJARA,SENEGAL; INST CANC RES,CHESTER BEATTY LABS,LONDON SW3 6JB,ENGLAND; UNIV TOKYO,INST MED SCI,DEPT TUMOR BIOL,TOKYO 108,JAPAN	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Tokyo	ROWLANDJONES, S (corresponding author), JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC IMMUNOL GRP,OXFORD OX3 9DU,ENGLAND.		Takiguchi, Masafumi/E-7468-2013	Dong, Tao/0000-0003-3545-3758; Gallimore, Awen/0000-0001-6675-7004				ALDHOUS MC, 1994, CLIN EXP IMMUNOL, V97, P61; ALLSOPP CEM, 1992, AM J HUM GENET, V50, P411; BERRY NJ, 1994, RETROVIRUSES, V8, P1031; BRETSCHER PA, 1992, SCIENCE, V257, P539, DOI 10.1126/science.1636090; BURROWS SR, 1994, J EXP MED, V179, P1155, DOI 10.1084/jem.179.4.1155; CARBONE FR, 1989, J EXP MED, V167, P1767; CARMICHAEL A, 1993, J EXP MED, V177, P249, DOI 10.1084/jem.177.2.249; CHEYNIER R, 1992, EUR J IMMUNOL, V22, P2211, DOI 10.1002/eji.1830220905; CLERICI M, 1994, JAMA-J AM MED ASSOC, V271, P42, DOI 10.1001/jama.271.1.42; CLERICI M, 1993, AIDS, V7, P1427, DOI 10.1097/00002030-199311000-00004; CLERICI M, 1994, AIDS, V8, P1391, DOI 10.1097/00002030-199410000-00004; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; CLERICI M, 1992, J INFECT DIS, V1165, P1012; CULMANN B, 1991, J IMMUNOL, V146, P1560; DEBRUIJN MLH, 1992, EUR J IMMUNOL, V22, P3013, DOI 10.1002/eji.1830221137; DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083; ELLIOTT T, 1993, CURR BIOL, V3, P854, DOI 10.1016/0960-9822(93)90219-E; GEORGE JR, 1992, LANCET, V340, P337, DOI 10.1016/0140-6736(92)91406-X; GOTCH F, 1993, J IMMUNOL, V151, P3361; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; HILL AVS, 1992, NATURE, V360, P434, DOI 10.1038/360434a0; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; JOHNSON RP, 1993, J VIROL, V67, P438, DOI 10.1128/JVI.67.1.438-445.1993; JOHNSON RP, 1992, J EXP MED, V175, P961, DOI 10.1084/jem.175.4.961; KALAMS SA, 1994, J EXP MED, V179, P1261, DOI 10.1084/jem.179.4.1261; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; KOS FJ, 1992, EUR J IMMUNOL, V22, P3183, DOI 10.1002/eji.1830221224; LANGLADEDEMOYEN P, 1994, J CLIN INVEST, V93, P1293, DOI 10.1172/JCI117085; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; LEE S, IN PRESS EV J IMMUNO; LEONARD G, 1993, AIDS, V7, P1185, DOI 10.1097/00002030-199309000-00006; LEVY JA, 1993, AIDS, V7, P1401, DOI 10.1097/00002030-199311000-00001; MABEY DCW, 1988, BRIT MED J, V296, P83, DOI 10.1136/bmj.296.6615.83; MACATONIA SE, 1989, J EXP MED, P1255; MARKOVITZ DM, 1993, ANN INTERN MED, V118, P211, DOI 10.7326/0003-4819-118-3-199302010-00010; MARTINSON F, 1990, EUR J IMMUNOL, V21, P2171; MIEDEMA F, 1993, SCIENCE, V262, P1074, DOI 10.1126/science.8235627; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; NEEFJES JJ, 1986, HUM IMMUNOL, V16, P169, DOI 10.1016/0198-8859(86)90046-7; NIXON DF, 1990, AIDS, V4, P841, DOI 10.1097/00002030-199009000-00002; NIXON DF, 1988, NATURE, V336, P484, DOI 10.1038/336484a0; PEETERS M, 1992, LANCET, V340, P339, DOI 10.1016/0140-6736(92)91407-Y; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; PICKERING H, 1993, AIDS, V7, P271, DOI 10.1097/00002030-199302000-00017; PINTO LA, 1993, AIDS, V7, P1389, DOI 10.1097/00002030-199310000-00016; PLATA F, 1987, NATURE, V328, P348, DOI 10.1038/328348a0; ROBERTGUROFF M, 1992, J VIROL, V66, P3602, DOI 10.1128/JVI.66.6.3602-3608.1992; ROWLANDJONES SL, 1993, LANCET, V341, P860, DOI 10.1016/0140-6736(93)93063-7; SAFRIT JT, 1994, J EXP MED, V179, P463, DOI 10.1084/jem.179.2.463; SALK J, 1993, SCIENCE, V262, P1075, DOI 10.1126/science.262.5136.1075; SALK J, 1993, SCIENCE, V260, P1270, DOI 10.1126/science.8098553; SCHECHTER MT, 1993, LANCET, V341, P658, DOI 10.1016/0140-6736(93)90421-C; SCHILD H, 1991, J EXP MED, V174, P1665, DOI 10.1084/jem.174.6.1665; SCHULZ TF, 1990, J VIROL, V64, P5177, DOI 10.1128/JVI.64.10.5177-5182.1990; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; SILVER J, 1993, NUCLEIC ACIDS RES, V21, P3593, DOI 10.1093/nar/21.15.3593; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; SIMON F, 1993, AIDS, V7, P1411, DOI 10.1097/00002030-199311000-00002; WALKER BD, 1987, NATURE, V328, P345, DOI 10.1038/328345a0; WILKINS A, 1991, AIDS, V5, P1529, DOI 10.1097/00002030-199112000-00018	60	675	706	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JAN	1995	1	1					59	64		10.1038/nm0195-59	http://dx.doi.org/10.1038/nm0195-59			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX557	7584954	Bronze			2022-12-25	WOS:A1995QX55700027
J	BIONE, S; MAESTRINI, E; RIVELLA, S; MANCINI, M; REGIS, S; ROMEO, G; TONIOLO, D				BIONE, S; MAESTRINI, E; RIVELLA, S; MANCINI, M; REGIS, S; ROMEO, G; TONIOLO, D			IDENTIFICATION OF A NOVEL X-LINKED GENE RESPONSIBLE FOR EMERY-DREIFUSS MUSCULAR-DYSTROPHY	NATURE GENETICS			English	Article							SEQUENCES; XQ28	Emery-Dreifuss muscular dystrophy (EDMD) is an X-linked recessive disorder characterized by slowly progressing contractures, wasting of skeletal muscle and cardiomyopathy. Heart block is a frequent cause of death. The disease gene has been mapped to distal Xq28. Among many genes in this region, we selected eight transcripts expressed at high levels in skeletal muscle, heart and/or brain as the best candidates for the disease. We now report, in all five patients studied, unique mutations in one of the genes, STA: these mutations result in the loss of all or part of the protein, The EDMD gene encodes a novel serine-rich protein termed emerin, which contains a 20 amino acid hydrophobic domain at the C terminus, similar to that described for many membrane proteins of the secretory pathway involved in vesicular transport.	CNR, IST GENET BIOCHIM & EVOLUZIONIST, I-27100 PAVIA, ITALY; IST GIANNINA GASLINI, GENET MOLEC LAB, I-16148 GENOA, ITALY	Consiglio Nazionale delle Ricerche (CNR); University of Genoa; IRCCS Istituto Giannina Gaslini			Rivella, Stefano/A-1597-2010; Maestrini, Elena/K-7508-2012; Toniolo, Daniela/AAE-2969-2019; Regis, Stefano/AAA-7794-2020	Maestrini, Elena/0000-0001-5924-3179; Toniolo, Daniela/0000-0001-9545-6032; Regis, Stefano/0000-0002-7723-2294; Bione, Silvia/0000-0002-3924-4606; Rivella, Stefano/0000-0002-0938-6558	Telethon [325, 271] Funding Source: Medline	Telethon(Fondazione Telethon)		BIENVENU T, 1994, HUM GENET, V94, P65, DOI 10.1007/BF02272843; BIONE S, 1993, P NATL ACAD SCI USA, V90, P10977, DOI 10.1073/pnas.90.23.10977; DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E; EMERY AEH, 1989, J MED GENET, V26, P637, DOI 10.1136/jmg.26.10.637; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; HARRIS CA, 1994, P NATL ACAD SCI USA, V91, P6283, DOI 10.1073/pnas.91.14.6283; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; McKusick VA, 1990, MENDELIAN INHERITANC; ROMEO G, 1988, HUM GENET, V80, P59, DOI 10.1007/BF00451457; Sambrook J, 1989, MOL CLONING LABORATO; TRIBIOLI C, 1994, HUM MOL GENET, V3, P1061, DOI 10.1093/hmg/3.7.1061; WARREN G, 1993, NATURE, V362, P297, DOI 10.1038/362297a0; WILLARD HF, 1994, CYTOGENET CELL GENET, V67, P296; WONG C, 1989, BLOOD, V73, P914; YATES JRW, 1993, J MED GENET, V30, P108, DOI 10.1136/jmg.30.2.108	18	697	722	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1994	8	4					323	327		10.1038/ng1294-323	http://dx.doi.org/10.1038/ng1294-323			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894480				2022-12-25	WOS:A1994PV68200010
J	MCALLISTER, KA; GROGG, KM; JOHNSON, DW; GALLIONE, CJ; BALDWIN, MA; JACKSON, CE; HELMBOLD, EA; MARKEL, DS; MCKINNON, WC; MURRELL, J; MCCORMICK, MK; PERICAKVANCE, MA; HEUTINK, P; OOSTRA, BA; HAITJEMA, T; WESTERMAN, CJJ; PORTEOUS, ME; GUTTMACHER, AE; LETARTE, M; MARCHUK, DA				MCALLISTER, KA; GROGG, KM; JOHNSON, DW; GALLIONE, CJ; BALDWIN, MA; JACKSON, CE; HELMBOLD, EA; MARKEL, DS; MCKINNON, WC; MURRELL, J; MCCORMICK, MK; PERICAKVANCE, MA; HEUTINK, P; OOSTRA, BA; HAITJEMA, T; WESTERMAN, CJJ; PORTEOUS, ME; GUTTMACHER, AE; LETARTE, M; MARCHUK, DA			ENDOGLIN, A TGF-BETA BINDING-PROTEIN OF ENDOTHELIAL-CELLS, IS THE GENE FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA TYPE-1	NATURE GENETICS			English	Article							RGD-CONTAINING GLYCOPROTEIN; HEMORRHAGIC TELANGIECTASIA; RECEPTOR SYSTEM; EXPRESSION; ULTRASTRUCTURE; IDENTIFICATION; BETAGLYCAN; COMPONENT; DISEASE	Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by multisystemic vascular dysplasia and recurrent haemorrhage. Linkage for some families has been established to chromosome 9q33-q34, In the present study, endoglin, a transforming growth factor beta (TGF-beta) binding protein, was analysed as a candidate gene for the disorder based on chromosomal location, expression pattern and function, We have identified mutations in three affected individuals: a C to G substitution converting a tyrosine to a termination codon, a 39 base pair deletion and a 2 basepair deletion which creates a premature termination codon, We have identified endoglin as the HHT gene mapping to 9q3 and have established HHT as the first human disease defined by a mutation in a member of the TGF-beta receptor complex.	DUKE UNIV,MED CTR,DEPT GENET,DURHAM,NC 27710; HENRY FORD HOSP,DIV CLIN & MOLEC GENET,DETROIT,MI 48202; UNIV MICHIGAN,MED CTR,CTR HUMAN GENOME,STUDIES FAMILY CORE,ANN ARBOR,MI 48109; UNIV VERMONT,COLL MED,DEPT PEDIAT,BURLINGTON,VT 05401; MASSACHUSETTS GEN HOSP,MOLEC NEUROGENET LAB,BOSTON,MA 02129; DUKE UNIV,MED CTR,DIV NEUROL,DURHAM,NC 27710; ERASMUS UNIV ROTTERDAM,DEPT CLIN GENET,3000 DR ROTTERDAM,NETHERLANDS; ST ANTONIUS HOSP,3430 EM NIEUWEGEIN,NETHERLANDS; UNIV EDINBURGH,DEPT HUMAN GENET,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; HOSP SICK CHILDREN,DIV IMMUNOL & CANC,RES INST,TORONTO M5G 1X8,ON,CANADA	Duke University; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; University of Vermont; Harvard University; Massachusetts General Hospital; Duke University; Erasmus University Rotterdam; St. Antonius Hospital Utrecht; University of Edinburgh; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)				Markel, Dorene/0000-0002-3382-6779; Marchuk, Douglas/0000-0002-3110-6671	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049171] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 49171] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BELLON T, 1993, EUR J IMMUNOL, V23, P2340, DOI 10.1002/eji.1830230943; Blanchard M M, 1993, PCR Methods Appl, V2, P234; BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569; CHEIFETZ S, 1990, J BIOL CHEM, V265, P20533; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; FERNANDEZRUIZ E, 1993, CYTOGENET CELL GENET, V64, P204, DOI 10.1159/000133576; GOUGOS A, 1992, INT IMMUNOL, V4, P83, DOI 10.1093/intimm/4.1.83; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; GREENSPAN DS, IN PRESS GENOMICS; HASHIMOTO K, 1972, ORAL SURG ORAL MED O, V34, P751, DOI 10.1016/0030-4220(72)90293-9; HEUTINK P, 1994, J MED GENET, V31, P933, DOI 10.1136/jmg.31.12.933; JAHNKE V, 1970, ARCHIV OTOLARYNGOL, V91, P262; JENNINGS JC, 1988, J CELL PHYSIOL, V137, P167, DOI 10.1002/jcp.1041370120; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; LASTRES P, 1992, EUR J IMMUNOL, V22, P393, DOI 10.1002/eji.1830220216; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; LEVERSHA MA, 1994, ANN HUM GENET, V58, P224; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; LOPEZCASILLAS F, 1993, CELL, V73, P1435, DOI 10.1016/0092-8674(93)90368-Z; LUSCINSKAS FW, 1994, FASEB J, V8, P929, DOI 10.1096/fasebj.8.12.7522194; MADRI JA, 1992, ENDOTHELIAL CELL DYS; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; MATHEW S, 1994, GENOMICS, V20, P114, DOI 10.1006/geno.1994.1134; MCALLISTER KA, 1994, J MED GENET, V31, P927, DOI 10.1136/jmg.31.12.927; MCDONALD MT, 1994, NAT GENET, V6, P197, DOI 10.1038/ng0294-197; MENEFEE MG, 1975, ARCH OTOLARYNGOL, V101, P246; PILZ A, 1994, ANN HUM GENET, V58, P231; PORTEOUS MEM, 1994, J MED GENET, V31, P925, DOI 10.1136/jmg.31.12.925; POVEY S, 1994, ANN HUM GENET, V58, P177, DOI 10.1111/j.1469-1809.1994.tb01887.x; SHOVLIN CL, 1994, NAT GENET, V6, P205, DOI 10.1038/ng0294-205; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; STJACQUES S, 1994, ENDOCRINOLOGY, V134, P2645, DOI 10.1210/en.134.6.2645; WANG XF, 1991, CELL, V67, P797, DOI 10.1016/0092-8674(91)90074-9; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; YAMASHITA H, 1994, J BIOL CHEM, V269, P1995	36	1114	1159	0	30	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1994	8	4					345	351		10.1038/ng1294-345	http://dx.doi.org/10.1038/ng1294-345			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PV682	7894484	Green Published			2022-12-25	WOS:A1994PV68200014
J	BAIN, SC; PRINS, JB; HEARNE, CM; RODRIGUES, NR; ROWE, BR; PRITCHARD, LE; RITCHIE, RJ; HALL, JRS; UNDLIEN, DE; RONNINGEN, KS; DUNGER, DB; BARNETT, AH; TODD, JA				BAIN, SC; PRINS, JB; HEARNE, CM; RODRIGUES, NR; ROWE, BR; PRITCHARD, LE; RITCHIE, RJ; HALL, JRS; UNDLIEN, DE; RONNINGEN, KS; DUNGER, DB; BARNETT, AH; TODD, JA			INSULIN GENE REGION-ENCODED SUSCEPTIBILITY TO TYPE-1 DIABETES IS NOT RESTRICTED TO HLA-DR4-POSITIVE INDIVIDUALS	NATURE GENETICS			English	Article							HLA-DR; MELLITUS; ASSOCIATION; LINKAGE; DISEASE; HETEROGENEITY; POLYMORPHISM; HLA-DR3; FAMILY; MICE	Type 1 or insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease of the insulin-producing pancreatic beta-cells which is determined by both genetic and environmental factors. The major histocompatibility complex and the insulin gene region (INS) on human chromosomes 6p and 11p, respectively, contain susceptibility genes. Using a mostly French data set, evidence for linkage of INS to IDDM was recently obtained but only in male meioses (suggesting involvement of maternal imprinting) and only in HLA-DR4-positive diabetics. In contrast, we find evidence for linkage in both male and female meioses and that the effect of the susceptibility gene(s) in the INS region is not dependent on the presence of HLA-DR4.	UNIV OXFORD, JOHN RADCLIFFE HOSP, NUFFIELD DEPT SURG, OXFORD OX3 9DU, ENGLAND; E BIRMINGHAM DIST GEN HOSP, BIRMINGHAM B9 5ST, W MIDLANDS, ENGLAND; UNIV OXFORD, JOHN RADCLIFFE HOSP, DEPT PAEDIAT, OXFORD OX3 9DU, ENGLAND; UNIV BIRMINGHAM, DEPT MED, BIRMINGHAM B15 2TT, W MIDLANDS, ENGLAND; NATL HOSP, INST TRANSPLANTAT IMMUNOL, N-0027 OSLO, NORWAY	University of Oxford; University of Oxford; University of Birmingham; University of Oslo; National Hospital Norway			Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Prins, Jan-Bas/0000-0002-1831-8522	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AWAD J, 1987, TISSUE ANTIGENS, V29, P55; BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; BAIN SC, IN PRESS METHODS MOL; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; CAILLATZUCMAN S, 1992, IN PRESS J CLIN INVE; CASTANO L, 1990, ANNU REV IMMUNOL, V8, P647, DOI 10.1146/annurev.iy.08.040190.003243; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; COX NJ, 1988, AM J HUM GENET, V43, P495; DCCT Res Grp, 1987, J CLIN ENDOCR METAB, V65, P30; DESCHAMPS I, 1988, DIABETOLOGIA, V31, P896; DONALD JA, 1989, GENET EPIDEMIOL, V6, P77, DOI 10.1002/gepi.1370060115; FIELD LL, 1991, BAILLIERE CLIN ENDOC, V5, P413, DOI 10.1016/S0950-351X(05)80139-9; HALDANE JBS, 1956, ANN HUM GENET, V20, P309; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; HYER RN, 1991, AM J HUM GENET, V48, P243; JENKINS D, 1990, DIABETOLOGIA, V33, P387, DOI 10.1007/BF00404086; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KARJALAINEN J, 1989, NEW ENGL J MED, V320, P881, DOI 10.1056/NEJM198904063201401; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; MCGINNIS RE, 1991, AM J HUM GENET S, V49, pA476; OKOYE RC, 1989, TISSUE ANTIGENS, V33, P445, DOI 10.1111/j.1399-0039.1989.tb01693.x; OWERBACH D, 1990, DIABETES, V39, P1504, DOI 10.2337/diabetes.39.12.1504; RAFFEL LJ, 1991, METABOLISM, V40, P1244, DOI 10.1016/0026-0495(91)90023-P; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1987, AM J HUM GENET, V40, P1; TARN AC, 1988, LANCET, V1, P845; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TODD JA, 1991, DIABETIC MED, V8, P906, DOI 10.1111/j.1464-5491.1991.tb01528.x; TODD JA, 1990, DIABETIC MED, V164, P17; WINEARLS BC, 1984, TISSUE ANTIGENS, V24, P234, DOI 10.1111/j.1399-0039.1984.tb02132.x; WOLF E, 1983, DIABETOLOGIA, V24, P224; ZHANG YH, 1992, NAT GENET, V1, P40, DOI 10.1038/ng0492-40	34	124	124	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1992	2	3					212	215		10.1038/ng1192-212	http://dx.doi.org/10.1038/ng1192-212			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345171				2022-12-25	WOS:A1992JW16500011
J	MCCOMBIE, WR; ADAMS, MD; KELLEY, JM; FITZGERALD, MG; UTTERBACK, TR; KHAN, M; DUBNICK, M; KERLAVAGE, AR; VENTER, JC; FIELDS, C				MCCOMBIE, WR; ADAMS, MD; KELLEY, JM; FITZGERALD, MG; UTTERBACK, TR; KHAN, M; DUBNICK, M; KERLAVAGE, AR; VENTER, JC; FIELDS, C			CAENORHABDITIS-ELEGANS EXPRESSED SEQUENCE TAGS IDENTIFY GENE FAMILIES AND POTENTIAL DISEASE GENE HOMOLOGS	NATURE GENETICS			English	Article							C-ELEGANS; MOLECULAR ANALYSIS; LEADER SEQUENCE; SPLICED LEADER; COLLAGEN GENES; MESSENGER-RNA; BETA-TUBULIN; PROTEIN; CLONING; GENOME	A database containing mapped partial cDNA sequences from Caenorhabdhitis elegans will provide a ready starting point for identifying nematode homologues of important human genes and determining their functions in C. elegans. A total of 720 expressed sequence tags (ESTs) have been generated from 585 clones randomly selected from a mixed-stage C. elegans cDNA library. Comparison of these ESTs with sequence databases identified 422 new C. elegans genes, of which 317 are not similar to any sequences in the database. Twenty-six new genes have been mapped by YAC clone hybridization. Members of several gene families, including cuticle collagens, GTP-binding proteins, and RNA helicases were discovered. Many of the new genes are similar to known or potential human disease genes, including CFTR and the LDL receptor.	NINCDS, RECEPTOR BIOCHEM & MOLEC BIOL SECT, PK BLDG, ROOM 405, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)				Fields, Chris/0000-0002-4812-0744; Kerlavage, Anthony/0000-0002-3954-9653; McCombie, W. Richard/0000-0003-1899-0682				ADAMS MD, 1992, NATURE, V355, P632, DOI 10.1038/355632a0; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BEKTESH S, 1988, GENE DEV, V2, P1277, DOI 10.1101/gad.2.10.1277; BRENNER S, 1974, GENETICS, V77, P71; BRYANT PJ, 1992, CELL, V68, P621, DOI 10.1016/0092-8674(92)90136-Z; BURGESS S, 1990, CELL, V60, P705, DOI 10.1016/0092-8674(90)90086-T; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; CHEN JH, 1990, NUCLEIC ACIDS RES, V18, P6447, DOI 10.1093/nar/18.21.6447; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; COX GN, 1989, GENE, V76, P331, DOI 10.1016/0378-1119(89)90173-X; DEVALOIR T, 1991, P NATL ACAD SCI USA, V88, P2113, DOI 10.1073/pnas.88.6.2113; DIBB NJ, 1989, J MOL BIOL, V205, P603, DOI 10.1016/0022-2836(89)90229-5; DRISCOLL M, 1989, J CELL BIOL, V109, P2993, DOI 10.1083/jcb.109.6.2993; EDGLEY ML, 1990, GENETIC MAPS, V5, P3111; FIRE A, 1991, DEVELOPMENT, V113, P503; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; GRIDLEY T, 1990, DEVELOPMENT, V109, P235; GUILLEMOT F, 1989, P NATL ACAD SCI USA, V86, P4594, DOI 10.1073/pnas.86.12.4594; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HESCHL MFP, 1989, DNA-J MOLEC CELL BIO, V8, P233, DOI 10.1089/dna.1.1989.8.233; HODGKIN J, 1983, GENETICS, V103, P43; HOOG C, 1991, NUCLEIC ACIDS RES, V19, P6123, DOI 10.1093/nar/19.22.6123; HUANG XY, 1989, P NATL ACAD SCI USA, V86, P8640, DOI 10.1073/pnas.86.22.8640; KAGAWA H, 1989, J MOL BIOL, V207, P311, DOI 10.1016/0022-2836(89)90257-X; KRAUSE M, 1989, J MOL BIOL, V208, P381, DOI 10.1016/0022-2836(89)90503-2; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; KURODA MI, 1991, CELL, V66, P935, DOI 10.1016/0092-8674(91)90439-6; LINDER P, 1989, NATURE, V337, P11; MCCOMBIE WR, IN PRESS DNA SEQUENC; McKusick VA, 1990, MENDELIAN INHERITANC; NIELSEN PJ, 1985, NUCLEIC ACIDS RES, V13, P6867, DOI 10.1093/nar/13.19.6867; PARK YS, 1990, J MOL BIOL, V211, P395, DOI 10.1016/0022-2836(90)90360-X; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RIORDAN JR, 1989, SCIENCE, V245, P1066; RUFF P, 1991, P NATL ACAD SCI USA, V88, P6595, DOI 10.1073/pnas.88.15.6595; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; Schatz B. R., 1991, Journal of Management Information Systems, V8, P87; SPEITH J, 1991, J MOL EVOL, V32, P429; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; SPIETH J, 1985, NUCLEIC ACIDS RES, V13, P5283, DOI 10.1093/nar/13.14.5283; VONMENDE N, 1988, CELL, V55, P567, DOI 10.1016/0092-8674(88)90215-2; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; Wood WB, 1988, NEMATODE CAENORHABDI; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X	48	164	197	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	1992	1	2					124	131		10.1038/ng0592-124	http://dx.doi.org/10.1038/ng0592-124			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JC980	1302005				2022-12-25	WOS:A1992JC98000011
J	HO, C; CONNER, DA; POLLAK, MR; LADD, DJ; KIFOR, O; WARREN, HB; BROWN, EM; SEIDMAN, JG; SEIDMAN, CE				HO, C; CONNER, DA; POLLAK, MR; LADD, DJ; KIFOR, O; WARREN, HB; BROWN, EM; SEIDMAN, JG; SEIDMAN, CE			A MOUSE MODEL OF HUMAN FAMILIAL HYPOCALCIURIC HYPERCALCEMIA AND NEONATAL SEVERE HYPERPARATHYROIDISM	NATURE GENETICS			English	Article							PARATHYROID-HORMONE LEVELS; KINDREDS	Mice lacking the calcium-sensing receptor (Casr) were created to examine the receptor's role in calcium homeostasis and to elucidate the mechanism by which inherited human Casr gene defects cause diseases. Casr(+/-) mice, analogous to humans with familial hypocalciuric hypercalcemia, had benign and modest elevations of serum calcium, magnesium and parathyroid hormone levels as well as hypocalciuria. In contrast, Casr(-/-) mice, like humans with neonatal severe hyperparathyroidism, had markedly elevated serum calcium and parathyroid hormone levels, parathyroid hyperplasia, bone abnormalities, retarded growth and premature death. Our findings suggest that Casr mutations cause these human disorders by reducing the number of functional receptor molecules on the cell surface.	BRIGHAM & WOMENS HOSP,DEPT MED,DIV RENAL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,HOWARD HUGHES MED INST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,DIV ENDOCRINE HYPERTENS,BOSTON,MA 02115; HARVARD UNIV,SCH MED,CTR ANIM RESOURCES & COMPARAT MED,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School					NIDDK NIH HHS [DK02138, DK41415, DK46422] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K11DK002138, R01DK041415, R01DK046422] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLAIR JW, 1991, EUR J PEDIATR SURG, V1, P110, DOI 10.1055/s-2008-1042470; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; BRENT GA, 1988, J CLIN ENDOCR METAB, V67, P944, DOI 10.1210/jcem-67-5-944; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; BROWN EM, 1995, AM J KIDNEY DIS, V25, P506, DOI 10.1016/0272-6386(95)90118-3; DUNN TB, 1949, J NATL CANCER I, V10, P725; ERICKSON PA, 1993, ANTIBODIES CELL BIOL, P283; HENDRICKSON BA, IN PRESS J EXP MED; HUMMEL KP, 1966, BIOL LABORATORY MOUS, P258; INGMAN F, 1966, MICROCHEM J, V10, P545, DOI 10.1016/0026-265X(66)90239-6; LAW WM, 1985, ANN INTERN MED, V102, P511, DOI 10.7326/0003-4819-102-4-511; MARX SJ, 1982, NEW ENGL J MED, V306, P257, DOI 10.1056/NEJM198202043060502; MARX SJ, 1985, AM J MED, V78, P15, DOI 10.1016/0002-9343(85)90455-3; MARX SJ, 1981, MEDICINE, V60, P397, DOI 10.1097/00005792-198111000-00002; MCMURTRY CT, 1992, AM J MED, V93, P247, DOI 10.1016/0002-9343(92)90229-5; POLLAK MR, 1994, J CLIN INVEST, V93, P1108, DOI 10.1172/JCI117062; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; POWELL BR, 1992, PEDIATRICS, V91, P144; RICCARDI D, 1994, P NATL ACAD SCI USA, V92, P131; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; SARKAR BCR, 1967, ANAL BIOCHEM, V20, P155, DOI 10.1016/0003-2697(67)90273-4; WARREN HB, 1989, ENDOCRINOLOGY, V125, P2683, DOI 10.1210/endo-125-5-2683	24	472	486	1	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					389	394		10.1038/ng1295-389	http://dx.doi.org/10.1038/ng1295-389			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493018				2022-12-25	WOS:A1995TH62900015
J	MEYERS, GA; ORLOW, SJ; MUNRO, IR; PRZYLEPA, KA; JABS, EW				MEYERS, GA; ORLOW, SJ; MUNRO, IR; PRZYLEPA, KA; JABS, EW			FIBROBLAST-GROWTH-FACTOR-RECEPTOR-3 (FGFR3) TRANSMEMBRANE MUTATION IN CROUZON-SYNDROME WITH ACANTHOSIS NIGRICANS	NATURE GENETICS			English	Note							EXPRESSION PATTERN		NYU,SCH MED,RONALD O PERELMAN DEPT DERMATOL,DEPT CELL BIOL,NEW YORK,NY 10016; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PEDIAT,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT MED,BALTIMORE,MD 21287; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT SURG,BALTIMORE,MD 21287; MED CITY DALLAS HOSP,CTR CHILDREN,CTR CRANIOFACIAL,DALLAS,TX 75230	New York University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Medical City Dallas Hospital				Jabs, Ethylin/0000-0001-8983-5466; Orlow, Seth/0000-0003-2548-7380	NICHD NIH HHS [HD24061] Funding Source: Medline; NIDCR NIH HHS [DE10180, DE11131] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE010180, P50DE011131] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AVIVI A, 1993, FEBS LETT, V330, P249, DOI 10.1016/0014-5793(93)80882-U; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; BELLUS GA, 1995, AM J HUM GENET, V56, P368; BREITBART AS, 1989, ANN PLAS SURG, V22, P310, DOI 10.1097/00000637-198904000-00005; CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620; GORRY MC, 1995, HUM MOL GENET, V4, P1387, DOI 10.1093/hmg/4.8.1387; JABS EW, 1994, NAT GENET, V8, P275, DOI 10.1038/ng1194-275; LAJEUNIE E, 1995, NAT GENET, V9, P108, DOI 10.1038/ng0295-108; LI X, 1995, NAT GENET, V9, P232, DOI 10.1038/ng0395-232; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; MURGUE B, 1994, CANCER RES, V54, P5206; NOJI S, 1993, PROG CLIN BIOL RES, V63, P645; ORLOW SJ, 1992, ARCH DERMATOL, V128, P1379, DOI 10.1001/archderm.128.10.1379; PARK WJ, 1995, AM J HUM GENET, V57, P321; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PETERS K, 1993, DEV BIOL, V155, P423, DOI 10.1006/dbio.1993.1040; REARDON W, 1994, NAT GENET, V8, P98, DOI 10.1038/ng0994-98; RENDON MI, 1989, J AM ACAD DERMATOL, V21, P461, DOI 10.1016/S0190-9622(89)70208-5; ROUSSEAU F, 1995, NAT GENET, V10, P11, DOI 10.1038/ng0595-11; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; RUTLAND P, 1995, NAT GENET, V9, P173, DOI 10.1038/ng0295-173; SCHELL U, 1995, HUM MOL GENET, V4, P323, DOI 10.1093/hmg/4.3.323; SHI DL, 1994, J CELL SCI, V107, P417; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; STOILOV I, 1995, AM J MED GENET, V55, P127, DOI 10.1002/ajmg.1320550132; SUPERTIFURGA A, 1995, EUR J PEDIATR, V154, P215, DOI 10.1007/BF01954274; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165	30	306	319	0	10	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	DEC	1995	11	4					462	464		10.1038/ng1295-462	http://dx.doi.org/10.1038/ng1295-462			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TH629	7493034				2022-12-25	WOS:A1995TH62900031
J	ADLKOFER, K; MARTINI, R; AGUZZI, A; ZIELASEK, J; TOYKA, KV; SUTER, U				ADLKOFER, K; MARTINI, R; AGUZZI, A; ZIELASEK, J; TOYKA, KV; SUTER, U			HYPERMYELINATION AND DEMYELINATING PERIPHERAL NEUROPATHY IN PMP22-DEFICIENT MICE	NATURE GENETICS			English	Article							TOOTH DISEASE TYPE-1A; TREMBLER-J MOUSE; ARREST-SPECIFIC GENE; MYELIN PROTEIN; POINT MUTATION; SCHWANN-CELLS; HEREDITARY NEUROPATHY; PRESSURE PALSIES; NERVOUS-SYSTEM; PMP22 GENE	Peripheral myelin protein PMP22 has been suggested to have a role in peripheral nerve myelination and cell proliferation. Defects at the PMP22 locus are associated with peripheral neuropathies such as Charcot-Marie-Tooth disease type 1A. We now demonstrate that mice devoid of Pmp22 are retarded in the onset of myelination and develop abundant sausage-like hypermyelination structures (tomacula) at a young age followed by severe demyelination, axonal loss and functional impairment. Mice carrying one functional copy of Pmp22 are less affected but they also exhibit focal tomacula comparable to the morphological features in hereditary neuropathy with liability to pressure palsies (HNPP). We conclude that Pmp22 is required for the correct development of peripheral nerves, the maintenance of axons and the determination of myelin thickness and stability.	ETH HONGGERBERG,DEPT CELL BIOL,CH-8093 ZURICH,SWITZERLAND; ETH HONGGERBERG,DEPT NEUROBIOL,CH-8093 ZURICH,SWITZERLAND; UNIV ZURICH HOSP,INST NEUROPATHOL,CH-8091 ZURICH,SWITZERLAND; UNIV WURZBURG,DEPT NEUROL,D-97080 WURZBURG,GERMANY	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Wurzburg			Aguzzi, Adriano/A-3351-2008; Suter, Ueli/A-1624-2010	Aguzzi, Adriano/0000-0002-0344-6708; Martini, Rudolf/0000-0002-5463-5592				AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; BAECHER D, IN PRESS J NEUROSCI; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; CHANCE PF, 1994, HUM MOL GENET, V3, P323; COLLELO RJ, 1994, J NEUROSCI, V14, P2594; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Dyck P.J, 1993, PNP, P1094; DYCK PJ, 1984, PERIPHERAL NEUROPATH, P760; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HENRY EW, 1983, J NEUROPATH EXP NEUR, V42, P688, DOI 10.1097/00005072-198311000-00008; LOW PA, 1977, J NEUROL NEUROSUR PS, V40, P434, DOI 10.1136/jnnp.40.5.434; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANFIOLETTI G, 1990, MOL CELL BIOL, V10, P2924, DOI 10.1128/MCB.10.6.2924; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; MARTINI R, 1995, J NEUROSCI, V15, P4488; MATSUNAMI N, 1992, NAT GENET, V1, P176, DOI 10.1038/ng0692-176; MEIER C, 1982, J NEUROL, V228, P73, DOI 10.1007/BF00313754; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; NAVE KA, 1994, J NEUROSCI RES, V38, P607, DOI 10.1002/jnr.490380602; NICHOLSON GA, 1994, NAT GENET, V6, P263, DOI 10.1038/ng0394-263; PAREEK S, 1993, J BIOL CHEM, V268, P10372; PARMANTIER E, 1995, EUR J NEUROSCI, V7, P1080, DOI 10.1111/j.1460-9568.1995.tb01095.x; PATEL PI, 1992, NAT GENET, V1, P159, DOI 10.1038/ng0692-159; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Peters A., 1991, FINE STRUCTURE NERVO, P212; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; ROA BB, 1993, NAT GENET, V5, P269, DOI 10.1038/ng1193-269; RUFFNER H, 1993, P NATL ACAD SCI USA, V90, P11503, DOI 10.1073/pnas.90.24.11503; SHINE HD, 1992, J NEUROCHEM, V58, P342, DOI 10.1111/j.1471-4159.1992.tb09316.x; SKRE H, 1974, CLIN GENET, V6, P98; SNIPES GJ, 1995, J ANAT, V186, P483; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; SPREYER P, 1991, EMBO J, V10, P3661, DOI 10.1002/j.1460-2075.1991.tb04933.x; SUTER U, 1993, TRENDS NEUROSCI, V16, P50, DOI 10.1016/0166-2236(93)90015-E; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1995, ANNU REV NEUROSCI, V18, P45, DOI 10.1146/annurev.ne.18.030195.000401; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; SUTER U, 1995, J NEUROSCI RES, V40, P145, DOI 10.1002/jnr.490400202; SUTER U, 1994, J BIOL CHEM, V269, P25795; TAYLOR V, IN PRESS J BIOL CHEM; THOMAS FP, 1994, ACTA NEUROPATHOL, V87, P91; TIMMERMAN V, 1992, NAT GENET, V1, P171, DOI 10.1038/ng0692-171; UNCINI A, 1995, MUSCLE NERVE, V18, P628, DOI 10.1002/mus.880180610; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; VALENTIJN LJ, 1992, NAT GENET, V1, P166, DOI 10.1038/ng0692-166; VALENTIJN LJ, 1995, HUM MUTAT, V5, P76, DOI 10.1002/humu.1380050110; WELCHER AA, 1991, P NATL ACAD SCI USA, V88, P7195, DOI 10.1073/pnas.88.16.7195; Windebank A, 1993, PERIPHERAL NEUROPATH, V2, P1137; ZOIDL G, 1995, EMBO J, V14, P1122, DOI 10.1002/j.1460-2075.1995.tb07095.x	53	267	271	0	11	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	NOV	1995	11	3					274	280		10.1038/ng1195-274	http://dx.doi.org/10.1038/ng1195-274			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TC639	7581450				2022-12-25	WOS:A1995TC63900015
J	WANG, MZ; JIN, P; BUMCROT, DA; MARIGO, V; MCMAHON, AP; WANG, EA; WOOLF, T; PANG, K				WANG, MZ; JIN, P; BUMCROT, DA; MARIGO, V; MCMAHON, AP; WANG, EA; WOOLF, T; PANG, K			INDUCTION OF DOPAMINERGIC NEURON PHENOTYPE IN THE MIDBRAIN BY SONIC HEDGEHOG PROTEIN	NATURE MEDICINE			English	Article							CELL PATTERN; FLOOR PLATE; NOTOCHORD	Loss of substantia nigra dopaminergic neurons, which develop from the ventral region of the midbrain, is associated with Parkinson's disease. During embryogenesis, induction of these and other ventral neurons is influenced by interactions with the underlying mesoderm of the notochord and the floor plate, which lies at the ventral midline of the developing CNS. Sonic hedgehog encodes a secreted peptide, which is expressed in notochord and floor plate cells and can induce appropriate ventral cell types in the basal forebrain and spinal cord. Here we demonstrate that Sonic hedgehog is sufficient to induce dopaminergic and other neuronal phenotypes in chick mesencephalic explants in vitro. We find that Sonic hedgehog is a general ventralizing signal in the CNS, the specific response being determined by the receiving cells. These results suggest that Sonic hedgehog may have utility in the induction of clinically important cell types.	ONTOGENY INC,CAMBRIDGE,MA 02139; HARVARD UNIV,DEPT MOLEC & CELLULAR BIOL,CAMBRIDGE,MA 02138; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School			Marigo, Valeria/B-7947-2015; McMahon, Andrew P/ABE-7520-2020	Marigo, Valeria/0000-0002-4428-2084; 				ANG SL, 1993, DEVELOPMENT, V119, P1301; BUMCROT DA, 1995, MOL CELL BIOL, V15, P2294; CHANG DT, 1994, DEVELOPMENT, V120, P3339; COULY GF, 1987, DEV BIOL, V120, P198, DOI 10.1016/0012-1606(87)90118-7; DONLACH T, 1992, SCIENCE, V257, P542; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; ERICSON J, 1995, CELL, V81, P1; FORBES AJ, 1993, DEVELOPMENT, P115; FREED CR, 1992, NEW ENGL J MED, V327, P1549, DOI 10.1056/NEJM199211263272202; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HYNES M, 1995, CELL, V80, P95, DOI 10.1016/0092-8674(95)90454-9; KORDOWER JH, 1995, NEW ENGL J MED, V332, P1118, DOI 10.1056/NEJM199504273321702; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; LINDVALL O, 1994, FUNCTIONAL NEURAL TR, P103; MARIGO V, 1995, GENOMICS, V28, P44, DOI 10.1006/geno.1995.1104; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; MITRANI E, 1990, SCIENCE, V247, P1092, DOI 10.1126/science.11032544; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V75, P761; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; METHODS APPLICATIONS, P39	29	141	154	1	7	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	NOV	1995	1	11					1184	1188		10.1038/nm1195-1184	http://dx.doi.org/10.1038/nm1195-1184			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	TC537	7584992				2022-12-25	WOS:A1995TC53700044
J	LI, YM; TAN, AX; VLASSARA, H				LI, YM; TAN, AX; VLASSARA, H			ANTIBACTERIAL ACTIVITY OF LYSOZYME AND LACTOFERRIN IS INHIBITED BY BINDING OF ADVANCED GLYCATION-MODIFIED PROTEINS TO A CONSERVED MOTIF	NATURE MEDICINE			English	Article							GLYCOSYLATION END-PRODUCTS; DIABETES-MELLITUS; DEFENSINS; PEPTIDES; INVIVO	Why diabetes is associated with abnormally high susceptibility to infection remains unknown, although two major antibacterial proteins, lysozyme and lactoferrin, have now been shown to specifically bind glucose-modified proteins bearing advanced glycation end products (AGEs). Exposure to AGE-modified proteins inhibits the enzymatic and bactericidal activity of lysozyme, and blocks the bacterial agglutination and bacterial killing activities of lactoferrin. Peptide mapping revealed a single AGE binding domain in lysozyme and two AGE binding domains in lactoferrin; each domain contains a 17- to 18-amino acid cysteine-bounded loop motif (CX(15-16)C) that is markedly hydrophilic. Synthetic peptides corresponding to these motifs in lysozyme and lactoferrin exhibited AGE binding activity, and similar domains are also present in other antimicrobial proteins. These results suggest that elevated levels of AGEs in tissues and serum of diabetic patients may inhibit endogenous antibacterial proteins by binding to this conserved AGE-binding cysteine-bounded domain 'ABCD' motif, thereby increasing susceptibility to bacterial infections in the diabetic population.			LI, YM (corresponding author), PICOWER INST MED RES,350 COMMUNITY DR,MANHASSET,NY 11030, USA.							ANDERSON B, 1992, NATURE, V344, P784; BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; Ben-Aryeh Hanna, 1993, Journal of Diabetes and its Complications, V7, P57, DOI 10.1016/1056-8727(93)90025-T; BUCALA R, 1992, POSTTRANSLATIONAL MO, P53; CASEY JI, 1991, DIABETES MELLITUS TH, P617; GABAY JE, 1993, CURR OPIN IMMUNOL, V5, P97, DOI 10.1016/0952-7915(93)90087-9; JOHNSTONE AP, 1978, BIOCHEMISTRY-US, V17, P1337, DOI 10.1021/bi00600a031; LECHOWSKI R, 1991, J VET MED A, V38, P530, DOI 10.1111/j.1439-0442.1991.tb01044.x; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; MAHONEY WC, 1979, BIOCHEMISTRY-US, V18, P3810, DOI 10.1021/bi00584a026; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; MOUTSCHEN MP, 1992, DIABETES METAB, V18, P187; MURATSU K, 1985, INFECT IMMUN, V48, P389, DOI 10.1128/IAI.48.2.389-394.1985; OBERG G, 1986, DIABETOLOGIA, V29, P426, DOI 10.1007/BF00506533; PERILLIE PE, 1974, LYSOZYME, P359; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; REITER B, 1969, NATURE, V216, P643; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; SOUKKA T, 1993, ARCH ORAL BIOL, V38, P277; TAKADA K, 1994, INFECT IMMUN, V62, P1171, DOI 10.1128/IAI.62.4.1171-1175.1994; TENOVUO J, 1991, Proceedings of the Finnish Dental Society, V87, P197; TENOVUO J, 1986, J DENT RES, V65, P62, DOI 10.1177/00220345860650011101; VELIKOV VK, 1985, TERAPEVT ARKH, V57, P20; VLASSARA H, 1986, J EXP MED, V164, P1301, DOI 10.1084/jem.164.4.1301; VLASSARA H, 1994, LAB INVEST, V70, P138; HOPP WOODS METHOD AN	27	135	144	1	17	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	OCT	1995	1	10					1057	1061		10.1038/nm1095-1057	http://dx.doi.org/10.1038/nm1095-1057			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RX951	7489363				2022-12-25	WOS:A1995RX95100047
J	ZEITLIN, S; LIU, JP; CHAPMAN, DL; PAPAIOANNOU, VE; EFSTRATIADIS, A				ZEITLIN, S; LIU, JP; CHAPMAN, DL; PAPAIOANNOU, VE; EFSTRATIADIS, A			INCREASED APOPTOSIS AND EARLY EMBRYONIC LETHALITY IN MICE NULLIZYGOUS FOR THE HUNTINGTONS-DISEASE GENE HOMOLOG	NATURE GENETICS			English	Article							PROGRAMMED CELL-DEATH; TRINUCLEOTIDE REPEAT; DYNAMIC MUTATIONS; MOUSE EMBRYOS; LENGTH; GROWTH; DISRUPTION; TISSUES; ONSET; IT-15	The expansion of CAG triplet repeats in the translated region of the human HD gene, encoding a protein (huntingtin) of unknown function, is a dominant mutation leading to manifestation of Huntington's disease. Targeted disruption of the homologous mouse gene (Hdh), to examine the normal role of huntingtin, shows that this protein is functionally indispensable, since nullizygous embryos become developmentally retarded and disorganized, and die between days 8.5 and 10.5 of gestation. Based on the observation that the level of the regionalized apoptotic cell death in the embryonic ectoderm, a layer expressing the Hdh gene, is much higher than normal in the null mutants, we propose that huntingtin is involved in processes counterbalancing the operation of an apoptotic pathway.	COLUMBIA UNIV,CTR NEUROBIOL & BEHAV,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT GENET & DEV,NEW YORK,NY 10032	Columbia University; Columbia University	ZEITLIN, S (corresponding author), COLUMBIA UNIV,DEPT PATHOL,701 W 168TH ST,NEW YORK,NY 10032, USA.		Zeitlin, Scott/P-5787-2019	Papaioannou, Virginia/0000-0001-7558-8601; Chapman, Deborah/0000-0002-8695-6243				ABRAMS JM, 1993, DEVELOPMENT, V117, P29; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALBIN RL, 1995, TRENDS NEUROSCI, V18, P11, DOI 10.1016/0166-2236(95)93943-R; AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; AMBROSE MP, 1995, ANN NEUROL, V37, P218; ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; BARNES GT, 1994, SOMAT CELL MOLEC GEN, V20, P87, DOI 10.1007/BF02290678; BARRON LH, 1994, HUM MOL GENET, V3, P173, DOI 10.1093/hmg/3.1.173; BELLAMY COC, 1995, SEMIN CANCER BIOL, V6, P3, DOI 10.1006/scbi.1995.0002; BRADLEY A, 1987, TERATOCARCINOMAS EMB, P131; CHEN WS, 1994, GENE DEV, V8, P2466, DOI 10.1101/gad.8.20.2466; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; GAO X, 1994, TERATOLOGY, V49, P1, DOI 10.1002/tera.1420490103; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; GREER CE, 1994, PCR METH APPL, V3, pS113; GUSELLA JF, 1995, SEMIN CELL BIOL, V6, P21, DOI 10.1016/1043-4682(95)90011-X; HARLAND RM, 1991, METHOD CELL BIOL, V36, P675; HARPER PS, 1991, MAJOR PROBLEMS NEURO, V22; Hogan B, 1994, MANIPULATING MOUSE E; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; JOLLIE WP, 1990, TERATOLOGY, V41, P361, DOI 10.1002/tera.1420410403; JOU YS, 1995, HUM MOL GENET, V4, P465, DOI 10.1093/hmg/4.3.465; KADOKAWA Y, 1987, CELL DIFFER DEV, V21, P69, DOI 10.1016/0045-6039(87)90450-7; KREMER HPH, 1994, NEW ENGL J MED, V330, P1401; LEWIS SE, 1976, J EMBRYOL EXP MORPH, V36, P363; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; LIN B, 1994, HUM MOL GENET, V3, P1541; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MARTIN SJ, 1994, TRENDS BIOCHEM SCI, V19, P26, DOI 10.1016/0968-0004(94)90170-8; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; NISWANDER L, 1988, DEVELOPMENT, V102, P45; POELMANN RE, 1980, J EMBRYOL EXP MORPH, V55, P33; POELMANN RE, 1977, J ANAT, V124, P238; POELMANN RE, 1976, PROGR DIFFERENTIATIO, P93; PORTERACAILLIAU C, 1995, J NEUROSCI, V15, P3775, DOI 10.1523/jneurosci.15-05-03775.1995; RABIZADEH S, 1995, P NATL ACAD SCI USA, V92, P3024, DOI 10.1073/pnas.92.7.3024; RAFF MC, 1992, NATURE, V365, P397; RICHARDS RI, 1992, CELL, V70, P709, DOI 10.1016/0092-8674(92)90302-S; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; SCHUBERT EL, 1993, HUM MUTAT, V2, P123, DOI 10.1002/humu.1380020211; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; SNOW MHL, 1981, BRIT MED BULL, V37, P221, DOI 10.1093/oxfordjournals.bmb.a071706; SNOW MHL, 1979, NATURE, V279, P555, DOI 10.1038/279555a0; SNOW MHL, 1986, HUMAN GROWTH COMPREH, V3, P67; SPYROPOULOS DD, 1994, GENE DEV, V8, P1949, DOI 10.1101/gad.8.16.1949; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; SUTHERLAND GR, 1993, J MED GENET, V30, P978, DOI 10.1136/jmg.30.12.978; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; THOMAS LB, IN PRESS EXP NEUROL; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; 1993, CELL, V72, P971	60	606	616	0	21	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	OCT	1995	11	2					155	163		10.1038/ng1095-155	http://dx.doi.org/10.1038/ng1095-155			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RX806	7550343				2022-12-25	WOS:A1995RX80600017
J	CHEN, HH; KONG, WP; ZHANG, L; WARD, PL; ROOS, RP				CHEN, HH; KONG, WP; ZHANG, L; WARD, PL; ROOS, RP			A PICORNAVIRAL PROTEIN SYNTHESIZED OUT OF FRAME WITH THE POLYPROTEIN PLAYS A KEY ROLE IN A VIRUS-INDUCED IMMUNE-MEDIATED DEMYELINATING DISEASE	NATURE MEDICINE			English	Article							MURINE ENCEPHALOMYELITIS VIRUS; THEILERS VIRUS; DA STRAIN; INITIATION SITE; TRANSLATION; RNA; NEUROVIRULENCE; INFECTION; MICE	The DA strain and other members of the TO subgroup of Theiler's murine encephalomyelitis virus (TMEV) induce a chronic demyelinating disease with a restricted virus expression. This disease serves as an experimental model of multiple sclerosis; in both diseases the immune system contributes to a similar demyelinating pathology. Like all picornaviruses, TMEV encodes a polyprotein translated from one long open reading frame. The polyprotein is then processed into structural and non-structural viral proteins. Here, we demonstrate that the DA strain of TMEV has an additional alternative open reading frame that encodes a protein called L* that is present in infected cells. Virus with a mutation of L* has a dramatically decreased demyelinating activity, indicating that L* plays a critical role in TO subgroup-induced demyelinating disease. L* is associated with membranes, suggesting that L* may interact with the immune system and thereby mediate the viral-induced demyelinating disease.	UNIV CHICAGO,MED CTR,DEPT NEUROL,CHICAGO,IL 60637; UNIV MICHIGAN,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV CHICAGO,MARJORIE B KOVLER VIRAL ONCOL LABS,CHICAGO,IL 60637	University of Chicago; University of Chicago Medical Center; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Chicago				Chen, Hsiao-Huei/0000-0003-2914-6057	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024575, P01NS021442] Funding Source: NIH RePORTER; NINDS NIH HHS [1 PO1 NS 24575, 1 PO1 NS 21442] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAINES JD, 1991, J VIROL, V65, P6414, DOI 10.1128/JVI.65.12.6414-6424.1991; CELMA ML, 1975, J MOL BIOL, V65, P3395; CLATCH RJ, 1986, J IMMUNOL, V136, P920; DORNER AJ, 1984, J VIROL, V50, P507, DOI 10.1128/JVI.50.2.507-514.1984; FU JL, 1990, P NATL ACAD SCI USA, V87, P4125, DOI 10.1073/pnas.87.11.4125; FUJINAMI RS, 1988, J NEUROIMMUNOL, V20, P25, DOI 10.1016/0165-5728(88)90110-5; GORDON J, 1994, IMMUNOL TODAY, V15, P411, DOI 10.1016/0167-5699(94)90270-4; HILL JR, 1992, J BIOL CHEM, V267, P21886; IMATAKA H, 1994, J BIOL CHEM, V269, P20668; JAROUSSE N, 1994, J VIROL, V68, P3364, DOI 10.1128/JVI.68.5.3364-3368.1994; KAMINSKI A, 1990, EMBO J, V9, P3753, DOI 10.1002/j.1460-2075.1990.tb07588.x; KAMINSKI A, 1994, EMBO J, V13, P1673, DOI 10.1002/j.1460-2075.1994.tb06431.x; KONG WP, 1991, J VIROL, V65, P3395, DOI 10.1128/JVI.65.6.3395-3399.1991; NUNEZ R, 1993, PATHOBIOLOGY, V61, P128, DOI 10.1159/000163781; OLESZAK EL, 1988, J GEN VIROL, V69, P2413, DOI 10.1099/0022-1317-69-9-2413; PATICK AK, 1990, J GEN VIROL, V71, P2123, DOI 10.1099/0022-1317-71-9-2123; PHILLIPS BA, 1986, VIROLOGY, V148, P255, DOI 10.1016/0042-6822(86)90323-5; PRITCHARD AE, 1992, J VIROL, V66, P1951, DOI 10.1128/JVI.66.4.1951-1958.1992; RODRIGUEZ M, 1992, J VIROL, V66, P217, DOI 10.1128/JVI.66.1.217-225.1992; ROOS RP, 1989, J VIROL, V63, P5492, DOI 10.1128/JVI.63.12.5492-5496.1989; ROOS RP, 1989, J VIROL, V63, P5344, DOI 10.1128/JVI.63.12.5344-5353.1989; ROOS RP, 1989, J VIROL, V63, P4469, DOI 10.1128/JVI.63.10.4469-4473.1989; ROOS RP, 1992, MOL NEUROVIROLOGY, P283; SANGAR DV, 1987, NUCLEIC ACIDS RES, V15, P3305, DOI 10.1093/nar/15.8.3305; SPEAR PG, 1972, J VIROL, V9, P143, DOI 10.1128/JVI.9.1.143-159.1972; TESAR M, 1992, VIROLOGY, V186, P609, DOI 10.1016/0042-6822(92)90027-M; WIMMER E, 1993, ANNU REV GENET, V27, P353, DOI 10.1146/annurev.ge.27.120193.002033; ZHANG L, 1995, J VIROL, V69, P3171, DOI 10.1128/JVI.69.5.3171-3175.1995; ZURBRIGGEN A, 1991, J VIROL, V65, P1929, DOI 10.1128/JVI.65.4.1929-1937.1991	29	62	62	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	SEP	1995	1	9					927	931		10.1038/nm0995-927	http://dx.doi.org/10.1038/nm0995-927			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585219				2022-12-25	WOS:A1995RT30300047
J	YANG, YP; TRINCHIERI, G; WILSON, JM				YANG, YP; TRINCHIERI, G; WILSON, JM			RECOMBINANT IL-12 PREVENTS FORMATION OF BLOCKING IGA ANTIBODIES TO RECOMBINANT ADENOVIRUS AND ALLOWS REPEATED GENE-THERAPY TO MOUSE LUNG	NATURE MEDICINE			English	Article							STIMULATORY FACTOR INTERLEUKIN-12; MICE; CELLS	Enthusiasm for the use of recombinant adenoviruses in gene therapy has been tempered by the problematic immune responses that develop to the virus and virus-infected cells. Humoral immune responses to the input viral proteins generate neutralizing antibodies that thwart attempts to effectively administer the therapy more than once. Previous studies in murine models of gene therapy for cystic fibrosis (CF) have shown that the formation of adenoviral antibodies of the IgA subtype, a process that is dependent on T helper cells of the T-H2 subset, contributes to a block in gene transfer that occurs following a second administration of virus. We show in this report that coadministration of interferon-gamma (lFN-gamma) (or interleukin-12 which activates T-H1 cells to secrete IFN-gamma) with the recombinant adenovirus into the airway of C57BL/6 mice diminishes the activation of T-H2 cells and formation of neutralizing antibody, allowing for efficient readministration of recombinant virus. This suggests a strategy for gene therapy of CF in which administration of a short-acting immune modulator at the time of gene therapy may be sufficient to overcome the problems of humoral immunity.	UNIV PENN,MED CTR,WISTAR INST,INST HUMAN GENE THERAPY,PHILADELPHIA,PA 19104; UNIV PENN,MED CTR,DEPT MED,PHILADELPHIA,PA 19104; UNIV PENN,MED CTR,DEPT MOLEC & CELLULAR ENGN,PHILADELPHIA,PA 19104	The Wistar Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania			Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131				DAI Y, IN PRESS P NATN ACAD; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; ENGELHARDT JF, 1994, HUM GENE THER, V5, P1217, DOI 10.1089/hum.1994.5.10-1217; HEINZEL FP, 1993, J EXP MED, V177, P1505, DOI 10.1084/jem.177.5.1505; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; KAY MA, 1994, P NATL ACAD SCI USA, V91, P2353, DOI 10.1073/pnas.91.6.2353; KOZARSKY KF, 1994, J BIOL CHEM, V269, P13695; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; MORRIS SC, 1994, J IMMUNOL, V152, P1047; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; QUINN B, 1992, P NATL ACAD SCI USA, V89, P2581; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337; SIMON RH, 1993, HUM GENE THER, V4, P771, DOI 10.1089/hum.1993.4.6-771; SMITH TAG, 1993, NAT GENET, V5, P397, DOI 10.1038/ng1293-397; YANG Y, IN PRESS P NATN ACAD; YANG Y, 1994, NAT GENET, V7, P363; YANG YP, 1995, J VIROL, V69, P2004, DOI 10.1128/JVI.69.4.2004-2015.1995; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4; YEI SP, 1994, GENE THER, V1, P192	21	223	231	1	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	SEP	1995	1	9					890	893		10.1038/nm0995-890	http://dx.doi.org/10.1038/nm0995-890			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RT303	7585213				2022-12-25	WOS:A1995RT30300041
J	ELDADAH, ZA; GRIFO, JA; DIETZ, HC				ELDADAH, ZA; GRIFO, JA; DIETZ, HC			MARFAN-SYNDROME AS A PARADIGM FOR TRANSCRIPT-TARGETED PREIMPLANTATION DIAGNOSIS OF HETEROZYGOUS MUTATIONS	NATURE MEDICINE			English	Article							POLYMERASE CHAIN-REACTION; GENETIC DIAGNOSIS; CYSTIC-FIBROSIS; AMPLIFICATION; CELL; DNA	Among the many clinical applications of the polymerase chain reaction (PCR) is its potential use in preimplantation diagnosis of genetic disorders. Performing PCR on single blastomeres from early cleavage stage (six-to eight-cell) human embryos should, in principle, enable reliable determination of disease status for certain inherited conditions. However, reports of misdiagnoses using this technique have diminished enthusiasm for its widespread clinical use. One principal source of error is the propensity for genome-targeted PCR to exclusively amplify one allele in reactions assaying a single heterozygous diploid cell. Complete reaction failure is also common. Employing the Marfan syndrome (MFS) as a paradigm, we have developed a reliable, reverse transcription-PCR-based method of genotyping single cells that overcomes these obstacles. The technique should facilitate accurate preimplantation diagnosis of MFS and other selected genetic diseases caused by heterozygous or compound-heterozygous mutations.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205; CORNELL UNIV,COLL MED,CTR REPROD MED & INFERTIL,NEW YORK,NY 10021	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Cornell University				Grifo, James/0000-0003-0439-2374				ARNHEIM N, 1992, HUM REPROD, V7, P1481, DOI 10.1093/oxfordjournals.humrep.a137599; BOEHNKE M, 1989, AM J HUM GENET, V45, P21; BRIDGES AB, 1992, J MED GENET, V29, P81, DOI 10.1136/jmg.29.2.81; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; CUI X, 1993, P NATL ACAD SCI USA, V86, P9389; CUL KH, 1994, LANCET, V343, P972; Dietz Harry C., 1992, Human Mutation, V1, P366, DOI 10.1002/humu.1380010504; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; GRIFO JA, 1994, HUM REPROD, V9, P912, DOI 10.1093/oxfordjournals.humrep.a138616; GRIFO JA, 1992, JAMA-J AM MED ASSOC, V268, P727, DOI 10.1001/jama.268.6.727; HANDYSIDE A, 1992, HUM REPROD, V7, P1481, DOI 10.1093/oxfordjournals.humrep.a137600; Handyside A.H., 1993, PREIMPLANTATION DIAG, P239; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; HANDYSIDE AH, 1992, NEW ENGL J MED, V327, P905, DOI 10.1056/NEJM199209243271301; HANDYSIDE AH, 1989, LANCET, V2, P532; HEWETT DR, 1994, AM J HUM GENET, V52, P447; KONTOGIANNI EH, 1991, 1ST P S PREIMPL GEN, P139; KRISTJANSSON K, 1994, NAT GENET, V6, P19, DOI 10.1038/ng0194-19; LI A, 1988, NATURE, V335, P414; LIU J, 1994, HUM REPROD, V9, P716, DOI 10.1093/oxfordjournals.humrep.a138576; MCKUSICK VA, 1993, MENDELIAN INHERITANC; MCKUSICK VA, 1977, HERITABLE DISORDERS; MUGGLETONHARRIS AL, 1994, INT REV CYTOL, V151, P1, DOI 10.1016/S0074-7696(08)62629-7; NAVIDI W, 1991, HUM REPROD, V6, P836, DOI 10.1093/oxfordjournals.humrep.a137438; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; PEREIRA L, 1994, NEW ENGL J MED, V331, P148, DOI 10.1056/NEJM199407213310302; PICKERING SJ, 1992, HUM REPROD, V7, P630, DOI 10.1093/oxfordjournals.humrep.a137710; PYERITZ RE, 1977, NEW ENGL J MED, V300, P772; SNABES MC, 1994, P NATL ACAD SCI USA, V91, P6181, DOI 10.1073/pnas.91.13.6181; TROUNSON AL, 1992, HUM REPROD, V7, P583; VERLINSKY Y, 1992, PRENATAL DIAG, V12, P103, DOI 10.1002/pd.1970120205; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	32	37	37	0	2	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1995	1	8					798	803		10.1038/nm0895-798	http://dx.doi.org/10.1038/nm0895-798			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585183				2022-12-25	WOS:A1995RM63500037
J	HUNG, LF; CRAWFORD, MLJ; SMITH, EL				HUNG, LF; CRAWFORD, MLJ; SMITH, EL			SPECTACLE LENSES ALTER EYE GROWTH AND THE REFRACTIVE STATUS OF YOUNG MONKEYS	NATURE MEDICINE			English	Article							CHROMATIC ABERRATION; OPTICAL DEFOCUS; VISUAL-ACUITY; EMMETROPIZATION; ACCOMMODATION; CHICKEN; MODEL; MYOPIA; DEPRIVATION; PROGRESSION	The influence of visual experience on ocular development in higher primates is not well understood. To investigate the possible role of defocus in regulating ocular growth, spectacle lenses were used to optically simulate refractive anomalies in young monkeys (for example, myopia or nearsightedness). Both positive and negative lenses produced compensating ocular growth that reduced the lens-induced refractive errors and, at least for low lens powers, minimized any refractive-error differences between the two eyes. These results indicate that the developing primate visual system can detect the presence of refractive anomalies and alter each eye's growth to eliminate these refractive errors. Moreover, these results support the hypothesis that spectacle lenses can alter eye development in young children.	UNIV HOUSTON,COLL OPTOMETRY,HOUSTON,TX 77204; UNIV TEXAS,GRAD SCH BIOMED SCI,CTR SENSORY SCI,HOUSTON,TX 77030	University of Houston System; University of Houston; University of Texas System					NATIONAL EYE INSTITUTE [R01EY003611, P30EY007551] Funding Source: NIH RePORTER; NEI NIH HHS [EY 03611, EY 07551] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Atkinson J., 1993, EARLY VISUAL DEV NOR, P335; BOOTHE RG, 1985, ANNU REV NEUROSCI, V8, P495, DOI 10.1146/annurev.ne.08.030185.002431; CHARMAN WN, 1991, VISION VISUAL DYSFUN, V1, P1; CHUNG KM, 1993, OPTOMETRY VISION SCI, V70, P228, DOI 10.1097/00006324-199303000-00010; CRAWFORD MLJ, 1979, T OPHTHAL SOC UK, V99, P369; CREWTHER SG, 1988, CLIN VISION SCI, V3, P221; GREEN DG, 1980, VISION RES, V20, P827, DOI 10.1016/0042-6989(80)90063-2; GWIAZDA J, 1993, CLIN VISION SCI, V8, P337; HENDRICKSON P, 1985, INVEST OPHTH VIS SCI, V26, P343; HOWLAND HC, 1985, AM J OPTOM PHYS OPT, V62, P621; INGRAM RM, 1991, BRIT J OPHTHALMOL, V75, P414, DOI 10.1136/bjo.75.7.414; IRVING EL, 1992, OPHTHAL PHYSL OPT, V12, P448, DOI 10.1111/j.1475-1313.1992.tb00315.x; IRVING EL, 1991, OPTOMETRY VISION SCI, V68, P364, DOI 10.1097/00006324-199105000-00007; KIELY PM, 1987, CLIN VISION SCI, V1, P269; KIORPES L, 1995, VISION RES, V35, P1289, DOI 10.1016/0042-6989(94)00239-I; MEDINA A, 1987, ACTA OPHTHALMOL, V65, P565; MEDINA A, 1987, OPHTHALMOLOGICA, V194, P133, DOI 10.1159/000309750; NI JR, 1989, VISION RES, V29, P929, DOI 10.1016/0042-6989(89)90107-7; RAVIOLA E, 1985, NEW ENGL J MED, V312, P1609, DOI 10.1056/NEJM198506203122505; ROHRER B, 1992, J PHYSIOL-LONDON, V449, P363, DOI 10.1113/jphysiol.1992.sp019090; SCHAEFFEL F, 1990, VISUAL NEUROSCI, V4, P177, DOI 10.1017/S0952523800002327; SCHAEFFEL F, 1988, VISION RES, V28, P639, DOI 10.1016/0042-6989(88)90113-7; SCHAEFFEL F, 1988, J OPT SOC AM A, V5, P2080, DOI 10.1364/JOSAA.5.002080; SCHAEFFEL F, 1991, VISION RES, V31, P717, DOI 10.1016/0042-6989(91)90011-S; SCHAEFFEL F, 1987, APPL OPTICS, V26, P1505, DOI 10.1364/AO.26.001505; SCHAEFFEL F, 1986, VISION RES, V26, P1977, DOI 10.1016/0042-6989(86)90123-9; SMITH EL, 1985, INVEST OPHTH VIS SCI, V26, P330; SMITH EL, 1987, INVEST OPHTH VIS SCI, V28, P1236; SMITH EL, 1994, VISION RES, V34, P293, DOI 10.1016/0042-6989(94)90088-4; TROILO D, 1991, VISION RES, V31, P1237, DOI 10.1016/0042-6989(91)90048-A; WALLMAN J, 1987, SCIENCE, V237, P73, DOI 10.1126/science.3603011; WILDSOET CF, 1993, VISION RES, V33, P1593, DOI 10.1016/0042-6989(93)90026-S	32	359	369	2	46	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	AUG	1995	1	8					761	765		10.1038/nm0895-761	http://dx.doi.org/10.1038/nm0895-761			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RM635	7585177				2022-12-25	WOS:A1995RM63500031
J	YAN, SD; YAN, SF; CHEN, X; FU, J; CHEN, M; KUPPUSAMY, P; SMITH, MA; PERRY, G; GODMAN, GC; NAWROTH, P; ZWEITER, JL; STERN, D				YAN, SD; YAN, SF; CHEN, X; FU, J; CHEN, M; KUPPUSAMY, P; SMITH, MA; PERRY, G; GODMAN, GC; NAWROTH, P; ZWEITER, JL; STERN, D			NONENZYMATICALLY GLYCATED-TAU IN ALZHEIMERS-DISEASE INDUCES NEURONAL OXIDANT STRESS RESULTING IN CYTOKINE GENE-EXPRESSION AND RELEASE OF AMYLOID BETA-PEPTIDE	NATURE MEDICINE			English	Article							KAPPA-B; PROTEIN; IMMUNOREACTIVITY; INTERLEUKIN-6; ACTIVATION; INITIATION; CELLS	Paired helical filament (PHF) tau is the principal component of neurofibrillary tangles, a characteristic feature of the neurodegenerative pathology in Alzheimer's disease (AD). Post-translational modification of tau, especially phosphorylation, has been considered a major factor in aggregation and diminished microtubule interactions of PHF-tau. Recently, it has been recognized that PHF-tau is also subject to non-enzymatic glycation, with formation of advanced glycation end products (AGEs). We now show that as a consequence of glycation, PHF-tau from AD and ACE-tau generate oxygen free radicals, thereby activating transcription via nuclear factor-kappa B, increasing amyloid beta-protein precursor and release of similar to 4 kD amyloid beta-peptides. These data provide Insight into how PHF-tau disturbs neuronal function, and add to a growing body of evidence that oxidant stress contributes to the pathogenesis of AD.	COLUMBIA UNIV COLL PHYS & SURG, DEPT SURG, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21224 USA; CASE WESTERN RESERVE UNIV, INST PATHOL, CLEVELAND, OH 44106 USA; UNIV HEIDELBERG, DEPT MED, W-6900 HEIDELBERG, GERMANY	Columbia University; Columbia University; Johns Hopkins University; Case Western Reserve University; Ruprecht Karls University Heidelberg	YAN, SD (corresponding author), COLUMBIA UNIV COLL PHYS & SURG, DEPT PHYSIOL, 630 W 168TH ST, NEW YORK, NY 10032 USA.		Perry, George/A-8611-2009; Fu, Jin/A-3510-2012; Smith, Mark A/A-9053-2009	Perry, George/0000-0002-6547-0172; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042507, P50HL017655, P50HL021006] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 42507, HL 21006, HL 17655] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAYNES JW, 1991, DIABETES, V40, P405, DOI 10.2337/diabetes.40.4.405; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; COLLINS T, 1993, LAB INVEST, V68, P499; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FINKELSTEIN E, 1982, MOL PHARMACOL, V21, P262; FRAPPIER TF, 1994, J NEUROCHEM, V63, P2288; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KOSIK KS, 1994, J CELL BIOL, V127, P1501, DOI 10.1083/jcb.127.6.1501; LEDESMA MD, 1994, J BIOL CHEM, V269, P21614; LIN MF, 1993, BIOCHEM BIOPH RES CO, V192, P413, DOI 10.1006/bbrc.1993.1431; LIU WK, 1991, J BIOL CHEM, V266, P21723; LOO DT, 1993, P NATL ACAD SCI USA, V90, P7951, DOI 10.1073/pnas.90.17.7951; RAY A, 1988, P NATL ACAD SCI USA, V85, P6701, DOI 10.1073/pnas.85.18.6701; RUDERMAN NB, 1992, FASEB J, V6, P2905, DOI 10.1096/fasebj.6.11.1644256; SAKURAI T, 1988, FEBS LETT, V236, P406, DOI 10.1016/0014-5793(88)80066-8; Sambrook J, 1989, MOL CLONING LABORATO; SCHRECK R, 1991, EMBO J, V10, P2247, DOI 10.1002/j.1460-2075.1991.tb07761.x; SELL DR, 1989, J BIOL CHEM, V264, P21597; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SMITH MA, 1994, P NATL ACAD SCI USA, V91, P5710, DOI 10.1073/pnas.91.12.5710; STRAUSS S, 1992, LAB INVEST, V66, P223; TROJANOWSKI JQ, 1994, AM J PATHOL, V144, P449; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Wischik CM, 1989, CURR OPIN CELL BIOL, V1, P115, DOI 10.1016/S0955-0674(89)80047-X; YAN SD, 1994, P NATL ACAD SCI USA, V91, P7787, DOI 10.1073/pnas.91.16.7787; YAN SD, 1994, J BIOL CHEM, V269, P9889; YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540; ZWEIER JL, 1988, P NATL ACAD SCI USA, V85, P4046, DOI 10.1073/pnas.85.11.4046	32	353	368	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	1995	1	7					693	699		10.1038/nm0795-693	http://dx.doi.org/10.1038/nm0795-693			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RQ066	7585153				2022-12-25	WOS:A1995RQ06600046
J	BENZAQUEN, LR; BRUGNARA, C; BYERS, HR; GATTONICELLI, S; HALPERIN, JA				BENZAQUEN, LR; BRUGNARA, C; BYERS, HR; GATTONICELLI, S; HALPERIN, JA			CLOTRIMAZOLE INHIBITS CELL-PROLIFERATION IN-VITRO AND IN-VIVO	NATURE MEDICINE			English	Article							CYTOCHROME-P-450 INHIBITORS; HUMAN NEUTROPHILS; GROWTH-FACTORS; CALCIUM; STORES; INFLUX; CHANNELS; ENTRY; RAT; MELANOMA	Cell proliferation is critically dependent on the regulated movement of ions across various cellular compartments. The antimycotic drug clotrimazole (CLT) has been shown to inhibit movement of Ca2+ and K+ across the plasma membrane. Our results show that CLT inhibits the rate of cell proliferation of normal and cancer cell fines in a reversible and dose-dependent manner in vitro. Moreover, CLT depletes the intracellular Ca2+ stores and prevents the rise in cytosolic Ca2+ that normally follows mitogenic stimulation. In mice with severe combined immunodeficiency disease (SCID) and inoculated intravenously with MM-RU human melanoma cells, daily subcutaneous injections of CLT induced a significant reduction in the number of lung metastases. Modulation of early ionic mitogenic: signals and potent inhibition of cell proliferation both in vitro and in vivo are new and potentially useful clinical effects of CLT.	HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115; BETH ISRAEL HOSP,BOSTON,MA 02115; CHILDRENS HOSP,HEMATOL LAB,BOSTON,MA 02115; BOSTON UNIV,SCH MED,DEPT DERMATOL,BOSTON,MA 02118; MED UNIV S CAROLINA,DEPT RADIAT ONCOL,CHARLESTON,SC 29425	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Boston University; Medical University of South Carolina			Brugnara, Carlo/A-8041-2010	Brugnara, Carlo/0000-0001-8192-8713				ALVAREZ J, 1992, J BIOL CHEM, V267, P11789; BENZAQUEN L, 1993, J EXP MED, V179, P985; BERGER HJ, 1993, AM J PHYSIOL, V265, pH267, DOI 10.1152/ajpheart.1993.265.1.H267; BORZAK S, 1990, AM J PHYSIOL, V259, pH973, DOI 10.1152/ajpheart.1990.259.3.H973; BYERS HR, 1993, MELANOMA RES, V3, P247; BYERS HR, 1991, AM J PATHOL, V139, P423; CLAPHAM DE, 1993, NATURE, V364, P763, DOI 10.1038/364763a0; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; EGUCHI K, 1992, J RHEUMATOL, V19, P1925; FLOEGE J, 1993, J CLIN INVEST, V90, P2362; French J E, 1966, Int Rev Exp Pathol, V5, P253; HALPERIN JA, 1993, J CLIN INVEST, V91, P1974, DOI 10.1172/JCI116418; LOGAN DM, 1993, INT C AIDS, V9, P399; LYTTON J, 1991, J BIOL CHEM, V66, P17067; MAGNI M, 1991, J BIOL CHEM, V261, P9321; MILES SA, 1992, SCIENCE, V255, P1432, DOI 10.1126/science.1542793; MONTERO M, 1991, BIOCHEM J, V277, P73, DOI 10.1042/bj2770073; MONTERO M, 1993, BIOCHIM BIOPHYS ACTA, V1177, P127, DOI 10.1016/0167-4889(93)90031-J; PEPPELENBOSCH MP, 1991, J BIOL CHEM, V266, P19938; PUTNEY JW, 1990, PHARMACOL THERAPEUT, V48, P427, DOI 10.1016/0163-7258(90)90059-B; PUTNEY JW, 1993, SCIENCE, V262, P676, DOI 10.1126/science.8235587; RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SEO M, 1977, CURR MED RES OPIN, V5, P169, DOI 10.1185/03007997709110160; SHEETS JJ, 1986, BIOCHEM PHARMACOL, V35, P487, DOI 10.1016/0006-2952(86)90224-8; SHORT AD, 1993, P NATL ACAD SCI USA, V90, P4986, DOI 10.1073/pnas.90.11.4986; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; VILLALOBOS C, 1992, FASEB J, V6, P2742, DOI 10.1096/fasebj.6.9.1319362; VOSTAL JG, 1993, BIOCHEM J, V295, P525, DOI 10.1042/bj2950525; WEUTA H, 1974, POSTGRAD MED J, V50, P45	32	143	153	0	13	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	JUN	1995	1	6					534	540		10.1038/nm0695-534	http://dx.doi.org/10.1038/nm0695-534			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	RN101	7585119				2022-12-25	WOS:A1995RN10100036
J	HENGGE, UR; CHAN, EF; FOSTER, RA; WALKER, PS; VOGEL, JC				HENGGE, UR; CHAN, EF; FOSTER, RA; WALKER, PS; VOGEL, JC			CYTOKINE GENE-EXPRESSION IN EPIDERMIS WITH BIOLOGICAL EFFECTS FOLLOWING INJECTION OF NAKED DNA	NATURE GENETICS			English	Article							ATTRACTANT ACTIVATION PROTEIN-1; BETA-GALACTOSIDASE; IMMUNE-RESPONSES; MOUSE MUSCLE; PLASMID DNA; KERATINOCYTES; CELLS; THERAPY; MICE; VACCINES	The epidermis is readily accessible for genetic manipulation and is easily monitored. Using pig skin because it is very similar to human skin morphologically, we have developed a method to transiently express biologically active factors in epidermis. Following direct injection of naked plasmid DNA into skin, DNA is taken up and transiently expressed at high levels by epidermal keratinocytes. Injection of interleukin-8 plasmid DNA into skin results in the appropriate biological response of neutrophil recruitment, demonstrating functional utility. In addition to this model's therapeutic uses, the biological effects of structural gene products on the epidermis could also be studied in vivo.	NCI,DERMATOL BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; BARON S, 1991, JAMA-J AM MED ASSOC, V266, P1375, DOI 10.1001/jama.266.10.1375; COTTEN M, 1994, GENE THER, V1, P239; COX GJM, 1993, J VIROL, V67, P5664, DOI 10.1128/JVI.67.9.5664-5667.1993; FENJVES ES, 1989, P NATL ACAD SCI USA, V86, P8803, DOI 10.1073/pnas.86.22.8803; FENJVES ES, 1990, DNA DAMAGE REPAIR HU, P215; FLOWERS MED, 1990, P NATL ACAD SCI USA, V87, P2349, DOI 10.1073/pnas.87.6.2349; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; FYNAN EF, 1993, P NATL ACAD SCI USA, V90, P11478, DOI 10.1073/pnas.90.24.11478; GERRARD AJ, 1993, NAT GENET, V3, P180, DOI 10.1038/ng0293-180; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; JAIN VK, 1991, ANAL BIOCHEM, V199, P119, DOI 10.1016/0003-2697(91)90278-2; KANGESU T, 1993, BRIT J PLAST SURG, V46, P393, DOI 10.1016/0007-1226(93)90045-D; LEONARD EJ, 1991, J INVEST DERMATOL, V96, P690, DOI 10.1111/1523-1747.ep12470612; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; MORGAN JR, 1987, SCIENCE, V237, P1476; PARDOLL DM, 1993, IMMUNOL TODAY, V14, P310, DOI 10.1016/0167-5699(93)90051-L; RAZ E, 1994, P NATL ACAD SCI USA, V91, P9519, DOI 10.1073/pnas.91.20.9519; ROT A, 1991, CYTOKINE, V3, P21, DOI 10.1016/1043-4666(91)90006-Y; SCHWARZ MA, 1990, ANNU REV CELL BIOL, V6, P461, DOI 10.1146/annurev.cb.06.110190.002333; SIMONET WS, 1994, J CLIN INVEST, V94, P1310, DOI 10.1172/JCI117450; TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; VOGEL J, 1988, NATURE, V335, P606, DOI 10.1038/335606a0; VOGEL JC, 1993, ARCH DERMATOL, V129, P1478, DOI 10.1001/archderm.129.11.1478; WANG B, 1993, P NATL ACAD SCI USA, V90, P4156, DOI 10.1073/pnas.90.9.4156; WILLIAMS RS, 1991, P NATL ACAD SCI USA, V88, P2726, DOI 10.1073/pnas.88.7.2726; WOLFF JA, 1992, J CELL SCI, V103, P1249; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; YANG NS, 1990, P NATL ACAD SCI USA, V87, P9568, DOI 10.1073/pnas.87.24.9568	34	221	230	0	4	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	JUN	1995	10	2					161	166		10.1038/ng0695-161	http://dx.doi.org/10.1038/ng0695-161			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA857	7545056				2022-12-25	WOS:A1995RA85700012
J	TSUKAMOTO, M; OCHIYA, T; YOSHIDA, S; SUGIMURA, T; TERADA, M				TSUKAMOTO, M; OCHIYA, T; YOSHIDA, S; SUGIMURA, T; TERADA, M			GENE-TRANSFER AND EXPRESSION IN PROGENY AFTER INTRAVENOUS DNA INJECTION INTO PREGNANT MICE	NATURE GENETICS			English	Article							GERM-LINE; RETROVIRAL VECTORS; TRANSGENIC ANIMALS; CELLS; INSERTION; CARCINOMA; DELIVERY; CHIMERAS	Several methods that enable foreign genes to be transferred directly into germ cells and adult animals have been developed(1-4), which have stimulated great interest in manipulating genes in vivo. However, there have been no methods available for introducing genes into fetuses. We report here that a single intravenous injection of expression plasmid:lipopolyamine complexes into pregnant mice resulted in successful gene transfer into the embryos. The transgenes thus introduced were expressed in the fetuses and newborn progeny. This simple and new method of gene transfer into embryos will facilitate rapid analysis of transgene effects in the fetuses and will be useful for studying gene-deficient animal models to gain transgene functions at desired stages of embryogenesis.	NATL CANC CTR,RES INST,DIV GENET,CHUO KU,TOKYO 104,JAPAN; CHIBA UNIV,SCH MED,DEPT INTERNAL MED 2,CHUO KU,CHIBA 260,JAPAN	National Cancer Center - Japan; Chiba University			Ochiya, Takahiro/AAH-7585-2019					ACSADI G, 1991, NATURE, V352, P815, DOI 10.1038/352815a0; BEHR JP, 1989, P NATL ACAD SCI USA, V86, P6982, DOI 10.1073/pnas.86.18.6982; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; CHENG TC, 1993, SCIENCE, V261, P215, DOI 10.1126/science.8392225; DEBS RJ, 1987, BIOCHIM BIOPHYS ACTA, V901, P183, DOI 10.1016/0005-2736(87)90114-3; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; JAHNER D, 1985, P NATL ACAD SCI USA, V82, P6927, DOI 10.1073/pnas.82.20.6927; Loeffler Jean-Philippe, 1993, V217, P599; MARUYAMA K, 1990, P NATL ACAD SCI USA, V87, P5744, DOI 10.1073/pnas.87.15.5744; MERCOLA M, 1985, SCIENCE, V227, P266, DOI 10.1126/science.3917575; MERLINO GT, 1991, FASEB J, V5, P2996, DOI 10.1096/fasebj.5.14.1752364; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; NISHIMORI K, 1991, PLASMID, V26, P201, DOI 10.1016/0147-619X(91)90043-V; OCHIYA T, 1986, P NATL ACAD SCI USA, V83, P4993, DOI 10.1073/pnas.83.14.4993; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PORTMAN OW, 1969, AM J PHYSIOL, V216, P143, DOI 10.1152/ajplegacy.1969.216.1.143; Rugh R, 1990, MOUSE ITS REPROD DEV, P116; SAKURA H, 1989, P NATL ACAD SCI USA, V86, P5758, DOI 10.1073/pnas.86.15.5758; SANDS AT, 1993, MOL REPROD DEV, V34, P117, DOI 10.1002/mrd.1080340202; STEWART CL, 1985, EMBO J, V4, P3701, DOI 10.1002/j.1460-2075.1985.tb04138.x; SZABO AJ, 1969, METABOLIS, V18, P406, DOI 10.1016/0026-0495(69)90069-9; VANDERPUTTEN H, 1985, P NATL ACAD SCI USA, V82, P6148, DOI 10.1073/pnas.82.18.6148; WU GY, 1991, J BIOL CHEM, V266, P14338; YAMAGUCHI R, 1964, J Jpn Obstet Gynecol Soc, V11, P151; ZHU N, 1993, SCIENCE, V261, P209, DOI 10.1126/science.7687073	26	106	115	0	1	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1061-4036			NAT GENET	Nature Genet.	MAR	1995	9	3					243	248		10.1038/ng0395-243	http://dx.doi.org/10.1038/ng0395-243			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QL232	7773286				2022-12-25	WOS:A1995QL23200012
J	GILLIAM, TC				GILLIAM, TC			IS THE SPINAL MUSCULAR-ATROPHY GENE FOUND	NATURE MEDICINE			English	Editorial Material							CONTIG	Three articles claim to have identified the spinal muscular atrophy gene, yet they do not appear to have enough in common to identify the same gene.			GILLIAM, TC (corresponding author), COLUMBIA UNIV,COLL PHYS & SURG,DEPT GENET & DEV,NEW YORK,NY 10032, USA.							BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; BURGHES AHM, 1994, GENOMICS, V21, P394, DOI 10.1006/geno.1994.1282; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; FRANCIS MJ, 1993, HUM MOL GENET, V2, P1161, DOI 10.1093/hmg/2.8.1161; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; KLEYN PW, 1993, P NATL ACAD SCI USA, V90, P6801, DOI 10.1073/pnas.90.14.6801; LEFEBVRE S, 1995, CELL, V80, P1; MCLEAN MD, 1994, HUM MOL GENET, V3, P1951; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; PEDEUTOUR F, 1994, GENOMICS, V19, P31, DOI 10.1006/geno.1994.1008; ROY N, 1995, CELL, V80, P21; SARGENT CA, 1991, CYTOGENET CELL GENET, V58, P1901; THOMPSON TG, 1995, NAT GENET, V9, P56, DOI 10.1038/ng0195-56	14	9	11	0	0	NATURE PUBLISHING CO	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707	1078-8956			NAT MED	Nat. Med.	FEB	1995	1	2					124	127		10.1038/nm0295-124	http://dx.doi.org/10.1038/nm0295-124			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	QX558	7585007				2022-12-25	WOS:A1995QX55800021
J	RABBITTS, TH; FORSTER, A; LARSON, R; NATHAN, P				RABBITTS, TH; FORSTER, A; LARSON, R; NATHAN, P			FUSION OF THE DOMINANT-NEGATIVE TRANSCRIPTION REGULATOR CHOP WITH A NOVEL GENE FUS BY TRANSLOCATION T(12-16) IN MALIGNANT LIPOSARCOMA	NATURE GENETICS			English	Article							BURKITT-LYMPHOMA CELLS; C-MYC ONCOGENE; CHROMOSOMAL TRANSLOCATION; LOCUS; LEUKEMIA; FRAGMENTS; BREAKPOINTS; ASSIGNMENT; REGION; CODES	The search for tumour-specific markers is one of the chief goals in cancer biology. We show that the translocation t(12;16)(q13:p11) in malignant myxoid liposarcoma can be a fusion of the CHOP dominant negative transcription factor gene with a novel gene, FUS, which can result in fusion of the FUS glycine-rich protein with the whole CHOP coding region. The data support the concept that protein fusion may commonly occur in solid tumours resulting in tumour-specific markers of potential clinical importance. The data also indicate the importance of transcription disruption in the pathogenesis of solid tumours.			RABBITTS, TH (corresponding author), MRC, MOLEC BIOL LAB, HILLS RD, CAMBRIDGE CB2 2QH, ENGLAND.		Rabbitts, Terence/D-6262-2016	Rabbitts, Terence/0000-0002-4982-2609				ALCALAY M, 1991, P NATL ACAD SCI USA, V88, P1977, DOI 10.1073/pnas.88.5.1977; AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; BANKIER AT, 1989, NUCLEIC ACID SEQUENC, P78; BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; BUROKER NE, 1986, HUM GENET, V72, P86, DOI 10.1007/BF00278825; CLEARY ML, 1991, CELL, V66, P619, DOI 10.1016/0092-8674(91)90105-8; CROCE CM, 1983, P NATL ACAD SCI-BIOL, V80, P6922, DOI 10.1073/pnas.80.22.6922; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DAVIS M, 1984, NATURE, V308, P286, DOI 10.1038/308286a0; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DUBE ID, 1991, BLOOD, V78, P2996; ENEROTH M, 1990, CANCER GENET CYTOGEN, V48, P101, DOI 10.1016/0165-4608(90)90222-V; ERICKSON P, 1992, BLOOD, V80, P1825; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; HAMLYN PH, 1983, NATURE, V304, P135, DOI 10.1038/304135a0; HATANO M, 1991, SCIENCE, V253, P79, DOI 10.1126/science.1676542; HEIM S, 1991, REC ADV PATH, V3, P37; KAMPS MP, 1990, CELL, V60, P547, DOI 10.1016/0092-8674(90)90658-2; KENNEDY MA, 1991, P NATL ACAD SCI USA, V88, P8900, DOI 10.1073/pnas.88.20.8900; LU M, 1991, EMBO J, V10, P2905, DOI 10.1002/j.1460-2075.1991.tb07840.x; Mertens F., 1991, CATALOG CHROMOSOME A; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MIYOSHI H, IN PRESS EMBO J; MULLEY JC, 1986, ANN GENET, V29, P235; NOURSE J, 1990, CELL, V60, P535, DOI 10.1016/0092-8674(90)90657-Z; NOWELL PC, 1960, SCIENCE, V132, P1497; PARK JS, 1992, GENE, V116, P259, DOI 10.1016/0378-1119(92)90523-R; POVEY S, 1980, ANN HUM GENET, V43, P241, DOI 10.1111/j.1469-1809.1980.tb01557.x; RABBITTS TH, 1991, ADV IMMUNOL, V50, P119; RABBITTS TH, 1991, CELL, V67, P641, DOI 10.1016/0092-8674(91)90057-6; RIEGER M, 1988, J MOL BIOL, V204, P841, DOI 10.1016/0022-2836(88)90045-9; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPURR NK, 1991, ANN HUM GENET, V55, P217, DOI 10.1111/j.1469-1809.1991.tb00416.x; TAUB R, 1984, CELL, V37, P511, DOI 10.1016/0092-8674(84)90381-7; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TRENT JM, 1993, NAT GENET, V3, P101, DOI 10.1038/ng0293-101; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687	44	484	494	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	1993	4	2					175	180		10.1038/ng0693-175	http://dx.doi.org/10.1038/ng0693-175			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LF816	7503811				2022-12-25	WOS:A1993LF81600019
J	SOONG, NW; HINTON, DR; CORTOPASSI, G; ARNHEIM, N				SOONG, NW; HINTON, DR; CORTOPASSI, G; ARNHEIM, N			MOSAICISM FOR A SPECIFIC SOMATIC MITOCHONDRIAL-DNA MUTATION IN ADULT HUMAN BRAIN	NATURE GENETICS			English	Article							DELETIONS; DISEASE; INCREASE; TISSUES; MUSCLE; DAMAGE; GENE	The levels of a specific mitochondrial DNA deletion (mtDNA4977 measured in 12 brain regions of 6 normal adults 39 to 82 years old exhibited striking variation among anatomical locations. Comparisons of the same region among individuals showed an increase of mtDNA4977 With age. The three regions with the highest levels, caudate, putamen and substantia nigra, are characterized by a high dopamine metabolism. The breakdown of dopamine by mitochondrial MAO produces H2O2 which can lead to oxygen radical formation. We suggest that mtDNA4977 may be the "tip of the iceberg" of the spectrum of somatic mutations produced by oxidative damage.	USC, SCH MED, DEPT PATHOL, LOS ANGELES, CA 90033 USA; UNIV SO CALIF, INST TOXICOL, LOS ANGELES, CA 90033 USA	University of Southern California; University of Southern California	SOONG, NW (corresponding author), UNIV SO CALIF, MOLEC BIOL SECT, LOS ANGELES, CA 90089 USA.			Arnheim, Norman/0000-0003-1247-1347				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; BULPITT KJ, 1984, BRAIN RES, V300, P41, DOI 10.1016/0006-8993(84)91339-8; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; COLEMAN PD, 1987, NEUROBIOL AGING, V8, P521, DOI 10.1016/0197-4580(87)90127-8; CORRALDEBRINSKI M, 1991, JAMA-J AM MED ASSOC, V266, P1812, DOI 10.1001/jama.266.13.1812; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; CORTOPASSI GA, 1992, PROGR PARKINSONS DIS, V2; DEKEYSER J, 1990, ANN NEUROL, V27, P157, DOI 10.1002/ana.410270210; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GOLDSTEIN M, 1992, NEUROLOGY, V42, P8; GROSS NJ, 1969, J BIOL CHEM, V244, P1552; GUPTA KP, 1990, MUTAT RES, V237, P17, DOI 10.1016/0921-8734(90)90028-P; HARDING AE, 1991, TRENDS NEUROSCI, V14, P132, DOI 10.1016/0166-2236(91)90081-5; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1981, P NATL ACAD SCI-BIOL, V78, P7124, DOI 10.1073/pnas.78.11.7124; HATTORI K, 1991, AM HEART J, V121, P1735, DOI 10.1016/0002-8703(91)90020-I; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1989, NUCLEIC ACIDS RES, V17, P4465, DOI 10.1093/nar/17.12.4465; IKEBE S, 1990, BIOCHEM BIOPH RES CO, V170, P1044, DOI 10.1016/0006-291X(90)90497-B; JENNER P, 1992, NEUROL CLIN, V10, P387, DOI 10.1016/S0733-8619(18)30217-2; JOHNS DR, 1989, P NATL ACAD SCI USA, V86, P8059, DOI 10.1073/pnas.86.20.8059; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; LUBIN MB, 1991, MOL CELL PROBE, V5, P307, DOI 10.1016/0890-8508(91)90054-N; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; MORAES CT, 1991, CURRENT NEUROLOGY, V11, P83; MULLERHOCKER, 1992, J BRAIN PATHOLOGY, V2, P149; OZAWA T, 1990, BIOCHEM BIOPH RES CO, V170, P830, DOI 10.1016/0006-291X(90)92166-W; PHELPS ME, 1982, J CEREBR BLOOD F MET, V2, P113, DOI 10.1038/jcbfm.1982.14; PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; RIEDERER P, 1992, ANN NEUROL, V32, pS101, DOI 10.1002/ana.410320717; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SHOFFNER JM, 1990, ADV HUM GENET, V19, P267; Sokal R. R, 1981, BIOMETRY; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; WESTLUND KN, 1988, NEUROSCIENCE, V25, P439, DOI 10.1016/0306-4522(88)90250-3	44	356	361	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	1992	2	4					318	323						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB495	1303287				2022-12-25	WOS:A1992KB49500018
J	GLASER, T; WALTON, DS; MAAS, RL				GLASER, T; WALTON, DS; MAAS, RL			GENOMIC STRUCTURE, EVOLUTIONARY CONSERVATION AND ANIRIDIA MUTATIONS IN THE HUMAN PAX6 GENE	NATURE GENETICS			English	Article							BOX-CONTAINING GENE; WILMS TUMOR; NEURAL-TUBE; MOUSE; MAP; EXPRESSION; DELETION; LOCUS; 11P13; LENS	Aniridia is a semidominant disorder in which development of the iris, lens, cornea and retina is disturbed. The mouse mutation Small eye (Sey), which has been proposed as a model for aniridia, results from defects in Pax-6, a gene containing paired-box and homeobox motifs that is specifically expressed in the developing eye and brain. To test the role of PAX6 in aniridia, we isolated human cDNA clones and determined the intron-exon structure of this gene. PAX6 spans 22 kilobases and is divided into 14 exons. Analysis of DNA from 10 unrelated aniridia patients revealed intragenic mutations in three familial and one sporadic case. These findings indicate that the human aniridia and murine Small eye phenotypes arise from homologous defects in PAX6.	HARVARD UNIV, BRIGHAM & WOMENS HOSP,SCH MED,DEPT MED,DIV GENET, BOSTON, MA 02115 USA; HARVARD UNIV, MASSACHUSETTS EYE & EAR INFIRM, SCH MED, BOSTON, MA 02114 USA; HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute								AEBI M, 1986, CELL, V47, P555, DOI 10.1016/0092-8674(86)90620-3; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BASTIAN H, 1990, EMBO J, V9, P1839, DOI 10.1002/j.1460-2075.1990.tb08309.x; CHALEPAKIS G, 1991, CELL, V66, P873, DOI 10.1016/0092-8674(91)90434-Z; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULOMBRE ALFRED J., 1965, INVEST OPHTHALMOL, V4, P411; DAVIS LM, 1989, SOMAT CELL MOLEC GEN, V15, P605, DOI 10.1007/BF01534921; DEROBERTIS EM, 1989, CELL, V57, P189, DOI 10.1016/0092-8674(89)90954-9; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GESSLER M, 1989, SCIENCE, V244, P1575, DOI 10.1126/science.2544995; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141; GLASER T, 1990, GENOMICS, V6, P48, DOI 10.1016/0888-7543(90)90447-3; GLASER T, 1986, NATURE, V321, P882, DOI 10.1038/321882a0; GRUNDY P, 1988, NATURE, V336, P374, DOI 10.1038/336374a0; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; HENRY JJ, 1990, DEV BIOL, V141, P149, DOI 10.1016/0012-1606(90)90110-5; HILL RE, 1992, NATURE, V355, P750, DOI 10.1038/355750a0; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HODGSON SV, 1980, J MED GENET, V17, P478, DOI 10.1136/jmg.17.6.478; HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95; HUFF V, 1988, NATURE, V336, P377, DOI 10.1038/336377a0; HUNT P, 1991, DEVELOPMENT, V112, P43; JOHNSTON MC, 1979, EXP EYE RES, V29, P27, DOI 10.1016/0014-4835(79)90164-7; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; LECHTENBERG R, 1981, NEUROLOGY, V31, P95, DOI 10.1212/WNL.31.1.95; LEWIS EB, 1950, ADV GENET, V3, P73, DOI 10.1016/S0065-2660(08)60083-8; LEWIS W H, 1988, Genomics, V3, P25, DOI 10.1016/0888-7543(88)90154-1; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; LYONS LA, IN PRESS GENOMICS; MARCHUK D, 1991, NUCLEIC ACIDS RES, V19, P1154, DOI 10.1093/nar/19.5.1154; MAUMENEE IH, 1977, AM J OPHTHALMOL, V83, P718, DOI 10.1016/0002-9394(77)90139-8; MCAVOY JW, 1980, DIFFERENTIATION, V17, P137, DOI 10.1111/j.1432-0436.1980.tb01091.x; MCAVOY JW, 1980, EXP EYE RES, V31, P527, DOI 10.1016/S0014-4835(80)80011-X; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; MORRISSEY D, 1991, GENE DEV, V5, P1684, DOI 10.1101/gad.5.9.1684; Nei M, 1983, MOL EVOLUTIONARY GEN, P39; NELSON LB, 1984, SURV OPHTHALMOL, V28, P621, DOI 10.1016/0039-6257(84)90184-X; NJOLSTAD PR, 1988, NUCLEIC ACIDS RES, V16, P9097, DOI 10.1093/nar/16.19.9097; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PUSCHEL AW, 1992, DEVELOPMENT, V114, P643; ROSE EA, 1990, CELL, V60, P495, DOI 10.1016/0092-8674(90)90600-J; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SIMOLA KOJ, 1983, HUM GENET, V63, P158, DOI 10.1007/BF00291536; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; THEILER K, 1978, ANAT EMBRYOL, V155, P81, DOI 10.1007/BF00315732; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; TREISMAN J, 1991, GENE DEV, V5, P594, DOI 10.1101/gad.5.4.594; TREISMAN J, 1989, CELL, V59, P553; VANDERMEERDEJONG R, 1990, GENOMICS, V7, P270, DOI 10.1016/0888-7543(90)90550-E; WALTHER C, 1991, GENOMICS, V11, P424, DOI 10.1016/0888-7543(91)90151-4; WALTHER C, 1991, DEVELOPMENT, V113, P1435	62	537	559	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	1992	2	3					232	239		10.1038/ng1192-232	http://dx.doi.org/10.1038/ng1192-232			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JW165	1345175				2022-12-25	WOS:A1992JW16500015
